PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	EY	PG	WC	SC	GA	UT	PM	OA	HC	HP	DA
J	Ahmad, R; Ahmad, N; Naqvi, AA; Cos, P; Maes, L; Apers, S; Hermans, N; Pieters, L				Ahmad, Rizwan; Ahmad, Niyaz; Naqvi, Atta Abbas; Cos, Paul; Maes, Louis; Apers, Sandra; Hermans, Nina; Pieters, Luc			Anti-infective, cytotoxic and antioxidant activity of Ziziphus oxyphylla and Cedrela serrata	ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE			English	Article								Objective: To search for the most active antimicrobial and antioxidant sub-fractions related to traditional use of Ziziphus oxyphylla (Z. oxyphylla) and Cedrela serrata (C. serrata) in Pakistan against infectious and liver diseases. Methods: Factions of different polarity were tested in vitro for their antiprotozoal, antimalarial, antibacterial and antifungal activity against different pathogens. Cytotoxicity on MRC-5 cell lines (human lung fibroblasts) as well as, in vitro radical scavenging activity was evaluated using the 1, 1-diphenyl-2-picrylhydrazyl radical assay. Results: The highest antiprotozoal activity was observed for the CHCl3 fractions of Z. oxyphylla roots and leaves, and C. serrata bark. The CHCl3 and EtOAc fractions of Z. oxyphylla roots, the CHCl3 fraction of Z. oxyphylla leaves, the EtOAc and the residual MeOH:H2O fraction of C. serrata bark showed antibacterial activity against Staphylococcus aureus. The same residual MeOH:H2O fraction of C. serrata bark was active against Candida albicans. The highest antioxidant activity was observed for the more hydrophilic EtOAc fractions of Z. oxyphylla leaves, C. serrata bark and leaves, and the residual MeOH:H2O fraction of C. serrata bark. Conclusions: This study supports at least in part the traditional uses of these plants for antimicrobial purposes and against liver diseases.	[Ahmad, Rizwan] Univ Dammam, Coll Clin Pharm, Nat Prod & Alternat Med, Dammam, Saudi Arabia; [Ahmad, Niyaz] Univ Dammam, Dept Pharmaceut, Coll Clin Pharm, Dammam, Saudi Arabia; [Naqvi, Atta Abbas] Univ Dammam, Dept Pharm Practice, Coll Clin Pharm, Dammam, Saudi Arabia; [Cos, Paul; Maes, Louis] Univ Antwerp, LMPH, Fac Pharmaceut Biomed & Vet Sci, Univ Pl 1, B-2610 Antwerp, Belgium; [Apers, Sandra; Hermans, Nina; Pieters, Luc] Univ Antwerp, Nat Prod & Food Res & Anal NatuRA, Fac Pharmaceut Biomed & Vet Sci, Univ Pl 1, B-2610 Antwerp, Belgium	Ahmad, R (reprint author), Univ Dammam, Coll Clin Pharm, Nat Prod & Alternat Med, Dammam, Saudi Arabia.	rizvistar_36@yahoo.com	Hermans, Nina/A-5244-2017	Hermans, Nina/0000-0003-3946-7313			Ahmad R., 2013, European Journal of Medicinal Plants, V3, P520; Ahmad R, 2016, ANTIOXIDANTS BASEL, V5, pE9; Ahmad R, 2014, PAK J PHARM SCI, V27, P1477; Al-Yemni M. N., 2011, Scientific Research and Essays, V6, P966; Alviano Daniela Sales, 2012, Front Microbiol, V3, P283, DOI 10.3389/fmicb.2012.00283; Awan MR, 2011, J MED PLANTS RES, V5, P3958; Buckner FS, 1996, ANTIMICROB AGENTS CH, V40, P2592, DOI 10.1128/AAC.40.11.2592; Choudhary MI, 2011, PHYTOCHEM LETT, V4, P404, DOI 10.1016/j.phytol.2011.08.006; Cos P, 2003, J PHARM PHARMACOL, V55, P1291, DOI 10.1211/0022357021693; Cos P, 2006, J ETHNOPHARMACOL, V106, P290, DOI 10.1016/j.jep.2006.04.003; Debrabant A, 2004, INT J PARASITOL, V34, P205, DOI 10.1016/j.ijpara.2003.10.011; Eloff JN, 1998, PLANTA MED, V64, P711, DOI 10.1055/s-2006-957563; Gabrielson J, 2002, J MICROBIOL METH, V50, P63, DOI 10.1016/S0167-7012(02)00011-8; GUTTERIDGE JMC, 1993, FREE RADICAL RES COM, V19, P141, DOI 10.3109/10715769309111598; Hadacek F, 2000, PHYTOCHEM ANALYSIS, V11, P137, DOI 10.1002/(SICI)1099-1565(200005/06)11:3<137::AID-PCA514>3.0.CO;2-I; Halliwell B, 2000, LANCET, V355, P1179, DOI 10.1016/S0140-6736(00)02075-4; Harborne J. B., 1988, PHYTOCHEMICAL METHOD; Inayat-Ur-Rahman, 2007, NAT PROD RES, V21, P243, DOI 10.1080/14786410600906574; Jan G, 2011, AFR J BIOTECHNOL, V10, P19075, DOI 10.5897/AJB10.980; Jan Gul, 2009, ETHNOBOT LEAFLETS, V13, P1029; M.I. European Committee for Antimicrobial Susceptibility Testing of the European Society of Clinical Diseases, 2003, CLIN MICROBIOL INFEC, V9, pix, DOI DOI 10.1046/J.1469-0691.2003.00790.X; Maes L, 2004, ANTIMICROB AGENTS CH, V48, P130, DOI 10.1128/AAC.48.1.130-136.2004; McMillian MK, 2002, CELL BIOL TOXICOL, V18, P157, DOI 10.1023/A:1015559603643; Morel AF, 2005, PHYTOCHEMISTRY, V66, P2571, DOI 10.1016/j.phytochem.2005.08.016; Morel AF, 2002, PHYTOCHEMISTRY, V61, P561, DOI 10.1016/S0031-9422(02)00287-X; Morel AF, 2009, ALKALOIDS CHEM BIOL; Nisar M, 2010, PAK J BOT, V42, P4063; Nisar M, 2010, NAT PROD COMMUN, V5, P1205; Panseeta P, 2011, PHYTOCHEMISTRY, V72, P909, DOI 10.1016/j.phytochem.2011.03.003; Perveen F., 2012, Journal of Natural Products (India), V5, P207; Raz B, 1997, ACTA TROP, V68, P139, DOI 10.1016/S0001-706X(97)00079-X; SHARON A, 1992, PLANT PHYSIOL, V98, P303, DOI 10.1104/pp.98.1.303; Singh A. K., 2007, Mycobiology, V35, P62, DOI 10.4489/MYCO.2007.35.2.062; Suksamrarn S, 2005, TETRAHEDRON, V61, P1175, DOI 10.1016/j.tet.2004.11.053; Takahashi M, 2004, BIOL PHARM BULL, V27, P921, DOI 10.1248/bpb.27.921; World Health Organization, 2012, WORL MAL REP 2012	36	1	1	0	1	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2221-1691	2588-9222		ASIAN PAC J TROP BIO	Asian Pac. Trop. Biomed.	AUG	2016	6	8					671	676		10.1016/j.apjtb.2016.04.012				6	Tropical Medicine	Tropical Medicine	DQ9HV	WOS:000379521900007		DOAJ Gold			2019-04-02	
J	Beletew, M; Getahun, A; Vanhove, MPM				Beletew, Moges; Getahun, Abebe; Vanhove, Maarten P. M.			First report of monogenean flatworms from Lake Tana, Ethiopia: gill parasites of the commercially important Clarias gariepinus (Teleostei: Clariidae) and Oreochromis niloticus tana (Teleostei: Cichlidae)	PARASITES & VECTORS			English	Article						Cichlidogyrus; Dactylogyridea; Gyrodactylidea; Gyrodactylus; Macrogyrodactylus; Monogenea; Perciformes; Scutogyrus; Siluriformes; Quadriacanthus	WEST-AFRICA; CYPRINIDAE; CATFISHES; CESTODA; FISHES; GENUS; SPP.; GYRODACTYLIDAE; DACTYLOGYRIDAE; QUADRIACANTHUS	Background: Lake Tana is the largest lake in Ethiopia and the source of the Blue Nile. The lake harbours unique endemic cyprinid fish species, as well as the commercially important endemic Nile tilapia subspecies Oreochromis niloticus tana and the North African catfish Clarias gariepinus. Its endemicity, especially within the Labeobarbus radiation, its conservation importance and its economic indispensability attract scientific interest to the lake's ichthyofauna. Fish parasites of Lake Tana, however, are hitherto poorly known, and no formal report exists on its monogenean flatworms. For sustainable aquaculture and fisheries development, it is essential to study monogenean fish parasites in these economically most important fish species. Moreover, it remains to be verified whether this unique ecosystem and its endemicity gave rise to a distinct parasite fauna as well. Results: Nile tilapia and North African catfish hosts were collected from Lake Tana in 2013. Nine species of monogenean parasites of two orders, Gyrodactylidea Bychowsky, 1937 and Dactylogyridea Bychowsky, 1937, were recovered. Gyrodactylus gelnari Prikrylova, Blazek & Vanhove, 2012, Macrogyrodactylus clarii Gussev, 1961, Quadriacanthus aegypticus El-Naggar & Serag, 1986 and two undescribed Quadriacanthus species were recovered from C. gariepinus. Oreochromis niloticus tana hosted Cichlidogyrus cirratus Paperna, 1964, C. halli (Price & Kirk, 1967), C. thurstonae Ergens, 1981 and Scutogyrus longicornis (Paperna & Thurston, 1969). Conclusions: Except for M. clarii, all species represent new records for Ethiopia. This first study on the monogenean fauna of Lake Tana revealed that the lake's North African catfish, as well as its endemic Nile tilapia subspecies, harbour parasites that are known from these host species elsewhere in Africa.	[Beletew, Moges] Debre Markos Univ, Dept Biol, Coll Nat & Computat Sci, POB 269, Debre Markos, Ethiopia; [Beletew, Moges; Getahun, Abebe] Univ Addis Ababa, Dept Zool Sci, Fisheries & Aquat Sci Stream, POB 1176, Addis Ababa, Ethiopia; [Vanhove, Maarten P. M.] Royal Museum Cent Africa, Dept Biol, Leuvensesteenweg 13, B-3080 Tervuren, Belgium; [Vanhove, Maarten P. M.] Masaryk Univ, Fac Sci, Dept Bot & Zool, Kotlarska 2, CS-61137 Brno, Czech Republic; [Vanhove, Maarten P. M.] Univ Leuven, Dept Biol, Lab Biodivers & Evolutionary Genom, Charles Deberiotstr 32, B-3000 Leuven, Belgium; [Vanhove, Maarten P. M.] Hellen Ctr Marine Res, Inst Marine Biol Resources & Inland Waters, 46-7 Km Athens Sounio Ave,POB 712, Anavyssos 19013, Greece; [Vanhove, Maarten P. M.] Royal Belgian Inst Nat Sci, Capac Biodivers & Sustainable Dev, Operat Directorate Nat Environm, Vautierstr 29, B-1000 Brussels, Belgium	Beletew, M (reprint author), Debre Markos Univ, Dept Biol, Coll Nat & Computat Sci, POB 269, Debre Markos, Ethiopia.; Beletew, M (reprint author), Univ Addis Ababa, Dept Zool Sci, Fisheries & Aquat Sci Stream, POB 1176, Addis Ababa, Ethiopia.	mogesbele@gmail.com		Vanhove, Maarten/0000-0003-3100-7566	Czech Science Foundation [P505/12/G112]; All Cypriniformes Species Inventory; African Biodiversity Information Centre (ABIC) of the RMCA; Belgian Development Cooperation	MB was supported for a study visit by the African Biodiversity Information Centre (ABIC) of the RMCA through an agreement with the Belgian Development Cooperation. MPMV is partly supported by the Czech Science Foundation, Project no. P505/12/G112 (European Centre of Ichthyoparasitology (ECIP) - Centre of excellence) and by the All Cypriniformes Species Inventory, with thanks to Prof. Dr. Jonathan W. Armbruster. The funding bodies had no role in the design of the study, in the collection, analysis, and interpretation of the data, or in writing the manuscript.	Anteneh W, 2013, AFR J AQUAT SCI, V38, P61, DOI 10.2989/16085914.2013.776942; Barson M, 2010, PARASITOLOGY, V137, P1585, DOI 10.1017/S0031182010000302; de Chambrier A, 2009, J PARASITOL, V95, P160, DOI 10.1645/GE-1594.1; de Graaf M, 2010, MOL PHYLOGENET EVOL, V54, P336, DOI 10.1016/j.ympev.2009.10.029; Dejen E, 2006, HYDROBIOLOGIA, V556, P109, DOI 10.1007/s10750-005-1187-0; Duker L, 2001, LAKENET REPORT SERIE; Garcia-Vasquez A, 2011, ACTA PARASITOL, V56, P20, DOI 10.2478/s11686-011-0005-2; Getahun A, 2012, FISHES LAKE TANA GUI; Jimenez-Garcia MI, 2001, J PARASITOL, V87, P907, DOI 10.2307/3285151; Kmentova N, 2016, PEERJ, V4, DOI 10.7717/peerj.1629; KRITSKY DC, 1988, P HELM SOC WASH, V55, P175; Kuchta R, 2006, ZOOTAXA, V3309, P1; Lim LHS, 2001, SYST PARASITOL, V50, P159, DOI 10.1023/A:1012237801974; Luus-Powell WJ, 2003, FOLIA PARASIT, V50, P49, DOI 10.14411/fp.2003.009; Malmberg G., 1957, Arkiv for Zoologi, V10, P317; Maneepitaksanti Worawit, 2012, Biogeography, V14, P111; N'Douba V, 1999, SYST PARASITOL, V44, P105, DOI 10.1023/A:1006130208695; Nagelkerke LAJ, 2000, NETH J ZOOL, V50, P179, DOI 10.1163/156854200505946; Nagelkerke LAJ, 1996, J FISH BIOL, V49, P1244; Paperna I, 1996, 31 CIFA FAO UN; PAPERNA I, 1979, ANN SCI ZOOLOGIQUE 8, V226, P1; Pariselle A., 2003, HOMMAGE L EUZET TAXO, P147; Pariselle A, 2009, ZOOSYSTEMA, V31, P849, DOI 10.5252/z2009n4a6; Pouomogne V., CULTURED AQUATIC SPE; Prikrylova I, 2012, PARASITOL RES, V110, P1185, DOI 10.1007/s00436-011-2612-0; Prikrylova I, 2009, J PARASITOL, V95, P555, DOI 10.1645/GE-1652.1; Scholz T, 2009, J PARASITOL, V95, P443, DOI 10.1645/GE-1715.1; Vijverberg J, 2009, MONOGR BIOL, V89, P163; Waiswa Mwanja W, 2011, TECHNICAL DOCUMENT S; Zhokhov A. E., 2012, ZOOSYSTEMATICA ROSSICA, V21, P193; Zhokhov AE, 2012, INLAND WATER BIOL, V5, P293, DOI 10.1134/S1995082912020162; Zhokhov A. E., 2010, ZOOSYSTEMATICA ROSSICA, V19, P9; Zhokhov AE, 2010, INLAND WATER BIOL, V3, P160, DOI 10.1134/S1995082910020094	33	3	3	1	17	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	JUL 25	2016	9								410	10.1186/s13071-016-1691-2				7	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	DS1CR	WOS:000380333900001	27457488	DOAJ Gold, Green Published			2019-04-02	
J	Gunasekaran, K; Sahu, SS; Vijayakumar, T; Subramanian, S; Yadav, RS; Pigeon, O; Jambulingam, P				Gunasekaran, Kasinathan; Sahu, Sudhansu Sekhar; Vijayakumar, Tharmalingam; Subramanian, Swaminathan; Yadav, Rajpal Singh; Pigeon, Olivier; Jambulingam, Purushothaman			An experimental hut evaluation of Olyset Plus, a long-lasting insecticidal net treated with a mixture of permethrin and piperonyl butoxide, against Anopheles fluviatilis in Odisha State, India	MALARIA JOURNAL			English	Article						Anopheles fluviatilis; Experimental-hut; Olyset Plus; Olyset Net; Odisha; India	MALARIA CONTROL; CULICIFACIES; RESISTANCE; SUSCEPTIBILITY; EFFICACY; VECTOR; BENIN	Background: Fast development of pyrethroid resistance in malaria vectors prompted the development of new vector control tools including combination of insecticides with different modes of action as part of resistance management strategies. Olyset Plus (R) is a new long-lasting insecticidal net, in which, permethrin and a synergist, piperonyl butoxide (PBO), are incorporated into filaments. Mixture nets such as this may have application against resistant mosquitoes, particularly those whose resistance is based on oxidative metabolism. There may also be enhanced activity against susceptible mosquitoes since mixed function oxidases are involved in a many metabolic activities including activation to form bioactive compounds. Methods: Bio-efficacy of Olyset Plus was evaluated against susceptible malaria vector, Anopheles fluviatilis in experimental huts. Deterrence, blood feeding inhibition, induced exophily and killing effect were measured to assess the bio-efficacy. The results were compared with Olyset Net (R), a polyethylene permethrin-incorporated LLIN and a conventionally treated polyester net (with permethrin) washed to just before exhaustion. Results: Results showed significant reduction in entry (treatment: 0.4-0.8; control: 4.2 per trap-night) and increase in exit (56.3-82.9 % and 44.2 %) rates of Anopheles fluviatilis in the treatment arms compared to control (P < 0.05). While blood feeding rates declined in treatment arms (18.8-30.6 %), it increased in control (77.6 %) (P < 0.05). This was further evident from the blood-feeding inhibition rates in treatment arms (60.6-90.6 %). Total mortality was significantly higher in all treatment arms (96.3-100 %) compared to control arm (2 %) (P < 0.05). Chemical analysis for active ingredient (AI) showed retention of 75 and 88 % in Olyset plus and Olyset net respectively after 20 washes. Performance of Olyset Plus washed 20 times was equal to the CTN and Olyset Net against the susceptible malaria vector An. fluviatilis, fulfilling the WHO efficacy criteria of Phase II evaluation for LLIN. However, the benefit of incorporating PBO and permethrin together in a long-lasting treatment could not be demonstrated in the current study as the target vector species was fully susceptible to pyrethroids. Conclusion: Olyset Plus, with its intrinsic bio-efficacy could be an effective vector control tool to prevent transmission of malaria by susceptible vectors like An. fluviatilis. However, the results of the current study need to be further supported by testing the net at village level (Phase III) for community acceptability. Before taking the net to village level, it needs to be verified whether the net is better than pyrethroid nets in terms of bio-efficacy against resistant An. culicifacies, another malaria vector that has developed resistance to synthetic pyrethroids in India.	[Gunasekaran, Kasinathan; Sahu, Sudhansu Sekhar; Vijayakumar, Tharmalingam; Subramanian, Swaminathan; Jambulingam, Purushothaman] Vector Control Res Ctr ICMR, Med Complex, Pondicherry 605006, India; [Yadav, Rajpal Singh] WHO, Dept Control Neglected Trop Dis, Pesticide Evaluat Scheme, Geneva, Switzerland; [Pigeon, Olivier] Walloon Agr Res Ctr CRA W, Agr & Nat Environm Dept D3, Gembloux, Belgium	Gunasekaran, K; Sahu, SS (reprint author), Vector Control Res Ctr ICMR, Med Complex, Pondicherry 605006, India.	k_guna@yahoo.com; sssahu1961@gmail.com	Sankarasubbu, Kandasami/K-8191-2017	Yadav, Rajpal Singh/0000-0001-8264-1204	WHO Pesticide Evaluation Scheme	Financial support for conducting the study was received from the WHO Pesticide Evaluation Scheme.	[Anonymous], 2009, 12 WHOPES WORK GROUP; [Anonymous], 2014, SUMITOMO CHEM VECTOR; Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Awolola TS, 2009, T ROY SOC TROP MED H, V103, P1139, DOI 10.1016/j.trstmh.2008.08.021; Banek K, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-84; Bhatia R, 2013, J VECTOR DIS, V50, P239; Corbel V, 2010, MALARIA J, V27, P113; Directorate of National Vector Borne Disease Control Programme Directorate General of Health Services Ministry of Health and Family Welfare and Government of India, 2012, STRAT PLAN MAL CONTR; Enayati A, 2010, ANNU REV ENTOMOL, V55, P569, DOI 10.1146/annurev-ento-112408-085423; Gimnig JE, 2005, TROP MED INT HEALTH, V10, P1022, DOI 10.1111/j.1365-3156.2005.01481.x; Gunasekaran K, 2014, J MED ENTOMOL, V51, P785, DOI 10.1603/ME13136; Ministry of Health and Family Welfare, 2015, MAL SIT IND 2015; Mittal PK, 2002, CURR SCI INDIA, V82, P185; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Pennetier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075134; Raghavendra K, 2014, J VECTOR DIS, V51, P230; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Rivero A, 2010, PLOS PATHOG, V5; Sahu SS, 2015, INDIAN J MED RES, V142, P59, DOI 10.4103/0971-5916.176621; Sharma VP, 1998, CURR SCI INDIA, V75, P1127; Singh R. K., 2014, INT J MOSQ RES A, V1, P5; Tami A, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-19; WHO, 2009, 13 WHOPES WORK GROUP; WHO, 2012, GLOB PLAN INS RES MA; WHO, 2007, 10 WHOPES WORK GROUP; *WHO, 2001, 5 WHOPES WORK GROUP; World Health Organization, 2005, WHOCDSWHOPESGCDPP200; World Health Organization, 2014, WHOHTMNTDWHOPES20143	28	3	3	1	8	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	JUL 21	2016	15								375	10.1186/s12936-016-1424-1				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DR7TB	WOS:000380101500001	27439398	DOAJ Gold, Green Published			2019-04-02	
J	de Gier, B; Nga, TT; Winichagoon, P; Dijkhuizen, MA; Khan, NC; van de Bor, M; Ponce, MC; Polman, K; Wieringa, FT				de Gier, Brechje; Tran Thuy Nga; Winichagoon, Pattanee; Dijkhuizen, Marjoleine A.; Nguyen Cong Khan; van de Bor, Margot; Ponce, Maiza Campos; Polman, Katja; Wieringa, Frank T.			Species-Specific Associations between Soil-Transmitted Helminths and Micronutrients in Vietnamese Schoolchildren	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							VITAMIN-A SUPPLEMENTATION; INTESTINAL HELMINTHS; NUTRITIONAL-STATUS; SCHOOL-CHILDREN; SERUM RETINOL; ASCARIASIS; INFECTIONS; METAANALYSIS; IMPACT; IRON	Soil-transmitted helminth (STH) infections and micronutrient deficiencies are closely related and often coexist among low-income populations. We studied the association between infections with specific STH species and micronutrient status in rural Vietnamese schoolchildren. Children (N = 510) aged 6-9 years were recruited from two primary schools. STH infections were determined in stool samples. Hemoglobin, ferritin, retinol, and zinc were measured in blood samples, as well as C-reactive protein to control for inflammation. Iodine excretion was measured in urine. Associations of single and multiple infections with Ascaris lumbricoides, Trichuris trichiura, and hookworm with micronutrient status (hemoglobin, plasma ferritin, retinol, zinc, and urinary iodine) were estimated by multiple regression analysis. Ascaris infections showed a specific and intensity-dependent negative association with vitamin A. Trichuris and hookworm infections were associated with lower hemoglobin concentration, but not with plasma ferritin. Trichuris-infected children had zinc deficiency less often than uninfected children. In conclusion, our study shows species-specific associations between STH infections and micronutrient status in children. The different life cycles of STH species might have specific effects on the absorption or loss of specific micronutrients. Tailor-made combinations of deworming and nutritional interventions may be needed to improve child health and nutrition.	[de Gier, Brechje; van de Bor, Margot] Vrije Univ VU Univ, Athena Inst, Sect Hlth & Life Sci, Amsterdam, Netherlands; [Tran Thuy Nga] Natl Inst Nutr, Hanoi, Vietnam; [Winichagoon, Pattanee] Mahidol Univ, Inst Nutr, Salaya, Nakhon Pathom, Thailand; [Dijkhuizen, Marjoleine A.] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Nguyen Cong Khan] Minist Hlth, Hanoi, Vietnam; [Ponce, Maiza Campos; Polman, Katja] Vrije Univ VU Univ, Dept Hlth Sci, Sect Infect Dis, Amsterdam, Netherlands; [Polman, Katja] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Wieringa, Frank T.] Inst Rech Dev, UMR NutriPass IRD UM SupAgro 204, Montpellier, France	Wieringa, FT (reprint author), IRD, UMR Nutripass 204, 911 Ave Agropolis, F-34394 Montpellier, France.	franck.wieringa@ird.fr	Wieringa, Frank/K-7565-2017	Wieringa, Frank/0000-0002-6010-355X; Campos Ponce, Maiza/0000-0003-1700-4756	Neys-van Hoogstraten Foundation, The Netherlands; Ellison Medical Foundation	This study was supported by the Neys-van Hoogstraten Foundation, The Netherlands, and the Ellison Medical Foundation.	Ahmed A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-119; AHMED F, 1993, BRIT J NUTR, V69, P817, DOI 10.1079/BJN19930082; Ahmed T, 2012, ANN NUTR METAB, V61, P8, DOI 10.1159/000345165; Al-Mekhlafi HM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-367; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Crompton DWT, 2002, ANNU REV NUTR, V22, P35, DOI 10.1146/annurev.nutr.22.120501.134539; Curtale F, 1995, J TROP PEDIATRICS, V41, P334, DOI 10.1093/tropej/41.6.334; de Gier B, 2014, AM J CLIN NUTR, V99, P1499, DOI 10.3945/ajcn.113.069955; de Pee S, 2002, J NUTR, V132, p2895S, DOI 10.1093/jn/132.9.2895S; Finlay CM, 2014, IMMUNOL REV, V259, P206, DOI 10.1111/imr.12164; Friis H, 1997, AM J CLIN NUTR, V66, P665; Gnat D, 2003, CLIN CHEM, V49, P186, DOI 10.1373/49.1.186; Hall A, 2008, MATERN CHILD NUTR, V4, P118, DOI 10.1111/j.1740-8709.2007.00127.x; Hotz C, 2004, FOOD NUTR B; Knopp S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000331; Kongsbak K, 2006, BRIT J NUTR, V96, P725, DOI 10.1079/BJN20061898; Laurberg P., 2014, Modern nutrition in health and disease, P217; Long KZ, 2007, PEDIATRICS, V120, pE846, DOI 10.1542/peds.2006-2187; MAHALANABIS D, 1979, AM J CLIN NUTR, V32, P313; McCullough FSW, 1999, P NUTR SOC, V58, P289, DOI 10.1017/S0029665199000403; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Muniz-Junqueira Maria Imaculada, 2002, Rev. Soc. Bras. Med. Trop., V35, P133, DOI 10.1590/S0037-86822002000200002; Nga TT, 2011, AM J TROP MED HYG, V85, P333, DOI 10.4269/ajtmh.2011.10-0651; Nikolay B, 2014, INT J PARASITOL, V44, P765, DOI 10.1016/j.ijpara.2014.05.009; Pal R, 2008, EYE CONTACT LENS, V34, P106, DOI 10.1097/ICL.0b013e3181379fd7; Payne LG, 2007, J NUTR, V137, P1455; Persson V, 2000, PUBLIC HEALTH NUTR, V3, P83; Quihui-Cota L, 2008, INT J VITAM NUTR RES, V78, P51, DOI 10.1024/0300-9831.78.2.51; Rai SK, 2000, NUTR RES, V20, P15, DOI 10.1016/S0271-5317(99)00134-7; Ross A. C, 2014, MODERN NUTR HLTH DIS; Suchdev PS, 2014, AM J TROP MED HYG, V90, P299, DOI 10.4269/ajtmh.13-0560; TAREN DL, 1987, PARASITOLOGY, V95, P603, DOI 10.1017/S0031182000058029; Thurnham DI, 2014, P NUTR SOC, V73, P1, DOI 10.1017/S0029665113003662; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; Tran TN, 2009, J NUTR, V139, P1013, DOI 10.3945/jn.108.099754; TRIPATHY K, 1972, AM J CLIN NUTR, V25, P1276; Valentine AR, 2004, J NUTR, V134, P1186; Verhagen LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077581; WEINBERG ED, 1975, JAMA-J AM MED ASSOC, V231, P39, DOI 10.1001/jama.231.1.39; WHO, 2001, IR DEF AN ASS PREV C	41	3	3	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	JUL	2016	95	1					77	82		10.4269/ajtmh.15-0533				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	ET3UX	WOS:000400206100018	27246448	Green Published, Bronze			2019-04-02	
J	Baly, A; Toledo, ME; Lambert, I; Benitez, E; Rodriguez, K; Rodriguez, E; Vanlerberghe, V; Van der Stuyft, P				Baly, Alberto; Toledo, Maria Eugenia; Lambert, Isora; Benitez, Elizabeth; Rodriguez, Karina; Rodriguez, Esther; Vanlerberghe, Veerle; Van der Stuyft, Patrick			Cost of intensive routine control and incremental cost of insecticide-treated curtain deployment in a setting with low Aedes aegypti infestation	REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL			English	Article						Dengue; Insecticide-treated curtains; Routine vector control; Cost-analysis; Cuba	DENGUE VECTOR CONTROL; CLUSTER-RANDOMIZED-TRIAL; WATER CONTAINER COVERS; EPIDEMIC; CUBA; THAILAND; CAMBODIA; LESSONS	Introduction: Information regarding the cost of implementing insecticide-treated curtains (ITCs) is scarce. Therefore, we evaluated the ITC implementation cost, in addition to the costs of intensive conventional routine activities of the Aedes control program in the city of Guantanamo, Cuba. Methods: A cost-analysis study was conducted from the perspective of the Aedes control program, nested in an ITC effectiveness trial, during 2009-2010. Data for this study were obtained from bookkeeping records and activity registers of the Provincial Aedes Control Programme Unit and the account records of the ITC trial. Results: The annual cost of the routine Aedes control program activities was US$16.80 per household (p.h). Among 3,015 households, 6,714 ITCs were distributed. The total average cost per ITC distributed was US$3.42, and 74.3% of this cost was attributed to the cost of purchasing the ITCs. The annualized costs p.h. of ITC implementation was US$3.80. The additional annualized cost for deploying ITCs represented 19% and 48.4% of the total cost of the routine Aedes control and adult-stage Aedes control programs, respectively. The trial did not lead to further reductions in the already relatively low Aedes infestation levels. Conclusions: At current curtain prices, ITC deployment can hardly be considered an efficient option in Guantanamo and other comparable environments.	[Baly, Alberto; Toledo, Maria Eugenia] Inst Med Trop Pedro Kouri, Dept Epidemiol, Havana, Cuba; [Lambert, Isora; Benitez, Elizabeth; Rodriguez, Karina; Rodriguez, Esther] Ctr Prov Higiene & Epidemiol, Unidad Prov Vigilancia & Lucha Antivectorial, Guantanamo, Cuba; [Vanlerberghe, Veerle; Van der Stuyft, Patrick] Inst Trop Med, Epidemiol & Dis Control Unit, Antwerp, Belgium; [Van der Stuyft, Patrick] Univ Ghent, Dept Publ Hlth, Ghent, Belgium	Baly, A (reprint author), Inst Med Trop Pedro Kouri, Dept Epidemiol, Havana, Cuba.	baly@ipk.sld.cu			Institute of Tropical Medicine, Antwerp; Belgium Directorate General for Development Cooperation	The study was partially funded through the framework agreement between the Institute of Tropical Medicine, Antwerp, and the Belgium Directorate General for Development Cooperation.	[Anonymous], 2009, DENGUE DENGUE HAEMOR; Armien B, 2008, AM J TROP MED HYG, V79, P364, DOI 10.4269/ajtmh.2008.79.364; Baly A, 2012, TROP MED INT HEALTH, V17, P123, DOI 10.1111/j.1365-3156.2011.02881.x; Baly A, 2011, AM J TROP MED HYG, V84, P747, DOI 10.4269/ajtmh.2011.10-0532; Baly A, 2009, AM J TROP MED HYG, V81, P88, DOI 10.4269/ajtmh.2009.81.88; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Drummond M, 2005, METHODS EC EVALUATIO; Toledo ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119373; GUZMAN M G, 1988, Revista Cubana de Medicina Tropical, V40, P29; Guzman MG, 2006, REV PANAM SALUD PUBL, V19, P282, DOI 10.1590/S1020-49892006000400014; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Tirado MGG, 2012, MEDICC REV, V14, P46; Johns B, 2003, COST EFF RESOUR ALLO, V1, P1; KOURI GP, 1989, B WORLD HEALTH ORGAN, V67, P375; Kroeger A, 2006, BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247; Lenhart A, 2013, AM J TROP MED HYG, V88, P254, DOI 10.4269/ajtmh.2012.12-0423; Oficina Nacional de Estadisticas de Cuba, 2012, AN EST MED AMB; Parks W., 2004, WHOCDSWMC20042; Quintero J, 2015, T ROY SOC TROP MED H, V109, P116, DOI 10.1093/trstmh/tru208; Rizzo N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-931; Rodriguez JL, 2013, HOY POSIBLE COMENZAR; Romani MET, 2007, SOC SCI MED, V64, P976, DOI 10.1016/j.socscimed.2006.10.033; Sanchez L, 2009, TROP MED INT HEALTH, V14, P1356, DOI 10.1111/j.1365-3156.2009.02379.x; Seng CM, 2008, J VECTOR ECOL, V33, P333, DOI 10.3376/1081-1710-33.2.333; Suaya JA, 2007, TROP MED INT HEALTH, V12, P1026, DOI 10.1111/j.1365-3156.2007.01889.x; Tun-Lin W, 2009, TROP MED INT HEALTH, V14, P1143, DOI 10.1111/j.1365-3156.2009.02341.x; Vanlerberghe V, 2010, TROP MED INT HEALTH, V15, P1067, DOI 10.1111/j.1365-3156.2010.02582.x; Vanlerberghe V, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1959; Vanlerberghe V, 2013, AM J TROP MED HYG, V89, P93, DOI 10.4269/ajtmh.13-0015; Vanlerberghe V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000994; World Health Organization, 2006, SCI WORK GROUP M DEN; World Health Organization, 2016, DENG SEV DENG FACT S, V2012	32	4	4	0	4	SOC BRASILEIRA MEDICINA TROPICAL	BRASILIA	UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356, BRASILIA, DF 70919-970, BRAZIL	0037-8682			REV SOC BRAS MED TRO	Rev. Soc. Bras. Med. Trop.	JUL-AUG	2016	49	4					418	424		10.1590/0037-8682-0368-2015				7	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	DU8IT	WOS:000382457200005	27598627	DOAJ Gold			2019-04-02	
J	Ofori-Anyinam, B; Kanuteh, F; Agbla, SC; Adetifa, I; Okoi, C; Dolganov, G; Schoolnik, G; Secka, O; Antonio, M; de Jong, BC; Gehre, F				Ofori-Anyinam, Boatema; Kanuteh, Fatoumatta; Agbla, Schadrac C.; Adetifa, Ifedayo; Okoi, Catherine; Dolganov, Gregory; Schoolnik, Gary; Secka, Ousman; Antonio, Martin; de Jong, Bouke C.; Gehre, Florian			Impact of the Mycobaterium africanum West Africa 2 Lineage on TB Diagnostics in West Africa: Decreased Sensitivity of Rapid Identification Tests in The Gambia	PLOS NEGLECTED TROPICAL DISEASES			English	Article							MYCOBACTERIUM-TUBERCULOSIS COMPLEX; TIME; MPT64	Background MPT64 rapid speciation tests are increasingly being used in diagnosis of tuberculosis (TB). Mycobacterium africanum West Africa 2 (Maf 2) remains an important cause of TB in West Africa and causes one third of disease in The Gambia. Since the introduction of MPT64 antigen tests, a higher than expected rate of suspected non-tuberculous mycobacteria (NTM) was seen among AFB smear positive TB suspects, which led us to prospectively assess sensitivity of the MPT64 antigen test in our setting. Methodology/Principal Findings We compared the abundance of mRNA encoded by the mpt64 gene in sputa of patients with untreated pulmonary TB caused by Maf 2 and Mycobacterium tuberculosis (Mtb). Subsequently, prospectively collected sputum samples from presumptive TB patients were inoculated in the BACTEC MGIT 960 System. One hundred and seventy-three acid fast bacilli (AFB)-positive and blood agar negative MGIT cultures were included in the study. Cultures were tested on the day of MGIT positivity with the BD MGIT TBc Identification Test. A random set of positives and all negatives were additionally tested with the SD Bioline Ag MPT64 Rapid. MPT64 negative cultures were further incubated at 37 degrees C and retested until positive. Bacteria were spoligotyped and assigned to different lineages. Maf 2 isolates were 2.52-fold less likely to produce a positive test result and sensitivity ranged from 78.4% to 84.3% at the beginning and end of the recommended 10 day testing window, respectively. There was no significant difference between the tests. We further showed that the decreased rapid test sensitivity was attributable to variations in mycobacterial growth behavior and the smear grades of the patient. Conclusions/Significance In areas where Maf 2 is endemic MPT64 tests should be cautiously used and MPT64 negative results confirmed by a second technique, such as nucleic acid amplification tests, to avoid their misclassification as NTMs.	[Ofori-Anyinam, Boatema; de Jong, Bouke C.; Gehre, Florian] Inst Trop Med, Mycobacteriol Unit, Antwerp, Belgium; [Ofori-Anyinam, Boatema; Kanuteh, Fatoumatta; Agbla, Schadrac C.; Okoi, Catherine; Secka, Ousman; Antonio, Martin; de Jong, Bouke C.; Gehre, Florian] MRC Unit, Vaccines & Immun Theme, Serrekunda, Gambia; [Adetifa, Ifedayo] MRC Unit, Dis Control & Eliminat Theme, Serrekunda, Gambia; [Adetifa, Ifedayo] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Dolganov, Gregory; Schoolnik, Gary] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA USA; [Antonio, Martin] Warwick Med Sch, Div Microbiol & Immun, Coventry, W Midlands, England; [Antonio, Martin] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England; [de Jong, Bouke C.] NYU, Div Infect Dis, New York, NY USA	Gehre, F (reprint author), Inst Trop Med, Mycobacteriol Unit, Antwerp, Belgium.; Gehre, F (reprint author), MRC Unit, Vaccines & Immun Theme, Serrekunda, Gambia.	fgehre@mrc.gm		de Jong, Bouke/0000-0002-1017-4675; Antonio, Martin/0000-0002-4810-1308	European Research Council [311725]; Medical Research Council [MC_UP_A900_1122, MC_U190081991]	FG, BCdJ and BOA were supported by a European Research Council Starting grant INTERRUPTB, no.: 311725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliyu G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063170; Basu I, 2015, INT J TUBERC LUNG D, V19, P1073, DOI 10.5588/ijtld.15.0032; Bekmurzayeva A, 2013, TUBERCULOSIS, V93, P381, DOI 10.1016/j.tube.2013.03.003; Dalton T, 2012, LANCET, V380, P1406, DOI 10.1016/S0140-6736(12)60734-X; de Jong BC, 2006, J INFECT DIS, V193, P1279, DOI 10.1086/502977; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; de Jong BC, 2010, FEMS IMMUNOL MED MIC, V58, P102, DOI 10.1111/j.1574-695X.2009.00628.x; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gaillard T, 2011, DIAGN MICR INFEC DIS, V70, P154, DOI 10.1016/j.diagmicrobio.2010.12.011; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; Garcia B, 2014, ANAL BIOCHEM, V458, P11, DOI 10.1016/j.ab.2014.04.021; Gehre F, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002220; Hirano K, 2004, J CLIN MICROBIOL, V42, P390, DOI 10.1128/JCM.42.1.390-392.2004; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907; Lu PL, 2011, J CLIN MICROBIOL, V49, P2290, DOI 10.1128/JCM.00571-11; Peres RL, 2009, INT J TUBERC LUNG D, V13, P1572; Shabbeer A, 2012, INFECT GENET EVOL, V12, P789, DOI 10.1016/j.meegid.2012.02.010; Sun JG, 1996, STAT MED, V15, P1387, DOI 10.1002/(SICI)1097-0258(19960715)15:13<1387::AID-SIM268>3.0.CO;2-R; Vadwai V, 2012, DIAGN MICR INFEC DIS, V74, P282, DOI 10.1016/j.diagmicrobio.2012.06.018; Viana-Niero C, 2001, J CLIN MICROBIOL, V39, P57, DOI 10.1128/JCM.39.1.57-65.2001; Walter ND, 2015, J INFECT DIS; Wang ZH, 2007, J MOL BIOL, V366, P375, DOI 10.1016/j.jmb.2006.11.039; Yin XM, 2013, J INFECTION, V67, P369, DOI 10.1016/j.jinf.2013.06.009; Yu MC, 2011, J CLIN MICROBIOL, V49, P802, DOI 10.1128/JCM.02243-10	26	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUL	2016	10	7							e0004801	10.1371/journal.pntd.0004801				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DS8FC	WOS:000381017800020	27387550	DOAJ Gold, Green Published			2019-04-02	
J	Robinson, TP; Bu, DP; Carrique-Mas, J; Fevre, EM; Gilbert, M; Grace, D; Hay, SI; Jiwakanon, J; Kakkar, M; Kariuki, S; Laxminarayan, R; Lubroth, J; Magnusson, U; Ngoc, PT; Van Boeckel, TP; Woolhouse, MEJ				Robinson, T. P.; Bu, D. P.; Carrique-Mas, J.; Fevre, E. M.; Gilbert, M.; Grace, D.; Hay, S. I.; Jiwakanon, J.; Kakkar, M.; Kariuki, S.; Laxminarayan, R.; Lubroth, J.; Magnusson, U.; Ngoc, P. Thi; Van Boeckel, T. P.; Woolhouse, M. E. J.			Antibiotic resistance is the quintessential One Health issue	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Editorial Material						Antibiotics; Antimicrobial resistance (AMR); Environment; Health; Livestock; One Health	ANTIMICROBIAL RESISTANCE; ESCHERICHIA-COLI; AGRICULTURE; BACTERIA; CHINA		[Robinson, T. P.; Grace, D.] Int Livestock Res Inst, Nairobi, Kenya; [Bu, D. P.] Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China; [Carrique-Mas, J.] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam; [Fevre, E. M.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Gilbert, M.] Univ Libre Bruxelles, Brussels, Belgium; [Hay, S. I.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Hay, S. I.] Li Ka Shing Ctr Hlth Informat & Discovery, Oxford Big Data Inst, Oxford, England; [Jiwakanon, J.] Khon Kaen Univ, Fac Vet Med, Res Grp Prevent Technol Livestock, Khon Kaen, Thailand; [Kakkar, M.] Publ Hlth Fdn India, Delhi, India; [Kariuki, S.] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Laxminarayan, R.] Ctr Dis Dynam Econ & Policy, Washington, DC USA; [Lubroth, J.] Food & Agr Org United Nations, Rome, Italy; [Magnusson, U.] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Ngoc, P. Thi] Natl Inst Vet Res, Hanoi, Vietnam; [Van Boeckel, T. P.] Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland; [Van Boeckel, T. P.] Swiss Fed Inst Technol, Ctr Adaptat Changing Environm, Zurich, Switzerland; [Woolhouse, M. E. J.] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland	Robinson, TP (reprint author), Int Livestock Res Inst, Nairobi, Kenya.	t.robinson@cgiar.org	Hay, Simon/F-8967-2015; Carrique-Mas, Juan/H-1834-2012	Hay, Simon/0000-0002-0611-7272; Fevre, Eric/0000-0001-8931-4986; Carrique-Mas, Juan/0000-0001-9161-8890	Biotechnology and Biological Sciences Research Council; Wellcome Trust [095066]; Medical Research Council; Biotechnology and Biological Sciences Research Council [BB/L019019/1]; Medical Research Council [G1100783]		American Veterinary Medical Association (AVMA), 2008, ON HLTH NEW PROF IMP; [Anonymous], 2015, GLOB ACT PLAN ANT RE; Chang QZ, 2015, EVOL APPL, V8, P240, DOI 10.1111/eva.12185; Diwan V, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-414; FDA, 2014, ANT SOLD DISTR US FO; Henriksson PJG, 2015, P NATL ACAD SCI USA, V112, pE3317, DOI 10.1073/pnas.1508952112; Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; Ji XL, 2012, J HAZARD MATER, V235, P178, DOI 10.1016/j.jhazmat.2012.07.040; Larsson DGJ, 2007, J HAZARD MATER, V148, P751, DOI 10.1016/j.jhazmat.2007.07.008; Laxminarayan R, 2016, LANCET, V387, P168, DOI 10.1016/S0140-6736(15)00474-2; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Martinez JL, 2009, P ROY SOC B-BIOL SCI, V276, P2521, DOI 10.1098/rspb.2009.0320; McGann P, 2016, ANTIMICROB AGENTS CH, V60, P4420, DOI 10.1128/AAC.01103-16; Moellering RC, 2010, NEW ENGL J MED, V363, P2377, DOI 10.1056/NEJMp1011715; O'Neill J, 2016, TACKLING DRUG RESIST; Oliver SP, 2012, VET CLIN N AM-FOOD A, V28, P165, DOI 10.1016/j.cvfa.2012.03.005; Reinthaler FF, 2003, WATER RES, V37, P1685, DOI 10.1016/S0043-1354(02)00569-9; Robinson TP, 2016, LANCET, V387, pE1, DOI 10.1016/S0140-6736(15)00730-8; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Stockwell VO, 2012, REV SCI TECH OIE, V31, P199; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1; Woolhouse M, 2014, NATURE, V509, P555, DOI 10.1038/509555a; World Health Organization, 2014, ANT RES GLOB REP SUR; Zhang QQ, 2015, ENVIRON SCI TECHNOL, V49, P6772, DOI 10.1021/acs.est.5b00729	25	59	61	6	55	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	JUL	2016	110	7					377	380		10.1093/trstmh/trw048				4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	DT0TC	WOS:000381194900001	27475987	Other Gold, Green Published			2019-04-02	
J	Jaenson, TGT; Varv, K; Frojdman, I; Jaaskelainen, A; Rundgren, K; Versteirt, V; Estrada-Pena, A; Medlock, JM; Golovljova, I				Jaenson, Thomas G. T.; Varv, Kairi; Frojdman, Isabella; Jaaskelainen, Anu; Rundgren, Kaj; Versteirt, Veerle; Estrada-Pena, Agustin; Medlock, Jolyon M.; Golovljova, Irina			First evidence of established populations of the taiga tick Ixodes persulcatus (Acari: Ixodidae) in Sweden	PARASITES & VECTORS			English	Article						Ixodes persulcatus; Ixodes ricinus; Taiga tick; Geographical distribution; Sweden; Bothnian Bay; Norrbotten; Moose; Alces alces; Tick-borne pathogens	BORNE ENCEPHALITIS-VIRUS; CANDIDATUS NEOEHRLICHIA MIKURENSIS; ANAPLASMA-PHAGOCYTOPHILUM; GEOGRAPHICAL-DISTRIBUTION; RICINUS; RUSSIA; FINLAND; PREVALENCE; RICKETTSIA; DISEASES	Background: The tick species Ixodes ricinus and I. persulcatus are of exceptional medical importance in the western and eastern parts, respectively, of the Palaearctic region. In Russia and Finland the range of I. persulcatus has recently increased. In Finland the first records of I. persulcatus are from 2004. The apparent expansion of its range in Finland prompted us to investigate if I. persulcatus also occurs in Sweden. Methods: Dog owners and hunters in the coastal areas of northern Sweden provided information about localities where ticks could be present. In May-August 2015 we used the cloth-dragging method in 36 localities potentially harbouring ticks in the Bothnian Bay area, province Norrbotten (NB) of northern Sweden. Further to the south in the provinces Vasterbotten (VB) and Uppland (UP) eight localities were similarly investigated. Results: Ixodes persulcatus was detected in 9 of 36 field localities in the Bothnian Bay area. Nymphs, adult males and adult females (n = 46 ticks) of I. persulcatus were present mainly in Alnus incana - Sorbus aucuparia - Picea abies - Pinus sylvestris vegetation communities on islands in the Bothnian Bay. Some of these I. persulcatus populations seem to be the most northerly populations so far recorded of this species. Dog owners asserted that their dogs became tick-infested on these islands for the first time 7-8 years ago. Moose (Alces alces), hares (Lepus timidus), domestic dogs (Canis lupus familiaris) and ground-feeding birds are the most likely carriers dispersing I. persulcatus in this area. All ticks (n = 124) from the more southern provinces of VB and UP were identified as I. ricinus. Conclusions: The geographical range of the taiga tick has recently expanded into northern Sweden. Increased information about prophylactic, anti-tick measures should be directed to people living in or visiting the coastal areas and islands of the Baltic Bay.	[Jaenson, Thomas G. T.] Uppsala Univ, Dept Organismal Biol, Evolutionary Biol Ctr, Med Entomol Unit, Norbyvagen 18d, SE-75236 Uppsala, Sweden; [Varv, Kairi; Golovljova, Irina] Natl Inst Hlth Dev, Dept Virol, Hiiu 42, EE-11619 Tallinn, Estonia; [Frojdman, Isabella] Aalto Univ, POB 11130, FI-00076 Aalto, Finland; [Jaaskelainen, Anu] Univ Helsinki, Dept Virol, POB 21, FI-00014 Helsinki, Finland; [Rundgren, Kaj] Jarvis Vag 50, SE-95395 Nikkala, Sweden; [Versteirt, Veerle] Avia GIS, Precis Pest Management Unit, Risschotlei 33, BE-2980 Zoersel, Belgium; [Estrada-Pena, Agustin] Univ Zaragoza, Dept Parasitol, Miguel Servet 177, ES-50013 Zaragoza, Spain; [Medlock, Jolyon M.] Publ Hlth England, Emergency Response Dept, Med Entomol Grp, Salisbury, Wilts, England; [Medlock, Jolyon M.] Hlth Protect Res Unit Emerging Infect & Zoonoses, Salisbury, Wilts, England	Jaenson, TGT (reprint author), Uppsala Univ, Dept Organismal Biol, Evolutionary Biol Ctr, Med Entomol Unit, Norbyvagen 18d, SE-75236 Uppsala, Sweden.	Thomas.Jaenson@ebc.uu.se		Jaenson, Thomas/0000-0003-0780-7475; Estrada Pena, Agustin/0000-0001-7483-046X	Carl Trygger's stiftelse; Helge Ax:son Johnson's stiftelse; Langmanska kulturfonden; Magnus Bergvall's stiftelse, all in Stockholm, Sweden; ESGBOR (the European Study Group on Lyme Borrelioses); European Food Safety Authority (EFSA) [OC/EFSA/AHAW/2013/02-FWC1]; European Centre for Disease prevention and Control (ECDC)	TGTJ's research on the ecology of ticks and tick-borne infections is funded by Carl Trygger's stiftelse, Helge Ax:son Johnson's stiftelse, Langmanska kulturfonden and Magnus Bergvall's stiftelse, all in Stockholm, Sweden. This work was carried out under the auspices of ESGBOR (the European Study Group on Lyme Borrelioses) and VectorNet, a European network for sharing data on the geographic distribution of arthropod vectors, transmitting human and animal disease agents (framework contract OC/EFSA/AHAW/2013/02-FWC1) funded by the European Food Safety Authority (EFSA) and the European Centre for Disease prevention and Control (ECDC).	Alekseev AN, 2004, INT J MED MICROBIOL, V293, P104, DOI 10.1016/S1433-1128(04)80015-9; Alekseev AN, 2003, EXP APPL ACAROL, V29, P345, DOI 10.1023/A:1025841901909; Bjarvall A, 2010, VARA VILDA ARTER SVE; Bormane A, 2004, INT J MED MICROBIOL, V293, P36, DOI 10.1016/S1433-1128(04)80007-X; Bugmyrin S, 2011, ENTOMOL FENNICA, V22, P268; Bugmyrin SV, 2013, TICKS TICK-BORNE DIS, V4, P57, DOI 10.1016/j.ttbdis.2012.07.004; Burri C, 2014, TICKS TICK-BORNE DIS, V5, P245, DOI 10.1016/j.ttbdis.2013.11.007; Caporale DA, 1995, MOL PHYLOGENET EVOL, V4, P361, DOI 10.1006/mpev.1995.1033; Charrel RN, 2004, CLIN MICROBIOL INFEC, V10, P1040, DOI 10.1111/j.1469-0691.2004.01022.x; Filippova N. A., 1985, TAIGA TICK IXODES PE; Filippova N. A., 1977, FAUNA SSSR PAUKOOBRA; Franke J, 2013, TICKS TICK-BORNE DIS, V4, P11, DOI 10.1016/j.ttbdis.2012.06.007; Hubalek Z, 2012, PARASITOL RES, V111, P9, DOI 10.1007/s00436-012-2910-1; Hvidsten D, 2014, TICKS TICK-BORNE DIS, V5, P107, DOI 10.1016/j.ttbdis.2013.09.003; Inokuma H, 2007, J VET MED SCI, V69, P661, DOI 10.1292/jvms.69.661; Jaaskelainen A, 2011, THESIS; Jaaskelainen A, 2016, TICKS TICK-BORNE DIS, V7, P216, DOI 10.1016/j.ttbdis.2015.10.013; Jaaskelainen AE, 2006, EMERG INFECT DIS, V12, P1568, DOI 10.3201/eid1210.060320; Jaaskelainen AE, 2011, EMERG INFECT DIS, V17, P323, DOI 10.3201/eid1702.101487; Jaaskelainen AE, 2010, J GEN VIROL, V91, P2706, DOI 10.1099/vir.0.023663-0; Jaenson TGT, 2009, MED VET ENTOMOL, V23, P226, DOI 10.1111/j.1365-2915.2009.00813.x; JAENSON TGT, 1994, J MED ENTOMOL, V31, P240, DOI 10.1093/jmedent/31.2.240; Jaenson TGT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-8; Jaenson TGT, 2011, TICKS TICK-BORNE DIS, V2, P44, DOI 10.1016/j.ttbdis.2010.10.006; Jore S, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-84; Josefsen TD, 2014, NORSK VETERINAERTIDS, V126, P216; Karnath C, 2016, TICKS TICK-BORNE DIS, V7, P357, DOI 10.1016/j.ttbdis.2015.12.007; Katargina O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061374; Katargina O, 2011, VECTOR-BORNE ZOONOT, V11, P923, DOI 10.1089/vbz.2010.0199; Kolonin GV, 2014, FAUNA IXODID TICKS W; Korenberg Edward I., 2002, P175, DOI 10.1079/9780851996325.0175; Labuda M, 2004, PARASITOLOGY, V129, pS221, DOI 10.1017/S0031182004005220; Nicholson William L., 2009, P493; OLSEN B, 1995, APPL ENVIRON MICROB, V61, P3082; Perttu K, 1995, FAKTA SKOG SAMMANFAT; Pomerantzev BI, 1950, FAUNA USSR; Rar VA, 2005, EMERG INFECT DIS, V11, P1708, DOI 10.3201/eid1111.041195; Shpynov S. N., 2004, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P10; Sjors H, 1999, ACTA PHYTOGEOGR SUEC, V84, P5; Suss J, 2010, TICKS TICK-BORNE DIS, V1, P1, DOI [10.1016/j.ttbdis.2010.10.007, 10.1016/j.ttbdis.2010.01.003]; Tokarevich NK, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.8448; Uspensky I, 2003, J MED ENTOMOL, V40, P119, DOI 10.1603/0022-2585-40.1.119; Yamaguti N, 1971, TICKS JAPAN KOREA RY, VXV; Yasyukevich VV, 2009, DOKL EARTH SCI, V427, P1030, DOI 10.1134/S1028334X09060312; ZILBER LA, 1939, ARK BIOL NAUK, V56, P255	45	11	11	4	18	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	JUL 1	2016	9								377	10.1186/s13071-016-1658-3				8	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	DP9RY	WOS:000378835700001	27370406	DOAJ Gold, Green Published			2019-04-02	
J	Traore, FA; Sako, FB; Sylla, D; Traore, M; Kpamy, DO; Doumbouya, M; Sylla, AO; Diallo, MOS				Traore, F. A.; Sako, F. B.; Sylla, D.; Traore, M.; Kpamy, D. O.; Doumbouya, M.; Sylla, A. O.; Diallo, M. O. S.			Tetanus in women of childbearing age in the infectious disease department in the national hospital of Conakry (Guinea)	MEDECINE ET SANTE TROPICALES			French	Article						tetanus; Woman; women of childbearing age; Guinea		Objectives: This study aimed to determine the hospital prevalence rate of tetanus in women of childbearing age in the infectious disease department of Donka CHU in Conakry and to describe their sociodemographic characteristics and outcomes. Methodology: This descriptive retrospective study examined the records of all patients aged 15 to 495 years hospitalized for tetanus over a 10-year period. Results: During the study period, 74555 patients were hospitalized - 239 for tetanus. In all, 22 woman of childbearing age had tetanus, that is, 9.2%. Their mean age was 325 years. Most of the women were married (13/22) and lived in Conakry (18/22); 165 were housewives, and 65 patients had begun but not completed the required vaccinations. The incubation period was > 75 days for 165 patients. Tetanus infection resulted from medical procedures for 9 women and trauma for 6. We recorded 125 deaths. The average duration of hospitalization was 215 days. Conclusion: Preventing tetanus requires a reinforcement of vaccination drives and especially the implementation of policies for booster reminders.	[Traore, F. A.; Sako, F. B.; Kpamy, D. O.; Sylla, A. O.; Diallo, M. O. S.] CHU Conakry, Serv Malad Infect, BP 817 S-C Ibrahima Traore OMS Guinee, Conakry 224, Guinea; [Sylla, D.] Univ Conakry, Conakry, Guinea; [Traore, M.] Med San Frontieres, Paris, France; [Doumbouya, M.] Med San Frontieres, Brussels, Belgium	Traore, FA (reprint author), CHU Conakry, Serv Malad Infect, BP 817 S-C Ibrahima Traore OMS Guinee, Conakry 224, Guinea.	fatraore01@gmail.com					ANTONA D, 2006, B EPIDEMIOL HEBDO, V7, P53; Manga N M, 2009, Bull Soc Pathol Exot, V102, P221; Ministere de la Sante et de l'Hygiene publique, 2012, RAPP PREM TOUR CAMP; Ndour CT, 2002, MED MALADIES INFECT, V32, P399, DOI 10.1016/S0399-077X(02)00392-X; Service de pediatrie de l'hopital national Donka du CHU de Conakry Guinee, 2011, STAT ANNUELLES; Seydi M, 2000, DAKAR MED, V41, P5	6	0	0	0	0	JOHN LIBBEY EUROTEXT LTD	MONTROUGE	127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE	2261-3684	2261-2211		MED SANTE TROP	Med. Sante Trop.	JUL-SEP	2016	26	3					323	325		10.1684/mst.2016.0594				3	Tropical Medicine	Tropical Medicine	VD6SI	WOS:000437449800023	27694092				2019-04-02	
J	Okello, AL; Thomas, L; Inthavong, P; Ash, A; Khamlome, B; Keokamphet, C; Newberry, K; Gauci, CG; Gabriel, S; Dorny, P; Thompson, RCA; Lightowlers, MW; Allen, J				Okello, Anna L.; Thomas, Lian; Inthavong, Phouth; Ash, Amanda; Khamlome, Boualam; Keokamphet, Chattouphone; Newberry, Kim; Gauci, Charles G.; Gabriel, Sarah; Dorny, Pierre; Thompson, R. C. Andrew; Lightowlers, Marshall W.; Allen, John			Assessing the impact of a joint human-porcine intervention package for Taenia solium control: Results of a pilot study from northern Lao PDR	ACTA TROPICA			English	Article							SOUTHEAST-ASIA; CYSTICERCOSIS; EPILEPSY; PEOPLE; HEALTH; FOCUS; PCR	Following confirmation that a remote village of approximately 300 inhabitants in northern Lao PDR was hyperendemic for the Neglected Tropical Disease Taenia solium, a pilot human-porcine therapeutic control intervention was implemented between October 2013 and November 2014. Mass drug administration with a three day albendazole 400 mg protocol was offered to all eligible humans in October 2013 and March 2014. At these times, and again in October 2014, eligible village pigs received the anti-cysticercosis TSOL18 vaccination and an oral dose of oxfendazole anthelmintic at 30 mg/kg, both repeated one month later. Community and individual human taeniasis prevalences were estimated via copro-antigen ELISA of volunteered human faecal samples prior to October 2013, and again in January 2015, in order to examine the short term impact of the intervention. (C) 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license.	[Okello, Anna L.; Newberry, Kim; Allen, John] CSIRO, Australian Anim Hlth Lab AAHL Reg Programme, Geelong, Vic, Australia; [Okello, Anna L.] Univ Edinburgh, Coll Med & Vet Med, Div Pathway Med, Sch Biomed Sci, Chancellors Bldg,49 Little France Crescent, Edinburgh EH16 4SB, Midlothian, Scotland; [Okello, Anna L.] Univ Edinburgh, Coll Med & Vet Med, Ctr Infect Dis, Sch Biomed Sci, Chancellors Bldg,49 Little France Crescent, Edinburgh EH16 4SB, Midlothian, Scotland; [Inthavong, Phouth; Keokamphet, Chattouphone] Minist Agr, Dept Livestock & Fisheries, Natl Anim Hlth Lab, Viangchan, Laos; [Ash, Amanda; Thompson, R. C. Andrew] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Khamlome, Boualam] Minist Hlth, Dept Hyg & Prevent, Viangchan, Laos; [Gauci, Charles G.; Lightowlers, Marshall W.] Univ Melbourne, Fac Vet & Agr Sci, 250 Princes Highway, Werribee, Vic 3030, Australia; [Gabriel, Sarah; Dorny, Pierre] Inst Trop Med, Dept Biomed Sci, Natl Str 155, B-2000 Antwerp, Belgium	Okello, AL (reprint author), CSIRO, Australian Anim Hlth Lab AAHL Reg Programme, Geelong, Vic, Australia.; Okello, AL (reprint author), Univ Edinburgh, Coll Med & Vet Med, Div Pathway Med, Sch Biomed Sci, Chancellors Bldg,49 Little France Crescent, Edinburgh EH16 4SB, Midlothian, Scotland.; Okello, AL (reprint author), Univ Edinburgh, Coll Med & Vet Med, Ctr Infect Dis, Sch Biomed Sci, Chancellors Bldg,49 Little France Crescent, Edinburgh EH16 4SB, Midlothian, Scotland.	anna.okello1@gmail.com		Gauci, Charles/0000-0001-5097-2164; Ash, Amanda/0000-0001-8218-7048; GABRIEL, SARAH/0000-0002-2523-233X; Thomas, Lian/0000-0001-8447-1210	Australian Centre for International Agricultural Research (ACIAR) Animal Health Programme [AH2009/001-019]; Australian National Health and Medical Research Council [1003546, 1043327]; Lao PDR national WHO office	The SPSP human and animal health component wish to thank their project counterparts from the Centre for International Agriculture in the Tropics (CIAT) and the Lao PDR National Agricultural and Forestry Research Institute (NAFRI) for their assistance during the pig interventions. The team also wish to thank the Lao PDR national WHO office for their overall support, as well as the Lao PDR Department for Communicable Disease Control (DCDC) for their facilitation and assistance in the human MDA interventions. In particular, the project team would like to thank the staff from the provincial and district Ministry of Health offices for their care and support in building community rapport during the project lifetime, and finally the community themselves for their hospitality, cooperation and trust. This research was funded by the Australian Centre for International Agricultural Research (ACIAR) Animal Health Programme, grant number AH2009/001-019. Funding support is also acknowledged from the Australian National Health and Medical Research Council, grants 1003546 and 1043327 (MWL).	Allan JC, 2006, PARASITOL INT, V55, pS75, DOI 10.1016/j.parint.2005.11.010; Ash A., 2015, ACTA TROP; Bardosh K, 2014, SOC SCI MED, V120, P215, DOI 10.1016/j.socscimed.2014.09.030; Carabin H., 2014, CURR TROP MED REP, P1; Conlan J, 2008, PARASITOL INT, V57, P252, DOI 10.1016/j.parint.2008.04.002; Conlan JV, 2011, VET PARASITOL, V182, P22, DOI 10.1016/j.vetpar.2011.07.013; Deckers N, 2010, TRENDS PARASITOL, V26, P137, DOI 10.1016/j.pt.2009.12.008; Del Brutto O.H., 2012, SCI WORLD J, P1, DOI 10.1100/2012/159821; Dorny P, 2004, INT J PARASITOL, V34, P569, DOI 10.1016/j.ijpara.2003.11.014; Dorny P, 2004, SE ASIAN J TROP MED, V35, P223; FAO, 2014, TOP 10 LIST FOOD BOR; Gabriel S, 2015, VET PARASITOL, V213, P38, DOI 10.1016/j.vetpar.2015.03.006; Garcia HH, 2006, AM J TROP MED HYG, V74, P850, DOI 10.4269/ajtmh.2006.74.850; Kyvsgaard NC, 2007, INT J PARASITOL, V37, P547, DOI 10.1016/j.ijpara.2006.11.018; Lightowlers M.W., 2013, PARASITOLOGY, V140; Maurice J, 2014, LANCET, V384, P571, DOI 10.1016/S0140-6736(14)61353-2; Moreno L, 2012, FOOD CHEM TOXICOL, V50, P3819, DOI 10.1016/j.fct.2012.07.023; Ndimubanzi PC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000870; Okello A.L, 2015, AM J TROP MED HYG, P14; Okello A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-134; Praet N, 2013, TROP MED INT HEALTH, V18, P608, DOI 10.1111/tmi.12089; R Development Core Team, 2005, R LANG ENV STAT COMP; Steinmann P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025003; Stevenson M., 2013, R PACKAGE VERSION 0, P9; Trachsel D, 2007, PARASITOLOGY, V134, P911, DOI 10.1017/S0031182007002235; Tran Duc Si, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P537; WHO, 2012, UN COMB NEGL TROP DI; WHO, 2015, LANDSC AN MAN NEUR E; WHO, 2015, 4 INT M CONTR NEGL Z; WHO, 2006, MAN HLTH PROF PROGR; Willingham AL, 2010, ADV PARASIT, V72, P235, DOI 10.1016/S0065-308X(10)72009-1; Wolak ME, 2012, METHODS ECOL EVOL, V3, P129, DOI 10.1111/j.2041-210X.2011.00125.x	32	9	9	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	JUL	2016	159						185	191		10.1016/j.actatropica.2016.03.012				7	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	DN8DM	WOS:000377309400024	26992295	Green Published, Other Gold			2019-04-02	
J	Seidel, B; Nowotny, N; Bakonyi, T; Allerberger, F; Schaffner, F				Seidel, Bernhard; Nowotny, Norbert; Bakonyi, Tamas; Allerberger, Franz; Schaffner, Francis			Spread of Aedes japonicus japonicus (Theobald, 1901) in Austria, 2011-2015, and first records of the subspecies for Hungary, 2012, and the principality of Liechtenstein, 2015	PARASITES & VECTORS			English	Article						Aedes japonicus; Asian bush mosquito; Invasive mosquito species; Active spread; First record; Austria; Hungary; Bavaria; Liechtenstein	ASIAN BUSH MOSQUITO; DIPTERA-CULICIDAE; INVASIVE MOSQUITOS; PUBLIC-HEALTH; EUROPE; ESTABLISHMENT; SURVEILLANCE; SWITZERLAND; POPULATION; GERMANY	Background: The Asian bush mosquito, Aedes (Hulecoeteomyia) japonicus japonicus (Theobald, 1901) (Diptera: Culicidae), was first identified in Austria in August 2011 in the federal state of Styria at the border to Slovenia. Methods: Between 2011 and 2015 the spread of Ae. j. japonicus was monitored in southern, eastern and western Austrian provinces as well as in neighbouring countries by checking natural and man-made container habitats for the aquatic stages. The search concentrated around the most recent occurrence of Ae. j. japonicus and extended up to several kilometres until the subspecies could not be found anymore. Results: Between May and July 2012 the distribution area of Ae. j. japonicus was found to be extended westwards into Carinthia, and eastwards towards the federal state of Burgenland. In August 2012, the subspecies was found in Hungary, representing the first record of an invasive mosquito species in this country. In 2013 its expansion was confirmed at several sites in Austria. Additionally, between April and July 2015, the subspecies was detected in all districts of the westernmost Austrian state Vorarlberg reaching the alpine Montafon valley at the end of October 2015, at all three examined sites in southern Bavaria bordering Vorarlberg, and in the adjacent Principality of Liechtenstein, for which it also represents the first record of an invasive mosquito species. One remarkable finding of the subspecies was located close to the city of Kufstein in the lower Inn valley of the Tyrol in September 2015, which is an isolated occurrence without spatial connection to any known established population. Conclusions: Our findings demonstrate the ongoing spread of Ae. j. japonicus towards all directions within Austria and beyond. Together with the absence of supposed natural barriers, e.g. high mountain chains, at the borders of the current subspecies' distribution area in south-eastern Austria, these findings suggest a further spread to the Austrian capital Vienna and the Hungarian tourist region of Lake Balaton within the upcoming few years. The observed intrusions in western Austria represent most probably extensions of the population established and spreading in eastern Switzerland and southern Germany. The putative role of the subspecies in pathogen transmission together with its rapid spread observed argues for the implementation of comprehensive nation-wide surveillance and response preparedness.	[Seidel, Bernhard] Tech Off Ecol & Landscape Assessment, Nibelungenstr 51, A-3680 Persenbeug, Austria; [Seidel, Bernhard] Univ Vienna, Dept Theoret Biol, Althanstr 14, A-1090 Vienna, Austria; [Nowotny, Norbert; Bakonyi, Tamas] Univ Vet Med, Inst Virol, Viral Zoonoses Emerging & Vector Borne Infect Grp, Veterinaerpl 1, A-1210 Vienna, Austria; [Nowotny, Norbert] Mohammed Bin Rashid Univ Med & Hlth Sci, Coll Med, Dept Basic Med Sci, Dubai Healthcare City, POB 505055, Dubai, U Arab Emirates; [Bakonyi, Tamas] Szent Istvan Univ, Fac Vet Sci, Dept Microbiol & Infect Dis, Hungaria Krt 23-25, H-1143 Budapest, Hungary; [Allerberger, Franz] Austrian Agcy Hlth & Food Safety AGES, Inst Med Microbiol & Hyg, Waehringerstr 25a, A-1096 Vienna, Austria; [Schaffner, Francis] Avia GIS, Agro Vet Informat & Anal, Risschotlei 33, B-2980 Zoersel, Belgium; [Schaffner, Francis] Univ Zurich, Inst Parasitol, Natl Ctr Vector Entomol, Winterthurerstr 266a, CH-8057 Zurich, Switzerland	Seidel, B (reprint author), Tech Off Ecol & Landscape Assessment, Nibelungenstr 51, A-3680 Persenbeug, Austria.; Nowotny, N (reprint author), Mohammed Bin Rashid Univ Med & Hlth Sci, Coll Med, Dept Basic Med Sci, Dubai Healthcare City, POB 505055, Dubai, U Arab Emirates.	bernhard.seidel@univie.ac.at; norbert.nowotny@vetmeduni.ac.at	Bakonyi, Tamas/L-7953-2017	Allerberger, Franz/0000-0002-0045-8164; Schaffner, Francis/0000-0001-9166-7617; Nowotny, Norbert/0000-0002-3548-571X	EU [FP7-261504]; Austrian Climate Research Programme (ACRP7) [KR14AC7K11954]; European Food Safety Authority (EFSA) [OC/EFSA/AHAW/2013/02-FWC1]; European Centre for Disease Prevention and Control (ECDC) [OC/EFSA/AHAW/2013/02-FWC1]	This study was partially funded by the EU grant FP7-261504 EDENext and the Austrian Climate Research Programme (ACRP7; KR14AC7K11954). Part of the work was carried out under the frame of the EurNegVec COST Action TD1303. The publication is catalogued by the EDENext Steering Committee as EDENext438 (http://www.edenext.eu). The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission. The VectorNet field work was carried out under the framework contract OC/EFSA/AHAW/2013/02-FWC1 funded by the European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC). The funding bodies had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	Balestrino F, 2016, MED VET ENTOMOL, V30, P64, DOI 10.1111/mve.12152; Harris MC, 2015, EMERG INFECT DIS, V21, P646, DOI 10.3201/eid2104.140734; Kalan K, 2014, PARASIT VECTORS S1, P9; KAMPEN H, 2014, PARASITE VECTOR, V7, DOI DOI 10.1186/1756-3305-7-59; Kampen H, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-284; Krebs T, 2014, J VECTOR ECOL, V39, P437, DOI 10.1111/jvec.12119; Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103; Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189; Schaffner F, 2009, MED VET ENTOMOL, V23, P448, DOI 10.1111/j.1365-2915.2009.00825.x; Schaffner F, 2003, J AM MOSQUITO CONTR, V19, P1; Schaffner F, 2001, MOSQUITOES EUROPE; Schaffner F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-209; Schonenberger AC, 2016, MED VET ENTOMOL, V30, P39, DOI 10.1111/mve.12155; Seidel B, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1566-6; Seidel Bernhard, 2012, Entomologische Zeitschrift, V122, P223; Toth S., 2012, European Mosquito Bulletin, P30; Versteirt V, 2009, J MED ENTOMOL, V46, P1464, DOI 10.1603/033.046.0632; Wilkerson RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133602; Zielke DE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1447-z	19	11	11	0	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	JUN 24	2016	9								356	10.1186/s13071-016-1645-8				7	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	DP9SE	WOS:000378836500001	27343074	DOAJ Gold, Green Published			2019-04-02	
J	Cook, CA; Netherlands, EC; Smit, NJ				Cook, Courtney A.; Netherlands, Edward C.; Smit, Nico J.			Redescription, molecular characterisation and taxonomic re-evaluation of a unique African monitor lizard haemogregarine Karyolysus paradoxa (Dias, 1954) n. comb. (Karyolysidae)	PARASITES & VECTORS			English	Article						Haemogregarine taxonomy; Hepatozoon; Monitor lizard; Haematozoa; Hemolivia	APICOMPLEXA ADELEORINA HEPATOZOIDAE; TORTOISES CRYPTODIRA TESTUDINIDAE; HAEMOGREGARINA-FITZSIMONSI DIAS; PHYLOGENETIC ANALYSIS; LIFE-CYCLE; PARVULA DIAS; NORTH-AFRICA; HEMOLIVIA; INFECTION; PARASITES	Background: Within the African monitor lizard family Varanidae, two haemogregarine genera have been reported. These comprise five species of Hepatozoon Miller, 1908 and a species of Haemogregarina Danilewsky, 1885. Even though other haemogregarine genera such as Hemolivia Petit, Landau, Baccam & Lainson, 1990 and Karyolysus Labbe, 1894 have been reported parasitising other lizard families, these have not been found infecting the Varanidae. The genus Karyolysus has to date been formally described and named only from lizards of the family Lacertidae and to the authors' knowledge, this includes only nine species. Molecular characterisation using fragments of the 18S gene has only recently been completed for but two of these species. To date, three Hepatozoon species are known from southern African varanids, one of these Hepatozoon paradoxa (Dias, 1954) shares morphological characteristics alike to species of the family Karyolysidae. Thus, this study aimed to morphologically redescribe and characterise H. paradoxa molecularly, so as to determine its taxonomic placement. Methods: Specimens of Varanus albigularis albigularis Daudin, 1802 (Rock monitor) and Varanus niloticus (Linnaeus in Hasselquist, 1762) (Nile monitor) were collected from the Ndumo Game Reserve, South Africa. Upon capture animals were examined for haematophagous arthropods. Blood was collected, thin blood smears prepared, stained with Giemsa, screened and micrographs of parasites captured. Haemogregarine morphometric data were compared with the data for named haemogregarines of African varanids. Primer set HepF300 and HepR900 was employed to target a fragment of the 18S rRNA gene and resulting sequences compared with other known haemogregarine sequences selected from the GenBank database. Results: Hepatozoon paradoxa was identified infecting two out of eight (25 %) V. a. albigularis and a single (100 %) V. niloticus examined. Phylogenetic analyses revealed that H. paradoxa clustered with the 'Karyolysus' clade, and not with those of reptilian Hepatozoon spp. Conclusions: In addition to this being the first morphological and molecular characterisation of a haemogregarine within the African Varanidae, it is the first report of a species of Karyolysus infecting the monitor lizard family. Furthermore, this constitutes now only the third described and named Karyolysus species for which there is a nucleotide sequence available.	[Cook, Courtney A.; Netherlands, Edward C.; Smit, Nico J.] North West Univ, Unit Environm Sci & Management, Potchefstroom, South Africa; [Netherlands, Edward C.] Univ Leuven, Lab Aquat Ecol Evolut & Conservat, B-3000 Leuven, Belgium	Cook, CA (reprint author), North West Univ, Unit Environm Sci & Management, Potchefstroom, South Africa.	apicomplexan@yahoo.co.za	J, Nico/L-4905-2013	J, Nico/0000-0001-7950-193X; Netherlands, Edward/0000-0003-1856-0586	National Research Foundation (NRF) of South Africa [SFP13090332476]; Flemish Interuniversity Council (VLIR) [ZEIN21013PR396]	We would like to thank Ndumo Game Reserve and Ezemvelo KZN Wildlife, for access to sites and research permits (OP 839/2014; OP 1262/2015; OP 2492/2015) for sample collection. In addition, we would like to thank Microbiology, Unit for Environmental Sciences and Management, (NWU-PC), for the use of their facilities. The financial assistance of the National Research Foundation (NRF) of South Africa to CAC (NRF Scarce Skills Postdoctoral Scholarship - Grant SFP13090332476), and the Flemish Interuniversity Council (VLIR) to ECN (VLIR-OUS project - ZEIN21013PR396) is acknowledged. Opinions expressed and conclusions arrived at are those of the authors and are not necessarily to be attributed to the NRF or VLIR.	BALL GH, 1967, J PROTOZOOL, V14, P198, DOI 10.1111/j.1550-7408.1967.tb01983.x; Barta JR, 2012, J EUKARYOT MICROBIOL, V59, P171, DOI 10.1111/j.1550-7408.2011.00607.x; Bates M. F, 2014, ATLAS RED LIST REPTI; Cook CA, 2010, J PARASITOL, V96, P1168, DOI 10.1645/GE-2527.1; Cook CA, 2015, AFR ZOOL, V50, P165, DOI 10.1080/15627020.2015.1044467; Cook CA, 2014, AFR ZOOL, V49, P290, DOI 10.3377/004.049.0204; Cook CA, 2014, PARASITOLOGY, V141, P1611, DOI 10.1017/S003118201400081X; Cook CA, 2009, FOLIA PARASIT, V56, P173; Criado-Fornelio A, 2006, J PARASITOL, V92, P93, DOI 10.1645/GE-464R.1; Criado-Fornelio A, 2009, ACTA PARASITOL, V54, P187, DOI 10.2478/s11686-009-0031-5; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davies AJ, 2000, ADV PARASIT, V45, P1, DOI 10.1016/S0065-308X(00)45003-7; Dias JATS, 1954, B SOC EST MOC, V87, P71; Dvorakova N, 2013, PARASITOLOGY, V141, P522; Dvorakova N, 2015, PARASITOLOGY, V142, P816, DOI 10.1017/S0031182014001930; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Franca C., 1911, ARQIV REAL I BACTERI, V3, P229; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haklova-Kocikova B, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0555-x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Harris DJ, 2014, J PARASITOL, V100, P117, DOI 10.1645/13-203.1; Karadjian G, 2015, PARASITE, V22, DOI 10.1051/parasite/2015031; Kopecna J, 2006, PROTIST, V157, P173, DOI 10.1016/j.protis.2006.02.005; Kvicerova J, 2014, PROTIST, V165, P688, DOI 10.1016/j.protis.2014.06.001; Laveran A., 1909, Bulletin de la Societe de Pathologie Exotique Paris, V2; Laveran A., 1905, COMPTES RENDUS SOC B, V59, P175; Leger M., 1914, Bulletin de la Societe de Pathologie Exotique Paris, V7; Maia JP, 2014, PARASITE, V21, DOI 10.1051/parasite/2014046; Maia JPMC, 2012, FOLIA PARASIT, V59, P241, DOI 10.14411/fp.2012.033; Maia JPMC, 2011, J PARASITOL, V97, P513, DOI 10.1645/GE-2666.1; Mathew JS, 2000, J PARASITOL, V86, P366, DOI 10.1645/0022-3395(2000)086[0366:PROHAA]2.0.CO;2; Merino S, 2015, J PARASITOL, V101, P123, DOI [10.1645/13-325.1, 10.1645/GE-13-325.1]; Netherlands EC, 2015, INT J PARASITOL-PAR, V4, P135, DOI 10.1016/j.ijppaw.2015.01.003; Netherlands EC, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0552-0; Netherlands EC, 2014, FOLIA PARASIT, V61, P293; Nicolle MMC, 1906, COMPTES RENDUS SOC B, V61, P310; Ogedengbe JD, 2015, PARASITOL RES, V114, P4149, DOI 10.1007/s00436-015-4646-1; Ramdan Nadia F., 1996, Qatar University Science Journal, V16, P119; Rousselot R, 1953, NOTES PARASITOLOGIE; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Siroky P, 2007, FOLIA PARASIT, V54, P13, DOI 10.14411/fp.2007.002; Sloboda M, 2007, J PARASITOL, V93, P1189, DOI 10.1645/GE-1200R.1; Smallridge C, 1997, PARASITE, V4, P359, DOI 10.1051/parasite/1997044359; Smith TG, 1996, J PARASITOL, V82, P565, DOI 10.2307/3283781; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Telford SR, 2009, HEMPPARASITES REPTIL; Todd JL, 1912, J MED RES, V26, P195; Tome B, 2016, J PARASITOL, V102, P476, DOI 10.1645/15-908; Tome B, 2013, J PARASITOL, V99, P883, DOI 10.1645/12-95.1; Tome B, 2012, J PARASITOL, V98, P913, DOI 10.1645/GE-3111.1; Ujvari B, 2004, J PARASITOL, V90, P670, DOI 10.1645/GE-204R; Van As J, 2015, FOLIA PARASIT, V62; Van As J, 2013, ZOOTAXA, V3608, P345, DOI 10.11646/zootaxa.3608.5.3; Wolbach SB, 1914, J MED RES, V29, P473	55	5	5	0	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	JUN 16	2016	9								347	10.1186/s13071-016-1600-8				13	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	DP3HZ	WOS:000378385200001	27305899	DOAJ Gold, Green Published			2019-04-02	
J	Kuijpers, LMF; Maltha, J; Guiraud, I; Kabore, B; Lompo, P; Devlieger, H; Van Geet, C; Tinto, H; Jacobs, J				Kuijpers, Laura Maria Francisca; Maltha, Jessica; Guiraud, Issa; Kabore, Berenger; Lompo, Palpouguini; Devlieger, Hugo; Van Geet, Chris; Tinto, Halidou; Jacobs, Jan			Severe anaemia associated with Plasmodium falciparum infection in children: consequences for additional blood sampling for research	MALARIA JOURNAL			English	Article						Child; Blood specimen collection; Blood volume; Practice guidelines as topic	IMMUNOLOGICAL REFERENCE VALUES; TANZANIAN CHILDREN; POPULATION; MALARIA	Background: Plasmodium falciparum infection may cause severe anaemia, particularly in children. When planning a diagnostic study on children suspected of severe malaria in sub-Saharan Africa, it was questioned how much blood could be safely sampled; intended blood volumes (blood cultures and EDTA blood) were 6 mL (children aged <6 years) and 10 mL (6-12 years). A previous review [Bull World Health Organ. 89: 46-53. 2011] recommended not to exceed 3.8 % of total blood volume (TBV). In a simulation exercise using data of children previously enrolled in a study about severe malaria and bacteraemia in Burkina Faso, the impact of this 3.8 % safety guideline was evaluated. Methods: For a total of 666 children aged >2 months to <12 years, data of age, weight and haemoglobin value (Hb) were available. For each child, the estimated TBV (TBVe) (mL) was calculated by multiplying the body weight (kg) by the factor 80 (ml/kg). Next, TBVe was corrected for the degree of anaemia to obtain the functional TBV (TBVf). The correction factor consisted of the rate 'Hb of the child divided by the reference Hb'; both the lowest ('best case') and highest ('worst case') reference Hb values were used. Next, the exact volume that a 3.8 % proportion of this TBVf would present was calculated and this volume was compared to the blood volumes that were intended to be sampled. Results: When applied to the Burkina Faso cohort, the simulation exercise pointed out that in 5.3 % (best case) and 11.4 % (worst case) of children the blood volume intended to be sampled would exceed the volume as defined by the 3.8 % safety guideline. Highest proportions would be in the age groups 2-6 months (19.0 %; worst scenario) and 6 months-2 years (15.7 %; worst case scenario). A positive rapid diagnostic test for P. falciparum was associated with an increased risk of violating the safety guideline in the worst case scenario (p = 0.016). Conclusions: Blood sampling in children for research in P. falciparum endemic settings may easily violate the proposed safety guideline when applied to TBVf. Ethical committees and researchers should be wary of this and take appropriate precautions.	[Kuijpers, Laura Maria Francisca; Maltha, Jessica; Jacobs, Jan] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Kuijpers, Laura Maria Francisca; Jacobs, Jan] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Maltha, Jessica; Van Geet, Chris] Ctr Mol & Vasc Biol, Leuven, Belgium; [Guiraud, Issa; Kabore, Berenger; Lompo, Palpouguini; Tinto, Halidou] IRSS, CRUN, Nanoro, Burkina Faso; [Devlieger, Hugo; Van Geet, Chris] Univ Hosp Leuven, Paediat, Leuven, Belgium	Kuijpers, LMF (reprint author), Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.; Kuijpers, LMF (reprint author), Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium.	lkuijpers@itg.be		Tinto, Halidou/0000-0002-0472-3586	Steunfonds Margeurite-Marie Delacroix [GV/B-125r]; Fund for Scientific Research-Flanders (FWO-Vlaanderen, Belgium) [V453812 N]; Junior Mobility programme of KU Leuven [JUMO/12/008]; McKinsey Co; Flemish Ministry of Sciences (EWI)	We thank CRUN laboratory staff, clinical staff of CMA and Nanoro Health District as well as Benedikt Ley and Emmanuel Bottieau for their collaboration with regard to the original study [4]. The work of JM was supported by Steunfonds Margeurite-Marie Delacroix (reference number GV/B-125r). For the original study, she received additional Grants from the Fund for Scientific Research-Flanders (FWO-Vlaanderen, Belgium) (Grant number V453812 N), the Junior Mobility programme of KU Leuven (Grant number JUMO/12/008) and McKinsey & Co (no Grant number). LK is supported by the Flemish Ministry of Sciences (EWI, SOFI project IDIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Heart Association, 2006, PED ADV LIF SUPP, P273; Biggs HM, 2014, CLIN INFECT DIS, V58, P638, DOI 10.1093/cid/cit798; Broder-Fingert S, 2009, J PEDIATR-US, V154, P578, DOI 10.1016/j.jpeds.2008.10.007; Buchanan AM, 2010, TROP MED INT HEALTH, V15, P1011, DOI 10.1111/j.1365-3156.2010.02585.x; Buseri FI, 2010, PATHOL LAB MED INT, V2, P65; Cole M, 2006, PEDIATR BLOOD CANCER, V46, P723, DOI 10.1002/pbc.20463; Dosoo DK, 2014, AM J TROP MED HYG, V90, P767, DOI 10.4269/ajtmh.13-0098; Dzik WH, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0248-5; Green HK, 2011, PARASITOLOGY, V138, P1534, DOI 10.1017/S0031182011001016; Howie SRC, 2011, B WORLD HEALTH ORGAN, V89, P46, DOI 10.2471/BLT.10.080010; Kahigwa E, 2002, TROP MED INT HEALTH, V7, P823, DOI 10.1046/j.1365-3156.2002.00938.x; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; Maltha J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089103; Pearson H, 2003, RUDOLPHS PEDIAT, P1521; Quinto L, 2006, TROP MED INT HEALTH, V11, P1741, DOI 10.1111/j.1365-3156.2006.01764.x; Stead LJ, 2010, 1 AID PEDIAT CLERKSH; WHO, 2014, CHILD GROWTH STAND W; [World Health Organization Severe falciparum malaria], 2000, T R SOC TROP MED S1, V94, pS1, DOI DOI 10.1016/S0035-9203(00)90300-6	18	2	2	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	JUN 2	2016	15								304	10.1186/s12936-016-1356-9				6	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DN6JR	WOS:000377180600002	27251128	DOAJ Gold, Green Published			2019-04-02	
J	Watanaveeradej, V; Simasathien, S; Mammen, MP; Nisalak, A; Tournay, E; Kerdpanich, P; Samakoses, R; Putnak, RJ; Gibbons, RV; Yoon, IK; Jarman, RG; De La Barrera, R; Moris, P; Eckels, KH; Thomas, SJ; Innis, BL				Watanaveeradej, Veerachai; Simasathien, Sriluck; Mammen, Mammen P., Jr.; Nisalak, Ananda; Tournay, Elodie; Kerdpanich, Phirangkul; Samakoses, Rudiwilai; Putnak, Robert J.; Gibbons, Robert V.; Yoon, In-Kyu; Jarman, Richard G.; De La Barrera, Rafael; Moris, Philippe; Eckels, Kenneth H.; Thomas, Stephen J.; Innis, Bruce L.			Long-Term Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine and Evaluation of a Booster Dose Administered to Healthy Thai Children	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							VIRUS-VACCINE; PHASE-II; ADULTS; TRIAL	We evaluated the safety and immunogenicity of two doses of a live-attenuated, tetravalent dengue virus vaccine (F17/Pre formulation) and a booster dose in a dengue endemic setting in two studies. Seven children (7- to 8-year-olds) were followed for 1 year after dose 2 and then given a booster dose (F17/Pre formulation), and followed for four more years (Child study). In the Infant study, 49 2-year-olds, vaccinated as infants, were followed for approximately 3.5 years after dose 2 and then given a booster dose (F17) and followed for one additional year. Two clinically notable events were observed, both in dengue vaccine recipients in the Infant study: 1 case of dengue approximately 2.7 years after dose 2 and 1 case of suspected dengue after booster vaccinations. The booster vaccinations had a favorable safety profile in terms of reactogenicity and adverse events reported during the 1-month follow-up periods. No vaccine-related serious adverse events were reported during the studies. Neutralizing antibodies against dengue viruses 1-4 waned during the 1-3 years before boosting, which elicited a short-lived booster response but did not provide a long-lived, multivalent antibody response in most subjects. Overall, this candidate vaccine did not elicit a durable humoral immune response.	[Watanaveeradej, Veerachai; Simasathien, Sriluck; Kerdpanich, Phirangkul; Samakoses, Rudiwilai] Phramongkutklao Hosp, Dept Pediat, Bangkok, Thailand; [Nisalak, Ananda] USAMC AFRIMS, Dept Virol, Bangkok, Thailand; [Tournay, Elodie; Moris, Philippe] GSK Vaccines, Rixensart, Belgium; [Putnak, Robert J.; Jarman, Richard G.; Thomas, Stephen J.] Walter Reed Army Inst Res, Viral Dis Branch, 503 Robert Grant Ave, Silver Spring, MD 20910 USA; Int Vaccine Inst, Dengue Vaccine Initiat, Seoul, South Korea; [De La Barrera, Rafael; Eckels, Kenneth H.] Walter Reed Army Inst Res, Pilot Bioprod Facil, Translat Med Branch, Silver Spring, MD USA; [Innis, Bruce L.] GSK Vaccines, Philadelphia, PA USA	Thomas, SJ (reprint author), Walter Reed Army Inst Res, Viral Dis Branch, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	stephen.j.thomas3.mil@mail.mil		Innis, Bruce/0000-0002-1753-7248	U.S. Army Medical Research and Materiel Command (Fort Detrick, MD); GlaxoSmithKline Biologicals SA (Rixensart, Belgium)	This work was funded by the U.S. Army Medical Research and Materiel Command (Fort Detrick, MD) and GlaxoSmithKline Biologicals SA (Rixensart, Belgium) under a Cooperative Research and Development Agreement. GlaxoSmithKline Biologicals SA was involved in all stages of study conduct, including analysis of the data, in addition to costs related to the development of the publication of this manuscript.	[Anonymous], 2009, DENG GUID DIAGN TREA; Bauer K, 2015, AM J TROP MED HYG, V93, P441, DOI 10.4269/ajtmh.14-0625; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Chanthavanich P, 2006, AM J TROP MED HYG, V75, P26, DOI 10.4269/ajtmh.2006.75.1.0750026; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171; Moris P, 2011, J CLIN IMMUNOL, V31, P443, DOI 10.1007/s10875-010-9490-6; Nisalak A, 2003, AM J TROP MED HYG, V68, P191, DOI 10.4269/ajtmh.2003.68.191; RUSSELL PK, 1967, J IMMUNOL, V99, P285; Sadon N, 2008, J VIROL METHODS, V153, P1, DOI 10.1016/j.jviromet.2008.06.023; Simasathien S, 2008, AM J TROP MED HYG, V78, P426, DOI 10.4269/ajtmh.2008.78.426; Sun W, 2009, HUM VACCINES, V5, P33, DOI 10.4161/hv.5.1.6348; Thailand Ministry of Public Health, 2013, ANN EP SURV REP, P30; Thisyakorn Usa, 2014, Ther Adv Vaccines, V2, P3, DOI 10.1177/2051013613507862; Thomas SJ, 2013, AM J TROP MED HYG, V88, P73, DOI 10.4269/ajtmh.2012.12-0361; Watanaveeradej V, 2014, AM J TROP MED HYG, V91, P119, DOI 10.4269/ajtmh.13-0452; Watanaveeradej V, 2011, AM J TROP MED HYG, V85, P341, DOI 10.4269/ajtmh.2011.10-0501; Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002	18	0	0	0	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA		1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	JUN	2016	94	6					1348	1358		10.4269/ajtmh.15-0659				11	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	ET3UV	WOS:000400205900027	27022153	Other Gold, Green Published			2019-04-02	
J	Suryapranata, FST; Ang, CW; Chong, LL; Murk, JL; Falconi, J; Huits, RMHG				Suryapranata, Franciska S. T.; Ang, C. Wim; Chong, Luis L.; Murk, Jean -Luc; Falconi, Jaime; Huits, Ralph M. H. G.			Epidemiology of Guillain-Barre Syndrome in Aruba	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							NEUROLOGICAL MANIFESTATIONS; CYTOMEGALOVIRUS-INFECTION; DENGUE INFECTION; FEATURES	The epidemiology of Guillain-Barre syndrome (GBS) in tropical areas is different compared with developed countries. We investigated the epidemiology of GBS on the Caribbean island of Aruba. Data were collected retrospectively from all 36 patients hospitalized with GBS between 2003 and 2011 in Aruba. We observed a seasonal distribution of GBS cases with a peak in February. The incidence rate (IR) fluctuated heavily between individual years. The overall IR was 3.93/100,000,which is higher than that observed in developed countries. Serological studies indicated a possible relation of GBS cases with dengue virus infections. We also observed a relation between the annual number of dengue cases in Aruba and the number of GBS cases in the same year. We conclude that the epidemiology of GBS in tropical areas can be different from temperate climate regions and that dengue may be a trigger for developing GBS.	[Suryapranata, Franciska S. T.] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Control, De Boelelaan 1117, NL-1007 MB Amsterdam, Netherlands; [Falconi, Jaime] Dr Horacio E Oduber Hosp, Dept Neurol, Oranjestad, Aruba; Dr Horacio E Oduber Hosp, Dept Internal Med, Oranjestad, Aruba; [Chong, Luis L.] Landslaboratorium, Dept Microbiol, Oranjestad, Aruba; [Murk, Jean -Luc] UMCU, Dept Virol, Utrecht, Netherlands; [Huits, Ralph M. H. G.] Inst Trop Med, Antwerp, Belgium	Suryapranata, FST (reprint author), Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Control, De Boelelaan 1117, NL-1007 MB Amsterdam, Netherlands.	fsuryapranata@gmail.com		Huits, Ralph/0000-0001-8803-9468			ALTER M, 1990, ANN NEUROL, V27, pS7, DOI 10.1002/ana.410270704; Arami MA, 2006, ANN SAUDI MED, V26, P22, DOI 10.5144/0256-4947.2006.22; ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707; Govoni V, 2001, CURR OPIN NEUROL, V14, P605, DOI 10.1097/00019052-200110000-00009; Govoni V, 1999, J NEUROL, V246, P1010, DOI 10.1007/s004150050505; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Hughes RAC, 1997, J INFECT DIS, V176, pS92, DOI 10.1086/513793; Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110; Jiang GX, 1997, J NEUROL NEUROSUR PS, V62, P447, DOI 10.1136/jnnp.62.5.447; Leslie T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095002; McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748; Orlikowski D, 2011, CLIN INFECT DIS, V52, P837, DOI 10.1093/cid/cir074; *PAHO, 2003, NUMB REP CAS DENG DE; Puccioni-Sohler M, 2009, NEUROLOGY, V73, P1413, DOI 10.1212/WNL.0b013e3181bd8258; Ratnam I, 2013, J TRAVEL MED, V20, P384, DOI 10.1111/jtm.12052; REES JH, 1995, NEW ENGL J MED, V333, P1374, DOI 10.1056/NEJM199511233332102; Rocha MSG, 2004, ARQ NEURO-PSIQUIAT, V62, P33, DOI 10.1590/S0004-282X2004000100006; Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003; Sejvar JJ, 2003, EMERG INFECT DIS, V9, P788; Soares CN, 2006, J NEUROL SCI, V249, P19, DOI 10.1016/j.jns.2006.05.068; Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5; Susuki K, 2004, NEUROLOGY, V62, P949, DOI 10.1212/01.WNL.0000115123.42929.FD; van Koningsveld R, 2001, NEUROLOGY, V56, P1467, DOI 10.1212/WNL.56.11.1467; Van Koningsveld R, 2000, NEUROLOGY, V54, P620, DOI 10.1212/WNL.54.3.620; van Koningsveld R, 2007, LANCET NEUROL, V6, P589, DOI 10.1016/S1471-4422(07)70130-8; Visser LH, 1996, NEUROLOGY, V47, P668, DOI 10.1212/WNL.47.3.668; Vucic S, 2009, J CLIN NEUROSCI, V16, P733, DOI 10.1016/j.jocn.2008.08.033	27	5	5	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA		1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	JUN	2016	94	6					1380	1384		10.4269/ajtmh.15-0070				5	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	ET3UV	WOS:000400205900032	27022152	Bronze, Green Published			2019-04-02	
J	Robertson, LJ; Devleesschauwer, B; de Noya, BA; Gonzalez, ON; Torgerson, PR				Robertson, Lucy J.; Devleesschauwer, Brecht; Alarcon de Noya, Belkisyole; Noya Gonzalez, Oscar; Torgerson, Paul R.			Trypanosoma cruzi: Time for International Recognition as a Foodborne Parasite	PLOS NEGLECTED TROPICAL DISEASES			English	Article							ACUTE CHAGAS-DISEASE; GLOBAL BURDEN; SYSTEMATIC ANALYSIS; TRANSMISSION; REDUVIIDAE; INFECTIVITY; DISABILITY; HEMIPTERA; INJURIES; MUCOSAL		[Robertson, Lucy J.] Norwegian Univ Life Sci, Sect Microbiol Immunol & Parasitol, Dept Food Safety & Infect Biol, Parasitol Lab, Adamstuen Campus, Oslo, Norway; [Devleesschauwer, Brecht] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Ghent, Belgium; [Devleesschauwer, Brecht] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Devleesschauwer, Brecht] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA; [Alarcon de Noya, Belkisyole] Cent Univ Venezuela, Fac Med, Inst Med Trop, Immunol Sect, Caracas, Venezuela; [Noya Gonzalez, Oscar] Cent Univ Venezuela, Fac Med, Inst Med Trop, Biohelmintiasis Sect, Caracas, Venezuela; [Noya Gonzalez, Oscar] MPPS, Inst Nacl Higiene, Inst Altos Estudios Dr Arnoldo Gabaldon, Ctr Estudios Malaria, Caracas, Venezuela; [Torgerson, Paul R.] Univ Zurich, Vetsuisse Fac, Epidemiol Sect, Zurich, Switzerland	Robertson, LJ (reprint author), Norwegian Univ Life Sci, Sect Microbiol Immunol & Parasitol, Dept Food Safety & Infect Biol, Parasitol Lab, Adamstuen Campus, Oslo, Norway.	lucy.robertson@nmbu.no	Devleesschauwer, Brecht/G-9895-2018; Torgerson, Paul/A-7510-2010; Torgerson, Paul/M-4447-2013	Devleesschauwer, Brecht/0000-0002-2867-6892; Torgerson, Paul/0000-0003-4277-9983; Torgerson, Paul/0000-0003-4277-9983			Alarcon de Noya B, 2015, SPRINGER BRIEFS FOOD; de Noya BA, 2015, ACTA TROP, V151, P94, DOI 10.1016/j.actatropica.2015.06.004; Bocchi EA, 2013, CURR CARDIOL REV, V9, P147, DOI 10.2174/1573403X11309020007; Andrade DV, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003010; Barbosa RL, 2012, J FOOD PROTECT, V75, P601, DOI 10.4315/0362-028X.JFP-11-233; Bastos CJC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000711; Bestetti RB, 2015, NEW ENGL J MED, V373, P1881, DOI [10.1056/NEJMra1410150, 10.1056/NEJMc1510996]; Calvo-Mendez M. Lourdes, 1994, Revista Latinoamericana de Microbiologia, V36, P67; Carrasco HJ, 2005, INT J PARASITOL, V35, P1379, DOI 10.1016/j.ijpara.2005.05.003; Diaz-Bello Z, 2011, BIOMEDICA S3, V31, P278; Diaz-Ungria C, 1970, REV VET VZLANA, V44, P114; Eickhoff CS, 2013, MEM I OSWALDO CRUZ, V108, P508, DOI [10.1590/0074-0276108042013018, 10.1590/S0074-02762013000400018]; Ferreira Cláudio Santos, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P41, DOI 10.1590/S0036-46652003000100008; Hoft DF, 1996, AM J TROP MED HYG, V55, P360, DOI 10.4269/ajtmh.1996.55.360; Lee BY, 2013, LANCET INFECT DIS, V13, P342, DOI 10.1016/S1473-3099(13)70002-1; Loza-Murguia M, 2010, NEOTROP ENTOMOL, V39, P799, DOI 10.1590/S1519-566X2010000500020; Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114; Matias Reyes-Lugo, 2009, REV BIOMED, V20, P180; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Noya O, 2015, REV ESP EPIDEM XI WO, P23; Pereira KS, 2010, ADV FOOD NUTR RES, V59, P63, DOI 10.1016/S1043-4526(10)59003-X; Pereira KS, J FOOD PROT, V72, P441; Reyes-Lugo M, 2000, T ROY SOC TROP MED H, V94, P508, DOI 10.1016/S0035-9203(00)90068-3; Roque ALR, 2008, AM J TROP MED HYG, V79, P742, DOI 10.4269/ajtmh.2008.79.742; Schmunis G, 2013, LANCET INFECT DIS, V13, P283, DOI 10.1016/S1473-3099(13)70032-X; Schofield CJ, 1999, MEM I OSWALDO CRUZ, V94, P375, DOI 10.1590/S0074-02761999000700073; Torgerson PR, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001920; UrdanetaMorales S, 1996, MEM I OSWALDO CRUZ, V91, P399, DOI 10.1590/S0074-02761996000400002; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Yoshida N, 2008, PARASITOL INT, V57, P105, DOI 10.1016/j.parint.2007.12.008; Yoshida N, 2011, TRENDS PARASITOL, V27, P459, DOI 10.1016/j.pt.2011.06.006; Zeledon R., 1977, Acta Tropica, V34, P65	32	13	13	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUN	2016	10	6							e0004656	10.1371/journal.pntd.0004656				6	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DQ6WL	WOS:000379346200007	27253136	DOAJ Gold, Green Published			2019-04-02	
J	Rooze, S; Mathieu, F; Claus, W; Yangzom, T; Yangzom, D; Goyens, P; de Maertelaer, V				Rooze, Shancy; Mathieu, Francoise; Claus, William; Yangzom, Tashi; Yangzom, Dikki; Goyens, Philippe; de Maertelaer, Viviane			Effect of calcium and vitamin D on growth, rickets and Kashin-Beck disease in 0-to 5-year-old children in a rural area of central Tibet	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						rickets; Kashin-Beck disease; stunting; Tibet Autonomous Region; rachitisme; maladie de Kashin-Beck; retard de croissance; Region Autonome du Tibet; raquitismo; enfermedad de Kashin-Beck; retraso en el crecimiento; Region Autonoma del Tibet	HIGH-ALTITUDES; ASSOCIATION; PREVALENCE; DEFICIENCY	ObjectiveTo evaluate the effect of calcium (15 mmol/day) and vitamin D (625 g/month), as single supplement or in combination, vs. no supplement on growth, clinical signs of rickets and Kashin-Beck disease (KBD) and dental health. MethodsProspective controlled trial involving children aged 0-5 years living in four groups of villages in a KBD-endemic rural area of central Tibet who received either calcium and/or vitamin D or no supplement. The cohort was followed over 3 years. Primary outcome was the impact of the different supplementation regimes on KBD, rickets and growth; secondary outcomes were impact on urinary levels of calcium and phosphorus, biomarkers of bone and cartilage turnover, and dental health. ResultsNo difference was observed between the four groups with regard to anthropometric data, rickets, KBD, urinary levels of CrossLaps((R)) and CartiLaps((R)). Weight for height or age, mid-upper arm circumference and skinfold thickness decreased in the four groups. Height for age increased and the prevalence of KBD fell in the four groups. Dental health was better in the group receiving calcium and vitamin D. Urinary calcium levels increased after 3 years of follow-up in all groups; the group receiving vitamin D had a higher increase (P-value: 0.044). The same global increase was observed for urinary phosphorus levels; the group receiving calcium had a higher increase (P-value: 0.01). ConclusionsCalcium and vitamin D failed to improve growth and bone metabolism of children living in a KBD-endemic rural area. Calcium and vitamin D supplementation improved dental health. ObjectifEvaluer l'effet du calcium (15 mmol/jour) et de la vitamine D (625 g/mois), comme supplement unique ou en combinaison, par rapport a aucun supplement sur la croissance, les signes cliniques du rachitisme et de la maladie de Kashin-Beck (KBD) et la sante dentaire. MethodesEssai controle prospectif impliquant des enfants ages de 0 a 5 ans vivant dans 4 groupes de villages dans une zone rurale endemique pour la KBD dans le centre du Tibet qui ont recu soit du calcium et/ou de la vitamine D ou aucun supplement. La cohorte a ete suivie sur 3 ans. Le principal resultat a ete l'impact des differents regimes de supplementation sur la KBD, le rachitisme et la croissance; les resultats secondaires etaient l'impact sur les taux urinaires de calcium et de phosphore, biomarqueurs de l'os et du renouvellement du cartilage, et la sante dentaire. ResultatsAucune difference n'a ete observee entre les 4 groupes en ce qui concerne les donnees anthropometriques, le rachitisme, la KBD, les taux urinaires de Croslaps((R)) et de Cartilaps((R)). Le poids pour la taille ou de l'age, la circonference a mi-hauteur du bras et l'epaisseur du pli cutane ont diminue dans les 4 groupes. La taille pour l'age a augmente et la prevalence de la KBD a chute dans les quatre groupes. La sante dentaire etait meilleure dans le groupe recevant du calcium et de la vitamine D. Les taux urinaires de calcium ont augmente apres 3 ans de suivi dans tous les groupes; le groupe recevant la vitamine D a connu une augmentation plus elevee (valeur p: 0,044). La meme augmentation globale a ete observee pour les taux de phosphore urinaires; le groupe recevant le calcium a connu une augmentation plus elevee (valeur p: 0,01). ConclusionsLe calcium et la vitamine D n'ont pas reussi a ameliorer la croissance et le metabolisme osseux des enfants vivant dans une zone rurale endemique pour la KBD. La supplementation en calcium et en vitamine D a ameliore la sante dentaire. ObjetivoEvaluar el efecto del calcio (15 mmol/dia) y de la vitamina D (625 g/meses), como suplementos unicos o en combinacion versus la no suplementacion, sobre el crecimiento, los signos clinicos de raquitismo y la enfermedad de Kashin-Beck (EKB) y la salud dental. MetodosEnsayo prospectivo y controlado en una cohorte de ninos con edades entre los 0-5 anos, que vivian en 4 grupos de poblados en un area rural endemica para EKB en el Tibet Central. Los ninos recibieron calcio y/o vitamina D o ningun suplemento. La cohorte fue seguida a lo largo de 3 anos. El resultado principal era el impacto de los diferentes que los diferentes regimenes de suplementos tenian sobre la EKB, el raquitismo y el crecimiento. Los resultados secundarios eran el impacto sobre los niveles en orina de biomarcadores de calcio y fosforo, biomarcadores de recambio de hueso y cartilago, y salud dental. ResultadoNo se observaron diferencias entre los 4 grupos con respecto a datos antropometricos, raquitismo, EKB, o niveles en orina de Croslaps((R)) y Cartilaps((R)). El peso por altura o edad, la medida de la circunferencia del brazo superior y el espesor del pliegue cutaneo disminuyo en los 4 grupos. La altura por edad aumento y la prevalencia de EKB disminuyo en los cuatro grupos. La salud dental era mejor en el grupo que recibia calcio y vitamina D. Los niveles de calcio en orina aumentaron tras 3 anos de seguimiento en todos los grupos; el grupo que recibia vitamina D tenia un mayor aumento (p = 0,044). El mismo aumento global se observo para los niveles de fosforo en orina; el grupo que recibio calcio tuvo un mayor aumento (p = 0,01). ConclusionesEl calcio y la vitamina D no consiguieron mejorar el crecimiento y el metabolismo oseo en ninos viviendo en un area rural endemica para la EKB. La suplementacion con calcio y vitamina D mejoro la salud dental.	[Rooze, Shancy; Goyens, Philippe] Univ Libre Bruxelles, Univ Childrens Hosp Queen Fabiola, Nutr & Metab Unit, Rue Eugene Desmet 15, B-1090 Brussels, Belgium; [Mathieu, Francoise; Claus, William] Kashin Beck Dis Fund, Forrieres, Belgium; [Yangzom, Tashi; Yangzom, Dikki] Kashin Beck Dis Fdn, Tibet, Peoples R China; [de Maertelaer, Viviane] Univ Libre Bruxelles, Dept Biostat & Med Informat, Inst Interdisciplinary Res Human & Mol Biol, Brussels, Belgium	Rooze, S (reprint author), Univ Libre Bruxelles, Univ Childrens Hosp Queen Fabiola, Nutr & Metab Unit, Rue Eugene Desmet 15, B-1090 Brussels, Belgium.	srooze@ulb.ac.be			Belgian Government, Department of Foreign Affairs	We thank Dominique Willems (Clinical biology, CHU Brugmann, Universite Libre de Bruxelles, Belgium) and Pierre Bergmann (Department of Radioisotopes, CHU Brugmann, Universite Libre de Bruxelles, Belgium). This study was made possible thanks to the close collaboration and the support of the Center for Disease Control and Prevention of Tibet Autonomous Region (P.R. China). We are indebted to the former National Institute of Nutrition and Food Safety (CDC in Beijing) and the China National Center for Food Safety Risk Assessment, which performed all biological analyses. We are very grateful to the Belgian Government, Department of Foreign Affairs, for financial support.	Baroncelli GI, 2000, ACTA PAEDIATR, V89, P513, DOI 10.1080/080352500750027763; Crofton PM, 2002, CLIN CHEM, V48, P671; Dang S, 2004, EUR J CLIN NUTR, V58, P938, DOI 10.1038/sj.ejcn.1601915; Davit-Beal T, 2014, PEDIATRICS, V133, pE1077, DOI 10.1542/peds.2013-0733; desVoghel P, 2008, THESIS; Dutta A, 2009, FOOD NUTR BULL, V30, P77, DOI 10.1177/156482650903000108; Fisher AM, 2005, STATE GROWTH SOCIAL; Gajewska Joanna, 2005, Wiad Lek, V58, P476; Garnero P, 2002, ARTHRITIS RHEUM, V46, P21, DOI 10.1002/1529-0131(200201)46:1<21::AID-ART10061>3.0.CO;2-Q; Goyens P, 2008, BIG BONE DIS MULTIDI, P57; Harris NS, 2001, NEW ENGL J MED, V344, P341, DOI 10.1056/NEJM200102013440504; Haubruge E, 2001, INT ORTHOP, V25, P159, DOI 10.1007/s002640100240; Kolsteren P, 1995, CAHIERS SANTE, V5, P247; Lin HS, 2014, KAOHSIUNG J MED SCI, V30, P206, DOI 10.1016/j.kjms.2013.12.002; Malaisse F, 2008, BIG BONE DIS MULTIDI, P37; Martelli FS, 2014, CLIN CASES MINER BON, V11, P15, DOI 10.11138/ccmbm/2014.11.1.015; Mathieu F, 1997, INT ORTHOP, V21, P151, DOI 10.1007/s002640050139; Moreno-Reyes R, 2001, INT ORTHOP, V25, P164, DOI 10.1007/s002640000216; Rooze S, 2012, EUR J PEDIATR, V171, P1185, DOI 10.1007/s00431-012-1699-3; Suetens C, 2001, INT ORTHOP, V25, P180, DOI 10.1007/s002640100247; United Nations Economic and Social Commission for Asia and Pacific, 2010, BAS DAT POP SIT; Wang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028439; Wu SX, 2014, GENE, V535, P124, DOI 10.1016/j.gene.2013.11.050; Yoa Y, 2011, NUTRITION, V27, P1095; Zhan Y, 2014, J DENT RES, V93, P639, DOI 10.1177/0022034514534985; Zhang Q, 2000, MOUNTAIN GEOECOLOGY	26	1	1	4	23	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	JUN	2016	21	6					768	775		10.1111/tmi.12706				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	DP5PB	WOS:000378548400009	27102369	Bronze			2019-04-02	
J	Tabernero, P; Parker, M; Ravinetto, R; Phanouvong, S; Yeung, S; Kitutu, FE; Cheah, PY; Mayxay, M; Guerin, PJ; Newton, PN				Tabernero, Patricia; Parker, Michael; Ravinetto, Raffaella; Phanouvong, Souly; Yeung, Shunmay; Kitutu, Freddy E.; Cheah, Phaik Yeong; Mayxay, Mayfong; Guerin, Philippe J.; Newton, Paul N.			Ethical challenges in designing and conducting medicine quality surveys	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						ethics; poor quality; medicines; surveys; falsified and substandard medicines; counterfeit; ethique; mauvaise qualite; medicaments; surveillances; medicaments falsifies et de qualite inferieure; contrefacon; etica; mala calidad; medicamentos; encuestas; medicamentos falsificados y subestandar; falsificacion	PLASMODIUM-FALCIPARUM MALARIA; MIDDLE-INCOME COUNTRIES; HEALTH SYSTEMS RESEARCH; POOR-QUALITY; CONCEPTUAL EXPLORATION; SUBSTANDARD MEDICINES; CLINICAL-RESEARCH; ANTI-MALARIALS; RESISTANCE; DRUGS	ObjectivesIn this paper we discuss the main ethical challenges related to the conduct of medicine quality surveys and make suggestions on how to address them. MethodMost evidence-based information regarding medicine quality derives from surveys. However, existing research ethical guidelines do not provide specific guidance for medicine quality surveys. Hence, those conducting surveys are often left wondering how to judge what counts as best practice. A list of the main ethical challenges in the design and conduct of surveys is presented. Results and conclusionsIt is vital that the design and conduct of medicine quality surveys uphold moral and ethical obligations and analyse the ethical implications and consequences of such work. These aspects include the impact on the local availability of and access to medicines; the confidentiality and privacy of the surveyors and the surveyed; questions as to whether outlet staff personnel should be told they are part of a survey; the need of ethical and regulatory approvals; and how the findings should be disseminated. Medicine quality surveys should ideally be conducted in partnership with the relevant national Medicine Regulatory Authorities. An international, but contextually sensitive, model of good ethical practice for such surveys is needed. ObjectifsIdentifier et discuter les principaux enjeux ethiques lies a la conduite des surveillances et formuler des suggestions sur la facon de les aborder. MethodeLa plupart des informations fondees sur des preuves en ce qui concerne la qualite des medicaments decoule des enquetes. Cependant, les directives ethiques de recherche existantes ne fournissent pas d'indications precises pour les enquetes sur la qualite de la medecine. Par consequent, ceux menant des enquetes sont souvent laisses a se demander comment juger ce qui compte comme la meilleure pratique. Une liste des principaux defis ethiques dans la conception et la conduite des enquetes est presentee. Resultats et conclusionsIl est essentiel que la conception et la conduite des enquetes sur la qualite de la medecine respectent les obligations morales et ethiques et analysent les implications ethiques et les consequences d'un tel travail. Celles-ci sont: l'impact sur la disponibilite locale et l'acces aux medicaments, la confidentialite et la protection de la vie privee des enqueteurs et des enquetes, des questions quant a savoir si les membres du personnel de sortie doivent etre informes quils font partie d'une enquete, la necessite d'approbations reglementaires et d'ethique et la facon dont les resultats devraient etre diffuses. Les enquetes sur la qualite de la medecine devraient idealement etre menees en partenariat avec les autorites relevantes de reglementation des medicaments nationaux. Un modele international, mais contextuellement sensible, de bonne pratique ethique pour ces enquetes est necessaire. ObjetivosIdentificar y discutir los principales retos eticos relacionados con la realizacion de encuestas y hacer sugerencias sobre la forma de abordarlas. MetodoLa mayor parte de la informacion basada en la evidencia en lo que respecta a la calidad de los medicamentos se obtiene a traves de encuestas. Sin embargo, las guias eticas de investigacion existentes no proveen una guia especifica para las encuestas de calidad de medicamentos. Por lo tanto, aquellos que llevan a cabo las encuestas a menudo no saben como definir lo que se considera como la mejor practica. Aqui se presenta una lista de los principales retos eticos en el diseno y en la realizacion de encuestas. Resultados y conclusionesEs vital que el diseno y el pase de encuestas de calidad de medicamentos apoyen obligaciones eticas y morales, asi como el analisis de las implicaciones y las consecuencias eticas de dicho trabajo. Estas son: el impacto sobre la disponibilidad local de y el acceso a las medicinas; la confidencialidad y la privacidad de los encuestados y encuestadores; preguntas sobre si los trabajadores del punto de entrega deberian ser avisados de que estan formando parte de un estudio; la necesidad de aprobaciones eticas y regulatorias; y como diseminar los hallazgos obtenidos. Las encuestas sobre la calidad de los medicamentos deberian idealmente realizarse junto con las autoridades nacionales relevantes en regulacion de medicamentos. Se requiere un modelo internacional, pero contextualmente sensible, de buenas practicas eticas	[Tabernero, Patricia; Mayxay, Mayfong; Newton, Paul N.] Mahosot Hosp, Lao Oxford Mahosot Hosp Wellcome Trust Res Unit, Viangchan, Laos; [Tabernero, Patricia; Guerin, Philippe J.; Newton, Paul N.] WorldWide Antimalarial Resistance Network, Oxford, England; [Tabernero, Patricia; Cheah, Phaik Yeong; Mayxay, Mayfong; Guerin, Philippe J.; Newton, Paul N.] Univ Oxford, Ctr Trop Med & Global Hlth, Oxford, England; [Parker, Michael; Cheah, Phaik Yeong] Univ Oxford, Ethox Ctr, Oxford, England; [Ravinetto, Raffaella] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Ravinetto, Raffaella] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium; [Phanouvong, Souly] US Pharmacopeial Convent Inc, Promoting Qual Med Program, US Pharmacopeia, Rockville, MD USA; [Yeung, Shunmay] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Global Hlth & Dev, London WC1, England; [Kitutu, Freddy E.] Makerere Univ, Coll Hlth Sci, Dept Pharm, Kampala, Uganda; [Kitutu, Freddy E.] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda; [Kitutu, Freddy E.] Uppsala Univ, Dept Womens & Childrens Hlth, Int Maternal & Child Hlth Unit, Uppsala, Sweden; [Cheah, Phaik Yeong] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Mayxay, Mayfong] Univ Hlth Sci, Fac Postgrad Studies, Viangchan, Laos; [Newton, Paul N.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England	Tabernero, P; Newton, PN (reprint author), Ctr Trop Med & Global Hlth, Roosevelt Dr, Oxford OX3 7FZ, England.	patriciataberneroestevez@gmail.com; paul.newton@tropmedres.ac	Tabernero, Patricia/O-8340-2017	Tabernero, Patricia/0000-0002-1015-6207; Kitutu, Freddy/0000-0003-2277-9572; Guerin, Philippe/0000-0002-6008-2963	Institut de Recherche sur l'Asie du Sud-Est Contemporaine (IRASEC); French Ministry of Foreign Affairs and International Development; Wellcome Trust of Great Britain; Wellcome Trust; Belgian Directorate-General for Development Cooperation; Institute of Tropical Medicine, Antwerp	We are very grateful to all those who have given advice and have helped in the completion of this publication: Roger Bate, American Enterprise Institute, Washington D.C., United States of America; Facundo M. Fernandez, Georgia Institute of Technology, Atlanta, Georgia, United States of America; Michael D. Green, US Centers for Disease Control and Prevention (CDC), Division of Parasitic Diseases and Malaria, Atlanta, Georgia, United States of America; Manuel Hetzel, Swiss Tropical and Public Health Institute, Switzerland; Harparkash Kaur, London School of Hygiene and Tropical Medicine, United Kingdom; Kazuko Kimura, Institute of Medical, Pharmaceutical & Health Sciences, Kanazawa University, Kanazawa-city, Japan; Henrik Pallos, Kanazawa University, Kanazawacity, Japan; Philippe Passmore, Pharmaceutical Services Management (PSM) International, Perth, Australia; Benedetta Schiavetti, QUAMED, Institute of Tropical Medicine Antwerp, Belgium. Patricia Tabernero was supported by WWARN funded by the Institut de Recherche sur l'Asie du Sud-Est Contemporaine (IRASEC), with finance from the French Ministry of Foreign Affairs and International Development and the Wellcome Trust of Great Britain. Paul N. Newton is supported by the Wellcome Trust. Michael Parker's and Phaik Yeong Cheah's research in global health ethics is supported by a Wellcome Trust Strategic Award. Raffaella Ravinetto's research in the field of quality of medicines is carried out within QUAMED, a project supported by the Belgian Directorate-General for Development Cooperation under a Framework Agreement with the Institute of Tropical Medicine, Antwerp.	AAA, 1998, COD ETH AM ANTHR ASS; Aldhous P, 2005, NATURE, V434, P132, DOI 10.1038/434132a; American Sociological Association, 2014, ASA COD OF ETH; Attaran A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7381; Caudron JM, 2008, TROP MED INT HEALTH, V13, P1062, DOI 10.1111/j.1365-3156.2008.02106.x; Cockburn Robert, 2005, PLoS Med, V2, pe100, DOI 10.1371/journal.pmed.0020100; Council for International Organizations of Medical Sciences, 2002, INT ETH GUID BIOM RE; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Dorlo TPC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001544; Emanuel EJ, 2004, J INFECT DIS, V189, P930, DOI 10.1086/381709; Francis PA, 2003, TIP ICEBERG; Hyder AA, 2014, AM J BIOETHICS, V14, pW1, DOI 10.1080/15265161.2014.881212; Hyder AA, 2014, AM J BIOETHICS, V14, P28, DOI 10.1080/15265161.2013.868950; ICH, 1996, GUID GOOD CLIN PRACT; IOM, 2013, COUNT PROBL FALS SUB; Keoluangkhot V, 2008, AM J TROP MED HYG, V78, P552, DOI 10.4269/ajtmh.2008.78.552; Khan MH, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-306; Laing R, 2004, INT J TUBERC LUNG D, V8, P1043; Leslie T, 2009, EMERG INFECT DIS, V15, P1753, DOI 10.3201/eid1511.090886; Madden JM, 1997, SOC SCI MED, V45, P1465, DOI 10.1016/S0277-9536(97)00076-2; Newton PN, 2006, PLOS MED, V3, P752, DOI 10.1371/journal.pmed.0030197; Newton PN, 2006, LANCET INFECT DIS, V6, P602, DOI 10.1016/S1473-3099(06)70581-3; Newton PN, 2014, LANCET GLOB HEALTH, V2, pE509, DOI 10.1016/S2214-109X(14)70279-7; Newton PN, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001139; Newton PN, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-352; Newton PN, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000052; Nishtar S, 2012, LANCET, V379, P1084, DOI 10.1016/S0140-6736(12)60277-3; Nuffield Foundation, 1991, NUFF COUNC BIOETH; Organization WH, 2014, QAS14590 ORG WH; Pouplin T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102047; Ravinetto R, 2011, TROP MED INT HEALTH, V16, P527, DOI 10.1111/j.1365-3156.2011.02732.x; Ravinetto Raffaella M, 2013, Indian J Med Ethics, V10, P118; Ravinetto RM, 2012, TROP MED INT HEALTH, V17, P1412, DOI 10.1111/j.1365-3156.2012.03076.x; Schopper D, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0002-3; Syhakhang L, 2004, HEALTH POLICY PLANN, V19, P391, DOI 10.1093/heapol/czh054; Tabernero P, 2012, PATHOG GLOB HEALTH, V106, P77, DOI 10.1179/204777312X13419245939520; Tabernero P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-139; United Nations Human Rights Council, 2013, ACC MED CONT RIGHT E; United States Pharmacopeial Convention (USP), 2014, MED QUAL DAT MQDB; US Department of Health and Human Services, 1979, THE BELM REP; White NJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-253; WHO, 2014, QUAL PRACT BAS BIOM; WHO, 2013, ETH ISS PAT SAF RES; WHO, 2012, AMSM1INF1 WHO; WHO, 2014, MED PROD AL; *WHO, 1995, GUID GOOD CLIN PRACT; World Health Organization, 2014, ETH CHALL STUD DES I; World Health Organization, 2012, 6519 WHA WHO; World Health Organization, 2011, STAND OP GUID ETH RE; World Health Organization, 2011, SURV QUAL ANT MED CI; World Medical Association (WMA), 2013, WMA DECL HELS ETH PR	51	4	4	1	18	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	JUN	2016	21	6					799	806		10.1111/tmi.12707				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	DP5PB	WOS:000378548400013	27102573	Green Published, Other Gold			2019-04-02	
J	Zater, H; Huet, J; Fontaine, V; Benayache, S; Stevigny, C; Duez, P; Benayache, F				Zater, Hanene; Huet, Joelle; Fontaine, Veronique; Benayache, Samir; Stevigny, Caroline; Duez, Pierre; Benayache, Fadila			Chemical constituents, cytotoxic, antifungal and antimicrobial properties of Centaurea diluta Ait. subsp algeriensis (Coss. & Dur.) Maire	ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE			English	Article						Flavonoids; Lignans; Centaurea diluta; Asteraceae; Cytotoxic activity	BIOACTIVITY-GUIDED ISOLATION; CELL-CYCLE ARREST; SESQUITERPENE LACTONES; ANTIPROLIFERATIVE COMPOUNDS; SECONDARY METABOLITES; ANTIOXIDANT ACTIVITY; WILD BORAGINACEAE; CORDIA-GILLETII; POLYACETYLENVERBINDUNGEN; PROLIFERATION	Objective: To investigate the chemical composition of a moderately polar extract (CHCl3 soluble part of the MeOH-H2O extract) obtained from the aerial parts (leaves and flowers) of Centaurea diluta Ait. subsp. algeriensis (Coss. & Dur.) Maire, a species endemic to Algeria and Morocco on which no reports are available to date. To evaluate in vitro the cytotoxic, antifungal and antimicrobial activities of this extract and the cytotoxic and antimicrobial activities of its isolated secondary metabolites. Methods: The cytotoxic effects of the extract were investigated on 3 human cancer cell lines i.e. the A549 non-small-cell lung carcinoma (NSCLC), the MCF7 breast adenocarcinoma and the U373 glioblastoma using a MTT colorimetric assay. Biological data allowed to guide the fractionation of the extract by separation and purification on silica gel 60 (CC and TLC). The isolated compounds which were characterized by spectral analysis, mainly HR-ESIMS, HR-EIMS, UV and NMR experiments (H-1, C-13, COSY, ROESY, HSQC and HMBC) and comparison of their spectroscopic data with those reported in the literature, were evaluated for cytotoxic activities on six cancer cell lines (A549, MCF7, U373, Hs683 human glioma, PC3 human prostate and B16-F10 murine melanoma). The direct and indirect antibacterial and antifungal activities were determined using microdilution methods for the raw extract and TLC-bioautography and microdilution methods against standard and clinical strains for the isolated compounds. Results: The raw extract reduced cell viability with IC(50)s of 27, 25 and 21 mu g/mL on A549, MCF7 and U373, respectively. Five secondary metabolites: two phenolic compounds (vanillin 1, paridol 3), a lignan [(-)-arctigenin 2] and two flavonoid aglycones (eupatilin 4 and jaceosidin 5), were then isolated from this extract. Moderate cytotoxic effects were observed for (-)-arctigenin 2 (IC50s: 28 and 33 mu M on Hs683 and B16-F10, respectively), eupatilin 4 (IC50s: 33 and 47 mM on B16-F10 and PC3, respectively) and jaceosidin 5 (IC50s: 32 and 40 mM on PC3 and B16-F10, respectively). Conclusions: All the isolated compounds were described for the first time from this species. Although inactive against 7 tested microorganisms (fungi, bacteria and yeast, human or plant pathogens), the raw extract was able to potentiate the effect of beta-lactam antibiotics on methicillin-resistant Staphylococcus aureus (MRSA), reducing the minimal inhibitory concentrations (MICs) by a factor of 2-32-fold. No synergy was found between the extract and streptomycin. From the five isolated compounds only jaseosidin 5 showed a moderate antimicrobial activity.	[Zater, Hanene; Benayache, Samir; Benayache, Fadila] Univ Freres Mentouri Constantine 1, Fac Sci Exactes, Unite Rech Valorisat Ressources Nat Mol Bioact &, Constantine 25000, Algeria; [Zater, Hanene] Univ Ziane Achour, Cite 5 Juillet,Route Moudjbara,BP 3117, Djelfa, Algeria; [Zater, Hanene; Stevigny, Caroline; Duez, Pierre] Univ Libre Bruxelles, Lab Pharmacognosie Bromatol & Nutr Humaine, B-1050 Brussels, Belgium; [Huet, Joelle] Univ Libre Bruxelles, Lab Biopolymere & Nanomat Supramol, B-1050 Brussels, Belgium; [Fontaine, Veronique] Univ Libre Bruxelles, Fac Pharm, Unite Microbiol Pharmaceut & Hyg, B-1050 Brussels, Belgium; [Duez, Pierre] Univ Mons UMONS, Serv Chim Therapeut & Pharmacognosie, B-7000 Mons, Belgium	Benayache, F (reprint author), Univ Freres Mentouri Constantine 1, Fac Sci Exactes, Unite Rech Valorisat Ressources Nat Mol Bioact &, Constantine 25000, Algeria.; Duez, P (reprint author), Univ Libre Bruxelles, Lab Pharmacognosie Bromatol & Nutr Humaine, B-1050 Brussels, Belgium.	pierre.duez@umons.ac.be; fbenayache@yahoo.fr		Benayache, Samir/0000-0003-2298-2466	Algerian government	We thank Algerian government for financial support, HCDS Djelfa for helping us in the process of exploration and the harvest of plant material, professor M. Kaabeche for the identification of the plant material and C. Delporte (Laboratoire de Chimie Pharmaceutique Organique, Faculte de Pharmacie, Universite Libre de Bruxelles (ULB) for the mass spectrometry measurement.	ACLINOU P, 1982, Plantes Medicinales et Phytotherapie, V16, P303; Aktumsek A, 2013, FOOD CHEM, V141, P91, DOI 10.1016/j.foodchem.2013.02.092; Alapetite GP, 1981, FLORE TUNISIE, P1060; Aliouche L, 2007, CHEM NAT COMPD+, V43, P618, DOI 10.1007/s10600-007-0208-9; Arif R, 2004, GAZI U J SCI, V17, P149; Aslan U, 1999, TURK J CHEM, V23, P15; Barnes EC, 2013, PHYTOCHEMISTRY, V93, P162, DOI 10.1016/j.phytochem.2013.02.021; Baytop T, 1999, THERAPY MED PLANTS T, P316; Belkacem S., 2014, Research Journal of Pharmaceutical, Biological and Chemical Sciences, V5, P1275; Ben Jemia M, 2015, REC NAT PROD, V9, P580; BOHLMANN F, 1958, CHEM BER-RECL, V91, P1642, DOI 10.1002/cber.19580910812; BOHLMANN F, 1966, CHEM BER-RECL, V99, P3544, DOI 10.1002/cber.19660991121; BOHLMANN F, 1968, CHEM BER-RECL, V101, P2056, DOI 10.1002/cber.19681010621; Boudjerda A, 2008, BIOCHEM SYST ECOL, V36, P461, DOI 10.1016/j.bse.2007.11.006; Cho JH, 2011, FOOD CHEM TOXICOL, V49, P1737, DOI 10.1016/j.fct.2011.04.019; Ciric A, 2011, J SERB CHEM SOC, V76, P27, DOI 10.2298/JSC100127008C; Csapi B, 2010, PHYTOTHER RES, V24, P1664, DOI 10.1002/ptr.3187; Damak N, 2000, J SOC CHIM TUNIS, V4, P653; Demir S, 2016, PHYTOCHEM LETT, V15, P245, DOI 10.1016/j.phytol.2016.02.012; Djeddi S, 2012, J APPL SCI RES, V8, P2876; Djeddi S, 2007, J NAT PROD, V70, P1796, DOI 10.1021/np070125i; Erol-Dayi O, 2011, FREE RAD ANTIOX, V1, P32; Fakhfakh JA, 2007, NAT PROD RES, V21, P1037, DOI 10.1080/14786410701483028; Gelbrich T, 2013, CRYST GROWTH DES, V13, P1206, DOI 10.1021/cg301639r; Ifantis TM, 2013, PHYTOCHEMISTRY, V94, P159, DOI 10.1016/j.phytochem.2013.05.014; Jahandiez E, 1934, CAT PL MAROC, V3, P813; Karamenderes C, 2006, PHARM BIOL, V44, P534, DOI 10.1080/13880200600883080; KHAMMAR A, 2012, EUR J SCI RES, V84, P398; Kitouni R, 2015, CHEM NAT COMPD+, V51, P762, DOI 10.1007/s10600-015-1404-7; Kolli E, 2012, J BRAZIL CHEM SOC, V23, P977, DOI 10.1590/S0103-50532012000500026; Koukoulitsa C, 2005, J COMPUT AID MOL DES, V19, P617, DOI 10.1007/s10822-005-9018-y; Kubacey T. M., 2012, Journal of Pharmacy Research, V5, P3352; Lee JG, 2013, FOOD CHEM TOXICOL, V55, P214, DOI 10.1016/j.fct.2012.12.026; Lopez-Rodriguez M, 2009, ACTA CRYSTALLOGR E, V65, pO1867, DOI 10.1107/S1600536809026701; Lu Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125727; Mathieu V, 2013, MOLECULES, V18, P3543, DOI 10.3390/molecules18033543; Medjroubi K, 2005, FITOTERAPIA, V76, P744, DOI 10.1016/j.fitote.2005.08.005; Mohamad Nasir MI, 2008, CLEAN, V36, P287; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Okusa PN, 2007, J ETHNOPHARMACOL, V112, P476, DOI 10.1016/j.jep.2007.04.003; Okusa PN, 2010, JPC-J PLANAR CHROMAT, V23, P245, DOI 10.1556/JPC.23.2010.4.1; Ozenda P, 1958, FLORE SAHARA SEPTENT, P450; Quezel P, 1963, NOUVELLE FLORE ALGER, P1016; Sajan D, 2006, J MOL STRUCT, V785, P43, DOI 10.1016/j.molstruc.2005.09.041; SARKER SD, 2005, ORIENTAL PHARM EXPT, V5, P246; Seghiri R, 2009, PHYTOCHEM LETT, V2, P114, DOI 10.1016/j.phytol.2009.03.002; Shoeb M, 2006, ARS PHARM, V47, P315; Shoeb M, 2006, PHYTOCHEMISTRY, V67, P2370, DOI 10.1016/j.phytochem.2006.08.012; Shoeb Mohammad, 2007, Rev. bras. farmacogn., V17, P155, DOI 10.1590/S0102-695X2007000200003; Son JE, 2013, PLANTA MED, V79, P1009, DOI 10.1055/s-0033-1350621; Song GC, 2013, MOLECULES, V18, P12877, DOI 10.3390/molecules181012877; Susanti S, 2012, J NAT MED-TOKYO, V66, P614, DOI 10.1007/s11418-012-0628-0; Wang Y. L., 2011, J CHINESE PHARM SCI, V20, P235; Williamson EM, 2001, PHYTOMEDICINE, V8, P401, DOI 10.1078/0944-7113-00060; Yaglioglu AS, 2014, PHYTOCHEM LETT, V8, P213, DOI 10.1016/j.phytol.2014.01.003	55	5	5	0	30	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1995-7645			ASIAN PAC J TROP MED	Asian Pac. J. Trop. Med.	JUN	2016	9	6					554	561		10.1016/j.apjtm.2016.04.016				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	DN9UK	WOS:000377426000006	27262066	DOAJ Gold			2019-04-02	
J	Chaudhury, S; Ockenhouse, CF; Regules, JA; Dutta, S; Wallqvist, A; Jongert, E; Waters, NC; Lemiale, F; Bergmann-Leitner, E				Chaudhury, Sidhartha; Ockenhouse, Christian F.; Regules, Jason A.; Dutta, Sheetij; Wallqvist, Anders; Jongert, Erik; Waters, Norman C.; Lemiale, Franck; Bergmann-Leitner, Elke			The biological function of antibodies induced by the RTS,S/AS01 malaria vaccine candidate is determined by their fine specificity	MALARIA JOURNAL			English	Article						Malaria; Antibody; Phagocytosis; Epitope; Protection	FALCIPARUM CIRCUMSPOROZOITE PROTEIN; C-TERMINAL FRAGMENT; PLASMODIUM-BERGHEI; IMMUNE-RESPONSE; LEISHMANIA PARASITES; PROTECTIVE RESPONSE; NAIVE ADULTS; DOUBLE-BLIND; EFFICACY; CELL	Background: Recent vaccine studies have shown that the magnitude of an antibody response is often insufficient to explain efficacy, suggesting that characteristics regarding the quality of the antibody response, such as its fine specificity and functional activity, may play a major role in protection. Previous studies of the lead malaria vaccine candidate, RTS,S, have shown that circumsporozoite protein (CSP)-specific antibodies and CD4(+) T cell responses are associated with protection, however the role of fine specificity and biological function of CSP-specific antibodies remains to be elucidated. Here, the relationship between fine specificity, opsonization-dependent phagocytic activity and protection in RTS, S-induced antibodies is explored. Methods: A new method for measuring the phagocytic activity mediated by CSP-specific antibodies in THP-1 cells is presented and applied to samples from a recently completed phase 2 RTS,S/AS01 clinical trial. The fine specificity of the antibody response was assessed using ELISA against three antigen constructs of CSP: the central repeat region, the C-terminal domain and the full-length protein. A multi-parameter analysis of phagocytic activity and fine-specificity data was carried out to identify potential correlates of protection in RTS, S. Results: Results from the newly developed assay revealed that serum samples from RTS, S recipients displayed a wide range of robust and repeatable phagocytic activity. Phagocytic activity was correlated with full-length CSP and C-terminal specific antibody titres, but not to repeat region antibody titres, suggesting that phagocytic activity is primarily driven by C-terminal antibodies. Although no significant difference in overall phagocytic activity was observed with respect to protection, phagocytic activity expressed as 'opsonization index', a relative measure that normalizes phagocytic activity with CS antibody titres, was found to be significantly lower in protected subjects than non-protected subjects. Conclusions: Opsonization index was identified as a surrogate marker of protection induced by the RTS,S/AS01 vaccine and determined how antibody fine specificity is linked to opsonization activity. These findings suggest that the role of opsonization in protection in the RTS, S vaccine may be more complex than previously thought, and demonstrate how integrating multiple immune measures can provide insight into underlying mechanisms of immunity and protection.	[Chaudhury, Sidhartha; Wallqvist, Anders] US Army Med Res & Mat Command, Biotechnol High Performance Comp Software Applica, Telemed & Adv Technol Res Ctr, Ft Detrick, MD USA; [Ockenhouse, Christian F.; Lemiale, Franck] PATH Malaria Vaccine Initiat, Washington, DC USA; [Regules, Jason A.] US Army, Dept Clin Res, Med Res Inst Infect Dis, Ft Detrick, MD USA; [Dutta, Sheetij; Waters, Norman C.; Bergmann-Leitner, Elke] Walter Reed Army Inst Res, Malaria Vaccine Branch, US Mil Malaria Res Program, 503 Robert Grant Ave,3W53, Silver Spring, MD 20910 USA; [Jongert, Erik] GSK Vaccine, Rixensart, Belgium	Bergmann-Leitner, E (reprint author), Walter Reed Army Inst Res, Malaria Vaccine Branch, US Mil Malaria Res Program, 503 Robert Grant Ave,3W53, Silver Spring, MD 20910 USA.	elke.s.bergmannleitner.civ@mail.mil	Bergmann-Leitner, Elke/B-3548-2011	Bergmann-Leitner, Elke/0000-0002-8571-8956; wallqvist, anders/0000-0002-9775-7469	PATH Malaria Vaccine Initiative	We would like to thank Ms. Tanisha Robinson and Ms. Lisa Dlugosz for technical assistance and Dominique Wauters (GSK Vaccines) for his input into the scope of work. The opinions and assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the US Army or the US Department of Defense. This paper has been approved for public release with unlimited distribution. Funding for this study was provided by PATH Malaria Vaccine Initiative.	Ajua A, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0605-7; Bergmann-Leitner ES, 2005, INT IMMUNOL, V17, P245, DOI 10.1093/intimm/dxh205; Bournazos S, 2015, J EXP MED, V212, P1361, DOI 10.1084/jem.20151267; CERAMI C, 1992, MOL BIOCHEM PARASIT, V54, P1, DOI 10.1016/0166-6851(92)90089-3; Chanput W, 2014, INT IMMUNOPHARMACOL, V23, P37, DOI 10.1016/j.intimp.2014.08.002; FRIES LF, 1992, P NATL ACAD SCI USA, V89, P358, DOI 10.1073/pnas.89.1.358; GOUNDIS D, 1988, NATURE, V335, P82, DOI 10.1038/335082a0; Graewe S, 2012, FEMS MICROBIOL REV, V36, P111, DOI 10.1111/j.1574-6976.2011.00297.x; Hill DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074627; Kane MM, 2000, CURR OPIN HEMATOL, V7, P26, DOI 10.1097/00062752-200001000-00006; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Leroux-Roels G, 2014, HUM VACC IMMUNOTHER, V10, P2211, DOI 10.4161/hv.29375; MEIS JFGM, 1985, Z PARASITENKD, V71, P473, DOI 10.1007/BF00928350; Meraldi V, 2003, VACCINE, V21, P2485, DOI 10.1016/S0264-410X(03)00093-8; MOSSER DM, 1987, NATURE, V327, P329, DOI 10.1038/327329b0; Ockenhouse CF, 1998, J INFECT DIS, V177, P1664, DOI 10.1086/515331; Ockenhouse CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131571; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Olotu A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115126; Osier FHA, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-108; Pincetic A, 2014, NAT IMMUNOL, V15, P707, DOI 10.1038/ni.2939; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Porter MD, 2013, CLIN VACCINE IMMUNOL, V20, P803, DOI 10.1128/CVI.00066-13; Ramasamy R, 1998, BBA-MOL BASIS DIS, V1406, P10, DOI 10.1016/S0925-4439(97)00078-1; Roggero MA, 2000, EUR J IMMUNOL, V30, P2679, DOI 10.1002/1521-4141(200009)30:9<2679::AID-IMMU2679>3.0.CO;2-#; SCHOFIELD L, 1990, J IMMUNOL, V144, P2781; Schwenk R, 2003, PARASITE IMMUNOL, V25, P17, DOI 10.1046/j.1365-3024.2003.00495.x; Schwenk R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111020; Sedegah M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-185; Stoute JA, 1998, J INFECT DIS, V178, P1139, DOI 10.1086/515657; Teo A, 2015, METHODS MOL BIOL, V1325, P145, DOI 10.1007/978-1-4939-2815-6_12; VANDERBERG JP, 1990, J PROTOZOOL, V37, P528, DOI 10.1111/j.1550-7408.1990.tb01260.x; Wang TT, 2015, CELL, V162, P160, DOI 10.1016/j.cell.2015.06.026; Wang TT, 2015, IMMUNITY, V42, P213, DOI 10.1016/j.immuni.2015.01.022; White MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061395	35	17	17	0	14	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	MAY 28	2016	15								301	10.1186/s12936-016-1348-9				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DN6JN	WOS:000377180200004	27245446	DOAJ Gold, Green Published			2019-04-02	
J	Lagatie, O; Ediage, EN; Debrah, LB; Diels, L; Nolten, C; Vinken, P; Debrah, A; Dillen, L; Silber, S; Stuyver, LJ				Lagatie, Ole; Ediage, Emmanuel Njumbe; Debrah, Linda Batsa; Diels, Luc; Nolten, Christ; Vinken, Petra; Debrah, Alex; Dillen, Lieve; Silber, Steven; Stuyver, Lieven J.			Evaluation of the diagnostic potential of urinary N-Acetyltyramine-O,beta-glucuronide (NATOG) as diagnostic biomarker for Onchocerca volvulus infection	PARASITES & VECTORS			English	Article						Onchocerca volvulus; River blindness; Onchocerciasis; Biomarker; NATOG; Urine; Diagnostic	PARASITE-DERIVED MICRORNAS; JC POLYOMAVIRUS INFECTION; IVERMECTIN TREATMENT; RIVER-BLINDNESS; BIOGENIC-AMINES; BANCROFTIAN FILARIASIS; WOLBACHIA ENDOBACTERIA; WUCHERERIA-BANCROFTI; MICROFLUIDIC DEVICES; DIROFILARIA-IMMITIS	Background: Onchocerciasis, also known as river blindness is one of the neglected tropical diseases affecting millions of people, mainly in sub-Saharan Africa and is caused by the filarial nematode Onchocerca volvulus. Efforts to eliminate this disease are ongoing and are based on mass drug administration programs with the microfilaricide ivermectin. In order to monitor the efficacy of these programs, there is an unmet need for diagnostic tools capable of identifying infected patients. We have investigated the diagnostic potential of urinary N-acetyltyramine-O,beta-glucuronide (NATOG), which is a promising O. volvulus specific biomarker previously identified by urine metabolome analysis. Methods: A liquid chromatography tandem mass spectrometry (LC-MS/MS) method was used to assess the stability characteristics of NATOG and to evaluate the levels of NATOG in study samples. An LC-fluorescence method was also developed. Results: Stability characteristics of NATOG were investigated and shown to be ideally suited for use in tropical settings. Also, an easy and more accessible method based on liquid chromatography coupled to fluorescence detection was developed and shown to have the necessary sensitivity (limit of quantification 1 mu M). Furthermore, we have evaluated the levels of NATOG in a population of 98 nodule-positive individuals from Ghana with no or low levels of microfilaria in the skin and compared them with the levels observed in different control groups (endemic controls (n = 50), non-endemic controls (n = 18) and lymphatic filariasis (n = 51). Only a few (5 %) of nodule-positive individuals showed an increased level (> 10 mu M) of NATOG and there was no statistical difference between the nodule-positive individuals and the control groups (P > 0.05). Conclusions: Results of the present study indicate the limited potential of NATOG as a diagnostic biomarker for O. volvulus infection in amicrofilaridermic individuals.	[Lagatie, Ole; Stuyver, Lieven J.] Janssen R&D, Janssen Diagnost, Turnhoutseweg 30, B-2340 Beerse, Belgium; [Ediage, Emmanuel Njumbe; Diels, Luc; Dillen, Lieve] Janssen R&D, Bioanal, Turnhoutseweg 30, B-2340 Beerse, Belgium; [Debrah, Linda Batsa] Kwame Nkrumah Univ Sci & Technol, Kumasi Ctr Collaborat Res, Kumasi, Ghana; [Nolten, Christ] Janssen R&D, Neurosci, Turnhoutseweg 30, B-2340 Beerse, Belgium; [Vinken, Petra] Janssen R&D, Toxicol, Turnhoutseweg 30, B-2340 Beerse, Belgium; [Debrah, Alex] Kwame Nkrumah Univ Sci & Technol, Fac Allied Hlth Sci, Kumasi, Ghana; [Silber, Steven] Janssen R&D, Janssen Global Publ Hlth, 12 W Sunset Ave, Philadelphia, PA 19118 USA	Lagatie, O (reprint author), Janssen R&D, Janssen Diagnost, Turnhoutseweg 30, B-2340 Beerse, Belgium.	olagatie@its.jnj.com					[Anonymous], 2010, 1 WHO REP NEGL TROP; Borup LH, 2003, CUTIS, V72, P297; Buck AH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6488; Chandrashekar R, 1996, TROP MED INT HEALTH, V1, P575; Debrah AY, 2015, CLIN INFECT DIS, V61, P517, DOI 10.1093/cid/civ363; Denery JR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000834; Duke BOL, 2002, PARASITOLOGY, V125, P431, DOI 10.1017/S0031182002002305; Enk CD, 2006, CLIN DERMATOL, V24, P176, DOI 10.1016/j.clindermatol.2005.11.008; Fiorini GS, 2005, BIOTECHNIQUES, V38, P429, DOI 10.2144/05383RV02; Fu Y, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-3; Garms R, 2015, PARASITOL RES, V114, P1129, DOI 10.1007/s00436-014-4287-9; GEORGE CF, 1981, CLIN PHARMACOKINET, V6, P259, DOI 10.2165/00003088-198106040-00002; Globisch D, 2013, P NATL ACAD SCI USA, V110, P4218, DOI 10.1073/pnas.1221969110; Golden A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069231; Hoerauf A, 2000, LANCET, V355, P1242, DOI 10.1016/S0140-6736(00)02095-X; Hoerauf A, 2001, LANCET, V357, P1415, DOI 10.1016/S0140-6736(00)04581-5; Hoerauf A, 2009, PARASITOL RES, V104, P437, DOI 10.1007/s00436-008-1217-8; Hoerauf A, 2008, MED MICROBIOL IMMUN, V197, P295, DOI 10.1007/s00430-007-0062-1; Hoy AM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002701; Ladero V, 2012, FOOD MICROBIOL, V30, P132, DOI 10.1016/j.fm.2011.12.016; Lagatie O, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-174; Lagatie O, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-158; Lagatie O, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-41; LAVEBRATT C, 1994, T ROY SOC TROP MED H, V88, P303, DOI 10.1016/0035-9203(94)90090-6; Lazar IM, 2015, BIOANALYSIS, V7, P2677, DOI 10.4155/bio.15.164; Lipner EM, 2006, J INFECT DIS, V194, P216, DOI 10.1086/505081; Marcobal A, 2012, CRIT REV FOOD SCI, V52, P448, DOI 10.1080/10408398.2010.500545; MORE SJ, 1990, TROP MED PARASITOL, V41, P403; Osei-Atweneboano MY, 2007, LANCET, V369, P2021, DOI 10.1016/S0140-6736(07)60942-8; Perez M, 2015, APPL MICROBIOL BIOT, V99, P3547, DOI 10.1007/s00253-014-6301-7; Pion SDS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002084; Poole CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096498; Poole CB, 2010, MOL BIOCHEM PARASIT, V169, P87, DOI 10.1016/j.molbiopara.2009.10.004; Quintana JF, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0656-1; Spano G, 2010, EUR J CLIN NUTR, V64, pS95, DOI 10.1038/ejcn.2010.218; Specht S, 2009, PARASITOL RES, V105, P1531, DOI 10.1007/s00436-009-1588-5; Steel C, 2015, CLIN VACCINE IMMUNOL, V22, P896, DOI 10.1128/CVI.00227-15; Stuyver LJ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-192; Suzzi G, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00472; TAYLOR HR, 1989, AM J TROP MED HYG, V41, P467, DOI 10.4269/ajtmh.1989.41.467; Tritten L, 2014, MOL BIOCHEM PARASIT, V198, P14, DOI 10.1016/j.molbiopara.2014.11.001; Tritten L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002971; Van Loy T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070950; Vlaminck J, 2015, TRENDS PARASITOL, V31, P571, DOI 10.1016/j.pt.2015.06.007; Waikar SS, 2010, KIDNEY INT, V78, P486, DOI 10.1038/ki.2010.165; Warrack BM, 2009, J CHROMATOGR B, V877, P547, DOI 10.1016/j.jchromb.2009.01.007; Weil GJ, 2013, AM J TROP MED HYG, V89, P11, DOI 10.4269/ajtmh.13-0089; Weil GJ, 2000, J INFECT DIS, V182, P1796, DOI 10.1086/317629; WEIL GJ, 1987, EXP PARASITOL, V64, P244, DOI 10.1016/0014-4894(87)90149-4; Weil GJ, 1997, PARASITOL TODAY, V13, P401, DOI 10.1016/S0169-4758(97)01130-7; YU PH, 1979, CAN J BIOCHEM CELL B, V57, P1204, DOI 10.1139/o79-157	51	7	7	2	7	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	MAY 23	2016	9								302	10.1186/s13071-016-1582-6				10	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	DN8NK	WOS:000377335700001	27216752	DOAJ Gold, Green Published			2019-04-02	
J	Canavati, SE; Lawpoolsri, S; Quintero, CE; Nguon, C; Ly, P; Pukrittayakamee, S; Sintasath, D; Singhasivanon, P; Grietens, KP; Whittaker, MA				Canavati, Sara E.; Lawpoolsri, Saranath; Quintero, Cesia E.; Nguon, Chea; Ly, Po; Pukrittayakamee, Sasithon; Sintasath, David; Singhasivanon, Pratap; Grietens, Koen Peeters; Whittaker, Maxine Anne			Village malaria worker performance key to the elimination of artemisinin-resistant malaria: a Western Cambodia health system assessment	MALARIA JOURNAL			English	Article						Community malaria worker; Artemisinin resistance; Cambodia; Malaria elimination; Health system strengthening	COMMUNITY PARTICIPATION; MANAGEMENT; KNOWLEDGE; SATISFACTION; MOTIVATION; ATTITUDES; DISTRICT; ETHIOPIA; QUALITY; SENEGAL	Background: Village malaria workers (VMWs) and mobile malaria workers (MMWs) are a critical component of Cambodia's national strategy to eliminate Plasmodium falciparum malaria by 2025. Since 2004, VMWs have been providing malaria diagnosis through the use of rapid diagnostic tests and free-of-charge artemisinin-based combination therapy in villages more than 5 km away from the closest health facility. They have also played a key role in the delivery of behaviour change communication interventions to this target population. This study aimed to assess the job performance of VMWs/MMWs, and identify challenges they face, which may impede elimination efforts. Methods: A mixed-methods assessment was conducted in five provinces of western Cambodia. One hundred and eighty five VMW/MMW participants were surveyed using a structured questionnaire. Qualitative data was gathered through a total of 60 focus group discussions and 65 in-depth interviews. Data triangulation of the qualitative and quantitative data was used during analysis. Results: Overall, VMWs/MMWs met or exceeded the expected performance levels (80 %). Nevertheless, some performance gaps were identified. Misconceptions regarding malaria transmission and prevention were found among workers. The recommended approach for malaria treatment, directly-observed treatment (DOT), had low implementation rates. Stock-outs, difficulties in reaching out to migrant and mobile populations, insufficient means of transportation and dwindling worker satisfaction also affected job performance. Discussion: VMW/MMW job performance must be increased from 80 to 100 % in order to achieve elimination. In order to do this, it is recommended for the national malaria programme to eliminate worker malaria knowledge gaps. Barriers to DOT implementation and health system failures also need to be addressed. The VMW programme should be expanded on several fronts in order to tackle remaining performance gaps. Findings from this evaluation are useful to inform the planning of future activities of the programme and to improve the effectiveness of interventions in a context where artemisinin drug resistance is a significant public health issue.	[Canavati, Sara E.; Pukrittayakamee, Sasithon] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, 420-6 Ratchawithi Rd, Bangkok 10400, Thailand; [Canavati, Sara E.; Quintero, Cesia E.] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Lawpoolsri, Saranath; Singhasivanon, Pratap] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, 420-6 Ratchawithi Rd, Bangkok 10400, Thailand; [Nguon, Chea; Ly, Po] Minist Hlth, Natl Ctr Parasitol Entomol & Malaria Control, Corner St 92, Khan Sensok, Phnom Penh, Cambodia; [Pukrittayakamee, Sasithon] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, 420-6 Ratchawithi Rd, Bangkok 10400, Thailand; [Sintasath, David] Mahidol Univ, Fac Trop Med, Malaria Consortium Asia, 420-6 Rajavidhi Rd,Room 805, Bangkok 10400, Thailand; [Grietens, Koen Peeters] Inst Trop Med, Med Anthropol Unit, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Grietens, Koen Peeters] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki 852, Japan; [Grietens, Koen Peeters] Partners Appl Social Sci PASS Int, Tessenderlo, Belgium; [Whittaker, Maxine Anne] James Cook Univ, Div Trop Hlth & Med, Coll Publ Hlth Med & Vet Sci, Townsville, Qld 4811, Australia; [Whittaker, Maxine Anne] Univ Queensland, Sch Publ Hlth, Herston, Qld 4006, Australia	Canavati, SE (reprint author), Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, 420-6 Ratchawithi Rd, Bangkok 10400, Thailand.; Canavati, SE (reprint author), Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia.	s.canavatidelatorre@kellogg.oxon.org	Ucar, Abdullah/P-8329-2017; Whittaker, Maxine/H-1990-2011	Peeters Grietens, Koen/0000-0001-6570-9887; Whittaker, Maxine/0000-0002-1677-2991; Niyom, Saranath Lawpoolsri/0000-0003-4841-7924; Singhasivanon, Pratap/0000-0002-9759-1702	Bill and Melinda Gates Foundation through WHO Containment Project	We would like to thank the staff at the VMW Unit at CNM for their assistance and collaboration with field data collection. We would also like to thank the health department staff for their collaboration and assistance in data collection, and to all the individuals who kindly gave their time to participate in this study. Funding for this study was obtained from the Bill and Melinda Gates Foundation through the WHO Containment Project. We thank the reviewers for their valuable input in this paper.	Abate A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-312; Adedotun AA, 2010, J VECTOR DIS, V47, P155; [Anonymous], 2015, GLOB TECHN STRAT MAL; Astatkie A, 2010, ETHIOP J HEALTH SCI, V20, P185; BERMAN PA, 1987, SOC SCI MED, V25, P443, DOI 10.1016/0277-9536(87)90168-7; Blanas DA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-95; Canavati SE, 2016, MALARIA J, V15, DOI 10.1186/s12936-015-1062-z; Canavati SE, 2013, NAT CONS WORKSH BCC, V1, P23; Canavati SE, 2013, COMMUNITY KNOWLEDGE; CNM, 2010, REP CAMB CONT SURV 2, V1, P67; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Dysoley L, 2010, CAMBODIA MALARIA SUR; Franco LM, 2004, SOC SCI MED, V58, P343, DOI 10.1016/S0277-9536(03)00203-X; Franco LM, 2002, SOC SCI MED, V54, P1255, DOI 10.1016/S0277-9536(01)00094-6; Frankel S, 1992, COMMUNITY HLTH WORKE, P63; Gelade GA, 2003, PERS PSYCHOL, V56, P383, DOI 10.1111/j.1744-6570.2003.tb00155.x; Gosling J, 2015, AM J TROP MED HYG, V93, P135, DOI 10.4269/ajtmh.14-0255; Grietens KP, 2015, SCI REP-UK, V5, DOI 10.1038/srep16837; Gryseels C, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0689-0; Gryseels C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080343; Gyapong M, 2007, LESSONS LEARNED HOME; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Hewitt S, 2012, REV CAMBODIAS VILLAG; Hochbaum G.M., 1958, PUBLIC HLTH SERVICE, V572; Hustedt J, 2014, USE RESPONDENT DRIVE; Jacobs B, 2006, HEALTH POLICY PLANN, V21, P27, DOI 10.1093/heapol/czj001; Jayasuriya R, 2011, VOICES FIELD FACTORS; Jayasuriya R, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-156; Khamsiriwatchara A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-120; Kheang Soy Ty, 2011, Am J Public Health, V101, pe6, DOI 10.2105/AJPH.2011.300228; Kinung'hi SM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-395; Kulig JC, 2009, PUBLIC HEALTH NURS, V26, P430, DOI 10.1111/j.1525-1446.2009.00801.x; LE Collins D, 2007, SCALING CHILD SURVIV; Legesse M, 2009, ETHIOP J HEALTH DEV, V23, P40; Legesse Y, 2007, ETHIOP J HEALTH DEV, V21, P157; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Liu A, 2011, MT SINAI J MED, V78, P419, DOI 10.1002/msj.20260; Manongi Rachel N, 2006, Hum Resour Health, V4, P6, DOI 10.1186/1478-4491-4-6; Mathauer Inke, 2006, Hum Resour Health, V4, P24, DOI 10.1186/1478-4491-4-24; Moeun CN, 2011, CAMBODIAN LAUNCHES N; NIPH, 2004, CAMB NAT MAL SURV 20; NIPH, 2007, CAMB MAL SURV 2007, P55; O'Brien P, 2011, HTLH WORKER SHORTAGE; Okanurak Kamolnetr, 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P36; Paintain LS, 2014, AM J TROP MED HYG, V91, P461, DOI 10.4269/ajtmh.14-0094; Palmer K, 2012, CAMBODIA NATL MALARI; Pellini A, 2007, DEV PRACT, V17, P404, DOI 10.1080/09614520701337004; Perez F, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-28; Perry H, 2012, EFFECTIVE ARE COMMUN; Phanouvong S, 2013, SE ASIAN J TROP MED, V44, P349; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Plowe CV, 2014, DANGER UNTREATABLE M; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Purcell J., 2007, Human Resource Management Journal, V17, P3, DOI 10.1111/j.1748-8583.2007.00022.x; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; RUEBUSH TK, 1994, AM J TROP MED HYG, V50, P85, DOI 10.4269/ajtmh.1994.50.85; Souares A, 2008, T ROY SOC TROP MED H, V102, P751, DOI 10.1016/j.trstmh.2008.05.016; Thomson A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-94; Ui S, 2010, CRIT PUBLIC HEALTH, V20, P97, DOI 10.1080/09581590902829173; Wangroongsarb P, 2011, MALARIA J, V10, P117; WHO, 2011, GLOB PLAN ART RES CO, P56; WHO/Global Malaria Programme, 2008, STRAT CONT ART UNPUB; Yeung SVDW, 2008, MALARIA J, V7, P243	63	16	16	0	9	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	MAY 20	2016	15								282	10.1186/s12936-016-1322-6				15	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DM2AJ	WOS:000376147700002	27206729	DOAJ Gold, Green Published			2019-04-02	
J	Moradin, N; Torre, S; Gauthier, S; Tam, M; Hawari, J; Vandercruyssen, K; De Spiegeleer, B; Fortin, A; Stevenson, MM; Gros, P				Moradin, Neda; Torre, Sabrina; Gauthier, Susan; Tam, Mifong; Hawari, Jalal; Vandercruyssen, Kirsten; De Spiegeleer, Bart; Fortin, Anny; Stevenson, Mary M.; Gros, Philippe			Cysteamine broadly improves the anti-plasmodial activity of artemisinins against murine blood stage and cerebral malaria	MALARIA JOURNAL			English	Article						Plasmodium; Blood-stage malaria; Cerebral malaria; Cysteamine; Artemisinins; Drug resistance	NEPHROPATHIC CYSTINOSIS; FALCIPARUM MALARIA; GENETIC-CONTROL; RESISTANCE; SUSCEPTIBILITY; BITARTRATE; DIHYDROARTEMISININ; PHARMACOKINETICS; ARTESUNATE; PARASITES	Background: The potential emergence and spread of resistance to artemisinins in the Plasmodium falciparum malaria parasite constitutes a major global health threat. Hence, improving the efficacy of artemisinins and of artemisinin-based combination therapy (ACT) represents a major short-term goal in the global fight against malaria. Mice defective in the enzyme pantetheinase (Vnn3) show increased susceptibility to blood-stage malaria (increased parasitaemia, reduced survival), and supplementation of Vnn3 mutants with the reaction product of pantetheinase, cysteamine, corrects in part the malaria-susceptibility phenotype of the mutants. Cysteamine (Cys) is a small, naturally occurring amino-thiol that has very low toxicity in vivo and is approved for clinical use in the life-long treatment of the kidney disorder nephropathic cystinosis. Methods: The ability of Cys to improve the anti-plasmodial activity of different clinically used artemisinins was tested. The effect of different CYS/ART combinations on malarial phenotypes (parasite blood-stage replication, overall and survival from lethal infection) was assessed in a series of in vivo experiments using Plasmodium strains that induce either blood-stage (Plasmodium chabaudi AS) or cerebral disease (Plasmodium berghei ANKA). This was also evaluated in an ex vivo experimental protocol that directly assesses the effect of such drug combinations on the viability of Plasmodium parasites, as measured by the ability of tested parasites to induce a productive infection in vivo in otherwise naive animals. Results: Cys is found to potentiate the anti-plasmodial activity of artesunate, artemether, and arteether, towards the blood-stage malaria parasite P. chabaudi AS. Ex vivo experiments, indicate that potentiation of the anti-plasmodial activity of artemisinins by Cys is direct and does not require the presence of host factors. In addition, potentiation occurs at sub-optimal concentrations of artemisinins and Cys that on their own have little or no effect on parasite growth. Cys also dramatically enhances the efficacy and protective effect of artemisinins against cerebral malaria induced by infection with the P. berghei ANKA parasite. Conclusion: These findings indicate that inclusion of Cys in current formulations of ACT, or its use as adjunct therapy could improve the anti-plasmodial activity of artemisinin, decrease mortality in cerebral malaria patients, and prevent or delay the development and spread of artemisinin resistance.	[Moradin, Neda; Gauthier, Susan; Fortin, Anny; Gros, Philippe] McGill Univ, Dept Biochem, 3649 Promenade Sir William Osler,Room 366, Montreal, PQ H3G 0B1, Canada; [Torre, Sabrina] McGill Univ, Dept Human Genet, 3649 Promenade Sir William Osler,Room 366, Montreal, PQ H3G 0B1, Canada; [Gauthier, Susan; Stevenson, Mary M.] McGill Univ, Ctr Hlth, Res Inst, 3649 Promenade Sir William Osler,Room 366, Montreal, PQ H3G 0B1, Canada; [Hawari, Jalal] Univ Montreal, Ecole Polytech, Dept Civil Geol & Min Engn, Montreal, PQ, Canada; [Vandercruyssen, Kirsten; De Spiegeleer, Bart] Univ Ghent, Fac Pharmaceut Sci, B-9000 Ghent, Belgium	Gros, P (reprint author), McGill Univ, Dept Biochem, 3649 Promenade Sir William Osler,Room 366, Montreal, PQ H3G 0B1, Canada.	philippe.gros@mcgill.ca	De Spiegeleer, Bart/A-2001-2008	De Spiegeleer, Bart/0000-0001-6794-3108	Canadian Institutes of Health Research; Raptor Pharmaceuticals	This work was supported by a research grant to PG from the Canadian Institutes of Health Research, with additional funding from Raptor Pharmaceuticals.	Allison AC, 2009, CURR OPIN IMMUNOL, V21, P499, DOI 10.1016/j.coi.2009.04.001; Amaratunga C, 2016, LANCET INFECT DIS, V16, P357, DOI 10.1016/S1473-3099(15)00487-9; Antoine T, 2014, J ANTIMICROB CHEMOTH, V69, P1005, DOI 10.1093/jac/dkt486; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Batty KT, 1996, J CHROMATOGR B, V677, P345, DOI 10.1016/0378-4347(95)00428-9; Belldina EB, 2003, BRIT J CLIN PHARMACO, V56, P520, DOI 10.1046/j.1365-2125.2003.01927.x; Berghout J, 2010, GENES IMMUN, V11, P310, DOI 10.1038/gene.2009.79; Berghout J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003491; Bongfen SE, 2009, TRENDS PARASITOL, V25, P417, DOI 10.1016/j.pt.2009.05.012; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Dohil R, 2010, J PEDIATR-US, V156, P71, DOI 10.1016/j.jpeds.2009.07.016; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Eastman RT, 2009, NAT REV MICROBIOL, V7, P864, DOI 10.1038/nrmicro2239; Efferth T, 2010, CRIT REV TOXICOL, V40, P405, DOI 10.3109/10408441003610571; Fidler MC, 2007, BRIT J CLIN PHARMACO, V63, P36, DOI 10.1111/j.1365-2125.2006.02734.x; Fortin A, 2001, P NATL ACAD SCI USA, V98, P10793, DOI 10.1073/pnas.191288998; Gangoiti JA, 2010, BRIT J CLIN PHARMACO, V70, P376, DOI 10.1111/j.1365-2125.2010.03721.x; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Isah MB, 2014, PARASITOL RES, V113, P801, DOI 10.1007/s00436-014-3804-1; Kleta R, 2004, EXPERT OPIN PHARMACO, V5, P2255, DOI 10.1517/14656566.5.11.2255; Kokwaro G, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S1-S2; Kotecka BM, 2003, ACTA TROP, V87, P371, DOI 10.1016/S0001-706X(03)00118-9; Krishna S, 2013, TRENDS PARASITOL, V29, P313, DOI 10.1016/j.pt.2013.04.001; Lamb Tracey J., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010581; Laroque A, 2012, GENES IMMUN, V13, P155, DOI 10.1038/gene.2011.67; Longley R, 2011, MAMM GENOME, V22, P32, DOI 10.1007/s00335-010-9302-6; Malmquist NA, 2015, ANTIMICROB AGENTS CH, V59, P950, DOI 10.1128/AAC.04419-14; Min-Oo G, 2007, J EXP MED, V204, P511, DOI 10.1084/jem.20061252; Min-Oo G, 2010, ANTIMICROB AGENTS CH, V54, P3262, DOI 10.1128/AAC.01719-09; Min-Oo G, 2010, EXP PARASITOL, V125, P315, DOI 10.1016/j.exppara.2010.02.009; Miotto O, 2015, NAT GENET, V47, P226, DOI 10.1038/ng.3189; Mishra SK, 2009, NAT REV NEUROL, V5, P189, DOI 10.1038/nrneurol.2009.23; Mishra S, 2008, BIOORGAN MED CHEM, V16, P2894, DOI 10.1016/j.bmc.2007.12.054; Mok S, 2015, SCIENCE, V347, P431, DOI 10.1126/science.1260403; Thanh NX, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-217; Nilsen A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005029; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Reddy RC, 2005, BIOCHEM BIOPH RES CO, V326, P472, DOI 10.1016/j.bbrc.2004.11.051; Sinclair D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007483.pub2; Smith CM, 2015, BLOOD, V125, P534, DOI 10.1182/blood-2014-04-567149; Soh PN, 2009, ANTIMICROB AGENTS CH, V53, P1100, DOI 10.1128/AAC.01175-08; Stickles AM, 2015, AM J TROP MED HYG, V92, P1195, DOI 10.4269/ajtmh.14-0553; Straimer J, 2015, SCIENCE, V347, P428, DOI 10.1126/science.1260867; Taylor SM, 2014, CURR OPIN HEMATOL, V21, P193, DOI 10.1097/MOH.0000000000000039; Torre S, 2015, INFECT IMMUN, V83, P759, DOI 10.1128/IAI.02586-14; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165	47	3	3	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	MAY 6	2016	15								260	10.1186/s12936-016-1317-3				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DL0TK	WOS:000375345300001	27150250	DOAJ Gold, Green Published			2019-04-02	
J	Colebunders, R; Tepage, F; Rood, E; Mandro, M; Abatih, EN; Musinya, G; Mambandu, G; Kabeya, J; Komba, M; Levick, B; Mokili, JL; Laudisoit, A				Colebunders, Robert; Tepage, Floribert; Rood, Ente; Mandro, Michel; Abatih, Emmanuel Nji; Musinya, Gisele; Mambandu, Germain; Kabeya, Jose; Komba, Michel; Levick, Bethany; Mokili, John L.; Laudisoit, Anne			Prevalence of River Epilepsy in the Orientale Province in the Democratic Republic of the Congo	PLOS NEGLECTED TROPICAL DISEASES			English	Article							SUB-SAHARAN AFRICA; ACTIVE CONVULSIVE EPILEPSY; NODDING SYNDROME; RETARDED GROWTH; WESTERN UGANDA; ONCHOCERCIASIS; METAANALYSIS; DISTRICT; AREAS; FOCUS	Background An increased prevalence of epilepsy has been reported in many onchocerciasis endemic areas. Objective To determine the prevalence and distribution of epilepsy in an onchocerciasis endemic region in the Democratic Republic of the Congo (DRC). Design/Methods An epilepsy prevalence study was carried out in 2014, in two localities of the Bas-Uele district, an onchocerciasis endemic region in the Orientale Province of the DRC. Risk factors for epilepsy were identified using a random effects logistic regression model and the distribution of epilepsy cases was investigated using the Moran's I statistic of spatial auto-correlation. Results Among the 12,776 individuals of Dingila, 373 (2.9%) individuals with epilepsy were identified. In a house-to-house survey in Titule, 68 (2.3%) of the 2,908 people who participated in the survey were found to present episodes of epilepsy. Epilepsy showed a marked spatial pattern with clustering of cases occurring within and between adjacent households. Individual risk of epilepsy was found to be associated with living close to the nearest fast flowing river where blackflies (Diptera: Simuliidae)- the vector of Onchocerca volvulus-oviposit and breed. Conclusions The prevalence of epilepsy in villages in the Bas-Uele district in the DRC was higher than in non-onchocerciasis endemic regions in Africa. Living close to a blackflies infested river was found to be a risk factor for epilepsy.	[Colebunders, Robert; Laudisoit, Anne] Univ Antwerp, Global Hlth Inst, B-2020 Antwerp, Belgium; [Tepage, Floribert] Natl Onchocerciasis Control Program, Kisangani, DEM REP CONGO; [Rood, Ente] Royal Trop Inst, NL-1105 AZ Amsterdam, Netherlands; [Mandro, Michel] Prov Hlth Div Ituri, Bunia, DEM REP CONGO; [Abatih, Emmanuel Nji] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Mambandu, Germain; Kabeya, Jose] Prov Minist Publ Hlth, Kisangani, DEM REP CONGO; [Komba, Michel] Univ Kisangani, Fac Sci, Biodivers Monitoring Ctr CSB, Kisangani, DEM REP CONGO; [Levick, Bethany; Laudisoit, Anne] Univ Liverpool, Sch Biol Sci, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Mokili, John L.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Laudisoit, Anne] Univ Antwerp, Evolutionary Biol Grp, B-2020 Antwerp, Belgium	Colebunders, R (reprint author), Univ Antwerp, Global Hlth Inst, B-2020 Antwerp, Belgium.	robert.colebunders@uantwerpen.be	Laudisoit, Anne/F-2646-2017	Laudisoit, Anne/0000-0001-7626-9426	Doctors Without Borders Geneva	This work was supported by Doctors Without Borders Geneva. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boussinesq M, 2002, T ROY SOC TROP MED H, V96, P537, DOI 10.1016/S0035-9203(02)90433-5; Colebunders R, 2015, TROP MED INT HEALTH, V20, P194, DOI 10.1111/tmi.12421; Colebunders R, 2015, 2 INT NODD SYNDR C G; Colebunders R, 2014, INT J INFECT DIS, V27, P74, DOI 10.1016/j.ijid.2014.08.001; Commission on Epidemiology and Prognosis, 1993, EPILEPSIA, V34, P592; Dowell SF, 2013, EMERG INFECT DIS, V19, P1374, DOI 10.3201/eid1909.130401; Dozie INS, 2006, PUBLIC HEALTH, V120, P448, DOI 10.1016/j.puhe.2005.10.010; Duke BOL, 1998, T ROY SOC TROP MED H, V92, P236, DOI 10.1016/S0035-9203(98)90763-5; Edwards T, 2008, LANCET NEUROL, V7, P50, DOI 10.1016/S1474-4422(07)70292-2; Foltz JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066419; Forsgren L, 2008, LANCET NEUROL, V7, P21, DOI 10.1016/S1474-4422(07)70295-8; Jarvis A, 2008, HOLE FILLED SEAMLESS; Jeliffe DB, 1962, TROP GEOGR MED, V14, P97; Jilek-Aall L, 2014, INVESTIGACION SALUD, V1, P22; Kaiser C, 1996, B WORLD HEALTH ORGAN, V74, P361; Kaiser C, 1998, EPILEPSY RES, V30, P247, DOI 10.1016/S0920-1211(98)00007-2; Kaiser C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002147; Kamuyu G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002908; Kariuki SM, 2016, CLIN NEUROPHYSIOL, V127, P1099, DOI 10.1016/j.clinph.2015.07.033; Kipp W, 1996, AM J TROP MED HYG, V54, P80, DOI 10.4269/ajtmh.1996.54.80; Mandro M, 2015, 2 INT NODD SYDR C GU; McCullagh P, 1989, GEN LINEAR MODELS; Newell ED, 1997, T ROY SOC TROP MED H, V91, P525, DOI 10.1016/S0035-9203(97)90009-2; Ngugi AK, 2012, EMERG THEMES EPIDEMI, V9, DOI [10.1186/742-622-9-8, 10.1186/1742-7622-9-8]; OOMEN AP, 1967, TROP GEOGR MED, V19, P231; OVUGA E, 1992, E AFR MED J, V69, P554; Paul Abigail, 2012, J Glob Health, V2, P020405, DOI 10.7189/jogh.02.020405; Pion SDS, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000461; Preux PM, 2005, LANCET NEUROL, V4, P21, DOI 10.1016/S1474-4422(04)00963-9; Rapert A.B., 1950, E AFR MED J, P339; Seibert J MB, 2007, WATER RESOUR RES, V43, P43; Silverman BW, 1986, DENSITY ESTIMATION S; Twum-Danso NA, 2003, FILARIA J, V2, pS7, DOI DOI 10.1186/1475-2883-2-S1-S7; Vogel G, 2012, SCIENCE, V336, P144, DOI 10.1126/science.336.6078.144; Wamala JF, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003880; Winkler AS, 2012, PATHOG GLOB HEALTH, V106, P261, DOI 10.1179/2047773212Y.0000000047; Wold Health Organisation, 2009, SINGL DOS IV CONTR D; World Health Organization, 2012, INT SCI M NODD SYNDR	38	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAY	2016	10	5							e0004478	10.1371/journal.pntd.0004478				13	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DO4QY	WOS:000377769300002	27139245	DOAJ Gold, Green Published			2019-04-02	
J	Kenyon, CR; Osbak, K; Tsoumanis, A				Kenyon, Chris Richard; Osbak, Kara; Tsoumanis, Achilleas			The Global Epidemiology of Syphilis in the Past Century - A Systematic Review Based on Antenatal Syphilis Prevalence	PLOS NEGLECTED TROPICAL DISEASES			English	Review							CONCURRENT SEXUAL PARTNERSHIPS; UNITED-STATES; HIV PREVALENCE; VENEREAL-DISEASES; TRANSMITTED-DISEASES; SEROLOGICAL TESTS; POPULATION; INFECTIONS; HEALTH; SURVEILLANCE	Background How can we explain the uneven decline of syphilis around the world following the introduction of penicillin? In this paper we use antenatal syphilis prevalence (ASP) to investigate how syphilis prevalence varied worldwide in the past century, and what risk factors correlate with this variance. Methods 1) A systematic review using PubMed and Google Scholar was conducted to identify countries with published data relating to ASP estimates from before 1952 until the present. Eleven countries were identified (Canada, Denmark, Finland, India, Japan, Norway, Singapore, South Africa, United States of America (USA), United Kingdom (UK) and Zimbabwe). The ASP epidemic curve for each population was depicted graphically. In South Africa and the USA, results are reported separately for the black and white populations. 2) National antenatal syphilis prevalence estimates for 1990 to 1999 and 2008 were taken from an Institute for Health Metrics and Evaluation database on the prevalence of syphilis in low risk populations compiled for the Global Burden of Diseases study and from a recent review paper respectively. National ASPs were depicted graphically and regional median ASPs were calculated for both time periods. 3) Linear regression was used to test for an association between ASP in 1990-1999 and 2008 and four risk factors (efficacy of syphilis screening/treatment, health expenditure, GDP per capita and circumcision prevalence). WHO world regions were included as potential explanatory variables. Results In most populations, ASP dropped to under 1% before 1960. In Zimbabwe and black South Africans, ASP was high in the pre-penicillin period, dropped in the post-penicillin period, but then plateaued at around 6% until the end of the 20th century when ASP dropped to just above 1%. In black Americans, ASP declined in the post penicillin period, but plateaued at 3-5% thereafter. ASP was statistically significantly higher in sub-Saharan Africa in 19901999 and 2008 than in the other world regions (P < 0.001). On multivariate analysis in both time periods, ASP was only associated with residence in sub-Saharan Africa. Conclusions Further research is necessary to elucidate the reasons for the higher prevalence of syphilis in sub-Saharan Africa.	[Kenyon, Chris Richard; Osbak, Kara] Inst Trop Med, HIV STI Unit, B-2000 Antwerp, Belgium; [Kenyon, Chris Richard] Univ Cape Town, Div Infect Dis & HIV Med, ZA-7925 Cape Town, South Africa; [Tsoumanis, Achilleas] Inst Trop Med, Clin Trials Unit, B-2000 Antwerp, Belgium	Kenyon, CR (reprint author), Inst Trop Med, HIV STI Unit, B-2000 Antwerp, Belgium.; Kenyon, CR (reprint author), Univ Cape Town, Div Infect Dis & HIV Med, ZA-7925 Cape Town, South Africa.	ckenyon@itg.be		Meehan, Conor/0000-0003-0724-8343			[Anonymous], 2001, GLOBAL PREVALENCE AN; Aral SO, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P311; Aral SO, 1996, SEX TRANSM DIS, V23, P9, DOI 10.1097/00007435-199601000-00005; Bates G, 1939, AM J PUBLIC HEALTH N, V29, P143, DOI 10.2105/AJPH.29.2.143; Bhargava N, 1974, INDIAN JOURNAL OF DE, V40, P215; BOWELL P, 1989, J CLIN PATHOL, V42, P1281, DOI 10.1136/jcp.42.12.1281; BREDE HD, 1974, S AFR MED J, V48, P1191; Chakraborty S, 1989, Indian J Public Health, V33, P33; Chesson HW, 2003, SEX TRANSM DIS, V30, P419, DOI 10.1097/00007435-200305000-00008; Chico RM, 2012, JAMA-J AM MED ASSOC, V307, P2079, DOI 10.1001/jama.2012.3428; Cormia FE, 1940, CAN MED ASSOC J, V42, P476; COWAN W, 1962, Cent Afr J Med, V8, P202; DESCHRYVER A, 1990, TRANSFUSION, V30, P844; Dewar T F, 1923, Proc R Soc Med, V16, P81; Eagle H, 1937, THE CV MOSBY CO ST L, P21; EISENBERG L, 1973, S AFR MED J, V47, P2181; ENG J, 1959, BRIT J VENER DIS, V35, P10; European Centre for Disease Prevention and Control, 2014, SEXUALLY TRANSMITTED; European Centre for Disease Prevention and Control, 2011, SEXUALLY TRANSMITTED; Fenton KA, 2005, INFECT DIS CLIN N AM, V19, P311, DOI 10.1016/j.idc.2005.04.004; Fleming A, 1911, LANCET, V1, P1631; Francis AM, 2013, ARCH SEX BEHAV, V42, P5, DOI 10.1007/s10508-012-0018-4; Gerbase AC, 1998, SEX TRANSM INFECT, V74, pS12; Gonese E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013819; GORDON T, 1965, Vital Health Stat 11, V11, P1; Gottlieb SL, 2008, SEX TRANSM DIS, V35, P507, DOI 10.1097/OLQ.0b013e3181644bae; Gray RH, 1998, LANCET, V351, P98, DOI 10.1016/S0140-6736(97)09381-1; GRECO D, 1990, GENITOURIN MED, V66, P383; GUTHE T, 1960, BRIT J VENER DIS, V36, P67; GUTHE T, 1951, J Soc Hyg, V37, P182; HAHN RA, 1989, AM J PUBLIC HEALTH, V79, P467, DOI 10.2105/AJPH.79.4.467; Ham D Cal, 2015, Int J Gynaecol Obstet, V130 Suppl 1, pS10, DOI 10.1016/j.ijgo.2015.04.012; Hamilton DT, 2015, EPIDEMICS-NETH, V11, P56, DOI 10.1016/j.epidem.2015.02.003; HARE MJ, 1973, J OBSTET GYN BR COMM, V80, P515; HARRIS A, 1946, J Vener Dis Inf, V27, P169; Hartmann O, 1943, ACTA MED SCAND, V114, P236; Herbert Liam J, 2012, J Glob Health, V2, P010402, DOI 10.7189/jogh.02.010402; Holland S, 1976, Cent Afr J Med, V22, P193; Holland S, 1976, Cent Afr J Med, V22, P216; Holtgrave DR, 2003, SEX TRANSM INFECT, V79, P62, DOI 10.1136/sti.79.1.62; IDSOE O, 1967, BRIT J VENER DIS, V43, P227; Jochelson K, 2001, COLOUR DIS SYPHILIS; Johnson LF, 2011, SEX REPROD HEALTHC, V2, P13, DOI 10.1016/j.srhc.2010.08.006; Kark SL, 2003, INT J EPIDEMIOL, V32, P181, DOI 10.1093/ije/dyg025; Kenyon C, 2014, EUROSURVEILLANCE, V19, P22, DOI 10.2807/1560-7917.ES2014.19.45.20958; Kenyon C, 2014, INT J STD AIDS, V25, P898, DOI 10.1177/0956462414526575; Kenyon C, 2014, INT J INFECT DIS, V18, P73, DOI 10.1016/j.ijid.2013.09.014; Kenyon C, 2013, INT J STD AIDS, V24, P375, DOI 10.1177/0956462412472816; Kenyon C, 2013, INT J STD AIDS, V24, P211, DOI 10.1177/0956462412472455; Kenyon C, JOURNAL OF SEXUALLY; Kenyon C, 2014, INTERDISCIPLINARY PE; Kenyon C, 2016, JOURNAL OF SEXUALLY; Kenyon CR, 2015, INT J STD AIDS, V26, P556, DOI 10.1177/0956462414546392; Kenyon CR, 2014, INT J INFECT DIS, V29, P54, DOI 10.1016/j.ijid.2014.05.014; Kenyon CR, 2015, WORLD JOURNAL OF AID, V5, P131; Kenyon CR, 2014, INTERNATIONAL JOURNA; KOSKELA P, 1988, J RHEUMATOL, V15, P70; Koumans EH, 2001, SEX TRANSM DIS, V28, P497, DOI 10.1097/00007435-200109000-00004; Kurewa NE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-127; Lagarde E, 2001, AIDS, V15, P877, DOI 10.1097/00002030-200105040-00008; LARSEN SA, 1995, CLIN MICROBIOL REV, V8, P1; Larsen SA, 1998, MANUAL OF TESTS FOR; LATIF AS, 1981, BRIT J VENER DIS, V57, P181; Laumann EO, 1994, THE SOCIAL ORGANIZAT; LEIBY GM, 1947, AM J HYG, V46, P260, DOI 10.1093/oxfordjournals.aje.a119167; LOSSING EH, 1956, BRIT J VENER DIS, V32, P150; Lowndes CM, 2004, SEX TRANSM INFECT, V80, P264, DOI 10.1136/sti.2004.010389; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Majoko F, 2003, Cent Afr J Med, V49, P90; Mapingure MP, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-45; Marks M, 2014, T ROY SOC TROP MED H, V108, P601, DOI 10.1093/trstmh/tru128; Meredith S, 2007, THE GLOBAL ELIMINATI; Montana LS, 2008, SEX TRANSM INFECT, V84, pI78, DOI 10.1136/sti.2008.030106; MOORE JE, 1952, JAMA-J AM MED ASSOC, V150, P467, DOI 10.1001/jama.1952.03680050033010; Morris M, 2009, AM J PUBLIC HEALTH, V99, P1023, DOI 10.2105/AJPH.2008.147835; MORTON RS, 1954, BMJ-BRIT MED J, V1, P1470, DOI 10.1136/bmj.1.4877.1470; MUNGALE MD, 1958, BRIT J VENER DIS, V34, P113; Musinguzi J, 2009, JAIDS-J ACQ IMM DEF, V51, P78, DOI 10.1097/QAI.0b013e3181990713; Nakashima AK, 1996, SEX TRANSM DIS, V23, P16, DOI 10.1097/00007435-199601000-00006; National Department of Health, 2006, THE NATIONAL ANTENAT; National Department of Health, 2009, THE NATIONAL ANTENAT; National Department of Health, 2010, THE NATIONAL ANTENAT; National Department of Health, 2011, THE NATIONAL ANTENAT; National Department of Health, 2012, THE NATIONAL ANTENAT; National Department of Health, 2008, THE NATIONAL ANTENAT; National Institute for Communicable Diseases, 2003, COMMUNICABLE DISEASE, V2, P1; National Institute for Communicable Diseases, 2003, COMMUNICABLE DIS COM, V2, P3; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396; Nielsen L, 2011, IMF WORKING PAPERS, P1; OMalley CK, 1940, SOUTH AFRICAN MEDICA, V14, P459; Osbak KK, 2016, SEX TRANSM DIS, V43, P255, DOI 10.1097/OLQ.0000000000000422; Otieno-Nyunya B, 2011, SEX TRANSM INFECT, V87, P521, DOI 10.1136/sextrans-2011-050026; Parran T, 1936, AM J PUBLIC HEALTH N, V26, P329, DOI 10.2105/AJPH.26.4.329; Pentinnen K, 1946, ON THE WASSERMAN AND; Peterman T., 2008, Morbidity and Mortality Weekly Report, V57, P872; Pettifor A, 2000, SEX TRANSM DIS, V27, P371, DOI 10.1097/00007435-200008000-00002; Pham L, 2005, Cent Afr J Med, V51, P24; Purcell F, 1940, S AFR MED J, V14, P453; PUTKONEN T, 1950, ANN MED EXP BIOL FEN, V28, P246; RAJAM RV, 1956, BRIT J VENER DIS, V32, P79; RAM LM, 1960, BRIT J VENER DIS, V36, P93; Reingold AL, 1998, EMERG INFECT DIS, V4, P21, DOI 10.3201/eid0401.980104; ROLFS RT, 1990, JAMA-J AM MED ASSOC, V264, P1432, DOI 10.1001/jama.264.11.1432; Rowley J, 2012, GLOBAL INCIDENCE AND; RUTGERS S, 1993, CENT AFR J MED, V39, P117; Sawers L, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17431; SCHOFIELD CB, 1973, BRIT J VENER DIS, V49, P420; Sena AC, 2010, CLIN INFECT DIS, V51, P700, DOI 10.1086/655832; Sethi S, 2007, SEX TRANSM INFECT, V83, P592, DOI 10.1136/sti.2007.025551; Singh AE, 1999, CLIN MICROBIOL REV, V12, P187, DOI 10.1128/CMR.12.2.187; Smallman-Raynor M, 2012, ATLAS EPIDEMIC BRITA; STRAYPEDERSEN B, 1983, SEX TRANSM DIS, V10, P167, DOI 10.1097/00007435-198311000-00001; TANAMI Y, 1958, Bull World Health Organ, V19, P519; Tanser F, 2011, LANCET, V378, P247, DOI 10.1016/S0140-6736(11)60779-4; THIRUMOORTHY T, 1986, GENITOURIN MED, V62, P75; Totten S, 2015, Can Commun Dis Rep, V41, P30; Tramont E, 2010, PRINCIPLES AND PRACT; UNAIDS, 2009, AIDS EPIDEMIC UPDATE; UNDP, 2010, HUMAN DEVELOPMENT RE; UNDP, 1996, HUMAN DEVELOPMENT RE; VOGELSANG T M, 1950, Acta Derm Venereol Suppl (Stockh), V31, P100; Vonderlehr RA, 1942, J AMER MED ASSOC, V120, P1369, DOI 10.1001/jama.1942.02830520019006; Weiss H., 2008, MALE CIRCUMCISION GL; WILLCOX R R, 1951, Bull World Health Organ, V4, P283; WILLCOX RR, 1967, BRIT J VENER DIS, V43, P1; WILLCOX RR, 1962, BRIT J VENER DIS, V38, P189; Willcox RR, 1949, REPORT ON A VENEREAL; World Health Oganization, 2002, REPORT OF A WHO CONS; World Health Organization, 1995, GLOBAL PREVALENCE AN; World Health Organization, 2011, PREVALENCE AND INCID; Xiao Y, 2010, JAIDS-J ACQ IMM DEF, V53, pS66, DOI 10.1097/QAI.0b013e3181c7db43	132	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAY	2016	10	5							e0004711	10.1371/journal.pntd.0004711				23	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DO4QY	WOS:000377769300052	27167068	DOAJ Gold, Green Published			2019-04-02	
J	Sow, SO; Muhsen, K; Nasrin, D; Blackwelder, WC; Wu, YK; Farag, TH; Panchalingam, S; Sur, D; Zaidi, AKM; Faruque, ASG; Saha, D; Adegbola, R; Alonso, PL; Breiman, RF; Bassat, Q; Tamboura, B; Sanogo, D; Onwuchekwa, U; Manna, B; Ramamurthy, T; Kanungo, S; Ahmed, S; Qureshi, S; Quadri, F; Hossain, A; Das, SK; Antonio, M; Hossain, MJ; Mandomando, I; Nhampossa, T; Acacio, S; Omore, R; Oundo, JO; Ochieng, JB; Mintz, ED; O'Reilly, CE; Berkeley, LY; Livio, S; Tennant, SM; Sommerfelt, H; Nataro, JP; Ziv-Baran, T; Robins-Browne, RM; Mishcherkin, V; Zhang, JX; Liu, J; Houpt, ER; Kotloff, KL; Levine, MM				Sow, Samba O.; Muhsen, Khitam; Nasrin, Dilruba; Blackwelder, William C.; Wu, Yukun; Farag, Tamer H.; Panchalingam, Sandra; Sur, Dipika; Zaidi, Anita K. M.; Faruque, Abu S. G.; Saha, Debasish; Adegbola, Richard; Alonso, Pedro L.; Breiman, Robert F.; Bassat, Quique; Tamboura, Boubou; Sanogo, Doh; Onwuchekwa, Uma; Manna, Byomkesh; Ramamurthy, Thandavarayan; Kanungo, Suman; Ahmed, Shahnawaz; Qureshi, Shahida; Quadri, Farheen; Hossain, Anowar; Das, Sumon K.; Antonio, Martin; Hossain, M. Jahangir; Mandomando, Inacio; Nhampossa, Tacilta; Acacio, Sozinho; Omore, Richard; Oundo, Joseph O.; Ochieng, John B.; Mintz, Eric D.; O'Reilly, Ciara E.; Berkeley, Lynette Y.; Livio, Sofie; Tennant, Sharon M.; Sommerfelt, Halvor; Nataro, James P.; Ziv-Baran, Tomer; Robins-Browne, Roy M.; Mishcherkin, Vladimir; Zhang, Jixian; Liu, Jie; Houpt, Eric R.; Kotloff, Karen L.; Levine, Myron M.			The Burden of Cryptosporidium Diarrheal Disease among Children < 24 Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa and South Asia, Utilizing Data from the Global Enteric Multicenter Study (GEMS)	PLOS NEGLECTED TROPICAL DISEASES			English	Article							DEVELOPING-COUNTRIES; PARVUM INFECTION; YOUNG-CHILDREN; GUINEA-BISSAU; COMMUNITY; EPIDEMIOLOGY; INFANTS; IDENTIFICATION; POPULATION; ANTIBODIES	Background The importance of Cryptosporidium as a pediatric enteropathogen in developing countries is recognized. Methods Data from the Global Enteric Multicenter Study (GEMS), a 3-year, 7-site, case-control study of moderate-to-severe diarrhea (MSD) and GEMS-1A (1-year study of MSD and less-severe diarrhea [LSD]) were analyzed. Stools from 12,110 MSD and 3,174 LSD cases among children aged <60 months and from 21,527 randomly-selected controls matched by age, sex and community were immunoassay-tested for Cryptosporidium. Species of a subset of Cryptosporidium-positive specimens were identified by PCR; GP60 sequencing identified anthroponotic C. parvum. Combined annual Cryptosporidium-attributable diarrhea incidences among children aged < 24 months for African and Asian GEMS sites were extrapolated to sub-Saharan Africa and South Asian regions to estimate region-wide MSD and LSD burdens. Attributable and excess mortality due to Cryptosporidium diarrhea were estimated. Findings Cryptosporidium was significantly associated with MSD and LSD below age 24 months. Among Cryptosporidium-positive MSD cases, C. hominis was detected in 77.8% (95% CI, 73.0%-81.9%) and C. parvum in 9.9%(95% CI, 7.1%-13.6%); 92% of C. parvum tested were anthroponotic genotypes. Annual Cryptosporidium-attributable MSD incidence was 3.48 (95% CI, 2.27-4.67) and 3.18 (95% CI, 1.85-4.52) per 100 child-years in African and Asian infants, respectively, and 1.41 (95% CI, 0.73-2.08) and 1.36 (95% CI, 0.66-2.05) per 100 child-years in toddlers. Corresponding Cryptosporidium-attributable LSD incidences per 100 child-years were 2.52 (95% CI, 0.33-5.01) and 4.88 (95% CI, 0.82-8.92) in infants and 4.04 (95% CI, 0.56-7.51) and 4.71 (95% CI, 0.24-9.18) in toddlers. We estimate 2.9 and 4.7 millio nCryptosporidium-attributable cases annually in children aged < 24 months in the sub-Saharan Africa and India/Pakistan/Bangladesh/Nepal/Afghanistan regions, respectively, and similar to 202,000 Cryptosporidium-attributable deaths (regions combined). similar to 59,000 excess deaths occurred among Cryptosporidium-attributable diarrhea cases over expected if cases had been Cryptosporidium-negative. Conclusions The enormous African/Asian Cryptosporidium disease burden warrants investments to develop vaccines, diagnostics and therapies.	[Sow, Samba O.; Tamboura, Boubou; Sanogo, Doh; Onwuchekwa, Uma] Ctr Dev Vaccins, Bamako, Mali; [Muhsen, Khitam; Nasrin, Dilruba; Blackwelder, William C.; Wu, Yukun; Farag, Tamer H.; Panchalingam, Sandra; Berkeley, Lynette Y.; Livio, Sofie; Tennant, Sharon M.; Nataro, James P.; Mishcherkin, Vladimir; Kotloff, Karen L.; Levine, Myron M.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Nasrin, Dilruba; Blackwelder, William C.; Wu, Yukun; Farag, Tamer H.; Berkeley, Lynette Y.; Livio, Sofie; Tennant, Sharon M.; Levine, Myron M.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Wu, Yukun] Emergent Biosolut, Gaithersburg, MD USA; [Sur, Dipika; Ramamurthy, Thandavarayan; Kanungo, Suman] Natl Inst Cholera & Enter Dis, Kolkata, India; [Zaidi, Anita K. M.; Qureshi, Shahida; Quadri, Farheen] Aga Khan Univ, Dept Paediat & Child Hlth, Karachi, Pakistan; [Faruque, Abu S. G.; Ahmed, Shahnawaz; Hossain, Anowar; Das, Sumon K.] Int Ctr Diarrhoeal Dis Res, GPO Box 128, Dhaka 1000, Bangladesh; [Saha, Debasish; Adegbola, Richard; Antonio, Martin; Hossain, M. Jahangir] Med Res Council United Kingdom Unit, Fajara, Gambia; [Saha, Debasish; Adegbola, Richard] GSK Vaccines, Wavre, Belgium; [Alonso, Pedro L.; Bassat, Quique; Mandomando, Inacio; Nhampossa, Tacilta; Acacio, Sozinho] Ctr Invest Saude Manhica, Maputo, Mozambique; [Alonso, Pedro L.; Mandomando, Inacio; Nhampossa, Tacilta; Acacio, Sozinho] Minist Saude, Inst Nacl Saude, Maputo, Mozambique; [Alonso, Pedro L.; Bassat, Quique] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Breiman, Robert F.] Kenya Off US Ctr Dis Control & Prevent, Global Dis Detect Div, Nairobi, Kenya; [Omore, Richard; Oundo, Joseph O.; Ochieng, John B.] Ctr Dis Control & Prevent, Kenya Med Res Inst, Kisumu, Kenya; [Mintz, Eric D.; O'Reilly, Ciara E.] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA; [Sommerfelt, Halvor] Univ Bergen, Ctr Intervent Sci Maternal & Child Hlth, Ctr Int Hlth, Bergen, Norway; [Sommerfelt, Halvor] Norwegian Inst Publ Hlth, Dept Int Publ Hlth, Oslo, Norway; [Muhsen, Khitam; Ziv-Baran, Tomer] Tel Aviv Univ, Dept Epidemiol & Prevent Med, Sch Publ Hlth, Sackler Fac Med, Ramat Aviv, Israel; [Robins-Browne, Roy M.] Univ Melbourne, Murdoch Childrens Res Inst, Dept Microbiol & Immunol, Royal Childrens Hosp, Parkville, Vic, Australia; [Zhang, Jixian; Liu, Jie; Houpt, Eric R.] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA USA; [Kotloff, Karen L.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Farag, Tamer H.; Zaidi, Anita K. M.] Bill & Melinda Gates Fdn, Seattle, WA USA; [Sur, Dipika; Ramamurthy, Thandavarayan] Translat Hlth Sci & Technol Inst, Faridabad, India; [Alonso, Pedro L.] WHO Global Malaria Programme, Geneva, Switzerland; [Breiman, Robert F.] Emory Univ, Global Hlth Inst, Atlanta, GA 30322 USA; [Berkeley, Lynette Y.] US FDA, Silver Spring, MD USA; [Nataro, James P.] Univ Virginia, Sch Med, Dept Pediat, Charlottesville, VA 22908 USA	Levine, MM (reprint author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.; Levine, MM (reprint author), Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.	mlevine@medicine.umaryland.edu	Bassat, Quique/P-2341-2016	Bassat, Quique/0000-0003-0875-7596; Muhsen, Khitam/0000-0003-1086-7559	Bill & Melinda Gates Foundation [38774, OPP1033572]; Medical Research Council [MC_U190081991, MC_UP_A900_1122]	This work was supported by grants 38774 and OPP1033572 from the Bill & Melinda Gates Foundation to MML, URL of the funder's website: http://www.gatesfoundation.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajjampur SSR, 2010, AM J TROP MED HYG, V83, P1110, DOI [10.4269/ajtmh.2010.09.0644, 10.4269/ajtmh.2010.09-0644]; Ajjampur SSR, 2007, J CLIN MICROBIOL, V45, P915, DOI 10.1128/JCM.01590-06; Ajjampur SSR, 2010, J CLIN MICROBIOL, V48, P2075, DOI 10.1128/JCM.02509-09; Alves M, 2003, J CLIN MICROBIOL, V41, P2744, DOI 10.1128/JCM.41.6.2744-2747.2003; Amadi B, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-195; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Blackwelder WC, 2012, CLIN INFECT DIS, V55, pS246, DOI 10.1093/cid/cis788; Borad AJ, 2012, AM J TROP MED HYG, V86, P214, DOI 10.4269/ajtmh.2012.11-0273; Chappell CL, 2002, CURR OPIN INFECT DIS, V15, P523, DOI 10.1097/00001432-200210000-00012; Chappell CL, 1996, J INFECT DIS, V173, P232, DOI 10.1093/infdis/173.1.232; Checkley W, 1998, AM J EPIDEMIOL, V148, P497; Checkley W, 2015, LANCET INFECT DIS, V15, P85, DOI 10.1016/S1473-3099(14)70772-8; Eibach D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003551; Farag TH, 2012, CLIN INFECT DIS, V55, pS225, DOI 10.1093/cid/cis787; Hadfield SJ, 2011, J CLIN MICROBIOL, V49, P918, DOI 10.1128/JCM.01733-10; Haque R, 2009, CLIN INFECT DIS, V48, P1191, DOI 10.1086/597580; Johansen OH, 2015, EPIDEMIOL INFECT, V143, P1702, DOI 10.1017/S095026881400243X; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kotloff KL, 2012, CLIN INFECT DIS, V55, pS232, DOI 10.1093/cid/cis753; Kovacs SD, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-014-0728-4; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; Lazarus RP, 2015, AM J TROP MED HYG, V93, P931, DOI 10.4269/ajtmh.15-0044; Levine MM, 2012, CLIN INFECT DIS, V55, pS215, DOI 10.1093/cid/cis761; Liu J, 2014, LANCET INFECT DIS, V9, P10; Liu L, 2015, LANCET, V385, P2461, DOI [10.1016/S0140-6736(15)61132-1, 10.1016/S0140-6736(15)60663-8]; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MACKENZIE WR, 1994, NEW ENGL J MED, V331, P161, DOI 10.1056/NEJM199407213310304; McDonald CM, 2013, AM J CLIN NUTR, V97, P896, DOI 10.3945/ajcn.112.047639; MOLBAK K, 1993, BRIT MED J, V307, P417, DOI 10.1136/bmj.307.6901.417; Molbak K, 1997, AM J CLIN NUTR, V65, P149; Molloy SF, 2010, AM J TROP MED HYG, V82, P608, DOI 10.4269/ajtmh.2010.09-0624; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nasrin D, 2013, AM J TROP MED HYG, V89, P3, DOI 10.4269/ajtmh.12-0749; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; NEWMAN RD, 1994, ANN INTERN MED, V120, P500, DOI 10.7326/0003-4819-120-6-199403150-00009; Newman RD, 1999, J INFECT DIS, V180, P167, DOI 10.1086/314820; Olofin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064636; Panchalingam S, 2012, CLIN INFECT DIS, V55, pS294, DOI 10.1093/cid/cis754; Platts-Mills JA, 2015, LANCET GLOB HEALTH, P10; Rolando RFR, 2012, MEM I OSWALDO CRUZ, V107, P476, DOI 10.1590/S0074-02762012000400006; Robin G, 2001, AM J EPIDEMIOL, V153, P194, DOI 10.1093/aje/153.2.194; Sarkar R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003042; Sheoran A, 2012, J INFECT DIS, V205, P1019, DOI 10.1093/infdis/jir874; SHEPHERD RC, 1988, J CLIN PATHOL, V41, P1104, DOI 10.1136/jcp.41.10.1104; Shirley DAT, 2012, CURR OPIN INFECT DIS, V25, P555, DOI 10.1097/QCO.0b013e328357e569; Snelling WJ, 2007, J INFECT DEV COUNTR, V1, P242, DOI 10.3855/jidc.360; United Nations, 2013, WORLD POP PROSP 2012; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Wanyiri JW, 2014, AM J TROP MED HYG, V91, P319, DOI 10.4269/ajtmh.13-0254; Widmer G, 2012, PARASITE IMMUNOL, V34, P61, DOI 10.1111/j.1365-3024.2011.01301.x; Xiao LH, 2001, J INFECT DIS, V183, P492, DOI 10.1086/318090; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018	53	55	55	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAY	2016	10	5							e0004729	10.1371/journal.pntd.0004729				20	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DO4QY	WOS:000377769300066	27219054	DOAJ Gold, Green Published			2019-04-02	
J	Zmurko, J; Marques, RE; Schols, D; Verbeken, E; Kaptein, SJF; Neyts, J				Zmurko, Joanna; Marques, Rafael E.; Schols, Dominique; Verbeken, Erik; Kaptein, Suzanne J. F.; Neyts, Johan			The Viral Polymerase Inhibitor 7-Deaza-2 '-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection Model	PLOS NEGLECTED TROPICAL DISEASES			English	Article							TRANSMISSION; ENCEPHALITIS; AMERICA; THREAT; BRAZIL	Zika virus (ZIKV) is an emerging flavivirus typically causing a dengue-like febrile illness, but neurological complications, such as microcephaly in newborns, have potentially been linked to this viral infection. We established a panel of in vitro assays to allow the identification of ZIKV inhibitors and demonstrate that the viral polymerase inhibitor 7-deaza-2'-C-methyladenosine (7DMA) efficiently inhibits replication. Infection of AG129 (IFN-alpha/beta and IFN-gamma receptor knock-out) mice with ZIKV resulted in acute neutrophilic encephalitis with viral antigens accumulating in neurons of the brain and spinal cord. Additionally, high levels of viral RNA were detected in the spleen, liver and kidney, and levels of IFN-gamma and IL-18 were systematically increased in serum of ZIKV-infected mice. Interestingly, the virus was also detected in testicles of infected mice. In line with its in vitro anti-ZIKV activity, 7DMA reduced viremia and delayed virus-induced morbidity and mortality in infected mice, which also validates this small animal model to assess the in vivo efficacy of novel ZIKV inhibitors. Since AG129 mice can generate an antibody response, and have been used in dengue vaccine studies, the model can also be used to assess the efficacy of ZIKV vaccines.	[Zmurko, Joanna; Schols, Dominique; Kaptein, Suzanne J. F.; Neyts, Johan] KU Leuven Univ Leuven, Lab Virol & Chemotherapy, Leuven, Belgium; [Marques, Rafael E.] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil; [Verbeken, Erik] Univ Leuven, Dept Pathol, Leuven, Belgium; [Verbeken, Erik] Leuven Univ Hosp, Leuven, Belgium	Neyts, J (reprint author), KU Leuven Univ Leuven, Lab Virol & Chemotherapy, Leuven, Belgium.	Johan.Neyts@rega.kuleuven.be	Kaptein, Suzanne/O-8855-2018; Marques, Rafael Elias/R-4890-2016; Schols, Dominique/S-9057-2017; Neyts, Johan/U-8267-2017	Kaptein, Suzanne/0000-0002-7935-0219; Marques, Rafael Elias/0000-0002-6949-0947; Schols, Dominique/0000-0003-3256-5850; Neyts, Johan/0000-0002-0033-7514	EU FP7 [264286]; Belgian Interuniversity Attraction Poles (IAP) [P7/45]; Fondation Dormeur, Vaduz; Hercules Foundation [ZW13-02]; Rega Foundation, KU Leuven	JZ's work was supported by: EU FP7 [FP7/2007-2013] project EUVIRNA under grant agreement no [264286] http://cordis.europa.eu/result/rcn/176954_de.html, a grant from the Belgian Interuniversity Attraction Poles (IAP) phase VII - P7/45 (BELVIR) and the Fondation Dormeur, Vaduz. Part of this research work was performed using the 'Caps-It' research infrastructure (project ZW13-02) that was financially supported by the Hercules Foundation and Rega Foundation, KU Leuven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, RAP RISK ASS ZIK VIR; Bischoff K, 2012, VETERINARY TOXICOLOGY: BASIC AND CLINICAL PRINCIPLES, 2ND EDITION, P443, DOI 10.1016/B978-0-12-385926-6.00028-4; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138; Centers for Disease Control and Prevention, 2015, ZIK VIR SYMPT TREATM; Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983; European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR; Eyer L, 2015, ANTIMICROB AGENTS CH, V59, P5483, DOI 10.1128/AAC.00807-15; Fauci A.S., 2016, N ENGL J MED; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Goorhuis A., 2015, PROMED; Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681; Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008; Iversen PW, 2006, J BIOMOL SCREEN, V11, P247, DOI 10.1177/1087057105285610; Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683; Leyssen P, 2003, BRAIN PATHOL, V13, P279; McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212; Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707; Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Oehler E., 2014, Eurosurveillance, V19, P20720; Olsen DB, 2004, ANTIMICROB AGENTS CH, V48, P3944, DOI 10.1128/AAC.48.10.3944-3953.2004; Paeshuyse J, 2011, CURR OPIN VIROL, V1, P590, DOI 10.1016/j.coviro.2011.10.030; Pan American Health Organization /World Health Organization, 2015, NEUR SYDNDR CONG MAL; Petrilli V, 2005, CURR BIOL, V15, pR581, DOI 10.1016/j.cub.2005.07.049; Rathore APS, 2011, ANTIVIR RES, V92, P453, DOI 10.1016/j.antiviral.2011.10.002; Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230; Sarathy VV, 2015, VACCINE, V33, P7051, DOI 10.1016/j.vaccine.2015.09.112; Sarathy VV, 2015, J VIROL, V89, P1254, DOI 10.1128/JVI.01320-14; Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310; Tappe D., 2015, MED MICROBIOL IMMUNO; Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302; Zammarchi L., 2015, Eurosurveillance, V20, P21153; Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005	38	122	124	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAY	2016	10	5							e0004695	10.1371/journal.pntd.0004695				15	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DO4QY	WOS:000377769300037	27163257	DOAJ Gold, Green Published	Y	N	2019-04-02	
J	Baly, A; Gonzalez, K; Cabrera, P; Popa, JC; Toledo, ME; Hernandez, C; Montada, D; Vanlerberghe, V; Van der Stuyft, P				Baly, Alberto; Gonzalez, Karelia; Cabrera, Pedro; Popa, Julio C.; Toledo, Maria E.; Hernandez, Claudia; Montada, Domingo; Vanlerberghe, Veerle; Van der Stuyft, Patrick			Incremental cost of implementing residual insecticide treatment with delthametrine on top of intensive routine Aedes aegypti control	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						Aedes; dengue; residual insecticide treatment; residual spraying; routine vector control; cost; incremental cost; Cuba	CLUSTER RANDOMIZED-TRIAL; DENGUE VECTOR CONTROL; ECONOMIC-IMPACT; CUBA; PREVENTION; EPIDEMIC; INTERVENTIONS; SANTIAGO	ObjectiveInformation on the cost of implementing residual insecticide treatment (RIT) for Aedes control is scarce. We evaluated the incremental cost on top of intensive conventional routine activities of the Aedes control programme (ACP) in the city of Santiago de Cuba, Cuba. MethodsWe conducted the cost analysis study in 2011-2012, from the perspective of the ACP. Data sources were bookkeeping records, activity registers of the Provincial ACP Centre and the accounts of an RIT implementation study in 21 clusters of on average four house blocks comprising 5180 premises. ResultsThe annual cost of the routine ACP activities was 19.66 US$ per household. RIT applications in rounds at 4-month intervals covering, on average, 97.2% and using 8.5g of delthametrine annually per household, cost 3.06 US$ per household per year. Delthametrine comprised 66.5% of this cost; the additional cost for deploying RIT comprised 15.6% of the total ACP routine cost and 27% of the cost related to routine adult stage Aedes control. ConclusionsThe incremental cost of implementing RIT is high. It should be weighed against the incremental effect on the burden caused by the array of pathogens transmitted by Aedes. The cost could be reduced if the insecticide became cheaper, by limiting the number of yearly applications or by targeting transmission hot spots.	[Baly, Alberto; Toledo, Maria E.; Hernandez, Claudia; Montada, Domingo] Inst Med Trop Pedro Kouri, Havana, Cuba; [Gonzalez, Karelia; Cabrera, Pedro; Popa, Julio C.] Unidad Prov Vigilancia & Lucha Antivectorial, Santiago De Cuba, Cuba; [Vanlerberghe, Veerle; Van der Stuyft, Patrick] Inst Trop Med, Gen Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium; [Van der Stuyft, Patrick] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium	Baly, A (reprint author), Inst Med Trop Pedro Kouri, Dept Epidemiol, Havana, Cuba.	baly@ipk.sld.cu			Institute of Tropical Medicine, Antwerp; Belgium Directorate General for Development Cooperation	We gratefully acknowledge the participation of the households in the study area and the role played by the health sector and provincial vector control programme staff in Santiago. The study was partially funded through the framework agreement between the Institute of Tropical Medicine, Antwerp, and the Belgium Directorate General for Development Cooperation.	Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655; Andersson N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3267; [Anonymous], 2009, DENG GUID DIAGN TREA; Armien B, 2008, AM J TROP MED HYG, V79, P364, DOI 10.4269/ajtmh.2008.79.364; Baly A, 2012, TROP MED INT HEALTH, V17, P123, DOI 10.1111/j.1365-3156.2011.02881.x; Baly A, 2011, AM J TROP MED HYG, V84, P747, DOI 10.4269/ajtmh.2011.10-0532; Baly A, 2009, AM J TROP MED HYG, V81, P88, DOI 10.4269/ajtmh.2009.81.88; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bisset Juan A., 2002, Rev Cubana Med Trop, V54, P202; Drummond M, 2005, METHODS EC EVALUATIO; Guzman MG, 2006, REV PANAM SALUD PUBL, V19, P282, DOI 10.1590/S1020-49892006000400014; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Johns B, 2003, COST EFF RESOUR ALLO, V1, P1; Meltzer MI, 1998, AM J TROP MED HYG, V59, P265, DOI 10.4269/ajtmh.1998.59.265; Oficina Nacional de Estadisticas, 2015, CENS POBL VIV; Pandey A, 2015, EPIDEMIOL INFECT, V143, P1276, DOI 10.1017/S0950268814001939; Parks W, 2004, PLANNING SOCIAL MOBI; Quintero J, 2015, T ROY SOC TROP MED H, V109, P116, DOI 10.1093/trstmh/tru208; Rodriguez JL, 2015, HOY POSIBLE COMENZAR; Romani MET, 2007, SOC SCI MED, V64, P976, DOI 10.1016/j.socscimed.2006.10.033; Sanchez L, 2009, TROP MED INT HEALTH, V14, P1356, DOI 10.1111/j.1365-3156.2009.02379.x; Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503; Suaya JA, 2007, TROP MED INT HEALTH, V12, P1026, DOI 10.1111/j.1365-3156.2007.01889.x; TDR, 2007, SCI WORK GROUP M DEN; Toledo ME, 2011, TROP MED INT HEALTH, V16, P744, DOI 10.1111/j.1365-3156.2011.02762.x; Tun-Lin W, 2009, TROP MED INT HEALTH, V14, P1143, DOI 10.1111/j.1365-3156.2009.02341.x; Valdés G Luis, 2002, Rev Cubana Med Trop, V54, P220; Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000920; White MT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-337; WHO, 2015, MAN IND RES SPRAYING; World Health Organization, GLOB STRAT DENG PREV	31	5	5	0	8	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2016	21	5					597	602		10.1111/tmi.12693				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	DK1TK	WOS:000374697000003	26996279	Bronze			2019-04-02	
J	Feucht, UD; Van Bruwaene, L; Becker, PJ; Kruger, M				Feucht, Ute D.; Van Bruwaene, Lore; Becker, Piet J.; Kruger, Mariana			Growth in HIV-infected children on long-term antiretroviral therapy	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						children; HIV; antiretroviral therapy; growth; tuberculosis	HUMAN-IMMUNODEFICIENCY-VIRUS; SOUTH-AFRICAN CHILDREN; 1-INFECTED CHILDREN; NUTRITIONAL-STATUS; WEIGHT GROWTH; BASE-LINE; COHORT; HEIGHT; OUTCOMES; IMPACT	ObjectivesTo describe growth in HIV-infected children on long-term antiretroviral therapy (ART) and to assess social, clinical, immunological and virological factors associated with suboptimal growth. MethodsThis observational cohort study included all HIV-infected children at an urban ART site in South Africa who were younger than 5 years at ART initiation and with more than 5 years of follow-up. Growth was assessed using weight-for-age Z-scores (WAZ), height-for-age Z-scores (HAZ) and body mass index (BMI)-for-age Z-scores (BAZ). Children were stratified according to pre-treatment anthropometry and age. Univariate and mixed linear analysis were used to determine associations between independent variables and weight and height outcomes. ResultsThe majority of the 159 children presented with advanced clinical disease (90%) and immunosuppression (89%). Before treatment underweight, stunting and wasting were common (WAZ<-2 = 50%, HAZ<-2 = 73%, BAZ<-2 = 19%). Weight and BMI improved during the initial 12 months, while height improved over the entire 5-year period. Height at study exit was significantly worse for children with growth impairment at ART initiation (P < 0.001), and infants (<1 year) demonstrated superior improvement in terms of BMI (P = 0.04). Tuberculosis was an independent risk factor for suboptimal weight (P = 0.01) and height (P = 0.02) improvement. Weight gain was also hindered by lack of electricity (P = 0.04). Immune reconstitution and virological suppression were not associated with being underweight or stunted at study endpoint. ConclusionsMalnutrition was a major clinical concern for this cohort of HIV-infected children. Early ART initiation, tuberculosis co-infection management and nutritional interventions are crucial to ensure optimal growth in HIV-infected children.	[Feucht, Ute D.; Van Bruwaene, Lore] Univ Pretoria, Dept Paediat, Kalafong Hosp, ZA-0002 Pretoria, South Africa; [Van Bruwaene, Lore] Univ Hosp Gasthuisberg, Leuven, Belgium; [Becker, Piet J.] Univ Pretoria, Fac Hlth Sci, ZA-0002 Pretoria, South Africa; [Kruger, Mariana] Univ Stellenbosch, Dept Paediat & Child Hlth, ZA-7505 Tygerberg, South Africa	Feucht, UD (reprint author), Kalafong Hosp, Dept Pediat, Klinikala Bldg,Private Bag X396, ZA-0001 Pretoria, South Africa.	ute.feucht@up.ac.za	; Kruger, Mariana/E-2184-2012	Feucht, Ute/0000-0002-6339-1040; Kruger, Mariana/0000-0002-6838-0180			Benjamin DK, 2003, AIDS, V17, P2331, DOI 10.1097/01.aids.0000076347.42412.de; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Buchacz K, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e72; Buonora S, 2008, ANN TROP PAEDIATR, V28, P59, DOI 10.1179/146532808X270699; Campbell DI, 2003, J NUTR, V133, P1332; Chhagan MK, 2012, TROP MED INT HEALTH, V17, P1092, DOI 10.1111/j.1365-3156.2012.03026.x; Davies MA, 2009, SAMJ S AFR MED J, V99, P730; DesBenedetti F., 2009, HORM RES S1, V72, P26; Devi NPG, 2011, INDIAN PEDIATR, V48, P333; Dollfus C, 2010, CLIN INFECT DIS, V51, P214, DOI 10.1086/653674; Feinstein L, 2012, JAIDS-J ACQ IMM DEF, V61, P235, DOI 10.1097/QAI.0b013e3182634e09; Ghaffari G, 2004, PEDIATRICS, V114, pE604, DOI 10.1542/peds.2004-0274; Gsponer T, 2012, PEDIATRICS, V130, pE966, DOI 10.1542/peds.2011-3020; Guillen S, 2007, PEDIATR INFECT DIS J, V26, P334, DOI 10.1097/01.inf.0000257427.19764.ff; Isanaka S, 2009, NUTR REV, V67, P343, DOI 10.1111/j.1753-4887.2009.00207.x; Jesson J, 2015, MED MALADIES INFECT, V45, P149, DOI 10.1016/j.medmal.2015.03.002; Jesson J, 2015, PEDIATR INFECT DIS J, V34, pE159, DOI 10.1097/INF.0000000000000734; Kabue MM, 2008, AIDS PATIENT CARE ST, V22, P245, DOI 10.1089/apc.2007.0049; Kekitiinwa A, 2008, JAIDS-J ACQ IMM DEF, V49, P384, DOI 10.1097/QAI.0b013e31818cdef5; Kruger HS, 2011, PUBLIC HEALTH NUTR, V15, P594; Lindsey JC, 2000, J INFECT DIS, V182, P1385, DOI 10.1086/315865; Lundeen EA, 2014, AM J CLIN NUTR, V100, P821, DOI 10.3945/ajcn.114.084368; Marais BJ, 2014, J PAEDIATR CHILD H, V50, P759, DOI 10.1111/jpc.12503; McGrath CJ, 2011, AIDS, V25, P345, DOI 10.1097/QAD.0b013e32834171db; McHenry Megan S, 2015, J Int Assoc Provid AIDS Care, V14, P313, DOI 10.1177/2325957414539044; Miller TL, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.5.e77; Miller TL, 2008, J PEDIATR GASTR NUTR, V47, P247, DOI 10.1097/MPG.0b013e318181b254; Musoke PM, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-56; Mwiru RS, 2014, J TROP PEDIATRICS, V60, P179, DOI 10.1093/tropej/fmt104; Nachman SA, 2005, PEDIATR INFECT DIS J, V24, P352, DOI 10.1097/01.inf.0000157095.75081.43; Naidoo R, 2010, PEDIATR INFECT DIS J, V29, P511, DOI 10.1097/INF.0b013e3181d1e989; Diniz LMO, 2011, J PEDIAT-BRAZIL, V87, P131, DOI [10.1590/S0021-75572011000200008, 10.2223/JPED.2064]; Parchure RS, 2015, INDIAN J PEDIATR, V82, P519, DOI 10.1007/s12098-014-1659-1; Reddi Anand, 2007, BMC Pediatr, V7, P13, DOI 10.1186/1471-2431-7-13; Shiau S, 2013, J PEDIATR-US, V162, P1138, DOI 10.1016/j.jpeds.2012.11.025; South African National Department of Health, 2004, NAT ANT TREATM GUID; Stephen CR, 2011, SAVING CHILDREN 2009; Sunguya BF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098308; Suresh E, 2015, INDIAN PEDIATR, V52, P250; Sutcliffe CG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-54; Venturini E, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-S1-S5; Verweel G, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e25; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Wamalwa DC, 2007, JAIDS-J ACQ IMM DEF, V45, P311; Weigel R, 2010, TROP MED INT HEALTH, V15, P934, DOI 10.1111/j.1365-3156.2010.02561.x; WHO, 2011, WHONMHNHDMNM111; WHO, 2009, GUID INT APPR NUTR C; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; World Health Organization, 1999, CLIN US BLOOD GEN ME; World Health Organization, 2007, WHO CAS DEF HIV SURV	50	5	5	1	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2016	21	5					619	629		10.1111/tmi.12685				11	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	DK1TK	WOS:000374697000006	26914715				2019-04-02	
J	Dao, TTH; Van Bui, T; Abatih, EN; Gabriel, S; Nguyen, TTG; Huynh, QH; Van Nguyen, C; Dorny, P				Thanh Thi Ha Dao; Tuan Van Bui; Abatih, Emmanuel Nji; Gabriel, Sarah; Thanh Thi Giang Nguyen; Quang Hong Huynh; Chuong Van Nguyen; Dorny, Pierre			Opisthorchis viverrini infections and associated risk factors in a lowland area of Binh Dinh Province, Central Vietnam	ACTA TROPICA			English	Article						Opisthorchis viverrini; Human; Prevalence; Risk factors; Vietnam	LIVER FLUKE; PREVALENCE; CHOLANGIOCARCINOMA; THAILAND; ALCOHOL; LAOS	Opisthorchiasis caused by Opisthorchis viverrini is a major public health problem in the Mekong Basin in South East Asia. It is associated with cholangiocarcinoma, a fatal cancer of the bile duct, which is very common in some areas of Thailand and Lao PDR. Although there is evidence of opisthorchiasis in the central and Southern provinces of Vietnam, data are scarce and Vietnam is often not considered an opisthorchiasis endemic area in the international literature. We conducted a cross-sectional survey in June 2015 in a lowland rural area of Binh Dinh Province in Central Vietnam to investigate the apparent prevalence of O. viverrini infection in the population and the associated risk factors. A total of 254 stool samples were collected and examined by the Kato Katz method. Consenting people shedding Opisthorchis-like eggs with their stools were treated with praziquantel and MgSO4 and adult worms were collected from stools for morphological and molecular identifications. Risk factors were studied with a structured questionnaire and the association with infection was evaluated by univariate and multivariate Firth's logistic regression analysis. The apparent prevalence in the investigated population determined by stool examination was 11.4% (CI: 8-16%). Infection with O. viverrini was confirmed in all 11 individuals consenting to receive praziquantel treatment and subsequent worm recovery from stools. The mean number of worms recovered after treatment/purgation was 14.5 (range 2-44). Male gender and the consumption of dishes prepared from raw small wild-caught freshwater fish (Carassius auratus) were found to be significant risk factors associated with opisthorchiasis in the area. These findings confirm the presence of O. viverrini infection in Central Vietnam related to the consumption of raw fish dishes. Awareness campaigns and control programs should be implemented in the region to combat this potentially fatal fluke infection. (C) 2016 Elsevier B.V. All rights reserved.	[Thanh Thi Ha Dao] Natl Inst Vet Res, 86 Truong Chinh St, Hanoi, Vietnam; [Thanh Thi Ha Dao; Dorny, Pierre] Univ Ghent, Salisburylaan 133, B-9820 Merelbeke, Belgium; [Thanh Thi Ha Dao; Abatih, Emmanuel Nji; Gabriel, Sarah; Dorny, Pierre] Inst Trop Med, Natl Str 155, B-2000 Antwerp, Belgium; [Tuan Van Bui; Quang Hong Huynh; Chuong Van Nguyen] Inst Malariol Parasitol & Entolom Quy Nhon, 611 Nguyen Thai Hoc St, Quy Nhon City, Binh Dinh Provi, Vietnam; [Thanh Thi Giang Nguyen] Minist Hlth, 138A,Giang Vo St, Hanoi, Vietnam	Dorny, P (reprint author), Inst Trop Med, Dept Biomed Sci, Vet Helminthol Unit, Natl Str 155, B-2000 Antwerp, Belgium.	pdorny@itg.be		GABRIEL, SARAH/0000-0002-2523-233X	Directorate General for Development Cooperation (DGD)-PhD Program, Belgium	This study was financially supported by the Directorate General for Development Cooperation (DGD)-PhD Program, Belgium. The authors would like to thank the staffs of the Parasitology Department of IMPE Quy Nhon, Vietnam and of the Biomedical Science Department of ITM, Belgium for logistic and technical help.	Andrews R. H., 2008, TRENDS PARASITOL, V11, P497; BOWLES J, 1993, ACTA TROP, V55, P217, DOI 10.1016/0001-706X(93)90079-Q; Bray R. A., 2008, BOOK, V3, P1; Chai JY, 2005, J HELMINTHOL, V79, P283, DOI 10.1079/JOH2005302; Chaiputcha Kusumaporn, 2015, Asian Pac J Cancer Prev, V16, P4173; Chudthaisong Nittaya, 2015, Asian Pac J Cancer Prev, V16, P4593; Dao TH, 2014, J HELMINTHOL, V88, P441, DOI 10.1017/S0022149X13000400; De N. V., 2012, EXP PARASITOL, V129, P355; Do T. D., 2007, EMERG INFECT DIS, V12, P1828; Dorny P, 2015, J HELMINTHOL, V89, P257, DOI 10.1017/S0022149X13000722; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Forrer A., 2012, PLOS NEGLECT TROP D, V2, pe1481; Grundy -Warr C., 2012, PARASITOL INT, V1, P65; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Kaewkes S, 2003, ACTA TROP, V88, P177, DOI 10.1016/j.actatropica.2003.05.001; Kaewpitoon SJ, 2012, ASIAN PAC J CANCER P, V13, P5245, DOI 10.7314/APJCP.2012.13.10.5245; Maleewong Wanchai, 1992, Journal of the Medical Association of Thailand, V75, P231; Nguyen M. H., 2015, PARASITE VECTOR, V8, P21; Nguyen V. C., 2009, J MALAR PARASIT DIS, V1, P78; Phongluxa K, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-328; Ram R., 2009, AM J TROP MED HYG, V81, P152; Sithithaworn P, 2012, PARASITOL INT, V61, P10, DOI 10.1016/j.parint.2011.08.014; Songserm N, 2011, ASIAN PAC J CANCER P, V12, P1341; Sripa B., 2007, PLOS MED, V7, pe201; Sripa B, 2011, ACTA TROP, V120, P158; Sripa B, 2012, TRENDS PARASITOL, V28, P395, DOI 10.1016/j.pt.2012.07.006; Sriraj P, 2013, PARASITOL RES, V112, P2971, DOI 10.1007/s00436-013-3469-1; Sriraj P, 2013, PARASITOL RES, V112, P2397, DOI 10.1007/s00436-013-3346-y; Tai-Soon Y., 2012, KOREAN J PARASITOL, V50, P173; Thaenkham U, 2011, J PARASITOL, V97, P1152, DOI 10.1645/GE-2764.1; Thrusfield M., 2005, VET EPIDEMIOLOGY, V32, P228; Wagner B, 2004, PREV VET MED, V66, P1, DOI 10.1016/j.prevetmed.2004.07.008; *WHO, 1991, BAS LAB METH MED PAR, P1; WHO, 2011, IARC MONOGRAPHS EVAL, V100 B, P341; World Health Organization, 2008, REV EP PROF HELM THE, P114	36	9	9	3	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	MAY	2016	157						151	157		10.1016/j.actatropica.2016.01.029				7	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	DH4MZ	WOS:000372761400018	26872984				2019-04-02	
J	Seyoum, D; Kifle, YG; Rondeau, V; Yewhalaw, D; Duchateau, L; Rosas-Aguirre, A; Speybroeck, N				Seyoum, Dinberu; Kifle, Yehenew Getachew; Rondeau, Virginie; Yewhalaw, Delenasaw; Duchateau, Luc; Rosas-Aguirre, Angel; Speybroeck, Niko			Identification of different malaria patterns due to Plasmodium falciparum and Plasmodium vivax in Ethiopian children: a prospective cohort study	MALARIA JOURNAL			English	Article						Frailty model; Recurrent malaria; Plasmodium vivax; Plasmodium falciparum; Ethiopia	PENALIZED LIKELIHOOD ESTIMATION; DISCONTINUOUS RISK INTERVALS; NEW-GUINEAN CHILDREN; RECURRENT EVENTS; FRAILTY MODELS; RESERVOIR; IMPACT; TIME; DAM; INFECTION	Background: The identification of epidemiological pattern of infection with Plasmodium falciparum and Plasmodium vivax in malaria-endemic area, where multiple episodes are common, is important for intervention programmes. Methods: A longitudinal cohort study based on weekly house-to-house visits was conducted between July 2008 and June 2010 in 2040 children less than 10 years of age, living nearby the Gilgel-Gibe hydroelectric power dam reservoir in order to determine factors associated with increased P. vivax and P. falciparum incidence. Two types of multivariate frailty models were applied (using time-to-first malaria episode data and time-to-recurrent malaria episode data), allowing the estimation of adjusted hazard ratios (AHR) of potential risk factors (gender, age, proximity to the dam reservoir, and season) for species-specific malaria incidence. Results: Of 2040 children in 96 weeks of follow up, 864 children experienced at least one malaria episode: 685 due to P. falciparum in 548 children, and 385 due to P. vivax in 316 children. Plasmodium vivax and P. falciparum malaria incidence rates were 8.2 (95 % CI: 7.3-9.1) and 14.6 (95 % CI: 13.4-15.6) per 1000 children per month, respectively. According to the time-to-recurrent event models, children aged >= 7 years had a lower risk of presenting P. vivax episodes (AHR = 0.6; 95 % CI: 0.4-0.9), but a higher risk of P. falciparum episodes, when compared with children under <= 3 years (AHR = 1.2; 95 % CI: 1.1-1.6). In addition, P. vivax (AHR = 2.7; 95 % CI: 2.2-3.5) and P. falciparum (AHR = 16.9; 95 % CI: 14.3-20.2) episodes were respectively 2.7 and 16.9 times more frequent in the dry season than in the long rainy season. Conclusions: The analysis of all malaria episodes (first and recurrent episodes) in the malaria cohort suggests different species-specific patterns of malaria disease in children, with mild seasonality in the incidence of P. vivax episodes mostly observed in younger age groups, and with marked seasonality in the incidence of P. falciparum episodes mainly seen in older children.	[Seyoum, Dinberu; Rosas-Aguirre, Angel; Speybroeck, Niko] Univ Catholique Louvain, Inst Hlth & Soc IRSS, B-1200 Brussels, Belgium; [Seyoum, Dinberu] Jimma Univ, Dept Stat, Coll Nat Sci, Jimma, Ethiopia; [Kifle, Yehenew Getachew] Univ Limpopo, Dept Stat & Operat Res, ZA-0727 Polokwane, South Africa; [Rondeau, Virginie] Univ Bordeaux 2, INSERM, EMI Biostat 0338, 146 Rue Leo Saignat, F-33076 Bordeaux, France; [Yewhalaw, Delenasaw] Jimma Univ, Dept Lab Technol Sci & Pathol, Coll Publ Hlth & Med Sci, Jimma, Ethiopia; [Duchateau, Luc] Univ Ghent, Fac Vet Med, Dept Comparat Physiol & Biometr, B-9000 Ghent, Belgium; [Rosas-Aguirre, Angel] Univ Peruana Cayetano Heredia, Inst Trop Med Alexander von Humboldt, Lima, Peru	Speybroeck, N (reprint author), Univ Catholique Louvain, Inst Hlth & Soc IRSS, B-1200 Brussels, Belgium.	niko.speybroeck@uclouvain.be	rondeau, virginie/E-4192-2014	rondeau, virginie/0000-0001-7109-4831; Rosas Aguirre, Angel/0000-0002-3271-7028	Institutional University Cooperation IUC-JU project under the umbrella of the Flemish Interuniversity Council (VLIR-UOS)	We acknowledge the financial support from the Institutional University Cooperation IUC-JU project under the umbrella of the Flemish Interuniversity Council (VLIR-UOS). We thank also Kibiralem Sisay who is Statistics Department staff in Jimma University for helping with me in writing R codes to manage the data. We would like to than the two anonymous reviewers and the editor-in-chief, for their constructive comments which helped to improve the paper.	Abate A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-312; Cheung YB, 2010, STAT MED, V29, P328, DOI 10.1002/sim.3783; da Silva-Nunes M, 2008, AM J TROP MED HYG, V79, P624, DOI 10.4269/ajtmh.2008.79.624; Duchateau L, 2003, J ROY STAT SOC C-APP, V52, P355, DOI 10.1111/1467-9876.00409; Duchateau L, 2008, STAT BIOL HEALTH, P1; FDRE, 2012, NAT MAL GUID; Gabbett TJ, 2012, J SCI MED SPORT, V15, P496, DOI 10.1016/j.jsams.2012.03.017; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Ghebreyesus TA, 2000, T ROY SOC TROP MED H, V94, P17, DOI 10.1016/S0035-9203(00)90424-3; Guo Z, 2008, METHOD INFORM MED, V47, P107, DOI 10.3414/ME0478; Kibret S, 2009, IWMI RES REP, V132, P47; Kibret S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0873-2; Lautze J, 2007, TROP MED INT HEALTH, V12, P982, DOI 10.1111/j.1365-3156.2007.01878.x; Lawpoolsri S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-143; Le Port A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000342; Lin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009047; Liu L, 2004, BIOMETRICS, V60, P747, DOI 10.1111/j.0006-341X.2004.00225.x; Maitland K, 1996, T ROY SOC TROP MED H, V90, P614, DOI 10.1016/S0035-9203(96)90406-X; Mayagaya VS, 2015, MALARIA J, V14, DOI 10.1186/s12936-014-0536-8; Michon P, 2007, AM J TROP MED HYG, V76, P997, DOI 10.4269/ajtmh.2007.76.997; MOH, 2012, NAT MAL GUID; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; NIGATU W, 1992, TROP MED PARASITOL, V43, P181; Olana D, 2011, EMERG INFECT DIS, V17, P1336, DOI 10.3201/eid1707.100942; Parpia S, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-44; Phimpraphi W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-99; Rondeau V, 2006, STAT MED, V25, P4036, DOI 10.1002/sim.2510; Rondeau V, 2012, J STAT SOFTW, V47, P1; Sagara I, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-293; Sena L, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0625-x; Stefani A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-246; Twisk JWR, 2005, J EPIDEMIOL COMMUN H, V59, P706, DOI 10.1136/jech.2004.030759; Ullah S, 2014, BRIT J SPORT MED, V48, P1287, DOI 10.1136/bjsports-2011-090803; Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297; World Health Organization, 2015, WORLD MAL REP 2015; Woyessa A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-84; Yeshiwondim AK, 2010, ACTA TROP, V113, P105, DOI 10.1016/j.actatropica.2009.10.001; Yewhalaw D, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-161; Yewhalaw D, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-21	40	6	6	1	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	APR 14	2016	15								208	10.1186/s12936-016-1253-2				11	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DJ9EV	WOS:000374517700001	27075667	DOAJ Gold, Green Published			2019-04-02	
J	Tungu, P; Kirby, M; Malima, R; Kisinza, W; Magesa, S; Maxwell, C; Batengana, B; Pigeon, O; Rowland, M				Tungu, Patrick; Kirby, Matthew; Malima, Robert; Kisinza, William; Magesa, Stephen; Maxwell, Caroline; Batengana, Benard; Pigeon, Olivier; Rowland, Mark			Interceptor (R) long-lasting insecticidal net: phase III evaluation over three years of household use and calibration with Phase II experimental hut outcomes	PARASITES & VECTORS			English	Article						Long-lasting insecticidal net; LLIN; Anopheles gambiae; Tanzania; Randomised controlled trial; Alpha-cypermethrin	WASH-RESISTANCE; MOSQUITO NETS; EFFICACY; INDIA; DURABILITY; AREA	Background: Long-lasting insecticidal nets (LN) are an effective tool for malaria prevention. The World Health Organization Pesticide Evaluation Scheme has established evaluation criteria to facilitate registration for public use. A household randomised trial was conducted in Tanzania according to WHOPES Phase III procedures to evaluate the alpha-cypermethrin coated Interceptor (R) LN (BASF) over three years' use. Outcomes were calibrated against results of Phase II experimental hut trials. Methods: Interceptor LN (200 mg/m(2) alpha-cypermethrin) and conventionally treated nets CTN (40 mg/m(2) alpha-cypermethrin) were randomly distributed to 934 households. At 6-monthly intervals, household surveys recorded net use, durability, adverse effects, user acceptance and washing practices. Concurrently, 30 nets of each type were collected and tested for knock-down and kill of Anopheles gambiae mosquitoes in cone and tunnel bioassays. Alpha-cypermethrin content of nets was assessed annually. Results: At 12 months 97 % of Interceptor LN met the efficacy criteria by cone or tunnel test; this pass rate declined to 90 % at 24 months and 87 % at 36 months. In contrast only 63 % of CTN met the efficacy criteria at 12 months, 14 % at 24 months and 0 % at 36 months. The alpha-cypermethrin content at 36 months on Interceptor LN was 20 % (42 +/- 13 mg/m(2)) of the initial content but on CTNs only 4 % (1.3 +/- 1.6 mg/m(2)) remained. Interceptor LN was reported to be used year-round and washed 4.3 times/year. A few recalled facial tingling during the first days of use but this did not deter usage. The average number of holes at 36 months was 18, hole area per net was 229 cm(2) and hole index was 332. Insecticide content and cone bioefficacy of LN and CTN after 36 months' use were similar to that of LN and CTN used in earlier Phase II hut trials, but while the 20 times washed LN tested in experimental huts gave adequate personal protection the 20 times washed CTN did not. Conclusions: More than 80 % Interceptor LN fulfilled the WHOPES Phase III criteria at 36 months and thus the LLIN was granted full WHO recommendation. Phase III outcomes at 36 months were anticipated by Phase II outcomes after 20 standardized washes.	[Tungu, Patrick; Malima, Robert; Kisinza, William; Magesa, Stephen; Maxwell, Caroline; Batengana, Benard] Natl Inst Med Res, Amani Med Res Ctr, Muheza, Tanzania; [Kirby, Matthew; Maxwell, Caroline; Rowland, Mark] Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England; [Pigeon, Olivier] Walloon Agr Res Ctr, Agr & Nat Environm Dept, Rue Bordia 11, B-5030 Gembloux, Belgium	Tungu, P (reprint author), Natl Inst Med Res, Amani Med Res Ctr, Muheza, Tanzania.	patrickkijatungu@hotmail.com			WHO Pesticide Evaluation Scheme	The trial was supported by a grant from the WHO Pesticide Evaluation Scheme. We acknowledge Stephen Mkongewa, Teddy Massawe, Mathias Stephano, Eliapendavyo Msuya and Tito John for technical assistance. We thank Morteza Zaim and Rajpal Yadav of WHOPES for supporting the trial, and Harparkash Kaur of LSHTM for chemical analysis of the CTNs sampled after 24 and 36 months. This paper is published with permission from the Director General, National Institute for Medical Research Tanzania.	Banek K, 2011, MALARIA J, V9, P84; Bhatt RM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-189; Dev V, 2010, T ROY SOC TROP MED H, V104, P273, DOI 10.1016/j.trstmh.2009.08.010; Guillet P, 2001, B WORLD HEALTH ORGAN, V79, P998; Kayedi MH, 2008, T ROY SOC TROP MED H, V102, P811, DOI 10.1016/j.trstmh.2008.05.025; Kilian A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-299; Kweka EJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-156; Malima R, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-296; Mboera LE, 1999, ANN TROP MED PARASIT, V95, P325; N'Guessan R, 2001, MED VET ENTOMOL, V15, P97, DOI 10.1046/j.1365-2915.2001.00284.x; PLEASS RJ, 1993, B ENTOMOL RES, V83, P133, DOI 10.1017/S0007485300041870; Sharma SK, 2010, ACTA TROP, V116, P24, DOI 10.1016/j.actatropica.2010.05.002; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2011, GUID MON DUR LONG LA; WHO, 2007, WHOCDSNTDWHOPES20071; WHO, 2012, WHOHTMNTDWHOPES20125; WHO, 2007, INS TREAT MOSQ NETS; WHO Malaria Policy Advisory Committee and Secretariat, 2014, MALARIA J, V13, P253; World Health Organization, 2005, WHOCDSWHOPESGCDPP200; World Health Organization, 2009, WHOSEAGLP20093, P28; World Health Organization, 2001, WHOCDSWHOPES20014; World Health Organization, 2015, WORLD MAL REP 2015; World Health Organization (WHO), 2013, GUID LAB FIELD TEST; World Health Organization. (WHO), 2008, WAIST CIRC WAIST HIP, P8, DOI DOI 10.1016/J.VACCINE.2016.10.034; Yates A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-52	25	1	1	0	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	APR 13	2016	9								204	10.1186/s13071-016-1490-9				13	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	DJ3WX	WOS:000374138500001	27075874	DOAJ Gold, Green Published			2019-04-02	
J	Jaiteh, F; Dierickx, S; Gryseels, C; O'Neill, S; D'Alessandro, U; Scott, S; Balen, J; Grietens, KP				Jaiteh, Fatou; Dierickx, Susan; Gryseels, Charlotte; O'Neill, Sarah; D'Alessandro, Umberto; Scott, Susana; Balen, Julie; Grietens, Koen Peeters			'Some anti-malarials are too strong for your body, they will harm you.'Socio-cultural factors influencing pregnant women's adherence to anti-malarial treatment in rural Gambia	MALARIA JOURNAL			English	Article						Adherence; Anti-malarials; Pregnancy; Rural Gambia	PLASMODIUM-VIVAX	Background: Despite declining prevalence of malaria in The Gambia, non-adherence to anti-malarial treatment still remains a challenge to control efforts. There is limited evidence on the socio-cultural factors that influence adherence to anti-malarial treatment in pregnancy. This study explored perceptions of malaria in pregnancy and their influence on adherence to anti-malarial treatment in a rural area of The Gambia. Methods: An exploratory ethnographic study was conducted ancillary to a cluster-randomized trial on scheduled screening and treatment of malaria in pregnancy at village level in the Upper River Region of The Gambia from June to August 2014. Qualitative data were collected through interviewing and participant observation. Analysis was concurrent to data collection and carried out using NVivo 10. Results: Although women had good bio-medical knowledge of malaria in pregnancy, adherence to anti-malarial treatment was generally perceived to be low. Pregnant women were perceived to discontinue the provided antimalarial treatment after one or 2 days mainly due to non-recognition of symptoms, perceived ineffectiveness of the anti-malarial treatment, the perceived risks of medication and advice received from mothers-in-law. Conclusion: Improving women's knowledge of malaria in pregnancy is not sufficient to assure adherence to antimalarial treatment. Addressing structural barriers such as unclear health workers' messages about medication dosage, illness recognition, side effects of the medication and the integration of relatives, especially the mothers-in-law, in community-based programmes are additionally required.	[Jaiteh, Fatou] Univ Sheffield, Dept Geog, Sheffield S10 2TN, S Yorkshire, England; [Jaiteh, Fatou; Dierickx, Susan; Gryseels, Charlotte; O'Neill, Sarah; D'Alessandro, Umberto; Grietens, Koen Peeters] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Jaiteh, Fatou; D'Alessandro, Umberto; Scott, Susana] MRC Unit, Fajara, Gambia; [Dierickx, Susan; Gryseels, Charlotte] Amsterdam Inst Social Sci Res, Amsterdam, Netherlands; [D'Alessandro, Umberto; Scott, Susana] London Sch Hyg & Trop Med, London WC1, England; [Balen, Julie] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Grietens, Koen Peeters] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki 852, Japan; [Grietens, Koen Peeters] PASS Int, Tessenderlo, Belgium	Jaiteh, F (reprint author), Univ Sheffield, Dept Geog, Sheffield S10 2TN, S Yorkshire, England.; Jaiteh, F (reprint author), Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.; Jaiteh, F (reprint author), MRC Unit, Fajara, Gambia.	fjaiteh@mrc.gm		Peeters Grietens, Koen/0000-0001-6570-9887; Gryseels, Charlotte/0000-0002-8963-4469; Balen, Julie/0000-0002-4736-8465	Demba Njie (COSMIC study nurse coordinator); Medical Research Council [MC_EX_MR/J002364/1]	We like to express our sincere gratitude to Demba Njie (COSMIC study nurse coordinator) and Teeda Sonko (COSMIC study field nurse) for all their support given during the study period. We are also grateful to the community members of the Demba Kunda Kuta, Koto and Mandinka for their cooperation during the study period.	Andrew EVW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119077; Banek K, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-7; Bernard HR, 2006, RES METHODS ANTHR QU; Boene H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086038; Brabin L, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-25; Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242; Conteh L, 2007, TROP MED INT HEALTH, V12, P382, DOI 10.1111/j.1365-3156.2006.01806.x; Grietens KP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012013; Grietens KP, 2010, AM J TROP MED HYG, V82, P1017, DOI 10.4269/ajtmh.2010.09-0521; Gryseels C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080343; Hartman TK, 2010, ANN TROP PAEDIATR, V30, P271, DOI 10.1179/146532810X12858955921032; Hausmann Muela S, 2012, MALARIA REPORTS, V1, P17; Heggenhougen HK, 2003, BEHAV SOCIAL ASPECTS; Manderson L, 1998, TROP MED INT HEALTH, V3, P1020, DOI 10.1046/j.1365-3156.1998.00334.x; McCombie SC, 1996, SOC SCI MED, V43, P933, DOI 10.1016/0277-9536(95)00446-7; Mwesigwa J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0829-6; Ndyomugyenyi R, 1998, HEALTH POLICY PLANN, V13, P94; Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2; Pell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022452; Ribera JM, 2007, PLOS MED, V4, P631, DOI 10.1371/journal.pmed.0040092; Scott S, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-340; Shanks GD, 2006, J POSTGRAD MED, V52, P277; Spencer L, 2003, QUALITY QUALITATIVE; Stark L, 2010, PRACTICAL GUIDE RES; Stokes E, 2008, BJOG-INT J OBSTET GY, V115, P1641, DOI 10.1111/j.1471-0528.2008.01950.x; Tagbor H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132247; Telfer Michelle L, 2002, Afr J Reprod Health, V6, P74, DOI 10.2307/3583148; The Ministry of Health and Social Affairs. The Government of The Gambia, 2012, NAT MAL STRAT PAP; Tolhurst R, 2008, MIDWIFERY, V24, P83, DOI 10.1016/j.midw.2006.09.003; WHITE N, 1998, ANN TROP MED PARASIT, V92, P367; Williams HA, 2004, SOC SCI MED, V59, P501, DOI 10.1016/j.socscimed.2003.11.010; World Health Organisation, 2015, GUID TREATM MAL	32	4	4	0	13	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	APR 11	2016	15								195	10.1186/s12936-016-1255-0				7	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DI7EZ	WOS:000373663400001	27068760	DOAJ Gold, Green Published			2019-04-02	
J	Montalvo, AM; Fraga, J; Montano, I; Monzote, L; Van der Auwera, G; Marin, M; Muskus, C				Montalvo, Ana M.; Fraga, Jorge; Montano, Ivon; Monzote, Lianet; Van der Auwera, Gert; Marin, Marcel; Muskus, Carlos			Molecular identification of Leishmania spp. in clinical isolates from Colombia based on hsp70 gene	BIOMEDICA			Spanish	Article						Leishmania; diagnosis; polymerase chain reaction; polymorphism; restriction fragment length	CUTANEOUS LEISHMANIASIS; MUCOCUTANEOUS LEISHMANIASIS; HEAT-SHOCK-PROTEIN-70 PCR; EPIDEMIOLOGY; BRAZILIENSIS; DIAGNOSIS; EVOLUTION; WORLD; RFLP	Introduction: Leishmaniasis is highly prevalent in Colombia, where at least six different species can cause disease of varying clinical presentations in humans. The identification of the infecting species is quite important for prognosis, therapeutics and epidemiology. Different techniques with variable discriminatory power have been used for the identification. Objective: To carry out the molecular identification of Leishmania species through the amplification of a fragment of the hsp70 gene. Materials and methods: Molecular amplification of the hsp70 gene fragment (PCR-hsp70) followed by restriction fragment length polymorphism analysis (RFLP) was done for identification purposes using DNA from 81 clinical isolates of Leishmania. Results: A single amplicon was obtained for all samples analyzed. The enzymatic restrictions of the 81 PCR products identified 70 with a banding pattern corresponding to L. braziliensis with two different patterns (62 and eight isolates, respectively), nine isolates compatible with L. panamensis and two with L. guyanensis. The geographical origin of the isolates is consistent with previous reports about the distribution of the corresponding species in Colombia. Conclusions: The PCR-hsp70/RFLP technique used is a valid tool for the identification of Leishmania species isolated from clinical samples of patients in Colombia, which may also be applicable to the study of strains obtained from vectors and reservoirs with epidemiological significance.	[Montalvo, Ana M.; Fraga, Jorge; Montano, Ivon; Monzote, Lianet] Inst Med Trop Pedro Kouri, Dept Parasitol, Havana, Cuba; [Van der Auwera, Gert] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Marin, Marcel; Muskus, Carlos] Univ Antioquia, Fac Med, PECET, Medellin, Colombia	Muskus, C (reprint author), Univ Antioquia, Fac Med, PECET, Sede Invest Univ, Carrera 53 61-30,Lab 632, Medellin, Colombia.	carmusk@yahoo.com					Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Banuls AL, 2007, ADV PARASIT, V64, P1, DOI 10.1016/S0065-308X(06)64001-3; Buitrago R, 2011, INFECT GENET EVOL, V11, P557, DOI 10.1016/j.meegid.2010.11.019; CORREDOR A, 1990, AM J TROP MED HYG, V42, P206; CUPOLILLO E, 1995, MOL BIOCHEM PARASIT, V73, P145, DOI 10.1016/0166-6851(95)00108-D; da Silva LA, 2010, INFECT GENET EVOL, V10, P77, DOI 10.1016/j.meegid.2009.11.001; Fraga J, 2013, DIAGN MICR INFEC DIS, V77, P245, DOI 10.1016/j.diagmicrobio.2013.07.023; Fraga J, 2012, DIAGN MICR INFEC DIS, V74, P142, DOI 10.1016/j.diagmicrobio.2012.06.010; Garcia L, 2004, J CLIN MICROBIOL, V42, P2294, DOI 10.1128/JCM.42.5.2294-2297.2004; Handman E, 2005, ADV PARASIT, V59, P1, DOI 10.1016/S0065-308X(05)59001-8; Kato H, 2013, ACTA TROP, V128, P710, DOI 10.1016/j.actatropica.2013.09.001; Monroy-Ostria M, 2014, INTERDISCIP PERSP IN, V2014; Montalvo AM, 2012, EUR J CLIN MICROBIOL, V31, P1453, DOI 10.1007/s10096-011-1463-z; Montalvo AM, 2010, PARASITOLOGY, V137, P1159, DOI 10.1017/S0031182010000089; Alvarez AMM, 2010, T ROY SOC TROP MED H, V104, P364, DOI 10.1016/j.trstmh.2009.12.002; Neves-Rocha M, 2010, DIAGN MICROBIOL INF, V68, P401; Odiwuor S, 2012, INFECT GENET EVOL, V12, P1994, DOI 10.1016/j.meegid.2012.03.028; Bracho CO, 2007, MEM I OSWALDO CRUZ, V102, P549, DOI 10.1590/S0074-02762007005000061; Ovalle Clemencia Elena, 2006, Biomédica, V26, P145; Martinez LP, 2010, PARASITOL RES, V106, P647, DOI 10.1007/s00436-009-1712-6; Perez-Ayala A, 2009, J TRAVEL MED, V16, P395, DOI 10.1111/j.1708-8305.2009.00341.x; Reithinger R, 2007, J CLIN MICROBIOL, V45, P21, DOI 10.1128/JCM.02029-06; Rincón Melvin Y, 2009, Rev. salud pública, V11, P145, DOI 10.1590/s0124-00642009000100015; Rivas L, 2004, TRENDS PARASITOL, V20, P297, DOI 10.1016/j.pt.2004.05.005; Rodriguez-Barraquer I, 2008, AM J TROP MED HYG, V78, P276, DOI 10.4269/ajtmh.2008.78.276; Ruiz FL, 2011, ACTA OTORRINOLARINGO, V39, P39; Sambrook J, 1989, MOL CLONING LAB MANU; Schonian G, 2011, PARASITOLOGY, V138, P405, DOI 10.1017/S0031182010001538; Schriefer A, 2008, CURR OPIN INFECT DIS, V2, P483; Urbano J, 2011, REV IBERO LATINOAMER, V70, P16; Volpini AC, 2004, ACTA TROP, V90, P31, DOI 10.1016/j.actatropica.2003.10.008; WEIGLE KA, 1987, AM J TROP MED HYG, V36, P489, DOI 10.4269/ajtmh.1987.36.489	32	4	5	0	34	INST NACIONAL SALUD	BOGOTA D C	AVENIDA CALLE 26 NO 51-60, APARTADO AEREO 80334 Y 80080, BOGOTA D C, 00000, COLOMBIA	0120-4157			BIOMEDICA	Biomedica	APR	2016	36			1			37	44		10.7705/biomedica.v36i2.2688				8	Tropical Medicine	Tropical Medicine	DL6MB	WOS:000375752200006	27622623	DOAJ Gold			2019-04-02	
J	Akiner, MM; Demirci, B; Babuadze, G; Robert, V; Schaffner, F				Akiner, Muhammet M.; Demirci, Berna; Babuadze, Giorgi; Robert, Vincent; Schaffner, Francis			Spread of the Invasive Mosquitoes Aedes aegypti and Aedes albopictus in the Black Sea Region Increases Risk of Chikungunya, Dengue, and Zika Outbreaks in Europe	PLOS NEGLECTED TROPICAL DISEASES			English	Article									[Akiner, Muhammet M.] Recep Tayyip Erdogan Univ, Fac Arts & Sci, Dept Biol, Fener, Rize, Turkey; [Demirci, Berna] Kafkas Univ, Dept Mol Biol & Genet, Kars, Turkey; [Babuadze, Giorgi] Natl Ctr Dis Control & Publ Hlth NCDC, Div Virol & Mol Biol, Tbilisi, Georgia; [Robert, Vincent] Inst Rech Dev, Res Unit MIVEGEC, Montpellier, France; [Schaffner, Francis] Avia GIS, Zoersel, Belgium	Schaffner, F (reprint author), Avia GIS, Zoersel, Belgium.	fschaffner@avia-gis.com		Schaffner, Francis/0000-0001-9166-7617	European Food Safety Authority (EFSA) [OC/EFSA/AHAW/2013/02-FWC1]; European Centre for Disease prevention and Control (ECDC)	This work was carried out under the VectorNet framework contract OC/EFSA/AHAW/2013/02-FWC1 funded by the European Food Safety Authority (EFSA) and the European Centre for Disease prevention and Control (ECDC). The funders contributed to the study design, but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Baldacchino F, 2015, PEST MANAG SCI, V71, P1471, DOI 10.1002/ps.4044; Cauchemez S, 2014, EURO SURVEILL, V19; ECDC (European Centre for Disease Control and Prevention), 2014, GUID SURV NAT MOSQ E; European Environment Agency, BIOG REG EUR; Foussadier R, 2010, EURO SURVEILL, V15; Ganushkina LA, 2016, VECTOR-BORNE ZOONOT, V16, P58, DOI 10.1089/vbz.2014.1761; GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571; Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; Porse Charsey Cole, 2015, Emerg Infect Dis, V21, P1827, DOI 10.3201/3210.150494; Roth A, 2014, EURO SURVEILL, V19; Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5; Schaffner F, 2014, LANCET INFECT DIS, V14, P1044, DOI 10.1016/S1473-3099(14)70925-9; Schaffner F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-209; Seixas G, 2013, MEM I OSWALDO CRUZ, V108, P3, DOI 10.1590/0074-0276130386; Septfons A., 2015, Bulletin Epidemiologique Hebdomadaire, P204; SOPER FL, 1963, AM J PUBLIC HEALTH N, V53, P7, DOI 10.2105/AJPH.53.1.7; Van den Berg W, 2013, REGIONAL FRAMEWORK S; WHO, 2012, GLOB STRAT DENG PREV; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192	20	37	38	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	APR	2016	10	4							e0004664	10.1371/journal.pntd.0004664				5	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DL1FC	WOS:000375376700076	27115737	DOAJ Gold, Green Published			2019-04-02	
J	Birhanu, H; Gebrehiwot, T; Goddeeris, BM; Buscher, P; Van Reet, N				Birhanu, Hadush; Gebrehiwot, Tadesse; Goddeeris, Bruno Maria; Buscher, Philippe; Van Reet, Nick			New Trypanosoma evansi Type B Isolates from Ethiopian Dromedary Camels	PLOS NEGLECTED TROPICAL DISEASES			English	Article							BLOOD-STREAM FORMS; KINETOPLAST DNA; DRUG-SENSITIVITY; IN-VITRO; ISOENZYME CHARACTERIZATION; ISOMETAMIDIUM CHLORIDE; INVITRO CULTIVATION; BRUCEI EVANSI; RESISTANCE; EQUIPERDUM	Background Trypanosoma (T.) evansi is a dyskinetoplastic variant of T. brucei that has gained the ability to be transmitted by all sorts of biting flies. T. evansi can be divided into type A, which is the most abundant and found in Africa, Asia and Latin America and type B, which has so far been isolated only from Kenyan dromedary camels. This study aimed at the isolation and the genetic and phenotypic characterisation of type A and B T. evansi stocks from camels in Northern Ethiopia. Methodology/principal findings T. evansi was isolated in mice by inoculation with the cryopreserved buffy coat of parasito-logically confirmed animals. Fourteen stocks were thus isolated and subject to genotyping with PCRs targeting type-specific variant surface glycoprotein genes, mitochondrial minicircles and maxicircles, minisatellite markers and the F1-ATP synthase. subunit gene. Nine stocks corresponded to type A, two stocks were type B and three stocks represented mixed infections between A and B, but not hybrids. One T. evansi type A stock was completely akinetoplastic. Five stocks were adapted to in vitro culture and subjected to a drug sensitivity assay with melarsomine dihydrochloride, diminazene diaceturate, isometamidium chloride and suramin. In vitro adaptation induced some loss of kinetoplasts within 60 days. No correlation between drug sensitivity and absence of the kinetoplast was observed. Sequencing the full coding sequence of the F1-ATP synthase. subunit revealed new type-specific single nucleotide polymorphisms and deletions. Conclusions/significance This study addresses some limitations of current molecular markers for T. evansi genotyping. Polymorphism within the F1-ATP synthase. subunit gene may provide new markers to identify the T. evansi type that do not rely on variant surface glycoprotein genes or kinetoplast DNA.	[Birhanu, Hadush; Gebrehiwot, Tadesse] Mekelle Univ, Coll Vet Med, Mekelle, Ethiopia; [Birhanu, Hadush; Goddeeris, Bruno Maria] Katholieke Univ Leuven, Fac Biosci Engn, Dept Biosyst, Leuven, Belgium; [Birhanu, Hadush; Buscher, Philippe; Van Reet, Nick] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium	Birhanu, H (reprint author), Mekelle Univ, Coll Vet Med, Mekelle, Ethiopia.; Birhanu, H (reprint author), Katholieke Univ Leuven, Fac Biosci Engn, Dept Biosyst, Leuven, Belgium.; Birhanu, H (reprint author), Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium.	hadushbirhanu@yahoo.com		Buscher, Philippe/0000-0002-1926-7472; Goddeeris, Bruno/0000-0003-3729-7592	Belgian Directorate General for Development Cooperation [0410057701]; "Les Amis de l'Institut Pasteur de Bruxelles" a.s.b.l.	The PhD fellowship of BH was financed by the Belgian Directorate General for Development Cooperation (contract number, 0410057701). NVR is supported by "Les Amis de l'Institut Pasteur de Bruxelles" a.s.b.l. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alsford S, 2012, NATURE, V482, P232, DOI 10.1038/nature10771; Amer S, 2011, ACTA TROP, V117, P39, DOI 10.1016/j.actatropica.2010.09.010; Baker N, 2015, P NATL ACAD SCI USA, V112, P9112, DOI 10.1073/pnas.1505411112; Birhanu H, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0818-1; Biteau N, 2000, MOL BIOCHEM PARASIT, V105, P185, DOI 10.1016/S0166-6851(99)00171-1; BOID R, 1989, EXP PARASITOL, V69, P317, DOI 10.1016/0014-4894(89)90080-5; BOID R, 1988, TROP MED PARASITOL, V39, P45; BORST P, 1987, MOL BIOCHEM PARASIT, V23, P31, DOI 10.1016/0166-6851(87)90184-8; BRUN R, 1994, VET PARASITOL, V52, P37, DOI 10.1016/0304-4017(94)90033-7; Buscher P, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000471; Carnes J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003404; Claes F, 2005, TRENDS PARASITOL, V21, P316, DOI 10.1016/j.pt.2005.05.010; CLAES F, 2004, KINETOPLASTID BIOL D, V3, P3; Dargantes AP, 2009, INT J PARASITOL, V39, P1109, DOI 10.1016/j.ijpara.2009.02.012; Dean S, 2013, P NATL ACAD SCI USA, V110, P14741, DOI 10.1073/pnas.1305404110; Desquesnes M, 2013, BIOMED RES INT, DOI 10.1155/2013/194176; Dobson RJ, 2009, INT J PARASITOL, V39, P1115, DOI 10.1016/j.ijpara.2009.02.013; Domingo GJ, 2003, EUKARYOT CELL, V2, P569, DOI 10.1128/EC.2.3.569-577.2003; El Rayah IE, 1999, VET PARASITOL, V80, P281, DOI 10.1016/S0304-4017(98)00221-0; Elhaig MM, 2013, VET PARASITOL, V198, P214, DOI 10.1016/j.vetpar.2013.08.003; Gillingwater K, 2007, VET PARASITOL, V148, P114, DOI 10.1016/j.vetpar.2007.05.020; Gould MK, 2014, ANTIMICROB AGENTS CH, V58, P2925, DOI 10.1128/AAC.00122-14; Graf FE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002475; Hagos A, 2010, VET PARASITOL, V171, P200, DOI 10.1016/j.vetpar.2010.03.041; Hagos A, 2009, REV MED VET-TOULOUSE, V160, P569; HERBERT WJ, 1976, EXP PARASITOL, V40, P427, DOI 10.1016/0014-4894(76)90110-7; HIDE G, 1990, MOL BIOCHEM PARASIT, V39, P213, DOI 10.1016/0166-6851(90)90060-Y; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Hirumi H, 1997, TROP MED INT HEALTH, V2, P240, DOI 10.1046/j.1365-3156.1997.d01-268.x; Hoare C. A., 1972, ZOOLOGICAL MONOGRAPH; Kaminsky R, 1997, PARASITOL RES, V83, P816, DOI 10.1007/s004360050346; Kaminsky R, 1998, ANTIMICROB AGENTS CH, V42, P2858, DOI 10.1128/AAC.42.11.2858; Lai DH, 2008, P NATL ACAD SCI USA, V105, P1999, DOI 10.1073/pnas.0711799105; LUN ZR, 1991, ANN PARASIT HUM COMP, V66, P51, DOI 10.1051/parasite/199166251; Masiga DK, 2006, EXP PARASITOL, V114, P147, DOI 10.1016/j.exppara.2006.03.002; Munday JC, 2015, MOL MICROBIOL, V96, P887, DOI 10.1111/mmi.12979; Munday JC, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00032; Munday JC, 2014, J ANTIMICROB CHEMOTH, V69, P651, DOI 10.1093/jac/dkt442; Ngaira JM, 2005, EXP PARASITOL, V110, P30, DOI 10.1016/j.exppara.2005.01.001; Njiru ZK, 2010, EXP PARASITOL, V125, P196, DOI 10.1016/j.exppara.2010.01.017; Njiru ZK, 2006, INFECT GENET EVOL, V6, P292, DOI 10.1016/j.meegid.2005.08.002; OU YC, 1991, MOL BIOCHEM PARASIT, V46, P97, DOI 10.1016/0166-6851(91)90203-I; PAYNE RC, 1994, TROP ANIM HEALTH PRO, V26, P219, DOI 10.1007/BF02240385; Pyana PP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001025; Raz B, 1997, ACTA TROP, V68, P139, DOI 10.1016/S0001-706X(97)00079-X; Reid SA, 2002, TRENDS PARASITOL, V18, P219, DOI 10.1016/S1471-4922(02)02250-X; Sahin A, 2014, VET PARASITOL, V203, P270, DOI 10.1016/j.vetpar.2014.04.002; Salim B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-31; Sanchez E, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1129-2; Schnaufer A, 2005, EMBO J, V24, P4029, DOI 10.1038/sj.emboj.7600862; Schnaufer A, 2002, INT J PARASITOL, V32, P1071, DOI 10.1016/S0020-7519(02)00020-6; Schnaufer A, 2010, TRENDS PARASITOL, V26, P557, DOI 10.1016/j.pt.2010.08.001; SONGA EB, 1988, ANN SOC BELG MED TR, V68, P233; STEVENS JR, 1989, ACTA TROP, V46, P213, DOI 10.1016/0001-706X(89)90021-1; Sultana K, 1996, PAK J PHARM SCI, V9, P298; Urakawa T, 2001, EXP PARASITOL, V99, P181, DOI 10.1006/expr.2001.4670; Van Reet N, 2011, EXP PARASITOL, V128, P285, DOI 10.1016/j.exppara.2011.02.018; Van Reet N, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003054; Van Reet N, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-207; Ventura RM, 2000, J PARASITOL, V86, P1289, DOI 10.2307/3285015; Verloo D, 2001, VET PARASITOL, V97, P183, DOI 10.1016/S0304-4017(01)00412-5; Witola WH, 2004, EXP PARASITOL, V107, P47, DOI 10.1016/j.exppara.2004.03.013; Zhou JL, 2004, ACTA TROP, V90, P271, DOI 10.1016/j.actatropica.2004.02.002; ZWEYGARTH E, 1986, ANN SOC BELG MED TR, V66, P145; ZWEYGARTH E, 1990, ACTA TROP, V48, P95, DOI 10.1016/0001-706X(90)90048-5	65	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	APR	2016	10	4							e0004556	10.1371/journal.pntd.0004556				22	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DL1FC	WOS:000375376700021	27035661	DOAJ Gold, Green Published			2019-04-02	
J	Bisser, S; Lumbala, C; Nguertoum, E; Kande, V; Flevaud, L; Vatunga, G; Boelaert, M; Buscher, P; Josenando, T; Bessell, PR; Bieler, S; Ndung'u, JM				Bisser, Sylvie; Lumbala, Crispin; Nguertoum, Etienne; Kande, Victor; Flevaud, Laurence; Vatunga, Gedeao; Boelaert, Marleen; Buescher, Philippe; Josenando, Theophile; Bessell, Paul R.; Bieler, Sylvain; Ndung'u, Joseph M.			Sensitivity and Specificity of a Prototype Rapid Diagnostic Test for the Detection of Trypanosoma brucei gambiense Infection: A Multi-centric Prospective Study	PLOS NEGLECTED TROPICAL DISEASES			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; SLEEPING SICKNESS; SURVEILLANCE; SERODIAGNOSIS; AMPLIFICATION; ACCURACY	Background A major challenge in the control of human African trypanosomiasis (HAT) is lack of reliable diagnostic tests that are rapid and easy to use in remote areas where the disease occurs. In Trypanosoma brucei gambiense HAT, the Card Agglutination Test for Trypanosomiasis (CATT) has been the reference screening test since 1978, usually on whole blood, but also in a 1/8 dilution (CATT 1/8) to enhance specificity. However, the CATT is not available in a single format, requires a cold chain for storage, and uses equipment that requires electricity. A solution to these challenges has been provided by rapid diagnostic tests (RDT), which have recently become available. A prototype immunochromatographic test, the SD BIOLINE HAT, based on two native trypanosomal antigens (VSG LiTat 1.3 and VSG LiTat 1.5) has been developed. We carried out a non-inferiority study comparing this prototype to the CATT 1/8 in field settings. Methodology/Principal Findings The prototype SD BIOLINE HAT, the CATT Whole Blood and CATT 1/8 were systematically applied on fresh blood samples obtained from 14,818 subjects, who were prospectively enrolled through active and passive screening in clinical studies in three endemic countries of central Africa: Angola, the Democratic Republic of the Congo and the Central African Republic. One hundred and forty nine HAT cases were confirmed by parasitology. The sensitivity and specificity of the prototype SD BIOLINE HAT was 89.26% (95% confidence interval (CI) = 83.27-93.28) and 94.58% (95% CI = 94.20-94.94) respectively. The sensitivity and specificity of the CATT on whole blood were 93.96% (95% CI = 88.92-96.79) and 95.91% (95% CI = 95.58-96.22), and of the CATT 1/8 were 89.26% (95% CI = 83.27-93.28) and 98.88% (95% CI = 98.70-99.04) respectively. Conclusion/Significance After further optimization, the prototype SD BIOLINE HAT could become an alternative to current screening methods in primary healthcare settings in remote, resource-limited regions where HAT typically occurs.	[Bisser, Sylvie] Inst Neuroepidemiol & Trop Neurol, INSERM, UMR1094, Limoges, France; [Lumbala, Crispin; Kande, Victor] PNLTHA, Kinshasa, Zaire; [Nguertoum, Etienne] ICRA, Bangui, Cent Afr Republ; [Flevaud, Laurence] OCBA, MSF, Barcelona, Spain; [Vatunga, Gedeao; Josenando, Theophile] Inst Combate & Controlo Tripanossomiases, Luanda, Angola; [Boelaert, Marleen; Buescher, Philippe] Inst Trop Med Antwerp, Antwerp, Belgium; [Bessell, Paul R.] Epi Intervent Ltd, Edinburgh, Midlothian, Scotland; [Bieler, Sylvain; Ndung'u, Joseph M.] Fdn Innovat New Diagnost, Campus Biotech, Geneva, Switzerland	Bisser, S (reprint author), Inst Neuroepidemiol & Trop Neurol, INSERM, UMR1094, Limoges, France.	sbisser@hotmail.com		Boelaert, Marleen/0000-0001-8051-6776; Buscher, Philippe/0000-0002-1926-7472	Bill & Melinda Gates Foundation [OPP1033712]	This work was supported by the Bill & Melinda Gates Foundation (grant Nr. OPP1033712). This funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLACKWELDER WC, 1982, CONTROL CLIN TRIALS, V3, P345, DOI 10.1016/0197-2456(82)90024-1; Buscher P, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000471; Buscher P, 2014, LANCET GLOB HEALTH, V2, pE359, DOI 10.1016/S2214-109X(14)70203-7; Chappuis F, 2010, EMERG INFECT DIS, V16, P354, DOI 10.3201/eid1602.090967; Deborggraeve S, 2010, LANCET INFECT DIS, V10, P433, DOI 10.1016/S1473-3099(10)70077-3; Franco JR, 2014, PARASITOLOGY, V141, P748, DOI 10.1017/S0031182013002102; Harrell Jr Frank E, 2014, HMISC HARRELL MISCEL; Hasker E, 2011, TROP MED INT HEALTH, V16, P869, DOI 10.1111/j.1365-3156.2011.02772.x; Ilboudo H, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004469; Jacobs JFM, 2015, AUTOIMMUN REV, V14, P160, DOI 10.1016/j.autrev.2014.10.018; Jamonneau V, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003480; Kennedy PGE, 2013, LANCET NEUROL, V12, P186, DOI 10.1016/S1474-4422(12)70296-X; MAGNUS E, 1978, ANN SOC BELG MED TR, V58, P169; MASIGA DK, 1992, INT J PARASITOL, V22, P909, DOI 10.1016/0020-7519(92)90047-O; MITASHI P, 2013, PLOS NEGL TROP DIS, V7; Mitashi P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001919; Mugasa CM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001438; Ndung'u JM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000715; Ngoyi DM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002954; R Core Team, 2014, R LANG ENV STAT COMP; Simarro PP, 2013, RES REP TROP MED, V4, P1, DOI 10.2147/RRTM.S40157; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Simarro PP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001007; Sternberg JM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003373; VanMeirvenne N, 1995, ACTA TROP, V60, P189, DOI 10.1016/0001-706X(95)00127-Z; WHO, 2013, 17 NEGL TROP DIS; World Health Organisation, 2012, ACC WORK OV GLOB IMP, P1; World Health Organization, 2015, HUM AFR TRYP CAS SLE	28	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	APR	2016	10	4							e0004608	10.1371/journal.pntd.0004608				16	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DL1FC	WOS:000375376700045	27058033	DOAJ Gold, Green Published			2019-04-02	
J	Menger, DJ; Omusula, P; Wouters, K; Oketch, C; Carreira, AS; Durka, M; Derycke, JL; Loy, DE; Hahn, BH; Mukabana, WR; Mweresa, CK; van Loon, JJA; Takken, W; Hiscox, A				Menger, David J.; Omusula, Philemon; Wouters, Karlijn; Oketch, Charles; Carreira, Ana S.; Durka, Maxime; Derycke, Jean-Luc; Loy, Dorothy E.; Hahn, Beatrice H.; Mukabana, Wolfgang R.; Mweresa, Collins K.; van Loon, Joop J. A.; Takken, Willem; Hiscox, Alexandra			Eave Screening and Push-Pull Tactics to Reduce House Entry by Vectors of Malaria	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							POLYMERASE-CHAIN-REACTION; MM-X TRAPS; ANOPHELES-GAMBIAE; PYRETHROID RESISTANCE; WESTERN KENYA; INSECTICIDE RESISTANCE; MOSQUITO REPELLENT; BITING MOSQUITOS; FIELD-EVALUATION; CARBON-DIOXIDE	Long-lasting insecticidal nets and indoor residual spraying have contributed to a decline in malaria over the last decade, but progress is threatened by the development of physiological and behavioral resistance of mosquitoes against insecticides. Acknowledging the need for alternative vector control tools, we quantified the effects of eave screening in combination with a push-pull system based on the simultaneous use of a repellent (push) and attractant-baited traps (pull). Field experiments in western Kenya showed that eave screening, whether used in combination with an attractant -baited trap or not, was highly effective in reducing house entry by malaria mosquitoes. The magnitude of the effect varied for different mosquito species and between two experiments, but the reduction in house entry was always considerable (between 61% and 99%). The use of outdoor, attractant -baited traps alone did not have a significant impact on mosquito house entry but the high number of mosquitoes trapped outdoors indicates that attractant -baited traps could be used for removal trapping, which would enhance outdoor as well as indoor protection against mosquito bites. As eave screening was effective by itself, addition of a repellent was of limited value. Nevertheless, repellents may play a role in reducing outdoor malaria transmission in the peridomestic area.	[Menger, David J.; Wouters, Karlijn; van Loon, Joop J. A.; Takken, Willem; Hiscox, Alexandra] Univ Wageningen & Res Ctr, Entomol Lab, POB 16, NL-6700 AA Wageningen, Netherlands; [Omusula, Philemon; Oketch, Charles; Mweresa, Collins K.] Int Ctr Insect Physiol & Ecol, POB 30772, Nairobi, Kenya; [Carreira, Ana S.] Univ Coimbra, Dept Chem Engn, Chem Proc Engn & Forest Prod Res Ctr, Coimbra, Portugal; [Carreira, Ana S.] Devan Micropolis, Tecmaia Parque Ciencia & Tecnol Maia, Maia, Portugal; [Durka, Maxime] Devan Chem NV, Ronse, Belgium; [Derycke, Jean-Luc] Utexbel NV, Ronse, Belgium; [Loy, Dorothy E.; Hahn, Beatrice H.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Loy, Dorothy E.; Hahn, Beatrice H.] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Mukabana, Wolfgang R.] Univ Nairobi, Sch Biol Sci, Nairobi, Kenya	Hiscox, A (reprint author), Univ Wageningen & Res Ctr, Entomol Lab, POB 16, NL-6700 AA Wageningen, Netherlands.	davidmenger@hotmail.com; pomusulabtr@yahoo.com; karlijncmw@gmail.com; charlesamara9l@yahoo.com; ana.carreira@devan-pt.com; maxime.durka@devan-be.com; jl.derycke@utexbel.be; eloy@mail.med.upenn.edu; bhahn@mail.med.upenn.edu; rmukabana@yahoo.co.uk; cmweresa@icipe.org; joop.vanloon@wur.nl; willem.takken@wur.nl; hiscoxalexandra@gmail.com		Loy, Dorothy/0000-0002-3207-0893; Hahn, Beatrice/0000-0002-9400-9887	COmON Foundation through the Food for Thought campaign of the Wageningen University Fund, The Netherlands; National Institutes of Health [R01 AI091595, T32 AI007532, P30 AI045008]; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BDE/51601/2011]	This study was funded by the COmON Foundation through the Food for Thought campaign of the Wageningen University Fund, The Netherlands, and grants from the National Institutes of Health (R01 AI091595, T32 AI007532, P30 AI045008). Ana S. Carreira gratefully acknowledges the Fundacao para a Ciencia e Tecnologia, Portugal, for the financial support under the PhD grant (SFRH/BDE/51601/2011), which includes the microencapsulation work.	Abilio AP, 2011, MALARIA J, V110; Baker Judy, 2000, EVALUATING IMPACT DE; Campos E, 2013, EUR POLYM J, V49, P2005, DOI 10.1016/j.eurpolymj.2013.04.033; Carroll SP, 2006, J AM MOSQUITO CONTR, V22, P507, DOI 10.2987/8756-971X(2006)22[507:PARBMR]2.0.CO;2; Chanda E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024336; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Costantini C, 1998, B ENTOMOL RES, V88, P503, DOI 10.1017/S000748530002602X; DAY JF, 1994, AM J TROP MED HYG, V50, P126, DOI 10.4269/ajtmh.1994.50.126; Day Jonathan F., 1994, American Entomologist, V40, P162; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; Fillinger U, 2004, TROP MED INT HEALTH, V9, P1274, DOI 10.1111/j.1365-3156.2004.01335.x; Gillies MT, 1987, PUBL S AFR I MED RES, V55, P1; Hao HL, 2008, J MED ENTOMOL, V45, P533, DOI 10.1603/0022-2585(2008)45[533:HABBOA]2.0.CO;2; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Hiscox A, 2012, MALARIA J, V11, pO45; Hiscox A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-257; Jawara M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008167; Kampango A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-99; Kanza JPB, 2012, T R SOC TROP MED HYG, V107, P8; Khan Z, 2011, INT J AGR SUSTAIN, V9, P162, DOI 10.3763/ijas.2010.0558; Killeen GF, 2007, T ROY SOC TROP MED H, V101, P867, DOI 10.1016/j.trstmh.2007.04.022; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-330; Kirby MJ, 2010, AM J TROP MED HYG, V83, P965, DOI [10.4269/ajtmh.2010.10.0311, 10.4269/ajtmh.2010.10-0311]; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Kline DL, 2006, J AM MOSQUITO CONTR, V22, P490, DOI 10.2987/8756-971X(2006)22[490:TATTFA]2.0.CO;2; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; Koenraadt CJM, 2008, J MED ENTOMOL, V45, P28, DOI 10.1603/0022-2585(2008)45[28:FEOROC]2.0.CO;2; Kulkarni MA, 2007, TROP MED INT HEALTH, V12, P1061, DOI 10.1111/j.1365-3156.2007.01883.x; LIN F M, 1970, Journal of Food Science, V35, P538, DOI 10.1111/j.1365-2621.1970.tb04802.x; Lindsay SW, 2003, TROP MED INT HEALTH, V8, P512, DOI 10.1046/j.1365-3156.2003.01059.x; Lindsay SW, 2002, TRENDS PARASITOL, V18, P510, DOI 10.1016/S1471-4922(02)02382-6; LINDSAY SW, 1988, T ROY SOC TROP MED H, V82, P645, DOI 10.1016/0035-9203(88)90546-9; LINES JD, 1991, B ENTOMOL RES, V81, P77, DOI 10.1017/S0007485300053268; Mahajan SS, 2004, J DAIRY SCI, V87, P4057, DOI 10.3168/jds.S0022-0302(04)73547-X; Maia MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084875; Mawejje HD, 2013, MED VET ENTOMOL, V27, P276, DOI 10.1111/j.1365-2915.2012.01055.x; Menger DJ, 2014, MED VET ENTOMOL, V28, P407, DOI 10.1111/mve.12061; Menger DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123415; Menger DJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-119; Specos MMM, 2010, T ROY SOC TROP MED H, V104, P653, DOI 10.1016/j.trstmh.2010.06.004; Mukabana WR, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-202; Mukabana WR, 2012, J CHEM ECOL, V38, P235, DOI 10.1007/s10886-012-0088-8; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Mweresa CK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121533; Mweresa CK, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-160; N'Guessan R, 2008, T ROY SOC TROP MED H, V102, P259, DOI 10.1016/j.trstmh.2007.10.012; Njie M, 2009, J MED ENTOMOL, V46, P505, DOI 10.1603/033.046.0314; Njiru BN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-39; Ochomo E, 2013, MED VET ENTOMOL, V27, P156, DOI 10.1111/j.1365-2915.2012.01039.x; Ogoma SB, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000773; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011573; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951; Pask GM, 2013, CHEM SENSES, V38, P19, DOI 10.1093/chemse/bjs074; Qiu YT, 2007, J MED ENTOMOL, V44, P970, DOI 10.1603/0022-2585(2007)44[970:AOMTBW]2.0.CO;2; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; SNOW WF, 1987, MED VET ENTOMOL, V1, P9, DOI 10.1111/j.1365-2915.1987.tb00318.x; Toe KH, 2014, EMERG INFECT DIS, V20, P1691, DOI 10.3201/eid2010.140619; Tusting LS, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0724-1; van Loon JJA, 2015, J CHEM ECOL, V41, P567, DOI 10.1007/s10886-015-0587-5; Wagman JM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0692-5; WHO, 2015, WORLD MAL REP 2014	62	10	10	0	15	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	APR	2016	94	4					868	878		10.4269/ajtmh.15-0632				11	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	DI1FQ	WOS:000373242400027	26834195	Green Published, Bronze			2019-04-02	
J	Habtewold, T; Duchateau, L; Christophides, GK				Habtewold, Tibebu; Duchateau, Luc; Christophides, George K.			Flow cytometry analysis of the microbiota associated with the midguts of vector mosquitoes	PARASITES & VECTORS			English	Article						Anopheles Coluzzii; Microbiota; Midgut homogenate; Flow cytometry; Propidium Iodide; Live; Dead; discrimination; Fixed cells	RIBOSOMAL-RNA GENE; ANOPHELES-GAMBIAE; SPOROGONIC DEVELOPMENT; VIABILITY ASSESSMENT; PERITROPHIC MATRIX; MOLECULAR ANALYSIS; MALARIA VECTOR; BACTERIA; ADULT; DNA	Background: The scientific interest to understand the function and structure of the microbiota associated with the midgut of mosquito disease vectors is increasing. The advancement of such a knowledge has encountered challenges and limitations associated with conventional culture-based and PCR techniques. Methods: Flow cytometry (FCM) combined with various cell marking dyes have been successfully applied in the field of ecological microbiology to circumvent the above shortcomings. Here, we describe FCM technique coupled with live/dead differential staining dyes SYBR Green I (SGI) and Propidium Iodide (PI) to quantify and study other essential characteristics of the mosquito gut microbiota. Results: A clear discrimination between cells and debris, as well as between live and dead cells was achieved when the midgut homogenate was subjected to staining with 5 x 103 dilution of the SGI and 30 mu M concentration of the PI. Reproducibly, FCM event collections produced discrete populations including non-fluorescent cells, SYBR positive cells, PI fluorescing cells and cells that fluoresce both in SYBR and PI, all these cell populations representing, respectively, background noise, live bacterial, dead cells and inactive cells with partial permeability to PI. The FCM produced a strong linear relationship between cell counts and their corresponding dilution factors (R-2 = 0.987), and the technique has a better precision compared to qRT-PCR. The FCM count of the microbiota reached a peak load at 18 h post-feeding and started declining at 24 h. The present FCM technique also successfully applied to quantify bacterial cells in fixed midgut samples that were homogenized in 4 % PFA. Conclusion: The FCM technique described here offers enormous potential and possibilities of integration with advanced molecular biochemical techniques for the study of the microbiota community in disease vector mosquitoes.	[Habtewold, Tibebu; Christophides, George K.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England; [Habtewold, Tibebu; Duchateau, Luc] Univ Ghent, Dept Comparat Physiol & Biometr, B-9000 Ghent, Belgium	Habtewold, T (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England.; Habtewold, T (reprint author), Univ Ghent, Dept Comparat Physiol & Biometr, B-9000 Ghent, Belgium.	t.habtewold@imperial.ac.uk		Christophides, George/0000-0002-3323-1687	BBSRC Project [BB/K009338/1]; VLIR-OUS, IUC/Jimma; Biotechnology and Biological Sciences Research Council [BB/K009338/1]	We thank Lara Selles Vidal, Catherine Simpsons and Jane Srivastava for the technical support, Idir Akhouayri for reviewing the paper. Work was supported through grants BBSRC Project BB/K009338/1 and VLIR-OUS, IUC/Jimma.	AHRENHOLTZ I, 1994, ARCH MICROBIOL, V161, P176, DOI 10.1007/s002030050039; Atyame CM, 2011, MOL ECOL, V20, P286, DOI 10.1111/j.1365-294X.2010.04937.x; Barbesti S, 2000, CYTOMETRY, V40, P214, DOI 10.1002/1097-0320(20000701)40:3<214::AID-CYTO6>3.3.CO;2-D; Bellemare MJ, 2009, J PHYS CHEM B, V113, P8391, DOI 10.1021/jp8104375; Bensch G, 2014, APPL MICROBIOL BIOT, V98, P4897, DOI 10.1007/s00253-014-5592-z; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; CARON GNV, 1995, J MICROSC-OXFORD, V179, P55, DOI 10.1111/j.1365-2818.1995.tb03612.x; Catteruccia F, 2009, METHODS MOL BIOL, V555, P63, DOI 10.1007/978-1-60327-295-7_5; Chao J., 1960, Journal of Insect Pathology, V2, P220; CHAO JOWETT, 1959, JOUR INSECT PATHOL, V1, P311; Chavshin AR, 2012, ACTA TROP, V121, P129, DOI 10.1016/j.actatropica.2011.10.015; Cirimotich CM, 2011, CELL HOST MICROBE, V10, P307, DOI 10.1016/j.chom.2011.09.006; Clayton AM, 2014, J INNATE IMMUN, V6, P169, DOI 10.1159/000353602; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; Devenport M, 2004, INSECT MOL BIOL, V13, P349, DOI 10.1111/j.0962-1075.2004.00488.x; Djadid ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028484; Favia G, 2007, P NATL ACAD SCI USA, V104, P9047, DOI 10.1073/pnas.0610451104; FERGUSON MJ, 1961, J INSECT PATHOL, V3, P112; Garver Lindsey, 2007, J Vis Exp, P230, DOI 10.3791/230; Gonzalez-Ceron L, 2003, J MED ENTOMOL, V40, P371, DOI 10.1603/0022-2585-40.3.371; Gregori G, 2001, APPL ENVIRON MICROB, V67, P4662, DOI 10.1128/AEM.67.10.4662-4670.2001; GREISEN K, 1994, J CLIN MICROBIOL, V32, P335; JADIN J, 1966, Bulletin de la Societe de Pathologie Exotique, V59, P514; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Lindh JM, 2005, APPL ENVIRON MICROB, V71, P7217, DOI 10.1128/AEM.71.11.7217-7223.2005; LORENZ MG, 1987, APPL ENVIRON MICROB, V53, P2948; LORENZ MG, 1994, MICROBIOL REV, V58, P563; Magalhaes T, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-362; Manini E, 2006, FEMS MICROBIOL ECOL, V55, P416, DOI 10.1111/j.1574-6941.2005.00042.x; Mary I, 2008, FEMS MICROBIOL ECOL, V63, P36, DOI 10.1111/j.1574-6941.2007.00414.x; Meister S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000542; Nossa CW, DESIGN 16S RRNA GENE; Oliveira JHM, 2011, INSECT BIOCHEM MOLEC, V41, P349, DOI 10.1016/j.ibmb.2011.02.001; Oliver JD, 2005, J MICROBIOL, V43, P93; Ponton F, 2013, J INSECT PHYSIOL, V59, P130, DOI 10.1016/j.jinsphys.2012.10.011; Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214; Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96; Rogers GB, 2013, ISME J, V7, P697, DOI 10.1038/ismej.2012.145; Stathopoulos S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003897; Straif SC, 1998, J MED ENTOMOL, V35, P222, DOI 10.1093/jmedent/35.3.222; Strauber H, 2010, CYTOM PART A, V77A, P623, DOI 10.1002/cyto.a.20920; Thao MLL, 2004, CURR MICROBIOL, V48, P140, DOI 10.1007/s00284-003-4157-7; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Wagner AO, 2008, APPL ENVIRON MICROB, V74, P2537, DOI 10.1128/AEM.02288-07; Walker A, 2008, NAT REV MICROBIOL, V6, P176, DOI 10.1038/nrmicro1862; Wallner G, 1997, APPL ENVIRON MICROB, V63, P4223; Wang Yan, 2011, SCI TECHNOLOGY IND, V6, P9, DOI DOI 10.1371/J0URNAL.P0NE.0023993; Wang YY, 2009, ISME J, V3, P889, DOI 10.1038/ismej.2009.46; Weiss BL, 2012, J IMMUNOL, V188, P3395, DOI 10.4049/jimmunol.1103691; Yu JS, 2011, CLIN VACCINE IMMUNOL, V18, P43, DOI 10.1128/CVI.00292-10; Zipper H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh101	52	5	5	0	25	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	MAR 22	2016	9								167	10.1186/s13071-016-1438-0				10	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	DH1XP	WOS:000372578600001	27004717	DOAJ Gold, Green Published			2019-04-02	
J	Massue, DJ; Moore, SJ; Mageni, ZD; Moore, JD; Bradley, J; Pigeon, O; Maziba, EJ; Mandike, R; Kramer, K; Kisinza, WN; Overgaard, HJ; Lorenz, LM				Massue, Dennis J.; Moore, Sarah J.; Mageni, Zawadi D.; Moore, Jason D.; Bradley, John; Pigeon, Olivier; Maziba, Erasto J.; Mandike, Renata; Kramer, Karen; Kisinza, William N.; Overgaard, Hans J.; Lorenz, Lena M.			Durability of Olyset campaign nets distributed between 2009 and 2011 in eight districts of Tanzania	MALARIA JOURNAL			English	Article						Durability; LLINs; Olyset; Universal coverage campaign; Attrition; Physical integrity; Chemical content; Bio-efficacy; Tanzania	LASTING INSECTICIDAL NETS; PHYSICAL DURABILITY; NATIONAL CAMPAIGN; MALARIA CONTROL; WESTERN KENYA; MOSQUITO NET; BED NETS; LIFE; IMPLEMENTATION; ENVIRONMENT	Background: Long-lasting insecticidal nets (LLINs) are the first line choice for malaria vector control in sub-Saharan Africa, with most countries adopting universal coverage campaigns. However, there is only limited information on LLIN durability under user conditions. Therefore, this study aimed to assess the durability of Olyset (R) LLINs distributed during campaigns between 2009 and 2011 in Tanzania. Methods: A retrospective field survey was conducted in eight districts in Tanzania mainland to assess the durability of Olyset campaign nets. Household questionnaires were used to assess attrition, i.e. net loss. All nets remaining in households were collected. A sub-sample of 198 Olyset campaign nets was examined for bio-efficacy against Anopheles gambiae s.s. mosquitoes, permethrin content and physical integrity following standard World Health Organization (WHO) methods. Results: Of 6067 campaign nets reported to have been received between 2009 and 2011, 35 % (2145 nets) were no longer present. Most of those nets had been discarded (84 %) mainly because they were too torn (94 %). Of the 198 sub-sampled Olyset LLINs, 61 % were still in serviceable physical condition sufficient to provide personal protection while 39 % were in unserviceable physical condition according to WHO proportionate Hole Index (pHI). More than 96 % (116/120) of nets in serviceable condition passed WHO bioefficacy criteria while all nets in unserviceable condition passed WHO bioefficacy criteria. Overall mean permethrin content was 16.5 g/kg (95 % CI 16.2-16.9) with 78 % of the sub-sampled nets retaining recommended permethrin content regardless of their age or physical condition. Nets aged 4 years and above had a mean permethrin content of 14 g/kg (95 % CI 12.0-16.0). The only statistically significant predictor of reduced physical net integrity was rats in the house. Conclusions: Two-to-four years after a mass campaign, only 39 % of distributed nets remain both present and in serviceable physical condition, a functional survival considerably below WHO assumptions of 50 % survival of a 'three-year' net. However, the majority of nets still retained substantial levels of permethrin and could still be bio-chemically useful against mosquitoes if their holes were repaired, adding evidence to the value of net care and repair campaigns.	[Massue, Dennis J.; Kisinza, William N.] Swiss Inst Trop & Publ Hlth, Epidemiol & Publ Hlth Dept, Soccinstr 57, CH-4002 Basel, Switzerland; [Massue, Dennis J.; Moore, Sarah J.; Kramer, Karen] Univ Basel, Peterspl 1, CH-4003 Basel, Switzerland; [Massue, Dennis J.; Moore, Sarah J.] Amani Res Ctr, Natl Inst Med Res, POB 81, Muheza, Tanga, Tanzania; [Moore, Sarah J.; Mageni, Zawadi D.; Moore, Jason D.; Maziba, Erasto J.; Lorenz, Lena M.] Bagamoyo Res & Training Ctr, Ifakara Hlth Inst, POB 74, Bagamoyo, Pwani, Tanzania; [Mageni, Zawadi D.; Moore, Jason D.; Lorenz, Lena M.] Univ London London Sch Hyg & Trop Med, Dept Dis Control, Fac Infect & Trop Dis, Keppel St, London WC1E 7HT, England; [Bradley, John] Univ London London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, Keppel St, London WC1E 7HT, England; [Pigeon, Olivier] Walloon Agr Res Ctr CRA W, Plant Protect Prod & Biocides Physicochem & Resid, Agr & Nat Environm Dept, Gembloux, Belgium; [Mandike, Renata; Kramer, Karen] Natl Malaria Control Programme, Dar Es Salaam, Tanzania; [Overgaard, Hans J.] MIVEGEC, IRD, Montpellier, France; [Overgaard, Hans J.] Kasetsart Univ, Dept Entomol, Bangkok, Thailand; [Overgaard, Hans J.] Norwegian Univ Life Sci, Dept Math Sci & Technol, As, Norway	Massue, DJ (reprint author), Univ Basel, Peterspl 1, CH-4003 Basel, Switzerland.	d.massue@unibas.ch			Research Council of Norway through the ABCDR Project [220757]; Medical Research Council [MR/K012126/1]	Thanks to our advisory panel Albert Kilian and Jo Lines for invaluable input in the design of this study. We acknowledge and thank Nick Brown from A-Z Textiles Mills Ltd for asking us to answer these questions in the first place. Our special thanks are addressed to Hassan Ngonyani, Edgar Mbeyela, Anthony Mseka, Emmanuel Simfukwe, Peter Ngwasi and Bernard Liseki for data collection in the field and in the laboratory. We wish to thank the SAVVY management team including coordinators, enumerators and participating villagers in all study districts. This paper is published with the permission of the Director-General of the National Institute for Medical Research (NIMR) in Tanzania. The study was funded by Research Council of Norway through the ABCDR Project no. 220757.	ABBOTT WS, 1987, J AM MOSQUITO CONTR, V3, P302; [Anonymous], TANZ HIV AIDS MAL IN; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bonner K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-73; Burnham KP, 2002, MODEL SELECTION MULT; Craig AS, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0754-8; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gerber EJ, 1970, AMCA B; Hakizimana E, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-344; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Kabadi GS, 2014, INT J EPIDEMIOL, V44, P79; Kilian A, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0640-4; Kilian A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-299; Koenker H, 2015, MALARIA J, V14, DOI 10.1186/s12936-014-0538-6; Koenker H, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-464; Krishnan V, 2010, CONSTRUCTING AREA BA; Loll DK, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-337; Lorenz LM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1266; MAGESA SM, 1991, ACTA TROP, V49, P97, DOI 10.1016/0001-706X(91)90057-Q; Mejia P, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-158; MILLER JE, 1991, MED VET ENTOMOL, V5, P465, DOI 10.1111/j.1365-2915.1991.tb00575.x; Morgan J, 2015, AM J TROP MED HYG, V92, P286, DOI 10.4269/ajtmh.14-0023; Mutuku FM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-46; Nathan R, 2013, EVALUATION SCH NET P; Nkya TE, 2013, INSECT BIOCHEM MOLEC, V43, P407, DOI 10.1016/j.ibmb.2012.10.006; Picado A, 2012, T ROY SOC TROP MED H, V106, P150, DOI 10.1016/j.trstmh.2011.10.014; Renggli S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-85; Sutcliffe J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0713-4; Tan KR, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1154-4; USAID/Tanzania. National Voucher Scheme Evaluation, 2011, NAT VOUCH SCHEM EV; Walloon Agricultural Research Centre, 2014, THE CRA W REG; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2011, WHOPES GUID MON DUR; WHO, REP 13 WHOPES WORK G; WHO [World Health Organization], 2005, GUID LAB FIELD TEST; Wills AB, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-242; World Health Organization, 2013, EST FUNCT SURV LONG	37	5	5	0	8	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	MAR 18	2016	15								176	10.1186/s12936-016-1225-6				11	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DH2GH	WOS:000372601900002	26993981	DOAJ Gold, Green Published			2019-04-02	
J	Opondo, KO; Weetman, D; Jawara, M; Diatta, M; Fofana, A; Crombe, F; Mwesigwa, J; D'Alessandro, U; Donnelly, MJ				Opondo, Kevin Ochieng'; Weetman, David; Jawara, Musa; Diatta, Mathurin; Fofana, Amfaal; Crombe, Florence; Mwesigwa, Julia; D'Alessandro, Umberto; Donnelly, Martin James			Does insecticide resistance contribute to heterogeneities in malaria transmission in The Gambia?	MALARIA JOURNAL			English	Article							MOSQUITOS VECTORIAL CAPACITY; CROSS-SECTIONAL SURVEY; WESTERN BURKINA-FASO; TREATED BED NETS; ANOPHELES-GAMBIAE; PYRETHROID RESISTANCE; MOLECULAR-FORMS; KDR MUTATION; URBAN AGRICULTURE; COTE-DIVOIRE	Background: Malaria hotspots, areas with consistently higher than average transmission, may become increasingly common as malaria declines. This phenomenon, currently observed in The Gambia, may be caused by several factors, including some related to the local vectors, whose contribution is poorly understood. Methods: Using WHO susceptibility bioassays, insecticide resistance status was determined in vector populations sampled from six pairs of villages across The Gambia, each pair contained a low and high prevalence village. Results: Three vector species were observed (23.5 % Anopheles arabiensis, 31.2 % Anopheles gambiae, 43.3 % Anopheles coluzzii and 2.0 % An. coluzzii x An. gambiae hybrids). Even at a fine scale, significant differences in species composition were detected within village pairs. Resistance to both DDT and deltamethrin was more common in An. gambiae, most markedly in the eastern part of The Gambia and partly attributable to differing frequencies of resistance mutations. The Vgsc-1014F target site mutation was strongly associated with both DDT (OR = 256.7, (95 % CI 48.6-6374.3, p < 0.001) and deltamethrin survival (OR = 9.14, (95 % CI 4.24-21.4, p < 0.001). A second target site mutation, Vgsc-1575Y, which co-occurs with Vgsc-1014F, and a metabolic marker of resistance, Gste2-114T, conferred additional survival benefits to both insecticides. DDT resistance occurred significantly more frequently in villages with high malaria prevalence (p = 0.025) though this did not apply to deltamethrin resistance. Conclusion: Whilst causality of relationships requires further investigation, variation in vector species and insecticide resistance in The Gambia is associated with malaria endemicity; with a notably higher prevalence of infection and insecticide resistance in the east of the country. In areas with heterogeneous malaria transmission, the role of the vector should be investigated to guide malaria control interventions.	[D'Alessandro, Umberto; Donnelly, Martin James] London Sch Hyg & Trop Med, London WC1, England; [Opondo, Kevin Ochieng'; Jawara, Musa; Diatta, Mathurin; Fofana, Amfaal; Mwesigwa, Julia; D'Alessandro, Umberto] MRC Unit, POB 273, Banjul, Gambia; [Opondo, Kevin Ochieng'; Weetman, David; Crombe, Florence; Donnelly, Martin James] Univ Liverpool, Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England; [D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium	Donnelly, MJ (reprint author), London Sch Hyg & Trop Med, London WC1, England.	Martin.Donnelly@lstmed.ac.uk	; Weetman, David/M-1261-2014	Mwesigwa, Julia/0000-0003-2452-3677; Opondo, Kevin Ochieng'/0000-0001-8975-6266; Donnelly, Martin/0000-0001-5218-1497; Weetman, David/0000-0002-5820-1388	UK Medical Research Council (MRC); UK Department for International Development (DFID) under the MRC/DFID Concordat; European Union; Medical Research Council [MC_EX_MR/J002364/1]	This work is jointly funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement and is also part of the EDCTP2 programme supported by the European Union.	Antonio-Nkondjio C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-154; Bass C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-155; Bass C, 2010, PESTIC BIOCHEM PHYS, V96, P80, DOI 10.1016/j.pestbp.2009.09.004; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Browne ENL, 2000, ANN TROP MED PARASIT, V94, P15, DOI 10.1080/00034980057572; Bryan J, 1986, PARASSITOLOGIA, V29, P221; BRYAN JH, 1982, GENETICA, V59, P167, DOI 10.1007/BF00056539; BURKOT TR, 1988, AM J TROP MED HYG, V39, P135, DOI 10.4269/ajtmh.1988.39.135; BUSVINE JR, 1978, NATURE, V273, P604, DOI 10.1038/273604a0; BUSVINE JR, 1969, B WORLD HEALTH ORGAN, V40, P731; Caputo B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-182; Casimiro S, 2006, J MED ENTOMOL, V43, P276, DOI 10.1603/0022-2585(2006)043[0276:IRIAAA]2.0.CO;2; Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242; Chandre F, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P319; Clarkson CS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5248; Coetzee M., 2006, Bulletin de la Societe de Pathologie Exotique, V99, P400; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; Dabire KR, 2007, J MED ENTOMOL, V44, P990, DOI 10.1603/0022-2585(2007)44[990:AFDCIA]2.0.CO;2; Dabire KR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-188; DE ZULUETA J, 1959, Bull World Health Organ, V20, P797; Diatta M, 1998, T ROY SOC TROP MED H, V92, P270, DOI 10.1016/S0035-9203(98)91005-7; Djegbe I, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-261; Edi CVA, 2012, EMERG INFECT DIS, V18, P1508, DOI 10.3201/eid1809.120262; Ernst KC, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-78; GARRETTJ.C, 1964, B WORLD HEALTH ORGAN, V31, P71; Gaudart J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-286; Gillies M.T., 1988, MALARIA PRINCIPLES P, V1, P453; Gimonneau G, 2012, MED VET ENTOMOL, V26, P9, DOI 10.1111/j.1365-2915.2011.00957.x; GNMCP, 2011, MAL IND SURV; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Henry MC, 2005, AM J TROP MED HYG, V73, P859, DOI 10.4269/ajtmh.2005.73.859; Ijumba JN, 2002, MED VET ENTOMOL, V16, P28, DOI 10.1046/j.0269-283x.2002.00337.x; Jawara M, 2008, MALARIA J, V7, P9; Jones CM, 2012, P NATL ACAD SCI USA, V109, P6614, DOI 10.1073/pnas.1201475109; Kleinschmidt I, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0782-4; Klinkenberg E, 2006, TROP MED INT HEALTH, V11, P578, DOI 10.1111/j.1365-3156.2006.01609.x; Klinkenberg E, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-151; Kloke RG, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-16; Kreuels B, 2008, J INFECT DIS, V197, P85, DOI 10.1086/524066; Lindblade KA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0554-1; LINDSAY SW, 1993, T ROY SOC TROP MED H, V87, P45, DOI 10.1016/0035-9203(93)90175-P; Lindsay SW, 2003, TROP MED INT HEALTH, V8, P512, DOI 10.1046/j.1365-3156.2003.01059.x; Macdonald G., 1953, Tropical Diseases Bulletin, V50, P871; Majambere S, 2008, AM J TROP MED HYG, V79, P19, DOI 10.4269/ajtmh.2008.79.19; Majambere S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-76; MARASCUILO LA, 1966, PSYCHOL BULL, V65, P280, DOI 10.1037/h0023189; Mawejje HD, 2013, MED VET ENTOMOL, V27, P276, DOI 10.1111/j.1365-2915.2012.01055.x; Midega JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1672; Mitchell SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092662; MoH, 2012, NAT HLTH POL 2012 20, P22; MOLINEAUX L, 1979, B WORLD HEALTH ORGAN, V57, P265; Mwesigwa J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0829-6; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Ndiath MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097700; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Niang E. A, 2014, VARIABILITE GENETIQU; Ochomo E, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-310; Okebe J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110926; Padonou GG, 2011, J PARASITOL VECTOR B, V3, P59; Pinder M, 2015, LANCET, V385, P1436, DOI 10.1016/S0140-6736(14)61007-2; Pinder M, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-147; Reimer L, 2008, J MED ENTOMOL, V45, P260, DOI 10.1603/0022-2585(2008)45[260:RBKMAR]2.0.CO;2; Reimer LJ, 2005, INSECT MOL BIOL, V14, P683, DOI 10.1111/j.1365-2583.2005.00599.x; SAMCP, 2001, KWAZ NAT MAL CRIS PR; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-163; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-74; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; SMITH T, 1995, ACTA TROP, V59, P1, DOI 10.1016/0001-706X(94)00082-C; SNMCP, 2011, PROF ENT PAL SEN MIN; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; Stump AD, 2004, AM J TROP MED HYG, V70, P591, DOI 10.4269/ajtmh.2004.70.591; Tangena JAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074351; Taylor C, 2001, GENETICS, V157, P743; Thomas CJ, 2000, T ROY SOC TROP MED H, V94, P159, DOI 10.1016/S0035-9203(00)90257-8; THOMSON MC, 1994, T ROY SOC TROP MED H, V88, P638, DOI 10.1016/0035-9203(94)90204-6; Tokponnon FT, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-76; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; Weetman D, 2012, MOL BIOL EVOL, V29, P279, DOI 10.1093/molbev/msr199; Weill M, 2000, INSECT MOL BIOL, V9, P451, DOI 10.1046/j.1365-2583.2000.00206.x; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2007, MAL EL FIELD MAN LOW; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Wondji CS, 2012, P NATL ACAD SCI USA, V109, P19063, DOI 10.1073/pnas.1217229109; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; World Health Organisation, 2013, TEST PROC INS RES MO; Zhou GF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020318	89	5	5	1	13	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	MAR 15	2016	15								166	10.1186/s12936-016-1203-z				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DG3JT	WOS:000371966200008	26980461	DOAJ Gold, Green Published			2019-04-02	
J	Etang, J; Pennetier, C; Piameu, M; Bouraima, A; Chandre, F; Awono-Ambene, P; Marc, C; Corbel, V				Etang, Josiane; Pennetier, Cedric; Piameu, Michael; Bouraima, Aziz; Chandre, Fabrice; Awono-Ambene, Parfait; Marc, Coosemans; Corbel, Vincent			When intensity of deltamethrin resistance in Anopheles gambiae s.l. leads to loss of Long Lasting Insecticidal Nets bio-efficacy: a case study in north Cameroon	PARASITES & VECTORS			English	Article						Deltamethrin; Anopheles gambiae s.l; Malaria; Resistance intensity; Long-Lasting Insecticidal Nets; Vector control	PYRETHROID RESISTANCE; MALARIA VECTOR; TREATED NETS; PROTECTIVE EFFICACY; MOLECULAR-FORMS; CENTRAL-AFRICA; COTE-DIVOIRE; POPULATIONS; AREA; BENIN	Background: In Cameroon, insecticide resistance in Anopheles (An.) gambiae s.l. has been reported in several foci, prompting further investigations on associated patterns of Long-Lasting Insecticidal Nets (LLINs) bio-efficacy. The current study, conducted from June to August 2011, explored the intensity of deltamethrin resistance in An. gambiae s.l. from Pitoa and its impact on the residual bio-efficacy of LifeNet, a LLIN with deltamethrin incorporated into polypropylene nets (PND). Methods: Two-four days old females An. gambiae s.l. reared from larval collections in Pitoa were tested for susceptibility to DDT, permethrin and deltamethrin, using standard World Health Organization (WHO) tube assays. Intensity of deltamethrin resistance was explored using WHO tube assays, but across six working concentrations from 0.001 % to 0.5 %. Bio-efficacy of unwashed and washed PND was assessed using WHO cone test. Species identification and kdr 1014 genotyping were performed on mosquito samples that were not exposed to insecticides, using PCR-RFLP and HOLA methods respectively. The Kisumu reference susceptible strain of An. gambiae s.s. was used for comparisons. Results: A total of 1895 An. gambiae s.l. specimens from Pitoa were used for resistance and PND bio-efficacy testing. This mosquito population was resistant to DDT, permethrin and deltamethrin, with 18-40 min knockdown times for 50 % of tested mosquitoes and 59-77 % mortality. Deltamethrin Resistance Ratio compared with the Kisumu strain was estimated at >= 500 fold. LifeNets were effective against the susceptible Kisumu (100 % knockdown (KD60min) and mortality) and the resistant Pitoa samples (95 % KD60min, 83-95 % mortality). However, the bio-efficacy gradually dropped against the Pitoa samples when nets were washed (X-2 = 35.887, df = 8, p < 0.001), and fell under the WHO efficacy threshold (80 % mortality and/or 95 % KD60min) between 10 and 15 washes. The Pitoa samples were composed of three sibling species: An. arabiensis (132/154, 86 %), An. coluzzii (19/154, 12 %) and An. gambiae s.s. (3/154, 2 %). The kdr L1014F allele was found only in An. coluzzii (N-positive = 13/19), at 34 % frequency and heterozygote stage. No specimen carried the kdr L1014S allele. Conclusions: The current study showed that LifeNet might still offer some protection against the resistant An. gambiae s.l. population from Pitoa, provided appropriate dose of insecticide is available on the nets.	[Etang, Josiane; Awono-Ambene, Parfait] OCEAC, IRY, BP 288, Yaounde, Cameroon; [Etang, Josiane] Univ Douala, Fac Med & Pharmaceut Sci, POB 2701, Douala, Cameroon; [Pennetier, Cedric; Chandre, Fabrice; Corbel, Vincent] IRD, MIVEGEC UMR224, F-34394 Montpellier, France; [Pennetier, Cedric] IPR, BP1500, Bouake, Cote Ivoire; [Piameu, Michael] Univ Catholique Afrique Cent, Ecole Sci Sante, BP 1110, Yaounde, Cameroon; [Bouraima, Aziz] CREC, 01 BP 4414, Cotonou, Benin; [Marc, Coosemans] Inst Trop Med, Dept Parasitol Entomol, Natl Str 155, B-2000 Antwerp, Belgium; [Marc, Coosemans] Univ Antwerp, B-2020 Antwerp, Belgium; [Corbel, Vincent] Kasetsart Univ, Fac Agr, Dept Entomol, Bangkok 10900, Thailand	Etang, J (reprint author), OCEAC, IRY, BP 288, Yaounde, Cameroon.; Etang, J (reprint author), Univ Douala, Fac Med & Pharmaceut Sci, POB 2701, Douala, Cameroon.	josyet2@gmail.com	Corbel, VIncent/G-9576-2016; Pennetier, Cedric/K-2010-2016	Pennetier, Cedric/0000-0002-3362-6371; Chandre, Fabrice/0000-0002-1994-9705	Anopheles Biology and Control Network; Bayer Environmental Science	The study was funded by Anopheles Biology and Control Network, with the support of Bayer Environmental Science. Authors are grateful to Mr. Feshu Nono Betrand for his assistance in statistical analysis.	Antonio-Nkondjio C, 2006, J MED ENTOMOL, V43, P1215, DOI 10.1603/0022-2585(2006)43[1215:COTMVS]2.0.CO;2; Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Bagi J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0721-4; Busula AO, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0635-1; Chandre F, 1999, J AM MOSQUITO CONTR, V15, P53; Chareonviriyaphap T, 2002, J VECTOR ECOL, V27, P222; Chouaibou M, 2008, TROP MED INT HEALTH, V13, P476, DOI 10.1111/j.1365-3156.2008.02025.x; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; Corbel V, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P579, DOI 10.5772/56117; Damien GB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-380; Darriet F, 2000, B SOC PATHOL EXOT, V93, P131; Etang J, 2003, J MED ENTOMOL, V40, P491, DOI 10.1603/0022-2585-40.4.491; Etang J, 2007, T ROY SOC TROP MED H, V101, P881, DOI 10.1016/j.trstmh.2007.05.012; Etang J, 2007, J VECTOR ECOL, V32, P123, DOI 10.3376/1081-1710(2007)32[123:SOMRTD]2.0.CO;2; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Finney DJ, 1971, PROBIT ANAL; Gillies MT, 1968, ANOPHELINAE AFRICA S, P54; Gillies MT, 1968, SUPPLEMENT ANOPHELIN, P55; Glunt KD, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0807-z; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Henry MC, 2005, AM J TROP MED HYG, V73, P859, DOI 10.4269/ajtmh.2005.73.859; Kleinschmidt I, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0782-4; Lynd A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-16; MINSANTE, 2011, PLAN STRAT NAT LUTT; Mnzava AP, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0693-4; Muller P, 2008, MOL ECOL, DOI [10.1111/j.1365-294x.200703617.x, DOI 10.1111/J.1365-294X.200703617.X]; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Nwane P, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-41; Nwane Philippe, 2011, BMC Res Notes, V4, P463, DOI 10.1186/1756-0500-4-463; Nwane P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-163; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Same-Ekobo A, 2005, J CAM ACADSCI, V5, P3; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-74; Strode C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001619; [WHO] World Health Organization, 2013, WHOHTMNTDWHOPES20131; World Health Organisation, 2013, TEST PROC INS RES MO	36	8	8	0	15	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	MAR 8	2016	9								132	10.1186/s13071-016-1420-x				10	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	DF6ID	WOS:000371458200001	26951758	DOAJ Gold, Green Published			2019-04-02	
J	Ribera, JM; Hausmann-Muela, S; Gryseels, C; Grietens, KP				Muela Ribera, Joan; Hausmann-Muela, Susanna; Gryseels, Charlotte; Grietens, Koen Peeters			Re-imagining adherence to treatment from the "other side": local interpretations of adverse anti-malarial drug reactions in the Peruvian Amazon	MALARIA JOURNAL			English	Article						Treatment adherence; Adverse drug reactions; Community perspectives; Hot and cold theory; Images and metaphors	HOME TREATMENT; MALARIA	Background: Patients' adherence to malaria treatment is a key issue in malaria control and elimination efforts. Previous studies have reported on problems with adherence to anti-malarials, which in part can be related to adverse drug reactions (ADRs) of anti-malarials. However, there has been a relative inattention to the cultural and social aspects of these anti-malarial side-effects and, more broadly, to how cultural representations of body functions may affect people's behaviour. In this article, an in-depth analysis is presented of the cultural logics underlying local interpretations of adverse drug reactions to anti-malarials in the Peruvian Amazon. Methods: Ethnographic fieldwork was carried out during two periods of 3 months in 2007 and 2008. Fieldwork was carried out in 10 communities in the department of Loreto, the administrative area corresponding to the Peruvian Amazon. Thirty in-depth interviews of key and general informants, focusing on perceived adverse anti-malarial drug reactions, were carried out in Spanish, recorded, transcribed and analysed. Results: Informants reported surprisingly elevated problems of adverse drug reactions. Frequent statements about medication that "shocked", "cut the blood" or provoked "allergic reactions" are difficult to interpret from a biomedical perspective, and only make when considering the underlying cultural logics. The logic of maintaining a 'temperate' physical and moral balance by avoiding excesses of 'hot' or 'cold' or sudden changes of 'body heat' can explain the locally constructed adverse drug reactions to anti-malarials. Discussion: Adherence is a continuous process during which the patient evaluates and re-evaluates the course of his illness and the perceived benefits and risks of the treatment. What counts are the processes, the interpretations and the logics which underlie the decisions to adhere to or to abandon treatment. Adherence can only be adequately addressed if such interpretations are understood and taken into account.	[Muela Ribera, Joan] Univ Rovira & Virgili, Dept Antropol, Filosofia & Treball Social Med Anthropol Res Ctr, Avinguda Catalunya 85, Tarragona 43002, Spain; [Muela Ribera, Joan; Hausmann-Muela, Susanna; Grietens, Koen Peeters] Partners Appl Social Sci PASS Int, Tessenderlo, Belgium; [Gryseels, Charlotte; Grietens, Koen Peeters] Inst Trop Med, Dept Publ Hlth, Med Anthropol Unit, Natl Str 155, B-2000 Antwerp, Belgium; [Grietens, Koen Peeters] Nagasaki Univ, Sch Int Hlth Dev, Nagasaki 852, Japan	Ribera, JM (reprint author), Univ Rovira & Virgili, Dept Antropol, Filosofia & Treball Social Med Anthropol Res Ctr, Avinguda Catalunya 85, Tarragona 43002, Spain.; Ribera, JM (reprint author), Partners Appl Social Sci PASS Int, Tessenderlo, Belgium.	joan.muela@yahoo.es		Gryseels, Charlotte/0000-0002-8963-4469; Peeters Grietens, Koen/0000-0001-6570-9887	Institute of Tropical Medicine (ITM), Antwerp-Belgium; ITM Alexander von Humboldt (ITM-AvH) in Lima, Peru; National Institute of Health/National Institute of Allergy and Infectious Diseases [RO1-AI067727-03, 95502]	The study was funded by the Belgian Cooperation within the Framework Agreement 3 consisting of a bilateral cooperation between the Institute of Tropical Medicine (ITM), Antwerp-Belgium, and the ITM Alexander von Humboldt (ITM-AvH) in Lima, Peru. Project 95502 DG was supported by National Institute of Health/National Institute of Allergy and Infectious Diseases (RO1-AI067727-03).	[Anonymous], 2015, GLOB TECHN STRAT MAL; [Anonymous], 2015, ROLL BACK MALARIA AC; Arroyo LJ, 2001, INTERCULTURALIDAD AT; De Montenegro P, 1945, MATERIA MED MISIONER; Epstein RM, 2011, ANN FAM MED, V9, P100, DOI 10.1370/afm.1239; Foster George M., 1994, HIPPOCRATES LATIN AM; Foster GM, 1987, MED ANTHROPOL Q, V1, P355; Grietens KP, 2010, AM J TROP MED HYG, V82, P1017, DOI 10.4269/ajtmh.2010.09-0521; Gryseels C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080343; Gutierrez EM, 2009, QUADERNS I CATALA AN, V25, P141; Hausmann-Muela S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0703-6; Iskander D, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0770-8; Kamat Vinay R, 2009, Anthropol Med, V16, P293, DOI 10.1080/13648470903246854; Kidane G, 2000, LANCET, V356, P550, DOI 10.1016/S0140-6736(00)02580-0; Llanos F., 2001, REV MED EXP, V18, P63; Lockhart James, 2000, THINGS INDIES ESSAYS; LOGAN MH, 1973, HUM ORGAN, V32, P385, DOI 10.17730/humo.32.4.y87jrn479x558676; Makemba AM, 1996, TROP MED INT HEALTH, V1, P201; Maqdsen W., 1955, J AM FOLKLORE, V68, P123; Marsh VM, 1999, TROP MED INT HEALTH, V4, P383, DOI 10.1046/j.1365-3156.1999.00403.x; Morrison J., 2008, J PERINATOL, V28, P14; Muela Ribera J, 2015, MEDICUS MUNDI SWITZE; Muela SH, 2002, SOC SCI MED, V55, P403; Nichter Mark, 2004, Subst Use Misuse, V39, P1907, DOI 10.1081/LSUM-200033233; O'Neill S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0687-2; Olivier de Sardan J-P, 1995, ANTHR DEV ESSAI SOCI; Tashakkori A., 2002, HDB MIXED METHODS SO; Trevino Carlos Viesca, 1986, MED PREHISPANICA MEX; Yepez M C, 2000, Rev Cubana Med Trop, V52, P81; Yeung S, 2005, TROP MED INT HEALTH, V10, P121, DOI 10.1111/j.1365-3156.2004.01364.x	30	3	3	0	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	MAR 2	2016	15								136	10.1186/s12936-016-1193-x				7	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DF3CY	WOS:000371222500001	26935955	DOAJ Gold, Green Published			2019-04-02	
J	Adem, E; Tajebe, F; Getahun, M; Kiflie, A; Diro, E; Hailu, A; Shkedy, Z; Mengesha, B; Mulaw, T; Atnafu, S; Deressa, T; Mathewos, B; Abate, E; Modolell, M; Munder, M; Muller, I; Takele, Y; Kropf, P				Adem, Emebet; Tajebe, Fitsumbirhan; Getahun, Mulusew; Kiflie, Amare; Diro, Ermias; Hailu, Asrat; Shkedy, Ziv; Mengesha, Bewketu; Mulaw, Tadele; Atnafu, Saba; Deressa, Tekalign; Mathewos, Biniam; Abate, Ebba; Modolell, Manuel; Munder, Markus; Mueller, Ingrid; Takele, Yegnasew; Kropf, Pascale			Successful Treatment of Human Visceral Leishmaniasis Restores Antigen-Specific IFN-gamma, but not IL-10 Production	PLOS NEGLECTED TROPICAL DISEASES			English	Article							ARGINASE ACTIVITY; DONOVANI; BLOOD; CELLS; INFECTION; RELEASE; MARKER	One of the key immunological characteristics of active visceral leishmaniasis (VL) is a profound immunosuppression and impaired production of Interferon-gamma (IFN-gamma). However, recent studies from Bihar in India showed using a whole blood assay, that whole blood cells have maintained the capacity to produce IFN-gamma. Here we tested the hypothesis that a population of low-density granulocytes (LDG) might contribute to T cell responses hyporesponsiveness via the release of arginase. Our results show that this population is affected by the anticoagulant used to collect blood: the frequency of LDGs is significantly lower when the blood is collected with heparin as compared to EDTA; however, the anticoagulant does not impact on the levels of arginase released. Next, we assessed the capacity of whole blood cells from patients with active VL to produce IFN-gamma and IL-10 in response to antigen-specific and polyclonal activation. Our results show that whole blood cells produce low or levels below detection limit of IFN-gamma and IL-10, however, after successful treatment of VL patients, these cells gradually regain their capacity to produce IFN-gamma, but not IL-10, in response to activation. These results suggest that in contrast to VL patients from Bihar, India, whole blood cells from VL patients from Gondar, Ethiopia, have lost their ability to produce IFN-gamma during active VL and that active disease is not associated with sustained levels of IL-10 production following stimulation.	[Adem, Emebet; Tajebe, Fitsumbirhan; Getahun, Mulusew; Kiflie, Amare; Deressa, Tekalign; Mathewos, Biniam; Abate, Ebba] Univ Gondar, Dept Immunol, Gondar, Ethiopia; [Diro, Ermias] Univ Gondar, Dept Internal Med, Gondar, Ethiopia; [Hailu, Asrat] Univ Addis Ababa, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia; [Shkedy, Ziv] Univ Hasselt, Dept Math & Stat, Diepenbeek, Belgium; [Mengesha, Bewketu; Mulaw, Tadele; Atnafu, Saba; Takele, Yegnasew] Gondar Univ, Leishmaniasis Res & Treatment Ctr, Gondar, Ethiopia; [Modolell, Manuel] Max Planck Inst Immunobiol & Epigenet, Dept Cellular Immunol, Freiburg, Germany; [Munder, Markus] Univ Med Ctr Mainz, Dept Med Hematol Oncol & Pneumol 3, Mainz, Germany; [Mueller, Ingrid; Takele, Yegnasew; Kropf, Pascale] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England	Kropf, P (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England.	p.kropf@imperial.ac.uk		Takele, Yegnasew/0000-0003-1070-7459	DNDi; Wellcome Trust [104027/B/14/Z]	The authors would like to also thank DNDi for their in-kind support in funding the staff of Gondar University Leishmaniasis Research and Treatment Centre. Yegnasew Takele is supported by a fellowship from the Wellcome Trust (104027/B/14/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002134; Banfi G, 2007, CLIN CHEM LAB MED, V45, P565, DOI 10.1515/CCLM.2007.110; Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313; Brandau S, 2011, J LEUKOCYTE BIOL, V89, P311, DOI 10.1189/jlb.0310162; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; CHULAY JD, 1983, AM J TROP MED HYG, V32, P475, DOI 10.4269/ajtmh.1983.32.475; CILLARI E, 1988, J IMMUNOL, V140, P2721; Cloke T, 2011, IMMUNOREGULATION BY; Cloke TE, 2010, J INFECT DIS, V202, P374, DOI 10.1086/653736; Denny MR, 2010, J IMMUNOL, V184, P3284, DOI 10.4049/jimmunol.0902199; Freltas M, 2008, CLIN BIOCHEM, V41, P570, DOI 10.1016/j.clinbiochem.2007.12.021; Fu J, 2014, ANN ALLERG ASTHMA IM, V113, P635, DOI 10.1016/j.anai.2014.08.024; Gautam S, 2011, J INFECT DIS, V204, P1134, DOI 10.1093/infdis/jir461; Gelanew T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000889; GHOSE AC, 1979, T ROY SOC TROP MED H, V73, P725, DOI 10.1016/0035-9203(79)90032-4; Gidwani K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001042; Goto H, 2009, REV I MED TROP, V51, P241, DOI 10.1590/S0036-46652009000500002; Hailu A, 2005, CLIN IMMUNOL, V117, P182, DOI 10.1016/j.clim.2005.06.015; HO M, 1983, CLIN EXP IMMUNOL, V51, P207; Khalil EAG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002613; Kropf P, 2007, EUR J IMMUNOL, V37, P935, DOI 10.1002/eji.200636542; Kumar R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003198; Kumar R, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00251; Leish GENC, 2013, NAT GENET, V45, P208, DOI [10.1038/ng.2518, DOI 10.1038/NG.2518]; Modolell M, 2009, PLOS NEGLECT TROP D, V14, pe480, DOI DOI 10.1371/J0URNAL.PNTD.0000480; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; NIELSEN H, 1985, ACTA PATH MICRO IM C, V93, P49; Nylen S, 2007, TRENDS IMMUNOL, V28, P378, DOI 10.1016/j.it.2007.07.004; Rodriguez PC, 2008, IMMUNOL REV, V222, P180, DOI 10.1111/j.1600-065X.2008.00608.x; Singh OP, 2012, CLIN VACCINE IMMUNOL, V19, P961, DOI 10.1128/CVI.00143-12; Takele Y, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001977; Vanaerschot M, 2012, J INFECT DIS, V206, P752, DOI 10.1093/infdis/jis424; WHO, 2010, WHO TECH REP SER, V949, P1	33	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAR	2016	10	3							e0004468	10.1371/journal.pntd.0004468				15	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DI1RF	WOS:000373272500016	26962865	DOAJ Gold, Green Published			2019-04-02	
J	Decuypere, S; Maltha, J; Deborggraeve, S; Rattray, NJW; Issa, G; Berenger, K; Lompo, P; Tahita, MC; Ruspasinghe, T; McConville, M; Goodacre, R; Tinto, H; Jacobs, J; Carapetis, JR				Decuypere, Saskia; Maltha, Jessica; Deborggraeve, Stijn; Rattray, Nicholas J. W.; Issa, Guiraud; Berenger, Kabore; Lompo, Palpouguini; Tahita, Marc C.; Ruspasinghe, Thusitha; McConville, Malcolm; Goodacre, Royston; Tinto, Halidou; Jacobs, Jan; Carapetis, Jonathan R.			Towards Improving Point-of-Care Diagnosis of Non-malaria Febrile Illness: A Metabolomics Approach	PLOS NEGLECTED TROPICAL DISEASES			English	Article							PLASMODIUM-FALCIPARUM MALARIA; BLOOD-STREAM INFECTIONS; PITUITARY-ADRENAL AXIS; CHILDREN; BACTERIAL; TRANSMISSION; METAANALYSIS; MOZAMBIQUE; CYTOKINES; COUNTRIES	Introduction Non-malaria febrile illnesses such as bacterial bloodstream infections (BSI) are a leading cause of disease and mortality in the tropics. However, there are no reliable, simple diagnostic tests for identifying BSI or other severe non-malaria febrile illnesses. We hypothesized that different infectious agents responsible for severe febrile illness would impact on the host metabololome in different ways, and investigated the potential of plasma metabolites for diagnosis of non-malaria febrile illness. Methodology We conducted a comprehensive mass-spectrometry based metabolomics analysis of the plasma of 61 children with severe febrile illness from a malaria-endemic rural African setting. Metabolite features characteristic for non-malaria febrile illness, BSI, severe anemia and poor clinical outcome were identified by receiver operating curve analysis. Principal Findings The plasma metabolome profile of malaria and non-malaria patients revealed fundamental differences in host response, including a differential activation of the hypothalamic-pituitaryadrenal axis. A simple corticosteroid signature was a good classifier of severe malaria and non-malaria febrile patients (AUC 0.82, 95% CI: 0.70-0.93). Patients with BSI were characterized by upregulated plasma bile metabolites; a signature of two bile metabolites was estimated to have a sensitivity of 98.1%(95% CI: 80.2-100) and a specificity of 82.9% (95% CI: 54.7-99.9) to detect BSI in children younger than 5 years. This BSI signature demonstrates that host metabolites can have a superior diagnostic sensitivity compared to pathogendetecting tests to identify infections characterized by low pathogen load such as BSI. Conclusions This study demonstrates the potential use of plasma metabolites to identify causality in children with severe febrile illness in malaria-endemic settings.	[Decuypere, Saskia; Carapetis, Jonathan R.] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia; [Maltha, Jessica; Jacobs, Jan] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Maltha, Jessica] Katholieke Univ Leuven, Ctr Mol & Vasc Biol, Leuven, Belgium; [Deborggraeve, Stijn] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Rattray, Nicholas J. W.; Goodacre, Royston] Univ Manchester, Manchester Inst Biotechnol, Sch Chem, Manchester, Lancs, England; [Issa, Guiraud; Berenger, Kabore; Lompo, Palpouguini; Tahita, Marc C.; Tinto, Halidou] CRUN, IRSS, Clin Res Unit Nanoro, Nanoro, Burkina Faso; [Ruspasinghe, Thusitha; McConville, Malcolm] Univ Melbourne, Inst Mol Sci & Biotechnol, Metabol Australia & Bio21, Melbourne, Vic, Australia; [Jacobs, Jan] Katholieke Univ Leuven, Dept Immunol & Microbiol, Leuven, Belgium	Decuypere, S (reprint author), Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia.	saskia.decuypere@telethonkids.org.au	Goodacre, Roy/J-1600-2012	Goodacre, Roy/0000-0003-2230-645X; Decuypere, Saskia/0000-0001-5036-4601; Tinto, Halidou/0000-0002-0472-3586; Deborggraeve, Stijn/0000-0003-1501-5355	Telethon Kids Institute; Department of Health Western Australia; Institute of Tropical Medicine Belgium; UK Medical Research Council; Flemish Ministry of Sciences	This work was supported by a Telethon Kids Institute small grant & a Merit Award of the Department of Health Western Australia to SDec, JRC, MM and TR; the Institute of Tropical Medicine Belgium to JM, JJ, GI, KB, PL, MCT and HT; the UK Medical Research Council to NJWR and RG; and the Flemish Ministry of Sciences (EWI, SOFI grant) to SDeb and JJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annane D, 2008, CURR PHARM DESIGN, V14, P1882, DOI 10.2174/138161208784980626; Bottieau E, 2013, T ROY SOC TROP MED H, V107, P176, DOI 10.1093/trstmh/trs012; Chheng K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060634; Chin CD, 2013, CLIN CHEM, V59, P629, DOI 10.1373/clinchem.2012.199596; Church J, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-31; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; Davis TME, 1997, J CLIN ENDOCR METAB, V82, P3029, DOI 10.1210/jc.82.9.3029; Deen J, 2012, LANCET INFECT DIS, V12, P480, DOI 10.1016/S1473-3099(12)70028-2; Gething PW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000301; Graham SM, 2009, LANCET, V373, P267, DOI 10.1016/S0140-6736(09)60073-8; Green RM, 1996, GASTROENTEROLOGY, V111, P193, DOI 10.1053/gast.1996.v111.pm8698199; Ibrahim EA, 2011, ASIAN PAC J TROP MED, V4, P146, DOI 10.1016/S1995-7645(11)60056-4; Iqbal J, 2004, J CLIN MICROBIOL, V42, P4237, DOI 10.1128/JCM.42.9.4237-4241.2004; Libonati RMF, 2006, ACTA TROP, V98, P270, DOI 10.1016/j.actatropica.2006.05.008; Maltha J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089103; Nadjm B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1350; Parola P, 2004, PARASITOL RES, V92, P464, DOI 10.1007/s00436-003-1012-5; Peeling RW, 2010, CLIN MICROBIOL INFEC, V16, P1062, DOI 10.1111/j.1469-0691.2010.03279.x; Penno EC, 2015, AM J TROP MED HYG; Phoba MF, 2014, EUR J CLIN MICROBIOL, V33, P79, DOI 10.1007/s10096-013-1931-8; Punjabi NH, 2012, AM J TROP MED HYG, V86, P46, DOI 10.4269/ajtmh.2012.10-0497; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Seymour CW, 2013, INTENS CARE MED, V39, P1423, DOI 10.1007/s00134-013-2935-7; Shwe Tin, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P46; Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d; Silverman MN, 2005, VIRAL IMMUNOL, V18, P41, DOI 10.1089/vim.2005.18.41; Surowiec I, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv062; Trauner M, 1998, J CLIN INVEST, V101, P2092, DOI 10.1172/JCI1680; Visser BJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-442; Webster JI, 2004, J ENDOCRINOL, V181, P207, DOI 10.1677/joe.0.1810207; Wilson Moira, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P689; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; Xu ZL, 2009, ANAL CHIM ACTA, V647, P125, DOI 10.1016/j.aca.2009.06.003	33	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAR	2016	10	3							e0004480	10.1371/journal.pntd.0004480				19	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DI1RF	WOS:000373272500020	26943791	DOAJ Gold, Green Published			2019-04-02	
J	Gehre, F; Kumar, S; Kendall, L; Ejo, M; Secka, O; Ofori-Anyinam, B; Abatih, E; Antonio, M; Berkvens, D; de Jong, BC				Gehre, Florian; Kumar, Samrat; Kendall, Lindsay; Ejo, Mebrat; Secka, Oumie; Ofori-Anyinam, Boatema; Abatih, Emmanuel; Antonio, Martin; Berkvens, Dirk; de Jong, Bouke C.			A Mycobacterial Perspective on Tuberculosis in West Africa: Significant Geographical Variation of M. africanum and Other M. tuberculosis Complex Lineages	PLOS NEGLECTED TROPICAL DISEASES			English	Article							GENETIC DIVERSITY; MOLECULAR EPIDEMIOLOGY; BURKINA-FASO; STRAINS; NIGERIA; TRANSMISSION; BACILLI; GAMBIA	Background Phylogenetically distinct Mycobacterium tuberculosis lineages differ in their phenotypes and pathogenicity. Consequently, understanding mycobacterial population structures phylogeographically is essential for design, interpretation and generalizability of clinical trials. Comprehensive efforts are lacking to date to establish the West African mycobacterial population structure on a sub-continental scale, which has diagnostic implications and can inform the design of clinical TB trials. Methodology/Principal Findings We collated novel and published genotyping (spoligotyping) data and classified spoligotypes into mycobacterial lineages/families using TBLineage and Spotclust, followed by phylogeographic analyses using statistics (logistic regression) and lineage axis plot analysis in GenGIS, in which a phylogenetic tree constructed in MIRU-VNTRplus was analysed. Combining spoligotyping data from 16 previously published studies with novel data from The Gambia, we obtained a total of 3580 isolates from 12 countries and identified 6 lineages comprising 32 families. By using stringent analytical tools we demonstrate for the first time a significant phylogeographic separation between western and eastern West Africa not only of the two M. africanum (West Africa 1 and 2) but also of several major M. tuberculosis sensu stricto families, such as LAM10 and Haarlem 3. Moreover, in a longitudinal logistic regression analysis for grouped data we showed that M. africanum West Africa 2 remains a persistent health concern. Conclusions/Significance Because of the geographical divide of the mycobacterial populations in West Africa, individual research findings from one country cannot be generalized across the whole region. The unequal geographical family distribution should be considered in placement and design of future clinical trials in West Africa.	[Gehre, Florian; Ejo, Mebrat; Ofori-Anyinam, Boatema; de Jong, Bouke C.] Inst Trop Med, Mycobacterial Unit, Biomed Sci, B-2000 Antwerp, Belgium; [Gehre, Florian; Secka, Oumie; Ofori-Anyinam, Boatema; Antonio, Martin; de Jong, Bouke C.] Med Res Council MRC Unit, Vaccines & Immun Theme, Fajara, Gambia; [Kumar, Samrat; Abatih, Emmanuel; Berkvens, Dirk] Inst Trop Med, Biomed Sci, B-2000 Antwerp, Belgium; [Kendall, Lindsay] Med Res Council MRC Unit, Stat & Bioinformat Dept, Fajara, Gambia; [Ejo, Mebrat] Univ Gondar, Gondar, Ethiopia; [de Jong, Bouke C.] NYU, Div Infect Dis, Dept Med, New York, NY USA	Gehre, F (reprint author), Inst Trop Med, Mycobacterial Unit, Biomed Sci, B-2000 Antwerp, Belgium.; Gehre, F (reprint author), Med Res Council MRC Unit, Vaccines & Immun Theme, Fajara, Gambia.	fgehre@mrc.gm		Ejo, Mebrat/0000-0001-8119-8394; de Jong, Bouke/0000-0002-1017-4675	European Research Council [311725]; Medical Research Council [MC_UP_A900_1122, MC_U190081991]	FG, BCdJ, and BOA were supported by a European Research Council Starting grant INTERRUPTB (grant No.: 311725). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolabi D, 2009, EMERG INFECT DIS, V15, P1123, DOI 10.3201/eid1507.080697; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Aminian M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S3-S4; Ani A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-189; Cadmus S, 2006, J CLIN MICROBIOL, V44, P29, DOI 10.1128/JCM.44.1.29-34.2006; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; de Jong BC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000744; Gehre F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110393; Gehre F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077000; Gehre F, 2013, EMERG INFECT DIS, V19, P1598, DOI 10.3201/eid1910.121023; Godreuil S, 2007, J CLIN MICROBIOL, V45, P921, DOI 10.1128/JCM.01918-06; Gomgnimbou MK, 2012, EMERG INFECT DIS, V18, P117, DOI 10.3201/eid1801.110275; Groenheit R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018601; Hill PC, 2010, LANCET INFECT DIS, V10, P723, DOI 10.1016/S1473-3099(10)70164-X; Homolka S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-103; Koro FK, 2013, J CLIN MICROBIOL, V51, P299, DOI 10.1128/JCM.01196-12; Lawson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038409; Mokrousov I, 2014, J BACTERIOL, V196, P1833, DOI 10.1128/JB.01485-13; Nahid P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010753; Niang MN, 1999, MICROBES INFECT, V1, P1189, DOI 10.1016/S1286-4579(99)00243-9; Ouassa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045363; Parks DH, 2009, GENOME RES, V19, P1896, DOI 10.1101/gr.095612.109; Thumamo BP, 2012, INFECT GENET EVOL, V12, P671, DOI 10.1016/j.meegid.2011.08.011; Traore B, 2012, INT J TUBERC LUNG D, V16, P911, DOI 10.5588/ijtld.11.0397; United Nations Development Programme, 2014, 2014 HUM DEV REP SUS; Vitol I, 2006, INFECT GENET EVOL, V6, P491, DOI 10.1016/j.meegid.2006.03.003; Yeboah-Manu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021906	28	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAR	2016	10	3							e0004408	10.1371/journal.pntd.0004408				11	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DI1RF	WOS:000373272500009	26964059	DOAJ Gold, Green Published			2019-04-02	
J	Palich, R; Gala, JL; Petitjean, F; Shepherd, S; Peyrouset, O; Abdoul, BM; Kinda, M; Danel, C; Augier, A; Anglaret, X; Malvy, D; Blackwell, N				Palich, Romain; Gala, Jean-Luc; Petitjean, Frederic; Shepherd, Susan; Peyrouset, Olivier; Abdoul, Bing M.; Kinda, Moumouni; Danel, Christine; Augier, Augustin; Anglaret, Xavier; Malvy, Denis; Blackwell, Nicole		Alima N'zerekore Ebola Treatment	A 6-Year-Old Child with Severe Ebola Virus Disease: Laboratory-Guided Clinical Care in an Ebola Treatment Center in Guinea	PLOS NEGLECTED TROPICAL DISEASES			English	Article							WEST-AFRICA; PATIENT		[Palich, Romain; Petitjean, Frederic; Shepherd, Susan; Peyrouset, Olivier; Abdoul, Bing M.; Kinda, Moumouni; Augier, Augustin; Blackwell, Nicole] Alliance Int Med Act, Dakar, Senegal; [Gala, Jean-Luc] Louvain Catholic Univ, Ctr Appl Mol Technol, Brussels, Belgium; [Danel, Christine; Anglaret, Xavier; Malvy, Denis] INSERM, Ctr 1219, Bordeaux, France; [Malvy, Denis] Univ Hosp Bordeaux, Dept Trop Med & Clin Int Hlth, Div Infect & Trop Dis, Bordeaux, France; [Blackwell, Nicole] Univ Queensland, Dept Crit Care, Div Anesthesiol & Crit Care, Brisbane, Qld, Australia	Palich, R (reprint author), Alliance Int Med Act, Dakar, Senegal.	romain.palich@alima-ngo.org	blackwell, nikki/H-4222-2013				Agua-Agum J, 2015, NEW ENGL J MED, V372, P1274, DOI 10.1056/NEJMc1415318; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Kourtis AP, 2015, PEDIATR INFECT DIS J, V34, P893, DOI 10.1097/INF.0000000000000707; Sissoko D, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001967; Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004; Wolf T, 2015, LANCET, V385, P1428, DOI 10.1016/S0140-6736(14)62384-9	6	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAR	2016	10	3							e0004393	10.1371/journal.pntd.0004393				5	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DI1RF	WOS:000373272500007	27011342	DOAJ Gold, Green Published			2019-04-02	
J	van Griensven, J; Gadisa, E; Aseffa, A; Hailu, A; Beshah, AM; Diro, E				van Griensven, Johan; Gadisa, Endalamaw; Aseffa, Abraham; Hailu, Asrat; Beshah, Abate Mulugeta; Diro, Ermias			Treatment of Cutaneous Leishmaniasis Caused by Leishmania aethiopica: A Systematic Review	PLOS NEGLECTED TROPICAL DISEASES			English	Article							SODIUM STIBOGLUCONATE; CLINICAL-TRIAL; MUCOCUTANEOUS LEISHMANIASIS; LEISH-F1+MPL-SE VACCINE; MEGLUMINE ANTIMONIATE; AMPHOTERICIN-B; ETHIOPIA; MILTEFOSINE; COMBINATION; PAROMOMYCIN	Leishmania aethiopica is the etiological agent of cutaneous leishmaniasis (CL) in Ethiopia and can cause severe and complicated cases such as diffuse CL (DCL), mucocutaneous leishmaniasis or extensive CL, requiring systemic treatment. Despite the substantial burden, evidence-based treatment guidelines are lacking. We conducted a systematic review of clinical studies reporting on treatment outcomes of CL due to L aethiopica in order to help identify potentially efficacious medications on CL that can be taken forward for clinical trials. We identified a total of 24 records reporting on 506 treatment episodes of CL presumably due to L aethiopica. The most commonly used drugs were antimonials (n = 201), pentamidine (n = 150) and cryotherapy (n = 103). There were 20 case reports/series, with an overall poor study quality. We only identified two small and/or poor quality randomized controlled trials conducted a long time ago. There were two prospective non-randomized studies reporting on cryotherapy, antimonials and pentamidine. With cryotherapy, cure rates were 60-80%, and 69-85% with antimonials. Pentamidine appeared effective against complicated CL, also in cases non-responsive to antimonials. However, all studies suffered from methodological limitations. Data on miltefosine, paromomycin and liposomal amphotericin B are extremely scarce. Only a few studies are available on DCL. The only potentially effective treatment options for DCL seem to be antimonials with paromomycin in combination or pentamidine, but none have been properly evaluated. In conclusion, the evidence-base for treatment of complicated CL due to L aethiopica is extremely limited. While antimonials remain the most available CL treatment in Ethiopia, their efficacy and safety in CL should be better defined. Most importantly, alternative first line treatments (such as miltefosine or paromomycin) should be explored. High quality trials on CL due to L aethiopica are urgently needed, exploring group sequential methods to evaluate several options in parallel.	[van Griensven, Johan] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Gadisa, Endalamaw; Aseffa, Abraham] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Hailu, Asrat] Univ Addis Ababa, Sch Med, Addis Ababa, Ethiopia; [Beshah, Abate Mulugeta] World Hlth Org, Addis Ababa, Ethiopia; [Diro, Ermias] Univ Gondar, Dept Internal Med, Gondar, Ethiopia	van Griensven, J (reprint author), Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.	jvangriensven@itg.be	Aseffa, Abraham/J-3248-2016	Aseffa, Abraham/0000-0002-8028-1150	World Health Organization [001]		Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; [Anonymous], 2011, P INT CONS M CUT LEI; ASHFORD RW, 1973, T ROY SOC TROP MED H, V67, P568, DOI 10.1016/0035-9203(73)90088-6; Badaro R, 2006, J INFECT DIS, V194, P1151, DOI 10.1086/507708; Balasegaram M, 2012, EXPERT OPIN EMERG DR, V17, P493, DOI 10.1517/14728214.2012.748036; BARNETSON RS, 1978, T ROY SOC TROP MED H, V72, P160, DOI 10.1016/0035-9203(78)90052-4; BARNETSON RSC, 1978, T ROY SOC TROP MED H, V72, P516, DOI 10.1016/0035-9203(78)90173-6; BELEHU A, 1978, BRIT J DERMATOL, V99, P421, DOI 10.1111/j.1365-2133.1978.tb06181.x; BELEHU A, 1982, LANCET, V1, P1463; BERHE N, 1995, T ROY SOC TROP MED H, V89, P400, DOI 10.1016/0035-9203(95)90027-6; Bode C, 2011, EXPERT REV VACCINES, V10, P499, DOI [10.1586/erv.10.174, 10.1586/ERV.10.174]; Bryceson A, 1968, East Afr Med J, V45, P110; Bryceson A, 1969, East Afr Med J, V46, P170; BRYCESON A, 1969, T ROY SOC TROP MED H, V63, P152, DOI 10.1016/0035-9203(69)90111-4; BRYCESON AD, 1970, T ROY SOC TROP MED H, V64, P369, DOI 10.1016/0035-9203(70)90173-2; Caneda-Guzman IC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112410; CHULAY JD, 1983, T ROY SOC TROP MED H, V77, P717, DOI 10.1016/0035-9203(83)90213-4; Convit J, 2004, MEM I OSWALDO CRUZ, V99, P57, DOI 10.1590/S0074-02762004000100010; Correia D, 1996, Rev Soc Bras Med Trop, V29, P447; Dassoni F, 2013, ACTA DERM-VENEREOL, V93, P74, DOI 10.2340/00015555-1338; Dorlo TPC, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000225; Duthie MS, 2012, VACCINE, V30, P134, DOI 10.1016/j.vaccine.2011.11.005; Escobar P, 2002, ACTA TROP, V81, P151, DOI 10.1016/S0001-706X(01)00197-8; Fitzherbert M, 1965, ETHIOPIAN MED J, V3, P57; GEBREHIWOT A, 1992, ACTA TROP, V51, P237, DOI 10.1016/0001-706X(92)90042-V; Gonzalez U, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005067.pub3; Gonzalez U, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004834.pub2; Goto H, 2010, EXPERT REV ANTI-INFE, V8, P419, DOI [10.1586/eri.10.19, 10.1586/ERI.10.19]; Gupta S, 2011, ANTIMICROB AGENTS CH, V55, P3461, DOI 10.1128/AAC.00137-11; HENRIKSEN TH, 1983, LANCET, V1, P126; HEPBURN NC, 1994, T ROY SOC TROP MED H, V88, P700, DOI 10.1016/0035-9203(94)90237-2; Higgens JGS, 2011, COCHRANE HDB SYSTEMA; LEMMA A, 1969, ANN TROP MED PARASIT, V63, P455, DOI 10.1080/00034983.1969.11686649; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700; Llanos-Cuentas A, 2010, VACCINE, V28, P7427, DOI 10.1016/j.vaccine.2010.08.092; MENGISTU G, 1992, T ROY SOC TROP MED H, V86, P149, DOI 10.1016/0035-9203(92)90546-O; Mohebali M, 2007, ACTA TROP, V103, P33, DOI 10.1016/j.actatropical.2007.05.005; Mosimann V, 2013, INFECTION, V41, P1177, DOI 10.1007/s15010-013-0500-5; NAAFS B, 1985, T ROY SOC TROP MED H, V79, P141, DOI 10.1016/0035-9203(85)90267-6; Nascimento E, 2010, VACCINE, V28, P6581, DOI 10.1016/j.vaccine.2010.07.063; Negera E, 2008, T ROY SOC TROP MED H, V102, P883, DOI 10.1016/j.trstmh.2008.03.021; Negera E, 2012, T ROY SOC TROP MED H, V106, P496, DOI 10.1016/j.trstmh.2012.02.006; Olliaro P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002130; Olliaro P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001545; Padovese V, 2009, T ROY SOC TROP MED H, V103, P707, DOI 10.1016/j.trstmh.2009.02.023; Pratlong F, 2009, TROP MED INT HEALTH, V14, P1071, DOI 10.1111/j.1365-3156.2009.02336.x; Raman VS, 2010, J IMMUNOL, V185, P1701, DOI 10.4049/jimmunol.1000238; Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8; SAROJINI A, 1984, ETHIOPIAN MED J, V22, P7; Seid A, 2014, GEOSPATIAL HEALTH, V8, P377, DOI 10.4081/gh.2014.27; SOTO J, 1994, T ROY SOC TROP MED H, V88, P695, DOI 10.1016/0035-9203(94)90235-6; Strazzulla A, 2013, BIOMED RES INT, DOI 10.1155/2013/805108; Sundar S, 2011, LANCET, V377, P477, DOI 10.1016/S0140-6736(10)62050-8; TEKLEMARIAM S, 1994, T ROY SOC TROP MED H, V88, P334, DOI 10.1016/0035-9203(94)90106-6; Utaile M, 2013, EXP PARASITOL, V134, P68, DOI 10.1016/j.exppara.2013.01.022; Valencia BM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002196; VANDERMEULEN J, 1981, LANCET, V2, P197; Verthelyi D, 2002, J IMMUNOL, V168, P1659, DOI 10.4049/jimmunol.168.4.1659; Verthelyi D, 2001, J IMMUNOL, V166, P2372, DOI 10.4049/jimmunol.166.4.2372; VIALLET J, 1986, AM J TROP MED HYG, V35, P491, DOI 10.4269/ajtmh.1986.35.491; WEINRAUCH L, 1987, J AM ACAD DERMATOL, V16, P1268, DOI 10.1016/S0190-9622(87)80033-6; Wells G, 2011, NEWCASTLE OTTAWA SCA; ZAAR K, 1982, ANN TROP MED PARASIT, V76, P595, DOI 10.1080/00034983.1982.11687589; Zanger P, 2011, AM J TROP MED HYG, V84, P692, DOI 10.4269/ajtmh.2011.10-0712; Zerpa O, 2007, BRIT J DERMATOL, V156, P1328, DOI 10.1111/j.1365-2133.2007.07872.x	65	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAR	2016	10	3							e0004495	10.1371/journal.pntd.0004495				20	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DI1RF	WOS:000373272500028	26938448	DOAJ Gold, Green Published			2019-04-02	
J	Vlaminck, J; Supali, T; Geldhof, P; Hokke, CH; Fischer, PU; Weil, GJ				Vlaminck, Johnny; Supali, Taniawati; Geldhof, Peter; Hokke, Cornelis H.; Fischer, Peter U.; Weil, Gary J.			Community Rates of IgG4 Antibodies to Ascaris Haemoglobin Reflect Changes in Community Egg Loads Following Mass Drug Administration	PLOS NEGLECTED TROPICAL DISEASES			English	Article							TRANSMITTED HELMINTH INFECTIONS; GLYCOMIC ANALYSIS; SUUM HEMOGLOBIN; LUMBRICOIDES; PIGS; SERODIAGNOSIS; EXPRESSION; HUMANS; IMPACT; SEROPOSITIVITY	Background Conventional diagnostic methods for human ascariasis are based on the detection of Ascaris lumbricoides eggs in stool samples. However, studies of ascariasis in pigs have shown that the prevalence and the number of eggs detected in the stool do not correlate well with exposure of the herd to the parasite. On the other hand, an ELISA test measuring antibodies to Ascaris suum haemoglobin (AsHb) has been shown to be useful for estimating transmission intensity on pig farms. In this study, we further characterized the AsHb antigen and screened samples from a population-based study conducted in an area that is endemic for Ascaris lumbricoides in Indonesia to assess changes in AsHb antibody rates and levels in humans following mass drug administration (MDA). Methodology/Principal findings We developed and evaluated an ELISA to detect human IgG4 antibodies to AsHb. We tested 1066 plasma samples collected at different times from 599 subjects who lived in a village in rural Indonesia that was highly endemic for ascariasis. The community received 6 rounds of MDA for lymphatic filariasis with albendazole plus diethylcarbamazine between 2002 and 2007. While the AsHb antibody assay was not sensitive for detecting all individuals with Ascaris eggs in their stools, the percentage of seropositive individuals decreased rapidly following MDA. Reductions in antibody rates reflected decreased mean egg output per person both at the community level and in different age groups. Two years after the last round of MDA the community egg output and antibody prevalence rate were reduced by 81.6% and 78.9% respectively compared to baseline levels. Conclusion/Significance IgG4 antibody levels to AsHb appear to reflect recent exposure to Ascaris. The antibody prevalence rate may be a useful indicator for Ascaris transmission intensity in communities that can be used to assess the impact of control measures on the force of transmission.	[Vlaminck, Johnny; Fischer, Peter U.; Weil, Gary J.] Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA; [Supali, Taniawati] Univ Indonesia, Fac Med, Dept Parasitol, Jakarta, Indonesia; [Geldhof, Peter] Univ Ghent, Dept Virol Parasitol & Immunol, Parasitol Lab, Merelbeke, Belgium; [Hokke, Cornelis H.] Leiden Univ, Med Ctr, Ctr Infect Dis, Dept Parasitol, Leiden, Netherlands	Vlaminck, J (reprint author), Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA.	Vlaminck.johnny@gmail.com			Glaxo Smith Kline; Barnes Jewish Hospital Foundation [6794-33]	Sample collection in Indonesia was funded in part by Glaxo Smith Kline and laboratory research was supported by a grant of the Barnes Jewish Hospital Foundation (6794-33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of the funders.	Araujo Z, 2015, REV INST MED TROP SP, V57, P47, DOI 10.1590/S0036-46652015000100007; Bhattacharyya T, 2001, J CLIN MICROBIOL, V39, P2991, DOI 10.1128/JCM.39.8.2991-2994.2001; Bisoffi Z, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002640; Boes J, 1998, PARASITOLOGY, V117, P589, DOI 10.1017/S0031182098003382; Borloo J, 2013, J PROTEOME RES, V12, P3900, DOI 10.1021/pr400114y; Brady MA, 2006, TRENDS PARASITOL, V22, P285, DOI 10.1016/j.pt.2006.05.007; Brooker S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000779; Buonfrate D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003491; Chatterjee BP, 1996, TROP MED INT HEALTH, V1, P633; Chehayeb JF, 2014, PLOS NTD, V8, DOI [10.1371/journal.pntd.0002939, DOI 10.1371/J0URNAL.PNTD.0002939]; Fischer PU, 2011, AM J TROP MED HYG, V84, P1005, DOI 10.4269/ajtmh.2011.11-0027; HALE OM, 1985, J ANIM SCI, V60, P220; Hall A, 2000, PARASITOL TODAY, V16, P540, DOI 10.1016/S0169-4758(00)01779-8; HASWELLELKINS MR, 1992, PARASITOLOGY, V104, P153, DOI 10.1017/S0031182000060893; HASWELLELKINS MR, 1989, PARASITE IMMUNOL, V11, P615, DOI 10.1111/j.1365-3024.1989.tb00925.x; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; King EM, 2005, PARASITE IMMUNOL, V27, P89, DOI 10.1111/j.1365-3024.2005.00753.x; LAL RB, 1988, J INFECT DIS, V158, P1034, DOI 10.1093/infdis/158.5.1034; Lewis R, 2009, J HELMINTHOL, V83, P1, DOI 10.1017/S0022149X08912402; LYNCH NR, 1993, PARASITOL RES, V79, P547, DOI 10.1007/BF00932238; Nikolay B, 2014, INT J PARASITOL, V44, P765, DOI 10.1016/j.ijpara.2014.05.009; Oqueka Tim, 2005, Filaria J, V4, P5, DOI 10.1186/1475-2883-4-5; PALMER DR, 1995, PARASITOLOGY, V111, P385, DOI 10.1017/S0031182000081944; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Poltl G, 2007, FEBS J, V274, P714, DOI 10.1111/j.1742-4658.2006.05615.x; PRITCHARD DI, 1991, T ROY SOC TROP MED H, V85, P511, DOI 10.1016/0035-9203(91)90239-U; Pullan R.L, 2014, PARASITE VECTOR, V7, P37, DOI DOI 10.1186/1756-3305-7-37; Rascoe LN, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003694; Roepstorff A, 1997, PARASITOLOGY, V115, P443, DOI 10.1017/S0031182097001480; Rosa BA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002678; Santra A, 2001, T ROY SOC TROP MED H, V95, P289, DOI 10.1016/S0035-9203(01)90236-6; Smit CH, 2015, MOL CELL PROTEOMICS, V14, P1750, DOI 10.1074/mcp.M115.048280; Supali T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002586; THEIN H, 1984, T R SOC TROP MED HYG, V78, P497, DOI DOI 10.1016/0035-9203(84)90071-3; Vlaminck J, 2011, PARASITE IMMUNOL, V33, P250, DOI 10.1111/j.1365-3024.2010.01274.x; Vlaminck J, 2015, VET PARASITOL, V210, P151, DOI 10.1016/j.vetpar.2015.04.012; Vlaminck J, 2014, PARASITOLOGY, V141, P1904, DOI 10.1017/S0031182014000328; Vlaminck J, 2012, VET PARASITOL, V189, P267, DOI 10.1016/j.vetpar.2012.04.024; WHO, 2011, HELMINTH CONTROL IN SCHOOL-AGE CHILDREN: A GUIDE FOR MANAGERS OF CONTROL PROGRAMMES, SECOND EDITION, P1; World Health Organisation, 2015, WHOHTMNTDPCT20152; World Health Organization, 2012, WHOHTMNTDPCT20124	41	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAR	2016	10	3							e0004532	10.1371/journal.pntd.0004532				18	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DI1RF	WOS:000373272500055	26991326	DOAJ Gold, Green Published			2019-04-02	
J	Munos, M; Guiella, G; Roberton, T; Maiga, A; Tiendrebeogo, A; Tam, Y; Bryce, J; Baya, B				Munos, Melinda; Guiella, Georges; Roberton, Timothy; Maiga, Abdoulaye; Tiendrebeogo, Adama; Tam, Yvonne; Bryce, Jennifer; Baya, Banza			Independent Evaluation of the Rapid Scale-Up Program to Reduce Under-Five Mortality in Burkina Faso	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							COMMUNITY CASE-MANAGEMENT; IMPLEMENTATION; ILLNESS; POLICY	We conducted a prospective evaluation of the "Rapid Scale-Up" (RSU) program in Burkina Faso, focusing on the integrated community case management (iCCM) component of the program. We used a quasi-experimental design in which nine RSU districts were compared with seven districts without the program. The evaluation included documentation of program implementation, assessments of implementation and quality of care, baseline and endline coverage surveys, and estimation of mortality changes using the Lives Saved Tool. Although the program trained large numbers of community health workers, there were implementation shortcomings related to training, supervision, and drug stockouts. The quality of care provided to sick children was poor, and utilization of community health workers was low. Changes in intervention coverage were comparable in RSU and comparison areas. Estimated under-five mortality declined by 6.2% (from 110 to 103 deaths per 1,000 live births) in the RSU area and 4.2% (from 114 to 109 per 1,000 live births) in the comparison area. The RSU did not result in coverage increases or mortality reductions in Burkina Faso, but we cannot draw conclusions about the effectiveness of the iCCM strategy, given implementation shortcomings. The evaluation results highlight the need for greater attention to implementation of iCCM programs.	[Munos, Melinda; Roberton, Timothy; Tam, Yvonne; Bryce, Jennifer] Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, 615 N Wolfe St, Baltimore, MD 21205 USA; [Guiella, Georges; Maiga, Abdoulaye] Univ Ouagadougou, Inst Super Sci Populat, Ouagadougou, Burkina Faso; [Maiga, Abdoulaye] Catholic Univ Louvain, Louvain La Neuve, Belgium; [Tiendrebeogo, Adama; Baya, Banza] Inst Natl Stat & Demog, Ouagadougou, Burkina Faso	Munos, M (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, 615 N Wolfe St, Baltimore, MD 21205 USA.	mmunos1@jhu.edu; guiella@yahoo.com; timroberton@gmail.com; mailayebf@yahoo.fr; adamatiendre@gmail.com; yvonneyotam@jhu.edu; jbryce1@jhu.edu; bayabanza@yahoo.fr		Munos, Melinda/0000-0002-1349-8026; Maiga, Abdoulaye/0000-0002-0475-1106; Tam, Yvonne/0000-0003-4849-5084			Amouzou A, 2014, J GLOB HEALTH, V4, P177, DOI 10.7189/jogh.04.020411; Bennett S, 2014, TROP MED INT HEALTH, V19, P872, DOI 10.1111/tmi.12319; Bhutta ZA, 2014, LANCET, V383, P1333; BINDER DA, 1983, INT STAT REV, V51, P279, DOI 10.2307/1402588; Bryce J, 2011, INT HEALTH, V3, P139, DOI 10.1016/j.inhe.2011.04.003; Burkina Faso Ministry of Mines and Energy, 2014, 2012 STAT HDB MIN MI; Campbell H, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001421, 10.1371/journal.pmed.1001422]; de Sousa A, 2012, B WORLD HEALTH ORGAN, V90, P183, DOI 10.2471/BLT.11.093989; Department of Child and Adolescent Health and Development World Health Organization, 2003, HLTH FAC SURV TOOL E; Department of Foreign Affairs Trade and Development Canada, 2007, IN SAV MILL LIV; Direction generale de l'information et des statistiques sanitaires du Ministere de la Sante, 2014, ANN STAT 2013; Direction generale de l'information et des statistiques sanitaires du Ministere de la Sante, 2011, ANN STAT 2010; Direction generale de l'information et des statistiques sanitaires du Ministere de la Sante, 2009, ANN STAT 2008; Hayes RJ, 2010, CLUSTER RANDOMIZED T; Institut National de la Statistiqe et de la Demographie, 2008, REC GEN POP HAB 2006; Institut pour la Recherche en Sciences de la Sante, 2012, EV QUAL SOINS PROD E; Institut Superieur des Sciences de la Population Institute for International Programs Johns Hopkins University, 2014, EV IND PROJ ACC RED; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Miller NP, 2014, AM J TROP MED HYG, V91, P424, DOI 10.4269/ajtmh.13-0751; Ministere de Ia Sante du Burkina Faso, 2008, REQ BURK FAS AUPR PA; Ministere de la Sante du Burkina Faso, 2014, PROF AG SANT BAS COM; Nsungwa-Sabiiti J, 2004, J HLTH POPUL DEV CTR, DOI 10.12927/whp.2004.17643; Pendragon Software Corporation, 2011, PENDR FORMS; QSR International Pty Ltd, 2012, NVIVO QUAL DAT AN SO; Sauerborn R, 1996, SOC SCI MED, V43, P281, DOI 10.1016/0277-9536(95)00374-6; SPSS Inc, 2009, SPSS VERS 17; StataCorp, 2011, STAT STAT SOFTW VERS; StataCorp, 2013, STAT STAT SOFTW VERS; UNICEF, 2014, UNICEF STAT MON MULT; United Nations Development Programme, 2014, HUM DEV REP 2014 SUS; United Nations Inter-Agency Group on Mortality Estimation, 2015, CHILD MORT EST BURK; US Census Bureau, 2010, CENS SURV PROC SYST; Walker N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S1; World Health Organization, 2015, RAP ACC EXP 2015 PRO; [World Health Organization WHO UNICEF UNFPA], 2014, TRENDS MAT MORT 1990; World Health Organization UNICEF, 2009, WHO UNICEF JOINT STA; World Health Organization/United Nations Childrens Fund, 2012, WHO UNICEF JOINT STA	37	14	14	0	4	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	MAR	2016	94	3					584	595		10.4269/ajtmh.15-0585				12	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	DF5DS	WOS:000371372600020	26787147	Green Published, Other Gold			2019-04-02	
J	Becskei, C; Geurden, T; Liebenberg, J; Cuppens, O; Mahabir, SP; Six, RH				Becskei, Csilla; Geurden, Thomas; Liebenberg, Julian; Cuppens, Otto; Mahabir, Sean P.; Six, Robert H.			Comparative speed of kill of oral treatments with Simparica (TM)(sarolaner) and Bravecto (R)(fluralaner) against induced infestations of Rhipicephalus sanguineus on dogs	PARASITES & VECTORS			English	Article						Rhipicephalus sanguineus; Sarolaner; Simparica (TM); Fluralaner; Speed of kill; Tick; Dog; Oral; Isoxazoline; Bravecto (R)	TICK INFESTATION; PATHOGENS; SURVEILLANCE; EFFICACY	Background: Rhipicephalus sanguineus is the most widely distributed tick species infesting dogs worldwide, which may cause discomfort to the host and transmit diseases. Acaricides with a rapid and sustained speed of kill are thus important to prevent infestation and to reduce the risk of disease transmission. In this study, the speed of kill of a monthly administered Simparica (TM)(sarolaner) treatment against induced infestations with R. sanguineus on dogs was evaluated and compared with a single dose of Bravecto (R)(fluralaner) for 95 days after the initial treatment. Methods: Twenty four dogs were randomly allocated to treatment and were treated with either placebo or sarolaner (at 2 to 4 mg/kg) on Days 0, 30 and 60 or with fluralaner (at 25 to 56 mg/kg) once on Day 0. Tick counts were performed in situ 8 and 12 h and with removal of the ticks 24 h after treatment and subsequent re-infestations on Days 14, 28, 44, 56, 74, 90 and 95. Acaricidal efficacy was determined at each time point relative to the placebo group. Results: Both products significantly reduced live ticks within 8 h after treatment against an existing infestation with R. sanguineus, and killed all ticks on all dogs within 24 h. After re-infestation, sarolaner provided >= 98.5 % reduction within 24 h on all days except Days 74 and 95 (P < 0.0001), compared to fluralaner which provided >= 95.5 % reduction until Day 44. Geometric mean live tick counts for sarolaner were significantly lower (P <= 0.0415) at 24 h than those for fluralaner on all days, except on Days 0, 14 and 28 (P >= 0.0678). There were no treatment-related adverse reactions observed during the study. Conclusions: When dosed at monthly intervals for 3 consecutive months, Simparica (TM) has a faster and more consistent speed of kill against R. sanguineus than a single oral dose of Bravecto (R) for which efficacy decreased after Day 44.	[Becskei, Csilla; Geurden, Thomas; Cuppens, Otto] Zoetis, Vet Med Res & Dev, Mercuriusstr 20, B-1930 Zaventem, Belgium; [Liebenberg, Julian] ClinVet Int Pty Ltd, ZA-9338 Bloemfontein, South Africa; [Mahabir, Sean P.; Six, Robert H.] Zoetis, Vet Med Res & Dev, 333 Portage St, Kalamazoo, MI 49007 USA	Geurden, T (reprint author), Zoetis, Vet Med Res & Dev, Mercuriusstr 20, B-1930 Zaventem, Belgium.	thomas.geurden@zoetis.com			Zoetis, Florham Park, NJ	The study reported here was funded by Zoetis, Florham Park, NJ. CB, TG, OC, SPM, and RHS are current employees of Zoetis. JL was an independent investigator contracted for the study. There were no conflicting interests that could have influenced the conduct and reporting of this study.	Beck S, 2014, TICKS TICK-BORNE DIS, V5, P336, DOI 10.1016/j.ttbdis.2013.12.009; Becskei C, PARASIT VEC IN PRESS; Beugnet F, 2015, VET PARASITOL, V209, P142, DOI 10.1016/j.vetpar.2015.02.002; Beugnet F, 2011, GEOSPATIAL HEALTH, V5, P255, DOI 10.4081/gh.2011.178; Claerebout E, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-183; Featherstone C, 2012, VET REC, V171, P225, DOI 10.1136/vr.e5831; Geurden T, VET PARASIT IN PRESS; Hansford KM, 2015, VET REC, V176, DOI 10.1136/vr.h496; Hansford KM, 2014, VET REC, V175, DOI 10.1136/vr.g6226; Mancini F, 2014, ANN AGR ENV MED, V21, P723, DOI 10.5604/12321966.1129922; Marchiondo AA, 2013, VET PARASITOL, V194, P84, DOI 10.1016/j.vetpar.2013.02.003; Nicholson WL, 2010, TRENDS PARASITOL, V26, P205, DOI 10.1016/j.pt.2010.01.007; Six RH, VET PARASIT IN PRESS; Uspensky I, 2014, TICKS TICK-BORNE DIS, V5, P41, DOI 10.1016/j.ttbdis.2013.07.011; Xhaxhiu D, 2009, PARASITOL RES, V105, P1577, DOI 10.1007/s00436-009-1591-x	15	2	2	0	10	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	FEB 24	2016	9									10.1186/s13071-016-1376-x				6	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	DE5OZ	WOS:000370682200001	26911244	DOAJ Gold, Green Published			2019-04-02	
J	Becskei, C; Geurden, T; Erasmus, H; Cuppens, O; Mahabir, SP; Six, RH				Becskei, Csilla; Geurden, Thomas; Erasmus, Heidi; Cuppens, Otto; Mahabir, Sean P.; Six, Robert H.			Comparative speed of kill after treatment with Simparica (TM) (sarolaner) and Advantix (R) (imidacloprid plus permethrin) against induced infestations of Dermacentor reticulatus on dogs	PARASITES & VECTORS			English	Article						Dermacentor reticulatus; Sarolaner; Simparica (TM); Imidacloprid plus permethrin; Speed of kill; Tick; Dog; Oral; Isoxazoline; Advantix (R)	BORNE DISEASES; BABESIA-CANIS; TICK; VECTOR; EFFICACY; COMBINATION; PREVENTION; GERMANY	Background: Ticks are common ectoparasites that infest dogs globally. Acaricides with rapid and sustained speed of kill are critical to control infestations and to reduce the risk of disease transmission. This study evaluated the speed of kill for 5 weeks after a single dose of orally administered Simparica (TM) (sarolaner) against induced infestations with Dermacentor reticulatus on dogs, compared to Advantix (R) Spot-on solution for dogs (imidacloprid + permethrin). Methods: Twenty four dogs were randomly allocated to treatment with either a placebo tablet, a sarolaner tablet (at 2 to 4 mg/kg) or with Advantix (R) as per label instructions. Dogs were treated on Day 0 and tick counts were performed in situ at 8 and 12 hours and with removal of the ticks at 24 hours after treatment and subsequent re-infestations on Days 7, 14, 21, 28 and 35. Acaricidal efficacy was determined at each time point relative to live tick counts from the placebo-treated dogs. Results: Based on arithmetic (geometric) mean tick counts, the efficacy of sarolaner was >= 75.6 % (89.6 %) within 8 hours of treatment and tick counts were significantly lower than placebo and imidacloprid + permethrin-treated dogs (P < 0.0001), while imidacloprid + permethrin had no significant reduction (P >= 0.3990) at 8 or 12 hours after treatment. Sarolaner killed all ticks on the dogs within 24 hours after treatment, while imidacloprid + permethrin efficacy was only 48.1 %. After weekly re-infestations sarolaner significantly reduced the tick counts versus placebo within 8 hours on Days 7, 14 and 35 (P <= 0.0239), and at 12 hours and 24 hours (P <= 0.0079) until Day 35. Sarolaner efficacy was >= 95.8 % within 24 hours for 35 days. Significantly more live ticks (P <= 0.0451) were recovered from imidacloprid + permethrin-treated dogs than from sarolaner-treated dogs at 24 hours after infestation on all days. There were no sarolaner-related adverse reactions during the study. Conclusions: This study demonstrated that Simparica (TM) had a faster and more consistent speed of kill against D. reticulatus compared to Advantix (R). The rapid and consistent efficacy within 24 hours for 5 weeks after a single oral dose of Simparica (TM) provides effective and reliable control of D. reticulatus and reduces the risk of transmission of tick-borne diseases.	[Becskei, Csilla; Geurden, Thomas; Cuppens, Otto] Zoetis, Vet Med Res & Dev, Mercuriusstr 20, B-1930 Zaventem, Belgium; [Erasmus, Heidi] ClinVet Int Pty Ltd, ZA-9338 Bloemfontein, South Africa; [Mahabir, Sean P.; Six, Robert H.] Zoetis, Vet Med Res & Dev, 333 Portage St, Kalamazoo, MI 49007 USA	Geurden, T (reprint author), Zoetis, Vet Med Res & Dev, Mercuriusstr 20, B-1930 Zaventem, Belgium.	thomas.geurden@zoetis.com			Zoetis, Florham Park, NJ	The study reported here was funded by Zoetis, Florham Park, NJ. CB, TG, OC, SPM, and RHS are current employees of Zoetis. HE was an independent investigator contracted for the study. There were no conflicting interests that could have influenced the conduct and reporting of this study.	Beck S, 2014, TICKS TICK-BORNE DIS, V5, P336, DOI 10.1016/j.ttbdis.2013.12.009; Beugnet F, 2009, VET PARASITOL, V163, P298, DOI 10.1016/j.vetpar.2009.03.028; Claerebout E, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-183; Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003; Dautel H, 2006, INT J MED MICROBIOL, V296, P149, DOI 10.1016/j.ijmm.2006.01.013; Doyle V, 2005, VET THER, V6, P303; Foldvari G, 2005, VET PARASITOL, V129, P125, DOI 10.1016/j.vetpar.2004.11.032; Fourie JJ, 2011, PARASITE, V18, P319, DOI 10.1051/parasite/2011184319; Geurden T, VET PARASITOL UNPUB; Little S.E., 2007, 2 CAN VECT BORN DIS, P30; Marchiondo AA, 2013, VET PARASITOL, V194, P84, DOI 10.1016/j.vetpar.2013.02.003; MARTINOD S, 1985, J PARASITOL, V71, P269, DOI 10.2307/3282004; Matijatko V, 2012, TRENDS PARASITOL, V28, P99, DOI 10.1016/j.pt.2011.11.003; Otranto D, 2010, VET PARASITOL, V172, P323, DOI 10.1016/j.vetpar.2010.05.017; Siroky P, 2011, VET PARASITOL, V183, P130, DOI 10.1016/j.vetpar.2011.07.006; Six RH, VET PARASITOL UNPUB; Tielemans E, 2010, PARASITE, V17, P343, DOI 10.1051/parasite/2010174343; Zygner W, 2009, POL J VET SCI, V12, P549	18	2	2	0	8	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	FEB 24	2016	9								104	10.1186/s13071-016-1377-9				6	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	DE5OT	WOS:000370681600001	26911323	DOAJ Gold, Green Published			2019-04-02	
J	Laranjo-Gonzalez, M; Devleesschauwer, B; Gabriel, S; Dorny, P; Allepuz, A				Laranjo-Gonzalez, Minerva; Devleesschauwer, Brecht; Gabriel, Sarah; Dorny, Pierre; Allepuz, Alberto			Epidemiology, impact and control of bovine cysticercosis in Europe: a systematic review	PARASITES & VECTORS			English	Review						Bovine cysticercosis; Taenia saginata; Prevalence; Risk factors; Burden; Cattle; Europe; Systematic review	TAENIA-SAGINATA CYSTICERCOSIS; RISK-FACTORS; MEAT INSPECTION; SOCIOECONOMIC BURDEN; SPATIAL-ANALYSIS; PREVALENCE; CATTLE; INFECTION; DIAGNOSIS; ELISA	Background: Bovine cysticercosis in Europe has been known for centuries but the data showing the occurrence of this zoonosis are scarce. The aim of this paper is to review and present the current knowledge on bovine cysticercosis in Europe. Methods: We conducted a systematic review of studies published between 1990 and November 2014. Qualitative and quantitative data on prevalence, risk factors, burden and interventions were extracted and analysed. Results: Reports on prevalence were available for 23 European countries, mostly from western and central Europe; for a few of these only data before 1990 were available. Prevalence based on meat inspection was generally low (below 6.2 % in 95 % of the records) and varied between and within countries. Serology and detailed meat inspection provided a higher prevalence range (0.41-14 %). Only few studies analysing risk factors were identified. Reported factors related to access to pastures and risky waters, dairy production and uncontrolled human defecation in the proximity of the farm among others. Only one estimate of the economic impact of the disease could be identified. Recommended interventions were focused on increasing diagnostic tests sensitivity or the application of risk based surveillance strategies. Conclusions: There is a lack of complete and updated data on most countries, especially in eastern Europe. Further risk factor studies might be needed together with estimates on the burden of the disease in all European countries. Risk-based interventions are being encouraged but current data are limited to guide this approach.	[Laranjo-Gonzalez, Minerva; Allepuz, Alberto] IRTA, CReSA, Campus UAB, Barcelona 08193, Spain; [Devleesschauwer, Brecht] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA; [Devleesschauwer, Brecht] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Devleesschauwer, Brecht; Dorny, Pierre] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Gabriel, Sarah; Dorny, Pierre] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Allepuz, Alberto] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, E-08193 Barcelona, Spain	Laranjo-Gonzalez, M (reprint author), IRTA, CReSA, Campus UAB, Barcelona 08193, Spain.	minervalaranjo@gmail.com	Devleesschauwer, Brecht/G-9895-2018; Allepuz, Alberto/N-2398-2014	Devleesschauwer, Brecht/0000-0002-2867-6892; Allepuz, Alberto/0000-0003-3518-1991; Laranjo Gonzalez, Minerva/0000-0001-7417-807X	CYSTINET	This work is a collaboration within the framework of CYSTINET, the European network on taeniasis/cysticercosis, COST ACTION TD1302.	Abuseir S, 2010, BERL MUNCH TIERARZTL, V123, P392, DOI 10.2376/0005-9366-123-392; Afonso M., 2008, PREVALENCIA TAENIA S; Alimentarius C., 2014, GUIDELINES CONTROL T; Allepuz A, 2012, RES VET SCI, V92, P393, DOI 10.1016/j.rvsc.2011.03.027; Allepuz A, 2009, VET PARASITOL, V159, P43, DOI 10.1016/j.vetpar.2008.09.027; [Anonymous], 2003, OJ L, VL325, P31; [Anonymous], 2004, OFFICIAL J EUROPEA L, VL139, P206; [Anonymous], 2004, EFSA J, V176, P1, DOI [10.2903/j.efsa.2005.176, DOI 10.2903/J.EFSA.2005.176]; [Anonymous], 2007, EFSA J, V130, P2; Bangoura B, 2009, PRAKT TIERARZT, V90, P10; Boelaert F, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.3991; Boone I, 2007, PREV VET MED, V82, P1, DOI 10.1016/j.prevetmed.2007.05.002; BRANDT JRA, 1992, INT J PARASITOL, V22, P471, DOI 10.1016/0020-7519(92)90148-E; BRUCE AM, 1990, J INST WATER ENV MAN, V4, P1; Cabaret J, 2002, VET RES, V33, P575, DOI 10.1051/vetres:2002040; Calvo-Artavia FF, 2013, PREV VET MED, V110, P177, DOI 10.1016/j.prevetmed.2012.11.017; Calvo-Artavia FF, 2013, ZOONOSES PUBLIC HLTH, V60, P311, DOI 10.1111/j.1863-2378.2012.01537.x; Cassini R, 2014, GEOSPATIAL HEALTH, V8, P509, DOI 10.4081/gh.2014.40; Chiesa F, 2010, FOODBORNE PATHOG DIS, V7, P1171, DOI 10.1089/fpd.2009.0530; Devleesschauwer B, 2017, ACTA TROP, V165, P96, DOI 10.1016/j.actatropica.2015.08.006; Dorny P, 2007, VET PARASITOL, V149, P22, DOI 10.1016/j.vetpar.2007.07.004; Dorny P, 2000, VET PARASITOL, V88, P43, DOI 10.1016/S0304-4017(99)00196-X; Dupuy C, 2015, FOOD CONTROL, V47, P348, DOI 10.1016/j.foodcont.2014.07.025; Dupuy C, 2014, VET PARASITOL, V203, P65, DOI 10.1016/j.vetpar.2014.02.054; Dupuya C, 2014, PREV VET MED, V115, P288, DOI 10.1016/j.prevetmed.2014.03.024; EFSA, 2004, EFSA J, V142, P1, DOI DOI 10.2903/J.EFSA.2005.142; EFSA (European Food Safety Authority), 2010, EFSA J, V8, P1496, DOI [DOI 10.2903/J.EFSA.2010.1496, 10.2903/j.efsa.2010.1496]; Eichenberger RM, 2013, INT J PARASITOL, V43, P853, DOI 10.1016/j.ijpara.2013.05.011; Eichenberger RM, 2011, FOOD CONTROL, V22, P989, DOI 10.1016/j.foodcont.2010.11.033; European Food Safety Authority and European Centre for Disease Prevention and Control, 2014, EFSA J, V12, P3547; European Food Safety Authority [EFSA], 2011, EFSA J, V9, P2105, DOI DOI 10.2903/J.EFSA.2011.2090; Flutsch F, 2008, PARASITOLOGY, V135, P641, DOI 10.1017/S0031182008004228; Geerts S, 1996, VLAAMS DIERGEN TIJDS, V65, P280; Geerts S, 1990, Verh K Acad Geneeskd Belg, V52, P537; Geerts S, 1992, Verh K Acad Geneeskd Belg, V54, P329; Geerts S, 1990, ACAD GENEESKD BELG, V52, P563; Gemmell M, 1983, GUIDELINES SURVEILLA, P207; Gracey J. F., 1999, MEAT HYGIENE; Hill AA, 2014, FOOD CONTROL, V38, P96, DOI 10.1016/j.foodcont.2013.10.002; ILSOE B, 1990, ACTA VET SCAND, V31, P159; Kus Fatma Selcan, 2014, Turkiye Parazitoloji Dergisi, V38, P41, DOI 10.5152/tpd.2014.3244; KYVSGAARD NC, 1991, ACTA VET SCAND, V32, P243; KYVSGAARD NC, 1991, ACTA VET SCAND, V32, P233; Lightowlers MW, 2006, PARASITOLOGY, V133, pS27, DOI 10.1017/S003118200600179X; Lightowlers M.W., 1990, Revue Scientifique et Technique Office International des Epizooties, V9, P463; Lightowlers MW, 1996, INT J PARASITOL, V26, P819; MOBIUS G, 1993, DEUT TIERARZTL WOCH, V100, P110; Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097; Murrell KD, 2013, REV SCI TECH OIE, V32, P559; Murrell K D, 1991, Southeast Asian J Trop Med Public Health, V22 Suppl, P377; Murrell K.D., 2005, WHO FAO OIE GUIDELIN; Ogunremi O, 2004, J VET DIAGN INVEST, V16, P438, DOI 10.1177/104063870401600513; Ring C., 1992, ENV FOOD HYGIENE ASP, P295; ROBERTS T, 1994, PARASITOL TODAY, V10, P419, DOI 10.1016/0169-4758(94)90171-6; Scandrett WB, 2012, VET PARASITOL, V186, P301, DOI 10.1016/j.vetpar.2011.11.014; Silva Claudio V., 2010, Infectious Disorders - Drug Targets, V10, P313; Skjerve E, 1999, J FOOD PROTECT, V62, P1320, DOI 10.4315/0362-028X-62.11.1320; Torgerson PR, 2013, VET PARASITOL, V195, P223, DOI 10.1016/j.vetpar.2013.04.004; Torgerson PR, 2011, VET PARASITOL, V182, P79, DOI 10.1016/j.vetpar.2011.07.017; Uradzinski Jan, 1992, Medycyna Weterynaryjna, V48, P564; van der Logt PB, 2000, VET REC, V146, P610, DOI 10.1136/vr.146.21.610; YODER DR, 1994, J AM VET MED ASSOC, V205, P45; Zdolec N, 2012, HELMINTHOLOGIA, V49, P229, DOI 10.2478/s11687-012-0043-9	63	18	21	2	18	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	FEB 10	2016	9								81	10.1186/s13071-016-1362-3				12	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	DD1SJ	WOS:000369701800001	26860313	DOAJ Gold, Green Published			2019-04-02	
J	Uwineza, A; Hitayezu, J; Jamar, M; Caberg, JH; Murorunkwere, S; Janvier, N; Bours, V; Mutesa, L				Uwineza, Annette; Hitayezu, Janvier; Jamar, Mauricette; Caberg, Jean-Hubert; Murorunkwere, Seraphine; Janvier, Ndinkabandi; Bours, Vincent; Mutesa, Leon			Cytogenetic Studies of Rwandan Pediatric Patients Presenting with Global Developmental Delay, Intellectual Disability and/or Multiple Congenital Anomalies	JOURNAL OF TROPICAL PEDIATRICS			English	Article						global developmental delay; intellectual disability; multiple congenital anomalies; karyotype; chromosomal abnormality; Rwandan pediatric patients	SUSPECTED CHROMOSOMAL-ABNORMALITIES; MENTAL-RETARDATION; CHILD; POPULATION	Global developmental delay (GDD) is defined as a significant delay in two or more developmental domains: gross or fine motor, speech/language, cognitive, social/personal and activities of daily living. Many of these children will go on to be diagnosed with intellectual disability (ID), which is most commonly defined as having an IQ <75 in addition to impairment in adaptive functioning. Cytogenetic studies have been performed in 664 Rwandan pediatric patients presenting GDD/ID and/or multiple congenital abnormalities (MCA). Karyotype analysis was performed in all patients and revealed 260 chromosomal abnormalities. The most frequent chromosomal abnormality was Down syndrome and then Edward syndrome and Patau syndrome. Other identified chromosomal abnormalities included 47, XX,+del(9)(q11), 46, XY, del(13)(q34) and 46, XX, der(22) t(10; 22) (p10; p10) mat. In conclusion, our results highlight the high frequency of cytogenetically detectable abnormalities in this series, with implications for the burden on the healthcare. This study demonstrates the importance of cytogenetic analysis in patients with GDD/ID and MCA.	[Uwineza, Annette; Hitayezu, Janvier; Murorunkwere, Seraphine; Janvier, Ndinkabandi; Mutesa, Leon] Univ Rwanda, Ctr Med Genet, Coll Med & Hlth Sci, Huye, Rwanda; [Uwineza, Annette; Jamar, Mauricette; Caberg, Jean-Hubert; Bours, Vincent] Univ Liege, Ctr Human Genet, Ctr Hosp Univ Sart Tilman, Liege, Belgium	Mutesa, L (reprint author), Univ Rwanda, Ctr Med Genet, Coll Med & Hlth Sci, Huye, Rwanda.	L.MUTESA@ur.ac.rw	UWINEZA, Annette/I-3984-2016	UWINEZA, Annette/0000-0003-1749-0395	WBI (Wallonie Bruxelles International); Cooperation Universitaire au Developpement (CUD)	Our sincere thanks go to the WBI (Wallonie Bruxelles International) for their fellowship, the University of Rwanda and Center for Human Genetics at University of Liege. We are grateful for the support from the Cooperation Universitaire au Developpement (CUD). We also thank all lab technicians from the Center for Human Genetics at the University of Liege and the University of Rwanda. This study could not have been completed without the cooperation of patients and their parents; we are very thankful.	Aboussair N, 2012, GENET TEST MOL BIOMA, V16, P569, DOI 10.1089/gtmb.2011.0265; Balkan M, 2010, GENET MOL RES, V9, P1094, DOI 10.4238/vol9-2gmr827; Ballarati L, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.043059; Chen Z, 2001, AM J MED GENET, V102, P379, DOI 10.1002/ajmg.1470; Curry CJ, 1997, AM J MED GENET, V72, P468, DOI 10.1002/(SICI)1096-8628(19971112)72:4<468::AID-AJMG18>3.0.CO;2-P; Dayakar S, 2010, GENET TEST MOL BIOMA, V14, P197, DOI 10.1089/gtmb.2009.0098; Duarte A C, 2004, Genet Mol Res, V3, P303; Flore LA, 2012, SEMIN PEDIATR NEUROL, V19, P173, DOI 10.1016/j.spen.2012.09.004; Hitayezu J, 2013, RWANDA MED J, V70, P27; Kim SS, 1999, J KOREAN MED SCI, V14, P373, DOI 10.3346/jkms.1999.14.4.373; Rosa RFM, 2010, REV ASSOC MED BRAS, V56, P462, DOI 10.1590/S0104-42302010000400021; Moeschler JB, 2008, CURR OPIN NEUROL, V21, P117, DOI 10.1097/WCO.0b013e3282f82c2d; Mundhofir FEP, 2012, GENET TEST MOL BIOMA, V16, P412, DOI 10.1089/gtmb.2011.0157; Penchaszadeh Victor B, 2002, Community Genet, V5, P61, DOI 10.1159/000064632; Rauch A, 2006, AM J MED GENET A, V140A, P2063, DOI 10.1002/ajmg.a.31416; Shevell M, 2003, NEUROLOGY, V60, P367, DOI 10.1212/01.WNL.0000031431.81555.16; Thillainathan S, 2014, WORLD J PEDIAT; Uwineza A, 2012, RWANDA MED J, V69, P27; Uwineza A, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-79	19	1	1	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0142-6338	1465-3664		J TROP PEDIATRICS	J. Trop. Pediatr.	FEB	2016	62	1					38	45		10.1093/tropej/fmv065				8	Pediatrics; Tropical Medicine	Pediatrics; Tropical Medicine	DJ5FH	WOS:000374231700006	26507407	Green Published, Bronze			2019-04-02	
J	Bennett, JW; Yadava, A; Tosh, D; Sattabongkot, J; Komisar, J; Ware, LA; McCarthy, WF; Cowden, JJ; Regules, J; Spring, MD; Paolino, K; Hartzell, JD; Cummings, JF; Richie, TL; Lumsden, J; Kamau, E; Murphy, J; Lee, C; Parekh, F; Birkett, A; Cohen, J; Ballou, WR; Polhemus, ME; Vanloubbeeck, YF; Vekemans, J; Ockenhouse, CF				Bennett, Jason W.; Yadava, Anjali; Tosh, Donna; Sattabongkot, Jetsumon; Komisar, Jack; Ware, Lisa A.; McCarthy, William F.; Cowden, Jessica J.; Regules, Jason; Spring, Michele D.; Paolino, Kristopher; Hartzell, Joshua D.; Cummings, James F.; Richie, Thomas L.; Lumsden, Joanne; Kamau, Edwin; Murphy, Jittawadee; Lee, Cynthia; Parekh, Falgunee; Birkett, Ashley; Cohen, Joe; Ballou, W. Ripley; Polhemus, Mark E.; Vanloubbeeck, Yannick F.; Vekemans, Johan; Ockenhouse, Christian F.			Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01(B) in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy	PLOS NEGLECTED TROPICAL DISEASES			English	Article							CIRCUMSPOROZOITE PROTEIN; SPOROZOITES; RTS,S/AS02A; VOLUNTEERS; ANTIBODIES; PRIMAQUINE	Background A vaccine to prevent infection and disease caused by Plasmodium vivax is needed both to reduce the morbidity caused by this parasite and as a key component in efforts to eradicate malaria worldwide. Vivax malaria protein 1 (VMP001), a novel chimeric protein that incorporates the amino-and carboxy-terminal regions of the circumsporozoite protein (CSP) and a truncated repeat region that contains repeat sequences from both the VK210 (type 1) and the VK247 (type 2) parasites, was developed as a vaccine candidate for global use. Methods We conducted a first-in-human Phase 1 dose escalation vaccine study with controlled human malaria infection (CHMI) of VMP001 formulated in the GSK Adjuvant System AS01(B). A total of 30 volunteers divided into 3 groups (10 per group) were given 3 intramuscular injections of 15 mu g, 30 mu g, or 60 mu g respectively of VMP001, all formulated in 500 mu L of AS01(B) at each immunization. All vaccinated volunteers participated in a P. vivax CHMI 14 days following the third immunization. Six non-vaccinated subjects served as infectivity controls. Results The vaccine was shown to be well tolerated and immunogenic. All volunteers generated robust humoral and cellular immune responses to the vaccine antigen. Vaccination did not induce sterile protection; however, a small but significant delay in time to parasitemia was seen in 59% of vaccinated subjects compared to the control group. An association was identified between levels of anti-type 1 repeat antibodies and prepatent period. Significance This trial was the first to assess the efficacy of a P. vivax CSP vaccine candidate by CHMI. The association of type 1 repeat-specific antibody responses with delay in the prepatency period suggests that augmenting the immune responses to this domain may improve strain-specific vaccine efficacy. The availability of a P. vivax CHMI model will accelerate the process of P. vivax vaccine development, allowing better selection of candidate vaccines for advancement to field trials.	[Bennett, Jason W.; Yadava, Anjali; Tosh, Donna; Komisar, Jack; Ware, Lisa A.; Cowden, Jessica J.; Regules, Jason; Spring, Michele D.; Paolino, Kristopher; Cummings, James F.; Lumsden, Joanne; Kamau, Edwin; Murphy, Jittawadee; Polhemus, Mark E.; Ockenhouse, Christian F.] Walter Reed Army Inst Res, Malaria Vaccine Brach, Silver Spring, MD USA; [Sattabongkot, Jetsumon] Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand; [McCarthy, William F.] US Army Med Mat Dev Act, Frederick, MD USA; [Hartzell, Joshua D.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Richie, Thomas L.] Naval Med Res Ctr, Silver Spring, MD USA; [Lee, Cynthia; Parekh, Falgunee; Birkett, Ashley] PATH MVI, Washington, DC USA; [Cohen, Joe; Ballou, W. Ripley; Vanloubbeeck, Yannick F.; Vekemans, Johan] GSK Vaccines, Rixensart, Belgium; [Cohen, Joe] Cohen Biopharm Consulting, Brussels, Belgium	Yadava, A (reprint author), Walter Reed Army Inst Res, Malaria Vaccine Brach, Silver Spring, MD USA.	Anjali.Yadava.Civ@mail.mil			Military Infectious Diseases Research Program, Maryland; PATH-MVI	This work was supported by intramural funding from the Military Infectious Diseases Research Program, Maryland and PATH-MVI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstey NM, 2009, TRENDS PARASITOL, V25, P220, DOI 10.1016/j.pt.2009.02.003; Bejon P, 2005, J INFECT DIS, V191, P619, DOI 10.1086/427243; Bell BA, 2009, VACCINE, V27, P1448, DOI 10.1016/j.vaccine.2008.12.027; Bennett JW, 2013, NEW ENGL J MED, V369, P1381, DOI 10.1056/NEJMc1301936; Campo JJ, 2015, MOL CELL PROTEOMICS, V14, P519, DOI 10.1074/mcp.M114.044677; Cohen J, 2010, HUM VACCINES, V6, P90, DOI 10.4161/hv.6.1.9677; Douglas NM, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0217-z; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Herrera S, 2011, AM J TROP MED HYG, V84, P4, DOI 10.4269/ajtmh.2011.09-0498; Hill DR, 2006, AM J TROP MED HYG, V75, P402, DOI 10.4269/ajtmh.2006.75.402; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; NUSSENZWEIG V, 1989, ADV IMMUNOL, V45, P283, DOI 10.1016/S0065-2776(08)60695-1; Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI 10.1016/51473-3099(10)70262-0; Polhemus ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006465; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; ROSENBERG R, 1989, SCIENCE, V245, P973, DOI 10.1126/science.2672336; Siqueira AM, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0302-y; Spring MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005254; Vanloubbeeck Y, 2013, VACCINE, V31, P6216, DOI 10.1016/j.vaccine.2013.10.041; Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005; White MT, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0117-2; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297; Yadava A, 2007, INFECT IMMUN, V75, P1177, DOI 10.1128/IAI.01667-06; Yadava A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003268	24	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	FEB	2016	10	2							e0004423	10.1371/journal.pntd.0004423				16	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DH1TH	WOS:000372567300039	26919472	DOAJ Gold, Green Published			2019-04-02	
J	Decuypere, S; Meehan, CJ; Van Puyvelde, S; De Block, T; Maltha, J; Palpouguini, L; Tahita, M; Tinto, H; Jacobs, J; Deborggraeve, S				Decuypere, Saskia; Meehan, Conor J.; Van Puyvelde, Sandra; De Block, Tessa; Maltha, Jessica; Palpouguini, Lompo; Tahita, Marc; Tinto, Halidou; Jacobs, Jan; Deborggraeve, Stijn			Diagnosis of Bacterial Bloodstream Infections: A 16S Metagenomics Approach	PLOS NEGLECTED TROPICAL DISEASES			English	Article							PLASMODIUM-FALCIPARUM MALARIA; AFRICAN CHILDREN; SEPSIS; COINFECTION; SALMONELLA; DIVERSITY; MORTALITY; PLATFORM; DISEASE; HEME	Background Bacterial bloodstream infection (bBSI) is one of the leading causes of death in critically ill patients and accurate diagnosis is therefore crucial. We here report a 16S metagenomics approach for diagnosing and understanding bBSI. Methodology/Principal Findings The proof-of-concept was delivered in 75 children (median age 15 months) with severe febrile illness in Burkina Faso. Standard blood culture and malaria testing were conducted at the time of hospital admission. 16S metagenomics testing was done retrospectively and in duplicate on the blood of all patients. Total DNA was extracted from the blood and the V3-V4 regions of the bacterial 16S rRNA genes were amplified by PCR and deep sequenced on an Illumina MiSeq sequencer. Paired reads were curated, taxonomically labeled, and filtered. Blood culture diagnosed bBSI in 12 patients, but this number increased to 22 patients when combining blood culture and 16S metagenomics results. In addition to superior sensitivity compared to standard blood culture, 16S metagenomics revealed important novel insights into the nature of bBSI. Patients with acute malaria or recovering from malaria had a 7-fold higher risk of presenting polymicrobial bloodstream infections compared to patients with no recent malaria diagnosis (p-value = 0.046). Malaria is known to affect epithelial gut function and may thus facilitate bacterial translocation from the intestinal lumen to the blood. Importantly, patients with such polymicrobial blood infections showed a 9-fold higher risk factor for not surviving their febrile illness (p-value = 0.030). Conclusions/Significance Our data demonstrate that 16S metagenomics is a powerful approach for the diagnosis and understanding of bBSI. This proof-of-concept study also showed that appropriate control samples are crucial to detect background signals due to environmental contamination.	[Decuypere, Saskia] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia; [Meehan, Conor J.; Van Puyvelde, Sandra; De Block, Tessa; Deborggraeve, Stijn] Inst Trop Med Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Maltha, Jessica; Jacobs, Jan] Inst Trop Med Antwerp, Dept Clin Sci, Antwerp, Belgium; [Maltha, Jessica] Katholieke Univ Leuven, Ctr Mol & Vasc Biol, Leuven, Belgium; [Palpouguini, Lompo; Tahita, Marc; Tinto, Halidou] Clin Res Unit Nanoro, Nanoro, Burkina Faso; [Jacobs, Jan] Katholieke Univ Leuven, Dept Immunol & Microbiol, Leuven, Belgium	Deborggraeve, S (reprint author), Inst Trop Med Antwerp, Dept Biomed Sci, Antwerp, Belgium.	sdeborggraeve@itg.be		Deborggraeve, Stijn/0000-0003-1501-5355; Tinto, Halidou/0000-0002-0472-3586; Decuypere, Saskia/0000-0001-5036-4601	Flemish Ministry of Sciences (EWI); Flemish Ministry of Sciences (SOFI project IDIS)	This work was supported by the Flemish Ministry of Sciences (EWI, SOFI project IDIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chang SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062323; Church J, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-31; Cunnington AJ, 2012, NAT MED, V18, P120, DOI 10.1038/nm.2601; Diaz MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066183; Faria MMP, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0557-7; Frickmann H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135923; Gaieski DF, 2013, CRIT CARE MED, V41, P1167, DOI 10.1097/CCM.0b013e31827c09f8; Gomez-Perez GP, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-335; Gordon MA, 2010, CLIN INFECT DIS, V50, P953, DOI 10.1086/651080; Gyarmati P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135756; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Liesenfeld O, 2014, EUR J MICROBIOL IMMU, V4, P1, DOI 10.1556/EuJMI.4.2014.1.1; Maltha J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089103; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Pammi M, 2011, PEDIATRICS, V128, pE973, DOI 10.1542/peds.2011-1208; Pei AY, 2010, APPL ENVIRON MICROB, V76, P3886, DOI 10.1128/AEM.02953-09; Roux CM, 2010, INFECT IMMUN, V78, P1520, DOI 10.1128/IAI.00887-09; Schirmer M, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1341; Taramelli D, 2000, LAB INVEST, V80, P1781, DOI 10.1038/labinvest.3780189; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Weinstock GM, 2012, NATURE, V489, P250, DOI 10.1038/nature11553; Wilairatana P, 1997, CLIN INFECT DIS, V24, P430	27	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	FEB	2016	10	2							e0004470	10.1371/journal.pntd.0004470				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DH1TH	WOS:000372567300070	26927306	DOAJ Gold, Green Published			2019-04-02	
J	Devleesschauwer, B; Aryal, A; Sharma, BK; Ale, A; Declercq, A; Depraz, S; Gaire, TN; Gongal, G; Karki, S; Pandey, BD; Pun, SB; Duchateau, L; Dorny, P; Speybroeck, N				Devleesschauwer, Brecht; Aryal, Arjun; Sharma, Barun Kumar; Ale, Anita; Declercq, Anne; Depraz, Stephanie; Gaire, Tara Nath; Gongal, Gyanendra; Karki, Surendra; Pandey, Basu Dev; Pun, Sher Bahadur; Duchateau, Luc; Dorny, Pierre; Speybroeck, Niko			Epidemiology, Impact and Control of Rabies in Nepal: A Systematic Review	PLOS NEGLECTED TROPICAL DISEASES			English	Review							KATHMANDU VALLEY; TRAVELERS; POPULATIONS; PREVENTION; EXPOSURE; BURDEN; VIRUS; BITES	Background Rabies is a vaccine-preventable viral zoonosis belonging to the group of neglected tropical diseases. Exposure to a rabid animal may result in a fatal acute encephalitis if effective post-exposure prophylaxis is not provided. Rabies occurs worldwide, but its burden is disproportionately high in developing countries, including Nepal. We aimed to summarize current knowledge on the epidemiology, impact and control of rabies in Nepal. Methods We performed a systematic review of international and national scientific literature and searched grey literature through the World Health Organization Digital Library and the library of the National Zoonoses and Food Hygiene Research Centre, Nepal, and through searching Google and Google Scholar. Further data on animal and human rabies were obtained from the relevant Nepalese government agencies. Finally, we surveyed the archives of a Nepalese daily to obtain qualitative information on rabies in Nepal. Findings So far, only little original research has been conducted on the epidemiology and impact of rabies in Nepal. Per year, rabies is reported to kill about 100 livestock and 10-100 humans, while about 1,000 livestock and 35,000 humans are reported to receive rabies post-exposure prophylaxis. However, these estimates are very likely to be serious underestimations of the true rabies burden. Significant progress has been made in the production of cell culture-based anti-rabies vaccine and rabies immunoglobulin, but availability and supply remain a matter of concern, especially in remote areas. Different state and non-state actors have initiated rabies control activities over the years, but efforts typically remained focalized, of short duration and not harmonized. Communication and coordination between veterinary and human health authorities is limited at present, further complicating rabies control in Nepal. Important research gaps include the reporting biases for both human and animal rabies, the ecology of stray dog populations and the true contribution of the sylvatic cycle. Interpretation Better data are needed to unravel the true burden of animal and human rabies. More collaboration, both within the country and within the region, is needed to control rabies. To achieve these goals, high level political commitment is essential. We therefore propose to make rabies the model zoonosis for successful control in Nepal.	[Devleesschauwer, Brecht; Dorny, Pierre] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, B-9000 Ghent, Belgium; [Devleesschauwer, Brecht; Speybroeck, Niko] Catholic Univ Louvain, Inst Hlth & Soc IRSS, B-1200 Brussels, Belgium; [Devleesschauwer, Brecht] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Devleesschauwer, Brecht] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA; [Aryal, Arjun] Cent Vet Hosp, Minist Agr Dev, Kathmandu, Nepal; [Sharma, Barun Kumar; Gaire, Tara Nath] Minist Agr Dev, Dept Livestock Serv, Kathmandu, Nepal; [Sharma, Barun Kumar] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Ale, Anita] Natl Zoonoses & Food Hyg Res Ctr, Kathmandu, Nepal; [Declercq, Anne] Univ Antwerp, Fac Med & Hlth Sci, Vaccine & Infect Dis Inst Vaxinfectio, Lab Expt Hematol, Edegem, Belgium; [Depraz, Stephanie] CIRAD, Exot & Mergentes UMR CMAEE, Unite Mixte Rech Controle Malad Anim, Petit Bourg, Guadeloupe; [Gongal, Gyanendra] WHO Reg Off South East Asia, Dis Surveillance & Epidemiol, New Delhi, India; [Karki, Surendra] Univ Illinois, Coll Vet Med, Dept Pathobiol, Urbana, IL 61801 USA; [Pandey, Basu Dev] Minist Hlth & Populat, Dept Hlth Serv, Leprosy Control Div, Kathmandu, Nepal; [Pun, Sher Bahadur] Sukraraj Trop & Infect Dis Hosp, Clin Res Unit, Kathmandu, Nepal; [Duchateau, Luc] Univ Ghent, Fac Vet Med, Dept Comparat Physiol & Biometr, B-9000 Ghent, Belgium; [Dorny, Pierre] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium	Devleesschauwer, B (reprint author), Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, B-9000 Ghent, Belgium.; Devleesschauwer, B (reprint author), Catholic Univ Louvain, Inst Hlth & Soc IRSS, B-1200 Brussels, Belgium.; Devleesschauwer, B (reprint author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.; Devleesschauwer, B (reprint author), Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA.	brechtdv@gmail.com	Devleesschauwer, Brecht/G-9895-2018	Devleesschauwer, Brecht/0000-0002-2867-6892	Special Research Fund (BOF) of Ghent University	BD was supported by the Special Research Fund (BOF) of Ghent University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors received no specific funding for this work.	Acharya M., 2015, Bangladesh Journal of Veterinary Medicine, V13, P65, DOI 10.3329/bjvm.v13i1.23722; [Anonymous], 2014, B OIE, V2014, P80; [Anonymous], 2010, WKLY EPIDEMIOL REC, V85, P309; Arai Yohko T, 2005, Nihon Rinsho, V63, P2167; Bahmanyar M, 1984, ASSIGNMENT REPORT DE; Basgoz N, 1998, NEW ENGL J MED, V339, P105, DOI 10.1056/NEJM199807093390208; BOGEL K, 1990, B WORLD HEALTH ORGAN, V68, P611; Boggild AK, 2007, J TRAVEL MED, V14, P361, DOI 10.1111/j.1708-8305.2007.00145.x; Budde A, 1985, ASSIGNMENT REPORT CO; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P267; Centers for Disease Control (CDC), 1988, MMWR Morb Mortal Wkly Rep, V37, P351; Department of Health Services, 2014, 206970 GOV NEP MIN H; Department of Health Services, 2007, 206465 GOV NEP MIN H; Department of Health Services, 2011, 206667 GOV NEP MIN H; Department of Health Services, 2013, 206869 GOV NEP MIN H; Department of Health Services, 2006, 206364 GOV NEP MIN H; Department of Health Services, 2005, 206263 GOV NEP MIN H; Department of Health Services, 2004, 206162 GOV NEP MIN H; Department of Health Services, 2015, 207071 GOV NEP MIN H; Department of Health Services, 2012, 206768 GOV NEP MIN H; Department of Health Services, 2008, 206566 GOV NEP MIN H; Devleesschauwer B, 2013, J Nepal Health Res Counc, V11, P221; Devleesschauwer B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002634; Devleesschauwer B, 2013, VECTOR-BORNE ZOONOT, V13, P872, DOI 10.1089/vbz.2013.1313; Directorate of Animal Health, 2011, 20672068 DIR AN HLTH; Directorate of Animal Health, 2013, 20692070 DIR AN HLTH; Directorate of Animal Health, 2010, 20662067 DIR AN HLTH; Directorate of Animal Health, 2012, 206869 DIR AN HLTH; Directorate of Animal Health, 2009, 20652066 DIR AN HLTH; Dodet B, 2007, VACCINE, V25, P4123, DOI 10.1016/j.vaccine.2007.03.002; Fox CB, 2013, HUM VACC IMMUNOTHER, V9, P2007, DOI 10.4161/hv.25340; Gautret P, 2015, EMERG INFECT DIS, V21, P569, DOI 10.3201/eid2104.141479; Gongal G, 2005, P MED HLTH TROP 4 EU, P45; Gongal G., 2006, APCRI J, V8; Gongal G. N., 1993, JNMA, Journal of the Nepal Medical Association, V31, P69; Gongal GN, 2001, RABIES CONTROL IN ASIA, P231; Gongal GN, 2004, APCRI J, V6; Gongal Gyanendra, 2011, Adv Prev Med, V2011, P383870, DOI 10.4061/2011/383870; Hasler B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003270; Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003709; Ide SVS, 2005, JICA NEPAL OFFICE NE, V37, P3; Inoue S., 2014, Journal of Veterinary Epidemiology, V18, P11; Joshi D D, 1991, Rev Sci Tech, V10, P1101; JOSHI DD, 1988, REV INFECT DIS, V10, pS600; Joshi DD, 2002, P RAB SLAUGHT WORKSH; Joshi DD, 2001, P 1 NAT SEM RAB 17 2; Joshi DD, 2009, P WORKSH SNAK ENV RA, P56; Joshi DD, 2007, P 1 INT C RAB AS RIA, P22; Joshi DD, 2000, P 9 S INT SOC VET EP, P500; Kakati K, 2012, STREET DOG POPULATIO; Kakati K, 2010, STREET DOG POPULATIO; Kakkar M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001748; Kappeler A, 1991, DOG POPULATION STUDI; Karki S, 2010, P 9 C NEP VET ASS KA, P105; Kato M, 2003, ACTA MED OKAYAMA, V57, P261; Kaufman G, 2009, P TUFTS U RES DAYS 2, P48; Kaufman GE, 2010, P 3 ANN MER WORLD RA; Lembo Tiziana, 2011, Vet Med Int, V2011, P923149, DOI 10.4061/2011/923149; Lembo T, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001388; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Muzzini E., 2013, URBAN GROWTH SPATIAL; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; NZFHRC, 2008, ZOONOSES FOOD HYGIEN, V14, P4; Pandey P, 2002, J TRAVEL MED, V9, P127; Pant G, 2011, J I MED, V33, P5; Pant GR, 2011, ARCH VIROL, V156, P681, DOI 10.1007/s00705-010-0868-9; Pant GR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002560; Pant GR, 2009, P WORKSH SNAK ENV RA, P52; Pant GR, 2013, P INC M OIE JTF PROJ; Ranney M, 2006, J TRAVEL MED, V13, P329, DOI 10.1111/j.1708-8305.2006.00067.x; Sharma M, 2005, J NEPAL HLTH RES COU, V3, P11; SHLIM DR, 1991, J WILDERNESS MED, V2, P15, DOI 10.1580/0953-9859-2.1.15; Shultz S, 2004, P ROY SOC B-BIOL SCI, V271, pS458, DOI 10.1098/rsbl.2004.0223; Singh S, 2011, P RIA SAARC INT MEET, P71; Stevens V, 2011, ECOHEALTH, V7, pS150; Tenzin, 2012, ZOONOSES PUBLIC HLTH, V59, P451, DOI 10.1111/j.1863-2378.2012.01489.x; Thakuri K. C., 1992, Veterinary Review (Kathmandu), V7, P41; Veeraraghavan N, 1972, ASSIGNMENT REPORT PR; Wandeler A.I., 1993, Revue Scientifique et Technique Office International des Epizooties, V12, P51; Wandeler AI, 1987, ASSIGNMENT REPORT IN; WHO, 2013, SUSTAINING THE DRIVE TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: SECOND WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1; Wilde H, 2013, CURR TOP MICROBIOL, V365, P185, DOI 10.1007/82_2012_228; World Health Organization, 2013, World Health Organ Tech Rep Ser, P1; World Health Organization, 2014, WHOHISHSIGHE20147; World Health Organization, 2012, STRAT FRAM EL HUM RA; World Health Organization, 2013, WHOHISHSIGHE20134; Yamamoto S, 2008, J TRAVEL MED, V15, P372, DOI 10.1111/j.1708-8305.2008.00241.x	88	6	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	FEB	2016	10	2							e0004461	10.1371/journal.pntd.0004461				18	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DH1TH	WOS:000372567300066	26871689	DOAJ Gold, Green Published			2019-04-02	
J	Van Hong, N; Delgado-Ratto, C; Thanh, PV; Van den Eede, P; Guetens, P; Binh, NTH; Phuc, BQ; Duong, TT; Van Geertruyden, JP; D'Alessandro, U; Erhart, A; Rosanas-Urgell, A				Nguyen Van Hong; Delgado-Ratto, Christopher; Pham Vinh Thanh; Van den Eede, Peter; Guetens, Pieter; Nguyen Thi Huong Binh; Bui Quang Phuc; Tran Thanh Duong; Van Geertruyden, Jean Pierre; D'Alessandro, Umberto; Erhart, Annette; Rosanas-Urgell, Anna			Population Genetics of Plasmodium vivax in Four Rural Communities in Central Vietnam	PLOS NEGLECTED TROPICAL DISEASES			English	Article							HUMAN MALARIA PARASITE; MICROSATELLITE DIVERSITY; FALCIPARUM POPULATIONS; TRANSMISSION DYNAMICS; INFECTION; AMAZONIA; ELIMINATION; PREVALENCE; COMPLEXITY; CLUSTERS	Background The burden of malaria in Vietnam has drastically reduced, prompting the National Malaria Control Program to officially engage in elimination efforts. Plasmodium vivax is becoming increasingly prevalent, remaining a major problem in the country's central and southern provinces. A better understanding of P. vivax genetic diversity and structure of local parasite populations will provide baseline data for the evaluation and improvement of current efforts for control and elimination. The aim of this study was to examine the population genetics and structure of P. vivax isolates from four communities in Tra Leng commune, Nam Tra My district in Quang Nam, Central Vietnam. Methodology/Principal Findings P. vivax mono infections collected from 234 individuals between April 2009 and December 2010 were successfully analyzed using a panel of 14 microsatellite markers. Isolates displayed moderate genetic diversity (He = 0.68), with no significant differences between study communities. Polyclonal infections were frequent (71.4%) with a mean multiplicity of infection of 1.91 isolates/person. Low but significant genetic differentiation (F-ST value from -0.05 to 0.18) was observed between the community across the river and the other communities. Strong linkage disequilibrium (I-A(S) = 0.113, p < 0.001) was detected across all communities, suggesting gene flow within and among them. Using multiple approaches, 101 haplotypes were grouped into two genetic clusters, while 60.4% of haplotypes were admixed. Conclusions/Significance In this area of Central Vietnam, where malaria transmission has decreased significantly over the past decade, there was moderate genetic diversity and high occurrence of polyclonal infections. Local human populations have frequent social and economic interactions that facilitate gene flow and inbreeding among parasite populations, while decreasing population structure. Findings provide important information on parasites populations circulating in the study area and are relevant to current malaria elimination efforts.	[Nguyen Van Hong; Pham Vinh Thanh; Nguyen Thi Huong Binh; Bui Quang Phuc; Tran Thanh Duong] NIMPE, Hanoi, Vietnam; [Nguyen Van Hong; Van den Eede, Peter; Guetens, Pieter; D'Alessandro, Umberto; Erhart, Annette; Rosanas-Urgell, Anna] ITM, Antwerp, Belgium; [Nguyen Van Hong; Delgado-Ratto, Christopher] Univ Antwerp, Fac Med, Int Hlth Unit, Antwerp, Belgium; [D'Alessandro, Umberto] MRC Unit, Fajara, Gambia	Rosanas-Urgell, A (reprint author), ITM, Antwerp, Belgium.	arosanas@itg.be	Rosanas-Urgell, Anna/D-3193-2015; Van geertruyden, Jean-Pierre/K-6425-2014	Rosanas-Urgell, Anna/0000-0002-0432-5203; Van geertruyden, Jean-Pierre/0000-0001-5006-6364	FWO "Krediet aan Navorsers" [1.5.197.13N]; UBS Optimus Foundation [Opt1648]; Belgian Directorate-General for Development Cooperation (DGDC) within DGD-ITM Framework Agreement [3.2, 3.3]	This work was supported by FWO "Krediet aan Navorsers" (www.fwo.be, grant 1.5.197.13N), UBS Optimus Foundation (www.ubs.com/optimus, grant number Opt1648) and the Belgian Directorate-General for Development Cooperation (DGDC) within DGD-ITM Framework Agreement 3.2 and 3.3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; Arnott A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-14; Barry AE, 2013, AM J TROP MED HYG, V88, P718, DOI 10.4269/ajtmh.12-0056; Batista CL, 2015, PARASITOLOGY, V142, P374, DOI 10.1017/S0031182014001176; Chenet SM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-412; Christopher D, 2014, MALARIA J, V13, P8; Duong TT, 2015, MALARIA EPIDEMIOLOGI, V11, P21; Earl Dent A, 2014, CONVERSATION GENET R, V4, P359; Erhart A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-58; Erhart E, 2004, AM J TROP MED HYG, V70, P110; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fansisco AP, 2012, BMC BIOINFORMATICS, P13; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Ferreira MU, 2007, J INFECT DIS, V195, P1218, DOI 10.1086/512685; Gluikart G, 1998, J HERED, V89, P238; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gunawardena S, 2014, PARASITOLOGY, V141, P880, DOI 10.1017/S0031182013002278; Gunawardena S, 2010, AM J TROP MED HYG, V82, P235, DOI 10.4269/ajtmh.2010.09-0588; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Nguyen HV, 2012, AM J TROP MED HYG, V87, P989, DOI 10.4269/ajtmh.2012.12-0047; Imwong M, 2007, INT J PARASITOL, V37, P1013, DOI 10.1016/j.ijpara.2007.02.010; Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241; Iwagami M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001592; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Karunaweera ND, 2007, MOL ECOL NOTES, V7, P172, DOI 10.1111/j.1471-8286.2006.01534.x; Karunaweera ND, 2008, GENE, V410, P105, DOI 10.1016/j.gene.2007.11.022; Koepfli C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066041; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Meirmans P, RECODE DATA V 0 1; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Mzilahowa T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000613; National Institute of Malarialogy Parasitology and Entomology, 2015, ANN REP NAT MAL CONT; National Institute of Malarialogy Parasitology and Entomology, 2011, NAT STRAT MAL CONTR; Noah A., 2004, MOL ECOLOGY NOTE, V4, P137; Obaldia N, 2015, J INFECT DIS, V211, P1087, DOI 10.1093/infdis/jiu575; Orjuela-Sanchez P, 2013, EXP PARASITOL, V134, P318, DOI 10.1016/j.exppara.2013.03.029; Orjuela-Sanchez P, 2009, AM J TROP MED HYG, V81, P961, DOI 10.4269/ajtmh.2009.09-0337; Peakall R, 2012, BIOINFORMATICS, V10, P1093; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Pham VT, 2015, MALARIA J, V14, P86, DOI [10.1186/s12936-015-0601-y, DOI 10.1186/S12936-015-0601-Y]; Phuc BQ, 2011, NATL REPORT MALARIOL; Quang Nam provincial Malaria Station, 2009, INTERNAL REPORT; Rubio J M, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS199, DOI 10.1016/S0035-9203(02)90077-5; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Sutton PL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-447; Thanh PV, 2015, ANTIMICROB AGENTS CH, P00791; Trung HD, 2004, TROP MED INT HEALTH, V9, P230, DOI 10.1046/j.1365-3156.2003.01179.x; Van den Eede P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016257; Van den Eede P, 2010, AM J TROP MED HYG, V82, P223, DOI 10.4269/ajtmh.2010.09-0458; Van NV, 2015, SOME EPIDEMIOLOGICAL, P22; Whilte NJ, 2011, MALARIA J, V10, P297, DOI [10.1186/1475-2875-10-297, DOI 10.1186/1475-2875-10-297]; WHO, 2010, GUID TREATM MAL; World Health Organization, 2012, MAL POL COMM M 11 13	55	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	FEB	2016	10	2							e0004434	10.1371/journal.pntd.0004434				16	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DH1TH	WOS:000372567300047		DOAJ Gold, Green Published			2019-04-02	
J	Odongo, S; Sterckx, YGJ; Stijlemans, B; Pillay, D; Baltz, T; Muyldermans, S; Magez, S				Odongo, Steven; Sterckx, Yann G. J.; Stijlemans, Benoit; Pillay, Davita; Baltz, Theo; Muyldermans, Serge; Magez, Stefan			An Anti-proteome Nanobody Library Approach Yields a Specific Immunoassay for Trypanosoma congolense Diagnosis Targeting Glycosomal Aldolase	PLOS NEGLECTED TROPICAL DISEASES			English	Article							FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE; AFRICAN TRYPANOSOMIASIS; SENSITIVE DETECTION; ANTIBODIES; VIVAX; PCR; AMPLIFICATION; INFECTIONS; DISEASES; CATTLE	Background Infectious diseases pose a severe worldwide threat to human and livestock health. While early diagnosis could enable prompt preventive interventions, the majority of diseases are found in rural settings where basic laboratory facilities are scarce. Under such field conditions, point-of-care immunoassays provide an appropriate solution for rapid and reliable diagnosis. The limiting steps in the development of the assay are the identification of a suitable target antigen and the selection of appropriate high affinity capture and detection antibodies. To meet these challenges, we describe the development of a Nanobody (Nb)-based antigen detection assay generated from a Nb library directed against the soluble proteome of an infectious agent. In this study, Trypanosoma congolense was chosen as a model system. Methodology/Principal Findings An alpaca was vaccinated with whole-parasite soluble proteome to generate a Nb library from which the most potent T. congolense specific Nb sandwich immunoassay (Nb474H-Nb474B) was selected. First, the Nb474-homologous sandwich ELISA (Nb474-ELISA) was shown to detect experimental infections with high Positive Predictive Value (98%), Sensitivity (87%) and Specificity (94%). Second, it was demonstrated under experimental conditions that the assay serves as test-of-cure after Berenil treatment. Finally, this assay allowed target antigen identification. The latter was independently purified through immuno-capturing from (i) T. congolense soluble proteome, (ii) T. congolense secretome preparation and (iii) sera of T. congolense infected mice. Subsequent mass spectrometry analysis identified the target as T. congolense glycosomal aldolase. Conclusions/Significance The results show that glycosomal aldolase is a candidate biomarker for active T. congolense infections. In addition, and by proof-of-principle, the data demonstrate that the Nb strategy devised here offers a unique approach to both diagnostic development and target discovery that could be widely applied to other infectious diseases.	[Odongo, Steven; Sterckx, Yann G. J.; Stijlemans, Benoit; Muyldermans, Serge; Magez, Stefan] Vrije Univ Brussel, Lab Cellular & Mol Immunol CMIM, Brussels, Belgium; [Odongo, Steven; Sterckx, Yann G. J.; Magez, Stefan] VIB, Struct Biol Res Ctr, Brussels, Belgium; [Odongo, Steven] Makerere Univ, Coll Vet Med Anim Resources & Biosecur COVAB, Dept Biotechn & Diagnost Sci, Kampala, Uganda; [Stijlemans, Benoit] VIB, Inflammat Res Ctr, Lab Myeloid Cell Immunol, Ghent, Belgium; [Pillay, Davita; Baltz, Theo] Univ Bordeaux, CNRS, Microbiol Fondamentale & Pathogenicite, Bordeaux, France	Odongo, S (reprint author), Vrije Univ Brussel, Lab Cellular & Mol Immunol CMIM, Brussels, Belgium.; Odongo, S (reprint author), VIB, Struct Biol Res Ctr, Brussels, Belgium.; Odongo, S (reprint author), Makerere Univ, Coll Vet Med Anim Resources & Biosecur COVAB, Dept Biotechn & Diagnost Sci, Kampala, Uganda.	sodongo@vub.ac.be	Magez, Stefan/D-9497-2014; Sterckx, Yann/F-2269-2017	Magez, Stefan/0000-0003-3760-7968; Sterckx, Yann/0000-0002-7420-0983; Pillay, Dorsamy/0000-0003-3640-2573; Stijlemans, Benoit/0000-0003-0082-9751	European Union/FP7 HEALTH NANOTRYP project [2007-2.3.4-1]	This work was supported with funds from the European Union/FP7 HEALTH 2007-2.3.4-1 NANOTRYP project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alleman AR, 1996, J CLIN MICROBIOL, V34, P270; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arts IS, 2013, MBIO, V4, DOI 10.1128/mBio.00912-13; Blazkova M, 2011, BIOSENS BIOELECTRON, V26, P2828, DOI 10.1016/j.bios.2010.10.001; Boucher LE, 2014, ACTA CRYSTALLOGR F, V70, P1186, DOI 10.1107/S2053230X14017087; Chudzik DM, 2000, J MOL BIOL, V300, P697, DOI 10.1006/jmbi.2000.3910; Clerc O, 2010, CLIN MICROBIOL INFEC, V16, P1054, DOI 10.1111/j.1469-0691.2010.03281.x; Coustou V, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000618; Cox A, 2005, EXP PARASITOL, V111, P24, DOI 10.1016/j.exppara.2005.03.014; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; de Walque S, 1999, MOL BIOCHEM PARASIT, V103, P279, DOI 10.1016/S0166-6851(99)00140-1; Deckers N, 2009, INT J PARASITOL, V39, P625, DOI 10.1016/j.ijpara.2008.10.012; Desquesnes M, 2001, INT J PARASITOL, V31, P610, DOI 10.1016/S0020-7519(01)00161-8; Dzakah EE, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-199; Eisler MC, 1998, VET PARASITOL, V79, P187, DOI 10.1016/S0304-4017(98)00173-3; ESPINO AM, 1992, T ROY SOC TROP MED H, V86, P649, DOI 10.1016/0035-9203(92)90174-B; Ewert S, 2003, J MOL BIOL, V325, P531, DOI 10.1016/S0022-2836(02)01237-8; Feasey N, 2010, BRIT MED BULL, V93, P179, DOI 10.1093/bmb/ldp046; Fredricks DN, 1999, CLIN INFECT DIS, V29, P475; Galland N, 2010, MOL BIOCHEM PARASIT, V171, P45, DOI 10.1016/j.molbiopara.2010.01.002; Geysen D, 2003, VET PARASITOL, V110, P171, DOI 10.1016/S0304-4017(02)00313-8; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Grebaut P, 2009, INT J PARASITOL, V39, P1137, DOI 10.1016/j.ijpara.2009.02.018; GUOBADIA EE, 1995, VET PARASITOL, V58, P247, DOI 10.1016/0304-4017(94)00721-N; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hutchinson OC, 2004, TRENDS PARASITOL, V20, P519, DOI 10.1016/j.pt.2004.08.007; Kim H, 1998, BIOCHEMISTRY-US, V37, P4388, DOI 10.1021/bi972233h; LAMBERT PH, 1981, J CLIN INVEST, V67, P77, DOI 10.1172/JCI110035; LANHAM SM, 1970, EXP PARASITOL, V28, P521, DOI 10.1016/0014-4894(70)90120-7; Lejon V, 2003, VET PARASITOL, V116, P87, DOI 10.1016/S0304-4017(03)00257-7; Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841; MASIGA DK, 1992, INT J PARASITOL, V22, P909, DOI 10.1016/0020-7519(92)90047-O; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; MURRAY M, 1977, T ROY SOC TROP MED H, V71, P325, DOI 10.1016/0035-9203(77)90110-9; Muyldermans S, 2001, J Biotechnol, V74, P277; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; Nantulya V.M., 1990, Revue Scientifique et Technique Office International des Epizooties, V9, P357; NANTULYA VM, 1989, TROP MED PARASITOL, V40, P267; Ngaira JM, 2005, EXP PARASITOL, V110, P30, DOI 10.1016/j.exppara.2005.01.001; Ngaira JM, 2004, VET PARASITOL, V120, P23, DOI 10.1016/j.vetpar.2003.12.007; Niemz A, 2011, TRENDS BIOTECHNOL, V29, P240, DOI 10.1016/j.tibtech.2011.01.007; Njiru ZK, 2005, PARASITOL RES, V95, P186, DOI 10.1007/s00436-004-1267-5; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Obishakin E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115893; OPPERDOES FR, 1977, FEBS LETT, V80, P360, DOI 10.1016/0014-5793(77)80476-6; PETYOVKA N, 1995, J IMMUNOL METHODS, V186, P161, DOI 10.1016/0022-1759(95)00183-B; Rebeski DE, 1999, PARASITOL RES, V85, P550, DOI 10.1007/s004360050594; Rebeski DE, 2000, VET PARASITOL, V89, P187, DOI 10.1016/S0304-4017(00)00194-1; Rebeski DE, 1999, MEM I OSWALDO CRUZ, V94, P249; Saerens D, 2008, J IMMUNOL METHODS, V329, P138, DOI 10.1016/j.jim.2007.10.005; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Skottrup PD, 2011, ANAL BIOCHEM, V415, P158, DOI 10.1016/j.ab.2011.04.015; Sousa LP, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-49; Wang PY, 2014, TOXICON, V92, P186, DOI 10.1016/j.toxicon.2014.10.024; WEIBLEN BJ, 1990, LANCET, V335, P988, DOI 10.1016/0140-6736(90)91061-E; Zheng ZF, 2004, J BIOL CHEM, V279, P42106, DOI 10.1074/jbc.M403780200; Zhu M, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0352-5	57	8	8	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	FEB	2016	10	2							e0004420	10.1371/journal.pntd.0004420				24	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DH1TH	WOS:000372567300036	26835967	DOAJ Gold, Green Published			2019-04-02	
J	Boukhalfa, C; Abouchadi, S; Cunden, N; Witter, S				Boukhalfa, C.; Abouchadi, S.; Cunden, N.; Witter, S.			The free delivery and caesarean policy in Morocco: how much do households still pay?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						fee exemptions; deliveries; caesarean section; household expenditures; maternal mortality; Morocco	CARE; COUNTRIES	BackgroundThe Free Deliveries and Caesarean Policy (FDCP) entitles all women in Morocco to deliver free of charge within public hospitals. This study assesses the policy's effectiveness by analysing household expenditures related to childbirth, by delivery type and quintile. MethodsStructured exit survey of 973 women in six provinces at five provincial hospitals, two regional hospitals, two university hospitals and three primary health centres with maternity units. ResultsHouseholds reported spending a median of US$ 59 in total for costs inside and outside of hospitals. Women requiring caesareans payed more than women with uncomplicated deliveries (P < 0.0001). The median cost was US$45 for a uncomplicated delivery, US$50 for a complicated delivery and US$65 for a caesarean section. The prescription given upon exiting the hospital comprised 62% of the total costs. Eighty-eight per cent of women from the poorest quintiles faced catastrophic expenditures. The women's perception of their hospital stay and the FDCP policy was overwhelmingly positive, but differences were noted at the various sites. ConclusionThe policy has been largely but not fully effective in removing financial barriers for delivery care in Morocco. More progress should also be made on increasing awareness of the policy and on easing the financial burden, which is still borne by households with lower incomes.	[Boukhalfa, C.; Abouchadi, S.] Ecole Natl Sante Publ, Rue Lamfadel Cherkaoui,BP 6329, Rabat, Morocco; [Abouchadi, S.] Univ Libre Bruxelles, Brussels, Belgium; [Abouchadi, S.] Inst Trop Med, B-2000 Antwerp, Belgium; [Cunden, N.; Witter, S.] Univ Aberdeen, Aberdeen, Scotland	Boukhalfa, C (reprint author), Ecole Natl Sante Publ, Rue Lamfadel Cherkaoui,BP 6329, Rabat, Morocco.	chakib.boukhalfa@gmail.com			EC	This work was conducted as part of the project FEM-Health (www.abdn.ac.uk /femhealth), thanks to funding from the FP7 programme of the EC. We thank the women who answered our questions. Our thanks for their collaboration also go to the teams in hospitals for their commitment and their contribution to this study. Particular thanks go to Vincent De Brouwere (Maternal & Reproductive Health Unit, Institute of Tropical Medicine), and Chakib Nejjari (Ecole Nationale de Sante Publique, Morocco) for their useful comments, Fatima Zahra Meski (Ecole Nationale de Sante Publique, Morocco) and Saad-Ellah Berhili (Conseil Superieur de l'Enseignement, Morocco) for their help in data analysis and finally to Carolyn Lamboley for help with translation.	Agence Nationale d'Assurance Maladie, 2015, FEUILL ROUT 2014 201; Bennis I, 2010, MEMOIRE FIN ETUDE CY; Bennis I, 2012, ARCH PUBLIC HEALTH, V70, DOI 10.1186/0778-7367-70-3; Borghi J, 2008, STUDIES IN HSO P, P25; El-Khoury M, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-49; FEMHealth Morocco, 2014, ASS IMP FREE DEL CAE; Gruenais ME, 2006, C INT FAM SANT REG S; HERA Belgium, 2003, ET PROF EP MORB HOSP; Ministere de la sante, 2015, RAMED ENTR TRAD ASS; Ministere de la Sante du Royaume du Maroc, 2008, PLAN ACT SANT 2008 2; Ministere de la Sante du Royaume du Maroc, 2011, ENQ NAT POP SANT FAM; Ministere de la Sante du Royaume du Maroc ORC Macro & Projet PAPFAM, 2005, ENQ POP SANT FAM 200; Ministry of Health, 2011, RED MAT MORT SHAR EX; Perkins M, 2009, HEALTH POLICY PLANN, V24, P289, DOI 10.1093/heapol/czp013; Ridde V, 2010, PRESSIONS EXERCEES A; Storeng KT, 2008, SOC SCI MED, V66, P545, DOI 10.1016/j.socscimed.2007.10.001; Tinasti K, 2015, PAN AFR MED J, V21, DOI 10.11604/pamj.2015.21.53.6727; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; Witter S, 2008, STUDIES IN HSO P, P25; Witter S, 2013, INT J HEALTH PLAN M, V28, pe95, DOI 10.1002/hpm.2146; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5	21	5	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	FEB	2016	21	2					245	252		10.1111/tmi.12638				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	DD5FO	WOS:000369948300011	26584606	Bronze			2019-04-02	
J	Garcia, C; Astocondor, L; Rojo-Bezares, B; Jacobs, J; Saenz, Y				Garcia, Coralith; Astocondor, Lizeth; Rojo-Bezares, Beatriz; Jacobs, Jan; Saenz, Yolanda			Molecular Characterization of Extended-Spectrum beta-Lactamase-Producer Klebsiella pneumoniae Isolates Causing Neonatal Sepsis in Peru	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							INTENSIVE-CARE-UNIT; ANTIMICROBIAL RESISTANCE TRENDS; BLOOD-STREAM INFECTIONS; GRAM-NEGATIVE BACILLI; INTRAABDOMINAL INFECTIONS; RISK-FACTORS; SUSCEPTIBILITY; EPIDEMIOLOGY; EMERGENCE; OUTBREAK	Klebsiella pneumoniae (KP) is the most common cause of neonatal sepsis in the low- and middle-income countries. Our objective was to describe the phenotypic and molecular characteristics of extended-spectrum beta-lactamase (ESBL)-producer KP in neonatal care centers from Peru. We collected 176 non-duplicate consecutive KP isolates from blood isolates of neonates from eight general public hospitals of Lima, Peru. The overall rate of ESBL production was 73.3% (N = 129). The resistance rates were higher among ESBL-producer isolates when compared with the nonproducers: 85.3% versus 12.8% for gentamicin (P < 0.01), 59.7% versus 8.5% for trimethoprim-sulfamethoxazole (P < 0.01), 45.0% versus 8.5% for ciprofloxacin (P < 0.01), and 36.4% versus 12.8% for amikacin (P < 0.01). A total of 359 beta-lactamase-encoding genes were detected among 129 ESBL-producer isolates; 109 isolates (84.5%) carried two or more genes. Among 37 ESBL-producer isolates randomly selected, CTX-M-15 and CTX-M-2 were the most common ESBLs detected. Most of the isolates (92%) belonged to the group KpI. Pulsed-field gel electrophoresis showed that multiple KP clones were circulating among the eight neonatal units included.	[Garcia, Coralith] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Ave Honorio Delgado 430, Lima 31, Peru; Ctr Invest Biomed La Rioja, Logrono, Spain; Inst Trop Med Antwerp, Antwerp, Belgium; Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium	Garcia, C (reprint author), Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Ave Honorio Delgado 430, Lima 31, Peru.	coralith.garcia@upch.pe	Saenz, Yolanda/G-8847-2016	Saenz, Yolanda/0000-0002-2457-4258; Rojo-Bezares, Beatriz/0000-0003-2742-0980; Garcia, Coralith/0000-0002-7933-1843	Directorate General for Development Cooperation of the Belgian Government; Universidad Peruana Cayetano Heredia; Agencia Espanola de Cooperacion Internacional para el Desarrollo (AECID)	This study was sponsored by the Directorate General for Development Cooperation of the Belgian Government, Universidad Peruana Cayetano Heredia, and Agencia Espanola de Cooperacion Internacional para el Desarrollo (AECID).	Ben-Hamouda T, 2003, J MED MICROBIOL, V52, P427, DOI 10.1099/jmm.0.04981-0; Bertrand S, 2006, J CLIN MICROBIOL, V44, P2897, DOI 10.1128/JCM.02549-05; Brisse S, 2004, CLIN MICROBIOL INFEC, V10, P942, DOI 10.1111/j.1469-0691.2004.00973.x; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Clinical and Laboratory Standards Institute, 2012, M100S22 CLIN LAB STA; Cotton MF, 2000, J HOSP INFECT, V44, P13, DOI 10.1053/jhin.1999.0650; Dashti AA, 2010, J MED MICROBIOL, V59, P687, DOI 10.1099/jmm.0.019208-0; Garcia DD, 2008, ANTIMICROB AGENTS CH, V52, P1790, DOI 10.1128/AAC.01440-07; Hawser SP, 2011, ANTIMICROB AGENTS CH, V55, P3917, DOI 10.1128/AAC.00070-11; Hopkins KL, 2006, INT J ANTIMICROB AG, V27, P572, DOI 10.1016/j.ijantimicag.2006.03.003; Jones RN, 2013, BRAZ J INFECT DIS, V17, P672, DOI 10.1016/j.bjid.2013.07.002; KNOTHE H, 1983, INFECTION, V11, P315, DOI 10.1007/BF01641355; Martinez-Aguilar G, 2001, INFECT CONT HOSP EP, V22, P725, DOI 10.1086/501855; Nagata E, 2002, AM J INFECT CONTROL, V30, P26, DOI 10.1067/mic.2002.119823; Pallecchi L, 2007, ANTIMICROB AGENTS CH, V51, P2720, DOI 10.1128/AAC.00026-07; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pessoa-Silva CL, 2003, J HOSP INFECT, V53, P198, DOI 10.1053/jhin.2002.1373; Rossi F, 2006, J ANTIMICROB CHEMOTH, V58, P205, DOI 10.1093/jac/dkl199; Sader HS, 2002, DIAGN MICR INFEC DIS, V44, P273, DOI 10.1016/S0732-8893(02)00469-8; Seki LM, 2013, BRAZ J INFECT DIS, V17, P640, DOI 10.1016/j.bjid.2013.03.012; Sennati S, 2012, ANTIMICROB AGENTS CH, V56, P6003, DOI 10.1128/AAC.00745-12; Sjahrodji A M, 1990, Paediatr Indones, V30, P191; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233; Vinue L, 2008, J MED MICROBIOL, V57, P916, DOI 10.1099/jmm.0.47723-0; Villegas MV, 2011, BRAZ J INFECT DIS, V15, P34, DOI 10.1590/S1413-86702011000100007; Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X	26	5	5	0	5	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	FEB	2016	94	2					285	288		10.4269/ajtmh.15-0373				4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	DC8JK	WOS:000369465500007	26643537	Bronze, Green Published			2019-04-02	
J	Bower, H; Grass, JE; Veltus, E; Brault, A; Campbell, S; Basile, AJ; Wang, D; Paddock, CD; Erickson, BR; Salzer, JS; Belser, J; Chege, E; Seneca, D; Saffa, G; Stroeher, U; Decroo, T; Caleo, GM				Bower, Hilary; Grass, Julian E.; Veltus, Emily; Brault, Aaron; Campbell, Shelley; Basile, Alison Jane; Wang, David; Paddock, Christopher D.; Erickson, Bobbie R.; Salzer, Johanna S.; Belser, Jessica; Chege, Eunice; Seneca, Dean; Saffa, Gbessay; Stroeher, Ute; Decroo, Tom; Caleo, Grazia M.			Delivery of an Ebola Virus-Positive Stillborn Infant in a Rural Community Health Center, Sierra Leone, 2015	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article								We report the case of an Ebola virus (EBOV) RNA negative pregnant woman who delivered an EBOV RNA positive stillborn infant at a community health center in rural Sierra Leone, 1 month after the mother's last possible exposure. The mother was later found to be immunoglobulins M and G positive indicating previous infection. The apparent absence of Ebola symptoms and not recognizing that the woman had previous contact with an Ebola patient led health workers performing the delivery to wear only minimal personal protection, potentially exposing them to a high risk of EBOV infection. This case emphasizes the importance of screening for epidemiological risk factors as well as classic and atypical symptoms of Ebola when caring for pregnant women, even once they have passed the typical time frame for exposure and incubation expected in nonpregnant adults. It also illustrates the need for healthcare workers to use appropriate personal protection equipment when caring for pregnant women in an Ebola setting.	Medecins Sans Frontieres Operat Ctr Amsterdam, MSF Ebola Management Ctr Project, Bo, Sierra Leone; Ctr Dis Control & Prevent, Atlanta, GA USA; Ctr Dis Control & Prevent, Ft Collins, CO USA; World Hlth Org, Bo, Sierra Leone; Sierra Leone Minist Hlth & Sanitat, Dist Hlth Management Team Surveillance Unit, Bo, Sierra Leone; Medecins Sans Frontieres Operat Ctr Brussels, Luxembourg Operat Res Unit, Brussels, Belgium; Medecins Sans Frontieres Operat Ctr Amsterdam, Mansons Unit, London, England	Bower, H (reprint author), Medecins Sans Frontieres Operat Ctr Amsterdam, Plantage Middenlaan 14, NL-1018 DD Amsterdam, Netherlands.	hilarybower@gmail.com		Decroo, Tom/0000-0002-1205-1484; Bower, Hilary/0000-0002-1541-6637	World Health Organization [001]		Akerlund E, 2015, NEW ENGL J MED, V372, P2467, DOI 10.1056/NEJMc1503275; Baggi F. M., 2014, Eurosurveillance, V19, P20983, DOI 10.2807/1560-7917.ES2014.19.49.20983; Caluwaerts S, 2014, GUIDANCE PAPER PREGN; Ksiazek TG, 1999, J INFECT DIS, V179, pS192, DOI 10.1086/514313; Mupapa K, 1999, J INFECT DIS, V179, pS11, DOI 10.1086/514289; Oduyebo T, 2015, OBSTET GYNECOL, P1; Sierra Leone Ministry of Health and Sanitation World Health Organization, 2014, CLIN MAN PAT EB TREA	7	15	16	0	4	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	FEB	2016	94	2					417	419		10.4269/ajtmh.15-0619				3	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	DC8JK	WOS:000369465500030	26556830	Bronze, Green Published			2019-04-02	
J	Cameron, MM; Acosta-Serrano, A; Bern, C; Boelaert, M; den Boer, M; Burza, S; Chapman, LAC; Chaskopoulou, A; Coleman, M; Courtenay, O; Croft, S; Das, P; Dilger, E; Foster, G; Garlapati, R; Haines, L; Harris, A; Hemingway, J; Hollingsworth, TD; Jervis, S; Medley, G; Miles, M; Paine, M; Picado, A; Poche, R; Ready, P; Rogers, M; Rowland, M; Sundar, S; de Vlas, SJ; Weetman, D				Cameron, Mary M.; Acosta-Serrano, Alvaro; Bern, Caryn; Boelaert, Marleen; den Boer, Margriet; Burza, Sakib; Chapman, Lloyd A. C.; Chaskopoulou, Alexandra; Coleman, Michael; Courtenay, Orin; Croft, Simon; Das, Pradeep; Dilger, Erin; Foster, Geraldine; Garlapati, Rajesh; Haines, Lee; Harris, Angela; Hemingway, Janet; Hollingsworth, T. Deirdre; Jervis, Sarah; Medley, Graham; Miles, Michael; Paine, Mark; Picado, Albert; Poche, Richard; Ready, Paul; Rogers, Matthew; Rowland, Mark; Sundar, Shyam; de Vlas, Sake J.; Weetman, David			Understanding the transmission dynamics of Leishmania donovani to provide robust evidence for interventions to eliminate visceral leishmaniasis in Bihar, India	PARASITES & VECTORS			English	Review						Visceral leishmaniasis; Transmission; Leishmania donovani; Elimination; Control; Indian sub-continent; Phlebotomus argentipes	CLUSTER-RANDOMIZED-TRIAL; LASTING INSECTICIDAL NETS; PHLEBOTOMINE SAND FLIES; VECTOR CONTROL; RISK-FACTORS; KALA-AZAR; ARGENTIPES; NEPAL; SUBCONTINENT; BANGLADESH	Visceral Leishmaniasis (VL) is a neglected vector-borne disease. In India, it is transmitted to humans by Leishmania donovani-infected Phlebotomus argentipes sand flies. In 2005, VL was targeted for elimination by the governments of India, Nepal and Bangladesh by 2015. The elimination strategy consists of rapid case detection, treatment of VL cases and vector control using indoor residual spraying (IRS). However, to achieve sustained elimination of VL, an appropriate post elimination surveillance programme should be designed, and crucial knowledge gaps in vector bionomics, human infection and transmission need to be addressed. This review examines the outstanding knowledge gaps, specifically in the context of Bihar State, India. The knowledge gaps in vector bionomics that will be of immediate benefit to current control operations include better estimates of human biting rates and natural infection rates of P. argentipes, with L. donovani, and how these vary spatially, temporally and in response to IRS. The relative importance of indoor and outdoor transmission, and how P. argentipes disperse, are also unknown. With respect to human transmission it is important to use a range of diagnostic tools to distinguish individuals in endemic communities into those who: 1) are to going to progress to clinical VL, 2) are immune/refractory to infection and 3) have had past exposure to sand flies. It is crucial to keep in mind that close to elimination, and post-elimination, VL cases will become infrequent, so it is vital to define what the surveillance programme should target and how it should be designed to prevent resurgence. Therefore, a better understanding of the transmission dynamics of VL, in particular of how rates of infection in humans and sand flies vary as functions of each other, is required to guide VL elimination efforts and ensure sustained elimination in the Indian subcontinent. By collecting contemporary entomological and human data in the same geographical locations, more precise epidemiological models can be produced. The suite of data collected can also be used to inform the national programme if supplementary vector control tools, in addition to IRS, are required to address the issues of people sleeping outside.	[Cameron, Mary M.; Burza, Sakib; Croft, Simon; Medley, Graham; Miles, Michael; Ready, Paul; Rogers, Matthew; Rowland, Mark] London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England; [Acosta-Serrano, Alvaro; Coleman, Michael; Foster, Geraldine; Haines, Lee; Hemingway, Janet; Paine, Mark; Weetman, David] Univ Liverpool Liverpool Sch Trop Med, Pembroke Pl, Liverpool L3 5QA, Merseyside, England; [Bern, Caryn] UCSF Sch Med, 550 16th St, San Francisco, CA 94158 USA; [Boelaert, Marleen] Inst Trop Med, B-2000 Antwerp, Belgium; [den Boer, Margriet] KalaCORE, London, England; [Chapman, Lloyd A. C.; Courtenay, Orin; Dilger, Erin; Hollingsworth, T. Deirdre; Jervis, Sarah] Univ Warwick, Gibbet Hill Campus, Coventry CV4 7AL, W Midlands, England; [Chaskopoulou, Alexandra] USDA ARS, European Biol Control Lab, Tsimiski 43 St, Thessaloniki 54623, Greece; [Das, Pradeep] Rajendra Mem Res Inst Med Sci, Patna, Bihar, India; [Garlapati, Rajesh; Picado, Albert; Poche, Richard] Genesis Labs Inc, Wellington, CO 80549 USA; [Harris, Angela] Bill & Melinda Gates Fdn, Seattle, WA USA; [Picado, Albert] FIND, Campus Biotech,Chemin Mines 9, CH-1202 Geneva, Switzerland; [Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [de Vlas, Sake J.] Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands	Cameron, MM (reprint author), London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	Mary.Cameron@lshtm.ac.uk	Acosta-Serrano, Alvaro/L-5503-2015; Hollingsworth, Deirdre/D-2421-2009; Medley, Graham/B-7289-2008; Haines, Lee/K-9264-2017; Weetman, David/M-1261-2014	Acosta-Serrano, Alvaro/0000-0002-2576-7959; Hollingsworth, Deirdre/0000-0001-5962-4238; Medley, Graham/0000-0002-0030-7278; Haines, Lee/0000-0001-8821-6479; Boelaert, Marleen/0000-0001-8051-6776; Picado, Albert/0000-0001-7344-628X; Bern, Caryn/0000-0001-8195-7303; Rogers, Matthew/0000-0002-6542-6438; Coleman, Michael/0000-0003-4186-3526; Weetman, David/0000-0002-5820-1388; Chapman, Lloyd/0000-0001-7727-7102	Bill and Melinda Gates Foundation [31343]; Biotechnology and Biological Sciences Research Council [BB/H022406/1]	We thank The Bill and Melinda Gates Foundation for funding a consultancy for MMC (ID 31343) and for hosting the meetings held in Patna, India and London, UK.	Barnett PG, 2005, AM J TROP MED HYG, V73, P720, DOI 10.4269/ajtmh.2005.73.720; Bates PA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0712-x; Bern C, 2005, EMERG INFECT DIS, V11, P655, DOI 10.3201/eid1105.040718; Bern C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000599; Bhattacharyya T, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003273; Bhattarai NR, 2009, T ROY SOC TROP MED H, V103, P1087, DOI 10.1016/j.trstmh.2009.03.008; Bhunia GS, 2011, GEOSPATIAL HEALTH, V5, P205; Bhunia GS, MEM I O CRUZ; Boelaert M, 2009, TROP MED INT HEALTH, V14, P639, DOI 10.1111/j.1365-3156.2009.02279.x; Boelaert M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009135.pub2; Bora D, 1999, NATL MED J INDIA, V12, P62; Chapman LAC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1136-3; Chowdhury R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003020; Coleman M, 2015, P NATL ACAD SCI USA, V112, P8573, DOI 10.1073/pnas.1507782112; Garlapati RB, 2012, J MED ENTOMOL, V49, P515, DOI 10.1603/ME11115; Gidwani K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001296; Hasker E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002657; HATI AK, 1991, INDIAN J MED RES-A, V93, P388; Joshi AB, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-54; Kelly DW, 1997, MED VET ENTOMOL, V11, P13, DOI 10.1111/j.1365-2915.1997.tb00285.x; Kumar V, 2015, INT J TROP DIS HEAL, V7, P69; LANE RP, 1990, MED VET ENTOMOL, V4, P79, DOI 10.1111/j.1365-2915.1990.tb00263.x; Le Rutte EA, 2016, PARASITES V IN PRESS; Malaviya P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014751; Martin-Martin I, 2013, ACTA TROP, V126, P229, DOI 10.1016/j.actatropica.2013.02.008; Matlashewski G, 2014, LANCET GLOB HEALTH, V2, pE683, DOI 10.1016/S2214-109X(14)70318-3; Matlashewski G, 2011, LANCET INFECT DIS, V11, P322, DOI 10.1016/S1473-3099(10)70320-0; Mondal D, 2013, EMERG INFECT DIS, V19, P1131, DOI 10.3201/eid1907.120932; Muller GC, 2011, J VECTOR ECOL, V36, pS64, DOI 10.1111/j.1948-7134.2011.00113.x; Ostyn B, 2008, TROP MED INT HEALTH, V13, P1073, DOI 10.1111/j.1365-3156.2008.02110.x; Ostyn B, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003966; Perry D, 2013, AM J TROP MED HYG, V88, P778, DOI 10.4269/ajtmh.12-0442; Picado A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087641; Picado A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6760; Picado A, 2010, J MED ENTOMOL, V47, P283, DOI 10.1603/ME09175; Picado A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000587; Poche D, 2011, J VECTOR ECOL, V36, pS106, DOI 10.1111/j.1948-7134.2011.00119.x; Poche RM, 2013, J MED ENTOMOL, V50, P833, DOI 10.1603/ME12259; Poche RM, 2012, J VECTOR ECOL, V37, P148, DOI 10.1111/j.1948-7134.2012.00211.x; Ready PD, 2013, ANNU REV ENTOMOL, V58, P227, DOI 10.1146/annurev-ento-120811-153557; Rock KS, 2015, TRENDS PARASITOL, V31, P251, DOI 10.1016/j.pt.2015.03.007; Rogers ME, 2007, PLOS PATHOG, V3, P818, DOI 10.1371/journal.ppat.0030091; Singh OP, 2014, CLIN INFECT DIS, V58, P1424, DOI 10.1093/cid/ciu102; Singh RP, 2012, TROP MED INT HEALTH, V17, P1345, DOI 10.1111/j.1365-3156.2012.03067.x; Stauch A, 2011, PLOS NEGLECT TROP D, V5, P11, DOI DOI 10.1371/J0URNAL.PNTD.0001405; Stauch A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002810; Tiwary P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061370; Tiwary P, 2012, VECTOR-BORNE ZOONOT, V12, P467, DOI 10.1089/vbz.2011.0808; Vanlerberghe V, 2010, TROP MED INT HEALTH, V15, P60, DOI 10.1111/j.1365-3156.2009.02433.x; WHO, 2005, SEAVBC85 WHO REG OFF; WHO, 2010, MON EV TOOL KIT IND; Yangzom T, 2012, AM J TROP MED HYG, V87, P1028, DOI 10.4269/ajtmh.2012.12-0211	52	19	19	1	23	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	JAN 27	2016	9								25	10.1186/s13071-016-1309-8				9	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	DC0LG	WOS:000368908100001	26812963	DOAJ Gold, Green Published			2019-04-02	
J	Le Rutte, EA; Coffeng, LE; Bontje, DM; Hasker, EC; Postigo, JAR; Argaw, D; Boelaert, MC; De Vlas, SJ				Le Rutte, Epke A.; Coffeng, Luc E.; Bontje, Daniel M.; Hasker, Epco C.; Postigo, Jose A. Ruiz; Argaw, Daniel; Boelaert, Marleen C.; De Vlas, Sake J.			Feasibility of eliminating visceral leishmaniasis from the Indian subcontinent: explorations with a set of deterministic age-structured transmission models	PARASITES & VECTORS			English	Article						Visceral leishmaniasis; Elimination; Mathematical modelling; Indoor residual spraying; Indian subcontinent; Neglected tropical disease; Kala-azar; Reservoir of infection; Sandfly; Transmission dynamics	AZAR DERMAL LEISHMANIASIS; LASTING INSECTICIDAL NETS; CLUSTER RANDOMIZED-TRIAL; PHLEBOTOMUS-ARGENTIPES; SAND FLIES; KALA-AZAR; DONOVANI INFECTION; VECTOR CONTROL; BIHAR STATE; NEPAL	Background: Visceral leishmaniasis (VL) is a neglected tropical disease transmitted by sandflies. On the Indian subcontinent (ISC), VL is targeted for elimination as a public health problem by 2017. In the context of VL, the elimination target is defined as an annual VL incidence of < 1 per 10,000 capita at (sub-) district level. Interventions focus on vector control, surveillance and on diagnosing and treating VL cases. Many endemic areas have not yet achieved optimal control due to logistical, biological as well as technical challenges. We used mathematical modelling to quantify VL transmission dynamics and predict the feasibility of achieving the VL elimination target with current control strategies under varying assumptions about the reservoir of infection in humans. Methods: We developed three deterministic age-structured transmission models with different main reservoirs of infection in humans: asymptomatic infections (model 1), reactivation of infection after initial infection (model 2), and post kala-azar dermal leishmaniasis (PKDL; model 3). For each model, we defined four sub-variants based on different assumptions about the duration of immunity and age-patterns in exposure to sandflies. All 12 model sub-variants were fitted to data from the KalaNet study in Bihar (India) and Nepal, and the best sub-variant was selected per model. Predictions were made for optimal and sub-optimal indoor residual spraying (IRS) effectiveness for three different levels of VL endemicity. Results: Structurally different models explained the KalaNet data equally well. However, the predicted impact of IRS varied substantially between models, such that a conclusion about reaching the VL elimination targets for the ISC heavily depends on assumptions about the main reservoir of infection in humans: asymptomatic cases, recovered (immune) individuals that reactivate, or PKDL cases. Conclusions: Available data on the impact of IRS so far suggest one model is probably closest to reality (model 1). According to this model, elimination of VL (incidence of < 1 per 10,000) by 2017 is only feasible in low and medium endemic settings with optimal IRS. In highly endemic settings and settings with sub-optimal IRS, additional interventions will be required.	[Le Rutte, Epke A.; Coffeng, Luc E.; Bontje, Daniel M.; De Vlas, Sake J.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Hasker, Epco C.; Boelaert, Marleen C.] Inst Trop Med, B-2000 Antwerp, Belgium; [Postigo, Jose A. Ruiz; Argaw, Daniel] WHO, CH-1211 Geneva, Switzerland	Le Rutte, EA (reprint author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	e.lerutte@erasmusmc.nl		Boelaert, Marleen/0000-0001-8051-6776; Coffeng, Luc Edgar/0000-0002-4425-2264	NTD Modelling Consortium by the Bill and Melinda Gates Foundation; Task Force for Global Health	We are thankful to Anette Stauch and Hans Peter Duerr for providing the code and background information regarding their deterministic VL model. We also want to express our gratitude to Ed Zijlstra, Bart Ostyn and Albert Picado for the in-depth discussions regarding VL transmission dynamics. EALR, LEC, DMB and SJDV gratefully acknowledge funding of the NTD Modelling Consortium by the Bill and Melinda Gates Foundation in partnership with the Task Force for Global Health. The views, opinions, assumptions or any other information set out in this article are solely those of the authors.	ADDY M, 1992, B WORLD HEALTH ORGAN, V70, P341; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Bern C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000599; Bhattarai NR, 2010, EMERG INFECT DIS, V16, P231, DOI 10.3201/eid1602.090623; Bhattarai NR, 2009, T ROY SOC TROP MED H, V103, P1087, DOI 10.1016/j.trstmh.2009.03.008; Chapman LAC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1136-3; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Chappuis F, 2006, BRIT MED J, V333, P723, DOI 10.1136/bmj.38917.503056.7C; Chowdhury R, 2011, ANN TROP MED PARASIT, V105, P31, DOI 10.1179/136485911X12899838683124; Coffeng LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115886; Coffeng LE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002032; Coleman M, 2015, P NATL ACAD SCI USA, V112, P8573, DOI 10.1073/pnas.1507782112; Das ML, 2010, ACTA TROP, V113, P162, DOI 10.1016/j.actatropica.2009.10.012; de Ruiter CM, 2014, J CLIN MICROBIOL, V52, P3147, DOI 10.1128/JCM.00372-14; De Vlas SJ, 2016, PLOS NEGL T IN PRESS; De Vlas SJ, 2015, HLTH EC IMPACT ACHIE; Desjeux P, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-196; HATI AK, 1991, INDIAN J MED RES-A, V93, P388; India Ministry of Health and Family Welfare, 2013, HLTH FAM WELF STAT I; Jarvis JN, 2013, CURR OPIN INFECT DIS, V26, P1, DOI 10.1097/QCO.0b013e32835c2198; Joshi AB, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-54; Joshi S, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00380; Kabasenche WP, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-62; KIRK R., 1955, TRANS ROY SOC TROP MED AND HYG, V49, P229, DOI 10.1016/0035-9203(55)90066-3; Kumar V, 2009, J VECTOR DIS, V46, P225; Kumar V, 2015, INT J TROP DIS HEAL, V7, P69; Lee BY, 2012, AM J TROP MED HYG, V86, P417, DOI 10.4269/ajtmh.2012.10-0415; Maintz E-M, 2014, J TROP MED, V2014; Malaviya P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014751; Minister of Health & Family Welfare Government of India, 2014, NAT ROADM KAL AZ EL; Mouri O, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1191-6; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Ostyn B, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003966; Ostyn B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001284; Picado A, 2012, INDIAN J MED RES, V136, P22; Picado A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6760; Picado A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000587; Poche RM, 2012, J VECTOR ECOL, V37, P148, DOI 10.1111/j.1948-7134.2012.00211.x; R Development Core Team, 2013, R LANG ENV STAT COMP; Rahman KM, 2010, CLIN INFECT DIS, V50, P73, DOI 10.1086/648727; Rock KS, 2015, TRENDS PARASITOL, V31, P251, DOI 10.1016/j.pt.2015.03.007; SACKS DL, 1985, AM J TROP MED HYG, V34, P456, DOI 10.4269/ajtmh.1985.34.456; Savioli LS, 2010, 1 WHO, P1; Singh R, 2015, JPN J INFECT DIS, V68, P33, DOI 10.7883/yoken.JJID.2013.262; Singh RP, 2012, TROP MED INT HEALTH, V17, P1345, DOI 10.1111/j.1365-3156.2012.03067.x; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; Stauch A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001405; Stolk WA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001984; Sundar S, 2011, LANCET, V377, P477, DOI 10.1016/S0140-6736(10)62050-8; Sundar S, 2010, NEW ENGL J MED, V362, P504, DOI 10.1056/NEJMoa0903627; Tiwary P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061370; Tiwary P, 2012, VECTOR-BORNE ZOONOT, V12, P467, DOI 10.1089/vbz.2011.0808; Uniting to Combat Neglected Tropical Diseases, 2012, LOND DECL NEGL TROP; Uranw S, 2011, PLOS NEGLECT TROP D, V5, P1; WHO, 2010, WHO TECH REP SER, V949, P1; WHO, 2012, POSTK AZ DERM LEISHM; World Bank, 2011, CRUD BIRTH RAT PER 1; World Health Organization, 2012, ACC WORK OV GLOB IMP; World Health Organization, 2014, REG STRAT FRAM EL KA; World Health Organization South-East Asia Government of the People's Republic of Bangladesh Royal Government of Bhutan Government of India Government of Nepal Royal Thai Government., 2014, MEM UND BANGL BHUT I	60	16	17	0	13	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	JAN 19	2016	9								24	10.1186/s13071-016-1292-0				14	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	DB3KR	WOS:000368410700002	26787302	DOAJ Gold, Green Published			2019-04-02	
J	Rosas-Aguirre, A; Gamboa, D; Manrique, P; Conn, JE; Moreno, M; Lescano, AG; Sanchez, JF; Rodriguez, H; Silva, H; Llanos-Cuentas, A; Vinetz, JM				Rosas-Aguirre, Angel; Gamboa, Dionicia; Manrique, Paulo; Conn, Jan E.; Moreno, Marta; Lescano, Andres G.; Sanchez, Juan F.; Rodriguez, Hugo; Silva, Hermann; Llanos-Cuentas, Alejandro; Vinetz, Joseph M.			Epidemiology of Plasmodium vivax Malaria in Peru	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							ANOPHELES-DARLINGI MOSQUITOS; FALCIPARUM-MALARIA; INTERNATIONAL CENTERS; POPULATION-STRUCTURE; BENARROCHI DIPTERA; AMAZONIAN PERU; RADICAL CURE; TRANSMISSION; CHLOROQUINE; VECTOR	Malaria in Peru, dominated by Plasmodium vivax, remains a public health problem. The 1990s saw newly epidemic malaria emerge, primarily in the Loreto Department in the Amazon region, including areas near to Iquitos, the capital city, but sporadic malaria transmission also occurred in the 1990s-2000s in both north-coastal Peru and the gold mining regions of southeastern Peru. Although a Global Fund-supported intervention (PAMAFRO, 2005-2010) was temporally associated with a decrease of malaria transmission, from 2012 to the present, both P.vivax and Plasmodium falciparum malaria cases have rapidly increased. The Peruvian Ministry of Health continues to provide artemesinin-based combination therapy for microscopy-confirmed cases of P.falciparum and chloroquine-primaquine for P.vivax. Malaria transmission continues in remote areas nonetheless, where the mobility of humans and parasites facilitates continued reintroduction outside of ongoing surveillance activities, which is critical to address for future malaria control and elimination efforts. Ongoing P.vivax research gaps in Peru include the following: identification of asymptomatic parasitemics, quantification of the contribution of patent and subpatent parasitemics to mosquito transmission, diagnosis of nonparasitemic hypnozoite carriers, and implementation of surveillance for potential emergence of chloroquine-and 8-aminoquinoline-resistant P.vivax. Clinical trials of tafenoquine in Peru have been promising, and glucose-6-phosphate dehydrogenase deficiency in the region has not been observed to be a limitation to its use. Larger-scale challenges for P.vivax (and malaria in general) in Peru include logistical difficulties in accessing remote riverine populations, consequences of government policy and poverty trends, and obtaining international funding for malaria control and elimination.	[Rosas-Aguirre, Angel; Gamboa, Dionicia; Manrique, Paulo; Llanos-Cuentas, Alejandro; Vinetz, Joseph M.] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Ave Honorio Delgado 430, Lima, Peru; [Rosas-Aguirre, Angel] Catholic Univ Louvain, Res Inst Hlth & Soc, Brussels, Belgium; [Gamboa, Dionicia; Vinetz, Joseph M.] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Dept Ciencias Celulares & Mol, Lima, Peru; [Conn, Jan E.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA; [Conn, Jan E.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Moreno, Marta; Vinetz, Joseph M.] Univ Calif San Diego, Dept Med, Div Infect Dis, San Diego, CA 92103 USA; [Lescano, Andres G.; Sanchez, Juan F.] Univ Peruana Cayetano Heredia, Fac Salud Publ, Lima, Peru; [Rodriguez, Hugo; Silva, Hermann] Minist Salud, Direcc Reg Salud Loreto, Iquitos, Peru	Vinetz, JM (reprint author), Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Ave Honorio Delgado 430, Lima, Peru.; Vinetz, JM (reprint author), Univ Calif San Diego, MC0760,9500 Gilman Dr, La Jolla, CA 92093 USA.	jvinetz@ucsd.edu	Lescano, Andres/B-8479-2008	Lescano, Andres/0000-0001-9779-633X; Moreno, Marta/0000-0002-9091-5612; Rosas Aguirre, Angel/0000-0002-3271-7028; Gamboa, Dionicia/0000-0002-1420-7729	U.S. Public Health Service from the U.S. National Institutes of Health [U19AI089681, D43TW007120, K24AI068903, D43TW007393]; "Strengthening the diagnosis, treatment and surveillance strategies for malaria control and elimination in the Peruvian Amazon" Agency: L'Academie Belge de Recherche et d'Enseignement superieur-Commission de la Cooporation au Developpement (ARES-CCD); "Circulo de Investigacion: Hacia la eliminacion de la malaria en el Peru," (Convenio de Financiamiento) [008-2014-FONDECY]; Produccion-Evaluacion de antigenos candidatos a vacunas y desarrollo de pruebas diagnosticas rapidas para Plasmodium falciparum en la Amazonia peruana [178-FINCyT-IB-2013]	This work was supported by the following: U.S. Public Health Service grants U19AI089681, D43TW007120, and K24AI068903 (Joseph M. Vinetz), and D43TW007393 (Andres G. Lescano) from the U.S. National Institutes of Health; "Strengthening the diagnosis, treatment and surveillance strategies for malaria control and elimination in the Peruvian Amazon" Agency: L'Academie Belge de Recherche et d'Enseignement superieur-Commission de la Cooporation au Developpement (ARES-CCD); "Circulo de Investigacion Nro. 4: Hacia la eliminacion de la malaria en el Peru," (Convenio de Financiamiento No 008-2014-FONDECYT); and "Produccion-Evaluacion de antigenos candidatos a vacunas y desarrollo de pruebas diagnosticas rapidas para Plasmodium falciparum en la Amazonia peruana" (178-FINCyT-IB-2013).	Abeles SR, 2013, AM J TROP MED HYG, V88, P1130, DOI 10.4269/ajtmh.12-0752; Arevalo-Herrera M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099754; Arevalo-Herrera M, 2012, ACTA TROP, V121, P303, DOI 10.1016/j.actatropica.2011.06.008; Baird JK, 2013, CLIN MICROBIOL REV, V26, P36, DOI 10.1128/CMR.00074-12; Bautista CT, 2006, AM J TROP MED HYG, V75, P1216, DOI 10.4269/ajtmh.2006.75.1216; Beck HP, 2016, J INFECT DIS, V213, P794, DOI 10.1093/infdis/jiv508; Bendezu J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-154; Bharti AR, 2006, AM J TROP MED HYG, V75, P610, DOI 10.4269/ajtmh.2006.75.610; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Branch O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-27; Chowell G, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-142; Chuquiyauri R, 2013, AM J TROP MED HYG, V89, P326, DOI 10.4269/ajtmh.13-0060; Chuquiyauri R, 2012, ACTA TROP, V121, P292, DOI 10.1016/j.actatropica.2011.11.003; Conn J, 2015, GENETIC CONTROL MALA; Conn JE, 2013, AM J TROP MED HYG, V88, P319, DOI 10.4269/ajtmh.2012.12-0429; Cueto Marcos, 1997, REGRESO EPIDEMIAS SA; da Silva-Nunes M, 2012, ACTA TROP, V121, P281, DOI 10.1016/j.actatropica.2011.10.001; Das R, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1139-3; Delgado-Ratto C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004376; Delgado-Ratto C, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-8; dos Reis IC, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0947-1; Drakeley C, 2009, ADV PARASIT, V69, P299, DOI 10.1016/S0065-308X(09)69005-9; Durand S, 2014, AM J TROP MED HYG, V91, P18, DOI 10.4269/ajtmh.13-0053; Elliott Salenna R, 2014, F1000Prime Rep, V6, P100, DOI 10.12703/P6-100; Ferreira MU, 2015, PATHOG GLOB HEALTH, V109, P89, DOI 10.1179/2047772415Z.000000000263; Flores-Mendoza C, 2004, J MED ENTOMOL, V41, P489, DOI 10.1603/0022-2585-41.3.489; Gagnon AS, 2002, J BIOMETEOROL, V46, P81; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Goncalves LA, 2014, MEM I OSWALDO CRUZ, V109, P534, DOI 10.1590/0074-0276130579; Graf Paul C F, 2012, Malar Res Treat, V2012, P936067, DOI 10.1155/2012/936067; Grietens KP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050294; Grietens KP, 2010, AM J TROP MED HYG, V82, P1017, DOI 10.4269/ajtmh.2010.09-0521; Griffing SM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-303; Guarda JA, 1999, EMERG INFECT DIS, V5, P209; Guthmann JP, 2002, TROP MED INT HEALTH, V7, P518, DOI 10.1046/j.1365-3156.2002.00883.x; Hiwat H, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-177; Hupalo DN, 2016, NAT GENET, V48, P953, DOI 10.1038/ng.3588; Hwang J, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu034; INEI, 2012, PER EST PROYECC POBL; Kobayashi T, 2015, AM J TROP MED HYG, V93, P99, DOI 10.4269/ajtmh.15-0004; Kosek M, 2012, AM J TROP MED HYG, V86, P580, DOI 10.4269/ajtmh.2012.11-0627; Lacerda MVG, 2012, CLIN INFECT DIS, V55, pE67, DOI 10.1093/cid/cis615; Lacerda MVG, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-12; Llanos-Chea F, 2015, AM J TROP MED HYG, V93, P1249, DOI 10.4269/ajtmh.14-0652; Llanos-Cuentas A, 2014, LANCET, V383, P1049, DOI 10.1016/S0140-6736(13)62568-4; Maltha J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043094; Manrique P, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0842-9; Marquino W, 2003, AM J TROP MED HYG, V68, P120, DOI 10.4269/ajtmh.2003.68.120; McCollum AM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-67; McNeely J. A., 1990, CONSERVING WORLDS BI; MENDIS KN, 1987, INFECT IMMUN, V55, P369; Ministerio de Salud del Peru, 2015, B EPIDEMIOL, V24, P975; Ministerio de Salud del Peru (MINSA), 2015, 054MINSADGSPV01; Ministerio de Salud del Peru (MINSA), 2010, AN SIT SAL PER ASIS; Ministerio de Salud del Peru (MINSA), 2010, NORM TECN SAL CONTR; Moreno M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0804-2; Moreno M, 2014, AM J TROP MED HYG, V90, P612, DOI 10.4269/ajtmh.13-0708; Moss WJ, 2015, AM J TROP MED HYG, V93, P5, DOI 10.4269/ajtmh.15-0006; PAMAFRO, 2009, COMP LECC APR PROYEC; Parekh FK, 2007, AM J TROP MED HYG, V77, P451, DOI 10.4269/ajtmh.2007.77.451; Parker BS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-178; Pearson RD, 2016, NAT GENET, V48, P959, DOI 10.1038/ng.3599; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; Quispe AM, 2014, AM J TROP MED HYG, V91, P11, DOI 10.4269/ajtmh.12-0610; Reinbold-Wasson DD, 2012, AM J TROP MED HYG, V86, P459, DOI 10.4269/ajtmh.2012.11-0547; Rosas-Aguirre A, 2015, UNDERSTANDING MALARI; Rosas-Aguirre A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137458; Rosas-Aguirre A, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0670-y; Rosas-Aguirre A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-339; Rosas-Aguirre Angel, 2011, Rev. perú. med. exp. salud publica, V28, P228, DOI 10.1590/s1726-46342011000200009; Rosas-Aguirre Ángel, 2010, Rev. perú. med. exp. salud publica, V27, P540, DOI 10.1590/s1726-46342010000400008; Roshanravan B, 2003, AM J TROP MED HYG, V69, P45, DOI 10.4269/ajtmh.2003.69.45; Ruebush TK, 2004, J PUBLIC HEALTH POL, V25, P328, DOI 10.1057/palgrave.jphp.3190032; Ruebush TK, 2003, AM J TROP MED HYG, V69, P548, DOI 10.4269/ajtmh.2003.69.548; Sachs P, 2013, J AM MOSQUITO CONTR, V29, P319, DOI 10.2987/13-6360.1; Siqueira AM, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0302-y; Sturrock HJW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001467; SULZER AJ, 1975, B WORLD HEALTH ORGAN, V52, P273; Sutton PL, 2009, AM J TROP MED HYG, V81, P950, DOI 10.4269/ajtmh.2009.09-0132; Van den Eede P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016257; Van den Eede P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-151; Villarreal-Trevino C, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0733-0; Vittor AY, 2009, AM J TROP MED HYG, V81, P5; Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297; WHO, 2014, TROP MED INT HLTH S1, V19, P7, DOI DOI 10.1111/TMI.12313_2; Williams HA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-85	87	16	16	1	6	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA		1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2016	95	6		S			133	144		10.4269/ajtmh.16-0268				12	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	EW6HU	WOS:000402611300013	27799639	Green Published, Other Gold			2019-04-02	
J	Mshana, HJ; Baraka, V; Misinzo, G; Makunde, WH				Mshana, Happyness J.; Baraka, Vito; Misinzo, Gerald; Makunde, Williams H.			Current Epidemiological Assessment of Bancroftian Filariasis in Tanga Region, Northeastern Tanzania	JOURNAL OF TROPICAL MEDICINE			English	Article							LYMPHATIC FILARIASIS; COMMUNITIES; DISEASE	Background. Tanzania started a countrywide lymphatic filariasis elimination programme in 2000 adopting the mass drug administration (MDA) strategy. The drug used for the programme was the combination of ivermectin and albendazole. However, there is limited information on the current epidemiological trend of the infections, where MDA implementation is ongoing. The present study aimed at assessing the current status of Bancroftian filariasis infection rate and morbidity where MDA has been distributed and administered for over eight rounds. Methodology. The study was a cross-sectional descriptive study involving 272 individuals (>18 years) from endemic communities in Tanga region where MDA has been implemented. Clinical, sociodemographic, and circulating filarial antigen (CFA) test was undertaken using immune chromatographic card test according to the manufacturer's instructions. Results. A total of 472 individuals were screened: 307/472 (65.1%) were males while 165/472 (34.9%) were females. The overall prevalence of CFA was 5.51%, that of hydrocoele was 73.2%, and that of lymphoedema was 16.0%. The prevalence of hydrocoele combined with lymphoedema was 5.5%. Conclusion. Our findings demonstrate a considerable reduction in filarial infection. However, there is clear evidence of ongoing transmission despite the 8 rounds of MDA. It is unlikely that the annual MDA would interrupt filarial transmission; therefore, additional strategies are needed to accelerate lymphatic filariasis control and elimination.	[Mshana, Happyness J.; Baraka, Vito; Makunde, Williams H.] Natl Inst Med Res, Tanga Res Ctr, POB 5004, Tanga, Tanzania; [Mshana, Happyness J.; Misinzo, Gerald] Sokoine Univ Agr, Morogoro, Tanzania; [Baraka, Vito] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium	Mshana, HJ (reprint author), Natl Inst Med Res, Tanga Res Ctr, POB 5004, Tanga, Tanzania.; Mshana, HJ (reprint author), Sokoine Univ Agr, Morogoro, Tanzania.	jeremiahappiness@yahoo.com			University Hospital Bonn, Institute for Medical Microbiology, Immunology and Parasitology [PF 673/2-1]	The authors are grateful to the villagers in Tanga region for their dedicated cooperation and to the technical staff from NIMR-Tanga (Fidelis Mumburi, Xavaeli Ngowi, Charles Guzo, and Tembo) for their assistance in the field and the laboratory. This study received financial support from University Hospital Bonn, Institute for Medical Microbiology, Immunology and Parasitology (Grant Code PF 673/2-1).	Addiss David G, 2007, Filaria J, V6, P2, DOI 10.1186/1475-2883-6-2; Babu S, 2012, SEMIN IMMUNOPATHOL, V34, P847, DOI 10.1007/s00281-012-0346-4; Batsa L., 2012, THESIS; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Ichimori Kazuyo, 2014, Trop Med Health, V42, P21, DOI 10.2149/tmh.2014-S03; Meyrowitsch DW, 1995, ANN TROP MED PARASIT, V89, P653, DOI 10.1080/00034983.1995.11812999; Mwakitalu ME, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-286; National Bureau of Statistics (NBS) and Office of Chief Government Statistician (OCGS) Zanzibar, 2013, 2012 POP HOUS CENS P; Nuchprayoon Surang, 2007, Filaria J, V6, P6, DOI 10.1186/1475-2883-6-6; Original L., 2000, PREPARING IMPLEMENTI; Ottesen EA, 2000, TROP MED INT HEALTH, V5, P591, DOI 10.1046/j.1365-3156.2000.00620.x; Pfarr KM, 2009, PARASITE IMMUNOL, V31, P664, DOI 10.1111/j.1365-3024.2009.01133.x; Protopopoff N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-149; Rwegoshora RT, 2005, ANN TROP MED PARASIT, V99, P253, DOI 10.1179/136485905X29675; Simonsen PE, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0507-5; Wanji S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1556-8; WHO Europe, 2013, HLTH RISK ASS NUCL A, P1; Wynd S, 2007, B WORLD HEALTH ORGAN, V85, P493, DOI 10.2471/BLT.06.031047	18	0	0	0	0	HINDAWI PUBLISHING CORP	NEW YORK	315 MADISON AVE 3RD FLR, STE 3070, NEW YORK, NY 10017 USA	1687-9686	1687-9694		J TROP MED	J. Trop. Med.		2016									7408187	10.1155/2016/7408187				5	Tropical Medicine	Tropical Medicine	EF6SM	WOS:000390461100001	28050171	DOAJ Gold, Green Published			2019-04-02	
J	Delgado-Ratto, C; Gamboa, D; Soto-Calle, VE; Van den Eede, P; Torres, E; Sanchez-Martinez, L; Contreras-Mancilla, J; Rosanas-Urgell, A; Ferrucci, HR; Llanos-Cuentas, A; Erhart, A; Van Geertruyden, JP; D'Alessandro, U				Delgado-Ratto, Christopher; Gamboa, Dionicia; Soto-Calle, Veronica E.; Van den Eede, Peter; Torres, Eliana; Sanchez-Martinez, Luis; Contreras-Mancilla, Juan; Rosanas-Urgell, Anna; Ferrucci, Hugo Rodriguez; Llanos-Cuentas, Alejandro; Erhart, Annette; Van Geertruyden, Jean-Pierre; D'Alessandro, Umberto			Population Genetics of Plasmodium vivax in the Peruvian Amazon	PLOS NEGLECTED TROPICAL DISEASES			English	Article							ALLELE FREQUENCY DATA; TRANSMISSION DYNAMICS; MALARIA CONTROL; MICROSATELLITE DIVERSITY; RURAL AMAZONIA; FALCIPARUM; INFECTIONS; GENOMICS; CLUSTERS; PROGRAM	Background Characterizing the parasite dynamics and population structure provides useful information to understand the dynamic of transmission and to better target control interventions. Despite considerable efforts for its control, vivax malaria remains a major health problem in Peru. In this study, we have explored the population genetics of Plasmodium vivax isolates from Iquitos, the main city in the Peruvian Amazon, and 25 neighbouring peri-urban as well as rural villages along the Iquitos-Nauta Road. Methodology/Results From April to December 2008, 292 P. vivax isolates were collected and successfully genotyped using 14 neutral microsatellites. Analysis of the molecular data revealed a similar proportion of monoclonal and polyclonal infections in urban areas, while in rural areas monoclonal infections were predominant (p = 0.002). Multiplicity of infection was higher in urban (MOI = 1.5-2) compared to rural areas (MOI = 1) (p = 0.003). The level of genetic diversity was similar in all areas (He = 0.66-0.76, p = 0.32) though genetic differentiation between areas was substantial (PHIPT = 0.17, p<0.0001). Principal coordinate analysis showed a marked differentiation between parasites from urban and rural areas. Linkage disequilibrium was detected in all the areas (I-A(S) = 0.08-0.49, for all p<0.0001). Gene flow among the areas was stablished through Bayesian analysis of migration models. Recent bottleneck events were detected in 4 areas and a recent parasite expansion in one of the isolated areas. In total, 87 unique haplotypes grouped in 2 or 3 genetic clusters described a sub-structured parasite population. Conclusion/Significance Our study shows a sub-structured parasite population with clonal propagation, with most of its components recently affected by bottleneck events. Iquitos city is the main source of parasite spreading for all the peripheral study areas. The routes of transmission and gene flow and the reduction of the parasite population described are important from the public health perspective as well for the formulation of future control policies.	[Delgado-Ratto, Christopher; Van Geertruyden, Jean-Pierre] Univ Antwerp, Epidemiol Global Hlth Inst, B-2020 Antwerp, Belgium; [Gamboa, Dionicia; Soto-Calle, Veronica E.; Torres, Eliana; Sanchez-Martinez, Luis; Contreras-Mancilla, Juan; Llanos-Cuentas, Alejandro] Univ Peruana Cayetano Heredia, Inst Trop Med Alexander von Humboldt, Lima, Peru; [Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Dept Ciencias Celulares & Mol, Lima, Peru; [Rosanas-Urgell, Anna; Erhart, Annette] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Ferrucci, Hugo Rodriguez] Minist Hlth, Loreto, Peru; [D'Alessandro, Umberto] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [D'Alessandro, Umberto] MRC Unit, Fajara, Gambia; [D'Alessandro, Umberto] London Sch Hyg & Trop Med, London WC1, England	Delgado-Ratto, C (reprint author), Univ Antwerp, Epidemiol Global Hlth Inst, B-2020 Antwerp, Belgium.	chris.delgadoratto@uantwerp.be	Van geertruyden, Jean-Pierre/K-6425-2014; Rosanas-Urgell, Anna/D-3193-2015	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Rosanas-Urgell, Anna/0000-0002-0432-5203; Delgado-Ratto, Christopher/0000-0003-2300-5181; Contreras Mancilla, Juan Jose/0000-0003-0447-0926; Gamboa, Dionicia/0000-0002-1420-7729	Directorate General for Development Cooperation (DGCD) of the Belgian Government [95501, 95502]	The sample collection was funded by the Directorate General for Development Cooperation (DGCD) of the Belgian Government (framework agreement 2 and 3; project 95501 and 95502 respectively): http://diplomatie.belgium.be/en/policy/development_cooperation/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TJC, 2000, MOL ECOL, V9, P1599, DOI 10.1046/j.1365-294x.2000.01057.x; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; Arnott A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-14; Barry AE, 2015, PATHOG GLOB HEALTH, V109, P142, DOI 10.1179/2047773215Y.0000000012; Batista CL, 2014, PARASITOLOGY, P1; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Beerli P, 2009, USE MIGRATE WHY ARE; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Branch O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-27; Carlton JM, 2013, ADV PARASIT, V81, P203, DOI 10.1016/B978-0-12-407826-0.00005-9; Chapilliquen F, 2015, SITUACION EPIDEMIOLO; Chenet SM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-412; Cornuet JM, 1996, GENETICS, V144, P2001; Cristescu R, 2009, CONSERV GENET, V11, P1043; Delgado-Ratto C, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-8; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Erhart A, 2014, 63 ANN M AM SOC TROP, P291; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Ferreira MU, 2007, J INFECT DIS, V195, P1218, DOI 10.1086/512685; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Gething PW, 2012, PLOS NEGLECT TROP D, V6, pe1814, DOI [10.1371/journal.pntd.0001814, DOI 10.1371/J0URNAL.PNTD.0001814]; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Graf Paul C F, 2012, Malar Res Treat, V2012, P936067, DOI 10.1155/2012/936067; Griffing SM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-303; Guarda JA, 1999, EMERG INFECT DIS, V5, P209; Gunawardena S, 2014, PARASITOLOGY, V141, P880, DOI 10.1017/S0031182013002278; Gutierrez S, 2003, MANUAL PROCEDIMIENTO, P7; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Imwong M, 2007, INT J PARASITOL, V37, P1013, DOI 10.1016/j.ijpara.2007.02.010; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; Karunaweera ND, 2007, MOL ECOL NOTES, V7, P172, DOI 10.1111/j.1471-8286.2006.01534.x; Karunaweera ND, 2008, GENE, V410, P105, DOI 10.1016/j.gene.2007.11.022; Koepfli C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003872; Kosek M, 2012, AM J TROP MED HYG, V86, P580, DOI 10.4269/ajtmh.2012.11-0627; Luikart G, 1998, MOL ECOL, V7, P963, DOI 10.1046/j.1365-294x.1998.00414.x; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Mateo Lizarbe S, 2013, REEMERGENCIA MALARIA; McCollum AM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-67; Meirmans PG, 2012, J HERED, V103, P744, DOI 10.1093/jhered/ess047; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Menegon M, 2014, INFECT GENET EVOL, V27, P244, DOI 10.1016/j.meegid.2014.07.029; ORAS-CONHU, 2009, COMP LECC APR PROYEC; Orjuela-Sanchez P, 2013, EXP PARASITOL, V134, P318, DOI 10.1016/j.exppara.2013.03.029; Orjuela-Sanchez P, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-65; Orjuela-Sanchez P, 2009, AM J TROP MED HYG, V81, P961, DOI 10.4269/ajtmh.2009.09-0337; Peakall R, 2012, BIOINFORMATICS; PEAKALL R, 2006, MOL ECOL NOTES, V6, P288, DOI DOI 10.1111/J.1471-8286.2005.01155.X; Piry S, 1999, BOTTLENECK COMPUTER; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Roshanravan B, 2003, AM J TROP MED HYG, V69, P45, DOI 10.4269/ajtmh.2003.69.45; Rubio J M, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS199, DOI 10.1016/S0035-9203(02)90077-5; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Sutton PL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-447; Sutton PL, 2009, AM J TROP MED HYG, V81, P950, DOI 10.4269/ajtmh.2009.09-0132; Thanapongpichat S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-275; Tibayrenc M, 2014, ADV PARASIT, V84, P253, DOI 10.1016/B978-0-12-800099-1.00005-3; Van den Eede P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016257; Van den Eede P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-151; Van den Eede P, 2010, AM J TROP MED HYG, V82, P223, DOI 10.4269/ajtmh.2010.09-0458; Volkman SK, 2012, NAT REV GENET, V13, P315, DOI 10.1038/nrg3187; Volkman SK, 2012, ACTA TROP, V121, P324, DOI 10.1016/j.actatropica.2011.12.002; WHO, 2013, WORLD MALARIA REPORT 2013, P1	65	13	13	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JAN	2016	10	1							e0004376	10.1371/journal.pntd.0004376				23	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DH1SR	WOS:000372565700070	26766548	DOAJ Gold, Green Published			2019-04-02	
J	Duysburgh, E; Temmerman, M; Ye, M; Williams, A; Massawe, S; Williams, J; Mpembeni, R; Loukanova, S; Haefeli, WE; Blank, A				Duysburgh, Els; Temmerman, Marleen; Ye, Maurice; Williams, Afua; Massawe, Siriel; Williams, John; Mpembeni, Rose; Loukanova, Svetla; Haefeli, Walter E.; Blank, Antje			Quality of antenatal and childbirth care in rural health facilities in Burkina Faso, Ghana and Tanzania: an intervention study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						quality of care; maternal health; newborn health; childbirth; health IT; QUALMAT	CLINICAL DECISION-SUPPORT; OF-CARE; PRACTITIONER PERFORMANCE; PATIENT OUTCOMES; SYSTEM; WORKERS; STRATEGIES; MORTALITY; COUNTRIES; ATTITUDES	OBJECTIVE To assess the impact of an intervention consisting of a computer-assisted clinical decision support system and performance-based incentives, aiming at improving quality of antenatal and childbirth care. METHODS Intervention study in rural primary healthcare (PHC) facilities in Burkina Faso, Ghana and Tanzania. In each country, six intervention and six non-intervention PHC facilities, located in one intervention and one non-intervention rural districts, were selected. Quality was assessed in each facility by health facility surveys, direct observation of antenatal and childbirth care, exit interviews, and reviews of patient records and maternal and child health registers. Findings of pre- and post-intervention and of intervention and non-intervention health facility quality assessments were analysed and assessed for significant (P < 0.05) quality of care differences. RESULTS Post-intervention quality scores do not show a clear difference to pre-intervention scores and scores at non-intervention facilities. Only a few variables had a statistically significant better post-intervention quality score and when this is the case this is mostly observed in only one study-arm, being pre-/post-intervention or intervention/non-intervention. Post-intervention care shows similar deficiencies in quality of antenatal and childbirth care and in detection, prevention, and management of obstetric complications as at baseline and non-intervention study facilities. CONCLUSION Our intervention study did not show a significant improvement in quality of care during the study period. However, the use of new technology seems acceptable and feasible in rural PHC facilities in resource-constrained settings, creating the opportunity to use this technology to improve quality of care.	[Duysburgh, Els; Temmerman, Marleen] Univ Ghent, Int Ctr Reprod Hlth, De Pintelaan 185,UZP114, B-9000 Ghent, Belgium; [Ye, Maurice] Ctr Rech Sante Nouna, Nouna, Burkina Faso; [Williams, Afua; Williams, John] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Massawe, Siriel; Mpembeni, Rose] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Loukanova, Svetla] Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany; [Haefeli, Walter E.; Blank, Antje] Univ Heidelberg Hosp, Dept Clin Pharmacol & Pharmacoepidemiol, Heidelberg, Germany	Duysburgh, E (reprint author), Univ Ghent, Int Ctr Reprod Hlth, De Pintelaan 185,UZP114, B-9000 Ghent, Belgium.	els.duysburgh@ugent.be		Blank, Antje/0000-0001-8743-5194	European Union	We thank all QUALMAT project consortium members for supporting this study. QUALMAT (Quality of Maternal and Prenatal Care: Bridging the Know-do Gap) was funded as part of the 7th Framework Programme of the European Union.	Althabe F, 2008, PAEDIATR PERINAT EP, V22, P42, DOI 10.1111/j.1365-3016.2007.00912.x; Baltussen R, 2006, INT J QUAL HEALTH C, V18, P30, DOI 10.1093/intqhc/mzi079; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Birungi H, 2006, ACCEPTABILITY SUSTAI; Blank A, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-44; BRUCE J, 1990, STUD FAMILY PLANN, V21, P61, DOI 10.2307/1966669; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Campbell SM, 2000, SOC SCI MED, V51, P1611, DOI 10.1016/S0277-9536(00)00057-5; Dalaba MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106416; Delvaux T, 2008, TROP MED INT HEALTH, V13, P970, DOI 10.1111/j.1365-3156.2008.02105.x; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Duysburgh E, 2014, BJOG-INT J OBSTET GY, V121, P117, DOI 10.1111/1471-0528.12905; Duysburgh E, 2013, TROP MED INT HEALTH, V18, P534, DOI 10.1111/tmi.12076; Fauveau V, 2006, INT J GYNECOL OBSTET, V94, P179, DOI 10.1016/j.ijgo.2006.05.020; Flodgren G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009255; Franco LM, 2011, BMJ QUAL SAF, V20, P658, DOI 10.1136/bmjqs.2010.044388; Freedman LP, 2007, LANCET, V370, P1383, DOI 10.1016/S0140-6736(07)61581-5; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Gorter A, 2013, EVIDENCE REV RESULTS; Horner V, 2013, APPL CLIN INFORM, V4, P25, DOI 10.4338/ACI-2012-10-RA-0044; Hulton L, 2000, FRAMEWORK EVALUATION; Hulton LA, 2007, SOC SCI MED, V64, P2083, DOI 10.1016/j.socscimed.2007.01.019; Jahn A, 2013, PEER REV RESULTS BAS; Jaspers MWM, 2011, J AM MED INFORM ASSN, V18, P327, DOI 10.1136/amiajnl-2011-000094; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Langer A, 2002, BMC WOMENS HEALTH, V2, P7, DOI DOI 10.1186/1472-6874-2-7; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; McNabb M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123940; Mensah N, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.25756; Miller S, 2003, INT J GYNECOL OBSTET, V82, P89, DOI 10.1016/S0020-7292(03)00148-6; Nyamtema AS, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-30; Oluoch T, 2012, INT J MED INFORM, V81, pE83, DOI 10.1016/j.ijmedinf.2012.07.010; Pitchforth E, 2010, SOC SCI MED, V71, P1739, DOI 10.1016/j.socscimed.2010.08.001; PMNCH, 2011, ESS INT COMM GUID RE; Sukums F, 2015, INT J MED INFORM, V84, P647, DOI 10.1016/j.ijmedinf.2015.05.002; Sukums F, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24534; Tuncalp O, 2015, BJOG-INT J OBSTET GY, V122, P1045, DOI 10.1111/1471-0528.13451; UN DESA, 2014, WORLD POP PROSP 2012; UNICEF WHO The World Bank UN, 2014, LEV TRENDS CHILD MOR; van den Broek NR, 2009, BJOG-INT J OBSTET GY, V116, P18, DOI 10.1111/j.1471-0528.2009.02333.x; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; WHO, 2007, EV BUS STRENGTH HLTH; WHO UNFPA UNICEF AMDD, 2009, MON EM OBST CAR HDB; WHO UNFPA UNICEF World Bank, 2006, PREGN CHILDB POSTP N; WHO UNICEF UNFPA The World Bank The United Nations Population Division, 2014, TRENDS MAT MORT 1990; WHO World Bank UNICEF UNFPA, 2010, WHOFCH1006 UNICEF UN; Witter S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007899.pub2; Ye M, 2014, RURAL REMOTE HEALTH, V14; Zakane SA, 2014, INT J MED INFORM, V83, P459, DOI 10.1016/j.ijmedinf.2014.01.013	50	5	5	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	JAN	2016	21	1					70	83		10.1111/tmi.12627				14	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	DD5FX	WOS:000369949200008		Bronze			2019-04-02	
J	Rakotonirina, EJ; Ravaoarisoa, L; Raherinandrasana, A; Vololonarivelo, B; Rakotonjanahary, M; Rakotomanga, JDM; Macq, J				Rakotonirina, E. J.; Ravaoarisoa, L.; Raherinandrasana, A.; Vololonarivelo, B.; Rakotonjanahary, M.; Rakotomanga, J. D. M.; Macq, J.			Contextual factors regarding the effectiveness of tuberculosis control in Madagascar: a nationwide validity study	MEDECINE ET SANTE TROPICALES			French	Article						TB treatment follow-up; local initiatives; Madagascar		Introduction: This study assesses the nationwide applicability of results from a study in the tuberculosis (TB) diagnostic and treatment centers (DTCs) in a sample of six districts in Madagascar, which identified adaptations of national guidelines and local initiatives that might explain the effectiveness of individual DTCs in improving adherence to TB treatment and thus reducing treatment default. Objective: To assess, at a national level, the importance of these adaptations/initiatives for TB treatment adherence. Methods: This analytical cross-sectional study assessed the responses to a questionnaire based on the previously identified adaptations/initiatives, which was sent to the heads of all 205 DTCs in Madagascar. Results: Decentralization of TB care decreased the rate of patient default. The private DTCs report better results than public DTCs. Adaptations/initiatives in relation to local contexts often lead to good results. The relation between some adaptations/initiatives and continued adherence sometimes varies with the local context of the DTC; the same initiatives can result in better adherence or in higher of treatment default rates, depending on the setting. Conclusion: These initiatives should be applied after adaptation to the context.	[Rakotonirina, E. J.; Ravaoarisoa, L.; Rakotomanga, J. D. M.] INSPC, BP 176, Antananarivo 101, Madagascar; [Rakotonirina, E. J.] Ctr Hosp Univ Soins & Sante Publ Analakely, Antananarivo, Madagascar; [Raherinandrasana, A.; Vololonarivelo, B.; Rakotomanga, J. D. M.] Fac Med, Dept Sante Publ, Antananarivo, Madagascar; [Rakotonjanahary, M.] Programme Natl Lutte TB, Antananarivo, Madagascar; [Macq, J.] Catholic Univ Louvain, Inst Rech Sante & Soc, Louvain La Neuve, Belgium	Rakotonirina, EJ (reprint author), INSPC, BP 176, Antananarivo 101, Madagascar.; Rakotonirina, EJ (reprint author), Ctr Hosp Univ Soins & Sante Publ Analakely, Antananarivo, Madagascar.	juliorakotonirina@yahoo.fr					Ai XQ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-112; Auregan G., 1995, Archives de l'Institut Pasteur de Madagascar, V62, P41; Auregan G., 1995, Archives de l'Institut Pasteur de Madagascar, V62, P37; Beith A, WORLDWIDE INCENTIVES; Bernatas JJ, 2003, INT J TUBERC LUNG D, V7, P724; Chang KC, 2004, INT J TUBERC LUNG D, V8, P1492; Chowdhury AMR, 1997, LANCET, V350, P169, DOI 10.1016/S0140-6736(96)11311-8; Comolet TM, 1998, INT J TUBERC LUNG D, V2, P891; Davidson H, 2000, INT J TUBERC LUNG D, V4, P860; Davidson H, 1999, AM J PUBLIC HEALTH, V89, P1567, DOI 10.2105/AJPH.89.10.1567; Dembele Sm, 2008, Sante, V18, P135, DOI 10.1684/san.2008.0121; Franco LM, 2002, SOC SCI MED, V54, P1255, DOI 10.1016/S0277-9536(01)00094-6; Gebremariam MK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-651; Hane F, 2007, INT J TUBERC LUNG D, V11, P539; Harling G, 2008, SOC SCI MED, V66, P492, DOI 10.1016/j.socscimed.2007.08.026; Hill RC, 2005, INT J TUBERC LUNG D, V9, P1349; Kamolratanakul P, 1999, T ROY SOC TROP MED H, V93, P552, DOI 10.1016/S0035-9203(99)90379-6; Kiefer E, 2009, J INFECT DEV COUNTR, V3, P783; MacIntyre CR, 2003, INT J TUBERC LUNG D, V7, P848; Manders AJE, 2001, INT J TUBERC LUNG D, V5, P838; Martins N, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4248; OMS, PROGR MOND LUTT TUB; Pungrassami P, 2002, INT J TUBERC LUNG D, V6, P389; Rakotonirina E J, 2009, Med Trop (Mars), V69, P493; Rakotonirina EJ, PROGRAMME NATL LUTTE; Rakotonirina EJ, 2008, INT J TUBERC LUNG D, V12, pS96; Rakotonirina EJ, 2010, THESIS; Rakotonirina ECJ, 2009, SANTE PUBLIQUE, V21, P139, DOI 10.3917/spub.092.0139; Rice E, 2009, AIDS BEHAV, V13, P1253, DOI 10.1007/s10461-009-9554-x; SPLF, 2004, MED MALADIES INFECT, V34, P386; Styblo K, 1988, Bull Int Union Tuberc Lung Dis, V63, P39; WHO, IMPL WHO STOP TB STR; World Health Organization, GLOB PLAN STOP TB 20	33	1	1	0	0	JOHN LIBBEY EUROTEXT LTD	MONTROUGE	127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE	2261-3684	2261-2211		MED SANTE TROP	Med. Sante Trop.	JAN-MAR	2016	26	1					64	70		10.1684/mst.2016.0543				7	Tropical Medicine	Tropical Medicine	VD6RP	WOS:000437437700018	27046929				2019-04-02	
J	Sauboin, CJ; Van Bellinghen, LA; Van De Velde, N; Van Vlaenderen, I				Sauboin, Christophe J.; Van Bellinghen, Laure-Anne; Van De Velde, Nicolas; Van Vlaenderen, Ilse			Potential public health impact of RTS,S malaria candidate vaccine in sub-Saharan Africa: a modelling study	MALARIA JOURNAL			English	Article						Malaria; Vaccination; RTS; S candidate vaccine; Public health	PLASMODIUM-FALCIPARUM MALARIA; III MULTICENTER TRIAL; PHASE-III; PREERYTHROCYTIC VACCINE; TRANSMISSION INTENSITY; CASE-MANAGEMENT; MORTALITY; CHILDREN; EFFICACY; AGE	Background: Adding malaria vaccination to existing interventions could help to reduce the health burden due to malaria. This study modelled the potential public health impact of the RTS,S candidate malaria vaccine in 42 malaria-endemic countries in sub-Saharan Africa. Methods: An individual-based Markov cohort model was constructed with three categories of malaria transmission intensity and six successive malaria immunity levels. The cycle time was 5 days. Vaccination was assumed to reduce the risk of infection, with no other effects. Vaccine efficacy was assumed to wane exponentially over time. Malaria incidence and vaccine efficacy data were taken from a Phase III trial of the RTS, S vaccine with 18 months of follow-up (NCT00866619). The model was calibrated to reproduce the malaria incidence in the control arm of the trial in each transmission category and published age distribution data. Individual-level heterogeneity in malaria exposure and vaccine protection was accounted for. Parameter uncertainty and variability were captured by using stochastic model transitions. The model followed a cohort from birth to 10 years of age without malaria vaccination, or with RTS, S malaria vaccination administered at age 6, 10 and 14 weeks or at age 6, 7-and-a-half and 9 months. Median and 95 % confidence intervals were calculated for the number of clinical malaria cases, severe cases, malaria hospitalizations and malaria deaths expected to be averted by each vaccination strategy. Univariate sensitivity analysis was conducted by varying the values of key input parameters. Results: Vaccination assuming the coverage of diphtheria-tetanus-pertussis (DTP3) at age 6, 10 and 14 weeks is estimated to avert over five million clinical malaria cases, 119,000 severe malaria cases, 98,600 malaria hospitalizations and 31,000 malaria deaths in the 42 countries over the 10-year period. Vaccination at age 6, 7-and-a-half and 9 months with 75 % of DTP3 coverage is estimated to avert almost 12.5 million clinical malaria cases, 250,000 severe malaria cases, 208,000 malaria hospitalizations and 65,400 malaria deaths in the 42 countries. Univariate sensitivity analysis indicated that for both vaccination strategies, the parameters with the largest impact on the malaria mortality estimates were waning of vaccine efficacy and malaria case-fatality rate. Conclusions: Addition of RTS, S malaria vaccination to existing malaria interventions is estimated to reduce substantially the incidence of clinical malaria, severe malaria, malaria hospitalizations and malaria deaths across 42 countries in sub-Saharan Africa.	[Sauboin, Christophe J.; Van De Velde, Nicolas] GSK Vaccines, B-1300 Wavre, Belgium; [Van Bellinghen, Laure-Anne; Van Vlaenderen, Ilse] CHESS Hlth, B-2820 Bonheiden, Belgium	Sauboin, CJ (reprint author), GSK Vaccines, Ave Fleming 20, B-1300 Wavre, Belgium.	christophe.j.sauboin@gsk.com		Sauboin, Christophe/0000-0003-0913-039X	GlaxoSmithKline Biologicals SA [HO1414955]; GlaxoSmithKline Biologicals SA	This study was funded by GlaxoSmithKline Biologicals SA (internal study identifier: HO1414955), which was involved in all stages of the study conduct and analysis including: design and operation of the model; data inputs, analysis and interpretation; manuscript preparation, review and decision to submit for publication. GlaxoSmithKline Biologicals SA also funded all costs associated with the development and the publishing of the present manuscript. All authors had full access to the data and agreed with the submission of the publication. The authors would like to thank Lisa White (Mahidol-Oxford Tropical Medicine Research Unit, Centre for Tropical Medicine) for her participation to the method selection, the development of the model, and the determination of the inputs; Edouard Ledent (GSK Vaccines) for his input on the statistical analysis of the calibration, Carole Nadin (Fleetwith Ltd, on behalf of GSK Vaccines) for medical writing assistance and Fabien Debailleul (Business and Decision Life Sciences, on behalf of GSK Vaccines) for publication co-ordination.	Carneiro I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008988; Cohen JM, 2015, OPTIMIZING INVESTMEN; Cohen JM, 2012, SCIENCE, V338, P612, DOI 10.1126/science.1229045; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Griffin JT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4136; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Griffin JT, 2013, MULT IN MAL MIM 6 PA, P320; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Leach A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-224; Lievens M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-222; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Maire N, 2006, AM J TROP MED HYG, V75, P111, DOI 10.4269/ajtmh.2006.75.111; Marsh K, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P241; McCarthy KA, 2015, MALARIA J, V14, DOI 10.1186/1475-2875-14-6; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Roset Bahmanyar E, 2012, AM SOC TROP MED HYG; Ross A, 2006, AM J TROP MED HYG, V75, P63, DOI 10.4269/ajtmh.2006.75.63; *RTS S CLIN TRIALS, 2014, PLOS MED, V0011; Sahai H, 1995, STAT EPIDEMIOLOGY ME; Sicuri E, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-307; Tediosi F, 2006, AM J TROP MED HYG, V75, P90, DOI 10.4269/ajtmh.2006.75.90; Thwing J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S14; ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507; UN Interagency Group for Child Mortality Estimation, 2012, LEV TRENDS CHILD MOR; United Nations Department of Economic and Social Affairs Population Division, 2015, WORLD POP PROSP 2012; Vekemans J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-221; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2012, WHO POL REC SEAS MAL; WHO, 2010, GUID TREATM MAL; WHO, 2014, TROP MED INT HLTH S1, V19, P7, DOI DOI 10.1111/TMI.12313_2	32	2	2	0	10	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	DEC 23	2015	14								524	10.1186/s12936-015-1046-z				17	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CZ5MZ	WOS:000367148000001	26702637	DOAJ Gold, Green Published			2019-04-02	
J	Mgode, GF; Machang'u, RS; Mhamphi, GG; Katakweba, A; Mulungu, LS; Durnez, L; Leirs, H; Hartskeerl, RA; Belmain, SR				Mgode, Georgies F.; Machang'u, Robert S.; Mhamphi, Ginethon G.; Katakweba, Abdul; Mulungu, Loth S.; Durnez, Lies; Leirs, Herwig; Hartskeerl, Rudy A.; Belmain, Steven R.			Leptospira Serovars for Diagnosis of Leptospirosis in Humans and Animals in Africa: Common Leptospira Isolates and Reservoir Hosts	PLOS NEGLECTED TROPICAL DISEASES			English	Article							MASTOMYS-NATALENSIS; NORTHERN TANZANIA; CATTLE; IDENTIFICATION; GUIDELINES; ZIMBABWE; ABORTION; POMONA; KENYA	The burden of leptospirosis in humans and animals in Africa is higher than that reported from other parts of the world. However, the disease is not routinely diagnosed in the continent. One of major factors limiting diagnosis is the poor availability of live isolates of locally circulating Leptospira serovars for inclusion in the antigen panel of the gold standard microscopic agglutination test (MAT) for detecting antibodies against leptospirosis. To gain insight in Leptospira serovars and their natural hosts occurring in Tanzania, concomitantly enabling the improvement of the MAT by inclusion of fresh local isolates, a total of 52 Leptospira isolates were obtained from fresh urine and kidney homogenates, collected between 1996 and 2006 from small mammals, cattle and pigs. Isolates were identified by serogrouping, cross agglutination absorption test (CAAT), and molecular typing. Common Leptospira serovars with their respective animal hosts were: Sokoine (cattle and rodents); Kenya (rodents and shrews); Mwogolo (rodents); Lora (rodents); Qunjian (rodent); serogroup Grippotyphosa (cattle); and an unknown serogroup from pigs. Inclusion of local serovars particularly serovar Sokoine in MAT revealed a 10-fold increase in leptospirosis prevalence in Tanzania from 1.9% to 16.9% in rodents and 0.26% to 10.75% in humans. This indicates that local serovars are useful for diagnosis of human and animal leptospirosis in Tanzania and other African countries.	[Mgode, Georgies F.; Machang'u, Robert S.; Mhamphi, Ginethon G.; Katakweba, Abdul; Mulungu, Loth S.] Sokoine Univ Agr, Ctr Pest Management, Morogoro, Tanzania; [Durnez, Lies] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Leirs, Herwig] Univ Antwerp, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium; [Hartskeerl, Rudy A.] WHO, Royal Trop Inst KIT, KIT Biomed Res, FAO,OIE, Amsterdam, Netherlands; [Hartskeerl, Rudy A.] Natl Collaborating Ctr Reference & Res Leptospiro, Amsterdam, Netherlands; [Belmain, Steven R.] Univ Greenwich, Nat Resources Inst, London SE18 6PF, England	Mgode, GF (reprint author), Sokoine Univ Agr, Ctr Pest Management, Morogoro, Tanzania.	gfmgode@hotmail.com		Mgode, Georgies/0000-0001-9660-8202; Belmain, Steven/0000-0002-5590-7545; Mgode, Georgies/0000-0002-5618-5644	NUFFIC (The Netherlands) through NFP fellowship; Flemish Inter-university Council (VLIR) (Belgium); European Union [INCO-Dev ICA4-CT-2002-10056, EDF FED 2013-330-223]; COSTECH (Tanzania); International Foundation for Science [IFS: D-4666-2]	This research was supported by grants from NUFFIC (The Netherlands) through NFP fellowship granted to GFM, funding from the Flemish Inter-university Council (VLIR) (Belgium), the European Union (Ratzooman Project, INCO-Dev ICA4-CT-2002-10056 and StopRats Project EDF FED 2013-330-223), COSTECH (Tanzania) and the International Foundation for Science (IFS: D-4666-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Niyaz, 2006, Ann Clin Microbiol Antimicrob, V5, P28, DOI 10.1186/1476-0711-5-28; [Anonymous], 2015, TYP MON ANT; Biggs HM, 2011, AM J TROP MED HYG, V85, P275, DOI 10.4269/ajtmh.2011.11-0176; Bourhy P, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000724; BRUGGE LAT, 1985, ONDERSTEPOORT J VET, V52, P51; Christensen JT, 1996, AFR J ECOL, V34, P298, DOI 10.1111/j.1365-2028.1996.tb00624.x; COLE JR, 1973, APPL MICROBIOL, V25, P976; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; DIKKEN H, 1981, TROP GEOGR MED, V33, P343; EZEH AO, 1991, CENT AFR J MED, V37, P11; Faine S, 1999, LEPTOSPIRA LEPTOSPIR; Faine S., 1982, GUIDELINES CONTROL L; Felt SA, 2011, AM J TROP MED HYG, V84, P420, DOI 10.4269/ajtmh.2011.10-0393; FERESU SB, 1995, RES VET SCI, V59, P92, DOI 10.1016/0034-5288(95)90038-1; Feresu SB, 1998, INT J SYST BACTERIOL, V48, P207, DOI 10.1099/00207713-48-1-207; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Goris M.G., 2013, CURRENT PROTOCOLS E; Hartskeerl R. A., 2001, INT COURSE LAB METHO; HERR S, 1982, ONDERSTEPOORT J VET, V49, P57; HOGERZEIL HV, 1986, TROP GEOGR MED, V38, P408; International Committee on Systematics of Prokaryotes: subcommittee on the taxonomy of Leptospiraceae, 2008, INT J SYST EVOL MICR, V58, P1049; Kessy MJ, 2010, TROP ANIM HEALTH PRO, V42, P523, DOI 10.1007/s11250-009-9455-z; Kranendork O., 1968, WHO ZOON, V111, P1; Leirs H, 1996, MAMMALIA, V60, P545, DOI 10.1515/mamm.1996.60.4.545; Machang'u R., 2006, RATZOOMAN WORKSH 3 6, P26; Machang'u R, 2003, RATS MICE PEOPLE ROD, P40; Machang'u RS, 2004, FEMS IMMUNOL MED MIC, V41, P117, DOI 10.1016/j.femsim.2004.02.002; Machangu RS, 1997, BELG J ZOOL, V127, P97; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Mgode GF, 2005, BELG J ZOOL, V135, P17; Mgode GF, 2006, INT J SYST EVOL MICR, V56, P593, DOI 10.1099/ijs.0.63278-0; Mgode GF, 2014, TANZANIA J HLTH RES, V16; Pappas G, 2008, INT J INFECT DIS, V12, P351, DOI 10.1016/j.ijid.2007.09.011; Rahelinirina S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014111; SMITH D. J. W., 1955, JOUR HYG, V53, P436; Trueba G, 2004, INT MICROBIOL, V7, P35; Vinetz JM, 1996, ANN INTERN MED, V125, P794, DOI 10.7326/0003-4819-125-10-199611150-00002; WHO, 2011, 2 M LEPT BURD EP REF; World Medical Association (WMA), 2001, B WORLD HEALTH ORGAN, V79, P373; ZUERNER RL, 1995, J CLIN MICROBIOL, V33, P3284; Zuerner RL, 1997, J CLIN MICROBIOL, V35, P2612	41	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	DEC	2015	9	12							e0004251	10.1371/journal.pntd.0004251				19	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DB2NG	WOS:000368345100028	26624890	DOAJ Gold, Green Published			2019-04-02	
J	Rooney, B; Piening, T; Buscher, P; Roge, S; Smales, CM				Rooney, Barrie; Piening, Turid; Buscher, Philippe; Roge, Stijn; Smales, C. Mark			Expression of Trypanosoma brucei gambiense Antigens in Leishmania tarentolae. Potential for Use in Rapid Serodiagnostic Tests (RDTs)	PLOS NEGLECTED TROPICAL DISEASES			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; OPERATING CHARACTERISTIC CURVES; VARIANT SURFACE GLYCOPROTEINS; SLEEPING SICKNESS; AGGLUTINATION-TEST; DIAGNOSIS; ELIMINATION; INFECTIONS; ANTIBODIES; PLATFORM	The development of rapid serodiagnostic tests for sleeping sickness and other diseases caused by kinetoplastids relies on the affordable production of parasite-specific recombinant antigens. Here, we describe the production of recombinant antigens from Trypanosoma brucei gambiense (T.b. gambiense) in the related species Leishmania tarentolae (L. tarentolae), and compare their diagnostic sensitivity and specificity to native antigens currently used in diagnostic kits against a panel of human sera. A number of T.b. gambiense protein antigen candidates were chosen for recombinant expression in L. tarentolae based on current diagnostics in field use and recent findings on immunodiagnostic antigens found by proteomic profiling. In particular, the extracellular domains of invariant surface glycoprotein 65 (ISG65), variant surface glycoproteins VSG LiTat 1.3 and VSG LiTat 1.5 were fused with C-terminal histidine tags and expressed as soluble proteins in the medium of cultured, recombinant L. tarentolae. Using affinity chromatography, on average 10 mg/L of recombinant protein was purified from cultures and subsequently tested against a panel of sera from sleeping sickness patients from controls, i.e. persons without sleeping sickness living in HAT endemic countries. The evaluation on sera from 172 T.b. gambiense human African trypanosomiasis (HAT) patients and from 119 controls showed very high diagnostic potential of the two recombinant VSG and the rISG65 fragments with areas under the curve between 0.97 and 0.98 compared to 0.98 and 0.99 with native VSG LiTat 1.3 and VSG LiTat 1.5 (statistically not different). Evaluation on sera from 78 T.b. rhodesiense HAT patients and from 100 controls showed an acceptable diagnostic potential of rISG65 with an area under the curve of 0.83. These results indicate that a combination of these recombinant antigens has the potential to be used in next generation rapid serodiagnostic tests. In addition, the L. tarentolae expression system enables simple, cheap and efficient production of recombinant kinetoplatid proteins for use in diagnostic, vaccine and drug discovery research that does not rely on animal use to generate materials.	[Rooney, Barrie; Smales, C. Mark] Univ Kent, Sch Biosci, Ctr Mol Proc, Canterbury, Kent, England; [Piening, Turid] Med Sans Frontieres, Amsterdam, Netherlands; [Buscher, Philippe; Roge, Stijn] Inst Trop Med, Dept Biomed Sci, Unit Parasite Diagnost, B-2000 Antwerp, Belgium	Rooney, B (reprint author), Univ Kent, Sch Biosci, Ctr Mol Proc, Canterbury, Kent, England.	b.c.rooney@kent.ac.uk; c.m.smales@kent.ac.uk		Buscher, Philippe/0000-0002-1926-7472	Biotechnology and Biological Sciences Research Council (BBSRC, UK) Flexible Interchange Programme (FLIP) award [BB/L026279/1]	This work was funded via a Biotechnology and Biological Sciences Research Council (BBSRC, UK) Flexible Interchange Programme (FLIP) award (grant number BB/L026279/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmer O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000961; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Breitling R, 2002, PROTEIN EXPRES PURIF, V25, P209, DOI 10.1016/S1046-5928(02)00001-3; Buscher P, ACTA TROPICA, V73, P11; Buscher P, 2015, EXPERT REV MOL DIAGN, V15, P607, DOI 10.1586/14737159.2015.1027195; Buscher P, 2014, LANCET GLOB HEALTH, V2, pE359, DOI 10.1016/S2214-109X(14)70203-7; CLARKE MW, 1987, MOL IMMUNOL, V24, P707, DOI 10.1016/0161-5890(87)90052-6; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fevre EM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000333; FIND Diagnostics, 2012, 1 RAP TEST SCREEN SL; Franco JR, 2014, PARASITOLOGY, V141, P748, DOI 10.1017/S0031182013002102; Franco JR, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001571; Hall JPJ, 2014, TRYPANOSOMES TRYPANO, P61; Hogwood CEM, 2013, BIOTECHNOL BIOENG, V110, P240, DOI 10.1002/bit.24607; Jackson AP, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000658; Jamonneau V, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003480; Klatt S., 2012, J PROTEOME RES, V12, P396; Lejon V, 2005, INT J PARASITOL, V35, P455, DOI 10.1016/j.ijpara.2004.12.015; Lejon V, 2003, VET PARASITOL, V116, P87, DOI 10.1016/S0304-4017(03)00257-7; Lutumba P, 2007, EMERG INFECT DIS, V13, P1484, DOI 10.3201/eid1310.060358; MAGNUS E, 1978, ANN SOC BELG MED TR, V58, P169; Malvy D, 2011, CLIN MICROBIOL INFEC, V17, P986, DOI 10.1111/j.1469-0691.2011.03536.x; Peeling RW, 2006, SEX TRANSM INFECT, V82, pV1, DOI 10.1136/sti.2006.024265; REINITZ DM, 1992, MOL BIOCHEM PARASIT, V51, P119, DOI 10.1016/0166-6851(92)90207-Z; Rodgers J, 2010, PARASITOLOGY, V137, P1995, DOI 10.1017/S0031182009991806; Roge S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003006; Simarro PP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001859; Sternberg JM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003373; Sullivan L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002976; Sullivan L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002087; VanMeirvenne N, 1995, ACTA TROP, V60, P189, DOI 10.1016/0001-706X(95)00127-Z; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	32	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	DEC	2015	9	12							e0004271	10.1371/journal.pntd.0004271				13	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DB2NG	WOS:000368345100045	26650813	DOAJ Gold, Green Published			2019-04-02	
J	Silva-Gomes, R; Marcq, E; Trigo, G; Goncalves, CM; Longatto, A; Castro, AG; Pedrosa, J; Fraga, AG				Silva-Gomes, Rita; Marcq, Elly; Trigo, Gabriela; Goncalves, Carine M.; Longatto-Filho, Adhemar; Castro, Antonio G.; Pedrosa, Jorge; Fraga, Alexandra G.			Spontaneous Healing of Mycobacterium ulcerans Lesions in the Guinea Pig Model	PLOS NEGLECTED TROPICAL DISEASES			English	Article							BURULI ULCER; PROTECTIVE EFFICACY; TOXIN MYCOLACTONE; DNA VACCINE; BOVIS BCG; INFECTION; MICE; MACROPHAGES; CELLS; SKIN	Buruli Ulcer (BU) is a necrotizing skin disease caused by Mycobacterium ulcerans infection. BU is characterized by a wide range of clinical forms, including non-ulcerative cutaneous lesions that can evolve into severe ulcers if left untreated. Nevertheless, spontaneous healing has been reported to occur, although knowledge on this process is scarce both in naturally infected humans and experimental models of infection. Animal models are useful since they mimic different spectrums of human BU disease and have the potential to elucidate the pathogenic/protective pathway(s) involved in disease/healing. In this time-lapsed study, we characterized the guinea pig, an animal model of resistance to M. ulcerans, focusing on the macroscopic, microbiological and histological evolution throughout the entire experimental infectious process. Subcutaneous infection of guinea pigs with a virulent strain of M. ulcerans led to early localized swelling, which evolved into small well defined ulcers. These macroscopic observations correlated with the presence of necrosis, acute inflammatory infiltrate and an abundant bacterial load. By the end of the infectious process when ulcerative lesions healed, M. ulcerans viability decreased and the subcutaneous tissue organization returned to its normal state after a process of continuous healing characterized by tissue granulation and reepethelialization. In conclusion, we show that the experimental M. ulcerans infection of the guinea pig mimics the process of spontaneous healing described in BU patients, displaying the potential to uncover correlates of protection against BU, which can ultimately contribute to the development of new prophylactic and therapeutic strategies.	[Silva-Gomes, Rita; Marcq, Elly; Trigo, Gabriela; Goncalves, Carine M.; Longatto-Filho, Adhemar; Castro, Antonio G.; Pedrosa, Jorge; Fraga, Alexandra G.] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Silva-Gomes, Rita; Marcq, Elly; Trigo, Gabriela; Goncalves, Carine M.; Longatto-Filho, Adhemar; Castro, Antonio G.; Pedrosa, Jorge; Fraga, Alexandra G.] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Marcq, Elly] Inst Trop Med, Dept Biomed Sci, Mycobacteriol Unit, B-2000 Antwerp, Belgium; [Trigo, Gabriela] Univ Minho, Ctr Biol Engn, Inst Biotechnol & Bioengn, Braga, Portugal; [Longatto-Filho, Adhemar] Univ Sao Paulo, Fac Med, Lab Med Invest LIM14, Sao Paulo, Brazil; [Longatto-Filho, Adhemar] Barretos Canc Hosp, Mol Oncol Res Ctr, Barretos, Brazil	Silva-Gomes, R (reprint author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.	jpedrosa@ecsaude.uminho.pt	longatto-filho, adhemar/D-7039-2013; Pedrosa, Jorge/H-4877-2011; Fraga, Alexandra/T-5174-2018; Castro, Gil/T-7584-2018	longatto-filho, adhemar/0000-0002-5779-9752; Pedrosa, Jorge/0000-0002-8204-4888; Fraga, Alexandra/0000-0003-2029-1629; Castro, Gil/0000-0002-4684-4183; Marcq, Elly/0000-0003-3173-0500; Branquinho, Gabriela/0000-0002-6826-8543; Goncalves, Carine/0000-0002-4512-6147	European Community [241500]; Health Services of the Fundacao Calouste Gulbenkian [94776]; Fundacao para a Ciencia e Tecnologia (FCT); Programa Operacional Regional do Norte (ON.2-O Novo Norte); Quadro de Referencia Estrategico Nacional (QREN) through the Fundo Europeu de Desenvolvimento Regional (FEDER); Projeto Estrategico - LA 26 [PEst-C/SAU/LA0026/2013]; FCT fellowship [SFRH/BPD/68547/2010, SFRH/BPD/64032/2009]; QREN fellowship [UMINHO/BPD/40/2013]; Life Long Learning Erasmus program	The research leading to these results has received funding from the European Community's Seventh Framework Program (FP7/2007-2013) under grant agreement No 241500 (BuruliVac). This work was additionally financed from the Health Services of the Fundacao Calouste Gulbenkian under the grant Proc.No94776 LJ; from the Fundacao para a Ciencia e Tecnologia (FCT), cofunded by Programa Operacional Regional do Norte (ON.2-O Novo Norte); from the Quadro de Referencia Estrategico Nacional (QREN) through the Fundo Europeu de Desenvolvimento Regional (FEDER) and from the Projeto Estrategico - LA 26 - 2013-2014 (PEst-C/SAU/LA0026/2013). A.G. Fraga and G. Trigo received an individual FCT fellowship (SFRH/BPD/68547/2010 and SFRH/BPD/64032/2009), C.M. Goncalves received an individual QREN fellowship (UMINHO/BPD/40/2013), and E. Marcq received funding from the Life Long Learning Erasmus program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentoucha A, 2001, ANTIMICROB AGENTS CH, V45, P3109, DOI 10.1128/AAC.45.11.3109-3112.2001; Bolz M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002968; Carson C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002668; Connor DH, 1966, ARCH PATH, V81, P17; Coutanceau E, 2007, J EXP MED, V204, P1395, DOI 10.1084/jem.20070234; Coutanceau E, 2006, MICROBES INFECT, V8, P2075, DOI 10.1016/j.micinf.2006.03.009; Dega H, 2000, ANTIMICROB AGENTS CH, V44, P2367, DOI 10.1128/AAC.44.9.2367-2372.2000; Dega H, 2002, ANTIMICROB AGENTS CH, V46, P3193, DOI 10.1128/AAC.46.10.3193-3196.2002; Ellen DE, 2003, TROP MED INT HEALTH, V8, P90, DOI 10.1046/j.1365-3156.2003.00976.x; Fraga AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033406; Fraga AG, 2011, INFECT IMMUN, V79, P421, DOI 10.1128/IAI.00820-10; Fyfe JAM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000791; Gama JB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003066; George KM, 1999, SCIENCE, V283, P854, DOI 10.1126/science.283.5403.854; George KM, 2000, INFECT IMMUN, V68, P877, DOI 10.1128/IAI.68.2.877-883.2000; Gordon CL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001290; Hong H, 2005, CHEMBIOCHEM, V6, P643, DOI 10.1002/cbic.200400339; Huygen K, 2009, MED MICROBIOL IMMUN, V198, P69, DOI 10.1007/s00430-009-0109-6; KRIEG RE, 1974, ARCH DERMATOL, V110, P783, DOI 10.1001/archderm.110.5.783; Lagarrigue V, 2000, Med Trop (Mars), V60, P262; MACCALLUM P, 1948, J PATHOL BACTERIOL, V60, P93, DOI 10.1002/path.1700600111; Marsollier L, 2003, INT J ANTIMICROB AG, V22, P562, DOI 10.1016/S0924-8579(03)00240-1; Martins TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032740; O'Brien C, 2013, AUST VET J, V91, P296, DOI 10.1111/avj.12071; O'Brien CR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002666; Oliveira MS, 2005, INFECT IMMUN, V73, P6299, DOI 10.1128/IAI.73.10.6299-6310.2005; Portaels F, 2003, B SEANC ACAD R SCI O, V49, P30; READ JK, 1974, INFECT IMMUN, V9, P1114; REVILL WDL, 1973, LANCET, V2, P873; Silva MT, 2009, LANCET INFECT DIS, V9, P699, DOI 10.1016/S1473-3099(09)70234-8; Tanghe A, 2001, INFECT IMMUN, V69, P5403, DOI 10.1128/IAI.69.9.5403-5411.2001; Tanghe A, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000199; Tanghe A, 2007, INFECT IMMUN, V75, P2642, DOI 10.1128/IAI.01622-06; Torrado E, 2007, INFECT IMMUN, V75, P3979, DOI 10.1128/IAI.00290-07; Torrado E, 2007, INFECT IMMUN, V75, P977, DOI 10.1128/IAI.00889-06; Torrado E, 2010, J IMMUNOL, V184, P947, DOI 10.4049/jimmunol.0902717; Walsh DS, 2008, T ROY SOC TROP MED H, V102, P969, DOI 10.1016/j.trstmh.2008.06.006; Walsh DS, 2007, AM J TROP MED HYG, V76, P132, DOI 10.4269/ajtmh.2007.76.132; *WHO, 2004, WHOCDSCPEGBUI200410	39	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	DEC	2015	9	12							e0004265	10.1371/journal.pntd.0004265				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DB2NG	WOS:000368345100040	26625302	DOAJ Gold, Green Published			2019-04-02	
J	Vanderelst, D				Vanderelst, Dieter			Social Network Analysis As a Tool for Research Policy	PLOS NEGLECTED TROPICAL DISEASES			English	Editorial Material									[Vanderelst, Dieter] Univ W England, Fac Environm & Technol, Bristol BS16 1QY, Avon, England; [Vanderelst, Dieter] Univ Antwerp, Fac Appl Econ, B-2020 Antwerp, Belgium	Vanderelst, D (reprint author), Univ W England, Fac Environm & Technol, Frenchay Campus, Bristol BS16 1QY, Avon, England.	dieter.vanderelst@uwe.ac.uk					Acuna DE, 2012, NATURE, V489, P201, DOI 10.1038/489201a; Bender ME, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004182; Bollen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006022; Morel CM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000501; Thonon F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122239; Van Noorden R, 2010, NATURE, V465, P864, DOI 10.1038/465864a; Weisstein EW, ADJACENCY MATRIX WOL	7	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	DEC	2015	9	12							e0004266	10.1371/journal.pntd.0004266				3	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DB2NG	WOS:000368345100041	26720414	DOAJ Gold, Green Published			2019-04-02	
J	Wardrop, NA; Thomas, LF; Atkinson, PM; de Glanville, WA; Cook, EAJ; Wamae, CN; Gabriel, S; Dorny, P; Harrison, LJS; Fevre, EM				Wardrop, Nicola A.; Thomas, Lian F.; Atkinson, Peter M.; de Glanville, William A.; Cook, Elizabeth A. J.; Wamae, C. Njeri; Gabriel, Sarah; Dorny, Pierre; Harrison, Leslie J. S.; Fevre, Eric M.			The Influence of Socio-economic, Behavioural and Environmental Factors on Taenia spp. Transmission in Western Kenya: Evidence from a Cross-Sectional Survey in Humans and Pigs	PLOS NEGLECTED TROPICAL DISEASES			English	Article							PORCINE CYSTICERCOSIS; SOLIUM CYSTICERCOSIS; RISK-FACTORS; HELMINTH INFECTIONS; TAPEWORM CARRIERS; NORTHERN TANZANIA; PREVALENCE; DIAGNOSIS; DISTRICT; EASTERN	Taenia spp. infections, particularly cysticercosis, cause considerable health impacts in endemic countries. Despite previous evidence of spatial clustering in cysticercosis and the role of environmental factors (e. g. temperature and humidity) in the survival of eggs, little research has explored these aspects of Taenia spp. epidemiology. In addition, there are significant gaps in our understanding of risk factors for infection in humans and pigs. This study aimed to assess the influence of socio-economic, behavioural and environmental variables on human and porcine cysticercosis. A cross-sectional survey for human taeniasis (T. solium and T. saginata), human cysticercosis (T. solium) and pig cysticercosis (T. solium) in 416 households in western Kenya was carried out. These data were linked to questionnaire responses and environmental datasets. Multi-level regression was used to examine the relationships between covariates and human and porcine cysticercosis. The HP10 Ag-ELISA sero-prevalence (suggestive of cysticercosis) was 6.6% for humans (95% CI 5.6%-7.7%), and 17.2% for pigs (95% CI 10.2%-26.4%). Human taeniasis prevalence, based on direct microscopic observation of Taenia spp. eggs (i. e. via microscopy results only) was 0.2% (95% CI 0.05%-0.5%). Presence of Taenia spp. antigen in both humans and pigs was significantly associated with a range of factors, including positive correlations with land cover. The presence of HP10 antigen in humans was correlated (non-linearly) with the proportion of land within a 1 km buffer that was flooding agricultural land and grassland (odds ratio [OR] = 1.09 and 0.998; p = 0.03 and 0.03 for the linear and quadratic terms respectively), gender (OR = 0.58 for males compared to females, p = 0.02), level of education (OR = 0.62 for primary level education versus no formal education, p = 0.09), use of well water for drinking (OR = 2.76 for those who use well water versus those who do not, p = 0.02) and precipitation (OR = 0.998, p = 0.02). Presence of Taenia spp. antigen in pigs was significantly correlated with gender and breeding status of the pig (OR = 10.35 for breeding sows compared to boars, p = 0.01), and the proportion of land within a 1 km buffer that was flooding agricultural land and grassland (OR = 1.04, p = 0.004). These results highlight the role of multiple socio-economic, behavioural and environmental factors in Taenia spp. transmission patterns. Environmental contamination with Taenia spp. eggs is a key issue, with landscape factors influencing presence of Taenia spp. antigens in both pigs and humans.	[Wardrop, Nicola A.] Univ Southampton, Geog & Environm, Southampton, Hants, England; [Thomas, Lian F.; de Glanville, William A.; Cook, Elizabeth A. J.] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland; [Thomas, Lian F.; de Glanville, William A.; Cook, Elizabeth A. J.; Fevre, Eric M.] Int Livestock Res Inst, Nairobi, Kenya; [Atkinson, Peter M.] Univ Lancaster, Fac Sci & Technol, Lancaster, England; [Atkinson, Peter M.] Univ Utrecht, Fac Geosci, Utrecht, Netherlands; [Atkinson, Peter M.] Queens Univ Belfast, Sch Geog Archaeol & Palaeoecol, Belfast, Antrim, North Ireland; [Wamae, C. Njeri] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Wamae, C. Njeri] Mt Kenya Univ, Thika, Kenya; [Gabriel, Sarah; Dorny, Pierre] Inst Trop Med, Unit Vet Helminthol, B-2000 Antwerp, Belgium; [Harrison, Leslie J. S.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Fevre, Eric M.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England	Wardrop, NA (reprint author), Univ Southampton, Geog & Environm, Southampton, Hants, England.	Nicola.Wardrop@soton.ac.uk		Fevre, Eric/0000-0001-8931-4986; Thomas, Lian/0000-0001-8447-1210; Cook, Elizabeth/0000-0001-6081-8363; Atkinson, Peter/0000-0002-5489-6880	Wellcome Trust [085308]; Medical Research Council, UK [MR/J012343/1]; UK BBSRC DTG; Medical Research Council, UK; University of Utrecht; CGIAR Research Program for Agriculture for Nutrition and Health; KEMRI; Biotechnology and Biological Sciences Research Council [1067974, BB/L019019/1]; Medical Research Council [971282, MR/J012343/1, 1525363]	The People, Animals and their Zoonoses project was funded by the Wellcome Trust (085308). NAW was funded by the Medical Research Council, UK (project MR/J012343/1). EMF was funded by the Wellcome Trust (085308). LFT and WAdG were funded by a UK BBSRC DTG. EAJC was funded by the Medical Research Council, UK. PMA is grateful to the University of Utrecht for supporting him with The Belle van Zuylen Chair. Financial support was received from the CGIAR Research Program for Agriculture for Nutrition and Health, led by IFPRI. We also thank the Director KEMRI for financial support of KEMRI staff involved in the project. NAW, LFT, SG, PD and LJSH are members of EU COST Action TD1302: European Network on Taeniosis/Cysticercosis, CYSTINET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alila PO, 2006, AGR POLICY KENTA ISS; Allan JC, 1996, AM J TROP MED HYG, V54, P352, DOI 10.4269/ajtmh.1996.54.352; [Anonymous], 2010, 1 WHO REP NEGL TROP; Assana E, 2013, VET PARASITOL, V195, P14, DOI 10.1016/j.vetpar.2012.12.022; Bimi L, 2012, J BACTERIOLOGY PARAS, V3, P129; Braae U.C., 2015, TROP ANIM HLTH PROD; Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218; Carrique-Mas J, 2001, ACTA TROP, V80, P229, DOI 10.1016/S0001-706X(01)00161-9; CHENG RWK, 1991, VET PARASITOL, V39, P161, DOI 10.1016/0304-4017(91)90071-3; Coral-Almeida M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003919; Dorny P, 2004, INT J PARASITOL, V34, P569, DOI 10.1016/j.ijpara.2003.11.014; Eshitera EE, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-234; Ferrer E, 2005, T ROY SOC TROP MED H, V99, P568, DOI 10.1016/j.trstmh.2005.02.003; Fleury A, 2007, J NEUROL NEUROSUR PS, V78, P970, DOI 10.1136/jnnp.2006.107243; Garcia HH, 2003, AM J TROP MED HYG, V68, P268, DOI 10.4269/ajtmh.2003.68.268; GARCIA HH, 2006, PRACT NEUROL, V6, P288, DOI DOI 10.1136/JNNP.2006.101253; Gwimbi P, 2011, AFR HEALTH SCI, V11, P474; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Krecek RC, 2011, VET PARASITOL, V183, P198, DOI 10.1016/j.vetpar.2011.09.033; Lawson JR, 1983, ADV PARASIT, P262; Lescano AG, 2007, AM J TROP MED HYG, V76, P376, DOI 10.4269/ajtmh.2007.76.376; Lescano AG, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000371; Mabaso MLH, 2003, TROP MED INT HEALTH, V8, P722, DOI 10.1046/j.1365-3156.2003.01086.x; Morris B. L., 2003, GROUNDWATER ITS SUSC; Mwanjali G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002102; Mwape KE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001594; Ngowi HA, 2004, TROP ANIM HEALTH PRO, V36, P335, DOI 10.1023/B:TROP.0000026663.07862.2a; Ngowi HA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000652; Pawlowski Zbigniew S., 2002, P1, DOI 10.1079/9780851996288.0001; Phiri IK, 2003, ACTA TROP, V87, P13, DOI [10.1016/S0001-706X(03)00051-2, 10.1016/S0001-706X(03)00202-X]; Pondja A, 2010, PLOS NEGLECT TROP D, V4, P594, DOI DOI 10.1371/J0URNAL.PNTD.0000594; Praet N, 2013, TROP MED INT HEALTH, V18, P608, DOI 10.1111/tmi.12089; Pullan RL, 2011, PLOS NEGLECTED TROPI, V5; Raghava MV, 2010, T ROY SOC TROP MED H, V104, P601, DOI 10.1016/j.trstmh.2010.06.002; Scholte RGC, 2013, GEOSPATIAL HEALTH, V8, P97, DOI 10.4081/gh.2013.58; Sciutto E, 1998, VET PARASITOL, V79, P299, DOI 10.1016/S0304-4017(98)00180-0; Sikasunge CS, 2007, VET PARASITOL, V143, P59, DOI 10.1016/j.vetpar.2006.07.023; Sikasunge CS, 2008, VET J, V176, P240, DOI 10.1016/j.tvjl.2007.02.030; Thomas LF, 2013, BMC VET RES, V9; Weka RP, 2013, J INFECT DEV COUNTR, V7, P67, DOI [10.3855/jidc.2309, DOI 10.3855/JIDC.2309]; World Health Organization, 2014, TAEN CYST; Zoli A, 2003, ACTA TROP, V87, P35, DOI 10.1016/S0001-706X(02)00289-9	42	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	DEC	2015	9	12							e0004223	10.1371/journal.pntd.0004223				16	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DB2NG	WOS:000368345100018	26641459	DOAJ Gold, Green Published			2019-04-02	
J	Atia, AM; Mumina, A; Tayler-Smith, K; Boulle, P; Alcoba, G; Elhag, MS; Alnour, M; Shah, S; Chappuis, F; van Griensven, J; Zachariah, R				Atia, Atia M.; Mumina, Ann; Tayler-Smith, Katherine; Boulle, Philippa; Alcoba, Gabriel; Elhag, Mousab Siddig; Alnour, Mubarak; Shah, Safieh; Chappuis, Francois; van Griensven, Johan; Zachariah, Rony			Sodium stibogluconate and paromomycin for treating visceral leishmaniasis under routine conditions in eastern Sudan	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						Operational Research; sodium stibogluconate; paromomycin; Sudan; leishmaniasis; kala-azar	LIPOSOMAL AMPHOTERICIN-B; KALA-AZAR; SOUTHERN SUDAN; AFRICA; AMBISOME(R); EFFICACY; PATIENT; TRIAL; INDIA	ObjectivesAmong patients with primary and relapse visceral leishmaniasis (VL) in eastern Sudan, we determined the proportion eligible for treatment with sodium stibogluconate and paromomycin (SSG/PM) and, of these, their demographic and clinical characteristics; initial treatment outcomes including adverse side effects requiring treatment discontinuation; treatment outcomes by 6months; and risk factors associated with initial (slow responders) and late treatment failure (relapses and post-kala-azar dermal leishmaniasis, PKDL). MethodsA retrospective cohort study in Tabarak Allah Hospital, Gedaref Province, eastern Sudan, from July 2011 to January 2014. ResultsOf 1252 individuals diagnosed with VL (1151 primary and 101 relapses), 65% were eligible for SSG/PM including 83% children, almost half of them malnourished and anaemic. About 4% of individuals discontinued treatment due to side effects; 0.7% died during treatment. Initial cure was achieved in 93% of 774 primary cases and 77% of 35 relapse cases (P<0.001). Among the 809 patients eligible for SSG/PM, 218 (27%) were lost to follow-up. Outcomes by six months among the 591 patients with available follow-up data were: definitive cure (n=506; 86%), relapse (n=38; 6%), treatment discontinuation (n=33; 6%), PKDL (n=7; 1%) and death (n=7; 1%). Among those completing a full course of SSG/PM, relapses and under-fives were at significantly higher risk of early and late treatment failure, respectively. ConclusionWhether SSG/PM as a first-line regimen is an undeniable progress compared to SSG monotherapy, it excluded a considerable proportion of VL patients due to drug safety concerns. We call for accelerated development of new drugs and treatment regimens to improve VL treatment in Sudan.	[Atia, Atia M.; Mumina, Ann] Med Sans Frontieres Switzerland, Sudan Mission, Gedaref, Sudan; [Tayler-Smith, Katherine; Shah, Safieh; Zachariah, Rony] Med Sans Frontieres Brussels, Operat Ctr, Brussels, Luxembourg; [Boulle, Philippa; Alcoba, Gabriel; Chappuis, Francois] Med Sans Frontieres Switzerland, Operat Ctr Geneva, Geneva, Switzerland; [Alcoba, Gabriel; Chappuis, Francois] Univ Hosp Geneva, Geneva, Switzerland; [Elhag, Mousab Siddig] Fed Minist Hlth, Khartoum, Sudan; [Alnour, Mubarak] Minist Hlth, Gedaref, Gedaref State, Sudan; [van Griensven, Johan] Inst Trop Med, B-2000 Antwerp, Belgium	Atia, AM (reprint author), Med Sans Frontieres Switzerland, Sudan Mission, Gedaref, Sudan.	alatiaby@yahoo.com	Shah, Safieh/Z-2078-2018	Shah, Safieh/0000-0001-5358-9240	The Union; MSF; Department for International Development; WHO	This research was conducted through the Structured Operational Research and Training Initiative, a global partnership led by the Special Programme for Research and Training in Tropical Diseases at the World Health Organization. The model is based on a course developed jointly by the International Union Against Tuberculosis and Lung Disease and Medecins sans Frontieres. The specific SORT IT programme which resulted in this publication was jointly developed and implemented by the Operational Research Unit, Medecins Sans Frontieres, Brussels Operational Center, Luxembourg; the Centre for Operational Research, The Union, Paris, France; the Centre for International health, University of Bergen, Norway; the Institute of Tropical Medicine, Antwerp, Belgium; the University of Nairobi, Kenya; and the University of Chester, United Kingdom. The programme was funded by The Union, MSF, the Department for International Development and WHO. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Collin S, 2004, CLIN INFECT DIS, V38, P612, DOI 10.1086/381203; Gorski S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000705; Harhay MO, 2011, AM J TROP MED HYG, V84, P543, DOI 10.4269/ajtmh.2011.10-0321; Khalil EAG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002613; Melaku Y, 2007, AM J TROP MED HYG, V77, P89, DOI 10.4269/ajtmh.2007.77.89; MEREDITH SEO, 1995, J CLIN MICROBIOL, V33, P1742; MSF, 2013, PROT DIAGN TREATM KA; Musa A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001674; Musa AM, 2005, ANN TROP MED PARASIT, V99, P563, DOI 10.1179/136485905X514127; Osman OF, 2000, TROP MED INT HEALTH, V5, P553, DOI 10.1046/j.1365-3156.2000.00598.x; Ritmeijer K, 2006, AM J TROP MED HYG, V74, P76, DOI 10.4269/ajtmh.2006.74.76; Salih NA, 2014, TROP MED INT HEALTH, V19, P146, DOI 10.1111/tmi.12238; Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121; Sundar S, 2010, NEW ENGL J MED, V362, P504, DOI 10.1056/NEJMoa0903627; vansGriensven J, 2012, INFECT DIS CLIN N AM, V26, P309, DOI DOI 10.1016/J.IDC.2012.03.005; WHO, 2010, WHO TECH REP SER, V949, P1; WHO, 2010, IND MON EV KAL EL PR; Zachariah R, 2012, INT J TUBERC LUNG D, V16, P714, DOI 10.5588/ijtld.11.0635	20	10	11	0	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	DEC	2015	20	12					1674	1684		10.1111/tmi.12603				11	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CZ8JA	WOS:000367344800008	26427033	Other Gold			2019-04-02	
J	van Griensven, J; Choun, K; Chim, B; Thai, S; Lorent, N; Lynen, L				van Griensven, Johan; Choun, Kimcheng; Chim, Bopha; Thai, Sopheak; Lorent, Natalie; Lynen, Lutgarde			Implementation of isoniazid preventive therapy in an HIV clinic in Cambodia: high rates of discontinuation when combined with antiretroviral therapy	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						isoniazid; prophylactic; adverse events; completion; adverse effects; Asia	LATENT TUBERCULOSIS INFECTION; PLACEBO-CONTROLLED TRIAL; RIO-DE-JANEIRO; SOUTH-AFRICA; PROSPECTIVE COHORT; DOUBLE-BLIND; DIAGNOSIS; THAILAND; ADULTS; PROPHYLAXIS	ObjectiveData on feasibility and completion rates of isoniazid preventive therapy (IPT) in HIV-infected patient in Asia are limited. Within a hospital-based HIV programme in Phnom Penh, Cambodia, we determined the proportion completing IPT and reasons for non-completion. MethodsRetrospective cohort study using HIV/IPT programme data, including all adults starting IPT (300 mg/day self-administered for 24 weeks) from February 2011 to March 2013. All patients underwent symptom screening and further investigations as indicated. After ruling out tuberculosis (TB), IPT was started, with monthly follow-up visits. As per national guideline, IPT was only prescribed for ART-naive patients. IPT completion was defined as taking IPT for at least 22 of the planned 24 weeks. Stavudine/lamivudine/nevirapine was the preferential first-line ART regimen. ResultsAmong 445 ART-naive patients starting IPT (median age: 35 years (IQR: 31-43), median CD4 count 354 cells/l (IQR 215-545) and 288 (65%) were female), 214 (48%) started ART after a median of 4 weeks (IQR 2-6) on IPT (concurrent ART'). Overall, 348 (78%) completed IPT. Among individuals with concurrent ART, the completion rate was 73% (157/214). Those without concurrent ART had a higher completion rate (83%; 191/231; P 0.017). The main reason for non-completion with concurrent ART was drug toxicity (mainly hepatotoxicity/rash), occurring in 22% (48/214). Without concurrent ART, the main reason for non-completion was loss to follow-up (16/231; 7%). Fourteen (3%) patients were diagnosed with TB while on IPT, of whom three had a positive TB culture at baseline. An additional 14 TB cases were diagnosed after IPT completion; four were bacteriologically confirmed. ConclusionAlthough overall completion rates were acceptable, IPT discontinuation due to drug toxicity was common in patients subsequently initiating ART. Future studies should evaluate whether this relates to IPT, ARVs or both, and whether the increased toxicity would justify delaying IPT initiation until stabilisation on ART.	[van Griensven, Johan; Choun, Kimcheng; Chim, Bopha; Thai, Sopheak; Lorent, Natalie] HOPE, Dept Infect Dis, Sihanouk Hosp Ctr, Phnom Penh, Cambodia; [van Griensven, Johan; Lorent, Natalie; Lynen, Lutgarde] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium	van Griensven, J (reprint author), Inst Trop Med, Nationalestr 155, B-2000 Antwerp, Belgium.	jvangriensven@itg.be	Lynen, Lutgarde/A-1212-2014	Lynen, Lutgarde/0000-0001-7183-4895	Belgian Directorate General of Development Cooperation; Global Fund to fight AIDS, Tuberculosis and Malaria; Hope World Wide	The HIV programme was supported by the Belgian Directorate General of Development Cooperation, the Global Fund to fight AIDS, Tuberculosis and Malaria, and Hope World Wide.	AISU T, 1995, AIDS, V9, P267; Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; Bark CM, 2010, INT J TUBERC LUNG D, V14, P1647; Bristow CC, 2012, INT J TUBERC LUNG D, V16, P1020, DOI 10.5588/ijtld.11.0744; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Chehab JC, 2012, INT J TUBERC LUNG D, V16, P903, DOI 10.5588/ijtld.11.0722; Choun K, 2013, T ROY SOC TROP MED H, V107, P235, DOI 10.1093/trstmh/trt001; Choun K, 2013, B WORLD HEALTH ORGAN, V91, P195, DOI 10.2471/BLT.12.111153; Churchyard GJ, 2014, NEW ENGL J MED, V370, P301, DOI 10.1056/NEJMoa1214289; Durovni B, 2013, LANCET INFECT DIS, V13, P852, DOI 10.1016/S1473-3099(13)70187-7; Eang MT, 2012, HEALTH RES POLICY SY, V10, DOI 10.1186/1478-4505-10-34; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Goswami ND, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-468; Grant AD, 2010, AIDS, V24, pS29, DOI 10.1097/01.aids.0000391019.10661.66; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Hiransuthikul N, 2005, INT J TUBERC LUNG D, V9, P270; Khawcharoenporn T, 2012, INT J TUBERC LUNG D, V16, P336, DOI 10.5588/ijtld.11.0402; Khongphatthanayothin M, 2012, AIDS RES HUM RETROV, V28, P270, DOI 10.1089/aid.2011.0041; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Lester R, 2010, AIDS, V24, pS45, DOI 10.1097/01.aids.0000391021.18284.12; LoBue PA, 2003, AM J RESP CRIT CARE, V168, P443, DOI 10.1164/rccm.200303-390OC; Moolphate Saiyud, 2013, Glob J Health Sci, V5, P60, DOI 10.5539/gjhs.v5n4p60; MOSIMANEOTSILE B, 2004, J ACQ IMMUN DEF SYND, V54, P71; Munseri PJ, 2008, INT J TUBERC LUNG D, V12, P1037; Mwinga A, 1998, AIDS, V12, P2447, DOI 10.1097/00002030-199818000-00014; Aung MN, 2013, J INFECT DEV COUNTR, V7, P191, DOI 10.3855/jidc.2903; National Tuberculosis Program (CENAT), 2012, NAT HLTH STRAT PLAN; Ngamvithayapong J, 1997, AIDS, V11, P107, DOI 10.1097/00002030-199701000-00016; Phan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030647; Rangaka MX, 2014, LANCET, V384, P682, DOI 10.1016/S0140-6736(14)60162-8; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Sculier D, 2010, JAIDS-J ACQ IMM DEF, V55, P500, DOI 10.1097/QAI.0b013e3181e6a703; Swaminathan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047400; Tedla Z, 2010, AM J RESP CRIT CARE, V182, P278, DOI 10.1164/rccm.200911-1783OC; UNAIDS, 2013, UNAIDS REP GLOB AIDS; vansGriensven J, 2011, T R SOC TROP MED HYG, V105, P694; vansGriensven J, 2009, AIDS, V23, P2374; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, 2008, WHO 3 1S M INT CAS F; WHO (World Health Organization), 2011, GLOB TUB CONTR WHO R; World Health Organization, 2008, ESS PREV CAR INT AD; World Health Organization, 2013, GLOB TUB CONTR WHO R; World Health Organization, 2006, IMPR DIAGN TREATM SM; World Health Organization, 2011, GUID INT TUB CAS FIN; World Health Organization (WHO), 2010, ANT THER HIV INF AD; Zaeh S, 2013, INT J TUBERC LUNG D, V17, P1396, DOI 10.5588/ijtld.13.0315	47	7	7	0	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	DEC	2015	20	12					1823	1831		10.1111/tmi.12609				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CZ8JA	WOS:000367344800023	26426387	Other Gold			2019-04-02	
J	Vandenheede, H; Willaert, D; De Grande, H; Simoens, S; Vanroelen, C				Vandenheede, Hadewijch; Willaert, Didier; De Grande, Hannelore; Simoens, Steven; Vanroelen, Christophe			Mortality in adult immigrants in the 2000s in Belgium: a test of the "healthy-migrant' and the "migration-as-rapid-health-transition' hypotheses	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						migrants; mortality; infection; chronic disease; Belgium	DIABETES-RELATED MORTALITY; SOCIOECONOMIC POSITION; ETHNIC-DIFFERENCES; PARADOX; DISEASE; ENGLAND; COHORT; AGE; ACCULTURATION; NETHERLANDS	ObjectiveFirstly, to map out and compare all-cause and cause-specific mortality patterns by migrant background in Belgium; and secondly, to probe into explanations for the observed patterns, more specifically into the healthy-migrant, acculturation and the migration-as-rapid-health-transition theories. MethodsData comprise individually linked Belgian census-mortality follow-up data for the period 2001-2011. All official inhabitants aged 25-54 at time of the census were included. To delve into the different explanations, differences in all-cause and chronic- and infectious-disease mortality were estimated using Poisson regression models, adjusted for age, socioeconomic position and urbanicity. ResultsFirst-generation immigrants have lower all-cause and chronic-disease mortality than the host population. This mortality advantage wears off with length of stay and is more marked among non-Western than Western first-generation immigrants. For example, Western and non-Western male immigrants residing 10 years or more in Belgium have a mortality rate ratio for cardiovascular disease of 0.72 (95% CI 0.66-0.78) and 0.59 (95% CI 0.53-0.66), respectively (vs host population). The pattern of infectious-disease mortality in migrants is slightly different, with rather high mortality rates in first-generation sub-Saharan Africans and rather low rates in all other immigrant groups. As for second-generation immigrants, the picture is gloomier, with a mortality disadvantage that disappears after control for socioeconomic position. ConclusionFindings are largely consistent with the healthy-migrant, acculturation and the migration-as-rapid-health-transition theories. The convergence of the mortality profile of second-generation immigrants towards that of the host population with similar socioeconomic position indicates the need for policies simultaneously addressing different areas of deprivation.	[Vandenheede, Hadewijch; Willaert, Didier; De Grande, Hannelore; Vanroelen, Christophe] Vrije Univ Brussel, Dept Sociol, Interface Demog, B-1050 Brussels, Belgium; [Simoens, Steven] Community Hlth Ctr De Sleep, Ghent, Belgium; [Vanroelen, Christophe] Univ Pompeu Fabra, Employment Condit Knowledge Network, Barcelona, Spain	Vandenheede, H (reprint author), Vrije Univ Brussel, Dept Sociol, Interface Demog, Pl Laan 5, B-1050 Brussels, Belgium.	hadewijch.vandenheede@vub.ac.be					Abraido-Lanza AF, 1999, AM J PUBLIC HEALTH, V89, P1543, DOI 10.2105/AJPH.89.10.1543; Agyemang C, 2012, AM J HYPERTENS, V25, P89, DOI 10.1038/ajh.2011.160; Anson J, 2004, EUR J POPUL, V20, P191, DOI 10.1007/s10680-004-0883-1; Arnold M, 2011, EUR J CANCER PREV, V20, P150, DOI 10.1097/CEJ.0b013e3283431c40; Arnold M, 2010, EUR J CANCER, V46, P2647, DOI 10.1016/j.ejca.2010.07.050; Arrey AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119653; Berry JW, 2005, INT J INTERCULT REL, V29, P697, DOI 10.1016/j.ijintrel.2005.07.013; Bonaventure K, 2001, COURRIER HEBDOMADAIR, V16, P5; Bos V, 2004, INT J EPIDEMIOL, V33, P1112, DOI 10.1093/ije/dyh189; Boulogne R, 2012, SOC SCI MED, V74, P1213, DOI DOI 10.1016/J.S0CSCIMED.2012.01.002; Cappuccio FP, 2004, INT J EPIDEMIOL, V33, P387, DOI 10.1093/ije/dyh091; Courbage Y, 1996, Popul, V8, P59; Deboosere P, 2005, POPULATION, V5-6, P655; DesGrande H, 2014, ETHN HLTH, V19, P122; desValk HAG, 2012, DEV I POLICY ASPECTS; Erdem H, 2012, CLIN MICROBIOL INFEC, V18, P1056, DOI 10.1111/1469-0691.12000; Garenne M, 2007, J HEALTH POPUL NUTR, V25, P212; Harding S, 2004, INT J EPIDEMIOL, V33, P382, DOI 10.1093/ije/dyh059; Harding S, 2008, INT J EPIDEMIOL, V37, P162, DOI 10.1093/ije/dym252; Ingleby David, 2012, Psychosocial Intervention, V21, P331, DOI 10.5093/in2012a29; Khlat M, 2003, INT J EPIDEMIOL, V32, P1115, DOI 10.1093/ije/dyg308; Kimbro RT, 2009, SOC SCI QUART, V90, P1145, DOI 10.1111/j.1540-6237.2009.00651.x; Kouris-Blazos A, 2002, ASIA PAC J CLIN NUTR, V11, pS569, DOI 10.1046/j.1440-6047.11.supp3.2.x; MARMOT MG, 1984, LANCET, V1, P1455; Marmot MG, 1992, PUBLIC HLTH REV, V21, P185; Marsiglia FF, 2005, AM J ORTHOPSYCHIAT, V75, P585, DOI 10.1037/0002-9432.75.4.585; Martiniello M., 2010, NIEUWE MIGRATIES NIE; Nicolaou M, 2009, J NUTR EDUC BEHAV, V41, P232, DOI 10.1016/j.jneb.2008.05.011; Norredam M, 2015, EUR J PUBLIC HEALTH, V25, P84, DOI 10.1093/eurpub/cku138; Norredam M, 2014, TROP MED INT HEALTH, V19, P958, DOI 10.1111/tmi.12340; Parkin DM, 1996, EUR J CANCER, V32A, P761, DOI 10.1016/0959-8049(96)00062-7; Razum O, 1998, TROP MED INT HEALTH, V3, P297, DOI 10.1046/j.1365-3156.1998.00233.x; Razum O, 2002, TROP MED INT HEALTH, V7, P4, DOI 10.1046/j.1365-3156.2002.00833.x; Spallek J, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-6; Szaflarski M, 2011, J IMMIGR MINOR HEALT, V13, P647, DOI 10.1007/s10903-010-9394-9; Tarnutzer S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1104; Uitenbroek DG, 2002, SOC SCI MED, V54, P1379, DOI 10.1016/S0277-9536(01)00120-4; Vandenheede H, 2013, J EPIDEMIOL COMMUN H, V67, P765, DOI 10.1136/jech-2012-202290; Vandenheede H, 2011, INT J PUBLIC HEALTH, V56, P533, DOI 10.1007/s00038-011-0235-y; VansHecke E, 2007, BELGISCHE STADSGEWES; Wallace M, 2014, SOC SCI MED, V120, P100, DOI 10.1016/j.socscimed.2014.08.032	41	21	21	0	14	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	DEC	2015	20	12					1832	1845		10.1111/tmi.12610				14	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CZ8JA	WOS:000367344800024	26426523	Bronze			2019-04-02	
J	Gonzalez, AE; Bustos, JA; Garcia, HH; Rodriguez, S; Zimic, M; Castillo, Y; Praet, N; Gabriel, S; Gilman, RH; Dorny, P				Gonzalez, Armando E.; Bustos, Javier A.; Garcia, Hector H.; Rodriguez, Silvia; Zimic, Mirko; Castillo, Yesenia; Praet, Nicolas; Gabriel, Sarah; Gilman, Robert H.; Dorny, Pierre		Cysticercosis Working Grp Peru	Successful Antiparasitic Treatment for Cysticercosis Is Associated with a Fast and Marked Reduction of Circulating Antigen Levels in a Naturally Infected Pig Model	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							TAENIA-SAGINATA CYSTICERCOSIS; INTRAVENTRICULAR HUMAN NEUROCYSTICERCOSIS; LINKED IMMUNOELECTROTRANSFER BLOT; IN-FIELD CONDITIONS; PORCINE CYSTICERCOSIS; FOLLOW-UP; SOLIUM CYSTICERCOSIS; CEREBROSPINAL-FLUID; HP10 ANTIGEN; DIAGNOSIS	Taenia solium cysticercosis is a common parasitic infection of humans and pigs. We evaluated the posttreatment evolution of circulating parasite-specific antigen titers in 693 consecutive blood samples from 50 naturally infected cysticercotic pigs, which received different regimes of antiparasitic drugs (N = 39, 7 groups), prednisone (N = 5), or controls (N = 6). Samples were collected from baseline to week 10 after treatment, when pigs were euthanized and carefully dissected at necropsy. Antigen levels decreased proportionally to the efficacy of treatment and correlated with the remaining viable cysts at necropsy (Pearson's p = 0.67, P = 0.000). A decrease of 5 times in antigen levels (logarithmic scale) compared with baseline was found in 20/26 pigs free of cysts at necropsy, compared with 1/24 of those who had persisting viable cysts (odds ratio [OR] = 76.7, 95% confidence interval [CI] = 8.1-3308.6, P < 0.001). Antigen monitoring reflects the course of infection in the pig. If a similar correlation exists in infected humans, this assay may provide a minimally invasive and easy monitoring assay to assess disease evolution and efficacy of antiparasitic treatment in human neurocysticercosis.	Univ Nacl Mayor San Marcos, Sch Vet Med, Lima 14, Peru; [Bustos, Javier A.; Rodriguez, Silvia] Univ Peruana Cayetano Heredia, Dept Microbiol, Sch Sci, Ctr Global Hlth Tumbes, Lima 31, Peru; [Zimic, Mirko] Univ Peruana Cayetano Heredia, Labs Invest & Desarrollo, Unidad Bioinformat, Lima 31, Peru; [Garcia, Hector H.] Inst Nacl Ciencias Neurol, Cysticercosis Unit, Lima, Peru; [Bustos, Javier A.; Rodriguez, Silvia] Inst Peruano Parasitol Clin & Expt, Lima, Peru; Prince Leopold Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Gonzalez, Armando E.] Sch Vet Med, Lima, Peru; [Garcia, Hector H.; Castillo, Yesenia] Univ Peruana Cayetano Heredia, Dept Microbiol, Sch Sci, Lima 31, Peru; [Garcia, Hector H.; Castillo, Yesenia] Univ Peruana Cayetano Heredia, Ctr Global Hlth Tumbes, Lima 31, Peru; [Praet, Nicolas; Gabriel, Sarah; Dorny, Pierre] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Gilman, Robert H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Garcia, HH (reprint author), Univ Peruana Cayetano Heredia, Dept Microbiol, SMP, Ave Honorio Delgado 430, Lima 31, Peru.	agonza41@jhu.edu; javier.bustos@jhu.edu; hgarcia@jhsph.edu; silvia@peruresearch.org; mirko.zimic@upch.pe; yesicabe9@yahoo.es; npraet@itg.be; sgabriel@itg.be; gilmanbob@gmail.com; pdomy@itg.be		Gonzalez, Armando/0000-0003-1909-1873; GABRIEL, SARAH/0000-0002-2523-233X	Fogarty International Center/NIH [TW001140]; Bill and Melinda Gates Foundation [23981, NIH-1R01AI116456-01]; Wellcome Trust Senior Research Fellowship in Tropical Medicine and Public Health	Partial support from the Fogarty International Center/NIH (Training Grant no. TW001140), the Bill and Melinda Gates Foundation (Grant no. 23981), and NIH-1R01AI116456-01 is acknowledged. Hector H. Garcia is supported by a Wellcome Trust Senior Research Fellowship in Tropical Medicine and Public Health.	Bobes RJ, 2006, TROP MED INT HEALTH, V11, P943, DOI 10.1111/j.1365-3156.2006.01642.x; BRANDT JRA, 1992, INT J PARASITOL, V22, P471, DOI 10.1016/0020-7519(92)90148-E; Bustos JA, 2005, T ROY SOC TROP MED H, V99, P775, DOI 10.1016/j.trstmh.2005.04.011; Castillo Y, 2009, AM J TROP MED HYG, V80, P379, DOI 10.4269/ajtmh.2009.80.379; CORREA D, 1989, T ROY SOC TROP MED H, V83, P814, DOI 10.1016/0035-9203(89)90340-4; Dayan AD, 2003, ACTA TROP, V86, P141, DOI 10.1016/S0001-706X(03)00031-7; Deckers N, 2008, INT J PARASITOL, V38, P1191, DOI 10.1016/j.ijpara.2008.01.005; Del Brutto OH, 2012, SCI WORLD J, DOI 10.1100/2012/159821; Dixon HB, 1961, CYSTICERCOSIS ANAL F, V299; Dorny P, 2004, INT J PARASITOL, V34, P569, DOI 10.1016/j.ijpara.2003.11.014; Dorny P, 2000, VET PARASITOL, V88, P43, DOI 10.1016/S0304-4017(99)00196-X; Fleury A, 2007, J NEUROL NEUROSUR PS, V78, P970, DOI 10.1136/jnnp.2006.107243; Fleury A, 2003, T ROY SOC TROP MED H, V97, P542, DOI 10.1016/S0035-9203(03)80019-6; Fleury A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002096; Flores Menendez JA, 1986, GANADO PORCINO CRIA; Garcia HH, 2014, LANCET NEUROL, V13, P1202, DOI 10.1016/S1474-4422(14)70094-8; Garcia HH, 2012, TROP MED INT HEALTH, V17, P1014, DOI 10.1111/j.1365-3156.2012.03037.x; Garcia HH, 2001, AM J TROP MED HYG, V65, P31, DOI 10.4269/ajtmh.2001.65.31; Garcia HH, 2005, AM J TROP MED HYG, V72, P3, DOI 10.4269/ajtmh.2005.72.3; Gavidia CM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002192; GONZALEZ AE, 1995, AM J TROP MED HYG, V53, P571, DOI 10.4269/ajtmh.1995.53.571; GONZALEZ AE, 1990, AM J TROP MED HYG, V43, P194, DOI 10.4269/ajtmh.1990.43.194; Gonzalez AE, 2012, AM J TROP MED HYG, V87, P292, DOI 10.4269/ajtmh.2012.11-0371; HARRISON LJS, 1989, PARASITE IMMUNOL, V11, P351, DOI 10.1111/j.1365-3024.1989.tb00673.x; Jung Helgi, 2002, P363, DOI 10.1079/9780851996288.0363; Mkupasi EM, 2013, ACTA TROP, V128, P48, DOI 10.1016/j.actatropica.2013.06.010; Nguekam, 2003, PARASITE, V10, P65, DOI 10.1051/parasite/2003101p65; Nguekam A, 2003, VET PARASITOL, V111, P323, DOI 10.1016/S0304-4017(02)00391-6; O'Keefe KA, 2015, AM J TROP MED HYG, V92, P354, DOI 10.4269/ajtmh.14-0506; Peniche-Cardena A, 2002, VET PARASITOL, V108, P63, DOI 10.1016/S0304-4017(02)00177-2; Praet N, 2010, AM J TROP MED HYG, V83, P413, DOI 10.4269/ajtmh.2010.10-0121; Rodriguez S, 2009, J INFECT DIS, V199, P1345, DOI 10.1086/597757; Santamaria E, 2002, J PARASITOL, V88, P69, DOI 10.2307/3285392; Sciutto E, 1998, VET PARASITOL, V79, P299, DOI 10.1016/S0304-4017(98)00180-0; Sciutto E, 1998, VET PARASITOL, V78, P185, DOI 10.1016/S0304-4017(98)00129-0; Straw BJ, 1992, DIS SWINE, P793; TSANG VCW, 1989, J INFECT DIS, V159, P50, DOI 10.1093/infdis/159.1.50; Van Kerckhoven I, 1998, VET PARASITOL, V76, P269, DOI 10.1016/S0304-4017(97)00226-4; Wallin MT, 2004, NEUROLOGY, V63, P1559, DOI 10.1212/01.WNL.0000142979.98182.FF; WILSON M, 1991, J INFECT DIS, V164, P1007, DOI 10.1093/infdis/164.5.1007; Zamora HSR, 2004, AM J TROP MED HYG  S, V71, P42	41	5	5	0	10	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2015	93	6					1305	1310		10.4269/ajtmh.15-0370				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CY6TD	WOS:000366540800030	26392159	Green Published, Bronze			2019-04-02	
J	Heng, S; Durnez, L; Gryseels, C; Van Roey, K; Mean, V; Uk, S; Siv, S; Grietens, KP; Sochantha, T; Coosemans, M; Sluydts, V				Heng, Somony; Durnez, Lies; Gryseels, Charlotte; Van Roey, Karel; Mean, Vanna; Uk, Sambunny; Siv, Sovannaroth; Grietens, Koen Peeters; Sochantha, Tho; Coosemans, Marc; Sluydts, Vincent			Assuring access to topical mosquito repellents within an intensive distribution scheme: a case study in a remote province of Cambodia	MALARIA JOURNAL			English	Article						Distribution; Access; Malaria; Repellents	INSECTICIDE-TREATED NETS; MALARIA TRANSMISSION; MEASLES VACCINATION; PERSONAL-PROTECTION; EQUITABLE COVERAGE; COMMUNITY TRIAL; BED NETS; CAMPAIGN; INTERVENTIONS; OWNERSHIP	Background: The public health value of a vector control tool depends on its epidemiological efficacy, but also on its ease of implementation. This study describes an intensive distribution scheme of a topical repellent implemented in 2012 and 2013 for the purpose of a cluster-randomized trial using the existing public health system. The trial aimed to assess the effectiveness of repellents in addition to long-lasting insecticidal nets (LLIN) and occurred in a province of Cambodia. Determinants for accessibility and consumption of this tool were explored. Methods: 135 individuals were appointed to be repellent distributors in 57 villages. A 2-weekly bottle exchange programme was organized. Distributors recorded information regarding the amount of bottles exchanged, repellent leftover, and reasons for not complying in household data sheets. Distributor-household contact rates and average 2-weekly consumption of repellent were calculated. Household and distributors characteristics were obtained using questionnaires, surveying 50 households per cluster and all distributors. Regression models were used to explore associations between contact and consumption rates and determinants such as socio-economic status. Operational costs for repellent and net distribution were obtained from the MalaResT project and the provincial health department. Results: A fourfold increase in distributor-household contact rates was observed in 2013 compared to 2012 (median(2012) = 20 %, median(2013) = 88.9 %). Consumption rate tripled over the 2-year study period (median(2012) = 20 %, median(2013) = 57.89 %). Contact rates were found to associate with district, commune and knowing the distributor, while consumption was associated with district and household head occupation. The annual operational cost per capita for repellent distribution was 31 times more expensive than LLIN distribution (USD 4.33 versus USD 0.14). Discussion: After the existing public health system was reinforced with programmatic and logistic support, an intense 2-weekly distribution scheme of a vector control tool over a 2-year period was operated successfully in the field. Lack of associations with socio-economic status suggested that the free distribution strategy resulted in equitable access to repellents. The operational costs for the repellent distribution and exchange programme were much higher than LLIN distribution. Such effort could only be justified in the context of malaria elimination where these interventions are expected to be limited in time.	[Heng, Somony; Mean, Vanna; Uk, Sambunny; Siv, Sovannaroth; Sochantha, Tho] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Heng, Somony; Durnez, Lies; Gryseels, Charlotte; Van Roey, Karel; Grietens, Koen Peeters; Coosemans, Marc; Sluydts, Vincent] Inst Trop Med, B-2000 Antwerp, Belgium; [Heng, Somony; Coosemans, Marc; Sluydts, Vincent] Univ Antwerp, B-2020 Antwerp, Belgium; [Grietens, Koen Peeters] Nagasaki Univ, Sch Int Hlth Dev, Nagasaki 852, Japan; [Grietens, Koen Peeters] Partners Appl Social Sci PASS Int, Tessenderlo, Belgium	Heng, S (reprint author), Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia.	hengsomony@gmail.com		Peeters Grietens, Koen/0000-0001-6570-9887; Gryseels, Charlotte/0000-0002-8963-4469	Bill and Melinda Gates foundation [OPP1032354]; Belgian Co-operation	This study was funded by the Bill and Melinda Gates foundation within the MalaResT project (Global Health Grant number OPP1032354). SC Johnson provided the repellents for free of charge distribution. Capacity strengthening of CNM was financially supported by the Belgian Co-operation (Framework Agreement ITM-CNM-Directorate-General for Development Cooperation). We sincerely acknowledge all those who assisted the study including Ratanakiri provincial health department and health centre staff, supervisors, local authorities and especially all participants who volunteered in the study.	Al-Delaimy AK, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-416; Amoran OE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-728; Babu BV, 2007, ANN TROP MED PARASIT, V101, P601, DOI 10.1179/136485907X193897; Bates D., 2014, LME4 LINEAR MIXED EF, DOI DOI 10.18637/JSS.V067.I01; Bekker LG, 2015, LANCET, V385, P72, DOI 10.1016/S0140-6736(14)60974-0; Bernard J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-65; Bonner K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-73; Cambodia National Malaria Center, 2011, CAMBODIA NATL MALARI; de Oliveira AM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-222; Deribew A., 2012, MALARIA J, V11, P11; Desrochers RE, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-260; Dickinson KL, 2012, GLOB PUBLIC HEALTH, V7, P384, DOI 10.1080/17441692.2010.539573; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; Fox J, 2009, SE ASIAN STUD, V47, P309; Frances S.P., 2007, INSECT REPELLENTS PR, P397; Gething PW, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-39; Govella NJ, 2010, AM J TROP MED HYG, V82, P415, DOI 10.4269/ajtmh.2010.09-0579; Grabowsky M, 2005, TROP MED INT HEALTH, V10, P1151, DOI 10.1111/j.1365-3156.2005.01502.x; Grabowsky M, 2005, B WORLD HEALTH ORGAN, V83, P195; Gryseels C, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0689-0; Gryseels C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080343; Hansen Melissa, 2008, NCSL Legisbrief, V16, P1; Hill J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001488; Kajubi P, 2005, JAIDS-J ACQ IMM DEF, V40, P77, DOI 10.1097/01.qai.0000157391.63127.b2; Kimani EW, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-63; Lu L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003643; Maude RJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-385; Monroe A, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0543-4; Onwujekwe O, 2006, HEALTH POLICY PLANN, V21, P10, DOI 10.1093/hepol/czj004; Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439; Pinheiro J., 2015, NLME LINEAR NONLINEA; R Core Team, 2015, R LANG ENV STAT COMP; RACHA, 2012, RACHA COMMUNITY ENGA; Rowland M, 1999, T ROY SOC TROP MED H, V93, P465, DOI 10.1016/S0035-9203(99)90341-3; Singh M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-268; Singhasivanon P, 2013, SE ASIAN J TROP MED, V44, P249; Suwonkerd W, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P273, DOI 10.5772/56347; Thang Ngo Duc, 2009, PLoS One, V4, pe7369, DOI 10.1371/journal.pone.0007369; Tusting LS, 2013, LANCET, V382, P963, DOI 10.1016/S0140-6736(13)60851-X; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Xu JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103780; Yasuoka J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-4; Yasuoka J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-109; Yeung S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-96	44	3	3	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	NOV 24	2015	14								468	10.1186/s12936-015-0960-4				13	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CW7DV	WOS:000365159100001	26597653	DOAJ Gold, Green Published			2019-04-02	
J	Madinga, J; Linsuke, S; Mpabanzi, L; Meurs, L; Kanobana, K; Speybroeck, N; Lutumba, P; Polman, K				Madinga, Joule; Linsuke, Sylvie; Mpabanzi, Liliane; Meurs, Lynn; Kanobana, Kirezi; Speybroeck, Niko; Lutumba, Pascal; Polman, Katja			Schistosomiasis in the Democratic Republic of Congo: a literature review	PARASITES & VECTORS			English	Review							TARGETED MASS TREATMENT; INTESTINAL SCHISTOSOMIASIS; KIVU-PROVINCE; MANSONI FOCUS; ZAIRE; MANIEMA; KINSHASA; PREVALENCE; DISEASES; BURDEN	Schistosomiasis is a poverty-related parasitic infection, leading to chronic ill-health. For more than a century, schistosomiasis has been known to be endemic in certain provinces of the Democratic Republic of Congo (DRC). However, a clear overview on the status of the disease within the country is currently lacking, which is seriously hampering control. Here, we review the available information on schistosomiasis in DRC of the past 60 years. Findings and data gaps are discussed in the perspective of upcoming control activities. An electronic literature search via PubMed complemented by manual search of non-peer-reviewed articles was conducted up to January 2015. The search concerned all relevant records related to schistosomiasis in the DRC from January 1955 onwards. A total of 155 records were found, of which 30 met the inclusion criteria. Results were summarized by geographical region, mapped, and compared with those reported sixty years ago. The available data reported schistosomiasis in some areas located in 10 of the 11 provinces of DRC. Three species of Schistosoma were found: S. mansoni, S. haematobium and S. intercalatum. The prevalence of schistosomiasis varied greatly between regions and between villages, with high values of up to 95 % observed in some communities. The overall trend over 60 years points to the spread of schistosomiasis to formerly non-endemic areas. The prevalence of schistosomiasis has increased in rural endemic areas and decreased in urban/peri-urban endemic areas of Kinshasa. Hepatosplenomegaly, urinary tract lesions and anaemia were commonly reported in schistosomiasis endemic areas but not always associated with infection status. The present review confirms that schistosomiasis is still endemic in DRC. However, available data are scattered across time and space and studies lack methodological uniformity, hampering a reliable estimation of the current status of schistosomiasis in DRC. There is a clear need for updated prevalence data and well-designed studies on the epidemiology and transmission of schistosomiasis in DRC. This will aid the national control program to adequately design and implement strategies for sustainable and comprehensive control of schistosomiasis throughout the country.	[Madinga, Joule; Speybroeck, Niko] Catholic Univ Louvain, Inst Hlth & Soc, B-1200 Brussels, Belgium; [Madinga, Joule; Mpabanzi, Liliane; Meurs, Lynn; Kanobana, Kirezi; Polman, Katja] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Linsuke, Sylvie; Lutumba, Pascal] Inst Natl Rech Biomed, Kinshasa, Zaire; [Lutumba, Pascal] Univ Kinshasa, Dept Trop Med, Kinshasa, Zaire	Madinga, J (reprint author), Catholic Univ Louvain, Inst Hlth & Soc, B-1200 Brussels, Belgium.	jmadinga@yahoo.fr	Meurs, Lynn/J-8661-2016	Meurs, Lynn/0000-0002-6973-1237; Joule, Madinga/0000-0003-2661-234X	"developping cooperation" scholarschip of the Universite catholique de Louvain, Belgium	The authors received no specific funding for this work. Joule Madinga is a PhD student supported by the "developping cooperation" scholarschip of the Universite catholique de Louvain, Belgium. The authors would like to thank the OSFAC team for geographical data.	Baluku B, 2000, THESIS GEORGIA STATE, V60, P163; BENNIKE T, 1976, ANN SOC BELG MED TR, V56, P419; Chitsulo L, 2004, NAT REV MICROBIOL, V2, P12, DOI 10.1038/nrmicro801; COLAERT J, 1977, ANN SOC BELG MED TR, V57, P157; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; DECLERCQ D, 1987, ANN SOC BELG MED TR, V67, P345; DECLERCQ D, 1985, ANN SOC BELG MED TR, V65, P153; deOnis M, 1996, AM J CLIN NUTR, V64, P650; Friedman JF, 2005, TRENDS PARASITOL, V21, P386, DOI 10.1016/j.pt.2005.06.006; GILLET J, 1954, Bull World Health Organ, V10, P315; GRYSEELS B, 1983, ANN SOC BELG MED TR, V63, P341; Gryseels B, 1981, Ann Soc Belg Med Trop, V60, P313; GRYSEELS B, 1987, T ROY SOC TROP MED H, V81, P202, DOI 10.1016/0035-9203(87)90215-X; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Hall A, 2008, MATERN CHILD NUTR, V4, P118, DOI 10.1111/j.1740-8709.2007.00127.x; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Jukes MCH, 2002, TROP MED INT HEALTH, V7, P104; Lengeler C, 2000, ACTA TROP, V74, P77, DOI 10.1016/S0001-706X(99)00046-7; Linsuke S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003387; MANDAHL-BARTH G, 1974, Revue de Zoologie Africaine, V88, P553; Matangila JR, 2014, DEMOCRATIC REPUBLIC, V9; Mbuyi MK, 2012, THESIS; MONSEUR J, 1972, Bulletin de la Societe de Pathologie Exotique, V65, P822; MULLER G, 1986, ANN SOC BELG MED TR, V66, P225; POLDERMAN A M, 1982, Acta Leidensia, V49, P17; POLDERMAN AM, 1985, ANN SOC BELG MED TR, V65, P243; POLDERMAN AM, 1986, TROP MED PARASITOL, V37, P195; POLDERMAN AM, 1984, SOC SCI MED, V19, P1073, DOI 10.1016/0277-9536(84)90311-3; POLDERMAN AM, 1989, TROP MED PARASITOL, V40, P177; POLDERMAN AM, 1985, ANN SOC BELG MED TR, V65, P251; POLDERMAN AM, 1984, T ROY SOC TROP MED H, V78, P752, DOI 10.1016/0035-9203(84)90007-5; POLDERMAN AM, 1988, T ROY SOC TROP MED H, V82, P115, DOI 10.1016/0035-9203(88)90282-9; POLDERMAN AM, 1981, LANCET, V1, P27; Pullan R, 2008, PARASITOLOGY, V135, P783, DOI 10.1017/S0031182008000346; Raccurt C., 1974, Bulletin Soc Path Exot, V67, P402; Republique Democratique du Congo Ministere de la Sante Publique, 2012, PLAN CADR LUTT INT M; Richter J, 1996, ULTRASOUND SCHISTOSO; Ripert C, 1970, Bull Soc Pathol Exot Filiales, V63, P580; Ripert C, 1970, Bull Soc Pathol Exot Filiales, V63, P562; Ripert C, 1969, Bull Soc Pathol Exot Filiales, V62, P571; SCHWETZ J, 1956, Ann Soc Belg Med Trop (1920), V36, P845; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Stephenson LS, 2000, PARASITOLOGY, V121, pS23, DOI 10.1017/S0031182000006491; Tchuente LAT, 1997, T ROY SOC TROP MED H, V91, P263, DOI 10.1016/S0035-9203(97)90068-7; United Nations Environment Programme, 2011, WAT ISS DEM REP CONG; VANEE JH, 1984, TROP GEOGR MED, V36, P259; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; WHO, 2011, HELMINTH CONTROL IN SCHOOL-AGE CHILDREN: A GUIDE FOR MANAGERS OF CONTROL PROGRAMMES, SECOND EDITION, P1; WHO, 2001, IR DEF AN ASS PREV C; World Health Organisation, 1967, EPID CONTR SCHIST RE; World Health Organization & UNICEF, 2004, PREV CONTR SCHIST SO	51	5	5	0	8	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	NOV 19	2015	8								601	10.1186/s13071-015-1206-6				10	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CW9PL	WOS:000365330600002	26586232	DOAJ Gold, Green Published			2019-04-02	
J	Degarege, A; Erko, B; Mekonnen, Z; Legesse, M; Negash, Y; Vercruysse, J; Levecke, B				Degarege, Abraham; Erko, Berhanu; Mekonnen, Zeleke; Legesse, Mengistu; Negash, Yohannes; Vercruysse, Jozef; Levecke, Bruno			Comparison of individual and pooled urine samples for estimating the presence and intensity of Schistosoma haematobium infections at the population level	PARASITES & VECTORS			English	Article						Schistosoma haematobium; Pooling; Infection intensity; Sensitivity; Mass drug administration; Monitoring and evaluation; Ethiopia	NEGLECTED TROPICAL DISEASES; STOOL SAMPLES; GLOBAL BURDEN; PREVALENCE; DIAGNOSIS; ETHIOPIA; MANSONI	Background: There is a lack of cost-effective diagnostic strategies to evaluate whether mass drug administration (MDA) programmes to control Schistosoma haematobium progress as anticipated. The purpose of this study is to provide a proof-of-principle for examination of pooled urine samples as a strategy for rapid assessment of presence and intensity of Schistosoma haematobium infections at the population level. Methods: A total of 640 urine samples were collected from 520 school-aged children (520 at baseline and 120 at follow-up) during a clinical trial that was designed to assess the efficacy of praziquantel against Schistosoma haematobium infections in Ethiopia. Individual and pooled urine samples were screened using the filtration technique (volume of 10 ml urine) to determine the number of S. haematobium eggs in 10 ml of urine. Samples were pooled into pools of 5 (n = 128), 10 (n = 64) and 20 (n = 32) individual samples. The sensitivity, the probability of finding at least one egg in a pooled sample when the mean urine egg count (UEC) of the corresponding individual urine samples was not zero, was calculated for each pool size. UECs of a pooled examination strategy were compared with the mean UECs of the corresponding individual samples. Results: The sensitivity of a pooled examination strategy was 50.6 % for pools of 5, 68.6 % for pools of 10 and 63.3 % for pools of 20. The sensitivity of a pooled examination strategy increased as a function of increasing mean UEC of the corresponding individual urine samples. For each of the three pool sizes, there was a significant positive correlation between mean UECs of individual and those obtained in pooled samples (correlation coefficient: 0.81 - 0.93). Examination of pools of 5 provided significantly lower UECs compared to the individual examination strategy (3.9 eggs/10 ml urine versus 5.0 eggs/10 ml urine). For pools of 10 (4.4 eggs/10 ml) and 20 (4.2 eggs/10 ml), no significant difference in UECs was observed. Conclusions: Examination of pooled urine samples applying urine filtration holds promise for rapid assessment of intensity of S. haematobium infections, but may fail to detect presence of infections when endemicity is low. Further investigation is required to determine when and how pooling can be optimally implemented in monitoring of mass drug administration programmes.	[Degarege, Abraham; Erko, Berhanu; Legesse, Mengistu; Negash, Yohannes] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Degarege, Abraham] Florida Int Univ, Dept Epidemiol, Robert Stempel Coll Publ Hlth & Social Work, Miami, FL 33199 USA; [Mekonnen, Zeleke] Jimma Univ, Dept Med Lab Sci & Pathol, Coll Publ Hlth & Med Sci, Jimma, Ethiopia; [Vercruysse, Jozef; Levecke, Bruno] Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, Merelbeke, Belgium	Degarege, A (reprint author), Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia.	abrahamdegarege@yahoo.com		Levecke, Bruno/0000-0001-8912-5595			Ayele B, 2008, PARASITE, V15, P69, DOI 10.1051/parasite/2008151069; Deribew Ketema, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P307, DOI 10.1016/S2221-1691(13)60068-4; Eysker M, 2008, VET PARASITOL, V151, P249, DOI 10.1016/j.vetpar.2007.10.008; Fc B, 1990, AUST VET J, V67, P165; Hotez PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002865; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Ibironke OA, 2011, AM J TROP MED HYG, V84, P998, DOI 10.4269/ajtmh.2011.10-0691; Knopp S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003752; Kure A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1101-1; Levecke B, 2015, ADV PARASIT, V87, P193, DOI 10.1016/bs.apar.2015.01.001; Mekonnen Z, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002189; Mitchell S, 2012, AM J TROP MED HYG, V87, P850, DOI 10.4269/ajtmh.2012.12-0216; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Speybroeck N, 2012, MED VET ENTOMOL, V26, P361, DOI 10.1111/j.1365-2915.2012.01015.x; United to Combat Neglected Tropical Diseases, 2015, 3 NTDS; Ward MP, 1997, VET PARASITOL, V73, P181, DOI 10.1016/S0304-4017(97)00060-5; WHO, 2015, NEGL TROP DIS NEW AG; World Health Organization, 2012, ACC WORK OV GLOB IMP; World Health Organization, 1991, BASIC LAB METHODS ME	19	3	3	1	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	NOV 16	2015	8								593	10.1186/s13071-015-1205-7				8	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CW9OZ	WOS:000365329400001	26572138	DOAJ Gold, Green Published			2019-04-02	
J	Matangila, JR; Mitashi, P; da Luz, RAI; Lutumba, PT; Van Geertruyden, JP				Matangila, Junior R.; Mitashi, Patrick; da Luz, Raquel A. Inocencio; Lutumba, Pascal T.; Van Geertruyden, Jean-Pierre			Efficacy and safety of intermittent preventive treatment for malaria in schoolchildren: a systematic review	MALARIA JOURNAL			English	Article						Intermittent preventive treatment; Efficacy; Safety; Schoolchildren; Review	PLACEBO-CONTROLLED TRIAL; SULFADOXINE-PYRIMETHAMINE; RETROSPECTIVE ANALYSIS; CLINICAL MALARIA; DRUG-RESISTANCE; CHILDREN; ANEMIA; TRANSMISSION; IMPACT; MORBIDITY	Background: Intermittent preventive treatment (IPT) is a proven malaria control strategy in infants and pregnancy. School-aged children represent 26 % of the African population, and an increasing percentage of them are scholarized. Malaria is causing 50 % of deaths in this age group and malaria control efforts may shift the malaria burden to older age groups. Schools have been suggested as a platform for health interventions delivery (deworming, iron-folic acid, nutrients supplementation, (boost-) immunization) and as a possible delivery system for IPT in schoolchildren (IPTsc). However, the current evidence on the efficacy and safety of IPTsc is limited and the optimal therapeutic regimen remains controversial. Methods: A systematic search for studies reporting efficacy and safety of IPT in schoolchildren was conducted using PubMed, Web of Science, Clinicaltrials and WHO/ICTRP database, and abstracts from congresses with the following key words: intermittent, preventive treatment AND malaria OR Plasmodium falciparum AND schoolchildren NOT infant NOT pregnancy. Results: Five studies were identified. Most IPTsc regimes demonstrated substantial protection against malaria parasitaemia, with dihydroartemisinin-piperaquine (DP) given monthly having the highest protective effect (PE) (94 %; 95 % CI 93-96). Contrarily, SP did not provide any PE against parasitaemia. However, no IPT regimen provided a PE above 50 % in regard to anaemia, and highest protection was provided by SP+ amodiaquine (AQ) given four-monthly (50 %; 95 % CI 41-53). The best protection against clinical malaria was observed in children monthly treated with DP (97 %; 95 % CI 87-98). However, there was no protection when the drug was given three-monthly. No severe adverse events were associated with the drugs used for IPTsc. Conclusion: IPTsc may reduce the malaria-related burden in schoolchildren. However, more studies assessing efficacy of IPT in particular against malaria-related anaemia and clinical malaria in schoolchildren must be conducted.	[Matangila, Junior R.; Mitashi, Patrick; Lutumba, Pascal T.] Univ Kinshasa, Dept Med Tropicale, Fac Med, Kinshasa XI, DEM REP CONGO; [Matangila, Junior R.; da Luz, Raquel A. Inocencio; Van Geertruyden, Jean-Pierre] Univ Antwerp, Epidemiol Global Hlth Inst, B-2610 Antwerp, Belgium	Matangila, JR (reprint author), Univ Antwerp, Epidemiol Global Hlth Inst, Campus DrieEiken,Univ Pl 1, B-2610 Antwerp, Belgium.	matangilaj@yahoo.fr	Van geertruyden, Jean-Pierre/K-6425-2014; Inocencio da Luz, Raquel/L-9676-2016	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Inocencio da Luz, Raquel/0000-0002-2870-0311			Al Serouri AW, 2000, PARASITOLOGY, V121, P337, DOI 10.1017/S0031182099006502; [Anonymous], 2013, A681 UN; Aponte JJ, 2009, LANCET, V374, P1533, DOI 10.1016/S0140-6736(09)61258-7; Barger B, 2009, TROP MED INT HEALTH, V14, P784, DOI 10.1111/j.1365-3156.2009.02294.x; Beasley NMR, 1999, TROP MED INT HEALTH, V4, P744, DOI 10.1046/j.1365-3156.1999.00486.x; Bojang K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011225; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Brooker S, 2008, T ROY SOC TROP MED H, V102, P304, DOI 10.1016/j.trstmh.2008.01.010; Bundy DAP, 2000, PARASITOL TODAY, V16, P181, DOI 10.1016/S0169-4758(00)01658-6; Bundy DAP, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1091; Cairns M, 2009, T ROY SOC TROP MED H, V103, P1199, DOI 10.1016/j.trstmh.2009.06.007; Calis JC, 2010, PLOS ONE, V5; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Clarke SE, 2004, AM J TROP MED HYG, V71, P732, DOI 10.4269/ajtmh.2004.71.732; Clarke SE, 2008, LANCET, V372, P127, DOI 10.1016/S0140-6736(08)61034-X; Crawley J, 2004, AM J TROP MED HYG, V71, P25, DOI 10.4269/ajtmh.2004.71.25; Dicko A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-123; Fast-Track-Initiative, 2007, QUAL ED ALL CHILDR M; Francis D, 2006, J INFECT DIS, V193, P978, DOI 10.1086/500951; Greenwood B, 2006, TROP MED INT HEALTH, V11, P983, DOI 10.1111/j.1365-3156.2006.01657.x; Guyatt HL, 2001, B WORLD HEALTH ORGAN, V79, P695; K'Oyugi BO, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1398-x; King N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138362; Knoblauch AM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-194; Konate AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000408; Kweku M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004000; Lalloo DG, 2006, LANCET INFECT DIS, V6, P780, DOI 10.1016/S1473-3099(06)70655-7; Lengeler C, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; Likwela JL, 2012, TROP MED INT HEALTH, V17, P322, DOI 10.1111/j.1365-3156.2011.02935.x; McGready R, 2009, LANCET, V374, P1478, DOI 10.1016/S0140-6736(09)61629-9; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Naidoo I, 2011, PARASITOLOGY, V138, P1469, DOI 10.1017/S0031182011000746; Nankabirwa J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013438; Nankabirwa JI, 2014, CLIN INFECT DIS, V58, P1404, DOI 10.1093/cid/ciu150; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Price RN, 2001, AM J TROP MED HYG, V65, P614, DOI 10.4269/ajtmh.2001.65.614; SCHULTZ LJ, 1994, AM J TROP MED HYG, V51, P515, DOI 10.4269/ajtmh.1994.51.515; Shulman CE, 1999, LANCET, V353, P632, DOI 10.1016/S0140-6736(98)07318-8; TRAPE JF, 1985, T ROY SOC TROP MED H, V79, P435, DOI 10.1016/0035-9203(85)90054-9; White NJ, 2005, PLOS MED, V2, P28, DOI 10.1371/journal.pmed.0020003; WHO, 2013, WORLD MALARIA REPORT 2013, P1	41	9	9	0	12	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	NOV 14	2015	14								450	10.1186/s12936-015-0988-5				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CV9SL	WOS:000364626800001	26574017	DOAJ Gold, Green Published			2019-04-02	
J	Mandeng, FDM; Bilong, CFB; Pariselle, A; Vanhove, MPM; Nyom, ARB; Agnese, JF				Mandeng, Francoise D. Messu; Bilong, Charles F. Bilong; Pariselle, Antoine; Vanhove, Maarten P. M.; Nyom, Arnold R. Bitja; Agnese, Jean-Francois			A phylogeny of Cichlidogyrus spp. (Monogenea, Dactylogyridea) clarifies a host-switch between fish families and reveals an adaptive component to attachment organ morphology of this parasite genus	PARASITES & VECTORS			English	Article						Phylogeny; Lateral transfer; Cichlidogyrus amieti; Aphyosemion; Nothobranchiidae; Cichlidae; Cameroon; Africa	N.-SP MONOGENEA; ANCYROCEPHALIDAE GILL PARASITES; GUPPIES POECILIA-RETICULATA; NOTHOBRANCHIUS-FURZERI; GYRODACTYLUS MONOGENEA; NATURAL-POPULATIONS; ENDEMIC CICHLIDAE; HARD PARTS; BODY-SIZE; PLATYHELMINTHES	Background: Parasite switches to new host species are of fundamental scientific interest and may be considered an important speciation mechanism. For numerous monogenean fish parasites, infecting different hosts is associated with morphological adaptations, in particular of the attachment organ (haptor). However, haptoral morphology in Cichlidogyrus spp. (Monogenea, Dactylogyridea), parasites of African cichlids, has been mainly linked to phylogenetic rather than to host constraints. Here we determined the position of Cichlidogyrus amieti, a parasite of species of Aphyosemion (Cyprinodontiformes, Nothobranchiidae) in the phylogeny of its congeners in order to infer its origin and assess the morphological changes associated with host-switching events. Methods: The DNA of specimens of C. amieti isolated from Aphyosemion cameronense in Cameroon was sequenced and analyzed together with that of Cichlidogyrus spp. from cichlid hosts. In order to highlight the influence of the lateral transfer of C. amieti on the haptoral sclerotised parts we performed a Principal Component Analysis (PCA) to compare the attachment organ structure of C. amieti to that of congeners infecting cichlids. Results: Cichlidogyrus amieti was found to be nested within a strongly supported clade of species described from Hemichromis spp. (i.e. C. longicirrus and C. dracolemma). This clade is located at a derived position of the tree, suggesting that C. amieti transferred from cichlids to Cyprinodontiformes and not inversely. The morphological similarity between features of their copulatory organs suggested that C. amieti shares a recent ancestor with C. dracolemma. It also indicates that in this case, these organs do not seem subjected to strong divergent selection pressure. On the other hand, there are substantial differences in haptoral morphology between C. amieti and all of its closely related congeners described from Hemichromis spp.. Conclusions: Our study provides new evidence supporting the hypothesis of the adaptive nature of haptor morphology. It demonstrates this adaptive component for the first time within Cichlidogyrus, the attachment organs of which were usually considered to be mainly phylogenetically constrained.	[Mandeng, Francoise D. Messu; Bilong, Charles F. Bilong] Univ Yaounde I, Fac Sci, Lab Parasitol & Ecol, Yaounde, Cameroon; [Pariselle, Antoine; Agnese, Jean-Francois] Univ Montpellier, Inst Sci Evolut, IRD UMR 226, CNRS UMR 5554, F-34095 Montpellier 05, France; [Vanhove, Maarten P. M.] Royal Museum Cent Africa, Biol Dept, B-3080 Tervuren, Belgium; [Vanhove, Maarten P. M.] Masaryk Univ, Fac Sci, Dept Bot & Zool, CZ-61137 Brno, Czech Republic; [Vanhove, Maarten P. M.] Univ Leuven, Lab Biodivers & Evolutionary Genom, Dept Biol, B-3000 Leuven, Belgium; [Nyom, Arnold R. Bitja] Univ Ngaoundere, Dept Biol Sci, Ngaoundere, Cameroon	Pariselle, A (reprint author), IRD, BP 1857, Yaounde, Cameroon.	antoine.pariselle@ird.fr	Agnese, jean-Francois/J-8302-2016; Pariselle, Antoine/L-5776-2016	Agnese, jean-Francois/0000-0002-6883-551X; Pariselle, Antoine/0000-0002-1591-7423; Vanhove, Maarten/0000-0003-3100-7566	IRD (Institut de Recherche pour le Developpement) in Cameroon through the project "Programme Pilote Regional: Foret Tropicale Humide d'Afrique Centrale" (PPR FTH-AC); Czech Science Foundation [P505/12/G112]	This work was partially funded (2013) by the representation of IRD (Institut de Recherche pour le Developpement) in Cameroon through the project "Programme Pilote Regional: Foret Tropicale Humide d'Afrique Centrale" (PPR FTH-AC). M.P.M.V. is supported by the Czech Science Foundation, Project no. P505/12/G112 (European Centre of Ichthyoparasitology (ECIP) - Centre of excellence). Sequences were produced through the technical facilities of the Centre Mediterraneen Environnement Biodiversite (CeMEB). Authors want to thank W. Boeger and the two anonymous referees for their input to the revised version of the manuscript. This is publication ISE-M 2015-179 SUD.	Amiet J-L, 1987, 2 LE GENRE APHYOSEMI; Appleby C, 1996, SYST PARASITOL, V33, P199, DOI 10.1007/BF01531201; Bakke TA, 2007, ADV PARASIT, V64, P161, DOI 10.1016/S0065-308X(06)64003-7; Barson M, 2010, PARASITOLOGY, V137, P1585, DOI 10.1017/S0031182010000302; Bartakova V, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-196; Basolo AL, 2004, BIOL J LINN SOC, V83, P87, DOI 10.1111/j.1095-8312.2004.00369.x; BAUER ON, 1991, J FISH BIOL, V39, P679, DOI 10.1111/j.1095-8649.1991.tb04398.x; Bilong Bilong CF, 1995, THESIS U YAOUNDE YAO; BILONG CFB, 1991, ANN PARASIT HUM COMP, V66, P105, DOI 10.1051/parasite/1991663105; BIRGI E, 1983, B SOC ZOOL FR, V108, P101; Boeger WA, 2003, ZOOL SCR, V32, P437, DOI 10.1046/j.1463-6409.2003.00130.x; Brant SV, 2005, PLOS PATHOG, V1, P167, DOI 10.1371/journal.ppat.0010038; BROSSET A, 1982, REV ECOL-TERRE VIE, V36, P233; Bueno-Silva M, 2011, INT J PARASITOL, V41, P657, DOI 10.1016/j.ijpara.2011.01.002; Bush SE, 2006, J PARASITOL, V92, P25, DOI 10.1645/GE-612R.1; Butlin R., 1989, P158; BUTLIN RK, 1995, TRENDS ECOL EVOL, V10, P432, DOI 10.1016/S0169-5347(00)89173-9; BYCHOWSKY B E, 1970, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Zoologia, V41, P19; Cable J, 2007, BIOL J LINN SOC, V90, P647, DOI 10.1111/j.1095-8312.2006.00755.x; Cable J, 2005, SYST PARASITOL, V60, P159, DOI 10.1007/s11230-004-6348-4; Cable J, 2002, J PARASITOL, V88, P183, DOI 10.1645/0022-3395(2002)088[0183:BFTITV]2.0.CO;2; Cellerino A, 2016, BIOL REV, V91, P511, DOI 10.1111/brv.12183; Christison KW, 2005, SYST PARASITOL, V60, P165, DOI 10.1007/s11230-004-6342-x; Cooper N, 2012, ECOL LETT, V15, P1370, DOI 10.1111/j.1461-0248.2012.01858.x; Dargent F, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2371; DELEON GPP, 2005, J BIOGEOGR, V32, P645, DOI DOI 10.1111/J.1365-2699.2005.01218.X; Diesing KM, 1850, SYSTEMA HELMINTHUM, VI; DOSSOU C, 1984, ANN SCI NAT ZOOL, V6, P101; DOSSOU C, 1982, Bulletin de l'Institut Fondamental d'Afrique Noire Serie A Sciences Naturelles, V44, P295; El Gharbi S., 1993, Cahiers d'Ethologie, V13, P223; Endler JA, 1982, EVOLUTION, V36, P125; ERGENS R, 1981, FOLIA PARASIT, V28, P205; ERGENS R, 1985, FOLIA PARASIT, V32, P377; Euzet L., 1980, Memoires Societe Zoologique de France, V40, P239; Euzet L, 1977, B MUSEUM NATL HIST N, V329, P799; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Friedman M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1733; Genade T, 2005, AGING CELL, V4, P223, DOI 10.1111/j.1474-9726.2005.00165.x; GUEGAN JF, 1990, SYST PARASITOL, V17, P153, DOI 10.1007/BF00009552; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Huyse T, 2004, SYST PARASITOL, V58, P105, DOI 10.1023/B:SYPA.0000029423.68703.43; Huyse T, 2003, INT J PARASITOL, V33, P1679, DOI 10.1016/S0020-7519(03)00253-4; Huyse T, 2002, INT J PARASITOL, V32, P907, DOI 10.1016/S0020-7519(02)00026-7; Jiggins CD, 2000, TRENDS ECOL EVOL, V15, P250, DOI 10.1016/S0169-5347(00)01873-5; KANEKO JJ, 1988, J FISH DIS, V11, P295; King TA, 2009, PARASITOL INT, V58, P249, DOI 10.1016/j.parint.2009.04.005; Laurent P, 2006, MOL PHYLOGENET EVOL, V38, P241, DOI 10.1016/j.ympev.2005.08.013; Malmberg G., 1957, SKRIFTER UTGIVNA SOD, P19; Mancheva K., 2009, BIOTECHNOL BIOTECHNO, V23, P735; Marchiori NC, 2015, FOLIA PARASIT, V62; Marcogliese DJ, 2005, MARINE PARASITOLOGY, P279; Markevich AP, 1934, PARASITIC DIS FISH T, P3; Mendlova M, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-69; Mendlova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037268; Mendlova M, 2010, PARASITOL RES, V107, P1405, DOI 10.1007/s00436-010-2008-6; MIZELLE JD, 1965, J PARASITOL, V51, P30, DOI 10.2307/3275640; MIZELLE JOHN D., 1936, AMER MIDLAND NAT, V17, P785, DOI 10.2307/2420687; Morand S, 2000, BIOL J LINN SOC, V70, P239, DOI 10.1006/bijl.1999.0370; Morand S, 2002, INT J PARASITOL, V32, P111, DOI 10.1016/S0020-7519(01)00347-2; Murray AM, 2001, BIOL J LINN SOC, V74, P517, DOI 10.1006/bijl.2001.0599; PAPERNA I., 1969, Revue de Zoologie et de Botanique Africaines, V79, P15; PAPERNA I, 1964, ISRAEL J ZOOL, V13, P1; PAPERNA I, 1979, ANN SCI ZOOLOGIQUE 8, V226, P1; PAPERNA ILAN, 1960, BAMIDGEH, V12, P20; PAPERNA ILAN, 1965, BAMIDGEH, V17, P107; Parenti L. R, 1981, B AM MUS NAT HIST, V168, P335; PARISELLE A, 1994, SYST PARASITOL, V29, P229, DOI 10.1007/BF00009678; Pariselle A, 2004, PARASITE, V11, P359, DOI 10.1051/parasite/2004114359; Pariselle A, 2003, SYST PARASITOL, V56, P201, DOI 10.1023/B:SYPA.0000003807.27452.bd; Pariselle A, 1996, SYST PARASITOL, V34, P109, DOI 10.1007/BF00009685; PARISELLE A, 2003, TAXONOMIE ECOLOGIE E, V2, P147; Pariselle A, 2015, HYDROBIOLOGIA, V748, P99, DOI 10.1007/s10750-014-1975-5; Pariselle A, 2013, ZOOTAXA, V3599, P78, DOI 10.11646/zootaxa.3599.1.7; Pariselle Antoine, 2011, International Journal of Evolutionary Biology, V2011, P1, DOI 10.4061/2011/471480; Pariselle A, 2009, ZOOSYSTEMA, V31, P849, DOI 10.5252/z2009n4a6; Pinceel T, 2015, BIOL J LINN SOC, V114, P941, DOI 10.1111/bij.12474; Poisot T, 2010, BIOL J LINN SOC, V99, P559, DOI 10.1111/j.1095-8312.2009.01381.x; Price C. E., 1967, Revue de Zoologie et de Botanique Africaines, V76, P137; RAKOTOFIRINGA S, 1983, B SOC ZOOL FR, V108, P107; Rehulkova E, 2013, PARASITOL RES, V112, P1399, DOI 10.1007/s00436-013-3291-9; Reznick D, 2006, PLOS BIOL, V4, P136, DOI 10.1371/journal.pbio.0040007; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; Rohde K., 1986, P189; Rubtsova NY, 2006, J PARASITOL, V92, P486, DOI 10.1645/GE-747R.1; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Simkova A, 2008, J FISH BIOL, V73, P2210, DOI 10.1111/j.1095-8649.2008.02064.x; Simkova A, 2002, BIOL J LINN SOC, V76, P125, DOI 10.1046/j.1095-8312.2002.00056.x; Sonnenberg R, 2007, ZOOTAXA, P1; Stiassny M.L.J., 1991, CICHLID FISHES BEHAV, P1; Stiassny M. L. J., 2007, POISSONS EAUX DOUCES, V2; TAMURA K, 1993, MOL BIOL EVOL, V10, P512; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Terzibasi E, 2009, AGING CELL, V8, P88, DOI 10.1111/j.1474-9726.2009.00455.x; Valenzano DR, 2006, AGING CELL, V5, P275, DOI 10.1111/j.1474-9726.2006.00212.x; van Oosterhout C, 2006, HEREDITY, V97, P111, DOI 10.1038/sj.hdy.6800843; van Oosterhout C, 2003, J EVOLUTION BIOL, V16, P273, DOI 10.1046/j.1420-9101.2003.00511.x; VANEVERY LR, 1992, J HELMINTHOL SOC W, V59, P52; Vanhove MPM, 2015, PARASITE DIVERSITY AND DIVERSIFICATION: EVOLUTIONARY ECOLOGY MEETS PHYLOGENETICS, P401; Vences M, 2001, J BIOGEOGR, V28, P1091, DOI 10.1046/j.1365-2699.2001.00624.x; Vignon M, 2011, BIOL J LINN SOC, V102, P694, DOI 10.1111/j.1095-8312.2010.01607.x; Wu XY, 2005, PARASITOLOGY, V130, P669, DOI [10.1017/S0031182004007152, 10.1017/S2004007152]; Yamaguti S, 1937, STUDIES HELMINTH 19, P1; YOUNG PC, 1968, J ZOOL, V154, P41; Zietara MS, 2002, EVOLUTION, V56, P2445, DOI 10.1111/j.0014-3820.2002.tb00170.x	104	17	17	0	28	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	NOV 10	2015	8								582	10.1186/s13071-015-1181-y				12	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	DD3SK	WOS:000369842900001	26554914	DOAJ Gold, Green Published			2019-04-02	
J	Baraka, V; Ishengoma, DS; Fransis, F; Minja, DTR; Madebe, RA; Ngatunga, D; Van Geertruyden, JP				Baraka, Vito; Ishengoma, Deus S.; Fransis, Filbert; Minja, Daniel T. R.; Madebe, Rashid A.; Ngatunga, Deogratius; Van Geertruyden, Jean-Pierre			High-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in Tanzania	MALARIA JOURNAL			English	Article						Plasmodium falciparum; Single nucleotide polymorphisms; Sulphadoxine-pyrimethamine; Molecular markers; Septuple Pfdhfr; Pfdhps; Tanzania	NORTH-EASTERN TANZANIA; DIHYDROPTEROATE SYNTHASE GENE; ANTIMALARIAL-DRUG RESISTANCE; DIHYDROFOLATE-REDUCTASE; MOLECULAR MARKERS; MALARIA TREATMENT; DHFR; MUTATION; ARTEMISININ; BURDEN	Background: Tanzania abandoned sulfadoxine-pyrimethamine (SP) as the first-line treatment for uncomplicated malaria in 2006 due to high levels Plasmodium falciparum resistance. However, SP is still being used for intermittent preventive treatment during pregnancy (IPTp-SP). This study aimed to assess the pattern of P. falciparum dihydrofolate reductase (Pfdhfr) and dihydropteroate synthetase (Pfdhps) mutations and associated haplotypes in areas with different malaria transmission intensities in mainland Tanzania, 6 years after withdrawal of SP as a first-line treatment regimen for uncomplicated malaria. Methods: A total of 264 samples were collected during cross-sectional surveys in three districts of Muheza, Muleba and Nachingwea in Tanga, Kagera and Lindi regions, respectively. Parasite genomic DNA was extracted from P. falciparum positive samples. The Pfdhfr, Pfdhps single nucleotide polymorphisms (SNPs) were amplified using nested polymerase chain reaction and detected by sequence specific oligonucleotide probe-enzyme linked immunosorbent assay (SSOP-ELISA). Results: The prevalence of the mutant Pfdhfr-Pfdhps haplotypes was heterogenous and transmission dependent. The triple Pfdhfr mutant haplotypes (CIRNI) were predominant in all sites with significantly higher frequencies at Muheza (93.3%) compared to Muleba (75.0%) and Nachingwea districts (70.6%), (p < 0.001). Overall, the prevalence of the wild-type Pfdhps (SAKAA) haplotype was lowest at Muheza (1.3%), (p = 0.002). Double Pfdhps haplotype SGEAA was significantly high at Muheza (27.2 %) and Muleba (20.8 %) while none (0 %) was detected at Nachingwea (p < 0.001). The prevalence of triple Pfdhps SGEGA haplotype was significantly higher at Muheza compared to Muleba and Nachingwea (p < 0.001). In contrast, Nachingwea and Muleba had significantly higher prevalence of another triple Pfdhps AGEAA haplotype (X-2 = 39.9, p < 0.001). Conversely, Pfdhfr-Pfdhps as quintuple and sextuple haplotypes were predominant including the emergence of a septuple mutant haplotype CIRNI-AGEGA (n = 11) observed at Muheza and Muleba. Conclusion: These results ascertain the high prevalence and saturation of Pfdhfr and Pfdhps haplotypes conferring SP resistance in areas with changing malaria epidemiology; and this could undermine the use of IPTp-SP in improving pregnancy outcomes. In these settings where high level SP resistance is documented, additional control efforts are needed and evaluation of an alternative drug for IPTp is an urgent priority.	[Baraka, Vito; Ishengoma, Deus S.; Fransis, Filbert; Minja, Daniel T. R.; Madebe, Rashid A.] Tanga Res Ctr, Natl Inst Med Res, Tanga, Tanzania; [Baraka, Vito; Van Geertruyden, Jean-Pierre] Univ Antwerp, Dept Epidemiol, Int Hlth Unit, B-2610 Antwerp, Belgium; [Ngatunga, Deogratius] Tanzania Food & Drugs Author, Dar Es Salaam, Tanzania	Baraka, V (reprint author), Tanga Res Ctr, Natl Inst Med Res, POB 5004, Tanga, Tanzania.	vitobaraka@gmail.com	Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Baraka, Vito/0000-0001-9694-9293; Ishengoma, Deus/0000-0003-2040-3416	South Initiative Grant [ZAIN2014Z168]; VLIR UOS, Brussels, Belgium; UK Medical research Council (MRC) [G0600718]; Medical Research Council [G0600718]	We thank Lydia Lugomora (NIMR), Gwen Lemey and Jan Vervoort (Universiteit Antwerpen, Belgium), Michael Alifrangis, Ulla Abildtrup and Christentze Schmiegelow (CMP-Denmark) for their logistical assistance. Our thanks also extend to the staff at AMBRELA laboratory who participated in field data collection and data management. The study was supported by the South Initiative Grant (Code ZAIN2014Z168) and ICP PhD Grant by the VLIR UOS, Brussels, Belgium (for the laboratory component) while the sample and data collection was supported by the UK Medical research Council (MRC) (G0600718-Centennial award).	Alifrangis M, 2005, AM J TROP MED HYG, V72, P155, DOI 10.4269/ajtmh.2005.72.155; Alifrangis M, 2014, EMERG INFECT DIS, V20, P1280, DOI 10.3201/eid2008.131897; Alifrangis M, 2009, AM J TROP MED HYG, V80, P523, DOI 10.4269/ajtmh.2009.80.523; Alker AP, 2005, ANTIMICROB AGENTS CH, V49, P3919, DOI 10.1128/AAC.49.9.3919-3921.2005; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; BROOKS DR, 1994, EUR J BIOCHEM, V224, P397, DOI 10.1111/j.1432-1033.1994.00397.x; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Gesase S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004569; Griffin JT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4136; Harrington WE, 2009, P NATL ACAD SCI USA, V106, P9027, DOI 10.1073/pnas.0901415106; Harrington WE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056183; Harrington WE, 2011, CLIN INFECT DIS, V53, P224, DOI 10.1093/cid/cir376; Hastings MD, 2002, T ROY SOC TROP MED H, V96, P674, DOI 10.1016/S0035-9203(02)90349-4; Ishengoma DS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-338; Iyer JK, 2001, LANCET, V358, P1066, DOI 10.1016/S0140-6736(01)06201-8; Juma DW, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-250; Khalil I, 2003, AM J TROP MED HYG, V68, P586, DOI 10.4269/ajtmh.2003.68.586; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Lynch C, 2008, J INFECT DIS, V197, P1598, DOI 10.1086/587845; Malisa AL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-317; Malisa AL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-190; Matondo SI, 2014, MALARIA J, V13, P1; Matondo SI, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-152; McCollum AM, 2007, ANTIMICROB AGENTS CH, V51, P2085, DOI 10.1128/AAC.01228-06; McCollum AM, 2006, J INFECT DIS, V194, P189, DOI 10.1086/504687; Ministry of Health and Social Welfare (MOHSW) Tanzania, 2006, NAT GUID MAL DIAGN T; Minja DTR, 2013, EMERG INFECT DIS, V19, P1446, DOI 10.3201/eid1909.130133; Mmbando BP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-216; Mombo-Ngoma G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-123; Mugittu K, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-55; Mugittu K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-126; Mugittu K, 2007, TROP MED INT HEALTH, V12, P219, DOI 10.1111/j.1365-3165.2007.01813.x; Mulligan JA, 2006, TROP MED INT HEALTH, V11, P452, DOI 10.1111/j.1365-3156.2006.01590.x; Naidoo I, 2013, TRENDS PARASITOL, V29, P505, DOI 10.1016/j.pt.2013.08.002; Naidoo I, 2010, TRENDS PARASITOL, V26, P447, DOI 10.1016/j.pt.2010.05.001; National Bureau of Statistics, 2012, 2011 2012 TANZ HIV A; Nsimba B, 2005, TROP MED INT HEALTH, V10, P1030, DOI 10.1111/j.1365-3156.2005.01490.x; Pearce RJ, 2003, ANTIMICROB AGENTS CH, V47, P1347, DOI 10.1128/AAC.47.4.1347-1354.2003; Policy M, 2013, MALARIA J, V12, P213; Raman J, 2010, AM J TROP MED HYG, V82, P788, DOI 10.4269/ajtmh.2010.09-0401; Ringsted FM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-238; Shayo A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-376; Triglia T, 1997, P NATL ACAD SCI USA, V94, P13944, DOI 10.1073/pnas.94.25.13944; Triglia T, 1998, EMBO J, V17, P3807; Venkatesan M, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-41; Vinayak S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000830; Wellems TE, 2001, J INFECT DIS, V184, P770, DOI 10.1086/322858; WHO, 2010, GUID TREATM MAL; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; World Health Organisation, 2012, SEAS MAL CHEM SMC PL; World Health Organization, 2013, WHO EV REV GROUP INT; World Health Organization, 2013, WHO POL BRIEF IMPL I	52	5	5	1	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	NOV 5	2015	14								439	10.1186/s12936-015-0977-8				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CV5CU	WOS:000364284800002	26542942	DOAJ Gold, Green Published			2019-04-02	
J	Okello, WO; Muhanguzi, D; MacLeod, ET; Welburn, SC; Waiswa, C; Shaw, AP				Okello, Walter O.; Muhanguzi, Dennis; MacLeod, Ewan T.; Welburn, Susan C.; Waiswa, Charles; Shaw, Alexandra P.			Contribution of draft cattle to rural livelihoods in a district of southeastern Uganda endemic for bovine parasitic diseases: an economic evaluation	PARASITES & VECTORS			English	Article						Draft cattle; Animal traction; Trypanosomiasis; Gross margin analysis; Household income; Uganda	CROP-LIVESTOCK INTERACTIONS; SOUTH-EASTERN UGANDA; SUB-SAHARAN AFRICA; ANIMAL TRACTION; PRODUCTION SYSTEMS; SLEEPING SICKNESS; FARMING SYSTEMS; TORORO DISTRICT; WEST-AFRICA; PRODUCTIVITY	Background: A study was conducted in Tororo District eastern Uganda to assess the socio-economic contribution of draft cattle to rural livelihoods. The aim of the study was to empirically quantify the economic value of draft cattle thus contributing to understanding the impact of endemic parasitic diseases of cattle on livestock productivity and subsequently household income, labor and food security. Method: A total of 205 draft cattle keeping households (n = 205) were randomly selected and structured household questionnaires were administered, focusing on work oxen use, productivity, inputs and outputs. The data obtained was analyzed using standard statistical methods and used to calculate the gross margin from the draft cattle enterprise. Secondary data were obtained from focus group discussions and key informant interviews and these were analyzed using Bayesian methods. Results: The study showed that, apart from being labor saving, the use of animal traction is highly profitable with the gross margin per year from the use of draft cattle amounting to 245 United States dollars per work oxen owning household. The cash obtained from hiring out draft animals was equivalent to nearly a quarter of the average local household's monetary receipts. It also revealed that endemic bovine parasitic diseases such as trypanosomiasis and tick borne diseases reduced draft cattle output by 20.9 % and potential household income from the use of draft oxen by 32.2 %. Conclusion: The presence of endemic cattle diseases in rural Uganda is adversely affecting the productivity of draft cattle, which in turn affects household income, labor and ultimately food security. This study highlights the contribution of draft cattle to rural livelihoods, thus increasing the expected impact of cost-effective control strategies of endemic production limiting livestock diseases in Uganda.	[Okello, Walter O.; MacLeod, Ewan T.; Welburn, Susan C.] Univ Edinburgh, Coll Med & Vet Med, Sch Biomed Sci, Div Infect & Pathway Med, Edinburgh, Midlothian, Scotland; [Muhanguzi, Dennis; Waiswa, Charles] Makerere Univ, Dept Biomol & Biolab Sdences, Sch Biosecur Biotech & Lab Sci, Coll Vet Med Anim Resources & Biosecur, Kampala, Uganda; [Shaw, Alexandra P.] Avia GIS, Zoersel, Belgium	Okello, WO (reprint author), Univ Edinburgh, Coll Med & Vet Med, Sch Biomed Sci, Div Infect & Pathway Med, Edinburgh, Midlothian, Scotland.	W.O.Okello@sms.ed.ac.uk	Okello, Walter/T-9471-2017	Okello, Walter/0000-0002-9322-3486; Muhanguzi, Dennis/0000-0001-5458-8530	University of Edinburgh; European Union [221948]; DFID-RIU (Department for International Development - Research into Use)	We would like to thank the farmers in Tororo for providing the data. We also appreciate the assistance provided by the Tororo district Veterinary office staff and enumerators for coordinating the field work and data collection. We thank the University of Edinburgh for providing funds for the field work and preparing the manuscript. WO would like to acknowledge the Commonwealth Scholarship Commission who funded his studies on the International Animal Health programme. The questionnaire was adapted by the authors from questionnaires developed under two projects: ICONZ (Integrated Control of Neglected Zoonoses, which was funded under the European Union's Seventh Framework Program [FP7/2007-2013] under grant agreement no 221948) and DFID-RIU (Department for International Development - Research into Use). We are grateful to John Morton and Catherine Butcher whose contributions to the DFID-RIU questionnaires used in Uganda underpinned some of the questions used.	Adenisa AA, 1992, AGR SYST, V38, P131; Bardosh K, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-204; Barrett JC, 32B ODI; Binswanger H. P., 1987, AGR MECH EVOLUTION F; Dovie DBK, 2006, LAND USE POLICY, V23, P260, DOI 10.1016/j.landusepol.2004.08.004; Eisler MC, 2007, EPIDEMIOL INFECT, V135, P67, DOI 10.1017/S0950268806006571; Eisler MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040687; Food and Agriculture Organization of the United Nations, 1993, SYST EC ACC FOOD AGR; Guthiga PM, 2007, RENEW AGR FOOD SYST, V22, P290, DOI 10.1017/S174217050700186X; JAEGER WK, 1990, AM J AGR ECON, V72, P35, DOI 10.2307/1243143; James AD, 1996, AGR SYST, V52, P271, DOI 10.1016/0308-521X(96)00006-6; Jolly CM, 1996, AGR SYST, V51, P453, DOI 10.1016/0308-521X(95)00062-A; Magona JW, 2000, TROP ANIM HEALTH PRO, V32, P87, DOI 10.1023/A:1005278619023; MCINTIRE J, 1987, EXP AGR, V23, P235, DOI 10.1017/S0014479700017129; Muhanguzi D, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0998-8; Muhanguzi D, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0603-6; Muhanguzi D, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-91; Ocaido M., 2005, Livestock Research for Rural Development, V17, P93; Okello A, 2010, P 6 INT C WORK EQ, P80; PANIN A, 1989, AGR SYST, V30, P173, DOI 10.1016/0308-521X(89)90045-0; PANIN A, 1995, AGR SYST, V47, P199, DOI 10.1016/0308-521X(94)P4411-T; Perkins J, 1993, AUSTR CTR INT AGR RE, P77; Perry BD, 1999, VET PARASITOL, V84, P145, DOI 10.1016/S0304-4017(99)00040-0; Picozzi K, 2005, BMJ-BRIT MED J, V331, P1238, DOI 10.1136/bmj.331.7527.1238; Pingali P, 1987, AGR MECH EVOLUTION F, P43; Powell JM, 2004, AGRON J, V96, P469, DOI 10.2134/agronj2004.0469; R Development Core Team, 2007, R LANG ENV STAT COMP; RAMBERG JS, 1979, TECHNOMETRICS, V21, P201, DOI 10.2307/1268517; Randela R., 2003, Development Southern Africa, V20, P89, DOI 10.1080/0376835032000065507; Reardon T., 1999, Development Policy Review, V17, P375, DOI 10.1111/1467-7679.00093; ROCHA A, 1991, AGR SYST, V37, P55, DOI 10.1016/0308-521X(91)90047-E; Roderick S, 1998, ANIM SCI, V66, P585, DOI 10.1017/S1357729800009164; Rushton J, 2009, ECONOMICS OF ANIMAL HEALTH AND PRODUCTION, P1; Savadogo K, 1998, AGR SYST, V58, P441, DOI 10.1016/S0308-521X(98)00040-7; Selby R, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-281; Shaw APM, 2014, PREV VET MED, V113, P197, DOI 10.1016/j.prevetmed.2013.10.024; Shaw Alexandra, 2006, RES REPORT; Shumba E, 1984, J AGR RES, V81, P235; Simalenga TE, 2000, S AFRICAN AGR EXTENS, V29, P1; Swallow BM, 1999, PROGRAMME AFRICAN TR, V2; TAYLOR HM, 1994, INTRO STOCHASTIC MOD; Teweldmehidin MY, 2010, AFR J AGR RES, V5, P928, DOI 10.5897/AJAR09.161; THRUSFIELD M., 2005, VET EPIDEMIOLOGY; Uganda Bureau of Statistics (UBOS), EMPL EARN SURV REP 2; University of Columbia, 2008, CSURVEY VERS 2 0; Williams TO, 1997, SOIL TILL RES, V42, P295, DOI 10.1016/S0167-1987(96)01102-6; Zoller T, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-88	47	6	6	0	17	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	NOV 5	2015	8								571	10.1186/s13071-015-1191-9				9	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CV2ZK	WOS:000364127600002	26542357	DOAJ Gold, Green Published			2019-04-02	
J	Calvo-Cano, A; Cnops, L; Huyse, T; van Lieshout, L; Pardos, J; Valls, ME; Franco, A; Rollinson, D; Gascon, J				Calvo-Cano, Antonia; Cnops, Lieselotte; Huyse, Tine; van Lieshout, Lisette; Pardos, Josefina; Valls, M. E.; Franco, Agustin; Rollinson, David; Gascon, Joaquim			A Case of Urogenital Human Schistosomiasis from a Non-endemic Area	PLOS NEGLECTED TROPICAL DISEASES			English	Article							REAL-TIME PCR; HAEMATOBIUM; SAMPLES		[Calvo-Cano, Antonia; Gascon, Joaquim] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Cnops, Lieselotte; Huyse, Tine] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Huyse, Tine] Royal Museum Cent Africa, Dept Biol, Tervuren, Belgium; [van Lieshout, Lisette] Leiden Univ, Med Ctr, Ctr Infect Dis, Dept Parasitol, Leiden, Netherlands; [Pardos, Josefina; Valls, M. E.] Hosp Clin Barcelona, Dept Microbiol, Barcelona, Spain; [Franco, Agustin] Hosp Clin Barcelona, Dept Urol, Diagnost Unit, Barcelona, Spain; [Rollinson, David] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England	Calvo-Cano, A (reprint author), Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain.	acalvocano@gmail.com	Rollinson, David/C-7406-2009; Gascon, Joaquim/M-3598-2015	Gascon, Joaquim/0000-0002-5045-1585; Calvo-Cano, Antonia/0000-0001-7198-6952			Azar J E, 1972, J Med Liban, V25, P167; Berry A, 2014, EMERG INFECT DIS, V20, P1595, DOI 10.3201/eid2009.140928; Casella ML, 2009, REV SOC BRAS MED TRO, V42, P581, DOI 10.1590/S0037-86822009000500018; Cnops L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002413; Dionisio JLH, 2004, IBERUS, V22, P19; Huyse T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000571; Mone H, 1999, Adv Parasitol, V44, P99, DOI 10.1016/S0065-308X(08)60231-6; Obeng BB, 2008, ANN TROP MED PARASIT, V102, P625, DOI 10.1179/136485908X337490; SOUTHGATE VR, 1976, Z PARASITENKD, V49, P145, DOI 10.1007/BF00382422; Webster BL, 2010, J HELMINTHOL, V84, P107, DOI 10.1017/S0022149X09990447; Webster BL, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002110; Wichmann D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000422	12	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	NOV	2015	9	11							e0004053	10.1371/journal.pntd.0004053				4	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DB2NA	WOS:000368344400003	26540295	DOAJ Gold, Green Published			2019-04-02	
J	Carabin, H; Millogo, A; Cisse, A; Gabriel, S; Sahlu, I; Dorny, P; Bauer, C; Tarnagda, Z; Cowan, LD; Ganaba, R				Carabin, Helene; Millogo, Athanase; Cisse, Assana; Gabriel, Sarah; Sahlu, Ida; Dorny, Pierre; Bauer, Cici; Tarnagda, Zekiba; Cowan, Linda D.; Ganaba, Rasmane			Prevalence of and Factors Associated with Human Cysticercosis in 60 Villages in Three Provinces of Burkina Faso	PLOS NEGLECTED TROPICAL DISEASES			English	Article							TAENIA-SOLIUM INFECTIONS; RISK-FACTORS; EASTERN ZAMBIA; SEROPREVALENCE; COMMUNITY; ANTIGENS; EPILEPSY; AFRICA; FOCUS; AREA	Background Taenia solium, a zoonotic infection transmitted between humans and pigs, is considered an emerging infection in Sub-Saharan Africa, yet individual and community-level factors associated with the human infection with the larval stages (cysticercosis) are not well understood. This study aims to estimate the magnitude of association of individual-level and village-level factors with current human cysticercosis in 60 villages located in three Provinces of Burkina Faso. Methodology/Principal Findings Baseline cross-sectional data collected between February 2011 and January 2012 from a large community randomized-control trial were used. A total of 3609 individuals provided serum samples to assess current infection with cysticercosis. The association between individual and village-level factors and the prevalence of current infection with cysticercosis was estimated using Bayesian hierarchical logistic models. Diffuse priors were used for all regression coefficients. The prevalence of current cysticercosis varied across provinces and villages ranging from 0% to 11.5%. The results obtained suggest that increased age, being male and consuming pork as well as a larger proportion of roaming pigs and percentage of sand in the soil measured at the village level were associated with higher prevalences of infection. Furthermore, consuming pork at another village market had the highest increased prevalence odds of current infection. Having access to a latrine, living in a household with higher wealth quintiles and a higher soil pH measured at the village level decreased the prevalence odds of cysticercosis. Conclusions/Significance This is the first large-scale study to examine the association between variables measured at the individual-, household-, and village-level and the prevalence odds of cysticercosis in humans. Factors linked to people, pigs, and the environment were of importance, which further supports the need for a One Health approach to control cysticercosis infection.	[Carabin, Helene; Cowan, Linda D.] Univ Oklahoma, Dept Biostat & Epidemiol, Coll Publ Hlth, Hlth Sci Ctr, Oklahoma City, OK 73019 USA; [Millogo, Athanase] Ctr Hosp Univ Souro Sanou, Bobo Dioulasso, Burkina Faso; [Cisse, Assana; Tarnagda, Zekiba] Inst Rech & Sci Sante, Bobo Dioulasso, Burkina Faso; [Gabriel, Sarah; Dorny, Pierre] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Sahlu, Ida] Brown Sch Publ Hlth, Dept Epidemiol, Providence, RI USA; [Sahlu, Ida] Brown Univ, Populat Studies & Training Ctr, Providence, RI 02912 USA; [Bauer, Cici] Brown Sch Publ Hlth, Dept Biostat, Providence, RI USA; [Ganaba, Rasmane] Agence Format Rech & Expertise Sante Afr AFRICSan, Bobo Dioulasso, Burkina Faso	Carabin, H (reprint author), Univ Oklahoma, Dept Biostat & Epidemiol, Coll Publ Hlth, Hlth Sci Ctr, Oklahoma City, OK 73019 USA.	helene-carabin@ouhsc.edu			National Institute of Neurological Disorders and Stroke (NINDS); Forgarty International Center (FIC) of the National Institutes of Health (NIH) under the Brain in the Developing World: Research across the life span program [R01NS064901]; National Institute of Child Health and Human Development (NICHD) [2T32HD007338]	This work was conducted with the support of the National Institute of Neurological Disorders and Stroke (NINDS) and of the Forgarty International Center (FIC) of the National Institutes of Health (NIH) under the Brain in the Developing World: Research across the life span program, grant R01NS064901. The URL of the program is http://www.fic.nih.gov/Programs/Pages/brain-disorders.aspx. IS was supported by the National Institute of Child Health and Human Development (NICHD), grant 2T32HD007338. The URL of the program is https://www.nichd.nih.gov/training/extramural/Pages/institutional.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo-Florez P, 2003, REV NEUROLOGIA, V36, P706, DOI 10.33588/rn.3608.2002323; Agudelo-Flórez Piedad, 2009, Rev. salud pública, V11, P191; [Anonymous], 2010, MINISTERE RESSOURCES; Assana E, 2013, VET PARASITOL, V195, P14, DOI 10.1016/j.vetpar.2012.12.022; Carabin H, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001152; Carabin H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000555; Coral-Almeida M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003919; Dorny P, 2004, TRENDS PARASITOL, V20, P259, DOI 10.1016/j.pt.2004.04.001; Dorny P, 2000, VET PARASITOL, V88, P43, DOI 10.1016/S0304-4017(99)00196-X; FAO, 2012, REV NAT EL DIV PROD; Ganaba R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000927; Garcia HH, 2003, AM J TROP MED HYG, V68, P268, DOI 10.4269/ajtmh.2003.68.268; Gwatkin D. R., 2000, SOCIOECONOMIC DIFFER; Houinato D, 1998, T ROY SOC TROP MED H, V92, P621, DOI 10.1016/S0035-9203(98)90785-4; Husson F., 2015, MISSMDA HANDLING MIS; Husson F, 2015, FACTOMINER MULTIVARI; Jayaraman T, 2011, T ROY SOC TROP MED H, V105, P153, DOI 10.1016/j.trstmh.2010.10.007; Kanobana K, 2011, INT J PARASITOL, V41, P1015, DOI 10.1016/j.ijpara.2011.06.004; Lescano AG, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000371; Maya C, 2012, WATER RES, V46, P4770, DOI 10.1016/j.watres.2012.06.014; Mwanjali G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002102; Mwape KE, 2015, AM J TROP MED HYG, V92, P56, DOI 10.4269/ajtmh.13-0593; Mwape KE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002142; Mwape KE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001594; Ndimubanzi PC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000870; Nguekam JP, 2003, TROP MED INT HEALTH, V8, P144, DOI 10.1046/j.1365-3156.2003.01000.x; Praet N, 2010, INT J PARASITOL, V40, P85, DOI 10.1016/j.ijpara.2009.07.007; Praet N, 2010, AM J TROP MED HYG, V83, P413, DOI 10.4269/ajtmh.2010.10-0121; Quet F, 2010, EPILEPSIA, V51, P830, DOI 10.1111/j.1528-1167.2009.02401.x; R Development Core Team, 2014, R LANG ENV STAT COMP; Rao JNK, 2011, STAT SCI, V26, P240, DOI 10.1214/10-STS346; Sahel and West Africa Club (SWAC)/Organisation for Economic Co-operation and Development (OECD), 2008, LIV REG MARK SAH W A; Sanchez AL, 1998, ACTA TROP, V69, P141, DOI 10.1016/S0001-706X(97)00132-0; SARTI E, 1992, AM J TROP MED HYG, V46, P677, DOI 10.4269/ajtmh.1992.46.677; Secka A, 2011, ACTA TROP, V119, P199, DOI 10.1016/j.actatropica.2011.05.003; SPIEGELHALTER D. J., 1999, WINBUGS VERSION 1 2; Thys S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003570; TSANG VCW, 1989, J INFECT DIS, V159, P50, DOI 10.1093/infdis/159.1.50; Water and Sanitation Program-Africa Region, 2011, WAT SAN PROGR AFR RE	39	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	NOV	2015	9	11							e0004248	10.1371/journal.pntd.0004248				20	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DB2NA	WOS:000368344400048	26588468	DOAJ Gold, Green Published			2019-04-02	
J	Eddyani, M; Vandelannoote, K; Meehan, CJ; Bhuju, S; Porter, JL; Aguiar, J; Seemann, T; Jarek, M; Singh, M; Portaels, F; Stinear, TP; de Jong, BC				Eddyani, Miriam; Vandelannoote, Koen; Meehan, Conor J.; Bhuju, Sabin; Porter, Jessica L.; Aguiar, Julia; Seemann, Torsten; Jarek, Michael; Singh, Mahavir; Portaels, Francoise; Stinear, Timothy P.; de Jong, Bouke C.			A Genomic Approach to Resolving Relapse versus Reinfection among Four Cases of Buruli Ulcer	PLOS NEGLECTED TROPICAL DISEASES			English	Article							MYCOBACTERIUM-ULCERANS; TUBERCULOSIS; EVOLUTION; PHYLOGENIES; INFECTION; PATIENT; DISEASE; COHORT; BENIN; GHANA	Background Increased availability of Next Generation Sequencing (NGS) techniques allows, for the first time, to distinguish relapses from reinfections in patients with multiple Buruli ulcer (BU) episodes. Methodology We compared the number and location of single nucleotide polymorphisms (SNPs) identified by genomic screening between four pairs of Mycobacterium ulcerans isolates collected at the time of first diagnosis and at recurrence, derived from a collection of almost 5000 well characterized clinical samples from one BU treatment center in Benin. Principal Findings The findings suggest that after surgical treatment-without antibiotics-the second episodes were due to relapse rather than reinfection. Since specific antibiotics were introduced for the treatment of BU, the one patient with a culture available from both disease episodes had M. ulcerans isolates with a genomic distance of 20 SNPs, suggesting the patient was most likely reinfected rather than having a relapse. Conclusions To our knowledge, this study is the first to study recurrences in M. ulcerans using NGS, and to identify exogenous reinfection as causing a recurrence of BU. The occurrence of reinfection highlights the contribution of ongoing exposure to M. ulcerans to disease recurrence, and has implications for vaccine development.	[Eddyani, Miriam; Vandelannoote, Koen; Meehan, Conor J.; Portaels, Francoise; de Jong, Bouke C.] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Bhuju, Sabin; Jarek, Michael; Singh, Mahavir] GMAK, Helmholtz Ctr Infect Res, Braunschweig, Germany; [Porter, Jessica L.; Stinear, Timothy P.] Univ Melbourne, Dept Microbiol & Immunol, Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Aguiar, Julia] Ctr Depistage & Traitement Ulcere Buruli Gbemotin, Zagnanado, Benin; [Seemann, Torsten] Univ Melbourne, Victorian Life Sci Computat Initiat, Parkville, Vic 3052, Australia; [de Jong, Bouke C.] NYU, New York, NY USA	Eddyani, M (reprint author), Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium.	meddyani@itg.be	de Jong, Bouke/A-3636-2013	de Jong, Bouke/0000-0002-1017-4675; Meehan, Conor/0000-0003-0724-8343; Seemann, Torsten/0000-0001-6046-610X	UBS Optimus Foundation (Zurich, Switzerland); Department of Economy, Science and Innovation of the Flemish Government (Belgium); VLADOC PhD scholarship of VLIR-UOS (Belgium)	This work was supported by the UBS Optimus Foundation (Zurich, Switzerland) and the Department of Economy, Science and Innovation of the Flemish Government (Belgium). KV was supported by a VLADOC PhD scholarship of VLIR-UOS (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amofah G, 1998, TROP DOCT, V28, P81, DOI 10.1177/004947559802800208; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bolz M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003802; Bryant JM, 2013, LANCET RESP MED, V1, P786, DOI 10.1016/S2213-2600(13)70231-5; Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110; Chauty A, 2011, CLIN INFECT DIS, V52, P94, DOI 10.1093/cid/ciq072; Debacker M, 2005, EMERG INFECT DIS, V11, P584, DOI 10.3201/eid1104.041000; Eddyani M, 2008, J CLIN MICROBIOL, V46, P69, DOI 10.1128/JCM.00301-07; Eyre DW, 2014, J INFECT DIS, V209, P1446, DOI 10.1093/infdis/jit598; FAO, 2014, GLOB ADM UN LAY DAT; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Kaser M, 2009, APPL ENVIRON MICROB, V75, P414, DOI 10.1128/AEM.01358-08; Kanga J M, 2003, Bull Soc Pathol Exot, V96, P406; Kibadi K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000736; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LUNN H F, 1965, East Afr Med J, V42, P275; Nienhuis WA, 2010, LANCET, V375, P664, DOI 10.1016/S0140-6736(09)61962-0; O'Brien DP, 2013, MED J AUSTRALIA, V198, P436, DOI 10.5694/mja12.11708; QGIS Development Team, 2012, QGIS GEOGR INF SYST; Roltgen K, 2012, INFECT GENET EVOL, V12, P522, DOI 10.1016/j.meegid.2012.01.018; Schurch AC, 2010, INFECT GENET EVOL, V10, P108, DOI 10.1016/j.meegid.2009.10.002; Sopoh G, 2007, EMERG INFECT DIS, V13, P1375; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Teacher AGF, 2011, MOL ECOL RESOUR, V11, P151, DOI 10.1111/j.1755-0998.2010.02890.x; Teelken MA, 2003, ACTA TROP, V88, P51, DOI 10.1016/S0001-706X(03)00170-0; University of Edinburgh, 2014, FIGTREE; Vandelannoote K, 2014, APPL ENVIRON MICROB, V80, P1197, DOI 10.1128/AEM.02774-13; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; World Health Organisation, 2012, TREATM MYC ULC DIS B	29	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	NOV	2015	9	11							e0004158	10.1371/journal.pntd.0004158				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DB2NA	WOS:000368344400013	26618509	DOAJ Gold, Green Published			2019-04-02	
J	Ron-Garrido, L; Coral-Almeida, M; Gabriel, S; Benitez-Ortiz, W; Saegerman, C; Dorny, P; Berkvens, D; Abatih, EN				Ron-Garrido, Lenin; Coral-Almeida, Marco; Gabriel, Sarah; Benitez-Ortiz, Washington; Saegerman, Claude; Dorny, Pierre; Berkvens, Dirk; Abatih, Emmanuel Nji			Distribution and Potential Indicators of Hospitalized Cases of Neurocysticercosis and Epilepsy in Ecuador from 1996 to 2008	PLOS NEGLECTED TROPICAL DISEASES			English	Article							TAENIA-SOLIUM CYSTICERCOSIS; PORCINE CYSTICERCOSIS; DIAGNOSTIC-CRITERIA; CEREBRAL MALARIA; DISEASE BURDEN; PREVALENCE; AFRICA; MEXICO; AREA; INTERVENTION	Background Epilepsy is one of the most common signs of Neurocysticercosis (NCC). In this study, spatial and temporal variations in the incidence of hospitalized cases (IHC) of epilepsy and NCC in Ecuadorian municipalities were analyzed. Additionally, potential socio-economic and landscape indicators were evaluated in order to understand in part the macro-epidemiology of the Taenia solium taeniasis/cysticercosis complex. Methodology Data on the number of hospitalized epilepsy and NCC cases by municipality of residence were obtained from morbidity-hospital systems in Ecuador. SatScan software was used to determine whether variations in the IHC of epilepsy and NCC in space and time. In addition, several socio-economic and landscape variables at municipality level were used to study factors intervening in the macro-epidemiology of these diseases. Negative Binomial regression models through stepwise selection and Bayesian Model Averaging (BMA) were used to explain the variations in the IHC of epilepsy and NCC. Principal findings Different clusters were identified through space and time. Traditional endemic zones for NCC and epilepsy, recognized in other studies were confirmed in our study. However, for both disorders more recent clusters were identified. Among municipalities, an increasing tendency for IHC of epilepsy, and a decreasing tendency for the IHC of NCC were observed over time. In contrast, within municipalities a positive linear relationship between both disorders was found. An increase in the implementation of systems for eliminating excrements would help to reduce the IHC of epilepsy by 1.00% (IC95%; 0.2%-1.8%) and by 5.12% (IC95%; 3.63%-6.59%) for the IHC of NCC. The presence of pig production was related to IHC of NCC. Conclusion/Significance Both disorders were related to the lack of an efficient system for eliminating excrements. Given the appearance of recent epilepsy clusters, these locations should be studied in depth to discriminate epilepsies due to NCC from epilepsies due to other causes. Field studies are needed to evaluate the true prevalence of cysticercosis in humans and pigs in different zones of the country in order to better implement and manage prevention and/or control campaigns.	[Ron-Garrido, Lenin; Coral-Almeida, Marco; Benitez-Ortiz, Washington] Univ Cent Ecuador, Ctr Int Zoonosis, Quito, Ecuador; [Ron-Garrido, Lenin; Coral-Almeida, Marco; Gabriel, Sarah; Dorny, Pierre; Berkvens, Dirk; Abatih, Emmanuel Nji] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Ron-Garrido, Lenin; Saegerman, Claude] Univ Liege, Res Unit Epidemiol & Risk Anal Appl Vet Sci UREAR, Fundamental & Appl Res Anim & Hlth, Fac Vet Med, Liege, Belgium; [Coral-Almeida, Marco] Amer Univ, Escuela Med Vet & Zootecnia, Quito, Ecuador; [Coral-Almeida, Marco; Dorny, Pierre] Univ Ghent, Fac Vet Med, Merelbeke, Belgium	Ron-Garrido, L (reprint author), Univ Cent Ecuador, Ctr Int Zoonosis, Ciudadela Univ, Quito, Ecuador.	marco.coralalmeida@ugent.be		Coral, Marco/0000-0003-0211-2906	Institute of Tropical Medicine in Antwerp, Belgium; Centro Internacional de Zoonosis of the Central University of Ecuador	This work was financially supported by the Belgian Cooperation in the framework of the Institutional Collaboration between the Institute of Tropical Medicine in Antwerp, Belgium and the Centro Internacional de Zoonosis of the Central University of Ecuador. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrocalidad. Programa Nacional Sanitario Porcino. Agrocalidad, 2010, BOOK MONOGRAPH; Alarcon TA, 2012, PATHOG GLOB HEALTH, V106, P310, DOI 10.1179/2047773212Y.0000000044; [Anonymous], 2015, POL SCI COMP LAB PSC; [Anonymous], 2015, SUPP FUNCT DAT VEN R; [Anonymous], 2010, R TOP R PACK DISTR C; Assana E, 2010, J HELMINTHOL, V84, P441, DOI 10.1017/S0022149X10000167; Bhattarai R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001521; Carabin Helene, 2014, Curr Trop Med Rep, V1, P181; Coral-Almeida M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002887; CRUZ M, 1989, B WORLD HEALTH ORGAN, V67, P401; Cruz ME, 1999, INT J EPIDEMIOL, V28, P799, DOI 10.1093/ije/28.4.799; CRUZ ME, 1995, HEADACHE, V35, P93, DOI 10.1111/j.1526-4610.1995.hed3502093.x; Del Brutto OH, 2005, EPILEPSIA, V46, P583, DOI 10.1111/j.0013-9580.2005.36504.x; Del Brutto OH, 2001, NEUROLOGY, V57, P177, DOI 10.1212/WNL.57.2.177; Del Brutto OH, 2012, PATHOG GLOB HEALTH, V106, P299, DOI 10.1179/2047773212Y.0000000025; Flores MG, 2012, BOOK MONOGRAPH; Foyaca-Sibat H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000562; Garcia HH, 1998, AM J TROP MED HYG, V59, P902, DOI 10.4269/ajtmh.1998.59.902; Goodman KA, 1999, AM J TROP MED HYG, V60, P70, DOI 10.4269/ajtmh.1999.60.70; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; Hoeting JA, 1999, STAT SCI, V14, P382; Hu MC, 2011, AM J DRUG ALCOHOL AB, V37, P367, DOI 10.3109/00952990.2011.597280; Hueston W D, 1993, Rev Sci Tech, V12, P1197; Huisa BN, 2005, AM J TROP MED HYG, V73, P496, DOI 10.4269/ajtmh.2005.73.496; Idro R, 2010, PEDIATR RES, V68, P267, DOI [10.1203/PDR.0b013e3181eee738, 10.1203/00006450-201011001-00524]; INEC, 2010, CENS POBL VIV EC 201; Instituto Nacional de Estadisticas y Censos (INEC), 2002, 3 CEN NAC AGR; Instituto Nacional de Estadisticas y Censos (INEC), 2015, REF TYPE ONLINE SOUR; Instituto Nacional de Meteorologia e hidrologia (INHAMI), 2015, MAP PREC MED MULT 19; KEILBACH N M, 1989, Acta Leidensia, V57, P181; Kelvin EA, 2012, T ROY SOC TROP MED H, V106, P763, DOI 10.1016/j.trstmh.2012.09.004; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Lescano AG, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000371; Mafojane NA, 2003, ACTA TROP, V87, P25, DOI 10.1016/S0001-706X(03)00052-4; MEDINA MT, 1990, ARCH INTERN MED, V150, P325, DOI 10.1001/archinte.150.2.325; Ministerio de Salud Publica del Ecuador (MSP), 2012, DAT ES SAL MIR DEC 2; Ministerio de Salud Publica del Ecuador (MSP), 2009, ENF EV NOT OBL; Morales J, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000284; Murrell KD, 2005, FAO WHO OIE GUIDELIN, P1; Murrell KD, 2005, GUIDELINES SURVEILLA, P73; Mwape KE, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003972; Nash TE, 2004, NEUROLOGY, V62, P1934, DOI 10.1212/01.WNL.0000129481.12067.06; Ndimubanzi PC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000870; Ngoungou EB, 2008, EPILEPSIA, V49, P19, DOI 10.1111/j.1528-1167.2008.01752.x; OIE, 2005, WORLD AN HLTH INF DA; [Organization of American States (OAS) OAS], 2010, CRIT ACC CUMPL MET M; Pal DK, 2000, J NEUROL NEUROSUR PS, V68, P137, DOI 10.1136/jnnp.68.2.137; Patil GP, 2003, STAT SCI, V18, P457, DOI 10.1214/ss/1081443229; Pawlowski Z, 2005, INT J PARASITOL, V35, P1221, DOI 10.1016/j.ijpara.2005.07.015; PLACENCIA M, 1992, BRAIN, V115, P771, DOI 10.1093/brain/115.3.771; Pondja A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000594; Praet N, 2010, INT J PARASITOL, V40, P85, DOI 10.1016/j.ijpara.2009.07.007; Praet N, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000406; Preux PM, 2005, LANCET NEUROL, V4, P21, DOI 10.1016/S1474-4422(04)00963-9; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Raghava MV, 2010, T ROY SOC TROP MED H, V104, P601, DOI 10.1016/j.trstmh.2010.06.002; Rodriguez-Hidalgo R, 2006, MEM I OSWALDO CRUZ, V101, P779, DOI 10.1590/S0074-02762006000700012; Rodriguez-Hidalgo R, 2003, VET PARASITOL, V118, P51, DOI 10.1016/j.vetpar.2003.09.019; Sander JW, 2004, I MED US FOR MICR TH; Sarti E, 2000, T ROY SOC TROP MED H, V94, P85, DOI 10.1016/S0035-9203(00)90451-6; SARTIGUTIERREZ EJ, 1988, TROP MED PARASITOL, V39, P194; Sistema Integrado de Indicadores Sociales del Ecuador (SIISE, 2008, IND SOC EC 2008; Vaid N, 2012, SEIZURE-EUR J EPILEP, V21, P734, DOI 10.1016/j.seizure.2012.08.002; World Health Organization, 2014, INT CLASS DIS ICD; World Health Organization, 2015, EP FACT SHEET; Yanez A., 2013, SALUD DESDE MIRADA D; Yemadje LP, 2011, EPILEPSIA, V52, P1376, DOI 10.1111/j.1528-1167.2011.03099.x; Zuur AF, 2012, ZERO INFLATED MODELS	68	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	NOV	2015	9	11							e0004236	10.1371/journal.pntd.0004236				21	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DB2NA	WOS:000368344400043	26580210	DOAJ Gold, Green Published			2019-04-02	
J	Carlier, Y; Truyens, C				Carlier, Yves; Truyens, Carine			Congenital Chagas disease as an ecological model of interactions between Trypanosoma cruzi parasites, pregnant women, placenta and fetuses	ACTA TROPICA			English	Article						Trypanosoma cruzi; Congenital T. cruzi infection; Congenital Chagas disease; Maternal-fetal transmission; Placenta; Maternal and fetal/neonatal immune responses	POLYMERASE-CHAIN-REACTION; BLOOD NK CELLS; INTERFERON-GAMMA; CORD BLOOD; VERTICAL TRANSMISSION; MATERNAL INFECTION; ANTIINFLAMMATORY CYTOKINES; CHILD TRANSMISSION; IMMUNE DEVELOPMENT; CLINICAL-ASPECTS	The aim of this paper is to discuss the main ecological interactions between the parasite Trypanosoma cruzi and its hosts, the mother and the fetus, leading to the transmission and development of congenital Chagas disease. One or several infecting strains of T. cruzi (with specific features) interact with: (i) the immune system of a pregnant woman whom responses depend on genetic and environmental factors, (ii) the placenta harboring its own defenses, and, finally, (iii) the fetal immune system displaying responses also susceptible to be modulated by maternal and environmental factors, as well as his own genetic background which is different from her mother. The severity of congenital Chagas disease depends on the magnitude of such final responses. The paper is mainly based on human data, but integrates also complementary observations obtained in experimental infections. It also focuses on important gaps in our knowledge of this congenital infection, such as the role of parasite diversity vs host genetic factors, as well as that of the maternal and placental microbiomes and the microbiome acquisition by infant in the control of infection. Investigations on these topics are needed in order to improve the programs aiming to diagnose, manage and control congenital Chagas disease. (C) 2015 The Authors. Published by Elsevier B.V.	[Carlier, Yves; Truyens, Carine] Univ Libre Bruxelles, Fac Med, Lab Parasitol, B-1070 Brussels, Belgium; [Carlier, Yves] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Trop Med, New Orleans, LA 70112 USA	Carlier, Y (reprint author), Univ Libre Bruxelles, Fac Med, Lab Parasitol, CP 616,Route Lennik 808, B-1070 Brussels, Belgium.	ycarlier@ulb.ac.be; ctruyens@ulb.ac.be					Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Alarcon M, 2009, INVEST CLIN, V50, P335; Alkmim-Oliveira SM, 2013, PARASITOL RES, V112, P671, DOI 10.1007/s00436-012-3184-3; Altemani AM, 2000, AM J TROP MED HYG, V62, P319, DOI 10.4269/ajtmh.2000.62.319; Martins LPA, 2011, BRAZ J INFECT DIS, V15, P116, DOI 10.1590/S1413-86702011000200004; ANDRADE SG, 1982, T ROY SOC TROP MED H, V76, P123, DOI 10.1016/0035-9203(82)90036-0; APT W, 1968, Boletin Chileno de Parasitologia, V23, P9; APT W, 1968, Boletin Chileno de Parasitologia, V23, P15; Araujo-Jorge Tania C., 1993, Parasite Immunology (Oxford), V15, P539; ARAUJOJORGE T, 1993, INFECT IMMUN, V61, P4925; AZOGUE E, 1993, SOC SCI MED, V37, P503, DOI 10.1016/0277-9536(93)90285-C; AZOGUE E, 1985, T ROY SOC TROP MED H, V79, P176, DOI 10.1016/0035-9203(85)90328-1; Basile L, 2011, EUROSURVEILLANCE, V16, P14; Benirschke K, 2006, PATHOLOGY HUMAN PLAC; Bern C, 2009, CLIN INFECT DIS, V49, P1667, DOI 10.1086/648070; Bisio M, 2011, T ROY SOC TROP MED H, V105, P543, DOI 10.1016/j.trstmh.2011.07.003; BITTENCOURT A L, 1988, Memorias do Instituto Oswaldo Cruz, V83, P37; Bittencourt A L, 1972, Rev Inst Med Trop Sao Paulo, V14, P257; BITTENCOURT ACHILEA LISBOA, 1963, REV INST MED TROP SAO PAULO, V5, P62; BITTENCOURT AL, 1992, REV I MED TROP, V34, P403, DOI 10.1590/S0036-46651992000500006; BITTENCOURT AL, 1976, AM J DIS CHILD, V130, P97, DOI 10.1001/archpedi.1976.02120020099020; Boufker HI, 2006, AM J PATHOL, V169, P1730, DOI 10.2353/ajpath.2006.060309; BRENIERE S F, 1983, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V21, P139; Brutus L, 2008, ACTA TROP, V106, P195, DOI 10.1016/j.actatropica.2008.03.009; Brutus L, 2011, AM J TROP MED HYG, V84, P808, DOI 10.4269/ajtmh.2011.10-0577; Brutus L, 2010, AM J TROP MED HYG, V83, P1044, DOI [10.4269/ajtmh.2010.10.0326, 10.4269/ajtmh.2010.10-0326]; Bua J., 2013, PLOS NEGLECT TROP D, V10, pe2476, DOI DOI 10.1371/J0URNAL.PNTD; Bua J, 2012, T ROY SOC TROP MED H, V106, P623, DOI 10.1016/j.trstmh.2012.03.015; Burgos JM, 2007, INT J PARASITOL, V37, P1319, DOI 10.1016/j.ijpara.2007.04.015; Bustamante JM, 2002, INT J PARASITOL, V32, P889, DOI 10.1016/S0020-7519(02)00023-1; CABEZAMECKERT P, 1980, MEDICINA-BUENOS AIRE, V40, P40; Cao Bin, 2014, Neoreviews, V15, pe537; Cappa SMG, 1999, MEDICINA-BUENOS AIRE, V59, P69; Cardoni RL, 2004, ANN TROP MED PARASIT, V98, P883, DOI 10.1179/00034980X3234; Cardoni RL, 2004, ACTA TROP, V90, P65, DOI 10.1016/j.actatropica.2003.09.020; CARLIER Y, 1987, AM J TROP MED HYG, V37, P534, DOI 10.4269/ajtmh.1987.37.534; CARLIER Y, 1992, AM J TROP MED HYG, V46, P116, DOI 10.4269/ajtmh.1992.46.116; CARLIER Y, 1995, PARASITOL TODAY, V11, P94, DOI 10.1016/0169-4758(95)80165-0; Carlier Y, 2015, MEM I OSWALDO CRUZ, V110, P363, DOI [10.1590/0074-02760140405, 10.1590/0074-02760140410]; Carlier Y, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001250; Cartier Y., 2010, AM TRYPANOSOMIASIS C, P539; Castilho E.A., 1976, REV INST MED TROP SP, V18, P258; Castillo C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002376; Cencig S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002271; Cestari I, 2012, J IMMUNOL, V188, P1942, DOI 10.4049/jimmunol.1102053; Chippaux JP, 2010, TROP MED INT HEALTH, V15, P87, DOI 10.1111/j.1365-3156.2009.02431.x; Corrales RM, 2009, INFECT GENET EVOL, V9, P278, DOI 10.1016/j.meegid.2008.12.008; Cuna WR, 2009, J PARASITOL, V95, P891, DOI 10.1645/GE-1927.1; da Costa TA, 2014, J IMMUNOL RES, V2014; Dauby N, 2012, LANCET INFECT DIS, V12, P330, DOI 10.1016/S1473-3099(11)70341-3; Dauby N, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000571; Ramirez JD, 2012, EXP PARASITOL, V132, P487, DOI 10.1016/j.exppara.2012.09.017; DAVILA HO, 1994, AM J TROP MED HYG, V50, P506, DOI 10.4269/ajtmh.1994.50.506; Vieira PMD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032912; de Cunio R W, 1980, Medicina (B Aires), V40 Suppl 1, P50; DeAraujo SM, 1996, AM J TROP MED HYG, V54, P13, DOI 10.4269/ajtmh.1996.54.13; del Puerto F, 2010, AM J TROP MED HYG, V82, P386, DOI 10.4269/ajtmh.2010.09-0006; DELGADO MA, 1978, AM J TROP MED HYG, V27, P1108, DOI 10.4269/ajtmh.1978.27.1108; Di Pentima MC, 1999, AM J TROP MED HYG, V60, P211, DOI 10.4269/ajtmh.1999.60.211; Diaz-Lujan C, 2012, PLACENTA, V33, P264, DOI 10.1016/j.placenta.2012.01.005; Didoli GL, 2000, INT J IMMUNOPHARMACO, V22, P45, DOI 10.1016/S0192-0561(99)00063-6; Diez C, 2010, AM J TROP MED HYG, V82, P67, DOI 10.4269/ajtmh.2010.09-0391; Dolcini GL, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-53; Duaso J, 2010, PLACENTA, V31, P705, DOI 10.1016/j.placenta.2010.05.007; ELOISANTOS SM, 1989, J CLIN INVEST, V84, P1028, DOI 10.1172/JCI114225; Fernandez-Aguilar S, 2005, REV SOC BRAS MED TRO, V38, P84; Fernandez-Villegas A, 2014, ACTA TROP, V140, P84, DOI 10.1016/j.actatropica.2014.08.006; Frank F, 2000, EXP MOL PATHOL, V69, P144, DOI 10.1006/exmp.2000.2312; FREILIJ H, 1995, CLIN INFECT DIS, V21, P551, DOI 10.1093/clinids/21.3.551; FREILIJ H, 1995, PEDIATR INFECT DIS J, V14, P161; Galili U, 2013, IMMUNOLOGY, V140, P1, DOI 10.1111/imm.12110; Garcia A, 2014, PARASITOL INT, V63, P138, DOI 10.1016/j.parint.2013.10.010; Garcia MM, 2008, AM J TROP MED HYG, V78, P499, DOI 10.4269/ajtmh.2008.78.499; Guerreiro M.L., 2015, MEM I O CRUZ; Guilmot A, 2014, PARASITE IMMUNOL, V36, P43, DOI 10.1111/pim.12077; Guilmot A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002291; Scapellato PG, 2009, REV SOC BRAS MED TRO, V42, P107, DOI 10.1590/S0037-86822009000200002; Haider S, 2009, PLACENTA, V30, P111, DOI 10.1016/j.placenta.2008.10.012; Hall CA, 2010, J PARASITOL, V96, P371, DOI 10.1645/GE-2296.1; Hermann E, 2004, J INFECT DIS, V189, P1274, DOI 10.1086/382511; Hermann E, 2002, BLOOD, V100, P2153; Hermann E, 2006, PEDIATR RES, V60, P38, DOI 10.1203/01.pdr.0000220335.05588.ea; HERNANDEZMATHESON IM, 1983, T ROY SOC TROP MED H, V77, P405, DOI 10.1016/0035-9203(83)90174-8; HOFF R, 1978, T ROY SOC TROP MED H, V72, P247, DOI 10.1016/0035-9203(78)90203-1; Howard EJ, 2014, BJOG-INT J OBSTET GY, V121, P22, DOI 10.1111/1471-0528.12396; HOWARD J, 1968, Boletin Chileno de Parasitologia, V23, P107; Imai K, 2014, EMERG INFECT DIS, V20, P146, DOI 10.3201/eid2001.131071; Jonakait GM, 2007, INT J DEV NEUROSCI, V25, P415, DOI 10.1016/j.ijdevneu.2007.08.017; Kabat AM, 2014, TRENDS IMMUNOL, V35, P507, DOI 10.1016/j.it.2014.07.010; Koga K, 2014, AM J REPROD IMMUNOL, V72, P192, DOI 10.1111/aji.12258; Kurup SP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3616; Laucella SA, 2004, J INFECT DIS, V189, P909, DOI 10.1086/381682; Lazarte R.A., 2012, MORB MORTAL WKLY JUL, V61, P26; Liempi A, 2014, PLACENTA, V35, P1035, DOI 10.1016/j.placenta.2014.09.017; Llewellyn MS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003458; Mayer JP, 2010, ANN TROP MED PARASIT, V104, P485, DOI 10.1179/136485910X12786389891362; Menezes C A, 1992, Rev Soc Bras Med Trop, V25, P109; METZ G, 1993, PARASITE IMMUNOL, V15, P693, DOI 10.1111/j.1365-3024.1993.tb00584.x; MILES MA, 1975, T ROY SOC TROP MED H, V69, P286, DOI 10.1016/0035-9203(75)90171-6; Mjihdi A, 2004, EXP PARASITOL, V107, P58, DOI 10.1016/j.exppara.2004.03.016; Mjihdi A, 2002, AM J PATHOL, V161, P673, DOI 10.1016/S0002-9440(10)64223-X; Moreno Elio A., 2003, Invest. clín, V44, P241; Moretti E, 2005, REV SOC BRAS MED TRO, V38, P53, DOI 10.1590/S0037-86822005000100010; Moya P R, 1979, Rev Fac Cien Med Univ Nac Cordoba, V37, P21; Munyaka PM, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00109; Myatt L, 2004, HISTOCHEM CELL BIOL, V122, P369, DOI 10.1007/s00418-004-0677-x; Nanaev AK, 2000, PLACENTA, V21, P122, DOI 10.1053/plac.1999.0455; Neves SF, 1999, PARASITE IMMUNOL, V21, P631, DOI 10.1046/j.1365-3024.1999.00262.x; Nisida Isabelle Vera Vichr, 1999, Revista do Instituto de Medicina Tropical de Sao Paulo, V41, P305, DOI 10.1590/S0036-46651999000500007; Norman FF, 2013, EMERG INFECT DIS, V19, P1561, DOI 10.3201/eid1910.130203; OLIVEIRA FAUSTO da CUNHA, 1966, REV INST MED TROP SAO PAULO, V8, P184; Oliveira I, 2010, EXPERT REV ANTI-INFE, V8, P945, DOI 10.1586/ERI.10.74; Ortiz S, 2012, ACTA TROP, V124, P243, DOI 10.1016/j.actatropica.2012.08.001; Poncini CV, 2008, INFECT IMMUN, V76, P2633, DOI 10.1128/IAI.01298-07; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Quintin J, 2014, CURR OPIN IMMUNOL, V29, P1, DOI 10.1016/j.coi.2014.02.006; Racicot K, 2014, AM J REPROD IMMUNOL, V72, P107, DOI 10.1111/aji.12289; Rendell VR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119527; REYES MB, 1990, P NATL ACAD SCI USA, V87, P2846, DOI 10.1073/pnas.87.7.2846; RIVERA MT, 1995, INFECT IMMUN, V63, P591; Rodriguez P, 2005, REV SOC BRAS MED TRO, V38, P62; Rodriguez P, 2012, MED MICROBIOL IMMUN, V201, P287, DOI 10.1007/s00430-012-0230-9; Rodriguez P, 2012, MED MICROBIOL IMMUN, V201, P157, DOI 10.1007/s00430-011-0217-y; Romano-Keeler J, 2015, PEDIATR RES, V77, P189, DOI 10.1038/pr.2014.163; Rytter MJH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105017; Salas NA, 2007, TROP MED INT HEALTH, V12, P1498, DOI 10.1111/j.1365-3156.2007.01958.x; Sanchez NO, 2005, PEDIATRICS, V115, pe668; Sartori MJ, 2002, EXP MOL PATHOL, V72, P84, DOI 10.1006/exmp.2001.2412; SCHENONE H, 1985, Boletin Chileno de Parasitologia, V40, P24; Schijman AG, 2003, J ANTIMICROB CHEMOTH, V52, P441, DOI 10.1093/jac/dkg338; SHAW GL, 1975, EXP PARASITOL, V37, P211, DOI 10.1016/0014-4894(75)90072-7; Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7; Siriano LD, 2011, AM J TROP MED HYG, V84, P569, DOI 10.4269/ajtmh.2011.10-0015; Solana ME, 2009, PARASITOLOGY, V136, P627, DOI 10.1017/S0031182009005770; Solana ME, 2002, J PARASITOL, V88, P102, DOI 10.2307/3285399; Sosa-Estani S, 2008, AM J TROP MED HYG, V79, P755, DOI 10.4269/ajtmh.2008.79.755; TERUEL J R, 1970, Revista do Instituto de Medicina Tropical de Sao Paulo, V12, P239; Torrico F, 2005, REV SOC BRAS MED TRO, V38, P17; Torrico F, 2006, TROP MED INT HEALTH, V11, P628, DOI 10.1111/j.1365-3156.2006.01623.x; Torrico F, 2004, AM J TROP MED HYG, V70, P201, DOI 10.4269/ajtmh.2004.70.201; Torrico MC, 2005, REV SOC BRAS MED TRO, V38, P58; Truyens C, 2005, REV SOC BRAS MED TRO, V38, P96; Truyens C, 2010, ELSEV INSIGHT, P601, DOI 10.1016/B978-0-12-384876-5.00024-1; Vekemans J, 2000, INFECT IMMUN, V68, P5430, DOI 10.1128/IAI.68.9.5430-5434.2000; Virreira M, 2007, AM J TROP MED HYG, V77, P102, DOI 10.4269/ajtmh.2007.77.102; Virreira M, 2006, AM J TROP MED HYG, V75, P871, DOI 10.4269/ajtmh.2006.75.871; Virreira M, 2006, AM J TROP MED HYG, V75, P1082, DOI 10.4269/ajtmh.2006.75.1082; VLEUGELS MP, 1986, AM J OBSTET GYNECOL, V155, P118, DOI 10.1016/0002-9378(86)90092-X; WERNER H, 1971, Z TROPENMED PARASIT, V22, P224; Werner H., 1958, Zeitschrift fuer Tropenmedizin und Parasitologie, V9, P17; World Health Organization, 2015, WKLY EPIDEMIOL REC, V90, P33; Pavia PX, 2009, BIOMEDICA, V29, P513; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	153	26	28	0	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	NOV	2015	151				SI		103	115		10.1016/j.actatropica.2015.07.016				13	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CW2CE	WOS:000364797900011	26293886	Other Gold			2019-04-02	
J	Assarag, B; Dujardin, B; Essolbi, A; Cherkaoui, I; De Brouwere, V				Assarag, Bouchra; Dujardin, Bruno; Essolbi, Amina; Cherkaoui, Imad; De Brouwere, Vincent			Consequences of severe obstetric complications on women's health in Morocco: please, listen to me!	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						maternal near-miss case; physical consequences; mental consequences; Morocco	BURKINA-FASO; NEAR-MISS; MATERNAL MORBIDITY; COUNTRIES; DEPRESSION; WORLD; BENIN; CARE	ObjectiveIn Morocco, medical care for women with severe obstetric complications (near-miss cases) ends at discharge from the hospital. Little information exists regarding what happens after returning home. The aim of the study was to assess the physical and mental health consequences of near-miss events on Moroccan women 8months after childbirth. MethodsA prospective cohort study of 76 near-miss women was conducted in three hospitals. For every case, we recruited at least two women from the same hospital who had uncomplicated deliveries (n=169). We used a mixed-methods approach. For the quantitative part, we analysed sociodemographic characteristics collected via a questionnaire and medical complications extracted from the medical records during a medical consultation at 8months post-partum. Forty in-depth interviews were also conducted with 20 near-miss cases and 20 women with uncomplicated deliveries. ResultsThe near-miss women were poorer and less educated than those who had uncomplicated deliveries. The proportion of physical consequences (serious illness) was higher among near-miss cases (22%) than uncomplicated deliveries (6%, P=0.001). The risk of depression was significantly higher among near-miss cases with perinatal death (OR=7.16; [95% CI: 2.85-17.98]) than among those who had an uncomplicated delivery. Interviews revealed that the economic burden of near-miss care contributed to social problems among the women and their households. ConclusionA near-miss event has consequences that go beyond the first days after delivery. Developing new mechanisms for maternal and newborn health follow-up is essential and should address the mother's physical and mental health problems and involve husbands and family members.	[Assarag, Bouchra; Essolbi, Amina] Natl Sch Publ Hlth, Minist Hlth, Rabat, Morocco; [Assarag, Bouchra; De Brouwere, Vincent] Inst Trop Med, Dept Publ Hlth, Woman & Child Hlth Res Ctr, B-2000 Antwerp, Belgium; [Assarag, Bouchra; Dujardin, Bruno] Univ Libre Bruxelles, Sch Publ Hlth, Brussels, Belgium; [Cherkaoui, Imad] Directorate Epidemiol & Dis Control, Minist Hlth, Rabat, Morocco	Assarag, B (reprint author), Natl Sch Publ Hlth, Minist Hlth, 3 Rue Lafedal Cherkaoui, Rabat, Morocco.	bassarag@gmail.com					Assarag B, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-225; Borghi J, 2003, HEALTH POLICY PLANN, V18, P383, DOI 10.1093/heapol/czg046; Braveman P, 2010, MATERN CHILD HLTH J, V14, P20, DOI 10.1007/s10995-008-0427-0; Cox J., 1994, PERINATAL PSYCHIAT U; Dennis CL, 2006, J ADV NURS, V56, P588, DOI 10.1111/j.1365-2648.2006.04059.x; Filippi V, 2007, LANCET, V370, P1329, DOI 10.1016/S0140-6736(07)61574-8; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; Fottrell E, 2010, BRIT J PSYCHIAT, V196, P18, DOI 10.1192/bjp.bp.108.062489; Hardee K, 2012, GLOB PUBLIC HEALTH, V7, P603, DOI 10.1080/17441692.2012.668919; Hoque Monjurul, 2010, East Afr J Public Health, V7, P171; Jabir M, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-11; Johnson K., 2004, PROFILING DOMESTIC V; Kielmann K, 2002, MED ANTHROPOL, V21, P115; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Mantel GD, 1998, BRIT J OBSTET GYNAEC, V105, P985, DOI 10.1111/j.1471-0528.1998.tb10262.x; Mezgueldi Z, 2008, LECTORA, V14, P51; Ministere de la Sante du Royaume du Maroc, 2012, ENQ NAT POP SANT FAM; Ministere de la sante. Sante en chiffres, 2012, DIR PLAN RESS FIN; Patel V, 2002, AM J PSYCHIAT, V159, P43, DOI 10.1176/appi.ajp.159.1.43; Patel V, 2001, BRIT MED J, V322, P482, DOI 10.1136/bmj.322.7284.482; Ross LE, 2004, ACTA PSYCHIAT SCAND, V109, P457, DOI 10.1111/j.1600-0047.2004.00296.x; Sadana R, 2000, B WORLD HEALTH ORGAN, V78, P640; Sahel A, 2001, Sante, V11, P229; Souza J P, 2007, BMC Pregnancy Childbirth, V7, P20, DOI 10.1186/1471-2393-7-20; Stanton ME, 2010, COMMUNICATION; Storeng KT, 2008, SOC SCI MED, V66, P545, DOI 10.1016/j.socscimed.2007.10.001; Storeng KT, 2010, SOC SCI MED, V71, P1749, DOI 10.1016/j.socscimed.2010.03.056; Tabassum F, 2013, B WORLD HEALTH ORGAN, V91, P794; Vogel JP, 2014, BJOG-INT J OBSTET GY, V121, P76, DOI 10.1111/1471-0528.12633; Waterstone M, 2003, BJOG-INT J OBSTET GY, V110, P128, DOI 10.1046/j.1471-0528.2003.02151.x; Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089; WHO, 2009, REP WHO WORK GROUP C	33	3	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	NOV	2015	20	11					1406	1414		10.1111/tmi.12586				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CT1TC	WOS:000362583100001		Other Gold, Green Published			2019-04-02	
J	Helleringer, S; Pison, G; Masquelier, B; Kante, AM; Douillot, L; Ndiaye, CT; Duthe, G; Sokhna, C; Delaunay, V				Helleringer, Stephane; Pison, Gilles; Masquelier, Bruno; Kante, Almamy Malick; Douillot, Laetitia; Ndiaye, Cheikh Tidiane; Duthe, Geraldine; Sokhna, Cheikh; Delaunay, Valerie			Improving survey data on pregnancy-related deaths in low-and middle-income countries: a validation study in Senegal	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						maternal mortality; siblings' survival histories; survey data; sensitivity and specificity; Senegal	SUB-SAHARAN AFRICA; MATERNAL MORTALITY; ADULT MORTALITY; HEALTH; INFORMATION; SIBLINGS; TRENDS; MATLAB	ObjectiveIn low- and middle-income countries (LMICs), siblings' survival histories (SSH) are often used to estimate maternal mortality, but SSH data on causes of death at reproductive ages have seldom been validated. We compared the accuracy of two SSH instruments: the standard questionnaire used during the demographic and health surveys (DHS) and the siblings' survival calendar (SSC), a new questionnaire designed to improve survey reports of deaths among women of reproductive ages. MethodsWe recruited 1189 respondents in a SSH survey in Niakhar, Senegal. Mortality records from a health and demographic surveillance system (HDSS) constituted the reference data set. Respondents were randomly assigned to an interview with the DHS or SSC questionnaires. A total of 164 respondents had a sister who died at reproductive ages over the past 15years before the survey according to the HDSS. ResultsThe DHS questionnaire led to selective omissions of deaths: DHS respondents were significantly more likely to report their sister's death if she had died of pregnancy-related causes than if she had died of other causes (96.4% vs. 70.9%, P<0.007). Among reported deaths, both questionnaires had high sensitivity (>90%) in recording pregnancy-related deaths. But the DHS questionnaire had significantly lower specificity than the SSC (79.5% vs. 95.0%, P=0.015). The DHS questionnaire overestimated the proportion of deaths due to pregnancy-related causes, whereas the SSC yielded unbiased estimates of this parameter. ConclusionStatistical models informed by SSH data collected using the DHS questionnaire might exaggerate maternal mortality in Senegal and similar settings. A new questionnaire, the SSC, could permit better tracking progress towards the reduction in maternal mortality.	[Helleringer, Stephane] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Pison, Gilles; Duthe, Geraldine] Inst Natl Etud Demog, F-75675 Paris, France; [Pison, Gilles] Museum Natl Hist Nat, UMR Ecoanthropol & Ethnobiol 7206, F-75231 Paris, France; [Masquelier, Bruno] Univ Catholique Louvain la Neuve, Ctr Rech Demog, Louvain La Neuve, Belgium; [Kante, Almamy Malick] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Kante, Almamy Malick] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Douillot, Laetitia; Sokhna, Cheikh] Inst Rech Developpement, Unite Rech Malad Infect & Trop Emergentes, Dakar, Senegal; [Ndiaye, Cheikh Tidiane] Agence Natl Stat & Demog, Dakar, Senegal; [Delaunay, Valerie] Inst Rech Dev, Lab Populat Environm Dev, Marseille, France	Helleringer, S (reprint author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA.	sheller7@jhu.edu	Delaunay, Valerie/A-4173-2011	Delaunay, Valerie/0000-0003-2073-7176; Masquelier, Bruno/0000-0002-9585-891X			Baiden F, 2006, B WORLD HEALTH ORGAN, V84, P163, DOI 10.2471/BLT.05.025577; Baskind R, 2005, EPILEPSY BEHAV, V7, P68, DOI 10.1016/j.yabeh.2005.04.009; Chandramohan D, 1998, STUD FAMILY PLANN, V29, P414, DOI 10.2307/172253; Delaunay V, 2013, INT J EPIDEMIOL, V42, P1002, DOI 10.1093/ije/dyt100; elsArifeen S, 2014, LANCET, V384, P1366; Freedman D, 1988, Sociol Methodol, V18, P37, DOI 10.2307/271044; Garenne M, 1997, STUD FAMILY PLANN, V28, P54, DOI 10.2307/2137971; Graham W, 1994, Kangaroo, V3, P184; Hakkert R, 2001, STAT MED, V20, P3505, DOI 10.1002/sim.1075; Helleringer S, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001652; Hill K, 2006, B WORLD HEALTH ORGAN, V84, P173, DOI 10.2471/BLT.05.027714; Hill K, 2007, LANCET, V370, P1726, DOI 10.1016/S0140-736(07)61309-9; Kassebaum N. J., 2014, LANCET, DOI [10.1016/S0140-6736(14)60696-6, DOI 10.1016/S0140-6736(14)60696-6]; Kodio B, 2002, TROP MED INT HEALTH, V7, P499, DOI 10.1046/j.1365-3156.2002.00892.x; Masquelier B, 2014, POP STUD-J DEMOG, V68, P161, DOI 10.1080/00324728.2013.856458; Merdad L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059834; Ngom P, 1999, STUD FAMILY PLANN, V30, P142, DOI 10.1111/j.1728-4465.1999.00142.x; Obermeyer Z, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000260; Pison G, 2005, DEMOGR RES, V13, P301, DOI 10.4054/DemRes.2005.13.13; Pison G, 2000, POPULATION, V55, P1003, DOI 10.2307/1534925; Reniers G, 2011, INT HANDB POPUL, V2, P151, DOI 10.1007/978-90-481-9996-9_7; SHAHIDULLAH M, 1995, STUD FAMILY PLANN, V26, P101, DOI 10.2307/2137935; SHAHIDULLAH M, 1995, INT J EPIDEMIOL, V24, P937, DOI 10.1093/ije/24.5.937; Stanton C, 2000, STUD FAMILY PLANN, V31, P111, DOI 10.1111/j.1728-4465.2000.00111.x; Timaeus IM, 2004, DEMOGRAPHY, V41, P757, DOI 10.1353/dem.2004.0037; United Nations, 2013, WORLD POP PROSP 2012; Wang H, 2010, LANCET, V380, p2071 , DOI DOI 10.1016/S0140-6736(12)61719-X; WHO, 1992, ICD 10 CLASS MENT BE; WHO, 2014, WHO METH LIF EXP HLT; Wilmoth J. R., 2012, STAT POLITICS POLICY, V3, P1; Zureick-Brown S, 2013, INT PERSPECT SEX R H, V39, P32, DOI 10.1363/3903213	31	3	3	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	NOV	2015	20	11					1415	1423		10.1111/tmi.12583				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CT1TC	WOS:000362583100002					2019-04-02	
J	Delamou, A; Delvaux, T; Utz, B; Camara, BS; Beavogui, AH; Cole, B; Levin, K; Diallo, M; Millimono, S; Barry, TH; El Ayadi, AM; Zhang, WH; De Brouwere, V				Delamou, Alexandre; Delvaux, Therese; Utz, Bettina; Camara, Bienvenu Salim; Beavogui, Abdoul Habib; Cole, Bethany; Levin, Karen; Diallo, Moustapha; Millimono, Sita; Barry, Thierno Hamido; El Ayadi, Alison Marie; Zhang, Wei-Hong; De Brouwere, Vincent			Factors associated with loss to follow-up in women undergoing repair for obstetric fistula in Guinea	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						Obstetric fistula; loss to follow-up; Guinea; Conakry; Fistula care	FEMALE GENITAL FISTULA; TRANSPORT COSTS; OUTCOMES; ETHIOPIA; PROGRAM; UGANDA	ObjectivesTo analyse the trend of loss to follow-up over time and identify factors associated with women being lost to follow-up after discharge in three fistula repair hospitals in Guinea. MethodsThis retrospective cohort study used data extracted from medical records of fistula repairs conducted from 1 January 2007 to 30 September 2013. A woman was considered lost to follow-up if she did not return within 4months post-discharge. Factors associated with loss to follow-up were identified using a subsample of the data covering the period 2010-2013. ResultsOver the study period, the proportion of loss to follow-up was 21.5% (448/2080) and varied across repair hospitals and over time with an increase from 2% in 2009 to 52% in 2013. After adjusting for other variables in a multivariate logistic regression model, women who underwent surgery at Labe hospital and at Kissidougou hospital were more likely to be lost to follow-up than women operated at Jean Paul II hospital (OR: 50.6; 95% CI: 24.9-102.8) and (OR: 11.5; 95% CI: 6.1-22.0), respectively. Women with their fistula closed at hospital discharge (OR: 3.2; 95% CI: 2.1-4.8) and women admitted for repair in years 2011-2013 showed higher loss to follow-up as compared to 2010. Finally, loss to follow-up increased by 2 for each additional kilometre of distance a client lived from the repair hospital (OR: 1.002; 95% CI: 1.001-1.003). ConclusionReimbursement of transport was the likely reason for change over time of LTFU. Reducing geographical barriers to care for women with fistula could sustain fistula care positive outcomes.	[Delamou, Alexandre; Zhang, Wei-Hong] Univ Libre Bruxelles, Ecole Sante Publ, Brussels, Belgium; [Delamou, Alexandre; Camara, Bienvenu Salim; Beavogui, Abdoul Habib] Ctr Natl Format & Rech Sante Rurale Maferinyah, Maferinyah, Guinea; [Delamou, Alexandre; Delvaux, Therese; Utz, Bettina; De Brouwere, Vincent] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Diallo, Moustapha; Millimono, Sita] EngenderHlth, Conakry, Guinea; [Cole, Bethany; Levin, Karen] EngenderHlth, New York, NY USA; [Barry, Thierno Hamido] Hop Prefectoral Kissidougou, Kissidougou, Guinea; [El Ayadi, Alison Marie] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA	Delamou, A (reprint author), Ctr Natl Format & Rech Sante Rurale Maferinyah, POB 4099, Conakry, Guinea.	adelamou@gmail.com		Zhang, Wei-Hong/0000-0003-0380-770X; Utz, Bettina/0000-0002-7263-3320			Adler AJ, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-246; Arrowsmith SD, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-73; Barone MA, 2015, LANCET, V386, P56, DOI 10.1016/S0140-6736(14)62337-0; Barone MA, 2012, OBSTET GYNECOL, V120, P524, DOI 10.1097/AOG.0b013e31826579e8; Barone MA, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-5; Bishinga A, 2013, PUBLIC HEALTH ACTION, V3, P113, DOI 10.5588/pha.13.0001; Browning A, 2008, BJOG-INT J OBSTET GY, V115, P1564, DOI 10.1111/j.1471-0528.2008.01900.x; De Ridder D, 2012, OBSTETRIC FISTULA DE, P87; Delamou A, 2015, TROP MED INT HEALTH, V20, P813, DOI 10.1111/tmi.12489; Fiander A, 2013, INT J GYNECOL OBSTET, V120, P292, DOI 10.1016/j.ijgo.2012.09.026; Hawkins L, 2013, INT J GYNECOL OBSTET, V120, P178, DOI 10.1016/j.ijgo.2012.08.014; Institut National des Statistiques, 2014, ENQ DEM SANT ET IND; Kayondo M, 2011, BMC UROL, V11, DOI 10.1186/1471-2490-11-23; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Lubega M, 2013, PATIENT PREFER ADHER, V7, P447, DOI 10.2147/PPA.S19327; Mattison C, 2011, STRENGTHENING HLTH S; Maulet N, 2013, TROP MED INT HEALTH, V18, P524, DOI 10.1111/tmi.12086; Mselle LT, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-49; Nielsen HS, 2009, BJOG-INT J OBSTET GY, V116, P1258, DOI 10.1111/j.1471-0528.2009.02200.x; Osotimehin B, 2013, LANCET, V381, P1702, DOI 10.1016/S0140-6736(13)61001-6; Peterman A, 2015, INT J GYNECOL OBSTET, V128, P77, DOI 10.1016/j.ijgo.2014.08.007; Project report, 2013, PROJECT REPORT; Sidze LK, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1555-2; Tayler-Smith K, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-164; Wilson AL, 2011, INT J GYNECOL OBSTET, V113, P196, DOI 10.1016/j.ijgo.2011.01.006; Yeakey MP, 2009, CULT HEALTH SEX, V11, P499, DOI 10.1080/13691050902874777	26	4	4	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	NOV	2015	20	11					1454	1461		10.1111/tmi.12584				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CT1TC	WOS:000362583100007		Green Published, Other Gold			2019-04-02	
J	Diaz, AG; Battaglioli, T; Rodriguez, RD; Valdes, RG; Ochoa, EG; Van der Stuyft, P				Gonzalez Diaz, Alexander; Battaglioli, Tullia; Diaz Rodriguez, Raul; Goza Valdes, Roxana; Gonzalez Ochoa, Edilberto; Van der Stuyft, Patrick			Molecular epidemiology of tuberculosis in Havana, Cuba, 2009	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						tuberculosis; molecular epidemiology; MIRU-VNTR typing; Havana; Cuba	FRAGMENT-LENGTH-POLYMORPHISM; MYCOBACTERIUM-TUBERCULOSIS; TRANSMISSION; RESISTANCE; CITY	ObjectivesTo estimate the proportion of tuberculosis cases attributable to recent transmission and the risk factors possibly associated with tuberculosis clustering. MethodsPopulation-based study combining information from epidemiological investigation of tuberculosis cases notified to the National Tuberculosis Control Program in Havana, Cuba, in 2009 with the results of genotyping of Mycobacterium tuberculosis isolates with variable number tandem repeat of mycobacterial interspersed repetitive units (MIRU-VNTR) typing. ResultsOf 186 cases, 61 were genotyped: 33 patterns and five clusters with 19, 7, 3, 2 and 2 cases were found. The proportion of cases due to recent transmission was 45% (95% confidence interval 33-58%). Routine contact investigation failed to identify a substantial number of epidemiological links. A history of living in a closed setting was strongly associated with clustering. ConclusionsThe proportion of cases due to recent transmission in Havana in 2009 is high. The existing control measures in closed settings should be strengthened. A study on a larger number of cases and for a longer time period should be carried out to obtain more precise estimates. Further studies on the utility and cost-effectiveness of the addition of molecular epidemiology techniques to support the progress towards tuberculosis elimination in Cuba, a low-incidence resource-limited setting, are also needed.	[Gonzalez Diaz, Alexander; Gonzalez Ochoa, Edilberto] Inst Trop Med Pedro Kouri, Res & Surveillance Grp TB, Leprosy & ARI, Havana, Cuba; [Battaglioli, Tullia; Van der Stuyft, Patrick] Inst Trop Med, Dept Publ Hlth, Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium; [Diaz Rodriguez, Raul; Goza Valdes, Roxana] Inst Trop Med Pedro Kouri, Natl Reference Lab TB & Mycobacteria, Havana, Cuba; [Van der Stuyft, Patrick] Univ Ghent, Fac Med, Dept Publ Hlth, B-9000 Ghent, Belgium	Battaglioli, T (reprint author), Inst Trop Med, Dept Publ Hlth, Epidemiol & Dis Control Unit, Natl Str 155, B-2000 Antwerp, Belgium.	tbattaglioli@itg.be					ALLAND D, 1994, NEW ENGL J MED, V330, P1710, DOI 10.1056/NEJM199406163302403; Borgdorff MW, 2013, CLIN MICROBIOL INFEC, V19, P889, DOI 10.1111/1469-0691.12253; Borrell S, 2009, J CLIN MICROBIOL, V47, P198, DOI 10.1128/JCM.00507-08; CANETTI G, 1963, B WORLD HEALTH ORGAN, V29, P565; Centers for Disease Control and Prevention, 2012, TUB GEN US 2004 2010; de Beer JL, 2012, J CLIN MICROBIOL, V50, P662, DOI 10.1128/JCM.00607-11; DesVries G, 2009, BMC INFECT DIS, V9, P151; Diaz R, 1998, INT J TUBERC LUNG D, V2, P743; Diaz R, 2001, MEM I OSWALDO CRUZ, V96, P437, DOI 10.1590/S0074-02762001000400001; Direccion Provincial de Salud Ciudad Habana Departamento de Estadistica, 2009, SIT SAL IND BAS; Fok A, 2008, INT J TUBERC LUNG D, V12, P480; Glynn JR, 1999, INT J TUBERC LUNG D, V3, P1055; González Díaz Alexander, 2012, Rev Cubana Med Trop, V64, P163; Diaz AG, 2010, REV PANAM SALUD PUBL, V28, P275, DOI 10.1590/S1020-49892010001000006; Kamper-Jorgensen Z, 2012, J CLIN MICROBIOL, V50, P2660, DOI 10.1128/JCM.06358-11; Lambregts-van Weezenbeek CSB, 2003, INT J TUBERC LUNG D, V7, pS463; Liu RX, 2013, INT J TUBERC LUNG D, V17, P243, DOI 10.5588/ijtld.12.0777; Lonnroth K, 2015, EUR RESPIR J, V45, P928, DOI 10.1183/09031936.00214014; McNabb SJN, 2004, AM J EPIDEMIOL, V160, P589, DOI 10.1093/aje/kwh253; Ministerio de Salud Publica, 2010, AN EST SAL 2009; Ministerio de Salud Publica, 2013, AN NAC EST 2012; Montoro E, 2011, REV PANAM SALUD PUBL, V30, P615, DOI 10.1590/S1020-49892011001200020; Programa Nacional de Control de la Tuberculosis en Cuba, 2009, MAN NORM PROC; Scurch A, 2012, INFECT GENET EVOL, V12, P602; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; World Health Organization, 2014, GLOB TUB REP 2014	27	2	3	0	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	NOV	2015	20	11					1534	1542		10.1111/tmi.12569				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CT1TC	WOS:000362583100016		Bronze			2019-04-02	
J	Brook, CE; Beauclair, R; Ngwenya, O; Worden, L; Ndeffo-Mbah, M; Lietman, TM; Satpathy, SK; Galvani, AP; Porco, TC				Brook, Cara E.; Beauclair, Roxanne; Ngwenya, Olina; Worden, Lee; Ndeffo-Mbah, Martial; Lietman, Thomas M.; Satpathy, Sudhir K.; Galvani, Alison P.; Porco, Travis C.			Spatial heterogeneity in projected leprosy trends in India	PARASITES & VECTORS			English	Article						Leprosy; Mycobacterium leprae; India; Linear mixed effects regression	HOUSEHOLD CONTACTS; BCG VACCINATION; EPIDEMIOLOGY; TRANSMISSION; TUBERCULOSIS; DISTRICT; IMMUNITY; CARRIERS; PROGRAM; DISEASE	Background: Leprosy is caused by infection with Mycobacterium leprae and is characterized by peripheral nerve damage and skin lesions. The disease is classified into paucibacillary (PB) and multibacillary (MB) leprosy. The 2012 London Declaration formulated the following targets for leprosy control: (1) global interruption of transmission or elimination by 2020, and (2) reduction of grade-2 disabilities in newly detected cases to below 1 per million population at a global level by 2020. Leprosy is treatable, but diagnosis, access to treatment and treatment adherence (all necessary to curtail transmission) represent major challenges. Globally, new case detection rates for leprosy have remained fairly stable in the past decade, with India responsible for more than half of cases reported annually. Methods: We analyzed publicly available data from the Indian Ministry of Health and Family Welfare, and fit linear mixed-effects regression models to leprosy case detection trends reported at the district level. We assessed correlation of the new district-level case detection rate for leprosy with several state-level regressors: TB incidence, BCG coverage, fraction of cases exhibiting grade 2 disability at diagnosis, fraction of cases in children, and fraction multibacillary. Results: Our analyses suggest an endemic disease in very slow decline, with substantial spatial heterogeneity at both district and state levels. Enhanced active case finding was associated with a higher case detection rate. Conclusions: Trend analysis of reported new detection rates from India does not support a thesis of rapid progress in leprosy control.	[Brook, Cara E.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Beauclair, Roxanne] Univ Ghent, Int Ctr Reprod Hlth, B-9000 Ghent, Belgium; [Beauclair, Roxanne; Ngwenya, Olina] Univ Stellenbosch, Ctr Excellence Epidemiol Modelling & Anal SACEMA, South African Dept Sci & Technol, Natl Res Fdn DST NRF, ZA-7600 Stellenbosch, South Africa; [Worden, Lee; Lietman, Thomas M.; Porco, Travis C.] Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA; [Ndeffo-Mbah, Martial; Galvani, Alison P.] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Lietman, Thomas M.; Porco, Travis C.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA USA; [Lietman, Thomas M.; Porco, Travis C.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Satpathy, Sudhir K.] KIIT Univ, Sch Publ Hlth, Bhubaneswar, Odisha, India	Porco, TC (reprint author), Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA.	travis.porco@ucsf.edu		Worden, Lee/0000-0001-9799-0183	NTD Modelling Consortium by Novartis Foundation; Meaningful Modeling of Epidemiological Data (MMED) program, a NIH under the University of Florida; South African Centre for Epidemiological Modelling and Analysis (SACEMA); African Institute for Mathematical Sciences (AIMS) [NIH NIGMS R25GM102149]; US NIH NIGMS MIDAS [U01-GM087728, U01-GM087719]	TCP, MN, TML, LW and AP gratefully acknowledge funding of the NTD Modelling Consortium by Novartis Foundation. The views, opinions, assumptions and conclusions or any other information set out in this article are solely those of the authors and not of Novartis Foundation. Novartis Foundation was not involved in the establishment of this article and this article should not be attributed to Novartis Foundation or any person connected with Novartis Foundation. TCP, CEB, RB, and ON gratefully acknowledge support from the Meaningful Modeling of Epidemiological Data (MMED) program, a NIH-funded joint initiative under the University of Florida, the South African Centre for Epidemiological Modelling and Analysis (SACEMA), and the African Institute for Mathematical Sciences (AIMS) (NIH NIGMS R25GM102149 to J.R.C. Pulliam and A. Welte.) TCP and TML acknowledge support from the US NIH NIGMS MIDAS program, U01-GM087728. AG and MN acknowledge support from US NIH NIGMS MIDAS award U01-GM087719. The authors acknowledge useful comments from J. Scott, S. Bellan and the anonymous reviewers, and data entry assistance from Lina Zhong.	Alberts CJ, 2011, B WORLD HEALTH ORGAN, V89, P487, DOI 10.2471/BLT.10.085662; Araujo S, 2012, MEM I OSWALDO CRUZ, V107, P55, DOI 10.1590/S0074-02762012000900010; Bartoszynski R., 1967, P 5 BERK S, P259; Beyene D, 2003, EPIDEMIOL INFECT, V131, P841, DOI 10.1017/S0950268803001079; Blok DJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1143-4; Blumberg S, 2015, PLOS CURR; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Central Leprosy Division DG of HSN, 2013, PROGR REP YEAR 2012; Central Leprosy Division DG of HSN, 2012, PROGR REP YEAR 2011; Central Leprosy Division DG of HSN, 2010, PROGR REP YEAR 2009; Central Leprosy Division DG of HSN, 2011, PROGR REP YEAR 2010; Central Leprosy Division DG of HSN, 2014, PROGR REP YEAR 2013; Central Leprosy Division DG or HSN, 2009, PROGR REP YEAR 2008; CHAUSSINAND R., 1948, INTERNAT JOUR LEPROSY, V16, P431; CHAUSSINAND R, 1953, Lepr Rev, V24, P90; Crump RE, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1142-5; DAVEY TF, 1974, LEPROSY REV, V45, P121; Deepak S, 2012, LEPROSY PRACTICAL GU, P361; Efron B., 1993, INTRO BOOTSTRAP; FINE PEM, 1988, BRIT MED BULL, V44, P691, DOI 10.1093/oxfordjournals.bmb.a072277; FINE PEM, 1982, EPIDEMIOL REV, V4, P161, DOI 10.1093/oxfordjournals.epirev.a036245; Harris T.E, 1963, THEORY BRANCHING PRO; Husain S, 2013, ISRN TROPICAL MED, V2013; Job CK, 2008, AM J TROP MED HYG, V78, P518, DOI 10.4269/ajtmh.2008.78.518; Johnson PCD, 2014, METHODS ECOL EVOL, V5, P944, DOI 10.1111/2041-210X.12225; KLATSER PR, 1993, J CLIN MICROBIOL, V31, P2947; Kumar A, 2013, LEPROSY REV, V84, P124; Kuper H, 2006, TRACHOMA CONTROL GUI; Lietman T, 1997, AM J PUBLIC HEALTH, V87, P1923, DOI 10.2105/AJPH.87.12.1923; Lockwood DNJ, 2005, B WORLD HEALTH ORGAN, V83, P230; MCDOUGALL AC, 1975, J PATHOL, V115, P215, DOI 10.1002/path.1711150406; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Pandey A, 2015, RES REP TROP MED, V2015, P643; Parkash O, 2009, FEMS IMMUNOL MED MIC, V55, P1, DOI 10.1111/j.1574-695X.2008.00491.x; Program NLE, 2013, DISTR WIS ANN NEW CA; Program NLE, 2012, DISTR WIS ANN NEW CA; Program NLE, 2011, DISTR WIS ANN NEW CA; Program NLE, 2014, DISTR WIS ANN NEW CA; Program NLE, 2015, DISTR WIS ANN NEW CA; Program NLE, 2010, DISTR WIS ANN NEW CA; Program NLE, 2009, DISTR WIS ANN NEW CA; Programme NLE, 2008, DISTR WIS ANN NEW CA; Rao PN, 2005, INT J LEPROSY, V73, P211; REICH CV, 1987, REV INFECT DIS, V9, P590; Revised National Tuberculosis Control Programme (RNTCP), 2015, ANN REP; Richardus JH, 2015, CLIN DERMATOL, V33, P19, DOI 10.1016/j.clindermatol.2014.07.009; Rodrigues LC, 2011, LANCET INFECT DIS, V11, P464, DOI 10.1016/S1473-3099(11)70006-8; Shetty VP, 2009, LEPROSY REV, V80, P22; Shukla LK, 2015, INDIAN J DERMATOL VE, V81, P257, DOI 10.4103/0378-6323.154793; Smith WC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003658; Suzuki K, 2012, J DERMATOL, V39, P121, DOI 10.1111/j.1346-8138.2011.01370.x; Tripathy V. M., 2009, PLOS ONE, V4; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; West B. T., 2014, LINEAR MIXED MODELS; WEST BC, 1988, ARCH INTERN MED, V148, P1987, DOI 10.1001/archinte.148.9.1987; WHO, 2009, ENH GLOB STRAT FURTH; WHO, 2013, INT LEPR SUMM OV REM; World Health Organization, 2012, ACC WORK OV GLOB IMP; World Health Organization, 2005, NAT PROGR MAN LEPR E; World Health Organization, 2015, WKLY EPIDEMIOL REC, V36, P461	60	20	20	1	9	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	OCT 22	2015	8								542	10.1186/s13071-015-1124-7				11	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CU1UQ	WOS:000363307400002	26490137	DOAJ Gold, Green Published			2019-04-02	
J	de la Fuente, J; Estrada-Pena, A; Cabezas-Cruz, A; Brey, R				de la Fuente, Jose; Estrada-Pena, Agustin; Cabezas-Cruz, Alejandro; Brey, Ricardo			Flying ticks: anciently evolved associations that constitute a risk of infectious disease spread	PARASITES & VECTORS			English	Review						Tick; Bird; Evolution; Genetics; Pathogen	ANAPLASMA-PHAGOCYTOPHILUM; COMPARATIVE GENOMICS; MIGRATORY BIRDS; EVOLUTION; PATHOGENS; ACARI; BACTERIA; IXODIDAE; ANIMALS; MODELS	Ticks are important vectors of emerging zoonotic diseases affecting human and animal health worldwide. Ticks are often found on wild birds, which have been long recognized as a potential risk factor for dissemination of ticks and tick-borne pathogens (TBP), thus raising societal concerns and prompting research into their biology and ecology. To fully understand the role of birds in disseminating some ticks species and TBP, it is important to consider the evolutionary relationships between birds, ticks and transmitted pathogens. In this paper we reviewed the possible role of birds in the dissemination of TBP as a result of the evolution of host-tick-pathogen associations. Birds are central elements in the ecological networks of ticks, hosts and TBP. The study of host-tick-pathogen associations reveals a prominent role for birds in the dissemination of Borrelia spp. and Anaplasma phagocytophilum, with little contribution to the possible dissemination of other TBP. Birds have played a major role during tick evolution, which explains why they are by far the most important hosts supporting the ecological networks of ticks and several TBP. The immune response of birds to ticks and TBP has been largely overlooked. To implement effective measures for the control of tick-borne diseases, it is necessary to study bird-tick and bird-pathogen molecular interactions including the immune response of birds to tick infestation and pathogen infection.	[de la Fuente, Jose] IREC CSIC UCLM JCCM, SaBio Inst Invest Recursos Cineget, Ciudad Real 13005, Spain; [de la Fuente, Jose] Oklahoma State Univ, Dept Vet Pathobiol, Ctr Vet Hlth Sci, Stillwater, OK 74078 USA; [Estrada-Pena, Agustin] Univ Zaragoza, Fac Vet, E-50013 Zaragoza, Spain; [Cabezas-Cruz, Alejandro] Univ Lille Nord France, Inst Pasteur Lille, CNRS, CIIL,INSERM,U1019,UMR 8204, F-59019 Lille, France; [Brey, Ricardo] Ricardo Brey Studio, B-9000 Gante, Belgium	de la Fuente, J (reprint author), IREC CSIC UCLM JCCM, SaBio Inst Invest Recursos Cineget, Ronda Toledo S-N, Ciudad Real 13005, Spain.	jose_delafuente@yahoo.com	Cabezas-Cruz, Alejandro/P-2755-2017	Cabezas-Cruz, Alejandro/0000-0002-8660-730X; Estrada Pena, Agustin/0000-0001-7483-046X	EU [278976]; Ministere de l'Education Superieure et de la Recherche of France	Part of this research was supported by EU FP7 ANTIGONE project number 278976. ACC was supported by a grant from the Ministere de l'Education Superieure et de la Recherche of France.	Aardema ML, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0335-z; BABUDIERI B, 1952, NATURE, V169, P195, DOI 10.1038/169195a0; Barker SC, 2008, TICKS: BIOLOGY, DISEASE AND CONTROL, P1, DOI 10.1017/CBO9780511551802.002; Benson RBJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001853; Benton MJ, 2014, CURR BIOL, V24, pR87, DOI 10.1016/j.cub.2013.11.063; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Clayton Dale H., 2010, Open Ornithology Journal, V3, P41; Darby AC, 2007, TRENDS GENET, V23, P511, DOI 10.1016/j.tig.2007.08.002; de la Fuente J, 2005, VECTOR-BORNE ZOONOT, V5, P390, DOI 10.1089/vbz.2005.5.390; De La Fuente J, 2003, EXP APPL ACAROL, V29, P331, DOI 10.1023/A:1025824702816; de la Fuente J, 2015, EXPERT REV IN PRESS; de la Fuente J, 2013, VACCINE, V31, P5923, DOI 10.1016/j.vaccine.2013.10.049; Estrada-Pena A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10361; Estrada-Pena A, 2014, TRENDS PARASITOL, V30, P205, DOI 10.1016/j.pt.2014.02.003; Gorirossi-Bourdeau Flora, 1995, Bulletin and Annales de la Societe Royale Belge d'Entomologie, V131, P3; Green RE, 2014, SCIENCE, V346, P1335, DOI 10.1126/science.1254449; Harrington D, 2009, VACCINE, V27, P4056, DOI 10.1016/j.vaccine.2009.04.014; Hasle G, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00048; Hoogstraal H, 1970, BIBLIO TICKS TICK BO, V2; Hornok S, 2013, VECTOR-BORNE ZOONOT, V13, P77, DOI 10.1089/vbz.2012.1032; Hubalek Z, 2004, J WILDLIFE DIS, V40, P639, DOI 10.7589/0090-3558-40.4.639; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Johnson KL, 2008, J PARASITOL, V94, P296, DOI 10.1645/GE-1059.1; Klompen H, 2001, ANN ENTOMOL SOC AM, V94, P10, DOI 10.1603/0013-8746(2001)094[0010:FMROAP]2.0.CO;2; Kurtenbach K, 2006, NAT REV MICROBIOL, V4, P660, DOI 10.1038/nrmicro1475; Laakkonen Juha, 2009, Memoranda Societatis pro Fauna et Flora Fennica, V85, P16; LUNDGREN DL, 1966, J BACTERIOL, V91, P963; Mans BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049461; Margos G, 2011, INFECT GENET EVOL, V11, P1545, DOI 10.1016/j.meegid.2011.07.022; Merhej V, 2011, BIOL REV, V86, P379, DOI 10.1111/j.1469-185X.2010.00151.x; Newman EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118146; Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009; Owen JP, 2010, TRENDS PARASITOL, V26, P530, DOI 10.1016/j.pt.2010.06.005; Poinar G, 2015, HIST BIOL, V27, P565, DOI 10.1080/08912963.2014.897699; Prum RO, 2008, SCIENCE, V322, P1799, DOI 10.1126/science.1168808; Rar V, 2011, INFECT GENET EVOL, V11, P1842, DOI 10.1016/j.meegid.2011.09.019; Rossini S, 1989, EGYPTIAN HIEROGLYPHI; Sahney S, 2010, GEOLOGY, V38, P1079, DOI 10.1130/G31182.1; Stuen S, 2007, VET RES COMMUN, V31, P79, DOI 10.1007/s11259-007-0071-y; Tzika AC, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-19; Weinert LA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-6; Wells K, 2013, OECOLOGIA, V172, P307, DOI 10.1007/s00442-012-2511-9; Xu X, 2014, SCIENCE, V346, P1341, DOI 10.1126/science.1253293; Zhang GJ, 2014, SCIENCE, V346, P1311, DOI 10.1126/science.1251385	44	9	9	3	30	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	OCT 15	2015	8								538	10.1186/s13071-015-1154-1				11	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CU2YK	WOS:000363389500001	26467109	DOAJ Gold, Green Published			2019-04-02	
J	Oriero, EC; Okebe, J; Jacobs, J; Van Geertruyden, JP; Nwakanma, D; D'Alessandro, U				Oriero, Eniyou C.; Okebe, Joseph; Jacobs, Jan; Van Geertruyden, Jean-Pierre; Nwakanma, Davis; D'Alessandro, Umberto			Diagnostic performance of a novel loop-mediated isothermal amplification (LAMP) assay targeting the apicoplast genome for malaria diagnosis in a field setting in sub-Saharan Africa	MALARIA JOURNAL			English	Article						Malaria diagnosis; LAMP; RDT; Microscopy; PCR; Field-based; Resource-limited settings	DRIED BLOOD SPOTS; INFECTIONS; PARASITE; KIT; TRANSMISSION; PREVALENCE; CARRIERS; SAMPLES; GAMBIA	Background: New diagnostic tools to detect reliably and rapidly asymptomatic and low-density malaria infections are needed as their treatment could interrupt transmission. Isothermal amplification techniques are being explored for field diagnosis of malaria. In this study, a novel molecular tool (loop-mediated isothermal amplification-LAMP) targeting the apicoplast genome of Plasmodium falciparum was evaluated for the detection of asymptomatic malaria-infected individuals in a rural setting in The Gambia. Methods: A blood was collected from 341 subjects (median age 9 years, range 1-68 years) screened for malaria. On site, a rapid diagnostic test (RDT, SD Bioline Malaria Antigen P.f) was performed, thick blood films (TBF) slides for microscopy were prepared and dry blood spots (DBS) were collected on Whatman (R) 903 Specimen collection paper. The TBF and DBS were transported to the field laboratory where microscopy and LAMP testing were performed. The latter was done on DNA extracted from the DBS using a crude (methanol/heating) extraction method. A laboratory-based PCR amplification was done on all the samples using DNA extracted with the Qiagen kit and its results were taken as reference for all the other tests. Results: Plasmodium falciparum malaria prevalence was 37 % (127/341) as detected by LAMP, 30 % (104/341) by microscopy and 37 % (126/341) by RDT. Compared to the reference PCR method, sensitivity was 92 % for LAMP, 78 % for microscopy, and 76 % for RDT; specificity was 97 % for LAMP, 99 % for microscopy, and 88 % for RDT. Area under the receiver operating characteristic (ROC) curve in comparison with the reference standard was 0.94 for LAMP, 0.88 for microscopy and 0.81 for RDT. Turn-around time for the entire LAMP assay was approximately 3 h and 30 min for an average of 27 +/- 9.5 samples collected per day, compared to a minimum of 10 samples an hour per operator by RDT and over 8 h by microscopy. Conclusion: The LAMP assay could produce reliable results the same day of the screening. It could detect a higher proportion of low density malaria infections than the other methods tested and may be used for large campaigns of systematic screening and treatment.	[Oriero, Eniyou C.; Okebe, Joseph; Nwakanma, Davis; D'Alessandro, Umberto] MRC Unit, Banjul, Gambia; [Oriero, Eniyou C.; Okebe, Joseph; Jacobs, Jan; D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium; [Oriero, Eniyou C.; Okebe, Joseph; Van Geertruyden, Jean-Pierre] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium; [Jacobs, Jan] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [D'Alessandro, Umberto] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	Oriero, EC (reprint author), MRC Unit, POB 273, Banjul, Gambia.	eoriero@mrc.gm	Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Oriero, Eniyou/0000-0002-7911-6457; Okebe, Joseph/0000-0001-5466-1611; Nwakanma, Davis/0000-0002-6706-6069	UK Medical Research Council (MRC); UK Department for International Development (DFID) under the MRC/DFID; Medical Research Council [MC_U190092708, MR/J002364/1]	We would like to thank all the study participants who made this study possible. We acknowledge the entire field and laboratory staff of the PRINOGAM Trial, as well as David Jefferies for statistical support. This study has been jointly funded by The UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement.	[Anonymous], 2011, PLOS MED, V8; Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364; Canier L, 2015, AM J TROP MED HYG, V92, P573, DOI 10.4269/ajtmh.14-0614; Cook J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0573-y; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Han ET, 2007, J CLIN MICROBIOL, V45, P2521, DOI 10.1128/JCM.02117-06; Han ET, 2013, EXPERT REV MOL DIAGN, V13, P205, DOI [10.1586/ERM.12.144, 10.1586/erm.12.144]; Hopkins H, 2013, J INFECT DIS, V208, P645, DOI 10.1093/infdis/jit184; Hsiang MS, 2010, J CLIN MICROBIOL, V48, P3539, DOI 10.1128/JCM.00522-10; Lindblade KA, 2013, EXPERT REV ANTI-INFE, V11, P623, DOI [10.1586/ERI.13.45, 10.1586/eri.13.45]; Mayxay M, 2001, T ROY SOC TROP MED H, V95, P179, DOI 10.1016/S0035-9203(01)90156-7; McMorrow ML, 2011, CLIN MICROBIOL INFEC, V17, P1624, DOI 10.1111/j.1469-0691.2011.03639.x; Okebe J, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0597-1; Oriero CE, 2015, CLIN MICROBIOL INFEC, V21; Polley SD, 2013, J INFECT DIS, V208, P637, DOI 10.1093/infdis/jit183; Polley SD, 2010, J CLIN MICROBIOL, V48, P2866, DOI 10.1128/JCM.00355-10; Satoguina J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-274; Sattabongkot J, 2014, J CLIN MICROBIOL, V52, P1471, DOI 10.1128/JCM.03313-13; Sirichaisinthop J, 2011, AM J TROP MED HYG, V85, P594, DOI 10.4269/ajtmh.2011.10-0676; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Takem EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067108; Vallejo AF, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003453	22	12	12	0	11	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	OCT 9	2015	14								396	10.1186/s12936-015-0926-6				6	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CT2KO	WOS:000362630600003	26450599	DOAJ Gold, Green Published			2019-04-02	
J	Blumental, S; Lambermont, M; Heijmans, C; Rodenbach, MP; El Kenz, H; Sondag, D; Bottieau, E; Truyens, C				Blumental, Sophie; Lambermont, Micheline; Heijmans, Catherine; Rodenbach, Marie-Pierre; El Kenz, Hanane; Sondag, DaniSle; Bottieau, Emmanuel; Truyens, Carine			First Documented Transmission of Trypanosoma cruzi Infection through Blood Transfusion in a Child with Sickle-Cell Disease in Belgium	PLOS NEGLECTED TROPICAL DISEASES			English	Article							CHRONIC CHAGAS-DISEASE; BONE-MARROW TRANSPLANT; NORTH-AMERICA; DONORS; SPAIN; RECIPIENT; IMPLEMENTATION; BENZNIDAZOLE; SWITZERLAND; PREVALENCE		[Blumental, Sophie] Hop Univ Enfants Reine Fabiola, Pediat Infect Dis Unit, Brussels, Belgium; [Lambermont, Micheline; Rodenbach, Marie-Pierre; El Kenz, Hanane; Sondag, DaniSle] Belgian Red Cross, Serv Sang, Brussels, Belgium; [Heijmans, Catherine] Hop Univ Enfants Reine Fabiola, Hematooncol Dept, Brussels, Belgium; [Bottieau, Emmanuel] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Truyens, Carine] Univ Libre Bruxelles, Fac Med, Parasitol Lab, Brussels, Belgium	Blumental, S (reprint author), Hop Univ Enfants Reine Fabiola, Pediat Infect Dis Unit, Brussels, Belgium.	ctruyens@ulb.ac.be					Altcheh J, 2011, PEDIATRICS, V127, pE212, DOI 10.1542/peds.2010-1172; Altclas J, 2005, BONE MARROW TRANSPL, V36, P123, DOI 10.1038/sj.bmt.1705006; Altclas J, 2014, BLOOD TRANSFUS-ITALY, V12, pS380, DOI 10.2450/2013.0009-13; Basile L, 2011, EURO SURVEILL, V16; Benjamin RJ, 2012, TRANSFUSION, V52, P1913, DOI 10.1111/j.1537-2995.2011.03554.x; Buekens P, 2008, MATERN CHILD HLTH J, V12, P283, DOI 10.1007/s10995-007-0246-8; Cancino-Faure B, 2015, TRANSFUSION, V55, P1249, DOI 10.1111/trf.12989; Carlier Y, 2011, Bull Mem Acad R Med Belg, V166, P347; Castro E, 2007, TRANSFUSION, V47, P434, DOI 10.1111/j.1537-2995.2007.01133.x; El Ghouzzi MH, 2010, TRANSFUSION, V50, P575, DOI 10.1111/j.1537-2995.2009.02476.x; Fabbro DL, 2007, REV SOC BRAS MED TRO, V40, P1, DOI 10.1590/S0037-86822007000100001; Flores-Chavez M, 2008, CLIN INFECT DIS, V46, pE44, DOI 10.1086/527448; Fores R, 2007, BONE MARROW TRANSPL, V39, P127, DOI 10.1038/sj.bmt.1705551; Gascon J, 2010, ACTA TROP, V115, P22, DOI 10.1016/j.actatropica.2009.07.019; Guedes PMM, 2011, EXPERT REV ANTI-INFE, V9, P609, DOI [10.1586/eri.11.31, 10.1586/ERI.11.31]; Hotez PJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002300; Jackson Y, 2010, CLIN INFECT DIS, V51, pE69, DOI 10.1086/656917; Jackson Y, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000592; Jackson Y, 2009, EMERG INFECT DIS, V15, P601, DOI 10.3201/eid1504.080438; Kitchen AD, 2012, TRANSFUSION, V52, P1931, DOI 10.1111/j.1537-2995.2012.03599.x; Lattes R, 2014, CLIN MICROBIOL INFEC, V20, P300, DOI 10.1111/1469-0691.12585; Lescure FX, 2008, EMERG INFECT DIS, V14, P644, DOI 10.3201/eid1404.070489; Munoz J, 2009, CLIN INFECT DIS, V48, P1736, DOI 10.1086/599223; O'Brien SF, 2013, TRANSFUSION, V53, P1706, DOI 10.1111/j.1537-2995.2012.03950.x; Perkins HA, 2010, TRANSFUSION, V50, P2080, DOI 10.1111/j.1537-2995.2010.02851.x; Piron M, 2008, TRANSFUSION, V48, P1862, DOI 10.1111/j.1537-2995.2008.01789.x; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Requena-Mendez A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003540; Requena-Mendez A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003245; Schmidt M, 2014, TRANSFUS MED HEMOTH, V41, P10, DOI 10.1159/000358017; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Schubert P, 2014, TRANSFUSION; VILLALBA R, 1992, CLIN INFECT DIS, V14, P594, DOI 10.1093/clinids/14.2.594; Viotti R, 2009, EXPERT REV ANTI-INFE, V7, P157, DOI 10.1586/14787210.7.2.157; Virreira M, 2003, AM J TROP MED HYG, V68, P574, DOI 10.4269/ajtmh.2003.68.574; Ware Russell E, 2009, Hematology Am Soc Hematol Educ Program, P62, DOI 10.1182/asheducation-2009.1.62; *WHO, 2002, 905 WHO	37	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	OCT	2015	9	10							e0003986	10.1371/journal.pntd.0003986				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CV7NC	WOS:000364459600003	26469272	DOAJ Gold, Green Published			2019-04-02	
J	Diro, E; Ritmeijer, K; Boelaert, M; Alves, F; Mohammed, R; Abongomera, C; Ravinetto, R; De Crop, M; Fikre, H; Adera, C; Colebunders, R; van Loen, H; Menten, J; Lynen, L; Hailu, A; van Griensven, J				Diro, Ermias; Ritmeijer, Koert; Boelaert, Marleen; Alves, Fabiana; Mohammed, Rezika; Abongomera, Charles; Ravinetto, Raffaella; De Crop, Maaike; Fikre, Helina; Adera, Cherinet; Colebunders, Robert; van Loen, Harry; Menten, Joris; Lynen, Lutgarde; Hailu, Asrat; van Griensven, Johan			Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study	PLOS NEGLECTED TROPICAL DISEASES			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; AMPHOTERICIN-B; ISETHIONATE	Background Visceral leishmaniasis (VL) has become an important opportunistic infection in persons with HIV-infection in VL-endemic areas. The co-infection leads to profound immunosuppression and high rate of annual VL recurrence. This study assessed the effectiveness, safety and feasibility of monthly pentamidine infusions to prevent recurrence of VL in HIV co-infected patients. Methods A single-arm, open-label trial was conducted at two leishmaniasis treatment centers in northwest Ethiopia. HIV-infected patients with a VL episode were included after parasitological cure. Monthly infusions of 4mg/kg pentamidine-isethionate diluted in normal-saline were started for 12months. All received antiretroviral therapy (ART). Time-to-relapse or death was the primary end point. Results Seventy-four patients were included. The probability of relapse-free survival at 6months and at 12 months was 79% and 71% respectively. Renal failure, a possible drug-related serious adverse event, occurred in two patients with severe pneumonia. Forty-one patients completed the regimen taking at least 11 of the 12 doses. Main reasons to discontinue were: 15 relapsed, five died and seven became lost to follow-up. More patients failed among those with a CD4+cell count <= 50cells/mu l, 5/7 (71.4%) than those with counts above 200 cells/mu l, 2/12 (16.7%), (p = 0.005). Conclusion Pentamidine secondary prophylaxis led to a 29% failure rate within one year, much lower than reported in historical controls (50%-100%). Patients with low CD4+cell counts are at increased risk of relapse despite effective initial VL treatment, ART and secondary prophylaxis. VL should be detected and treated early enough in patients with HIV infection before profound immune deficiency installs.	[Diro, Ermias; Mohammed, Rezika; Fikre, Helina] Univ Gondar, Gondar, Ethiopia; [Diro, Ermias; Boelaert, Marleen; Ravinetto, Raffaella; De Crop, Maaike; Colebunders, Robert; van Loen, Harry; Menten, Joris; Lynen, Lutgarde; van Griensven, Johan] Inst Trop Med, B-2000 Antwerp, Belgium; [Ritmeijer, Koert] Med Frontieres, Amsterdam, Netherlands; [Alves, Fabiana] Drugs Neglected Dis Initiat, Geneva, Switzerland; [Abongomera, Charles; Adera, Cherinet] Med Frontieres, Abdurafi, Ethiopia; [Ravinetto, Raffaella] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium; [Hailu, Asrat] Univ Addis Ababa, Sch Med, Addis Ababa, Ethiopia	Diro, E (reprint author), Univ Gondar, Gondar, Ethiopia.	Ermi_diro@yahoo.com		Boelaert, Marleen/0000-0001-8051-6776	European Union [305178]; Drugs for Neglected Diseases initiative; Belgian Directorate General for Development Cooperation	This work was supported by the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 305178 via AfriCoLeish project, and the Drugs for Neglected Diseases initiative. ED has received a PhD scholarship granted from the Belgian Directorate General for Development Cooperation under the ITM-DGDC framework agreement FA-III and from the European Union Seventh Framework Programme through AfriCoLeish Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, PANEL OPPORTUNISTIC, pT; [Anonymous], 2008, GUIDELINES MANAGEMEN; Arce A, 2013, EUROSURVEILLANCE, V18, P5, DOI 10.2807/1560-7917.ES2013.18.30.20546; Bossolasco S, 2003, J CLIN MICROBIOL, V41, P5080, DOI 10.1128/JCM.41.11.5080-5084.2003; Bourgeois N, 2010, HIV MED, V11, P670, DOI 10.1111/j.1468-1293.2010.00846.x; Calza L, 2001, J CHEMOTHERAPY, V13, P653, DOI 10.1179/joc.2001.13.6.653; Cota GF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001153; Dorlo TPC, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000225; FENSKE S, 1991, KLIN WOCHENSCHR, V69, P793, DOI 10.1007/BF01744270; Gazapo E, 2010, INT C AIDS; Laguna F, 1997, EUR J CLIN MICROBIOL, V16, P898, DOI 10.1007/BF01700556; Lopez-Velez R, 2004, J ANTIMICROB CHEMOTH, V53, P540, DOI 10.1093/jac/dkh084; Lopez-Velez R, 2003, ANN TROP MED PARASIT, V97, P143, DOI 10.1179/000349803225002615; MATHERON S, 1992, AIDS, V6, P238; Molina I, 2007, J ANTIMICROB CHEMOTH, V60, P837, DOI 10.1093/jac/dkm294; Molina R, 2003, ANN TROP MED PARASIT, V97, P29, DOI 10.1179/000349803225002516; Monge-Maillo B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003021; Patel TA, 2009, TROP MED INT HEALTH, V14, P1064, DOI 10.1111/j.1365-3156.2009.02329.x; PerezMolina JA, 1996, AIDS, V10, P237, DOI 10.1097/00002030-199602000-00023; Petter A, 2001, SCAND J INFECT DIS, V33, P236, DOI 10.1080/00365540151061049; Pintado V, 2001, MEDICINE, V80, P54, DOI 10.1097/00005792-200101000-00006; Ribera E, 1996, AM J MED, V100, P496, DOI 10.1016/S0002-9343(97)89503-4; ter Horst R, 2008, CLIN INFECT DIS, V46, P1702, DOI 10.1086/587899; van GJ, 2014, PLOS NEGLECT TROP D, V8, pe3011, DOI [10.1371/journal.pntd.0003011, DOI 10.1371/JOURNAL.PNTD.0003011]; WHO, 2010, WHO TECH REP SER, V949, P1; World Health Organization, 2007, 5 CONS M LEISHM HIV	26	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	OCT	2015	9	10							e0004087	10.1371/journal.pntd.0004087				15	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CV7NC	WOS:000364459600016	26431253	DOAJ Gold, Green Published			2019-04-02	
J	Montresor, A; Addiss, D; Albonico, M; Ali, SM; Ault, SK; Gabrielli, AF; Garba, A; Gasimov, E; Gyorkos, T; Jamsheed, MA; Levecke, B; Mbabazi, P; Mupfasoni, D; Savioli, L; Vercruysse, J; Yajima, A				Montresor, Antonio; Addiss, David; Albonico, Marco; Ali, Said Mohammed; Ault, Steven K.; Gabrielli, Albis-Francesco; Garba, Amadou; Gasimov, Elkhan; Gyorkos, Theresa; Jamsheed, Mohamed Ahmed; Levecke, Bruno; Mbabazi, Pamela; Mupfasoni, Denise; Savioli, Lorenzo; Vercruysse, Jozef; Yajima, Aya			Methodological Bias Can Lead the Cochrane Collaboration to Irrelevance in Public Health Decision-Making	PLoS Neglected Tropical Diseases			English	Article							IRON-DEFICIENCY; CHILDREN; HELMINTHIASIS; METAANALYSIS; INFECTION		[Montresor, Antonio; Garba, Amadou; Mbabazi, Pamela; Mupfasoni, Denise] WHO, Control Neglected Trop Dis, CH-1211 Geneva, Switzerland; [Addiss, David] Task Force Global Hlth, Children Worms, Decatur, GA USA; [Albonico, Marco; Ali, Said Mohammed] Publ Hlth Lab Ivo de Carneri, WHO Collaborating Ctr Neglected Trop Dis, Zanzibar, Tanzania; [Ault, Steven K.] World Hlth Reg Off Amer, Pan Amer Hlth Org, Neglected Infect Dis, Washington, DC USA; [Gabrielli, Albis-Francesco] WHO, Reg Off Eastern Mediterranean, Neglected Trop Dis, Cairo, Egypt; [Gasimov, Elkhan] WHO, Reg Off Europe, Malaria Other Vectorborne & Parasit Dis, DK-2100 Copenhagen, Denmark; [Gyorkos, Theresa] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, WHO Collaborating Ctr Res & Training Parasite Epi, Montreal, PQ, Canada; [Jamsheed, Mohamed Ahmed] WHO, Reg Off Southeast Asia, Vector Borne & Neglected Trop Dis Control, New Delhi, India; [Levecke, Bruno; Vercruysse, Jozef] Univ Ghent, WHO Collaborating Ctr Monitoring Anthelminth Drug, Dept Virol Parasitol & Immunol, B-9000 Ghent, Belgium; [Savioli, Lorenzo] Global Schistosomiasis Alliance, Zanzibar, Tanzania; [Savioli, Lorenzo] Publ Hlth Lab Ivo de Carneri, Zanzibar, Tanzania; [Yajima, Aya] WHO, Reg Off Western Pacific, Malaria Other Vectorborne & Parasit Dis, Manila, Philippines	Montresor, A (reprint author), WHO, Control Neglected Trop Dis, CH-1211 Geneva, Switzerland.	montresora@who.int		ALBONICO, Marco/0000-0002-7805-2391; Levecke, Bruno/0000-0001-8912-5595			Bhargava A, 2000, BRIT MED J, V321, P1225; Bundy D, 2000, BRIT MED J, V321, P1225; Christian P, 2004, LANCET, V364, P981, DOI 10.1016/S0140-6736(04)17023-2; Cooper E, 2000, BRIT MED J, V321, P1225; Dickson R, 2007, COCHRANE DB SYST REV; Gabrielli AF, 2011, T ROY SOC TROP MED H, V105, P683, DOI 10.1016/j.trstmh.2011.08.013; Hall A, 2008, MATERN CHILD NUTR, V4, P118, DOI 10.1111/j.1740-8709.2007.00127.x; Hill GB, 2000, J CLIN EPIDEMIOL, V53, P1189, DOI 10.1016/S0895-4356(00)00253-5; Jonker FAM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001555; Joseph SA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003369; Kaminsky RG, 2015, ASIAN PAC J TROP BIO, V5, P581; MARTIN J, 1984, PARASITOLOGY, V88, P333; Michael E, 2000, BRIT MED J, V321, P1224; Montresor A, 2015, T ROY SOC TROP MED H, V109, P262, DOI 10.1093/trstmh/tru180; Montresor A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002299; Savioli L, 2000, BRIT MED J, V321, P1226; Shelton JD, 2014, GLOB HLTH SCI PRACT, V3, P253; Silva De, 1997, TROP MED INT HEALTH, V2, P189; Smith GCS, 2003, BMJ-BRIT MED J, V327, P1460; Stephenson LS, 2000, PARASITOLOGY, V121, pS73, DOI 10.1017/S0031182000006867; Stoltzfus RJ, 1996, AM J TROP MED HYG, V55, P399, DOI 10.4269/ajtmh.1996.55.399; Taylor-Robinson DC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000371.pub5; Taylor-Robinson DC, 2015, COCHRANE DB SYST REV, V7, DOI DOI 10.1002/14651858.CD000371.PUB6; World Health Organization (WHO), 2012, EL SOIL TRANSM HELM	24	21	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	OCT	2015	9	10							e0004165	10.1371/journal.pntd.0004165				4	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CV7NC	WOS:000364459600063	26492178	DOAJ Gold, Green Published			2019-04-02	
J	Gryseels, C; Grietens, KP; Dierickx, S; Xuan, XN; Uk, S; Bannister-Tyrrell, M; Trienekens, S; Ribera, JM; Hausmann-Muela, S; Gerrets, R; D'Alessandro, U; Sochantha, T; Coosemans, M; Erhart, A				Gryseels, Charlotte; Grietens, Koen Peeters; Dierickx, Susan; Xuan, Xa Nguyen; Uk, Sambunny; Bannister-Tyrrell, Melanie; Trienekens, Suzan; Ribera, Joan Muela; Hausmann-Muela, Susanna; Gerrets, Rene; D'Alessandro, Umberto; Sochantha, Tho; Coosemans, Marc; Erhart, Annette			High Mobility and Low Use of Malaria Preventive Measures among the Jarai Male Youth along the Cambodia-Vietnam Border	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							SOUTHEAST-ASIA; FOREST MALARIA; RISK-FACTORS; RANDOMIZED TRIAL; TREATED HAMMOCK; VECTOR CONTROL; NET COVERAGE; TRANSMISSION; EPIDEMIOLOGY; ELIMINATION	Malaria control along the Vietnam Cambodia border presents a challenge for both countries' malaria elimination targets as the region is forested, inhabited by ethnic minority populations, and potentially characterized by early and outdoor malaria transmission. A mixed methods study assessed the vulnerability to malaria among the Jarai population living on both sides of the border in the provinces of Ratanakiri (Cambodia) and Gia Lai (Vietnam). A qualitative study generated preliminary hypotheses that were quantified in two surveys, one targeting youth (N = 498) and the other household leaders (N = 449). Jarai male youth, especially in Cambodia, had lower uptake of preventive measures (57.4%) and more often stayed overnight in the deep forest (35.8%) compared with the female youth and the adult population. Among male youth, a high-risk subgroup was identified that regularly slept at friends' homes or outdoors, who had fewer bed nets (32.5%) that were torn more often (77.8%). The vulnerability of Jarai youth to malaria could be attributed to the transitional character of youth itself, implying less fixed sleeping arrangements in nonpermanent spaces or non-bed sites. Additional tools such as long-lasting hammock nets could be suitable as they are in line with current practices.	Inst Trop Med, B-2000 Antwerp, Belgium; Amsterdam Inst Social Sci Res, Amsterdam, Netherlands; Partners Appl Social Sci PASS Int, Tessenderlo, Belgium; Nagasaki Univ, Sch Int Hlth Dev, Nagasaki 852, Japan; Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam; Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; MRC Unit, Fajara, Gambia; London Sch Hyg & Trop Med, London WC1, England; Univ Antwerp, B-2020 Antwerp, Belgium	Gryseels, C (reprint author), Inst Trop Med, Med Anthropol Unit, Natl Str 155, B-2000 Antwerp, Belgium.	cgryseels@itg.be		Peeters Grietens, Koen/0000-0001-6570-9887; Gryseels, Charlotte/0000-0002-8963-4469	Belgian Co-operation (Directorate General for Development Cooperation)	This study was conducted in the framework of the Institutional Collaboration between the National Centre for Malaria Control (CNM) Cambodia and the Institute of Tropical Medicine, Belgium, supported by the Belgian Co-operation (Directorate General for Development Cooperation).	AAA, COD ETH AM ANTHR ASS; Abe T, 2009, SE ASIAN J TROP MED, V40, P18; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Charlwood JD, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-2; Coosemans M, 2006, P INT C HUBS HARB DE, P551; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Cui LW, 2012, ACTA TROP, V121, P227, DOI 10.1016/j.actatropica.2011.02.016; Delacollette C, 2009, SE ASIAN J TROP MED, V40, P674; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; Durnez L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-329; Erhart A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-58; Erhart A, 2004, AM J TROP MED HYG, V70, P110, DOI 10.4269/ajtmh.2004.70.110; Gaudart J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-286; Greenwood B.M., 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene, V83, P25, DOI 10.1016/0035-9203(89)90599-3; Grietens KP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050294; Grietens KP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029991; Gryseels C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080343; Hougard JM, 2007, J MED ENTOMOL, V44, P651, DOI 10.1603/0022-2585(2007)44[651:PFTOAL]2.0.CO;2; Iwashita H, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-176; Kar NP, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-265; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-330; Konradsen F, 2003, AM J TROP MED HYG, V68, P177, DOI 10.4269/ajtmh.2003.68.177; Levine R. A., 2008, ANTHR CHILD DEV; Lindsay SW, 2003, TROP MED INT HEALTH, V8, P512, DOI 10.1046/j.1365-3156.2003.01059.x; Lwetoijera DW, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-57; Magris M, 2007, TROP MED INT HEALTH, V12, P392, DOI 10.1111/j.1365-3156.2006.01801.x; Morrow M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-85; Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2; Nourein AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016948; Obsomer V, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-26; Peeters Grietens K, 2010, MALARIA J, V9, P1; Pindolia DK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-205; Pongvongsa T, 2012, VIETNAM MALAR J, V11, P262, DOI DOI 10.1186/1475-2875-11-262; Prothero RM, 1999, SINGAPORE J TROP GEO, V20, P76, DOI 10.1111/1467-9493.00044; Sanh NH, 2008, AM J TROP MED HYG, V79, P652, DOI 10.4269/ajtmh.2008.79.652; Sluydts V, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-387; Sochantha T, 2006, TROP MED INT HEALTH, V11, P1166, DOI 10.1111/j.1365-3156.2006.01673.x; Somboon Pradya, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P3; TASHAKKORI A, 1998, APPL SOCIAL RES METH; Thang Ngo Duc, 2009, PLoS One, V4, pe7369, DOI 10.1371/journal.pone.0007369; Thang ND, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-28; Toe LP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-175; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; Trung HD, 2004, TROP MED INT HEALTH, V9, P230, DOI 10.1046/j.1365-3156.2003.01179.x; Van Bortel W, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-373; WHO, 2008, MAL GREAT MEK SUBR; Zimmerman R H, 1997, Rev Panam Salud Publica, V2, P18, DOI 10.1590/S1020-49891997000700004	49	13	13	1	5	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4					810	818		10.4269/ajtmh.15-0259				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CS8BX	WOS:000362311800026	26283747	Green Published, Other Gold			2019-04-02	
J	Becker, SL; Chatigre, JK; Coulibaly, JT; Mertens, P; Bonfoh, B; Herrmann, M; Kuijper, EJ; N'Goran, EK; Utzinger, J; von Muller, L				Becker, Soeren L.; Chatigre, Justin K.; Coulibaly, Jean T.; Mertens, Pascal; Bonfoh, Bassirou; Herrmann, Mathias; Kuijper, Ed J.; N'Goran, Eliezer K.; Utzinger, Juerg; von Mueller, Lutz			Molecular and culture-based diagnosis of Clostridium difficile isolates from Cote d'Ivoire after prolonged storage at disrupted cold chain conditions	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Cote d'Ivoire; Diagnosis; Diarrhoea; Polymerase chain reaction; Rapid diagnostic test; Storage conditions	PERSISTENT DIGESTIVE DISORDERS; ANTIMICROBIAL SUSCEPTIBILITY; PCR-AMPLIFICATION; TYPING METHODS; HUMAN FECES; INFECTION; TESTS; DIARRHEA; PREVALENCE; COMMUNITY	Background: Although Clostridium difficile is a major cause of diarrhoea, its epidemiology in tropical settings is poorly understood. Strain characterisation requires work-up in specialised laboratories, often after prolonged storage without properly maintained cold chain. Methods: We screened 298 human faecal samples from Cote d'Ivoire using a rapid test for C. difficile glutamate dehydrogenase (GDH). GDH-positive samples were aerobically stored at disrupted cold chain conditions (mean duration: 11 days) before transfer to a reference laboratory for anaerobic culture, susceptibility testing, PCR assays and ribotyping. Results: Sixteen samples (5.4%) had a positive GDH screening test. C. difficile infection was confirmed in six specimens by culture and PCR, while no nucleic acids of C. difficile were detected in the culture-negative samples. Further analysis of stool samples harbouring toxigenic C. difficile strains confirmed that both GDH and toxins remained detectable for at least 28 days, regardless of storage conditions (aerobic storage at 4 degrees C or 20 degrees C). Conclusions: Storage conditions only minimally affect recovery of C. difficile and its toxins in stool culture. A rapid GDH screening test and subsequent transfer of GDH-positive stool samples to reference laboratories for in-depth characterisation may improve our understanding of the epidemiology of C. difficile in the tropics.	[Becker, Soeren L.; Herrmann, Mathias; von Mueller, Lutz] Univ Saarland, Inst Med Microbiol & Hyg, D-66421 Homburg, Germany; [Becker, Soeren L.; Coulibaly, Jean T.; Utzinger, Juerg] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, CH-4002 Basel, Switzerland; [Becker, Soeren L.; Coulibaly, Jean T.; Utzinger, Juerg] Univ Basel, CH-4003 Basel, Switzerland; [Chatigre, Justin K.] Hop Methodiste Dabou, Dept Med Interne, Dabou, Cote Ivoire; [Coulibaly, Jean T.; N'Goran, Eliezer K.] Univ Felix Houphouet Boigny, Unite Format & Rech Biosci, Abidjan 02, Cote Ivoire; [Coulibaly, Jean T.; Bonfoh, Bassirou; N'Goran, Eliezer K.] Ctr Suisse Rech Sci Cote Ivore, Abidjan 01, Cote Ivoire; [Mertens, Pascal] Coris BioConcept, B-5032 Gembloux, Belgium; [Kuijper, Ed J.] Leiden Univ, Med Ctr, Dept Med Microbiol, NL-2333 Leiden, Netherlands	Becker, SL (reprint author), Univ Saarland, Inst Med Microbiol & Hyg, Kirrberger Str,Bldg 43, D-66421 Homburg, Germany.	soeren.becker@uks.eu	Herrmann, Mathias/B-6475-2013	von Muller, Lutz/0000-0001-9013-4245; Kuijper, Ed/0000-0001-5726-2405	European Union [260260]	This work is part of the NIDIAG European research network (Collaborative Project), supported by the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no. 260260. The funders had no role in study design, data collection, data analysis, decision to publish or preparation of the manuscript.	APIC, GUID PREV CLOSTR DIF; Arroyo LG, 2005, J CLIN MICROBIOL, V43, P5341, DOI 10.1128/JCM.43.10.5341-5343.2005; Arroyo LG, 2005, J MED MICROBIOL, V54, P163, DOI 10.1099/jmm.0.45805-0; Bagdasarian N, 2015, JAMA-J AM MED ASSOC, V313, P398, DOI 10.1001/jama.2014.17103; Balassiano IT, 2012, J MED MICROBIOL, V61, P169, DOI 10.1099/jmm.0.037077-0; Becker SL, 2015, CLIN MICROBIOL INFEC, V21; Becker SL, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-37; Brecher SM, 2013, CLIN INFECT DIS, V57, P1175, DOI 10.1093/cid/cit424; Chappuis F, 2013, CLIN MICROBIOL INFEC, V19, P422, DOI 10.1111/1469-0691.12154; Davies KA, 2014, LANCET INFECT DIS, V14, P1208, DOI 10.1016/S1473-3099(14)70991-0; EMERUWA AC, 1990, MICROBIOLOGICA, V13, P323; European Committee on Antimicrobial Susceptibility Testing (EUCAST), BREAKP TABL INT MICS; Freeman J, 2003, J CLIN PATHOL, V56, P126, DOI 10.1136/jcp.56.2.126; GURTLER V, 1993, J GEN MICROBIOL, V139, P3089, DOI 10.1099/00221287-139-12-3089; Hensgens MPM, 2012, CLIN MICROBIOL INFEC, V18, P635, DOI 10.1111/j.1469-0691.2012.03853.x; Hink T, 2013, ANAEROBE, V19, P39, DOI 10.1016/j.anaerobe.2012.12.001; Huber CA, 2013, J CLIN MICROBIOL, V51, P2810, DOI 10.1128/JCM.00143-13; Jaeggi T, 2015, GUT, V64, P731, DOI 10.1136/gutjnl-2014-307720; Joost I, 2009, INT J ANTIMICROB AG, V33, pS13, DOI 10.1016/S0924-8579(09)70010-X; Khanna S, 2012, AM J GASTROENTEROL, V107, P89, DOI 10.1038/ajg.2011.398; Knetsch CW, 2013, EUROSURVEILLANCE, V18, P57; Kouassi KA, 2014, ANAEROBE, V28, P90, DOI 10.1016/j.anaerobe.2014.05.012; Leffler DA, 2015, NEW ENGL J MED, V372, P1539, DOI 10.1056/NEJMra1403772; Lekalakala MR, 2010, J HOSP INFECT, V75, P328, DOI 10.1016/j.jhin.2010.03.016; Lessa FC, 2015, NEW ENGL J MED, V372, P2369, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Lessa FC, 2012, CLIN INFECT DIS, V55, pS65, DOI 10.1093/cid/cis319; Lubbert C, 2014, DTSCH ARZTEBL INT, V111, P723, DOI 10.3238/arztebl.2014.0723; Merad S A, 1992, Arch Inst Pasteur Alger, V58, P169; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Mwachari C, 1998, J INFECTION, V37, P48, DOI 10.1016/S0163-4453(98)90561-8; Nechvatal JM, 2008, J MICROBIOL METH, V72, P124, DOI 10.1016/j.mimet.2007.11.007; Neuberger A, 2013, J TRAVEL MED, V20, P37, DOI 10.1111/j.1708-8305.2012.00676.x; Ngamskulrungroj P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127026; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; OGUIKE JU, 1990, MICROBIOLOGICA, V13, P267; Onwueme K, 2011, T ROY SOC TROP MED H, V105, P667, DOI 10.1016/j.trstmh.2011.07.014; Polman K, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1074-x; Rajabally N, 2013, SAMJ S AFR MED J, V103, P168, DOI [10.7196/SAMJ.6012, 10.7196/samj.6012]; ROTIMI VO, 1989, E AFR MED J, V66, P319; Samie A, 2008, AM J TROP MED HYG, V78, P577, DOI 10.4269/ajtmh.2008.78.577; Schmidt ML, 2009, ANAEROBE, V15, P270, DOI 10.1016/j.anaerobe.2009.10.005; Shetty N, 2011, J HOSP INFECT, V77, P1, DOI 10.1016/j.jhin.2010.07.024; Simango C, 2008, INT J FOOD MICROBIOL, V124, P268, DOI 10.1016/j.ijfoodmicro.2008.03.020; Simango C, 2006, T ROY SOC TROP MED H, V100, P1146, DOI 10.1016/j.trstmh.2006.01.009; Simango C, 2014, T ROY SOC TROP MED H, V108, P354, DOI 10.1093/trstmh/tru042; Van Broeck J, 2012, INT C ANT AG CHEM IC; Van der Palen M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-90; von Muller L, 2012, BUNDESGESUNDHEITSBLA, V55, P1410, DOI 10.1007/s00103-012-1556-6; Weese JS, 2000, J VET DIAGN INVEST, V12, P332, DOI 10.1177/104063870001200406; Yansouni CP, 2013, LANCET INFECT DIS, V13, P546, DOI 10.1016/S1473-3099(13)70004-5; Yansouni CP, 2012, CLIN INFECT DIS, V55, P610, DOI 10.1093/cid/cis466; Zhang LH, 2015, ANAEROBE, V34, P1, DOI 10.1016/j.anaerobe.2015.03.008; Zulu I, 2000, T ROY SOC TROP MED H, V94, P167, DOI 10.1016/S0035-9203(00)90260-8	53	4	4	0	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	OCT	2015	109	10					660	668		10.1093/trstmh/trv071				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CR7ZR	WOS:000361571400009	26354793	Bronze			2019-04-02	
J	Bekana, T; Mekonnen, Z; Zeynudin, A; Ayana, M; Getachew, M; Vercruysse, J; Levecke, B				Bekana, Teshome; Mekonnen, Zeleke; Zeynudin, Ahmed; Ayana, Mio; Getachew, Mestawet; Vercruysse, Jozef; Levecke, Bruno			Comparison of Kato-Katz thick-smear and McMaster egg counting method for the assessment of drug efficacy against soil-transmitted helminthiasis in school children in Jimma Town, Ethiopia	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Anthelminthic drug efficacy; Egg reduction rate; Ethiopia; Kato-Katz thick smear; McMaster egg counting method; Soil-transmitted helminths		Background: There is a paucity of studies that compare efficacy of drugs obtained by different diagnostic methods. Methods: We compared the efficacy of a single oral dose albendazole (400 mg), measured as egg reduction rate, against soil-transmitted helminth infections in 210 school children (Jimma Town, Ethiopia) using both Kato-Katz thick smear and McMaster egg counting method. Results: Our results indicate that differences in sensitivity and faecal egg counts did not imply a significant difference in egg reduction rate estimates. Conclusion: The choice of a diagnostic method to assess drug efficacy should not be based on sensitivity and faecal egg counts only.	[Bekana, Teshome] Mettu Univ, Fac Publ Hlth & Med Sci, Dept Med Sci, Mettu, Ethiopia; [Mekonnen, Zeleke; Zeynudin, Ahmed; Ayana, Mio] Jimma Univ, Dept Med Lab Sci & Pathol, Coll Publ Hlth & Med Sci, Jimma, Ethiopia; [Getachew, Mestawet] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Pharm, Jimma, Ethiopia; [Vercruysse, Jozef; Levecke, Bruno] Univ Ghent, Dept Virol Parasitol & Immunol, B-9000 Ghent, Belgium	Levecke, B (reprint author), Univ Ghent, Dept Virol Parasitol & Immunol, B-9000 Ghent, Belgium.	Bruno.Levecke@UGent.be		Levecke, Bruno/0000-0001-8912-5595	College of Public Health and Medical Sciences Post Graduate Studies, Jimma University; VLIR/IUC/JU project	This study received financial support from the College of Public Health and Medical Sciences Post Graduate Studies, Jimma University and a VLIR/IUC/JU project.	Albonico M, 2013, T R SOC TROP MED HYG, V106, P199; Levecke B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001201; Mekonnen Z, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002189; World Health Organization, 2012, SOIL TRANSM HELM EL; World Health Organization, 2013, ASS EFF ANTH DRUGS S; World Health Organization (WHO), 1991, BAS LAB METH MED PAR	6	2	2	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	OCT	2015	109	10					669	671		10.1093/trstmh/trv073				3	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CR7ZR	WOS:000361571400010	26385937				2019-04-02	
J	Ntambue, AM; Malonga, FK; Dramaix-Wilmet, M; Donnen, P				Ntambue, Abel M.; Malonga, Francoise K.; Dramaix-Wilmet, Michele; Donnen, Philippe			PREVENTING MATERNAL MORTALITY THE THE DEMOCRATIC REPUBLIC OF THE CONGO: EFFECT OF THE ORGANIZATIONAL MODEL OF HEALTH CARE	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Ntambue, Abel M.; Malonga, Francoise K.] Univ Lubumbashi, Lubumbashi, DEM REP CONGO; [Dramaix-Wilmet, Michele; Donnen, Philippe] Univ Libre Bruxelles, Brussels, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		74	24	24						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844101074					2019-04-02	
J	Lin, LY; Martinez, LJ; Jarman, RG; De la Barrera, R; Paolino, K; Eckels, KH; Lepine, E; Innis, BL; Collard, A; Ruck, RC; Schmidt, AC; Thomas, SJ				Lin, Leyi; Martinez, Luis J.; Jarman, Richard G.; De la Barrera, Rafael; Paolino, Kristopher; Eckels, Kenneth H.; Lepine, Edith; Innis, Bruce L.; Collard, Alix; Ruck, Richard C.; Schmidt, Alexander C.; Thomas, Stephen J.			PHASE 1 STUDY OF A TETRAVALENT DENGUE PURIFIED INACTIVATED VACCINE (DPIV) IN HEALTHY US ADULTS: SAFETY AND IMMUNOGENICITY RESULTS THROUGH MONTH 13 AND AFTER A BOOSTER DOSE IN A SUBSET OF SUBJECTS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Lin, Leyi; Martinez, Luis J.; Jarman, Richard G.; De la Barrera, Rafael; Paolino, Kristopher; Eckels, Kenneth H.; Ruck, Richard C.; Thomas, Stephen J.] Walter Reed Army Inst Res, Silver Spring, MD USA; [Lepine, Edith; Collard, Alix; Schmidt, Alexander C.] GlaxoSmithKline Vaccines, Rixensart, Belgium; [Innis, Bruce L.] GlaxoSmithKline Vaccines, King Of Prussia, PA USA								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		163	49	49						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844101163					2019-04-02	
J	Bowyer, G; Ewer, K; Rampling, T; Wright, D; Imoukuhede, EB; Payne, R; Venkatraman, N; Krahling, V; Stanley, DA; Sullivan, NJ; Ledgerwood, JE; Strecker, T; Fehling, SK; Biedenkopf, N; Becker, S; Graham, B; Ballou, WR; Gilbert, SC; Hill, AV				Bowyer, Georgina; Ewer, Katie; Rampling, Thomas; Wright, Danny; Imoukuhede, Egeruan B.; Payne, Ruth; Venkatraman, Navin; Kraehling, Verena; Stanley, Daphne A.; Sullivan, Nancy J.; Ledgerwood, Julie E.; Strecker, Thomas; Fehling, Sarah Katharina; Biedenkopf, Nadine; Becker, Stephan; Graham, Barney; Ballou, W. Ripley; Gilbert, Sarah C.; Hill, Adrian V.			BOOSTING THE NOVEL EBOLA VACCINE CANDIDATE CHADEBOV Z WITH MODIFIED VACCINIA VIRUS ANKARA (MVA) SIGNIFICANTLY ENHANCES EBOLA-SPECIFIC ANTIBODY RESPONSES	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Bowyer, Georgina; Ewer, Katie; Rampling, Thomas; Wright, Danny; Imoukuhede, Egeruan B.; Payne, Ruth; Venkatraman, Navin; Gilbert, Sarah C.; Hill, Adrian V.] Univ Oxford, Jenner Inst, Oxford, England; [Bowyer, Georgina; Ewer, Katie; Rampling, Thomas; Wright, Danny; Imoukuhede, Egeruan B.; Payne, Ruth; Venkatraman, Navin; Gilbert, Sarah C.; Hill, Adrian V.] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Kraehling, Verena; Strecker, Thomas; Fehling, Sarah Katharina; Biedenkopf, Nadine; Becker, Stephan] Philipps Univ Marburg, Inst Virol, Marburg, Germany; [Stanley, Daphne A.; Sullivan, Nancy J.; Ledgerwood, Julie E.; Graham, Barney] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Biedenkopf, Nadine; Becker, Stephan] German Ctr Infect Res DZIF, Marburg, Germany; [Ballou, W. Ripley] GlaxoSmithKline Biol, Rixensart, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		180	54	54						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844101180					2019-04-02	
J	Wright, D; Ewer, K; Rampling, T; Bowyer, G; Imoukuhede, E; Payne, R; Venkatraman, N; Sullivan, N; Ledgerwood, J; Graham, B; Ballou, WR; Gilbert, S; Hill, A				Wright, Danny; Ewer, Katie; Rampling, Thomas; Bowyer, Georgina; Imoukuhede, Egeruan; Payne, Ruth; Venkatraman, Navin; Sullivan, Nancy; Ledgerwood, Julie; Graham, Barney; Ballou, W. Ripley; Gilbert, Sarah; Hill, Adrian			IMPACT ON IMMUNOGENICITY OF VARYING THE INTERVAL BETWEEN THE PRIME AND BOOST OF A CANDIDATE EBOLA VACCINE CHAD3-EBO Z AND MVA-BN FILO IN HEALTHY UK ADULTS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Wright, Danny; Ewer, Katie; Rampling, Thomas; Bowyer, Georgina; Imoukuhede, Egeruan; Payne, Ruth; Venkatraman, Navin; Gilbert, Sarah; Hill, Adrian] Jenner Inst, Oxford, England; [Sullivan, Nancy; Ledgerwood, Julie; Graham, Barney] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Ballou, W. Ripley] GlaxoSmithKline Biol, Rixensart, Belgium								0	0	0	1	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		182	54	55						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844101182					2019-04-02	
J	Oriero, EC; Okebe, J; Njie, S; Jacobs, J; Van Geertruyden, JP; Nwakanma, D; D'Alessandro, U				Oriero, Eniyou C.; Okebe, Joseph; Njie, Sarjo; Jacobs, Jan; Van Geertruyden, Jean-Pierre; Nwakanma, Davis; D'Alessandro, Umberto			DIAGNOSTIC PERFORMANCE OF A NOVEL MALARIA LOOP MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) ASSAY IN A FIELD SETTING	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Oriero, Eniyou C.; Okebe, Joseph; Njie, Sarjo; Nwakanma, Davis; D'Alessandro, Umberto] MRC Unit, Fajara, Gambia; [Jacobs, Jan] Inst Trop Med, Antwerp, Belgium; [Van Geertruyden, Jean-Pierre] Univ Antwerp, Antwerp, Belgium			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		232	69	69						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844101232					2019-04-02	
J	Mvumbi, DM; Kayembe, JMN; Bobanga, TL; Situakibanza, HNT; Nsibu, CN; Mvumbi, GL; De Mol, P; Hayette, MP				Mvumbi, Dieudonn M.; Kayembe, Jean-Marie N.; Bobanga, Thierry L.; Situakibanza, Hippolyte N-T.; Nsibu, Celestin N.; Mvumbi, Georges L.; De Mol, Patrick; Hayette, Marie-Pierre			HIGH PREVALENCE OF FALCIPARUM MALARIA IN ASYMPTOMATIC INDIVIDUALS AND NO PFMDR1 AMPLIFICATION IDENTIFIED IN DEMOCRATIC REPUBLIC OF CONGO	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Mvumbi, Dieudonn M.; Mvumbi, Georges L.] Sch Med, Dept Basic Sci, Biochem & Mol Biol Unit, Kinshasa, DEM REP CONGO; [Kayembe, Jean-Marie N.] Univ Kinshasa, Sch Med, Dept Internal Med, Kinshasa, DEM REP CONGO; [Bobanga, Thierry L.; Situakibanza, Hippolyte N-T.] Univ Kinshasa, Sch Med, Dept Trop Med & Infect Dis, Kinshasa, DEM REP CONGO; [Nsibu, Celestin N.] Univ Kinshasa, Sch Med, Dept Pediat, Kinshasa, DEM REP CONGO; [De Mol, Patrick; Hayette, Marie-Pierre] Univ Hosp Liege, Dept Clin Microbiol, Liege, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		290	87	87						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844102035					2019-04-02	
J	Rosas, A; Speybroeck, N; Llanos-Cuentas, A; Rosanas-Urgell, A; Carrasco-Escobar, G; Rodriguez, H; D'Alessandro, U; Erhart, A				Rosas, Angel; Speybroeck, Niko; Llanos-Cuentas, Alejandro; Rosanas-Urgell, Anna; Carrasco-Escobar, Gabriel; Rodriguez, Hugo; D'Alessandro, Umberto; Erhart, Annette			HETEROGENEITY IN MALARIA TRANSMISSION IN THE PERUVIAN AMAZON: RAPID ASSESSMENT THROUGH A PARASITOLOGICAL AND SEROLOGICAL SURVEY	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Rosas, Angel; Llanos-Cuentas, Alejandro; Carrasco-Escobar, Gabriel] Univ Peruana Cayetano Heredia, Lima, Peru; [Speybroeck, Niko] Catholic Univ Louvain, Brussels, Belgium; [Rosanas-Urgell, Anna; Erhart, Annette] Inst Trop Med, Antwerp, Belgium; [Rodriguez, Hugo] Reg Salud Loreto, Loreto, Peru; [D'Alessandro, Umberto] MRC, Dis Control & Eliminat, Fajara, Gambia								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		303	90	91						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844102048					2019-04-02	
J	Neafsey, DE; Juraska, M; Bedford, T; Benkeser, DC; Valim, C; Griggs, AD; Lievens, M; Agbenyega, T; Anderson, S; Bruls, M; Connolly, KM; D'Alessandro, U; Dobano, C; Grimsby, J; Hamel, MJ; Leach, A; Lennon, NJ; Moss, EL; Park, DJ; Pelle, KG; Robbins, D; Russ, C; Ryan, EM; Sogoloff, B; Volkman, SK; Yu, Q; Lapierre, D; Birren, BW; Gilbert, PB; Wirth, DF				Neafsey, Daniel E.; Juraska, Michal; Bedford, Trevor; Benkeser, David C.; Valim, Clarissa; Griggs, Allison D.; Lievens, Marc; Agbenyega, Tsiri; Anderson, Scott; Bruls, Myriam; Connolly, Kristen M.; D'Alessandro, Umberto; Dobano, Carlota; Grimsby, Jonna; Hamel, Mary J.; Leach, Amanda; Lennon, Niall J.; Moss, Eli L.; Park, Daniel J.; Pelle, Karell G.; Robbins, Dana; Russ, Carsten; Ryan, Elizabeth M.; Sogoloff, Brian; Volkman, Sarah K.; Yu, Qing; Lapierre, Didier; Birren, Bruce W.; Gilbert, Peter B.; Wirth, Dyann F.			PARASITE GENETIC DIVERSITY AND PROTECTIVE EFFICACY IN A PHASE 3 TRIAL OF THE RTS,S/AS01 MALARIA VACCINE	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Neafsey, Daniel E.; Griggs, Allison D.; Anderson, Scott; Connolly, Kristen M.; Grimsby, Jonna; Lennon, Niall J.; Moss, Eli L.; Park, Daniel J.; Robbins, Dana; Russ, Carsten; Ryan, Elizabeth M.; Sogoloff, Brian; Yu, Qing; Birren, Bruce W.] Broad Inst, Cambridge, MA USA; [Juraska, Michal; Bedford, Trevor; Gilbert, Peter B.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Benkeser, David C.] Univ Washington, Seattle, WA 98195 USA; [Valim, Clarissa; Pelle, Karell G.; Volkman, Sarah K.; Wirth, Dyann F.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Lievens, Marc; Bruls, Myriam; Leach, Amanda; Lapierre, Didier] GlaxoSmithKline Vaccines, Rixensart, Belgium; [Agbenyega, Tsiri] Sch Med Sci, Kumasi, Ghana; [D'Alessandro, Umberto] MRC Unit, Banjul, Gambia; [Dobano, Carlota] Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Hamel, Mary J.] Ctr Dis Control & Prevent, Atlanta, GA USA			Dobano, Carlota/N-4119-2014	Dobano, Carlota/0000-0002-6751-4060				0	0	0	1	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		371	112	112						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844102116					2019-04-02	
J	Vandepitte, J				Vandepitte, Judith			HOW TO ADDRESS THE METHODOLOGICAL AND LOGISTICAL CHALLENGES OF PERFORMING MALARIA VACCINE EFFECTIVENESS STUDIES IN THE SUB-SAHARAN COUNTRIES	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Vandepitte, Judith] GlaxoSmithKline Vaccines, Wavre, Belgium								0	0	0	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		373	113	113						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844102118					2019-04-02	
J	Decuypere, S; Meehan, C; Jacobs, J; Maltha, J; Carapetis, J; Palpouguini, L; Tinto, H; Deborggraeve, S				Decuypere, Saskia; Meehan, Conor; Jacobs, Jan; Maltha, Jessica; Carapetis, Jonathan; Palpouguini, Lompo; Tinto, Halidou; Deborggraeve, Stijn			MAPPING BACTERIAL BLOODSTREAM INFECTIONS: A METAGENOMICS APPROACH	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Decuypere, Saskia; Carapetis, Jonathan] Telethon Kids Inst, Perth, WA, Australia; [Meehan, Conor; Jacobs, Jan; Maltha, Jessica; Deborggraeve, Stijn] Inst Trop Med, Antwerp, Belgium; [Palpouguini, Lompo; Tinto, Halidou] Clin Res Unit Nanoro, Nanoro, Burkina Faso								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		419	126	127						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844102164					2019-04-02	
J	Oliveira, RG; Easton, A; Kepha, S; Njenga, SM; Mwandawiro, CS; Lamberton, PH; Vlaminck, J; Beaumier, CM; Hotez, PJ; Geldhof, P; Drakeley, C; Brooker, SJ; Anderson, RM				Oliveira, Rita G.; Easton, Alice; Kepha, Stella; Njenga, Sammy M.; Mwandawiro, Charles S.; Lamberton, Poppy H.; Vlaminck, Johnny; Beaumier, Coreen M.; Hotez, Peter J.; Geldhof, Peter; Drakeley, Chris; Brooker, Simon J.; Anderson, Roy M.			IMMUNO-EPIDEMIOLOGY OF SOIL-TRANSMITTED HELMINTH INFECTIONS AFTER REPEATED SCHOOL-BASED DEWORMING: A COMMUNITY-WIDE CROSS SECTIONAL STUDY IN WESTERN KENYA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Oliveira, Rita G.; Easton, Alice; Lamberton, Poppy H.; Anderson, Roy M.] Imperial Coll London, London, England; [Kepha, Stella] Makerere Univ, Kampala, Uganda; [Njenga, Sammy M.; Mwandawiro, Charles S.] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Vlaminck, Johnny] Washington Univ, St Louis, MO USA; [Beaumier, Coreen M.; Hotez, Peter J.] Baylor Coll Med, Houston, TX 77030 USA; [Geldhof, Peter] Univ Ghent, Merelbeke, Belgium; [Drakeley, Chris; Brooker, Simon J.] London Sch Hyg & Trop Med, London, England								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		461	138	138						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844102203					2019-04-02	
J	Vlaminck, J; Geldhof, P; Hokke, CH; Supali, T; Fischer, PU; Weil, GJ				Vlaminck, Johnny; Geldhof, Peter; Hokke, Cornelius H.; Supali, Taniawati; Fischer, Peter U.; Weil, Gary J.			THE USE OF ASCARIS SUUM HAEMOGLOBIN AS DIAGNOSTIC ANTIGEN FOR HUMAN ASCARIASIS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Vlaminck, Johnny; Fischer, Peter U.; Weil, Gary J.] Washington Univ, St Louis, MO USA; [Geldhof, Peter] Univ Ghent, Ghent, Belgium; [Hokke, Cornelius H.] Univ Med Ctr, Leiden, Netherlands; [Supali, Taniawati] Univ Indonesia, Jakarta, Indonesia								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		465	140	140						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844102207					2019-04-02	
J	Affara, M; Van Loon, I; Ceesay, SJ; Mwesigwa, J; Ngwa, AA; D'Alessandro, U; Nwakanma, D				Affara, Muna; Van Loon, Ine; Ceesay, Serign Jawo; Mwesigwa, Julia; Ngwa, Alfred Amambua; D'Alessandro, Umberto; Nwakanma, Davis			SCHISTOSOMIASIS SEROPREVALENCE IN THE GAMBIA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Affara, Muna; Ceesay, Serign Jawo; Mwesigwa, Julia; Ngwa, Alfred Amambua; D'Alessandro, Umberto; Nwakanma, Davis] MRC, Banjul, Gambia; [Van Loon, Ine] Inst Trop Med, Antwerp, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		529	159	159						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844102271					2019-04-02	
J	Carrasco-Escobar, G; Rosas-Aguirre, A; Melendez, M; Gamboa, D; Contreras-Mancilla, J; Rosanas-Urgell, A; Speybroeck, N; Erhart, A; Herrera, S; Llanos-Cuentas, A				Carrasco-Escobar, Gabriel; Rosas-Aguirre, Angel; Melendez, Monica; Gamboa, Dionicia; Contreras-Mancilla, Juan; Rosanas-Urgell, Anna; Speybroeck, Niko; Erhart, Annette; Herrera, Socrates; Llanos-Cuentas, Alejandro			SPATIAL ANALYSIS USING SEROLOGICAL MARKERS FOR THE IDENTIFICATION OF AREAS OF HIGH MALARIA TRANSMISSION IN THE LOW ENDEMIC NORTHERN COAST OF PERU	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Carrasco-Escobar, Gabriel; Contreras-Mancilla, Juan; Llanos-Cuentas, Alejandro] Univ Peruana Cayetano Heredia, Inst Trop Med Alexander von Humboldt, Lima, Peru; [Rosas-Aguirre, Angel; Speybroeck, Niko] Catholic Univ Louvain, Res Inst Hlth & Soc, Brussels, Belgium; [Melendez, Monica] Subreg Salud Luciano Castillo Colonna, Sullana, Peru; [Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Dept Ciencias Celulares & Mol, Lima, Peru; [Rosanas-Urgell, Anna] Inst Trop Med, Unit Malariol, Antwerp, Belgium; [Erhart, Annette] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Herrera, Socrates] Caucaseco Sci Res Ctr, Cali, Colombia								0	0	0	2	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		567	170	170						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844102309					2019-04-02	
J	Carabin, H; Ganaba, R; Millogo, A; Dorny, P; Bauer, C; Sahlu, I; Ouedraogo, JB; Gabriel, S; Cisse, A; Tarnagda, Z				Carabin, Helene; Ganaba, Rasmane; Millogo, Athanase; Dorny, Pierre; Bauer, Cici; Sahlu, Ida; Ouedraogo, Jean-Bosco; Gabriel, Sarah; Cisse, Assana; Tarnagda, Zekiba			ASSOCIATION BETWEEN INDIVIDUAL- AND VILLAGE-LEVEL FACTORS AND THE PREVALENCE OF CURRENT INFECTION WITH TAENIA SOLIUM CYSTICERCOSIS IN 60 VILLAGES OF BURKINA FASO	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Carabin, Helene] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; [Ganaba, Rasmane] AFRICSante, Bobo Dioulasso, Burkina Faso; [Millogo, Athanase] Univ Ouagadougou, Bobo Dioulasso, Burkina Faso; [Dorny, Pierre; Gabriel, Sarah] Inst Trop Med, Antwerp, Belgium; [Bauer, Cici; Sahlu, Ida] Brown Univ, Providence, RI 02912 USA; [Ouedraogo, Jean-Bosco; Cisse, Assana; Tarnagda, Zekiba] Res Inst Hlth Sci, Bobo Dioulasso, Burkina Faso								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		573	172	173						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844102315					2019-04-02	
J	de Gier, B; Nga, TT; Winichagoon, P; Dijkhuizen, MA; Khan, NC; Ponce, MC; Polman, K; Wieringa, FT				de Gier, Brechje; Tran Thuy Nga; Winichagoon, Pattanee; Dijkhuizen, Marjoleine A.; Khan, Nguyen Cong; Ponce, Maiza Campos; Polman, Katja; Wieringa, Frank T.			SPECIES-SPECIFIC ASSOCIATIONS BETWEEN HELMINTHS AND MICRONUTRIENTS IN VIETNAMESE SCHOOLCHILDREN	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[de Gier, Brechje; Ponce, Maiza Campos] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Tran Thuy Nga] Minist Hlth, Natl Inst Nutr, Hanoi, Vietnam; [Winichagoon, Pattanee] Mahidol Univ, Inst Nutr, Bangkok, Thailand; [Dijkhuizen, Marjoleine A.] Univ Copenhagen, Copenhagen, Denmark; [Khan, Nguyen Cong] Minist Hlth, Hanoi, Vietnam; [Polman, Katja] Inst Trop Med, Antwerp, Belgium; [Wieringa, Frank T.] Inst Rech Dev, Montpellier, France								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		610	184	184						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844102352					2019-04-02	
J	Dierickx, S; Gryseels, C; Mwesigwa, J; O'Neill, S; Jaiteh, F; Bannister-Tyrrell, M; Irani, J; Ronse, M; Achan, J; D'Alessandro, U; Peeters, KG				Dierickx, Susan; Gryseels, Charlotte; Mwesigwa, Julia; O'Neill, Sarah; Jaiteh, Fatou; Bannister-Tyrrell, Melanie; Irani, Julia; Ronse, Maya; Achan, Jane; D'Alessandro, Umberto; Peeters, Koen G.			COMMUNITY BARRIERS FOR THE IMPLEMENTATION OF A MASS DRUGS ADMINISTRATION FOR MALARIA IN THE GAMBIA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Dierickx, Susan; Gryseels, Charlotte; O'Neill, Sarah; Bannister-Tyrrell, Melanie; Irani, Julia; Ronse, Maya; Peeters, Koen G.] Inst Trop Med, Antwerp, Belgium; [Mwesigwa, Julia; Jaiteh, Fatou; Achan, Jane; D'Alessandro, Umberto] MRC Unit, Fajara, Gambia								0	0	0	1	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		653	197	197						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844102395					2019-04-02	
J	Coulibaly, YI; Coulibaly, SY; Dolo, H; Konate, S; Diallo, AA; Doumbia, SS; Soumaoro, L; Coulibaly, ME; Dicko, I; Sangare, MB; Sangare, M; Dembele, M; Toure, YT; Kelly-Hope, L; Polman, K; Kyelem, D; Traore, SF; Bockarie, M; Klion, AD; Nutman, TB				Coulibaly, Yaya I.; Coulibaly, Siaka Y.; Dolo, Housseini; Konate, Siaka; Diallo, Abdallah A.; Doumbia, Salif S.; Soumaoro, Lamine; Coulibaly, Michel E.; Dicko, Ilo; Sangare, Moussa B.; Sangare, Modibo; Dembele, Massitan; Toure, Yeya T.; Kelly-Hope, Louise; Polman, Katja; Kyelem, Dominique; Traore, Sekou F.; Bockarie, Moses; Klion, Amy D.; Nutman, Thomas B.			INTEGRATED ENTOMOLOGIC, PARASITOLOGIC AND IMMUNOLOGIC SURVEILLANCE FOLLOWING CESSATION FOR MDA IN SENTINEL COMMUNITIES IN SIKASSO, MALI	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Coulibaly, Yaya I.; Coulibaly, Siaka Y.; Dolo, Housseini; Konate, Siaka; Diallo, Abdallah A.; Doumbia, Salif S.; Soumaoro, Lamine; Coulibaly, Michel E.; Dicko, Ilo; Sangare, Moussa B.; Sangare, Modibo; Traore, Sekou F.] Int Ctr Excellence Res, Filariasis Unit, Bamako, Mali; [Dembele, Massitan] Natl Lymphat Filariasis Eliminat Program, Bamako, Mali; [Toure, Yeya T.] WHO, Geneva, Switzerland; [Kelly-Hope, Louise; Bockarie, Moses] Univ Liverpool Liverpool Sch Trop Med, Ctr Neglected Trop Dis, Liverpool, Merseyside, England; [Polman, Katja] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Kyelem, Dominique] Task Force Global Hlth, Neglected Trop Dis Support Ctr, Decatur, GA USA; [Klion, Amy D.; Nutman, Thomas B.] NIAID, Lab Parasit Dis, NIH, Bethesda, MD 20892 USA								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		727	220	220						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844102468					2019-04-02	
J	Thanh, PV; Hong, NV; Van, NV; Louisa, M; Baird, K; Tinh, TT; Xa, NX; Grietens, KP; Hung, LX; Duong, TT; Rosanas-Urgell, A; Speybroeck, N; D'Alessandro, U; Erhart, A				Pham Vinh Thanh; Nguyen Van Hong; Nguyen Van Van; Louisa, Melva; Baird, Kevin; Ta Thi Tinh; Nguyen Xuan Xa; Grietens, Koen Peeters; Le Xuan Hung; Tran Thanh Duong; Rosanas-Urgell, Anna; Speybroeck, Niko; D'Alessandro, Umberto; Erhart, Annette			CONFIRMED PLASMODIUM VIVAX RESISTANCE TO CHLOROQUINE IN CENTRAL VIETNAM	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Pham Vinh Thanh; Nguyen Van Hong; Ta Thi Tinh; Nguyen Xuan Xa; Le Xuan Hung; Tran Thanh Duong] NIMPE, Hanoi, Vietnam; [Nguyen Van Van] Prov Malaria Stn, Tam Ky, Vietnam; [Louisa, Melva] Univ Indonesia, Jakarta, Indonesia; [Baird, Kevin] Eijkman Oxford Clin Res Unit, Jakarta, Indonesia; [Grietens, Koen Peeters; Rosanas-Urgell, Anna] ITM, Antwerp, Belgium; [Speybroeck, Niko] Univ Catholic Louvain, Brussels, Belgium; [D'Alessandro, Umberto] MRC, Fajara, Gambia								0	0	0	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		804	244	244						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844102545					2019-04-02	
J	O'Neill, S; Gryseels, C; Dierickx, S; Mwesigwa, J; Okebe, J; d'Alessandro, U; Grietens, KP				O'Neill, Sarah; Gryseels, Charlotte; Dierickx, Susan; Mwesigwa, Julia; Okebe, Joseph; d'Alessandro, Umberto; Grietens, Koen Peeters			FOUL WIND, SPIRITS AND WITCHCRAFT: ILLNESS CONCEPTIONS AND HEALTH-SEEKING BEHAVIOR FOR MALARIA IN THE GAMBIA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[O'Neill, Sarah; Gryseels, Charlotte; Dierickx, Susan; Grietens, Koen Peeters] Inst Trop Med, Antwerp, Belgium; [Mwesigwa, Julia; Okebe, Joseph; d'Alessandro, Umberto] MRC, Fajara, Gambia								0	0	0	1	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		871	265	265						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844102612					2019-04-02	
J	Conteh, S; Anderson, C; Lambert, L; Orr-Gonzales, S; Herrod, J; Robbins, YL; Carter, D; Karhemere, S; Pyana, P; Buscher, P; Duffy, P				Conteh, Solomon; Anderson, Charles; Lambert, Lynn; Orr-Gonzales, Sachy; Herrod, Jessica; Robbins, Yvette L.; Carter, Dariyen; Karhemere, Stomy; Pyana, Pati; Buscher, Philippe; Duffy, Patrick			PILOT STUDIES OF GRAMMOMYS SURDASTER (G. DOLICHURUS), THE NATURAL HOST FOR PLASMODIUM BERGHEI PARASITES, AS A MODEL TO STUDY WHOLE ORGANISM VACCINES AGAINST MALARIA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Conteh, Solomon; Anderson, Charles; Lambert, Lynn; Orr-Gonzales, Sachy; Herrod, Jessica; Robbins, Yvette L.; Carter, Dariyen; Duffy, Patrick] NIH, Rockville, MD USA; [Karhemere, Stomy; Pyana, Pati] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Buscher, Philippe] Inst Trop Med, Dept Biomed Sci, Unit Parasite Diagnost, Antwerp, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		878	267	267						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844102619					2019-04-02	
J	Mussa, MA; Cowgill, KD; Colebunders, R; Tepage, F; Mandro, M; Laudisoit, A				Mussa, Moise A.; Cowgill, Karen D.; Colebunders, Robert; Tepage, Floribert; Mandro, Michel; Laudisoit, Anne			"RIVER EPILEPSY" IN DEMOCRATIC REPUBLIC OF THE CONGO? PREVALENCE OF EPILEPSY SYMPTOMS IN A ZONE ENDEMIC FOR ONCHOCERCIASIS, KATANGA PROVINCE, 2015	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Mussa, Moise A.] Univ Lubumbashi, Lubumbashi, DEM REP CONGO; [Cowgill, Karen D.] Seattle Univ, Seattle, WA 98122 USA; [Colebunders, Robert] Inst Trop Med, Antwerp, Belgium; [Tepage, Floribert] Minist Sante Publ, Programme Natl Lutte Onchocercose, Buta, DEM REP CONGO; [Mandro, Michel] Univ Bunia, Bunia, DEM REP CONGO; [Laudisoit, Anne] Univ Antwerp, Antwerp, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		1069	326	326						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844103064					2019-04-02	
J	Stuyver, L; Holmes, J; Lagatie, O; Freeman, A; Boussinesq, M; Townson, S				Stuyver, Lieven; Holmes, Jon; Lagatie, Ole; Freeman, Andrew; Boussinesq, Michel; Townson, Simon			FEASIBILITY STUDIES TOWARDS A VIRTUAL SKIN BIOPSY FOR ONCHOCERCIASIS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Stuyver, Lieven; Lagatie, Ole] Janssen Diagnost, Beerse, Belgium; [Holmes, Jon] Michelson Diagnost, Maidstone, Kent, England; [Freeman, Andrew; Townson, Simon] Northwick Pk Inst Med Res, London, England; [Boussinesq, Michel] Inst Rech Dev, Montpellier, France								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		1079	329	329						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844103074					2019-04-02	
J	Celes, FS; Trovatti, E; Khouri, R; Van Weyenbergh, J; Ribeiro, SJ; Borges, VM; Barud, H; de Oliveira, CI				Celes, Fabiana S.; Trovatti, Eliane; Khouri, Ricardo; Van Weyenbergh, Johan; Ribeiro, Sidney J.; Borges, Valeria M.; Barud, Hernane; de Oliveira, Camila I.			BACTERIAL CELLULOSE BIO-CURATIVES CONTAINING DIETHYLDITHIOCARBAMATE (DETC) FOR THE TOPICAL TREATMENT OF CUTANEOUS LEISHMANIASIS CAUSED BY LEISHMANIA BRAZILIENSIS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Celes, Fabiana S.; Khouri, Ricardo; Borges, Valeria M.; de Oliveira, Camila I.] Ctr Pesquisas Goncalo Moniz FIOCRUZ BA, Salvador, BA, Brazil; [Trovatti, Eliane; Ribeiro, Sidney J.; Barud, Hernane] Univ Estadual Paulista, Inst Quim, Araraquara, SP, Brazil; [Van Weyenbergh, Johan] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Leuven, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		1092	333	333						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844103087					2019-04-02	
J	Grietens, KP; Gryseels, C; Dierickx, S; Uk, S; Gerrets, R; Hoibak, S; Ribera, JM; Hausmann-Muela, S; Tho, S; Durnez, L; Sluydts, V; d'Alessandro, U; Coosemans, M; Erhart, A				Grietens, Koen Peeters; Gryseels, Charlotte; Dierickx, Susan; Uk, Sambunny; Gerrets, Rene; Hoibak, Sarah; Ribera, Joan Muela; Hausmann-Muela, Susanna; Tho, Sochantha; Durnez, Lies; Sluydts, Vincent; d'Alessandro, Umberto; Coosemans, Marc; Erhart, Annette			CHARACTERIZING TYPES OF HUMAN MOBILITY TO INFORM DIFFERENTIAL AND TARGETED MALARIA ELIMINATION STRATEGIES IN NORTHEAST CAMBODIA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Grietens, Koen Peeters; Gryseels, Charlotte; Dierickx, Susan; Durnez, Lies; Sluydts, Vincent; Coosemans, Marc; Erhart, Annette] Inst Trop Med, Antwerp, Belgium; [Uk, Sambunny; Tho, Sochantha] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Gerrets, Rene] Amsterdam Inst Social Sci Res, Amsterdam, Netherlands; [Hoibak, Sarah] Global Fund, Geneva, Switzerland; [Ribera, Joan Muela; Hausmann-Muela, Susanna] PASS Int, Tessenderlo, Belgium; [d'Alessandro, Umberto] London Sch Hyg & Trop Med, London, England								0	0	0	1	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		1213	369	370						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844103208					2019-04-02	
J	Okebe, J; Affara, M; DiTanna, GL; Sanya-Isijola, F; Dabira, E; Eziefula, AC; Gaye, A; Nwakanma, D; Bousema, T; Van Geertruyden, JP; Drakeley, C; D'Alessandro, U				Okebe, Joseph; Affara, Muna; DiTanna, Gian Luca; Sanya-Isijola, Frank; Dabira, Edgard; Eziefula, Alice C.; Gaye, Abdoulaye; Nwakanma, Davis; Bousema, Teun; Van Geertruyden, Jean-Pierre; Drakeley, Chris; D'Alessandro, Umberto			THE GAMETOCYTOCIDAL EFFICACY OF PRIMAQUINE IN MALARIA ASYMPTOMATIC PLASMODIUM FALCIPARUM CARRIERS IN THE GAMBIA: RESULTS OF A RANDOMIZED CONTROLLED TRIAL	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Okebe, Joseph; Affara, Muna; Sanya-Isijola, Frank; Dabira, Edgard; Gaye, Abdoulaye; Nwakanma, Davis; D'Alessandro, Umberto] MRC Unit, Banjul, Gambia; [DiTanna, Gian Luca; Eziefula, Alice C.; Bousema, Teun; Drakeley, Chris] London Sch Hyg & Trop Med, London, England; [Van Geertruyden, Jean-Pierre] Inst Trop Med, Antwerp, Belgium			Bousema, Teun/N-3574-2014; Van geertruyden, Jean-Pierre/K-6425-2014	Bousema, Teun/0000-0003-2666-094X; Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		1215	370	370						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844103210					2019-04-02	
J	Diaz, C; Martinez, LJ; Eckels, KH; Lin, L; Campos, M; Jarman, RG; De La Barrera, R; Lepine, E; Collard, A; Innis, BL; Febo, I; Thomas, SJ; Schmidt, AC				Diaz, Clemente; Martinez, Luis J.; Eckels, Kenneth H.; Lin, Leyi; Campos, Maribel; Jarman, Richard G.; De La Barrera, Rafael; Lepine, Edith; Collard, Alix; Innis, Bruce L.; Febo, Irma; Thomas, Stephen J.; Schmidt, Alexander C.			PHASE 1 STUDY OF DIFFERENT FORMULATIONS OF A TETRAVALENT DENGUE PURIFIED INACTIVATED VACCINE (DPIV): SAFETY AND IMMUNOGENICITY DATA IN HEALTHY ADULTS FROM PUERTO RICO THROUGH MONTH 13	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Diaz, Clemente; Campos, Maribel; Febo, Irma] Univ Puerto Rico, Sch Med, San Juan, PR 00936 USA; [Martinez, Luis J.; Eckels, Kenneth H.; Lin, Leyi; Jarman, Richard G.; De La Barrera, Rafael; Thomas, Stephen J.] Walter Reed Army Inst Res, Silver Spring, MD USA; [Lepine, Edith; Collard, Alix; Schmidt, Alexander C.] GlaxoSmithKline Vaccines, Rixensart, Belgium; [Innis, Bruce L.] GlaxoSmithKline Vaccines, King Of Prussia, PA USA								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		1219	372	372						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844103214					2019-04-02	
J	le Rutte, EA; Coffeng, LE; Bontje, DM; Hasker, EC; Hoekstra, RC; Bakker, R; Boelaert, M; de Vlas, SJ				le Rutte, Epke A.; Coffeng, Luc E.; Bontje, Daniel M.; Hasker, Epco C.; Hoekstra, Rinke C.; Bakker, Roel; Boelaert, Marleen; de Vlas, Sake J.			FEASIBILITY OF ELIMINATING VISCERAL LEISHMANIASIS FROM THE INDIAN SUBCONTINENT	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[le Rutte, Epke A.; Coffeng, Luc E.; Bontje, Daniel M.; Hoekstra, Rinke C.; Bakker, Roel; de Vlas, Sake J.] Erasmus MC, Rotterdam, Netherlands; [Hasker, Epco C.; Boelaert, Marleen] Inst Trop Med, Antwerp, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		1250	382	382						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844103245					2019-04-02	
J	van Griensven, J				van Griensven, Johan		Ebola TX Consortium	EMERGENCY EVALUATION OF CONVALESCENT PLASMA FOR EBOLA VIRUS DISEASE (EVD) IN GUINEA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[van Griensven, Johan; Ebola TX Consortium] Inst Trop Med, Antwerp, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		1267	387	387						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844103262					2019-04-02	
J	Regules, JA; Cicatelli, SB; Bennett, JW; Paolino, KM; Twomey, PS; Moon, JE; Kathcart, AK; Hauns, KD; Komisar, JL; Qabar, AN; Davidson, SA; Griffith, ME; Magee, CD; Wojnarski, M; Livezey, JR; Kress, AT; Jongert, E; Wille-Reece, U; Lievens, M; Morelle, D; Lee, CK; Yassin-Rajkumar, B; Weltzin, R; Cohen, J; Paris, RM; Waters, NC; Birkett, AJ; Kaslow, DC; Ballou, WR; Ockenhouse, CF; Vekemans, J				Regules, Jason A.; Cicatelli, Susan B.; Bennett, Jason W.; Paolino, Kristopher M.; Twomey, Patrick S.; Moon, James E.; Kathcart, April K.; Hauns, Kevin D.; Komisar, Jack L.; Qabar, Aziz N.; Davidson, Silas A.; Griffith, Matthew E.; Magee, Charles D.; Wojnarski, Mariusz; Livezey, Jeffrey R.; Kress, Adrian T.; Jongert, Erik; Wille-Reece, Ulrike; Lievens, Marc; Morelle, Danielle; Lee, Cynthia K.; Yassin-Rajkumar, Bebi; Weltzin, Richard; Cohen, Joe; Paris, Robert M.; Waters, Norman C.; Birkett, Ashley J.; Kaslow, David C.; Ballou, W. Ripley; Ockenhouse, Christian F.; Vekemans, Johan			LONG TERM EFFICACY, SAFETY, REACTOGENICITY, AND IMMUNOGENICITY OF PHASE IIA, OPEN-LABEL, CONTROLLED STUDY FOR THE RTS, S/AS01B MALARIA VACCINE CANDIDATE ADMINISTERED AS STANDARD DOSES AT 0 AND 1 MONTHS AND 1/5TH STANDARD DOSE AT 7 MONTHS (DELAYED FRACTIONAL DOSE GROUP) AND ADMINISTERED AS THREE STANDARD DOSES ONE MONTH APART (0, 1, 2-MONTH GROUP) IN HEALTHY MALARIA-NAIVE VOLUNTEERS AGED 18-50 YEARS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Regules, Jason A.; Cicatelli, Susan B.; Bennett, Jason W.; Paolino, Kristopher M.; Twomey, Patrick S.; Moon, James E.; Kathcart, April K.; Hauns, Kevin D.; Komisar, Jack L.; Qabar, Aziz N.; Davidson, Silas A.; Wojnarski, Mariusz; Livezey, Jeffrey R.; Kress, Adrian T.; Paris, Robert M.; Waters, Norman C.] Walter Reed Army Inst Res, Silver Spring, MD USA; [Griffith, Matthew E.; Magee, Charles D.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Jongert, Erik; Lievens, Marc; Morelle, Danielle; Cohen, Joe; Ballou, W. Ripley; Vekemans, Johan] GlaxoSmithKline Vaccines, Rixensart, Belgium; [Wille-Reece, Ulrike; Lee, Cynthia K.; Yassin-Rajkumar, Bebi; Weltzin, Richard; Birkett, Ashley J.; Kaslow, David C.; Ockenhouse, Christian F.] PATH Malaria Vaccine Initiat, Washington, DC USA								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		1276	390	390						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844103271					2019-04-02	
J	Bennett, JW; Tosh, D; Bergmann-Leitner, E; Paolino, K; Regules, J; Duncan, EH; Twomey, P; Moon, J; Kathcart, A; Hosie, HE; Storme, CK; Spring, M; Hauns, K; Komisar, J; Qabar, A; Davidson, S; Ockenhouse, CF; Vekemans, J; Soisson, L; Ballou, R; Diggs, C; Waters, NC; Paris, RM; Angov, E				Bennett, Jason W.; Tosh, Donna; Bergmann-Leitner, Elke; Paolino, Kristopher; Regules, Jason; Duncan, Elizabeth H.; Twomey, Patrick; Moon, James; Kathcart, April; Hosie, Heather E.; Storme, Casey K.; Spring, Michele; Hauns, Kevin; Komisar, Jack; Qabar, Aziz; Davidson, Silas; Ockenhouse, Christian F.; Vekemans, Johan; Soisson, Lorraine; Ballou, Ripley; Diggs, Carter; Waters, Norman C.; Paris, Robert M.; Angov, Evelina			PHASE 1 TRIAL WITH CONTROLLED HUMAN MALARIA INFECTION: AN OPEN LABEL DOSE-ESCALATION SAFETY, REACTOGENICITY, IMMUNOGENICITY, AND EFFICACY STUDY OF THE CANDIDATE VACCINE PLASMODIUM FALCIPARUM MALARIA PROTEIN (FMP012), AN E-COLI-EXPRESSED CELL-TRAVERSAL PROTEIN FOR OOKINETES AND SPOROZOITES (PFCELTOS), ADMINISTERED INTRAMUSCULARLY WITH THE ADJUVANT SYSTEM AS01(B) IN HEALTHY, MALARIA-NAIVE ADULTS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Bennett, Jason W.; Tosh, Donna; Bergmann-Leitner, Elke; Paolino, Kristopher; Regules, Jason; Duncan, Elizabeth H.; Twomey, Patrick; Moon, James; Kathcart, April; Hosie, Heather E.; Storme, Casey K.; Spring, Michele; Hauns, Kevin; Komisar, Jack; Qabar, Aziz; Davidson, Silas; Waters, Norman C.; Paris, Robert M.; Angov, Evelina] Walter Reed Army Inst Res, Silver Spring, MD USA; [Ockenhouse, Christian F.] PATH Malaria Vaccine Initiat, Washington, DC USA; [Vekemans, Johan; Ballou, Ripley] GlaxoSmithKline Vaccines, Rixenart, Belgium; [Soisson, Lorraine; Diggs, Carter] US Agcy Int Dev, Washington, DC 20523 USA			Bergmann-Leitner, Elke/B-3548-2011	Bergmann-Leitner, Elke/0000-0002-8571-8956				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		1278	391	391						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844103273					2019-04-02	
J	Rampling, T; Bowyer, G; Wright, D; Venkatraman, N; Payne, R; Sridhar, S; Edwards, N; Poulton, I; Imoukhuede, EB; Vekemans, J; Sinden, R; Roberts, R; Weltzin, R; Morelle, D; Yassin-Rajkumar, B; Birkett, AJ; Ivinson, KL; Ockenhouse, CF; Wille-Reece, U; Lee, CK; Faust, S; Cooke, G; Lewis, D; Lawrie, A; Ballou, WR; Ewer, K; Hill, A				Rampling, Tommy; Bowyer, Georgina; Wright, Danny; Venkatraman, Navin; Payne, Ruth; Sridhar, Saranya; Edwards, Nick; Poulton, Ian; Imoukhuede, Egeruan B.; Vekemans, Johan; Sinden, Robert; Roberts, Rachel; Weltzin, Richard; Morelle, Danielle; Yassin-Rajkumar, Bebi; Birkett, Ashley J.; Ivinson, Karen L.; Ockenhouse, Christian F.; Wille-Reece, Ulrike; Lee, Cynthia K.; Faust, Saul; Cooke, Graham; Lewis, David; Lawrie, Alison; Ballou, W. Ripley; Ewer, Katie; Hill, Adrian			SAFETY, IMMUNOGENICITY AND EFFICACY OF THE COMBINATION MALARIA VACCINE REGIMEN OF RTS, S/AS01B CONCOMITANTLY ADMINISTERED WITH CHAD-MVA VIRAL VECTORS EXPRESSING ME-TRAP	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Rampling, Tommy; Bowyer, Georgina; Wright, Danny; Venkatraman, Navin; Payne, Ruth; Sridhar, Saranya; Edwards, Nick; Poulton, Ian; Imoukhuede, Egeruan B.; Sinden, Robert; Roberts, Rachel; Lawrie, Alison; Ewer, Katie; Hill, Adrian] Univ Oxford, Oxford, England; [Vekemans, Johan; Morelle, Danielle; Ballou, W. Ripley] GlaxoSmithKline Biol, Rixensart, Belgium; [Weltzin, Richard; Yassin-Rajkumar, Bebi; Birkett, Ashley J.; Ivinson, Karen L.; Ockenhouse, Christian F.; Wille-Reece, Ulrike; Lee, Cynthia K.] PATH MVI, Washington, DC USA; [Faust, Saul] Univ Southampton, Southampton, Hants, England; [Cooke, Graham] Imperial Coll London, London, England; [Lewis, David] Univ Surrey, Guildford, Surrey, England								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		1277	391	391						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844103272					2019-04-02	
J	Tihon, EE; Imamura, H; Van den Broeck, F; Dujardin, JC; Van den Abbeele, J				Tihon, Eliane E.; Imamura, Hideo; Van den Broeck, Frederik; Dujardin, Jean-Claude; Van den Abbeele, Jan			GENETIC DIVERSITY IN THE NATURAL TRYPANOSOMA CONGOLENSE POPULATION	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Tihon, Eliane E.; Imamura, Hideo; Van den Broeck, Frederik; Dujardin, Jean-Claude; Van den Abbeele, Jan] Inst Trop Med, Antwerp, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		1318	403	403						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844103313					2019-04-02	
J	Rampling, T; Ewer, K; Bowyer, G; Wright, D; Venkatraman, N; Imoukhuede, EB; Payne, R; Hartnell, F; Nicosia, A; Ledgerwood, JE; Sullivan, NJ; Graham, BS; Moorthy, V; Becker, S; Ballou, WR; Draper, S; Lawrie, A; Gilbert, S; Hill, A				Rampling, Tommy; Ewer, Katie; Bowyer, Georgina; Wright, Danny; Venkatraman, Navin; Imoukhuede, Egeruan B.; Payne, Ruth; Hartnell, Felicity; Nicosia, Alfredo; Ledgerwood, Julie E.; Sullivan, Nancy J.; Graham, Barney S.; Moorthy, Vasee; Becker, Stephan; Ballou, W. Ripley; Draper, Simon; Lawrie, Alison; Gilbert, Sarah; Hill, Adrian			SAFETY AND IMMUNOGENICITY OF THE HETEROLOGOUS PRIME-BOOST EBOLAVIRUS VACCINE REGIMEN CHAD3-EBO Z AND MVA-BN (R) FILO IN HEALTHY UK ADULTS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Rampling, Tommy; Ewer, Katie; Bowyer, Georgina; Wright, Danny; Venkatraman, Navin; Imoukhuede, Egeruan B.; Payne, Ruth; Hartnell, Felicity; Draper, Simon; Lawrie, Alison; Gilbert, Sarah; Hill, Adrian] Univ Oxford, Oxford, England; [Nicosia, Alfredo] ReiThera, Rome, Italy; [Ledgerwood, Julie E.; Sullivan, Nancy J.; Graham, Barney S.] NIH, Bethesda, MD 20892 USA; [Moorthy, Vasee] WHO, Geneva, Switzerland; [Becker, Stephan] Philipps Univ Marburg, Marburg, Germany; [Ballou, W. Ripley] GlaxoSmithKline Biol, Rixensart, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		1462	446	447						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844103457					2019-04-02	
J	Dierickx, S; Gryseels, C; Mwesigwa, J; Jaiteh, F; O'Neill, S; Bannister-Tyrrell, M; Irani, J; Ronse, M; Achan, J; D'Alessandro, U; Peeters, KG				Dierickx, Susan; Gryseels, Charlotte; Mwesigwa, Julia; Jaiteh, Fatou; O'Neill, Sarah; Bannister-Tyrrell, Melanie; Irani, Julia; Ronse, Maya; Achan, Jane; D'Alessandro, Umberto; Peeters, Koen G.			HOUSE STRUCTURE AND SLEEPING ARRANGEMENT AFFECTS BED NET USE IN THE GAMBIA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Dierickx, Susan; Gryseels, Charlotte; O'Neill, Sarah; Bannister-Tyrrell, Melanie; Irani, Julia; Ronse, Maya; Peeters, Koen G.] Inst Trop Med, Antwerp, Belgium; [Mwesigwa, Julia; Jaiteh, Fatou; Achan, Jane; D'Alessandro, Umberto] MRC Unit, Fajara, Gambia								0	0	0	1	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		1615	493	494						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844103610					2019-04-02	
J	Lachau-Durand, S; Voets, M; Psathas, P; Boeykens, P				Lachau-Durand, Sophie; Voets, Marieke; Psathas, Petros; Boeykens, Peter			A NOVEL APPROACH TO IMPROVE THE BIOAVAILABILITY OF FLUBENDAZOLE BY USING A SPRAY DRIED FORMULATION IN JIRDS, RATS AND DOGS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Lachau-Durand, Sophie] Janssen Infect Dis, Beerse, Belgium; [Voets, Marieke; Boeykens, Peter] Janssen Res & Dev, Div Janssen Pharmaceut NV, Beerse, Belgium; [Psathas, Petros] Janssen Res & Dev LLC, Raritan, NJ USA								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		1720	526	527						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844103715					2019-04-02	
J	Howard, RF; Mukhtar, M; Abdoun, AO; Ghalib, H; Boelaert, M; Menten, J; Peeling, R; Mohamath, R; Duthie, MS; Mondal, D; Mekuria, AH; Vallur, A; Reed, SG				Howard, Randall F.; Mukhtar, Maowia; Abdoun, Asim O.; Ghalib, Hashim; Boelaert, Marleen; Menten, Joris; Peeling, Rosanna; Mohamath, Raodoh; Duthie, Malcolm S.; Mondal, Dinesh; Mekuria, Asrat Hailu; Vallur, Aarthy; Reed, Steven G.			TOOLS FOR IMPROVED MANAGEMENT OF VISCERAL LEISHMANIASIS: CLINICAL EVALUATION OF THE RK28 RAPID DIAGNOSTIC TEST AND ASSESSMENT OF AN ANTIGEN-DETECTION TEST OF CURE	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Howard, Randall F.; Mohamath, Raodoh; Duthie, Malcolm S.; Vallur, Aarthy; Reed, Steven G.] IDRI, Seattle, WA USA; [Mukhtar, Maowia; Abdoun, Asim O.] IEND, Khartoum, Sudan; [Ghalib, Hashim] Univ Lausanne, Epilanges, Switzerland; [Boelaert, Marleen; Menten, Joris] ITM, Antwerp, Belgium; [Peeling, Rosanna] London Sch Hyg & Trop Med, London, England; [Mondal, Dinesh] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Mekuria, Asrat Hailu] Addis Ababa Univ, Addis Ababa, Ethiopia								0	0	0	1	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		1740	533	533						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844103735					2019-04-02	
J	Lasry, E; Coldiron, M; Koscalova, A; Grandesso, F; Milligan, P; Lima, MA; Stassjins, J; Sterk, E; Elder, G; de Smet, M				Lasry, Estrella; Coldiron, Matthew; Koscalova, Alena; Grandesso, Francesco; Milligan, Paul; Lima, Ma Angeles; Stassjins, Jorgen; Sterk, Esther; Elder, Greg; de Smet, Martin			SEASONAL MALARIA CHEMOPREVENTION, THREE YEARS OF IMPLEMENTATION	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract									[Lasry, Estrella] Med Sans Frontieres Doctors Borders, New York, NY USA; [Coldiron, Matthew; Grandesso, Francesco] Epicentre, Paris, France; [Koscalova, Alena; Sterk, Esther] Med Sans Frontieres Doctors Borders, Geneva, Switzerland; [Milligan, Paul] London Sch Hyg & Trop Med, London, England; [Lima, Ma Angeles] Med Sans Frontieres Doctors Borders, Barcelona, Spain; [Stassjins, Jorgen; de Smet, Martin] Med Sans Frontieres Doctors Borders, Brussels, Belgium; [Elder, Greg] Med Sans Frontieres Doctors Borders, Paris, France								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4		S		1906	583	583						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	VB0ZJ	WOS:000412844104134					2019-04-02	
J	Maotela, JK; Ramazani, SY; Misingi, P; Dramaix-Wilmet, M				Maotela, Kabinda J.; Ramazani, S. Y.; Misingi, P.; Dramaix-Wilmet, M.			Blood transfusion in the Democratic Republic of Congo: efforts and challenges	MEDECINE ET SANTE TROPICALES			French	Article						transfusion; Democratic Republic of Congo; challenges		The authors trace the history of blood transfusion in the Democratic Republic of Congo, as inherited through the colonial organization of the health system. The current configuration of transfusion system begins with the drafting of the national blood transfusion policy and the establishment of a national technical office within the Ministry of Health to coordinate transfusion activities and of its agents in each province. Despite countless difficulties, several positive points were noted. These involve essentially the drafting of all the necessary documents and standards and the integration of the blood safety system into the country's health system. Initially, the blood transfusion system applied a vertical approach, but with the reform of the country's health system, the performance of blood safety became transversal. In the 12 years from 2001 to 2012, it mobilized 112,882 volunteer blood donors; more than 80% of blood products were checked for safety and covered all blood needs; and 81,806 HIV infections were avoided by routine testing of blood products. During the same period, 7560 people were trained in blood transfusion. The prevalence of viral markers among donors has diminished sharply. Thus, HIV prevalence decreased from 4.7% to 2.1% between 2001 and 2012 that of hepatitis B dropped from 7.1% to 3.5% during the same period, and hepatitis C from 11.8% to 2.3% from 2004 to 2012. Despite this performance, enormous efforts are still required, for the organization of blood safety monitoring, the establishment of a safe supply of reagents and supplies, for sustaining the dynamics of voluntary associations of blood donors, and finally for providing stable funding for these blood safety activities.	[Maotela, Kabinda J.] Univ Catholique Bukavu, Fac Med, Bukavu, DEM REP CONGO; [Maotela, Kabinda J.] Ctr Prov Transfus Sanguine Bukavu Sud Kivu, Bukavu, DEM REP CONGO; [Ramazani, S. Y.; Misingi, P.] Ctr Natl Transfus Sanguine Kinshasa, Kinshasa, DEM REP CONGO; [Dramaix-Wilmet, M.] Univ Libre Bruxelles, Ecole Sante Publ, Brussels, Belgium; [Dramaix-Wilmet, M.] Ctr Rech Biostat & Epidemiol, Brussels, Belgium	Maotela, JK (reprint author), Univ Catholique Bukavu, Fac Med, Bukavu, DEM REP CONGO.	kabindaalu@yahoo.fr					Agbovi KK, 2006, TRANSFUS CLIN BIOL, V13, P260, DOI 10.1016/j.tracli.2006.06.002; Bates I, 2007, TRANSFUSION MED, V17, P434, DOI 10.1111/j.1365-3148.2007.00798.x; OMS, 1999, SEC TRANSF AID MEM P; OMS, 2009, EB12619 OMS; OMS, 2010, DEP INF TRANSM DONS; Takpo JB, REPORT STATUS BLOOD	6	0	0	0	0	JOHN LIBBEY EUROTEXT LTD	MONTROUGE	127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE	2261-3684	2261-2211		MED SANTE TROP	Med. Sante Trop.	OCT-DEC	2015	25	4					342	349		10.1684/mst.2015.0487				8	Tropical Medicine	Tropical Medicine	VD6RB	WOS:000437432400002	26742551				2019-04-02	
J	Kuwekita, M; Gosset, C; Guillaume, M; Semutsari, MPB; Kabongo, ET; Bruyere, O; Reginster, JY				Kuwekita, Manzambi; Gosset, C.; Guillaume, M.; Semutsari, Balula M-P; Kabongo, Tshiama E.; Bruyere, O.; Reginster, J. Y.			Combining microcredit, microinsurance, and the provision of health care can improve access to quality care in urban areas of Africa: Results of an experiment in the Bandalungwa health zone in Kinshasa, the Congo	MEDECINE ET SANTE TROPICALES			French	Article						microcredit; microinsurance; health care; access to health care; compulsory health insurance; Democratic Republic of the Congo		This study, based on a survey conducted in 2008, examines how combining microcredit, microinsurance, and health care provision can improve access to quality care in the health zone of Bandalungwa, in Kinshasa. The bivariate analysis showed a significant association between increased purchasing power and earnings (p = 0.001), between earnings and savings (p = 0.000), and between health insurance and improved access to health care. These results show that 68.8% of borrowers reported an increase in their purchasing power, of whom 82% reported profits. Those with savings were 24.7 times more likely to purchase health insurance than those without; and 72% of those who regularly made health insurance payments improved their access to care. Combining microcredit, health microinsurance, and health care can improve access to quality health care at lower cost. This suggests that health insurance could usefully be integrated into the primary health-care system.	[Kuwekita, Manzambi; Bruyere, O.; Reginster, J. Y.] Univ Liege, Fac Med, Dept Sci Sante Publ, Quartier Hop,CHU Sart Tilman,Tour Pathol, 13 Ave Hippocrate,B23, B-4000 Liege, Belgium; [Kuwekita, Manzambi] Inst Super Tech Med Kinshasa, Kinshasa, DEM REP CONGO; [Gosset, C.] Univ Liege, Ecole Sante Publ, Aspects Gen, Sante Publ, Liege, Belgium; [Guillaume, M.] Univ Liege, Ecole Sante Publ, Aspects Specif, Sante Publ, Liege, Belgium; [Semutsari, Balula M-P] Inst Super Tech Med Ipamu, Sante Publ, Idiofa, DEM REP CONGO; [Kabongo, Tshiama E.] Inst Super Tech Med, Sante Communautaire, Kinshasa, DEM REP CONGO	Kuwekita, M (reprint author), Univ Liege, Fac Med, Dept Sci Sante Publ, Quartier Hop,CHU Sart Tilman,Tour Pathol, 13 Ave Hippocrate,B23, B-4000 Liege, Belgium.	jk.manzambi@ulg.ac.be		Bruyere, Olivier/0000-0003-4269-9393			Audibert M, 2004, Med Trop (Mars), V64, P552; Bockel L, 2009, MODULE EASYPOL, V206, P1; Bouquet E., 2007, AUTREPART, V44, P157; Bureau International du Travail /Strategies et Techniques contre l'Exclusion sociale et la Pauvrete (BIT/STEP), MICR SANT GUID INTR; Criel B, 2006, ASSURANCE MALADIE AF, P353; D'Espallier B, 2011, WORLD DEV, V39, P758, DOI 10.1016/j.worlddev.2010.10.008; Develtere P, 2004, MICROASSURANCE SOINS; Duflo E, 2009, SECTEUR PRIVE DEV, V3, P10; DUSSAULT G., 2006, ASSURANCE MALADIE AF; Groupe consultatif d'assistance aux plus pauvres (GCAP), 2000, FOCUS, V17, P1; Guillaume M, 2013, JESP, V12, P47; Kuwekita JM, 2015, SANTE PUBLIQUE, V27, P129; Labie M, 2007, MONDES DEV, V3, P57; Manzambi JK, 2000, TROP MED INT HEALTH, V5, P563, DOI 10.1046/j.1365-3156.2000.00588.x; Manzambi JK, 2008, PSYCHOL SOC NOUV, V7, P280; Manzambi Kuwekita J, PERCEPTION COMPORTEM; Manzambi Kuwekita J, 2013, PSYCHOL SOC NOUV, V12, P3; Mondiale Banque, 1993, RAPP DEV MOND, P112; Mwabu G., 1990, 457 WORLD BANK; Navajas S, 2000, WORLD DEV, V28, P333, DOI 10.1016/S0305-750X(99)00121-7; Okpukpara B., 2009, J DEV AGR EC, V1, P41; Programme des Nations Unies pour le Developpement (PNUD), 2009, PAUVR COND VIE MEN V; Sery JP, 2006, ASSURANCE MALADIE AF; Tizio S, 2005, MONDES DEV, V3, P45	24	2	2	0	0	JOHN LIBBEY EUROTEXT LTD	MONTROUGE	127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE	2261-3684	2261-2211		MED SANTE TROP	Med. Sante Trop.	OCT-DEC	2015	25	4					381	385		10.1684/mst.2015.0520				5	Tropical Medicine	Tropical Medicine	VD6RB	WOS:000437432400014	26643890				2019-04-02	
J	Khabala, KB; Edwards, JK; Baruani, B; Sirengo, M; Musembi, P; Kosgei, RJ; Walter, K; Kibachio, JM; Tondoi, M; Ritter, H; Wilkinson, E; Reid, T				Khabala, Kelly B.; Edwards, Jeffrey K.; Baruani, Bienvenu; Sirengo, Martin; Musembi, Phylles; Kosgei, Rose J.; Walter, Kizito; Kibachio, Joseph M.; Tondoi, Monique; Ritter, Helga; Wilkinson, Ewan; Reid, Tony			Medication Adherence Clubs: a potential solution to managing large numbers of stable patients with multiple chronic diseases in informal settlements	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						operational research; SORT IT; Hypertension; Diabetes Mellitus	NAIROBI; KENYA; PREVALENCE	ObjectivesTo assess the care of hypertension, diabetes mellitus and/or HIV patients enrolled into Medication Adherence Clubs (MACs). MethodsRetrospective descriptive study was carried out using routinely collected programme data from a primary healthcare clinic at informal settlement in Nairobi, Kenya. All patients enrolled into MACs were selected for the study. MACs are nurse-facilitated mixed groups of 25-35 stable hypertension, diabetes mellitus and/or HIV patients who met quarterly to confirm their clinical stability, have brief health discussions and receive medication. Clinical officer reviewed MACs yearly, when a patient developed complications or no longer met stable criteria. ResultsA total of 1432 patients were enrolled into 47 clubs with 109 sessions conducted between August 2013 and August 2014. There were 1020 (71%) HIV and 412 (29%) non-communicable disease patients. Among those with NCD, 352 (85%) had hypertension and 60 (15%) had DM, while 12 had HIV concurrent with hypertension. A total of 2208 consultations were offloaded from regular clinic. During MAC attendance, blood pressure, weight and laboratory testing were completed correctly in 98-99% of consultations. Only 43 (2%) consultations required referral for clinical officer review before their routine yearly appointment. Loss to follow-up from the MACs was 3.5%. ConclusionsThis study demonstrates the feasibility and early efficacy of MACs for mixed chronic disease in a resource-limited setting. It supports burden reduction and flexibility of regular clinical review for stable patients. Further assessment regarding long-term outcomes of this model should be completed to increase confidence for deployment in similar contexts.	[Khabala, Kelly B.; Edwards, Jeffrey K.; Baruani, Bienvenu; Walter, Kizito; Tondoi, Monique; Ritter, Helga] Med Sans Frontieres, Nairobi, Kenya; [Sirengo, Martin] Natl AIDs & STI Control Programme, Nairobi, Kenya; [Musembi, Phylles] MOH Langata Subcty, Nairobi, Kenya; [Kosgei, Rose J.] Univ Nairobi, Coll Hlth Sci, Dept Obstet & Gynaecol, Nairobi, Kenya; [Kibachio, Joseph M.] Kenya Minist Hlth, Noncommunicable Dis Control Unit, Nairobi, Kenya; [Wilkinson, Ewan] Chester Univ, Chester, Cheshire, England; [Reid, Tony] Med Sans Frontieres, Operat Res Unit, Luxembourg, Luxembourg	Khabala, KB (reprint author), Med Sans Frontieres, Brussels, Belgium.	khabaxkelly@yahoo.com			MSF; Department for International Development (DFID); WHO	We recognise the daily work of Kibera project staff, as they continue serving patients while adapting to new models of care trying to answer to the needs of the beneficiaries in a rapidly dynamic urban informal settlement of the capital Nairobi. This research was conducted through the Structured Operational Research and Training Initiative (SORT IT), a global partnership led by the Special Programme for Research and Training in Tropical Diseases at the World Health Organization (WHO/TDR). The model is based on a course developed jointly by the International Union Against Tuberculosis and Lung Disease (The Union) and Medecins sans Frontieres. The specific SORT IT Programme which resulted in this publication was jointly developed and implemented by the following: the Operational Research Unit (LUXOR), Medecins Sans Frontieres, Brussels Operational Center, Luxembourg; the Centre for Operational Research, The Union, Paris, France; the Centre for International health, University of Bergen, Norway; the institute of Tropical Medicine, Antwerp, Belgium; and The University of Nairobi, Kenya and the University of Chester, United Kingdom. The Programme was funded by The Union, MSF, the Department for International Development (DFID) and WHO. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2009, UNTANGLING WEB   JUL; Ayah R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-371; Dalal W, 2013, JAIDS-J ACQ IMM DEF, V62, pE47, DOI 10.1097/QAI.0b013e318276bea0; Kenya National AIDS Control council, KEN AIDS IND SURV 20; Kenya National Bureau of Statistics, 2009, KEN POP HOUS CENS 24; Luque-Fernandez MA, 2013, PLOS ONE, V8, P1; MSF Belgium Kibera, ANN REP 2013; MSF Belgium Kibera, PAT SAT SURV 2012; NCD Alliance, 2011, 1 KEN NAT FOR NCDS 2; Oti SO, 2013, TROP MED INT HEALTH, V18, P1520, DOI 10.1111/tmi.12200; Sobry A, 2013, MANAGEMENT HYPERTENS; van de Vijver SJM, 2013, J HYPERTENS, V31, P1018, DOI 10.1097/HJH.0b013e32835e3a56; vonsElm E, 2007, PLOS MED, V10, P1371; WHO, 2013, GLOB UPD HIV TREATM; Wilkinson LS, 2013, S AFR J HIV MED, V14, P48, DOI [10.7196/SAJHIVMED.924, 10.7196/sajhivmed.924]	15	24	24	0	8	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2015	20	10					1265	1270		10.1111/tmi.12539				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7DR	WOS:000360763600002	25962952	Other Gold, Green Published			2019-04-02	
J	Bennis, I; De Brouwere, V; Ameur, B; Laamrani, AE; Chichaoui, S; Hamid, S; Boelaert, M				Bennis, Issam; De Brouwere, Vincent; Ameur, Btissam; Laamrani, Abderrahmane El Idrissi; Chichaoui, Smaine; Hamid, Sahibi; Boelaert, Marleen			Control of cutaneous leishmaniasis caused by Leishmania major in south-eastern Morocco	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						cutaneous leishmaniasis; zoonoses; Leishmania major; rodenticide; Morocco	CENTRAL TUNISIA; NORTH-AFRICA; EPIDEMIOLOGY; CLIMATE; DIAGNOSIS; FEATURES; DISEASE; IRAN	Objective The incidence of cutaneous leishmaniasis (CL) caused by Leishmania major has increased in Morocco over the last decade, prompting the Ministry of Health to take intersectoral response measures including vector and reservoir control. The aim of this article was to describe the CL outbreak response measures taken in the province of Errachidia, where the reservoir of L.major, a sand rat (Meriones shawi), was targeted using strychnine-poisoned wheat baits from 2010 to 2012. Method We analysed routine surveillance data and other information using the data of the CL control programme. Results We present data on the evolution and the extension of CL in this province as well as the epidemiological profile of the disease. Between 2004 and 2013, 7099 cases of CL were recorded in Errachidia Province, gradually affecting all districts. Our results demonstrate that more women were affected than men and that all age groups were represented. ConclusionErrachidia Province was the epicentre of the recent CL outbreak in Morocco. A notable decline in incidence rates was observed after 2011. The outbreak control measures may have contributed to this decline, as well as climatic trends or progressing herd immunity.	[Bennis, Issam] Natl Sch Publ Hlth, Rabat, Morocco; [Bennis, Issam; De Brouwere, Vincent; Boelaert, Marleen] Inst Trop Med, B-2000 Antwerp, Belgium; [Ameur, Btissam; Laamrani, Abderrahmane El Idrissi] Minist Hlth, Directorate Epidemiol & Dis Control, Rabat, Morocco; [Chichaoui, Smaine] Minist Hlth, Rabat, Province Of Err, Morocco; [Hamid, Sahibi] Agron & Vet Inst Hassan II, Dept Parasitol, Rabat, Morocco	Bennis, I (reprint author), Natl Sch Publ Hlth, Lemfedal Cherkaoui St,MailBox 6329, Rabat, Morocco.	issambennis@gmail.com		Bennis, issam/0000-0002-3553-5430; Boelaert, Marleen/0000-0001-8051-6776			Akhavan AA, 2014, J VECTOR DIS, V51, P307; Al-Jawabreh A, 2003, East Mediterr Health J, V9, P805; Al-Tawfiq JA, 2004, INT J INFECT DIS, V8, P244, DOI 10.1016/j.ijid.2003.10.006; Amim TT, 2013, ASIAN PAC J TROP MED, V6, P667, DOI 10.1016/S1995-7645(13)60116-9; Aoun K, 2014, PARASITE, V21, DOI 10.1051/parasite/2014014; Ashford RW, 2000, INT J PARASITOL, V30, P1269, DOI 10.1016/S0020-7519(00)00136-3; Aytekin S, 2006, Dermatol Online J, V12, P14; Bounoua L, 2013, INT J ENV RES PUB HE, V10, P3172, DOI 10.3390/ijerph10083172; Calvopina M, 2004, MEM I OSWALDO CRUZ, V99, P663, DOI 10.1590/S0074-02762004000700001; Chaves LF, 2006, PLOS MED, V3, P1320, DOI 10.1371/journal.pmed.0030295; Chelbi I, 2007, J MED ENTOMOL, V44, P385, DOI 10.1603/0022-2585(2007)44[385:POPPDP]2.0.CO;2; Direction de l'Epidemiologie et la Lutte contre les Maladies, 2010, LUTT CONTR LEISHM GU; Dowlati Y, 1996, CLIN DERMATOL, V14, P425, DOI 10.1016/0738-081X(96)00058-2; Gramiccia M, 2005, INT J PARASITOL, V35, P1169, DOI 10.1016/j.ijpara.2005.07.001; Hunter PR, 2003, J APPL MICROBIOL, V94, p37S, DOI 10.1046/j.1365-2672.94.s1.5.x; INH, 2009, ET PHLEB NIV PROV ER; Kassiri H., 2012, ASIAN PAC J TROP DIS, V2, P382; KUBBA R, 1988, INT J DERMATOL, V27, P702, DOI 10.1111/j.1365-4362.1988.tb01268.x; LANE RP, 1991, ANN SOC BELG MED TR, V71, P65; Lindsey T, 2004, J ANAL TOXICOL, V28, P135, DOI 10.1093/jat/28.2.135; Louzir H, 2013, M S-MED SCI, V29, P1151, DOI 10.1051/medsci/20132912020; Mascari TM, 2013, PESTIC BIOCHEM PHYS, V106, P113, DOI 10.1016/j.pestbp.2013.04.006; Masmoudi A, 2013, J DERMATOL CASE REP, V7, P31, DOI 10.3315/jdcr.2013.1135; Mili AF, 2012, RETROSPECTIVE ANAL L; Motazedian MH, 2006, ARCH CLIN INFECT DIS, V1, P137; Mouttaki T, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-420; Okwor I, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00128; Postigo JAR, 2010, INT J ANTIMICROB AG, V36, pS62, DOI 10.1016/j.ijantimicag.2010.06.023; Pratlong F, 2009, TROP MED INT HEALTH, V14, P1071, DOI 10.1111/j.1365-3156.2009.02336.x; Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8; Rhajaoui M, 2011, PATHOL BIOL, V59, P226, DOI 10.1016/j.patbio.2009.09.003; RIOUX JA, 1982, CR ACAD SCI III-VIE, V294, P515; Riyad M, 2013, E MEDITERR HEALTH J, V19, P495; SAFJANOVA VM, 1971, B WORLD HEALTH ORGAN, V44, P561; Sharma U, 2009, INDIAN J EXP BIOL, V47, P412; Tlamcani Zineb, 2014, Turkiye Parazitoloji Dergisi, V38, P5, DOI 10.5152/tpd.2014.1401; Toumi A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001633; World Health Organization, 1988, GUID LEISHM CONTR RE; Yaghoobi-Ershadi MR, 2000, ANN SAUDI MED, V20, P386, DOI 10.5144/0256-4947.2000.386; YAGHOOBIERSHADI MR, 2001, MED J IR IRAN, V15, P175; ZAIME A, 1989, REV ECOL-TERRE VIE, V44, P153	41	10	10	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2015	20	10					1297	1305		10.1111/tmi.12543				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7DR	WOS:000360763600006	25975767	Bronze			2019-04-02	
J	Kure, A; Mekonnen, Z; Dana, D; Bajiro, M; Ayana, M; Vercruysse, J; Levecke, B				Kure, Ashenafi; Mekonnen, Zeleke; Dana, Daniel; Bajiro, Mitiku; Ayana, Mio; Vercruysse, Jozef; Levecke, Bruno			Comparison of individual and pooled stool samples for the assessment of intensity of Schistosoma mansoni and soil-transmitted helminth infections using the Kato-Katz technique	PARASITES & VECTORS			English	Article						Soil-transmitted helminths; Schistosoma mansoni; Infection intensity; Pooled samples; Mass drug administration; Cost-effectiveness	NEGLECTED TROPICAL DISEASES; DRUG EFFICACY; FECAL SAMPLES; SENSITIVITY; PREVALENCE; MCMASTER; FLOTAC; FECES; SHEEP; EGGS	Background: Our group has recently provided a proof-of-principle for the examination of pooled stool samples using McMaster technique as a strategy for the rapid assessment of intensity of soil-transmitted helminth infections (STH, Ascaris lumbricoides, Trichuris trichiura and hookworm). In the present study we evaluated this pooling strategy for the assessment of intensity of both STH and Schistosoma mansoni infections using the Kato-Katz technique. Methods: A cross-sectional survey was conducted in 360 children aged 5-18 years from six schools in Jimma Zone (southwest Ethiopia). We performed faecal egg counts (FECs) in both individual and pooled samples (pools sizes of 5, 10 and 20) to estimate the number of eggs per gram of stool (EPG) using the Kato-Katz technique. We also assessed the time to screen both individual and pooled samples. Results: Except for hookworms, there was a significant correlation (correlation coefficient = 0.53-0.95) between the mean of individual FECs and the FECs of pooled samples for A. lumbricoides, T. trichiura and S. mansoni, regardless of the pool size. Mean FEC were 2,596 EPG, 125 EPG, 47 EPG, and 41 EPG for A. lumbricoides, T. trichiura, S. mansoni and hookworm, respectively. There was no significant difference in FECs between the examination of individual and pooled stool samples, except for hookworms. For this STH, pools of 10 resulted in a significant underestimation of infection intensity. The total time to obtain individual FECs was 65 h 5 min. For pooled FECs, this was 19 h 12 min for pools of 5, 14 h 39 min for pools of 10 and 12 h 42 min for pools of 20. Conclusions: The results indicate that pooling of stool sample holds also promise as a rapid assessment of infections intensity for STH and S. mansoni using the Kato-Katz technique. In this setting, the time in the laboratory was reduced by 70 % when pools of 5 instead of individual stool samples were screened.	[Kure, Ashenafi] Nations Nationalities & Peoples Reg State Hlth Bu, Publ Hlth Lab, Hawassa, Ethiopia; [Mekonnen, Zeleke; Dana, Daniel; Bajiro, Mitiku; Ayana, Mio] Jimma Univ, Dept Med Lab Sci & Pathol, Jimma, Ethiopia; [Vercruysse, Jozef; Levecke, Bruno] Univ Ghent, Dept Virol Parasitol & Immunol, Merelbeke, Belgium	Levecke, B (reprint author), Univ Ghent, Dept Virol Parasitol & Immunol, Merelbeke, Belgium.	bruno.levecke@ugent.be		Levecke, Bruno/0000-0001-8912-5595			Anderson R, 2012, LANCET, V379, P289, DOI 10.1016/S0140-6736(12)60120-2; BALDOCK FC, 1990, AUST VET J, V67, P165, DOI 10.1111/j.1751-0813.1990.tb07746.x; Brooker S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000779; Eysker M, 2008, VET PARASITOL, V151, P249, DOI 10.1016/j.vetpar.2007.10.008; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Hurlimann E, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001404; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Levecke B, ADV PARASITOL; Levecke B, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000366; Levecke B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001201; Mekonnen Z, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002189; Mitchell S, 2012, AM J TROP MED HYG, V87, P850, DOI 10.4269/ajtmh.2012.12-0216; Nikolay B, 2014, INT J PARASITOL, V44, P765, DOI 10.1016/j.ijpara.2014.05.009; NTD Partner Website, 2012, UN COMB NEGL TROP DI; Pullan RL, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-81; Richardson DJ, 2006, COMP PARASITOL, V75, P339; Rinaldi L, 2014, VET PARASITOL, V205, P216, DOI 10.1016/j.vetpar.2014.06.011; Speich B, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-71; Speybroeck N, 2012, MED VET ENTOMOL, V26, P361, DOI 10.1111/j.1365-2915.2012.01015.x; Ward MP, 1997, VET PARASITOL, V73, P181, DOI 10.1016/S0304-4017(97)00060-5; WHO, 2011, HELMINTH CONTROL IN SCHOOL-AGE CHILDREN: A GUIDE FOR MANAGERS OF CONTROL PROGRAMMES, SECOND EDITION, P1; WHO, 2013, WEEK EPIDEMIOL REC, V90, P25; WHO, 2013, WEEK EPIDEMIOL REC, V90, P89; World Health Organization, 2012, ACC WORK OV GLOB IMP; World Health Organization, 2012, SOIL TRANSM HELM EL; World Health Organization (WHO), 1991, BAS LAB METH MED PAR; Yap P, 2012, JOVE-J VIS EXP, V66, pe3966, DOI DOI 10.3791/3966	27	12	12	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	SEP 24	2015	8								489	10.1186/s13071-015-1101-1				9	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CR8GS	WOS:000361589700001	26400064	DOAJ Gold, Green Published			2019-04-02	
J	Abdulla, S; Ashley, EA; Bassat, Q; Bethell, D; Bjorkman, A; Borrmann, S; D'Alessandro, U; Dahal, P; Day, NP; Diakite, M; Djimde, AA; Dondorp, AM; Duong, S; Edstein, MD; Fairhurst, RM; Faiz, MA; Falade, C; Flegg, JA; Fogg, C; Gonzalez, R; Greenwood, B; Guerin, PJ; Guthmann, JP; Hamed, K; Hien, TT; Htut, Y; Juma, E; Lim, P; Martensson, A; Mayxay, M; Mokuolu, OA; Moreira, C; Newton, P; Noedl, H; Nosten, F; Ogutu, BR; Onyamboko, MA; Owusu-Agyei, S; Phyo, AP; Premji, Z; Price, RN; Pukrittayakamee, S; Ramharter, M; Sagara, I; Se, Y; Suon, S; Stepniewska, K; Ward, SA; White, NJ; Winstanley, PA				Abdulla, Salim; Ashley, Elizabeth A.; Bassat, Quique; Bethell, Delia; Bjorkman, Anders; Borrmann, Steffen; D'Alessandro, Umberto; Dahal, Prabin; Day, Nicholas P.; Diakite, Mahamadou; Djimde, Abdoulaye A.; Dondorp, Arjen M.; Duong, Socheat; Edstein, Michael D.; Fairhurst, Rick M.; Faiz, M. Abul; Falade, Catherine; Flegg, Jennifer A.; Fogg, Carole; Gonzalez, Raquel; Greenwood, Brian; Guerin, Philippe J.; Guthmann, Jean-Paul; Hamed, Kamal; Tran Tinh Hien; Htut, Ye; Juma, Elizabeth; Lim, Pharath; Martensson, Andreas; Mayxay, Mayfong; Mokuolu, Olugbenga A.; Moreira, Clarissa; Newton, Paul; Noedl, Harald; Nosten, Francois; Ogutu, Bernhards R.; Onyamboko, Marie A.; Owusu-Agyei, Seth; Phyo, Aung Pyae; Premji, Zul; Price, Ric N.; Pukrittayakamee, Sasithon; Ramharter, Michael; Sagara, Issaka; Se, Youry; Suon, Seila; Stepniewska, Kasia; Ward, Stephen A.; White, Nicholas J.; Winstanley, Peter A.		WWARN Parasite Clearance Study Grp	Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis	MALARIA JOURNAL			English	Article						Malaria; Parasite clearance; Artemisinin resistance; Drug resistance; Plasmodium falciparum	RESISTANT PLASMODIUM-FALCIPARUM; ARTEMETHER-LUMEFANTRINE; UNCOMPLICATED MALARIA; WESTERN CAMBODIA; ORAL ARTESUNATE; AFRICAN INFANTS; SOUTHEAST-ASIA; NO EVIDENCE; CHILDREN; EFFICACY	Background: Artemisinin resistance in Plasmodium falciparum manifests as slow parasite clearance but this measure is also influenced by host immunity, initial parasite biomass and partner drug efficacy. This study collated data from clinical trials of artemisinin derivatives in falciparum malaria with frequent parasite counts to provide reference parasite clearance estimates stratified by location, treatment and time, to examine host factors affecting parasite clearance, and to assess the relationships between parasite clearance and risk of recrudescence during follow-up. Methods: Data from 24 studies, conducted from 1996 to 2013, with frequent parasite counts were pooled. Parasite clearance half-life (PC1/2) was estimated using the WWARN Parasite Clearance Estimator. Random effects regression models accounting for study and site heterogeneity were used to explore factors affecting PC1/2 and risk of recrudescence within areas with reported delayed parasite clearance (western Cambodia, western Thailand after 2000, southern Vietnam, southern Myanmar) and in all other areas where parasite populations are artemisinin sensitive. Results: PC1/2 was estimated in 6975 patients, 3288 of whom also had treatment outcomes evaluate d during 28-63 days follow-up, with 93 (2.8 %) PCR-confirmed recrudescences. In areas with artemisinin-sensitive parasites, the median PC1/2 following three-day artesunate treatment (4 mg/kg/day) ranged from 1.8 to 3.0 h and the proportion of patients with PC1/2 > 5 h from 0 to 10 %. Artesunate doses of 4 mg/kg/day decreased PC1/2 by 8.1 % (95 % CI 3.2-12.6) compared to 2 mg/kg/day, except in populations with delayed parasite clearance. PC1/2 was longer in children and in patients with fever or anaemia at enrolment. Long PC1/2 (HR = 2.91, 95 % CI 1.95-4.34 for twofold increase, p < 0.001) and high initial parasitaemia (HR = 2.23, 95 % CI 1.44-3.45 for tenfold increase, p < 0.001) were associated independently with an increased risk of recrudescence. In western Cambodia, the region with the highest prevalence of artemisinin resistance, there was no evidence for increasing PC1/2 since 2007. Conclusions: Several factors affect PC1/2. As substantial heterogeneity in parasite clearance exists between locations, early detection of artemisinin resistance requires reference PC1/2 data. Studies with frequent parasite count measurements to characterize PC1/2 should be encouraged. In western Cambodia, where PC1/2 values are longest, there is no evidence for recent emergence of higher levels of artemisinin resistance.	[Abdulla, Salim] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Ashley, Elizabeth A.; Dahal, Prabin; Day, Nicholas P.; Dondorp, Arjen M.; Guerin, Philippe J.; Tran Tinh Hien; Mayxay, Mayfong; Moreira, Clarissa; Newton, Paul; Nosten, Francois; Onyamboko, Marie A.; Price, Ric N.; Stepniewska, Kasia; White, Nicholas J.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England; [Ashley, Elizabeth A.; Day, Nicholas P.; Dondorp, Arjen M.; White, Nicholas J.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit MORU, Fac Trop Med, Bangkok 10700, Thailand; [Bassat, Quique] Univ Barcelona, Ctr Invest Saude Manhica Manhica Mozamb & ISGloba, Barcelona Ctr Int Hlth Res CRESIB, Hosp Clin, Barcelona, Spain; [Bethell, Delia] AFRIMS, Dept Immunol & Med, Bangkok, Thailand; [Bjorkman, Anders] Karolinska Inst, Dept Microbiol Tumour & Cell Biol, Malaria Res, Stockholm, Sweden; [Borrmann, Steffen] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya; [Borrmann, Steffen] Univ Magdeburg, Sch Med, D-39106 Magdeburg, Germany; [D'Alessandro, Umberto] Inst Trop Med, Unit Malariol, B-2000 Antwerp, Belgium; [D'Alessandro, Umberto] MRC Unit, Fajara, Gambia; [Dahal, Prabin; Guerin, Philippe J.; Moreira, Clarissa; Price, Ric N.; Stepniewska, Kasia] WorldWide Antimalarial Resistance Network WWARN, Oxford, England; [Diakite, Mahamadou] Univ Bamako, Malaria Res & Training Ctr, Bamako, Mali; [Duong, Socheat] Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Fairhurst, Rick M.; Lim, Pharath] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Faiz, M. Abul] Malaria Res Grp MRG & Dev Care Fdn, Dhaka, Bangladesh; [Falade, Catherine] Univ Ibadan, Coll Med, Ibadan, Nigeria; [Flegg, Jennifer A.] Monash Univ, Sch Math Sci, Clayton, Vic 3800, Australia; [Fogg, Carole] Univ Portsmouth, Portsmouth, Hants, England; [Gonzalez, Raquel] Ctr Invest Saude Manhica Manhica Mozamb, Barcelona, Spain; [Gonzalez, Raquel] CRESIB, Barcelona, Spain; [Greenwood, Brian] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Guthmann, Jean-Paul] Epicentre, Paris, France; [Hamed, Kamal] Novartis Pharmaceut, E Hanover, NJ USA; [Tran Tinh Hien] OUCRU, Wellcome Trust Major Overseas Programme MOP, Ho Chi Minh City, Vietnam; [Htut, Ye] Dept Med Res, Lower Myanmar, Yangon, Myanmar; [Juma, Elizabeth] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Lim, Pharath] US & Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Martensson, Andreas] Karolinska Inst, Dept Microbiol Cell & Tumour Biol, Dept Publ Hlth Sci, Malaria Res, Stockholm, Sweden; [Martensson, Andreas] Uppsala Univ, Ctr Clin Res Sormland, Uppsala, Sweden; [Mayxay, Mayfong; Newton, Paul] Mahosot Hosp, Lao Oxford Mahosot Hosp, Wellcome Trust Res Unit LOMWRU, Viangchan, Laos; [Mayxay, Mayfong] Univ Hlth Sci, Fac Postgrad Studies, Viangchan, Laos; [Mokuolu, Olugbenga A.] Univ Ilorin, Dept Paediat & Child Hlth, Ilorin, Nigeria; [Noedl, Harald] Med Univ Vienna, Inst Specif Prophylaxis & Trop Med, Vienna, Austria; [Nosten, Francois; Phyo, Aung Pyae] Mahidol Univ, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Fac Trop Med, Bangkok 10700, Thailand; [Ogutu, Bernhards R.] Kenya Govt Med Res Ctr, US Army Med Res Unit, Kisumu, Kenya; [Onyamboko, Marie A.] Kinshasa Sch Publ Hlth, Kinshasa, DEM REP CONGO; [Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, Kintampo, Ghana; [Premji, Zul] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Price, Ric N.] Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia; [Price, Ric N.] Charles Darwin Univ, Darwin, NT 0909, Australia; [Pukrittayakamee, Sasithon] Mahidol Univ, Fac Trop Med, Bangkok 10700, Thailand; [Ramharter, Michael] Med Univ Vienna, Div Infect Dis & Trop Med, Dept Med 1, Vienna, Austria; [Ramharter, Michael] Univ Tubingen, Inst Tropenmed, Tubingen, Germany; [Ramharter, Michael] Ctr Rech Med Lambarene, Lambarene, Gabon; [Sagara, Issaka] Univ Bamako, Fac Med Pharm & Odontostomatol, Dept Epidemiol Parasit Dis, Malaria Res & Training Ctr, Bamako, Mali; [Se, Youry] AFRIMS, Phnom Penh, Cambodia; [Suon, Seila] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Ward, Stephen A.] Univ Liverpool, Liverpool Sch Trop Med, Dept Parasitol, Liverpool L3 5QA, Merseyside, England; [Winstanley, Peter A.] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England	Abdulla, S (reprint author), Ifakara Hlth Inst, Dar Es Salaam, Tanzania.	sabdulla@ihi.or.tz; liz@tropmedres.ac; quique.bassat@isglobal.org; deliabethell@btinternet.com; anders.bjorkman@ki.se; sborrmann@kilifi.kemri-wellcome.org; udalessandro@mrc.gm; prabin.dahal@wwarn.org; nickd@tropmedres.ac; mdiakite@icermali.org; adjimde@icermali.org; arjen@tropmedres.ac; d_socheat@yahoo.com; Mike.Edstein@defence.gov.au; rfairhurst@niaid.nih.gov; drmafaiz@gmail.com; lillyfunke@yahoo.com; jennifer.flegg@monash.edu; carole.fogg@port.ac.uk; raquel.gonzalez@cresib.cat; brian.greenwood@lshtm.ac.uk; philippe.guerin@wwarn.org; jp.guthmann@invs.sante.fr; kamal.hamed@novartis.com; hientt@oucru.org; dr.y.htut@gmail.com; jumaelizabeth@yahoo.com; limp@niaid.nih.gov; andreas.martensson@ki.se; mayfong@tropmedres.ac; oamokuolu@yahoo.com; clarissa.moreira@wwarn.org; paul@tropmedres.ac; harald.noedl@meduniwien.ac.at; francois@tropmedres.ac; bernhards.ogutu@usamru-k.org; akatshimarie@yahoo.fr; owusu-agyei@kintampo-hrc.org; aungpyaephyo@shoklo-unit.com; zulpremji688@gmail.com; ric.price@wwarn.org; yon@tropmedres.ac; michael.ramharter@meduniwien.ac.at; isagara@mrtcbko.org; suon_seila012@yahoo.com; kasia.stepniewska@wwarn.org; saward@liverpool.ac.uk; nickwdt@tropmedres.ac; P.Winstanley@warwick.ac.uk	Ward, Steve/G-6003-2015; Bassat, Quique/P-2341-2016	Ward, Steve/0000-0003-2331-3192; Bassat, Quique/0000-0003-0875-7596; Nosten, Francois/0000-0002-7951-0745; Dahal, Prabin/0000-0002-2158-846X; Guerin, Philippe/0000-0002-6008-2963; Flegg, Jennifer/0000-0002-8809-726X; Ramharter, Michael/0000-0002-9259-1885; Lim, Pharath/0000-0002-1012-2461; Price, Richard/0000-0003-2000-2874; Moreira, Clarissa/0000-0001-9287-735X	Bill and Melinda Gates Foundation; NIAID, NIH	We thank the patients and staff who participated in the clinical trials at all sites. WWARN is funded by a Bill and Melinda Gates Foundation grant. The funder did not participate in developing the protocol or writing the paper. This study was supported in part by the Intramural Research Program of the NIAID, NIH. All clinical studies were approved by the respective ethics committees or institutional review boards of each collaborative entity and host country of conduct. All subjects provided informed consent before study participation, and parents or legal guardians provided informed consent on behalf of their children. Disclaimer: The opinions expressed are those of the authors and do not necessarily reflect those of the Australian Defence Organisation or any extant policy.	Abdulla S, 2008, LANCET, V372, P1819, DOI 10.1016/S0140-6736(08)61492-0; Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; [Anonymous], 2013, WORLD MAN REP 2013; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Bethell D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019283; Borrmann S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026005; Bouyou-Akotet MK, 2010, WIEN KLIN WOCHENSCHR, V122, P173, DOI 10.1007/s00508-010-1317-1; Chotivanich K, 2014, ANTIMICROB AGENTS CH, V58, P3157, DOI 10.1128/AAC.01924-13; Das D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-125; Das Debashish, 2013, Clin Infect Dis, V56, pe48, DOI 10.1093/cid/cis958; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Falade C, 2005, T ROY SOC TROP MED H, V99, P459, DOI 10.1016/j.trstmh.2004.09.013; Flegg JA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-411; Flegg JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-339; Fogg C, 2008, T ROY SOC TROP MED H, V102, P25, DOI 10.1016/j.trstmh.2007.09.014; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Glidden DV, 2004, STAT MED, V23, P369, DOI 10.1002/sim.1599; Hien TT, 1996, NEW ENGL J MED, V335, P76, DOI 10.1056/NEJM199607113350202; Hietala SF, 2010, ANTIMICROB AGENTS CH, V54, P4780, DOI 10.1128/AAC.00252-10; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; KWIATKOWSKI D, 1989, CLIN EXP IMMUNOL, V77, P361; Kyaw MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057689; Lee SJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-149; Lefevre G, 2001, AM J TROP MED HYG, V64, P247, DOI 10.4269/ajtmh.2001.64.247; Lopera-Mesa TM, 2013, J INFECT DIS, V207, P1655, DOI 10.1093/infdis/jit082; Maiga AW, 2012, AM J TROP MED HYG, V87, P23, DOI 10.4269/ajtmh.2012.12-0058; Mayxay M, 2012, AM J TROP MED HYG, V86, P403, DOI 10.4269/ajtmh.2012.11-0497; Muhindo MK, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-32; Thanh NX, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-217; Noedl H, 2010, CLIN INFECT DIS, V51, pE82, DOI 10.1086/657120; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Owusu-Agyei S, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0007302, 10.1371/journal.pone.0006682]; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Starzengruber P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052236; Suputtamongkol Y, 2001, BRIT J CLIN PHARMACO, V52, P655, DOI 10.1046/j.1365-2125.2001.01458.x; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; Hien TT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-355; Udomsangpetch R, 2002, P NATL ACAD SCI USA, V99, P11825, DOI 10.1073/pnas.172398999; van Vugt M, 1999, AM J TROP MED HYG, V60, P936, DOI 10.4269/ajtmh.1999.60.936; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-278; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA, P312; Witkowski B, 2013, LANCET INFECT DIS, V13, P1043, DOI 10.1016/S1473-3099(13)70252-4; World Health Organization (WHO), 2009, METH SURV ANT DRUG E	45	13	13	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	SEP 22	2015	14								359	10.1186/s12936-015-0874-1				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CR6AW	WOS:000361426500001	26390866	DOAJ Gold, Green Published			2019-04-02	
J	Mvumbi, DM; Kayembe, JM; Situakibanza, H; Bobanga, TL; Nsibu, CN; Mvumbi, GL; Melin, P; De Mol, P; Hayette, MP				Mvumbi, Dieudonne Makaba; Kayembe, Jean-Marie; Situakibanza, Hippolyte; Bobanga, Thierry L.; Nsibu, Celestin N.; Mvumbi, Georges L.; Melin, Pierrette; De Mol, Patrick; Hayette, Marie-Pierre			Falciparum malaria molecular drug resistance in the Democratic Republic of Congo: a systematic review	MALARIA JOURNAL			English	Article						Malaria; DR Congo; Molecular; Drug resistance	SUB-SAHARAN AFRICA; PLASMODIUM-FALCIPARUM; SULFADOXINE-PYRIMETHAMINE; CHLOROQUINE-RESISTANCE; ARTEMISININ RESISTANCE; PFCRT; MUTATIONS; HAPLOTYPES; GENE; SUSCEPTIBILITY	Background: Malaria cases were estimated to 207 million in 2013. One of the problems of malaria control is the emergence and spread of Plasmodium falciparum strains that become resistant to almost all drugs available. Monitoring drug resistance is essential for early detection and subsequent prevention of the spread of drug resistance by timely changes of treatment policy. This review was performed to gather all data available on P. falciparum molecular resistance in DR Congo, as baseline for future assessments. Methods: The search for this review was undertaken using the electronic databases PubMed and Google Scholar using the terms "malaria", "Congo", "resistance", "molecular", "antimalarial", "efficacy". Articles were classified based on year of collecting, year of publication, sample size and characteristics, molecular markers analysed and polymorphisms detected. Results: Thirteen articles were included and five genes have been analysed in these studies: pfcrt, pfdhps, pfdhfr, pfmdr1 and K13-propeller. The majority of studies included were not representative of the whole country. Conclusion: This systematic review demonstrates the lack of molecular resistance studies in DRC. Only 13 studies were identified in almost 15 years. The MOH must implement a national surveillance system for monitoring malaria drug resistance and this surveillance should be conducted frequently and country-representative.	[Mvumbi, Dieudonne Makaba; Mvumbi, Georges L.] Univ Kinshasa, Sch Med, Dept Basic Sci, Biochem & Mol Biol Unit, Kinshasa, DEM REP CONGO; [Kayembe, Jean-Marie] Univ Kinshasa, Sch Med, Dept Internal Med, Kinshasa, DEM REP CONGO; [Situakibanza, Hippolyte; Bobanga, Thierry L.] Univ Kinshasa, Sch Med, Dept Trop Med & Infect Dis, Kinshasa, DEM REP CONGO; [Nsibu, Celestin N.] Univ Kinshasa, Sch Med, Dept Paediat, Kinshasa, DEM REP CONGO; [Melin, Pierrette; De Mol, Patrick; Hayette, Marie-Pierre] Univ Hosp Liege, Dept Clin Microbiol, Liege, Belgium	Mvumbi, DM (reprint author), Univ Kinshasa, Sch Med, Dept Basic Sci, Biochem & Mol Biol Unit, Kinshasa, DEM REP CONGO.	didimvumbi@gmail.com		Melin, Pierrette/0000-0002-2159-5774			Alifrangis M, 2006, J INFECT DIS, V193, P1738, DOI 10.1086/504269; Alker AP, 2008, TROP MED INT HEALTH, V13, P1384, DOI 10.1111/j.1365-3156.2008.02150.x; Andriantsoanirina V, 2010, AM J TROP MED HYG, V82, P782, DOI 10.4269/ajtmh.2010.09-0327; Antonia AL, 2014, AM J TROP MED HYG, V90, P1094, DOI 10.4269/ajtmh.13-0378; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Beshir K, 2010, ANTIMICROB AGENTS CH, V54, P3714, DOI 10.1128/AAC.00358-10; Chavchich M, 2010, ANTIMICROB AGENTS CH, V54, P2455, DOI 10.1128/AAC.00947-09; Cohuet S, 2006, AM J TROP MED HYG, V75, P152, DOI 10.4269/ajtmh.2006.75.152; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(00)00084-8; Gama BE, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-174; Juliao PC, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-344; Kamau E, 2015, J INFECT DIS, V211, P1352, DOI 10.1093/infdis/jiu608; Kazadi WM, 2003, TROP MED INT HEALTH, V8, P868, DOI 10.1046/j.1365-3156.2003.01098.x; Kim H S, 2001, Nucleic Acids Res Suppl, P231; Kyaw MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057689; Mobula L, 2009, AM J TROP MED HYG, V80, P555, DOI 10.4269/ajtmh.2009.80.555; Mvumbi DM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-459; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; PETERSON DS, 1988, P NATL ACAD SCI USA, V85, P9114, DOI 10.1073/pnas.85.23.9114; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Severini C, 2006, INFECT GENET EVOL, V6, P262, DOI 10.1016/j.meegid.2005.07.002; Sidhu ABS, 2006, J INFECT DIS, V194, P528, DOI 10.1086/507115; Sisowath C, 2007, TROP MED INT HEALTH, V12, P736, DOI 10.1111/j.1365-3156.2007.01843.x; Swarthout TD, 2006, TROP MED INT HEALTH, V11, P1503, DOI 10.1111/j.1365-3156.2006.01710.x; Taylor SM, 2015, J INFECT DIS, V211, P680, DOI 10.1093/infdis/jiu467; Taylor SM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01165; Wang P, 1997, MOL MICROBIOL, V23, P979, DOI 10.1046/j.1365-2958.1997.2821646.x; Wellems TE, 2001, J INFECT DIS, V184, P770, DOI 10.1086/322858; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2001, ANT DRUG COMB THER R; WHO, 2003, WHOHTMRBM200350; Wilson PE, 2005, ACTA TROP, V93, P97, DOI 10.1016/j.actatropica.2004.09.010; World Health Organization (WHO), 2001, SURV RES ANT RAPP CO; World Health Organization (WHO), 2010, GLOB REP ANT DRUG EF	35	11	11	0	14	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	SEP 17	2015	14								354	10.1186/s12936-015-0892-z				6	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CR5DB	WOS:000361358800010	26376639	DOAJ Gold, Green Published			2019-04-02	
J	Habtewold, T; Groom, Z; Duchateau, L; Christophides, GK				Habtewold, Tibebu; Groom, Zoe; Duchateau, Luc; Christophides, George K.			Detection of viable plasmodium ookinetes in the midguts of anopheles coluzzi using PMA-qrtPCR	PARASITES & VECTORS			English	Article						Anopheles coluzzii; Propidium monoazide; Plasmodium; Midgut invasion; Commensal microbiota	REAL-TIME PCR; REVERSE-TRANSCRIPTION PCR; POLYMERASE-CHAIN-REACTION; PROPIDIUM MONOAZIDE; MESSENGER-RNA; ETHIDIUM MONOAZIDE; DEAD CELLS; MYCOBACTERIUM-TUBERCULOSIS; PHYTOPHTHORA-RAMORUM; MALARIA PARASITE	Background: Mosquito infection with malaria parasites depends on complex interactions between the mosquito immune response, the parasite developmental program and the midgut microbiota. Simultaneous monitoring of the parasite and bacterial dynamics is important when studying these interactions. PCR based methods of genomic DNA (gDNA) have been widely used, but their inability to discriminate between live and dead cells compromises their application. The alternative method of quantification of mRNA mainly reports on cell activity rather than density. Method: Quantitative real-time (qrt) PCR in combination with Propidium Monoazide (PMA) treatment (PMA-qrtPCR) has been previously used for selectively enumerating viable microbial cells. PMA penetrates damaged cell membranes and intercalates in the DNA inhibiting its PCR amplification. Here, we tested the potential of PMA-qrtPCR to discriminate between and quantify live and dead Plasmodium berghei malarial parasites and commensal bacteria in the midgut of Anopheles coluzzii Coetzee & Wilkerson 2013 (formerly An. gambiae M-form). Results: By combining microscopic observations with reverse transcriptase PCR (RT-PCR) we reveal that, in addition to gDNA, mRNA from dead parasites also persists inside the mosquito midgut, therefore its quantification cannot accurately reflect live-only parasites at the time of monitoring. In contrast, pre-treating the samples with PMA selectively inhibited qrtPCR amplification of parasite gDNA, with about 15 cycles (Ct-value) difference between PMA-treated and control samples. The limit of detection corresponds to 10 Plasmodium ookinetes. Finally, we show that the PMA-qrtPCR method can be used to quantify bacteria that are present in the mosquito midgut. Conclusion: The PMA-qrtPCR is a suitable method for quantification of viable parasites and bacteria in the midgut of Anopheles mosquitoes. The method will be valuable when studying the molecular interactions between the mosquito, the malaria parasite and midgut microbiota.	[Habtewold, Tibebu; Groom, Zoe; Christophides, George K.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England; [Habtewold, Tibebu; Duchateau, Luc] Univ Ghent, Dept Comparat Physiol & Biometr, B-9000 Ghent, Belgium; [Groom, Zoe] Costello Med Consulting, Cambridge, England	Habtewold, T (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England.	t.habtewold@ic.ac.uk		Christophides, George/0000-0002-3323-1687	Wellcome Trust [WT093587MA]; BBSRC Project [BB/K009338/1]; Biotechnology and Biological Sciences Research Council [BB/K009338/1]	We thank Katarzyna Sala for technical support and Valerie Ukegbu for supply of parasite cultures. The work was supported through grants by the Wellcome Trust, WT093587MA and the BBSRC Project BB/K009338/1.	Alavi Y, 2003, INT J PARASITOL, V33, P933, DOI 10.1016/S0020-7519(03)00112-7; ALIFANO P, 1994, GENETICA, V94, P157, DOI 10.1007/BF01443430; Alvarez G, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-1; Banihashemi A, 2012, J APPL MICROBIOL, V113, P863, DOI 10.1111/j.1365-2672.2012.05382.x; Bourgeois N, 2010, CLIN MICROBIOL INFEC, V16, P1305, DOI 10.1111/j.1469-0691.2009.02933.x; Brescia CC, 2009, APPL ENVIRON MICROB, V75, P6856, DOI 10.1128/AEM.00540-09; Cenciarini-Borde C, 2009, FUTURE MICROBIOL, V4, P45, DOI 10.2217/17460913.4.1.45; Chang B, 2010, JPN J INFECT DIS, V63, P119; Chimento A, 2012, FOREST PATHOL, V42, P14, DOI 10.1111/j.1439-0329.2011.00717.x; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; Dessens JT, 2003, MOL MICROBIOL, V49, P319, DOI 10.1046/j.1365-2958.2003.03566.x; Dong YM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002458; Farcas GA, 2006, CLIN INFECT DIS, V42, P622, DOI 10.1086/500134; Fittipaldi M, 2011, J EUKARYOT MICROBIOL, V58, P359, DOI 10.1111/j.1550-7408.2011.00557.x; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Garver LS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002737; Gendrin M, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P525, DOI 10.5772/55107; Ghosh A, 2000, PARASITOL TODAY, V16, P196, DOI 10.1016/S0169-4758(99)01626-9; Habtewold T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000070; Hellyer TJ, 1999, J CLIN MICROBIOL, V37, P290; Hellyer TJ, 1999, J CLIN MICROBIOL, V37, P518; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Li BG, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-273; Liang NJ, 2011, J FOOD SCI, V76, pM234, DOI 10.1111/j.1750-3841.2011.02123.x; Luckhart S, 1998, P NATL ACAD SCI USA, V95, P5700, DOI 10.1073/pnas.95.10.5700; Mendum TA, 1998, FEMS MICROBIOL LETT, V164, P369, DOI 10.1016/S0378-1097(98)00241-9; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Nocker A, 2007, APPL ENVIRON MICROB, V73, P5111, DOI 10.1128/AEM.02987-06; Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015; Nocker A, 2010, INT MICROBIOL, V13, P59, DOI 10.2436/20.1501.01.111; Oakley MSM, 2007, INFECT IMMUN, V75, P2012, DOI 10.1128/IAI.01236-06; Ono T, 2007, EXP PARASITOL, V115, P310, DOI 10.1016/j.exppara.2006.09.008; Pan Y, 2007, APPL ENVIRON MICROB, V73, P8028, DOI 10.1128/AEM.01198-07; Postollec F, 2011, FOOD MICROBIOL, V28, P848, DOI 10.1016/j.fm.2011.02.008; Rogers GB, 2013, ISME J, V7, P697, DOI 10.1038/ismej.2012.145; Saadati N, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-63; Sheridan GEC, 1998, APPL ENVIRON MICROB, V64, P1313; Taskin B, 2011, APPL ENVIRON MICROB, V77, P4329, DOI 10.1128/AEM.02895-10; Uyttendaele M, 1999, INT J FOOD MICROBIOL, V52, P85, DOI 10.1016/S0168-1605(99)00132-4; VAUGHAN JA, 1992, J PARASITOL, V78, P716, DOI 10.2307/3283550; VAUGHAN JA, 1994, J PARASITOL, V80, P674, DOI 10.2307/3283245; Vesper S, 2008, J MICROBIOL METH, V72, P180, DOI 10.1016/j.mimet.2007.11.017; Vettraino AM, 2010, PLANT PATHOL, V59, P289, DOI 10.1111/j.1365-3059.2009.02209.x; Wagner AO, 2008, APPL ENVIRON MICROB, V74, P2537, DOI 10.1128/AEM.02288-07; Weiss B, 2011, TRENDS PARASITOL, V27, P514, DOI 10.1016/j.pt.2011.05.001; Yasunaga A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-157	47	2	2	3	10	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	SEP 15	2015	8								455	10.1186/s13071-015-1087-8				10	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CR6KO	WOS:000361455900003	26373633	DOAJ Gold, Green Published			2019-04-02	
J	Kerkhof, K; Canier, L; Kim, S; Heng, S; Sochantha, T; Sovannaroth, S; Vigan-Womas, I; Coosemans, M; Sluydts, V; Menard, D; Durnez, L				Kerkhof, Karen; Canier, Lydie; Kim, Saorin; Heng, Somony; Sochantha, Tho; Sovannaroth, Siv; Vigan-Womas, Ines; Coosemans, Marc; Sluydts, Vincent; Menard, Didier; Durnez, Lies			Implementation and application of a multiplex assay to detect malaria-specific antibodies: a promising tool for assessing malaria transmission in Southeast Asian pre-elimination areas	MALARIA JOURNAL			English	Article						Malaria; Serological markers; Multiplex immunoassay; Cambodia	PLASMODIUM-FALCIPARUM ANTIGENS; GLUTAMATE-RICH PROTEIN; SERUM ANTIBODIES; IMMUNOASSAY; VIVAX; INFECTION; DIAGNOSIS; EXPOSURE; CAMBODIA; VALIDATION	Background: Epidemiological surveillance is a key activity in malaria control and elimination in low-transmission and pre-elimination settings. Hence, sensitive tools for estimating malaria force of infection are crucial. Serological markers might provide additional information in estimating force of infection in low-endemic areas along with classical parasite detection methods. Serological markers can be used to estimate recent, past or present malaria exposure, depending on the used markers and their half-life. Methods: An assay based on 14 Plasmodium-specific peptides, one peptide specific for Anopheles gambiae saliva protein and five Plasmodium-specific recombinant proteins was developed for the MAGPIX system, assessed for its performance, and applied on blood spots from 2000 individuals collected in the Ratanakiri Province, Cambodia. Results: A significant correlation for the use of 1000 and 2000 beads/antigen/well as well as for the monoplex versus multiplex assay was observed for all antigens (p < 0.05). For the majority of antigens, antigen-coupled beads were stable for at least 2 months. The assay was very reproducible with limited intercoupling, interplate and intraplate variability (mean RSD < 15 %). Estimating seroconversion and seroreversion per antigen using reversible catalytic models and models allowing two seroconversion rates showed higher seroconversion rates in adults. Conclusion: The multiplex bead-based immunoassay was successfully implemented and analysis of field blood samples shows that changes detected in force of malaria infection vary according to the serological markers used. Multivariate analysis of the antibody responses and insights into the half-life of antibodies are crucial for improving the interpretation of these results and for identifying the most useful serological markers of past and recent malaria infection.	[Kerkhof, Karen; Coosemans, Marc; Sluydts, Vincent; Durnez, Lies] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Kerkhof, Karen; Coosemans, Marc] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium; [Canier, Lydie; Kim, Saorin; Menard, Didier] Inst Pasteur Cambodge, Mol Epidemiol Unit, Phnom Penh, Cambodia; [Heng, Somony; Sochantha, Tho; Sovannaroth, Siv] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Vigan-Womas, Ines] Inst Pasteur Madagascar, Infect Dis Immunol, Antananarivo, Madagascar; [Sluydts, Vincent] Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium	Kerkhof, K (reprint author), Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium.	kkerkhof@itg.be; ldurnez@itg.be	Ines, VIGAN-WOMAS/I-8604-2012; Ines, VIGAN-WOMAS/A-7846-2017; Menard, Didier/O-3294-2013	Ines, VIGAN-WOMAS/0000-0001-7848-9297; Ines, VIGAN-WOMAS/0000-0001-7848-9297; Menard, Didier/0000-0003-1357-4495	Bill and Melinda Gates Foundation under the Global Health Grant [OPP1032354]; VLIRUOS; association of Les Amis des Instituts Pasteur a Bruxelles	We would like to thank all colleagues at the ITM and IPC for all their support and contributions to fulfil this manuscript. We are extremely grateful that Odile Mercereau-Puijalon provided us recombinant proteins Pf13 and PvDBP. We would like to thank Chris Drakeley for providing recombinant proteins PvMSP1-19 and PfMSP1-19 and Takafumi Tsuboi for providing recombinant proteins PvAMA1 and PvCSP-chimera. Furthermore, we would like to thank Prof Alfredo Mayor for the valuable discussions about this topic. This work is part of a larger project on the evaluation of large use of tropical repellent in addition to insecticide treated nets in control malaria transmission. This work was funded by the Bill and Melinda Gates Foundation under the Global Health Grant number OPP1032354. KK was supported by the VLIRUOS and the association of Les Amis des Instituts Pasteur a Bruxelles.	Ambrosino E, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-317; Arnold BF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093684; Binnicker MJ, 2008, CLIN VACCINE IMMUNOL, V15, P1410, DOI 10.1128/CVI.00082-08; Bousema T, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-36; Canier L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-405; Cham GKK, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-108; Cheng Y, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-323; Cook J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-86; Cook J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-169; Corporation Luminex, 2012, DESCR OP LUM TECHN, P20; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Drakeley C, 2009, ADV PARASIT, V69, P299, DOI 10.1016/S0065-308X(09)69005-9; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Drummond JE, 2008, J IMMUNOL METHODS, V334, P11, DOI 10.1016/j.jim.2008.01.017; Dudoit S, 2005, STAT METHODOL, V2, P131, DOI [10.1016/j.stamet.2005.02.003, DOI 10.1016/J.STAMET.2005.02.003]; Elshal MF, 2006, METHODS, V38, P317, DOI 10.1016/j.ymeth.2005.11.010; Ferbas J, 2007, CLIN VACCINE IMMUNOL, V14, P1165, DOI 10.1128/CVI.00157-07; Fernandez-Becerra C, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-29; Fidock A, 1994, J IMMUNOL, V153, P190; Fouda GG, 2006, CLIN VACCINE IMMUNOL, V13, P1307, DOI 10.1128/CVI.00183-06; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Helb DA, 2015, P NATL ACAD SCI USA, V112, P4438; Henry-Halldin CN, 2011, INFECT GENET EVOL, V11, P391, DOI 10.1016/j.meegid.2010.11.010; Hens N, 2012, MODELING INFECT DIS; Khaireh BA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-395; Khim N, 2011, EMERG INFECT DIS, V17, P1900, DOI 10.3201/eid1710.110355; Lammie PJ, 2012, INT J PARASITOL, V42, P797, DOI 10.1016/j.ijpara.2012.07.002; Luminex Corporation, XMAP TECHN; Luminex Corporation, FUND ASS TECHN PROT; Luminex Corporation, 2011, XMAP ANT COUPL KIT U; Menard D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002489; Michel A, 2009, HELICOBACTER, V14, P525, DOI 10.1111/j.1523-5378.2009.00723.x; Muench H., 1959, CATALYTIC MODELS EPI; Noor AM, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-121; Ondigo BN, 2014, J INFECT DIS, V210, P1123, DOI 10.1093/infdis/jiu225; Ondigo BN, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-427; Poinsignon A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002472; R Core Team, 2014, R LANG ENV STAT COMP; Sarr JB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-212; Scholzen A, 2013, TRENDS PARASITOL, V29, P252, DOI 10.1016/j.pt.2013.03.002; She RC, 2007, J TRAVEL MED, V14, P105, DOI 10.1111/j.1708-8305.2006.00087.x; Sluydts V, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-387; Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083; Sutherland CJ, 2009, MOL BIOCHEM PARASIT, V166, P93, DOI 10.1016/j.molbiopara.2009.03.007; Tangpukdee N, 2009, KOREAN J PARASITOL, V47, P93, DOI 10.3347/kjp.2009.47.2.93; Taylor RR, 1996, INT IMMUNOL, V8, P905, DOI 10.1093/intimm/8.6.905; Theisen M, 2000, VACCINE, V19, P204, DOI 10.1016/S0264-410X(00)00181-X; THEISEN M, 1995, CLIN DIAGN LAB IMMUN, V2, P30; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; van Gageldonk PGM, 2008, J IMMUNOL METHODS, V335, P79, DOI 10.1016/j.jim.2008.02.018; Vigan-Womas I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016544; Voller A., 1964, Bulletin of the World Health Organization, V30, P343; von Fricken ME, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-361; Whelan C, 2008, CLIN VACCINE IMMUNOL, V15, P1834, DOI 10.1128/CVI.00238-08; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Zeyrek FY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028126	56	11	12	0	14	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	SEP 4	2015	14								338	10.1186/s12936-015-0868-z				14	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CQ3SZ	WOS:000360524100003	26337785	DOAJ Gold, Green Published			2019-04-02	
J	Belew, S; Getachew, M; Suleman, S; Mohammed, T; Deti, H; D'Hondt, M; Wynendaele, E; Mekonnen, Z; Vercruysse, J; Duchateau, L; De Spiegeleer, B; Levecke, B				Belew, Sileshi; Getachew, Mestawet; Suleman, Sultan; Mohammed, Tesfaye; Deti, Habetewold; D'Hondt, Matthias; Wynendaele, Evelien; Mekonnen, Zeleke; Vercruysse, Jozef; Duchateau, Luc; De Spiegeleer, Bart; Levecke, Bruno			Assessment of Efficacy and Quality of Two Albendazole Brands Commonly Used against Soil-Transmitted Helminth Infections in School Children in Jimma Town, Ethiopia	PLOS NEGLECTED TROPICAL DISEASES			English	Article							TRICHURIS-TRICHIURA; DRUG EFFICACY; IN-VITRO; MEBENDAZOLE; INTENSITY; VIVO	Background There is a worldwide upscale in mass drug administration (MDA) programs to control the morbidity caused by soil-transmitted helminths (STHs): Ascaris lumbricoides, Trichuris trichiura and hookworm. Although anthelminthic drugs which are used for MDA are supplied by two pharmaceutical companies through donation, there is a wide range of brands available on local markets for which the efficacy against STHs and quality remain poorly explored. In the present study, we evaluated the drug efficacy and quality of two albendazole brands (Bendex and Ovis) available on the local market in Ethiopia. Methodology/Principal Findings A randomized clinical trial was conducted according to the World Health Organization (WHO) guidelines to assess drug efficacy, by means of egg reduction rate (ERR), of Bendex and Ovis against STH infections in school children in Jimma, Ethiopia. In addition, the chemical and physicochemical quality of the drugs was assessed according to the United States and European Pharmacopoeia, encompassing mass uniformity of the tablets, amount of active compound and dissolution profile. Both drugs were highly efficacious against A. lumbricoides (>97%), but showed poor efficacy against T. trichiura (similar to 20%). For hookworms, Ovis was significantly (p < 0.05) more efficacious compared to Bendex (98.1% vs. 88.7%). Assessment of the physicochemical quality of the drugs revealed a significant difference in dissolution profile, with Bendex having a slower dissolution than Ovis. Conclusion/Significance The study revealed that differences in efficacy between the two brands of albendazole (ABZ) tablets against hookworm are linked to the differences in the in-vitro drug release profile. Differences in uptake and metabolism of this benzimidazole drug among different helminth species may explain that this efficacy difference was only observed in hookworms and not in the two other species. The results of the present study underscore the importance of assessing the chemical and physicochemical quality of drugs before conducting efficacy assessment in any clinical trials to ensure appropriate therapeutic efficacy and to exclude poor drug quality as a factor of reduced drug efficacy other than anthelminthic resistance. Overall, this paper demonstrates that "all medicines are not created equal".	[Belew, Sileshi; Suleman, Sultan; Mohammed, Tesfaye; Deti, Habetewold] Jimma Univ, Sch Pharm, Jimma, Ethiopia; [Belew, Sileshi; Suleman, Sultan; D'Hondt, Matthias; Wynendaele, Evelien; De Spiegeleer, Bart] Univ Ghent, Drug Qual & Registrat Grp, Dept Pharmaceut Anal, Fac Pharmaceut Sci, B-9000 Ghent, Belgium; [Getachew, Mestawet] Jimma Univ, Jimma Univ Specialized Hosp, Jimma, Ethiopia; [Mekonnen, Zeleke] Jimma Univ, Dept Med Lab Sci & Pathol, Jimma, Ethiopia; [Vercruysse, Jozef; Levecke, Bruno] Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, Merelbeke, Belgium; [Duchateau, Luc] Univ Ghent, Dept Comparat Physiol & Biometr, Fac Vet Med, Merelbeke, Belgium	Belew, S (reprint author), Jimma Univ, Sch Pharm, Jimma, Ethiopia.	Bart.Despiegeleer@UGent.be; Bruno.Levecke@UGent.be	De Spiegeleer, Bart/A-2001-2008	De Spiegeleer, Bart/0000-0001-6794-3108; Levecke, Bruno/0000-0001-8912-5595	F.W.O.-Vlaanderen [FWO12/PDO/099]; BOF (Special Research Fund) [01W03714, DOZA/ILDDC/AM/0866b-2014]	BL is a postdoctoral fellow of the Fund for Scientific Research-Flanders (Belgium) (F.W.O.-Vlaanderen, grant no. FWO12/PDO/099). BOF (Special Research Fund) is funding a PhD scholarship of SB in Gent University (Scholarship code 01W03714, Reference number DOZA/ILDDC/AM/0866b-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albonico M, 2003, ACTA TROP, V86, P233, DOI 10.1016/S0001-706X(03)00043-3; AMIDON GL, 1995, PHARMACEUT RES, V12, P413, DOI 10.1023/A:1016212804288; [Anonymous], 2014, UNITING COMBAT NEGLE; Benjamin S, 2015, LANCET INFECT DIS, V15, P15; Bennett A, 2000, PARASITOL TODAY, V16, P71, DOI 10.1016/S0169-4758(99)01544-6; Dana D, 2014, T R SOC TROP MED HYG, V108, P673; Debalke S, 2013, ETHIOP J HEALTH SCI, V23, P237, DOI 10.4314/ejhs.v23i3.6; Diawara A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000397; Galia E, 1999, PHARMACEUT RES, V16, P1871, DOI 10.1023/A:1018907527253; Ghisi M, 2007, VET PARASITOL, V144, P313, DOI 10.1016/j.vetpar.2006.10.003; Hansen TVA, 2014, INT J PARASITOL-DRUG, V4, P112, DOI 10.1016/j.ijpddr.2014.03.003; Hesterberg T, 2010, INTRO PRACTICE STAT, P355; International conference on harmonization of technical requirements for regression of pharmaceutical for human use, 2005, INT C HARM TECHN REQ; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Kelesidis T, 2007, J ANTIMICROB CHEMOTH, V60, P214, DOI 10.1093/jac/dkm109; Kumsa B, 2010, TURK J VET ANIM SCI, V34, P417, DOI 10.3906/vet-0712-28; Legesse M, 2004, East Afr Med J, V81, P134; Leslie T, 2009, EMERG INFECT DIS, V15, P1753, DOI 10.3201/eid1511.090886; Levecke B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003204; Levecke B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001201; MARRINER SE, 1986, EUR J CLIN PHARMACOL, V30, P705, DOI 10.1007/BF00608219; Mekonnen Z, 2013, PATHOG GLOB HEALTH, V107, P207, DOI 10.1179/2047773213Y.0000000092; Mekonnen Z, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002189; Monteiro AM, 1998, VET REC, V142, P396, DOI 10.1136/vr.142.15.396; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Newton PN, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h602; Ph. Eur. European Pharmacopoeia, 2014, PH EUR EUR PHARM, P72; Ph. Eur. European Pharmacopoeia, 2014, PH EUR EUR PHARM, P297; Ph. Eur. European Pharmacopoeia, 2014, PH EUR EUR PHARM, P38; Pranzo MB, 2010, J PHARM SCI-US, V99, P3731, DOI 10.1002/jps.22072; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Medina JR, 2014, SAUDI PHARM J, V22, P141, DOI 10.1016/j.jsps.2013.02.001; Solana HD, 2001, PARASITOL RES, V87, P275, DOI 10.1007/PL00008578; Stephanie TG, 2014, INT J PHARM PHARM SC, V6, P355; Suleman S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003345; Surendran A, 2004, NAT MED, V10, P111, DOI 10.1038/nm0204-111a; United States Pharmacopeia, 2014, US PHARM USP 37 NF 3, P52; United States Pharmacopeia, 2014, USP 37 NF 32 USP MON, P1626; Vercruysse J, 2011, PLOS NEGLECT TROP D, V5, pe948, DOI DOI 10.1371/J0URNAL.PNTD.0000948; Vippagunta SR, 2001, ADV DRUG DELIVER REV, V48, P3, DOI 10.1016/S0169-409X(01)00097-7; WHO, 2013, ACC MAT NEWB CHILD S, P1; World Health Organization, 2012, SOIL TRANSM HELM EL; World Health Organization, 2011, WHO DRUG INF, V28, P223; Zhang GGZ, 2004, ADV DRUG DELIVER REV, V56, P371, DOI 10.1016/j.addr.2003.10.009	44	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	SEP	2015	9	9							e0004057	10.1371/journal.pntd.0004057				15	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CT7YI	WOS:000363031200039	26406600	DOAJ Gold, Green Published			2019-04-02	
J	Repetto, EC; Zachariah, R; Kumar, A; Angheben, A; Gobbi, F; Anselmi, M; Al Rousan, A; Torrico, C; Ruiz, R; Ledezma, G; Buoninsegna, MC; Khogali, M; Van den Bergh, R; De Maio, G; Egidi, AM; Maccagno, B; Garelli, S				Repetto, Ernestina Carla; Zachariah, Rony; Kumar, Ajay; Angheben, Andrea; Gobbi, Federico; Anselmi, Mariella; Al Rousan, Ahmad; Torrico, Carlota; Ruiz, Rosa; Ledezma, Gabriel; Buoninsegna, Maria Chiara; Khogali, Mohammed; Van den Bergh, Rafael; De Maio, Gianfranco; Egidi, Ada Maristella; Maccagno, Barbara; Garelli, Silvia			Neglect of a Neglected Disease in Italy: The Challenge of Access-to-Care for Chagas Disease in Bergamo Area	PLOS NEGLECTED TROPICAL DISEASES			English	Article							LATIN-AMERICAN MIGRANTS; TRYPANOSOMA-CRUZI; DRUG-REACTIONS; BENZNIDAZOLE; BOLIVIA; SAFETY	Objectives Chagas disease (CD) represents a growing problem in Europe; Italy is one of the most affected countries but there is no national framework for CD and access-to-care is challenging. In 2012 Medecins Sans Frontieres (MSF) started an intervention in Bergamo province, where many people of Latin American origin (PLAO) are resident. A new model-of-care for CD, initiated by Centre for Tropical Diseases of Sacro Cuore Hospital, Negrar (CTD), the NGO OIKOS and the Bolivian community since 2009 in the same area, was endorsed. Hereby, we aim to describe the prevalence of CD and the treatment management outcomes among PLAO screened from 1st June 2012 to 30th June 2013. Methods Retrospective cohort study using routine program data. Screening sessions were done in Bergamo at OIKOS outpatient service and serological confirmation, staging and treatment for CD was offered at the CTD. MSF provided health education on CD, awareness generation prior to screening days, pre-test and post-test counselling through cultural mediators of Latin American origin. Results Of 1305 PLAO screened, 223(17%) had CD. Among 210 patients eligible for treatment, 102 (49%) were lost-to-follow-up before treatment. The median delay from diagnosis to treatment was 4 months (range 0.7-16.6 months). Among 108 started on treatment, 63(58%) completed treatment, 36(33%) interrupted treatment, (33 for drug side-effects, two for patients decision and one due to pregnancy), 6(6%) were lost-to-follow-up and 3(3%) were on treatment at study censuring. Conclusion In this first study focusing on process of care for CD in Italy, less than 30% of patients completed treatment with drop-outs along the cascade of care. There is an urgent need to involve affected communities and local regional health authorities to take part to this model-of-care, adapting it to the local epidemiology. The Italian health authorities should take steps in advocating for a change in the current paradigm.	[Repetto, Ernestina Carla; Al Rousan, Ahmad; Torrico, Carlota; Ruiz, Rosa; Ledezma, Gabriel; De Maio, Gianfranco; Maccagno, Barbara; Garelli, Silvia] MSF Belgium, Operat Ctr Brussels, Medecins Sans Frontieres, Brussels, Belgium; [Zachariah, Rony; Khogali, Mohammed; Van den Bergh, Rafael] MSF Luxembourg, Dept Med, Medecins Sans Frontieres, Operat Ctr Brussels, Luxembourg, Luxembourg; [Kumar, Ajay] Int Union TB & Lung Dis, South East Asia Reg Off, New Delhi, India; [Angheben, Andrea; Gobbi, Federico] Sacro Cuore Hosp, Ctr Trop Dis, Negrar Verona, Italy; [Angheben, Andrea; Anselmi, Mariella] COHEMI Project, Milan, Italy; [Anselmi, Mariella] Ctr Trop Dis & Community Epidemiol CECOMET, Esmeraldas, Ecuador; [Buoninsegna, Maria Chiara] OIKOS Onlus, Bergamo, Italy; [Egidi, Ada Maristella] MSF Italy, Dept Med, Medecins Sans Frontieres, Operat Ctr Brussels, Rome, Italy	Repetto, EC (reprint author), MSF Belgium, Operat Ctr Brussels, Medecins Sans Frontieres, Brussels, Belgium.	erniesby@gmail.com	Ucar, Abdullah/P-8329-2017	Van den Bergh, Rafael/0000-0001-6277-8713			Angheben A, 2011, EUROSURVEILLANCE, V16, P2; Basile L, 2011, EUROSURVEILLANCE, V16, P14; Chappuis F, 2010, J CLIN MICROBIOL, V48, P2948, DOI 10.1128/JCM.00774-10; Fabbro DL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003312; Hasslocher-Moreno AM, 2012, J ANTIMICROB CHEMOTH, V67, P1261, DOI 10.1093/jac/dks027; Hotez PJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002300; Molina I, 2014, NEW ENGL J MED, V370, P1899, DOI 10.1056/NEJMoa1313122; MONCAYO A, 2000, GLOBAL BURDEN CHAGAS; Navarro M., 2011, Eurosurveillance, V16, P19973; Orti-Lucas RM, 2014, J PARASITOLOGY RES, V2014, DOI DOI 10.1155/2014/514794; Perez-Ayala A, 2011, CLIN MICROBIOL INFEC, V17, P1108, DOI 10.1111/j.1469-0691.2010.03423.x; Perez-Molina JA, 2009, J ANTIMICROB CHEMOTH, V64, P1139, DOI 10.1093/jac/dkp357; Pinazo MJ, 2013, ANTIMICROB AGENTS CH, V57, P390, DOI 10.1128/AAC.01401-12; Rassi A, 2012, INFECT DIS CLIN N AM, V26, P275, DOI 10.1016/j.idc.2012.03.002; Requena-Mendez A, 2013, EXPERT REV ANTI-INFE, V11, P957, DOI 10.1586/14787210.2013.824718; Rezende JM de, 1988, ARQ GASTROENTEROL, V25; Ribeiro I, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000484; Strasen J, 2014, CLIN RES CARDIOL, V103, P1, DOI 10.1007/s00392-013-0613-y; Tornheim JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002407; WHO, 2013, SUSTAINING THE DRIVE TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: SECOND WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1; WHO, 2010, WORKING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: FIRST WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1; WHO, 2012, ACCELERATING WORK TO; World Health Organization, 2010, 63 WORLD HLTH ASS CH; World Health Organization, 2010, 1 WHO DIAGN LAB TECH; World Health Organization Expert Committee, 2002, WHO TECHN REP SER, V905; Yun O, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000488	26	9	9	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	SEP	2015	9	9							e0004103	10.1371/journal.pntd.0004103				13	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CT7YI	WOS:000363031200067	26406325	DOAJ Gold, Green Published			2019-04-02	
J	Nelwan, EJ; Indrati, AK; Isa, A; Triani, N; Alam, NN; Herlan, MS; Husen, W; Pohan, HT; Alisjahbana, B; Meheus, A; Van Crevel, R; van der Ven, AJ				Nelwan, Erni J.; Indrati, Agnes K.; Isa, Ahmad; Triani, Nurlita; Alam, Nisaa Nur; Herlan, Maria S.; Husen, Wahid; Pohan, Herdiman T.; Alisjahbana, Bachti; Meheus, Andre; Van Crevel, Reinout; van der Ven, Andre Jam			EFFECT OF HIV PREVENTION AND TREATMENT PROGRAM ON HIV AND HCV TRANSMISSION AND HIV MORTALITY AT AN INDONESIAN NARCOTIC PRISON	SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH			English	Article						HIV; HCV; transmission; prison; prevention; treatment; Indonesia	INJECTING DRUG-USERS; C VIRUS-INFECTION; HUMAN-IMMUNODEFICIENCY-VIRUS; PROSPECTIVE CONTROLLED-TRIAL; HEPATITIS-C; INCOME COUNTRIES; RISK BEHAVIOR; STATE PRISON; PREVALENCE; JAIL	Validated data regarding HIV-transmission in prisons in developing countries is scarce. We examined sexual and injecting drug use behavior and HIV and HCV transmission in an Indonesian narcotic prison during the implementation of an HIV prevention and treatment program during 2004-2007 when the Banceuy Narcotic Prison in Indonesia conducted an HIV transmission prevention program to provide 1) HIV education, 2) voluntary HIV testing and counseling, 3) condom supply, 4) prevention of rape and sexual violence, 5) antiretroviral treatment for HIV-positive prisoners and 6) methadone maintenance treatment. During a first survey that was conducted between 2007 and 2009, new prisoners entered Banceuy Narcotics Prison were voluntary tested for HIV and HCV-infection after written informed consent was obtained. Information regarding sexual and injecting risk behavior and physical status were also recorded at admission to the prison. Participants who tested negative for both HIV and HCV during the first survey were included in a second survey conducted during 2008-2011. During both surveys, data on mortality among HIV-seropositive patients were also recorded. All HIV-seropositive participants receive treatment for HIV. HIV/AIDS-related deaths decreased: 43% in 2006, 18% in 2007, 9% in 2008 and 0% in 2009. No HIV and HCV seroconversion inside Banceuy Narcotic Prison were found after a median of 23 months imprisonment (maximum follow-up: 38 months). Total of 484.8 person-years observation was done. Participants reported HIV transmission risk-behavior in Banceuy Prison during the second survey was low. After implementation of HIV prevention and treatment program, no new HIV or HCV cases were detected and HIV-related mortality decreased.	[Nelwan, Erni J.] Univ Indonesia, Dept Internal Med, Div Trop & Infect Dis, Jakarta, Indonesia; [Nelwan, Erni J.; Isa, Ahmad] Padjadjaran State Univ, Hasan Sadikin Hosp, Fac Med, Hlth Res Unit, Bandung, Indonesia; [Indrati, Agnes K.] Padjadjaran State Univ, Hasan Sadikin Hosp, Fac Med, Dept Clin Pathol, Bandung, Indonesia; [Alisjahbana, Bachti] Padjadjaran State Univ, Hasan Sadikin Hosp, Fac Med, Dept Internal Med, Bandung, Indonesia; [Triani, Nurlita; Alam, Nisaa Nur; Herlan, Maria S.; Husen, Wahid] Banceuy Narcot Prison, Div Med, Bandung, Indonesia; [Meheus, Andre] Univ Antwerp, Dept Epidemiol & Social Med, B-2020 Antwerp, Belgium; [Van Crevel, Reinout; van der Ven, Andre Jam] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6500 HB Nijmegen, Netherlands	van der Ven, AJ (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, POB 9101, NL-6500 HB Nijmegen, Netherlands.	Andre.vanderVen@radboudumc.nl	Ven, A.J.A.M./H-8102-2014; van Crevel, reinout/A-6636-2010	Ven, A.J.A.M./0000-0003-1833-3391; van Crevel, reinout/0000-0002-6233-6410			Afriandi Irvan, 2009, Acta Med Indones, V41 Suppl 1, P75; Alvarez KJ, 2014, J INFECT PUBLIC HEAL, V7, P517, DOI 10.1016/j.jiph.2014.07.018; Angora B, 2011, AIDS, V25, P1244, DOI 10.1097/QAD.0b013e328347c0f1; [Anonymous], 2012, STAT JAW BAR PROV JA; Beckwith C. G., 2010, Morbidity and Mortality Weekly Report, V59, P742; Beckwith CG, 2010, JAIDS-J ACQ IMM DEF, V55, pS49, DOI 10.1097/QAI.0b013e3181f9c0f7; Beyrer C, 2010, LANCET, V376, P551, DOI 10.1016/S0140-6736(10)60928-2; Bonella K, 2009, SHOCKING INSIDE STOR; Boys A, 2002, ADDICTION, V97, P1551, DOI 10.1046/j.1360-0443.2002.00229.x; *CDCP, 2006, MMWR-MORBID MORTAL W, V55, P421; Dolan K, 2007, LANCET INFECT DIS, V7, P32, DOI 10.1016/S1473-3099(06)70685-5; El Maerrawi I, 2015, INT J STD AIDS, V26, P120, DOI 10.1177/0956462414531242; Flanigan TP, 2011, J INFECT DIS, V203, P1201, DOI 10.1093/infdis/jir034; HORSBURGH CR, 1990, AM J PUBLIC HEALTH, V80, P209, DOI 10.2105/AJPH.80.2.209; Iskandar S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-472; Jafa K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005416; Jurgens R, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-26; Jurgens R, 2009, LANCET INFECT DIS, V9, P57, DOI 10.1016/S1473-3099(08)70305-0; Kavasery R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008056; Kavasery R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007648; Kim AY, 2013, HEPATOLOGY, V57, P944, DOI 10.1002/hep.26113; Krebs CP, 2002, AIDS EDUC PREV, V14, P53, DOI 10.1521/aeap.14.7.53.23865; Larney S, 2007, HIV PREVENTION TREAT; MUTTER RC, 1994, ARCH INTERN MED, V154, P793, DOI 10.1001/archinte.154.7.793; Nelwan EJ, 2010, TROP MED INT HEALTH, V15, P1491, DOI 10.1111/j.1365-3156.2010.02655.x; Nelwan Erni Juwita, 2009, Acta Med Indones, V41 Suppl 1, P52; Rotily M, 2001, EUR J PUBLIC HEALTH, V11, P243, DOI 10.1093/eurpub/11.3.243; Sarasvita R, 2012, J SUBST ABUSE TREAT, V42, P239, DOI 10.1016/j.jsat.2011.07.009; Sharma M, 2012, HARM REDUCT J, V9, DOI 10.1186/1477-7517-9-24; Siregar AYM, 2011, TROP MED INT HEALTH, V16, P193, DOI 10.1111/j.1365-3156.2010.02675.x; Snow KJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-830; Wammes JJG, 2012, INT J DRUG POLICY, V23, P358, DOI 10.1016/j.drugpo.2012.06.009; Weinbaum CA, 2005, AIDS, V19, pS41, DOI 10.1097/01.aids.0000192069.95819.aa; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; World Health Organization (WHO), 2008, HIV AIDS PLAC DET TO; World Health Organization (WHO), 2009, HIV TEST COUNS PRIS; WRIGHT NH, 1994, AIDS, V8, P529, DOI 10.1097/00002030-199404000-00017	37	2	2	0	10	SOUTHEAST ASIAN MINISTERS EDUC ORGANIZATION	BANGKOK	SEAMEO-TROPMED, 420-6 RAJVITHI RD,, BANGKOK 10400, THAILAND	0125-1562			SE ASIAN J TROP MED	Southeast Asian J. Trop. Med. Public Health	SEP	2015	46	5					880	891						12	Public, Environmental & Occupational Health; Infectious Diseases; Tropical Medicine	Public, Environmental & Occupational Health; Infectious Diseases; Tropical Medicine	CU4JK	WOS:000363494300007	26863859				2019-04-02	
J	Mukhtar, M; Abdoun, A; Ahmed, AE; Ghalib, H; Reed, SG; Boelaert, M; Menten, J; Khair, MM; Howard, RF				Mukhtar, Maowia; Abdoun, Asim; Ahmed, Abdallah E.; Ghalib, Hashim; Reed, Steven G.; Boelaert, Marleen; Menten, Joris; Khair, Musa M.; Howard, Randall F.			Diagnostic accuracy of rK28-based immunochromatographic rapid diagnostic tests for visceral leishmaniasis: a prospective clinical cohort study in Sudan	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Clinical study; Diagnosis; East Africa; Leishmania donovani; rK28 RDT; Visceral leishmaniasis	DIRECT AGGLUTINATION-TEST; RK39 STRIP TEST; OF-CARE TESTS; KALA-AZAR; DAT; PROGNOSIS; KATEX; PCR	Background: Rapid diagnostic tests (RDTs) for visceral leishmaniasis (VL) based on rK39 antigen showed suboptimal sensitivity in East Africa. A prospective clinical cohort study in Sudan was designed to validate a novel rK28-based RDT for Leishmania donovani VL. Methods: Patients (n = 285) suspected of VL by residency, fever for = 2 weeks, splenomegaly with no prior reported VL, and negative for malaria were consecutively enrolled at three Sudanese sites in 2012-2013 and informed consent obtained. Two human readers, who were blinded to the clinical status and other RDT results, evaluated patient whole blood (WB) and serum on the rK28 RDT. Based on Leishmania parasite detection in lymph node or bone marrow aspirates (Giemsa-stained smears or culture in Novy-MacNeal-Nicolle medium), patients were categorized as VL cases (n = 200) or VL controls (n = 85). Results: The rK28 RDT had high specificity using either WB (100% [85/85]) or serum (97.6% [83/85]) and exhibited greater sensitivity (WB, 92.5% [185/200]; serum, 94.5% [189/200]) than a direct agglutination test performed with the same sera (92.9% [79/85] and 83.5% [167/200] for specificity and sensitivity, respectively). Two blinded readers scored a given WB or serum sample the same on the rK28 RDT 99.6% and 100% of the time, respectively. A reader scored each individual donor's paired WB and serum rK28 RDT results the same 97.2% of the time. Conclusions: An inexpensive rK28 RDT that performs robustly with WB or serum will be valuable for diagnosing cases of VL in East Africa.	[Mukhtar, Maowia; Abdoun, Asim; Ahmed, Abdallah E.] Univ Khartoum, Inst Endem Dis, Khartoum, Sudan; [Ghalib, Hashim; Reed, Steven G.; Howard, Randall F.] IDRI, Seattle, WA 98102 USA; [Boelaert, Marleen; Menten, Joris] Inst Trop Med, B-2000 Antwerp, Belgium; [Khair, Musa M.] Univ Khartoum, Fac Med, Khartoum, Sudan	Howard, RF (reprint author), IDRI, Seattle, WA 98102 USA.	randall.howard@idri.org		Boelaert, Marleen/0000-0001-8051-6776	Bill & Melinda Gates Foundation [OPP49932]	This research was supported with funding from the Bill & Melinda Gates Foundation [Grant #OPP49932 to SGR].	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Bezuneh A, 2014, AM J TROP MED HYG, V91, P1109, DOI [10.4269/ajtmh.14-0759, 10.4269/ajtmh.13-0759]; Boelaert M, 2008, T ROY SOC TROP MED H, V102, P32, DOI 10.1016/j.trstmh.2007.09.003; Boelaert M, 2014, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD009135.PUB2; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Cascio A, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e27; Cunningham J, 2012, CLIN INFECT DIS, V55, P1312, DOI 10.1093/cid/cis716; Deborggraeve S, 2008, TROP MED INT HEALTH, V13, P1378, DOI 10.1111/j.1365-3156.2008.02154.x; Diro E, 2007, T ROY SOC TROP MED H, V101, P908, DOI 10.1016/j.trstmh.2007.05.002; Gatti S, 2004, ANN TROP MED PARASIT, V98, P667, DOI 10.1179/000349804225011488; Guerin PJ, 2002, LANCET INFECT DIS, V2, P494, DOI 10.1016/S1473-3099(02)00347-X; HARITH AE, 1987, T ROY SOC TROP MED H, V81, P603, DOI 10.1016/0035-9203(87)90423-8; Medrano FJ, 1998, AM J TROP MED HYG, V59, P155, DOI 10.4269/ajtmh.1998.59.155; Menten J, 2008, STAT MED, V27, P4469, DOI 10.1002/sim.3317; Pattabhi S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000822; Romero HD, 2009, AM J TROP MED HYG, V81, P27; Sundar S, 2006, T ROY SOC TROP MED H, V100, P533, DOI 10.1016/j.trstmh.2005.08.018; Vallur AC, 2015, EUR J CLIN MICROBIOL, V34, P679, DOI 10.1007/s10096-014-2282-9; World Health Organization, 1996, MAN VISC LEISHM CONT; ZIJLSTRA EE, 1992, T ROY SOC TROP MED H, V86, P505, DOI 10.1016/0035-9203(92)90086-R; ZIJLSTRA EE, 1994, AM J TROP MED HYG, V51, P826, DOI 10.4269/ajtmh.1994.51.826; Zijlstra EE, 2001, T R SOC TROP MED S1, V95, P27	22	12	13	3	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	SEP	2015	109	9					594	600		10.1093/trstmh/trv060				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CR7ZN	WOS:000361571000009	26246251				2019-04-02	
J	Bauer, K; Esquilin, IO; Cornier, AS; Thomas, SJ; del Rio, AIQ; Bertran-Pasarell, J; Ramirez, JOM; Diaz, C; Carlo, S; Eckels, KH; Tournay, E; Toussaint, JF; De La Barrera, R; Fernandez, S; Lyons, A; Sun, W; Innis, BL				Bauer, Kristen; Esquilin, Ines O.; Cornier, Alberto Santiago; Thomas, Stephen J.; del Rio, Ana I. Quintero; Bertran-Pasarell, Jorge; Ramirez, Javier O. Morales; Diaz, Clemente; Carlo, Simon; Eckels, Kenneth H.; Tournay, Elodie; Toussaint, Jean-Francois; De La Barrera, Rafael; Fernandez, Stefan; Lyons, Arthur; Sun, Wellington; Innis, Bruce L.			A Phase II, Randomized, Safety and Immunogenicity Trial of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Children and Adults Living in Puerto Rico	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article								This was a double-blind, randomized, controlled, phase II clinical trial, two dose study of re-derived, live-attenuated, tetravalent dengue virus (TDEN) vaccine (two formulations) or placebo in subjects 1-50 years of age. Among the 636 subjects enrolled, 331 (52%) were primed, that is, baseline seropositive to at least one dengue virus (DENY) type. Baseline seropositivity prevalence increased with age (10% [< 2 years], 26% [2-4 years], 60% [5-20 years], and 93% [21-50 years]). Safety profiles of TDEN vaccines were similar to placebo regardless of priming status. No vaccine-related serious adverse events (SAEs) were reported. Among unprimed subjects, immunogenicity (geometric mean antibody titers [GMT] and seropositivity rates) for each DENV increased substantially in both TDEN vaccine groups with at least 74.6% seropositive for four DENV types. The TDEN vaccine candidate showed an acceptable safety and immunogenicity profile in children and adults ranging from 1 to 50 years of age, regardless of priming status.	[Thomas, Stephen J.] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD USA; [Esquilin, Ines O.; Bertran-Pasarell, Jorge; Diaz, Clemente] Univ Puerto Rico, Sch Med, San Juan, PR 00936 USA; [Cornier, Alberto Santiago; Carlo, Simon] La Concepc Hosp, Dept Mol Med, San German, PR USA; [Cornier, Alberto Santiago] Ponce Sch Med, Dept Biochem, Ponce, PR USA; [del Rio, Ana I. Quintero] Ctr Reumatol Pediat Puerto Rico, San Juan, PR USA; [Ramirez, Javier O. Morales] Clin Res Puerto Rico Inc, San Juan, PR USA; [Eckels, Kenneth H.; De La Barrera, Rafael] Walter Reed Army Inst Res, Pilot Bioprod Facil, Silver Spring, MD USA; GSK Vaccines, Wavre, Belgium; [Innis, Bruce L.] GSK Vaccines, King Of Prussia, PA USA; [Bauer, Kristen] Landstuhl Reg Med Ctr, Landstuh, Germany; [Carlo, Simon] Dept Biochem & Pediat PSMHS, Ponce, PR USA; [Tournay, Elodie] GSK Vaccines, Vaccine Value & Hlth Sci, Biomed Data Sci, Wavre, Belgium; [Toussaint, Jean-Francois] GSK Vaccines, Vaccine Discovery & Dev, Viral Dis Area Program, Rixensart, Belgium; [Fernandez, Stefan] US Army Med Component Armed Forces Res Inst Med S, Bangkok, Thailand; [Lyons, Arthur] Army Pentagon, OTSG, Washington, DC USA; [Sun, Wellington] US FDA, Div Vaccines & Related Product Applicat, CBER, Rockville, MD 20857 USA	Thomas, SJ (reprint author), Walter Reed Army Inst Res, Operat, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	kristen.m.bauer.mil@mail.mil; ines.esquilin@upr.edu; scornier@psm.edu; stephen.j.thomas3.mil@mail.mil; anaquintero8293@msn.com; jorge.bertran@upr.edu; morales@clinicalresearchpr.com; clemente.diaz@upr.edu; simoncarlo3@yahoo.com; kenneth.h.eckels.civ@mail.mil; elodie.x.tournay@gsk.com; jean-francois.x.toussaint@gsk.com; rafael.a.delabarrera.ctr@mail.mil; stefan.femandez@afrims.org; arthur.g.lyons.mil@mail.mil; wellington.sun@fda.hhs.gov; bruce.2.innis@gsk.com		Toussaint, Jean-Francois/0000-0003-1964-5039; Innis, Bruce/0000-0002-1753-7248	U.S. Army Medical Research and Materiel Command (Fort Detrick, MD); GlaxoSmithKline Biologicals SA (Rixensart, Belgium)	This work was funded by U.S. Army Medical Research and Materiel Command (Fort Detrick, MD) and GlaxoSmithKline Biologicals SA (Rixensart, Belgium) under a Cooperative Research and Development Agreement. GlaxoSmithKline Biologicals SA was involved in all stages of study conduct, including analysis of the data, in addition to costs related to the development of the publication of this manuscript.	Badurdeen S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-607; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Centers for Disease Control and Prevention (CDC), 2012, DENG WHO WHO TECHN R, V932; Centers for Disease Control and Prevention (CDC), 2011, DENG UPD 2010 LARG D, V3; Edelman R, 2003, AM J TROP MED HYG, V69, P48, DOI 10.4269/ajtmh.2003.69.48; Innis BL, 2003, AM J TROP MED HYG, V69, P1; International Committee on Harmonization, 2014, MED DICT REG ACT; Knope K, 2013, COMMUN DIS INTELL, V37, pE55; Lee IK, 2010, INT J INFECT DIS, V14, pE919, DOI 10.1016/j.ijid.2010.06.011; Sadon N, 2008, J VIROL METHODS, V153, P1, DOI 10.1016/j.jviromet.2008.06.023; Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332; Simasathien S, 2008, AM J TROP MED HYG, V78, P426, DOI 10.4269/ajtmh.2008.78.426; Thomas SJ, 2013, AM J TROP MED HYG, V88, P73, DOI 10.4269/ajtmh.2012.12-0361; Watanaveeradej V, 2014, AM J TROP MED HYG, V91, P119, DOI 10.4269/ajtmh.13-0452; Watanaveeradej V, 2011, AM J TROP MED HYG, V85, P341, DOI 10.4269/ajtmh.2011.10-0501; World Health Organization, 2012, WHOHTMNTDVEM20125; World Health Organization (WHO), 2013, IMP OF DENG	17	10	10	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	SEP	2015	93	3					441	453		10.4269/ajtmh.14-0625				13	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CR3TB	WOS:000361254900005	26175027	Other Gold, Green Published			2019-04-02	
J	Thanh, PV; Hong, NV; Van, NV; Louisa, M; Baird, K; Tinh, TT; Xa, NX; Grietens, KP; Hung, LX; Duong, TT; Rosanas-Urgell, A; Speybroeck, N; D'Alessandro, U; Erhart, A				Thanh, P. V.; Hong, N. V.; Van, N. V.; Louisa, M.; Baird, K.; Tinh, T. T.; Xa, N. X.; Grietens, K. Peeters; Hung, L. X.; Duong, T. T.; Rosanas-Urgell, A.; Speybroeck, N.; D'Alessandro, U.; Erhart, A.			Confirmed Plasmodium vivax resistance to chloroquine in Central Vietnam	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Thanh, P. V.; Hong, N. V.; Tinh, T. T.; Xa, N. X.; Hung, L. X.; Duong, T. T.] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam; [Thanh, P. V.; Hong, N. V.; Grietens, K. Peeters; Rosanas-Urgell, A.; D'Alessandro, U.; Erhart, A.] Inst Trop Med, B-2000 Antwerp, Belgium; [Thanh, P. V.; Speybroeck, N.] Catholic Univ Louvain, B-1200 Brussels, Belgium; [Hong, N. V.] Univ Antwerp, B-2020 Antwerp, Belgium; [Van, N. V.] Prov Malaria Stn, Tam Ky, Vietnam; [Louisa, M.] Univ Indonesia, Pharmacol, Jakarta, Indonesia; [Baird, K.] Eijkman Oxford Clin Res Unit, Jakarta, Indonesia; [D'Alessandro, U.] London Sch Hyg & Trop Med, London WC1, England; [D'Alessandro, U.] MRC, Gambia Unit, Fajara, Gambia			Rosanas-Urgell, Anna/D-3193-2015	Rosanas-Urgell, Anna/0000-0002-0432-5203				0	0	0	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		14	14						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800032					2019-04-02	
J	Payne, RO; Milne, KH; Elias, SC; Edwards, NJ; Douglas, AD; Brown, RE; Silk, SE; Biswas, S; Miura, K; Roberts, R; Rampling, TW; Venkatraman, N; Hodgson, SH; Labbe, GM; Halstead, FD; Ockenhouse, CF; Kathcart, AK; Qabar, AN; Waters, NC; Soisson, LA; Woods, C; Birkett, AJ; Long, CA; Vekemans, J; Diggs, CL; Hill, AVS; Lawrie, AM; Dutta, S; Draper, SJ				Payne, R. O.; Milne, K. H.; Elias, S. C.; Edwards, N. J.; Douglas, A. D.; Brown, R. E.; Silk, S. E.; Biswas, S.; Miura, K.; Roberts, R.; Rampling, T. W.; Venkatraman, N.; Hodgson, S. H.; Labbe, G. M.; Halstead, F. D.; Ockenhouse, C. F.; Kathcart, A. K.; Qabar, A. N.; Waters, N. C.; Soisson, L. A.; Woods, C.; Birkett, A. J.; Long, C. A.; Vekemans, J.; Diggs, C. L.; Hill, A. V. S.; Lawrie, A. M.; Dutta, S.; Draper, S. J.			Assessment of FMP2.1/AS01B, an asexual blood-stage malaria vaccine, in a phase I/II a clinical trial using blood-stage controlled human malaria infection	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Payne, R. O.; Milne, K. H.; Elias, S. C.; Edwards, N. J.; Douglas, A. D.; Brown, R. E.; Silk, S. E.; Biswas, S.; Roberts, R.; Rampling, T. W.; Venkatraman, N.; Hodgson, S. H.; Labbe, G. M.; Halstead, F. D.; Hill, A. V. S.; Lawrie, A. M.; Draper, S. J.] Univ Oxford, Jenner Inst, Oxford, England; [Miura, K.; Long, C. A.] NIH, Lab Malaria & Vector Res, Washington, DC USA; [Ockenhouse, C. F.; Kathcart, A. K.; Qabar, A. N.; Waters, N. C.; Dutta, S.] Walter Reed Army Inst Res, Mil Malaria Res Program, Silver Spring, MD USA; [Soisson, L. A.; Diggs, C. L.] US Agcy Int Dev, Washington, DC 20523 USA; [Woods, C.; Birkett, A. J.] PATH Malaria Vaccine Initiat, Washington, DC USA; [Vekemans, J.] GSK, Rixensart, Belgium								0	0	0	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		22	22						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800052					2019-04-02	
J	Coscolla, M; Copin, R; Sutherland, J; Giardina, F; Gehre, F; Mbayo, G; Isatou, T; de Jong, B; Ernst, J; Gagneux, S				Coscolla, M.; Copin, R.; Sutherland, J.; Giardina, F.; Gehre, F.; Mbayo, G.; Isatou, T.; de Jong, B.; Ernst, J.; Gagneux, S.			Identification of potential tuberculosis vaccine antigens by integrating population genomics and immunology	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Coscolla, M.; Giardina, F.; Gagneux, S.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Coscolla, M.; Gagneux, S.] Univ Basel, Basel, Switzerland; [Copin, R.; Ernst, J.] NYU, New York, NY USA; [Sutherland, J.; Gehre, F.; Mbayo, G.; Isatou, T.] MRC, Banjul, Gambia; [de Jong, B.] Inst Trop Med, B-2000 Antwerp, Belgium				Gagneux, Sebastien/0000-0001-7783-9048				0	0	0	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		23	23						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800055					2019-04-02	
J	Laudisoit, A; Baelo, P; Awazi, MM; VanHoutte, N; VanHees, M; Amundala, N; Leirs, H; Verheyen, E				Laudisoit, A.; Baelo, P.; Awazi, M. Mussaw; VanHoutte, N.; VanHees, M.; Amundala, N.; Leirs, H.; Verheyen, E.			Biodiversity, Bushmeat and Monkeypox in the Democratic Republic of the Congo: another viral threat upon larger cities?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Laudisoit, A.] Univ Antwerp, Evolutionary Biol, B-2020 Antwerp, Belgium; [Laudisoit, A.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Baelo, P.; Amundala, N.] Univ Kisangani, Kisangani, Belgium; [Awazi, M. Mussaw] Univ Lubumbashi, Lubumbashi, DEM REP CONGO; [VanHoutte, N.; VanHees, M.; Leirs, H.; Verheyen, E.] Univ Antwerp, B-2020 Antwerp, Belgium			VERHEYEN, ERIK/E-5550-2013	VERHEYEN, ERIK/0000-0001-7157-1474				0	0	0	3	15	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		30	31						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800074					2019-04-02	
J	Bhattacharyya, T; Hayes, K; Hafezi, H; Mertens, P; Thunissen, C; Sundar, S; El-Safi, S; Rijal, S; Boelaert, M; Miles, MA				Bhattacharyya, T.; Hayes, K.; Hafezi, H.; Mertens, P.; Thunissen, C.; Sundar, S.; El-Safi, S.; Rijal, S.; Boelaert, M.; Miles, M. A.			IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic test	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Bhattacharyya, T.; Hayes, K.; Hafezi, H.; Miles, M. A.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Mertens, P.; Thunissen, C.] Coris BioConcept, Gembloux, Belgium; [Sundar, S.] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [El-Safi, S.] Univ Khartoum, Fac Med, Khartoum, Sudan; [Rijal, S.] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Boelaert, M.] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium								0	0	0	1	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		31	32						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800076					2019-04-02	
J	Burza, S; den Boer, M; Mahajan, R; Das, AK; Mitra, G; Almeida, P; Lima, MA; Be-Nazir, A; Sunyoto, T; Das, P; Ritmeijer, K				Burza, S.; den Boer, M.; Mahajan, R.; Das, A. K.; Mitra, G.; Almeida, P.; Lima, M. A.; Be-Nazir, A.; Sunyoto, T.; Das, P.; Ritmeijer, K.			Post kala-azar dermal leishmaniasis treated with liposomal amphotericin B (AmBisome)	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Burza, S.; Mahajan, R.; Mitra, G.; Sunyoto, T.] Medecins Sans Frontieres, Delhi, India; [Burza, S.] Inst Trop Med, B-2000 Antwerp, Belgium; [den Boer, M.; Ritmeijer, K.] Medecins Sans Frontieres, Amsterdam, Netherlands; [Das, A. K.; Almeida, P.] Medecins Sans Frontieres, Dhaka, Bangladesh; [Lima, M. A.] Medecins Sans Frontieres, Barcelona, Spain; [Be-Nazir, A.] Minist Hlth & Family Welf, Communicable Dis Control, Dhaka, Bangladesh; [Das, P.] Rajendra Mamorial Res Inst, Patna, Bihar, India								0	0	0	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		32	32						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800078					2019-04-02	
J	Van der Auwera, G; Bart, A; Chicharro, C; Cortes, S; Davidsson, L; Di Muccio, T; Felger, I; Paglia, MG; Grimm, F; Harms, G; Jaffe, CL; Kortbeek, T; Maes, I; Manser, M; Ravel, C; Robert-Gangneux, F; Toz, S; Verweij, JJ; Chiodini, P				Van der Auwera, G.; Bart, A.; Chicharro, C.; Cortes, S.; Davidsson, L.; Di Muccio, T.; Felger, I.; Paglia, M. Grazia; Grimm, F.; Harms, G.; Jaffe, C. L.; Kortbeek, T.; Maes, I.; Manser, M.; Ravel, C.; Robert-Gangneux, F.; Toz, S.; Verweij, J. J.; Chiodini, P.		LeishMan ESCMID Study Grp Clin	Comparison of Leishmania species typing results in 17 European clinical laboratories	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Van der Auwera, G.] Inst Trop Med, BioMed Sci, B-2000 Antwerp, Belgium; [Bart, A.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Chicharro, C.] Inst Salud Carlos III, Madrid, Spain; [Cortes, S.] Inst Hyg & Trop Med, Lisbon, Portugal; [Davidsson, L.] Publ Hlth Agcy Sweden, Stockholm, Sweden; [Di Muccio, T.] Ist Super Sanita, I-00161 Rome, Italy; [Felger, I.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Paglia, M. Grazia] Natl Inst Infect Dis INMI Lazzaro Spallanzani, Rome, Italy; [Grimm, F.] Univ Zurich, Inst Parasitol, CH-8057 Zurich, Switzerland; [Harms, G.] Charite, Inst Trop Med & Int Hlth, D-13353 Berlin, Germany; [Jaffe, C. L.] Hebrew Univ Jerusalem, Hadassah Med Ctr, Jerusalem, Israel; [Kortbeek, T.] RIVM, Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands; [Maes, I.] Inst Trop Med, B-2000 Antwerp, Belgium; [Manser, M.] United Kingdom Natl External Qual Assessment Serv, London, England; [Ravel, C.] Univ Montpellier, F-34059 Montpellier, France; [Robert-Gangneux, F.] Ctr Hosp Univ Rennes, Rennes, France; [Toz, S.] Ege Univ, Fac Med, Izmir, Turkey; [Verweij, J. J.] St Elizabeth Hosp, Tilburg, Netherlands; [Chiodini, P.] Hosp Trop Dis, London NW1 0PE, England			Ravel, Christophe/A-7369-2008; Robert-Gangneux, Florence/I-4692-2015; Bart, Aldert/B-9520-2008; Cortes, Sofia/I-2800-2012	Bart, Aldert/0000-0001-6605-6347; Cortes, Sofia/0000-0001-5850-6950				0	0	0	0	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		34	35						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800083					2019-04-02	
J	Henry, B; Morizot, G; Blum, J; Van der Auwera, G; Clerinx, J; Harms, G; Bart, A; Armstrong, M; Ravel, C; Robert-Gangneux, F; Gangneux, JP; Felger, I; Bailey, M; Grogl, M; Lockwood, D; Buffet, P				Henry, B.; Morizot, G.; Blum, J.; Van der Auwera, G.; Clerinx, J.; Harms, G.; Bart, A.; Armstrong, M.; Ravel, C.; Robert-Gangneux, F.; Gangneux, J. -P.; Felger, I.; Bailey, M.; Groegl, M.; Lockwood, D.; Buffet, P.		LeishMan Network	Worldwide diversity of leishmaniasis: harmonized collection of data and isolates by the European "LeishMan" network: the LeishMan Network	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Henry, B.] Univ Paris 05, Hop Necker Enfants Malad, APHP, Serv Malad Infect & Trop,Sorbonne Paris Cite,Ctr, B-2000 Paris, France; [Morizot, G.] Inst Pasteur, Invest Clin & Acces Ressources Biol, D-13353 Paris, France; [Blum, J.; Felger, I.] Swiss Trop & Publ Hlth Inst, NL-1105 AZ Basel, Switzerland; [Van der Auwera, G.; Clerinx, J.] Inst Trop Med, Antwerp NW1 0PE, Belgium; [Harms, G.] Charite, Inst Tropenmed & Int Gesundheit, Berlin, Germany; [Bart, A.] Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands; [Armstrong, M.; Lockwood, D.] Hosp Trop Dis, London, England; [Ravel, C.] CHU Montpellier, Fac Med Montpellier, Montpellier, France; [Robert-Gangneux, F.; Gangneux, J. -P.] Univ Rennes 1, CHU Rennes, Rennes, France; [Bailey, M.] Royal Ctr Def Med, Birmingham, W Midlands, England; [Groegl, M.] Walter Reed Army Inst Res, Silver Spring, MD USA; [Buffet, P.] Univ Paris 06, Sorbonne Univ, Hop La Pitie Salpetriere, Serv Parasitol & Mycol, Paris, France			Ravel, Christophe/A-7369-2008; Buffet, Pierre/O-6189-2017; Bart, Aldert/B-9520-2008; Robert-Gangneux, Florence/I-4692-2015	Buffet, Pierre/0000-0003-4010-929X; Bart, Aldert/0000-0001-6605-6347; 				0	0	0	0	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		35	35						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800084					2019-04-02	
J	Sompwe, EM; Hasker, E; Kasombe, M; Luboya, O; Mapatano, A; Lutumba, P; Van Geertruyden, JP				Sompwe, E. M.; Hasker, E.; Kasombe, M.; Luboya, O.; Mapatano, A.; Lutumba, P.; Van Geertruyden, J. -P.			Malaria incidence and temperature show a steady and correlated increase between 2003 till 2014 in Lubumbashi, Democratic Republic of Congo: a spatio-temporal analysis	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Sompwe, E. M.; Kasombe, M.] Inspect Reg Sante Katanga, Lubumbashi, DEM REP CONGO; [Sompwe, E. M.; Luboya, O.; Mapatano, A.] Univ Lubumbashi, Lubumbashi, DEM REP CONGO; [Sompwe, E. M.; Van Geertruyden, J. -P.] Univ Antwerp, B-2020 Antwerp, Belgium; [Hasker, E.] Inst Trop Med, B-2000 Antwerp, Belgium; [Lutumba, P.] Univ Kinshasa, Kinshasa, DEM REP CONGO			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		38	38						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800093					2019-04-02	
J	Meurs, L; Mbow, M; Yazdanbakhsh, M; Polman, K				Meurs, L.; Mbow, M.; Yazdanbakhsh, M.; Polman, K.			Factors driving co-occurrence of Schistosoma mansoni and S. haematobium at the micro-geographical level	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Meurs, L.; Mbow, M.; Polman, K.] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Mbow, M.] Aristide Le Dantec Teaching Hosp, Lab Bacteriol & Virol, Dakar, Senegal; [Mbow, M.; Yazdanbakhsh, M.] Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands			Meurs, Lynn/J-8661-2016	Meurs, Lynn/0000-0002-6973-1237				0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		42	42						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800102					2019-04-02	
J	De Santis, O; Audran, R; Pothin, E; Warpelin-Decrausaz, L; Vallotton, L; Wuerzner, G; Cochet, C; Estoppey, D; Steiner-Monard, V; Lonchampt, S; Thierry, AC; Mayor, C; Bailer, RT; Mbaya, OT; Zhou, Y; Ploquin, A; Sullivan, NJ; Graham, BS; Roman, F; De Ryck, I; Ballou, R; Kieny, MP; Moorthy, V; Spertini, F; Genton, B				De Santis, O.; Audran, R.; Pothin, E.; Warpelin-Decrausaz, L.; Vallotton, L.; Wuerzner, G.; Cochet, C.; Estoppey, D.; Steiner-Monard, V.; Lonchampt, S.; Thierry, A. -C.; Mayor, C.; Bailer, R. T.; Mbaya, O. Tshiani; Zhou, Y.; Ploquin, A.; Sullivan, N. J.; Graham, B. S.; Roman, F.; De Ryck, I.; Ballou, R.; Kieny, M. P.; Moorthy, V.; Spertini, F.; Genton, B.			Safety and immunogenicity of the Chimpanzee-Adenovirus vectored Ebola vaccine: the Lausanne phase I/IIa clinical trial	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[De Santis, O.; Cochet, C.; Estoppey, D.; Lonchampt, S.; Genton, B.] Policlin Med Univ, Lausanne, Switzerland; [Audran, R.; Steiner-Monard, V.; Thierry, A. -C.; Mayor, C.; Spertini, F.] Univ Lausanne Hosp, Div Immunol & Allergy, Lausanne, Switzerland; [Pothin, E.; Genton, B.] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Warpelin-Decrausaz, L.; Vallotton, L.; Wuerzner, G.] Univ Lausanne Hosp, Clin Trial Unit, Lausanne, Switzerland; [Bailer, R. T.; Mbaya, O. Tshiani; Zhou, Y.; Ploquin, A.; Sullivan, N. J.; Graham, B. S.] NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA; [Roman, F.; De Ryck, I.; Ballou, R.] GSK Vaccines, Rixensart, Belgium; [Kieny, M. P.; Moorthy, V.] WHO, CH-1211 Geneva, Switzerland; [Genton, B.] Univ Lausanne Hosp, Infect Dis Serv, Lausanne, Switzerland			Kieny, Marie-Paule/N-3914-2017	Kieny, Marie-Paule/0000-0002-5943-6488				0	1	1	0	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		43	43						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800104					2019-04-02	
J	Antierens, A				Antierens, A.			The Ebola field reality for conducting clinical trials	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Antierens, A.] Med Sans Frontieres, Brussels, Belgium								0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		44	44						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800106					2019-04-02	
J	van Griensven, J				van Griensven, J.		Ebola Tx Consortium	Emergency evaluation of convalescent plasma for Ebola virus disease in Guinea	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[van Griensven, J.; Ebola Tx Consortium] Inst Trop Med, B-2000 Antwerp, Belgium								0	1	1	0	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		44	44						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800107					2019-04-02	
J	Meurs, L; Brienen, E; Mbow, M; Ochola, EA; Mboup, S; Karanja, DMS; Secor, WE; Polman, K; van Lieshout, L				Meurs, L.; Brienen, E.; Mbow, M.; Ochola, E. A.; Mboup, S.; Karanja, D. M. S.; Secor, W. E.; Polman, K.; van Lieshout, L.			Is PCR the next gold standard for the diagnosis of Schistosoma in stool? A comparison with microscopy in Senegal and Kenya	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Meurs, L.; Brienen, E.; van Lieshout, L.] Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands; [Meurs, L.; Polman, K.] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Mbow, M.; Mboup, S.] Aristide Le Dantec Teaching Hosp, Lab Bacteriol & Virol, Dakar, Senegal; [Ochola, E. A.; Karanja, D. M. S.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Secor, W. E.] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA USA								0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		47	47						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800115					2019-04-02	
J	Morales, FJ; Ramos, IS; Polman, K; Muyldermans, S				Morales, F. J.; Ramos, I. Sariego; Polman, K.; Muyldermans, S.			Nanobody (R)-based sandwich enzyme-linked immunosorbent assay for the detection of Toxocara canis excretory-secretory proteins	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Morales, F. J.; Muyldermans, S.] Vrije Univ Brussel, Lab Cellular & Mol Immunol, Brussels, Belgium; [Ramos, I. Sariego] Inst Med Trop Pedro Kouri, Dept Parasitol, Havana, Cuba; [Polman, K.] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium			Muyldermans, Serge/C-6418-2016	Muyldermans, Serge/0000-0002-3678-3575				0	0	0	0	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		49	49						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800120					2019-04-02	
J	Gilleman, Q; Buscher, P; Mertens, P; Leclipteux, T				Gilleman, Q.; Buscher, P.; Mertens, P.; Leclipteux, T.			Development of a rapid diagnostic test for active case detection in sleeping sickness control: recHAT Sero-Strip	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Gilleman, Q.; Mertens, P.; Leclipteux, T.] Gembloux, Coris BioConcept, Antwerp, Belgium; [Buscher, P.] Inst Trop Med, B-2000 Antwerp, Belgium								0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		50	50						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800122					2019-04-02	
J	Kishabongo, AS; Katchunga, P; Van Aken, E; Speeckaert, M; Lagniau, S; Coopman, R; Delanghe, JR				Kishabongo, A. S.; Katchunga, P.; Van Aken, E.; Speeckaert, M.; Lagniau, S.; Coopman, R.; Delanghe, J. R.			Glycated nail proteins as a biomarker of diabetes	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Kishabongo, A. S.; Van Aken, E.] Univ Ghent, B-9000 Ghent, Belgium; [Katchunga, P.] Catholic Univ Bukavu, Internal Med, Bukavu, Zaire; [Speeckaert, M.] Univ Ghent, Nephrol, B-9000 Ghent, Belgium; [Lagniau, S.; Coopman, R.; Delanghe, J. R.] Univ Ghent, Clin Chem, B-9000 Ghent, Belgium								0	0	0	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		58	59						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800142					2019-04-02	
J	Samadoulougou, S; Kirakoya-Samadoulougou, F; Robert, A				Samadoulougou, S.; Kirakoya-Samadoulougou, F.; Robert, A.			Geographic disparities in bednet ownership and usage: an analysis of Burkina Faso 2010 Demographic and Health Survey data	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Samadoulougou, S.; Robert, A.] IREC EPID, Brussels, Belgium; [Samadoulougou, S.; Kirakoya-Samadoulougou, F.; Robert, A.] Catholic Univ Louvain, B-1200 Brussels, Belgium								0	0	0	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		74	74						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800179					2019-04-02	
J	Ivanova, O; Wambua, S; Gichangi, P				Ivanova, O.; Wambua, S.; Gichangi, P.			Adolescents and youth taking control of their HIV treatment through the web-based peer support platform: the case of Mombasa, Kenya (ELIMIKA Project)	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ivanova, O.] Univ Ghent, ICRH, B-9000 Ghent, Belgium; [Wambua, S.; Gichangi, P.] ICRH Kenya, Mombasa, Kenya; [Gichangi, P.] UON Univ Nairobi, Nairobi, Kenya								0	0	0	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		76	76						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800184					2019-04-02	
J	Elhadidy, M; Elkhatib, WF; Pierard, D; De Reu, K; Heyndrickx, M				Elhadidy, M.; Elkhatib, W. F.; Pierard, D.; De Reu, K.; Heyndrickx, M.			Molecular risk assessment of Shiga toxin-producing E. coli O157: H7	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Elhadidy, M.] Mansoura Univ, Fac Vet Med, Dept Bacteriol Mycol & Immunol, Mansoura, Egypt; [Elkhatib, W. F.] Ain Shams Univ, African Union Org St Abbassia, Dept Microbiol & Immunol, Fac Pharm, Cairo, Egypt; [Elkhatib, W. F.] Hampton Univ, Sch Pharm, Dept Pharm Practice, Hampton, VA 23668 USA; [Pierard, D.] UZ Brussels, Dept Microbiol, Belgian VTEC Reference Lab, Brussels, Belgium; [De Reu, K.; Heyndrickx, M.] Inst Agr & Fisheries Res ILVO, Technol & Food Sci Unit, Melle, Belgium; [Heyndrickx, M.] Univ Ghent, Dept Pathol Bacteriol & Poultry Dis, Merelbeke, Belgium								0	0	0	0	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		77	77						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800186					2019-04-02	
J	Akerfeldt, K; Philips, M; Banda, A				Akerfeldt, K.; Philips, M.; Banda, A.			The Global Fund's new funding model in the context of international funding shortfalls: does it foster ambition in scale-up and quality of HIV programs?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Akerfeldt, K.] MSF, Operat Ctr Brussels, London, England; [Philips, M.] MSF, Operat Ctr Brussels, Brussels, Belgium; [Banda, A.] MSF, Johannesburg, South Africa								0	0	0	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		81	82						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800198					2019-04-02	
J	Van Belle, S				Van Belle, S.			Public accountability practices of district health management teams: a realist inquiry in two local health systems in Ghana	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Van Belle, S.] ITM Inst Trop Med Antwerp Belgium, Publ Hlth, Antwerp, Belgium; [Van Belle, S.] Univ Antwerp, Inst Dev Policy & Management, B-2020 Antwerp, Belgium								0	0	0	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		81	81						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800197					2019-04-02	
J	Hendrickx, D; Walker, R; Carapetis, J; Boelaert, M				Hendrickx, D.; Walker, R.; Carapetis, J.; Boelaert, M.			The human factor in the clinical management of infectious diseases of poverty in remote, low-resource settings - a discussion of four qualitative studies on healthcare provider attitudes and practices	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Hendrickx, D.; Walker, R.; Carapetis, J.] Telethon Kids Inst, Perth, WA, Australia; [Hendrickx, D.; Boelaert, M.] Inst Trop Med, B-2000 Antwerp, Belgium								0	0	0	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		90	90						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800218					2019-04-02	
J	Markham, A; Akerfeldt, K; Philips, M				Markham, A.; Akerfeldt, K.; Philips, M.			Political pressure from donors to reduce or end health aid on basis of country income classification risks damage to people's health in middle income countries and undermining effectiveness of global health initiatives	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Markham, A.; Philips, M.] MSF, Brussels, Belgium; [Akerfeldt, K.] MSF, London, England								0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		96	96						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800232					2019-04-02	
J	Meheus, F; Burza, S; Becker, S; N'Goran, EK; Sacko, M; Polman, K; Chappuis, F; Boelaert, M; Utzinger, J				Meheus, F.; Burza, S.; Becker, S.; N'Goran, E. K.; Sacko, M.; Polman, K.; Chappuis, F.; Boelaert, M.; Utzinger, J.			Modelling the cost-effectiveness of diagnosis of Schistosoma mansoni infection: a comparison of Kato-Katz and urine-circulating cathodic antigen cassette test	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Meheus, F.] Univ Cape Town, Hlth Econ Unit, ZA-7925 Cape Town, South Africa; [Burza, S.; Polman, K.; Boelaert, M.] Inst Trop Med, B-2000 Antwerp, Belgium; [Burza, S.] London Sch Hyg & Trop Med, London WC1, England; [Becker, S.; Utzinger, J.] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Pub Hlth, Basel, Switzerland; [Becker, S.; Utzinger, J.] Univ Basel, Basel, Switzerland; [Becker, S.] Inst Med Microbiol & Hyg, Homburg, Germany; [N'Goran, E. K.] Univ Felix Houphouet Boigny, Unite Format & Rech Biosci, Abidjan, Cote Ivoire; [N'Goran, E. K.] Ctr Suisse Rech Sci Cote Ivoire, Dept Environm & Sante, Abidjan, Cote Ivoire; [Sacko, M.] Inst Natl Rech Sante Publ, Bamako, Mali; [Chappuis, F.] Univ Hosp Geneva, Div Trop & Humanitarian Med, Geneva, Switzerland								0	1	1	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		103	103						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800250					2019-04-02	
J	Bottieau, E; Mukendi, D; Kalo, JR; Barbe, B; Gillet, P; Mpanya, A; Yansouni, C; Winkler, A; Lutumba, P; Jacobs, J; Verdonck, T; Chappuis, F; Boelaert, M				Bottieau, E.; Mukendi, D.; Kalo, J. -R.; Barbe, B.; Gillet, P.; Mpanya, A.; Yansouni, C.; Winkler, A.; Lutumba, P.; Jacobs, J.; Verdonck, T.; Chappuis, F.; Boelaert, M.		Neglected Infect Dis Diag NIDIAG	Clinical spectrum, main etiologies and outcome of neurological disorders in the rural Hospital of Mosango, Province of Bandundu, Democratic Republic of the Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Bottieau, E.; Barbe, B.; Gillet, P.; Jacobs, J.] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Mukendi, D.; Kalo, J. -R.; Mpanya, A.; Lutumba, P.] Inst Natl Rech Biomed, Kinshasa, Zaire; [Yansouni, C.] McGill Univ, Ctr Hlth, Ctr Trop Dis, Montreal, PQ, Canada; [Winkler, A.] Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, D-80290 Munich, Germany; [Verdonck, T.; Boelaert, M.] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Chappuis, F.] Univ Hosp Geneva, Div Int & Humanitarian Med, Geneva, Switzerland								0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		106	107						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800259					2019-04-02	
J	Chappuis, F; Barbe, B; Elshikh, H; Phe, T; Koirala, K; Mukendi, D; Saad, A; Leng, L; Khanal, B; Bhatta, N; Bhattarai, N; Yansouni, C; van Griensven, J; Seiko, NH; Alirol, E; Ravinetto, R; van Loen, H; Buyze, J; Meheus, F; Burza, S; Verdonck, K; Jacobs, J; Parola, P; El Safi, S; Lim, K; Lutumba, P; Bottieau, E; Rijal, S; Boelaert, M				Chappuis, F.; Barbe, B.; Elshikh, H.; Phe, T.; Koirala, K.; Mukendi, D.; Saad, A.; Leng, L.; Khanal, B.; Bhatta, N.; Bhattarai, N.; Yansouni, C.; van Griensven, J.; Seiko, N. Horie; Alirol, E.; Ravinetto, R.; van Loen, H.; Buyze, J.; Meheus, F.; Burza, S.; Verdonck, K.; Jacobs, J.; Parola, P.; El Safi, S.; Lim, K.; Lutumba, P.; Bottieau, E.; Rijal, S.; Boelaert, M.			Diagnostic guidance for patients presenting with persistent fever in neglected tropical disease endemic areas of Cambodia, the Democratic Republic of Congo, Nepal and Sudan	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Chappuis, F.; Seiko, N. Horie; Alirol, E.] Univ Hosp Geneva, Geneva, Switzerland; [Barbe, B.; van Griensven, J.; Ravinetto, R.; van Loen, H.; Buyze, J.; Burza, S.; Verdonck, K.; Jacobs, J.; Bottieau, E.; Boelaert, M.] ITM, Antwerp, Belgium; [Elshikh, H.; Saad, A.] Univ Khartoum, Khartoum, Sudan; [Phe, T.; Leng, L.; van Griensven, J.; Lim, K.] Sihanouk Hosp Ctr Hope, Phnom Penh, Cambodia; [Koirala, K.; Khanal, B.; Bhatta, N.; Bhattarai, N.; Rijal, S.] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Mukendi, D.; Lutumba, P.] Inst Natl Rech Biomed, Kinshasa, Zaire; [Yansouni, C.] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Meheus, F.] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Burza, S.] London Sch Hyg & Trop Med, London WC1, England; [Parola, P.] Univ Hosp Inst Infect & Trop Dis, Marseille, France			Buyze, Jozefien/B-8550-2014	Buyze, Jozefien/0000-0001-6780-380X				0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		106	106						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800258					2019-04-02	
J	Franco, L; Cnops, L; Navascues, A; Boillat, N; Neumayr, A; Norman, F; Vanio, K; Dudman, S; Van Esbroeck, M; Molero, F; Hernandez, L; Potente, A; Wilder-Smith, A; Hatz, C; Sanchez-Seco, MP				Franco, L.; Cnops, L.; Navascues, A.; Boillat, N.; Neumayr, A.; Norman, F.; Vanio, K.; Dudman, S.; Van Esbroeck, M.; Molero, F.; Hernandez, L.; Potente, A.; Wilder-Smith, A.; Hatz, C.; Sanchez-Seco, M. P.			Dengue in Africa: sustained and silent circulation of multiple serotypes and genotypes, detected in travelers from 2010 to 2014	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Franco, L.; Hernandez, L.; Potente, A.; Sanchez-Seco, M. P.] Inst Hlth Carlos III, Madrid, Spain; [Cnops, L.; Van Esbroeck, M.] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Antwerp, Belgium; [Navascues, A.] Complejo Hosp Navarra, Pamplona, Spain; [Boillat, N.; Neumayr, A.; Hatz, C.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Norman, F.] Hosp Ramon & Cajal, E-28034 Madrid, Spain; [Vanio, K.; Dudman, S.] 1 Norwegian Inst Publ Hlth, Dept Virol, Oslo, Norway; [Molero, F.] Inst Salud Carlos III, Madrid, Spain; [Wilder-Smith, A.] Umea Univ, Dept Publ Hlth & Clin Med Epidemiol & Global Hlth, Umea, Sweden								0	1	1	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		107	108						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800261					2019-04-02	
J	Bottieau, E; Mukendi, D; Verdonck, K; Yansouni, C; Kayembe, T; Burza, S; Mpanya, A; Kalo, JR; Barbe, B; Schurmans, C; Buscher, P; Ravinetto, R; Winkler, A; Menten, J; van Loen, H; Jacobs, J; Lutumba, P; Boelaert, M; Chappuis, F				Bottieau, E.; Mukendi, D.; Verdonck, K.; Yansouni, C.; Kayembe, T.; Burza, S.; Mpanya, A.; Kalo, J. -R.; Barbe, B.; Schurmans, C.; Buescher, P.; Ravinetto, R.; Winkler, A.; Menten, J.; van Loen, H.; Jacobs, J.; Lutumba, P.; Boelaert, M.; Chappuis, F.			Development of guidance for the diagnostic management of patients with neurological disorders in hospitals in Bandundu, Democratic Republic of the Congo, with a focus on not-to-miss infections of the central nervous system	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Bottieau, E.; Verdonck, K.; Burza, S.; Barbe, B.; Schurmans, C.; Buescher, P.; Ravinetto, R.; Menten, J.; van Loen, H.; Jacobs, J.; Boelaert, M.] Inst Trop Med, B-2000 Antwerp, Belgium; [Mukendi, D.; Kalo, J. -R.; Lutumba, P.] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Yansouni, C.] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Kayembe, T.] Univ Kinshasa, Kinshasa, DEM REP CONGO; [Burza, S.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Mpanya, A.] Programme Natl Lutte Trypanosomiase Humaine Afric, Kinshasa, DEM REP CONGO; [Winkler, A.] Tech Univ Munich, D-80290 Munich, Germany; [Chappuis, F.] Univ Geneva, Geneva, Switzerland								0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		116	116						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800282					2019-04-02	
J	Malaviya, P; Picado, A; Hasker, E; Ostyn, B; Kansal, S; Shankar, R; Boelaert, M; Sundar, S				Malaviya, P.; Picado, A.; Hasker, E.; Ostyn, B.; Kansal, S.; Shankar, R.; Boelaert, M.; Sundar, S.			Health and demographic surveillance system profile: the Muzaffarpur-TMRC Health and Demographic Surveillance System	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Malaviya, P.; Kansal, S.; Shankar, R.; Sundar, S.] Banaras Hindu Univ, Med, Varanasi 221005, Uttar Pradesh, India; [Picado, A.] Univ Bacelona, Barcelona, Spain; [Hasker, E.; Ostyn, B.; Boelaert, M.] Inst Trop Med, B-2000 Antwerp, Belgium			Malaviya, Paritosh/B-1819-2012	Malaviya, Paritosh/0000-0002-7558-152X				0	0	0	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		130	130						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800317					2019-04-02	
J	Claeys, Y; Custers, A; Michiels, M; Ravinetto, R; Dunkley, S; van Griensven, J				Claeys, Y.; Custers, A.; Michiels, M.; Ravinetto, R.; Dunkley, S.; van Griensven, J.			Data collection in a high-risk infectious zone: challenges and lessons learned in an Ebola clinical trial in Conakry, Guinea	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Michiels, M.] Inst Trop Med, ICT, B-2000 Antwerp, Belgium; [Dunkley, S.] Med Sans Frontieres, Brussels, Belgium								0	0	0	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		135	135						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800329					2019-04-02	
J	Thiongo, MN; Loen, HV; Ravinetto, RR; Ndanyisaba, G; Diep, L; Hardy, L; Gichangi, P				Thiongo, M. N.; Loen, H. V.; Ravinetto, R. R.; Ndanyisaba, G.; Diep, L.; Hardy, L.; Gichangi, P.			Data Management Protocol: blueprint to stamp good data management procedures - experience from a multicountry study in East and South Africa	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Thiongo, M. N.] Int Ctr Reprod Hlth Kenya, Data Management, Mombasa, Kenya; [Loen, H. V.; Ravinetto, R. R.; Hardy, L.] Inst Trop Med, B-2000 Antwerp, Belgium; [Ndanyisaba, G.] Rinda Ubuzima, Kingali, Rwanda; [Diep, L.] WITS Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Gichangi, P.] Int Ctr Reprod Hlth Kenya, Mombasa, Kenya								0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		135	136						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800331					2019-04-02	
J	Ravinetto, R; Mutolo, DN; de Spiegeleere, B; Marini, R; Hasker, E; Schiavetti, B				Ravinetto, R.; Mutolo, D. Ngeleka; de Spiegeleere, B.; Marini, R.; Hasker, E.; Schiavetti, B.			The quality of paediatric medicines supplied by private wholesalers in Kinshasa, DRC	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ravinetto, R.] Inst Trop Med, Clin Sci, B-2000 Antwerp, Belgium; [Mutolo, D. Ngeleka] Direct Pharm & Medicament, Kinshasa, DEM REP CONGO; [de Spiegeleere, B.] Univ Ghent, B-9000 Ghent, Belgium; [Marini, R.] Univ Liege, Liege, Belgium; [Hasker, E.; Schiavetti, B.] Inst Trop Med, Publ Hlth, B-2000 Antwerp, Belgium								0	1	1	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		136	136						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800332					2019-04-02	
J	Jasuja, J; Veit, J; Fofana, HKM; Nimmesgern, A; Saye, R; Doumbia, MN; Landoure, A; Traore, MS; Herrmann, M; Yap, P; Polman, K; Boelaert, M; Chappuis, F; Utzinger, J; Sacko, M; von Muller, L; Becker, SL				Jasuja, J.; Veit, J.; Fofana, H. K. M.; Nimmesgern, A.; Saye, R.; Doumbia, M. N.; Landoure, A.; Traore, M. S.; Herrmann, M.; Yap, P.; Polman, K.; Boelaert, M.; Chappuis, F.; Utzinger, J.; Sacko, M.; von Mueller, L.; Becker, S. L.			Stool-based polymerase chain reaction for the diagnosis of multiple pathogens in Mali: a case-control study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Jasuja, J.; Veit, J.; Nimmesgern, A.; Herrmann, M.; von Mueller, L.; Becker, S. L.] Univ Saarland, Inst Med Microbiol & Hyg, Homburg, Germany; [Fofana, H. K. M.; Saye, R.; Doumbia, M. N.; Landoure, A.; Traore, M. S.; Sacko, M.] Inst Natl Rech Sante Publ, Bamako, Mali; [Yap, P.; Utzinger, J.; Becker, S. L.] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Yap, P.; Utzinger, J.; Becker, S. L.] Univ Basel, Basel, Switzerland; [Polman, K.; Boelaert, M.] Inst Trop Med, B-2000 Antwerp, Belgium; [Chappuis, F.] Univ Hosp Geneva, Div Humanitarian & Trop Med, Geneva, Switzerland			Herrmann, Mathias/B-6475-2013					0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	O.LB1.002	142	142						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800347					2019-04-02	
J	Colebunders, R; Tepage, F; Mandro, M; Musinya, G; Mambandu, G; Mokili, JL; Pfarr, K; Rood, E; Laudisoit, A				Colebunders, R.; Tepage, F.; Mandro, M.; Musinya, G.; Mambandu, G.; Mokili, J. L.; Pfarr, K.; Rood, E.; Laudisoit, A.			Why such a high prevalence of epilepsy in the Orientale Province in the Democratic Republic of the Congo (DRC)?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Colebunders, R.; Laudisoit, A.] Univ Antwerp, B-2020 Antwerp, Belgium; [Tepage, F.] Natl Onchocerciasis Control Program, Kisangani, DEM REP CONGO; [Mandro, M.] Div Prov Sante Ituri, Bunja, DEM REP CONGO; [Mambandu, G.] Minist Hlth, Kisangani, Orientale Provi, DEM REP CONGO; [Mokili, J. L.] San Diego State Univ, San Diego, CA 92182 USA; [Pfarr, K.] Univ Hosp Bonn, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany; [Rood, E.] Royal Trop Inst, NL-1105 AZ Amsterdam, Netherlands; [Laudisoit, A.] Univ Liverpool, Liverpool L69 3BX, Merseyside, England								0	1	1	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	O.LB1.003	143	143						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800348					2019-04-02	
J	Saez, AM; Ronse, M; Delamou, A; Nyankoye, H; Matthias, B; Grietens, KP; Van Griensven, J				Saez, A. Mari; Ronse, M.; Delamou, A.; Nyankoye, H.; Matthias, B.; Grietens, K. Peeters; Van Griensven, J.			Acceptability of plasma donation for clinical trial on Ebola virus disease in Conakry, Guinea	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Saez, A. Mari; Matthias, B.] Charite, Inst Trop Med & Int Hlth, D-13353 Berlin, Germany; [Ronse, M.; Grietens, K. Peeters; Van Griensven, J.] Inst Trop Med, B-2000 Antwerp, Belgium; [Delamou, A.] Natl Ctr Training & Res Maferinyah, Maferinyah, Guinea; [Nyankoye, H.] NBTC, Conakry, Guinea								0	0	0	0	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	O.LB2.001	144	145						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800352					2019-04-02	
J	Schiavetti, B; Giralt, AN; Massat, P; Ravinetto, R				Schiavetti, B.; Giralt, A. Nebot; Massat, P.; Ravinetto, R.			Quality of medicines in resource-limited settings: an analysis of the compliance of pharmaceutical distributors with the WHO Quality Assurance standards	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Schiavetti, B.; Massat, P.] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Giralt, A. Nebot] Inst Trop Med, B-2000 Antwerp, Belgium; [Ravinetto, R.] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium								0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	O.LB2.004	146	146						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800355					2019-04-02	
J	Lula, Y; Engo, A; Muhindo, H; Nsimba, G; Mbo, J; Mulongo, R; Bisuta, S; Bakaswa, G; Lutumba, P; Van Geertruyden, JP; Tona, G				Lula, Y.; Engo, A.; Muhindo, H.; Nsimba, G.; Mbo, J.; Mulongo, R.; Bisuta, S.; Bakaswa, G.; Lutumba, P.; Van Geertruyden, J. -P.; Tona, G.			Safety of second-line antituberculosis agents in the context of multi-drug resistant tuberculosis therapy in Kinshasa: a pilot cohort study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Lula, Y.; Engo, A.; Nsimba, G.; Tona, G.] Univ Kinshasa, Clin Pharmacol & Pharmacovigilance Unit, Kinshasa, DEM REP CONGO; [Lula, Y.; Muhindo, H.; Van Geertruyden, J. -P.] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium; [Muhindo, H.; Lutumba, P.] Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO; [Mbo, J.; Mulongo, R.] Management Sci Hlth, Kinshasa, DEM REP CONGO; [Bisuta, S.; Bakaswa, G.] Natl Programme TB Control, Kinshasa, DEM REP CONGO			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PST1.011	152	152						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800367					2019-04-02	
J	Mavoko, HM; Llombe, G; da Luz, RI; Kutekemeni, A; van Geertruyden, JP; Lutumba, P				Mavoko, H. M.; Llombe, G.; da Luz, R. I.; Kutekemeni, A.; van Geertruyden, J. -P.; Lutumba, P.			Malaria policies versus practices, a reality check from Kinshasa, the capital of the Democratic Republic of Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mavoko, H. M.; Lutumba, P.] Univ Kinshasa, Kinshasa, DEM REP CONGO; [Mavoko, H. M.; da Luz, R. I.; van Geertruyden, J. -P.] Univ Antwerp, B-2020 Antwerp, Belgium; [Llombe, G.] Univ Kinshasa, Kinshasa, Belgium; [Kutekemeni, A.] Minist Sante Publ, Programme Natl Lutte Paludisme, Kinshasa, DEM REP CONGO			Van geertruyden, Jean-Pierre/K-6425-2014; Inocencio da Luz, Raquel/L-9676-2016	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Inocencio da Luz, Raquel/0000-0002-2870-0311				0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PST1.013	153	153						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800369					2019-04-02	
J	Mavoko, HM; Effa, J; Kalabuanga, M; Mukele, R; da Luz, R; Lunguya, O; Phoba, MF; van Geertruyden, JP; Lutumba, P				Mavoko, H. Muhindo; Effa, J.; Kalabuanga, M.; Mukele, R.; da Luz, R.; Lunguya, O.; Phoba, M. -F.; van Geertruyden, J-P.; Lutumba, P.			Non-malaria related acute fever, a preliminary study from Kinshasa the Democratic Republic of Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mavoko, H. Muhindo] Univ Kinshasa, Univ Antwerp, Int Hlth Unit, Kinshasa, DEM REP CONGO; [Mavoko, H. Muhindo; Effa, J.; da Luz, R.] Univ Antwerp, B-2020 Antwerp, Belgium; [Kalabuanga, M.] Lisungi Hlth Ctr, Kinshasa, DEM REP CONGO; [Mukele, R.; Lunguya, O.; Lutumba, P.] Univ Kinshasa, Kinshasa, DEM REP CONGO; [Phoba, M. -F.] Inst Natl Recherce Biomed, Kinshasa, DEM REP CONGO; [van Geertruyden, J-P.] Univ Antwerp, Antwerp, DEM REP CONGO			Van geertruyden, Jean-Pierre/K-6425-2014; Inocencio da Luz, Raquel/L-9676-2016	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Inocencio da Luz, Raquel/0000-0002-2870-0311				0	1	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PST3.014	163	163						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800394					2019-04-02	
J	Philips, M; Nadimpalli, A; Rius, J; Gerard, S				Philips, M.; Nadimpalli, A.; Rius, J.; Gerard, S.			Consequences of the Ebola outbreak crisis for non-Ebola health care offer and access in Liberia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Philips, M.; Gerard, S.] MSF, Anal & Advocacy Unit Hlth Access, DG, Brussels, Belgium; [Nadimpalli, A.; Rius, J.] MSF, Monrovia, Liberia								0	0	0	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PST4.002	164	164						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800397					2019-04-02	
J	Ccenhua, MRT; Pulido-Tamayo, S; Imamura, H; Verbeke, LP; Cotton, J; Dujardin, JC; Marchal, K				Ccenhua, M. R. Ticlla; Pulido-Tamayo, S.; Imamura, H.; Verbeke, L. P.; Cotton, J.; Dujardin, J. -C.; Marchal, K.			Studying the relationship between drug resistance and genomic variations in Leishmania donovani using a network-based method	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ccenhua, M. R. Ticlla; Pulido-Tamayo, S.; Marchal, K.] Katholieke Univ Leuven, Dept Microbial & Mol Syst, Ctr Microbial & Plant Genet, Leuven, Belgium; [Pulido-Tamayo, S.; Marchal, K.] Dept Plant Biotechnol & Bioinformat, Ghent, Belgium; [Pulido-Tamayo, S.; Verbeke, L. P.; Marchal, K.] Univ Ghent, Dept Informat Technol, IMinds, B-9000 Ghent, Belgium; [Imamura, H.; Dujardin, J. -C.] Inst Trop Med, Unit Mol Parasitol, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Cotton, J.] Wellcome Trust Sanger Inst, Hinxton, Cambs, England			Marchal, Kathleen/B-5001-2013	Marchal, Kathleen/0000-0002-2169-4588				0	0	0	0	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PST4.004	165	165						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800399					2019-04-02	
J	Ravinetto, R; Crucitti, T; Jacobs, J; van Griesven, J; Buve, A				Ravinetto, R.; Crucitti, T.; Jacobs, J.; van Griesven, J.; Buve, A.			Revisiting essential requirements of good clinical practices and good clinical laboratory practices in emergency research settings: a set of field-rooted recommendations	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ravinetto, R.; Crucitti, T.; Jacobs, J.; van Griesven, J.] Inst Trop Med, Clin Sci, B-2000 Antwerp, Belgium; [Buve, A.] Inst Trop Med, Publ Hlth, B-2000 Antwerp, Belgium								0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PST5.005	168	169						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758800408					2019-04-02	
J	Kamangu, EN; Chatte, A; Susin, F; Boreux, R; Kalala, RL; Mvumbi, GL; De Mol, P; Vaira, D; Hayette, MP				Kamangu, E. N.; Chatte, A.; Susin, F.; Boreux, R.; Kalala, R. L.; Mvumbi, G. L.; De Mol, P.; Vaira, D.; Hayette, M. -P.			Genetic diversity and antiretroviral drug resistance among drug-naive HIV type 1 infected patients attending clinics in Kinshasa, Democratic Republic of Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Kamangu, E. N.; Kalala, R. L.; Mvumbi, G. L.] Univ Kinshasa, Fac Med, Biol Mol, Sci Base, Kinshasa, DEM REP CONGO; [Chatte, A.] Univ Inst Sci & Technol Abeche, Abeche, Chad; [Susin, F.; Vaira, D.; Hayette, M. -P.] CHU ULg, LRS, Liege, Belgium; [Boreux, R.; De Mol, P.; Hayette, M. -P.] CHU ULg, Clin Microbiol, Liege, Belgium								0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.006	173	173						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801006					2019-04-02	
J	Kamangu, EN; Bulanda, BI; Bongenia, BI; Botomwito, HT; Mvumbi, GL; De Mol, P; Vaira, D; Hayette, MP				Kamangu, E. N.; Bulanda, B. I.; Bongenia, B. I.; Botomwito, H. T.; Mvumbi, G. L.; De Mol, P.; Vaira, D.; Hayette, M. -P.			Virological profile of patients infected with HIV starting antiretroviral treatment in Kinshasa	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Kamangu, E. N.; Mvumbi, G. L.] Univ Kinshasa, Fac Med, Sci Base, Biol Mol, Kinshasa, DEM REP CONGO; [Kamangu, E. N.; Bulanda, B. I.; Bongenia, B. I.; Botomwito, H. T.] Res Grp Focus HIV AIDS, Kinshasa, DEM REP CONGO; [De Mol, P.; Hayette, M. -P.] CHU ULg, Clin Microbiol, Liege, Belgium; [Vaira, D.; Hayette, M. -P.] CHU ULg, LRS, Liege, Belgium								0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.007	173	173						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801007					2019-04-02	
J	Bakiono, F; Guiguimde, PWL; Sanou, M; Ouedraogo, L; Robert, A				Bakiono, F.; Guiguimde, P. W. L.; Sanou, M.; Ouedraogo, L.; Robert, A.			Quality of life in persons living with HIV: a longitudinal study over 12 months in Ouagadougou-Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Bakiono, F.; Robert, A.] Catholic Univ Louvain, Inst Expt & Clin Res IREC Epidemiol & Biostat EPI, B-1200 Brussels, Belgium; [Guiguimde, P. W. L.; Sanou, M.; Ouedraogo, L.] Univ Ouagadougou, UFR Sci Sante, Ouagadougou, Burkina Faso; [Ouedraogo, L.] Inst Reg Sante Publ, Ouidah, Benin								0	0	0	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.010	174	174						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801010					2019-04-02	
J	Matangila, J; da Luz, RI; Lutumba, P; Van Geertruyden, JP				Matangila, J.; da Luz, R. I.; Lutumba, P.; Van Geertruyden, J. -P.			Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine (SP) and SP- piperaquine in schoolchildren in Kinshasa, The Democratic Republic of the Congo (RDC)	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Matangila, J.; Lutumba, P.] Univ Kinshasa, Kinshasa, DEM REP CONGO; [Matangila, J.; da Luz, R. I.; Van Geertruyden, J. -P.] Univ Antwerp, B-2020 Antwerp, Belgium			Inocencio da Luz, Raquel/L-9676-2016; Van geertruyden, Jean-Pierre/K-6425-2014	Inocencio da Luz, Raquel/0000-0002-2870-0311; Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.023	179	180						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801023					2019-04-02	
J	Matangila, J; Doua, JY; Linsuke, S; Madinga, J; da Luz, RI; Van Geertruyden, JP; Lutumba, P				Matangila, J.; Doua, J. Y.; Linsuke, S.; Madinga, J.; da Luz, R. I.; Van Geertruyden, J. -P.; Lutumba, P.			Malaria, schistosomiasis and soil transmitted helminth burden and their correlation with anemia in children attending primary schools in Kinshasa, The Democratic Republic of the Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Matangila, J.; Linsuke, S.; Madinga, J.; Lutumba, P.] Univ Kinshasa, Kinshasa, DEM REP CONGO; [Matangila, J.; Doua, J. Y.; da Luz, R. I.; Van Geertruyden, J. -P.] Univ Antwerp, B-2020 Antwerp, Belgium			Van geertruyden, Jean-Pierre/K-6425-2014; Inocencio da Luz, Raquel/L-9676-2016	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Inocencio da Luz, Raquel/0000-0002-2870-0311				0	0	0	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.024	180	180						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801024					2019-04-02	
J	Baraka, V; Ishengoma, DS; Fransis, F; Minja, DTR; Madebe, R; Ngatunga, D; Van Geertruyden, JP				Baraka, V.; Ishengoma, D. S.; Fransis, F.; Minja, D. T. R.; Madebe, R.; Ngatunga, D.; Van Geertruyden, J. -P.			High level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of the septuple haplotype in Tanzania	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Baraka, V.] NIMR Tanzania, Dept Biosci, Tanga, Tanzania; [Baraka, V.; Van Geertruyden, J. -P.] Univ Antwerp, Int Hlth Unit, Dept Epidemiol, B-2020 Antwerp, Belgium; [Ishengoma, D. S.; Fransis, F.; Minja, D. T. R.; Madebe, R.] NIMR Tanzania, Tanga, Tanzania; [Ngatunga, D.] Tanzania Food & Drugs Author, Dar Es Salaam, Tanzania			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.032	183	183						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801032					2019-04-02	
J	Mavoko, HM; Nabasumba, C; da Luz, RI; Grobusch, MP; Tinto, H; D'Alessandro, U; Kambugu, A; Lutumba, P; Van Geertruyden, JP				Mavoko, H. M.; Nabasumba, C.; da Luz, R. I.; Grobusch, M. P.; Tinto, H.; D'Alessandro, U.; Kambugu, A.; Lutumba, P.; Van Geertruyden, J. -P.			Efficacy and safety of retreatment with the same artemisinin-based combination compared to the recommended rescue treatments (QUINACT study)	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mavoko, H. M.; Nabasumba, C.; da Luz, R. I.; Van Geertruyden, J. -P.] Univ Antwerp, B-2020 Antwerp, Belgium; [Mavoko, H. M.; Lutumba, P.] Univ Kinshasa, Kinshasa, DEM REP CONGO; [Nabasumba, C.] Epictr Res Base, Mbarara, Uganda; [Grobusch, M. P.] Amsterdam Med Ctr, Amsterdam, Netherlands; [Tinto, H.] Ctr Muraz, Bobo Dioulasso, Burkina Faso; [D'Alessandro, U.] Inst Trop Med Antwerp, Antwerp, Belgium; [Kambugu, A.] Infect Dis Res Inst, Kampala, Uganda			Van geertruyden, Jean-Pierre/K-6425-2014; Inocencio da Luz, Raquel/L-9676-2016	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Inocencio da Luz, Raquel/0000-0002-2870-0311				0	0	0	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.033	183	184						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801033					2019-04-02	
J	Mavoko, HM; Kalabuanga, M; Mukele, R; Maketa, V; Fungula, B; Delgado, C; da Luz, RI; Lutumba, P; Van Geertruyden, JP				Mavoko, H. M.; Kalabuanga, M.; Mukele, R.; Maketa, V.; Fungula, B.; Delgado, C.; da Luz, R. I.; Lutumba, P.; Van Geertruyden, J. -P.			Uncomplicated malaria features and efficacy of artesunate-amodiaquine after 42 days of passive follow up in the Democratic Republic of Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mavoko, H. M.; Kalabuanga, M.; Mukele, R.; Maketa, V.; Fungula, B.; Lutumba, P.] Univ Kinshasa, Kinshasa, DEM REP CONGO; [Mavoko, H. M.; Maketa, V.; Delgado, C.; da Luz, R. I.; Van Geertruyden, J. -P.] Univ Antwerp, B-2020 Antwerp, Belgium			Inocencio da Luz, Raquel/L-9676-2016; Van geertruyden, Jean-Pierre/K-6425-2014	Inocencio da Luz, Raquel/0000-0002-2870-0311; Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.034	184	184						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801034					2019-04-02	
J	Lula, Y; Mavoko, HM; Kalabuanga, M; Fungula, B; Yumva, NN; Lutete, T; da Luz, RI; Van Geertruyden, JP; Lutumba, P				Lula, Y.; Mavoko, H. M.; Kalabuanga, M.; Fungula, B.; Yumva, N. N.; Lutete, T.; da Luz, R. I.; Van Geertruyden, J. -P.; Lutumba, P.			Safety of artesunate-amodiaquine, artemether-lumefantrine and quinine plus clindamycin as rescue treatment of uncomplicated Plasmodium falciparum malaria: an open-label, randomized trial in Kinshasa, the Democratic Republic of Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Lula, Y.; Mavoko, H. M.; Kalabuanga, M.; Fungula, B.; Yumva, N. N.; Lutete, T.; Lutumba, P.] Univ Kinshasa, Kinshasa, DEM REP CONGO; [Lula, Y.; Mavoko, H. M.; da Luz, R. I.; Van Geertruyden, J. -P.] Univ Antwerp, B-2020 Antwerp, Belgium			Inocencio da Luz, Raquel/L-9676-2016; Van geertruyden, Jean-Pierre/K-6425-2014	Inocencio da Luz, Raquel/0000-0002-2870-0311; Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.037	185	185						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801037					2019-04-02	
J	Tahita, MC; Tinto, H; Yarga, S; Kazienga, A; Coulibaly, MT; Valea, I; VanOvermeir, C; Rosanas-Urgell, A; Ouedraogo, JB; Guiguemde, RT; Van Geertruyden, JP; Erhart, A; D'Alessandro, U				Tahita, M. C.; Tinto, H.; Yarga, S.; Kazienga, A.; Coulibaly, M. Traore; Valea, I.; VanOvermeir, C.; Rosanas-Urgell, A.; Ouedraogo, J. -B.; Guiguemde, R. T.; Van Geertruyden, J. -P.; Erhart, A.; D'Alessandro, U.			Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Tahita, M. C.; Tinto, H.; Coulibaly, M. Traore; Ouedraogo, J. -B.] Direct Reg Ouest IRSS DRO, Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso; [Tahita, M. C.; Tinto, H.; Kazienga, A.; Coulibaly, M. Traore; Valea, I.; Ouedraogo, J. -B.; Guiguemde, R. T.] Clin Res Unit Nanoro IRSS CRUN, Nanoro, Burkina Faso; [Tahita, M. C.; Tinto, H.; VanOvermeir, C.; Rosanas-Urgell, A.; Erhart, A.; D'Alessandro, U.] Inst Trop Med ITM, Malariol Unit, Antwerp, Belgium; [Tahita, M. C.; Van Geertruyden, J. -P.] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium; [Yarga, S.; Valea, I.; Guiguemde, R. T.] Ctr Muraz, Unite Rech Paludisme & Malad Trop Negligees, Bobo Dioulasso, Burkina Faso; [Guiguemde, R. T.] Inst Super Sci Sante INSSA, Bobo Dioulasso, Burkina Faso; [D'Alessandro, U.] MRC Unit, Fajara, Gambia; [D'Alessandro, U.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England			Rosanas-Urgell, Anna/D-3193-2015; Van geertruyden, Jean-Pierre/K-6425-2014	Rosanas-Urgell, Anna/0000-0002-0432-5203; Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.040	186	187						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801040					2019-04-02	
J	Mvumbi, DM; Kayembe, JMN; Situakibanza, HNT; Mvumbi, GL; Bobanga, TL; Nsibu, CN; Melin, P; De Mol, P; Hayette, MP				Mvumbi, D. M.; Kayembe, J. -M. N.; Situakibanza, H. N. -T.; Mvumbi, G. L.; Bobanga, T. L.; Nsibu, C. N.; Melin, P.; De Mol, P.; Hayette, M. -P.			No SVMNT haplotype found in the Democratic Republic of Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract						SVMNT; Haplotype; DR Congo; resistance			[Mvumbi, D. M.; Mvumbi, G. L.] Univ Kinshasa, Basic Sci, Kinshasa, DEM REP CONGO; [Kayembe, J. -M. N.] Univ Kinshasa, Internal Med, Kinshasa, DEM REP CONGO; [Situakibanza, H. N. -T.; Bobanga, T. L.] Univ Kinshasa, Parasitol & Trop Med, Kinshasa, DEM REP CONGO; [Nsibu, C. N.] Univ Kinshasa, Pediat, Kinshasa, DEM REP CONGO; [Melin, P.; De Mol, P.; Hayette, M. -P.] Univ Liege, Clin Microbiol, Liege, Belgium								0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.041	187	187						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801041					2019-04-02	
J	Kaswa, MK; Bakaswa, GN; Boelaert, M				Kaswa, M. K.; Bakaswa, G. N.; Boelaert, M.			Outbreak investigation of tuberculosis and multidrug-resistant tuberculosis in the central prison of Mbuji-Mayi the diamond capital of the Democratic Republic of Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Kaswa, M. K.; Bakaswa, G. N.] Natl TB Program, Kinshasa, Zaire; [Boelaert, M.] ITM, Antwerp, Belgium								0	0	0	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.070	198	198						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801070					2019-04-02	
J	Kleine, C; Chertow, DS; Edwards, JK; Sprecher, A; Scaini, R; Guilliani, R				Kleine, C.; Chertow, D. S.; Edwards, J. K.; Sprecher, A.; Scaini, R.; Guilliani, R.			Ebola virus disease - clinical manifestations and management	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Kleine, C.] Univ Hosp Frankfurt, Frankfurt, Germany; [Kleine, C.; Chertow, D. S.; Edwards, J. K.; Sprecher, A.; Scaini, R.; Guilliani, R.] Medecins Sans Frontieres, Brussels, Belgium; [Chertow, D. S.] NIH, Bethesda, MD 20892 USA								0	0	0	0	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.085	204	204						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801085					2019-04-02	
J	le Rutte, EA; Coffeng, LE; Bontje, DM; Hasker, EC; Hoekstra, RC; Bakker, R; Boelaert, M; de Vlas, SJ				le Rutte, E. A.; Coffeng, L. E.; Bontje, D. M.; Hasker, E. C.; Hoekstra, R. C.; Bakker, R.; Boelaert, M.; de Vlas, S. J.			Feasibility of eliminating visceral leishmaniasis from the Indian subcontinent	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[le Rutte, E. A.; Coffeng, L. E.; Bontje, D. M.; Hoekstra, R. C.; Bakker, R.; de Vlas, S. J.] Erasmus MC, Rotterdam, Netherlands; [Hasker, E. C.; Boelaert, M.] Inst Trop Med, B-2000 Antwerp, Belgium								0	0	0	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.094	207	208						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801094					2019-04-02	
J	Mahajan, R; Das, P; Isaakidis, P; Sunyoto, T; Sagili, KD; Lima, MA; Mitra, G; Kumar, D; Pandey, K; Van Geertruyden, JP; Boelaert, M; Burza, S				Mahajan, R.; Das, P.; Isaakidis, P.; Sunyoto, T.; Sagili, K. D.; Lima, M. A.; Mitra, G.; Kumar, D.; Pandey, K.; Van Geertruyden, J. -P.; Boelaert, M.; Burza, S.			Combination treatment for visceral leishmaniasis patients co-infected with human immunodeficiency virus in India	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mahajan, R.; Sunyoto, T.; Mitra, G.; Kumar, D.; Burza, S.] Medecins Sans Frontieres, Delhi, India; [Das, P.; Pandey, K.] Rajendra Mamorial Res Inst, Patna, Bihar, India; [Isaakidis, P.] Medecins Sans Frontieres, Res Unit, Luxembourg, Luxembourg; [Sagili, K. D.] Int Union TB & Lung Dis Union, New Delhi, India; [Lima, M. A.] Medecins Sans Frontieres, Barcelona, Spain; [Van Geertruyden, J. -P.; Burza, S.] Univ Antwerp, Int Hlth, B-2020 Antwerp, Belgium; [Boelaert, M.; Burza, S.] Inst Trop Med, B-2000 Antwerp, Belgium			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.093	207	207						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801093					2019-04-02	
J	Burza, S; Jeleff, M; Das, VR; Sunyoto, T; Mahajan, R; Lima, MA; Boelaert, M; Van Geertruyden, JP; Burtscher, D; Das, P				Burza, S.; Jeleff, M.; Das, V. R.; Sunyoto, T.; Mahajan, R.; Lima, M. A.; Boelaert, M.; Van Geertruyden, J. -P.; Burtscher, D.; Das, P.			Patient perceptions of new treatment modalities for visceral leishmaniasis in Bihar, India: a qualitative study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Burza, S.; Sunyoto, T.; Mahajan, R.] Medecins Sans Frontieres, Delhi, India; [Burza, S.; Boelaert, M.] Inst Trop Med, B-2000 Antwerp, Belgium; [Burza, S.; Van Geertruyden, J. -P.] Univ Antwerp, Int Hlth, B-2020 Antwerp, Belgium; [Jeleff, M.; Burtscher, D.] Medecins Sans Frontieres, Vienna, Austria; [Das, V. R.; Das, P.] Rajendra Mamorial Res Inst, Patna, Bihar, India; [Lima, M. A.] Medecins Sans Frontieres, Barcelona, Spain			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.102	211	211						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801102					2019-04-02	
J	Ostyn, B; Uranw, S; Das, ML; Bhattarai, NR; Van der Auwera, G; Durnez, L; Dujardin, JC; Boelaert, M; Rijal, S				Ostyn, B.; Uranw, S.; Das, M. L.; Bhattarai, N. R.; Van der Auwera, G.; Durnez, L.; Dujardin, J. -C.; Boelaert, M.; Rijal, S.			Visceral leishmaniasis cases in non-endemic districts in Nepal: imported or local transmission?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ostyn, B.; Boelaert, M.] Inst Trop Med, Publ Hlth, B-2000 Antwerp, Belgium; [Uranw, S.; Rijal, S.] BP Koirala Inst Hlth Sci, Dept Internal Med, Dharan, Nepal; [Das, M. L.; Bhattarai, N. R.] BP Koirala Inst Hlth Sci, Dept Microbiol, Dharan, Nepal; [Van der Auwera, G.; Durnez, L.; Dujardin, J. -C.] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium								0	0	0	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.109	213	214						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801109					2019-04-02	
J	Meheus, F; Burza, S; Peeling, R; Chappuis, F; Mertens, P; Sundar, S; Rijal, S; Bhattarai, N; Bhattacharyya, T; Boelaert, M; Miles, M				Meheus, F.; Burza, S.; Peeling, R.; Chappuis, F.; Mertens, P.; Sundar, S.; Rijal, S.; Bhattarai, N.; Bhattacharyya, T.; Boelaert, M.; Miles, M.			The cost and cost-effectiveness of IgG1 as point-of-care rapid diagnostic tests to detect relapse of visceral leishmaniasis	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Meheus, F.] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Burza, S.; Boelaert, M.] Inst Trop Med, B-2000 Antwerp, Belgium; [Burza, S.; Peeling, R.; Bhattacharyya, T.; Miles, M.] London Sch Hyg & Trop Med, London WC1, England; [Chappuis, F.] Univ Hosp Geneva, Div Trop & Humanitarian Med, Geneva, Switzerland; [Mertens, P.] Coris BioConcept, Gembloux, Belgium; [Sundar, S.] Baranas Hindu Univ, Varanasi, Uttar Pradesh, India; [Bhattarai, N.] BP Koirala Inst Hlth Sci, Dharan, Nepal								0	0	0	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.112	214	215						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801112					2019-04-02	
J	Diro, E; Ritmeijer, K; Boelaert, M; Alves, F; Mohammed, R; Abongomera, C; Ravinetto, R; De Crop, M; Fikre, H; Adera, C; Colebunders, R; van Loen, H; Menten, J; Lynen, L; Hailu, A; van Griensven, J				Diro, E.; Ritmeijer, K.; Boelaert, M.; Alves, F.; Mohammed, R.; Abongomera, C.; Ravinetto, R.; De Crop, M.; Fikre, H.; Adera, C.; Colebunders, R.; van Loen, H.; Menten, J.; Lynen, L.; Hailu, A.; van Griensven, J.			Use of pentamidine as secondary prophylaxis to prevent visceral leishmaniasis relapse in HIV infected patients	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Diro, E.; Mohammed, R.; Fikre, H.] Univ Gondar, Gondar, Ethiopia; [Diro, E.; Boelaert, M.; Ravinetto, R.; De Crop, M.; Colebunders, R.; van Loen, H.; Menten, J.; Lynen, L.; van Griensven, J.] Inst Trop Med, B-2000 Antwerp, Belgium; [Ritmeijer, K.] Medecins Sans Frontieres, Amsterdam, Netherlands; [Alves, F.] Drugs Neglected Dis Initiat, Geneva, Switzerland; [Abongomera, C.; Adera, C.] Medecins Sans Frontieres, Abdurafi, Ethiopia; [Ravinetto, R.] KU, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium; [Hailu, A.] Univ Addis Ababa, Addis Ababa, Ethiopia								0	0	0	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.119	217	217						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801119					2019-04-02	
J	Malaviya, P; Kansal, S; Ostyn, B; Geertruyden, JPV; Boelaert, M; Sundar, S				Malaviya, P.; Kansal, S.; Ostyn, B.; Geertruyden, J-P. V.; Boelaert, M.; Sundar, S.			Control of visceral leishmaniasis: perceptions, acceptance and weaknesses of indoor insecticide spraying (IRS) campaign	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Malaviya, P.; Kansal, S.; Sundar, S.] Banaras Hindu Univ, Med, Varanasi 221005, Uttar Pradesh, India; [Ostyn, B.; Boelaert, M.] Inst Trop Med, B-2000 Antwerp, Belgium; [Geertruyden, J-P. V.] Univ Antwerp, B-2020 Antwerp, Belgium			Van geertruyden, Jean-Pierre/K-6425-2014; Malaviya, Paritosh/B-1819-2012	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Malaviya, Paritosh/0000-0002-7558-152X				0	0	0	1	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.128	221	221						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801128					2019-04-02	
J	Fortin, A; Dorlo, TPC; Matheeussen, A; Hendrickx, S; Cos, P; Maes, L				Fortin, A.; Dorlo, T. P. C.; Matheeussen, A.; Hendrickx, S.; Cos, P.; Maes, L.			Pharmacokinetics and pharmacodynamics of oral oleylphosphocholine in a hamster model of visceral leishmaniasis	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Fortin, A.] Dafra Pharma R&D, Turnhout, Belgium; [Fortin, A.] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Dorlo, T. P. C.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Dorlo, T. P. C.] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden; [Matheeussen, A.; Hendrickx, S.; Cos, P.; Maes, L.] Univ Antwerp, Lab Microbiol Parasitol & Hyg, B-2020 Antwerp, Belgium			Cos, Paul/L-9717-2015; Dorlo, Thomas/F-1339-2011; Maes, Louis/A-2384-2017	Cos, Paul/0000-0003-4361-8911; Dorlo, Thomas/0000-0003-3076-8435; Maes, Louis/0000-0002-2324-9509				0	0	0	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.131	222	222						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801131					2019-04-02	
J	Bizimana, P; Van Geertruyden, JP; Polman, K; Ortu, G				Bizimana, P.; Van Geertruyden, J-P.; Polman, K.; Ortu, G.			Gaps in health capacities for the case management of schistosomiasis and soil-transmitted helminths infections in Burundi	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Bizimana, P.] Inst Natl Sante Publ, Sante Publ, Gest Serv Sante & Sante Environm, Bujumbura, Burundi; [Bizimana, P.; Van Geertruyden, J-P.] Univ Antwerp, Int Hlth Unit, Fac Med, Antwerp, Belgium; [Polman, K.] Inst Trop Med, Med Helminthol Unit, B-2000 Antwerp, Belgium; [Ortu, G.] Schistosomiasis Control Initiat, Infect Dis, London, England			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.153	230	230						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801152					2019-04-02	
J	Maimela, E; Alberts, M; Van Geertruyden, JP; Meulemans, H; Fraeyman, J; Bastiaens, H				Maimela, E.; Alberts, M.; Van Geertruyden, J. P.; Meulemans, H.; Fraeyman, J.; Bastiaens, H.			Addressing non-communicable diseases through community health workers and traditional healers in Dikgale Health and Demographic Surveillance System site: a qualitative study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract						Chronic disease management; Community Health Workers; Traditional health practitioners; Integration; Support			[Maimela, E.; Alberts, M.] Univ Limpopo, Med Sci Hlth Promot & Publ Hlth, Polokwane, South Africa; [Van Geertruyden, J. P.] Int Hlth Unit, Antwerp, Belgium; [Meulemans, H.] Sociol & Res Ctr Longitudinal & Life Course Studi, Antwerp, Belgium; [Fraeyman, J.] Res Grp Med Sociol & Hlth Policy, Antwerp, Belgium; [Bastiaens, H.] Univ Antwerp, Primary & Interdisciplinary Care, B-2020 Antwerp, Belgium			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	1	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.207	250	251						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801205					2019-04-02	
J	Maimela, E; Alberts, M; Modjadji, SEP; Choma, S; Dikotope, S; Ntuli, S; Van Geertruyden, JP				Maimela, E.; Alberts, M.; Modjadji, S. E. P.; Choma, S.; Dikotope, S.; Ntuli, S.; Van Geertruyden, J. P.			The prevalence and determinants of chronic non-communicable disease risk factors among adults in Dikgale Health Demographic and Surveillance System (HDSS) site, Limpopo Province of South Africa	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract						Dikgale Health and Demographic Health Surveillance System; behavioural and biochemical risk factors; Non-communicable diseases; public health; Health System Performance			[Maimela, E.; Alberts, M.; Modjadji, S. E. P.; Choma, S.; Dikotope, S.; Ntuli, S.] Univ Limpopo, Med Sci Publ Hlth & Hlth Promot, Polokwane, South Africa; [Van Geertruyden, J. P.] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.206	250	250						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801204					2019-04-02	
J	Lutumba, P; Tanzi, E; da Luz, RI; Linsuke, S; Ali-Risasi, C; Numbi, L; Za, A; Preti, M; Moretti, R; Cremaschini, M; Arnaud, S; Morganti, P				Lutumba, P.; Tanzi, E.; da Luz, R. Inocencio; Linsuke, S.; Ali-Risasi, C.; Numbi, L.; Za, A.; Preti, M.; Moretti, R.; Cremaschini, M.; Arnaud, S.; Morganti, P.			Contribution to the rationalization and definition of an efficient policy for the prevention of cancer in DRCongo: entry point cervical cancer	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Lutumba, P.] Univ Kinshasa, Trop Med, Kinshasa, DEM REP CONGO; [Tanzi, E.; Za, A.] Univ Milan, Milan, Italy; [da Luz, R. Inocencio] Univ Antwerp, B-2020 Antwerp, Belgium; [Linsuke, S.] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Ali-Risasi, C.] Hop Prov Gen Reference Kinshasa, Kinshasa, DEM REP CONGO; [Numbi, L.] Assicas, Kinshasa, DEM REP CONGO; [Preti, M.] Ist Europeo Oncol Milano, Milan, Italy; [Moretti, R.; Cremaschini, M.] ASL Bergamo, Bergamo, Italy; [Arnaud, S.] APOF Pathologists Borders, Milan, Italy; [Morganti, P.] CESVI, Bergamo, Italy			Inocencio da Luz, Raquel/L-9676-2016	Inocencio da Luz, Raquel/0000-0002-2870-0311				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		252	252						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801208					2019-04-02	
J	Sawadogo, K; Ambroise, J; Vercauteren, S; Castadot, M; Vanhalewyn, M; Col, J; Robert, A				Sawadogo, K.; Ambroise, J.; Vercauteren, S.; Castadot, M.; Vanhalewyn, M.; Col, J.; Robert, A.			Characterization of daily weight, blood pressure and pulse rate using home telemonitoring in patients with heart failure	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Sawadogo, K.; Ambroise, J.; Robert, A.] Catholic Univ Louvain, Inst Rech Expt, B-1200 Brussels, Belgium; [Sawadogo, K.; Ambroise, J.; Robert, A.] Catholic Univ Louvain, Clin Pole Epidemiol & Biostat, B-1200 Brussels, Belgium; [Vercauteren, S.; Castadot, M.; Col, J.] BHC, Clin St Jean, Brussels, Belgium; [Vanhalewyn, M.] SSMG, Brussels, Belgium								0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.211	252	252						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801209					2019-04-02	
J	Fromont, AE; Mohand, AA; Misago, CN; Casini, A				Fromont, A. E.; Mohand, A. Ait; Misago, C. N.; Casini, A.			Studying the history of interventions in health systems for a better understanding of changes: the case of mental health care integration in Rwandese district hospitals	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Fromont, A. E.; Casini, A.] Univ Libre Bruxelles, Sch Publ Hlth, Brussels, Belgium; [Mohand, A. Ait] Belgium Tech Cooperat, Kigali, Belgium; [Misago, C. N.] Minist Hlth, Rwanda Biomed Ctr, Div Mental Hlth, Kigali, Belgium								0	0	0	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.219	255	255						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801216					2019-04-02	
J	Londono, EA; Rodriguez, AJ; Diaz, AM; Carbonell, I; Achiong, F; Garcia, R; Balcindes, S; De Vos, P; Van der Stuyft, P				Londono, E. A.; Rodriguez, A. J.; Diaz, A. M.; Carbonell, I.; Achiong, F.; Garcia, R.; Balcindes, S.; De Vos, P.; Van der Stuyft, P.			Improving chronic care in Cuba: assessment of hypertension control in the municipalities of Cardenas and Santiago de Cuba	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Londono, E. A.; Van der Stuyft, P.] Inst Trop Med, Publ Hlth Epidemiol, B-2000 Antwerp, Belgium; [Rodriguez, A. J.; Diaz, A. M.; Garcia, R.; Balcindes, S.] Inst Nacl Higiene Epidemiol & Microbiol Cuba INHE, Salud Publ, Havana, Cuba; [Carbonell, I.] Ctr Prov Higiene & Epidemiol, Epidemiol, Santiago De Cuba, Cuba; [Achiong, F.] Ctr Prov Higiene & Epidemiol, Epidemiol, Matanzas, Cuba; [De Vos, P.] Inst Trop Med, Publ Hlth, B-2000 Antwerp, Belgium			De Vos, Pol/D-3370-2009					0	0	0	0	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.227	257	258						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801224					2019-04-02	
J	Rodriguez, AJ; Diaz, AM; Garcia, R; Balcindes, S; Carbonell, I; Achiong, F; De Vos, P; Londono, EA; Van der Stuyft, P				Rodriguez, A. J.; Diaz, A. M.; Garcia, R.; Balcindes, S.; Carbonell, I.; Achiong, F.; De Vos, P.; Londono, E. A.; Van der Stuyft, P.			Assessment of primary care interventions for improving hypertension control in Cuba	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Rodriguez, A. J.; Diaz, A. M.; Garcia, R.; Balcindes, S.] Inst Nacl Higiene Epidemiol & Microbiol INHEM, Salud Publ, Havana, Cuba; [Carbonell, I.] Ctr Prov Higiene & Epidemiol, Epidemiol, Santiago De Cuba, Cuba; [Achiong, F.] Ctr Prov Higiene & Epidemiol, Epidemiol, Matanzas, Cuba; [De Vos, P.] Inst Trop Med, Publ Hlth, B-2000 Antwerp, Belgium; [Londono, E. A.; Van der Stuyft, P.] Inst Trop Med, Publ Hlth Epidemiol, B-2000 Antwerp, Belgium			De Vos, Pol/D-3370-2009					0	0	0	0	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.229	258	259						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801226					2019-04-02	
J	Bellali, H; Harizi, C; Hechaichi, A; Aissaoui, S; Bouland, C; Chahed, MK				Bellali, H.; Harizi, C.; Hechaichi, A.; Aissaoui, S.; Bouland, C.; Chahed, M. K.			Allergic respiratory illness and environment of schoolchildren in Tunisia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Bellali, H.; Harizi, C.; Hechaichi, A.; Aissaoui, S.; Chahed, M. K.] A Mami Hosp, Epidemiol & Stat Dept, Ariana, Tunisia; [Bouland, C.] Private Univ Brussels, Sch Publ Hlth, Environm & Occupat Hlth Dept, Brussels, Belgium								0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.239	262	262						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801235					2019-04-02	
J	Ngonzi, J; Fajardo, Y; Kabakyenga, J; Wouters, K; Jacquemyn, Y; Van Geertruyden, JP				Ngonzi, J.; Fajardo, Y.; Kabakyenga, J.; Wouters, K.; Jacquemyn, Y.; Van Geertruyden, J. -P.			Puerperal sepsis, the leading cause of maternal deaths at a tertiary university teaching hospital in Uganda	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ngonzi, J.; Fajardo, Y.; Kabakyenga, J.] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Wouters, K.] Univ Antwerp Hosp, Antwerp, Belgium; [Jacquemyn, Y.; Van Geertruyden, J. -P.] Univ Antwerp, B-2020 Antwerp, Belgium			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.275	275	276						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801269					2019-04-02	
J	Manyando, C; Njunju, EM; Hamed, K; Gomes, M; Geertruyden, JPV				Manyando, C.; Njunju, E. M.; Hamed, K.; Gomes, M.; Geertruyden, J. -P. V.			Exposure to artemether-lumefantrine (Coartem (R)) in first trimester pregnancy: an observational study in Zambia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Manyando, C.; Njunju, E. M.] Trop Dis Res Ctr, Ndola, Zambia; [Manyando, C.; Njunju, E. M.; Geertruyden, J. -P. V.] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium; [Hamed, K.] Novartis Pharmaceut, E Hanover, NJ USA; [Gomes, M.] World Hlth Org TDR, Geneva, Switzerland								0	0	0	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.276	276	276						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801270					2019-04-02	
J	Mongbo, V; Ouendo, EM; Buekens, P; Zhang, WH				Mongbo, V.; Ouendo, E. -M.; Buekens, P.; Zhang, W. -H.			Maternal and perinatal post-cesarean morbidity and mortality in Benin in 2013	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract						Cesarean section; maternal; perinatal; morbidity; mortality			[Mongbo, V.; Ouendo, E. -M.] Univ Abomey Calavi, Reg Inst Publ Hlth Ouidah, Dept Hlth Policies & Syst, Ouidah, Benin; [Buekens, P.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Zhang, W. -H.] Free Univ Brussels, Sch Publ Hlth, Dept Hlth Policies & Syst, Brussels, Belgium								0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.279	277	277						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801273					2019-04-02	
J	Arrey, AE; Bilsen, J; Lacor, P; Deschepper, R				Arrey, A. E.; Bilsen, J.; Lacor, P.; Deschepper, R.			Sexual behaviour among sub-Saharan African migrant women with HIV/AIDS in Belgium: a qualitative study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract						HIV/AIDS; sexual behaviour; sub-Saharan African migrant women; Belgium			[Arrey, A. E.; Bilsen, J.; Deschepper, R.] Vrije Univ Brussel, Dept Publ Hlth, Mental Hlth & Wellbeing Res Grp, Brussels, Belgium; [Lacor, P.] Univ Ziekenhuis Brussel, AIDS Reference Ctr, Internal Med Infect Dis, Brussels, Belgium								0	0	0	1	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.292	282	282						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801286					2019-04-02	
J	de Gier, B; Nga, TT; Winichagoon, P; Dijkhuizen, M; Khan, NC; Ponce, MC; Polman, K; Wieringa, F				de Gier, B.; Nga, T. Thuy; Winichagoon, P.; Dijkhuizen, M.; Khan, N. Cong; Ponce, M. Campos; Polman, K.; Wieringa, F.			Species-specific associations between helminths and micronutrients in Vietnamese schoolchildren	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[de Gier, B.] Vrije Univ Amsterdam, Hlth & Life Sci, Amsterdam, Netherlands; [Nga, T. Thuy] Natl Inst Nutr, Hanoi, Vietnam; [Winichagoon, P.] Mahidol Univ, Inst Nutr, Bangkok 10700, Thailand; [Dijkhuizen, M.] Univ Copenhagen, Copenhagen, Denmark; [Khan, N. Cong] Minist Hlth, Hanoi, Vietnam; [Ponce, M. Campos] Vrije Univ Amsterdam, Hlth Sci, Amsterdam, Netherlands; [Polman, K.] Inst Trop Med, B-2000 Antwerp, Belgium; [Wieringa, F.] Inst Rech Dev, Montpellier, France			Wieringa, Frank/K-7565-2017	Wieringa, Frank/0000-0002-6010-355X				0	1	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.317	290	290						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801308					2019-04-02	
J	Samadoulougou, S; Kirakoya-Samadoulougou, F; Robert, A				Samadoulougou, S.; Kirakoya-Samadoulougou, F.; Robert, A.			Spatial distribution of anemia in children under five in Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Samadoulougou, S.; Robert, A.] IREC EPID, Brussels, Belgium; [Samadoulougou, S.; Kirakoya-Samadoulougou, F.; Robert, A.] Catholic Univ Louvain, B-1200 Brussels, Belgium								0	0	0	0	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.315	290	290						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801306					2019-04-02	
J	Somasse, YE; Donnen, P				Somasse, Y. E.; Donnen, P.			Can local flour recipes made of locally available and cheap ingredients be used for adequate complementary feeding of infants in rural and poor settings in Burkina Faso?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Somasse, Y. E.; Donnen, P.] Univ Libre Bruxelles, Sch Publ Hlth, Brussels, Belgium								0	0	0	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.328	293	293						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801315					2019-04-02	
J	Kabongo, MM; Linsuke, S; Baloji, S; Mukunda, F; da Luz, RI; Van Geertruyden, JP; Lutumba, PT				Kabongo, M. M.; Linsuke, S.; Baloji, S.; Mukunda, F.; da Luz, R. Inocencio; Van Geertruyden, J. P.; Lutumba, P. T.			Schistosoma mansoni infection and its association with nutrition and health outcomes: a household survey in school-aged children living in Kasansa, Democratic Republic of the Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Kabongo, M. M.] Georgia State Univ, Atlanta, GA 30303 USA; [Linsuke, S.; Lutumba, P. T.] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Baloji, S.; da Luz, R. Inocencio; Van Geertruyden, J. P.] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium; [Mukunda, F.] Programme Natl Lutte Bilharziose & Parasitoses In, Kinshasa, DEM REP CONGO; [Lutumba, P. T.] Univ Kinshasa, Kinshasa, DEM REP CONGO			Van geertruyden, Jean-Pierre/K-6425-2014; Inocencio da Luz, Raquel/L-9676-2016	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Inocencio da Luz, Raquel/0000-0002-2870-0311				0	0	0	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS1.331	294	294						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801318					2019-04-02	
J	Colebunders, R; Mandro, M; Tepage, F; Mambandu, G; Musinya, G; Mokili, J; Rood, E; Wamala, JF; Kur, L; Laudisoit, A				Colebunders, R.; Mandro, M.; Tepage, F.; Mambandu, G.; Musinya, G.; Mokili, J.; Rood, E.; Wamala, J. F.; Kur, L.; Laudisoit, A.			Can increasing ivermectin coverage decrease the incidence of Nodding Syndrome and other forms of epilepsy in onchocerciasis endemic regions?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Colebunders, R.; Laudisoit, A.] Univ Antwerp, B-2020 Antwerp, Belgium; [Mandro, M.] Div Prov Sante Ituri, Bunja, DEM REP CONGO; [Tepage, F.] Natl Onchocerciasis Control Program, Kisangani, DEM REP CONGO; [Mambandu, G.] Minist Hlth, Orientale Prov, Kisangani, DEM REP CONGO; [Musinya, G.] Med Sans Frontieres Switzerland, Bunja, DEM REP CONGO; [Mokili, J.] San Diego State Univ, San Diego, CA 92182 USA; [Rood, E.] Royal Trop Inst, NL-1105 AZ Amsterdam, Netherlands; [Wamala, J. F.] Minist Hlth, Kampala, Uganda; [Kur, L.] Minist Hlth, Juba, Sudan; [Laudisoit, A.] Univ Liverpool, Liverpool L69 3BX, Merseyside, England								0	0	0	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.013	307	308						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802005					2019-04-02	
J	Zavala, GA; Garcia, OP; Ronquillo, D; Camacho, M; Campos-Ponce, M; Doak, C; Polman, K; Rosado, JL				Zavala, G. A.; Garcia, O. P.; Ronquillo, D.; Camacho, M.; Campos-Ponce, M.; Doak, C.; Polman, K.; Rosado, J. L.			Serum leptin concentration is associated with intestinal parasitic infection and co-infection in children of rural Mexico	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Zavala, G. A.; Campos-Ponce, M.; Doak, C.; Polman, K.] VU Amsterdam Univ, Hlth Sci, Amsterdam, Netherlands; [Garcia, O. P.; Ronquillo, D.; Camacho, M.; Rosado, J. L.] Univ Autonoma Queretaro, Sch Nat Sci, Queretaro, Mexico; [Polman, K.] Inst Trop Med, Biomed Sci, B-2000 Antwerp, Belgium								0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.042	319	319						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802034					2019-04-02	
J	Mpanya, A; Mbo, F; Lumbala, C; Hasker, E; Ilunga, J; Lutumba, P; Boelaert, M				Mpanya, A.; Mbo, F.; Lumbala, C.; Hasker, E.; Ilunga, J.; Lutumba, P.; Boelaert, M.			Direct comparison of the card agglutination test for trypanosomiasis (CATT) and a rapid diagnostic test in a highly endemic district	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mpanya, A.; Mbo, F.; Lumbala, C.; Ilunga, J.] PNLTHA, Kinshasa, Zaire; [Hasker, E.; Boelaert, M.] Inst Trop Med, B-2000 Antwerp, Belgium; [Lutumba, P.] Inst Natl Rech Biomed, Kinshasa, Zaire; [Lutumba, P.] Kinshasa Univ, Kinshasa, Zaire								0	1	1	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.060	325	326						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802052					2019-04-02	
J	Mitashi, P; Hasker, E; Mbo, F; Van Geertruyden, JP; Kaswa, M; Lumbala, C; Boelaert, M; Lutumba, P				Mitashi, P.; Hasker, E.; Mbo, F.; Van Geertruyden, J. -P.; Kaswa, M.; Lumbala, C.; Boelaert, M.; Lutumba, P.			Integration of diagnosis and treatment of sleeping sickness in primary healthcare facilities in the Democratic Republic of the Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mitashi, P.; Lutumba, P.] Kinshasa Univ, Trop Med, Kinshasa, Zaire; [Hasker, E.; Boelaert, M.] Prince Leopold Inst Trop Med, Antwerp, Belgium; [Mbo, F.; Lumbala, C.] Natl Program Control Human African Trypanosomiasi, Kinshasa, Zaire; [Van Geertruyden, J. -P.] Univ Antwerp, B-2020 Antwerp, Belgium; [Kaswa, M.] Natl TB Program, Kinshasa, Zaire			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.087	337	337						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802078					2019-04-02	
J	Hasker, E; Lumbala, C; Mpanya, A; Mbo, F; Snijders, R; Meheus, F; Lutumba, P; Boelaert, M				Hasker, E.; Lumbala, C.; Mpanya, A.; Mbo, F.; Snijders, R.; Meheus, F.; Lutumba, P.; Boelaert, M.			Alternative strategies for case finding in human African trypanosomiasis in the Democratic Republic of the Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Hasker, E.; Snijders, R.; Boelaert, M.] Inst Trop Med, B-2000 Antwerp, Belgium; [Lumbala, C.; Mpanya, A.; Mbo, F.] PNLTHA, Kinshasa, DEM REP CONGO; [Meheus, F.] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Lutumba, P.] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Lutumba, P.] Kinshasa Univ, Kinshasa, DEM REP CONGO								0	1	1	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.093	339	339						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802084					2019-04-02	
J	Mazuru, P; Brix, JH; Outtata, SS; Ashmore, J; Shroufi, A; Van Cutsem, G; Philips, M				Mazuru, P.; Brix, J. Hildebrant; Outtata, S. Sedlimaier; Ashmore, J.; Shroufi, A.; Van Cutsem, G.; Philips, M.			Important increase in maternal health care coverage by abolishing user fees for deliveries in Roma referral hospital, Lesotho	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mazuru, P.; Brix, J. Hildebrant; Outtata, S. Sedlimaier] MSF, Roma, Lesotho; [Ashmore, J.; Shroufi, A.; Van Cutsem, G.] MSF, Cape Town, South Africa; [Philips, M.] MSF, Brussels, Belgium								0	0	0	0	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.099	341	341						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802089					2019-04-02	
J	Mbonye, M; Burnett, SM; Naikoba, S; Colebunders, R; Van Geertruyden, JP; Weaver, MR				Mbonye, M.; Burnett, S. M.; Naikoba, S.; Colebunders, R.; Van Geertruyden, J. -P.; Weaver, M. R.			Disease diagnosis in primary care in Uganda	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mbonye, M.; Naikoba, S.] Infect Dis Res Inst, Kampala, Uganda; [Mbonye, M.; Colebunders, R.; Van Geertruyden, J. -P.] Univ Antwerp, B-2020 Antwerp, Belgium; [Burnett, S. M.] Accordia Global Hlth Fdn, Washington, DC USA; [Weaver, M. R.] Univ Washington, Seattle, WA 98195 USA			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.111	345	345						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802100					2019-04-02	
J	Mbonye, M; Burnett, SM; Naikoba, S; Colebunders, R; Van Geertruyden, JP; Weaver, MR				Mbonye, M.; Burnett, S. M.; Naikoba, S.; Colebunders, R.; Van Geertruyden, J. -P.; Weaver, M. R.			Comparing the effect of educational outreach on infectious diseases management by mid-level health providers with and without prior core course: a cluster randomized trial in Uganda	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mbonye, M.; Naikoba, S.] Infect Dis Res Inst, Kampala, Uganda; [Mbonye, M.; Colebunders, R.; Van Geertruyden, J. -P.] Univ Antwerp, B-2020 Antwerp, Belgium; [Burnett, S. M.] Accordia Global Hlth Fdn, Washington, DC USA; [Weaver, M. R.] Univ Washington, Seattle, WA 98195 USA			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.110	345	345						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802099					2019-04-02	
J	Thys, S; Boelaert, M				Thys, S.; Boelaert, M.			On the origin of Ebola. Popular interpretations versus the epidemiology discourse in Macenta, Guinea	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Thys, S.; Boelaert, M.] Inst Trop Med, Epidemiol & Trop Dis Control Unit, Dept Publ Hlth, B-2000 Antwerp, Belgium								0	0	0	0	8	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.121	348	349						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802109					2019-04-02	
J	Thys, S; Knobel, D; Simpson, G; Van Rooyen, J; Boelaert, M				Thys, S.; Knobel, D.; Simpson, G.; Van Rooyen, J.; Boelaert, M.			Dog ownership and rabies control among the Mnisi community, Mpumalanga, South Africa: social and cultural determinants at the wildlife interface	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Thys, S.; Boelaert, M.] Inst Trop Med, Epidemiol & Trop Dis Control Unit, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Knobel, D.; Van Rooyen, J.] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, ZA-0002 Pretoria, South Africa; [Simpson, G.] Univ Pretoria, Fac Vet Sci, Hluvukani Anim Hlth Clin, Onderstepoort Vet Acad Hosp, ZA-0110 Onderstepoort, South Africa								0	0	0	0	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.122	349	349						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802110					2019-04-02	
J	Maimela, E; Alberts, M; Van Geertruyden, JP; Meulemans, H; Fraeyman, J; Bastiaens, H				Maimela, E.; Alberts, M.; Van Geertruyden, J. P.; Meulemans, H.; Fraeyman, J.; Bastiaens, H.			The perceptions and perspectives of patients and health care providers on chronic diseases management in rural South Africa: a qualitative study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract						Chronic Disease Management; Chronic Patients; Knowledge; Medication Supply; Trainings; Nurses; Qualitative research			[Maimela, E.; Alberts, M.] Univ Limpopo, Med Sci Publ Hlth & Hlth Promot, Polokwane, South Africa; [Van Geertruyden, J. P.] Int Hlth Unit, Antwerp, Belgium; [Meulemans, H.] Sociol & Res Ctr Longitudinal & Life Course Studi, Antwerp, Belgium; [Fraeyman, J.] Res Grp Med Sociol & Hlth Policy, Antwerp, Belgium; [Bastiaens, H.] Univ Antwerp, Primary & Interdisciplinary Care, B-2020 Antwerp, Belgium			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.142	356	357						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802128					2019-04-02	
J	Maimela, E; Alberts, M; Van Geertruyden, JP; Meulemans, H; Fraeyman, J; Wens, J; Bastiaens, H				Maimela, E.; Alberts, M.; Van Geertruyden, J. P.; Meulemans, H.; Fraeyman, J.; Wens, J.; Bastiaens, H.			Evidence based interventions for improving management of chronic non-communicable diseases in Dikgale in Limpopo Province, South Africa	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract						Community involvement; Health System Performance; Integrated Chronic Disease Management; Interventions			[Maimela, E.; Alberts, M.] Univ Limpopo, Med Sci Publ Hlth & Hlth Promot, Polokwane, South Africa; [Van Geertruyden, J. P.] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium; [Meulemans, H.] Univ Antwerp, Sociol & Res Ctr Longitudinal & Life Course Studi, B-2020 Antwerp, Belgium; [Fraeyman, J.] Univ Antwerp, Res Grp Med Sociol & Hlth Policy, B-2020 Antwerp, Belgium; [Wens, J.; Bastiaens, H.] Univ Antwerp, Primary & Interdisciplinary Care, B-2020 Antwerp, Belgium			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	1	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.143	357	357						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802129					2019-04-02	
J	Bemelmans, M; Baert, S; Negussie, E; Philips, M; Biot, M; Ford, N				Bemelmans, M.; Baert, S.; Negussie, E.; Philips, M.; Biot, M.; Ford, N.			Sustaining the future of HIV/TB counseling: time to formalize the role of lay counselors	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Bemelmans, M.; Baert, S.; Philips, M.; Biot, M.] Medecins Sans Frontieres, Brussels, Belgium; [Negussie, E.; Ford, N.] World Hlth Org, HIV AIDS Dept, Geneva, Switzerland								0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.148	359	359						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802134					2019-04-02	
J	O'Neill, S; Dierickx, S; Okebe, J; Dabira, E; Gryseels, C; d'Alessandro, U; Grietens, KP				O'Neill, S.; Dierickx, S.; Okebe, J.; Dabira, E.; Gryseels, C.; d'Alessandro, U.; Grietens, K. Peeters			'The importance of blood is infinite': conceptions of blood as life force and fear of trial participation in a Fulani village in the Gambia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[O'Neill, S.; Dierickx, S.; Gryseels, C.; Grietens, K. Peeters] Inst Trop Med, B-2000 Antwerp, Belgium; [Okebe, J.; Dabira, E.; d'Alessandro, U.] MRC, Gambia Unit, Fajara, Gambia								0	1	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.153	360	360						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802138					2019-04-02	
J	Jaiteh, F; Dierickx, S; O'Neill, S; Alessandro, UD; Balen, J; Grietens, KP				Jaiteh, F.; Dierickx, S.; O'Neill, S.; Alessandro, U. D'; Balen, J.; Grietens, K. P.			Socio-cultural factors influencing pregnant women's adherence to anti-malarial treatment in rural Gambia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Jaiteh, F.; Alessandro, U. D'] MRC, Gambia Unit, Banjul, Gambia; [Dierickx, S.; O'Neill, S.; Grietens, K. P.] Insitute Trop Med Antwerp, Med Anthropol Unit, Antwerp, Belgium; [Alessandro, U. D'] London Sch Hyg & Trop Med, London WC1, England; [Balen, J.] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Grietens, K. P.] Nagasaki Univ, Sch Hlth Dev, Nagasaki 852, Japan; [Grietens, K. P.] Partners Appl Social Sci PASS Int, Antwerp, Belgium								0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.159	362	362						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802142					2019-04-02	
J	Njunju, M; Manyando, C; Mwakazanga, D; Champo, D; Chongwe, G; Mwewa, D; Mulenga, M; Claeys, Y; Schurmans, C; Van Overmeir, C; Menten, J; Thriemer, K; Erhart, A; Ravinetto, R; D'Alessandro, U; Van Geertruyden, JP				Njunju, M.; Manyando, C.; Mwakazanga, D.; Champo, D.; Chongwe, G.; Mwewa, D.; Mulenga, M.; Claeys, Y.; Schurmans, C.; Van Overmeir, C.; Menten, J.; Thriemer, K.; Erhart, A.; Ravinetto, R.; D'Alessandro, U.; Van Geertruyden, J. P.			Effectiveness and safety of cotrimoxazole and sulfadoxine-pyrimethamine in preventing malaria infection during pregnancy in HIV negative pregnant women in Zambia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Njunju, M.] Copperbelt Univ, Sch Med, Basic Sci, Kitwe, Zambia; [Manyando, C.; Mwakazanga, D.; Champo, D.] Trop Dis Res Ctr, Publ Hlth, Ndola, Zambia; [Chongwe, G.] Univ Zambia, Publ Hlth, Lusaka, Zambia; [Mwewa, D.] Nchelenge Dist Hlth Off, Nchelenge, Nchelenge, Zambia; [Mulenga, M.] Trop Dis Res Ctr, Ndola, Zambia; [Claeys, Y.; Schurmans, C.; Van Overmeir, C.; Menten, J.; Thriemer, K.; Erhart, A.; Ravinetto, R.; D'Alessandro, U.] Inst Trop Med, B-2000 Antwerp, Belgium; [Thriemer, K.] Menzies Sch Publ Hlth Res, Brisbane, Qld, Australia; [Erhart, A.; D'Alessandro, U.] MRC, Fajara, Gambia; [Ravinetto, R.] Katholieke Univ Leuven, Pharmaceut & Pharmacol Sci, Leuven, Belgium; [Van Geertruyden, J. P.] Univ Antwerp, Int Hlth, B-2020 Antwerp, Belgium			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.175	368	368						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802158					2019-04-02	
J	Vareilles, G; Marchal, B; Kane, S; Pictet, G; Petric, T; Pommier, J				Vareilles, G.; Marchal, B.; Kane, S.; Pictet, G.; Petric, T.; Pommier, J.			Understanding the motivation and performance of community health volunteers involved in the delivery of health programmes: a realist inquiry	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Vareilles, G.; Pictet, G.; Petric, T.] Int Federat Red Cross & Red Crescent Soc, Geneva, Switzerland; [Marchal, B.] Inst Trop Med, B-2000 Antwerp, Belgium; [Kane, S.] Royal Trop Inst, NL-1105 AZ Amsterdam, Netherlands; [Pommier, J.] Sch Publ Hlth, Rennes, France								0	0	0	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.193	375	375						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802176					2019-04-02	
J	Baly, A; Toledo, ME; Lambert, I; Benitez, E; Rodriguez, K; Rodriguez, E; Vanlerberghe, V; Van der Stuyft, P				Baly, A.; Toledo, M. E.; Lambert, I.; Benitez, E.; Rodriguez, K.; Rodriguez, E.; Vanlerberghe, V.; Van der Stuyft, P.			The cost of intensive routine control and cost-effectiveness of insecticide treated curtain deployment in a setting with low Aedes aegypti infestation	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Baly, A.; Toledo, M. E.] Inst Med Trop Pedro Kouri, Epidemiol, Havana, Cuba; [Lambert, I.; Benitez, E.; Rodriguez, K.; Rodriguez, E.] Ctr Prov Higiene & Epidemiol, Guantanamo, Cuba; [Vanlerberghe, V.; Van der Stuyft, P.] Inst Trop Med, B-2000 Antwerp, Belgium; [Van der Stuyft, P.] Univ Ghent, B-9000 Ghent, Belgium								0	0	0	0	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.205	380	380						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802188					2019-04-02	
J	Jouquet, G; Maccario, R; Aruna, P; Bezer, L; Van Overloop, C; Esmati, AS				Jouquet, G.; Maccario, R.; Aruna, P.; Bezer, L.; Van Overloop, C.; Esmati, A. S.			Cost and cost-effectiveness of an MSF district hospital in Ahmad Shah Baba, Kabul, Afghanistan	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Maccario, R.] Medecins Sans Frontieres, Rome, Italy; [Aruna, P.; Bezer, L.] Medecins Sans Frontieres, Kabul, Afghanistan; [Van Overloop, C.] Medecins Sans Frontieres, Brussels, Belgium; [Esmati, A. S.] Minist Publ Hlth, Kabul, Afghanistan								0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.207	380	381						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802190					2019-04-02	
J	Linsuke, S; da Luz, RI; Mpanya, A; Mbula, ML; Lutumba, P				Linsuke, S.; da Luz, R. Inocencio; Mpanya, A.; Mbula, M. L.; Lutumba, P.			Barriers to attend cervical screening services in Democratic Republic of Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Linsuke, S.; Lutumba, P.] Inst Natl Rech Biomed, Epidemiol, Kinshasa, DEM REP CONGO; [da Luz, R. Inocencio] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium; [Mpanya, A.] Programme Natl Lutte Trypanosomiase Humaine Afric, Kinshasa, DEM REP CONGO; [Mbula, M. L.] Minist Sante Publ, Kinshasa, DEM REP CONGO; [Lutumba, P.] Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO			Inocencio da Luz, Raquel/L-9676-2016	Inocencio da Luz, Raquel/0000-0002-2870-0311				0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.227	388	388						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802208					2019-04-02	
J	De Keukeleire, M; Vanwambeke, SO; Somasse, E; Kabamba, B; Luyasu, V; Robert, A				De Keukeleire, M.; Vanwambeke, S. O.; Somasse, E.; Kabamba, B.; Luyasu, V.; Robert, A.			Scouts and ticks: which environmental conditions favor the contact	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[De Keukeleire, M.; Vanwambeke, S. O.] Catholic Univ Louvain, Earth & Life Inst ELI Earth & Climate ELIC, Louvain La Neuve, Belgium; [De Keukeleire, M.; Somasse, E.; Luyasu, V.; Robert, A.] IREC, Pole Epidemiol & Biostat EPID, Brussels, Belgium; [Kabamba, B.] Catholic Univ Louvain, Clin Univ St Luc, Div Clin Biol, B-1200 Brussels, Belgium								0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.269	404	404						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802249					2019-04-02	
J	Musinguzi, G; Bastiaens, H; Wanyenze, R; Van Geertruyden, JP; Nuwaha, F				Musinguzi, G.; Bastiaens, H.; Wanyenze, R.; Van Geertruyden, J. -P.; Nuwaha, F.			Capacity of health facilities to manage hypertension in Mukono and Buikwe districts in Uganda: challenges and recommendations	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Musinguzi, G.; Wanyenze, R.; Nuwaha, F.] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Musinguzi, G.; Bastiaens, H.; Van Geertruyden, J. -P.] Univ Antwerp, B-2020 Antwerp, Belgium			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.304	417	417						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802283					2019-04-02	
J	Ravinetto, R; De Crop, M; Delamou, A; van Griensven, J				Ravinetto, R.; De Crop, M.; Delamou, A.; van Griensven, J.			Multiple ethical review in North-South collaborative research in an emergency context: the experience of the Ebola_Tx trial	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ravinetto, R.; De Crop, M.; van Griensven, J.] Inst Trop Med, B-2000 Antwerp, Belgium; [Delamou, A.] Natl Ctr Training & Res Maferinyah, Conakry, Guinea								0	0	0	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.341	431	432						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802320					2019-04-02	
J	Kalabuanga, M; Ravinetto, R; Maketa, V; Mavoko, HM; da Luz, R; Van Geertruyden, JP; Lutumba, P				Kalabuanga, M.; Ravinetto, R.; Maketa, V.; Mavoko, H. M.; da Luz, R.; Van Geertruyden, J. -P.; Lutumba, P.			The challenges of research informed consent in socio-economically vulnerable populations: a viewpoint from the Democratic Republic of Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Kalabuanga, M.; Maketa, V.; Mavoko, H. M.; Lutumba, P.] Univ Kinshasa, Kinshasa, Zaire; [Ravinetto, R.] Inst Trop Med, B-2000 Antwerp, Belgium; [Ravinetto, R.] Katholieke Univ Leuven, Leuven, Belgium; [Maketa, V.; Mavoko, H. M.; da Luz, R.; Van Geertruyden, J. -P.] Univ Antwerp, B-2020 Antwerp, Belgium; [Lutumba, P.] Inst Natl Rech Biomed, Kinshasa, Zaire			Inocencio da Luz, Raquel/L-9676-2016; Van geertruyden, Jean-Pierre/K-6425-2014	Inocencio da Luz, Raquel/0000-0002-2870-0311; Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	1	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.342	432	432						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802321					2019-04-02	
J	Becker, SL; Yap, P; Saye, R; Doumbia, MN; Fofana, HKM; Landoure, A; Traore, MS; Chappuis, F; Boelaert, M; van Loen, H; Polman, K; Bratschi, MW; Utzinger, J; Sacko, M				Becker, S. L.; Yap, P.; Saye, R.; Doumbia, M. N.; Fofana, H. K. M.; Landoure, A.; Traore, M. S.; Chappuis, F.; Boelaert, M.; van Loen, H.; Polman, K.; Bratschi, M. W.; Utzinger, J.; Sacko, M.			Parasitological characterisation of persistent digestive disorders in Mali: a case-control study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Becker, S. L.; Yap, P.; Bratschi, M. W.; Utzinger, J.] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Becker, S. L.; Yap, P.; Bratschi, M. W.; Utzinger, J.] Univ Basel, Basel, Switzerland; [Becker, S. L.] Univ Saarland, Inst Med Microbiol & Hyg, Homburg, Germany; [Saye, R.; Doumbia, M. N.; Fofana, H. K. M.; Landoure, A.; Traore, M. S.; Sacko, M.] Inst Natl Rech Sante Publ, Bamako, Mali; [Chappuis, F.] Univ Hosp Geneva, Div Humanitarian & Trop Med, Geneva, Switzerland; [Boelaert, M.; van Loen, H.; Polman, K.] Inst Trop Med, B-2000 Antwerp, Belgium								0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI	PS2.359.LB	438	438						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758802336					2019-04-02	
J	Linsuke, S; Mpabanzi, L; Nundu, S; Mukunda, F; Lutumba, P; Polman, K				Linsuke, S.; Mpabanzi, L.; Nundu, S.; Mukunda, F.; Lutumba, P.; Polman, K.			The road towards sustainable control of schistosomiasis in the Democratic Republic of Congo: pre-assessment of staff performance and material resources in endemic regions	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Linsuke, S.; Nundu, S.; Lutumba, P.] Inst Natl Rech Biomed, Epidemiol, Kinshasa, DEM REP CONGO; [Mpabanzi, L.; Polman, K.] Inst Trop Med, B-2000 Antwerp, Belgium; [Mukunda, F.] Programme Natl Lutte Bilharziose & Parasitoses In, Kinshasa, DEM REP CONGO; [Lutumba, P.] Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		234	234						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801161					2019-04-02	
J	Linsuke, S; Nundu, S; Kanobana, K; Mukunda, F; da Luz, RIE; Polman, K; Lutumba, P				Linsuke, S.; Nundu, S.; Kanobana, K.; Mukunda, F.; da Luz, R. Inocencio; Polman, K.; Lutumba, P.			Schistosomiasis and soil transmitted helminths in school-aged children: epidemiological profile in Kinshasa and Bas-Congo provinces of the Democratic Republic of Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Linsuke, S.; Nundu, S.; Lutumba, P.] Inst Natl Rech Biomed, Epidemiol, Kinshasa, DEM REP CONGO; [Kanobana, K.] Inst Trop Med, B-2000 Antwerp, Belgium; [Mukunda, F.] Programme Natl Lutte Bilharziose & Parasitoses In, Kinshasa, DEM REP CONGO; [da Luz, R. Inocencio] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium; [Polman, K.] Inst Trop Med, Unit Med Helminthol, B-2000 Antwerp, Belgium; [Lutumba, P.] Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO			Inocencio da Luz, Raquel/L-9676-2016	Inocencio da Luz, Raquel/0000-0002-2870-0311				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		234	234						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801162					2019-04-02	
J	Linsuke, S; Nundu, S; Mupoyi, S; Mukele, R; Mukunda, F; Kabongo, MM; da Luz, RI; Van Geertruyden, JP; Van Sprundel, M; Boelaert, M; Polman, K; Lutumba, P				Linsuke, S.; Nundu, S.; Mupoyi, S.; Mukele, R.; Mukunda, F.; Kabongo, M. Mbuyi; da Luz, R. Inocencio; Van Geertruyden, J. -P.; Van Sprundel, M.; Boelaert, M.; Polman, K.; Lutumba, P.			High prevalence of Schistosoma mansoni in six health areas of Kasansa health zone, Democratic Republic of the Congo: a short report	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Linsuke, S.; Nundu, S.; Lutumba, P.] Inst Natl Rech Biomed, Epidemiol, Kinshasa, DEM REP CONGO; [Mupoyi, S.] Programme Natl Lutte Bilharziose & Parasitoses In, Rech, Kinshasa, DEM REP CONGO; [Mukele, R.; Lutumba, P.] Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO; [Mukunda, F.] Programme Natl Lutte Bilharziose & Parasitoses In, Kinshasa, DEM REP CONGO; [Kabongo, M. Mbuyi] Georgia State Univ, Atlanta, GA 30303 USA; [da Luz, R. Inocencio; Van Geertruyden, J. -P.] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium; [Van Sprundel, M.] Univ Antwerp, B-2020 Antwerp, Belgium; [Boelaert, M.] Inst Trop Med, Unit Epidemiol & Control Trop Dis, B-2000 Antwerp, Belgium; [Polman, K.] Inst Trop Med, Unit Med Helminthol, B-2000 Antwerp, Belgium			Van geertruyden, Jean-Pierre/K-6425-2014; Inocencio da Luz, Raquel/L-9676-2016	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Inocencio da Luz, Raquel/0000-0002-2870-0311				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2015	20			1	SI		234	234						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CQ7BW	WOS:000360758801163					2019-04-02	
J	Maillard, O; Lernout, T; Olivier, S; Achirafi, A; Aubert, L; Lepere, JF; Thiria, J; Pages, F; Filleul, L				Maillard, Olivier; Lernout, Tinne; Olivier, Sophie; Achirafi, Aboubacar; Aubert, Lyderic; Lepere, Jean Francois; Thiria, Julien; Pages, Frederic; Filleul, Laurent			Major decrease in malaria transmission on Mayotte Island	MALARIA JOURNAL			English	Article						Malaria; Elimination; Plasmodium falciparum; Mayotte; Comoros; Indian ocean	COMMUNITY PARTICIPATION; PLASMODIUM-FALCIPARUM; INSECTICIDE RESISTANCE; TAFEA PROVINCE; INDIAN-OCEAN; ELIMINATION; DISEASE; ARCHIPELAGO; PREVALENCE; MADAGASCAR	Background: Plasmodium falciparum is responsible for most malaria cases on Mayotte Island, in the Comorian Archipelago. Malaria is endemic and a major public health problem in the archipelago with an intense, stable and permanent transmission. This study reports results of 8 years of malaria surveillance from 2007 to 2014 after the strengthening of malaria control activities in Mayotte and the neighbouring islands. Methods: Surveillance was based on physicians' reports of malaria cases between January 2007 and December 2014. Malaria cases were confirmed by at least a positive rapid diagnostic test and/or demonstration of Plasmodium sp. in a blood smear. The date, and the patients' age, sex, address, presentation of symptoms, biology, treatment and recent history of travel were collected by verbal questioning during consultation and/or hospitalization. Monthly rainfall data were also compiled during the study period. Results: From 2007 to 2014, 2073 cases were reported on Mayotte Island: 977 imported cases, 807 autochthonous cases and 289 cases of unknown origin. The total malaria annual parasite incidence lowered from 3.0 in 2007 to 0.07 per 1,000 inhabitants in 2014 as the autochthonous malaria incidence decreased from 1.6 to 0.004 per 1,000 inhabitants in the same period and in all age groups. Most of the imported cases came from Comoros (94 %). Severe forms represented approximately 11 % of cases, and only two deaths have been recorded among the imported cases. Approximately 19 % of cases were hospitalized (3 % in an intensive care unit). There is clearly a decrease in malaria transmission in Mayotte since 2007 and the goal of elimination seems more achievable than ever. In 2011, Mayotte entered the elimination phase when P. falciparum API passed under 1 case per 1,000 people at risk. Conclusions: The combination of vector control measures, active surveillance and case management, including effective treatment with artemisinin-based combination therapy, has been essential to achieve a present status of low and decreasing malaria transmission on the island. Mayotte has entered the elimination phase, but some goals remain to be accomplished before a programme re-orientation toward malaria elimination is contemplated. Moreover, a regional management policy is crucial because this would allow control measures to be targeted and based on a regional surveillance-response system rather than isolated.	[Maillard, Olivier; Lernout, Tinne; Pages, Frederic; Filleul, Laurent] French Inst Publ Hlth Surveillance InVS, Reg Off, Mayotte, France; [Lernout, Tinne] Sci Inst Publ Hlth, Epidemiol Infect Dis, Brussels, Belgium; [Olivier, Sophie; Lepere, Jean Francois] Hosp Ctr Mayotte, Mayotte, France; [Achirafi, Aboubacar; Thiria, Julien] Reg Hlth Agcy ARS, Mayotte, France; [Aubert, Lyderic] French Inst Publ Hlth Surveillance InVS, Reg Off, Ile De France, France	Maillard, O (reprint author), French Inst Publ Hlth Surveillance InVS, Reg Off, Mayotte, France.	olmaillard@yahoo.fr					Abilio AP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-110; Atkinson JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-225; Atkinson JAM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-93; Barnadas C, 2007, AM J TROP MED HYG, V77, P1039, DOI 10.4269/ajtmh.2007.77.1039; BLANCHY S, 1983, B SOC PATHOL EXOT, V76, P95; Blanchy S, 1999, B SOC PATHOL EXOT, V3, P177; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Demaison X, 2013, MED MALADIES INFECT, V43, P152, DOI 10.1016/j.medmal.2013.01.005; Elissa N, 2005, J AM MOSQUITO CONTR, V21, P472, DOI 10.2987/8756-971X(2006)21[472:ROAFAI]2.0.CO;2; GALTIER J, 1982, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V20, P145; JULVEZ J, 1987, B SOC PATHOL EXOT, V80, P505; Julvez J, 1986, CAH ORSTOM EMP, V4, P279; Le Goff G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100696; Lengeler C, 2004, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000363.PUB2; Menard D, 2007, EMERG INFECT DIS, V13, P1759, DOI 10.3201/eid1311.070235; Pettinelli FO, 2004, AM J TROP MED HYG, V70, P635, DOI 10.4269/ajtmh.2004.70.635; Pocquet N, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-299; QUATRESOUS I, 2005, EPIDEMIOLOGIE PALUDI; QUATRESOUS I, 2007, B EPIDEMIOL HEBD, V48, P409; Rebaudet S, 2010, EMERG INFECT DIS, V16, P1686, DOI 10.3201/eid1611.100694; Receveur M C, 2004, Bull Soc Pathol Exot, V97, P265; Roussin JM, 2002, PRESSE MED, V31, P1312; Silai R, 2007, Bull Soc Pathol Exot, V100, P6, DOI 10.3185/pathexo2898; Smith C, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-377; Solet J.L., 2007, B EPIDEMIOL HEB, V48, P407; Temu EA, 2012, PLOS ONE, V2, DOI [10.1371/journal, DOI 10.1371/JOURNAL]; Tsoka-Gwegweni JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107693; Tuseo L, 2015, P WHO EV REV GROUP M; Tynan A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-204; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2007, MAL EL	32	4	5	0	15	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	AUG 19	2015	14								323	10.1186/s12936-015-0837-6				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CP2DP	WOS:000359688000001	26285699	DOAJ Gold, Green Published			2019-04-02	
J	Duguma, R; Tasew, S; Olani, A; Damena, D; Alemu, D; Mulatu, T; Alemayehu, Y; Yohannes, M; Bekana, M; Hoppenheit, A; Abatih, E; Habtewold, T; Delespaux, V; Duchateau, L				Duguma, Reta; Tasew, Senbeta; Olani, Abebe; Damena, Delesa; Alemu, Dereje; Mulatu, Tesfaye; Alemayehu, Yoseph; Yohannes, Moti; Bekana, Merga; Hoppenheit, Antje; Abatih, Emmanuel; Habtewold, Tibebu; Delespaux, Vincent; Duchateau, Luc			Spatial distribution of Glossina sp. and Trypanosoma sp. in south-western Ethiopia	PARASITES & VECTORS			English	Article						Trypanosoma; Glossina; Ethiopia; Cattle; Risk factors	BOVINE TRYPANOSOMIASIS; SLEEPING SICKNESS; TSETSE CONTROL; MECHANICAL TRANSMISSION; VIVAX INFECTION; GHIBE VALLEY; CATTLE; FLIES; POPULATIONS; PREVALENCE	Background: Accurate information on the distribution of the tsetse fly is of paramount importance to better control animal trypanosomosis. Entomological and parasitological surveys were conducted in the tsetse belt of south-western Ethiopia to describe the prevalence of trypanosomosis (PoT), the abundance of tsetse flies (AT) and to evaluate the association with potential risk factors. Methods: The study was conducted between 2009 and 2012. The parasitological survey data were analysed by a random effects logistic regression model, whereas the entomological survey data were analysed by a Poisson regression model. The percentage of animals with trypanosomosis was regressed on the tsetse fly count using a random effects logistic regression model. Results: The following six risk factors were evaluated for PoT (i) altitude: significant and inverse correlation with trypanosomosis, (ii) annual variation of PoT: no significant difference between years, (iii) regional state: compared to Benishangul-Gumuz (18.0 %), the three remaining regional states showed significantly lower PoT, (iv) river system: the PoT differed significantly between the river systems, (iv) sex: male animals (11.0 %) were more affected than females (9.0 %), and finally (vi) age at sampling: no difference between the considered classes. Observed trypanosome species were T. congolense (76.0 %), T. vivax (18.1 %), T. b. brucei (3.6 %), and mixed T. congolense/vivax (2.4 %). The first four risk factors listed above were also evaluated for AT, and all have a significant effect on AT. In the multivariable model only altitude was retained with AT decreasing with increasing altitude. Four different Glossina species were identified i.e. G. tachinoides (52.0 %), G. pallidipes (26.0 %), G. morsitans submorsitans (15.0 %) and G. fuscipes fuscipes (7.0 %). Significant differences in catches/trap/day between districts were observed for each species. No association could be found between the tsetse fly counts and trypanosomosis prevalence. Conclusions: Trypanosomosis remains a constraint to livestock production in south-western Ethiopia. Four Glossina and three Trypanosoma species were observed. Altitude had a significant impact on AT and PoT. PoT is not associated with AT, which could be explained by the importance of mechanical transmission. This needs to be investigated further as it might jeopardize control strategies that target the tsetse fly population.	[Duguma, Reta; Bekana, Merga] Univ Addis Ababa, Coll Vet Med & Agr, Dept Clin Studies, Bishoftu, Oromia, Ethiopia; [Duguma, Reta; Habtewold, Tibebu; Duchateau, Luc] Univ Ghent, Fac Vet Sci, Dept Comparat Physiol & Biometr, B-9820 Merelbeke, Belgium; [Tasew, Senbeta; Alemu, Dereje] Natl Tsetse & Trypanosome Invest & Control Ctr, Illu Aba Bora, Bedelle, Ethiopia; [Olani, Abebe; Damena, Delesa; Mulatu, Tesfaye] Natl Anim Hlth Diagnost & Invest Ctr, Sebeta, Oromia, Ethiopia; [Alemayehu, Yoseph] Int Maize & Wheat Improvement Ctr CIMMYT, Socioecon Program, Global Cereal Rust Monitoring Syst, Addis Ababa, Ethiopia; [Yohannes, Moti] Jimma Univ, Sch Vet Med, Dept Microbiol & Vet Publ Hlth, Jimma, Ethiopia; [Hoppenheit, Antje] Free Univ Berlin, Inst Parasitol & Trop Vet Med, D-14163 Berlin, Germany; [Abatih, Emmanuel; Delespaux, Vincent] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium	Delespaux, V (reprint author), Inst Trop Med, Dept Biomed Sci, Natl Str 155, B-2000 Antwerp, Belgium.	vdelespaux@itg.be		Duguma, Reta/0000-0002-5660-7720	Agricultural Bureau of the four Regional States; Bedele National Trypanosomosis and Tsetse Control Centre; VLIR-UOS [ZIUS2014AP014]	We would like to thank the Agricultural Bureau of the four Regional States and the Bedele National Trypanosomosis and Tsetse Control Centre for their support during the field work. The VLIR-UOS is also acknowledged for financial support for the whole trypanosomosis project in the framework of the Institutional University Cooperation - Jimma University (IUC-JU) project ZIUS2014AP014.	Abebe G, 1996, REV MED VET-TOULOUSE, V147, P897; Abebe YD, 2010, GLIMPSE BIODIVERSITY, P1; Afewerk Y, 2000, ACTA TROP, V76, P231, DOI 10.1016/S0001-706X(00)00108-X; Ahmed A.B., 2005, African Journal of Biomedical Research, V8, P113; AHMED MMM, 1987, TROP ANIM HEALTH PRO, V19, P11, DOI 10.1007/BF02250840; Akoda K, 2009, ACTA TROP, V111, P263, DOI 10.1016/j.actatropica.2009.05.005; Awulachew SB, 2011, REP MINIST WATER ENE, P1; Baumgartner J, 2008, ECOL ECON, V65, P125, DOI 10.1016/j.ecolecon.2007.06.005; Bouyer J, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00047; Brightwell B., 2001, Agriculture and Human Values, V18, P219, DOI 10.1023/A:1011131826919; BURNETT G. F., 1961, BULL ENTOMOL RES, V52, P763; Buxton PA, 1955, MEMOIR, V10; Cherenet T, 2006, VET PARASITOL, V140, P251, DOI 10.1016/j.vetpar.2006.04.004; Comenetz J., 2002, GLOBAL ENV CHANGE B, V4, P113, DOI DOI 10.1016/J.HAZARDS.2003.08.001; Conner RJ, 1994, IMPROVING ANIMAL TRA; DEAN GJW, 1969, B ENTOMOL RES, V59, P423, DOI 10.1017/S0007485300003394; Dejene A, 1990, ENV FAMINE POLITICS; Desquesnes M, 2004, VET PARASITOL, V119, P9, DOI 10.1016/j.vetpar.2003.10.015; Desquesnes M, 2003, EXP PARASITOL, V103, P35, DOI 10.1016/S0014-4894(03)00067-5; Dicko AH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003921; DOHOO I., 2003, VET EPIDEMIOLOGIC RE; Fikru R, 2012, VET PARASITOL, V190, P355, DOI 10.1016/j.vetpar.2012.07.010; FORD J., 1962, BULL EPIZOOT DIS AFRICA, V10, P9; GOUTEUX JP, 1986, TROP MED PARASITOL, V37, P101; Gouteux JP, 1998, ACTA OECOL, V19, P453, DOI 10.1016/S1146-609X(98)80050-7; Hoppenheit A, 2013, MED VET ENTOMOL, V27, P222, DOI 10.1111/j.1365-2915.2012.01046.x; Hoppenheit A, 2010, WIEN KLIN WOCHENSCHR, V122, P81, DOI 10.1007/s00508-010-1443-9; Hosmer DW, 2013, APPL LOGISTIC REGRES; Institute of biodiversity and conservation (ICB), 2007, EC ETH; JEMAL A, 1995, PREV VET MED, V22, P29, DOI 10.1016/0167-5877(94)00404-7; Jordan AM, 1986, TRYPANOSOMOSIS CONTR; Kristjanson PM, 1999, AGR SYST, V59, P79, DOI 10.1016/S0308-521X(98)00086-9; Kubi C, 2006, MED VET ENTOMOL, V20, P388, DOI 10.1111/j.1365-2915.2006.00644.x; Langride WP, 1976, TSETSE TRYPANOSOMOSI; Leak S. G. A., 1999, TSETSE BIOL ECOLOGY; LEAK SGA, 1990, INSECT SCI APPL, V11, P293, DOI 10.1017/S1742758400012704; Lee CW, 1983, AFRICAN TRYPANOSOMIA; Lemecha H, 2006, VET PARASITOL, V141, P165, DOI 10.1016/j.vetpar.2006.04.035; Luckins A. G., 1992, World Animal Review, V70-71, P15; Majekodunmi AO, 2013, PARASITE VECTOR, V6, DOI [10.1186/1756-3305-6-239, 10.1186/1756-305-6-293, 10.1186/1756-3305-6-293]; Malele II, 2007, J VECTOR ECOL, V32, P263, DOI 10.3376/1081-1710(2007)32[263:GDIAAT]2.0.CO;2; Malele I, 2011, AFR J AGR RES, V6, P2341; Mekuria S, 2011, ACTA TROP, V117, P146, DOI 10.1016/j.actatropica.2010.11.009; Moti Y, 2012, VET PARASITOL, V189, P197, DOI 10.1016/j.vetpar.2012.04.022; MURRAY M, 1984, PREV VET MED, V2, P23, DOI 10.1016/0167-5877(84)90045-X; Nelder J. A., 1989, MONOGRAPHS STAT APPL; RAWLINGS P, 1984, B ENTOMOL RES, V74, P311, DOI 10.1017/S0007485300011421; Reid RS, 2000, LANDSCAPE ECOL, V15, P339, DOI 10.1023/A:1008177712995; Reifenberg JM, 1997, MED VET ENTOMOL, V11, P246, DOI 10.1111/j.1365-2915.1997.tb00402.x; Reusing M, 2000, INT ARCH PHOTOGRAMME, VXXXIII, P1253; ROEDER PL, 1984, TROP ANIM HEALTH PRO, V16, P141, DOI 10.1007/BF02252779; ROGERS DJ, 1984, INSECT SCI APPL, V5, P397, DOI 10.1017/S1742758400008729; ROWLANDS GJ, 1993, ACTA TROP, V53, P135, DOI 10.1016/0001-706X(93)90025-7; Simukoko H, 2007, ACTA TROP, V103, P98, DOI 10.1016/j.actatropica.2007.05.011; Sinshaw A, 2006, VET PARASITOL, V142, P35, DOI 10.1016/j.vetpar.2006.06.032; Slingenbergh J., 1992, World Animal Review, V70-71, P30; Specht EJK, 2008, ONDERSTEPOORT J VET, V75, P73; Stein J, 2011, VET PARASITOL, V178, P40, DOI 10.1016/j.vetpar.2010.12.025; Tasew S, 2012, REV MED VET-TOULOUSE, V163, P581; Tchouomene-Labou J, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-193; Tewelde N, 2004, ACTA TROP, V90, P163, DOI 10.1016/j.actatropica.2003.11.012; TIKUBET G, 1984, INSECT SCI APPL, V5, P389, DOI 10.1017/S1742758400008717; VALE GA, 1974, T ROY SOC TROP MED H, V68, P11, DOI 10.1016/0035-9203(74)90234-X; VanLeeuwen JA, 2010, PREV VET MED, V93, P129, DOI 10.1016/j.prevetmed.2009.11.013; Vreysen MJB, 1999, PROC INT SCI COUNC T, P202; Woo P. T. K., 1970, Acta trop., V27, P384; Wood A. P., 1993, NORDIC J AFRICAN STU, V2, P83	67	7	7	0	14	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	AUG 19	2015	8								430	10.1186/s13071-015-1041-9				10	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CP3DG	WOS:000359756400003	26286484	DOAJ Gold, Green Published			2019-04-02	
J	Mwesigwa, J; Okebe, J; Affara, M; Di Tanna, GL; Nwakanma, D; Janha, O; Opondo, K; Grietens, KP; Achan, J; D'Alessandro, U				Mwesigwa, Julia; Okebe, Joseph; Affara, Muna; Di Tanna, Gian Luca; Nwakanma, Davis; Janha, Omar; Opondo, Kevin; Grietens, Koen Peeters; Achan, Jane; D'Alessandro, Umberto			On-going malaria transmission in The Gambia despite high coverage of control interventions: a nationwide cross-sectional survey	MALARIA JOURNAL			English	Article						Malaria transmission; Asymptomatic parasitaemia; Heterogeneity; The Gambia	PLASMODIUM-FALCIPARUM; CHILDREN; PARASITEMIA; PREVALENCE; INFECTION; CARRIAGE; TANZANIA; INDEXES; FIELD	Background: As indicators of burden of malaria have substantially decreased in The Gambia, reaching a pre-elimination status may be attainable. Achieving this goal requires in-depth understanding of the current burden of Plasmodium falciparum infection. Methods: A nationwide cross-sectional survey was conducted in 2012 to determine the prevalence of P. falciparum infection, and to describe its heterogeneity and associated risk factors. Finger-prick blood samples were collected for microscopy, species-specific PCR and haemoglobin measurement. Results: A total of 9,094 participants were included and median age was 11.9 years (IQR 5, 28). Overall prevalence of P. falciparum was 16.01 % with marked heterogeneity between sites (4.32-36.75 %) and within villages in each site (1.63-49.13 %). Across all sites, 51.17 % (745/1,456) of infections were asymptomatic and 35.61 % (448/1,258) were sub-microscopic. The odds of P. falciparum infection were higher in older children; 5-15 years (OR = 1.90; 95 % CI 1.60-2.26), adults (OR = 1.48; 95 % CI 1.24-1.78) and participants with moderate anaemia (OR = 1.62; 95 % CI 1.32-1.99). Conclusions: The current malaria control interventions are not sufficient to interrupt transmission in The Gambia as malaria prevalence is still relatively high in the eastern part of the country. New interventions aiming at interrupting transmission are needed and should be urgently evaluated.	[Mwesigwa, Julia; Okebe, Joseph; Affara, Muna; Nwakanma, Davis; Janha, Omar; Opondo, Kevin; Achan, Jane; D'Alessandro, Umberto] MRC Unit, Banjul, Gambia; [Di Tanna, Gian Luca; D'Alessandro, Umberto] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Grietens, Koen Peeters; D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium; [Grietens, Koen Peeters] Nagasaki Univ, Sch Int Hlth Dev, Nagasaki 852, Japan; [Grietens, Koen Peeters] Partners Appl Social Sci PASS Int, Tessenderlo, Belgium	D'Alessandro, U (reprint author), MRC Unit, POB 273, Banjul, Gambia.	udalessandro@mrc.gm		Nwakanma, Davis/0000-0002-6706-6069; Di Tanna, Gian Luca/0000-0002-5470-3567; Mwesigwa, Julia/0000-0003-2452-3677; Peeters Grietens, Koen/0000-0001-6570-9887; Okebe, Joseph/0000-0001-5466-1611; Opondo, Kevin Ochieng'/0000-0001-8975-6266	Gambia Ministry of Health and Social Welfare; National Malaria Control Programme; Medical Research Council (MRC), UK; Department for International Development (DFID), UK, under the MRC/DFID Concordat Agreement [MC_EX_MR/J002364/1]; Medical Research Council [MC_EX_MR/J002364/1, MC_UP_A900_1117, MR/K012126/1]	The study team is grateful to the village leaders and study participants who gave tremendous support and willingly allowed us to collect the data and samples. We are grateful to Mr Archibald Worwui for his support on the data management. The tireless effort of our field teams (assistants and nurses) is greatly appreciated. We acknowledge the tremendous support received from The Gambia Ministry of Health and Social Welfare and National Malaria Control Programme.; This work is funded Medical Research Council (MRC), UK and the Department for International Development (DFID), UK, under the MRC/DFID Concordat Agreement. Grant number MC_EX_MR/J002364/1.	Bartlett J, 2014, STAT METHODS MED RES, V24, P462; Betson M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-187; Bogh C, 2007, AM J TROP MED HYG, V76, P875; Bousema JT, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-18; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI DOI 10.1177/0962280206074463; Canier L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-405; Caputo B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016415; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242; Crookston BT, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-39; Dal-Bianco MP, 2007, AM J TROP MED HYG, V77, P939, DOI 10.4269/ajtmh.2007.77.939; DALESSANDRO U, 1995, LANCET, V345, P479, DOI 10.1016/S0140-6736(95)90582-0; Drakeley CJ, 2005, J INFECT DIS, V191, P1589, DOI 10.1086/429669; Filipe JAN, 2007, PLOS COMPUT BIOL, V3, P2569, DOI 10.1371/journal.pcbi.0030255; Geiger C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-27; Gudo ES, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-244; Kimbi HK, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-193; Lawaly YR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011358; Lin JT, 2014, TRENDS PARASITOL, V30, P183, DOI 10.1016/j.pt.2014.02.004; Males S, 2008, CLIN INFECT DIS, V46, P516, DOI 10.1086/526529; Manirakiza P, 2003, ARCH ENVIRON CON TOX, V44, P171, DOI 10.1007/s00244-002-2006-5; Manjurano A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-370; Nankabirwa J, 2013, AM J TROP MED HYG, V88, P1102, DOI 10.4269/ajtmh.12-0633; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Oduro AR, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-222; Okebe J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110926; Patel JC, 2014, J INFECT DIS, V210, P1180, DOI 10.1093/infdis/jiu252; Quinones ML, 1997, MED VET ENTOMOL, V11, P71, DOI 10.1111/j.1365-2915.1997.tb00292.x; Snounou Georges, 2002, Methods Mol Med, V72, P189, DOI 10.1385/1-59259-271-6:189; Sturrock HJW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001467; Takem EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067108; Tangena JAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074351; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2009, WHONMHNHDMNM111	35	23	23	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	AUG 14	2015	14								314	10.1186/s12936-015-0829-6				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CO7KZ	WOS:000359339300001	26268225	DOAJ Gold, Green Published			2019-04-02	
J	Tehseen, S; Jahan, N; Qamar, MF; Desquesnes, M; Shahzad, MI; Deborggraeve, S; Buscher, P				Tehseen, Sonia; Jahan, Nusrat; Qamar, Muhammad Fiaz; Desquesnes, Marc; Shahzad, Mirza Imran; Deborggraeve, Stijn; Buscher, Philippe			Parasitological, serological and molecular survey of Trypanosoma evansi infection in dromedary camels from Cholistan Desert, Pakistan	PARASITES & VECTORS			English	Article						Trypanosoma evansi; Cholistan Desert; RoTat 1.2; ELISA/VSG RoTat 1.2; Immune trypanolysis; CATT/T. evansi; PCR; Pakistan	SENSITIVE DETECTION; PARASITE DETECTION; DNA AMPLIFICATION; DETECTION TESTS; WATER-BUFFALOS; CANARY-ISLANDS; DIAGNOSIS; ANTIGEN; ELISA; PCR	Background: Surra, a vector borne disease caused by Trypanosoma (T.) evansi, affects the health, productivity and working capacity of camels. Since clinical signs are not pathognomonic, diagnosis must be confirmed by laboratory methods. This is a first study on the prevalence of surra in Cholistan Desert, Pakistan using a broad variety of diagnostic tests thereby emphasizing it as a risk for the dromedaries of Pakistan. Methods: In a cross sectional study, 1005 dromedary camels from three districts in the Cholistan Desert were sampled to assess the prevalence of trypanosomosis due to T. evansi by means of parasitological (Giemsa stained thin smear), serological (formol gel test, CATT/T. evansi, ELISA/VSG RoTat 1.2, immune trypanolysis) and molecular tests (TBR1/2 PCR and RoTat 1.2 PCR). Kappa was calculated to assess the degree of agreement between different tests whereas chi-square test along with odds ratios and their 95 % confidence intervals were used to study influence of breed, gender, age and locality on disease prevalence. Results: Overall prevalence was 0.7 % with Giemsa stained thin smears (GST), 40.1 % with formol gel test (FGT), 47.7 % with CATT/T. evansi, 44.2 % with ELISA/VSG RoTat 1.2, 39.9 % with immune trypanolysis (TL), 31.9 % with TBR1/2 PCR and 30.5 % with RoTat1.2 PCR. Based on these results, the Cholistan Desert appears to be a high risk area for surra. According to TL and TBR1/2 PCR, camels at Bahawalpur are approximately two times more likely to be infected than those in Bahawalnagar (OR = 1.8; 95 % CI: 1.38-2.42) and Rahim Yar Khan (OR = 1.9; 95 % CI: 1.30-2.75). Test agreement of TL was moderate with CATT/T. evansi (k = 0.43; 95 % CI: 0.378-0.489) and ELISA/VSG RoTat 1.2 (k = 0.54; 95 % CI: 0.489-0.594) and poor with the other tests. Test agreement between TBR1/2 PCR and RoTat1.2 PCR was almost perfect (k = 0.96; 95 % CI: 0.950-0.984). We didn't find evidence for the presence of T. evansi type B in the studied population. Conclusion: Our study supports using antibody detection tests, rather than parasitological and molecular examination, to assess surra prevalence in camels. It also calls for implementation of measures to control surra in the Cholistan Desert.	[Tehseen, Sonia; Jahan, Nusrat; Qamar, Muhammad Fiaz] Govt Coll Univ Lahore, Dept Zool, Lahore, Pakistan; [Desquesnes, Marc] CIRAD Bios, Inter Tryp UMR17, Montpellier, France; [Shahzad, Mirza Imran] Islamia Univ Bahawalpur, Univ Coll Vet & Anim Sci, Bahawalpur, Pakistan; [Deborggraeve, Stijn; Buscher, Philippe] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium	Tehseen, S (reprint author), Govt Coll Univ Lahore, Dept Zool, Lahore, Pakistan.	soniaasghar@live.com		Buscher, Philippe/0000-0002-1926-7472; Desquesnes, Marc/0000-0002-7665-2422; Deborggraeve, Stijn/0000-0003-1501-5355			AKHTER R, 2006, SCI CHANG PLANET-SEC, V17, P210; Ali I, 2009, PAK VET J, V29, P85; Alsam A, 2010, PAK VET J, V42, P371; [Anonymous], 2015, PROF CHOL AGR CENS 2; Atarhouch T, 2003, VET PARASITOL, V111, P277, DOI 10.1016/S0304-4017(02)00382-5; BAJYANA SE, 1988, ANN SOC BELG MED TR, V68, P233; Berlin D, 2010, VET PARASITOL, V174, P317, DOI 10.1016/j.vetpar.2010.09.002; Bhutto B, 2009, PAK VET J, V30, P175; Bogale B, 2012, ACTA PARASITOL GLOB, V3, P12; Butt AA, 1996, J CAMEL PRACT RES, V3, P103; Chappuis F, 2005, J CLIN MICROBIOL, V43, P5973, DOI 10.1128/JCM.43.12.5973-5977.2005; Chartier C., 1986, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V39, P395; Claes F., 2004, KINETOPLASTID BIOL D, V3, P1, DOI DOI 10.1186/1475-9292-3-3; Clausen PH, 1998, ANN NY ACAD SCI, V849, P21, DOI 10.1111/j.1749-6632.1998.tb11029.x; Desquesnes M, 2013, BIOMED RES INT, DOI 10.1155/2013/194176; Desquesnes M, 2009, VET PARASITOL, V162, P214, DOI 10.1016/j.vetpar.2009.03.033; Dia M. L., 1997, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V50, P29; Diall O, 1993, Rev Elev Med Vet Pays Trop, V46, P455; Elamin EA, 1998, TROP ANIM HEALTH PRO, V30, P107, DOI 10.1023/A:1005047801206; Enwezor Felicia Nneka Chizoba, 2005, Veterinarski Arhiv, V75, P439; Eyob E., 2013, Journal of Veterinary Medicine and Animal Health, V5, P334; Gonzales JL, 2003, KINETOPLASTID BIOL D, V2, P8, DOI DOI 10.1186/1475-9292-2-8; Gutierrez C, 2000, VET PARASITOL, V90, P155, DOI 10.1016/S0304-4017(00)00225-9; Habila N, 2012, RES VET SCI, V93, P13, DOI 10.1016/j.rvsc.2011.08.011; Holland WG, 2002, ACTA TROP, V81, P159, DOI 10.1016/S0001-706X(01)00211-X; Jacquiet P, 1993, Rev Elev Med Vet Pays Trop, V46, P574; Jamonneau V, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000917; KATENDE JM, 1987, TROP MED PARASITOL, V38, P41; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Luckins A. G., 1998, Journal of Protozoology Research, V8, P106; LUCKINS AG, 1988, PARASITOL TODAY, V4, P137, DOI 10.1016/0169-4758(88)90188-3; LUN ZR, 1993, PARASITOL TODAY, V9, P41, DOI 10.1016/0169-4758(93)90029-F; MASIGA DK, 1992, INT J PARASITOL, V22, P909, DOI 10.1016/0020-7519(92)90047-O; Molina JM, 2000, PREV VET MED, V47, P53, DOI 10.1016/S0167-5877(00)00157-4; Nadeem A, 2011, PAK VET J, V31, P169; Ngaira JM, 2005, EXP PARASITOL, V110, P30, DOI 10.1016/j.exppara.2005.01.001; Ngaira JM, 2003, VET PARASITOL, V114, P131, DOI 10.1016/S0304-4017(03)00112-2; Ngaira JM, 2002, ONDERSTEPOORT J VET, V69, P263; Njiru ZK, 2006, INFECT GENET EVOL, V6, P292, DOI 10.1016/j.meegid.2005.08.002; Njiru ZK, 2004, VET PARASITOL, V124, P187, DOI 10.1016/j.vetpar.2004.06.029; OIE (Office Internatioal des Epizooties), 2012, MAN DIAGN TESTS VACC; OlahoMukani W, 1996, BRIT VET J, V152, P109, DOI 10.1016/S0007-1935(96)80091-1; Omer OH, 1998, J VET MED B, V45, P627, DOI 10.1111/j.1439-0450.1998.tb00836.x; Penchenier L, 1996, PARASITE, V3, P387, DOI 10.1051/parasite/1996034387; Sengupta PP, 2010, VET PARASITOL, V171, P22, DOI 10.1016/j.vetpar.2010.03.011; Shah SR, 2004, PAK VET J, V24, P209; Shahzad W, 2010, TROP ANIM HEALTH PRO, V42, P1597, DOI 10.1007/s11250-010-9616-0; Singh N, 2004, VET PARASITOL, V126, P365, DOI 10.1016/j.vetpar.2004.08.013; Tran T, 2009, CLIN VACCINE IMMUNOL, V16, P999, DOI 10.1128/CVI.00096-09; Ul HM, 2006, ANN NY ACAD SCI, V1081, P322; VanMeirvenne N, 1995, ACTA TROP, V60, P189, DOI 10.1016/0001-706X(95)00127-Z; Ventura R M, 2001, INT J PARASITOL, V31, P1; Verloo D, 2001, VET PARASITOL, V97, P183, DOI 10.1016/S0304-4017(01)00412-5; Verloo D., 1998, Journal of Protozoology Research, V8, P190; Verloo D, 2000, VET PARASITOL, V92, P87, DOI 10.1016/S0304-4017(00)00284-3; WAITUMBI JN, 1993, VET PARASITOL, V49, P159, DOI 10.1016/0304-4017(93)90116-5	56	13	13	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	AUG 12	2015	8								415	10.1186/s13071-015-1002-3				11	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CO5QY	WOS:000359214800001	26259616	DOAJ Gold, Green Published			2019-04-02	
J	Mweempwa, C; Marcotty, T; De Pus, C; Penzhorn, BL; Dicko, AH; Bouyer, J; De Deken, R				Mweempwa, Cornelius; Marcotty, Tanguy; De Pus, Claudia; Penzhorn, Barend Louis; Dicko, Ahmadou Hamady; Bouyer, Jeremy; De Deken, Reginald			Impact of habitat fragmentation on tsetse populations and trypanosomosis risk in Eastern Zambia	PARASITES & VECTORS			English	Article						Habitat fragmentation; Tsetse ecology; Trypanosomosis risk; Zambia	GLOSSINA-PALLIDIPES; INFECTION-RATES; BURKINA-FASO; FLIES; EPIDEMIOLOGY; PROVINCE; DIPTERA; CATTLE	Background: Fragmentation of tsetse habitat in eastern Zambia is largely due to encroachments by subsistence farmers into new areas in search of new agricultural land. The impact of habitat fragmentation on tsetse populations is not clearly understood. This study was aimed at establishing the impact of habitat fragmentation on physiological and demographic parameters of tsetse flies in order to enhance the understanding of the relationship between fragmentation and African animal trypanosomosis (AAT) risk. Methods: A longitudinal study was conducted to establish the age structure, abundance, proportion of females and trypanosome infection rate of Glossina morsitans morsitans Westwood (Diptera: Glossinidae) in areas of varying degrees of habitat fragmentation in Eastern Zambia. Black screen fly rounds were used to sample tsetse populations monthly for 1 year. Logistic regression was used to analyse age, proportion of females and infection rate data. Results: Flies got significantly older as fragmentation increased (p < 0.004). The proportion of old flies, i.e. above ovarian category four, increased significantly (P < 0.001) from 25.9 % (CI 21.4-31.1) at the least fragmented site (Lusandwa) to 74.2 % (CI 56.8-86.3) at the highly fragmented site (Chisulo). In the most fragmented area (Kasamanda), tsetse flies had almost disappeared. In the highly fragmented area a significantly higher trypanosome infection rate in tsetse (P < 0.001) than in areas with lower fragmentation was observed. Consequently a comparatively high trypanosomosis incidence rate in livestock was observed there despite lower tsetse density (p < 0.001). The overall proportion of captured female flies increased significantly (P < 0.005) as fragmentation reduced. The proportion increased from 0.135 (CI 0.10-0.18) to 0.285 (CI 0.26-0.31) at the highly and least fragmented sites, respectively. Conclusions: Habitat fragmentation creates conditions to which tsetse populations respond physiologically and demographically thereby affecting tsetse-trypanosome interactions and hence influencing trypanosomosis risk. Temperature rise due to fragmentation coupled with dominance of old flies in populations increases infection rate in tsetse and hence creates high risk of trypanosomosis in fragmented areas. Possibilities of how correlations between biological characteristics of populations and the degree of fragmentation can be used to structure populations based on their well-being, using integrated GIS and remote sensing techniques are discussed.	[Mweempwa, Cornelius] Dept Vet & Livestock Dev, Lusaka, Zambia; [Marcotty, Tanguy; De Pus, Claudia; De Deken, Reginald] Inst Trop Med, Dept Anim Hlth, B-2000 Antwerp, Belgium; [Mweempwa, Cornelius; Marcotty, Tanguy; Penzhorn, Barend Louis] Univ Pretoria, Dept Vet Trop Dis, Fac Vet Sci, ZA-0002 Pretoria, South Africa; [Dicko, Ahmadou Hamady] Cheikh Anta Diop Univ, West African Sci Serv Climate Change & Adapted La, Climate Change Econ Res Program, Dakar, Senegal; [Bouyer, Jeremy] Ctr Cooperat Int Rech Agron Dev, Unite Mixte Rech Controle Malad Anim Exot & Emerg, F-34398 Montpellier, France; [Bouyer, Jeremy] INRA, Unite Mixte Rech Controle Malad Anim Exot & Emerg, F-34398 Montpellier, France; [Bouyer, Jeremy] Ctr Cooperat Int Rech Agron Dev CIRAD, Unite Mixte Rech Interact Hotes Vecteurs Parasite, F-34398 Montpellier, France; [Bouyer, Jeremy] Inst Senegalais Rech Agr, Lab Natl Elevage & Rech Vet, Serv Parasitol, Dakar, Senegal; [Marcotty, Tanguy] VERDI R&D, B-4141 Louveigne, Belgium	Mweempwa, C (reprint author), Dept Vet & Livestock Dev, Lusaka, Zambia.	cmweempwa@yahoo.com		Penzhorn, Barend (Banie)/0000-0001-6935-5545; Dicko, Ahmadou Hamady/0000-0002-9654-7582	Wellcome Trust of London	This study could be carried out successfully thanks to the valuable contributions of several people to whom we are very grateful. Sincere gratitude goes to Dr. P. Sinyangwe, the Director of the Veterinary and Livestock Development Department of Zambia's Ministry of Agriculture and Cooperatives for giving permission to carry out the study. Further gratitude goes to the Late Professor Peter Van den Bossche of the Institute of Tropical Medicine (ITM), Belgium for initiating and designing the study. We dedicate this achievement to him. The study was sponsored by the Wellcome Trust of London to whom we are very thankful.	Bourn D, 2000, ENV CHANGE AUTONOMOU, P248; Bouyer J, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00047; BURSELL E., 1960, BULL ENT RES, V51, P33; BURTT E, 1946, ANN TROP MED PARASIT, V40, P18, DOI 10.1080/00034983.1946.11685259; BUXTON PA, 1955, MEMOIRS LONDON SCH H; Cuisance D., 1986, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V38, P153; Dicko AH, 2014, P NATL ACAD SCI USA, V111, P10149, DOI 10.1073/pnas.1407773111; Ewers RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058093; FAO, 1982, TRAIN MAN TSETS CONT; Ford J, 1977, B ANIMAL HLTH PRODUC, V15, P187; Gehlhausen SM, 2000, PLANT ECOL, V147, P21, DOI 10.1023/A:1009846507652; Glasgow J. P., 1970, AFRICAN TRYPANOSOMIA, P348; Guerrini L, 2008, J MED ENTOMOL, V45, P1180, DOI 10.1603/0022-2585(2008)45[1180:FAFPOS]2.0.CO;2; HALL DR, 1984, INSECT SCI APPL, V5, P335, DOI 10.1017/S1742758400008626; Hargrove John W., 2004, P113, DOI 10.1079/9780851994758.0113; Hargrove JW, 2000, B ENTOMOL RES, V90, P201; Hargrove JW, 1999, MED VET ENTOMOL, V13, P150, DOI 10.1046/j.1365-2915.1999.00152.x; Hargrove JW, 1999, MED VET ENTOMOL, V13, P165, DOI 10.1046/j.1365-2915.1999.00153.x; HARLEY JMB, 1966, B ENTOMOL RES, V57, P23, DOI 10.1017/S0007485300052676; JACKSON CHN, 1952, B ENTOMOL RES, V43, P703; Kone N, 2011, MED VET ENTOMOL, V25, P156, DOI 10.1111/j.1365-2915.2010.00938.x; Lloyd LL, 1924, B ENTOMOL RES, V14, P225; OTIENO LH, 1983, ANN TROP MED PARASIT, V77, P329, DOI 10.1080/00034983.1983.11811719; POTTS W. H. A, 1930, SO AFRICAN JOUR SCI, V27, P491; ROGERS DJ, 1985, ACTA TROP, V42, P5; Sedda L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096002; Sy I, 2011, EFFET TEMPERATURE AM; VALE GA, 1980, B ENTOMOL RES, V70, P563, DOI 10.1017/S0007485300007860; Van den Bossche P, 2000, ACTA TROP, V75, P247, DOI 10.1016/S0001-706X(00)00059-0; Van den Bossche P, 2009, PREV VET MED, V91, P11; Van den Bossche P, 2010, TRENDS PARASITOL, V26, P236, DOI 10.1016/j.pt.2010.02.010; VandenBossche P, 1997, ACTA TROP, V65, P105, DOI 10.1016/S0001-706X(97)00658-X; Warnes ML, 1997, HDB TSETSE FIELD STA, P201; WOOLHOUSE MEJ, 1993, PARASITOLOGY, V106, P479, DOI 10.1017/S0031182000076770	34	7	7	1	14	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	AUG 4	2015	8								406	10.1186/s13071-015-1018-8				10	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CO2LA	WOS:000358986500001	26238201	DOAJ Gold, Green Published			2019-04-02	
J	Mwape, KE; Blocher, J; Wiefek, J; Schmidt, K; Dorny, P; Praet, N; Chiluba, C; Schmidt, H; Phiri, IK; Winkler, AS; Gabriel, S				Mwape, Kabemba E.; Blocher, Joachim; Wiefek, Jasmin; Schmidt, Kathie; Dorny, Pierre; Praet, Nicolas; Chiluba, Clarance; Schmidt, Holger; Phiri, Isaac K.; Winkler, Andrea S.; Gabriel, Sarah			Prevalence of Neurocysticercosis in People with Epilepsy in the Eastern Province of Zambia	PLOS NEGLECTED TROPICAL DISEASES			English	Article							SUB-SAHARAN AFRICA; TAENIA-SOLIUM; PORCINE CYSTICERCOSIS; CLINICAL CHARACTERISTICS; DIAGNOSTIC-CRITERIA; SOUTHERN PROVINCES; COMMUNITY; EPIDEMIOLOGY; MANAGEMENT; COUNTRIES	Zambia is endemic for Taenia solium taeniosis and cysticercosis. In this single-centered, cross-sectional, community-based study, the role of neurocysticercosis (NCC) as a cause of epilepsy was examined. People with epilepsy (PWE, n = 56) were identified in an endemic area using a screening questionnaire followed by in-depth interviews and neurological examination. Computed tomography (CT) was performed on 49 people with active epilepsy (PWAE) and their sera (specific antibody and antigen detection, n = 56) and stools (copro-antigen detection, n = 54) were analyzed. The CT scan findings were compared to a group of 40 CT scan controls. Of the PWE, 39.3% and 23.2% were positive for cysticercal antibodies and antigens, respectively, and 14.8% for coproantigens (taeniosis). Lesions highly suggestive of NCC were detected in 24.5% and definite NCC lesions in 4.1% of CT scans of PWAE. This compares to 2.5% and 0%, respectively, in the control CT scans. Using the Del Brutto diagnostic criteria, 51.8% of the PWAE were diagnosed with probable or definitive NCC and this rose to 57.1% when the adapted criteria, as proposed by Gabriel et al. (adding the sero-antigen ELISA test as a major criterion), were used. There was no statistically significant relationship between NCC, current age, age at first seizure and gender. This study suggests that NCC is the single most important cause of epilepsy in the study area. Additional large-scale studies, combining a community based prevalence study for epilepsy with neuroimaging and serological analysis in different areas are needed to estimate the true impact of neurocysticercosis in endemic regions and efforts should be instituted to the control of T. solium.	[Mwape, Kabemba E.; Phiri, Isaac K.] Univ Zambia, Dept Clin Studies, Sch Vet Med, Lusaka, Zambia; [Blocher, Joachim] Med Univ Ctr Gottingen, Dept Neurol, Gottingen, Germany; [Blocher, Joachim; Schmidt, Holger] Elbe Kliniken Stade Buxtehude GmbH, Dept Neurol, Stade, Germany; [Wiefek, Jasmin] Europe Univ Flensburg, Flensburg, Germany; [Schmidt, Kathie] Med Univ Ctr Gottingen, Dept Neuroradiol, Gottingen, Germany; [Dorny, Pierre; Praet, Nicolas; Gabriel, Sarah] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Chiluba, Clarance] Levy Mwanawasa Gen Hosp, Lusaka, Zambia; [Winkler, Andrea S.] Tech Univ Munich, Dept Neurol, D-80290 Munich, Germany	Mwape, KE (reprint author), Univ Zambia, Dept Clin Studies, Sch Vet Med, Lusaka, Zambia.	Joachim.blocher@med.uni-goettingen.de			Flemish Inter-University Council [VLIR-UOS.ZIUS2008RIP-8961]; COST Action [TD1302]; German Research Foundation; Open Access Publication Funds of Gottingen University	The study was funded by the Flemish Inter-University Council (VLIR-UOS.ZIUS2008RIP-8961), the ITM-DVTD framework agreement 3 and COST Action TD1302 "European Network on Taeniosis/Cysticercosis CYSTINET". We acknowledge support by the German Research Foundation and the Open Access Publication Funds of the Gottingen University. The funding bodies had no influence on the study design, data collection, data analysis and decision to publish the data.	ALLAN JC, 1990, PARASITOLOGY, V101, P473, DOI 10.1017/S0031182000060686; Baskind R, 2005, EPILEPSY BEHAV, V7, P68, DOI 10.1016/j.yabeh.2005.04.009; Birbeck GL, 2004, TROP MED INT HEALTH, V9, P92, DOI 10.1046/j.1365-3156.2003.01149.x; Blocher J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001185; Bruno E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002480; Carabin H, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001152; Centres For Disease Control And Prevention, 1993, MMWR-MORBID MORTAL W, V42, P28; Del Brutto OH, 2005, SEMIN NEUROL, V25, P243, DOI 10.1055/s-2005-917661; Del Brutto OH, 2001, NEUROLOGY, V57, P177, DOI 10.1212/WNL.57.2.177; Del Brutto OH, 2012, PATHOG GLOB HEALTH, V106, P299, DOI 10.1179/2047773212Y.0000000025; Dorny P, 2004, TRENDS PARASITOL, V20, P259, DOI 10.1016/j.pt.2004.04.001; Dorny P, 2004, INT J PARASITOL, V34, P569, DOI 10.1016/j.ijpara.2003.11.014; Forsgren L, 2005, EPILEPSIA, V46, P18, DOI 10.1111/j.1528-1167.2005.00403.x; Forsgren L, 2008, LANCET NEUROL, V7, P21, DOI 10.1016/S1474-4422(07)70295-8; Foyaca-Sibat H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000562; Gabriel S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001851; Garcia HH, 2005, AM J TROP MED HYG, V72, P3, DOI 10.4269/ajtmh.2005.72.3; Garcia-Garcia MD, 1999, AM J TROP MED HYG, V61, P386; GarciaNoval J, 1996, AM J TROP MED HYG, V55, P282, DOI 10.4269/ajtmh.1996.55.282; Goel D, 2011, NEUROL INDIA, V59, P37, DOI 10.4103/0028-3886.76855; Murell KD, 2005, WHO FAO OIE GUIDELIN, P27; Mwape KE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002142; Mwape KE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001594; Nash TE, 2006, NEUROLOGY, V67, P1120, DOI 10.1212/01.wnl.0000238514.51747.3a; Nash TE, 2004, NEUROLOGY, V62, P1934, DOI 10.1212/01.WNL.0000129481.12067.06; Ndimubanzi PC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000870; Phiri IK, 2002, VET PARASITOL, V108, P31, DOI 10.1016/S0304-4017(02)00165-6; Preux PM, 2005, LANCET NEUROL, V4, P21, DOI 10.1016/S1474-4422(04)00963-9; SCHANTZ PM, 1992, NEW ENGL J MED, V327, P692, DOI 10.1056/NEJM199209033271004; Sikasunge CS, 2007, VET PARASITOL, V143, P59, DOI 10.1016/j.vetpar.2006.07.023; Sikasunge CS, 2008, VET J, V176, P240, DOI 10.1016/j.tvjl.2007.02.030; White AC, 2000, ANNU REV MED, V51, P187, DOI 10.1146/annurev.med.51.1.187; Winkler A. S., 2013, NOVEL ASPECTS CYSTIC, P307; Winkler AS, 2007, EPILEPSIA, V48, P1029, DOI 10.1111/j.1528-1167.2007.01009_1.x; Winkler AS, 2012, PATHOG GLOB HEALTH, V106, P261, DOI 10.1179/2047773212Y.0000000047; Winkler AS, 2009, EPILEPSIA, V50, P987, DOI 10.1111/j.1528-1167.2008.01867.x; Zea-Vera A, 2013, CLIN INFECT DIS, V57, pE154, DOI 10.1093/cid/cit422	37	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	AUG	2015	9	8							e0003972	10.1371/journal.pntd.0003972				15	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CQ6IO	WOS:000360708200030	26285031	DOAJ Gold, Green Published			2019-04-02	
J	Ostyn, B; Uranw, S; Bhattarai, NR; Das, ML; Rai, K; Tersago, K; Pokhrel, Y; Durnez, L; Marasini, B; Van der Auwera, G; Dujardin, JC; Coosemans, M; Argaw, D; Boelaert, M; Rijal, S				Ostyn, Bart; Uranw, Surendra; Bhattarai, Narayan Raj; Das, Murari L.; Rai, Keshav; Tersago, Katrien; Pokhrel, Yubraj; Durnez, Lies; Marasini, Baburam; Van der Auwera, Gert; Dujardin, Jean-Claude; Coosemans, Marc; Argaw, Daniel; Boelaert, Marleen; Rijal, Suman			Transmission of Leishmania donovani in the Hills of Eastern Nepal, an Outbreak Investigation in Okhaldhunga and Bhojpur Districts	PLOS NEGLECTED TROPICAL DISEASES			English	Article							DIRECT AGGLUTINATION-TEST; VISCERAL LEISHMANIASIS; KALA-AZAR; INFECTION; MARKERS; DIAGNOSIS; INDIA; FOCI; PCR	Background In the Indian subcontinent, Visceral leishmaniasis is endemic in a geographical area coinciding with the Lower Gangetic Plain, at low altitude. VL occurring in residents of hill districts is therefore often considered the result of Leishmania donovani infection during travel. Early 2014 we conducted an outbreak investigation in Okhaldhunga and Bhojpur districts in the Nepal hills where increasing number of VL cases have been reported. Methodology/Principal Findings A house-to-house survey in six villages documented retrospectively 35 cases of Visceral Leishmaniasis (VL). Anti-Leishmania antibodies were found in 22/23 past-VL cases, in 40/416 (9.6%) persons without VL and in 12/155 (7.7%) domestic animals. An age-and sex-matched case-control study showed that exposure to known VL-endemic regions was no risk factor for VL, but having a VL case in the neighbourhood was. SSU-rDNA PCR for Leishmania sp. was positive in 24 (5%) of the human, in 18 (12%) of the animal samples and in 16 (14%) bloodfed female Phlebotomus argentipes sand flies. L. donovani was confirmed in two asymptomatic individuals and in one sand fly through hsp70-based sequencing. Conclusions/Significance This is epidemiological and entomological evidence for ongoing local transmission of L. donovani in villages at an altitude above 600 meters in Nepal, in districts considered hitherto non-endemic for VL. The VL Elimination Initiative in Nepal should therefore consider extending its surveillance and control activities in order to assure VL elimination, and the risk map for VL should be redesigned.	[Ostyn, Bart; Tersago, Katrien; Boelaert, Marleen] Inst Trop Med, Dept Publ Heath, B-2000 Antwerp, Belgium; [Uranw, Surendra; Rijal, Suman] BP Koirala Inst Hlth Sci, Dept Internal Med, Dharan, Nepal; [Bhattarai, Narayan Raj; Das, Murari L.; Rai, Keshav] BP Koirala Inst Hlth Sci, Dept Microbiol, Dharan, Nepal; [Pokhrel, Yubraj; Marasini, Baburam] Minist Hlth & Populat MOHP, Epidemiol & Dis Control Div, Kathmandu, Nepal; [Durnez, Lies; Van der Auwera, Gert; Dujardin, Jean-Claude] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Dujardin, Jean-Claude; Coosemans, Marc] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium; [Argaw, Daniel] WHO, Dept Control Neglected Trop Dis, CH-1211 Geneva, Switzerland	Ostyn, B (reprint author), Inst Trop Med, Dept Publ Heath, B-2000 Antwerp, Belgium.	bostyn@itg.be	Rai, Keshav/Q-1350-2016	Rai, Keshav/0000-0002-9747-3431; Boelaert, Marleen/0000-0001-8051-6776; Das, Murari/0000-0001-6816-2389	Directorate-General for Development Cooperation [1.16]; ITM; NTD division of WHO-Geneva; Ministry of Sciences of the Flanders region (ITMA/SOFI-B, SINGLE) Department of Economy, Science and Innovation (EWI Department)	This research was funded by the Framework Agreement between ITM and the Directorate-General for Development Cooperation, Project number 1.16 http://diplomatie.belgium.be/nl/Beleid/Ontwikkelingssamenwerking/(MB, JCD), by the NTD division of WHO-Geneva http://www.who.int/neglected_diseases/en/(SU,SR), and by the Ministry of Sciences of the Flanders region (ITMA/SOFI-B, SINGLE) Department of Economy, Science and Innovation (EWI Department) http://www.ewivlaanderen.be/en (MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Bern C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000599; Bhattarai NR, 2010, EMERG INFECT DIS, V16, P231, DOI 10.3201/eid1602.090623; Bhattarai NR, 2009, TROP MED INT HEALTH, V14, P404, DOI 10.1111/j.1365-3156.2009.02242.x; Bhunia GS, 2010, GEOSPATIAL HEALTH, V4, P155, DOI 10.4081/gh.2010.197; Datta U, 1984, J Assoc Physicians India, V32, P1072; Deborggraeve S, 2008, TROP MED INT HEALTH, V13, P1378, DOI 10.1111/j.1365-3156.2008.02154.x; Jacquet D, 2006, TROP MED INT HEALTH, V11, P1777, DOI 10.1111/j.1365-3156.2006.01743.x; Joshi S, 2006, Kathmandu Univ Med J (KUMJ), V4, P232; Keogh RH, 2014, I MATH STAT MONOGRAP; Khanal B, 2010, PARASITOLOGY, V137, P1597, DOI 10.1017/S0031182010000521; Khanal B, 2010, TROP MED INT HEALTH, V15, P1390, DOI 10.1111/j.1365-3156.2010.02631.x; Lewis D.J., 1982, Bulletin of the British Museum (Natural History) Entomology, V45, P121; LYSENKO AJ, 1971, B WORLD HEALTH ORGAN, V44, P515; Mahajan Sanjay K., 2004, Journal of Communicable Diseases, V36, P117; Montalvo AM, 2012, EUR J CLIN MICROBIOL, V31, P1453, DOI 10.1007/s10096-011-1463-z; NAIK SR, 1979, T ROY SOC TROP MED H, V73, P61, DOI 10.1016/0035-9203(79)90131-7; Odiwuor S, 2012, PATHOG GLOB HEALTH, V106, P159, DOI 10.1179/2047773212Y.0000000015; Ozbel Y, 2011, J VECTOR ECOL, V36, pS77, DOI 10.1111/j.1948-7134.2011.00115.x; Pandey BD, 2011, AM J TROP MED HYG, V84, P107, DOI 10.4269/ajtmh.2011.10-0291; Park K, 2007, PARKS TXB PREVENTIVE, P256; Picado A, 2010, J MED ENTOMOL, V47, P283, DOI 10.1603/ME09175; R Core Team, 2013, R LANG ENV STAT COMP; Rao J. S., 2001, Journal of Communicable Diseases, V33, P7; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2006.01678.x; Rijal S, 2010, TROP MED INT HEALTH, V15, P21, DOI 10.1111/j.1365-3156.2010.02518.x; Seblova V, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-222; Singh Sarman, 1999, Journal of Communicable Diseases, V31, P73; Srivastava P, 2010, INFECT GENET EVOL, V10, P1145, DOI 10.1016/j.meegid.2010.07.009; Sundar S, 2006, T ROY SOC TROP MED H, V100, P533, DOI 10.1016/j.trstmh.2005.08.018; Swaminath CS, 2006, INDIAN J MED RES, V123, pA473; Van der Auwera G, 2013, EUROSURVEILLANCE, V18, P40, DOI 10.2807/1560-7917.ES2013.18.30.20543; Van der Auwera G, 2014, J CLIN MICROBIOL, V52, P1098, DOI 10.1128/JCM.02936-13; Versteirt V, 2014, MOL ECOL RESOUR; Yangzom T, 2012, AM J TROP MED HYG, V87, P1028, DOI 10.4269/ajtmh.2012.12-0211	35	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	AUG	2015	9	8							e0003966	10.1371/journal.pntd.0003966				13	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CQ6IO	WOS:000360708200054	26252494	DOAJ Gold, Green Published			2019-04-02	
J	Van den Broeck, F; Maes, GE; Larmuseau, MHD; Rollinson, D; Sy, I; Faye, D; Volckaert, FAM; Polman, K; Huyse, T				Van den Broeck, Frederik; Maes, Gregory E.; Larmuseau, Maarten H. D.; Rollinson, David; Sy, Ibrahima; Faye, Djibril; Volckaert, Filip A. M.; Polman, Katja; Huyse, Tine			Reconstructing Colonization Dynamics of the Human Parasite Schistosoma mansoni following Anthropogenic Environmental Changes in Northwest Senegal	PLOS NEGLECTED TROPICAL DISEASES			English	Article							RECENTLY EXPOSED COMMUNITY; RIVER-BASIN; NORTHERN SENEGAL; POPULATION-STRUCTURE; GENETIC DIVERSITY; PRAZIQUANTEL TREATMENT; INTESTINAL SCHISTOSOMIASIS; MICROSATELLITE MARKERS; BIOLOGICAL INVASIONS; MULTIPLE SOURCES	Background Anthropogenic environmental changes may lead to ecosystem destabilization and the unintentional colonization of new habitats by parasite populations. A remarkable example is the outbreak of intestinal schistosomiasis in Northwest Senegal following the construction of two dams in the '80s. While many studies have investigated the epidemiological, immunological and geographical patterns of Schistosoma mansoni infections in this region, little is known about its colonization history. Methodology/Principal Findings Parasites were collected at several time points after the disease outbreak and genotyped using a 420 bp fragment of the mitochondrial cytochrome c oxidase subunit 1 gene (cox1) and nine nuclear DNA microsatellite markers. Phylogeographic and population genetic analyses revealed the presence of (i) many genetically different haplotypes at the non-recombining mitochondrial marker and (ii) one homogenous S. mansoni genetic group at the recombining microsatellite markers. These results suggest that the S. mansoni population in Northwest Senegal was triggered by intraspecific hybridization (i.e. admixture) between parasites that were introduced from different regions. This would comply with the extensive immigration of infected seasonal agricultural workers from neighboring regions in Senegal, Mauritania and Mali. The spatial and temporal stability of the established S. mansoni population suggests a swift local adaptation of the parasite to the local intermediate snail host Biomphalaria pfeifferi at the onset of the epidemic. Conclusions/Significance Our results show that S. mansoni parasites are very successful in colonizing new areas without significant loss of genetic diversity. Maintaining high levels of diversity guarantees the adaptive potential of these parasites to cope with selective pressures such as drug treatment, which might complicate efforts to control the disease.	[Van den Broeck, Frederik; Maes, Gregory E.; Larmuseau, Maarten H. D.; Volckaert, Filip A. M.; Huyse, Tine] Univ Leuven, Dept Biol, Leuven, Belgium; [Van den Broeck, Frederik; Polman, Katja; Huyse, Tine] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Maes, Gregory E.] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld, Australia; [Larmuseau, Maarten H. D.] Univ Leuven, Dept Imaging & Pathol, Leuven, Belgium; [Rollinson, David] Nat Hist Museum, Div Life Sci, London SW7 5BD, England; [Sy, Ibrahima] Univ Caen Basse Normandie, UFR Pharm, Caen, France; [Faye, Djibril] Sant Plus, Dakar, Senegal; [Huyse, Tine] Royal Museum Cent Afr, Dept Biol, Tervuren, Belgium	Van den Broeck, F (reprint author), Univ Leuven, Dept Biol, Leuven, Belgium.	fvandenbroeck@gmail.com	Rollinson, David/C-7406-2009; Van den Broeck, Frederik/T-6182-2017; Maes, Gregory/C-5450-2008	Van den Broeck, Frederik/0000-0003-2542-5585; Maes, Gregory/0000-0002-1531-7321; Larmuseau, Maarten H.D./0000-0002-5974-7235	Flemish Interuniversity Council (VLIR-UOS) [VLADOC2010-07]; Research Foundation-Flanders (FWO Vlaanderen) [1.2.668.11. N. 01, 12E2315N, G.0552.10]	FVdB benefited from a doctoral fellowship (grant number VLADOC2010-07) from the Flemish Interuniversity Council (VLIR-UOS; www.vliruos.be). TH and MHDL benefited from a postdoctoral fellowship (grant numbers 1.2.668.11. N. 01 and 12E2315N resp.) from the Research Foundation-Flanders (FWO Vlaanderen; www.fwo.be). Research benefited from a Research Grant (grant number G.0552.10) of the Research Foundation - Flanders to TH, FAMV and KP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise JC, 2004, AUK; Barrett LG, 2008, TRENDS ECOL EVOL, V23, P678, DOI 10.1016/j.tree.2008.06.017; Bech N, 2010, INFECT GENET EVOL, V10, P1039, DOI 10.1016/j.meegid.2010.06.012; Belkhir K, GENETIX 4 05 LOGICIE; Besnier F, 2013, PLOS ONE, V8; Blair L, 2001, MOL ECOL NOTES, V1, P93, DOI 10.1046/j.1471-8278 .2001.00042.x; Blank WA, 2010, J PARASITOL, V96, P900, DOI 10.1645/GE-2463.1; Blanton RE, 2011, INT J PARASITOL, V41, P1093, DOI 10.1016/j.ijpara.2011.06.002; BOWLES J, 1992, MOL BIOCHEM PARASIT, V54, P165, DOI 10.1016/0166-6851(92)90109-W; Campbell G, 2010, MOL ECOL, V19, P241, DOI 10.1111/j.1365-294X.2009.04463.x; Chitsulo L, 2000, ACTA TROP, V77, P41, DOI 10.1016/S0001-706X(00)00122-4; Coeli R, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002596; Curtis J, 2001, MOL ECOL NOTES, V1, P143, DOI 10.1046/j.1471-8278.2001.00053.x; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; DIAW OT, 1991, B SOC PATHOL EXOT, V84, P174; Durand P, 2000, MOL ECOL, V9, P997, DOI 10.1046/j.1365-294x.2000.00939-4.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellstrand NC, 2006, EUPHYTICA, V148, P35, DOI 10.1007/s10681-006-5939-3; Emery AM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-185; Gaither MR, 2013, PLOS ONE, V8; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8278.2004.00828.x; Gower CM, 2013, ACTA TROP, V128, P261, DOI 10.1016/j.actatropica.2012.09.014; GRYSEELS B, 1995, MEM I OSWALDO CRUZ, V90, P271, DOI 10.1590/S0074-02761995000200025; GRYSEELS B, 1994, TROP GEOGR MED, V46, P209; HANDSCHUMACHER P, 1992, DISEASES, RHYTHMS AND EXTREME CLIMATIC CONDITIONS, P287; Hartl D. L., 2007, PRINCIPLES POPULATIO; Helsen K, 2013, PLOS ONE, V8; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Huyse T, 2013, INFECT GENET EVOL, V18, P100, DOI 10.1016/j.meegid.2013.05.007; Kanuch P, 2014, ECOL EVOL, V4, P1117, DOI 10.1002/ece3.1005; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Keller SR, 2010, J EVOLUTION BIOL, V23, P1720, DOI 10.1111/j.1420-9101.2010.02037.x; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kolbe JJ, 2007, CONSERV BIOL, V21, P1612, DOI 10.1111/j.1523-1739.2007.00826.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lockyer AE, 2003, PARASITOLOGY, V126, P203, DOI 10.1017/S0031182002002792; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Meurs L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003080; Meurs L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002608; Meurs L, 2012, INT J PARASITOL, V42, P305, DOI 10.1016/j.ijpara.2012.02.002; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Mitta G, 2012, DEV COMP IMMUNOL, V37, P1, DOI 10.1016/j.dci.2011.09.002; Morin PA, 2009, MOL ECOL RESOUR, V9, P1451, DOI 10.1111/j.1755-0998.2009.02672.x; Ndao B, 2013, Med Sante Trop, V23, P226, DOI 10.1684/mst.2013.0212; Nei M, 1987, MOL EVOLUTIONARY GEN; Norton AJ, 2010, AM J TROP MED HYG, V83, P951, DOI 10.4269/ajtmh.2010.10-0283; Novak CW, 2013, J PARASITOL, V99, P59, DOI 10.1645/GE-3145.1; Orsini L, 2013, MOL ECOL, V22, P5983, DOI 10.1111/mec.12561; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Picquet M, 1996, T ROY SOC TROP MED H, V90, P340, DOI 10.1016/S0035-9203(96)90501-5; Polman K, 2002, ANN TROP MED PARASIT, V96, P679, DOI 10.1179/000349802125001708; Polman K, 2001, TROP MED INT HEALTH, V6, P538, DOI 10.1046/j.1365-3156.2001.00742.x; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2013, R LANG ENV STAT COMP, P409, DOI DOI 10.1007/978-3-540-74686-7; Rosenthal DM, 2008, MOL ECOL, V17, P4657, DOI 10.1111/j.1365-294X.2008.03844.x; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Southgate VR, 2001, MEM I OSWALDO CRUZ, V96, P75, DOI 10.1590/S0074-02762001000900010; Southgate VR, 1997, J HELMINTHOL, V71, P125, DOI 10.1017/S0022149X00015790; Southgate VR, 2000, PARASITOLOGY, V121, P501, DOI 10.1017/S0031182099006708; Sow S, 2002, ANN TROP MED PARASIT, V96, P575, DOI 10.1179/000349802125001636; Stelma F, 1995, AM J TROP MED HYG, V63, P167; Suarez AV, 2008, MOL ECOL, V17, P351, DOI 10.1111/j.1365-294X.2007.03456.x; Swaegers J, 2013, HEREDITY, V111, P422, DOI 10.1038/hdy.2013.64; TALLA I, 1992, T ROY SOC TROP MED H, V86, P182, DOI 10.1016/0035-9203(92)90562-Q; TALLA I, 1990, ANN SOC BELG MED TR, V70, P173; TEMPLETON AR, 1992, GENETICS, V132, P619; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Van den Broeck F, 2014, HEREDITY, V113, P32, DOI 10.1038/hdy.2014.13; Van den Broeck F, 2011, INFECT GENET EVOL, V11, P1413, DOI 10.1016/j.meegid.2011.05.006; VERCRUYSSE J, 1994, TROP GEOGR MED, V46, P220; VERCRUYSSE J, 1985, ACTA TROP, V42, P249; VERHEYE WH, 1995, AGR WATER MANAGE, V28, P73, DOI 10.1016/0378-3774(95)01142-6; Verhoeven KJF, 2011, P ROY SOC B-BIOL SCI, V278, P2, DOI 10.1098/rspb.2010.1272; VERLE P, 1994, T ROY SOC TROP MED H, V88, P401, DOI 10.1016/0035-9203(94)90400-6; Webster BL, 2013, ACTA TROP, V128, P250, DOI 10.1016/j.actatropica.2012.08.009; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WHO, 2006, PREV CHEM HUM HELM, P62	78	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	AUG	2015	9	8							e0003998	10.1371/journal.pntd.0003998				21	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CQ6IO	WOS:000360708200042	26275049	DOAJ Gold, Green Published			2019-04-02	
J	Wamala, JF; Malimbo, M; Tepage, F; Lukwago, L; Okot, CL; Cannon, RO; Laudisoit, A; Colebunders, R				Wamala, Joseph Francis; Malimbo, Mugagga; Tepage, Floribert; Lukwago, Luswa; Okot, Charles Lukoya; Cannon, Robert O.; Laudisoit, Anne; Colebunders, Robert			Nodding Syndrome May Be Only the Ears of the Hippo	PLOS NEGLECTED TROPICAL DISEASES			English	Article							SYNDROME-A; EPILEPSY; ONCHOCERCIASIS; METAANALYSIS; TANZANIA; AREA		[Wamala, Joseph Francis; Malimbo, Mugagga; Lukwago, Luswa] Minist Hlth, Natl Dis Control, Kampala, Uganda; [Tepage, Floribert] Natl Onchocerciasis Control Program, Minist Hlth, Kisangani, DEM REP CONGO; [Okot, Charles Lukoya] WHO, Dis Prevent & Control Cluster, Kampala, Uganda; [Cannon, Robert O.] ROC Consulting, Palo Alto, CA USA; [Laudisoit, Anne] Univ Antwerp, Evolutionary Biol Grp, B-2020 Antwerp, Belgium; [Laudisoit, Anne] Univ Liverpool, Inst Integrat Ecol, Liverpool L69 3BX, Merseyside, England; [Colebunders, Robert] Univ Antwerp, Dept Epidemiol & Social Med, B-2020 Antwerp, Belgium; [Colebunders, Robert] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium	Wamala, JF (reprint author), Minist Hlth, Natl Dis Control, Kampala, Uganda.	robert.colebunders@uantwerpen.be	Laudisoit, Anne/F-2646-2017	Laudisoit, Anne/0000-0001-7626-9426	Department of Health and Human Services, Centers for Disease Control & Prevention (CDC) [GH0000046]	Funding for the 2012 epilepsy census was obtained from the Department of Health and Human Services, Centers for Disease Control & Prevention (CDC) Grant Number: GH0000046. Funders' URL: http://www.cdc.gov. The investigation protocol was designed by the Ministry of Health and reviewed by CDC. The CDC team provided technical guidance to the Ministry of Health teams during the data collection, entry, cleaning and data analysis. However, the decision to publish this viewpoint paper was solely taken and pursued by the Ministry of Health with support from the WHO Country Office.	Boussinesq M, 2002, T ROY SOC TROP MED H, V96, P537, DOI 10.1016/S0035-9203(02)90433-5; Colebunders R, 2015, EUR C CLIN MICR INF; Colebunders R, 2014, TROP MED INT HLTH; Colebunders R, 2014, INT J INFECT DIS, V27, P74, DOI 10.1016/j.ijid.2014.08.001; Dietmann A, 2014, AFR HEALTH SCI, V14, P434, DOI 10.4314/ahs.v14i2.20; Dowell SF, 2013, EMERG INFECT DIS, V19, P1374, DOI 10.3201/eid1909.130401; DUKE BOL, 1976, TROPENMED PARASITOL, V27, P123; Foltz JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066419; Idro R, 2013, BMJ OPEN, P3; Idro R, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006476; Iyengar PJ, 2014, MMWR-MORBID MORTAL W, V63, P603; Johnson T, 2014, J NEUROIMMUNOL, V275, P103, DOI 10.1016/j.jneuroim.2014.08.275; Kaiser C, 2008, AM J TROP MED HYG, V79, P643, DOI 10.4269/ajtmh.2008.79.643; Kaiser C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002147; Konig R, 2010, PARASITOLOGY, V137, P1559, DOI 10.1017/S0031182010000338; Ministry of Health Uganda, 2014, WEEKL EP B; Ngugi AK, 2013, LANCET NEUROL, V12, P253, DOI 10.1016/S1474-4422(13)70003-6; Pion SDS, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000461; Sejvar JJ, 2013, LANCET NEUROL, V12, P166, DOI 10.1016/S1474-4422(12)70321-6; Tumwine JK, 2012, AFR HEALTH SCI, V12, P242, DOI 10.4314/ahs.v12i3.1; Winkler AS, 2013, AFR HEALTH SCI, V13, P529, DOI 10.4314/ahs.v13i2.51; Winkler AS, 2014, EPILEPSIA, V55, P86, DOI 10.1111/epi.12483; Winkler AS, 2008, EPILEPSIA, V49, P2008, DOI 10.1111/j.1528-1167.2008.01671.x; World Health Organization, 2012, INT SCI M NODD SYNDR; Zoure HGM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-326	25	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	AUG	2015	9	8							e0003880	10.1371/journal.pntd.0003880				7	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CQ6IO	WOS:000360708200003	26270048	DOAJ Gold, Green Published			2019-04-02	
J	Messina, JP; Pigott, DM; Golding, N; Duda, KA; Brownstein, JS; Weiss, DJ; Gibson, H; Robinson, TP; Gilbert, M; Wint, GRW; Nuttall, PA; Gething, PW; Myers, MF; George, DB; Hay, SI				Messina, Jane P.; Pigott, David M.; Golding, Nick; Duda, Kirsten A.; Brownstein, John S.; Weiss, Daniel J.; Gibson, Harry; Robinson, Timothy P.; Gilbert, Marius; Wint, G. R. William; Nuttall, Patricia A.; Gething, Peter W.; Myers, Monica F.; George, Dylan B.; Hay, Simon I.			The global distribution of Crimean-Congo hemorrhagic fever	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Crimean-Congo hemorrhagic fever; Crimean-Congo hemorrhagic fever virus; Ecological niche modeling; Infectious diseases; Tick-borne diseases; Vector-borne diseases	SPECIES DISTRIBUTION MODELS; HEALTH-CARE WORKERS; SPATIAL-DISTRIBUTION; PSEUDO-ABSENCES; VIRUS; DISEASE; RISK; EPIDEMIOLOGY; TRANSMISSION; AFRICA	Background: Crimean-Congo hemorrhagic fever (CCHF) is a tick-borne infection caused by a virus (CCHFV) from the Bunyaviridae family. Domestic and wild vertebrates are asymptomatic reservoirs for the virus, putting animal handlers, slaughter-house workers and agricultural labourers at highest risk in endemic areas, with secondary transmission possible through contact with infected blood and other bodily fluids. Human infection is characterized by severe symptoms that often result in death. While it is known that CCHFV transmission is limited to Africa, Asia and Europe, definitive global extents and risk patterns within these limits have not been well described. Methods: We used an exhaustive database of human CCHF occurrence records and a niche modeling framework to map the global distribution of risk for human CCHF occurrence. Results: A greater proportion of shrub or grass land cover was the most important contributor to our model, which predicts highest levels of risk around the Black Sea, Turkey, and some parts of central Asia. Sub-Saharan Africa shows more focalized areas of risk throughout the Sahel and the Cape region. Conclusions: These new risk maps provide a valuable starting point for understanding the zoonotic niche of CCHF, its extent and the risk it poses to humans.	[Messina, Jane P.; Pigott, David M.; Duda, Kirsten A.; Weiss, Daniel J.; Gibson, Harry; Wint, G. R. William; Nuttall, Patricia A.; Gething, Peter W.; Myers, Monica F.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Golding, Nick; Hay, Simon I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Brownstein, John S.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Brownstein, John S.] Boston Childrens Hosp, Childrens Hosp Informat Program, Boston, MA USA; [Robinson, Timothy P.] Int Livestock Res Inst, LSE, Nairobi, Kenya; [Gilbert, Marius] Univ Libre Bruxelles, Biol Control & Spatial Ecol, Brussels, Belgium; [Gilbert, Marius] Fonds Natl Rech Sci, Brussels, Belgium; [George, Dylan B.; Hay, Simon I.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Hay, Simon I.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	Messina, JP (reprint author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	jane.messina@zoo.ox.ac.uk	Hay, Simon/F-8967-2015; Nuttall, Pat/I-6142-2012	Hay, Simon/0000-0002-0611-7272; Pigott, David/0000-0002-6731-4034; Golding, Nick/0000-0001-8916-5570; Nuttall, Pat/0000-0002-0385-8294; Wint, William/0000-0003-0916-0847; Gething, Peter/0000-0001-6759-5449	Wellcome Trust [095066]; Bill & Melinda Gates Foundation [OPP1093011, OPP1068048, OPP1106023, OPP1053338]; International Research Consortium on Dengue Risk Assessment Management and Surveillance (IDAMS) [21803]; RAPIDD program of the Science & Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; UK Medical Research Council (MRC) [K00669X]; UK Department for International Development (DFID); National Library of Medicine; National Institutes of Health [5R01LM010812-05]; Department of Zoology at the University of Oxford; CGIAR Research Programme on the Humidtropics; CGIAR Research Programme on the Climate Change, Agriculture and Food Security (CCAFS); Agriculture for Nutrition and Health (A4NH)	SIH is funded by a Senior Research Fellowship from the Wellcome Trust [#095066], which also supports AM and KAD, and a grant from the Bill & Melinda Gates Foundation [#OPP1093011]. JPM and SIH received funding from the International Research Consortium on Dengue Risk Assessment Management and Surveillance (IDAMS, [#21803], http://www.idams.eu). SIH would also like to acknowledge funding support from the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. PWG is a Career Development Fellow [#K00669X] jointly funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement and receives support from the Bill & Melinda Gates Foundation [#OPP1068048, #OPP1106023]. These grants also support DJW and HG. JSB is supported by a research grant from the National Library of Medicine, the National Institutes of Health [5R01LM010812-05]. DMP is funded by a Sir Richard Southwood Graduate Scholarship from the Department of Zoology at the University of Oxford. NG is funded by a grant from the Bill & Melinda Gates Foundation [#OPP1053338]. TPR is funded by the CGIAR Research Programmes on the Humidtropics, Climate Change, Agriculture and Food Security (CCAFS) and Agriculture for Nutrition and Health (A4NH).	Aktas M, 2006, VET PARASITOL, V138, P179, DOI 10.1016/j.vetpar.2006.01.052; Allaranga Yokouide, 2010, East Afr J Public Health, V7, P30; Anders KL, 2012, LANCET INFECT DIS, V12, P977, DOI 10.1016/S1473-3099(12)70246-3; Ansari H, 2014, J INFECT DEV COUNTR, V8, P749, DOI 10.3855/jidc.4020; Appannanavar SB, 2011, J GLOB INFECT DIS, V3, P285, DOI 10.4103/0974-777X.83537; Aradaib IE, 2010, EMERG INFECT DIS, V16, P837, DOI 10.3201/eid1605.091815; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Atkinson B, 2012, EURO SURVEILL, V17; Bannister B, 2010, BRIT MED BULL, V95, P193, DOI 10.1093/bmb/ldq022; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Bente DA, 2010, J VIROL, V84, P11089, DOI 10.1128/JVI.01383-10; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Breiman L, 1984, CLASSIFICATION REGRE; Brooker S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000779; Brownstein JS, 2008, PLOS MED, V5, P1019, DOI 10.1371/journal.pmed.0050151; Burt FJ, 2009, EPIDEMIOL INFECT, V137, P1302, DOI 10.1017/S0950268808001878; Burt FJ, 2005, EPIDEMIOL INFECT, V133, P659, DOI 10.1017/S0950268805003730; Buttigieg KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091516; Chamberlain J, 2013, GENOME ANNOUNC, P1; Chefaoui RM, 2008, ECOL MODEL, V210, P478, DOI 10.1016/j.ecolmodel.2007.08.010; Deyde VM, 2006, J VIROL, V80, P8834, DOI 10.1128/JVI.00752-06; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; Estrada-Pena A, 2010, EPIDEMIOL INFECT, V138, P1194, DOI 10.1017/S0950268809991026; Estrada-Pena A, 2007, VECTOR-BORNE ZOONOT, V7, P667, DOI 10.1089/vbz.2007.0134; FISHERHOCH SP, 1995, BRIT MED J, V311, P857, DOI 10.1136/bmj.311.7009.857; Freifeld CC, 2008, J AM MED INFORM ASSN, V15, P150, DOI 10.1197/jamia.M2544; Frieden TR, 2014, NEW ENGL J MED, V371, P1177, DOI 10.1056/NEJMp1409903; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; GIDEON, 2013, WORLDS PREM GLOB INF; Gilbert M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5116; GONZALEZ JP, 1990, T ROY SOC TROP MED H, V84, P573, DOI 10.1016/0035-9203(90)90045-G; Grard G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001350; Han Na, 2011, Virologica Sinica, V26, P229, DOI 10.1007/s12250-011-3211-z; Hay SI, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0250; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000209; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2012, ECOLOGY, V93, P679, DOI 10.1890/11-0826.1; HOOGSTRAAL H, 1979, J MED ENTOMOL, V15, P307, DOI 10.1093/jmedent/15.4.307; Izadi S, 2008, JPN J INFECT DIS, V61, P494; Karti SS, 2004, EMERG INFECT DIS, V10, P1379, DOI 10.3201/eid1008.030928; Leblebicioglu H, 2012, VECTOR-BORNE ZOONOT, V12, P805, DOI 10.1089/vbz.2011.0896; Lin QH, 2012, 2012 5TH INTERNATIONAL CONGRESS ON IMAGE AND SIGNAL PROCESSING (CISP), P1043, DOI 10.1109/CISP.2012.6470008; Lobo JM, 2011, J NAT CONSERV, V19, P1, DOI 10.1016/j.jnc.2010.03.002; Lumley S, 2014, EURO SURVEILL, V19; Lutomiah J, 2014, J MED ENTOMOL, V51, P269, DOI 10.1603/ME13039; Maltezou HC, 2010, EUROSURVEILLANCE, V15, P48; Maltezou HC, 2009, SCAND J INFECT DIS, V41, P877, DOI 10.3109/00365540903173619; Maltezou HC, 2010, TRAVEL MED INFECT DI, V8, P139, DOI 10.1016/j.tmaid.2010.04.008; Mardani M, 2009, AM J TROP MED HYG, V81, P675, DOI 10.4269/ajtmh.2009.09-0051; MCCORMICK JB, 1987, CURR TOP MICROBIOL, V134, P69; McIver z, 2000, GEOSC REM SENS S 200, V7, P3063; Messina JP, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.16; Mostafavi E, 2013, AM J TROP MED HYG, V89, P1135, DOI 10.4269/ajtmh.12-0509; Naderi HR, 2011, EPIDEMIOL INFECT, V139, P862, DOI 10.1017/S0950268810002001; Naderi H, 2013, AM J TROP MED HYG, V88, P469, DOI 10.4269/ajtmh.2012.12-0337; Okello-Onen J, 1999, EXP APPL ACAROL, V23, P79, DOI 10.1023/A:1006058317111; Ong E, 2014, CURRENT TREATMENT OP, V6, P245; Papa A, 2002, EUR J CLIN MICROBIOL, V21, P603, DOI 10.1007/s10096-002-0770-9; Patel Atul K, 2011, J Assoc Physicians India, V59, P585; Pigott DM, 2015, T ROY SOC TROP MED H, V109, P366, DOI 10.1093/trstmh/trv024; Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.04395, 10.7554/eLife.02851]; Preston P.M., 2007, TICKS DOMESTIC ANIMA; Rahnavardi M, 2008, J HOSP INFECT, V69, P77, DOI 10.1016/j.jhin.2008.02.007; Randolph SE, 2010, CRIMEAN CONGO HEMORR, P167; Rogers DJ, 2006, ADV PARASIT, V62, P345, DOI 10.1016/S0065-308X(05)62010-6; Sargianou M, 2013, INT J INFECT DIS, V17, pE1160, DOI 10.1016/j.ijid.2013.07.015; Smith J, 2010, AM J TROP MED HYG, V83, P160; Stevens KB, 2011, SPAT SPATIO-TEMPORAL, V2, P125, DOI 10.1016/j.sste.2011.07.007; Stokland JN, 2011, ECOL MODEL, V222, P1800, DOI 10.1016/j.ecolmodel.2011.02.025; Terzi O, 2011, J MED PLANTS RES, V5, P848; Vescio FM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1116; Vorou R, 2007, CURR OPIN INFECT DIS, V20, P495, DOI 10.1097/QCO.0b013e3282a56a0a; Wan ZM, 2002, INT GEOSCI REMOTE SE, P3683, DOI 10.1109/IGARSS.2002.1027290; Weiss DJ, 2014, ISPRS J PHOTOGRAMM, V98, P106, DOI 10.1016/j.isprsjprs.2014.10.001; Wenger SJ, 2012, METHODS ECOL EVOL, V3, P260, DOI 10.1111/j.2041-210X.2011.00170.x; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001; WHO, 2014, CRIM CONG HAEM FEV C; WILSON ML, 1990, AM J TROP MED HYG, V43, P557; Xia H, 2011, INT J INFECT DIS, V15, pE459, DOI 10.1016/j.ijid.2011.03.013; Yilmaz R, 2009, J CLIN VIROL, V44, P181, DOI 10.1016/j.jcv.2008.09.013; Zakhashvili K, 2010, EMERG INFECT DIS, V16, P1326, DOI [10.3201/eid1608.100181, 10.3201/eid1608.100097]	86	56	56	4	41	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	AUG	2015	109	8					503	513		10.1093/trstmh/trv050				11	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CP1FW	WOS:000359622700004	26142451	Green Published, Other Gold	Y	N	2019-04-02	
J	Trelles, M; Dominguez, L; Stewart, BT				Trelles, Miguel; Dominguez, Lynette; Stewart, Barclay T.			Surgery in low-income countries during crisis: experience at Medecins Sans Frontieres facilities in 20 countries between 2008 and 2014	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Editorial Material						humanitarian; global surgery; quality improvement; disaster; war	BURUNDI; CARE		[Trelles, Miguel; Dominguez, Lynette] Medecins Sans Frontieres, Surg Anesthesia Gynecol & Emergency Med Unit, Brussels, Belgium; [Stewart, Barclay T.] Univ Washington, Dept Surg, 1959 NE Pacific St,Suite BB-487,POB 356410, Seattle, WA 98195 USA; [Stewart, Barclay T.] Kwame Nkrumah Univ Sci & Technol, Dept Surg, Kumasi, Ghana	Stewart, BT (reprint author), Univ Washington, Dept Surg, 1959 NE Pacific St,Suite BB-487,POB 356410, Seattle, WA 98195 USA.	stewarb@uw.edu					Broek I, 2013, CLIN GUIDELINES CURA; Brown V, 2008, PLOS MED, V5, P553, DOI 10.1371/journal.pmed.0050089; Carlson L, 2015, WORLD J SURG, V39, P813, DOI 10.1007/s00268-014-2938-8; Chu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044484; Chu Kathryn M, 2011, Confl Health, V5, P12, DOI 10.1186/1752-1505-5-12; Chu KM, 2011, WORLD J SURG, V35, P1169, DOI 10.1007/s00268-011-1084-9; Giannou C, 2010, WAR SURG WORKING LTD; Groen RS, 2012, LANCET, V380, P1082, DOI 10.1016/S0140-6736(12)61081-2; Harries AD, 2011, INT J TUBERC LUNG D, V15, P144; Herard P, 2012, INT ORTHOP, V36, P1979, DOI 10.1007/s00264-012-1552-3; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Stewart B, 2014, BRIT J SURG, V101, pE9, DOI 10.1002/bjs.9329; Tayler-Smith K, 2013, TROP MED INT HEALTH, V18, P993, DOI 10.1111/tmi.12121; Tayler-Smith K, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-164; von Schreeb J, 2008, PREHOSPITAL DISASTER, V23, P144, DOI 10.1017/S1049023X00005768; Wong EG, 2015, WORLD J SURG, V39, P652, DOI 10.1007/s00268-014-2855-x; Wong EG, 2014, SURGERY, V156, P642, DOI 10.1016/j.surg.2014.02.002; Zachariah R, 2010, INT HEALTH, V2, P1, DOI 10.1016/j.inhe.2009.12.008	18	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	AUG	2015	20	8					968	971		10.1111/tmi.12523				4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CM3PH	WOS:000357594400001	25877854	Green Published, Bronze			2019-04-02	
J	Van Remoortel, H; De Buck, E; Singhal, M; Vandekerckhove, P; Agarwal, SP				Van Remoortel, Hans; De Buck, Emmy; Singhal, Maneesh; Vandekerckhove, Philippe; Agarwal, Satya P.			Effectiveness of insecticide-treated and untreated nets to prevent malaria in India	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Review						malaria; insecticide-treated bed nets; mosquito nets; India; primary prevention; systematic review; paludisme; malaria; moustiquaires impregnees d'insecticide; moustiquaires; Inde; prevention primaire; revue systematique; Malaria; mosquiteras impregnadas con insecticida; mosquiteras; India; prevencion primaria; revision sistematica	INDOOR RESIDUAL SPRAY; ENDEMIC AREA; BED NETS; ANOPHELES-CULICIFACIES; IMPREGNATED BEDNETS; MALKANGIRI DISTRICT; FIELD-EVALUATION; UTTAR-PRADESH; DELTAMETHRIN; ORISSA	ObjectivesIndia is the most malaria-endemic country in South-East Asia, resulting in a high socio-economic burden. Insecticide-treated or untreated nets are effective interventions to prevent malaria. As part of an Indian first-aid guideline project, we aimed to investigate the magnitude of this effect in India. MethodsWe searched MEDLINE, Embase and Central to systematically review Indian studies on the effectiveness of treated or untreated vs. no nets. Parasite prevalence and annual parasite incidence served as malaria outcomes. The overall effect was investigated by performing meta-analyses and calculating the pooled risk ratios (RR) and incidence rate ratios. ResultsOf 479 articles, we finally retained 16 Indian studies. Untreated nets decreased the risk of parasite prevalence compared to no nets [RR 0.69 (95% CI; 0.55, 0.87) in high-endemic areas, RR 0.49 (95% CI; 0.28, 0.84) in low-endemic areas], as was the case but more pronounced for treated nets [RR 0.35 (95% CI; 0.26, 0.47) in high-endemic areas, risk ratio 0.16 (95% CI; 0.06, 0.44) in low-endemic areas]. Incidence rate ratios showed a similar observation: a significantly reduced rate of parasites in the blood for untreated nets vs. no nets, which was more pronounced in low-endemic areas and for those who used treated nets. The average effect of treated nets (vs. no nets) on parasite prevalence was higher in Indian studies (RR 0.16-0.35) than in non-Indian studies (data derived from a Cochrane systematic review; RR 0.58-0.87). ConclusionsBoth treated and untreated nets have a clear protective effect against malaria in the Indian context. This effect is more pronounced there than in other countries. Objectifsl'Inde est le pays le plus endemique pour le paludisme en Asie du sud-est, ce qui entraine une charge socioeconomique elevee. Les moustiquaires impregnees ou non d'insecticide sont des interventions efficaces pour prevenir le paludisme. Dans le cadre d'un projet de directive de secourisme Indien, nous avons cherche a investiguer sur l'ampleur de cet effet en Inde. MethodesNous avons recherche dans MEDLINE, Embase et Centrale afin d'analyser systematiquement les etudes indiennes sur l'efficacite des moustiquaires traitees ou non traitees par rapport a l'absence de moustiquaires. La prevalence du parasite et l'incidence annuelle du parasite ont servi de resultats pour l'analyse. L'effet global a ete etudie en effectuant des meta-analyses et en calculant les rapports de risque (RR) pooles et les rapports des taux d'incidence. ResultatsSur 479 articles, nous avons finalement retenu 16 etudes indiennes. Les moustiquaires non traitees ont diminue le risque de prevalence du parasite compare a l'absence de moustiquaires (RR: 0,69 [IC 95%]; 0,55-0,87 dans les zones de forte endemie, RR: 0,49 [IC95%; 0,28-0,84] dans les zones de faible endemie), comme c'etait le cas aussi mais de facon plus prononcee pour les moustiquaires traitees (RR: 0,35 [IC95%]; 0,26-0,47 dans les zones de forte endemie et RR:0,16 [IC95%]; 0,06-0,44 dans les zones de faible endemie). Les rapports des taux d'incidence ont donne une observation similaire; un taux significativement reduit de parasites dans le sang pour les moustiquaires non traitees par rapport a l'absence de moustiquaires, qui etait plus prononce dans les zones de faible endemie et pour ceux qui ont utilise des moustiquaires traitees. L'effet moyen des moustiquaires impregnees (par rapport a l'absence de moustiquaires) sur la prevalence du parasite etait plus eleve dans les etudes indiennes (RR: 0,16-0,35) que dans les etudes non indiennes (donnees derivees d'une revue systematique de Cochrane; RR: 0,58-0,87). ConclusionsLes moustiquaires traites et non traitees ont un effet protecteur clair contre le paludisme dans le contexte indien. Cet effet est plus prononce que dans d'autres pays. ObjetivosIndia es el pais con mayor endemicidad para malaria en el sudeste asiatico, lo cual resulta en una gran carga socioeconomica. Las redes mosquiteras sin tratar y tratadas con insecticida son intervenciones efectivas para prevenir la malaria. Como una parte del proyecto para las primeras guias de primeros auxilios hindues, buscabamos averiguar la magnitud de este efecto en la India. MetodosRealizamos busquedas en MEDLINE, Embase y Central para revisar, de forma sistematica, estudios realizados en la India sobre la efectividad de las redes mosquiteras tratadas versus las no tratadas. La prevalencia de parasitos y la incidencia anual de parasitos servian como resultados de malaria. El efecto general fue evaluado mediante un meta-analisis y se calcularon el cociente de riesgos agrupado (RR) y la razon de densidades de incidencia (RDI) ResultadosDe 479 articulos, se escogieron 16 estudios hindues. Las mosquiteras no impregnadas disminuian el riesgo de prevalencia parasitaria al compararlas con no utilizar ninguna mosquitera (RR 0.69 [IC95%; 0.55,0.87] en areas altamente endemicas, RR 0.49 [IC95%; 0.28,0.84] en areas con baja endemicidad), como era tambien el caso para las mosquiteras impregnadas, pero con un efecto aun mas pronunciado (RR 0.35 [95%CI; 0.26,0.47] en areas altamente endemicas, RR 0.16 [IC 95%; 0.06,0.44] en areas de baja endemicidad. Con las RDI se observaba una tendencia similar: una tasa significativamente reducida de parasitos en sangre para el uso de mosquiteras sin tratar vs. no utilizar mosquiteras, lo cual era mas pronunciado en areas de baja endemicidad asi como para aquellos que utilizaban mosquiteras impregnadas. El efecto promedio de utilizar mosquiteras impregnadas (versus no utilizar mosquitera) sobre la prevalencia de parasitos era mayor en estudios de la India (RR 0.16-0.35) que en estudios fuera de la India (datos derivados de una revision sistematica de Cochrane; RR 0.58-0.87). ConclusionesTanto las mosquiteras impregnadas como las no impregnadas tienen un efecto protector claro frente a la malaria en el contexto de la India. Este efecto es mas pronunciado que en otros paises.	[Van Remoortel, Hans; De Buck, Emmy; Vandekerckhove, Philippe] Belgian Red Cross Flanders, B-2800 Mechelen, Belgium; [Singhal, Maneesh] All India Inst Med Sci, Dept Trauma Surg, New Delhi, India; [Vandekerckhove, Philippe] Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, Fac Med, Leuven, Belgium; [Vandekerckhove, Philippe] Univ Ghent, Fac Med, B-9000 Ghent, Belgium; [Agarwal, Satya P.] Indian Red Cross Soc, New Delhi, India	Van Remoortel, H (reprint author), Belgian Red Cross Flanders, Motstraat 40, B-2800 Mechelen, Belgium.	hans.vanremoortel@rodekruis.be			Belgian Directorate-General for Development Cooperation (DGD); Belgian Red Cross-Flanders	We thank Drs Hans Scheers for his statistical support to perform meta-analyses. Tessa Dieltjens, Nele Pauwels (Centre for Evidence-Based Practice, Belgian Red Cross-Flanders, Belgium), Axel Vande Veegaete (Scientific Coordinator, Belgian Red Cross-Flanders, Belgium) and Hugo Geuvens (Delegate, Belgian Red Cross-Flanders, India) are acknowledged for the interactive meetings and their input during the process of this project. The work described here forms part of a collaborative project between the Belgian Red Cross-Flanders and the Indian Red Cross Society to develop evidence-based Indian first aid and prevention guidelines. This work was supported by the Belgian Directorate-General for Development Cooperation (DGD) and Belgian Red Cross-Flanders.	[Anonymous], 2004, EST TRUE MAL BURD IN; Ansari M. A., 2002, Indian Journal of Malariology, V39, P66; Ansari M. A., 2003, Journal of Vector Borne Diseases, V40, P33; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Bhatia MR, 2004, SOC SCI MED, V59, P525, DOI 10.1016/j.socscimed.2003.11.005; Bhatt RM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-189; Das P. K., 1993, Southeast Asian Journal of Tropical Medicine and Public Health, V24, P513; De Buck E, 2014, INT J EVID-BASED HEA, V12, P39, DOI 10.1097/01.XEB.0000444637.88465.a3; Dev V, 2011, ACTA TROP, V119, P172, DOI 10.1016/j.actatropica.2011.05.013; Dev V, 2010, VECTOR-BORNE ZOONOT, V10, P403, DOI 10.1089/vbz.2008.0191; Dhiman RC, 2010, PARASITOL RES, V106, P763, DOI 10.1007/s00436-010-1767-4; Dhiman Sunil, 2014, Front Public Health, V2, P98, DOI 10.3389/fpubh.2014.00098; Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8; Gunasekaran K, 2009, ACTA TROP, V112, P149, DOI 10.1016/j.actatropica.2009.07.013; JANAKARA BR, 1995, J TROP MED HYG, V98, P73; Kumar A, 2012, ACTA TROP, V121, P246, DOI 10.1016/j.actatropica.2012.01.004; Lengeler C, 2004, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000363.PUB2; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mittal PK, 2012, J VECTOR DIS, V49, P181; NIMR N., 2007, IN DEPTH REV MAL NAT; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Sahu SS, 2008, INDIAN J MED RES, V128, P262; Sahu SS, 2003, ACTA TROP, V89, P55, DOI 10.1016/j.actatropica.2003.07.002; Sharma R, 2011, INDIAN J PEDIATR, V78, P1527, DOI 10.1007/s12098-011-0554-2; Sharma SK, 2006, J AM MOSQUITO CONTR, V22, P111, DOI 10.2987/8756-971X(2006)22[111:EOMNTW]2.0.CO;2; Sharma SK, 2012, INDIAN J MED RES, V135, P382; Sharma SK, 2009, ACTA TROP, V112, P181, DOI 10.1016/j.actatropica.2009.07.022; Sharma VP, 2012, INDIAN J MED RES, V136, P907; Sibanda MM, 2013, PHYS CHEM BIOL STRAT; Singh R. K., 2012, Journal of Communicable Diseases, V44, P169; Singh RK, 2013, J TROP DIS, V1, P1; Singh V, 2009, TRENDS PARASITOL, V25, P452, DOI 10.1016/j.pt.2009.06.004; Sood RD, 2010, J VECTOR DIS, V47, P243; Sreehari U., 2007, Journal of Vector Borne Diseases, V44, P137; Verma R, 2013, HUM VACC IMMUNOTHER, V9, P1268, DOI 10.4161/hv.23950; WHO, 2007, INS TREAT MOSQ NETS; World Health Organization, 2012, DIS SURV MAL EL; World Health Organization, 2014, WORLD MAL REP; Yadav RS, 1998, J AM MOSQUITO CONTR, V14, P444; Yadav RS, 2001, J MED ENTOMOL, V38, P613, DOI 10.1603/0022-2585-38.5.613	42	3	3	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	AUG	2015	20	8					972	982		10.1111/tmi.12522				11	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CM3PH	WOS:000357594400002	25877758				2019-04-02	
J	Muhanguzi, D; Okello, WO; Kabasa, JD; Waiswa, C; Welburn, SC; Shaw, APM				Muhanguzi, Dennis; Okello, Walter O.; Kabasa, John D.; Waiswa, Charles; Welburn, Susan C.; Shaw, Alexandra P. M.			Cost analysis of options for management of African Animal Trypanosomiasis using interventions targeted at cattle in Tororo District; south-eastern Uganda	PARASITES & VECTORS			English	Article						African animal trypanosomiasis; Cattle; Cost; Human African trypanosomiasis; Restricted insecticide application protocol; Trypanocides; Tsetse control; Tick-borne diseases; Trypanosoma; Theileria parva	RESTRICTED INSECTICIDE APPLICATION; RHODESIENSE SLEEPING SICKNESS; TSETSE CONTROL; BRUCEI-RHODESIENSE; SPATIAL-DISTRIBUTION; THEILERIA-PARVA; TREATED CATTLE; BORNE DISEASES; LIVESTOCK; GLOSSINIDAE	Background: Tsetse-transmitted African trypanosomes cause both nagana (African animal Trypanosomiasis-AAT) and sleeping sickness (human African Trypanosomiasis - HAT) across Sub-Saharan Africa. Vector control and chemotherapy are the contemporary methods of tsetse and trypanosomiasis control in this region. In most African countries, including Uganda, veterinary services have been decentralised and privatised. As a result, livestock keepers meet the costs of most of these services. To be sustainable, AAT control programs need to tailor tsetse control to the inelastic budgets of resource-poor small scale farmers. To guide the process of tsetse and AAT control toolkit selection, that now, more than ever before, needs to optimise resources, the costs of different tsetse and trypanosomiasis control options need to be determined. Methods: A detailed costing of the restricted application protocol (RAP) for African trypanosomiasis control in Tororo District was undertaken between June 2012 and December 2013. A full cost calculation approach was used; including all overheads, delivery costs, depreciation and netting out transfer payments to calculate the economic (societal) cost of the intervention. Calculations were undertaken in Microsoft Excel (TM) without incorporating probabilistic elements. Results: The cost of delivering RAP to the project was US$ 6.89 per animal per year while that of 4 doses of a curative trypanocide per animal per year was US$ 5.69. However, effective tsetse control does not require the application of RAP to all animals. Protecting cattle from trypanosome infections by spraying 25 %, 50 % or 75 % of all cattle in a village costs US$ 1.72, 3.45 and 5.17 per animal per year respectively. Alternatively, a year of a single dose of curative or prophylactic trypanocide treatment plus 50 % RAP would cost US$ 4.87 and US$ 5.23 per animal per year. Pyrethroid insecticides and trypanocides cost 22.4 and 39.1 % of the cost of RAP and chemotherapy respectively. Conclusions: Cost analyses of low cost tsetse control options should include full delivery costs since they constitute 77.6 % of all project costs. The relatively low cost of RAP for AAT control and its collateral impact on tick control make it an attractive option for livestock management by smallholder livestock keepers.	[Muhanguzi, Dennis] Makerere Univ, Dept Biomol & Biolab Sci, Sch Biosecur Biotech & Lab Sci, Coll Vet Med Anim Resources & Biosecur, Kampala, Uganda; [Muhanguzi, Dennis; Okello, Walter O.; Welburn, Susan C.; Shaw, Alexandra P. M.] Univ Edinburgh, Coll Med & Vet Med, Sch Biomed Sci, Ctr Infect Dis,Div Infect & Pathway Med, Edinburgh EH16 4SB, Midlothian, Scotland; [Kabasa, John D.] Makerere Univ, Coll Vet Med Anim Resources & Biosecur, Dept Biosecur Ecosyst & Vet Publ Hlth, Sch Biosecur Biotech & Lab Sci, Kampala, Uganda; [Waiswa, Charles] Makerere Univ, Sch Vet Med & Anim Resources, Dept Pharm Clin & Comparat Med, Coll Vet Med Anim Resources & Biosecur, Kampala, Uganda; [Shaw, Alexandra P. M.] Avia GIS, B-2980 Zoersel, Belgium	Muhanguzi, D (reprint author), Makerere Univ, Dept Biomol & Biolab Sci, Sch Biosecur Biotech & Lab Sci, Coll Vet Med Anim Resources & Biosecur, POB 7062, Kampala, Uganda.	luckydenno@covab.mak.ac.ug	Okello, Walter/T-9471-2017	Okello, Walter/0000-0002-9322-3486; Muhanguzi, Dennis/0000-0001-5458-8530	European Union's Seventh Framework Program (FP7), ICONZ (Integrated Control of Neglected Zoonoses) [221948]; Carnegie-Makerere University Next Generation of African Academics [NGAA-2010-2012]	The research leading to these results received funding from the European Union's Seventh Framework Program (FP7/2007-2013) under grant agreement no 221948, ICONZ (Integrated Control of Neglected Zoonoses) to JDK and CW. This study also received funding from The Carnegie-Makerere University Next Generation of African Academics under grant number NGAA-2010-2012 to MD. The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission or Carnegie Corporation of New York. Authors wish to acknowledge the assistance of the cattle keepers in the study villages and that of the Tororo District Department of Production during the implementation of this study.	Allsopp R., 2004, The trypanosomiases, P491, DOI 10.1079/9780851994758.0491; Bourn D, 2005, ASPECT APPL BIOL, V75, P81; Brownlow AC, 2007, EVALUATION NOVEL MET; Cecchi G, 2010, AGR ECOSYST ENVIRON, V135, P98, DOI 10.1016/j.agee.2009.08.011; Coleman PG, 2001, LANCET, V357, P1284, DOI 10.1016/S0140-6736(00)04410-X; Eisler MC, 2003, TRENDS PARASITOL, V19, P341, DOI 10.1016/S1471-4922(03)00164-8; Fevre EM, 2005, LANCET, V366, P745, DOI 10.1016/S0140-6736(05)67179-6; Fevre EM, 2001, LANCET, V358, P625, DOI 10.1016/S0140-6736(01)05778-6; Geerts S, 2001, TRENDS PARASITOL, V17, P25, DOI 10.1016/S1471-4922(00)01827-4; Grant IF, 2001, TRENDS PARASITOL, V17, P10, DOI 10.1016/S1471-4922(00)01848-1; Hargrove JW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001615; Holmes P. H., 2004, The trypanosomiases, P431, DOI 10.1079/9780851994758.0431; Itty P, 1992, EC VILLAGE CATTLE PR; Jordan AM, 1986, TRYPANOSOMIASIS CONT; Kabasa JD, 2007, TRENDS PARASITOL, V23, P191, DOI 10.1016/j.pt.2007.03.006; Kajunguri D, 2014, B MATH BIOL, V76, P673, DOI 10.1007/s11538-014-9938-6; Kgori PM, 2006, ACTA TROP, V99, P184, DOI 10.1016/j.actatropica.2006.07.007; Kivaria FM, 2006, TROP ANIM HEALTH PRO, V38, P291, DOI 10.1007/s11250-006-4181-2; Lancien J., 1993, Bulletin de la Societe Francaise de Parasitologie, V11, P107; LANCIEN J, 1991, ANN SOC BELG MED TR, V71, P35; Magona JW, 2005, VET PARASITOL, V128, P1, DOI 10.1016/j.vetpar.2004.10.020; Maudlin I., 2004, TRYPANOSOMIASES; Muhanguzi D, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0603-6; Muhanguzi D, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003284; Muhanguzi D, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-432; Muhanguzi D, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-91; Mulatu W, 1997, P 24 M INT SCI COUNC; Mulligan HW, 1971, AFRICAN TRYPANOSOMIA; Nash TAM, 1970, AFRICAS BANE TSETSE; Okello A, 2011, ECOHEALTH, V7, pS72; Okello Anna L, 2014, Front Public Health, V2, P218, DOI 10.3389/fpubh.2014.00218; OKOTH JO, 1991, ANN TROP MED PARASIT, V85, P315, DOI 10.1080/00034983.1991.11812567; Picozzi K, 2005, BMJ-BRIT MED J, V331, P1238, DOI 10.1136/bmj.331.7527.1238; Rowlands GJ, 2001, MED VET ENTOMOL, V15, P87, DOI 10.1046/j.1365-2915.2001.00272.x; Selby R, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-281; Shaw APM, 2013, PREV VET MED, V110, P290, DOI 10.1016/j.prevetmed.2012.12.014; Shaw APM, 2009, ONDERSTEPOORT J VET, V76, P27; Shaw AP, 2003, EC GUIDELINES STRATE; Thornton PK, 2003, LAND USE POLICY, V20, P311, DOI 10.1016/S0264-8377(03)00034-6; Torr SJ, 2007, MED VET ENTOMOL, V21, P53, DOI 10.1111/j.1365-2915.2006.00657.x; Torr SJ, 2001, MED VET ENTOMOL, V15, P78, DOI 10.1046/j.1365-2915.2001.00281.x; Vale G. A., 2004, The trypanosomiases, P509, DOI 10.1079/9780851994758.0509; Vale GA, 2005, MED VET ENTOMOL, V19, P293, DOI 10.1111/j.1365-2915.2005.00573.x; Vale GA, 1999, B ENTOMOL RES, V89, P569; Vale GA, 2002, B ENTOMOL RES, V92, P251, DOI 10.1079/BER2002162; VANDENBOSSCHE P, 2004, TRYPANOSOMIASES, P525; Vreysen MJB, 2000, J ECON ENTOMOL, V93, P123, DOI 10.1603/0022-0493-93.1.123; Waiswa C, 2006, ACTA TROP, V99, P23, DOI 10.1016/j.actatropica.2006.06.005; Waiswa C, 2003, ANN TROP MED PARASIT, V97, P149, DOI 10.1179/000349803235001688; Welburn SC, 2006, TRENDS PARASITOL, V22, P123, DOI 10.1016/j.pt.2006.01.011; Welburn SC, 2001, TRENDS PARASITOL, V17, P19, DOI 10.1016/S1471-4922(00)01839-0; Welburn SC, 2001, LANCET, V358, P2017, DOI 10.1016/S0140-6736(01)07096-9	52	13	13	1	14	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	JUL 22	2015	8								387	10.1186/s13071-015-0998-8				9	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CN1PP	WOS:000358192400004	26198109	DOAJ Gold, Green Published			2019-04-02	
J	Guyant, P; Corbel, V; Guerin, PJ; Lautissier, A; Nosten, F; Boyer, S; Coosemans, M; Dondorp, AM; Sinou, V; Yeung, S; White, N				Guyant, Philippe; Corbel, Vincent; Guerin, Philippe J.; Lautissier, Adeline; Nosten, Francois; Boyer, Sebastien; Coosemans, Marc; Dondorp, Arjen M.; Sinou, Veronique; Yeung, Shunmay; White, Nicholas			Past and new challenges for malaria control and elimination: the role of operational research for innovation in designing interventions	MALARIA JOURNAL			English	Article							PLASMODIUM-FALCIPARUM MALARIA; DIHYDROARTEMISININ-PIPERAQUINE FAILURE; ARTEMETHER-LUMEFANTRINE; ARTEMISININ RESISTANCE; CHLOROQUINE RESISTANCE; KNOCKDOWN RESISTANCE; ANOPHELES-GAMBIAE; SOUTHEAST-ASIA; MEKONG REGION; CAMBODIA	This meeting report presents the outcomes of a workshop held in Bangkok on December 1st 2014, where the following challenges were discussed: the threat of resistance to artemisinin and artemisinin-based combination therapy in the Greater Mekong Sub-region (GMS) and in Africa; access to treatment for most at risk and hard to reach population; insecticide resistance, residual and outdoors transmission. The role of operational research and the interactions between research institutions, National Malaria Control Programmes, Civil Society Organizations, and of financial and technical partners to address those challenges and to accelerate translation of research into policies and programmes were debated. The threat and the emergency of the artemisinin resistance spread and independent emergence in the GMS was intensely debated as it is now close to the border of India. The need for key messages, based on scientific evidence and information available and disseminated without delay, was highlighted as crucial for an effective and urgent response.	[Guyant, Philippe] Partners Dev, Phnom Penh, Cambodia; [Corbel, Vincent] IRD, Malad Infect & Vecteurs Ecol Genet Evolut & Contr, IRD 224, CNRS UM1 UM2 5290, Montpellier 5, France; [Corbel, Vincent] Kasetsart Univ, Fac Agr, Dept Entomol, Bangkok, Thailand; [Guerin, Philippe J.] Worldwide Antimalarial Resistance Network, Oxford, England; [Guerin, Philippe J.; Nosten, Francois; Dondorp, Arjen M.; White, Nicholas] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England; [Lautissier, Adeline] Expertise France, Initiat 5, Paris, France; [Nosten, Francois] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Shoklo Malaria Res Unit, Mae Sot, Thailand; [Boyer, Sebastien] Inst Pasteur Madagascar, Med Entomol Unit, Antananarivo, Madagascar; [Coosemans, Marc] Inst Trop Med, B-2000 Antwerp, Belgium; [Coosemans, Marc] Univ Antwerp, B-2020 Antwerp, Belgium; [Dondorp, Arjen M.; White, Nicholas] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Sinou, Veronique] Aix Marseille Univ, Fac Pharm, Parasitol Lab, UMR MD3, Marseille, France; [Yeung, Shunmay] London Sch Hyg & Trop Med, Malaria Ctr, Dept Global Hlth & Dev, London WC1, England	Guyant, P (reprint author), Partners Dev, Phnom Penh, Cambodia.	philippe.guyant@gmail.com	Corbel, VIncent/G-9576-2016	Guerin, Philippe/0000-0002-6008-2963; Boyer, Sebastien/0000-0002-2946-586X; Nosten, Francois/0000-0002-7951-0745	government of the Kingdom of Thailand; French Ministry of Foreign Affairs and International Development; French Embassy of Thailand; Roll Back Malaria Partnership; FEI	The authors would like to thank Expertise France (formerly known as France Expertise Internationale) and the 5% Initiative (indirect contribution of France to the Global Fund to fight AIDS, Tuberculosis and Malaria) for taking the initiative of this meeting, and the government of the Kingdom of Thailand, the French Ministry of Foreign Affairs and International Development, the French Embassy of Thailand and the Roll Back Malaria Partnership for supporting the organization of this event.; PG was funded by FEI to provide technical assistance in organising this meeting and in writing this manuscript.	[Anonymous], 1960, GLOB SPREAD ANT DRUG; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Bayoh MN, 2010, KENYA MAL J, V9, P62, DOI DOI 10.1186/1475-2875-9-62; Bethell D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019283; Bhumiratana A, 2013, BIOMED RES INT, V2013; Carrara VI, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001398; Chen-Hussey V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070664; Corbel V, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P579, DOI 10.5772/56117; Corbel V, 2013, TRENDS PARASITOL, V29, P623, DOI 10.1016/j.pt.2013.09.007; Denis MB, 2006, TROP MED INT HEALTH, V11, P1800, DOI 10.1111/j.1365-3156.2006.01739.x; Deressa W, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-132; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; Durnez L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-329; Hill N, 2007, BRIT MED J, V335, P1023, DOI 10.1136/bmj.39356.574641.55; Huang F, 2015, J INFECT DIS, DOI 10.1093/infdis/jiv249; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-330; Kiszewski AE, 2010, J VECTOR DIS, V47, P217; Leang R, 2015, ANTIMICROB AGENTS CH; Leang R, 2013, ANTIMICROB AGENTS CH, V57, P818, DOI 10.1128/AAC.00686-12; Lon C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093138; Lubell Y, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-452; Maia MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084875; Marsh K, 1998, LANCET, V352, P924, DOI 10.1016/S0140-6736(05)61510-3; Moiroux N, 2012, J INFECT DIS, V206, P1622, DOI 10.1093/infdis/jis565; Palevalut, 2015, EV OP LUTT INT CONTR; Pinto J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001243; RAYMOND M, 1991, NATURE, V350, P151, DOI 10.1038/350151a0; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-74; Saunders DL, 2014, NEW ENGL J MED, V371, P484, DOI 10.1056/NEJMc1403007; Sinou V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-164; Song JP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-231; Spring MD, 2015, LANCET INFECT DIS, V15, P683, DOI 10.1016/S1473-3099(15)70049-6; Tabernero P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-139; Takala-Harrison S, 2015, J INFECT DIS, V211, P670, DOI 10.1093/infdis/jiu491; Taylor B., 1975, T R ENTOMOL SOC LOND, V127, P227; Trape JF, 1998, CR ACAD SCI III-VIE, V321, P689, DOI 10.1016/S0764-4469(98)80009-7; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; Tun KM, 2015, LANCET INFECT DIS, V15, P415, DOI 10.1016/S1473-3099(15)70032-0; Van Bortel W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-102; Venkatesan M, 2014, AM J TROP MED HYG, V91, P833, DOI 10.4269/ajtmh.14-0031; Verhaeghen K, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-59; Wang ZL, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0672-9; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2015, ANT DRUG RES; WHO, 2014, MPAC M WORLD HLTH OR; WHO, 2015, GUID NOT CONTR RES M; WHO, 2014, 2 M VECT CONTR ADV G; WHO/GMP, 2014, STAT REP ART RES, V13; WHO-GMP, 2012, GLOB PLAN INS RES MA; World Health Organization, 2013, EM RESP ART RES GREA; World Health Organization, 2014, WORLD MAL REP; World Health Organization [WHO], 2007, CONT MAL MULT RES CA	55	15	15	0	19	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	JUL 17	2015	14								279	10.1186/s12936-015-0802-4				11	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CM8VU	WOS:000357981300001	26185098	DOAJ Gold, Green Published			2019-04-02	
J	Golassa, L; Kamugisha, E; Ishengoma, DS; Baraka, V; Shayo, A; Baliraine, FN; Enweji, N; Erko, B; Aseffa, A; Choy, A; Swedberg, G				Golassa, Lemu; Kamugisha, Erasmus; Ishengoma, Deus S.; Baraka, Vito; Shayo, Alex; Baliraine, Frederick N.; Enweji, Nizar; Erko, Berhanu; Aseffa, Abraham; Choy, Angel; Swedberg, Gote			Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania	MALARIA JOURNAL			English	Article						Malaria; Plasmodium falciparum; pfcrt; pfmdr-1; pfubp-1; Ethiopia; Tanzania	CHLOROQUINE RESISTANCE TRANSPORTER; IN-VIVO SELECTION; ARTEMETHER-LUMEFANTRINE; DRUG-RESISTANCE; ARTEMISININ RESISTANCE; MOLECULAR MARKERS; ANTIMALARIAL-DRUGS; MALARIA PARASITES; COPY NUMBER; POLYMORPHISMS	Background: Plasmodium falciparum resistance to anti-malarials is a major drawback in effective malaria control and elimination globally. Artemisinin-combination therapy (ACT) is currently the key first-line treatment for uncomplicated falciparum malaria. Plasmodium falciparum genetic signatures at pfmdr-1, pfcrt, and pfubp-1 loci are known to modulate in vivo and in vitro parasite response to ACT. The objective of this study was to assess the distribution of these resistance gene markers in isolates collected from different malaria transmission intensity in Ethiopia and Tanzania. Methods: Plasmodium falciparum clinical isolates were collected from different regions of Ethiopia and Tanzania. Genetic polymorphisms in the genes pfcrt, pfmdr-1 and pfubp-1 were analysed by PCR and sequencing. Frequencies of the different alleles in the three genes were compared within and between regions, and between the two countries. Results: The majority of the isolates from Ethiopia were mutant for the pfcrt 76 and wild-type for pfmdr-1 86. In contrast, the majority of the Tanzanian samples were wild-type for both pfcrt and pfmdr-1 loci. Analysis of a variable linker region in pfmdr-1 showed substantial variation in isolates from Tanzania as compared to Ethiopian isolates that had minimal variation. Direct sequencing of the pfubp-1 region showed that 92.8% (26/28) of the Ethiopian isolates had identical genome sequence with the wild type reference P. falciparum strain 3D7. Of 42 isolates from Tanzania, only 13 (30.9%) had identical genome sequences with 3D7. In the Tanzanian samples, 10 variant haplotypes were identified. Conclusion: The majority of Ethiopian isolates carried the main marker for chloroquine (CQ) resistance, while the majority of the samples from Tanzania carried markers for CQ susceptibility. Polymorphic genes showed substantially more variation in Tanzanian isolates. The low variability in the polymorphic region of pfmdr-1 in Ethiopia may be a consequence of low transmission intensity as compared to high transmission intensity and large variations in Tanzania.	[Golassa, Lemu; Erko, Berhanu] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Kamugisha, Erasmus] Catholic Univ Hlth & Allied Sci Bugando, Dept Biochem, Mwanza, Tanzania; [Ishengoma, Deus S.; Baraka, Vito] Natl Inst Med Res, Tanga, Tanzania; [Shayo, Alex] Nelson Mandela African Inst Sci & Technol, Arusha, Tanzania; [Baliraine, Frederick N.] LeTourneau Univ, Dept Biol, Longview, TX USA; [Golassa, Lemu; Aseffa, Abraham] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Enweji, Nizar; Choy, Angel; Swedberg, Gote] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Baraka, Vito] Univ Antwerp, Int Hlth Unit, Dept Epidemiol, B-2020 Antwerp, Belgium	Golassa, L (reprint author), Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia.	lgolassa@gmail.com	Aseffa, Abraham/J-3248-2016	Aseffa, Abraham/0000-0002-8028-1150; Shayo, Alex/0000-0002-7099-8537; Baraka, Vito/0000-0001-9694-9293; Ishengoma, Deus/0000-0003-2040-3416	Medical Research Council UK [G0600718]; Swedish Research Link Grant; Medical Research Council [G0600718]	We thank the respective health bureaus in Ethiopia and Tanzania for their support during the study. We also thank members of the study teams in Tanzania (Celine Mandara, Johari Sadi, Rashid Madebe, August Nyaki, Hatibu Athumani, Thomas Semdoe and Seth Nguhu) and Ethiopia (Diriba Dabushe, Tsehay Orlando, Tewabech Lemma and Arega Tsegaye), health facility staff and all study participants in the respective countries for voluntarily taking part in this study. The master students, Maria Tusell Rabassa, Sabri Kardi, Marwa Mani and Hadeel Ali are dully acknowledged for conducting molecular analysis of pfmdr-1 and pfubp-1 variation. Seed funding for the study sites in Ethiopia was obtained from Medical Research Council UK-G0600718. The molecular studies on all samples were supported by a Swedish Research Link Grant.	Abdel-Muhsin AMA, 2004, J INFECT DIS, V189, P1239, DOI 10.1086/382509; Abeku TA, 2003, ACTA TROP, V87, P331, DOI 10.1016/S0001-706X(03)00123-2; Aregawi MW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-46; Ariey F, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-34; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Baliraine FN, 2011, J INFECT DIS, V204, P1120, DOI 10.1093/infdis/jir486; Baliraine FN, 2011, ANTIMICROB AGENTS CH, V55, P615, DOI 10.1128/AAC.00954-10; Baraka V, 2015, ANTIMICROB AGENTS CH, V59, P734, DOI 10.1128/AAC.03647-14; Borrmann S, 2013, SCI REP-UK, V3, DOI 10.1038/srep03318; Conrad MD, 2014, J INFECT DIS, V210, P344, DOI 10.1093/infdis/jiu141; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Djimde AA, 2008, AM J TROP MED HYG, V78, P455, DOI 10.4269/ajtmh.2008.78.455; Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Duraisingh MT, 2005, ACTA TROP, V94, P181, DOI 10.1016/j.actatropica.2005.04.008; Duraisingh MT, 2000, PARASITOLOGY, V121, P1, DOI 10.1017/S0031182099006022; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(00)00084-8; Frosch AEP, 2014, J INFECT DIS, V210, P1110, DOI 10.1093/infdis/jiu216; Gadalla NB, 2011, ANTIMICROB AGENTS CH, V55, P5408, DOI 10.1128/AAC.05102-11; Happi CT, 2009, ANTIMICROB AGENTS CH, V53, P888, DOI 10.1128/AAC.00968-08; Henriques G, 2014, J INFECT DIS, V210, P2001, DOI 10.1093/infdis/jiu358; Humphreys GS, 2007, ANTIMICROB AGENTS CH, V51, P991, DOI 10.1128/AAC.00875-06; Hunt P, 2007, MOL MICROBIOL, V65, P27, DOI 10.1111/j.1365-2958.2007.05753.x; Hunt P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-499; Kamau E, 2015, J INFECT DIS, V211, P1352, DOI 10.1093/infdis/jiu608; Kamugisha E, 2012, ACTA TROP, V121, P148, DOI 10.1016/j.actatropica.2011.11.004; Karema C, 2012, RWANDA MALAR J, V11, P236, DOI DOI 10.1186/1475-2875-11-236; Kiwuwa MS, 2013, ACTA TROP, V125, P269, DOI 10.1016/j.actatropica.2012.11.013; Kublin JG, 2003, J INFECT DIS, V187, P1870, DOI 10.1086/375419; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Kyaw MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057689; Laufer MK, 2010, J INFECT DIS, V202, P801, DOI 10.1086/655659; Laufer MK, 2004, DRUG RESIST UPDATE, V7, P279, DOI 10.1016/j.drup.2004.08.003; Legrand E, 2012, ANTIMICROB AGENTS CH, V56, P1382, DOI 10.1128/AAC.05280-11; McKenzie FE, 2005, J INFECT DIS, V192, P323, DOI 10.1086/431152; Mehlotra RK, 2008, ANTIMICROB AGENTS CH, V52, P2212, DOI 10.1128/AAC.00089-08; Mekonnen SK, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-244; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Mulligan JA, 2006, TROP MED INT HEALTH, V11, P452, DOI 10.1111/j.1365-3156.2006.01590.x; Mwai L, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-106; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Nsobya SL, 2010, ANTIMICROB AGENTS CH, V54, P1200, DOI 10.1128/AAC.01412-09; Ochola LI, 2010, MOL BIOL EVOL, V27, P2344, DOI 10.1093/molbev/msq119; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Pillai DR, 2001, J INFECT DIS, V183, P789, DOI 10.1086/318836; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Setthaudom C, 2011, AM J TROP MED HYG, V85, P606, DOI 10.4269/ajtmh.2011.11-0108; Sisowath C, 2007, TROP MED INT HEALTH, V12, P736, DOI 10.1111/j.1365-3156.2007.01843.x; Sisowath C, 2009, J INFECT DIS, V199, P750, DOI 10.1086/596738; Suwanarusk R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001089; Takala-Harrison S, 2015, J INFECT DIS, V211, P670, DOI 10.1093/infdis/jiu491; Wang XH, 2005, AM J TROP MED HYG, V72, P410, DOI 10.4269/ajtmh.2005.72.410	52	2	2	0	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	JUL 8	2015	14								264	10.1186/s12936-015-0783-3				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CM3EL	WOS:000357564500002	26152336	DOAJ Gold, Green Published			2019-04-02	
J	Coral-Almeida, M; Gabriel, S; Abatih, EN; Praet, N; Benitez, W; Dorny, P				Coral-Almeida, Marco; Gabriel, Sarah; Abatih, Emmanuel Nji; Praet, Nicolas; Benitez, Washington; Dorny, Pierre			Taenia solium Human Cysticercosis: A Systematic Review of Sero-epidemological Data from Endemic Zones around the World	PLOS NEGLECTED TROPICAL DISEASES			English	Review							HUMAN NEUROCYSTICERCOSIS; SAGINATA CYSTICERCOSIS; RURAL-COMMUNITY; HIGH SEROPREVALENCE; DISEASE BURDEN; EASTERN ZAMBIA; TAPEWORM EGGS; BURKINA-FASO; RISK-FACTORS; VILLAGE	Background Taenia solium cysticercosis is a zoonotic neglected disease responsible for severe health disorders such as seizures and death. Understanding the epidemiology of human cysticercosis (HCC) in endemic regions will help to expose critical information about the transmission of the disease, which could be used to design efficient control programs. This review gathered serological data on apparent prevalence of T. solium circulating antigens and/or seroprevalence of T. solium antibodies, apparent prevalence of human taeniasis and risk factors for HCC from endemic communities in order to understand the differences in exposure to the parasite and active infections with T. solium metacestodes in endemic areas around the world. Methods Three databases were used to search sero-epidemiological data from community-based studies conducted between 1989 and 2014 in cysticercosis endemic communities worldwide. The search focused on data obtained from T. solium circulating antigen detection by monoclonal antibody-based sandwich ELISA and/or T. solium antibody seroprevalence determined by Enzyme-linked Immunoelectrotransfer Blot (EITB). A meta-analysis was performed per continent. Principal Findings A total of 39,271 participants from 19 countries, described in 37 articles were studied. The estimates for the prevalence of circulating T. solium antigens for Africa, Latin America and Asia were: 7.30%(95% CI [4.23-12.31]), 4.08% (95% CI [2.77-5.95]) and 3.98% (95% CI [2.81-5.61]), respectively. Seroprevalence estimates of T. solium antibodies were 17.37% (95% CI [3.33-56.20]), 13.03% (95% CI [9.95-16.88]) and 15.68% (95% CI [10.25-23.24]) respectively. Taeniasis reported prevalences ranged from 0 (95% CI [0.00-1.62]) to 17.25% (95% CI [14.55-20.23]). Significance A significant variation in the sero-epidemiological data was observed within each continent, with African countries reporting the highest apparent prevalences of active infections. Intrinsic factors in the human host such as age and immunity were main determinants for the occurrence of infections, while exposure was mostly related to environmental factors which varied from community to community.	[Coral-Almeida, Marco; Gabriel, Sarah; Abatih, Emmanuel Nji; Praet, Nicolas; Dorny, Pierre] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Coral-Almeida, Marco; Dorny, Pierre] Univ Ghent, Fac Vet Med, Merelbeke, Belgium; [Coral-Almeida, Marco; Benitez, Washington] Univ Cent Ecuador, Ctr Int Zoonosis, Quito, Ecuador; [Coral-Almeida, Marco] Amer Univ, Escuela Med Vet & Zootecnia, Quito, Ecuador; [Benitez, Washington] Univ Cent Ecuador, Fac Med Vet & Zootecnia, Quito, Ecuador	Coral-Almeida, M (reprint author), Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium.	marco.coralalmeida@ugent.be		Coral, Marco/0000-0003-0211-2906	Institute of Tropical Medicine in Antwerp, Belgium; Centro Internacional de Zoonosis, Quito-Ecuador	This work was financially supported by the Belgian Cooperation in the framework of the Institutional Collaboration between the Institute of Tropical Medicine in Antwerp, Belgium and the Centro Internacional de Zoonosis, Quito-Ecuador. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo-Florez P, 2003, REV NEUROLOGIA, V36, P706, DOI 10.33588/rn.3608.2002323; Agudelo-Flórez Piedad, 2009, Rev. salud pública, V11, P191; Allan JC, 1996, AM J TROP MED HYG, V54, P352, DOI 10.4269/ajtmh.1996.54.352; [Anonymous], 2012, R LANG ENV STAT COMP; [Anonymous], 2011, COUNTR AR RISK CYST; Arriola CS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003247; BRANDT JRA, 1992, INT J PARASITOL, V22, P471, DOI 10.1016/0020-7519(92)90148-E; Bruno E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002480; Carabin H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000555; Chavarria A, 2003, MICROBES INFECT, V5, P1109, DOI 10.1016/S1286-4579(03)00206-5; Conlan JV, 2012, AM J TROP MED HYG, V87, P281, DOI 10.4269/ajtmh.2012.11-0106; Conlan JV, 2009, TRENDS PARASITOL, V25, P398, DOI 10.1016/j.pt.2009.06.005; Coral-Almeida M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002887; CRUZ I, 1994, AM J TROP MED HYG, V51, P405, DOI 10.4269/ajtmh.1994.51.405; Deckers N, 2010, TRENDS PARASITOL, V26, P137, DOI 10.1016/j.pt.2009.12.008; DIAZ F, 1992, AM J EPIDEMIOL, V135, P875, DOI 10.1093/oxfordjournals.aje.a116383; Dorny P, 2003, ACTA TROP, V87, P79, DOI 10.1016/S0001-706X(03)00058-5; Dorny P, 2000, VET PARASITOL, V88, P43, DOI 10.1016/S0304-4017(99)00196-X; Dorny P., 2005, WHO FAO OIE GUIDELIN, P45; Erhart A, 2002, T ROY SOC TROP MED H, V96, P270, DOI 10.1016/S0035-9203(02)90095-7; Faleiros AC, 2009, BIOMEDICA, V29, P127; Ferrer E, 2003, T ROY SOC TROP MED H, V97, P522, DOI 10.1016/S0035-9203(03)80014-7; Fleury A, 2007, J NEUROL NEUROSUR PS, V78, P970, DOI 10.1136/jnnp.2006.107243; Fleury A, 2010, T ROY SOC TROP MED H, V104, P243, DOI 10.1016/j.trstmh.2010.01.005; Flisser A, 2006, VET PARASITOL, V139, P283, DOI 10.1016/j.vetpar.2006.04.019; Garcia HH, 2010, NEUROLOGY, V75, P654, DOI 10.1212/WNL.0b013e3181ed9eae; Garcia HH, 2008, EPILEPSIA, V49, P25, DOI 10.1111/j.1528-1167.2008.01753.x; Garcia HH, 2001, AM J TROP MED HYG, V65, P31, DOI 10.4269/ajtmh.2001.65.31; Garcia HH, 1998, T ROY SOC TROP MED H, V92, P411, DOI 10.1016/S0035-9203(98)91069-0; Garcia HH, 2003, AM J TROP MED HYG, V68, P268, DOI 10.4269/ajtmh.2003.68.268; Garcia HH, 1999, ACTA TROP, V73, P31, DOI 10.1016/S0001-706X(99)00011-X; Garcia HH, 1998, AM J TROP MED HYG, V59, P902, DOI 10.4269/ajtmh.1998.59.902; GarciaNoval J, 1996, AM J TROP MED HYG, V55, P282, DOI 10.4269/ajtmh.1996.55.282; Gomes I, 2002, ARQ NEURO-PSIQUIAT, V60, P219, DOI 10.1590/S0004-282X2002000200006; Gomez-Puerta LA, 2014, REV BRAS PARASITOL V, V23, P94, DOI 10.1590/S1984-29612014014; HALL A, 1981, PARASITOLOGY, V83, P91, DOI 10.1017/S003118200005006X; HARRISON LJS, 1989, PARASITE IMMUNOL, V11, P351, DOI 10.1111/j.1365-3024.1989.tb00673.x; Huerta M, 2008, T ROY SOC TROP MED H, V102, P374, DOI 10.1016/j.trstmh.2007.12.009; Ito A, 2003, ACTA TROP, V87, P95, DOI 10.1016/S0001-706X(03)00024-X; Jayaraman T, 2011, T ROY SOC TROP MED H, V105, P153, DOI 10.1016/j.trstmh.2010.10.007; Kadhiravan T, 2009, AM J TROP MED HYG, V80, P699, DOI 10.4269/ajtmh.2009.80.699; Kanobana K, 2011, INT J PARASITOL, V41, P1015, DOI 10.1016/j.ijpara.2011.06.004; Kyvsgaard NC, 2007, INT J PARASITOL, V37, P547, DOI 10.1016/j.ijpara.2006.11.018; LAWSON JR, 1985, PARASITOLOGY, V91, P129, DOI 10.1017/S0031182000056572; LAWSON JR, 1983, ADV PARASIT, V22, P261, DOI 10.1016/S0065-308X(08)60464-9; LAWSON JR, 1990, PARASITOLOGY, V100, P143, DOI 10.1017/S0031182000060224; Lescano AG, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000371; Lustigman S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001582; Martinez MJ, 2000, J MED ENTOMOL, V37, P489, DOI 10.1603/0022-2585-37.4.489; Martinez-Hernandez F, 2009, INFECT GENET EVOL, V9, P1108, DOI 10.1016/j.meegid.2009.09.005; Meza-Lucas A, 2003, AM J TROP MED HYG, V69, P223, DOI 10.4269/ajtmh.2003.69.223; Molyneux DH, 2004, TRENDS PARASITOL, V20, P347, DOI 10.1016/j.pt.2004.06.004; Montano SM, 2005, NEUROLOGY, V65, P229, DOI 10.1212/01.wnl.0000168828.83461.09; Moro PL, 2003, ANN TROP MED PARASIT, V97, P373, DOI [10.1197/000349803235002371, 10.1179/000349803235002371]; Mwanjali G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002102; Mwape KE, 2015, AM J TROP MED HYG, V92, P56, DOI 10.4269/ajtmh.13-0593; Mwape KE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002142; Mwape KE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001594; Nakao M, 2002, PARASITOLOGY, V124, P657, DOI 10.1017/S0031182002001725; Ndimubanzi PC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000870; Nguekam JP, 2003, TROP MED INT HEALTH, V8, P144, DOI 10.1046/j.1365-3156.2003.01000.x; Nitiema P, 2012, ACTA NEUROL SCAND, V126, P270, DOI 10.1111/j.1600-0404.2011.01639.x; Parija SC, 2009, REV I MED TROP, V51, P185, DOI 10.1590/S0036-46652009000400002; Praet N, 2010, INT J PARASITOL, V40, P85, DOI 10.1016/j.ijpara.2009.07.007; Praet N, 2013, TROP MED INT HEALTH, V18, P608, DOI 10.1111/tmi.12089; Praet N, 2010, AM J TROP MED HYG, V83, P413, DOI 10.4269/ajtmh.2010.10-0121; Praet N, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000406; Rabiela MT, 2000, ARCH MED RES, V31, P605, DOI 10.1016/S0188-4409(00)00253-8; Raghava MV, 2010, T ROY SOC TROP MED H, V104, P601, DOI 10.1016/j.trstmh.2010.06.002; Rodriguez-Hidalgo R, 2006, MEM I OSWALDO CRUZ, V101, P779, DOI 10.1590/S0074-02762006000700012; Rodriguez-Hidalgo R, 2003, VET PARASITOL, V118, P51, DOI 10.1016/j.vetpar.2003.09.019; Sanchez AL, 1999, ANN TROP MED PARASIT, V93, P247, DOI 10.1080/00034983.1999.11813420; Sanchez AL, 1998, ACTA TROP, V69, P141, DOI 10.1016/S0001-706X(97)00132-0; SARTI E, 1992, AM J TROP MED HYG, V46, P677, DOI 10.4269/ajtmh.1992.46.677; SARTI E, 1994, T ROY SOC TROP MED H, V88, P49, DOI 10.1016/0035-9203(94)90493-6; Sarti E, 2000, T ROY SOC TROP MED H, V94, P85, DOI 10.1016/S0035-9203(00)90451-6; SARTIGUTIERREZ EJ, 1988, TROP MED PARASITOL, V39, P194; SCHANTZ PM, 1992, NEW ENGL J MED, V327, P692, DOI 10.1056/NEJM199209033271004; Sciutto E, 2013, MICROBES INFECT, V15, P524, DOI 10.1016/j.micinf.2013.03.007; Secka A, 2011, ACTA TROP, V119, P199, DOI 10.1016/j.actatropica.2011.05.003; Singh G, 1997, ARQ NEURO-PSIQUIAT, V55, P349, DOI 10.1590/S0004-282X1997000300001; Somers R, 2006, TROP MED INT HEALTH, V11, P65, DOI 10.1111/j.1365-3156.2005.01537.x; Sorvillo FJ, 2007, EMERG INFECT DIS, V13, P230, DOI 10.3201/eid1302.060527; Takayanagui OM, 1998, AM J TROP MED HYG, V59, P1002, DOI 10.4269/ajtmh.1998.59.1002; Theis J. H., 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P464; Thomas LF, 2014, EPIDEMIOLOGY TAENIA; Torgerson PR, 2011, VET PARASITOL, V182, P79, DOI 10.1016/j.vetpar.2011.07.017; TSANG VCW, 1989, J INFECT DIS, V159, P50, DOI 10.1093/infdis/159.1.50; Van Kerckhoven I, 1998, VET PARASITOL, V76, P269, DOI 10.1016/S0304-4017(97)00226-4	89	32	35	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUL	2015	9	7							e0003919	10.1371/journal.pntd.0003919				20	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CO3SM	WOS:000359079700028	26147942	DOAJ Gold, Green Published			2019-04-02	
J	Meurs, L; Brienen, E; Mbow, M; Ochola, EA; Mboup, S; Karanja, DMS; Secor, WE; Polman, K; van Lieshout, L				Meurs, Lynn; Brienen, Eric; Mbow, Moustapha; Ochola, Elizabeth A.; Mboup, Souleymane; Karanja, Diana M. S.; Secor, W. Evan; Polman, Katja; van Lieshout, Lisette			Is PCR the Next Reference Standard for the Diagnosis of Schistosoma in Stool? A Comparison with Microscopy in Senegal and Kenya	PLOS NEGLECTED TROPICAL DISEASES			English	Article							REAL-TIME PCR; CIRCULATING-CATHODIC-ANTIGEN; POLYMERASE-CHAIN-REACTION; NEGLECTED TROPICAL DISEASES; NORTHERN SENEGAL; KATO-KATZ; HAEMATOBIUM INFECTION; MANSONI INFECTIONS; URINE SAMPLES; STRIP TEST	Background The current reference test for the detection of S. mansoni in endemic areas is stool microscopy based on one or more Kato-Katz stool smears. However, stool microscopy has several shortcomings that greatly affect the efficacy of current schistosomiasis control programs. A highly specific multiplex real-time polymerase chain reaction (PCR) targeting the Schistosoma internal transcriber-spacer-2 sequence (ITS2) was developed by our group a few years ago, but so far this PCR has been applied mostly on urine samples. Here, we performed more in-depth evaluation of the ITS2 PCR as an alternative method to standard microscopy for the detection and quantification of Schistosoma spp. in stool samples. Methodology/Principal findings Microscopy and PCR were performed in a Senegalese community (n = 197) in an area with high S. mansoni transmission and co-occurrence of S. haematobium, and in Kenyan schoolchildren (n = 760) from an area with comparatively low S. mansoni transmission. Despite the differences in Schistosoma endemicity the PCR performed very similarly in both areas; 13-15% more infections were detected by PCR when comparing to microscopy of a single stool sample. Even when 2-3 stool samples were used for microscopy, PCR on one stool sample detected more infections, especially in people with light-intensity infections and in children from low-risk schools. The low prevalence of soil-transmitted helminthiasis in both populations was confirmed by an additional multiplex PCR. Conclusions/Significance The ITS2-based PCR was more sensitive than standard microscopy in detecting Schistosoma spp. This would be particularly useful for S. mansoni detection in low transmission areas, and post-control settings, and as such improve schistosomiasis control programs, epidemiological research, and quality control of microscopy. Moreover, it can be complemented with other (multiplex real-time) PCRs to detect a wider range of helminths and thus enhance effectiveness of current integrated control and elimination strategies for neglected tropical diseases.	[Meurs, Lynn; Brienen, Eric; van Lieshout, Lisette] Leiden Univ, Dept Parasitol, Med Ctr, Leiden, Netherlands; [Meurs, Lynn; Polman, Katja] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Mbow, Moustapha; Mboup, Souleymane] Aristide Le Dantec Teaching Hosp, Lab Bacteriol & Virol, Dakar, Senegal; [Ochola, Elizabeth A.; Karanja, Diana M. S.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Secor, W. Evan] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA USA	Meurs, L (reprint author), Leiden Univ, Dept Parasitol, Med Ctr, Leiden, Netherlands.	lvanlieshout@lumc.nl	Meurs, Lynn/J-8661-2016	Meurs, Lynn/0000-0002-6973-1237	European Union's sixth framework program [INCO-CT-2006-032405 SCHISTOINIR]; University of Georgia Research Foundation through Bill and Melinda Gates Foundation; USAID	The Senegalese study received funding from the European Union's sixth framework program (INCO-CT-2006-032405 SCHISTOINIR to KP and SM; http://cordis.europa.eu/fp6/). The Kenyan study received financial support from The University of Georgia Research Foundation through a grant from the Bill and Melinda Gates Foundation and also from USAID-supported NTD control activities at the CDC, Atlanta. The PCR analysis at Leiden University Medical Center was partly supported by the Prof. Dr. P.C. Flu-Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Oliveira LMA, 2010, DIAGN MICR INFEC DIS, V68, P416, DOI 10.1016/j.diagmicrobio.2010.07.016; Allam AF, 2009, TROP MED INT HEALTH, V14, P316, DOI 10.1111/j.1365-3156.2009.02225.x; [Anonymous], 2006, PREV CHEM HUM HELM C; Basuni M, 2012, TROP BIOMED, V29, P434; Betson M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002561; do Espirito-Santo MCC, 2014, AM J TROP MED HYG, V90, P1146, DOI 10.4269/ajtmh.13-0746; do Espirito-Santo MCC, 2012, REV INST MED TROP SP, V54, P245, DOI 10.1590/S0036-46652012000500002; Espirito-Santo MCC, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0558-4; Espirito-Santo MCC, 2014, EXP PARASITOL, V143, P83, DOI 10.1016/j.exppara.2014.05.013; Cnops L, 2012, TROP MED INT HEALTH, V17, P1208, DOI 10.1111/j.1365-3156.2012.03060.x; Colley DG, 2013, AM J TROP MED HYG, V88, P426, DOI 10.4269/ajtmh.12-0639; de Carvalho GC, 2012, MEM I OSWALDO CRUZ, V107, P899, DOI 10.1590/S0074-02762012000700010; DEVLAS SJ, 1992, PARASITOLOGY, V104, P451, DOI 10.1017/S003118200006371X; Engels D, 1997, AM J TROP MED HYG, V57, P571, DOI 10.4269/ajtmh.1997.57.571; Glinz D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000754; Gobert GN, 2005, MOL CELL PROBE, V19, P250, DOI 10.1016/j.mcp.2005.01.006; Gomes LI, 2009, MEM I OSWALDO CRUZ, V104, P1194, DOI 10.1590/S0074-02762009000800021; Gomes LI, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000664; Gordon CA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003483; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; King CH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002431; Knopp S, 2014, AM J TROP MED HYG, V90, P535, DOI 10.4269/ajtmh.13-0268; Lamberton PHL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003139; Meurs L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002608; Meurs L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001829; Meurs L, 2012, INT J PARASITOL, V42, P305, DOI 10.1016/j.ijpara.2012.02.002; Niesters HGM, 2002, J CLIN VIROL, V25, pS3; Noya O, 2002, MEM I OSWALDO CRUZ, V97, P167, DOI 10.1590/S0074-02762002000900032; Obeng BB, 2008, ANN TROP MED PARASIT, V102, P625, DOI 10.1179/136485908X337490; Pillay P, 2014, AM J TROP MED HYG, V90, P546, DOI 10.4269/ajtmh.13-0406; POLDERMAN AM, 1985, ANN SOC BELG MED TR, V65, P243; Pontes LA, 2003, AM J TROP MED HYG, V68, P652, DOI 10.4269/ajtmh.2003.68.652; Pontes LA, 2002, AM J TROP MED HYG, V66, P157, DOI 10.4269/ajtmh.2002.66.157; RABELLO ALT, 1992, MEM I OSWALDO CRUZ, V87, P325, DOI 10.1590/S0074-02761992000800052; Schwarz NG, 2014, ACTA TROP, V134, P89, DOI 10.1016/j.actatropica.2014.03.003; ten Hove RJ, 2008, T ROY SOC TROP MED H, V102, P179, DOI 10.1016/j.trstmh.2007.10.011; Utzinger J, 2015, CLIN MICROBIOL INFEC; van Dam GJ, 2004, J CLIN MICROBIOL, V42, P5458, DOI 10.1128/JCM.42.12.5458-5461.2004; van Lieshout L, 2013, LANCET INFECT DIS, V13, P469, DOI [10.1016/S1473-3099(13)70094-X, 10.1016/s1473-3099(13)70094-X]; van Mens SP, 2013, T ROY SOC TROP MED H, V107, P269, DOI 10.1093/trstmh/trs094; Verweij JJ, 2014, CLIN MICROBIOL REV, V27, P371, DOI 10.1128/CMR.00122-13; Verweij JJ, 2001, TROP MED INT HEALTH, V6, P726, DOI 10.1046/j.1365-3156.2001.00770.x; Wiria AE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-77; World Health Organization, 2013, SCHIST PROGR REP 200; World Health Organization (WHO), 1991, BAS LAB METH MED PAR	46	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUL	2015	9	7							e0003959	10.1371/journal.pntd.0003959				16	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CO3SM	WOS:000359079700055	26217948	DOAJ Gold, Green Published			2019-04-02	
J	Suarez, M; Valencia, BM; Jara, M; Alba, M; Boggild, AK; Dujardin, JC; Llanos-Cuentas, A; Arevalo, J; Adaui, V				Suarez, Milagros; Valencia, Braulio M.; Jara, Marlene; Alba, Milena; Boggild, Andrea K.; Dujardin, Jean-Claude; Llanos-Cuentas, Alejandro; Arevalo, Jorge; Adaui, Vanessa			Quantification of Leishmania (Viannia) Kinetoplast DNA in Ulcers of Cutaneous Leishmaniasis Reveals Inter-site and Inter-sampling Variability in Parasite Load	PLOS NEGLECTED TROPICAL DISEASES			English	Article							TIME PCR ASSAY; MUCOCUTANEOUS LEISHMANIASIS; NEW-WORLD; DIAGNOSIS; LESIONS; SKIN; TEGUMENTARY; IMMUNOPATHOLOGY; COLOMBIA; SWAB	Background Cutaneous leishmaniasis (CL) is a skin disease caused by the protozoan parasite Leishmania. Few studies have assessed the influence of the sample collection site within the ulcer and the sampling method on the sensitivity of parasitological and molecular diagnostic techniques for CL. Sensitivity of the technique can be dependent upon the load and distribution of Leishmania amastigotes in the lesion. Methodology/Principal Findings We applied a quantitative real-time PCR (qPCR) assay for Leishmania (Viannia) minicircle kinetoplast DNA (kDNA) detection and parasite load quantification in biopsy and scraping samples obtained from 3 sites within each ulcer (border, base, and center) as well as in cytology brush specimens taken from the ulcer base and center. A total of 248 lesion samples from 31 patients with laboratory confirmed CL of recent onset (<= 3 months) were evaluated. The kDNA-qPCR detected Leishmania DNA in 97.6% (242/248) of the examined samples. Median parasite loads were significantly higher in the ulcer base and center than in the border in biopsies (P<0.0001) and scrapings (P = 0.0002). There was no significant difference in parasite load between the ulcer base and center (P = 0.80, 0.43, and 0.07 for biopsy, scraping, and cytology brush specimens, respectively). The parasite load varied significantly by sampling method: in the ulcer base and center, the descending order for the parasite load levels in samples was: cytology brushes, scrapings, and biopsies (P<0.0001); in the ulcer border, scrapings had higher parasite load than biopsies (P<0.0001). There was no difference in parasite load according to L. braziliensis and L. peruviana infections (P = 0.4). Conclusion/Significance Our results suggest an uneven distribution of Leishmania amastigotes in acute CL ulcers, with higher parasite loads in the ulcer base and center, which has implications for bedside collection of diagnostic specimens. The use of scrapings and cytology brushes is recommended instead of the more invasive biopsy.	[Suarez, Milagros; Valencia, Braulio M.; Jara, Marlene; Alba, Milena; Llanos-Cuentas, Alejandro; Arevalo, Jorge; Adaui, Vanessa] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Boggild, Andrea K.] Publ Hlth Ontario, Publ Hlth Ontario Labs, Toronto, ON, Canada; [Boggild, Andrea K.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Boggild, Andrea K.] Toronto Gen Hosp, Univ Hlth Network, Trop Dis Unit, Toronto, ON, Canada; [Dujardin, Jean-Claude] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Dujardin, Jean-Claude] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium; [Arevalo, Jorge; Adaui, Vanessa] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Dept Ciencias Celulares & Mol, Lima, Peru	Adaui, V (reprint author), Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru.	vanessa.adaui@upch.pe			Internal Competitive Fund of Universidad Peruana Cayetano Heredia ("Fondo Concursable para Apoyo a la Investigacion en la UPCH"); Belgian Directorate General for Development Cooperation [95502]	This work was financially supported by an Internal Competitive Fund of Universidad Peruana Cayetano Heredia ("Fondo Concursable para Apoyo a la Investigacion en la UPCH-2011") for covering working costs; and the Belgian Directorate General for Development Cooperation (FA3 project 95502) for personnel (MS, MJ, MA, VA) and facility support at the Molecular Epidemiology Unit of the Instituto de Medicina Tropical Alexander von Humboldt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ER, 2014, PARASITOLOGY, V141, P1891, DOI 10.1017/S0031182014001280; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; [Anonymous], 1990, World Health Organ Tech Rep Ser, V793, P1; Arevalo J, 2007, J INFECT DIS, V195, P1846, DOI 10.1086/518041; BARRAL A, 1987, PARASITE IMMUNOL, V9, P487, DOI 10.1111/j.1365-3024.1987.tb00525.x; Bensoussan E, 2006, J CLIN MICROBIOL, V44, P1435, DOI 10.1128/JCM.44.4.1435-1439.2006; Boggild AK, 2007, J CLIN MICROBIOL, V45, P3680, DOI 10.1128/JCM.01286-07; Boggild AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026395; Boggild AK, 2011, J CLIN MICROBIOL, V49, P1097, DOI 10.1128/JCM.02457-10; Boggild AK, 2010, CLIN INFECT DIS, V50, pE1, DOI 10.1086/648730; Brewster S, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS55, DOI 10.1016/S0035-9203(02)90052-0; de Oliveira DM, 2011, BRAZ J INFECT DIS, V15, P204, DOI 10.1590/S1413-86702011000300004; Dorlo TPC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001436; ESCOBAR MA, 1992, TROP DOCT, V22, P69, DOI 10.1177/00494755920220S110; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; GRIMALDI G, 1993, CLIN MICROBIOL REV, V6, P230; GUTIERREZ Y, 1991, AM J TROP MED HYG, V45, P281, DOI 10.4269/ajtmh.1991.45.281; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; Huse SM, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-5; Jara M, 2013, 5 WORLD C LEISHM WOR, P567; Jara M, 2013, J CLIN MICROBIOL, V51, P1826, DOI 10.1128/JCM.00208-13; LOPEZ M, 1993, AM J TROP MED HYG, V49, P348, DOI 10.4269/ajtmh.1993.49.348; Lumbreras H., 1985, LEISHMANIASIS, P297; Valencia BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049738; Mary C, 2004, J CLIN MICROBIOL, V42, P5249, DOI 10.1128/JCM.42.11.5249-5255.2004; Maurer-Cecchini A, 2009, INFECT IMMUN, V77, P2022, DOI 10.1128/IAI.01513-08; McMahon-Pratt D, 2004, IMMUNOL REV, V201, P206, DOI 10.1111/j.0105-2896.2004.00190.x; MIMORI T, 1987, ANN TROP MED PARASIT, V81, P681, DOI 10.1080/00034983.1987.11812170; Mimori T, 2002, ACTA TROP, V81, P197, DOI 10.1016/S0001-706X(01)00215-7; Montalvo AM, 2012, EUR J CLIN MICROBIOL, V31, P1453, DOI 10.1007/s10096-011-1463-z; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; NAVIN TR, 1990, AM J TROP MED HYG, V42, P36, DOI 10.4269/ajtmh.1990.42.36; Novais FO, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003504; Palma GI, 1997, AM J DERMATOPATH, V19, P585, DOI 10.1097/00000372-199712000-00006; PIRMEZ C, 1990, MEM I OSWALDO CRUZ, V85, P203, DOI 10.1590/S0074-02761990000200011; Prina E, 2007, MICROBES INFECT, V9, P1307, DOI 10.1016/j.micinf.2007.06.005; Ramirez JR, 2000, J CLIN MICROBIOL, V38, P3768; Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8; Reithinger R, 2007, J CLIN MICROBIOL, V45, P21, DOI 10.1128/JCM.02029-06; Robinson Ramirez Jose, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS169; Silveira FT, 2004, MEM I OSWALDO CRUZ, V99, P239, DOI 10.1590/S0074-02762004000300001; SOTTO MN, 1989, ACTA TROP, V46, P121, DOI 10.1016/0001-706X(89)90006-5; Valencia BM, 2014, 63 ANN M AM SOC TROP, P332; van der Meide WF, 2008, CLIN EXP DERMATOL, V33, P394, DOI 10.1111/j.1365-2230.2007.02680.x; Vergel C, 2005, AM J TROP MED HYG, V72, P423, DOI 10.4269/ajtmh.2005.72.423; Vergel C, 2006, J INFECT DIS, V194, P503, DOI 10.1086/505583; WEIGLE KA, 1987, AM J TROP MED HYG, V36, P489, DOI 10.4269/ajtmh.1987.36.489; Weigle KA, 2002, J CLIN MICROBIOL, V40, P601, DOI 10.1128/JCM.40.2.601-606.2002; Weina PJ, 2004, CLIN INFECT DIS, V39, P1674, DOI 10.1086/425747; Zvietcovich F, 2012, IEEE ENG MED BIO, P2025, DOI 10.1109/EMBC.2012.6346355	50	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUL	2015	9	7							e0003936	10.1371/journal.pntd.0003936				14	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CO3SM	WOS:000359079700040	26204525	DOAJ Gold, Green Published			2019-04-02	
J	Krishnananthasivam, S; Fernando, AN; Tippalagama, R; Tennekoon, R; De Man, J; Seneviratne, D; Premawansa, S; Premawansa, G; De Silva, AD				Krishnananthasivam, Shivankari; Fernando, Anira N.; Tippalagama, Rashmi; Tennekoon, Rashika; De Man, Jeroen; Seneviratne, Dammika; Premawansa, Sunil; Premawansa, Gayani; De Silva, Aruna Dharshan			EVALUATION OF A COMMERCIAL RAPID TEST KIT FOR DETECTION OF ACUTE DENGUE INFECTION	SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH			English	Article						dengue diagnostics; disease management; primary and secondary dengue infection; Sri Lanka	G AVIDITY TEST; HEMORRHAGIC-FEVER; VIRUS-INFECTIONS; ACUTE-PHASE; DIAGNOSIS; ANTIBODY; DISEASE; ANTIGEN; NS1; SPECIFICITY	Early diagnosis is important for clinical management of dengue disease. While classic laboratory tests are often tedious and time consuming, point of care devices offer a rapid, cost-effective and user-friendly alternative provided their accuracy is acceptable. This study evaluated the sensitivity, specificity and efficiency of SD BIOLINE Dengue Duo (R) rapid NS1, IgM and IgG test kit for diagnosis of acute dengue virus infection. Standard laboratory diagnostics, RT-PCR, IgM and IgG capture ELISAs were carried out on 143 suspected dengue patient samples obtained from a Sri Lankan population. Using the results of these standard laboratory tests as reference, the sensitivity and specificity of the SD Dengue Duo (R) NS1 test was 57% and 87%, respectively, and those of the IgM test was 50% and 84%, respectively. The combined sensitivity and specificity of the SD Dengue Duo (R) NS1/IgM test was 72% and 80%, respectively. The SD Dengue Duo (R) NS1 test detected NS1 for up to 9 days from onset of fever. Primary and secondary dengue cases were classified according to the IgG test, of which the kit identified 88% and 26% of primary and of secondary infection, respectively. Although the SD Dengue Duo (R) kit was not as accurate as the standard tests, it still can serve the useful reference for initial screening of suspected dengue cases, especially in poor resource hospital settings and aid in clinical disease management of dengue infection.	[Krishnananthasivam, Shivankari; Fernando, Anira N.; Tippalagama, Rashmi; Tennekoon, Rashika; Seneviratne, Dammika; De Silva, Aruna Dharshan] Genetech Res Inst, Colombo 8, Sri Lanka; [De Man, Jeroen] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [De Man, Jeroen] Univ N Carolina, Sch Publ Hlth, Dept Hlth Policy & Adm, Chapel Hill, NC USA; [Premawansa, Sunil] Univ Colombo, Fac Sci, Dept Zool, Colombo, Western Provinc, Sri Lanka; [Premawansa, Gayani] North Colombo Teaching Hosp, Ragama, Sri Lanka; [De Silva, Aruna Dharshan] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA	De Silva, AD (reprint author), Genetech Res Inst, 54 Kitulwatte Rd, Colombo 8, Sri Lanka.	dslv90@yahoo.com			National Institute of Health, USA [HHSN272200900042C]	The authors would like to thank staff of Genetech Molecular Diagnostics division for carrying out the RT-PCR assay and all the medical staff of Ward 9, North Colombo Teaching Hospital, Ragama, Sri Lanka for their contribution towards sample and clinical data collection. This study was partially supported by a grant from the National Institute of Health, USA (Grant no. HHSN272200900042C). The SD Dengue Duo (R) kits were provided as a donation by Professor Aravinda de Silva, Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill, USA.	Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.2.376-381.2002; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Blacksell SD, 2012, CLIN VACCINE IMMUNOL, V19, P804, DOI 10.1128/CVI.05717-11; Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P2095, DOI 10.1128/CVI.05285-11; de Souza VAUF, 2004, J CLIN MICROBIOL, V42, P1782, DOI 10.1128/JCM.42.4.1782-1784.2004; Epidemiology Unit Ministry of Health Sri Lanka, 2014, DISTR NOT H399 DENG; Gubler DJ, 1999, ADV VIRUS RES, V53, P35, DOI 10.1016/S0065-3527(08)60342-5; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Hunsperger EA, 2009, EMERG INFECT DIS, V15, P436, DOI 10.3201/eid1503.080923; Matheus S, 2005, J CLIN MICROBIOL, V43, P2793, DOI 10.1128/JCM.43.6.2793-2797.2005; Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361; Pan-ngum W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050765; Parikh R, 2008, INDIAN J OPHTHALMOL, V56, P45, DOI 10.4103/0301-4738.37595; Prince HE, 2011, CLIN VACCINE IMMUNOL, V18, P2183, DOI 10.1128/CVI.05425-11; Prince HE, 2011, CLIN VACCINE IMMUNOL, V18, P1951, DOI 10.1128/CVI.05278-11; RATNAM S, 1995, J CLIN MICROBIOL, V33, P811; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Sudiro TM, 1997, AM J TROP MED HYG, V56, P424, DOI 10.4269/ajtmh.1997.56.424; Tang KF, 2012, EXPERT REV ANTI-INFE, V10, P895, DOI [10.1586/eri.12.76, 10.1586/ERI.12.76]; Tricou Vianney, 2010, BMC Infect Dis, V10, P142, DOI 10.1186/1471-2334-10-142; de Souza VAUF, 2007, J CLIN VIROL, V39, P230, DOI 10.1016/j.jcv.2007.04.005; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Wang SM, 2010, AM J TROP MED HYG, V83, P690, DOI 10.4269/ajtmh.2010.10-0117; World Health Organization, 2009, DENG HEM FEV DIAGN T	25	2	2	0	6	SOUTHEAST ASIAN MINISTERS EDUC ORGANIZATION	BANGKOK	SEAMEO-TROPMED, 420-6 RAJVITHI RD,, BANGKOK 10400, THAILAND	0125-1562			SE ASIAN J TROP MED	Southeast Asian J. Trop. Med. Public Health	JUL	2015	46	4					602	610						9	Public, Environmental & Occupational Health; Infectious Diseases; Tropical Medicine	Public, Environmental & Occupational Health; Infectious Diseases; Tropical Medicine	CN1NF	WOS:000358186000007	26867379				2019-04-02	
J	Edwards, JK; Bygrave, H; Van den Bergh, R; Kizito, W; Cheti, E; Kosgei, RJ; Sobry, A; Vandenbulcke, A; Vakil, SN; Reid, T				Edwards, Jeffrey K.; Bygrave, Helen; Van den Bergh, Rafael; Kizito, Walter; Cheti, Erastus; Kosgei, Rose J.; Sobry, Agnes; Vandenbulcke, Alexandra; Vakil, Shobha N.; Reid, Tony			HIV with non-communicable diseases in primary care in Kibera, Nairobi, Kenya: characteristics and outcomes 2010-2013	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Africa; Chronic kidney disease; Diabetes; HIV; Hypertension; Non-communicable diseases	MIDDLE-INCOME COUNTRIES; SUB-SAHARAN-AFRICA; KIDNEY-DISEASE; ANTIRETROVIRAL THERAPY; HYPERTENSION; MANAGEMENT; RISK; PREVALENCE; PREVENTION; COMMUNITY	Background: Antiretroviral therapy (ART) has increased the life expectancy of people living with HIV (PLHIV); HIV is now considered a chronic disease. Non-communicable diseases (NCDs) and HIV care were integrated into primary care clinics operated within the informal settlement of Kibera, Nairobi, Kenya. We describe early cohort outcomes among PLHIV and HIV-negative patients, both of whom had NCDs. Methods: A retrospective analysis was performed of routinely collected clinic data from January 2010 to June 2013. All patients >14 years with hypertension and/or diabetes were included. Results: Of 2206 patients included in the analysis, 210 (9.5%) were PLHIV. Median age at enrollment in the NCD program was 43 years for PLHIV and 49 years for HIV-negative patients (p<0.0001). The median duration of follow up was 1.4 (IQR 0.7-2.1) and 1.0 (IQR 0.4-1.8) years for PLHIV and HIV-negative patients, respectively (p=0.003). Among patients with hypertension, blood pressure outcomes were similar, and for those with diabetes, outcomes for HbA1c, fasting glucose and cholesterol were not significantly different between the two groups. The frequency of chronic kidney disease (CKD) was 12% overall. Median age for PLHIV and CKD was 50 vs 55 years for those without HIV (p=0.005). Conclusions: In this early comparison of PLHIV and HIV-negative patients with NCDs, there were significant differences in age at diagnosis but both groups responded similarly to treatment. This study suggests that integrating NCD care for PLHIV along with HIV-negative patients is feasible and achieves similar results.	[Edwards, Jeffrey K.; Kizito, Walter; Cheti, Erastus; Sobry, Agnes; Vandenbulcke, Alexandra] Med Sans Frontieres, Nairobi, Kenya; [Bygrave, Helen] Med Sans Frontieres, Southern Africa Med Unit, Cape Town, South Africa; [Van den Bergh, Rafael; Reid, Tony] Med Sans Frontieres, Operat Ctr Brussels, Dept Med, Luxembourg Operat Res Unit, Brussels, Belgium; [Kosgei, Rose J.] Univ Nairobi, Dept Obstet & Gynaecol, Nairobi, Kenya; [Vakil, Shobha N.] HRH Capac Bridge Project, Kenya Natl AIDs & STI Control Program, Nairobi, Kenya	Edwards, JK (reprint author), Med Sans Frontieres, Nairobi, Kenya.	jeffreykedwards@gmail.com		Van den Bergh, Rafael/0000-0001-6277-8713	Institute for Tropical Medicine, Antwerp, Belgium; Center for International Health, University of Bergen; University of Nairobi, Kenya; Partners In Health, Rwanda; Operational Research Unit (LUXOR), Medecins Sans Frontieres, Brussels Operational Centre, Luxembourg; Centre for Operational Research, International Union Against Tuberculosis and Lung Disease (The Union), Paris, France; Union South-East Asia Regional Office, Delhi, India	This research was supported through an operational research course, which was jointly developed and run by the Operational Research Unit (LUXOR), Medecins Sans Frontieres, Brussels Operational Centre, Luxembourg; the Centre for Operational Research, International Union Against Tuberculosis and Lung Disease (The Union), Paris, France, and The Union South-East Asia Regional Office, Delhi, India. Additional support for running the course was provided by the Institute for Tropical Medicine, Antwerp, Belgium; the Center for International Health, University of Bergen; the University of Nairobi, Kenya and Partners In Health, Rwanda. This course is under the umbrella of the World Health Organization (WHO-TDR) SORT-IT programme (Structured Operational Research and Training Initiative) for capacity building in low- and middle-income countries.	Arogundade FA, 2008, AM J KIDNEY DIS, V51, P515, DOI 10.1053/j.ajkd.2007.12.006; Ayah R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-371; Belue R, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-10; Centers for Disease Control and Prevention, 2013, EP INF 7 1 2, V7.1.2, P1; Council on Foreign Relations, 2014, EM GLOB CRIS NONC DI; Dalal W, 2013, JAIDS-J ACQ IMM DEF, V62, pE47, DOI 10.1097/QAI.0b013e318276bea0; Desgroppes Amelie, 2011, CAHIERS AFRIQUE EST, V44, P23; Edwards JK, 2014, PUBLIC HEALTH ACTION, V4, P122, DOI 10.5588/pha.14.0009; Fabian J, 2013, NEPHROL DIAL TRANSPL, V28, P1543, DOI 10.1093/ndt/gft010; Fabian J, 2009, NAT REV NEPHROL, V5, P591, DOI 10.1038/nrneph.2009.141; Fedele F, 2011, AIDS REV, V13, P119; Fliser D, 2012, NEPHROL DIAL TRANSPL, V27, P4263, DOI 10.1093/ndt/gfs375; FUCHIA, 2011, FOLL UP CAR HIV INF; Harries AD, 2013, TROP MED INT HEALTH, V18, P1154, DOI 10.1111/tmi.12159; Kalra S, 2013, CURR DIABETES REP, V13, P419, DOI 10.1007/s11892-013-0369-9; Katz IJ, 2011, NEPHRON CLIN PRACT, V117, pC320, DOI 10.1159/000321524; Lauritsen JM, 2008, EPIDATA ENTRY VERSIO; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Levitt NS, 2011, AM J CLIN NUTR, V94, p1690S, DOI 10.3945/ajcn.111.019075; Nuesch R, 2013, JAIDS-J ACQ IMM DEF, V62, P396, DOI 10.1097/QAI.0b013e3182847cd0; Peck RN, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0125-2; Post Wendy S, 2011, Top Antivir Med, V19, P169; Remais JV, 2013, INT J EPIDEMIOL, V42, P221, DOI 10.1093/ije/dys135; Ryom L, 2013, J INFECT DIS, V207, P1359, DOI 10.1093/infdis/jit043; Samb B, 2010, LANCET, V376, P1785, DOI 10.1016/S0140-6736(10)61353-0; Sobry A, 2014, TROP MED INT HEALTH, V19, P47, DOI 10.1111/tmi.12210; van de Vijver SJM, 2013, J HYPERTENS, V31, P1018, DOI 10.1097/HJH.0b013e32835e3a56; Wyatt CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069601; Yahaya I, 2013, COCHRANE DATABASE SY; Zulu EM, 2011, J URBAN HEALTH, V88, P185, DOI 10.1007/s11524-011-9595-0	30	19	19	1	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	JUL	2015	109	7					440	446		10.1093/trstmh/trv038				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CM9IG	WOS:000358021300005	25997923	Green Published			2019-04-02	
J	Delabouglise, A; Dao, TH; Truong, DB; Nguyen, TT; Nguyen, NTX; Duboz, R; Fournie, G; Antoine-Moussiaux, N; Grosbois, V; Vu, DT; Le, TH; Nguyen, VK; Salem, G; Peyre, M				Delabouglise, A.; Dao, T. H.; Truong, D. B.; Nguyen, T. T.; Nguyen, N. T. X.; Duboz, R.; Fournie, G.; Antoine-Moussiaux, N.; Grosbois, V.; Vu, D. T.; Le, T. H.; Nguyen, V. K.; Salem, G.; Peyre, M.			When private actors matter: Information-sharing network and surveillance of Highly Pathogenic Avian Influenza in Vietnam	ACTA TROPICA			English	Article						Disease reporting; Social networks; Vietnam; H5N1 virus; Private sector; Participatory research; Influenza	EXPERIENCES	The effectiveness of animal health surveillance systems depends on their capacity to gather sanitary information from the animal production sector. In order to assess this capacity we analyzed the flow of sanitary information regarding Highly Pathogenic Avian Influenza (HPAI) suspicions in poultry in Vietnam. Participatory methods were applied to assess the type of actors and likelihood of information sharing between actors in case of HPAI suspicion in poultry. While the reporting of HPAI suspicions is mandatory, private actors had more access to information than public actors. Actors of the upstream sector (medicine and feed sellers) played a key role in the diffusion of information. The central role of these actors and the influence of the information flow on the adoption by poultry production stakeholders of behaviors limiting (e.g. prevention measures) or promoting disease transmission (e.g. increased animal movements) should be accounted for in the design of surveillance and control programs. (C) 2015 Elsevier B.V. All rights reserved.	[Delabouglise, A.; Duboz, R.; Grosbois, V.; Peyre, M.] CIRAD, UR 22 AGIRs, F-34398 Montpellier, France; [Delabouglise, A.; Salem, G.] Paris Quest Univ, CNRS, UR LADYSS, F-92001 Nanterre, France; [Dao, T. H.; Vu, D. T.] Vietnam Natl Univ Agr, Ctr Interdisciplinary Res Rural Dev, Gia Lam, Ha Noi, Vietnam; [Truong, D. B.; Nguyen, N. T. X.; Le, T. H.] Nong Lam Univ, Fac Anim Sci & Vet Med, Ho Chi Minh City, Vietnam; [Nguyen, T. T.; Nguyen, V. K.; Peyre, M.] Natl Inst Vet Res, Hanoi, Vietnam; [Duboz, R.] Asian Inst Technol, Klongluang 12120, Pathumthani, Thailand; [Fournie, G.] Univ London Royal Vet Coll, Vet Epidemiol Econ & Publ Hlth Res Ctr, London NW1 0TU, England; [Antoine-Moussiaux, N.] Univ Liege, Trop Vet Inst, B-4000 Liege, Belgium	Delabouglise, A (reprint author), CIRAD AGIRs Res Unit, Tac 22-E Campus Int Baillarguet, F-34398 Montpellier 5, France.	alexis.delabouglise@gmail.com		Delabouglise, Alexis/0000-0001-5837-7052; Fournie, Guillaume/0000-0002-6998-1201	French Agency for Development (AFD); National Institute of Veterinary Research; Department of Animal Health of Vietnam	This study was carried in the framework of the REVASIA project funded by the French Agency for Development (AFD). The study was officially supported by the National Institute of Veterinary Research and the Department of Animal Health of Vietnam. The authors thank all the participants involved in the different field studies and the sub-departments of agriculture and Sub-Departments of Animal Health of Hai Duong and Dong Nai province for their support.	Agrifood Consulting International, 2006, POULTR SECT REH PROJ; Bonacich P, 2001, SOC NETWORKS, V23, P191, DOI 10.1016/S0378-8733(01)00038-7; Catley A, 2012, VET J, V191, P151, DOI 10.1016/j.tvjl.2011.03.010; Csardi G., 2006, INT J COMPLEX SYST, V1695, P1695, DOI DOI 10.1080/01621459.1951.10500769; Department of Animal Health, 2011, 1109TYDT DEP AN HLTH; Desvaux S., 2011, B AEEMA, V59-60, P352; Dorea FC, 2011, PREV VET MED, V101, P1, DOI 10.1016/j.prevetmed.2011.05.004; ESRI, 2011, ARCGIS DESKT REL 10; Fournie G, 2013, P NATL ACAD SCI USA, V110, P9177, DOI 10.1073/pnas.1220815110; General Statistics Office of Vietnam, 2012, RES 2011 RUR AGR FIS; Hoinville L, 2011, PRE ICAHS WORKSH INT; Jackson MO, 2008, SOCIAL AND ECONOMIC NETWORKS, P1; MARD MOH, 2011, VIETN INT NAT OP PRO; Mariner J. C., 2000, MANUAL PARTICIPATORY; Mariner JC, 2014, ECOHEALTH, V11, P22, DOI 10.1007/s10393-014-0916-0; Minh PQ, 2011, SPAT SPATIO-TEMPORAL, V2, P49, DOI 10.1016/j.sste.2010.11.001; NSCAI, 2012, REP PREV CONTR AV IN; OIE World Organization for Animal Health, 2014, WORLD AN HLTH INF DA; R Core Team, 2014, R LANG ENV STAT COMP; Rasamoelina-Andriamanivo H, 2014, ACTA TROP, V135, P10, DOI 10.1016/j.actatropica.2014.03.008; Sadler GR, 2010, NURS HEALTH SCI, V12, P369, DOI 10.1111/j.1442-2018.2010.00541.x; Vallee E, 2013, VET J, V195, P59, DOI 10.1016/j.tvjl.2012.05.017; Wasserman S., 1994, SOCIAL NETWORK ANAL; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	24	5	5	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	JUL	2015	147						38	44		10.1016/j.actatropica.2015.03.025				7	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CJ4ZJ	WOS:000355496900007	25847263	Green Published			2019-04-02	
J	Shahabuddin, ASM; Delvaux, T; Abouchadi, S; Sarker, M; De Brouwere, V				Shahabuddin, A. S. M.; Delvaux, Therese; Abouchadi, Saloua; Sarker, Malabika; De Brouwere, Vincent			Utilization of maternal health services among adolescent women in Bangladesh: A scoping review of the literature	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Review						adolescent; pregnancy in adolescence; health-seeking behaviour or use of maternal health services; Bangladesh	RURAL BANGLADESH; DEVELOPING-COUNTRIES; ANTENATAL CARE; DELIVERY; DETERMINANTS; PREGNANCY; ASSOCIATION; MORTALITY; NEWBORN; MOTHERS	OBJECTIVE To understand the health-seeking behaviour of adolescent women in Bangladesh with respect to the use of maternal health services. METHODS Literature review of seven electronic databases: PubMed, ISI Web of Knowledge, PsycINFO, Embase, CINAHL, POPLINE and Global Health. Studies published in English between 1990 and 2013 which describe Bangladeshi adolescent women's healthcare-seeking behaviour during pregnancy, delivery and post-partum were included. RESULTS Twelve studies were included in this review. 11 used quantitative methods and one used a mixed-methods approach. All studies included married adolescent women only. Women with lower educational levels are less likely to seek skilled maternal health services than those with higher levels of education. Use of maternal health services is also less common among rural married adolescent women than women in urban areas. Being part of the richest bands of wealth, having had previous experiences of childbirth and higher women's autonomy positively influence the use of skilled maternal health services among married adolescent women in Bangladesh. Antenatal care is a key predictor of the use of skilled birth attendants for delivery and post-natal care. CONCLUSION Maternal health-related programmes should be designed targeting rural and uneducated married adolescent women in Bangladesh. More qualitative investigations are required to broaden our understanding on maternal health-seeking behaviour of both married and unmarried adolescent women.	[Shahabuddin, A. S. M.; Delvaux, Therese; Abouchadi, Saloua; De Brouwere, Vincent] Inst Trop Med, Woman & Child Hlth Res Ctr, B-2000 Antwerp, Belgium; [Abouchadi, Saloua] Ecole Natl Sante Publ, Rabat, Morocco; [Abouchadi, Saloua] Univ Libre Bruxelles, Sch Publ Hlth, Brussels, Belgium; [Sarker, Malabika] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh	Shahabuddin, ASM (reprint author), Inst Trop Med, Dept Publ Hlth, Woman & Child Hlth Res Ctr, Natl Str 155, B-2000 Antwerp, Belgium.	shahab@itg.be					Abu-Heija A, 2002, GYNECOL OBSTET INVES, V53, P90, DOI 10.1159/000053000; Ahmed S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011190; Anwar I, 2008, B WORLD HEALTH ORGAN, V86, P252, DOI 10.2471/BLT.07.042754; Arksey H, 2005, INT J SOC RES METHOD, V8, P19, DOI DOI 10.1080/1364557032000119616; Barkat A., 2003, ADOLESCENT REPROD HL; Basu AM, 2005, SOC SCI MED, V60, P2011, DOI 10.1016/j.socscimed.2004.08.057; Bosch AM, 2008, J BIOSOC SCI, V40, P223, DOI 10.1017/S0021932007002490; Chakraborty N, 2003, HEALTH PROMOT INT, V18, P327, DOI 10.1093/heapro/dag414; Child UN., 2014, 69 SESS NEW YORK GEN; Choudhury N, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-15; Chowdhury S, 2011, BJOG-INT J OBSTET GY, V118, P36, DOI 10.1111/j.1471-0528.2011.03111.x; De Brouwere V, 2010, TROP MED INT HEALTH, V15, P901, DOI 10.1111/j.1365-3156.2010.02558.x; Edmonds JK, 2012, MIDWIFERY, V28, P554, DOI 10.1016/j.midw.2011.12.004; El Arifeen S, 2013, LANCET, V382, P2012, DOI 10.1016/S0140-6736(13)62149-2; Godha D, 2013, J ADOLESCENT HEALTH, V52, P552, DOI 10.1016/j.jadohealth.2013.01.021; GOODBURN EA, 1995, STUD FAMILY PLANN, V26, P22, DOI 10.2307/2138048; Haque M., 2008, INTERNET J HLTH, V8; Haque SE, 2011, WOMEN HEALTH ISS, V22, pe171; Joffe H, 2004, RES METHODS CLIN HLT; Jolly MC, 2000, OBSTET GYNECOL, V96, P962, DOI 10.1016/S0029-7844(00)01075-9; Kamal S. M. M., 2009, Asian Population Studies, V5, P153, DOI 10.1080/17441730902992075; Kamal SMM, 2015, ASIA-PAC J PUBLIC HE, V27, pNP1467, DOI 10.1177/1010539513485786; Kamal SMM, 2013, J HEALTH POPUL NUTR, V31, P96; Keenan KF, 2005, J FAM PLAN REPROD H, V31, P40, DOI 10.1783/0000000052972825; Loto O M, 2004, J Obstet Gynaecol, V24, P395, DOI 10.1080/01443610410001685529; Mahavarkar SH, 2008, J OBSTET GYNAECOL, V28, P604, DOI 10.1080/01443610802281831; Mekonnen A., 2002, UTILIZATION MATERNAL; Mesko N., 2003, BMC INT HEALTH HUM R, V3, P3; Mrisho M, 2007, TROP MED INT HEALTH, V12, P862, DOI 10.1111/j.1365-3156.2007.01855.x; NIPORT, 2012, BANGL MAT HLTH CAR S; Overbosch GB, 2004, J AFR ECON, V13, P277, DOI 10.1093/jae/ejh008; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Rahman M, 2011, JOGNN-J OBST GYN NEO, V40, P262, DOI 10.1111/j.1552-6909.2011.01240.x; Rahman M, 2011, HEALTH SOC CARE COMM, V19, P138, DOI 10.1111/j.1365-2524.2010.00953.x; Rahman Mosiur, 2009, World Health Popul, V11, P5; Reynolds HW, 2006, INT FAM PLAN PERSPEC, V32, P6, DOI 10.1363/3200606; Sarin AR, 1997, WORLD HEALTH FORUM, V18, P67; Sayem AM, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-16; SCHOLL TO, 1994, J ADOLESCENT HEALTH, V15, P444, DOI 10.1016/1054-139X(94)90491-K; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; United Nations Fund for Population Activities (UNFPA), 2013, STAT WORLD POP 2013; Walton L. M., 2013, ONLINE J HLTH ETHICS, V9; WHO, 2012, 65 HLTH ASS ORG GEN; WHO, 2003, ANT CAR DEV COUNTR P	44	16	16	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	JUL	2015	20	7					822	829		10.1111/tmi.12503				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CJ7FY	WOS:000355661200001	25757880	Green Published, Bronze			2019-04-02	
J	Kaputu-Kalala-Malu, C; Kahamba, DM; Ntumba-Tahitenge, O; Musalu, EM; Ndahindwa, V; E-Andjafono, DOL; Kalula, TK; Mayamba, RMK; Misson, JP				Kaputu-Kalala-Malu, C.; Kahamba, Mukeba D.; Ntumba-Tahitenge, O.; Musalu, Mafuta E.; Ndahindwa, V; E-Andjafono, Okitundu Luwa D.; Kalula, Kayembe T.; Mayamba, Mukendi Kavulu R.; Misson, J. P.			Prolonged seizures in clhildren in sub-Saharan Africa Clinical aspects and management	MEDECINE ET SANTE TROPICALES			French	Article						children; prolonged seizures; sub-Saharan Africa; Democratic Republic of Congo; Rwanda		Background: There is a paucity of epidemiologic studies of prolonged seizures (persisting for more than 5 minutes) in the Democratic Republic of Congo (DRC) and in Rwanda. Objective: We sought to analyze the clinical presentation, causes, pharmacologic management, and short-term course of these seizures. Methods: We enrolled 436 children, aged five months to ten years, who presented with prolonged seizures at the pediatric emergency departments of nine hospitals. Findings: Overall, 57.8% of the children were younger than three years; 7% had pre-existing psychomotor delay. Although 21% had had previous seizures, only 13% were receiving antiepileptic therapy. On presentation, 63.5% of the patients had fever and 26% were in status epilepticus. The seizures were focal in 21% of the cases. Malaria was the most common cause, involving 63% of the cases. The recurrence rate was 38%, and the mortality rate 4%. Conclusion: Prolonged seizures in DRC and Rwanda are frequently associated with fever, most commonly caused by malaria. The immediate use of long-acting antiepileptic drug could improve their outcomes.	[Kaputu-Kalala-Malu, C.; Kahamba, Mukeba D.; E-Andjafono, Okitundu Luwa D.; Kalula, Kayembe T.] Univ Kinshasa, Serv Neurol Pediat, Dept Neurol, Ctr Neuropsychopathol,Fac Med, Kinshasa, DEM REP CONGO; [Kaputu-Kalala-Malu, C.; Misson, J. P.] Univ Liege, Serv Univ Pediat Neuropediat, CHR CHU Sart Tilman, B-4000 Liege, Belgium; [Ntumba-Tahitenge, O.] Univ Rwanda, Dept Pediat, Ctr Hosp Univ Butare, Butare, Rwanda; [Musalu, Mafuta E.] Univ Kinshasa, Ecole Sante Publ, Kinshasa, DEM REP CONGO; [Ndahindwa, V] Univ Rwanda, Coll Med & Hlth Sci, Sch Publ Hlth, Kigali, Rwanda; [Mayamba, Mukendi Kavulu R.] Hop St Joseph, Neurol Neuropediat, Mons, Belgium	Kaputu-Kalala-Malu, C (reprint author), Univ Kinshasa, Serv Neurol Pediat, Dept Neurol, Ctr Neuropsychopathol,Fac Med, Kinshasa, DEM REP CONGO.	ckaputukalalamalu@yahoo.fr					Bejon P, 2007, PLOS MED, V4, P1333, DOI 10.1371/journal.pmed.0040251; Berkley JA, 1999, QJM-INT J MED, V92, P151, DOI 10.1093/qjmed/92.3.151; Bosdure E., NEUROLOGIE PEDIAT, P403; Chandler CIR, 2008, HEALTH POLICY PLANN, V23, P170, DOI 10.1093/heapol/czm046; Chin JH, 2012, AFR HEALTH SCI, V12, P186, DOI 10.4314/ahs.v12i2.17; Clark IA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-85; Crawley J, 2000, LANCET, V355, P701, DOI 10.1016/S0140-6736(99)07148-2; De Waele L, 2013, ACTA NEUROL BELG, V113, P375, DOI 10.1007/s13760-013-0247-x; Gerardin P, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-51; Gwer S, 2007, AM J TROP MED HYG, V77, P6, DOI 10.4269/ajtmh.2007.77.6; Idro R, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-5; Kaputu Kalala Malu C, 2013, Rev Med Liege, V68, P180; Malu CKK, 2012, AFR J NEUROL SCI, V31, P23; Kariuki SM, 2011, BRAIN, V134, P1519, DOI 10.1093/brain/awr051; Kokwaro GO, 2003, BRIT J CLIN PHARMACO, V56, P453, DOI 10.1046/j.1365-2125.2003.01951.x; Laman M, 2010, CLIN INFECT DIS, V51, P534, DOI 10.1086/655679; Mafuta EM, 2012, ANN AFR MED, V5, P1106; MEREMIKWU M, 2002, COCHRANE DB SYST REV, V2; Newton CR, 2013, EPILEPSIA, V54, P50, DOI 10.1111/epi.12277; Newton CRJC, 2009, EPILEPSIA, V50, P54, DOI 10.1111/j.1528-1167.2009.02364.x; Ngoungou E B, 2006, Sante, V16, P225; Nguefack S, 2010, ARCH PEDIATRIE, V17, P480, DOI 10.1016/j.arcped.2010.02.018; Ngugi AK, 2013, LANCET NEUROL, V12, P253, DOI 10.1016/S1474-4422(13)70003-6; Ofovwe GE, 2002, J NEUROL SCI, V200, P49, DOI 10.1016/S0022-510X(02)00128-4; Preux PM, 2005, LANCET NEUROL, V4, P21, DOI 10.1016/S1474-4422(04)00963-9; Prevett Martin, 2013, Pract Neurol, V13, P14, DOI 10.1136/practneurol-2012-000388; Rakhade SN, 2009, NAT REV NEUROL, V5, P380, DOI 10.1038/nrneurol.2009.80; SANDER JWAS, 1987, J NEUROL NEUROSUR PS, V50, P829, DOI 10.1136/jnnp.50.7.829; Schubart CD, 2006, AM J TROP MED HYG, V75, P1148, DOI 10.4269/ajtmh.2006.75.1148; Schumacher RF, 2012, MEDITERR J HEMATOL I, V4, DOI 10.4084/MJHID.2012.073; Shinnar S, 2007, J CHILD NEUROL, V22, p14S, DOI 10.1177/0883073807303065; Sodarangani M, 2008, LANCET NEUROL, V7, P145, DOI [10.1016/S1474-4422(07)70331-9, 10.1016/SI474-4422(07)70331-9]; U.S. National Institute of Neurological Disorders and Stroke (NINDS), ENT LEV SEIZ CONTR P; Wilmshurst JM, 2005, SAMJ S AFR MED J, V95, P422; Wilmshurst JM, 2011, J CHILD NEUROL, V26, P1555, DOI 10.1177/0883073811420601; World Health Organization (WHO), GUID TREATM MAL; Wu LM, 2012, NEUROL SCI, V33, P1469, DOI 10.1007/s10072-012-0985-1	37	1	1	0	0	JOHN LIBBEY EUROTEXT LTD	MONTROUGE	127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE	2261-3684	2261-2211		MED SANTE TROP	Med. Sante Trop.	JUL-SEP	2015	25	3					306	311		10.1684/mst.2015.0469				6	Tropical Medicine	Tropical Medicine	VD6QR	WOS:000437429300018	26102636				2019-04-02	
J	Tahita, MC; Tinto, H; Yarga, S; Kazienga, A; Coulibaly, MT; Valea, I; Van Overmeir, C; Rosanas-Urgell, A; Ouedraogo, JB; Guiguemde, RT; van Geertruyden, JP; Erhart, A; D'Alessandro, U				Tahita, Marc C.; Tinto, Halidou; Yarga, Sibiri; Kazienga, Adama; Coulibaly, Maminata Traore; Valea, Innocent; Van Overmeir, Chantal; Rosanas-Urgell, Anna; Ouedraogo, Jean-Bosco; Guiguemde, Robert T.; van Geertruyden, Jean-Pierre; Erhart, Annette; D'Alessandro, Umberto			Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina Faso	MALARIA JOURNAL			English	Article							ARTEMISININ-RESISTANT MALARIA; IN-VITRO SUSCEPTIBILITY; DIHYDROARTEMISININ-PIPERAQUINE; ARTEMETHER-LUMEFANTRINE; SULFADOXINE-PYRIMETHAMINE; CHLOROQUINE USE; COMBINATION; MALAWI; ARTESUNATE; QINGHAOSU	Background: Ex vivo assays are usually carried out on parasite isolates collected from patients with uncomplicated Plasmodium falciparum malaria, from which pregnant women are usually excluded as they are often asymptomatic and with relatively low parasite densities. Nevertheless, P. falciparum parasites infecting pregnant women selectively sequester in the placenta and may have a different drug sensitivity profile compared to those infecting other patients. The drug sensitivity profile of P. falciparum isolates from infected pregnant women recruited in a treatment efficacy trial conducted in Burkina Faso was determined in an ex vivo study. Methods: The study was conducted between October 2010 and December 2012. Plasmodium falciparum isolates were collected before treatment and at the time of any recurrent infection whose parasite density was at least 100/mu l. A histidine-rich protein-2 assay was used to assess their susceptibility to a panel of seven anti-malarial drugs. The concentration of anti-malarial drug inhibiting 50% of the parasite maturation to schizonts (IC50) for each drug was determined with the IC Estimator version 1.2. Results: The prevalence of resistant isolates was 23.5% for chloroquine, 9.2% for mefloquine, 8.0% for monodesethylamodiaquine, and 4.4% for quinine. Dihydroartemisinin, mefloquine, lumefantrine, and monodesethylamodiaquine had the lowest mean IC50 ranging between 1.1 and 1.5 nM respectively. The geometric mean IC50 of the tested drugs did not differ between chloroquine-sensitive and resistant parasites, with the exception of quinine, for which the IC50 was higher for chloroquine-resistant isolates. The pairwise comparison between the IC50 of the tested drugs showed a positive and significant correlation between dihydroartemisinin and both mefloquine and chloroquine, between chloroquine and lumefantrine and between monodesethylamodiaquine and mefloquine. Conclusion: These ex vivo results suggest that treatment with the currently available artemisinin-based combinations is efficacious for the treatment of malaria in pregnancy in Burkina Faso.	[Tahita, Marc C.; Tinto, Halidou; Coulibaly, Maminata Traore; Ouedraogo, Jean-Bosco] IRSS DRO, Bobo Dioulasso, Burkina Faso; [Tahita, Marc C.; Tinto, Halidou; Kazienga, Adama; Coulibaly, Maminata Traore; Valea, Innocent; Ouedraogo, Jean-Bosco; Guiguemde, Robert T.] IRSS, CRUN, Nanoro, Burkina Faso; [Tinto, Halidou; Yarga, Sibiri; Valea, Innocent; Guiguemde, Robert T.] Ctr Muraz, Unite Rech Paludisme & Malad Trop Negligees, Bobo Dioulasso, Burkina Faso; [Tahita, Marc C.; Van Overmeir, Chantal; Rosanas-Urgell, Anna; Erhart, Annette; D'Alessandro, Umberto] Inst Trop Med, Malariol Unit, B-2000 Antwerp, Belgium; [Guiguemde, Robert T.] Inst Super Sci Sante INSSA, Bobo Dioulasso, Burkina Faso; [Tahita, Marc C.; van Geertruyden, Jean-Pierre] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium; [D'Alessandro, Umberto] MRC Unit, Fajara, Gambia; [D'Alessandro, Umberto] London Sch Hyg & Trop Med, London WC1, England	Tahita, MC (reprint author), IRSS DRO, Bobo Dioulasso, Burkina Faso.	marctahita@yahoo.fr	Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Tinto, Halidou/0000-0002-0472-3586	Bill and Melinda Gates Foundation (BMGF); Malaria in Pregnancy (MiP) Consortium; EDCTP	This publication is supported by the Malaria in Pregnancy (MiP) Consortium, which is funded through a grant from EDCTP and co-funding from Bill and Melinda Gates Foundation (BMGF).	Ashley EA, 2005, CURR OPIN INFECT DIS, V18, P531, DOI 10.1097/01.qco.0000186848.46417.6c; Bardaji A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-27; Basco LK, 2007, AM J TROP MED HYG, V76, P20, DOI 10.4269/ajtmh.2007.76.20; BASCO LK, 1994, ANN TROP MED PARASIT, V88, P137, DOI 10.1080/00034983.1994.11812851; Bassat Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007871; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Fall B, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-310; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Frosch AEP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-116; Gansane A, 2009, Bull Soc Pathol Exot, V102, P31, DOI 10.3185/pathexo3235; HIEN TT, 1993, LANCET, V341, P603; Kublin JG, 2003, J INFECT DIS, V187, P1870, DOI 10.1086/375419; Laufer MK, 2006, NEW ENGL J MED, V355, P1959, DOI 10.1056/NEJMoa062032; Mwai L, 2009, ANTIMICROB AGENTS CH, V53, P5069, DOI 10.1128/AAC.00638-09; Nambozi M, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-5; Noedl H, 2007, ANTIMICROB AGENTS CH, V51, P651, DOI 10.1128/AAC.01023-06; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Noedl H, 2009, NEW ENGL J MED, V361, P540, DOI 10.1056/NEJMc0900231; Nosten F, 2007, AM J TROP MED HYG, V77, P181, DOI 10.4269/ajtmh.2007.77.181; Nunes MC, 2007, PARASITOLOGY, V134, P1863, DOI 10.1017/S0031182007000133; Parzy D, 1997, AM J TROP MED HYG, V57, P646, DOI 10.4269/ajtmh.1997.57.646; Pascual A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-189; Pfeiffer K, 2008, TROP MED INT HEALTH, V13, P418, DOI 10.1111/j.1365-3156.2008.02017.x; Quashie NB, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-450; Ringwald P, 1999, AM J TROP MED HYG, V61, P187, DOI 10.4269/ajtmh.1999.61.187; Some AF, 2010, ANTIMICROB AGENTS CH, V54, P1949, DOI 10.1128/AAC.01413-09; Steketee RW, 1996, AM J TROP MED HYG, V55, P33, DOI 10.4269/ajtmh.1996.55.33; Tahita MC, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-464; Takala-Harrison S, 2015, J INFECT DIS, V211, P670, DOI 10.1093/infdis/jiu491; Tinto H, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-207; Ward SA, 2007, LANCET INFECT DIS, V7, P136, DOI 10.1016/S1473-3099(07)70025-7; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; White NJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S8; WHO, 2010, GUID TREATM MAL, P13; WHO, 2011, CONT MAL MULT RES CA; WHO, 2014, MAL STAT REP ART RES; Wongsrichanalai C, 2008, EMERG INFECT DIS, V14, P716, DOI 10.3201/eid1405.071601; Zongo I, 2007, CLIN INFECT DIS, V45, P1453, DOI 10.1086/522985	40	1	1	0	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	JUN 20	2015	14								251	10.1186/s12936-015-0769-1				6	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CK9VQ	WOS:000356588000001	26088768	DOAJ Gold, Green Published			2019-04-02	
J	Karanikola, SN; Krucken, J; Ramuenke, S; de Waal, T; Hoglund, J; Charlier, J; Weber, C; Muller, E; Kowalczyk, SJ; Kaba, J; von Samson-Himmelstjerna, G; Demeler, J				Karanikola, Sofia N.; Kruecken, Juergen; Ramuenke, Sabrina; de Waal, Theo; Hoeglund, Johan; Charlier, Johannes; Weber, Corinna; Mueller, Elisabeth; Kowalczyk, Slawomir J.; Kaba, Jaroslaw; von Samson-Himmelstjerna, Georg; Demeler, Janina			Development of a multiplex fluorescence immunological assay for the simultaneous detection of antibodies against Cooperia oncophora, Dictyocaulus viviparus and Fasciola hepatica in cattle	PARASITES & VECTORS			English	Article						Parasitic gastroenteritis; Lungworm; Liver fluke; Luminex; Multiplex immunoassays; Serum; Cattle; Diagnosis	LINKED-IMMUNOSORBENT-ASSAY; FLOW-CYTOMETRIC ASSAY; ADULT DAIRY-COWS; SIMULTANEOUS QUANTITATION; MICROSPHERE IMMUNOASSAY; INFLAMMATORY CYTOKINES; XMAP(TM) TECHNOLOGY; LUNGWORM INFECTION; MOLECULAR METHOD; CATHEPSIN L1	Background: A major constraint for the effective control and management of helminth parasites is the lack of rapid, high-throughput, routine diagnostic tests to assess the health status of individual animals and herds and to identify the parasite species responsible for these helminthoses. The capability of a multiplex platform for the simultaneous detection of three pasture associated parasite species was evaluated and compared to existing ELISAs. Methods: The recombinant antigens 14.2 kDa ES protein for Cooperia oncophora, major sperm protein for Dictyocaulus viviparus and Cathepsin L1 for Fasciola hepatica were recombinantly expressed either in Escherichia coli or Pichia pastoris. Antigens were covalently coupled onto magnetic beads. Optimal concentrations for coupling were determined following the examination of serum samples collected from experimentally mono-infected animals, before and after their infection with the target species. Absence of cross-reactivity was further determined with sera from calves mono-infected with Haemonchus contortus, Ostertagia ostertagi and Trichostrongylus colubriformis. Examination of negative serum samples was characterised by low median fluorescence intensity (MFI). Results: Establishment of the optimal serum dilution of 1:200 was achieved for all three bead sets. Receiver Operating Characteristic analyses were performed to obtain cut-off MFI values for each parasite separately. Sensitivity and specificity at the chosen cut-off values were close to, or 100 % for all bead sets. Examination of serum samples collected on different days post infection from different animals showed a high reproducibility of the assays. Serum samples were additionally examined with two already established ELISAs, an in-house ELISA using the recombinant MSP as an antigen and a DRG ELISA using Cathepsin L1 for liver fluke. The results between the assays were compared and kappa tests revealed an overall good agreement. Conclusions: A versatile bead-based assay using fluorescence detection (xMAP (R) technology) was developed to simultaneously detect antibodies against C. oncophora, D. viviparus and F. hepatica in cattle serum samples. This platform provides rapid, high-throughput results and is highly sensitive and specific in comparison to existing serological as well as coproscopical diagnostic techniques.	[Karanikola, Sofia N.; Kruecken, Juergen; Ramuenke, Sabrina; von Samson-Himmelstjerna, Georg; Demeler, Janina] Free Univ Berlin, Inst Parasitol & Trop Vet Med, Berlin, Germany; [de Waal, Theo] Univ Coll Dublin, Sch Agr Food Sci & Vet Med, Dublin 2, Ireland; [Hoeglund, Johan] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Sect Parasitol SWEPAR, Uppsala, Sweden; [Charlier, Johannes] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, B-9000 Ghent, Belgium; [Weber, Corinna; Mueller, Elisabeth] LABOKLIN GMBH & Co KG, Bad Kissingen, Germany; [Kowalczyk, Slawomir J.; Kaba, Jaroslaw] Warsaw Univ Life Sci, Fac Vet Med, Lab Vet Epidemiol & Econ, Warsaw, Poland	Demeler, J (reprint author), Free Univ Berlin, Inst Parasitol & Trop Vet Med, Berlin, Germany.	j.demeler@fu-berlin.de	von Samson, Georg/R-1123-2016; Krucken, Jurgen/B-6794-2009	Krucken, Jurgen/0000-0002-2842-8100; Ramunke, Sabrina/0000-0003-0195-4175; de Waal, Theo/0000-0002-9657-1857; Kaba, Jaroslaw/0000-0002-7977-9875; Charlier, Johannes/0000-0002-1332-1458	EU [288975]	The financial support from the EU funded FP 7 project GLOWORM (KBBE 2011.1.3-04, No 288975) is gratefully acknowledged.	Baker HN, 2012, JOVE-J VIS EXP, DOI 10.3791/4084; Barda BD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002344; BISSET SA, 1994, NEW ZEAL J ZOOL, V21, P9, DOI 10.1080/03014223.1994.9517972; Bjerre M, 2009, VET IMMUNOL IMMUNOP, V130, P53, DOI 10.1016/j.vetimm.2009.01.007; Bokken GCAM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-36; Bongoni AK, 2013, CYTOM PART A, V83A, P636, DOI 10.1002/cyto.a.22287; BOON JH, 1986, VET REC, V119, P475, DOI 10.1136/vr.119.19.475; BOS HJ, 1985, DEV BIOL STAND, V62, P45; Bott NJ, 2009, INT J PARASITOL, V39, P1277, DOI 10.1016/j.ijpara.2009.03.002; Carson RT, 1999, J IMMUNOL METHODS, V227, P41, DOI 10.1016/S0022-1759(99)00069-1; Charlier J, 2014, PARASITOLOGY, V141, P326, DOI 10.1017/S0031182013001662; Charlier J, 2008, VET PARASITOL, V153, P44, DOI 10.1016/j.vetpar.2008.01.035; Charlier J, 2009, VET PARASITOL, V164, P70, DOI 10.1016/j.vetpar.2009.04.012; Christopher-Hennings J, 2013, J VET DIAGN INVEST, V25, P671, DOI 10.1177/1040638713507256; Coles GC, 2002, VET RES, V33, P481, DOI 10.1051/vetres:2002034; Collins PR, 2004, J BIOL CHEM, V279, P17038, DOI 10.1074/jbc.M308831200; Cornelissen JBWJ, 1997, VET PARASITOL, V70, P153, DOI 10.1016/S0304-4017(96)01141-7; Demeler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061285; Dernfalk J, 2007, VET IMMUNOL IMMUNOP, V118, P40, DOI 10.1016/j.vetimm.2007.04.004; Dimander SO, 2000, VET PARASITOL, V90, P271, DOI 10.1016/S0304-4017(00)00256-9; Ducheyne E, 2015, GEOSPATIAL HEALTH, V9, P261, DOI 10.4081/gh.2015.348; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; Earley MC, 2002, CYTOMETRY, V50, P239, DOI 10.1002/cyto.10140; Elshal MF, 2006, METHODS, V38, P317, DOI 10.1016/j.ymeth.2005.11.010; Furst T, 2012, LANCET INFECT DIS, V12, P210, DOI 10.1016/S1473-3099(11)70294-8; Fulton RJ, 1997, CLIN CHEM, V43, P1749; Gibb MJ, 2005, VET PARASITOL, V133, P79, DOI 10.1016/j.vetpar.2004.11.038; Go YY, 2008, CLIN VACCINE IMMUNOL, V15, P76, DOI 10.1128/CVI.00388-07; Gozdzik K, 2012, RES VET SCI, V93, P813, DOI 10.1016/j.rvsc.2011.09.016; Holzhauer M, 2011, VET REC, V169, P494, DOI 10.1136/vr.d4736; Johannisson A, 2006, CYTOM PART A, V69A, P391, DOI 10.1002/cyto.a.20271; Kettman JR, 1998, CYTOMETRY, V33, P234, DOI 10.1002/(SICI)1097-0320(19981001)33:2<234::AID-CYTO19>3.0.CO;2-V; Klein DL, 2012, CLIN VACCINE IMMUNOL, V19, P1276, DOI 10.1128/CVI.05535-11; Kuerpick B, 2013, VET PARASITOL, V193, P206, DOI 10.1016/j.vetpar.2012.11.021; Lal G, 2005, J IMMUNOL METHODS, V296, P135, DOI 10.1016/j.jim.2004.11.006; Langenhorst RJ, 2012, CLIN VACCINE IMMUNOL, V19, P180, DOI 10.1128/CVI.05372-11; MARIUS V, 1979, ANN RECH VET, V10, P55; Morgan ER, 2013, AGRICULTURE-BASEL, V3, P484, DOI 10.3390/agriculture3030484; Nieuwhof GJ, 2005, ANIM SCI, V81, P23, DOI 10.1079/ASC41010023; Perraut R, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-410; Perry BD, 1999, VET PARASITOL, V84, P145, DOI 10.1016/S0304-4017(99)00040-0; Pickering JW, 2002, CLIN DIAGN LAB IMMUN, V9, P872, DOI 10.1128/CDLI.9.4.872-876.2002; Piekarska J, 2013, VET PARASITOL, V198, P250, DOI 10.1016/j.vetpar.2013.07.039; PLOEGER HW, 1994, VET PARASITOL, V55, P287, DOI 10.1016/0304-4017(94)90071-X; Poot J, 1997, J CLIN MICROBIOL, V35, P1728; Roeber F, 2011, INFECT GENET EVOL, V11, P849, DOI 10.1016/j.meegid.2011.01.013; Rojas CAA, 2014, ADV PARASIT, V85, P65, DOI 10.1016/B978-0-12-800182-0.00002-7; Salimi-Bejestani MR, 2005, RES VET SCI, V78, P177, DOI 10.1016/j.rvsc.2004.08.005; Sanchez J, 2004, PREV VET MED, V63, P237, DOI 10.1016/j.prevetmed.2004.01.006; SCHNIEDER T, 1992, PARASITOL RES, V78, P298, DOI 10.1007/BF00937087; Schunn AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074429; Schweizer G, 2005, VET REC, V157, P188, DOI 10.1136/vr.157.7.188; Spithill TW, 1999, FASCIOLOSIS, P377; Strube C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0733-5; Tighe PJ, 2015, PROTEOM CLIN APPL, V9, P406, DOI 10.1002/prca.201400130; van der Wal FJ, 2013, VET J, V196, P439, DOI 10.1016/j.tvjl.2012.10.029; von Holtum C, 2008, VET PARASITOL, V151, P218, DOI 10.1016/j.vetpar.2007.11.006; Willman JH, 2001, AM J CLIN PATHOL, V115, P764, DOI 10.1309/3F13-739A-NA7F-NV3X; Wyns H, 2013, VET IMMUNOL IMMUNOP, V151, P28, DOI 10.1016/j.vetimm.2012.09.041	59	10	10	0	27	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	JUN 19	2015	8								335	10.1186/s13071-015-0924-0				11	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CM1VY	WOS:000357469800001	26084663	DOAJ Gold, Green Published			2019-04-02	
J	Ghosh, P; Hasnain, MG; Ghosh, D; Hossain, F; Baker, J; Boelaert, M; Rijal, S; Mondal, D				Ghosh, Prakash; Hasnain, Md Golam; Ghosh, Debashis; Hossain, Faria; Baker, James; Boelaert, Marleen; Rijal, Suman; Mondal, Dinesh			A comparative evaluation of the performance of commercially available rapid immunochromatographic tests for the diagnosis of visceral leishmaniasis in Bangladesh	PARASITES & VECTORS			English	Article						Immunochromatographic test; Diagnosis; Visceral leishmaniasis; Bangladesh		Background: Accurate and early diagnosis of Visceral Leishmaniasis (VL) is a prerequisite for proper treatment and restricting disease propagation in enldemic foci. An rK39 antigen-based immunochromatographic test is now recommended for its diagnostic accuracy and operational feasibility at point of care. In endemic regions of Bangladesh, rK39 or rKE16 antigen-based Rapid Diagnostic Tests (RDTs) are routinely performed on whole blood for diagnosis of VL. However, manufacturer's instructions require use of serum. Therefore, we wanted to assess whether the diagnostic accuracy of these RDTs is as good on whole blood as on serum. Methods: We evaluated and compared the sensitivity and specificity of five different commercially available RDTs on whole blood and on serum. We enrolled 30 VL patients, 35 endemic healthy controls and 30 Tuberculosis (TB) patients in our study from Mymensingh, a hyper-endemic region in Bangladesh. Results: The sensitivity of all RDTs ranged between 96.67 % (95 % CI: 82.72-99.44 %) and 100 % (95 % CI: 96.34-100 %). The specificity ranged between 93.85 % (95 % CI: 84.97-98.26 %) and 98.46 % (95 % CI: 91.69-99.74 %), except for the Onsite leishmania Ab (Rev B) kit which showed markedly lower specificity (31.25-58.46 %). There was no significant difference in sensitivity and specificity between blood and serum. The Cohen kappa index (k >0.97) indicated excellent agreement. Conclusions: We conclude from the study that the use of blood for RDT in lieu of serum is appropriate for diagnosis of VL in peripheral endemic regions provided the manufacturer recommendations are followed and the RDT is of good quality.	[Ghosh, Prakash; Hasnain, Md Golam; Hossain, Faria; Baker, James; Mondal, Dinesh] Int Ctr Diarrheal Dis Res, Ctr Nutr & Food Secur, Dhaka, Bangladesh; [Ghosh, Debashis] Int Ctr Diarrheal Dis Res, Ctr Populat Urbanizat & Climate Change, Dhaka, Bangladesh; [Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, Antwrep, Belgium; [Rijal, Suman] Drugs Neglected Dis Initiat, New Delhi, India	Mondal, D (reprint author), Int Ctr Diarrheal Dis Res, Ctr Nutr & Food Secur, Dhaka, Bangladesh.	din63d@icddrb.org		Boelaert, Marleen/0000-0001-8051-6776	NIAID, NIH [P50AI074321]; Belgian Development Cooperation; Strategic Project "3.04 VL control"	The authors would like to thank all the participants for their valuable participation into the research. The authors would also like to thank all the staff of the Kala Azar Research Team, Parasitology Laboratory, icddrb for their assistance in collection of the samples used in this evaluation. This work was supported by NIAID, NIH Grant Number: P50AI074321. The study was also supported by a grant from the Belgian Development Cooperation under the 3rd Framework Agreement DGDC-ITM, Strategic Project "3.04 VL control".	[Anonymous], 2008, US VISC LEISHM RAP D, DOI [10.2471/TDR.08.978-924-1597357, DOI 10.2471/TDR.08.978-924-1597357]; Boelart M, 2007, NATURE REV MICROBIOL, V1, pS30, DOI DOI 10.1038/NRMICRO1766; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Cota GF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001665; Cunningham J, 2012, CLIN INFECT DIS, V55, P1312, DOI 10.1093/cid/cis716; Ferdousi Farhana, 2012, Trop Med Health, V40, P133, DOI 10.2149/tmh.2012-25; Gupta A, 2015, INT J TROP DIS HLTH, V3, P73; Hasnain MG, 2014, CLIN CASE REP, V2, P331, DOI 10.1002/ccr3.130; Hasnain MG, 2014, AM J TROP MED HYG, V91, P342, DOI 10.4269/ajtmh.13-0530; Khan Md Gulam Musawwir, 2011, J Parasitol Res, V2011, P862475, DOI 10.1155/2011/862475; Kumar D, 2014, J CLIN MICROBIOL JCM; Matlashewski G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002233; Mbui J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002441; Perez-Molina J. A., 1999, Clinical Microbiology and Infection, V5, P253, DOI 10.1111/j.1469-0691.1999.tb00137.x; Rennie W, 2007, T ROY SOC TROP MED H, V101, P9, DOI 10.1016/j.trstmh.2006.03.011; Sundar S, 2002, CLIN DIAGN LAB IMMUN, V9, P951, DOI 10.1128/CDLI.9.5.951-958.2002	16	4	4	1	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	JUN 16	2015	8								331	10.1186/s13071-015-0935-x				6	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CL0XY	WOS:000356667600003	26077956	DOAJ Gold, Green Published			2019-04-02	
J	Braae, UC; Saarnak, CFL; Mukaratirwa, S; Devleesschauwer, B; Magnussen, P; Johansen, MV				Braae, Uffe Christian; Saarnak, Christopher F. L.; Mukaratirwa, Samson; Devleesschauwer, Brecht; Magnussen, Pascal; Johansen, Maria Vang			Taenia solium taeniosis/cysticercosis and the co-distribution with schistosomiasis in Africa	PARASITES & VECTORS			English	Article						African pig population; Co-distribution; Cysticercosis; Mapping; Prevalence; Schistosomiasis; Taenia solium	PORCINE HELMINTH INFECTIONS; EASTERN CAPE PROVINCE; NORTH-WEST CAMEROON; 2 RURAL-AREAS; RISK-FACTORS; BURKINA-FASO; SOUTH-AFRICA; HUMAN CYSTICERCOSIS; SCHOOL-CHILDREN; HIGH PREVALENCE	Background: This study aimed to map the distribution of Taenia solium taeniosis/cysticercosis and the co-distribution with schistosomiasis in Africa. These two major neglected tropical diseases are presumed to be widely distributed in Africa, but currently the level of co-distribution is unclear. Methods: A literature search on T. solium taeniosis/cysticercosis was performed to compile all known studies on the presence of T. solium and apparent prevalence of taeniosis and porcine cysticercosis in Africa. Studies were geo-referenced using an online gazetteer. A Bayesian framework was used to combine the epidemiological data on the apparent prevalence with external information on test characteristics to estimate informed district-level prevalence of taeniosis and porcine cysticercosis. Districts with T. solium taeniosis/cysticercosis presence were cross-referenced with the Global Neglected Tropical Diseases Database for schistosomiasis presence. Results: The search strategies identified 141 reports of T. solium in Africa from 1985 to 2014 from a total of 476 districts in 29 countries, 20 with porcine cysticercosis, 22 with human cysticercosis, and 16 with taeniosis, in addition to 2 countries identified from OIE reports. All 31 countries were considered, on national scale, to have co-distribution with schistosomiasis. Presence of both parasites was confirmed in 124 districts in 17 countries. The informed prevalence of taeniosis and porcine cysticercosis were estimated for 14 and 41 districts in 10 and 13 countries, respectively. Conclusions: With the paucity of data, T. solium infection is grossly under-reported and expected to be more widespread than this study suggests. In areas where co-distribution occurs there is a need for increased emphasis on evaluation of integrated intervention approaches for these two helminth infections and allocation of resources for evaluating the extent of adverse effects caused by mass drug administration.	[Braae, Uffe Christian; Saarnak, Christopher F. L.; Magnussen, Pascal; Johansen, Maria Vang] Univ Copenhagen, Fac Hlth & Med Sci, Sect Parasitol & Aquat Dis, Dept Vet Dis Biol, DK-1870 Frederiksberg, Denmark; [Mukaratirwa, Samson] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa; [Devleesschauwer, Brecht] Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, B-9820 Merelbeke, Belgium; [Devleesschauwer, Brecht] Catholic Univ Louvain, Inst Hlth & Soc IRSS, B-1200 Brussels, Belgium; [Magnussen, Pascal] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Med Parasitol, DK-1353 Copenhagen, Denmark	Braae, UC (reprint author), Univ Copenhagen, Fac Hlth & Med Sci, Sect Parasitol & Aquat Dis, Dept Vet Dis Biol, DK-1870 Frederiksberg, Denmark.	braae@sund.ku.dk	Mukaratirwa, Samson/E-9752-2010; Braae, Uffe/J-4720-2017; Devleesschauwer, Brecht/G-9895-2018	Mukaratirwa, Samson/0000-0001-6843-1497; Braae, Uffe/0000-0002-2743-4584; Devleesschauwer, Brecht/0000-0002-2867-6892; Magnussen, Pascal/0000-0001-7372-0250			Adjide CC, 1996, B SOC PATHOL EXOT, V89, P24; Agbolade Olufemi Moses, 2007, Korean Journal of Parasitology, V45, P233, DOI 10.3347/kjp.2007.45.3; AKOGUN OB, 1989, J TROP MED HYG, V92, P193; Al Shahrani D, 2003, J TROP PEDIATRICS, V49, P58, DOI 10.1093/tropej/49.1.58; Andriantsimahavandy A, 1997, TROP MED INT HEALTH, V2, P741, DOI 10.1046/j.1365-3156.1997.d01-379.x; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P25; [Anonymous], 2009, COUNTRIES AREAS RISK; Anyanzo T, 1999, BACHELOR VET MED SPE; Assana E., 2001, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V54, P123; Assana E, 2010, J HELMINTHOL, V84, P441, DOI 10.1017/S0022149X10000167; Avode DG, 1998, EUR NEUROL, V39, P60; BAILY GG, 1989, T ROY SOC TROP MED H, V83, P95, DOI 10.1016/0035-9203(89)90723-2; Balogou AAK, 2000, REV NEUROL-FRANCE, V156, P270; Barba G, 1999, ARCH PEDIATRIE, V6, P315, DOI 10.1016/S0929-693X(99)80272-3; Barro-Traore F, 2008, Bull Soc Pathol Exot, V101, P17; BEGG CB, 1987, STAT MED, V6, P411, DOI 10.1002/sim.4780060402; Belo M, 2001, REV NEUROL-FRANCE, V157, P433; Berkvens D, 2006, EPIDEMIOLOGY, V17, P145, DOI 10.1097/01.ede.0000198422.64801.8d; Bernardin P, 1994, Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique, V71, P103; Biu A. A., 2012, Sokoto Journal of Veterinary Sciences, V10, P28, DOI 10.4314/sokjvs.v10i1.6; Blocher J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001185; Boa ME, 2006, VET PARASITOL, V139, P249, DOI 10.1016/j.vetpar.2006.02.012; Boa ME, 2002, VET PARASITOL, V106, P155, DOI 10.1016/S0304-4017(02)00037-7; BOA ME, 1995, J HELMINTHOL, V69, P113, DOI 10.1017/S0022149X00013997; Braae UC, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0574-7; Buchy P, 2003, Bull Soc Pathol Exot, V96, P41; Carabin H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000555; CARSTENSEN H, 1987, T ROY SOC TROP MED H, V81, P860, DOI 10.1016/0035-9203(87)90054-X; Chartier C, 1990, ANN SOC BELG MED TR, P213; Cortnum Soren, 2011, Ugeskr Laeger, V173, P2203; Deckers N, 2010, TRENDS PARASITOL, V26, P137, DOI 10.1016/j.pt.2009.12.008; Devleesschauwer B, 2014, PREVALENCE TOOLS PRE; Devleesschauwer B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002634; Devleesschauwer B, 2012, TROP MED INT HEALTH, V17, P1019, DOI 10.1111/j.1365-3156.2012.03017.x; Diagana M, 2005, NEUROPHYSIOL CLIN, V35, P1, DOI 10.1016/j.neucli.2004.12.002; Dongmo L, 2004, Bull Soc Pathol Exot, V97, P105; Dorny P, 2004, INT J PARASITOL, V34, P569, DOI 10.1016/j.ijpara.2003.11.014; Druet-Cabanac M, 1999, AM J EPIDEMIOL, V149, P565; DUMAS M, 1990, B SOC PATHOL EXOT, V83, P263; DUMAS M, 1989, Acta Leidensia, V57, P191; Ekpo UF, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000146; Elliott I, 2013, SEIZURE-EUR J EPILEP, V22, P283, DOI 10.1016/j.seizure.2013.01.012; Eom KS, 2011, KOREAN J PARASITOL, V49, P399, DOI 10.3347/kjp.2011.49.4.399; Eshitera EE, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-234; EVANS AC, 1989, T ROY SOC TROP MED H, V83, P681, DOI 10.1016/0035-9203(89)90397-0; FLISSER A, 1993, LANCET, V342, P748, DOI 10.1016/0140-6736(93)91743-6; Fortunato S, 2014, J INFECT DEV COUNTR, V8, P670, DOI 10.3855/jidc.3660; Foyaca-Sibat H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000562; Ganaba R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000927; Garcia HH, 2003, LANCET, V362, P547, DOI 10.1016/S0140-6736(03)14117-7; Gascon J, 1989, Med Trop (Mars), V49, P77; Githigia S, 2007, KENYA VET, V29, P37; GONZALEZ AE, 1990, AM J TROP MED HYG, V43, P194, DOI 10.4269/ajtmh.1990.43.194; Goussanou JSE, 2013, INT RES J MICROBIOL, V4, P188; Greiner M, 2000, PREV VET MED, V45, P3, DOI 10.1016/S0167-5877(00)00114-8; Grill J, 1996, ANN TROP PAEDIATR, V16, P185, DOI 10.1080/02724936.1996.11747824; GRUNITZKY E, 1995, ANN MED INTERNE, V146, P419; Gweba M, 2010, VET ITAL, V46, P57; Haridy Fouad M., 1999, Journal of the Egyptian Society of Parasitology, V29, P375; Hira PR, 2004, T ROY SOC TROP MED H, V98, P233, DOI 10.1016/S0035-9203(03)00061-0; Houinato D, 1998, T ROY SOC TROP MED H, V92, P621, DOI 10.1016/S0035-9203(98)90785-4; Hurlimann E, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001404; Kabatereine NB, 1997, E AFR MED J, V74, P311; Kagira JM, 2010, J HELMINTHOL, V84, P398, DOI 10.1017/S0022149X10000076; Kanobana K, 2011, INT J PARASITOL, V41, P1015, DOI 10.1016/j.ijpara.2011.06.004; Kanu I, 2005, THESCIENTIFICWORLDJO, V5, P401, DOI 10.1100/tsw.2005.51; Karshima N, 2013, J ANIM SCI ADV, V3, P109; Katabarwa M, 2008, AM J TROP MED HYG, V78, P400, DOI 10.4269/ajtmh.2008.78.400; Khan FY, 2011, TRAVEL MED INFECT DI, V9, P298, DOI 10.1016/j.tmaid.2011.07.002; Kisakye J, 2002, UGANDA J AGR SCI, V7, P23; Komba EVG, 2013, VET PARASITOL, V198, P284, DOI 10.1016/j.vetpar.2013.09.020; Krecek RC, 2008, VET PARASITOL, V154, P38, DOI 10.1016/j.vetpar.2008.03.005; Krecek RC, 2011, VET PARASITOL, V183, P198, DOI 10.1016/j.vetpar.2011.09.033; Kumwenda JJ, 2005, STROKE, V36, P960, DOI 10.1161/01.STR.0000162585.97216.ef; Kyvsgaard NC, 2007, INT J PARASITOL, V37, P547, DOI 10.1016/j.ijpara.2006.11.018; MAFOJANE NA, 1994, S AFR MED J, V84, P208; Maiga Y, 2009, Bull Soc Pathol Exot, V102, P211; Marty P, 1986, Med Trop (Mars), V46, P181; MASON P, 1992, CENT AFR J MED, V38, P149; Matenga E, 2002, P 11 ANN M ENRECA LI; Matos C, 2011, J S AFR VET ASSOC, V82, P166; Mellau BL, 2011, TROP ANIM HEALTH PRO, V43, P857, DOI 10.1007/s11250-010-9773-1; Menan E. I. H., 1997, Medecine d'Afrique Noire, V44, P415; MICHEL P, 1993, B SOC PATHOL EXOT, V86, P62; Michelet L, 2010, MOL PHYLOGENET EVOL, V55, P744, DOI 10.1016/j.ympev.2010.01.008; Migliani R., 2000, Archives de l'Institut Pasteur de Madagascar, V66, P39; Millogo A, 2012, EPILEPSIA, V53, P2194, DOI 10.1111/j.1528-1167.2012.03687.x; MISHRA GS, 1978, REV ELEVAGE MED VET, V31, P431, DOI 10.19182/remvt.8114; Mkupasi E, 2014, J HELMINTHOL, P1; Mkupasi EM, 2011, TROP ANIM HEALTH PRO, V43, P417, DOI 10.1007/s11250-010-9708-x; Mkupasi EM, 2013, ACTA TROP, V128, P48, DOI 10.1016/j.actatropica.2013.06.010; Motsepe T., 2012, Southern African Journal of Epidemiology & Infection, V27, P133; Mutua FK, 2007, J SWINE HEALTH PROD, V15, P206; Mwang'onde B. J., 2012, ADV INFECT DIS, V2, P62, DOI [10.4236/aid.2012.23009, DOI 10.4236/AID.2012.23009]; Mwanjali G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002102; Mwape KE, 2011, T ROY SOC TROP MED H, V105, P574, DOI 10.1016/j.trstmh.2011.05.010; Mwape KE, 2015, AM J TROP MED HYG, V92, P56, DOI 10.4269/ajtmh.13-0593; Mwape KE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002142; Mwape KE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001594; NAIDOO DV, 1987, S AFR MED J, V72, P837; Napon C, 2009, Bull Soc Pathol Exot, V102, P5, DOI 10.3185/pathexo3237; Naus CWA, 2003, TROP MED INT HEALTH, V8, P561, DOI 10.1046/j.1365-3156.2003.01056.x; Ndiaye D, 2013, MED SANTE TROP, V23, P35, DOI 10.1684/mst.2013.0141; Newell E, 1997, T ROY SOC TROP MED H, V91, P389, DOI 10.1016/S0035-9203(97)90251-0; Ngowi HA, 2008, PREV VET MED, V85, P52, DOI 10.1016/j.prevetmed.2007.12.014; Ngowi HA, 2004, TROP ANIM HEALTH PRO, V36, P335, DOI 10.1023/B:TROP.0000026663.07862.2a; Ngowi HA, 2004, VET PARASITOL, V120, P275, DOI 10.1016/j.vetpar.2004.01.015; Nguekam, 2003, PARASITE, V10, P65, DOI 10.1051/parasite/2003101p65; Nguekam JP, 2003, TROP MED INT HEALTH, V8, P144, DOI 10.1046/j.1365-3156.2003.01000.x; Ngugi AK, 2013, LANCET NEUROL, V12, P253, DOI 10.1016/S1474-4422(13)70003-6; Ngwing NAN, 2012, ASIAN PAC J TROP MED, V5, P814, DOI 10.1016/S1995-7645(12)60149-7; Nitiema P, 2012, ACTA NEUROL SCAND, V126, P270, DOI 10.1111/j.1600-0404.2011.01639.x; Nkouawa A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000732; Nkwengulila G, 2014, ONDERSTEPOORT J VET, V81, P5; Noormahomed EV, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003121; Noormahomed EV, 2003, ANN TROP MED PARASIT, V97, P31, DOI 10.1179/000349803125002742; Nsadha Z, 2011, AFRI J ANIM BIOMED S, V6, P67; Nsadha Z, 2010, AFRICA J ANIM BIOMED, V5, P43; Nsadha Z, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0239-y; Nsengiyumva G, 2003, EPILEPSIA, V44, P950, DOI 10.1046/j.1528-1157.2003.55302.x; Nzisabira L, 1991, B SOC PATHOL EXO, V85, P374; OIE World Organization for Animal Health, 2014, WORLD AN HLTH INF DA; Ojurongbe O, 2011, BRIT J BIOMED SCI, V68, P75; Okome-Nkoumou M. M. L., 2010, Asian Pacific Journal of Tropical Medicine, V3, P671; Oladele S. B., 2006, Bulletin of Animal Health and Production in Africa, V54, P234; Omonisi A E, 2014, Niger J Med, V23, P351; ONAH DN, 1995, ANN TROP MED PARASIT, V89, P399, DOI 10.1080/00034983.1995.11812968; PAMMENTER MD, 1987, T ROY SOC TROP MED H, V81, P242, DOI 10.1016/0035-9203(87)90228-8; Pampiglione S., 1987, Parassitologia (Rome), V29, P1; Pawlowski Z. S., 1991, Acta Tropica, V48, P83; Permin A, 1999, VET PARASITOL, V87, P63, DOI 10.1016/S0304-4017(99)00159-4; Phiri IK, 2006, J HELMINTHOL, V80, P69, DOI 10.1079/JOH2005314; Phiri IK, 2003, ACTA TROP, V87, P13, DOI [10.1016/S0001-706X(03)00051-2, 10.1016/S0001-706X(03)00202-X]; Phiri IK, 2002, VET PARASITOL, V108, P31, DOI 10.1016/S0304-4017(02)00165-6; Pondja A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001651; Pondja A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000594; Ponnighaus JM, 2001, HAUTARZT, V52, P1098, DOI 10.1007/s001050170020; Pouedet MSR, 2002, VET PARASITOL, V106, P45, DOI 10.1016/S0304-4017(02)00035-3; Prado-Jean A, 2007, TROP MED INT HEALTH, V12, P895, DOI 10.1111/j.1365-3156.2007.01860.x; Praet N, 2010, INT J PARASITOL, V40, P85, DOI 10.1016/j.ijpara.2009.07.007; Praet N, 2010, PLOS NEGLECT TROP D, V4, P9; Praet N, 2013, TROP MED INT HEALTH, V18, P608, DOI 10.1111/tmi.12089; Ramahefarisoa RM, 2010, VET PARASITOL, V173, P336, DOI 10.1016/j.vetpar.2010.05.002; Rottbeck R, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002558; Sacks L V, 1990, Trop Gastroenterol, V11, P30; Sakande B, 1998, B SOC PATHOL EXOT, V91, P217; SCHANTZ PM, 1992, NEW ENGL J MED, V327, P692, DOI 10.1056/NEJM199209033271004; Schur N, 2013, ACTA TROP, V128, P365, DOI 10.1016/j.actatropica.2011.10.006; Schur N, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001194; Secka A., 2010, J PARASITOL RES, V2010; Secka A, 2011, ACTA TROP, V119, P199, DOI 10.1016/j.actatropica.2011.05.003; SHASHA W, 1991, ANN TROP MED PARASIT, V85, P349, DOI 10.1080/00034983.1991.11812573; Shey-Njila O, 2003, J HELMINTHOL, V77, P351, DOI 10.1079/JOH2003179; Sikasunge CS, 2007, VET PARASITOL, V143, P59, DOI 10.1016/j.vetpar.2006.07.023; Sikasunge CS, 2008, VET J, V176, P240, DOI 10.1016/j.tvjl.2007.02.030; Siwila J, 2010, T ROY SOC TROP MED H, V104, P122, DOI 10.1016/j.trstmh.2009.07.024; Speybroeck N, 2013, INT J PUBLIC HEALTH, V58, P791, DOI 10.1007/s00038-012-0439-9; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Stensgaard AS, 2013, ACTA TROP, V128, P378, DOI 10.1016/j.actatropica.2011.11.010; Thomson A J, 1984, Ann Trop Paediatr, V4, P67; Tomlinson M, 2010, PUBLIC HEALTH NUTR, V13, P1314, DOI 10.1017/S1368980010000510; TORRES JR, 1989, REV I MED TROP, V31, P290, DOI 10.1590/S0036-46651989000400014; Tronnberg L, 2010, T ROY SOC TROP MED H, V104, P646, DOI 10.1016/j.trstmh.2010.06.009; VANAS AD, 1991, S AFR MED J, V80, P327; Vilhena M, 1999, AM J TROP MED HYG, V61, P59, DOI 10.4269/ajtmh.1999.61.59; Vondou L, 2002, PARASITE, V9, P271, DOI 10.1051/parasite/2002093271; Waiswa C, 2009, J PARASITOL RES, V2009; Waruingi M, 2002, AFR J NEUROL SCI, V21, P46; Weka RP, 2013, J INFECT DEV COUNTR, V7, P67, DOI [10.3855/jidc.2309, DOI 10.3855/JIDC.2309]; WHO, 2010, WORKING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: FIRST WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1; *WHO, 2002, PREV CONTR SCH SOIL; Winkler AS, 2008, T ROY SOC TROP MED H, V102, P1032, DOI 10.1016/j.trstmh.2008.05.004; Winkler AS, 2009, EPILEPSIA, V50, P987, DOI 10.1111/j.1528-1167.2008.01867.x; Yanagida T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109002; Yohana C., 2013, International Journal of Animal and Veterinary Advances, V5, P251; Zoli A, 2003, ACTA TROP, V87, P35, DOI 10.1016/S0001-706X(02)00289-9; Zoli AP, 2003, T ROY SOC TROP MED H, V97, P683, DOI 10.1016/S0035-9203(03)80103-7	177	19	19	0	14	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	JUN 12	2015	8								323	10.1186/s13071-015-0938-7				14	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CK2SM	WOS:000356062400004	26065414	DOAJ Gold, Green Published			2019-04-02	
J	Koepfli, C; Rodrigues, PT; Antao, T; Orjuela-Sanchez, P; Van den Eede, P; Gamboa, D; Hong, NV; Bendezu, J; Erhart, A; Barnadas, C; Ratsimbasoa, A; Menard, D; Severini, C; Menegon, M; Nour, BYM; Karunaweera, N; Mueller, I; Ferreira, MU; Felger, I				Koepfli, Cristian; Rodrigues, Priscila T.; Antao, Tiago; Orjuela-Sanchez, Pamela; Van den Eede, Peter; Gamboa, Dionicia; Nguyen Van Hong; Bendezu, Jorge; Erhart, Annette; Barnadas, Celine; Ratsimbasoa, Arsene; Menard, Didier; Severini, Carlo; Menegon, Michela; Nour, Bakri Y. M.; Karunaweera, Nadira; Mueller, Ivo; Ferreira, Marcelo U.; Felger, Ingrid			Plasmodium vivax Diversity and Population Structure across Four Continents	PLOS NEGLECTED TROPICAL DISEASES			English	Article							PAPUA-NEW-GUINEA; GENETIC DIVERSITY; TRANSMISSION DYNAMICS; RURAL AMAZONIA; GEOGRAPHIC STRUCTURE; GLOBAL DISTRIBUTION; PERUVIAN AMAZON; CENTRAL VIETNAM; SOUTH-AMERICA; P. FALCIPARUM	Plasmodium vivax is the geographically most widespread human malaria parasite. To analyze patterns of microsatellite diversity and population structure across countries of different transmission intensity, genotyping data from 11 microsatellite markers was either generated or compiled from 841 isolates from four continents collected in 1999-2008. Diversity was highest in South-East Asia (mean allelic richness 10.0-12.8), intermediate in the South Pacific (8.1-9.9) Madagascar and Sudan (7.9-8.4), and lowest in South America and Central Asia (5.5-7.2). A reduced panel of only 3 markers was sufficient to identify approx. 90% of all haplotypes in South Pacific, African and SE-Asian populations, but only 60-80% in Latin American populations, suggesting that typing of 2-6 markers, depending on the level of endemicity, is sufficient for epidemiological studies. Clustering analysis showed distinct clusters in Peru and Brazil, but little sub-structuring was observed within Africa, SE-Asia or the South Pacific. Isolates from Uzbekistan were exceptional, as a near-clonal parasite population was observed that was clearly separated from all other populations (F-ST>0.2). Outside Central Asia F-ST values were highest (0.11-0.16) between South American and all other populations, and lowest (0.04-0.07) between populations from South-East Asia and the South Pacific. These comparisons between P. vivax populations from four continents indicated that not only transmission intensity, but also geographical isolation affect diversity and population structure. However, the high effective population size results in slow changes of these parameters. This persistency must be taken into account when assessing the impact of control programs on the genetic structure of parasite populations.	[Koepfli, Cristian; Felger, Ingrid] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Koepfli, Cristian; Felger, Ingrid] Univ Basel, Basel, Switzerland; [Koepfli, Cristian; Barnadas, Celine; Mueller, Ivo] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Koepfli, Cristian; Barnadas, Celine; Mueller, Ivo] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Rodrigues, Priscila T.; Orjuela-Sanchez, Pamela; Ferreira, Marcelo U.] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil; [Antao, Tiago] Univ Liverpool, Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England; [Van den Eede, Peter; Erhart, Annette] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Gamboa, Dionicia; Bendezu, Jorge] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander Von Humboldt, Lima, Peru; [Nguyen Van Hong] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam; [Ratsimbasoa, Arsene] Inst Pasteur Madagascar, Immunol Unit, Antananarivo, Madagascar; [Menard, Didier] Inst Pasteur Cambodge, Malaria Mol Epidemiol Unit, Phnom Penh, Cambodia; [Severini, Carlo; Menegon, Michela] Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, I-00161 Rome, Italy; [Nour, Bakri Y. M.] Univ Gezira, Blue Nile Natl Inst Communicable Dis, Dept Parasitol, Wad Madani, Sudan; [Karunaweera, Nadira] Univ Colombo, Fac Med, Dept Parasitol, Colombo, Sri Lanka; [Mueller, Ivo] Barcelona Ctr Int Hlth Res, Barcelona, Spain	Koepfli, C (reprint author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	ingrid.felger@unibas.ch	Ferreira, Marcelo/G-8289-2011; SEVERINI, CARLO/C-4977-2016; Menard, Didier/O-3294-2013	Ferreira, Marcelo/0000-0002-5293-9090; Menard, Didier/0000-0003-1357-4495; Karunaweera, Nadira/0000-0003-3985-1817; Bendezu, Jorge/0000-0001-7102-3144; Antao, Tiago/0000-0002-7269-5513; Gamboa, Dionicia/0000-0002-1420-7729; Koepfli, Cristian/0000-0002-9354-0414; Felger, Ingrid/0000-0003-1255-2606	Brazilian Swiss Joint Research Programme (BSJRP) [0112-07]; Swiss National Science Foundation [310030_134889, P2BSP3_151880]; International Centers of Excellence in Malaria Research [U19 AI089686]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (senior research scholarship) [590106/2011-2]; Global Fund to fight AIDS, Tuberculosis and Malaria through Organismo Andino de SaludConvenio Hipolito Unanue [MAA-305-G01-M]; Directorate General for Development Cooperation (DGCD) of the Belgian Government [95502]; COPERNICUS-2 RTD project [ICA2-CT-2000-10046]; Sir Henry Wellcome postdoctoral fellowship [WT100066MA]	This work was supported by the Brazilian Swiss Joint Research Programme (BSJRP, grant 0112-07), the Swiss National Science Foundation (www.snf.ch, grants 310030_134889, P2BSP3_151880), the International Centers of Excellence in Malaria Research (grant U19 AI089686) and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br, grant #590106/2011-2 and senior research scholarship). The sample collection and analysis in Peru was supported by The Global Fund to fight AIDS, Tuberculosis and Malaria (www.theglobalfund.org) through the Organismo Andino de SaludConvenio Hipolito Unanue (grant MAA-305-G01-M) and by the Directorate General for Development Cooperation (DGCD) of the Belgian Government (framework agreement 03, project 95502). Sample collection in Armenia, Azerbaijan and Uzbekistan was supported by COPERNICUS-2 RTD project contract ICA2-CT-2000-10046 (VIVAXNIS) of the European Commission. This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS. TA is funded by a Sir Henry Wellcome postdoctoral fellowship (WT100066MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082553; Abeyasinghe RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043162; Anderson TJC, 2000, MOL ECOL, V9, P1599, DOI 10.1046/j.1365-294x.2000.01057.x; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Arnott A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002506; Baird JK, 2012, ADV PARASIT, V80, P203, DOI 10.1016/B978-0-12-397900-1.00004-9; Ballif M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-270; Baniecki ML, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003539; Barnadas C, 2008, ANTIMICROB AGENTS CH, V52, P4233, DOI 10.1128/AAC.00578-08; Barnadas C, 2011, ANTIMICROB AGENTS CH, V55, P4479, DOI 10.1128/AAC.01552-10; Batista CL, 2015, PARASITOLOGY, V142, P374, DOI 10.1017/S0031182014001176; Batista CL, 2014, PARASITOLOGY, P1; Battle KE, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-144; Bhatia R, 2013, J VECTOR DIS, V50, P239; Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364; Chenet SM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-412; de Araujo FCF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049871; de Sousa TN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022944; Delgado-Ratto C, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-8; Erhart A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-58; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ferreira MU, 2007, J INFECT DIS, V195, P1218, DOI 10.1086/512685; Ferreira MU, 2014, TRENDS PARASITOL, V30, P465, DOI 10.1016/j.pt.2014.08.003; Figtree M, 2000, MOL BIOCHEM PARASIT, V108, P53, DOI 10.1016/S0166-6851(00)00204-8; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Gonzalez-Ceron L, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-109; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gray KA, 2013, SOLOMON ISLANDS MALA, V12, P429, DOI DOI 10.1186/1475-2875-12-429; Griffing SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023486; Gunawardena S, 2014, PARASITOLOGY, V141, P880, DOI 10.1017/S0031182013002278; Gunawardena S, 2010, AM J TROP MED HYG, V82, P235, DOI 10.4269/ajtmh.2010.09-0588; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Howes RE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1265; Huelsenbeck JP, 2011, EVOL BIOINFORM, V7, P55, DOI 10.4137/EBO.S6761; Hwang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063433; Imwong M, 2007, INT J PARASITOL, V37, P1013, DOI 10.1016/j.ijpara.2007.02.010; Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241; Imwong M, 2012, J INFECT DIS, V205, P680, DOI 10.1093/infdis/jir806; Iwagami M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001592; Jennison C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003634; Joy DA, 2008, MOL BIOL EVOL, V25, P1245, DOI 10.1093/molbev/msn073; Juliano JJ, 2010, TRENDS PARASITOL, V26, P119, DOI 10.1016/j.pt.2009.12.007; Karunaweera ND, 2007, MOL ECOL NOTES, V7, P172, DOI 10.1111/j.1471-8286.2006.01534.x; Koepfli C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126747; Koepfli C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002403; Koepfli C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066041; Koepfli C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001424; Koepfli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019010; Leclerc M. C., 2004, MALARIA J, V9, P3; Lin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009047; Lischer HEL, 2012, BIOINFORMATICS, V28, P298, DOI 10.1093/bioinformatics/btr642; Liu YB, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-262; Matschiner M, 2009, BIOINFORMATICS, V25, P1982, DOI 10.1093/bioinformatics/btp303; McKelvey KS, 2005, MOL ECOL NOTES, V5, P716, DOI 10.1111/j.1471-8286.2005.01038.x; Menegon M, 2014, INFECT GENET EVOL, V27, P244, DOI 10.1016/j.meegid.2014.07.029; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Mu JB, 2005, MOL BIOL EVOL, V22, P1686, DOI 10.1093/molbev/msi160; Mueller I, 2002, AM J TROP MED HYG, V67, P459, DOI 10.4269/ajtmh.2002.67.459; Muller I, 2003, TRENDS PARASITOL, V19, P253, DOI 10.1016/S1471-4922(03)00091-6; Mzilahowa T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000613; Neafsey DE, 2012, NAT GENET, V44, P1046, DOI 10.1038/ng.2373; Nkhoma SC, 2013, MOL ECOL, V22, P273, DOI 10.1111/mec.12099; Noviyanti R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003739; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Orjuela-Sanchez P, 2013, EXP PARASITOL, V134, P318, DOI 10.1016/j.exppara.2013.03.029; Orjuela-Sanchez P, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-65; Orjuela-Sanchez P, 2009, AM J TROP MED HYG, V81, P961, DOI 10.4269/ajtmh.2009.09-0337; Patterson N, 2006, PLOS GENET, V2, pe190, DOI DOI 10.1371/JOURNAL.PGEN.0020190; Pritchard JK, 2000, GENETICS, V155, P945; Razakov Sh. A., 2001, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P39; Restrepo E, 2011, ACTA TROP, V119, P23, DOI 10.1016/j.actatropica.2011.03.012; Rodrigues PT, 2014, AM J TROP MED HYG, V90, P1102, DOI 10.4269/ajtmh.13-0588; Sutton PL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-447; Taylor JE, 2013, MOL BIOL EVOL, V30, P2050, DOI 10.1093/molbev/mst104; Van den Eede P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-151; Van den Eede P, 2010, AM J TROP MED HYG, V82, P223, DOI 10.4269/ajtmh.2010.09-0458; Volkman SK, 2012, NAT REV GENET, V13, P315, DOI 10.1038/nrg3187; Yalcindag E, 2012, P NATL ACAD SCI USA, V109, P511, DOI 10.1073/pnas.1119058109	79	30	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUN	2015	9	6							e0003872	10.1371/journal.pntd.0003872				23	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CM0VX	WOS:000357398100056	26125189	DOAJ Gold, Green Published			2019-04-02	
J	Moore, S; Miwanda, B; Sadji, AY; Thefenne, H; Jeddi, F; Rebaudet, S; de Boeck, H; Bidjada, B; Depina, JJ; Bompangue, D; Abedi, AA; Koivogui, L; Keita, S; Garnotel, E; Plisnier, PD; Ruimy, R; Thomson, N; Muyembe, JJ; Piarroux, R				Moore, Sandra; Miwanda, Berthe; Sadji, Adodo Yao; Thefenne, Helene; Jeddi, Fakhri; Rebaudet, Stanislas; de Boeck, Hilde; Bidjada, Bawimodom; Depina, Jean-Jacques; Bompangue, Didier; Abedi, Aaron Aruna; Koivogui, Lamine; Keita, Sakoba; Garnotel, Eric; Plisnier, Pierre-Denis; Ruimy, Raymond; Thomson, Nicholas; Muyembe, Jean-Jacques; Piarroux, Renaud			Relationship between Distinct African Cholera Epidemics Revealed via MLVA Haplotyping of 337 Vibrio cholerae Isolates	PLOS NEGLECTED TROPICAL DISEASES			English	Article							MULTILOCUS VARIABLE-NUMBER; TANDEM-REPEAT ANALYSIS; ENVIRONMENTAL DETERMINANTS; TRANSMISSION; OUTBREAKS; STRAINS	Background Since cholera appeared in Africa during the 1970s, cases have been reported on the continent every year. In Sub-Saharan Africa, cholera outbreaks primarily cluster at certain hot-spots including the African Great Lakes Region and West Africa. Methodology/Principal Findings In this study, we applied MLVA (Multi-Locus Variable Number Tandem Repeat Analysis) typing of 337 Vibrio cholerae isolates from recent cholera epidemics in the Democratic Republic of the Congo (DRC), Zambia, Guinea and Togo. We aimed to assess the relationship between outbreaks. Applying this method, we identified 89 unique MLVA haplotypes across our isolate collection. MLVA typing revealed the short-term divergence and microevolution of these Vibrio cholerae populations to provide insight into the dynamics of cholera outbreaks in each country. Our analyses also revealed strong geographical clustering. Isolates from the African Great Lakes Region (DRC and Zambia) formed a closely related group, while West African isolates (Togo and Guinea) constituted a separate cluster. At a country-level scale our analyses revealed several distinct MLVA groups, most notably DRC 2011/2012, DRC 2009, Zambia 2012 and Guinea 2012. We also found that certain MLVA types collected in the DRC persisted in the country for several years, occasionally giving rise to expansive epidemics. Finally, we found that the six environmental isolates in our panel were unrelated to the epidemic isolates. Conclusions/Significance To effectively combat the disease, it is critical to understand the mechanisms of cholera emergence and diffusion in a region-specific manner. Overall, these findings demonstrate the relationship between distinct epidemics in West Africa and the African Great Lakes Region. This study also highlights the importance of monitoring and analyzing Vibrio cholerae isolates.	[Moore, Sandra; Jeddi, Fakhri; Rebaudet, Stanislas; Piarroux, Renaud] Aix Marseille Univ, Assistance Publ Hop Marseille, Dept Parasitol & Mycol, UMR MD3, Marseille, France; [Miwanda, Berthe; Bompangue, Didier; Muyembe, Jean-Jacques] Minist Publ Hlth, Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Sadji, Adodo Yao; Bidjada, Bawimodom] Natl Inst Hyg, Dept Bacteriol, Lome, Togo; [Thefenne, Helene; Depina, Jean-Jacques; Garnotel, Eric] Hop Instruct Armees Laveran, Marseille, France; [de Boeck, Hilde] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Bompangue, Didier; Muyembe, Jean-Jacques] Univ Kinshasa, Fac Med, Dept Microbiol, Kinshasa, DEM REP CONGO; [Bompangue, Didier] Univ Franche Comte, CNRS, Lab Chronoenvironm, UMR 6249, F-25030 Besancon, France; [Abedi, Aaron Aruna] Minist Hlth, Kinshasa, DEM REP CONGO; [Koivogui, Lamine] Inst Natl Sante Publ, Conakry, Guinea; [Keita, Sakoba] Minist Sante Publ & Hyg Publ, Div Prevent & Lutte Maladie, Conakry, Guinea; [Plisnier, Pierre-Denis] Royal Museum Cent Africa, Tervuren, Belgium; [Ruimy, Raymond] Nice Univ Hosp, Dept Clin Res, Nice, France; [Thomson, Nicholas] Wellcome Trust Sanger Inst, Pathogen Genom, Cambridge, England; [Thomson, Nicholas] London Sch Hyg & Trop Med, London WC1, England	Moore, S (reprint author), Aix Marseille Univ, Assistance Publ Hop Marseille, Dept Parasitol & Mycol, UMR MD3, Marseille, France.	Renaud.PIARROUX@ap-hm.fr	Ruimy, Raymond/P-6068-2016; Thomson, Nicholas/P-5988-2014	Thomson, Nicholas/0000-0002-4432-8505	WHO; Epicentre; UNICEF; CHOLTIC project (Belgian Science Policy); VEOLIA Environment Foundation; AFRICHOL project; Bill AMP; Melinda Gates Foundation; Directorate General of Development Cooperation of the Belgian Government through institutional collaboration INRB-ITM; Assistance Publique - Hopitaux de Marseille; public health doctoral network of the EHESP (Ecole des hautes etudes en sante publique)	The collection of strains and biological analyses were supported by many partners, including the WHO, the VEOLIA Environment Foundation and AFRICHOL project. Africhol (African Cholera Surveillance Network) (http://www.africhol.org/), is supported by a grant from the Bill & Melinda Gates Foundation, which had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Epidemiological surveillance including some field investigations was financially supported by the WHO, Epicentre, UNICEF and the CHOLTIC project (Belgian Science Policy). The project was also partly supported by the Directorate General of Development Cooperation of the Belgian Government through institutional collaboration INRB-ITM (project 2.01). This work was co-financed by Assistance Publique - Hopitaux de Marseille. Sandra Moore was awarded a PhD contract from the public health doctoral network of the EHESP (Ecole des hautes etudes en sante publique). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bompangue D, 2012, PLOS CURR DISASTERS, V1, P1; Centers for Disease Control and Prevention, 2012, CHOLERA, V31, P289; Centers for Disease Control and Prevention, 2011, CHOLERA 2010, V31, P325; Centers for Disease Control and Prevention, 2014, CHOLERA, V31, P345; Centers for Disease Control and Prevention, 2013, CHOLERA, V31, P321; Choi SY, 2010, J MED MICROBIOL, V59, P763, DOI 10.1099/jmm.0.017939-0; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Echenberg M, 2011, AFRICA TIME CHOLERA; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Gaffga NH, 2007, AM J TROP MED HYG, V77, P705, DOI 10.4269/ajtmh.2007.77.705; Kendall EA, 2010, J BACTERIOL, V192, P4367, DOI 10.1128/JB.00698-10; Lam C, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-82; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Naha A, 2013, J CLIN MICROBIOL, V51, P1040, DOI 10.1128/JCM.03162-12; Nkoko DB, 2011, EMERG INFECT DIS, V17, P2026, DOI 10.3201/eid1711.110170; Oger P, 2011, WATER SANITATION HYG, P107; Olsen JS, 2009, J MICROBIOL METH, V78, P271, DOI 10.1016/j.mimet.2009.06.011; Ramisse V, 2004, J CLIN MICROBIOL, V42, P5722, DOI 10.1128/JCM.42.12.5722-5730.2004; Rebaudet S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002898; Rebaudet S, 2013, J INFECT DIS, V208, pS98, DOI 10.1093/infdis/jit202; Rebaudet S, 2013, J INFECT DIS, V208, pS46, DOI 10.1093/infdis/jit195; WHO UNICEF, 2014, CHOL OUTBR W CENTR A	23	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUN	2015	9	6							e0003817	10.1371/journal.pntd.0003817				15	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CM0VX	WOS:000357398100024	26110870	DOAJ Gold, Green Published			2019-04-02	
J	De, NV; Nga, VT; Dorny, P; Trung, NV; Minh, PN; Dung, DT; Pozio, E				Nguyen Van De; Vu Thi Nga; Dorny, Pierre; Nguyen Vu Trung; Pham Ngoc Minh; Do Trung Dung; Pozio, Edoardo			Trichinellosis in Vietnam	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							TRICHINELLA-SPIRALIS; MOLECULAR-IDENTIFICATION; EPIDEMIOLOGY; OUTBREAK; DIAGNOSIS; HUMANS; INFECTIONS; SPP.; PORK; LAOS	Trichinellosis is a zoonotic parasitic disease with a worldwide distribution. The aim of this work was to describe the epidemiological and clinical data of five outbreaks of trichinellosis, which affected ethnic minorities living in remote mountainous areas of northwestern Vietnam from 1970 to 2012. Trichinellosis was diagnosed in 126 patients, of which 11 (8.7%) were hospitalized and 8 (6.3%) died. All infected people had consumed raw pork from backyard and roaming pigs or wild boar at wedding, funeral, or New Year parties. The short incubation period (average of 9.5 days), the severity of the symptoms, which were characterized by diarrhea, abdominal pain, fever, myalgia, edema, weight loss, itch, and lisping, and the high mortality, suggest that patients had ingested a high number of larvae. The larval burden in pigs examined in one of the outbreaks ranged from 70 to 879 larvae/g. These larvae and those collected from a muscle biopsy taken from a patient from the 2012 outbreak were identified as Trichinella spiralis. Data presented in this work show that the northern regions of Vietnam are endemic areas for Trichinella infections in domestic pigs and humans.	[Nguyen Van De; Pham Ngoc Minh] Hanoi Med Univ Vietnam, Hanoi, Vietnam; [Vu Thi Nga] Natl Ctr Vet Diag, Parasitol Sect, Hanoi, Vietnam; [Dorny, Pierre] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Nguyen Vu Trung] Natl Hosp Trop Dis, Hanoi, Vietnam; [Do Trung Dung] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam; [Pozio, Edoardo] Ist Super Sanita, European Union Reference Lab Parasites, Dept Infect Parasit & Immunomediated Dis, I-00161 Rome, Italy	Pozio, E (reprint author), Ist Super Sanita, European Union Reference Lab Parasites, Dept Infect Parasit & Immunomediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	ngvdeyhn@gmail.com; ngancvd@gmail.com; pdorny@itg.be; nvutrung@fpt.vn; phamngocminhyhn@yahoo.com; dotrungdung.nimpe.vn@gmail.com; edoardo.pozio@iss.it			National Foundation for Science and Technology Development (NAFOSTED), Vietnam Grant [106-YS.05-2014.08]; National Hospital of Tropical Diseases, Bach Mai Hospital, National Centre for Veterinary Diagnosis, Hanoi, Vietnam; Institute of Tropical Medicine, Antwerp, Belgium; Directorate General for Health and Consumers of the European Commission for the European Union Reference Laboratory, Istituto Superiore di Sanita	This work was funded by National Foundation for Science and Technology Development (NAFOSTED), Vietnam Grant 106-YS.05-2014.08 (to N.V.D.) and the National Hospital of Tropical Diseases, Bach Mai Hospital, National Centre for Veterinary Diagnosis, Hanoi, Vietnam. Furthermore, this work was funded by the Institute of Tropical Medicine, Antwerp, Belgium, and the Directorate General for Health and Consumers of the European Commission for the European Union Reference Laboratory, Istituto Superiore di Sanita.	Barennes H, 2008, AM J TROP MED HYG, V78, P40, DOI 10.4269/ajtmh.2008.78.40; BLANC F., 1956, Annales de Medecine, V57, P201; Cui J, 2011, ACTA TROP, V118, P1, DOI 10.1016/j.actatropica.2011.02.005; Dupouy-Camet J., 2007, FAO WHO OIE GUIDELIN, P37; Dupouy-Camet Jean, 2002, Expert Opin Pharmacother, V3, P1117; Epprecht M, 2005, GEOGRAPHIC DIMENSION, V24; Fichi G, 2015, ZOONOSES PUBLIC HLTH, V62, P285, DOI 10.1111/zph.12148; General Statistics Office, 2013, CAP INC PER MONTH CU; Gomez-Morales MA, 2012, INT J PARASITOL, V42, P1017, DOI 10.1016/j.ijpara.2012.08.003; Gottstein B, 2009, CLIN MICROBIOL REV, V22, P127, DOI 10.1128/CMR.00026-08; Intapan PM, 2011, AM J TROP MED HYG, V84, P994, DOI 10.4269/ajtmh.2011.10-0675; International Trichinella Reference Center, 2014, DAT TRICH STRAINS; Kaewpitoon N, 2008, WORLD J GASTROENTERO, V14, P3471, DOI 10.3748/wjg.14.3471; Kociecka W, 2000, VET PARASITOL, V93, P365, DOI 10.1016/S0304-4017(00)00352-6; La Rosa G, 2012, INFECT GENET EVOL, V12, P369, DOI 10.1016/j.meegid.2012.01.008; Lam KT, 1973, B SCI RES I MALAR PA, P324; Le Louet GM, 1923, B SOC MED CHIR INDOC; Lemke U, 2007, TROP ANIM HEALTH PRO, V39, P237, DOI 10.1007/s11250-007-9001-9; MERLE A., 1957, Bulletin de l'Office International des Epizootics, V48, P95; Murrell KD, 2013, REV SCI TECH OIE, V32, P559; Murrell KD, 2011, EMERG INFECT DIS, V17, P2194, DOI 10.3201/eid1712.110896; Thi NV, 2014, ACTA TROP, V139, P93, DOI 10.1016/j.actatropica.2014.07.012; Thi NV, 2013, BIOMED RES INT, DOI 10.1155/2013/149890; De NV, 2012, KOREAN J PARASITOL, V50, P339, DOI 10.3347/kjp.2012.50.4.339; Nhan DH, 2004, J MALAR PARASIT DIS, V6, P76; Porto-Fett ACS, 2010, INT J FOOD MICROBIOL, V140, P61, DOI 10.1016/j.ijfoodmicro.2010.02.008; Pozio E, 2001, CLIN INFECT DIS, V32, P638, DOI 10.1086/318707; Pozio E, 2012, MOL DETECTION HUMAN, V691-703; Pozio E, 2007, VET PARASITOL, V149, P3, DOI 10.1016/j.vetpar.2007.07.002; Pozio E, 2006, ADV PARASIT, V63, P367, DOI 10.1016/S0065-308X(06)63005-4; Pozio E, 2014, TRENDS PARASITOL, V30, P4, DOI 10.1016/j.pt.2013.11.001; Romano F, 2011, PARASITE, V18, P85, DOI 10.1051/parasite/2011181085; Sayasone S, 2006, T ROY SOC TROP MED H, V100, P1126, DOI 10.1016/j.trstmh.2006.01.010; SICARD D, 1976, B SOC PATHOL EXOT, V69, P521; Takahashi Y, 2000, VET PARASITOL, V93, P227, DOI 10.1016/S0304-4017(00)00343-5; Taylor WR, 2009, CLIN INFECT DIS, V49, P79; Thai KTD, 2008, ACTA TROP, V106, P128, DOI 10.1016/j.actatropica.2008.02.005; Toan ND, 2002, J MALAR PARASIT DIS, V1, P76; Vu Tin N, 2010, VET PARASITOL, V168, P136; Zaiman H, 1970, TRICHINOSIS MAN ANIM, P329	40	7	7	0	6	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	JUN	2015	92	6					1265	1270		10.4269/ajtmh.14-0570				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CJ8WY	WOS:000355785400031	25846295	Green Published, Bronze			2019-04-02	
J	Delamou, A; Diallo, M; Beavogui, AH; Delvaux, T; Millimono, S; Kourouma, M; Beattie, K; Barone, M; Barry, TH; Khogali, M; Edginton, M; Hinderaker, SG; Ruminjo, J; Zhang, WH; De Brouwere, V				Delamou, Alexandre; Diallo, Moustapha; Beavogui, Abdoul Habib; Delvaux, Therese; Millimono, Sita; Kourouma, Mamady; Beattie, Karen; Barone, Mark; Barry, Thierno Hamidou; Khogali, Mohamed; Edginton, Mary; Hinderaker, Sven Gudmund; Ruminjo, Joseph; Zhang, Wei-Hong; De Brouwere, Vincent			Good clinical outcomes from a 7-year holistic programme of fistula repair in Guinea	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						obstetric fistula; Guinea; fistula care; operational research; SORT-IT; fistule obstetrique; Guinee; soins pour la fistule; recherche operationnelle; SORT-IT; fistula obstetrica; cuidados de fistula; Guinea; investigacion de operaciones; SORT-IT	OBSTETRIC FISTULA; FOLLOW-UP; WOMEN; COUNTRIES; DETERMINANTS; ETHIOPIA; SURGERY; DISEASE; HEALTH	ObjectivesFemale genital fistula remains a public health concern in developing countries. From January 2007 to September 2013, the Fistula Care project, managed by EngenderHealth in partnership with the Ministry of Health and supported by USAID, integrated fistula repair services in the maternity wards of general hospitals in Guinea. The objective of this article was to present and discuss the clinical outcomes of 7years of work involving 2116 women repaired in three hospitals across the country. MethodsThis was a retrospective cohort study using data abstracted from medical records for fistula repairs conducted from 2007 to 2013. The study data were reviewed during the period April to August 2014. ResultsThe majority of the 2116 women who underwent surgical repair had vesicovaginal fistula (n=2045, 97%) and 3% had rectovaginal fistula or a combination of both. Overall 1748 (83%) had a closed fistula and were continent of urine immediately after surgery. At discharge, 1795 women (85%) had a closed fistula and 1680 (79%) were dry, meaning they no longer leaked urine and/or faeces. One hundred and fifteen (5%) remained with residual incontinence despite fistula closure. Follow-up at 3months was completed by 1663 (79%) women of whom 1405 (84.5%) had their fistula closed and 80% were continent. Twenty-one per cent were lost to follow-up. ConclusionRoutine programmatic repair for obstetric fistula in low resources settings can yield good outcomes. However, more efforts are needed to address loss to follow-up, sustain the results and prevent the occurrence and/or recurrence of fistula. ObjectifsLa fistule genitale feminine reste un probleme de sante publique dans les pays en developpement. De janvier 2007 a septembre 2013, le projet Fistula Care, gere par Engender Health en partenariat avec le Ministere de la Sante et soutenu par l'USAID, a integre les services de reparation de fistules dans les maternites des hopitaux generaux en Guinee. L'objectif de cet article est de presenter et de discuter les resultats cliniques de sept annees de travail impliquant 2116 femmes traitees dans trois hopitaux a travers le pays. MethodesIl s'agit d'une etude de cohorte retrospective utilisant des donnees extraites des dossiers medicaux de reparations de fistules menees de 2007 a 2013. Les donnees de l'etude ont ete analysees au cours de la periode allant d'avril a aout 2014. ResultatsLa majorite des 2116 femmes qui ont subi une reparation chirurgicale avaient une fistule vesico vaginale (n=2 045, 97%) et 3% avaient une fistule recto vaginale ou une combinaison des deux. Au total, 1748 (83%) femmes ont eu leur fistule refermee et sont devenues continentes d'urine immediatement apres la chirurgie. la sortie, 1795 femmes (85%) avaient une fistule fermee et 1680 (79%) etaient seches, c'est a dire qu'elles n'avaient plus de fuite d'urine et/ou de matieres fecales. 115 (5%) femmes avaient toujours une incontinence residuelle malgre la fermeture de la fistule. Le suivi a trois mois a ete complete par 1663 (79%) femmes dont 1405 (84,5%) ont eu leur fistule fermee et 80% etaient continentes. 21% ont ete perdues au suivi. ConclusionLa reparation programmatique de routine de la fistule obstetricale dans les regions a faibles ressources peut donner de bons resultats. Toutefois, davantage d'efforts sont necessaires pour remedier a la perte au suivi, maintenir les resultats et prevenir l'apparition et/ou la reapparition de fistules. ObjetivosLa fistula genital femenina continua siendo una preocupacion de salud publica en paises en vias de desarrollo. Entre Enero 2007 y Septiembre 2013, el proyecto Fistula Care, manejado por EngenderHealth junto con el Ministerio de Salud de Guinea, y financiado por USAID, integro los servicios de reparacion de fistula en las maternidades de hospitales generales en Guinea. El objetivo de este articulo es presentar y discutir los resultados clinicos de 7 anos de trabajo con 2116 mujeres intervenidas en tres hospitales del pais. MetodosEstudio retrospectivo de cohortes utilizando datos tomados de historias clinicas de reparaciones de fistula realizadas entre el 2007 y el 2013. Los datos del estudio se revisaron durante el periodo entre Abril y Agosto 2014. ResultadosLa mayoria de las 2116 mujeres que se sometieron a la reparacion quirurgica tenian una fistula vesico-vaginal (n=2045, 97%) y 3% tenian una fistula recto-vaginal o una combinacion de ambas. En general, 1748 (83%) tenian la fistula cerrada y eran continentes inmediatamente despues de la cirugia. En el momento del alta, 1795 mujeres (85%) tenian la fistula cerrada y 1680 (79%) estaban secas, es decir que ya no perdian orina y/o heces. 115 (5%) continuaron teniendo incontinencia residual a pesar de que la fistula estaba cerrada. El seguimiento a los tres meses se completo para 1663 (79%) mujeres, de las cuales 1405 (84.5%) tenian la fistula cerrada y 80% eran continentes. Un 21% fueron perdidas durante el seguimiento. ConclusionLa reparacion rutinaria programada de la fistula obstetrica en lugares con pocos recursos puede dar buenos resultados. Sin embargo, se requieren mas esfuerzos para resolver la perdida durante el seguimiento, mantener los resultados y prevenir la aparicion y/o reaparicion de la fistula.	[Delamou, Alexandre; Zhang, Wei-Hong] Univ Libre Bruxelles, Ecole Sante Publ, Brussels, Belgium; [Delamou, Alexandre; Beavogui, Abdoul Habib] Ctr Natl Format & Rech Sante Rurale Maferinyah, Forecariah, Guinea; [Delamou, Alexandre; Delvaux, Therese; De Brouwere, Vincent] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Diallo, Moustapha; Millimono, Sita; Beattie, Karen; Ruminjo, Joseph] EngenderHlth, New York, NY USA; [Kourouma, Mamady] Minist Sante, Direct Natl Sante Familiale & Nutr, Conakry, Guinea; [Barry, Thierno Hamidou] Hop Prefectoral Kissidougou, Kissidougou, Guinea; [Khogali, Mohamed] MSF Luxembourg, Operat Ctr Brussels, Med Sans Frontieres, Luxembourg, Luxembourg; [Edginton, Mary] Int Union TB & Lung Dis, Paris, France; [Edginton, Mary] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Hinderaker, Sven Gudmund] Univ Bergen, Bergen, Norway	Delamou, A (reprint author), Ctr Natl Format & Rech Sante Rurale Maferinyah, POB 4099, Conakry, Guinea.	adelamou@gmail.com		Zhang, Wei-Hong/0000-0003-0380-770X	The Union, MSF; Department for International Development (DFID); WHO; U.S. Agency for International Development	This research was conducted through the Structured Operational Research and Training Initiative (SORT-IT), a global partnership led by the Special Programme for Research and Training in Tropical Diseases at WHO/TDR. The model is based on a course developed jointly by the International Union Against Tuberculosis and Lung Disease and Medecins sans Frontieres. The specific SORT-IT programme which resulted in this publication was jointly developed and implemented by Medecins Sans Frontieres, Luxembourg; the Centre for Operational Research, The Union, Paris, France; the Centre for International Health, University of Bergen, Norway; the Institute of Tropical Medicine, Antwerp, Belgium; The University of Nairobi, Kenya; and the University of Chester, United Kingdom. The programme was funded by The Union, MSF, the Department for International Development (DFID) and WHO. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Fistula Care was managed by EngenderHealth and funded by the U.S. Agency for International Development. Views expressed here do not necessarily reflect those of USAID, EngenderHealth or the Institute of Tropical Medicine of Antwerp.	Adler AJ, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-246; Arrowsmith SD, 2013, CURR OPIN OBSTET GYN, V25, P399, DOI 10.1097/GCO.0b013e3283648d60; Barone MA, 2012, OBSTET GYNECOL, V120, P524, DOI 10.1097/AOG.0b013e31826579e8; Barone MA, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-5; Bishinga A, 2013, PUBLIC HEALTH ACTION, V3, P113, DOI 10.5588/pha.13.0001; Browning A, 2008, BJOG-INT J OBSTET GY, V115, P1564, DOI 10.1111/j.1471-0528.2008.01900.x; Capes T, 2011, MT SINAI J MED, V78, P352, DOI 10.1002/msj.20265; Castille YJ, 2014, INT J GYNECOL OBSTET, V124, P77, DOI 10.1016/j.ijgo.2013.06.032; Delamou A, 2014, TROP MED INT HEALTH, V19, P65, DOI 10.1111/tmi.12219; Fistula C, 2013, PROJECT REPORT OCT 2; Frajzyngier V, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.02.006; Hawkins L, 2013, INT J GYNECOL OBSTET, V120, P178, DOI 10.1016/j.ijgo.2012.08.014; Institut National des Statistiques G, 2014, ENQ DEM SANT IND MUL; Kayondo M, 2011, BMC UROL, V11, DOI 10.1186/1471-2490-11-23; Landry E, 2013, GLOB PUBLIC HEALTH, V8, P926, DOI 10.1080/17441692.2013.824018; Leye MMM, 2012, SANTE PUBLIQUE, V24, P47; Longombe AO, 2008, REPROD HEALTH MATTER, V16, P132, DOI 10.1016/S0968-8080(08)31350-0; Maulet N, 2013, TROP MED INT HEALTH, V18, P524, DOI 10.1111/tmi.12086; Muleta M, 2010, ACTA OBSTET GYN SCAN, V89, P945, DOI 10.3109/00016341003801698; Nielsen HS, 2009, BJOG-INT J OBSTET GY, V116, P1258, DOI 10.1111/j.1471-0528.2009.02200.x; Osotimehin B, 2013, LANCET, V381, P1702, DOI 10.1016/S0140-6736(13)61001-6; Raassen TJIP, 2014, INT UROGYNECOL J, V25, P1699, DOI 10.1007/s00192-014-2445-3; Stanton C, 2007, INT J GYNECOL OBSTET, V99, pS4, DOI 10.1016/j.ijgo.2007.06.010; Tayler-Smith K, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-164; Umoiyoho Anifeiok J, 2012, Glob J Health Sci, V4, P40, DOI 10.5539/gjhs.v4n5p40; vonsElm E, 2008, J CLIN EPIDEMIOL, V61, P349; Wall LL, 2012, STUD FAMILY PLANN, V43, P255, DOI 10.1111/j.1728-4465.2012.00325.x; Wall LL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001769; Zheng AX, 2009, INT J GYNECOL OBSTET, V104, P85, DOI 10.1016/j.ijgo.2008.09.011	29	8	8	3	15	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	JUN	2015	20	6					813	819		10.1111/tmi.12489				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CH7AC	WOS:000354186900015	25706671	Green Published			2019-04-02	
J	Moti, Y; De Deken, R; Thys, E; Van den Abbeele, J; Duchateau, L; Delespaux, V				Moti, Y.; De Deken, R.; Thys, E.; Van den Abbeele, J.; Duchateau, L.; Delespaux, V.			PCR and microsatellite analysis of diminazene aceturate resistance of bovine trypanosomes correlated to knowledge, attitude and practice of livestock keepers in South-Western Ethiopia	ACTA TROPICA			English	Article						Trypanosoma; Congolense; 18S-PCR-RFLP; Microsatellite; PCV; Diminazene; Cattle; Ghibe; Ethiopia	TRYPANOCIDAL DRUG-RESISTANCE; PACKED CELL-VOLUME; ANIMAL TRYPANOSOMES; GHIBE VALLEY; CONGOLENSE RESISTANT; MOLECULAR TOOLS; EASTERN ZAMBIA; TSETSE CONTROL; BURKINA-FASO; CATTLE	African Animal Trypanosomosis is threatening the agricultural production and cattle breeding more severely than any other livestock disease in the continent, even more since the advent of drug resistance. A longitudinal study was conducted from November 2012 to May 2013 in the Ghibe valley to evaluate diminazene aceturate (DA) resistance and assess livestock owner's perception of trypanocidal drug use. Four Peasant Associations (PAs) were purposively selected and the cattle randomly sampled in each PAs. At the beginning of the study (t(0)), 106 bovines positive for trypanosomes by the haematocrit centrifugation technique (HCT) and 119 negative control animals were recruited for six months follow-up using HCT, 18S-PCR-RFLP, DpnII-PCR-RFLP and microsatellite analysis. Prevalence of trypanosomosis was 18.1% based on the HCT technique and the mean PCV value was 23.6 +/- 5.1% for the 587 sampled cattle. Out of the 106 HCT positive, 64 (60.4%) were positive for the presence of trypanosomes using the 18S-PCR-RFLP. Species detection showed 38 (59.4%) Trypanosoma congolense savannah, 18 (28.1%) Trypanosoma vivax, 5 (7.8%) Trypanosoma theileri and 3 (4.7%) T. congolense Kiln Among the T. congolense savannah samples, 31 (81.6%) showed a DA resistant RFLP profile, 2 (5.3%) a mixed profile and 5 did not amplify using the DpnII-PCR-RFLP. A positive HCT had a significant effect on PCV (p < 0.001) with the mean PCV value equal to 24.4 +/- 0.2% in the absence of trypanosomes and to 20.9 +/- 0.3% in the presence of trypanosomes. PCV increased significantly (p < 0.001) with 4.4 +/- 0.5% one month after treatment. All T. congolense savannah type were analyzed using microsatellite markers TCM1, TCM3 and TCM4. The main events were new infections (40.0%) and relapses (37.5%) with cures lagging at 22.5%. In 10 purposively selected PAs a semi-structured questionnaire was used. The average herd size was the highest in Abelti PA (6.7 +/- 1.8 TLU) and the mean herd size was statistically different (p = 0.01) in the 10 PAs. Trypanosomosis was designated as the main disease affecting cattle by 97% of the respondents. DA was used by 95.5% of the farmers though more than half of them (51.9%) were not familiar with isometamidium (ISM). There was a trend to overdose young small animals and to underdose large ones. Oxen were treated very frequently (nearly 20 times/year) and calves almost never. To improve the situation in the Ghibe valley, extension messages should be delivered to promote a rational drug use, improved livestock management and the application of strategic vector control methods. (C) 2015 Elsevier B.V. All rights reserved.	[Moti, Y.] Jimma Univ, Sch Vet Med, Dept Microbiol & Vet Publ Hlth, Jimma, Ethiopia; [De Deken, R.; Thys, E.; Van den Abbeele, J.; Delespaux, V.] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Moti, Y.; Duchateau, L.] Univ Ghent, Fac Vet Sci Comparat Physiol & Biometr, B-9820 Merelbeke, Belgium	Delespaux, V (reprint author), Inst Trop Med, Dept Biomed Sci, Natl Str 155, B-2000 Antwerp, Belgium.	vdelespaux@itg.be		Van Den Abbeele, Jan/0000-0002-4533-4480	VLIR-UOS, Institutional University Cooperation-Jimma University (IUC-JU) project [ZIUS2014AP014]	We would like to thank Lieve Vermeiren at the ITM for her help in the microsatellite analysis laboratory work. Our appreciation also extends to Bedele National Trypanosomosis and Tsetse Control Centre for their support during the longitudinal study field work. VLIR-UOS is also acknowledged for financial support for the whole trypanosomosis project in the framework of the Institutional University Cooperation-Jimma University (IUC-JU) project ZIUS2014AP014.	Abebe R, 2010, PARASITOL RES, V106, P911, DOI 10.1007/s00436-010-1758-5; Osorio ALAR, 2008, MEM I OSWALDO CRUZ, V103, P1, DOI 10.1590/S0074-02762008000100001; Awulachew S. B., 2007, 123 INT WAT MAN I, P1; BAUER B, 1995, TROP MED PARASITOL, V46, P183; CFSPH, 2009, AFR AN TRYP, P1; Cherenet T, 2004, ONDERSTEPOORT J VET, V71, P307; Chitanga S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001454; CODJIA V, 1993, ACTA TROP, V53, P151, DOI 10.1016/0001-706X(93)90026-8; Delespaux V, 2006, ACTA TROP, V100, P96, DOI 10.1016/j.actatropica.2006.10.001; Delespaux V, 2013, DRUG DISCOV INFEC DI, P335; Delespaux V, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000828; Delespaux V, 2008, DRUG RESIST UPDATE, V11, P205, DOI 10.1016/j.drup.2008.10.002; Desquesnes M, 2003, EXP PARASITOL, V105, P226, DOI 10.1016/j.exppara.2003.12.014; Desquesnes M, 2002, VET PARASITOL, V109, P213, DOI 10.1016/S0304-4017(02)00270-4; Duvallet G, 1999, MEM I OSWALDO CRUZ, V94, P245, DOI 10.1590/S0074-02761999000200023; FAO, 1983, AFR AN TRYP; FAO, 2002, PROGR AFR TRYP PAAT; Forman S, 2012, REV SCI TECH OIE, V31, P647; Getachew A., 2005, ETHIOP J BIOL SCI, V4, P75; Geysen D, 2003, VET PARASITOL, V110, P171, DOI 10.1016/S0304-4017(02)00313-8; Grace D., 2003, 4 ILRI, P1; Jahnke H. E., 1988, LIVESTOCK PRODUCTION, P3; Junqueira ACV, 1996, T ROY SOC TROP MED H, V90, P129, DOI 10.1016/S0035-9203(96)90111-X; Kebede N, 2009, TROP ANIM HEALTH PRO, V41, P1353, DOI 10.1007/s11250-009-9321-z; LEAK SGA, 1995, B ENTOMOL RES, V85, P241, DOI 10.1017/S0007485300034325; LEAK SGA, 1993, ACTA TROP, V53, P121, DOI 10.1016/0001-706X(93)90024-6; Machila N, 2003, ACTA TROP, V86, P25, DOI 10.1016/S0001-706X(02)00288-7; Mamoudou A, 2008, ACTA TROP, V106, P115, DOI 10.1016/j.actatropica.2008.02.003; Marcotty T, 2008, PREV VET MED, V87, P288, DOI 10.1016/j.prevetmed.2008.05.002; Mekuria S, 2011, ACTA TROP, V117, P146, DOI 10.1016/j.actatropica.2010.11.009; Morrison LJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005564; Moti Y, 2014, VET PARASITOL, V203, P253, DOI 10.1016/j.vetpar.2014.04.014; Moti Y, 2012, VET PARASITOL, V189, P197, DOI 10.1016/j.vetpar.2012.04.022; Mulugeta W, 1997, ACTA TROP, V64, P205, DOI 10.1016/S0001-706X(96)00645-6; Munday JC, 2013, INT J PARASITOL-DRUG, V3, P69, DOI 10.1016/j.ijpddr.2013.01.004; Mungube EO, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-164; Nicholson M J., 1986, GUIDE CONDITION SCOR; Pagabeleguem S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049762; Peregrine A, 1997, ANTIMICROB AGENTS CH, V41, P1604, DOI 10.1128/AAC.41.7.1604; Reid RS, 2000, LANDSCAPE ECOL, V15, P339, DOI 10.1023/A:1008177712995; Rowlands G. J., 2000, MED ENTOMOL, V15, P87; Rowlands GJ, 1999, TROP ANIM HEALTH PRO, V31, P279, DOI 10.1023/A:1005251722797; ROWLANDS GJ, 1993, ACTA TROP, V53, P135, DOI 10.1016/0001-706X(93)90025-7; Rowlands GJ, 2001, ACTA TROP, V79, P149, DOI 10.1016/S0001-706X(01)00068-7; Sinshaw A, 2006, VET PARASITOL, V142, P35, DOI 10.1016/j.vetpar.2006.06.032; Tafese W., 2012, ONDERSTEPOORT J VET, V79, P1; Tesfaye D, 2012, TROP ANIM HEALTH PRO, V44, P873, DOI 10.1007/s11250-011-9981-3; Tewelde N, 2004, ACTA TROP, V90, P163, DOI 10.1016/j.actatropica.2003.11.012; Torr SJ, 2007, MED VET ENTOMOL, V21, P53, DOI 10.1111/j.1365-2915.2006.00657.x; Van den Bossche P, 2000, ACTA TROP, V75, P247, DOI 10.1016/S0001-706X(00)00059-0; Van den Bossche P, 2001, ACTA TROP, V78, P163, DOI 10.1016/S0001-706X(00)00182-0; Vitouley H. S., 2011, PLOS NEGLECT TROP D, V5, P1223; Vitouley HS, 2012, VET PARASITOL, V190, P349, DOI 10.1016/j.vetpar.2012.07.015; WHO, 2012, WHO TECHNICAL REPORT, Vv-xii, P1; Woo P. T. K., 1970, Acta trop., V27, P384	55	5	5	1	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	JUN	2015	146						45	52		10.1016/j.actatropica.2015.02.015				8	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CI3QI	WOS:000354662100009	25738729				2019-04-02	
J	Dagnachew, S; Terefe, G; Abebe, G; Barry, D; McCulloch, R; Goddeeris, B				Dagnachew, Shimelis; Terefe, Getachew; Abebe, Getachew; Barry, Dave; McCulloch, Richard; Goddeeris, Bruno			In vivo experimental drug resistance study in Trypanosoma vivax isolates from tsetse infested and non-tsetse infested areas of Northwest Ethiopia	ACTA TROPICA			English	Article						Trypanosoma vivax; Drug resistance; Cattle; Northwest Ethiopia	AFRICAN TRYPANOSOMIASIS; CONGOLENSE POPULATIONS; BOVINE TRYPANOSOMIASIS; EASTERN PROVINCE; VILLAGE CATTLE; BURKINA-FASO; ISOMETAMIDIUM; INFECTIONS; GHIBE; MICE	Ethiopia, particularly in the Northwest region, is affected by both tsetse fly and non-tsetse fly transmitted trypanosomosis with a significant impact on livestock productivity. The control of trypanosomosis in Ethiopia relies on either curative or prophylactic treatment of animals with diminazene aceturate (DA) or isometamidium chloride (ISM), respectively. However, since these two trypanocides have been on the market for more than 40 years, this may have resulted in drug-resistance. Therefore, in vivo drug resistance tests on two Ethiopian isolates of Trypanosoma vivax were completed, one from an area where tsetse flies are present and one from an area where tsetse flies are not present. Twenty four cattle (Bos indicus) aged between 6 and 12 months, purchased from a trypanosome-free area (Debre Brehan: North-central Ethiopia) and confirmed to be trypanosome-negative, were randomly assigned into four groups of six animals, which were infected with T. vivax isolated from a tsetse-infested or non-tsetse infested area, and in each case treated with curative doses of DA or ISM. Each animal were inoculated intravenously 3 x 10(6) trypanosomes from donor animals. Parasitaemia became patent earlier in infections with non-tsetse T. vivax (similar to 7 days post-infection) than tsetse (similar to 14 days post-infection). Both groups were treated at the highest peak parasitaemia with DA or ISM and nine cattle, four with non-tsetse T. vivax (two ISM- and two DA-treated) and five with tsetse T. vivax (three ISM- and two DA-treated) showed relapses of parasitaemia. Moreover, treatment did not improve diagnostic host markers of trypanosome infections in these animals. In conclusion, in vivo drug tests indicated the presence of resistant parasites (>20% of treated animals in each group relapsed) against recommended doses of both available trypanocidal drugs. (C) 2015 Elsevier B.V. All rights reserved.	[Dagnachew, Shimelis; Terefe, Getachew] Univ Addis Ababa, Coll Vet Med & Agr, Debre Zeit, Ethiopia; [Abebe, Getachew] UN, FAO, Addis Ababa, Ethiopia; [Barry, Dave; McCulloch, Richard] Univ Glasgow, CMVLS, Glasgow G12 8TA, Lanark, Scotland; [Goddeeris, Bruno] Katholieke Univ Leuven, Fac Biosci Engn, B-3001 Heverlee, Belgium	Dagnachew, S (reprint author), Univ Addis Ababa, Coll Vet Med & Agr, POB 34, Debre Zeit, Ethiopia.	dagne2121@gmail.com	Goddeeris, Bruno/L-2440-2015	Goddeeris, Bruno/0000-0003-3729-7592	Ethio-Belgium VLIR Project [ZEIN2006PR324]; GALVmed; World Bank; Addis Ababa University; Biotechnology and Biological Sciences Research Council [BB/K006495/1]	The author would like to thank Bahir Dar Regional Veterinary Laboratory for logistic support and enthusiastic encouragement during the field work. This work was supported by Ethio-Belgium VLIR Project (grant No. ZEIN2006PR324), GALVmed, Robert S. McNamara Fellowships Program (RSM) of the World Bank and the thematic research project 'Animal Health Improvement' of Addis Ababa University.	Abebe G, 1996, REV MED VET-TOULOUSE, V147, P897; Ademe M., 2000, Bulletin of Animal Health and Production in Africa, V48, P131; Afewerk Y, 2000, ACTA TROP, V76, P231, DOI 10.1016/S0001-706X(00)00108-X; Aiello S. E., 1998, MERCK VET MANUAL, V8th, P2191; Akinwale O. P., 1999, NIGER J PARASITOL, V20, P27; Barrett M. P., 2004, The trypanosomiases, P445, DOI 10.1079/9780851994758.0445; CONNOR RJ, 1986, TROP ANIM HEALTH PRO, V18, P127, DOI 10.1007/BF02359520; Council of International Organizations of Medical Sciences (CIOMS), 1985, INT GUID PRINC BIOM; Dagnachew Shimelis, 2005, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V58, P151; Delespaux V, 2002, VET PARASITOL, V110, P117, DOI 10.1016/S0304-4017(02)00316-3; Desalegn W. Y., 2010, ETHIOP VET J, V14, P15; Duffy CW, 2009, INT J PARASITOL, V39, P1475, DOI 10.1016/j.ijpara.2009.05.012; Eisler MC, 2001, VET PARASITOL, V97, P171, DOI 10.1016/S0304-4017(01)00415-0; Fairclough R., 1963, Veterinary Record, V75, P855; Fikru R, 2012, VET PARASITOL, V190, P355, DOI 10.1016/j.vetpar.2012.07.010; Geerts S, 2001, TRENDS PARASITOL, V17, P25, DOI 10.1016/S1471-4922(00)01827-4; Geerts S, 1998, PAAT TECHNICAL SCI S, V1, P31; Getachew Abebe, 2005, Ethiopian Journal of Biological Sciences, V4, P75; HERBERT WJ, 1976, EXP PARASITOL, V40, P427, DOI 10.1016/0014-4894(76)90110-7; Hoare C. A., 1972, TRYPANOSOMES MAMMALS; Holmes P. H., 1976, Pathophysiology of parasitic infection (Proc. 7th Internat. Conf. World Ass. Adv. Vet. Parasit., Thessaloniki, Greece 14-16 July, 1975)., P199; KUPPER W, 1983, TROPENMED PARASITOL, V34, P203; LEEFLANG P, 1976, INT J PARASITOL, V6, P413, DOI 10.1016/0020-7519(76)90027-8; MASIGA DK, 1992, INT J PARASITOL, V22, P909, DOI 10.1016/0020-7519(92)90047-O; Mattioli RC, 2004, J FOOD AGRIC ENVIRON, V2, P310; Moti Y, 2012, VET PARASITOL, V189, P197, DOI 10.1016/j.vetpar.2012.04.022; Mulugeta W, 1997, ACTA TROP, V64, P205, DOI 10.1016/S0001-706X(96)00645-6; Mungube EO, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-155; MURRAY M, 1977, T ROY SOC TROP MED H, V71, P325, DOI 10.1016/0035-9203(77)90110-9; MURRAY M, 1988, ACTA TROP, V45, P389; Olila D, 2002, ACTA TROP, V84, P19, DOI 10.1016/S0001-706X(02)00137-7; ROTTCHER D, 1985, VET REC, V117, P557, DOI 10.1136/vr.117.21.557; ROWLANDS GJ, 1993, ACTA TROP, V53, P135, DOI 10.1016/0001-706X(93)90025-7; SEKONI VO, 1990, VET PARASITOL, V35, P11, DOI 10.1016/0304-4017(90)90112-O; Shimelis D., 2008, ETHIOP VET J, V12, P45; Sinshaw A, 2006, VET PARASITOL, V142, P35, DOI 10.1016/j.vetpar.2006.06.032; Soulsby E.J.L., 1982, HELMINTHS ARTHROPODS, P630; Sow A, 2012, VET PARASITOL, V187, P105, DOI 10.1016/j.vetpar.2011.12.019; Spence PJ, 2013, NATURE, V498, P228, DOI 10.1038/nature12231; Swallow B.M., 2002, PAAT TECHNICAL SCI S, V2, P35; Tewelde N, 2004, ACTA TROP, V90, P163, DOI 10.1016/j.actatropica.2003.11.012; TURNER CMR, 1995, PARASITOLOGY, V111, P289, DOI 10.1017/S0031182000081841; Van den Bossche P, 2000, ACTA TROP, V75, P247, DOI 10.1016/S0001-706X(00)00059-0; Vitouley HS, 2012, VET PARASITOL, V190, P349, DOI 10.1016/j.vetpar.2012.07.015	44	6	6	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	JUN	2015	146						95	100		10.1016/j.actatropica.2015.03.014				6	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CI3QI	WOS:000354662100016	25792418				2019-04-02	
J	Mathis, A; Depaquit, J; Dvorak, V; Tuten, H; Banuls, AL; Halada, P; Zapata, S; Lehrter, V; Hlavackova, K; Prudhomme, J; Volf, P; Sereno, D; Kaufmann, C; Pfluger, V; Schaffner, F				Mathis, Alexander; Depaquit, Jerome; Dvorak, Vit; Tuten, Holly; Banuls, Anne-Laure; Halada, Petr; Zapata, Sonia; Lehrter, Veronique; Hlavackova, Kristyna; Prudhomme, Jorian; Volf, Petr; Sereno, Denis; Kaufmann, Christian; Pflueger, Valentin; Schaffner, Francis			Identification of phlebotomine sand flies using one MALDI-TOF MS reference database and two mass spectrometer systems	PARASITES & VECTORS			English	Article						Arthropod identification; Bruker; Centralized reference database; Cross reference; Phlebotominae; Protein Profiling; Shimadzu; Spectra processing; Validation	DESORPTION IONIZATION-TIME; CULICOIDES BITING MIDGES; DIPTERA-PSYCHODIDAE; SPECIES IDENTIFICATION; DEVELOPMENTAL-STAGES; INVASIVE MOSQUITOS; LEISHMANIA-TROPICA; RANGE EXPANSION; SANDFLIES; VECTORS	Background: Rapid, accurate and high-throughput identification of vector arthropods is of paramount importance in surveillance programmes that are becoming more common due to the changing geographic occurrence and extent of many arthropod-borne diseases. Protein profiling by MALDI-TOF mass spectrometry fulfils these requirements for identification, and reference databases have recently been established for several vector taxa, mostly with specimens from laboratory colonies. Methods: We established and validated a reference database containing 20 phlebotomine sand fly (Diptera: Psychodidae, Phlebotominae) species by using specimens from colonies or field-collections that had been stored for various periods of time. Results: Identical biomarker mass patterns ('superspectra') were obtained with colony-or field-derived specimens of the same species. In the validation study, high quality spectra (i.e. more than 30 evaluable masses) were obtained with all fresh insects from colonies, and with 55/59 insects deep-frozen (liquid nitrogen/-80 degrees C) for up to 25 years. In contrast, only 36/52 specimens stored in ethanol could be identified. This resulted in an overall sensitivity of 87 % (140/161); specificity was 100 %. Duration of storage impaired data counts in the high mass range, and thus cluster analyses of closely related specimens might reflect their storage conditions rather than phenotypic distinctness. A major drawback of MALDI-TOF MS is the restricted availability of in-house databases and the fact that mass spectrometers from 2 companies (Bruker, Shimadzu) are widely being used. We have analysed fingerprints of phlebotomine sand flies obtained by automatic routine procedure on a Bruker instrument by using our database and the software established on a Shimadzu system. The sensitivity with 312 specimens from 8 sand fly species from laboratory colonies when evaluating only high quality spectra was 98.3 %; the specificity was 100 %. The corresponding diagnostic values with 55 field-collected specimens from 4 species were 94.7 % and 97.4 %, respectively. Conclusions: A centralized high-quality database (created by expert taxonomists and experienced users of mass spectrometers) that is easily amenable to customer-oriented identification services is a highly desirable resource. As shown in the present work, spectra obtained from different specimens with different instruments can be analysed using a centralized database, which should be available in the near future via an online platform in a cost-efficient manner.	[Mathis, Alexander; Tuten, Holly; Kaufmann, Christian; Schaffner, Francis] Univ Zurich, Inst Parasitol, Swiss Natl Ctr Vector Entomol, CH-8057 Zurich, Switzerland; [Depaquit, Jerome; Lehrter, Veronique] Univ Reims, ANSES, USC Transmiss Vectorielle & Epidemiosurveillance, SFR Cap Sante,EA4688, F-51096 Reims, France; [Dvorak, Vit; Hlavackova, Kristyna; Volf, Petr] Charles Univ Prague, Fac Sci, Dept Parasitol, CR-12844 Prague, Czech Republic; [Banuls, Anne-Laure; Prudhomme, Jorian; Sereno, Denis] Univ Montpellier, CNRS, MIVEGEC, UMR,Ctr IRD,Vinicna 7, F-34394 Montpellier, France; [Halada, Petr] Acad Sci Czech Republic, Inst Microbiol, Lab Mol Struct Characterizat, Videnska 1083, Prague 14220 4, Czech Republic; [Zapata, Sonia] Univ San Francisco Quito, Inst Microbiol, Quito, Ecuador; [Pflueger, Valentin] Mabritec SA, CH-4125 Riehen, Switzerland; [Schaffner, Francis] Avia GIS, B-2980 Zoersel, Belgium	Mathis, A (reprint author), Univ Zurich, Inst Parasitol, Swiss Natl Ctr Vector Entomol, Winterthurerstr 266a, CH-8057 Zurich, Switzerland.	alexander.mathis@uzh.ch	Volf, Petr/C-4300-2012; Halada, Petr/H-3330-2014; Dvorak, Vit/F-3852-2011	Volf, Petr/0000-0003-1790-1123; Dvorak, Vit/0000-0001-5636-7483; Sereno, Denis/0000-0002-0034-9291; Schaffner, Francis/0000-0001-9166-7617; Banuls, Anne-Laure/0000-0002-2106-8667; Prudhomme, Jorian/0000-0002-3672-2692	Czech Science Foundation [GACR 15-04329S]; Institutional Research Project of the Institute of Microbiology [RVO61388971]; EDENext project [EDENext329]; Swiss National Centre for Vector Entomology; Swiss Food Safety and Veterinary Office	We thank Jeannine Hauri for excellent technical support, and greatly acknowledge the Swiss Food Safety and Veterinary Office as sponsor of the Swiss National Centre for Vector Entomology. We also thank Bernard Pesson and Mohammad Akhoundi for providing us many specimens. The work of AM, VD, HT, CK and FS was done under the frame of EurNegVec COST Action TD1303. The work of VD, PH, PV and KH was supported by the Czech Science Foundation (project GACR 15-04329S). The work of PH was also supported by the Institutional Research Project of the Institute of Microbiology (RVO61388971). The work of ALB, JP and DS has been supported by the EDENext project (reference nr. EDENext329). We are also grateful to the PhDB group of Montpellier for the field collection.	Alby K, 2013, J CLIN MICROBIOL, V51, P3852, DOI 10.1128/JCM.01618-13; Alkan C, 2013, ANTIVIR RES, V100, P54, DOI 10.1016/j.antiviral.2013.07.005; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Aransay AM, 2000, INSECT MOL BIOL, V9, P157, DOI 10.1046/j.1365-2583.2000.00168.x; Campbell PM, 2005, SYST ENTOMOL, V30, P186, DOI 10.1111/j.1365-3113.2004.00279.x; Croxatto A, 2012, FEMS MICROBIOL REV, V36, P380, DOI 10.1111/j.1574-6976.2011.00298.x; DEDET J-P, 1984, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V22, P99; Depaquit J, 2002, INT J PARASITOL, V32, P1123, DOI 10.1016/S0020-7519(02)00088-7; Depaquit J, 2014, INFECT GENET EVOL, V28, P744, DOI 10.1016/j.meegid.2014.10.027; Depaquit J, 2013, INFECT GENET EVOL, V20, P500, DOI 10.1016/j.meegid.2013.10.006; Depaquit J, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-5; Dergousoff SJ, 2013, J MED ENTOMOL, V50, P510, DOI 10.1603/ME12193; Dieme C, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0544-0; Dvorak V, 2011, J VECTOR ECOL, V36, pS49, DOI 10.1111/j.1948-7134.2011.00111.x; Dvorak V, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-21; Esseghir S, 1997, INSECT MOL BIOL, V6, P211, DOI 10.1046/j.1365-2583.1997.00175.x; European Centre for Disease Prevention and Control, 2014, TECHNICAL REPORT, DOI [10.2900/37227, DOI 10.2900/37227]; Feltens R, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-95; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Hoppenheit A, 2014, PARASITOL RES, V113, P723, DOI 10.1007/s00436-013-3701-z; Hoppenheit A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002305; Jaenson TGT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-8; Karger A, 2012, TICKS TICK-BORNE DIS, V3, P78, DOI 10.1016/j.ttbdis.2011.11.002; Kaufmann C, 2011, MED VET ENTOMOL, V25, P32, DOI 10.1111/j.1365-2915.2010.00927.x; Kaufmann C, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-246; Kaufmann C, 2012, PARASITOLOGY, V139, P248, DOI 10.1017/S0031182011001764; Lewis D.J., 1982, Bulletin of the British Museum (Natural History) Entomology, V45, P121; Lohmann C, 2013, J CLIN MICROBIOL, V51, P1231, DOI 10.1128/JCM.03268-12; Marcondes CB, 2007, ENTOMOL NEWS, V118, P351, DOI 10.3157/0013-872X(2007)118[351:APOGAS]2.0.CO;2; Maroli M, 2013, MED VET ENTOMOL, V27, P123, DOI 10.1111/j.1365-2915.2012.01034.x; Medlock JM, 2014, J VECTOR ECOL, V39, P72, DOI 10.1111/j.1948-7134.2014.12072.x; Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814; Mellmann A, 2009, J CLIN MICROBIOL, V47, P3732, DOI 10.1128/JCM.00921-09; Muller P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057486; Nolan DV, 2008, MED VET ENTOMOL, V22, P340, DOI 10.1111/j.1365-2915.2008.00744.x; Parvizi Parviz, 2006, Iranian Biomedical Journal, V10, P69; Perera MR, 2005, ENTOMOL EXP APPL, V117, P243, DOI 10.1111/j.1570-7458.2005.00353.x; Poeppl W, 2013, PARASITOL RES, V112, P4231, DOI 10.1007/s00436-013-3615-9; Posterard B, 2013, EXPERT REV PROTEOMIC, V10, P151, DOI [10.1586/epr.13.8, 10.1586/EPR.13.8]; Prudhomme J, 2012, J VECTOR ECOL, V37, P137, DOI 10.1111/j.1948-7134.2012.00210.x; Ready PD, 2013, ANNU REV ENTOMOL, V58, P227, DOI 10.1146/annurev-ento-120811-153557; Schaffner F, 2009, MED VET ENTOMOL, V23, P448, DOI 10.1111/j.1365-2915.2009.00825.x; Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5; Schaffner F, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-142; Schaffner F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-209; Steinmann IC, 2013, PARASITOLOGY, V140, P318, DOI 10.1017/S0031182012001618; Wenk CE, 2012, VET PARASITOL, V184, P258, DOI 10.1016/j.vetpar.2011.08.034; Young DG, 1994, MEM AM ENTOMOL I, V54; Yssouf A, 2014, COMP IMMUNOL MICROB, V37, P153, DOI 10.1016/j.cimid.2014.05.002; Yssouf A, 2014, PARASITOL RES, V113, P2375, DOI 10.1007/s00436-014-3876-y; Yssouf A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072380; Yssouf A, 2013, J CLIN MICROBIOL, V51, P522, DOI 10.1128/JCM.02665-12; Zapata S, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-144	53	22	22	2	20	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	MAY 10	2015	8								266	10.1186/s13071-015-0878-2				9	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CI0NJ	WOS:000354433600001	25957576	DOAJ Gold, Green Published			2019-04-02	
J	Rosas-Aguirre, A; Erhart, A; Llanos-Cuentas, A; Branch, O; Berkvens, D; Abatih, E; Lambert, P; Frasso, G; Rodriguez, H; Gamboa, D; Sihuincha, M; Rosanas-Urgell, A; D'Alessandro, U; Speybroeck, N				Rosas-Aguirre, Angel; Erhart, Annette; Llanos-Cuentas, Alejandro; Branch, Oralee; Berkvens, Dirk; Abatih, Emmanuel; Lambert, Philippe; Frasso, Gianluca; Rodriguez, Hugo; Gamboa, Dionicia; Sihuincha, Moises; Rosanas-Urgell, Anna; D'Alessandro, Umberto; Speybroeck, Niko			Modelling the potential of focal screening and treatment as elimination strategy for Plasmodium falciparum malaria in the Peruvian Amazon Region	PARASITES & VECTORS			English	Article						Malaria; Plasmodium falciparum; Focal Screening and Treatment (FSAT); Modelling; Elimination; Peru	ASYMPTOMATIC CARRIERS; VIVAX-MALARIA; TRANSMISSION; INFECTION; COMMUNITY; PARASITEMIA; BRAZIL; RISK; POPULATIONS; MOSQUITOS	Background: Focal screening and treatment (FSAT) of malaria infections has recently been introduced in Peru to overcome the inherent limitations of passive case detection (PCD) and further decrease the malaria burden. Here, we used a relatively straightforward mathematical model to assess the potential of FSAT as elimination strategy for Plasmodium falciparum malaria in the Peruvian Amazon Region. Methods: A baseline model was developed to simulate a scenario with seasonal malaria transmission and the effect of PCD and treatment of symptomatic infections on the P. falciparum malaria transmission in a low endemic area of the Peruvian Amazon. The model was then adjusted to simulate intervention scenarios for predicting the long term additional impact of FSAT on P. falciparum malaria prevalence and incidence. Model parameterization was done using data from a cohort study in a rural Amazonian community as well as published transmission parameters from previous studies in similar areas. The effect of FSAT timing and frequency, using either microscopy or a supposed field PCR, was assessed on both predicted incidence and prevalence rates. Results: The intervention model indicated that the addition of FSAT to PCD significantly reduced the predicted P. falciparum incidence and prevalence. The strongest reduction was observed when three consecutive FSAT were implemented at the beginning of the low transmission season, and if malaria diagnosis was done with PCR. Repeated interventions for consecutive years (10 years with microscopy or 5 years with PCR), would allow reaching near to zero incidence and prevalence rates. Conclusions: The addition of FSAT interventions to PCD may enable to reach P. falciparum elimination levels in low endemic areas of the Amazon Region, yet the progression rates to those levels may vary substantially according to the operational criteria used for the intervention.	[Rosas-Aguirre, Angel; Llanos-Cuentas, Alejandro] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima 31, Peru; [Rosas-Aguirre, Angel; Erhart, Annette; Berkvens, Dirk; Abatih, Emmanuel; Rosanas-Urgell, Anna] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Rosas-Aguirre, Angel; Lambert, Philippe; Speybroeck, Niko] Catholic Univ Louvain, Res Inst Hlth & Soc IRSS, B-1200 Brussels, Belgium; [Branch, Oralee] NYU, Dept Med Parasitol, New York, NY 10012 USA; [Lambert, Philippe; Frasso, Gianluca] Univ Liege, Inst Sci Humaines & Sociales, B-4000 Liege, Belgium; [Rodriguez, Hugo] Reg Salud Loreto, Iquitos 160, Loreto, Peru; [Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Dept Ciencias Celulares & Mol, Lima 31, Peru; [Sihuincha, Moises] Univ Nacl Amazonia Peruana, Fac Med, Iquitos 160, Loreto, Peru; [D'Alessandro, Umberto] MRC Unit, Dis Control & Eliminat, Fajara 220, Gambia; [D'Alessandro, Umberto] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	Rosas-Aguirre, A (reprint author), Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima 31, Peru.	angelrosasa@gmail.com	Rosas Aguirre, Angel/A-5054-2016	Rosas Aguirre, Angel/0000-0002-3271-7028; Gamboa, Dionicia/0000-0002-1420-7729	Institute of Tropical Medicine "Alexander von Humboldt" - Universidad Peruana Cayetano Heredia, Lima; Institute of Tropical Medicine in Antwerp, Belgium (FA3-II project); National Institute of Allergy and Infectious Diseases-National Institutes of Health (NIAID-NIH) [R01 AI64831]	The study was funded by the Directorate General for Development Cooperation (DGCD) of the Belgian Government within the Third Framework Agreement of the Institutional Collaboration between the Institute of Tropical Medicine "Alexander von Humboldt" - Universidad Peruana Cayetano Heredia, Lima and the Institute of Tropical Medicine in Antwerp, Belgium (FA3-II project, 2011-2013)). Data of a cohort study in a rural community of the Peruvian Amazon were collected as part of the Malaria Immunology and Genetics project (MIGIA) which was funded by National Institute of Allergy and Infectious Diseases-National Institutes of Health (NIAID-NIH, R01 AI64831).	Alves FP, 2005, J MED ENTOMOL, V42, P777, DOI 10.1603/0022-2585(2005)042[0777:ACOPSA]2.0.CO;2; Anderson RM, 1991, INFECT DIS HUMANS DY; Babiker HA, 1998, AM J TROP MED HYG, V59, P582, DOI 10.4269/ajtmh.1998.59.582; Barbosa S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003109; Branch O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-27; Churcher TS, 2013, ELIFE, V2, DOI 10.7554/eLife.00626; Clark EH, 2012, INFECT IMMUN, V80, P1583, DOI 10.1128/IAI.05961-11; Coura JR, 2006, MEM I OSWALDO CRUZ, V101, P229, DOI 10.1590/S0074-02762006000300001; da Silva NS, 2010, T ROY SOC TROP MED H, V104, P343, DOI 10.1016/j.trstmh.2009.12.010; da Silva-Nunes M, 2007, MEM I OSWALDO CRUZ, V102, P341, DOI 10.1590/S0074-02762007005000051; da Silva-Nunes M, 2012, ACTA TROP, V121, P281, DOI 10.1016/j.actatropica.2011.10.001; Freeman J, 1999, AM J TROP MED HYG, V60, P774, DOI 10.4269/ajtmh.1999.60.774; GARRETTJONES C, 1964, NATURE, V204, P1173, DOI 10.1038/2041173a0; Griffin JT, 2010, PLOS MED, V7; HAMBY DM, 1994, ENVIRON MONIT ASSESS, V32, P135, DOI 10.1007/BF00547132; Hiwat H, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-177; Hopkins H, 2013, J INFECT DIS, V208, P645, DOI 10.1093/infdis/jit184; Hoyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045797; Kern SE, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-210; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Ladeia-Andrade S, 2009, AM J TROP MED HYG, V80, P452, DOI 10.4269/ajtmh.2009.80.452; Lin JT, 2014, TRENDS PARASITOL, V30, P183, DOI 10.1016/j.pt.2014.02.004; *MALERA CONS GROUP, 2011, PLOS MED, V0008; *MALERA CONS GROUP, 2011, PLOS MED, V0008; Mandal S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-202; Cucunuba ZM, 2013, T ROY SOC TROP MED H, V107, P129, DOI 10.1093/trstmh/trs021; Ministerio de Salud del Peru, 2013, BOL EPIDEMIOL, V22, P1088; Moiroux N, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-71; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; Nawaz H, 2001, AM J TROP MED HYG, V65, P252, DOI 10.4269/ajtmh.2001.65.252; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Parekh FK, 2007, AM J TROP MED HYG, V77, P451, DOI 10.4269/ajtmh.2007.77.451; Parker BS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-178; Rosas-Aguirre Angel, 2011, Rev. perú. med. exp. salud publica, V28, P228, DOI 10.1590/s1726-46342011000200009; Roshanravan B, 2003, AM J TROP MED HYG, V69, P45, DOI 10.4269/ajtmh.2003.69.45; Soetaert K, 2011, JNAIAM, V6, P51; Sturrock HJW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001467; Suárez-Mutis Martha C., 2007, Rev. Inst. Med. trop. S. Paulo, V49, P159, DOI 10.1590/S0036-46652007000300005; Sutcliffe CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031396; Sutton PL, 2009, AM J TROP MED HYG, V81, P950, DOI 10.4269/ajtmh.2009.09-0132; Taylor SM, 2010, J CLIN MICROBIOL, V48, P512, DOI 10.1128/JCM.01800-09; Tiono AB, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-79; Tynan A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-204; Van den Eede P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016257; Vinetz JM, 2002, AM J TROP MED HYG, V66, P639, DOI 10.4269/ajtmh.2002.66.639; World Health Organization, 2012, DIS SURV MAL EL; World Health Organization, 2009, MAL LIGHT MICR CREAT; Yamana TK, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-226	48	7	7	0	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	MAY 7	2015	8								261	10.1186/s13071-015-0868-4				12	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CH7TA	WOS:000354238300002	25948081	DOAJ Gold, Green Published			2019-04-02	
J	Diro, E; Lynen, L; Assefa, M; Takele, Y; Mengesha, B; Adem, E; Mohammed, R; Kimutai, R; Hailu, A; Boelaert, M; van Griensven, J				Diro, Ermias; Lynen, Lutgarde; Assefa, Mahlet; Takele, Yegnasew; Mengesha, Bewketu; Adem, Emebet; Mohammed, Rezika; Kimutai, Robert; Hailu, Asrat; Boelaert, Marleen; van Griensven, Johan			Impact of the Use of a Rapid Diagnostic Test for Visceral Leishmaniasis on Clinical Practice in Ethiopia: A Retrospective Study	PLOS NEGLECTED TROPICAL DISEASES			English	Article							DIRECT AGGLUTINATION-TEST; RK39 STRIP TEST; KALA-AZAR; NORTHWEST ETHIOPIA; FIELD-EVALUATION; DIPSTICK; UGANDA; KATEX; SUDAN; DAT	Background Diagnostic guidelines for Visceral Leishmaniasis (VL) in the East African region are complex. Patients meeting the VL clinical case definition should be tested by rK39 rapid diagnostic test (RDT) followed by the Direct Agglutination Test (DAT) or tissue aspiration if RDT-negative. Otherwise, RDT-positive patients should be started on VL treatment. We evaluated how this guideline is adhered to by assessing the routine clinical practice in a university hospital in North-West Ethiopia. Methods Retrospective record analysis was done for all patients who had an rK39-RDT done at University of Gondar (UoG) Hospital between June 2012 and June 2013. We described the diagnostic work-up performed and the proportion initiated on VL treatment by test result. Results/Findings From a total of 928 patients tested, 308 (33.2%) were rK39 RDT-positive. Spleen or bone marrow aspiration was done for 237 (77.2%) RDT-positive patients. Of these, 165 were confirmed parasitologically, yielding a positive predictive value of 69.6%. Only 126 (20.3%) of the 620 patients with a negative rK39 test underwent further testing by tissue aspiration, of which 22 (17.5%) were also parasitology positive. HIV test results were available for 570 (61.4%) patients and 36 (6.3%) were HIV-infected. Of the 187 parasitologically confirmed patients, 182 (97.3%) were started on VL treatment. Conclusions / Discussion A negative rK39 test was often not followed by further testing and a positive rK39 test result was followed by tissue aspiration in three out of four cases. Further research is required to understand why the diagnostic work-up did not comply with the guidelines, including evaluating adherence to the VL clinical case definition and quality of rK39-RDT testing.	[Diro, Ermias; Takele, Yegnasew; Mengesha, Bewketu; Adem, Emebet; Mohammed, Rezika] Univ Gondar, Gondar, Ethiopia; [Diro, Ermias; Lynen, Lutgarde; Boelaert, Marleen; van Griensven, Johan] Inst Trop Med, B-2000 Antwerp, Belgium; [Assefa, Mahlet] Yale Univ, Hartford, CT USA; [Kimutai, Robert] Drugs Neglected Dis Initiat DNDi Africa, Nairobi, Kenya; [Hailu, Asrat] Univ Addis Ababa, Addis Ababa, Ethiopia	Diro, E (reprint author), Univ Gondar, Gondar, Ethiopia.	Ermi_diro@yahoo.com		Boelaert, Marleen/0000-0001-8051-6776; Takele, Yegnasew/0000-0003-1070-7459	European Union [305178]; Drugs for Neglected Diseases initiative; Belgian Directorate General for Development Cooperation under the ITM-DGDC framework agreement FA-III	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 305178 via AfriCoLeish project, and the Drugs for Neglected Diseases initiative. ED has received a PhD scholarship granted from the Belgian Directorate General for Development Cooperation under the ITM-DGDC framework agreement FA-III and from the European Union Seventh Framework Programme through AfriCoLeish Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, GUID MAN OPP INF ANT; Boelaert M, 2008, T ROY SOC TROP MED H, V102, P32, DOI 10.1016/j.trstmh.2007.09.003; Boelaert M, 2004, AM J TROP MED HYG, V70, P72, DOI 10.4269/ajtmh.2004.70.72; Boelaert M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009135.pub2; Canavate C, 2011, AM J TROP MED HYG, V84, P102, DOI 10.4269/ajtmh.2011.10-0229; Chappuis F, 2003, TROP MED INT HEALTH, V8, P277, DOI 10.1046/j.1365-3156.2003.01026.x; Chappuis F, 2005, J CLIN MICROBIOL, V43, P5973, DOI 10.1128/JCM.43.12.5973-5977.2005; Chappuis F, 2006, BRIT MED J, V333, P723, DOI 10.1136/bmj.38917.503056.7C; Cunningham J, 2012, CLIN INFECT DIS, V55, P1312, DOI 10.1093/cid/cis716; Diro E, 2007, T ROY SOC TROP MED H, V101, P908, DOI 10.1016/j.trstmh.2007.05.002; Federal Ministry of Health Ethiopia, 2013, GUID DIAGN TREATM PR; Hurissa Z, 2010, TROP MED INT HEALTH, V15, P848, DOI 10.1111/j.1365-3156.2010.02550.x; Mengistu G, 2007, ETHIOP J HEALTH DEV, V21, P53; Mueller YK, 2014, AM J TROP MED HYG, V90, P33, DOI 10.4269/ajtmh.13-0150; Ritmeijer K, 2006, AM J TROP MED HYG, V74, P76, DOI 10.4269/ajtmh.2006.74.76; Rouf M A, 2009, Mymensingh Med J, V18, pS1; Singh DP, 2010, J HEALTH POPUL NUTR, V28, P281; Srividya G, 2012, PARASITOL RES, V110, P1065, DOI 10.1007/s00436-011-2680-1; Sundar S, 2006, T ROY SOC TROP MED H, V100, P533, DOI 10.1016/j.trstmh.2005.08.018; Sundar S, 2012, NATL MED J INDIA, V25, P85; ter Horst R, 2009, AM J TROP MED HYG, V80, P929, DOI 10.4269/ajtmh.2009.80.929; van Griensven J, 2012, INFECT DIS CLIN N AM, V26, P309, DOI 10.1016/j.idc.2012.03.005; Veeken H, 2003, TROP MED INT HEALTH, V8, P164, DOI 10.1046/j.1365-3156.2003.00996.x; WHO, 2010, WHO TECH REP SER, V949, P1; World Health Organization and UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, 2011, WHO DIAGN EV SER, V4; Zijlstra EE, 2001, TROP MED INT HEALTH, V6, P108, DOI 10.1046/j.1365-3156.2001.00680.x	26	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAY	2015	9	5							e0003738	10.1371/journal.pntd.0003738				11	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CJ2HA	WOS:000355303600017	25965564	DOAJ Gold, Green Published			2019-04-02	
J	Bradbury, RS; Barbe, B; Jacobs, J; Jallow, AT; Camara, KC; Colley, M; Wegmuller, R; Jassey, B; Cham, Y; Baldeh, I; Prentice, A				Bradbury, Richard S.; Barbe, Barbara; Jacobs, Jan; Jallow, Amadou T.; Camara, Karamo C.; Colley, Musa; Wegmueller, Rita; Jassey, Babucarr; Cham, Yorro; Baldeh, Ignatius; Prentice, Andrew			Enteric pathogens of food sellers in rural Gambia with incidental finding of Myxobolus species (Protozoa: Myxozoa)	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Africa; Food sellers; Gambia; Myxozoa; Parasitology; Salmonella	NON-TYPHOIDAL SALMONELLA; AGED 2-29 MONTHS; STOOL SAMPLES; CHILDREN; AFRICA; IDENTIFICATION; ALBENDAZOLE; MEBENDAZOLE; INFECTIONS; TRICHURIS	Background: Ongoing surveillance of enteric pathogens of public health significance among casual food sellers is undertaken in many resource-limited countries. We report the results of a survey in Kiang West province, The Gambia, and provide an exemplar methodology for such surveys in resource-limited laboratories. Methods: Unpreserved, unrefrigerated stool samples were subjected to Salmonella, Shigella and agar plate culture for rhabditoid nematodes. Direct microscopy, formalin-ethyl acetate concentration and iron-hematoxylin staining was performed later, following preservation. Results: Of 128 specimens received, no Shigella spp. was recovered, while four serovars of non-typhoidal Salmonella enterica, including Chandans, were isolated. Pathogenic parasitic infections were Necator americanus 10/128 (7.8%), Strongyloides stercoralis 3/128 (2.8%), Blastocystis species 45/128 (35.1%), Entamoeba histolytica complex 19/128 (14.8%) and Giardia intestinalis 4/128 (3.1%). A single case each of Hymenolepis diminuta and S. mansoni infection were detected. In one participant, myxozoan spores identical to those of Myxobolus species were found. Conclusions: Rare parasitoses and serovars of Salmonella enterica may occur relatively commonly in rural Africa. This paper describes intestinal pathogens found in a cohort of food sellers in such a setting. Furthermore, it describes two parasites rarely recovered from humans and demonstrates the need for methods other than microscopy to detect S. stercoralis infections.	[Bradbury, Richard S.; Jallow, Amadou T.; Camara, Karamo C.; Colley, Musa; Wegmueller, Rita; Prentice, Andrew] MRC Gambia, MRC Keneba, Keneba, Gambia; [Barbe, Barbara; Jacobs, Jan] Institserovarute Trop Med, Dept Clin Sci, Antwerp, Belgium; [Jacobs, Jan] Univ Leuven, Dept Microbiol & Immunol, KU Leuven, Leuven, Belgium; [Jassey, Babucarr; Cham, Yorro; Baldeh, Ignatius] Minist Hlth & Social Welf, Banjul, Gambia; [Prentice, Andrew] London Sch Hyg & Trop Med, MRC, Int Nutr Grp, London WC1, England	Bradbury, RS (reprint author), Cent Queensland Univ, Sch Med & Appl Sci, Rockhampton, Qld 4702, Australia.	r.bradbury@cqu.edu.au	Bradbury, Richard/A-2094-2019	Bradbury, Richard/0000-0002-5524-506X	UK Medical Research Council [MRC] [MC-A760-5QX00]; UK Department for International Development (DFID) under the MRC/DFID Concordat agreement [MC-A760-5QX00]	This work was supported by joint funding from the UK Medical Research Council [MRC, grant number MC-A760-5QX00] and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement.	ALBONICO M, 1994, T ROY SOC TROP MED H, V88, P585, DOI 10.1016/0035-9203(94)90174-0; Belding DL, 1965, TXB PARASITOLOGY; Boreham RE, 1998, J CLIN MICROBIOL, V36, P3728; Bradbury RS, 2014, J CLIN MICROBIOL, V52, P699, DOI 10.1128/JCM.02738-13; Bradbury RS, 2010, ANN AUSTRALAS COLL T, V11, P24; Brockmann SO, 2004, J FOOD PROTECT, V67, P178, DOI 10.4315/0362-028X-67.1.178; Bundy DAP, 1991, HUMAN PARASITIC DIS, V4; Capita R, 2003, INT J FOOD MICROBIOL, V81, P169, DOI 10.1016/S0168-1605(02)00195-2; Dione MM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001148; Dolabella SS, 2012, ANN HEPATOL, V11, P107; Enwere G, 2006, PEDIATR INFECT DIS J, V25, P700, DOI 10.1097/01.inf.0000226839.30925.a5; FALADE S, 1976, Journal of Wildlife Diseases, V12, P464; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Galanis E, 2006, EMERG INFECT DIS, V12, P381, DOI 10.3201/eid1203.050854; Garcia LS, 2007, DIAGNOSTIC MED PARAS; Ghadage Dnyaneshwari, 2003, Indian J Pathol Microbiol, V46, P268; Goldsmid JM, 1982, CRC HDB SERIES ZOO C, V2; Hessen Eman M., 2004, Journal of the Egyptian Society of Parasitology, V34, P925; Hill PC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-2; HINSHAW WR, 1948, J BACTERIOL, V55, P870; HOLZER BR, 1987, EUR J CLIN PHARMACOL, V32, P635, DOI 10.1007/BF02456002; Ikumapayi UN, 2007, J MED MICROBIOL, V56, P1479, DOI 10.1099/jmm.0.47416-0; Kapoor L, 2006, INDIAN J MED RES, V123, P691; Kawai T, 2012, CLIN INFECT DIS, V54, P1046, DOI 10.1093/cid/cir1040; Kidanemariam A, 2010, J S AFR VET ASSOC, V81, P37; KOGA K, 1990, J TROP MED HYG, V93, P183; Kumar Y, 2009, T R SOC TROP MED HYG, V103, P390; Madden RH, 2007, LETT APPL MICROBIOL, V44, P115, DOI 10.1111/j.1472-765X.2006.02064.x; McClelland RS, 1997, J CLIN MICROBIOL, V35, P2815; MCGREGOR IA, 1952, T ROY SOC TROP MED H, V46, P403, DOI 10.1016/0035-9203(52)90058-8; Moncada LI, 2001, J CLIN MICROBIOL, V39, P1938, DOI 10.1128/JCM.39.5.1938-1940.2001; Muley V A, 2004, Indian J Med Microbiol, V22, P51; Nayak R, 2003, BRIT POULTRY SCI, V44, P192, DOI 10.1080/0007166031000088370; Outbreak Investigation Group, 2005, EUROSURVEILLANCE, V10; Phoba MF, 2014, EUR J CLIN MICROBIOL, V33, P79, DOI 10.1007/s10096-013-1931-8; Royer TL, 2012, EMERG INFECT DIS, V18, P1543, DOI 10.3201/eid1809.120122; Shilangale RP, 2012, VET ITAL, V48, P125; Sillah F, 2013, NUTRITION, V29, P1368, DOI 10.1016/j.nut.2013.05.014; Speare R, 1989, STRONGYLOIDIASIS MAJ; Taylor J, 2012, J FOOD PROTECT, V75, P738, DOI 10.4315/0362-028X.JFP-11-408; Veitch M, 2012, GUIDELINES INVESTIGA; WILLIAMS AW, 1950, J PATHOL BACTERIOL, V62, P43, DOI 10.1002/path.1700620106	42	1	1	1	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	MAY	2015	109	5					334	339		10.1093/trstmh/trv020				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CJ1YB	WOS:000355279900007	25758855				2019-04-02	
J	Carlier, Y; Sosa-Estani, S; Luquetti, AO; Buekens, P				Carlier, Yves; Sosa-Estani, Sergio; Luquetti, Alejandro O.; Buekens, Pierre			Congenital Chagas disease: an update	MEMORIAS DO INSTITUTO OSWALDO CRUZ			English	Article; Proceedings Paper	13th International Congress of Parasitology	AUG 10-15, 2014	Mexico City, MEXICO			Trypanosoma cruzi; congenital T. cruzi infection; congenital Chagas disease; maternal-foetal transmission	TRYPANOSOMA-CRUZI; ORAL-TRANSMISSION; BRAZILIAN AMAZON; URBAN OUTBREAK; VENEZUELA; RESERVOIRS; INFECTION; SURVIVAL; VECTORS; STATE	Congenital infection with Trypanosoma cruzi is a global problem, occurring on average in 5% of children born from chronically infected mothers in endemic areas, with variations depending on the region. This presentation aims to focus on and update epidemiological data, research methods, involved factors, control strategy and possible prevention of congenital infection with T. cruzi. Considering that etiological treatment of the child is always effective if performed before one year of age, the diagnosis of infection in pregnant women and their newborns has to become the standard of care and integrated into the surveillance programs of syphilis and human immunodeficiency virus. In addition to the standard tests, polymerase chain reaction performed on blood of neonates of infected mothers one month after birth might improve the diagnosis of congenital infection. Recent data bring out that its transmission can be prevented through treatment of infected women before they become pregnant. The role of parasite genotypes and host genetic factors in parasite transmission and development of infection in foetuses/neonates has to be more investigated in order to better estimate the risk factors and impact on health of congenital infection with T. cruzi.	[Carlier, Yves] Univ Libre Bruxelles, Fac Med, Lab Parasitol, Brussels, Belgium; [Carlier, Yves; Buekens, Pierre] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA; [Sosa-Estani, Sergio] Minist Hlth, Inst Nacl Parasitol Dr Mario Fatala Cha, Buenos Aires, DF, Argentina; [Luquetti, Alejandro O.] Univ Fed Goias, Hosp Clin, Goiania, Go, Brazil	Carlier, Y (reprint author), Univ Libre Bruxelles, Fac Med, Lab Parasitol, Brussels, Belgium.	ycarlier@ulb.ac.be					Alarcon de Noya B, 2009, SALUS, V13, P11; Alarcon de Noya B, 2010, REV FAC MED, V33, P78; Alarcon de Noya BA, 2011, BIOMEDICA S3, V31, P64; de Noya BA, 2012, MEM I OSWALDO CRUZ, V107, P893, DOI 10.1590/S0074-02762012000700009; de Noya BA, 2010, B MALARIOL SALUD AMB, V50, P135; de Noya BA, 2010, J INFECT DIS, V201, P1308, DOI 10.1086/651608; Anez N, 2007, SALUS, V11, P87; Anez N, 2013, B MALARIOL SALUD AMB, V53, P1; Anez N, 2009, B MALARIOL SALUD AMB, V49, P91; Benitez JA, 2013, J INFECT DEV COUNTR, V7, P638, DOI 10.3855/jidc.3620; Bohorquez RMB, 1992, ACTA MED COLOMB, V17, P4; Briceno-Leon R, 1990, CASA ENFERMA SOCIOLO; Caceres D, 1999, INF QUINC EPIDEMIOL, V4, P170; Cardoso Adriana V.N., 2006, Rev. Inst. Med. trop. S. Paulo, V48, P287, DOI 10.1590/S0036-46652006000500009; Carrasco HJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001707; Carrasco HJ, 2005, INT J PARASITOL, V35, P1379, DOI 10.1016/j.ijpara.2005.05.003; Castro JA, 2006, HUM EXP TOXICOL, V25, P471, DOI 10.1191/0960327106het653oa; Cavalcanti LPG, 2009, CAD SAUDE COLET, V17, P911; Valente SADS, 2009, T ROY SOC TROP MED H, V103, P291, DOI 10.1016/j.trstmh.2008.10.047; Xavier SCD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002878; Pinto AYD, 2008, REV SOC BRAS MED TRO, V41, P602, DOI 10.1590/S0037-86822008000600011; de Noya Belkisyole Alarcon, 2013, Revista de Patologia Tropical, V42, P177, DOI 10.5216/rpt.v42i2.25523; Diaz-Bello Z, 2014, EPIDEMIOL INFECT, V142, P156, DOI 10.1017/S0950268813000757; Diaz-Bello Z, 2011, BIOMEDICA S3, V31, P278; Diaz-Ungria C., 1965, REV IBER PARASITOL, V25, P1; Duffy T, 2013, PLOS NEGLECT TROP D, V7, P1; Rios JF, 2011, BIOMEDICA, V31, P185, DOI 10.1590/S0120-41572011000200005; Freilij H., 1983, Journal of Clinical Microbiology, V18, P327; Gascon J, 2010, ACTA TROP, V115, P22, DOI 10.1016/j.actatropica.2009.07.019; Hernandez L. M., 2009, REV OBSERVATORIO SAL, V4, P28; Herrera C, 2009, J PARASITOL RES; Jansen AM, 1985, P REUN PESQ BAS DOEN, P39; LAINSON R, 1980, Revista do Instituto de Medicina Tropical de Sao Paulo, V22, P294; Luquetti A, 2000, TRYPANOSOMA CRUZI DO, P344; MAGUIRE JH, 1986, AM J TROP MED HYG, V35, P931, DOI 10.4269/ajtmh.1986.35.931; Martín Amando, 2009, Arch Venez Puer Ped, V72, P97; Matias Reyes-Lugo, 2009, REV BIOMED, V20, P180; Mazza S., 1936, MEPRA, V28, P41; MILES MA, 1972, PARASITOLOGY, V65, P1, DOI 10.1017/S0031182000044188; Miles MA, 2010, J INFECT DIS, V201, P1282, DOI 10.1086/651609; Beltrao HDM, 2009, TROP DOCT, V39, P231, DOI 10.1258/td.2009.090035; Munoz-Calderon A, 2013, INFECT GENET EVOL, V17, P113, DOI 10.1016/j.meegid.2013.03.036; Munoz-Calderon A, 2012, REV IBEROLATINOAM PA, V71, P14; Nery-Guimaraes F., 1968, HOSPITAL, V73, P1767; Nobrega AA, 2009, EMERG INFECT DIS, V15, P653, DOI 10.3201/eid1504.081450; Norman FF, 2013, EMERG INFECT DIS, V19, P1561, DOI 10.3201/eid1910.130203; OPS - Organizacion Panamericana de la Salud, 2009, OPS SER MAN TECN, V12; Organizacion Panamericana de la Salud/ Organizacion Mundial de la Salud (OPS/OMS), 2006, EST CUANT ENF CHAG A; Pereira KS, 2013, FOODBORNE PROTOZOAN, P189; ProMED, 2010, ENF CHAG OR BROT; ProMED, 2014, ENF DE CHAG; ProMED, 2010, TRYP FOODB; ProMED, 2012, ENF CHAG OR BROT TRA; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Roellig DM, 2009, J PARASITOL, V95, P360, DOI 10.1645/GE-1740.1; Schijman AG, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000931; Shikanai-Yasuda M. P., 1987, REV SOC BRAS MED S2, V20, pM14; Steindel M, 2008, DIAGN MICR INFEC DIS, V60, P25, DOI 10.1016/j.diagmicrobio.2007.07.016; Suarez J, 2010, GAC MED CARACAS, V118, P212; Suarez-Mutis MC, 2006, REV SOC BRAS MED TRO, V39, P495, DOI 10.1590/S0037-86822006000500014; SVS - Secretaria de Vigilancia em Saude, 2011, ASP EP CAS DOENC CHA; Thomas ME, 2007, MEM I OSWALDO CRUZ, V102, P559, DOI 10.1590/S0074-02762007005000068; Valente SAD, 1999, MEM I OSWALDO CRUZ, V94, P395, DOI 10.1590/S0074-02761999000700077; Valente SAS, 2001, REV SOC BRAS MED S1, V34, P19; Vargas JS, 2011, BIOFARBO, V19, P52; World Health Organization (WHO), 2007, CONS INT BIOL REF PR; World Health Organization (WHO), 2010, 1 WHO; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	68	59	62	3	10	FUNDACO OSWALDO CRUZ	RIO DE JANEIRO, RJ	AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL	0074-0276	1678-8060		MEM I OSWALDO CRUZ	Mem. Inst. Oswaldo Cruz	MAY	2015	110	3					363	386		10.1590/0074-02760140405				24	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CI7PJ	WOS:000354956000011	25760448	DOAJ Gold, Green Published			2019-04-02	
J	Rosas-Aguirre, A; Ponce, OJ; Carrasco-Escobar, G; Speybroeck, N; Contreras-Mancilla, J; Gamboa, D; Pozo, E; Herrera, S; Llanos-Cuentas, A				Rosas-Aguirre, Angel; Ponce, Oscar J.; Carrasco-Escobar, Gabriel; Speybroeck, Niko; Contreras-Mancilla, Juan; Gamboa, Dionicia; Pozo, Edwar; Herrera, Socrates; Llanos-Cuentas, Alejandro			Plasmodium vivax malaria at households: spatial clustering and risk factors in a low endemicity urban area of the northwestern Peruvian coast	MALARIA JOURNAL			English	Article						Malaria; Hotspots; Clustering; Risk factors; Low transmission	TRANSMISSION; FALCIPARUM; INFECTION; AMERICA; ELIMINATION; POPULATION; PATTERNS; DISTRICT; MEXICO; KENYA	Background: Peru has presented a decreasing malaria trend during the last decade, particularly in areas on northwestern coast; however, a limited number of cases continues to be reported yearly mainly in malaria hotspots. Methods: A two-phase study was conducted to identify spatial and temporal clusters of incident Plasmodium vivax malaria, as well as to determine risk factors associated with households (HH) presenting P. vivax malaria episodes in an urban area of the northwestern Peruvian Coast from June 2008 to May 2010. In the first stage, a full census of the study population was conducted, including geo-referencing of reported P. vivax episodes. In the second stage, a population-based case-control study allowed the identification of risk factors associated with HHs reporting episodes. A total of 117 case HHs with reported P. vivax and 117 control HHs without malaria episodes were assessed. A semi-structured questionnaire was used to interview the head of households and to collect data on HH location and structure, availability of public services, preventive malaria measures, family member with outdoor occupation (farmer, moto-taxi driver), and other HH characteristics. Univariate and multivariate logistic regression analyses were performed to determine case-HH risk factors. SaTScan was used to detect spatial and temporal P. vivax malaria clusters. Results: The most likely spatial cluster of malaria incidence included 1,040 people (22.4% of total population) in 245 HHs (24.6% of total HHs) accounting for 283 malaria episodes (40.1% of total episodes) during the study period (RR = 2.3, p < 0.001). A temporal cluster was also identified from April 12, 2009 to July 4, 2009 accounting for 355 malaria episodes (50.4% of total episodes) (RR = 7.2, p = 0.001). Factors significantly associated with case HHs compared with control HHs were: proximity to water drain < 200 metres (OR = 2.3, 95% CI: 1.3, 4.0); HH size >5 individuals (OR = 1.8, 95% CI: 1.0, 3.2); lack of potable water (OR = 1.8, 95% CI: 1.1, 3.2); and having domestic and peridomestic animals (OR = 3.6, 95% CI: 1.3, 9.5). Conclusion: Plasmodium vivax malaria incidence is highly heterogeneous in space and time in the urban study area with important geographical and housing risk factors associated with symptomatic episodes.	[Rosas-Aguirre, Angel; Ponce, Oscar J.; Carrasco-Escobar, Gabriel; Contreras-Mancilla, Juan; Gamboa, Dionicia; Llanos-Cuentas, Alejandro] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander Von Humboldt, Lima, Peru; [Rosas-Aguirre, Angel; Speybroeck, Niko] Catholic Univ Louvain, Res Inst Hlth & Soc IRSS, B-1200 Brussels, Belgium; [Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Dept Ciencias Celulares & Mol, Lima, Peru; [Pozo, Edwar] Sub Reg Salud Luciano Castillo Colonna, Sullana, Peru; [Herrera, Socrates] Caucaseco Sci Res Ctr, Cali, Colombia	Rosas-Aguirre, A (reprint author), Univ Peruana Cayetano Heredia, Inst Med Trop Alexander Von Humboldt, Lima, Peru.	angelrosasa@gmail.com	Rosas Aguirre, Angel/A-5054-2016	Rosas Aguirre, Angel/0000-0002-3271-7028; Contreras Mancilla, Juan Jose/0000-0003-0447-0926; Gamboa, Dionicia/0000-0002-1420-7729; Ponce, Oscar/0000-0001-5729-8408; Carrasco-Escobar, Gabriel/0000-0002-6945-0419	NIAID/ICEMR [U19AI089702]; NIH/NIAID [R01AI067727]; NIH/Fogarty International Center [D43TW007120]	We thank all study participants and the local authorities for their enthusiastic support provided to our study. This work was supported by NIAID/ICEMR (U19AI089702), NIH/NIAID (R01AI067727) and NIH/Fogarty International Center (D43TW007120) grants.	Abe T, 2009, SE ASIAN J TROP MED, V40, P18; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bejon P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021711; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Reyes AFB, 2011, B MED HOSP INFANT M, V68, P159; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Branch O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-27; Calderon G, 1995, REV PERUANA EPIDEMIO, V8, P5; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Coleman M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-68; Cook J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-86; Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195; Curtis V, 2011, LANCET INFECT DIS, V11, P312, DOI 10.1016/S1473-3099(10)70224-3; Danis-Lozano R, 2007, SALUD PUBLICA MEXICO, V49, P199, DOI 10.1590/S0036-36342007000300005; Ernst KC, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-78; BERLIN O G W, 1980, Contributions of the American Entomological Institute, V17, P1; Gagnon AS, 2002, INT J BIOMETEOROL, V46, P81, DOI 10.1007/s00484-001-0119-6; GAMAGEMENDIS AC, 1991, AM J TROP MED HYG, V45, P77, DOI 10.4269/ajtmh.1991.45.77; Ghebreyesus TA, 2000, T ROY SOC TROP MED H, V94, P17, DOI 10.1016/S0035-9203(00)90424-3; Global Malaria Programme WHO, 2013, WORLD MAL REP 2013; Grieco JP, 2002, J AM MOSQUITO CONTR, V18, P307; Guthmann JP, 2002, TROP MED INT HEALTH, V7, P518, DOI 10.1046/j.1365-3156.2002.00883.x; Rodriguez MH, 2011, SALUD PUBLICA MEXICO, V53, pS333; Hulden L, 2014, J R STAT SOC A STAT, V177, P725, DOI 10.1111/rssa.12036; Instituto Nacional de Estadistica e Informatica. Peru, 2014, AN EST AMB 2013; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M., 2011, SATSCAN USER GUIDE V; Lindsay SW, 2003, TROP MED INT HEALTH, V8, P512, DOI 10.1046/j.1365-3156.2003.01059.x; Mboera LEG, 1997, B ENTOMOL RES, V87, P173, DOI 10.1017/S0007485300027322; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Midega JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1672; Ministerio de Salud del Peru, 2007, NORM TECN AT MAL MAL; Ministerio de Salud del Peru - Direccion General de Epidemiologia, 2011, B EPIDEMIOL, V20, P1108; Ministerio de Salud del Peru - Direccion General de Epidemiologia, 2010, AN SIT SAL PER ASIS; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; RODRIGUEZ AD, 1993, J AM MOSQUITO CONTR, V9, P46; Rosas-Aguirre A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-339; Rubio J M, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS199, DOI 10.1016/S0035-9203(02)90077-5; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-72; Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083; Teklehaimanot A, 2008, ANN NY ACAD SCI, V1136, P32, DOI 10.1196/annals.1425.037; Torres-Estrada JL, 2003, SALUD PUBLICA MEXICO, V45, P497, DOI 10.1590/S0036-36342003000600010; Wangdi K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-89; Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005; Wen L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-88; WHO, 2007, MAL FLIM FIELD MAN L; Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017	47	15	16	2	11	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	APR 24	2015	14								176	10.1186/s12936-015-0670-y				11	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CH0CG	WOS:000353686000001	25903826	DOAJ Gold, Green Published			2019-04-02	
J	Gryseels, C; Durnez, L; Gerrets, R; Uk, S; Suon, S; Set, S; Phoeuk, P; Sluydts, V; Heng, S; Sochantha, T; Coosemans, M; Grietens, KP				Gryseels, Charlotte; Durnez, Lies; Gerrets, Rene; Uk, Sambunny; Suon, Sokha; Set, Srun; Phoeuk, Pisen; Sluydts, Vincent; Heng, Somony; Sochantha, Tho; Coosemans, Marc; Grietens, Koen Peeters			Re-imagining malaria: heterogeneity of human and mosquito behaviour in relation to residual malaria transmission in Cambodia	MALARIA JOURNAL			English	Article							CENTRAL VIETNAM; FOREST MALARIA; RURAL TANZANIA; VECTOR CONTROL; ELIMINATION; NETS; RISK; CHALLENGES; STRATEGIES; PERCEPTION	Background: In certain regions in Southeast Asia, where malaria is reduced to forested regions populated by ethnic minorities dependent on slash-and-burn agriculture, malaria vector populations have developed a propensity to feed early and outdoors, limiting the effectiveness of long-lasting insecticide-treated nets (LLIN) and indoor residual spraying (IRS). The interplay between heterogeneous human, as well as mosquito behaviour, radically challenges malaria control in such residual transmission contexts. This study examines human behavioural patterns in relation to the vector behaviour. Methods: The anthropological research used a sequential mixed-methods study design in which quantitative survey research methods were used to complement findings from qualitative ethnographic research. The qualitative research existed of in-depth interviews and participant observation. For the entomological research, indoor and outdoor human landing collections were performed. All research was conducted in selected villages in Ratanakiri province, Cambodia. Results: Variability in human behaviour resulted in variable exposure to outdoor and early biting vectors: (i) indigenous people were found to commute between farms in the forest, where malaria exposure is higher, and village homes; (ii) the indoor/outdoor biting distinction was less clear in forest housing often completely or partly open to the outside; (iii) reported sleeping times varied according to the context of economic activities, impacting on the proportion of infections that could be accounted for by early or nighttime biting; (iv) protection by LLINs may not be as high as self-reported survey data indicate, as observations showed around 40% (non-treated) market net use while (v) unprotected evening resting and deep forest activities impacted further on the suboptimal use of LLINs. Conclusions: The heterogeneity of human behaviour and the variation of vector densities and biting behaviours may lead to a considerable proportion of exposure occurring during times that people are assumed to be protected by the distributed LLINs. Additional efforts in improving LLIN use during times when people are resting in the evening and during the night might still have an impact on further reducing malaria transmission in Cambodia.	[Gryseels, Charlotte; Durnez, Lies; Sluydts, Vincent; Coosemans, Marc; Grietens, Koen Peeters] Inst Trop Med, B-2000 Antwerp, Belgium; [Gryseels, Charlotte; Gerrets, Rene] Univ Amsterdam, AISSR, Amsterdam, Netherlands; [Uk, Sambunny; Suon, Sokha; Set, Srun; Phoeuk, Pisen; Heng, Somony; Sochantha, Tho] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Coosemans, Marc] Univ Antwerp, B-2020 Antwerp, Belgium; [Grietens, Koen Peeters] Partners Appl Social Sci PASS Int, Tessenderlo, Belgium; [Grietens, Koen Peeters] Nagasaki Univ, Sch Int Hlth Dev, Nagasaki 852, Japan	Gryseels, C (reprint author), Inst Trop Med, B-2000 Antwerp, Belgium.	cgryseels@itg.be		Peeters Grietens, Koen/0000-0001-6570-9887; Gryseels, Charlotte/0000-0002-8963-4469	Ratanakiri	We would like to sincerely thank the indigenous communities in Ratanakiri who supported our research. The entomological research was made possible by the hard work of the entomological fieldwork teams of CNM. Special thanks goes to the malaria staff (Mr. Mean, Mr. Hien, Dr. Vannara) of the provincial health department for supporting and assisting us during fieldwork. Thanks to Dr. Siv Sovannaroth and Dr. Char Meng Chuor for supporting our research at CNM.	Bauch JA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-75; Bourdier F, 2006, MOUNTAIN PRECIOUS ST; Canier L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-405; Coosemans M, 2006, P INT C HUBS HARB DE, P551; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Cui LW, 2012, ACTA TROP, V121, P240, DOI 10.1016/j.actatropica.2011.04.006; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; Durnez L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-329; Erhart A, 2004, AM J TROP MED HYG, V70, P110, DOI 10.4269/ajtmh.2004.70.110; Grietens KP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050294; Grietens KP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029991; Grietens KP, 2010, AM J TROP MED HYG, V82, P1017, DOI 10.4269/ajtmh.2010.09-0521; Grietens KP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-23; Gryseels C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080343; Kamat Vinay R, 2009, Anthropol Med, V16, P293, DOI 10.1080/13648470903246854; Killeen GF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-161; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-330; LINES JD, 1987, MED VET ENTOMOL, V1, P37, DOI 10.1111/j.1365-2915.1987.tb00321.x; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; Najera JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000412; Ovesen J, 2004, CIVILIZING THE MARGINS: SOUTHEAST ASIAN GOVERNMENT POLICIES FOR THE DEVELOPMENT OF MINORITIES, P241; Packard Randall M., 2007, MAKING TROPICAL DIS; Pindolia DK, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-397; R Core Team, 2017, R LANG ENV STAT COMP; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Sluydts V, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-387; Tashakkori A, 1997, MIXED METHODOLOGY CO; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; Van Bortel W, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-373	29	28	28	0	10	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	APR 24	2015	14								165	10.1186/s12936-015-0689-0				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CG5IU	WOS:000353325500001	25908498	DOAJ Gold, Green Published			2019-04-02	
J	O'Neill, S; Gryseels, C; Dierickx, S; Mwesigwa, J; Okebe, J; d'Alessandro, U; Grietens, KP				O'Neill, Sarah; Gryseels, Charlotte; Dierickx, Susan; Mwesigwa, Julia; Okebe, Joseph; d'Alessandro, Umberto; Grietens, Koen Peeters			Foul wind, spirits and witchcraft: illness conceptions and health-seeking behaviour for malaria in the Gambia	MALARIA JOURNAL			English	Article						Malaria; Symptom interpretation; Health-seeking behaviour; Treatment seeking behaviour; Elimination; Disease categories; Folk illnesses	WEST-AFRICA; PREVENTION; DETERMINANTS; ELIMINATION; TANZANIA; PRINCIPE	Background: As the disease burden in the Gambia has reduced considerably over the last decade, heterogeneity in malaria transmission has become more marked, with infected but asymptomatic individuals maintaining the reservoir. The identification, timely diagnosis and treatment of malaria-infected individuals are crucial to further reduce or eliminate the human parasite reservoir. This ethnographic study focused on the relationship between local beliefs of the cause of malaria and treatment itineraries of suspected cases. Methods: An ethnographic qualitative study was conducted in twelve rural communities in the Upper River Region and the Central River Region in the Gambia. The data collection methods included in-depth interviews, participant observation, informal conversations, and focus group discussions. Results: While at first glance, the majority of people seek biomedical treatment for 'malaria', there are several constraints to seeking treatment at health centres. Certain folk illnesses, such as Jontinooje and Kajeje, translated and interpreted as 'malaria' by healthcare professionals, are often not considered to be malaria by local populations but rather as self-limiting febrile illnesses - consequently not leading to seeking care in the biomedical sector. Furthermore, respondents reported delaying treatment at a health centre while seeking financial resources, and consequently relying on herbal treatments. In addition, when malaria cases present symptoms, such as convulsions, hallucinations and/or loss of consciousness, the illness is often interpreted as having a supernatural aetiology, leading to diagnosis and treatment by traditional healers. Conclusion: Although malaria diagnostics and treatment-seeking in the biomedical sector has been reported to be relatively high in the Gambia compared to other sub-Saharan African countries, local symptom interpretation and illness conceptions can delay or stop people from seeking timely biomedical treatment, which may contribute to maintaining a parasite reservoir of undiagnosed and untreated malaria patients.	[O'Neill, Sarah; Gryseels, Charlotte; Dierickx, Susan; d'Alessandro, Umberto; Grietens, Koen Peeters] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Mwesigwa, Julia; Okebe, Joseph; d'Alessandro, Umberto] MRC, Fajara, Gambia; [d'Alessandro, Umberto] London Sch Hyg & Trop Med, London WC1, England; [Okebe, Joseph] Univ Antwerp, Fac Med Sci, B-2020 Antwerp, Belgium; [Grietens, Koen Peeters] Nagasaki Univ, Sch Int Hlth Dev, Nagasaki 852, Japan; [Grietens, Koen Peeters] Partners Appl Social Sci PASS Int, Tessenderlo, Belgium; [O'Neill, Sarah] Univ Oxford, Sch Anthropol, Oxford, England	O'Neill, S (reprint author), Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.	soneill@itg.be		Mwesigwa, Julia/0000-0003-2452-3677; Okebe, Joseph/0000-0001-5466-1611; Peeters Grietens, Koen/0000-0001-6570-9887; Gryseels, Charlotte/0000-0002-8963-4469	Joint Global Health Trials Scheme (DFID/MRC/Wellcome Trust) [MR/K007203/1]; Medical Research Council [MC_UP_A900_1119, MR/J002364/1, MC_EX_MR/J002364/1]	We are grateful to the MRC fieldworkers Fatou Y Manneh, Hejinkey Darboe, Michelle Demba, Dullo Baldeh, Bintou Jarju and Kebba Jassey for their assisting with data collection during fieldwork as well as for transcription and translation of recorded interviews and discussions. We would also like to thank them for re-reading early versions of the results and clarification of and discussions on local disease categories. This work is part of the study 'Primaquine's gametocytocidal efficacy in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine' (MR/K007203/1) funded by the Joint Global Health Trials Scheme (DFID/MRC/Wellcome Trust).	Ahorlu CK, 1997, TROP MED INT HEALTH, V2, P488, DOI 10.1046/j.1365-3156.1997.d01-298.x; [Anonymous], 1997, INT C MAL AFR 6 9 JA; Bernard HR, 2006, RES METHODS ANTHR QU; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Ceesay SJ, 2012, ACTA TROP, V121, P166, DOI 10.1016/j.actatropica.2011.11.005; Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242; CIAM, 2011, CIAM PUBL HLTH RES D; Clarke SE, 2003, TROP MED INT HEALTH, V8, P884, DOI 10.1046/j.1365-3156.2003.01095.x; Culture W, 1986, POETICS POLITICS ETH; Dilley RM, 2005, ISLAMIC CASTE KNOWLE; Dugas Marylene, 2009, Anthropol Med, V16, P307, DOI 10.1080/13648470903183487; FASSIN D., 1992, POUVOIR MALADIE AFRI; Hames C, 2008, CAH ETUD AFR, P81, DOI 10.4000/etudesafricaines.9842; Hausmann Muela S, 2012, MALARIA REPORTS, V2, pe3; KENGEYAKAYONDO JF, 1994, ACTA TROP, V58, P267, DOI 10.1016/0001-706X(94)90020-5; Kuczynski L, 2008, CAH ETUD AFR, V89, P237; Leach Melisse, 2007, VACCINE ANXIETIES GL; Lee PW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-26; Lindblade KA, 2013, EXPERT REV ANTI-INFE, V11, P623, DOI [10.1586/ERI.13.45, 10.1586/eri.13.45]; Madge C, 1998, HEALTH PLACE, V4, P293, DOI 10.1016/S1353-8292(98)00033-1; Makemba AM, 1996, TROP MED INT HEALTH, V1, P305; Muela S H, 1998, Anthropol Med, V5, P43, DOI 10.1080/13648470.1998.9964548; Muela SH, 2002, SOC SCI MED, V55, P403; MWENESI H, 1995, SOC SCI MED, V40, P1271, DOI 10.1016/0277-9536(94)00250-W; MWENESI H, 1993, THESIS U LONDON; O'Neill S., 2013, THESIS; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Takem EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067108; Tangena JAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074351; Tarimo DS, 1998, E AFR MED J, V75, P93; Teklehaimanot HD, 2009, AM J TROP MED HYG, V80, P133, DOI 10.4269/ajtmh.2009.80.133; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO AFRO, 1998, WORK GROUP M SOC SCI; WHO TDR, 1997, INT C MAL AFR 6 9 JA; Williams HA, 2004, SOC SCI MED, V59, P501, DOI 10.1016/j.socscimed.2003.11.010; Wiseman V, 2006, TROP MED INT HEALTH, V11, P419, DOI 10.1111/j.1365-3156.2006.01586.x; Wiseman V, 2008, SOC SCI MED, V67, P487, DOI 10.1016/j.socscimed.2008.04.007; World Health Organization, 2008, WHO PHARM NEWSLETTER, P6	40	14	14	0	12	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	APR 24	2015	14								167	10.1186/s12936-015-0687-2				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CG5IV	WOS:000353325600001	25908392	DOAJ Gold, Green Published			2019-04-02	
J	Jongejan, F; Ringenier, M; Putting, M; Berger, L; Burgers, S; Kortekaas, R; Lenssen, J; van Roessel, M; Wijnveld, M; Madder, M				Jongejan, Frans; Ringenier, Moniek; Putting, Michael; Berger, Laura; Burgers, Stefan; Kortekaas, Reinier; Lenssen, Jesse; van Roessel, Marleen; Wijnveld, Michiel; Madder, Maxime			Novel foci of Dermacentor reticulatus ticks infected with Babesia canis and Babesia caballi in the Netherlands and in Belgium	PARASITES & VECTORS			English	Article						Ticks; Dermacentor reticulatus; Netherlands; Belgium; Babesia canis; Babesia caballi	LINE BLOT HYBRIDIZATION; ANAPLASMA-PHAGOCYTOPHILUM; BORNE PATHOGENS; PREVALENCE; RICKETTSIA; THEILERIA; DOGS; TRANSMISSION; COLLECTION; PREVENTION	Background: Autochthonous populations of Dermacentor reticulatus ticks in the Netherlands were discovered after fatal cases of babesiosis occurred in resident dogs in 2004. The presence of D. reticulatus in the Netherlands has also linked with the emergence of piroplasmosis in the resident horse population. The aim of this study was to put together results of continued surveillance of field sites and hosts for this tick in the Netherlands and also in Belgium and determine their infection status for Babesia and Theileria species. Methods: Ticks were collected from the vegetation at 11 locations between 2011 and 2013. D. reticulatus ticks were also collected from different hosts between 2007 and 2013. Ticks were screened by PCR and reverse line blot (RLB). Results: A total of 1368 D. reticulatus ticks were collected from 4 previously known field locations and from 5 new locations in the Netherlands and from 2 sites in Belgium (one old and one new location). A total of 855 ticks collected from 8 locations in the Netherlands and 2 locations in Belgium were tested. Fourteen ticks (1,64%) collected at 4 field locations (Dintelse Gorzen, Rozenburg, Slikken van de Heen and St. Philipsland) were positive for Babesia canis, whereas two ticks were positive for Babesia caballi, one tick in the Dintelse Gorzen in the Netherlands and one tick was found positive in De Panne in Belgium. A further 1092 D. reticulatus ticks were collected between 2007 and 2013 from 40 dogs (132 ticks), two ticks from two humans, 51 ticks from 15 horses, two ticks from two cats, one tick from a roe deer, whereas most ticks (904) were collected from cattle (n = 25). Ticks were found throughout the year on dogs in nearly all provinces of the Netherlands. None of the ticks collected from these hosts were infected. Conclusions: D. reticulatus is continuing its spread into novel areas. The finding that some autochthonous ticks are infected with B. canis and B. caballi poses a threat to the resident dog and horse population and justifies year-round tick control measures.	[Jongejan, Frans; Ringenier, Moniek; Putting, Michael; Berger, Laura; Burgers, Stefan; Kortekaas, Reinier; Lenssen, Jesse; van Roessel, Marleen] Univ Utrecht, Fac Vet Med, FAO Reference Ctr Ticks & Tick Borne Dis, Utrecht Ctr Tick Borne Dis UCTD, NL-3584 CL Utrecht, Netherlands; [Madder, Maxime] Inst Trop Med, Dept Biomed Sci, Unit Vet Entomol, B-2000 Antwerp, Belgium; [Jongejan, Frans; Madder, Maxime] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, ZA-0110 Onderstepoort, South Africa	Jongejan, F (reprint author), Univ Utrecht, Fac Vet Med, FAO Reference Ctr Ticks & Tick Borne Dis, Utrecht Ctr Tick Borne Dis UCTD, Yalelaan 1, NL-3584 CL Utrecht, Netherlands.	F.Jongejan@uu.nl					Alberdi MP, 2012, TICKS TICK-BORNE DIS, V3, P348, DOI 10.1016/j.ttbdis.2012.10.020; Beugnet F, 2014, PARASITE VECTOR, P283; Beugnet F, 2009, VET PARASITOL, V163, P298, DOI 10.1016/j.vetpar.2009.03.028; Biernat B, 2014, EXP APPL ACAROL, V64, P543, DOI 10.1007/s10493-014-9836-5; Bonnet S, 2013, VECTOR-BORNE ZOONOT, V13, P226, DOI 10.1089/vbz.2011.0933; Butler CM, 2012, VET J, V193, P381, DOI 10.1016/j.tvjl.2011.12.014; Claerebout E, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-183; Cochez C, 2012, MED VET ENTOMOL, V26, P355, DOI 10.1111/j.1365-2915.2011.00998.x; Dantas-Torres F, 2013, EXP APPL ACAROL, V61, P119, DOI 10.1007/s10493-013-9671-0; Dautel H, 2006, INT J MED MICROBIOL, V296, P149, DOI 10.1016/j.ijmm.2006.01.013; Estrada-Pena A, 2013, EXP APPL ACAROL, V59, P351, DOI 10.1007/s10493-012-9600-7; Estrada-Pena A., 2004, TICKS DOMESTIC ANIMA; Fourie JJ, 2013, VET PARASITOL, V192, P273, DOI 10.1016/j.vetpar.2012.10.017; Georges K, 2001, VET PARASITOL, V99, P273, DOI 10.1016/S0304-4017(01)00488-5; Giangaspero A, 2015, TICKS TICK-BORNE DIS, V6, P75, DOI 10.1016/j.ttbdis.2014.09.007; Gray J S, 2009, Interdiscip Perspect Infect Dis, V2009, P593232, DOI 10.1155/2009/593232; Gubbels JM, 1999, J CLIN MICROBIOL, V37, P1782; Jongejan F, 2004, PARASITOLOGY, V129, pS3, DOI 10.1017/S0031182004005967; Jongejan F, 2011, VET PARASITOL, V179, P343, DOI 10.1016/j.vetpar.2011.03.047; Karbowiak G, 2014, VET PARASITOL, V204, P372, DOI 10.1016/j.vetpar.2014.05.030; Karbowiak Grzegorz, 2014, Annals of Parasitiology, V60, P37; Kubelova M, 2011, VET PARASITOL, V180, P191, DOI 10.1016/j.vetpar.2011.03.033; Lenssen J, 2011, TIJDSCHR DIERGENEESK, V136, P508; Losson B, 1999, ANN MED VET, V143, P119; MARTINOD S, 1991, EXP APPL ACAROL, V11, P215, DOI 10.1007/BF01246093; Matjila TP, 2005, VET PARASITOL, V131, P23, DOI 10.1016/j.vetpar.2005.04.020; Nijhof AM, 2003, J CLIN MICROBIOL, V41, P2249, DOI 10.1128/JCM.41.5.2249-2254.2003; Nijhof AM, 2007, VECTOR-BORNE ZOONOT, V7, P585, DOI 10.1089/vbz.2007.0130; Oines O, 2010, VET PARASITOL, V171, P350, DOI 10.1016/j.vetpar.2010.03.024; Parola P, 2009, EMERG INFECT DIS, V15, P1105, DOI 10.3201/eid1507.081449; Paulauskas A, 2012, COMP IMMUNOL MICROB, V35, P187, DOI 10.1016/j.cimid.2012.01.001; Rubel F, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0477-7; Schaarschmidt D, 2013, TICKS TICK-BORNE DIS, V4, P334, DOI 10.1016/j.ttbdis.2013.01.007; Schreiber C, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0535-1; Svehlova A, 2014, TICKS TICK-BORNE DIS, V5, P600, DOI 10.1016/j.ttbdis.2014.04.010; UILENBERG G, 1985, TIJDSCHR DIERGENEESK, V110, P93; Wirtgen M, 2011, VET REC, V168, P195, DOI 10.1136/vr.d1053; Wojcik-Fatla A, 2012, VECTOR-BORNE ZOONOT, V12, P841, DOI 10.1089/vbz.2011.0904; Wojcik-Fatla A, 2011, TICKS TICK-BORNE DIS, V2, P16, DOI 10.1016/j.ttbdis.2010.10.001; Zivkovic Zorica, 2007, BMC Vet Res, V3, P32, DOI 10.1186/1746-6148-3-32	40	27	28	2	16	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	APR 17	2015	8								232	10.1186/s13071-015-0841-2				10	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CG4OJ	WOS:000353265500001	25889392	DOAJ Gold, Green Published			2019-04-02	
J	Birhanu, H; Fikru, R; Said, M; Kidane, W; Gebrehiwot, T; Hagos, A; Alemu, T; Dawit, T; Berkvens, D; Goddeeris, BM; Buscher, P				Birhanu, Hadush; Fikru, Regassa; Said, Mussa; Kidane, Weldu; Gebrehiwot, Tadesse; Hagos, Ashenafi; Alemu, Tola; Dawit, Tesfaye; Berkvens, Dirk; Goddeeris, Bruno Maria; Buscher, Philippe			Epidemiology of Trypanosoma evansi and Trypanosoma vivax in domestic animals from selected districts of Tigray and Afar regions, Northern Ethiopia	PARASITES & VECTORS			English	Article						Trypanosoma evansi type A; Trypanosoma evansi type B; Dromedary camels; Equines; Ruminants; Ethiopia	EXCHANGE CENTRIFUGATION TECHNIQUE; INFECTED WATER-BUFFALOS; KINETOPLAST DNA; BOVINE TRYPANOSOMIASIS; SLEEPING SICKNESS; AFRICAN TRYPANOSOMIASIS; SOUTHWEST ETHIOPIA; CROSS-REACTIVITY; GHIBE VALLEY; FILTER-PAPER	Background: African animal trypanosomosis, transmitted cyclically by tsetse flies or mechanically by other biting flies, causes serious inflictions to livestock health. This study investigates the extent of non-tsetse transmitted animal trypanosomosis (NTTAT) by Trypanosoma (T.) evansi and T. vivax in domestic animals in the tsetse-free regions of Northern Ethiopia, Afar and Tigray. Methods: A cross sectional study was conducted on 754 dromedary camels, 493 cattle, 264 goats, 181 sheep, 84 donkeys, 25 horses and 10 mules. The microhaematocrit centrifugation technique was used as parasitological test. Plasma was collected for serodiagnosis with CATT/T.evansi and RoTat 1.2 immune trypanolysis (ITL) while buffy coat specimens were collected for molecular diagnosis with T. evansi type A specific RoTat 1.2 PCR, T. evansi type B specific EVAB PCR and T. vivax specific TvPRAC PCR. Results: The parasitological prevalence was 4.7% in Tigray and 2.7% in Afar and significantly higher (z = 2.53, p = 0.011) in cattle (7.3%) than in the other hosts. Seroprevalence in CATT/T.evansi was 24.6% in Tigray and 13.9% in Afar and was significantly higher (z = 9.39, p < 0.001) in cattle (37.3%) than in the other hosts. On the other hand, seroprevalence assessed by ITL was only 1.9% suggesting cross reaction of CATT/T.evansi with T. vivax or other trypanosome infections. Molecular prevalence of T. evansi type A was 8.0% in Tigray and in Afar and varied from 28.0% in horses to 2.2% in sheep. It was also significantly higher (p < 0.001) in camel (11.7%) than in cattle (6.1%), donkey (6%), goat (3.8%), and sheep (2.2%). Four camels were positive for T. evansi type B. Molecular prevalence of T. vivax was 3.0% and was similar in Tigray and Afar. It didn't differ significantly among the host species except that it was not detected in horses and mules. Conclusions: NTTAT caused by T. vivax and T. evansi, is an important threat to animal health in Tigray and Afar. For the first time, we confirm the presence of T. evansi type B in Ethiopian camels. Unexplained results obtained with the current diagnostic tests in bovines warrant particular efforts to isolate and characterise trypanosome strains that circulate in Northern Ethiopia.	[Birhanu, Hadush; Kidane, Weldu; Gebrehiwot, Tadesse] Mekelle Univ, Coll Vet Med, Mekelle, Ethiopia; [Birhanu, Hadush; Fikru, Regassa; Goddeeris, Bruno Maria] Katholieke Univ Leuven, Fac Biosci Engn, Dept Biosyst, B-3001 Leuven, Belgium; [Birhanu, Hadush; Fikru, Regassa; Berkvens, Dirk; Buscher, Philippe] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Fikru, Regassa; Hagos, Ashenafi; Alemu, Tola] Univ Addis Ababa, Coll Vet Med & Agr, Bishoftu, Ethiopia; [Said, Mussa] Mekelle Univ, Dept Stat, Coll Nat & Computat Sci, Mekelle, Ethiopia; [Dawit, Tesfaye] Hawassa Univ, Sch Vet Med, Hawassa, Ethiopia	Birhanu, H (reprint author), Mekelle Univ, Coll Vet Med, POB 2084, Mekelle, Ethiopia.	hadushbirhanu@yahoo.com	Buscher, Philippe/B-9956-2012; Goddeeris, Bruno/L-2440-2015	Buscher, Philippe/0000-0002-1926-7472; Goddeeris, Bruno/0000-0003-3729-7592	Belgian Directorate General for Development Cooperation	The PhD fellowships of Hadush Birhanu and Regassa Fikru were financed by the Belgian Directorate General for Development Cooperation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We acknowledge the Mekelle University in Tigray, Ethiopia and the Katholieke Unversiteit Leuven, Belgium for supporting laboratory and field work. We are grateful to Kumulachew Belay, Habtu Siyoum, Semere Kiros, Tsehaye, Gidena Desta, Berihu Gebrekidan and Abreha Tesfay, Stijn Deborggraeve, Stijn Roge, Nicolas Bebronne, Fatima Balharbi and Tessa De Block for technical assistance. The animal owners, contact persons and local administrators are acknowledged for their collaboration during the field work.	Abebe G, 1996, REV MED VET-TOULOUSE, V147, P897; Osorio ALAR, 2008, MEM I OSWALDO CRUZ, V103, P1, DOI 10.1590/S0074-02762008000100001; Aradaib Imadeldin E., 2006, Kinetoplastid Biology and Disease, V5, P1; Aref M, 2013, VET PARASITOL, V197, P638, DOI 10.1016/j.vetpar.2013.07.016; BOID R, 1988, TROP MED PARASITOL, V39, P45; BORST P, 1987, MOL BIOCHEM PARASIT, V23, P31, DOI 10.1016/0166-6851(87)90184-8; Buscher P, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000471; BUSCHER G, 1984, J PROTOZOOL, V31, P98, DOI 10.1111/j.1550-7408.1984.tb04297.x; Buscher P, 2001, WORLD CL PARASITES, V1, P51; Buscher P., 2014, TRYPANOSOMES TRYPANO, P189; Camara O, 2014, TROP MED INT HEALTH, V19, P828, DOI 10.1111/tmi.12316; Camargo RE, 2004, VET PARASITOL, V123, P67, DOI 10.1016/j.vetpar.2004.01.022; Cherenet T, 2006, VET PARASITOL, V140, P251, DOI 10.1016/j.vetpar.2006.04.004; CLAES F, 2004, KINETOPLASTID BIOL D, V3, P3; CODJIA V, 1993, ACTA TROP, V53, P151, DOI 10.1016/0001-706X(93)90026-8; Cortez AP, 2006, PARASITOLOGY, V133, P159, DOI 10.1017/S0031182006000254; CSA, 2011, AGR SAMPL SURV, VII, P1; CSA, 2012, AGR SAMPL REP LIV LI, P9; D'Archivio S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001461; Da Silva AS, 2010, J COMP PATHOL, V142, P170, DOI 10.1016/j.jcpa.2009.10.020; Da Silva AS, 2011, PARASITOL RES, V108, P23, DOI 10.1007/s00436-010-2036-2; Dagnatchew Z, 1982, 3 INT S VET EP EC, P467; David HS, 2013, HIST DICT ETHIOPIA; De Winne K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002633; Deborggraeve S, 2012, EXPERT REV MOL DIAGN, V12, P719, DOI [10.1586/erm.12.72, 10.1586/ERM.12.72]; Desquesnes M, 2001, INT J PARASITOL, V31, P610, DOI 10.1016/S0020-7519(01)00161-8; Desquesnes M, 2013, BIOMED RES INT, DOI 10.1155/2013/194176; Desquesnes M, 2013, BIOMED RES INT, DOI 10.1155/2013/321237; Fikru R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084819; Fikru R, 2012, VET PARASITOL, V190, P355, DOI 10.1016/j.vetpar.2012.07.010; GATHUO HKW, 1987, J PROTOZOOL, V34, P48, DOI 10.1111/j.1550-7408.1987.tb03130.x; Getachew Abebe, 2005, Ethiopian Journal of Biological Sciences, V4, P75; Gibson W, 2010, PARASITOLOGY, V137, P1799, DOI 10.1017/S0031182010000752; GIBSON WC, 1983, RES VET SCI, V34, P114, DOI 10.1016/S0034-5288(18)32293-8; Gutierrez C, 2005, VET PARASITOL, V130, P163, DOI 10.1016/j.vetpar.2005.02.009; Gutierrez C, 2006, ANN NY ACAD SCI, V1081, P300, DOI 10.1196/annals.1373.040; Hagos A, 2010, REV SCI TECH OIE, V29, P649, DOI 10.20506/rst.29.3.2005; Hagos A, 2009, REV MED VET-TOULOUSE, V160, P569; HERBERT WJ, 1976, EXP PARASITOL, V40, P427, DOI 10.1016/0014-4894(76)90110-7; Hilali M, 2004, VET PARASITOL, V121, P45, DOI 10.1016/j.vetpar.2004.02.009; Hoare CA, 1972, TRYPANOSOMES MAMALS; Holland WG, 2002, ACTA TROP, V81, P159, DOI 10.1016/S0001-706X(01)00211-X; Holland WG, 2003, VET PARASITOL, V111, P115, DOI 10.1016/S0304-4017(02)00363-1; Holland WG, 2001, VET PARASITOL, V102, P225, DOI 10.1016/S0304-4017(01)00534-9; Kebede N, 2009, J INFECT DEV COUNTR, V3, P245; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Konnai S, 2009, INFECT GENET EVOL, V9, P449, DOI 10.1016/j.meegid.2009.01.006; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langridge W. P., 1976, TSETSE TRYPANOSOMIAS; LANHAM SM, 1970, EXP PARASITOL, V28, P521, DOI 10.1016/0014-4894(70)90120-7; LOHR KF, 1986, TROP ANIM HEALTH PRO, V18, P103, DOI 10.1007/BF02359721; Losos GJ, 1986, INFECT DIS TROPICAL; LUMSDEN WHR, 1979, T ROY SOC TROP MED H, V73, P312, DOI 10.1016/0035-9203(79)90092-0; LUN ZR, 1992, MOL BIOCHEM PARASIT, V50, P189, DOI 10.1016/0166-6851(92)90215-6; MIHOK S, 1995, TROP MED PARASITOL, V46, P103; Miruk A, 2008, VET PARASITOL, V152, P141, DOI 10.1016/j.vetpar.2007.12.007; MOA, 2010, ETH AN HLTH YB, P1; MOLOO SK, 1993, PARASITOLOGY, V106, P277, DOI 10.1017/S0031182000075090; MONZON CM, 1990, VET PARASITOL, V36, P141, DOI 10.1016/0304-4017(90)90102-H; Monzon CM, 2003, VET PARASITOL, V111, P59, DOI 10.1016/S0304-4017(02)00331-X; MURRAY M, 1977, T ROY SOC TROP MED H, V71, P325, DOI 10.1016/0035-9203(77)90110-9; Ngaira JM, 2005, EXP PARASITOL, V110, P30, DOI 10.1016/j.exppara.2005.01.001; Njiru ZK, 2006, INFECT GENET EVOL, V6, P292, DOI 10.1016/j.meegid.2005.08.002; Njiru ZK, 2004, VET PARASITOL, V124, P187, DOI 10.1016/j.vetpar.2004.06.029; Oluwafemi RA, 2007, SCI RES ESSAYS, V2, P380; OU YC, 1991, MOL BIOCHEM PARASIT, V46, P97, DOI 10.1016/0166-6851(91)90203-I; Pillay D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078565; Pyana PP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001025; RAINA AK, 1985, VET PARASITOL, V18, P67, DOI 10.1016/0304-4017(85)90009-3; ROWLANDS GJ, 1993, ACTA TROP, V53, P135, DOI 10.1016/0001-706X(93)90025-7; Salim B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-31; Samson L, 2010, PREVALENCE SMALL RUM, V5, P215; Singla LD, 2010, TROP ANIM HEALTH PRO, V42, P589, DOI 10.1007/s11250-009-9461-1; SINHA P K, 1971, Indian Veterinary Journal, V48, P306; Sinshaw A, 2006, VET PARASITOL, V142, P35, DOI 10.1016/j.vetpar.2006.06.032; SONGA EB, 1990, MOL BIOCHEM PARASIT, V43, P167, DOI 10.1016/0166-6851(90)90142-9; SONGA EB, 1988, ANN SOC BELG MED TR, V68, P233; SONGA EB, 1987, ANN SOC BELG MED TR, V67, P137; StataCorp LP, 2013, STAT REL 13 STAT SOF; Tadesse A, 2010, TROP ANIM HEALTH PRO, V42, P1757, DOI 10.1007/s11250-010-9632-0; Takeet MI, 2013, RES VET SCI, V94, P555, DOI 10.1016/j.rvsc.2012.10.018; Tassew W, 2000, THESIS WAGENINGEN U; Thrusfield M., 2007, VET EPIDEMIOLOGY; Uzcanga G, 2002, PARASITOLOGY, V124, P287, DOI 10.1017/S0031182001001214; Uzcanga GL, 2004, BIOCHEMISTRY-US, V43, P595, DOI 10.1021/bi0301946; Van den Bossche P, 2000, THESIS U PRETORIA PR; Van Vlaenderen G, 1996, THESIS PRINCE LEOPOL; Verloo D, 2001, VET PARASITOL, V97, P183, DOI 10.1016/S0304-4017(01)00412-5; Verloo D., 1998, Journal of Protozoology Research, V8, P190; WOO P T K, 1971, Acta Tropica, V28, P298; WOO PTK, 1969, CAN J ZOOLOG, V47, P921, DOI 10.1139/z69-150; World Animal Health (OIE), 2012, TRYP EV INF SURR; World Animal Health (OIE), 2013, TRYP TSETS TRANSM; Zillmann U, 1996, ACTA TROP, V62, P183, DOI 10.1016/S0001-706X(96)00018-6	94	19	19	0	10	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	APR 9	2015	8								212	10.1186/s13071-015-0818-1				11	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	CG4NZ	WOS:000353264500005	25889702	DOAJ Gold, Green Published			2019-04-02	
J	Mpanya, A; Hendrickx, D; Baloji, S; Lumbala, C; da Luz, RI; Boelaert, M; Lutumba, P				Mpanya, Alain; Hendrickx, David; Baloji, Sylvain; Lumbala, Crispin; da Luz, Raquel Inocencio; Boelaert, Marleen; Lutumba, Pascal			From Health Advice to Taboo: Community Perspectives on the Treatment of Sleeping Sickness in the Democratic Republic of Congo, a Qualitative Study	PLOS NEGLECTED TROPICAL DISEASES			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; VISCERAL LEISHMANIASIS; GAMBIENSE; EFLORNITHINE; CHEMOTHERAPY; MELARSOPROL; BARRIERS; DISEASES; TRIAL	Background Socio-cultural and economic factors constitute real barriers for uptake of screening and treatment of Human African Trypanosomiasis (HAT) in the Democratic Republic of Congo (DRC). Better understanding and addressing these barriers may enhance the effectiveness of HAT control. Methods We performed a qualitative study consisting of semi-structured interviews and focus group discussions in the Bandundu and Kasai Oriental provinces, two provinces lagging behind in the HAT elimination effort. Our study population included current and former HAT patients, as well as healthcare providers and program managers of the national HAT control program. All interviews and discussions were voice recorded on a digital device and data were analysed with the ATLAS.ti software. Findings Health workers and community members quoted a number of prohibitions that have to be respected for six months after HAT treatment: no work, no sexual intercourse, no hot food, not walking in the sun. Violating these restrictions is believed to cause serious, and sometimes deadly, complications. These strong prohibitions are well-known by the community and lead some people to avoid HAT screening campaigns, for fear of having to observe such taboos in case of diagnosis. Discussion The restrictions originally aimed to mitigate the severe adverse effects of the melarsoprol regimen, but are not evidence-based and became obsolete with the new safer drugs. Correct health information regarding HAT treatment is essential. Health providers should address the perspective of the community in a constant dialogue to keep abreast of unintended transformations of meaning.	[Mpanya, Alain; Baloji, Sylvain; Lumbala, Crispin] Programme Natl Lutte Trypanosomiase Humaine Afric, Kinshasa, DEM REP CONGO; [Mpanya, Alain; Hendrickx, David; Boelaert, Marleen] Inst Trop Med, B-2000 Antwerp, Belgium; [Hendrickx, David] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia; [Baloji, Sylvain] Univ Pedagog Natl, Kinshasa, DEM REP CONGO; [da Luz, Raquel Inocencio] Univ Antwerp, B-2020 Antwerp, Belgium; [Lutumba, Pascal] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Lutumba, Pascal] Univ Kinshasa, Kinshasa, DEM REP CONGO	Mpanya, A (reprint author), Programme Natl Lutte Trypanosomiase Humaine Afric, Kinshasa, DEM REP CONGO.	mpanya_alain@yahoo.fr	Inocencio da Luz, Raquel/L-9676-2016	Inocencio da Luz, Raquel/0000-0002-2870-0311; Boelaert, Marleen/0000-0001-8051-6776	Institute of Tropical Medicine-Antwerp, Belgium through the Third Framework Agreement - Strategic Network on Neglected Diseases and Zoonoses	This study benefitted from the financial support of the Institute of Tropical Medicine-Antwerp, Belgium through a grant of the Third Framework Agreement - Strategic Network on Neglected Diseases and Zoonoses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, WHO TECHN REP SER, V881; Bailey EJ, 2000, MED ANTHR AFRICAN AM; Barrett MP, 2007, BRIT J PHARMACOL, V152, P1155, DOI 10.1038/sj.bjp.0707354; Barrett MP, 2000, CURR OPIN INFECT DIS, V13, P647, DOI 10.1097/00001432-200012000-00012; Beardsworth A KT, 1997, SOCIOLOGY MENU INVIT, P288; Blum J, 2006, ACTA TROP, V97, P55, DOI 10.1016/j.actatropica.2005.08.001; Boelaert M, 2010, ANN TROP MED PARASIT, V104, P535, DOI 10.1179/136485910X12786389891641; Burke J., 1976, TRYPANOSOMIASE HUMAI; Burri C, 2010, PARASITOLOGY, V137, P1987, DOI 10.1017/S0031182010001137; Chappuis F, 2005, CLIN INFECT DIS, V41, P748, DOI 10.1086/432576; Franco JR, 2012, RES REP TROP MED, V3, P93, DOI 10.2147/RRTM.S34399; Gouteux J P, 1985, Med Trop (Mars), V45, P259; HALLER L, 1986, AM J TROP MED HYG, V35, P94, DOI 10.4269/ajtmh.1986.35.94; Hasker E, 2012, TROP MED INT HEALTH, V17, P1127, DOI 10.1111/j.1365-3156.2012.03042.x; Hasker E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001950; Lutumba P, 2007, EMERG INFECT DIS, V13, P248, DOI 10.3201/eid1302.060075; MANDERSON L, 1987, SOC SCI MED, V25, P329, DOI 10.1016/0277-9536(87)90270-X; Manne JM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002488; Mpanya A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001467; PEPIN J, 1985, ANN SOC BELG MED TR, V65, P17; PEPIN J, 1994, ADV PARASIT, V33, P1, DOI 10.1016/S0065-308X(08)60410-8; Priotto G, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010039; Priotto G, 2008, BMJ-BRIT MED J, V336, P705, DOI 10.1136/bmj.39485.592674.BE; Priotto G, 2009, LANCET, V374, P56, DOI 10.1016/S0140-6736(09)61117-X; Rimoin AW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002118; Robays J, 2007, TROP MED INT HEALTH, V12, P290, DOI 10.1111/j.1365-3165.2006.01768.x; Robays J, 2004, TROP MED INT HEALTH, V9, P542, DOI 10.1111/j.1365-3156.2004.01240.x; Robays J, 2008, EMERG INFECT DIS, V14, P966, DOI 10.3201/eid1406.071266; Saldana J., 2013, CODING MANUAL QUALIT; Simarro PP, 2012, PARASITOLOGY, V139, P842, DOI 10.1017/S0031182012000169; Uranw S, 2013, TROP MED INT HEALTH, V18, P179, DOI 10.1111/tmi.12025; WHO, 2013, WHO TECH REP SER, V984, P1; Yansouni CP, 2013, LANCET INFECT DIS, V13, P546, DOI 10.1016/S1473-3099(13)70004-5	33	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	APR	2015	9	4							e0003686	10.1371/journal.pntd.0003686				14	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CI7VF	WOS:000354972200038	25856578	DOAJ Gold, Green Published			2019-04-02	
J	Picado, A; Ostyn, B; Rijal, S; Sundar, S; Singh, P; Chappuis, F; Das, ML; Khanal, B; Gidwani, K; Hasker, E; Dujardin, JC; Vanlerberghe, V; Menten, J; Coosemans, M; Boelaert, M				Picado, Albert; Ostyn, Bart; Rijal, Suman; Sundar, Shyam; Singh, Prakash; Chappuis, Francois; Das, Murari Lal; Khanal, Basudha; Gidwani, Kamlesh; Hasker, Epco; Dujardin, Jean Claude; Vanlerberghe, Veerle; Menten, Joris; Coosemans, Marc; Boelaert, Marleen			Long-lasting Insecticidal Nets to Prevent Visceral Leishmaniasis in the Indian Subcontinent; Methodological Lessons Learned from a Cluster Randomised Controlled Trial	PLOS NEGLECTED TROPICAL DISEASES			English	Review							PHLEBOTOMUS-ARGENTIPES; SEROLOGICAL MARKERS; DONOVANI INFECTION; VECTOR CONTROL; ENDEMIC AREAS; KALA-AZAR; BED-NETS; NEPAL; PSYCHODIDAE; DIPTERA		[Picado, Albert] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Ostyn, Bart; Hasker, Epco; Vanlerberghe, Veerle; Menten, Joris; Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Rijal, Suman] BP Koirala Inst Hlth Sci, Dept Med, Dharan, Nepal; [Sundar, Shyam; Gidwani, Kamlesh] Banaras Hindu Univ, Inst Med Sci, Dept Med, Varanasi 221005, Uttar Pradesh, India; [Singh, Prakash] Banaras Hindu Univ, Inst Med Sci, Dept Community Med, Varanasi 221005, Uttar Pradesh, India; [Chappuis, Francois] Univ Hosp Geneva, Div Trop & Humanitarian Med, Geneva, Switzerland; [Chappuis, Francois] Univ Geneva, Geneva, Switzerland; [Das, Murari Lal; Khanal, Basudha] BP Koirala Inst Hlth Sci, Dept Microbiol, Dharan, Nepal; [Dujardin, Jean Claude; Coosemans, Marc] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Dujardin, Jean Claude; Coosemans, Marc] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium	Picado, A (reprint author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.	mboelaert@itg.be		Picado, Albert/0000-0001-7344-628X; Boelaert, Marleen/0000-0001-8051-6776; Das, Murari/0000-0001-6816-2389	European Union [015374]	The KALANET community trial was part of a large project conducted by the KALANET consortium funded by the European Union under its 6th Framework Program (INCODEV/Project 015374). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Burniston I, 2010, J MED ENTOMOL, V47, P902, DOI 10.1603/ME09184; Das ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114915; Das ML, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000100; Dinesh DS, 2008, TROP MED INT HEALTH, V13, P953, DOI 10.1111/j.1365-3156.2008.02096.x; Dinesh DS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000859; Dinesh DS, 2001, ANN TROP MED PARASIT, V95, P197, DOI 10.1080/00034980120041071; Gavgani ASM, 2002, LANCET, V360, P374, DOI 10.1016/S0140-6736(02)09609-5; Gidwani K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001296; Gidwani K, 2011, CLIN VACCINE IMMUNOL, V18, P346, DOI 10.1128/CVI.00473-10; Gidwani K, 2009, AM J TROP MED HYG, V80, P566, DOI 10.4269/ajtmh.2009.80.566; Hasker E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002657; Hayes RJ, 2009, INTERD STAT, P3; Khanal B, 2010, TROP MED INT HEALTH, V15, P1390, DOI 10.1111/j.1365-3156.2010.02631.x; Kiware SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037661; Lengeler C, 2004, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000363.PUB2; Menten J, 2012, STAT MODEL, V12, P551, DOI 10.1177/1471082X12465797; Mishra RN, 2010, TROP MED INT HEALTH, V15, P36, DOI 10.1111/j.1365-3156.2010.02544.x; Mondal D, 2013, EMERG INFECT DIS, V19, P1131, DOI 10.3201/eid1907.120932; Nagpal S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002238; Olliaro P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001545; Ostyn B, 2008, TROP MED INT HEALTH, V13, P1073, DOI 10.1111/j.1365-3156.2008.02110.x; Ostyn B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001284; Picado A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114915; Picado A, 2010, PLOS NEGLECT TROP D, V4, P9; Picado A, 2012, INDIAN J MED RES, V136, P22; Picado A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6760; Picado A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000587; Poche RM, 2012, J VECTOR ECOL, V37, P148, DOI 10.1111/j.1948-7134.2012.00211.x; Stauch A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002810; Stauch A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001405; Stockdale L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002278; Vanlerberghe V, 2010, TROP MED INT HEALTH, V15, P60, DOI 10.1111/j.1365-3156.2009.02433.x; WHOPES, 2013, GUIDELINES FOR LABOR	33	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	APR	2015	9	4							e0003597	10.1371/journal.pntd.0003597				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CI7VF	WOS:000354972200011	25856238	DOAJ Gold, Green Published			2019-04-02	
J	Montresor, A; Porta, NA; Albonico, M; Gabrielli, AF; Jankovic, D; Fitzpatrick, C; Vercruysse, J; Levecke, B				Montresor, Antonio; Porta, Natacha A.; Albonico, Marco; Gabrielli, Albis Francesco; Jankovic, Dina; Fitzpatrick, Christopher; Vercruysse, Jozef; Levecke, Bruno			Soil-transmitted helminthiasis: the relationship between prevalence and classes of intensity of infection	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Epidemiology; Soil-transmitted helminths	PREVENTIVE CHEMOTHERAPY; PROGRAM; CHILDREN; VIETNAM; SCHOOLS; MODEL	Background: Recently, WHO has developed a predictive model to evaluate the impact of preventive chemotherapy programs to control the morbidity of soil-transmitted helminths (STHs). To make predictions, this model needs baseline information about the proportion of infections classified as low, moderate and high intensity, for each of the three STH species. However, epidemiological data available are often limited to prevalence estimates. Methods: We reanalyzed available data from 19 surveys in 10 countries and parameterized the relationship between prevalence of STH infections and the proportion of moderate and heavy intensity infections. Results: The equations derived allow feeding the WHO model with estimates of the proportion of the different classes of infection intensity when only prevalence data is available. Conclusions: The prediction capacities of the STH model using the equations developed in the present study, should be tested by comparing it with the changes on STH epidemiological data observed in control programs operating for several years.	[Montresor, Antonio; Porta, Natacha A.; Gabrielli, Albis Francesco; Fitzpatrick, Christopher] WHO, Dept Control Neglected Trop Dis, CH-1211 Geneva, Switzerland; [Albonico, Marco] Ivo de Carneri Fdn, Milan, Italy; [Jankovic, Dina] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Vercruysse, Jozef; Levecke, Bruno] Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, Merelbeke, Belgium	Montresor, A (reprint author), WHO, Dept Control Neglected Trop Dis, 20 Av Appia, CH-1211 Geneva, Switzerland.	montresora@who.int		Levecke, Bruno/0000-0001-8912-5595; ALBONICO, Marco/0000-0002-7805-2391	World Health Organization [001]		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albonico M, 2003, B WORLD HEALTH ORGAN, V81, P345; ANDERSON RM, 1982, NATURE, V297, P557, DOI 10.1038/297557a0; [Anonymous], 2014, Wkly Epidemiol Rec, V89, P133; [Anonymous], 2006, PREV CHEM HUM HELM C; Bundy D. A. P., 1992, World Health Statistics Quarterly, V45, P168; Frost C, 2000, J R STAT SOC A STAT, V163, P173, DOI 10.1111/1467-985X.00164; Gabrielli AF, 2011, T ROY SOC TROP MED H, V105, P683, DOI 10.1016/j.trstmh.2011.08.013; Gabrielli AF, 2005, J HELMINTHOL, V79, P381, DOI 10.1079/JOH2005316; Hall A, 2008, MATERN CHILD NUTR, V4, P118, DOI 10.1111/j.1740-8709.2007.00127.x; Howard R. A., 1960, DYNAMIC PROGRAMING M; Katz N, 1972, REV INST MED TROP SP, V14, P379; Knopp S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000331; Levecke B, 2014, PLOS NEGL TROP DIS; Levecke B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001201; Long J. S., 1997, REGRESSION MODELS CA; Long JS, 2002, CATEGORICAL DATA ANA, V2nd; Louviere J. J., 2000, STATED CHOICE METHOD; McFadden D, 1973, FRONTIERS ECONOMETRI; Ministry of Agriculture Fisheries and Food, 1986, MAN VET PAR LAB TECH, V418; Montresor A, 1997, Med Trop (Mars), V57, P294; Montresor A, 2013, T ROY SOC TROP MED H, V107, P313, DOI 10.1093/trstmh/trt019; Pasricha SR, 2008, AM J TROP MED HYG, V78, P375, DOI 10.4269/ajtmh.2008.78.375; Phommasack B, 2008, T ROY SOC TROP MED H, V102, P1201, DOI 10.1016/j.trstmh.2008.04.036; Vercruysse J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000948; WHO, 2011, HELMINTH CONTROL IN SCHOOL-AGE CHILDREN: A GUIDE FOR MANAGERS OF CONTROL PROGRAMMES, SECOND EDITION, P1; WHO, 2002, PREV CONTR SCHIST SO; WHO, 1991, LAB METH HUM PAR; World Bank, GDP PER CAP CONST 20; World Health Organization (WHO), 2012, EL SOIL TRANSM HELM	30	10	10	0	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	APR	2015	109	4					262	267		10.1093/trstmh/tru180				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CI5EJ	WOS:000354775900007	25404186	Green Accepted			2019-04-02	
J	George, S; Kaliappan, SP; Kattula, D; Roy, S; Geldhof, P; Kang, G; Vercruysse, J; Levecke, B				George, Santosh; Kaliappan, Saravanakumar Puthupalayam; Kattula, Deepthi; Roy, Sheela; Geldhof, Peter; Kang, Gagandeep; Vercruysse, Jozef; Levecke, Bruno			Identification of Ancylostoma ceylanicum in children from a tribal community in Tamil Nadu, India using a semi-nested PCR-RFLP tool	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Ancylostoma ceylanicum; Ancylostoma duodenale; India; Necator americanus; Tamil Nadu; Zoonosis	TRANSMITTED HELMINTH INFECTIONS; PREVALENCE; DOGS	Background: It is generally assumed that hookworm infections in humans are caused by Necator americanus and Ancylostoma duodenale. However, previous studies have also reported the presence of the animal hookworm A. ceylanicum in human stools. Methods: We determined hookworm infections in children in a tribal community in Tamil Nadu, India, using a semi-nested PCR-RFLP approach. Results: The results indicate that human species account for a majority of the hookworm infections (N. americanus 39/41 [95%]; A. duodenale 6/41 [15%]), whereas the animal hookworm A. ceylanicum only accounts for a minority of the infections (5%; 2/41). Conclusions: The results emphasize the need to consider zoonotic ancylostomiasis while developing strategies to control hookworm infections.	[George, Santosh; Geldhof, Peter; Vercruysse, Jozef; Levecke, Bruno] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, B-9000 Ghent, Belgium; [George, Santosh; Kaliappan, Saravanakumar Puthupalayam; Kattula, Deepthi; Roy, Sheela; Kang, Gagandeep] Christian Med Coll & Hosp, Div Gastrointestinal Sci, Vellore, Tamil Nadu, India	Levecke, B (reprint author), Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, B-9000 Ghent, Belgium.	Bruno.Levecke@Ugent.be		Levecke, Bruno/0000-0001-8912-5595	Division of Gastrointestinal Sciences, Christian Medical College, Vellore, India; Ghent University	This study was financially funded by the Division of Gastrointestinal Sciences, Christian Medical College, Vellore, India (www.cmcwtrl.in) and SG is supported by the Special Research Fund of Ghent University. BL is a postdoctoral fellow of FWO [Ref No. 05-05 1.2.853.13; www.fwo.be].	Bowman DD, 2010, TRENDS PARASITOL, V26, P162, DOI 10.1016/j.pt.2010.01.005; Inpankaew T, 2014, EMERG INFECT DIS, V20, P976, DOI 10.3201/eid2006.131770; Kaliappan SP, 2013, TROP MED INT HEALTH, V18, P1452, DOI 10.1111/tmi.12205; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Traub RJ, 2014, VET PARASITOL, V205, P233, DOI 10.1016/j.vetpar.2014.06.037; WHO, 2011, HELMINTH CONTROL IN SCHOOL-AGE CHILDREN: A GUIDE FOR MANAGERS OF CONTROL PROGRAMMES, SECOND EDITION, P1	6	8	10	0	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	APR	2015	109	4					283	285		10.1093/trstmh/trv001				3	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CI5EJ	WOS:000354775900011	25618132				2019-04-02	
J	Fernandez, S; Thomas, SJ; De la Barrera, R; Im-Erbsin, R; Jarman, RG; Baras, B; Toussaint, JF; Mossman, S; Innis, BL; Schmidt, A; Malice, MP; Festraets, P; Warter, L; Putnak, JR; Eckels, KH				Fernandez, Stefan; Thomas, Stephen J.; De la Barrera, Rafael; Im-Erbsin, Rawiwan; Jarman, Richard G.; Baras, Benoit; Toussaint, Jean-Francois; Mossman, Sally; Innis, Bruce L.; Schmidt, Alexander; Malice, Marie-Pierre; Festraets, Pascale; Warter, Lucile; Putnak, J. Robert; Eckels, Kenneth H.			An Adjuvanted, Tetravalent Dengue Virus Purified Inactivated Vaccine Candidate Induces Long-Lasting and Protective Antibody Responses Against Dengue Challenge in Rhesus Macaques	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							JAPANESE ENCEPHALITIS VACCINE; CLINICAL LABORATORY RESPONSES; HEMORRHAGIC-FEVER; DV INFECTION; DOUBLE-BLIND; B-CELLS; MONKEYS; PATHOGENESIS; TRIAL; IMMUNOGENICITY	The immunogenicity and protective efficacy of a candidate tetravalent dengue virus purified inactivated vaccine (TDENV PIV) formulated with alum or an Adjuvant System (AS01, AS03 tested at three different dose levels, or AS04) was evaluated in a 0,1-month vaccination schedule in rhesus macaques. One month after dose 2, all adjuvanted formulations elicited robust and persisting neutralizing antibody titers against all four dengue virus serotypes. Most of the formulations tested prevented viremia after challenge, with the dengue serotype 1 and 2 virus strains administered at 40 and 32 weeks post-dose 2, respectively. This study shows that inactivated dengue vaccines, when formulated with alum or an Adjuvant System, are candidates for further development.	[Fernandez, Stefan; Im-Erbsin, Rawiwan] USAMC AFRIMS, Bangkok, Thailand; [Thomas, Stephen J.; De la Barrera, Rafael; Jarman, Richard G.; Putnak, J. Robert; Eckels, Kenneth H.] WRAIR, Silver Spring, MD 20910 USA; [Baras, Benoit; Toussaint, Jean-Francois; Mossman, Sally; Schmidt, Alexander; Malice, Marie-Pierre; Festraets, Pascale; Warter, Lucile] GlaxoSmithKline Vaccines, Rixensart, Belgium; [Innis, Bruce L.] GlaxoSmithKline Vaccines, King Of Prussia, PA USA	Eckels, KH (reprint author), WRAIR, Silver Spring, MD 20910 USA.	Stefan.Fernandez@afrims.org; stephen.j.thomas3.mil@mail.mil; rafael.a.delabarrera.ctr@mail.mil; RawiwanI@afrims.org; richard.g.jarman.mil@mail.mil; benoit.baras@gsk.com; jean-francois.x.toussaint@gsk.com; sally.p.mossman@gsk.com; Bruce.2.Innis@gsk.com; alexander.c.schmidt@gsk.com; marie-pierre.x.malice@gsk.com; pascale.festraets@gsk.com; lucile.x.warter@gsk.com; j.r.putnak.ctr@mail.mil; Kenneth.h.eckels.civ@mail.mil		Toussaint, Jean-Francois/0000-0003-1964-5039; Innis, Bruce/0000-0002-1753-7248	US Army Medical Research and Materiel Command (Fort Detrick, MD); GlaxoSmithKline Biologicals S.A. (Rixensart, Belgium)	This work was funded by the US Army Medical Research and Materiel Command (Fort Detrick, MD) and GlaxoSmithKline Biologicals S.A. (Rixensart, Belgium) under a Cooperative Research and Development Agreement.	Alexander N, 2011, TROP MED INT HEALTH, V16, P936, DOI 10.1111/j.1365-3156.2011.02793.x; Baras B, 2008, INFLUENZA OTHER RESP, V2, P251, DOI 10.1111/j.1750-2659.2008.00054.x; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Blaney JE, 2005, J VIROL, V79, P5516, DOI 10.1128/JVI.79.9.5516-5528.2005; Blaney JE, 2007, VIROL J, V4, DOI 10.1186/1743-422-4-23; Blaney JE, 2008, VACCINE, V26, P817, DOI 10.1016/j.vaccine.2007.11.082; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Durbin AP, 2013, J INFECT DIS, V207, P957, DOI 10.1093/infdis/jis936; Durbin AP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001267; Durbin AP, 2010, CURR TOP MICROBIOL, V338, P129, DOI 10.1007/978-3-642-02215-9_10; Durier C, 2013, AIDS, V27, P87, DOI 10.1097/QAD.0b013e328359f27a; Eckels KH, 2003, AM J TROP MED HYG, V69, P12, DOI 10.4269/ajtmh.2003.69.12; Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280; FALGOUT B, 1990, J VIROL, V64, P4356; Fernandez S, 2011, CLIN VACCINE IMMUNOL, V18, P523, DOI 10.1128/CVI.00016-11; Garcon N, 2012, EXPERT REV VACCINES, V11, P349, DOI [10.1586/ERV.11.192, 10.1586/erv.11.192]; Garcon N, 2011, EXPERT REV VACCINES, V10, P471, DOI [10.1586/ERV.11.29, 10.1586/erv.11.29]; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098; HALSTEAD SB, 1973, J INFECT DIS, V128, P15, DOI 10.1093/infdis/128.1.15; HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P350; HALSTEAD SB, 1973, J INFECT DIS, V128, P7, DOI 10.1093/infdis/128.1.7; Halstead SB, 2013, VACCINE, V31, P4501, DOI 10.1016/j.vaccine.2013.06.079; Hombach J, 2005, VACCINE, V23, P5205, DOI 10.1016/j.vaccine.2004.11.040; Hombach J, 2007, VACCINE, V25, P4130, DOI 10.1016/j.vaccine.2007.02.079; INNIS BL, 1988, J INFECT DIS, V158, P876, DOI 10.1093/infdis/158.4.876; Kinney RM, 2001, INTERVIROLOGY, V44, P176, DOI 10.1159/000050045; Konishi E, 2013, EXPERT REV VACCINES, V12, P871, DOI 10.1586/14760584.2013.814828; Kou Z, 2008, J MED VIROL, V80, P134, DOI 10.1002/jmv.21051; Kurane Ichiro, 2011, Trop Med Health, V39, P45, DOI 10.2149/tmh.2011-S09; Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08; Leroux-Roels I, 2010, VACCINE, V28, P849, DOI 10.1016/j.vaccine.2009.10.017; Lyons A, 2007, VACCINE, V25, P3445, DOI 10.1016/j.vaccine.2006.12.046; MONATH TP, 1990, VIROLOGY, P763; Morel S, 2011, VACCINE, V29, P2461, DOI 10.1016/j.vaccine.2011.01.011; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Osorio JE, 2011, AM J TROP MED HYG, V84, P978, DOI 10.4269/ajtmh.2011.10-0592; Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004; Putnak JR, 2005, VACCINE, V23, P4442, DOI 10.1016/j.vaccine.2005.03.042; Putnak R, 1996, J INFECT DIS, V174, P1176, DOI 10.1093/infdis/174.6.1176; Risi G, 2011, VACCINE, V29, P6408, DOI 10.1016/j.vaccine.2011.04.072; Rothman AL, 2014, J INFECT DIS, V209, P561, DOI 10.1093/infdis/jiu111; Rothman AL, 2010, CURR TOP MICROBIOL, V338, P83, DOI 10.1007/978-3-642-02215-9_7; Sabchareon A, 2004, PEDIATR INFECT DIS J, V23, P99, DOI 10.1097/01.inf.0000109289.55856.27; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Sadon N, 2008, J VIROL METHODS, V153, P1, DOI 10.1016/j.jviromet.2008.06.023; Simmons M, 2006, J VIROL, V80, P9577, DOI 10.1128/JVI.00284-06; Simmons M, 2010, VIROLOGY, V396, P280, DOI 10.1016/j.virol.2009.10.023; Slifka MK, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00195; Sun W, 2006, J INFECT DIS, V193, P1658, DOI 10.1086/503372; Tauber E, 2008, J INFECT DIS, V198, P493, DOI 10.1086/590116; Thomas SJ, 2013, AM J TROP MED HYG, V88, P73, DOI 10.4269/ajtmh.2012.12-0361; Van Gessel Y, 2011, VACCINE, V29, P5925, DOI 10.1016/j.vaccine.2011.06.062; Yacoub S, 2013, CURR OPIN INFECT DIS, V26, P284, DOI 10.1097/QCO.0b013e32835fb938; Ye J, 2013, VACCINE, V31, P461, DOI 10.1016/j.vaccine.2012.11.015; Yoon IK, 2012, J INFECT DIS, V206, P389, DOI 10.1093/infdis/jis357	58	17	17	1	6	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	APR	2015	92	4					698	708		10.4269/ajtmh.14-0268				11	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CF8QY	WOS:000352828200007	25646261	Green Published, Other Gold			2019-04-02	
J	Duncombe, C; Rosenblum, S; Hellmann, N; Holmes, C; Wilkinson, L; Biot, M; Bygrave, H; Hoos, D; Garnett, G				Duncombe, Chris; Rosenblum, Scott; Hellmann, Nicholas; Holmes, Charles; Wilkinson, Lynne; Biot, Marc; Bygrave, Helen; Hoos, David; Garnett, Geoff			Reframing HIV care: putting people at the centre of antiretroviral delivery	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Review						AIDS; antiretroviral treatment; highly active; cascade; decentralisation; HIV; optimised care; patient-centred care; task shifting	SUB-SAHARAN AFRICA; SOUTH-AFRICA; THERAPY; UGANDA; MOZAMBIQUE; RETENTION; OUTCOMES; PROGRAM; PEPFAR; MODELS	The delivery of HIV care in the initial rapid scale-up of HIV care and treatment was based on existing clinic-based models, which are common in highly resourced settings and largely undifferentiated for individual needs. A new framework for treatment based on variable intensities of care tailored to the specific needs of different groups of individuals across the cascade of care is proposed here. Service intensity is characterised by four delivery components: (i) types of services delivered, (ii) location of service delivery, (iii) provider of health services and (iv) frequency of health services. How these components are developed into a service delivery framework will vary across countries and populations, with the intention being to improve acceptability and care outcomes. The goal of getting more people on treatment before they become ill will necessitate innovative models of delivering both testing and care. As HIV programmes expand treatment eligibility, many people entering care will not be patients' but healthy, active and productive members of society . To take the framework to scale, it will be important to: (i) define which individuals can be served by an alternative delivery framework; (ii) strengthen health systems that support decentralisation, integration and task shifting; (iii) make the supply chain more robust; and (iv) invest in data systems for patient tracking and for programme monitoring and evaluation. La delivrance des soins du VIH dans le deploiement initial rapide des soins et du traitement du VIH a ete basee sur des modeles existants dans les cliniques, qui sont courants dans les regions beneficiant d'importantes ressources et largement indifferenciees pour les besoins individuels. Un nouveau cadre est propose ici pour le traitement base selon les intensites variables de soins, adaptes aux besoins specifiques des differents groupes de personnes a travers la cascade de soins. L'intensite des services est caracterisee par quatre elements de delivrance: (1) les types de services delivres, (2) l'emplacement de la delivrance des services, (3) Les prestataires des services de sante et (4) la frequence des services de sante. La facon dont ces elements sont developpes dans un cadre de prestation de services peut varier selon les pays et les populations, l'intention etant d'ameliorer les resultats d'acceptabilite et des soins. Le but d'obtenir plus de personnes sous traitement avant qu'ils ne tombent malades necessitera des modeles innovateurs de prestation a la fois pour depistage et pour les soins. Comme les programmes VIH etendent l'eligibilite au traitement, beaucoup de gens qui entrent dans les soins ne seront pas des malades- mais des elements sains de la societe, actifs et productifs. Afin de tenir le cadre a l'echelle, il sera important de: (1) definir les individus qui peuvent etre traites par un cadre alternatif de prestation, (2) renforcer les systemes de sante qui soutiennent la decentralisation, l'integration et le transfert des taches; (3) rendre la chaine d'approvisionnement plus robuste et (4) investir dans des systemes de donnees pour le suivi des patients et pour le suivi et l'evaluation du programme. Los servicios de atencion del VIH durante el inicio de la primera etapa de rapida expansion del tratamiento y cuidados del VIH estaban basados en modelos clinicos existentes, comunes en lugares con abundancia de recursos y poco diferenciados en cuanto a necesidades individuales. Aqui se propone un nuevo marco para el tratamiento basado en intensidades variables de cuidados, hecho a medida segun las necesidades especificas de los diferentes grupos de individuos a lo largo del tratamiento. La intensidad del servicio se caracteriza por cuatro componentes de entrega: (1) tipologia de los servicios ofrecidos, (2) lugar de entrega de los servicios, (3) proveedor de los servicios sanitarios, y (4) frecuencia de los servicios sanitarios. El como estos componentes conforman un marco de entrega de servicios variara segun el pais y la poblacion, con la intencion de mejorar la aceptabilidad y los resultados de los cuidados. El objetivo de conseguir que mas personas reciban tratamiento antes de que enfermen requerira de modelos innovadores en la oferta tanto de pruebas para deteccion como de los cuidados. A medida que los programas para el VIH expandan los criterios de elegibilidad para el tratamiento, muchas de las personas que comiencen a recibir cuidados no seran pacientes- sino miembros sanos, activos y productivos de la sociedad. Con el fin de expandir la escala de esta estructura, seria importante: (1) definir cuales individuos pueden ser atendidos dentro de un marco de entrega de servicios alternativo; (2) fortalecer los sistemas sanitarios que apoyan la descentralizacion, integracion y delegacion de funciones; (3) robustecer la cadena de proveedores; e (4) invertir en sistemas de datos para el seguimiento de pacientes y para la monitorizacion y evaluacion de programas.	[Duncombe, Chris; Rosenblum, Scott; Garnett, Geoff] Bill & Melinda Gates Fdn, Seattle, WA 98109 USA; [Hellmann, Nicholas] Elizabeth Glaser Pediat AIDS Fdn, Washington, DC USA; [Holmes, Charles] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Wilkinson, Lynne; Biot, Marc; Bygrave, Helen] Med Sans Frontieres Operat Ctr, Brussels, Belgium; [Hoos, David] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	Duncombe, C (reprint author), Bill & Melinda Gates Fdn, 440 5th Ave North, Seattle, WA 98109 USA.	Chris.Duncombe@gatesfoundation.org	Garnett, Geoffrey/A-9312-2008				Amuron B, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-39; [Anonymous], 2012, PLOS MED; Babigumira JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018193; Babigumira JB, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-192; Barnabas RV, 2014, LANCET HIV, V1, pE68, DOI 10.1016/S2352-3018(14)70024-4; Bemelmans M, 2014, TROP MED INT HEALTH, V19, P968, DOI 10.1111/tmi.12332; Boyd MA, 2012, LANCET, V380, P1860, DOI 10.1016/S0140-6736(12)61154-4; Brennan AT, 2011, AIDS, V25, P2027, DOI 10.1097/QAD.0b013e32834b6480; Decroo T, 2014, TROP MED INT HEALTH, V19, P514, DOI 10.1111/tmi.12278; Decroo T, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-6; Eaton JW, 2014, LANCET GLOB HEALTH, V2, pE23, DOI 10.1016/S2214-109X(13)70172-4; El-Sadr WM, 2012, JAIDS-J ACQ IMM DEF, V60, pS96, DOI 10.1097/QAI.0b013e31825eb27b; Fairall L, 2012, LANCET, V380, P889, DOI 10.1016/S0140-6736(12)60730-2; Fatti G, 2010, PLOS MED, P5; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Holmes C, 2014, AIDS, V28, pS231, DOI 10.1097/QAD.0000000000000250; Humphreys CP, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-229; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; Kates J, FINANCING RESPONSE A; Katz IT, 2013, NEW ENGL J MED, V369, P1385, DOI 10.1056/NEJMp1310982; Kredo T, 2012, COCHRANE DATABASE SY; Kredo T, 2013, COCHRANE DATABASE SY; Long L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001055; Luque-Fernandez MA, 2013, PLOS MED, P8; McMahon JH, 2013, B WORLD HEALTH ORGAN, V91, P377, DOI 10.2471/BLT.12.112946; Rosen S, 2011, PLOS MED; Selke HM, 2010, JAIDS-J ACQ IMM DEF, V55, P483, DOI 10.1097/QAI.0b013e3181eb5edb; Zuber A, 2014, J ASSOC NURSE AIDS C, V25, P520, DOI 10.1016/j.jana.2014.02.003	28	40	40	1	16	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	APR	2015	20	4					430	447		10.1111/tmi.12460				18	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CD0IV	WOS:000350755800004	25583302	Green Published	Y	N	2019-04-02	
J	Dallatomasina, S; Crestani, R; Squire, JS; Declerk, H; Caleo, GM; Wolz, A; Stinson, K; Patten, G; Brechard, R; Gbabai, OBM; Spreicher, A; Van Herp, M; Zachariah, R				Dallatomasina, Silvia; Crestani, Rosa; Squire, James Sylvester; Declerk, Hilde; Caleo, Grazia Marta; Wolz, Anja; Stinson, Kathryn; Patten, Gabriela; Brechard, Raphael; Gbabai, Osman Bamba-Moi; Spreicher, Armand; Van Herp, Michel; Zachariah, Rony			Ebola outbreak in rural West Africa: epidemiology, clinical features and outcomes	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						Ebola; Kailahun; operational research; MSF; health workers	DISEASE OUTBREAK; VIRUS DISEASE; TRANSMISSION; WORKERS	ObjectiveTo describe Ebola cases in the district Ebola management centre of in Kailahun, a remote rural district of Sierra Leone, in terms of geographic origin, patient and hospitalisation characteristics, treatment outcomes and time from symptom onset to admission. MethodsData of all Ebola cases from June 23rd to October 5th 2014 were reviewed. Ebola was confirmed by reverse-transcriptase-polymerase-chain-reaction assay. ResultsOf 489 confirmed cases (51% male, median age 28years), 166 (34%) originated outside Kailahun district. Twenty-eight (6%) were health workers: 2 doctors, 11 nurses, 2 laboratory technicians, 7 community health workers and 6 other cadres. More than 50% of patients had fever, headache, abdominal pain, diarrhoea/vomiting. An unusual feature was cough in 40%. Unexplained bleeding was reported in 5%. Outcomes for the 489 confirmed cases were 227 (47%) discharges, 259 (53%) deaths and 3 transfers. Case fatality in health workers (68%) was higher than other occupations (52%, P=0.05). The median community infectivity time was 6.5days for both general population and health workers (P=0.4). ConclusionsOne in three admitted cases originated outside Kailahun district due to limited national access to Ebola management centres - complicating contact tracing, safe burial and disinfection measures. The comparatively high case fatality among health workers requires attention. The community infectivity time needs to be reduced to prevent continued transmission. ObjectifDecrire les cas d'Ebola dans le Centre de prise en charge Ebola a Kailahun, un district rural recule de la Sierra Leone, en termes d'origine geographique, des caracteristiques des patients et d'hospitalisation, des resultats du traitement et du temps entre l'apparition des symptomes et l'admission. MethodesLes donnees de tous les cas d'Ebola du 23 juin au 5 octobre 2014 ont ete examinees. Ebola a ete confirme par un test de reaction en chaine de la polymerase couplee a la transcriptase inverse. ResultatsSur 489 cas confirmes (51% de sexe masculin, age median: 28 ans), 166 (34%) provenaient de l'exterieur du district de Kailahun. Vingt-huit (6%) cas etaient des agents de la sante: 2 medecins, 11 infirmieres, 2 techniciens de laboratoire, 7 agents de la sante communautaires et 6 autres cadres. Plus de 50% des patients avaient de la fievre, des maux de tete, des douleurs abdominales, de la diarrhee et des vomissements. Une caracteristique inhabituelle etait la toux chez 40% des cas. Des saignements inexpliques ont ete rapportes chez 5% des cas. Les resultats pour les 489 cas confirmes etaient: 227 (47%) guerisons, 259 (53%) deces et 3 transferts. Le taux de letalite chez les agents de la sante (68%) etait plus eleve que pour les autres professions (52%, P = 0,05). Le delai median d'infectivite dans la communaute etait de 6,5 jours, a la fois dans la population generale et chez les agents la sante (P = 0,4). ConclusionsUn cas admis sur trois provenaient de l'exterieur district de Kailahun a cause de l'acces limite aux centres nationaux de prise en charge Ebola - compliquant ainsi la recherche des contacts, les mesures d'inhumation et de desinfection sures. Le taux de letalite relativement eleve chez les agents de la sante necessite une attention particuliere. Le delai d'infectivite dans la communaute devrait etre reduit afin de pouvoir prevenir la transmission continue. ObjetivoDescribir los casos de Ebola en el Centro para el Manejo del Ebola del distrito Kailahun, un distrito rural remoto de Sierra Leona, en terminos de origen geografico, caracteristicas del paciente y de la hospitalizacion, resultados del tratamiento y tiempo desde el comienzo de los sintomas hasta ser admitido. MetodosSe revisaron los datos de todos los casos de Ebola entre el 23 de Junio y el 5 de Octubre del 2014. El Ebola se confirmo mediante un ensayo de reaccion en cadena de la polimerasa con transcriptasa inversa. ResultadosDe 489 casos confirmados (51% eran hombres, con una edad media de 28 anos) y 166 (34%) se habian originado fuera del distrito de Kailahun. Veintiocho (6%) eran trabajadores sanitarios: 2 doctores, 11 enfermeras, 2 tecnicos de laboratorio, 7 trabajadores sanitarios comunitarios y 6 tenian otros perfiles. Mas de un 50% de los pacientes presentaban fiebre, dolor de cabeza, dolor abdominal, diarrea/vomito. Una caracteristica inusual era la tos en un 40%. Se reporto sangrado sin explicacion aparente en un 5%. Los resultados de los 489 casos confirmados fueron: 227 (47%) dados de alta, 259 (53%) decesos y 3 transferencias. La tasa de letalidad entre trabajadores sanitarios (68%) era mayor que entre otras ocupaciones (52%, P= 0.05). El tiempo medio de infectividad en la comunidad era de 6.5 dias, tanto para la poblacion general como para los trabajadores sanitarios. ConclusionesUno de cada tres casos ingresados se habian originado fuera del distrito de Kailahun, debido al acceso limitado a nivel nacional a los Centros para el Manejo del Ebola - lo cual complica el seguimiento de contactos, un entierro seguro y el control de las medidas de desinfeccion. La mortalidad comparativamente mayor entre trabajadores sanitarios requiere de atencion. El tiempo de infectividad en la comunidad deberia reducirse para prevenir la transmision continuada.	[Dallatomasina, Silvia; Stinson, Kathryn; Patten, Gabriela; Brechard, Raphael] Med Sans Frontieres, Freetown, Sierra Leone; [Crestani, Rosa; Declerk, Hilde; Wolz, Anja; Spreicher, Armand; Van Herp, Michel] Med Sans Frontieres, Brussels Operat Ctr, Ebola Task Force, Brussels, Belgium; [Squire, James Sylvester; Gbabai, Osman Bamba-Moi] Minist Hlth & Sanitat, Dist Hlth Serv, Kailahun, Sierra Leone; [Caleo, Grazia Marta] Med Sans Frontieres, Manson Unit, London, England; [Stinson, Kathryn] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Zachariah, Rony] Med Sans Frontieres, Brussels Operat Ctr, Operat Res Unit, Luxembourg, Luxembourg	Zachariah, R (reprint author), Med Sans Frontieres, Brussels Operat Ctr, Operat Res, 6 Rue De Gasperich, Luxembourg, Luxembourg.	rony.zachariah@brussels.msf.org		Patten, Gabriela/0000-0003-2511-1367			Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Bolten CE, 2014, ARTICULATING INVISIB; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Fitzpatrick G, 2014, EUROSURVEILLANCE, V19, P1; Gatherer D, 2014, J GEN VIROL, V95, P1619, DOI 10.1099/vir.0.067199-0; Gostin LO, 2014, JAMA-J AM MED ASSOC, V312, P1095, DOI 10.1001/jama.2014.11176; Khan AS, 1999, J INFECT DIS S1, V179, pS76, DOI DOI 10.1086/514306; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; MacNeil A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001546; Meltzer Martin I, 2014, MMWR Suppl, V63, P1; Philips M, 2014, LANCET, V384, P1181; Piot P, 2014, LANCET INFECT DIS, V14, P1034, DOI 10.1016/S1473-3099(14)70956-9; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680; Tomori O, 1999, J INFECT DIS, V179, pS98, DOI 10.1086/514307; Ulrich CM, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6672; Whitty CJM, 2014, NATURE, V515, P192, DOI 10.1038/515192a; WHO, 2014, EB VACC THER DIAGN; WHO, 2014, EB VIR DIS; World Health Organization, 2014, EB RESP ROADM SIT RE	21	52	55	2	178	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	APR	2015	20	4					448	454		10.1111/tmi.12454				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CD0IV	WOS:000350755800005	25565430	Green Published, Other Gold	Y	N	2019-04-02	
J	Walsh, DS; De Jong, BC; Meyers, WM; Portaels, F				Walsh, Douglas S.; De Jong, Bouke C.; Meyers, Wayne M.; Portaels, Francoise			Leprosy and Buruli ulcer: similarities suggest combining control and prevention of disability strategies in countries endemic for both diseases	LEPROSY REVIEW			English	Editorial Material							INFECTION		[Walsh, Douglas S.] Vet Affairs Med Ctr, Dermatol & Res & Dev Serv, Syracuse, NY 13210 USA; [De Jong, Bouke C.; Portaels, Francoise] Inst Trop Med, B-2000 Antwerp, Belgium; [Meyers, Wayne M.] Armed Forces Inst Pathol, Div Microbiol, Washington, DC 20306 USA	Walsh, DS (reprint author), Vet Affairs Med Ctr, Dermatol & Res & Dev Serv, Syracuse, NY 13210 USA.		de Jong, Bouke/A-3636-2013	de Jong, Bouke/0000-0002-1017-4675			Alberts CJ, 2011, B WORLD HEALTH ORGAN, V89, P487, DOI 10.2471/BLT.10.085662; [Anonymous], 2014, LANCET INFECT DIS, V14, P899, DOI 10.1016/S1473-3099(14)70928-4; Lockwood DNJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1136; Meyers W M, 1975, Lepr Rev, V46, P21; Meyers WM, 1996, BRIT J DERMATOL, V134, P1116, DOI 10.1111/j.1365-2133.1996.tb07955.x; Molyneux DH, 2014, INT HEALTH, V6, P172, DOI 10.1093/inthealth/ihu037; Polycarpou A, 2013, CURR OPIN INFECT DIS, V26, P413, DOI 10.1097/QCO.0b013e3283638b04; Portaels F, 2014, LAB DIAGN BUR ULC MA; Saunderson PR, 2013, T ROY SOC TROP MED H, V107, P533, DOI 10.1093/trstmh/trt058; Smith C, 2008, LANCET, V371, P969, DOI 10.1016/S0140-6736(08)60433-X; Walsh DS, 2010, CURR OPIN INFECT DIS, V23, P445, DOI 10.1097/QCO.0b013e32833c2209	11	4	4	0	5	LEPRA	COLCHESTER	28 MIDDLEBOROUGH, COLCHESTER CO1 1TG, ESSEX, ENGLAND	0305-7518	2162-8807		LEPROSY REV	Lepr. Rev.	MAR	2015	86	1					1	5						5	Dermatology; Infectious Diseases; Pathology; Tropical Medicine	Dermatology; Infectious Diseases; Pathology; Tropical Medicine	CH7PB	WOS:000354228000001	26065143				2019-04-02	
J	Ablordey, AS; Vandelannoote, K; Frimpong, IA; Ahortor, EK; Amissah, NA; Eddyani, M; Durnez, L; Portaels, F; de Jong, BC; Leirs, H; Porter, JL; Mangas, KM; Lam, MMC; Buultjens, A; Seemann, T; Tobias, NJ; Stinear, TP				Ablordey, Anthony S.; Vandelannoote, Koen; Frimpong, Isaac A.; Ahortor, Evans K.; Amissah, Nana Ama; Eddyani, Miriam; Durnez, Lies; Portaels, Francoise; de Jong, Bouke C.; Leirs, Herwig; Porter, Jessica L.; Mangas, Kirstie M.; Lam, Margaret M. C.; Buultjens, Andrew; Seemann, Torsten; Tobias, Nicholas J.; Stinear, Timothy P.			Whole Genome Comparisons Suggest Random Distribution of Mycobacterium ulcerans Genotypes in a Buruli Ulcer Endemic Region of Ghana	PLOS NEGLECTED TROPICAL DISEASES			English	Article							RISK-FACTORS; PROVIDES INSIGHTS; CAUSATIVE AGENT; INFECTION; BENIN; EPIDEMIOLOGY; EVOLUTION; CAMEROON; DISEASE; TUBERCULOSIS	Efforts to control the spread of Buruli ulcer - an emerging ulcerative skin infection caused by Mycobacterium ulcerans - have been hampered by our poor understanding of reservoirs and transmission. To help address this issue, we compared whole genomes from 18 clinical M. ulcerans isolates from a 30km(2) region within the Asante Akim North District, Ashanti region, Ghana, with 15 other M. ulcerans isolates from elsewhere in Ghana and the surrounding countries of Ivory Coast, Togo, Benin and Nigeria. Contrary to our expectations of finding minor DNA sequence variations among isolates representing a single M. ulcerans circulating genotype, we found instead two distinct genotypes. One genotype was closely related to isolates from neighbouring regions of Amansie West and Densu, consistent with the predicted local endemic clone, but the second genotype (separated by 138 single nucleotide polymorphisms [SNPs] from other Ghanaian strains) most closely matched M. ulcerans from Nigeria, suggesting another introduction of M. ulcerans to Ghana, perhaps from that country. Both the exotic genotype and the local Ghanaian genotype displayed highly restricted intra-strain genetic variation, with less than 50 SNP differences across a 5.2Mbp core genome within each genotype. Interestingly, there was no discernible spatial clustering of genotypes at the local village scale. Interviews revealed no obvious epidemiological links among BU patients who had been infected with identical M. ulcerans genotypes but lived in geographically separate villages. We conclude that M. ulcerans is spread widely across the region, with multiple genotypes present in any one area. These data give us new perspectives on the behaviour of possible reservoirs and subsequent transmission mechanisms of M. ulcerans. These observations also show for the first time that M. ulcerans can be mobilized, introduced to a new area and then spread within a population. Potential reservoirs of M. ulcerans thus might include humans, or perhapsM. ulcerans-infected animals such as livestock that move regularly between countries.	[Ablordey, Anthony S.; Ahortor, Evans K.; Amissah, Nana Ama] Univ Ghana, Noguchi Mem Inst Med Res, Dept Bacteriol, Accra, Ghana; [Vandelannoote, Koen; Eddyani, Miriam; Durnez, Lies; Portaels, Francoise; de Jong, Bouke C.] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Frimpong, Isaac A.] Univ Ghana, Dept Anim Biol & Conservat Sci, Accra, Ghana; [Leirs, Herwig] Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium; [Porter, Jessica L.; Mangas, Kirstie M.; Lam, Margaret M. C.; Buultjens, Andrew; Tobias, Nicholas J.; Stinear, Timothy P.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Seemann, Torsten] Victorian Life Sci Computat Initiat, Life Sci Computat Ctr, Carlton, Vic, Australia	Ablordey, AS (reprint author), Univ Ghana, Noguchi Mem Inst Med Res, Dept Bacteriol, Accra, Ghana.	aablordey@noguchi.ug.edu.gh; tstinear@unimelb.edu.au	de Jong, Bouke/A-3636-2013	de Jong, Bouke/0000-0002-1017-4675; Tobias, Nicholas/0000-0003-2725-3043; Seemann, Torsten/0000-0001-6046-610X; Lam, Margaret/0000-0001-9590-6849	Stop Buruli Initiative, UBS Optimus Foundation, Zurich, Switzerland; Flemish Interuniversity Council - University Development Cooperation, VLIRUOS; National Health and Medical Research Council of Australia; VLADOC PhD scholarship of VLIR-UOS (Belgium)	This study was supported in part by the Stop Buruli Initiative (www.stopburuli.org, UBS Optimus Foundation, Zurich, Switzerland) and the Flemish Interuniversity Council - University Development Cooperation (www.vliruos.be, VLIRUOS). TPS was supported by a Fellowship from the National Health and Medical Research Council of Australia (www.nhmrc.gov.au). KV was supported by a VLADOC PhD scholarship of VLIR-UOS (Belgium). The funders had no role in study design, data collection and analysis, decision to publish or preparations of the manuscript.	Aiga H, 2004, AM J TROP MED HYG, V71, P387, DOI 10.4269/ajtmh.2004.71.387; AMOFAH GK, 1993, T ROY SOC TROP MED H, V87, P644, DOI 10.1016/0035-9203(93)90272-R; Ampadu E, 2008, ANN REPORT NATL BURU; [Anonymous], T R SOC TROP MED HYG, V65, P763; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BARKER DJP, 1973, T ROY SOC TROP MED H, V67, P43, DOI 10.1016/0035-9203(73)90317-9; BOOM R, 1990, J CLIN MICROBIOL, V28, P495; Boritsch EC, 2014, MOL MICROBIOL, V93, P835, DOI 10.1111/mmi.12720; Bratschi MW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002252; Debacker M, 2006, EMERG INFECT DIS, V12, P1325, DOI 10.3201/eid1209.050598; Doig KD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-258; Durnez L, 2010, APPL ENVIRON MICROB, V76, P4574, DOI 10.1128/AEM.00199-10; Eddyani M, 2008, J CLIN MICROBIOL, V46, P69, DOI 10.1128/JCM.00301-07; Eddyani M, 2009, J CLIN MICROBIOL, V47, P1700, DOI 10.1128/JCM.00197-09; Fyfe JAM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000791; George KM, 1999, SCIENCE, V283, P854, DOI 10.1126/science.283.5403.854; Guenin-Mace L, 2013, J CLIN INVEST, V123, P1501, DOI 10.1172/JCI66576; Hall BS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004061; Hilty M, 2006, J BACTERIOL, V188, P1462, DOI 10.1128/JB.188.4.1462-1465.2006; Huang GKL, 2014, EXPERT REV ANTI-INFE, V12, P855, DOI 10.1586/14787210.2014.910113; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Johnson PDR, 2007, EMERG INFECT DIS, V13, P1653, DOI 10.3201/eid1311.061369; Johnson PDR, 2009, EMERG INFECT DIS, V15, P614, DOI 10.3201/eid1504.081162; Johnson RC, 2005, EMERG INFECT DIS, V11, P500, DOI 10.3201/eid1103.040597; Landier J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001392; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; MARION E, 2011, CAMEROON EMERG INFCT, V17, P551, DOI DOI 10.3201/EID1703.091859; Marion E, 2013, M S-MED SCI, V29, P912, DOI 10.1051/medsci/20132910021; MARSTON BJ, 1995, AM J TROP MED HYG, V52, P219, DOI 10.4269/ajtmh.1995.52.219; Meyers W M, 1974, Ann Soc Belg Med Trop, V54, P147; Monot M, 2005, SCIENCE, V308, P1040, DOI [10.1126/science/1109759, 10.1126/science.1109759]; Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477; Nackers F, 2007, AM J TROP MED HYG, V77, P834, DOI 10.4269/ajtmh.2007.77.834; Narh CA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003437; Nienhuis WA, 2010, LANCET, V375, P664, DOI 10.1016/S0140-6736(09)61962-0; OLUWASANMI JO, 1975, BRIT J PLAST SURG, V28, P111, DOI 10.1016/0007-1226(75)90170-8; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; PORTAELS F, 1988, J GEN MICROBIOL, V134, P849; Porten K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000466; Roltgen K, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001904; Roltgen K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000751; Ross BC, 1997, J CLIN MICROBIOL, V35, P1696; Stinear TP, 2007, GENOME RES, V17, P192, DOI 10.1101/gr.5942807; Stinear TP, 2004, P NATL ACAD SCI USA, V101, P1345, DOI 10.1073/pnas.0305877101; Supply P, 2013, NAT GENET, V45, P172, DOI 10.1038/ng.2517; Trubiano JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002463; Truman RW, 2011, NEW ENGL J MED, V364, P1626, DOI 10.1056/NEJMoa1010536; van Ravensway J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051074; Vandelannoote K, 2014, APPL ENVIRON MICROB, V80, P1197, DOI 10.1128/AEM.02774-13; VANDERWERF TS, 1989, T ROY SOC TROP MED H, V83, P410, DOI 10.1016/0035-9203(89)90521-X; Veitch MGK, 1997, EPIDEMIOL INFECT, V119, P313, DOI 10.1017/S0950268897008273; Wagner T, 2008, ECOHEALTH, V5, P69, DOI 10.1007/s10393-007-0148-7; Wheat WH, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003405; World Health Organization, 2014, BUR ULC	54	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAR	2015	9	3							e0003681	10.1371/journal.pntd.0003681				14	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CE9YK	WOS:000352199400111	25826332	DOAJ Gold, Green Published			2019-04-02	
J	Castillo-Acosta, VM; Ruiz-Perez, LM; Van Damme, EJM; Balzarini, J; Gonzalez-Pacanowska, D				Castillo-Acosta, Victor M.; Ruiz-Perez, Luis M.; Van Damme, Els J. M.; Balzarini, Jan; Gonzalez-Pacanowska, Dolores			Exposure of Trypanosoma brucei to an N-acetylglucosamine-Binding Lectin Induces VSG Switching and Glycosylation Defects Resulting in Reduced Infectivity	PLOS NEGLECTED TROPICAL DISEASES			English	Article							VARIANT SURFACE GLYCOPROTEIN; BLOOD-STREAM FORM; URTICA-DIOICA AGGLUTININ; LINKED OLIGOSACCHARIDES; AFRICAN TRYPANOSOMES; CELL-SURFACE; IN-VITRO; ENDOCYTOSIS; PROTEIN; MANNOSE	Trypanosoma brucei variant surface glycoproteins (VSG) are glycosylated by both paucimannose and oligomannose structures which are involved in the formation of a protective barrier against the immune system. Here, we report that the stinging nettle lectin (UDA), with predominant N-acetylglucosamine-binding specificity, interacts with glycosylated VSGs and kills parasites by provoking defects in endocytosis together with impaired cytokinesis. Prolonged exposure to UDA induced parasite resistance based on a diminished capacity to bind the lectin due to an enrichment of biantennary paucimannose and a reduction of triantennary oligomannose structures. Two molecular mechanisms involved in resistance were identified: VSG switching and modifications in N-glycan composition. Glycosylation defects were correlated with the down-regulation of the TbSTT3A and/or TbSTT3B genes (coding for oligosaccharyltransferases A and B, respectively) responsible for glycan specificity. Furthermore, UDA-resistant trypanosomes exhibited severely impaired infectivity indicating that the resistant phenotype entails a substantial fitness cost. The results obtained further support the modification of surface glycan composition resulting from down-regulation of the genes coding for oligosaccharyltransferases as a general resistance mechanism in response to prolonged exposure to carbohydrate-binding agents.	[Castillo-Acosta, Victor M.; Ruiz-Perez, Luis M.; Gonzalez-Pacanowska, Dolores] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Van Damme, Els J. M.] Univ Ghent, Dept Mol Biotechnol, Lab Biochem & Glycobiol, B-9000 Ghent, Belgium; [Balzarini, Jan] Katholieke Univ Leuven, Rega Inst Med Res, Leuven, Belgium	Castillo-Acosta, VM (reprint author), CSIC, Inst Parasitol & Biomed Lopez Neyra, Parque Tecnol Ciencias Salud, Granada, Spain.	dgonzalez@ipb.csic.es		Gonzalez-Pacanowska, Dolores/0000-0002-4303-5209; Ruiz-Perez, Luis M./0000-0001-7681-4471; Castillo Acosta, Victor Manuel/0000-0003-0938-2343; Van Damme, Els/0000-0001-9848-766X	VI Plan Nacional de Investigacion Cientifica; Desarrollo e Innovacion Tecnologica; Instituto de Salud Carlos III - Subdireccion General de Redes y Centros de Investigacion Cooperativa; Red de Investigacion Cooperativa en Enfermedades Tropicales (RICET) [RD06/0021]; Plan Estatal de Investigacion Cientifica y Tecnica y de Innovacion [SAF2010-20059]; Junta de Andalucia [BIO-199, P09-CVI-5367]; Katholieke Universiteit Leuven [GOA 10/14, PF 10/18]; Flemish Research Foundation Flanders (Flemish FWO) [G.0485.08]	This work was supported by grants from the VI Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica 2008-2011, Instituto de Salud Carlos III - Subdireccion General de Redes y Centros de Investigacion Cooperativa, Red de Investigacion Cooperativa en Enfermedades Tropicales (RICET) (RD06/0021), the Plan Estatal de Investigacion Cientifica y Tecnica y de Innovacion 2013-2016 (SAF2010-20059) (http://www.idi.mineco.gob.es), and the Junta de Andalucia (BIO-199, P09-CVI-5367) to DGP. Research of JB was supported by the Katholieke Universiteit Leuven (GOA 10/14 and PF 10/18) and the Flemish Research Foundation Flanders (Flemish FWO) (www.fwo.be), (G.0485.08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; Atrih A, 2005, J BIOL CHEM, V280, P865, DOI 10.1074/jbc.M411061200; Balzarini J, 2006, ANTIVIR RES, V71, P237, DOI 10.1016/j.antiviral.2006.02.004; BALZARINI J, 1992, ANTIVIR RES, V18, P191, DOI 10.1016/0166-3542(92)90038-7; Balzarini J, 2005, J BIOL CHEM, V280, P41005, DOI 10.1074/jbc.M508801200; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; BANGS JD, 1988, J BIOL CHEM, V263, P17697; BLUM ML, 1993, NATURE, V362, P603, DOI 10.1038/362603a0; BRICKMAN MJ, 1995, J CELL SCI, V108, P3611; Castillo-Acosta VM, 2013, MOL MICROBIOL, V90, P665, DOI 10.1111/mmi.12359; CROSS GAM, 1984, J CELL BIOCHEM, V24, P79, DOI 10.1002/jcb.240240107; CROSS GAM, 1975, PARASITOLOGY, V71, P311, DOI 10.1017/S0031182000046758; Denton H, 2010, BIOCHEM J, V425, P603, DOI 10.1042/BJ20090896; Engstler M, 2004, J CELL SCI, V117, P1105, DOI 10.1242/jcs.00938; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; Field MC, 2009, NAT REV MICROBIOL, V7, P775, DOI 10.1038/nrmicro2221; Grunfelder CG, 2003, MOL BIOL CELL, V14, P2029, DOI 10.1091/mbc.E02-10-0640; Hall B, 2004, MOL BIOCHEM PARASIT, V138, P67, DOI 10.1016/j.molbiopara.2004.07.007; Huskens D, 2010, J BIOL CHEM, V285, P24845, DOI 10.1074/jbc.M110.128546; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; Jeffries TR, 2001, J CELL SCI, V114, P2617; Jones DC, 2005, J BIOL CHEM, V280, P35929, DOI 10.1074/jbc.M509130200; KAKU H, 1990, ARCH BIOCHEM BIOPHYS, V279, P298, DOI 10.1016/0003-9861(90)90495-K; Manthri S, 2008, GLYCOBIOLOGY, V18, P367, DOI 10.1093/glycob/cwn014; Morrison LJ, 2009, CELL MICROBIOL, V11, P1724, DOI 10.1111/j.1462-5822.2009.01383.x; Naismith JH, 1996, J BIOL CHEM, V271, P972, DOI 10.1074/jbc.271.2.972; O'Beirne C, 1998, MOL BIOCHEM PARASIT, V91, P165, DOI 10.1016/S0166-6851(97)00191-6; Oguri S, 2005, GLYCOCONJUGATE J, V22, P453, DOI 10.1007/s10719-005-5329-4; Overath P, 2004, MOL MICROBIOL, V53, P735, DOI 10.1111/j.1365-2958.2004.04224.x; Pal A, 2003, BIOCHEM J, V374, P443, DOI 10.1042/BJ20030469; Pearson TW, 2000, MOL BIOCHEM PARASIT, V111, P333, DOI 10.1016/S0166-6851(00)00327-3; PEUMANS WJ, 1984, FEBS LETT, V177, P99, DOI 10.1016/0014-5793(84)80989-8; Rodgers MJ, 2007, EUKARYOT CELL, V6, P1108, DOI 10.1128/EC.0107-07; RUDENKO G, 1994, EMBO J, V13, P5470, DOI 10.1002/j.1460-2075.1994.tb06882.x; Saul FA, 2000, STRUCTURE, V8, P593, DOI 10.1016/S0969-2126(00)00142-8; Schwartz KJ, 2013, EUKARYOT CELL, V12, P132, DOI 10.1128/EC.00293-12; Sheader K, 2005, P NATL ACAD SCI USA, V102, P8716, DOI 10.1073/pnas.0501886102; Stijlemans B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002072; Stokes MJ, 2008, J BIOL CHEM, V283, P16147, DOI 10.1074/jbc.M709581200; Van Damme Els J M, 2011, Adv Exp Med Biol, V705, P757, DOI 10.1007/978-1-4419-7877-6_39; VANDAMME EJM, 1987, FEBS LETT, V215, P140, DOI 10.1016/0014-5793(87)80129-1; VANDAMME EJM, 1988, PLANT PHYSIOL, V86, P598, DOI 10.1104/pp.86.2.598; VanDamme EJM, 1988, PLANT PHYSIOL, V73, P51; WEBSTER P, 1990, J CELL SCI, V96, P249; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; ZAMZE SE, 1990, EUR J BIOCHEM, V187, P657, DOI 10.1111/j.1432-1033.1990.tb15350.x; Zitzmann N, 2000, GLYCOBIOLOGY, V10, P243, DOI 10.1093/glycob/10.3.243	47	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAR	2015	9	3							e0003612	10.1371/journal.pntd.0003612				21	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CE9YK	WOS:000352199400075	25746926	DOAJ Gold, Green Published			2019-04-02	
J	Okello, AL; Beange, I; Shaw, A; Moriyon, I; Gabriel, S; Bardosh, K; Johansen, MV; Saarnak, C; Mukaratirwa, S; Berkvens, D; Welburn, SC				Okello, Anna L.; Beange, Iona; Shaw, Alexandra; Moriyon, Ignacio; Gabriel, Sarah; Bardosh, Kevin; Johansen, Maria Vang; Saarnak, Christopher; Mukaratirwa, Samson; Berkvens, Dirk; Welburn, Susan C.		ICONZ; ADVANZ; OH-NEXTGEN	Raising the Political Profile of the Neglected Zoonotic Diseases: Three Complementary European Commission-Funded Projects to Streamline Research, Build Capacity and Advocate for Control	PLOS NEGLECTED TROPICAL DISEASES			English	Article							ANIMAL HEALTH; ELIMINATION; ZOONOSES; SETTINGS		[Okello, Anna L.; Beange, Iona] Univ Edinburgh, Coll Med & Vet Med, Sch Biomed Sci, Div Pathway Med, Edinburgh, Midlothian, Scotland; [Okello, Anna L.; Beange, Iona; Welburn, Susan C.] Univ Edinburgh, Coll Med & Vet Med, Sch Biomed Sci, Ctr Infect Dis, Edinburgh, Midlothian, Scotland; [Shaw, Alexandra] Agr & Vet Informat & Anal Avia GIS, Zoersel, Belgium; [Moriyon, Ignacio] Univ Navarra, Inst Salud Trop, E-31080 Pamplona, Spain; [Moriyon, Ignacio] Univ Navarra, Dept Microbiol & Parasitol, E-31080 Pamplona, Spain; [Gabriel, Sarah; Berkvens, Dirk] Inst Trop Med, B-2000 Antwerp, Belgium; [Bardosh, Kevin] Univ Edinburgh, Sch Social & Polit Sci, Ctr African Studies, Edinburgh, Midlothian, Scotland; [Johansen, Maria Vang; Saarnak, Christopher] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Sect Parasitol & Aquat Dis, Copenhagen, Denmark; [Mukaratirwa, Samson] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa	Okello, AL (reprint author), Univ Edinburgh, Coll Med & Vet Med, Sch Biomed Sci, Div Pathway Med, Edinburgh, Midlothian, Scotland.	anna.okello@ed.ac.uk	Moriyon, Ignacio/N-4764-2016; Mukaratirwa, Samson/E-9752-2010; Hattendorf, Jan/F-5371-2010	Moriyon, Ignacio/0000-0002-4288-0195; Mukaratirwa, Samson/0000-0001-6843-1497; Hattendorf, Jan/0000-0002-1176-401X; Michel, Anita/0000-0001-9240-2653	European Union [221948, 289412, 312030]	The projects described in this publication have all received funding from the European Union's Seventh Framework Program (FP7/2007-2014) under grant agreements no 221948 Integrated Control of Neglected Zoonoses (ICONZ), no 289412 Training of the One Health Next Scientific Generation (OH-NEXTGEN) and no 312030 Advocacy for the Neglected Zoonotic Diseases (ADVANZ). The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gibbs EPJ, 2014, VET REC, P85, DOI 10,1136/vr.g143; Graham TW, 2013, JAVMA-J AM VET MED A, V243, P1523, DOI 10.2460/javma.243.11.1523; Holveck JC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-6; Jones B, 2014, ZOONOSES WILDLIFE DO; Kirby T, 2010, LANCET, V375, P21, DOI 10.1016/S0140-6736(09)62174-7; Lehane R., 1996, BEATING ODDS BIG COU; Mableson HE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002800; Maudlin I, 2009, PHILOS T R SOC B, V364, P2777, DOI 10.1098/rstb.2009.0067; Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336; Okello A. L., 2014, HLTH POLICY PLAN, P1, DOI [10.1093/heapol/czu059, DOI 10.1093/HEAPOL/CZU059]; Okello AL, 2011, VET REC, V169, P281, DOI 10.1136/vr.d5378; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Schelling E, 2005, BRIT MED J, V331, P1264, DOI 10.1136/bmj.331.7527.1264; Vitasek J, 2004, VET MED-CZECH, V49, P171, DOI 10.17221/5692-VETMED; Zinsstag J, 2005, LANCET, V366, P2142, DOI 10.1016/S0140-6736(05)67731-8	15	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAR	2015	9	3							e0003505	10.1371/journal.pntd.0003505				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CE9YK	WOS:000352199400011	25741705	DOAJ Gold, Green Published			2019-04-02	
J	Perry, MR; Prajapati, VK; Menten, J; Raab, A; Feldmann, J; Chakraborti, D; Sundar, S; Fairlamb, AH; Boelaert, M; Picado, A				Perry, Meghan R.; Prajapati, Vijay K.; Menten, Joris; Raab, Andrea; Feldmann, Joerg; Chakraborti, Dipankar; Sundar, Shyam; Fairlamb, Alan H.; Boelaert, Marleen; Picado, Albert			Arsenic Exposure and Outcomes of Antimonial Treatment in Visceral Leishmaniasis Patients in Bihar, India: A Retrospective Cohort Study	PLOS NEGLECTED TROPICAL DISEASES			English	Article							RISK-FACTORS; TREATMENT FAILURE; DRUG-RESISTANCE; DRINKING-WATER; BANGLADESH; DIAGNOSIS; ELIMINATION; VARIABILITY; MORTALITY; SYSTEM	Background In the late twentieth century, emergence of high rates of treatment failure with antimonial compounds (SSG) for visceral leishmaniasis (VL) caused a public health crisis in Bihar, India. We hypothesize that exposure to arsenic through drinking contaminated groundwater may be associated with SSG treatment failure due to the development of antimonyresistant parasites. Methods A retrospective cohort design was employed, as antimony treatment is no longer in routine use. The study was performed on patients treated with SSG between 2006 and 2010. Outcomes of treatment were assessed through a field questionnaire and treatment failure used as a proxy for parasite resistance. Arsenic exposure was quantified through analysis of 5 water samples from within and surrounding the patient's home. A logistic regression model was used to evaluate the association between arsenic exposure and treatment failure. In a secondary analysis survival curves and Cox regression models were applied to assess the risk of mortality in VL patients exposed to arsenic. Results One hundred and ten VL patients treated with SSG were analysed. The failure rate with SSG was 59%. Patients with high mean local arsenic level had a non-statistically significant higher risk of treatment failure (OR = 1.78, 95% CI: 0.7-4.6, p = 0.23) than patients using wells with arsenic concentration < 10 mu g/L. Twenty one patients died in our cohort, 16 directly as a result of VL. Arsenic levels >= 10 mu g/L increased the risk of all-cause (HR 3.27; 95% CI: 1.4-8.1) and VL related (HR 2.65; 95% CI: 0.96-7.65) deaths. This was time dependent: 3 months post VL symptom development, elevated risks of all-cause mortality (HR 8.56; 95% CI: 2.5-29.1) and of VL related mortality (HR 9.27; 95% CI: 1.8-49.0) were detected. Discussion/ Conclusion This study indicates a trend towards increased treatment failure in arsenic exposed patients. The limitations of the retrospective study design may have masked a strong association between arsenic exposure and selection for antimonial resistance in the field. The unanticipated strong correlation between arsenic exposure and VL mortality warrants further investigation.	[Perry, Meghan R.; Fairlamb, Alan H.] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee, Scotland; [Prajapati, Vijay K.] Cent Univ Rajasthan, Dept Biochem, Ajmer, Rajasthan, India; [Prajapati, Vijay K.; Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Dept Med, Infect Dis Res Lab, Varanasi 221005, Uttar Pradesh, India; [Menten, Joris; Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Raab, Andrea; Feldmann, Joerg] Univ Aberdeen, Coll Phys Sci Chem, Trace Element Speciat Lab, Aberdeen, Scotland; [Chakraborti, Dipankar] Jadavpur Univ, Sch Environm Studies, Kolkata, India; [Picado, Albert] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain	Perry, MR (reprint author), Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee, Scotland.	a.h.fairlamb@dundee.ac.uk	; Fairlamb, Alan/A-5272-2009	Boelaert, Marleen/0000-0001-8051-6776; Fairlamb, Alan/0000-0001-5134-0329; Feldmann, Joerg/0000-0002-0524-8254; Picado, Albert/0000-0001-7344-628X	Wellcome Trust [090665, 079838]	This work was supported by a Clinical PhD Fellowship to MRP (090665) and a Principal Research Fellowship to AHF (079838) from the Wellcome Trust (http://www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Sampaio MJAD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000877; Boelaert M, 2009, TROP MED INT HEALTH, V14, P639, DOI 10.1111/j.1365-3156.2009.02279.x; Census Organization of India, 2014, IND CENS 2011; Chakraborti D, 2003, ENVIRON HEALTH PERSP, V111, P1194, DOI 10.1289/ehp.5966; Chakravarty J, 2010, J GLOB INFECT DIS, V2, P167, DOI 10.4103/0974-777X.62887; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Chappuis F, 2006, BRIT MED J, V333, P723, DOI 10.1136/bmj.38917.503056.7C; Cheng Z, 2005, ENVIRON SCI TECHNOL, V39, P4759, DOI 10.1021/es048065f; Dangleben NL, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-73; DEY S, 1994, MOL BIOCHEM PARASIT, V67, P49, DOI 10.1016/0166-6851(94)90095-7; Erickson ML, 2006, APPL GEOCHEM, V21, P305, DOI 10.1016/j.apgeochem.2005.12.005; Guerin PJ, 2002, LANCET INFECT DIS, V2, P494, DOI 10.1016/S1473-3099(02)00347-X; Hasker E, 2010, TROP MED INT HEALTH, V15, P55, DOI 10.1111/j.1365-3156.2010.02562.x; Hassan E, 2005, INTERNET J EPIDEMIOL, V3; HESS KR, 1995, STAT MED, V14, P1707, DOI 10.1002/sim.4780141510; Kaye PM, 2011, CLIN MICROBIOL INFEC, V17, P1462, DOI 10.1111/j.1469-0691.2011.03610.x; Kinniburgh DG, 2011, ARS CONT GROUNDW BAN, P175; Llanos-Cuentas A, 2008, CLIN INFECT DIS, V46, P223, DOI 10.1086/524042; Madalosso G, 2012, J TROP MED, V2012, DOI DOI 10.1155/2012/281572; Matlashewski G, 2011, LANCET INFECT DIS, V11, P322, DOI 10.1016/S1473-3099(10)70320-0; Mueller Y, 2009, TROP MED INT HEALTH, V14, P910, DOI 10.1111/j.1365-3156.2009.02305.x; Perry MR, 2013, P NATL ACAD SCI USA, V110, P19932, DOI 10.1073/pnas.1311535110; Perry MR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001227; Rahman A, 2007, AM J EPIDEMIOL, V165, P1389, DOI 10.1093/aje/kwm025; Ravenscroft P, 2009, ARSENIC POLLUTION GL; Rijal S, 2010, T ROY SOC TROP MED H, V104, P225, DOI 10.1016/j.trstmh.2009.08.002; Rijal S, 2007, MICROBES INFECT, V9, P529, DOI 10.1016/j.micinf.2007.01.009; School of Environmental Studies, 2014, GROUNDW ARS CONT MID; Sohel N, 2009, EPIDEMIOLOGY, V20, P824, DOI 10.1097/EDE.0b013e3181bb56ec; Sundar S, 2001, TROP MED INT HEALTH, V6, P849, DOI 10.1046/j.1365-3156.2001.00778.x; Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121; Sundar S, 2008, TROP MED INT HEALTH, V13, P2, DOI 10.1111/j.1365-3156.2007.01974.x; Thakur CP, 2004, INDIAN J MED RES, V120, P166; van den Bogaart E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-332; Vanaerschot M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023120; Vanaerschot M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012211; Williams PN, 2007, ENVIRON SCI TECHNOL, V41, P6854, DOI 10.1021/es070627i; Wyllie S, 2004, J BIOL CHEM, V279, P39925, DOI 10.1074/jbc.M405635200; Yan S, 2005, METALLOTHERAPEUTIC D, P441	40	21	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAR	2015	9	3							e0003518	10.1371/journal.pntd.0003518				17	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CE9YK	WOS:000352199400016	25730310	DOAJ Gold, Green Published			2019-04-02	
J	Stijlemans, B; Cnops, J; Naniima, P; Vaast, A; Bockstal, V; De Baetselier, P; Magez, S				Stijlemans, Benoit; Cnops, Jennifer; Naniima, Peter; Vaast, Axel; Bockstal, Viki; De Baetselier, Patrick; Magez, Stefan			Development of a pHrodo-Based Assay for the Assessment of In Vitro and In Vivo Erythrophagocytosis during Experimental Trypanosomosis	PLOS NEGLECTED TROPICAL DISEASES			English	Article							RED-BLOOD-CELLS; AFRICAN TRYPANOSOMIASIS; ERYTHROCYTE PHAGOCYTOSIS; MOLECULAR-MECHANISMS; IRON HOMEOSTASIS; ANEMIA; MACROPHAGES; CONGOLENSE; LIVER; INFLAMMATION	Extracellular trypanosomes can cause a wide range of diseases and pathological complications in a broad range of mammalian hosts. One common feature of trypanosomosis is the occurrence of anemia, caused by an imbalance between erythropoiesis and red blood cell clearance of aging erythrocytes. In murine models for T. brucei trypanosomosis, anemia is marked by a very sudden non-hemolytic loss of RBCs during the first-peak parasitemia control, followed by a short recovery phase and the subsequent gradual occurrence of an ever-increasing level of anemia. Using a newly developed quantitative pHrodo based in vitro erythrophagocytosis assay, combined with FACS-based ex vivo and in vivo results, we show that activated liver monocytic cells and neutrophils as well as activated splenic macrophages are the main cells involved in the occurrence of the early-stage acute anemia. In addition, we show that trypanosomosis itself leads to a rapid alteration of RBC membrane stability, priming the cells for accelerated phagocytosis.	[Stijlemans, Benoit; Cnops, Jennifer; Naniima, Peter; Vaast, Axel; Bockstal, Viki; De Baetselier, Patrick; Magez, Stefan] Vrije Univ Brussel, Lab Cellular & Mol Immunol, Brussels, Belgium; [Stijlemans, Benoit; De Baetselier, Patrick] VIB, Dept Myeloid Cell Immunol, Brussels, Belgium; [Cnops, Jennifer; Naniima, Peter; Vaast, Axel; Bockstal, Viki; Magez, Stefan] VIB, Dept Biol Struct, Brussels, Belgium	Stijlemans, B (reprint author), Vrije Univ Brussel, Lab Cellular & Mol Immunol, Brussels, Belgium.	bstijlem@vub.ac.be; jcnops@vub.ac.be	Vaast, Axel/H-2907-2013; Magez, Stefan/D-9497-2014	Magez, Stefan/0000-0003-3760-7968; Stijlemans, Benoit/0000-0003-0082-9751	Interuniversity Attraction Pole Program [PAI-IAP N.P7/41]; FWO [KaN 1515813N BS, fwoTM597]	This work, performed in the frame of an Interuniversity Attraction Pole Program (PAI-IAP N.P7/41, http://www.belspo.be/belspo/iap/index_en.stm), was supported by grants from the FWO (KaN 1515813N BS, Project fwoTM597 JC). BS is a research fellow supported by the VUB/SRP Targeting inflammation linked to infectious diseases and cancer (Nanobodies for Health). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ann V, 2010, IMMUNOBIOLOGY, V215, P833, DOI 10.1016/j.imbio.2010.05.028; Baloguna EO, 2014, VET PARASITOL, V199, P259, DOI 10.1016/j.vetpar.2013.10.013; Baral TN, 2007, J INFECT DIS, V195, P1513, DOI 10.1086/515577; Boas FE, 1998, P NATL ACAD SCI USA, V95, P3077, DOI 10.1073/pnas.95.6.3077; Bornman L, 1999, J CELL PHYSIOL, V178, P1; Bosschaerts T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001045; Bosschaerts T, 2009, IMMUNOBIOLOGY, V214, P737, DOI 10.1016/j.imbio.2009.06.010; Bratosin D, 1998, BIOCHIMIE, V80, P173, DOI 10.1016/S0300-9084(98)80024-2; Bratosin D, 1997, CYTOMETRY, V30, P269; Chisi J E, 2004, East Afr Med J, V81, P505; Czarnecka H, 1996, J BIOL CHEM, V271, P2023, DOI 10.1074/jbc.271.4.2023; Dasgupta SK, 2008, TRANSFUSION, V48, P2370, DOI 10.1111/j.1537-2995.2008.01841.x; Guegan F, 2013, CELL MICROBIOL, V15, P1285, DOI 10.1111/cmi.12123; Habila N, 2012, RES VET SCI, V93, P13, DOI 10.1016/j.rvsc.2011.08.011; Hod EA, 2010, VOX SANG, V99, P99, DOI 10.1111/j.1423-0410.2010.01327.x; Jambou R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001021; Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691; Kang Jing X., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-5; Kapur R, 2014, BLOOD, V123, P471, DOI 10.1182/blood-2013-09-527978; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Kuypers FA, 2004, CELL MOL BIOL, V50, P147; Lee SJ, 2011, BLOOD, V117, P5215, DOI 10.1182/blood-2010-10-313239; Magez S, 2004, J INFECT DIS, V189, P527, DOI 10.1086/381151; Magez S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000122; Mansfield JM, 2005, PARASITE IMMUNOL, V27, P361, DOI 10.1111/j.1365-3024.2005.00791.x; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Meurs I, 2005, EXP HEMATOL, V33, P1309, DOI 10.1016/j.exphem.2005.07.004; Miksa M, 2009, J IMMUNOL METHODS, V342, P71, DOI 10.1016/j.jim.2008.11.019; Naessens J, 2006, INT J PARASITOL, V36, P521, DOI 10.1016/j.ijpara.2006.02.012; Ngotho M, 2011, ACTA TROP, V119, P14, DOI 10.1016/j.actatropica.2011.02.013; Nishimura K, 2011, J PARASITOL, V97, P48, DOI 10.1645/GE-2466.1; Noyes HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005170; Radwanska M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000078; RIFKIN MR, 1990, P NATL ACAD SCI USA, V87, P801, DOI 10.1073/pnas.87.2.801; Stijlemans B, 2008, IMMUNOBIOLOGY, V213, P823, DOI 10.1016/j.imbio.2008.07.023; Stijlemans B, 2007, J IMMUNOL, V179, P4003, DOI 10.4049/jimmunol.179.6.4003; Stijlemans B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004414; Stijlemans Benoit, 2010, Endocrine Metabolic & Immune Disorders-Drug Targets, V10, P71; Stijlemans B, 2010, MICROBES INFECT, V12, P389, DOI 10.1016/j.micinf.2010.02.006; Taiwo VO, 2000, ONDERSTEPOORT J VET, V67, P273; Thuita JK, 2008, PLOS NEGLECT TROP D, V2, P238, DOI DOI 10.1371/J0URNAL.PNTD.0000238; Uilenberg G, 1998, FIELD GUIDE DIAGNOSI; Veale MF, 2014, VOX SANG, V106, P219, DOI 10.1111/vox.12095; Wallace PK, 2008, CYTOM PART A, V73A, P1019, DOI 10.1002/cyto.a.20619; Wan JH, 2014, HEPATOLOGY, V59, P130, DOI 10.1002/hep.26607; Witola WH, 2001, VET PARASITOL, V96, P115, DOI 10.1016/S0304-4017(00)00430-1; Zoller EE, 2011, J EXP MED, V208, P1203, DOI 10.1084/jem.20102538	47	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAR	2015	9	3							e0003561	10.1371/journal.pntd.0003561				21	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CE9YK	WOS:000352199400036	25742307	DOAJ Gold, Green Published			2019-04-02	
J	Thys, S; Mwape, KE; Lefevre, P; Dorny, P; Marcotty, T; Phiri, AM; Phiri, IK; Gabriel, S				Thys, Severine; Mwape, Kabemba E.; Lefevre, Pierre; Dorny, Pierre; Marcotty, Tanguy; Phiri, Andrew M.; Phiri, Isaak K.; Gabriel, Sarah			Why Latrines Are Not Used: Communities' Perceptions and Practices Regarding Latrines in a Taenia solium Endemic Rural Area in Eastern Zambia	PLOS NEGLECTED TROPICAL DISEASES			English	Article							PORCINE CYSTICERCOSIS; SOUTHERN PROVINCES; MBULU DISTRICT; RISK-FACTORS; INFECTIONS; PREVALENCE; TANZANIA; EPILEPSY; PEOPLE; HEALTH	Taenia solium cysticercosis is a neglected parasitic zoonosis occurring in many developing countries. Socio-cultural determinants related to its control remain unclear. Studies in Africa have shown that the underuse of sanitary facilities and the widespread occurrence of free-roaming pigs are the major risk factors for porcine cysticercosis. The study objective was to assess the communities' perceptions, practices and knowledge regarding latrines in a T. solium endemic rural area in Eastern Zambia inhabited by the Nsenga ethno-linguistic group, and to identify possible barriers to their construction and use. A total of 21 focus group discussions on latrine use were organized separately with men, women and children, in seven villages of the Petauke district. The themes covered were related to perceived latrine availability (absence-presence, building obstacles) and perceived latrine use (defecation practices, latrine management, socio-cultural constraints). The findings reveal that latrines were not constructed in every household because of the convenient use of existing latrines in the neighborhood. Latrines were perceived to contribute to good hygiene mainly because they prevent pigs from eating human feces. Men expressed reluctance to abandon the open-air defecation practice mainly because of toilet-associated taboos with in-laws and grown-up children of the opposite gender. When reviewing conceptual frameworks of people's approach to sanitation, we found that seeking privacy and taboos hindering latrine use and construction were mainly explained in our study area by the fact that the Nsenga observe a traditionally matrilineal descent. These findings indicate that in this local context latrine promotion messages should not only focus on health benefits in general. Since only men were responsible for building latrines and mostly men preferred open defecation, sanitation programs should also be directed to men and address related sanitary taboos in order to be effective.	[Thys, Severine; Lefevre, Pierre] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Mwape, Kabemba E.; Phiri, Andrew M.; Phiri, Isaak K.] Univ Zambia UNZA, Sch Vet Med, Lusaka, Zambia; [Mwape, Kabemba E.] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, ZA-0110 Onderstepoort, South Africa; [Dorny, Pierre; Gabriel, Sarah] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Marcotty, Tanguy] VERDI R&D, Louveigne, Belgium	Thys, S (reprint author), Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.	sthys@itg.be		Phiri, Andrew/0000-0002-8924-193X	ITM; Belgian Development Cooperation	The financial support for the conduct of the research and/or preparation of the article is the Strategic Network on Neglected Diseases and Zoonoses (http://www.snndz.net/) which is an initiative from the Institute of Tropical Medicine (Antwerp, Belgium) (ITM) funded by the Third Framework Agreement between the ITM and the Belgian Development Cooperation. This funding source had no role in study design; in the collection, analysis and interpretation of data; in the writing of the article; and in the decision to submit it for publication.	ASSANA E, 2010, J HELMINTHOL, V25, P1; Avvannavar SM, 2008, SCI TOTAL ENVIRON, V390, P1, DOI 10.1016/j.scitotenv.2007.09.018; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Bwire B, 2009, PLAN KENYA COUNTRY P, P107; Cairncross S, 2005, SOC SCI MED, V61, P2212, DOI 10.1016/j.socscimed.2005.04.019; Dittmer A., 2009, TOTAL SANITATION SOC; Douglas M, 1966, PURITY DANGER ANAL C; Douglas M., 1982, RISK CULTURE ESSAY S; Drangert J-O, 2004, NORMS ATTITUDES ECOS, P5; Esrey SA, 1996, AM J EPIDEMIOL, V143, P608; Grudens-Schuck N, 2004, FOCUS GROUP FUNDAMEN, VPM1969b; Hesse AAJ, 2012, SEMIN PEDIATR SURG, V21, P142, DOI 10.1053/j.sempedsurg.2012.01.009; Hunt C., 2001, SAFE IS SAFE CONCISE; Jenkins MW, 2005, SOC SCI MED, V61, P2446, DOI 10.1016/j.socscimed.2005.04.036; Kar Kamal, 2008, HDB COMMUNITY LED TO; Morgan D. L., 1998, FOCUS GROUP GUIDEBOO; Murrell K.D., 2005, WHO FAO OIE GUIDELIN; Mwape KE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002142; Mwape KE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001594; Ndimubanzi PC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000870; Ngowi HA, 2008, PREV VET MED, V85, P52, DOI 10.1016/j.prevetmed.2007.12.014; Ngowi HA, 2004, VET PARASITOL, V120, P275, DOI 10.1016/j.vetpar.2004.01.015; Phaswana-Mafuya Nancy, 2005, Afr Health Sci, V5, P21; Phiri IK, 2002, VET PARASITOL, V108, P31, DOI 10.1016/S0304-4017(02)00165-6; Pondja A, 2010, PLOS NEGLECTED TROPI, V4; Pruss-Ustun A, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-7; Robert M, 1998, COMMUNITY USE PIT LA; Rosenquist LED, 2005, J ENVIRON PSYCHOL, V25, P335, DOI 10.1016/j.jenvp.2005.07.003; Sikasunge CS, 2007, VET PARASITOL, V143, P59, DOI 10.1016/j.vetpar.2006.07.023; Sikasunge S, 2008, VET J, V176, P240; Van der Geest S., 1998, ANTHR TODAY, V14, P8, DOI [10.2307/2783049, DOI 10.2307/2783049]; Wohlgemut J, 2010, AM J TROP MED HYG, V82, P634, DOI 10.4269/ajtmh.2010.09-0404; World Bank, 2013, INF WHATS TOIL WORTH	33	27	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAR	2015	9	3							e0003570	10.1371/journal.pntd.0003570				20	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CE9YK	WOS:000352199400042	25739017	DOAJ Gold, Green Published			2019-04-02	
J	Van Den Broucke, S; Kanobana, K; Polman, K; Soentjens, P; Vekemans, M; Theunissen, C; Vlieghe, E; Van Esbroeck, M; Jacobs, J; Van Den Enden, E; Van Den Ende, J; Van Gompel, A; Clerinx, J; Bottieau, E				Van Den Broucke, Steven; Kanobana, Kirezi; Polman, Katja; Soentjens, Patrick; Vekemans, Marc; Theunissen, Caroline; Vlieghe, Erika; Van Esbroeck, Marjan; Jacobs, Jan; Van Den Enden, Erwin; Van Den Ende, Jef; Van Gompel, Alfons; Clerinx, Jan; Bottieau, Emmanuel			Toxocariasis Diagnosed in International Travelers at the Institute of Tropical Medicine, Antwerp, Belgium, from 2000 to 2013	PLOS NEGLECTED TROPICAL DISEASES			English	Article							VISCERAL LARVA MIGRANS; OF-THE-LITERATURE; BLOOD EOSINOPHILIA; CLINICAL-FEATURES; RISK-FACTORS; INFECTION; SEROPREVALENCE; EPIDEMIOLOGY; ALBENDAZOLE; EFFICACY	Although infection with Toxocara canis or T. catis (commonly referred as toxocariasis) appears to be highly prevalent in (sub) tropical countries, information on its frequency and presentation in returning travelers and migrants is scarce. In this study, we reviewed all cases of asymptomatic and symptomatic toxocariasis diagnosed during post-travel consultations at the reference travel clinic of the Institute of Tropical Medicine, Antwerp, Belgium. Toxocariasis was considered as highly probable if serum Toxocara-antibodies were detected in combination with symptoms of visceral larva migrans if present, elevated eosinophil count in blood or other relevant fluid and reasonable exclusion of alternative diagnosis, or definitive in case of documented seroconversion. From 2000 to 2013, 190 travelers showed Toxocara-antibodies, of a total of 3436 for whom the test was requested (5.5%). Toxocariasis was diagnosed in 28 cases (23 symptomatic and 5 asymptomatic) including 21 highly probable and 7 definitive. All but one patients were adults. Africa and Asia were the place of acquisition for 10 and 9 cases, respectively. Twelve patients (43%) were short-term travelers (<1 month). Symptoms, when present, developed during travel or within 8 weeks maximum after return, and included abdominal complaints (11/23 symptomatic patients, 48%), respiratory symptoms and skin abnormalities (10 each, 43%) and fever (9, 39%), often in combination. Two patients were diagnosed with transverse myelitis. At presentation, the median blood eosinophil count was 1720/mu L [ range: 510-14160] in the 21 symptomatic cases without neurological complication and 2080/mu L [range: 1100-2970] in the 5 asymptomatic individuals. All patients recovered either spontaneously or with an anti-helminthic treatment (mostly a 5-day course of albendazole), except both neurological cases who kept sequelae despite repeated treatments and prolonged corticotherapy. Toxocariasis has to be considered in travelers returning from a (sub) tropical stay with varying clinical manifestations or eosinophilia. Prognosis appears favorable with adequate treatment except in case of neurological involvement.	[Van Den Broucke, Steven; Soentjens, Patrick; Vekemans, Marc; Theunissen, Caroline; Vlieghe, Erika; Van Esbroeck, Marjan; Jacobs, Jan; Van Den Enden, Erwin; Van Den Ende, Jef; Van Gompel, Alfons; Clerinx, Jan; Bottieau, Emmanuel] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Kanobana, Kirezi; Polman, Katja] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium	Van Den Broucke, S (reprint author), Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.	ebottieau@itg.be					Ahn SJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002938; Baaten GG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-84; BASS JL, 1983, NEW ENGL J MED, V308, P723; Bottieau E, 2006, J INFECTION, V52, P339, DOI 10.1016/j.jinf.2005.07.022; Cassenote AJF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002830; Amaral HLD, 2010, VET PARASITOL, V174, P115, DOI 10.1016/j.vetpar.2010.07.016; Despommier D, 2003, CLIN MICROBIOL REV, V16, P265, DOI 10.1128/CMR.16.2.265-272.2003; Eberhardt O, 2005, CLIN NEUROL NEUROSUR, V107, P432, DOI 10.1016/j.clineuro.2004.10.003; Esposito DH, 2014, CLIN INFECT DIS, V59, P1401, DOI 10.1093/cid/ciu622; Fillaux J, 2013, VET PARASITOL, V193, P327, DOI 10.1016/j.vetpar.2012.12.028; GLICKMAN LT, 1987, AM J EPIDEMIOL, V125, P1019, DOI 10.1093/oxfordjournals.aje.a114618; JACQUIER P, 1991, J CLIN MICROBIOL, V29, P1831; Leder K, 2013, ANN INTERN MED, V158, P456, DOI 10.7326/0003-4819-158-6-201303190-00005; Lee IH, 2010, EUR J RADIOL, V75, P236, DOI 10.1016/j.ejrad.2009.04.024; Macpherson CNL, 2013, INT J PARASITOL, V43, P999, DOI 10.1016/j.ijpara.2013.07.004; Magnaval JF, 1998, ANTIMICROB AGENTS CH, V42, P2770, DOI 10.1128/AAC.42.10.2770; MAGNAVAL JF, 1995, PARASITOLOGY, V110, P529, DOI 10.1017/S0031182000065240; Meltzer E, 2008, AM J TROP MED HYG, V75, P705; Moreira-Silva Sandra F., 2004, Rev. Soc. Bras. Med. Trop., V37, P169, DOI 10.1590/S0037-86822004000200011; Othman AA, 2012, ACTA TROP, V124, P171, DOI 10.1016/j.actatropica.2012.08.003; Pinelli E, 2011, EUR J CLIN MICROBIOL, V30, P873, DOI 10.1007/s10096-011-1170-9; Rubinsky-Elefant G, 2010, ANN TROP MED PARASIT, V104, P3, DOI 10.1179/136485910X12607012373957; Saporito L, 2008, ACTA PAEDIATR, V97, P1301, DOI 10.1111/j.1651-2227.2008.00902.x; SCHANTZ P M, 1989, American Journal of Tropical Medicine and Hygiene, V41, P21; Schulte C, 2002, CLIN INFECT DIS, V34, P407, DOI 10.1086/338026; Smith H, 2009, TRENDS PARASITOL, V25, P182, DOI 10.1016/j.pt.2009.01.006; STURCHLER D, 1989, ANN TROP MED PARASIT, V83, P473; Swanson SJ, 2012, NEW ENGL J MED, V366, P1498, DOI 10.1056/NEJMoa1103360; TAYLOR MRH, 1987, SCAND J INFECT DIS, V19, P693, DOI 10.3109/00365548709117206; Turrientes MC, 2011, EMERG INFECT DIS, V17, P1263, DOI 10.3201/eid1707.101204; Vidal JE, 2003, AM J TROP MED HYG, V69, P341, DOI 10.4269/ajtmh.2003.69.341; Won KY, 2008, AM J TROP MED HYG, V79, P552, DOI 10.4269/ajtmh.2008.79.552; Woodhall DM, 2014, AM J TROP MED HYG, V90, P810, DOI 10.4269/ajtmh.13-0725	33	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAR	2015	9	3							e0003559	10.1371/journal.pntd.0003559				15	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CE9YK	WOS:000352199400034	25746418	DOAJ Gold, Green Published			2019-04-02	
J	Dana, D; Mekonnen, Z; Emana, D; Ayana, M; Getachew, M; Workneh, N; Vercruysse, J; Levecke, B				Dana, Daniel; Mekonnen, Zeleke; Emana, Daniel; Ayana, Mio; Getachew, Mestawet; Workneh, Netsanet; Vercruysse, Jozef; Levecke, Bruno			Prevalence and intensity of soil-transmitted helminth infections among pre-school age children in 12 kindergartens in Jimma Town, southwest Ethiopia	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Infection intensity; Mass drug administration; Pre-school age children; Soil-transmitted helminths		Background: Pre-school age children (preSAC) remain difficult to reach in mass drug administration (MDA) programmes to control soil-transmitted helminth (STH) infections. Kindergartens provide a unique platform to increase the coverage of MDA in preSAC in Ethiopia, but surveys assessing STHs among preSAC in kindergartens are scarce. Methods: We report the prevalence and intensity of STH infections among 622 preSAC in 12 kindergartens in Jimma, Ethiopia. Results: STHs were found in all kindergartens, with prevalence exceeding 50% in 8 kindergartens. The majority of the infections were of low intensity. Conclusions: This study highlights the importance of kindergartens as an additional opportunity for MDA in Ethiopia.	[Dana, Daniel; Mekonnen, Zeleke; Emana, Daniel; Ayana, Mio] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Med Lab Sci & Pathol, Jimma, Ethiopia; [Getachew, Mestawet] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Pharm, Jimma, Ethiopia; [Workneh, Netsanet] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Paediat, Jimma, Ethiopia; [Vercruysse, Jozef; Levecke, Bruno] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, B-9000 Ghent, Belgium	Levecke, B (reprint author), Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, B-9000 Ghent, Belgium.	Bruno.Levecke@Ugent.be		Levecke, Bruno/0000-0001-8912-5595	VLIR-UOS programme with Jimma University; Infectious Diseases and Epidemiology Project within a VLIR-UOS programme	This study was funded by the VLIR-UOS programme with Jimma University. BL is a postdoctoral fellow of FWO [05-05 1.2.853.13]. ZM is supported by the Infectious Diseases and Epidemiology Project within a VLIR-UOS programme.	Levecke B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001201; Mekonnen Z, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002189; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; WHO, 2011, HELMINTH CONTROL IN SCHOOL-AGE CHILDREN: A GUIDE FOR MANAGERS OF CONTROL PROGRAMMES, SECOND EDITION, P1; WHO, 2006, PREV CHEM HUM HELM; WHO, 2014, WEEK EPID REC, V89, P133; World Health Organization, 1998, GUID EV SOIL TRANSM	7	9	9	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	MAR	2015	109	3					225	227		10.1093/trstmh/tru178				3	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CD3LX	WOS:000350981100012	25371496				2019-04-02	
J	Canier, L; Khim, N; Kim, S; Earn, R; Khean, C; Loch, K; Ken, M; Pannus, P; Bosman, P; Stassijns, J; Nackers, F; Alipon, S; Char, MC; Chea, N; Etienne, W; De Smet, M; Kindermans, JM; Menard, D				Canier, Lydie; Khim, Nimol; Kim, Saorin; Earn, Rotha; Khean, Chanra; Loch, Kaknika; Ken, Malen; Pannus, Pieter; Bosman, Philippe; Stassijns, Jorgen; Nackers, Fabienne; Alipon, SweetC; Char, Meng Chuor; Chea, Nguon; Etienne, William; De Smet, Martin; Kindermans, Jean-Marie; Menard, Didier			Malaria PCR Detection in Cambodian Low-Transmission Settings: Dried Blood Spots versus Venous Blood Samples	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							RESISTANT PLASMODIUM-FALCIPARUM; ARTEMISININ RESISTANCE; WESTERN CAMBODIA; PROVINCE; VIVAX	In the context of malaria elimination, novel strategies for detecting very low malaria parasite densities in asymptomatic individuals are needed. One of the major limitations of the malaria parasite detection methods is the volume of blood samples being analyzed. The objective of the study was to compare the diagnostic accuracy of a malaria polymerase chain reaction assay, from dried blood spots (DBS, 5 mu L)and different volumes of venous blood (50 mu L, 200 mu L, and 1 mL). The limit of detection of the polymerase chain reaction assay, using calibrated Plasmodium falciparum blood dilutions, showed that venous blood samples (50 mu L, 200 mu L, 1 mL) combined with Qiagen extraction methods gave a similar threshold of 100 parasites/mL, similar to 100-fold lower than 5 mu L DBS/Instagene method. On a set of 521 field samples, collected in two different transmission areas in northern Cambodia, no significant difference in the proportion of parasite carriers, regardless of the methods used was found. The 5 mu L DBS method missed 27% of the samples detected by the 1 mL venous blood method, but most of the missed parasites carriers were infected by Plasmodium vivax (84%). The remaining missed P. falciparum parasite carriers (N = 3) were only detected in high-transmission areas.	Inst Pasteur Cambodge, Phnom Penh, Cambodia; [Pannus, Pieter; Bosman, Philippe; Stassijns, Jorgen; Etienne, William; De Smet, Martin; Kindermans, Jean-Marie] Med Sans Frontieres, Brussels, Belgium; Epictr, Paris, France; Med Sans Frontieres, Chamkarmon, Phnom Penh, Cambodia; Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Canier, Lydie; Khim, Nimol; Kim, Saorin; Earn, Rotha; Khean, Chanra; Loch, Kaknika; Ken, Malen; Menard, Didier] Inst Pasteur Cambodia, Malaria Mol Epidemiol Unit, Phnom Penh, Cambodia; [Nackers, Fabienne] Med Sans Frontieres, Paris, France; [Alipon, SweetC] Med Sans Frontieres, Phnom Penh, Cambodia; [Char, Meng Chuor; Chea, Nguon] Natl Ctr Parasitol Entomol & Malaria Control, Minist Hlth, Phnom Penh, Cambodia	Menard, D (reprint author), Inst Pasteur Cambodia, Malaria Mol Epidemiol Unit, 5 Blvd Monivong,POB 983, Phnom Penh, Cambodia.	lcanier@pasteur-kh.org; knimol@pasteur-kh.org; ksaorin@pasteur-kh.org; rotha@pasteur-kh.org; kchanra@pasteur-kh.org; lkaknika@pasteur-kh.org; kmalen@pasteur-kh.org; pieter.pannus@Brussels.msf.org; bosmanphil@yahoo.com; Jorgen.Stassijns@Brussels.msf.org; Fabienne.Nackers@Brussels.msf.org; sweetc.alipon@gmail.com; mengchuor@gmail.com; cheanguon@yahoo.com; William.Etienne@Brussels.msf.org; Martin.De.Smet@Brussels.msf.org; Jean-Marie.Kindermans@Brussels.msf.org; dmenard@pasteur-kh.org	Menard, Didier/O-3294-2013	Menard, Didier/0000-0003-1357-4495	Medecins Sans Frontieres, Belgium; French Ministry of Foreign Affairs	This study was supported by Medecins Sans Frontieres, Belgium. Didier Menard was supported by the French Ministry of Foreign Affairs.	Amaratunga C, 2014, LANCET INFECT DIS, V14, P449, DOI 10.1016/S1473-3099(14)70777-7; Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ataei S, 2011, J CLIN LAB ANAL, V25, P185, DOI 10.1002/jcla.20454; Bosman P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-394; Canier L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-405; Cui LW, 2012, ACTA TROP, V121, P227, DOI 10.1016/j.actatropica.2011.02.016; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Hoyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045797; Kyaw MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057689; Leang R, 2013, ANTIMICROB AGENTS CH, V57, P818, DOI 10.1128/AAC.00686-12; *MALERA CONS GROUP, 2011, PLOS MED, V0008; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Strom GEA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-137; Tran TH, 2013, MALARIA J, V11, P355; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Witkowski B, 2013, LANCET INFECT DIS, V13, P1043, DOI 10.1016/S1473-3099(13)70252-4	19	13	13	0	4	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	MAR	2015	92	3					573	577		10.4269/ajtmh.14-0614				5	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CC7EB	WOS:000350529400024	25561570	Green Published, Bronze			2019-04-02	
J	Otero, L; De Orbegoso, A; Navarro, AF; Rios, J; Parraga, T; Gotuzzo, E; Seas, C; Van der Stuyft, P				Otero, L.; De Orbegoso, A.; Navarro, A. F.; Rios, J.; Parraga, T.; Gotuzzo, E.; Seas, C.; Van der Stuyft, P.			Time to initiation of multidrug-resistant tuberculosis treatment and its relation with outcome in a high incidence district in Lima, Peru	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						tuberculosis; multidrug resistant; time to treatment; Peru; tuberculose; multiresistante; temps jusqu'au traitement; Perou; Tuberculosis; multirresistente; Tiempo hasta el inicio del tratamiento; Peru	XPERT MTB/RIF; IMPLEMENTATION; DIAGNOSIS; AFRICA	ObjectiveTo determine the time from diagnosis to start of multidrug resistant tuberculosis (MDR TB) treatment in Lima, Peru. MethodsWe studied new smear-positive TB adults that were started on MDR TB treatment or that were switched to it between June 2008 and December 2011. ResultsTime from the first positive smear to MDR-TB treatment was >30days in 35% (13/37) of patients. Among the 27% (24/88) of patients that switched to MDR-TB treatment, time from the last dose of a drug-susceptible regimen was >30days. ConclusionStart of and switching to MDR TB treatment is still delayed. ObjectifDeterminer la duree entre le diagnostic et le debut du traitement de la TB-MDR a Lima, au Perou. MethodesAnalyse retrospective des registres. ResultatsLa duree entre le premier frottis positif et le traitement de la TB-MDR etait >30 jours chez 35% (13/37) des patients. Chez 27% (24/88) des patients passes a un traitement de TB-MDR, la duree depuis la derniere dose d'un regime de traitement pour une TB sensible etait >30 jours. ConclusionLa oU des tests de diagnostic plus rapides de la TB-MDR ont ete implementes, le debut de traitement et le passage au traitement de la TB-MDR etaient encore retardes. L'implementation de technologies ameliorees necessite l'instauration simultanee de strategies pour accelerer l'initiation du traitement. ObjetivoDeterminar el tiempo entre el diagnostico y el comienzo del tratamiento de la TB-MDR en Lima, Peru. MetodosRevision retrospectiva de casos. ResultadosEl tiempo entre la primera baciloscopia positiva y el inicio del tratamiento de la TB-MDR era de >30 dias en un 35% (13/37) de los pacientes. En un 27% (24/88) de los pacientes, que cambiaron el tratamiento por uno para TB-MDR, el tiempo desde la ultima dosis del regimen de la medicacion ineficaz era de > 30 dias. ConclusionEn aquellos lugares en donde ya estaba implementado el uso de pruebas diagnosticas rapidas para TB-MDR, el comienzo o el cambio a un tratamiento para TB-MDR continuaba retrasandose. La implementacion de tecnologias mejoradas requiere de la implementacion simultanea de estrategias que aceleren el inicio del tratamiento.	[Otero, L.; De Orbegoso, A.; Navarro, A. F.; Parraga, T.; Gotuzzo, E.; Seas, C.] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima 31, Peru; [Otero, L.; Van der Stuyft, P.] Inst Trop Med, Dept Publ Hlth, Unit Gen Epidemiol & Dis Control, B-2000 Antwerp, Belgium; [Rios, J.] Minist Salud, Direcc Salud Lima Sur, Lima, Peru; [Van der Stuyft, P.] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium	Otero, L (reprint author), Univ Peruana Cayetano Heredia, Av Honorio Delgado 430, Lima 31, Peru.	larissa.otero@upch.pe		Seas, Carlos/0000-0001-7067-9141; Otero, Larissa/0000-0002-8348-4340	Belgian Directorate General for Development Cooperation; Institute of Tropical Medicine in Antwerp, Belgium; Instituto de Medicina Tropical Alexander von Humboldt in Lima, Peru; Peru ICOHRTA Network for AIDS/TB Research Training National Institutes of Health	This work was supported by the Belgian Directorate General for Development Cooperation through an institutional collaboration between the Institute of Tropical Medicine in Antwerp, Belgium and the Instituto de Medicina Tropical Alexander von Humboldt in Lima, Peru, and Peru ICOHRTA Network for AIDS/TB Research Training National Institutes of Health.	Clouse K, 2012, SAMJ S AFR MED J, V102, P805, DOI [10.7196/samj.5851, 10.7196/SAMJ.5851]; Davis JL, 2012, JAIDS-J ACQ IMM DEF, V61, pE6, DOI 10.1097/QAI.0b013e3182614bc5; Hanrahan CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049898; Jacobson KR, 2013, CLIN INFECT DIS, V56, P503, DOI 10.1093/cid/cis920; Ministerio de Salud, 2010, ESTR SAN NAC PREV CO; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306; Shin SS, 2008, EMERG INFECT DIS, V14, P701, DOI 10.3201/eid1405.070721; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; WHO, 2013, WORLD HLTH ORG GLOB; Yagui M, 2006, INT J TUBERC LUNG D, V10, P838	11	3	3	0	13	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	MAR	2015	20	3					322	325		10.1111/tmi.12430				4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CA1ID	WOS:000348665100008	25429916	Green Accepted, Bronze			2019-04-02	
J	Thanh, PV; Van Hong, N; Van Van, N; Van Malderen, C; Obsomer, V; Rosanas-Urgell, A; Grietens, KP; Xa, NX; Bancone, G; Chowwiwat, N; Duong, TT; D'Alessandro, U; Speybroeck, N; Erhart, A				Pham Vinh Thanh; Nguyen Van Hong; Nguyen Van Van; Van Malderen, Carine; Obsomer, Valerie; Rosanas-Urgell, Anna; Grietens, Koen Peeters; Nguyen Xuan Xa; Bancone, Germana; Chowwiwat, Nongnud; Tran Thanh Duong; D'Alessandro, Umberto; Speybroeck, Niko; Erhart, Annette			Epidemiology of forest malaria in Central Vietnam: the hidden parasite reservoir	MALARIA JOURNAL			English	Article						Malaria; Sub-patent infections; Elimination; Central Vietnam	PLASMODIUM-VIVAX; INFECTIONS; TRANSMISSION; GAMETOCYTEMIA; BEHAVIOR	Background: After successfully reducing the malaria burden to pre-elimination levels over the past two decades, the national malaria programme in Vietnam has recently switched from control to elimination. However, in forested areas of Central Vietnam malaria elimination is likely to be jeopardized by the high occurrence of asymptomatic and submicroscopic infections as shown by previous reports. This paper presents the results of a malaria survey carried out in a remote forested area of Central Vietnam where we evaluated malaria prevalence and risk factors for infection. Methods: After a full census (four study villages = 1,810 inhabitants), the study population was screened for malaria infections by standard microscopy and, if needed, treated according to national guidelines. An additional blood sample on filter paper was also taken in a random sample of the population for later polymerase chain reaction (PCR) and more accurate estimation of the actual burden of malaria infections. The risk factor analysis for malaria infections was done using survey multivariate logistic regression as well as the classification and regression tree method (CART). Results: A total of 1,450 individuals were screened. Malaria prevalence by microscopy was 7.8% (ranging from 3.9 to 10.9% across villages) mostly Plasmodium falciparum (81.4%) or Plasmodium vivax (17.7%) mono-infections; a large majority (69.9%) was asymptomatic. By PCR, the prevalence was estimated at 22.6% (ranging from 16.4 to 42.5%) with a higher proportion of P. vivax mono-infections (43.2%). The proportion of sub-patent infections increased with increasing age and with decreasing prevalence across villages. The main risk factors were young age, village, house structure, and absence of bed net. Conclusion: This study confirmed that in Central Vietnam a substantial part of the human malaria reservoir is hidden. Additional studies are urgently needed to assess the contribution of this hidden reservoir to the maintenance of malaria transmission. Such evidence will be crucial for guiding elimination strategies.	[Pham Vinh Thanh; Nguyen Van Hong; Nguyen Xuan Xa; Tran Thanh Duong] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam; [Nguyen Van Van] Prov Malaria Stn, Tam Ky City, Quang Nam Provi, Vietnam; [Van Malderen, Carine; Speybroeck, Niko] Catholic Univ Louvain, B-1200 Brussels, Belgium; [Obsomer, Valerie] Catholic Univ Louvain, Louvain La Neuve, Belgium; [Rosanas-Urgell, Anna; Grietens, Koen Peeters; D'Alessandro, Umberto; Erhart, Annette] Inst Trop Med Prince Leopold ITM, Antwerp, Belgium; [Bancone, Germana; Chowwiwat, Nongnud] Shoklo Malaria Res Unit, Mae Sot, Tak Province, Thailand; [D'Alessandro, Umberto] Med Res Council Unit MRC Unit, Fajara, Gambia	Thanh, PV (reprint author), Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam.	phamvinht@gmail.com		Peeters Grietens, Koen/0000-0001-6570-9887; Bancone, Germana/0000-0003-4550-0431	UBS Optimus Foundation; Belgium Cooperation (DGCD) [FA3]	We would like to thank the M'nong and Ca Dong communities in Tra Leng and Tra Don communes for their contribution to the present study, as well as the local authorities for their strong and continuous support. The study was funded by the UBS Optimus Foundation and the Framework Agreement project (FA3) of the Belgium Cooperation (DGCD).	Baird JK, 2004, CLIN INFECT DIS, V39, P1336, DOI 10.1086/424663; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Churcher TS, 2013, ELIFE, V2, DOI 10.7554/eLife.00626; Erhart A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-58; Garmin, ETREX HC SER PERS NA; Garros C, 2008, MALARIA J, V7, DOI 10.1186/147-2875-7-11; Greenwood B.M., 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene, V83, P25, DOI 10.1016/0035-9203(89)90599-3; HemoCue, ACC POC AN SCREEN PI; Nguyen HV, 2012, AM J TROP MED HYG, V87, P989, DOI 10.4269/ajtmh.2012.12-0047; McKenzie FE, 2007, J PARASITOL, V93, P627, DOI 10.1645/GE-1052R.1; McKenzie FE, 2006, J PARASITOL, V92, P1281, DOI 10.1645/GE-911R.1; Ministry of Health. National Malaria Control Program. National Institute of Malariology Parasitology and Entomology (NIMPE), 2011, INTERNAL REPORT; Modiano D, 1996, P NATL ACAD SCI USA, V93, P13206, DOI 10.1073/pnas.93.23.13206; Modiano D., 1995, Parassitologia (Rome), V37, P255; National Institute of Malarialogy Parasitology and Entomology, 2013, INTERNAL REPORT; Nuchprayoon I, 2002, Hum Mutat, V19, P185, DOI 10.1002/humu.9010; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Peeters Grietens K, 2010, MALARIA J, V9, P23; Proietti C, 2011, AM J TROP MED HYG, V84, P830, DOI 10.4269/ajtmh.2011.10-0498; Pukrittayakamee S, 2008, AM J TROP MED HYG, V79, P378, DOI 10.4269/ajtmh.2008.79.378; Speybroeck N, 2012, INT J PUBLIC HEALTH, V57, P243, DOI 10.1007/s00038-011-0315-z; Thang Ngo Duc, 2009, PLoS One, V4, pe7369, DOI 10.1371/journal.pone.0007369; Thang Ngo Duc, 2009, Malar J, V8, P3, DOI 10.1186/1475-2875-8-3; Thang ND, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-28; Van Bortel W, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-373; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WALSH PS, 1991, BIOTECHNIQUES, V10, P506; World Health Organization, 2014, STAT REP ART RES; Xu JW, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-417	31	21	21	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	FEB 19	2015	14								86	10.1186/s12936-015-0601-y				11	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CC8GB	WOS:000350605000001	25880664	DOAJ Gold, Green Published			2019-04-02	
J	Maketa, V; Mavoko, HM; da Luz, RI; Zanga, J; Lubiba, J; Kalonji, A; Lutumba, P; Van Geertruyden, JP				Maketa, Vivi; Mavoko, Hypolite Muhindo; da Luz, Raquel Inocencio; Zanga, Josue; Lubiba, Joachim; Kalonji, Albert; Lutumba, Pascal; Van Geertruyden, Jean-Pierre			The relationship between Plasmodium infection, anaemia and nutritional status in asymptomatic children aged under five years living in stable transmission zones in Kinshasa, Democratic Republic of Congo	MALARIA JOURNAL			English	Article						Plasmodium falciparum; Asymptomatic infection; Anaemia; Nutrition; Children under five; Democratic Republic of Congo	SEVERE FALCIPARUM-MALARIA; TREATED BED NETS; SULFADOXINE-PYRIMETHAMINE; ARTEMETHER-LUMEFANTRINE; DIAGNOSTIC-TESTS; AFRICAN CHILDREN; SURFACE-ANTIGENS; ENDEMIC AREAS; FOLLOW-UP; DISEASE	Background: Malaria is preventable and treatable when recommended interventions are properly implemented. Thus, diagnosis and treatment focus on symptomatic individuals while asymptomatic Plasmodium infection (PI) plays a role in the sustainability of the transmission and may also have an impact on the morbidity of the disease in terms of anaemia, nutritional status and even cognitive development of children. The objective of this study was to assess PI prevalence and its relationship with known morbidity factors in a vulnerable but asymptomatic stratum of the population. Methods: A simple random sample, household survey in asymptomatic children under the age of five was conducted from April to September 2012 in two health areas of the health zone of Mont Ngafula 1, Kinshasa, Democratic Republic of Congo. Results: The PI prevalence were 30.9% (95% CI: 26.5-35.9) and 14.3% (95% CI: 10.5-18.1) in Cite Pumbu and Kindele health areas, respectively, (OR: 2.7; p < 0.001). All were Plasmodium falciparum infected and 4% were co-infected with Plasmodium malariae. In Cite Pumbu and Kindele, the prevalence of anaemia (haemoglobin < 11 g/dL) was 61.6% (95% CI: 56.6-66.5) and 39.3% (95% CI: 34.0-44.6), respectively, (OR: 2.5; p < 0.001). The health area of Cite Pumbu had 32% (95% CI: 27.5-37.0) of chronic malnutrition (HAZ score <= -2SD) compared to 5.1% (95% CI: 2.8-7.6) in Kindele. PI was predictor factor for anaemia (aOR: 3.5, p = 0.01) and within infected children, there was an inverse relationship between parasite density and haemoglobin level (beta = -5*10(-5), p < 0.001). Age older than 12 months (aOR: 3.8, p = 0.01), presence of anaemia (aOR: 3.4, p = 0.001), chronic malnutrition (aOR: 1.8, p = 0.01), having a single parent/guardian (aOR: 1.6, p = 0.04), and the non-use of insecticide-treated nets (aOR: 1.7, p = 0.04) were all predictors for PI in the overall population. Conclusion: PI in asymptomatic children was correlated with anaemia and chronic malnutrition and was thus a harmful condition in the study population. Malaria control initiatives should not only focus on treatment of symptomatic infections but also take into consideration asymptomatic but infected children.	[Maketa, Vivi; Mavoko, Hypolite Muhindo; Zanga, Josue; Lutumba, Pascal] Univ Kinshasa, Dept Trop Med, Kinshasa, Zaire; [Maketa, Vivi; Mavoko, Hypolite Muhindo; da Luz, Raquel Inocencio; Van Geertruyden, Jean-Pierre] Univ Antwerp, Fac Med, Int Hlth Unit, B-2020 Antwerp, Belgium; [Lubiba, Joachim; Kalonji, Albert] Sante Rurale SANRU, Kinshasa, Zaire	Maketa, V (reprint author), Univ Kinshasa, Dept Trop Med, Kinshasa, Zaire.	vmaketa@yahoo.fr	Inocencio da Luz, Raquel/L-9676-2016; Van geertruyden, Jean-Pierre/K-6425-2014	Inocencio da Luz, Raquel/0000-0002-2870-0311; Van geertruyden, Jean-Pierre/0000-0001-5006-6364	VLIR-UOS; SACIDS	We thank the study participants and the study team: Henry Kabongo, Olga Kabedi, Eugene Paluku. This study was co-funded by VLIR-UOS and SACIDS.	Abdullah S, 2007, AM J TROP MED HYG, V77, P99; Amaratunga C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014798; Angus BJ, 1997, BLOOD, V90, P2037; Askjaer N, 2001, CLIN DIAGN LAB IMMUN, V8, P1289, DOI 10.1128/CDLI.8.6.1289-1291.2001; Baliraine FN, 2009, J INFECT DIS, V200, P66, DOI 10.1086/599317; Beavogui AH, 2010, INT J PARASITOL, V40, P1213, DOI 10.1016/j.ijpara.2010.04.010; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; Billig EMW, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-396; Bisoffi Z, 2008, BRIT MED J, V336, P168, DOI 10.1136/bmj.39401.486655.80; Bisoffi Z, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000063; Bottius E, 1996, T ROY SOC TROP MED H, V90, P15, DOI 10.1016/S0035-9203(96)90463-0; Bousema T, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-136; Bull PC, 2002, J INFECT DIS, V185, P1688, DOI 10.1086/340420; Caulfield LE, 2004, AM J TROP MED HYG, V71, P55, DOI 10.4269/ajtmh.2004.71.55; Cavanagh DR, 1998, J IMMUNOL, V161, P347; Chizema-Kawesha E, 2010, AM J TROP MED HYG, V83, P480, DOI 10.4269/ajtmh.2010.10-0035; CLARK IA, 1988, BRIT J HAEMATOL, V70, P99, DOI 10.1111/j.1365-2141.1988.tb02440.x; Crookston BT, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-39; Crowell V, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-4; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; DALESSANDRO U, 1995, LANCET, V345, P479, DOI 10.1016/S0140-6736(95)90582-0; DAVIS TME, 1990, J CLIN INVEST, V86, P793, DOI 10.1172/JCI114776; Deen JL, 2002, J TROP PEDIATRICS, V48, P78, DOI 10.1093/tropej/48.2.78; Dondorp AM, 1999, AM J TROP MED HYG, V60, P733, DOI 10.4269/ajtmh.1999.60.733; Douamba Z, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/198317; Doumbia SO, 2012, ACTA TROP, V121, P175, DOI 10.1016/j.actatropica.2011.11.009; Dunyo S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010020; Ehrhardt S, 2006, J INFECT DIS, V194, P108, DOI 10.1086/504688; ElHassan AMA, 1997, EUR J HAEMATOL, V59, P299; English M, 2009, PLOS MED, V6, P7, DOI 10.1371/journal.pmed.1000015; Gerstl S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-28; Ghani AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004383; GOYAL SC, 1991, J TROP PEDIATRICS, V37, P143, DOI 10.1093/tropej/37.3.143; Greenwood B, 2004, AM J TROP MED HYG, V70, P1; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; HENDRICKSE RG, 1971, ANN TROP MED PARASIT, V65, P1; Hodel EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008184; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000485; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000270; Ilombe G, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-308; Isah AY, 2011, ANN AFR MED, V10, P171, DOI 10.4103/1596-3519.82070; Jaenisch T, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-32; Jagannathan P, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-435; Jeremiah Z A, 2007, East Afr J Public Health, V4, P55; Kern SE, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-210; Kobbe R, 2011, J INFECT DIS, V203, P556, DOI 10.1093/infdis/jiq079; Koram KA, 2007, AM J TROP MED HYG, V77, P1; Laishram DD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-29; Matangila JR, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-132; McGready R, 2011, BJOG-INT J OBSTET GY, V118, P123, DOI 10.1111/j.1471-0528.2010.02810.x; MCGREGOR IA, 1982, REV INFECT DIS, V4, P798; Menendez C, 1997, LANCET, V350, P844, DOI 10.1016/S0140-6736(97)04229-3; Ministere de la Sante Publique de la sante, 2010, SECR GEN SANT KINSH; Ministere du Plan avec la collaboration du Ministere de la Sante, 2008, ENQ DEM SANT RDC 200; Muhindo M, 2013, TRIALS, V14, P307, DOI DOI 10.1186/1745-6215-14-307; Multicentre Growth Reference Study Group World Health Organization, 2006, WHO CHILD GROWTH STA; Njama-Meya D, 2004, TROP MED INT HEALTH, V9, P862, DOI 10.1111/j.1365-3156.2004.01277.x; Noland GS, 2012, CLIN INFECT DIS, V54, P178, DOI 10.1093/cid/cir768; Ogutu B, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-30; PHILLIPS RE, 1992, BAILLIERE CLIN HAEM, V5, P315, DOI 10.1016/S0950-3536(11)80022-3; Rogerson SJ, 2010, LANCET INFECT DIS, V10, P51, DOI 10.1016/S1473-3099(09)70322-6; Shankar AH, 2000, J INFECT DIS, V182, pS37, DOI 10.1086/315906; SHARP P T, 1980, Papua New Guinea Medical Journal, V23, P132; Stauffer W, 2003, CLIN INFECT DIS, V37, P1340, DOI 10.1086/379074; Sutherland CJ, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-161; Takakura Minoru, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P262; Tiono AB, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-535; Vafa M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-17; Van den Ende J, 1998, TROP MED INT HEALTH, V3, P632, DOI 10.1046/j.1365-3156.1998.00287.x; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2010, GUID TREATM MAL; WHO Multicentre Growth Reference Study Group, 2007, WHO CHILD GROWTH STA; World Health Organization, 2011, HAEM CONC DIAGN AN A; World Health Organization, 1991, BAS MAL MICR 1	75	12	12	0	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	FEB 18	2015	14								83	10.1186/s12936-015-0595-5				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CC8FZ	WOS:000350604800001	25880427	DOAJ Gold, Green Published			2019-04-02	
J	Manyando, C; Njunju, EM; Virtanen, M; Hamed, K; Gomes, M; Van Geertruyden, JP				Manyando, Christine; Njunju, Eric M.; Virtanen, Mailis; Hamed, Kamal; Gomes, Melba; Van Geertruyden, Jean-Pierre			Exposure to artemether-lumefantrine (Coartem (R)) in first trimester pregnancy in an observational study in Zambia	MALARIA JOURNAL			English	Article							GESTATIONAL-AGE; DEVELOPMENTAL TOXICITY; DOUBLE-BLIND; MALARIA; SAFETY; ARTESUNATE; PREVENTION; FALCIPARUM; STANDARDS; MORTALITY	Background: In general, safety data following exposure to drugs in the first trimester of pregnancy are scarce. More specifically, data on the safety of artemisinin-based combination therapy (ACT) in pregnancy still remain limited. Therefore, pregnant women from Choma, Zambia, who were exposed to artemether-lumefantrine (AL) for the treatment of uncomplicated malaria were followed up and evaluated in a prospective cohort study. This report assessed the longitudinal safety outcomes of the pregnant women inadvertently exposed during the first trimester. Methods: Participants were classified based on the drug used to treat their most recent malaria episode: artemether-lumefantrine (AL) versus sulphadoxine-pyrimethamine (SP) and/or quinine. All enrolled women were followed up until six weeks post-delivery and the live births for 12 months. Results: There were 294 first trimester exposures in the observational cohort (pregnant women: AL = 150, AL and SP = 9 and SP and/or quinine = 135). Similar rates of perinatal mortality (stillbirths and neonatal deaths) were observed for each treatment arm (AL 4.4%, SP and/or quinine 3.9%). At delivery (newborns: AL = 135, AL and SP = 7 and SP and/or quinine = 129), the gestational age (measured using the Dubowitz total scores), length and head circumference of the newborns were similar between the two arms. Low birth weights were reported in 10.2% (95% CI 6.0, 16.6) and 6.7% (95% CI 3.4, 12.6) of newborns in the AL and SP and/or quinine arms, respectively. Overall development (including neurodevelopmental parameters) was similar between the two arms, both at 14 weeks and 12 months of age. Conclusion: Exposure to AL and SP in the first trimester was not associated with particular safety risks such as perinatal mortality, preterm deliveries or low birth weights. Such outcomes as well as infant neurodevelopmental parameters up to 12 months were similar between the two arms. These findings add to the body of data suggesting that randomized clinical trials could now be the way forward to assess safety and efficacy of ACT in the first trimester of pregnancy.	[Manyando, Christine; Njunju, Eric M.] Tropical Dis Res Ctr, Ndola, Zambia; [Manyando, Christine; Njunju, Eric M.; Van Geertruyden, Jean-Pierre] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium; [Virtanen, Mailis] Novartis Pharma AG, Basel, Switzerland; [Hamed, Kamal] Novartis Pharmaceut, E Hanover, NJ USA; [Gomes, Melba] WHO, TDR, CH-1211 Geneva, Switzerland	Manyando, C (reprint author), Tropical Dis Res Ctr, Ndola, Zambia.	cmanyando@yahoo.com	Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Hamed, Kamal/0000-0003-1896-9736	Novartis; Novartis Pharma AG; WHO	The Authors would like to acknowledge the National Malaria Control Programme in Zambia for their unrelenting support during the conduct of this study, and also thank the study participants and local staff; without whom this study would not have been possible. The local staff consisted of: Choma site: Dr David Chibuye, Lucia Adams, Alice Changuba, Grace Chulu, Zodwa Hamweene, Berriate Hambwalu, Catherine Mabeta, Margaret C. Muchanga, Mary Mudenda, Tisa Muyola, Siphiwe Mwaba, Idah Nyanga, and the Laboratory staff at Choma Hospital and Shampande Clinic. Lusaka site: Dr Anthony Yeta, Happy Chipulu, Christine Tembo, Christine Omara, and laboratory staff from Chipata clinic. Ndola site: Dr Ignace Gashongore, Elizabeth N'gambi, Rachael Simutowe, Lungowe Musonda, Bupe Luyi, Lister Katongo, Margret Kaumba, Charity Chifita, and the Laboratory staff from Chipulukusu and Lubuto clinics. The authors would also like to thank Professor Chifumbe Chintu from the University of Zambia (Lusaka, Zambia) and Jurgen Lilienthal from DATAMAP GmbH (Freiburg, Germany) for their participation in the Study Advisory Committee, as well as Dr Gershom Chongwe and Joseph Mthetwa for their participation on the investigator team, Anne Claire Marrast, Fiyinfolu Oladiran, Nathan Mulure, Obiyo Nwaiwu, Gabriela Mani-Caplazi, Patricia Ibarra de Palacios, Kim Andriano, and Kirstin Stricker for their participation from the Novartis sponsor side. This study was co-sponsored by Novartis Pharma AG and WHO. The sponsors were responsible for data collection and analysis. Statistical analysis was carried out by DATAMAP GmbH (Freiburg, Germany), and the authors particularly thank Martina Wibberg and Tanya Widmayer for their input on data management.	Clark RL, 2008, BIRTH DEFECTS RES B, V83, P397, DOI 10.1002/bdrb.20165; DAWODU AH, 1977, NIG J PAEDIAT, V4, P1; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; DOLAN G, 1993, T ROY SOC TROP MED H, V87, P620, DOI 10.1016/0035-9203(93)90262-O; DUBOWITZ LM, 1970, J PEDIATR-US, V77, P1, DOI 10.1016/S0022-3476(70)80038-5; Haataja L, 2002, ANN TROP PAEDIATR, V22, P355, DOI 10.1179/027249302125002029; Manyando C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-141; Manyando C, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-249; McGready R, 2012, LANCET INFECT DIS, V12, P388, DOI 10.1016/S1473-3099(11)70339-5; McGready R, 2001, T ROY SOC TROP MED H, V95, P137, DOI 10.1016/S0035-9203(01)90137-3; Menendez C, 2008, PLOS MED, V5, P220, DOI 10.1371/journal.pmed.0050044; MUNJANJA SP, 1990, CENT AFR J MED, V36, P144; NOSTEN F, 1994, J INFECT DIS, V169, P595, DOI 10.1093/infdis/169.3.595; Nosten F, 2007, LANCET INFECT DIS, V7, P118, DOI 10.1016/S1473-3099(07)70023-3; Rosenberg RE, 2009, J HEALTH POPUL NUTR, V27, P332; Sandoy IF, 2006, TROP MED INT HEALTH, V11, P917, DOI 10.1111/j.1365-3156.2006.01629.x; SINCLAIR D, 2009, COCHRANE DB SYST REV, V3; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Van Geertruyden JP, 2004, AM J TROP MED HYG, V71, P35, DOI 10.4269/ajtmh.2004.71.35; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; White TEK, 2008, BIRTH DEFECTS RES B, V83, P407, DOI 10.1002/bdrb.20157; Whitty CJM, 2005, BJOG-INT J OBSTET GY, V112, P1189, DOI 10.1111/j.1471-0528.2005.00714.x; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2006, ASS SAF ART COMP PRE; WHO, 2010, GUID TREATM MAL	25	11	11	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	FEB 14	2015	14								77	10.1186/s12936-015-0578-6				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CB7IB	WOS:000349799100001	25877884	DOAJ Gold, Green Published			2019-04-02	
J	Ajua, A; Lell, B; Agnandji, ST; Asante, KP; Owusu-Agyei, S; Mwangoka, G; Mpina, M; Salim, N; Tanner, M; Abdulla, S; Vekemans, J; Jongert, E; Lievens, M; Cambron, P; Ockenhouse, CF; Kremsner, PG; Mordmuller, B				Ajua, Anthony; Lell, Bertrand; Agnandji, Selidji Todagbe; Asante, Kwaku Poku; Owusu-Agyei, Seth; Mwangoka, Grace; Mpina, Maxmilliam; Salim, Nahya; Tanner, Marcel; Abdulla, Salim; Vekemans, Johan; Jongert, Erik; Lievens, Marc; Cambron, Pierre; Ockenhouse, Chris F.; Kremsner, Peter G.; Mordmueller, Benjamin			The effect of immunization schedule with the malaria vaccine candidate RTS,S/AS01(E) on protective efficacy and anti-circumsporozoite protein antibody avidity in African infants	MALARIA JOURNAL			English	Article						Malaria; RTS,S; Vaccine; Plasmodium falciparum; Antibody; Avidity; Correlate of protection	PLASMODIUM-FALCIPARUM; EXPANDED-PROGRAM; PHASE-3 TRIAL; SAFETY	Background: The malaria vaccine RTS,S induces antibodies against the Plasmodium falciparum circumsporozoite protein (CSP) and the concentration of Immunoglobulin G (IgG) against the repeat region of CSP following vaccination is associated with protection from P. falciparum malaria. So far, only the quantity of anti-CSP IgG has been measured and used to predict vaccination success, although quality (measured as avidity) of the antigen-antibody interaction shall be important since only a few sporozoites circulate for a short time after an infectious mosquito bite, likely requiring fast and strong binding. Methods: Quantity and avidity of anti-CSP IgG in African infants who received RTS,S/AS01(E) in a 0-1-2-month or a 0 1 7 month schedule in a phase 2 clinical trial were measured by enzyme-linked immunosorbent assay. Antibody avidity was defined as the proportion of IgG able to bind in the presence of a chaotropic agent (avidity index). The effect of CSP-specific IgG concentration and avidity on protective efficacy was modelled using Cox proportional hazards. Results: After the third dose, quantity and avidity were similar between the two vaccination schedules. IgG avidity after the last vaccine injection was not associated with protection, whereas the change in avidity following second and third RTS,S/AS01(E) injection was associated with a 54% risk reduction of getting malaria (hazard ratio: 0.46; 95% confidence interval (CI): 0.22-0.99) in those participants with a change in avidity above the median. The change in anti-CSP IgG concentration following second and third injection was associated with a 77% risk reduction of getting malaria (hazard ratio: 0.23, 95% CI: 0.11-0.51). Conclusions: Change in IgG response between vaccine doses merits further evaluation as a surrogate marker for RTS,S efficacy.	[Ajua, Anthony; Lell, Bertrand; Kremsner, Peter G.; Mordmueller, Benjamin] Univ Tubingen, Inst Tropenmed, D-72074 Tubingen, Germany; [Lell, Bertrand; Agnandji, Selidji Todagbe; Kremsner, Peter G.; Mordmueller, Benjamin] Ctr Rech Med Lambarene CERMEL, Lambarene, Gabon; [Asante, Kwaku Poku; Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, Kintampo, Ghana; [Owusu-Agyei, Seth] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England; [Mwangoka, Grace; Mpina, Maxmilliam; Salim, Nahya; Tanner, Marcel; Abdulla, Salim] Ifakara Hlth Inst, Bagamoyo Res & Training Ctr, Dar Es Salaam, Tanzania; [Tanner, Marcel] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Vekemans, Johan; Jongert, Erik; Lievens, Marc; Cambron, Pierre] GlaxoSmithKline Biol, Rixensart, Belgium; [Ockenhouse, Chris F.] PATH Malaria Vaccine Initiat, Washington, DC 20001 USA	Mordmuller, B (reprint author), Univ Tubingen, Inst Tropenmed, Wilhelmstr 27, D-72074 Tubingen, Germany.	benjamin.mordmueller@uni-tuebingen.de		masoud, nahya salim/0000-0002-3784-6478	Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of the University of Tubingen	The authors thank the participants and their parents, the community members and the Chiefs in the traditional areas, and the management and staff of the local collaborating institutions (the Kintampo Municipal Hospital, Ghana Health Service, and the Kintampo North and South Health Directorates in Kintampo). We also thank Jarno Jansen (Keyrus Biopharma, on behalf of GSK Vaccines) for publication management and editorial assistance. The Deutsche Forschungsgemeinschaft and the Open Access Publishing Fund of the University of Tubingen supported publishing this manuscript under a Creative Commons Attribution License.	Agnandji ST, 2010, J INFECT DIS, V202, P1076, DOI 10.1086/656190; Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Asante KP, 2011, LANCET INFECT DIS, V11, P741, DOI 10.1016/S1473-3099(11)70100-1; Bachmann MF, 1997, SCIENCE, V276, P2024, DOI 10.1126/science.276.5321.2024; Busse CE, 2014, EUR J IMMUNOL, V44, P597, DOI 10.1002/eji.201343917; Clement F, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-384; EGAN JE, 1987, SCIENCE, V236, P453, DOI 10.1126/science.3551073; Fairley H, 1945, T R SOC TROP MED HYG, V38, P311; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Muellenbeck MF, 2013, J EXP MED, V210, P389, DOI 10.1084/jem.20121970; Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI 10.1016/51473-3099(10)70262-0; Porter MD, 2013, CLIN VACCINE IMMUNOL, V20, P803, DOI 10.1128/CVI.00066-13; Reed RC, 1996, VACCINE, V14, P828, DOI 10.1016/0264-410X(95)00175-Z; RICKMAN LS, 1991, LANCET, V337, P998, DOI 10.1016/0140-6736(91)92659-P; *RTS S CLIN TRIALS, 2014, PLOS MED, V0011; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202	18	12	12	0	8	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	FEB 13	2015	14								72	10.1186/s12936-015-0605-7				6	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CB9BG	WOS:000349925700001	25885325	DOAJ Gold, Green Published			2019-04-02	
J	Caljon, G; Hussain, S; Vermeiren, L; Van den Abbeele, J				Caljon, Guy; Hussain, Shahid; Vermeiren, Lieve; Van den Abbeele, Jan			Description of a Nanobody-based Competitive Immunoassay to Detect Tsetse Fly Exposure	PLOS NEGLECTED TROPICAL DISEASES			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; IGG ANTIBODY-RESPONSE; WEST-AFRICA; VISCERAL LEISHMANIASIS; SALIVARY ANTIGENS; IMMUNE-RESPONSE; BITES; IDENTIFICATION; BIOMARKER; VECTOR	Background Tsetse flies are the main vectors of human and animal African trypanosomes. The Tsal proteins in tsetse fly saliva were previously identified as suitable biomarkers of bite exposure. A new competitive assay was conceived based on nanobody (Nb) technology to ameliorate the detection of anti-Tsal antibodies in mammalian hosts. Methodology/Principal Findings A camelid-derived Nb library was generated against the Glossina morsitans morsitans sialome and exploited to select Tsal specific Nbs. One of the three identified Nb families (family III, TsalNb-05 and TsalNb-11) was found suitable for anti-Tsal antibody detection in a competitive ELISA format. The competitive ELISA was able to detect exposure to a broad range of tsetse species (G. morsitans morsitans, G. pallidipes, G. palpalis gambiensis and G. fuscipes) and did not cross-react with the other hematophagous insects (Stomoxys calcitrans and Tabanus yao). Using a collection of plasmas from tsetse-exposed pigs, the new test characteristics were compared with those of the previously described G. m. moristans and rTsal1 indirect ELISAs, revealing equally good specificities (> 95%) and positive predictive values (> 98%) but higher negative predictive values and hence increased sensitivity (> 95%) and accuracy (> 95%). Conclusion/Significance We have developed a highly accurate Nb-based competitive immunoassay to detect specific anti-Tsal antibodies induced by various tsetse fly species in a range of hosts. We propose that this competitive assay provides a simple serological indicator of tsetse fly presence without the requirement of test adaptation to the vertebrate host species. In addition, the use of monoclonal Nbs for antibody detection is innovative and could be applied to other tsetse fly salivary biomarkers in order to achieve a multi-target immunoprofiling of hosts. In addition, this approach could be broadened to other pathogenic organisms for which accurate serological diagnosis remains a bottleneck.	[Caljon, Guy; Vermeiren, Lieve; Van den Abbeele, Jan] Inst Trop Med Antwerp ITM, Dept Biomed Sci, Unit Vet Protozool, Antwerp, Belgium; [Caljon, Guy; Hussain, Shahid] Vrije Univ Brussel, Unit Cellular & Mol Immunol, Brussels, Belgium; [Caljon, Guy; Hussain, Shahid] VIB, Lab Myeloid Cell Immunol, Brussels, Belgium; [Van den Abbeele, Jan] Univ Ghent, Dept Physiol, Lab Zoophysiol, B-9000 Ghent, Belgium	Caljon, G (reprint author), Inst Trop Med Antwerp ITM, Dept Biomed Sci, Unit Vet Protozool, Antwerp, Belgium.	gcaljon@itg.be; jvdabbeele@itg.be	Caljon, Guy/E-1310-2017	Caljon, Guy/0000-0002-4870-3202; Van Den Abbeele, Jan/0000-0002-4533-4480	Research Foundation-Flanders [G031312N]; InterUniversity Attraction Pole program [P7/41]; EU/FP7 ERC starter grant	This work was funded by the Research Foundation-Flanders (G031312N), the InterUniversity Attraction Pole program P7/41 and an EU/FP7 ERC starter grant (Jan Van Den Abbeele). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001008; Alves-Silva J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-213; Caljon G, 2006, INT J PARASITOL, V36, P1025, DOI 10.1016/j.ijpara.2006.05.002; Caljon G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002911; Caljon G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047233; Caljon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009671; Cappello M, 1996, AM J TROP MED HYG, V54, P475; Dama E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002455; Dama E, 2013, MICROBES INFECT, V15, P416, DOI 10.1016/j.micinf.2013.03.001; Deckers N, 2009, INT J PARASITOL, V39, P625, DOI 10.1016/j.ijpara.2008.10.012; Doucoure S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001487; Drame PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015596; ELLIS JA, 1986, VET PATHOL, V23, P661, DOI 10.1177/030098588602300603; Fontaine A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-187; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; Gidwani K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001296; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hassanzadeh-Ghassabeh G, 2013, NANOMEDICINE-UK, V8, P1013, DOI [10.2217/NNM.13.86, 10.2217/nnm.13.86]; Hassanzadeh-Ghassabeh G, 2011, METHODS MOL BIOL, V790, P239, DOI 10.1007/978-1-61779-319-6_19; He T, 2014, ANAL CHEM, V86, P8873, DOI 10.1021/ac502390c; Huang L, 2005, BIOSENS BIOELECTRON, V21, P483, DOI 10.1016/j.bios.2004.11.016; Orlandi-Pradines E, 2007, MICROBES INFECT, V9, P1454, DOI 10.1016/j.micinf.2007.07.012; Poinsignon A, 2008, AM J TROP MED HYG, V78, P750, DOI 10.4269/ajtmh.2008.78.750; Poinsignon A, 2007, AM J TROP MED HYG, V76, P327, DOI 10.4269/ajtmh.2007.76.327; Poinsignon A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-198; Rayaisse JB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001332; Richard G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069495; Rohousova I, 2005, PARASITOLOGY, V130, P493, DOI [10.1017/S003118200400681X, 10.1017/S00311200400681X]; Saerens D, 2008, J IMMUNOL METHODS, V329, P138, DOI 10.1016/j.jim.2007.10.005; Sagna AB, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-68; Schwarz A, 2011, INT J PARASITOL, V41, P591, DOI 10.1016/j.ijpara.2011.02.001; Schwarz A, 2009, INT J PARASITOL, V39, P1021, DOI 10.1016/j.ijpara.2009.01.010; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Somda MB, 2013, VET PARASITOL, V197, P332, DOI 10.1016/j.vetpar.2013.05.018; Sow A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037124; Van Den Abbeele J, 2007, INSECT BIOCHEM MOLEC, V37, P1075, DOI 10.1016/j.ibmb.2007.06.006; Vinhas V, 2007, EUR J IMMUNOL, V37, P3111, DOI 10.1002/eji.200737431; VOLF P, 1993, VET PARASITOL, V47, P327, DOI 10.1016/0304-4017(93)90033-J; Vreysen MJB, 2000, J ECON ENTOMOL, V93, P123, DOI 10.1603/0022-0493-93.1.123; Watanabe J, 2014, SCIENCE, V344, P380, DOI 10.1126/science.1249656; Yardehnavi N, 2014, FASEB J	41	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	FEB	2015	9	2							e0003456	10.1371/journal.pntd.0003456				18	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CD3PW	WOS:000350992500018	25658871	DOAJ Gold, Green Published			2019-04-02	
J	Flueckiger, RM; Nikolay, B; Gelderblom, HC; Smith, JL; Haddad, D; Tack, W; Hendrickx, G; Addiss, D; Cano, J; Hatcher, DR; Hopkins, A; Pullan, RL; Pavluck, A; Ottesen, E; Brooker, SJ				Flueckiger, Rebecca M.; Nikolay, Birgit; Gelderblom, Huub C.; Smith, Jennifer L.; Haddad, Danny; Tack, Wesley; Hendrickx, Guy; Addiss, David; Cano, Jorge; Hatcher, Danny R.; Hopkins, Adrian; Pullan, Rachel L.; Pavluck, Alex; Ottesen, Eric; Brooker, Simon J.			Integrating Data and Resources on Neglected Tropical Diseases for Better Planning: The NTD Mapping Tool (NTDmap.org)	PLOS NEGLECTED TROPICAL DISEASES			English	Editorial Material							GLOBAL DISTRIBUTION; ATLAS; ONCHOCERCIASIS		[Flueckiger, Rebecca M.; Pavluck, Alex; Ottesen, Eric] Emory Univ, Task Force Global Hlth, NTD Support Ctr, Atlanta, GA 30322 USA; [Flueckiger, Rebecca M.; Gelderblom, Huub C.] Emory Univ, Task Force Global Hlth, Int Trachoma Initiat, Atlanta, GA 30322 USA; [Nikolay, Birgit; Smith, Jennifer L.; Cano, Jorge; Pullan, Rachel L.; Brooker, Simon J.] London Sch Hyg & Trop Med, London WC1, England; [Haddad, Danny] Emory Univ, Emory Eye Ctr, Atlanta, GA 30322 USA; [Tack, Wesley; Hendrickx, Guy] Avia GIS, Zoersel, Belgium; [Addiss, David] Emory Univ, Task Force Global Hlth, Children Worms, Atlanta, GA 30322 USA; [Hatcher, Danny R.] Environm Syst Res Inst, Redlands, CA USA; [Hopkins, Adrian] Emory Univ, Task Force Global Hlth, Mectizan Donat Program, Atlanta, GA 30322 USA; [Ottesen, Eric] RTI Int, Washington, DC USA	Flueckiger, RM (reprint author), Emory Univ, Task Force Global Hlth, NTD Support Ctr, Atlanta, GA 30322 USA.	r.m.flueckiger@gmail.com	; Cano, Jorge/E-2962-2016	Haddad, Danny/0000-0002-6299-1984; Cano, Jorge/0000-0001-9864-5058	Wellcome Trust [098045]		[Anonymous], 2006, PREV CHEM HUM HELM C; Brooker S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000779; Cano J, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0466-x; CWW, 2011, COMPR STRAT STH CONT; Hay SI, 2006, PLOS MED, V3, P2204, DOI 10.1371/journal.pmed.0030473; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Hurlimann E, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001404; Nikolay B, 2014, INT J PARASITOL, V44, P765, DOI 10.1016/j.ijpara.2014.05.009; Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.04395, 10.7554/eLife.02851]; Pullan RL FM, 2013, PLOS MED, V11; Simarro PP, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-57; Smith JL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000973; Thylefors B, 2004, TROP MED INT HEALTH, V9, pA1, DOI 10.1111/j.1365-3156.2004.01226.x; WHO, 2012, LYMPH FIL PROGR REP; WHO, 2013, WEEKLY EPIDEMIOLOGIC, P242; World Health Organization, 2012, ACC WORK OV GLOB IMP; World Health Organization, 2013, SCHIST PROGR REP 200; World Health Organization (WHO), 2013, PROGR EL NEGL DIS AF; World Health Organization (WHO), 2012, EL SOIL TRANSM HELM; Zoure HGM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-326	20	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	FEB	2015	9	2							e0003400	10.1371/journal.pntd.0003400				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CD3PW	WOS:000350992500007	25654670	DOAJ Gold, Green Published			2019-04-02	
J	Sumaye, RD; Abatih, EN; Thiry, E; Amuri, M; Berkvens, D; Geubbels, E				Sumaye, Robert David; Abatih, Emmanuel Nji; Thiry, Etienne; Amuri, Mbaraka; Berkvens, Dirk; Geubbels, Eveline			Inter-epidemic Acquisition of Rift Valley Fever Virus in Humans in Tanzania	PLOS NEGLECTED TROPICAL DISEASES			English	Article							LINKED-IMMUNOSORBENT-ASSAY; NORTHEASTERN KENYA; SOUTH-AFRICA; IGG-SANDWICH; RISK-FACTORS; OUTBREAK; TRANSMISSION; INFECTION; ANTIBODY; SEROPREVALENCE	Background In East Africa, epidemics of Rift Valley fever (RVF) occur in cycles of 5-15 years following unusually high rainfall. RVF transmission during inter-epidemic periods (IEP) generally passes undetected in absence of surveillance in mammalian hosts and vectors. We studied IEP transmission of RVF and evaluated the demographic, behavioural, occupational and spatial determinants of past RVF infection. Methodology Between March and August 2012 we collected blood samples, and administered a risk factor questionnaire among 606 inhabitants of 6 villages in the seasonally inundated Kilombero Valley, Tanzania. ELISA tests were used to detect RVFV IgM and IgG antibodies in serum samples. Risk factors were examined by mixed effects logistic regression. Findings RVF virus IgM antibodies, indicating recent RVFV acquisition, were detected in 16 participants, representing 2.6% overall and in 22.5% of inhibition ELISA positives (n = 71). Four of 16 (25.0%) IgM positives and 11/71 (15.5%) of individuals with inhibition ELISA sero-positivity reported they had had no previous contact with host animals. Sero-positivity on inhibition ELISA was 11.7%(95% CI 9.2-14.5) and risk was elevated with age (odds ratio (OR) 1.03 per year; 95% CI 1.01-1.04), among milkers (OR 2.19; 95% CI 1.23-3.91), and individuals eating raw meat (OR 4.17; 95% CI 1.18-14.66). Households keeping livestock had a higher probability of having members with evidence of past infection (OR = 3.04, 95% CI = 1.42-6.48) than those that do not keep livestock. Conclusion There is inter-epidemic acquisition of RVFV in Kilombero Valley inhabitants. In the wake of declining malaria incidence, these findings underscore the need for clinicians to consider RVF in the differential diagnosis for febrile illnesses. Several types of direct contact with livestock are important risk factors for past infection with RVFV in this study's population. However, at least part of RVFV transmission appears to have occurred through bites of infected mosquitoes.	[Sumaye, Robert David; Amuri, Mbaraka; Geubbels, Eveline] Ifakara Hlth Inst, Ifakara, Tanzania; [Sumaye, Robert David; Abatih, Emmanuel Nji; Berkvens, Dirk] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Sumaye, Robert David; Thiry, Etienne] Univ Liege, Fac Vet Med, Dept Infect & Parasit Dis, Liege, Belgium	Sumaye, RD (reprint author), Ifakara Hlth Inst, Ifakara, Tanzania.	rsumaye@ihi.or.tz		Geubbels, Eveline/0000-0002-9702-5460; AMURI, Mbaraka/0000-0002-8583-9555	Belgian Directorate General for Development Cooperation (DGDC), through Institute of Tropical Medicine, Antwerp	This work was funded through a scholarship awarded to RDS by Belgian Directorate General for Development Cooperation (DGDC), through Institute of Tropical Medicine, Antwerp. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuElyazeed R, 1996, B WORLD HEALTH ORGAN, V74, P155; [Anonymous], 2013, POP HOUS CENS GEN RE, P264; Anyamba A, 2009, P NATL ACAD SCI USA, V106, P955, DOI 10.1073/pnas.0806490106; Anyangu AS, 2010, AM J TROP MED HYG, V83, P14, DOI 10.4269/ajtmh.2010.09-0293; Archer BN, 2011, SAMJ S AFR MED J, V101, P263, DOI 10.7196/SAMJ.4544; Bird BH, 2009, JAVMA-J AM VET MED A, V234, P883, DOI 10.2460/javma.234.7.883; Chevalier V, 2009, TRANSBOUND EMERG DIS, V56, P372, DOI 10.1111/j.1865-1682.2009.01083.x; Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418; Durand JP, 2003, EMERG INFECT DIS, V9, P751; Easterday B C, 1965, Adv Vet Sci, V10, P65; Heinrich N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001557; LaBeaud AD, 2008, EMERG INFECT DIS, V14, P1240, DOI 10.3201/eid1408.080082; LaBeaud AD, 2007, AM J TROP MED HYG, V76, P795, DOI 10.4269/ajtmh.2007.76.795; LaBeaud AD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001265; LaBeaud AD, 2011, AM J TROP MED HYG, V84, P641, DOI 10.4269/ajtmh.2011.10-0187; Madani TA, 2003, CLIN INFECT DIS, V37, P1084, DOI 10.1086/378747; MCINTOSH BM, 1980, S AFR MED J, V58, P803; Mohamed M, 2010, AM J TROP MED HYG, V83, P22, DOI 10.4269/ajtmh.2010.09-0318; Morrill JC, 2011, J INFECT DIS, V204, P617, DOI 10.1093/infdis/jir354; MORVAN J, 1992, T ROY SOC TROP MED H, V86, P675, DOI 10.1016/0035-9203(92)90187-H; Mukasa O, 2002, POPULATION HLTH DEV, V1, P159; Ogoma SB, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000773; Olaleye OD, 1996, REV SCI TECH OIE, V15, P923, DOI 10.20506/rst.15.3.967; Paweska JT, 2005, J VIROL METHODS, V127, P10, DOI 10.1016/j.jviromet.2005.02.008; Paweska JT, 2005, J VIROL METHODS, V124, P173, DOI 10.1016/j.jviromet.2004.11.020; Paweska JT, 2003, J VIROL METHODS, V113, P103, DOI 10.1016/S0166-0934(03)00228-3; Pourrut X, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000763; Rich KM, 2010, AM J TROP MED HYG, V83, P52, DOI 10.4269/ajtmh.2010.09-0291; Russell TL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-187; Sumaye RD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002356; Swai ES, 2008, VECTOR-BORNE ZOONOT, V0, P1; Swanepoel R., 2004, INFECT DIS LIVESTOCK, P1037; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2006, WKLY EPIDEMIOL REC, V82, P169; WHO, 2008, WKLY EPIDEMIOL REC, V83, P17; WILSON ML, 1994, AM J TROP MED HYG, V50, P663, DOI 10.4269/ajtmh.1994.50.663; Woods CW, 2002, EMERG INFECT DIS, V8, P138, DOI 10.3201/eid0802.010023	37	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	FEB	2015	9	2							e0003536	10.1371/journal.pntd.0003536				11	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CD3PW	WOS:000350992500057	25723502	DOAJ Gold, Green Published			2019-04-02	
J	Colebunders, R; Post, R; O'Neill, S; Haesaert, G; Opar, B; Lakwo, T; Laudisoit, A; Hendy, A				Colebunders, R.; Post, R.; O'Neill, S.; Haesaert, G.; Opar, B.; Lakwo, T.; Laudisoit, A.; Hendy, A.			Nodding syndrome since 2012: recent progress, challenges and recommendations for future research	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Review						nodding syndrome; epilepsy; onchocerciasis; vector control; metagenomics; transsphenoidal brain biopsies	ONCHOCERCIASIS-CONTROL-PROGRAM; WEST-AFRICA; RIVER-BLINDNESS; MUNDRI COUNTY; CONTROL APOC; CASE SERIES; MANAGEMENT; UGANDA; MICROFILARIAE; LARVICIDES	We aim to review the current epidemiology of nodding syndrome (NS) and discuss relevant gaps in research. NS and convulsive epilepsy of unknown aetiology are clustered within the same villages and families in onchocerciasis-endemic areas. They are therefore potentially different clinical expressions of the same disease. It has been difficult to perform full autopsies on NS patients who die in remote villages. Adequate fixation of tissue immediately after death is critical for the examination of brain tissue. Therefore, post-mortem transsphenoidal brain biopsies, performed immediately after death by trained nurses, will provide the best option for obtaining tissue for analysis. We suspect that certain blackflies in onchocerciasis-endemic areas may transmit a novel pathogen that could cause NS and epilepsy. This is supported by a recent drop in the number of new NS cases coinciding with vector control activities aimed at reducing blackfly populations in northern Uganda. We propose that metagenomic studies of human samples, blackflies and microfilariae are conducted to screen for pathogens, and that a clinical trial is planned to evaluate the impact of larviciding against NS and epilepsy epidemics.	[Colebunders, R.] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Colebunders, R.; Laudisoit, A.] Univ Antwerp, Dept Epidemiol & Social Med, B-2020 Antwerp, Belgium; [Post, R.] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 5UX, Merseyside, England; [O'Neill, S.] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Haesaert, G.] Univ Ghent, Fac Appl Biosci Engn, B-9000 Ghent, Belgium; [Opar, B.; Lakwo, T.] Minist Hlth, Kampala, Uganda; [Laudisoit, A.] Univ Liverpool, Sch Biol Sci, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Hendy, A.] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium	Hendy, A (reprint author), Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium.	ahendy@itg.be	Laudisoit, Anne/F-2646-2017	Laudisoit, Anne/0000-0001-7626-9426	Uganda Ministry of Health; Carter Center	We thank the Uganda Ministry of Health and the Carter Center for their support for the entomological studies.	Amazigo U, 2008, ANN TROP MED PARASIT, V102, P19, DOI 10.1179/136485908X337436; Amazigo UV, 2002, ANN TROP MED PARASIT, V96, P41, DOI 10.1179/000349802125000646; Baker R. H. A., 1985, Sudan Medical Journal, V21, P19; BAKER RHA, 1990, PHILOS T ROY SOC B, V328, P731, DOI 10.1098/rstb.1990.0141; Boatin B, 2008, ANN TROP MED PARASIT, V102, P13, DOI 10.1179/136485908X337427; Colebunders R, 2014, INT J INFECT DIS, V27, P74, DOI 10.1016/j.ijid.2014.08.001; Collins F, 2014, UGANDA NIH SOLVE SEI; Cox JA, 2014, JAIDS-J ACQ IMM DEF, V67, P169, DOI 10.1097/QAI.0000000000000290; Dowell SF, 2013, EMERG INFECT DIS, V19, P1374, DOI 10.3201/eid1909.130401; Foltz JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066419; Food and Agriculture Organization of the United Nations (FAO), 2004, WORLDW REG MYC FOOD; Hausermann W, 1966, Acta Trop, V23, P365; HOUGARD JM, 1993, ANN TROP MED PARASIT, V87, P435, DOI 10.1080/00034983.1993.11812793; Idro R, 2013, AFR HEALTH SCI, V13, P219, DOI 10.4314/ahs.v13i2.4; Kaiser C, 2009, EPILEPSIA, V50, P2325, DOI 10.1111/j.1528-1167.2009.02280.x; KURTAK D, 1987, MED VET ENTOMOL, V1, P137, DOI 10.1111/j.1365-2915.1987.tb00334.x; Ministry of Health Uganda, 2014, WEEKL EP B; Musisi S, 2013, AFR HEALTH SCI, V13, P205, DOI 10.4314/ahs.v13i2.3; Mutamba B, 2013, AFR HEALTH SCI, V13, P986, DOI 10.4314/ahs.v13i4.18; Palmer RW, 2008, ONDERSTEPOORT J VET, V75, P299; Sejvar JJ, 2013, LANCET NEUROL, V12, P166, DOI 10.1016/S1474-4422(12)70321-6; Spencer PS, 2013, AFR HEALTH SCI, V13, P183, DOI 10.4314/ahs.v13i2.2; Spencer PS, 2013, AFR HEALTH SCI, V13, P176, DOI 10.4314/ahs.v13i2.1; Taylor MJ, 2005, ADV PARASIT, V60, P245, DOI 10.1016/S0065-308X(05)60004-8; The Carter Center, 2013, EYE EAGLE, V14, P5; Traore S, 2009, ACTA TROP, V111, P211, DOI 10.1016/j.actatropica.2009.03.007; Tumwine JK, 2012, AFR HEALTH SCI, V12, P242, DOI 10.4314/ahs.v12i3.1; TURELL MJ, 1987, AM J TROP MED HYG, V37, P197, DOI 10.4269/ajtmh.1987.37.197; TURELL MJ, 1984, SCIENCE, V225, P1039, DOI 10.1126/science.6474165; vansBemmel K, 2014, ETHNICITY HLTH, V19, P100; Vogel G, 2012, SCIENCE, V336, P144, DOI 10.1126/science.336.6078.144; WHO, 2014, LIST NEGL DIS; Winkler AS, 2013, AFR HEALTH SCI, V13, P529, DOI 10.4314/ahs.v13i2.51; Winkler AS, 2014, EPILEPSIA, V55, P86, DOI 10.1111/epi.12483; World Food Programme, 2014, FAO WFP CROP FOOD SE; World Health Organization, 2012, INT SCI M NODD SYNDR	36	12	12	0	13	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	FEB	2015	20	2					194	200		10.1111/tmi.12421				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	AY9UK	WOS:000347895700009	25348848	Bronze			2019-04-02	
J	Koleala, T; Karl, S; Laman, M; Moore, BR; Benjamin, J; Barnadas, C; Robinson, LJ; Kattenberg, JH; Javati, S; Wong, RPM; Rosanas-Urgell, A; Betuela, I; Siba, PM; Mueller, I; Davis, TME				Koleala, Tamarah; Karl, Stephan; Laman, Moses; Moore, Brioni R.; Benjamin, John; Barnadas, Celine; Robinson, Leanne J.; Kattenberg, Johanna H.; Javati, Sarah; Wong, Rina P. M.; Rosanas-Urgell, Anna; Betuela, Inoni; Siba, Peter M.; Mueller, Ivo; Davis, Timothy M. E.			Temporal changes in Plasmodium falciparum anti-malarial drug sensitivity in vitro and resistance-associated genetic mutations in isolates from Papua New Guinea	MALARIA JOURNAL			English	Article						Malaria; Plasmodium falciparum; in vitro drug susceptibility; Resistance mutations	DEHYDROGENASE IMMUNODETECTION ASSAY; SOUTHERN VIET-NAM; LACTATE-DEHYDROGENASE; CHLOROQUINE RESISTANCE; SUSCEPTIBILITY; PYRONARIDINE; ARTEMISININ; MALARIA; POLYMORPHISMS; EFFICACY	Background: In northern Papua New Guinea (PNG), most Plasmodium falciparum isolates proved resistant to chloroquine (CQ) in vitro between 2005 and 2007, and there was near-fixation of pfcrt K76T, pfdhfr C59R/S108N and pfmdr1 N86Y. To determine whether the subsequent introduction of artemisinin combination therapy (ACT) and reduced CQ-sulphadoxine-pyrimethamine pressure had attenuated parasite drug susceptibility and resistance-associated mutations, these parameters were re-assessed between 2011 and 2013. Methods: A validated fluorescence-based assay was used to assess growth inhibition of 52 P. falciparum isolates from children in a clinical trial in Madang Province. Responses to CQ, lumefantrine, piperaquine, naphthoquine, pyronaridine, artesunate, dihydroartemisinin, artemether were assessed. Molecular resistance markers were detected using a multiplex PCR ligase detection reaction fluorescent microsphere assay. Results: CQ resistance (in vitro concentration required for 50% parasite growth inhibition (IC50) > 100 nM) was present in 19% of isolates. All piperaquine and naphthoquine IC(50)s were < 100 nM and those for lumefantrine, pyronaridine and the artemisinin derivatives were in low nM ranges. Factor analysis of IC(50)s showed three groupings (lumefantrine; CQ, piperaquine, naphthoquine; pyronaridine, dihydroartemisinin, artemether, artesunate). Most isolates (96%) were monoclonal pfcrt K76T (SVMNT) mutants and most (86%) contained pfmdr1 N86Y (YYSND). No wild-type pfdhfr was found but most isolates contained wild-type (SAKAA) pfdhps. Compared with 2005-2007, the geometric mean (95% CI) CQ IC50 was lower (87 (71-107) vs 167 (141-197) nM) and there had been no change in the prevalence of pfcrt K76T or pfmdr1 mutations. There were fewer isolates of the pfdhps (SAKAA) wild-type (60 vs 100%) and pfdhfr mutations persisted. Conclusions: Reflecting less drug pressure, in vitro CQ sensitivity appears to be improving in Madang Province despite continued near-fixation of pfcrt K76T and pfmdr1 mutations. Temporal changes in IC(50)s for other anti-malarial drugs were inconsistent but susceptibility was preserved. Retention or increases in pfdhfr and pfdhps mutations reflect continued use of sulphadoxine-pyrimethamine in the study area including through paediatric intermittent preventive treatment. The susceptibility of local isolates to lumefantrine may be unrelated to those of other ACT partner drugs.	[Koleala, Tamarah; Laman, Moses; Moore, Brioni R.; Benjamin, John; Barnadas, Celine; Robinson, Leanne J.; Kattenberg, Johanna H.; Javati, Sarah; Rosanas-Urgell, Anna; Betuela, Inoni; Siba, Peter M.] Papua New Guinea Inst Med Res, Madang, Papua N Guinea; [Karl, Stephan; Laman, Moses; Moore, Brioni R.; Wong, Rina P. M.; Davis, Timothy M. E.] Univ Western Australia, Fremantle Hosp, Sch Med & Pharmacol, Fremantle, WA 6959, Australia; [Karl, Stephan; Barnadas, Celine; Robinson, Leanne J.; Kattenberg, Johanna H.; Mueller, Ivo] Walter & Eliza Hall Inst Med Res, Infect & Immun Div, Parkville, Vic, Australia; [Karl, Stephan; Barnadas, Celine; Robinson, Leanne J.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Rosanas-Urgell, Anna] Inst Trop Med, B-2000 Antwerp, Belgium; [Mueller, Ivo] Ctr Recerca Salut Int Barcelona CRESIB, Barcelona, Spain	Davis, TME (reprint author), Univ Western Australia, Fremantle Hosp, Sch Med & Pharmacol, POB 480, Fremantle, WA 6959, Australia.	tim.davis@uwa.edu.au	Moore, Brioni/H-5477-2014	Moore, Brioni/0000-0001-9792-7838; Davis, Timothy/0000-0003-0749-7411; Laman, Moses/0000-0003-0964-805X; Kattenberg, Eline/0000-0002-2971-5136	National Health and Medical Research Council (NHMRC) of Australia [634343]; Esso-Highlands PNG Institute of Medical Research scholarship; NHMRC Early Career Fellowship [1052760, 1036951]; Australian Award PhD Scholarship; NHMRC Senior Research Fellowship [1043345]; NHMRC [572561]	We acknowledge staff of the PNG Institute of Medical Research for assistance in conducting the field and laboratory studies, and Mangalam Pty Ltd, Bangalore, India for provision of anti-malarial drug samples. We would also like to thank Dr James Balmer from BMG Labtec for helpful discussion. This study was funded by a National Health and Medical Research Council (NHMRC) of Australia grant (#634343). TK was supported by an Esso-Highlands PNG Institute of Medical Research scholarship, SK by a NHMRC Early Career Fellowship (#1052760), ML by an Australian Award PhD Scholarship, BRM by a NHMRC Early Career Fellowship (#1036951), IM by a NHMRC Senior Research Fellowship (#1043345) and TMED by an NHMRC Practitioner Fellowship (#572561).	Al-Yaman Fadwa, 1996, Papua New Guinea Medical Journal, V39, P16; Alifrangis M, 2003, AM J TROP MED HYG, V69, P238, DOI 10.4269/ajtmh.2003.69.238; [Anonymous], EMEAHW002319; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Bacon DJ, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-120; Barnadas C, 2014, ANTIMICROB AGENTS CH, V58, P6958, DOI 10.1128/AAC.03323-14; Barnadas C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-282; Basco L, 2000, Sante, V10, P47; Basco LK, 2003, ANTIMICROB AGENTS CH, V47, P1391, DOI 10.1128/AAC.47.4.1391-1394.2003; Benjamin J, 2012, ANTIMICROB AGENTS CH, V56, P2465, DOI 10.1128/AAC.06248-11; Brockman A, 2004, ANTIMICROB AGENTS CH, V48, P1426, DOI 10.1128/AAC.48.4.1426-1429.2004; Casey GJ, 2004, AM J TROP MED HYG, V70, P251, DOI 10.4269/ajtmh.2004.70.251; Chen N, 2001, J INFECT DIS, V183, P1543, DOI 10.1086/320206; Dare JT, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-57; Elueze EI, 1996, J ANTIMICROB CHEMOTH, V37, P511, DOI 10.1093/jac/37.3.511; Frosch AEP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-116; Hetzel MW, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-192; Huong NM, 2001, T ROY SOC TROP MED H, V95, P325, DOI 10.1016/S0035-9203(01)90254-8; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; Kaddouri H, 2006, ANTIMICROB AGENTS CH, V50, P3343, DOI 10.1128/AAC.00367-06; Karl S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-116; Karl S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-294; Karunajeewa HA, 2008, NEW ENGL J MED, V359, P2545, DOI 10.1056/NEJMoa0804915; Kurth F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-79; Laman M, 2014, PLOS MED, V11; Laufer MK, 2006, NEW ENGL J MED, V355, P1959, DOI 10.1056/NEJMoa062032; MAKLER MT, 1993, AM J TROP MED HYG, V48, P739, DOI 10.4269/ajtmh.1993.48.739; Mbaisi A, 2004, ANTIMICROB AGENTS CH, V48, P3598, DOI 10.1128/AAC.48.9.3598-3601.2004; Muangnoicharoen S, 2009, ANTIMICROB AGENTS CH, V53, P1362, DOI 10.1128/AAC.01656-08; Mwai L, 2009, ANTIMICROB AGENTS CH, V53, P5069, DOI 10.1128/AAC.00638-09; Mwai L, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-106; Noedl H, 2003, TRENDS PARASITOL, V19, P175, DOI 10.1016/S1471-4922(03)00028-X; Papua New Guinea Department of Health, 2009, NAT MAL TREATM PROT; Petersen I, 2011, FEBS LETT, V585, P1551, DOI 10.1016/j.febslet.2011.04.042; Pradines B, 1998, J ANTIMICROB CHEMOTH, V42, P333, DOI 10.1093/jac/42.3.333; Pradines B, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-268; Pradines B, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-339; Quashie NB, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-95; Ringwald P, 1996, AM J TROP MED HYG, V55, P254, DOI 10.4269/ajtmh.1996.55.254; SAINT-YVES I F M, 1971, Papua New Guinea Medical Journal, V14, P77; Senn N, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001195; Shah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026746; Skinner TS, 1996, INT J PARASITOL, V26, P519, DOI 10.1016/0020-7519(96)89380-5; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Thanh NV, 2001, T ROY SOC TROP MED H, V95, P513, DOI 10.1016/S0035-9203(01)90023-9; Thomas SM, 2002, AM J TROP MED HYG, V66, P474, DOI 10.4269/ajtmh.2002.66.474; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; WHO, 2006, GUID TREATM MAL; Wong RPM, 2011, ANTIMICROB AGENTS CH, V55, P798, DOI 10.1128/AAC.00939-10; Wong RPM, 2010, TROP MED INT HEALTH, V15, P342, DOI 10.1111/j.1365-3156.2009.02463.x; Wongsrichanalai C, 2013, CLIN MICROBIOL INFEC, V19, P908, DOI 10.1111/1469-0691.12316; Yang HL, 2003, T ROY SOC TROP MED H, V97, P226	52	12	12	1	7	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	JAN 28	2015	14								37	10.1186/s12936-015-0560-3				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CB7GQ	WOS:000349795300001	25626445	DOAJ Gold, Green Published			2019-04-02	
J	Mukadi, P; Gillet, P; Barbe, B; Luamba, J; Lukuka, A; Likwela, J; Mumba, D; Muyembe, JJ; Lutumba, P; Jacobs, J				Mukadi, Pierre; Gillet, Philippe; Barbe, Barbara; Luamba, Jean; Lukuka, Albert; Likwela, Joris; Mumba, Dieudonne; Muyembe, Jean-Jacques; Lutumba, Pascal; Jacobs, Jan			SMS photograph-based external quality assessment of reading and interpretation of malaria rapid diagnostic tests in the Democratic Republic of the Congo	MALARIA JOURNAL			English	Article						Malaria RDT; External quality assessment; Short message service; DRC	MICROSCOPY; INSTRUCTIONS; PERFORMANCE; ZAMBIA	Background: The present External Quality Assessment (EQA) assessed reading and interpretation of malaria rapid diagnostic tests (RDTs) in the Democratic Republic of the Congo (DRC). Methods: The EQA consisted of (i) 10 high-resolution printed photographs displaying cassettes with real-life results and multiple choice questions (MCQ) addressing individual health workers (HW), and (ii) a questionnaire on RDT use addressing the laboratory of health facilities (HF). Answers were transmitted through short message services (SMS). Results: The EQA comprised 2344 HW and 1028 HF covering 10/11 provinces in DRC. Overall, median HW score (sum of correct answers on 10 MCQ photographs for each HW) was 9.0 (interquartile range 7.5 - 10); MCQ scores (the % of correct answers for a particular photograph) ranged from 54.8% to 91.6%. Most common errors were (i) reading or interpreting faint or weak line intensities as negative (3.3%, 7.2%, 24.3% and 29.1% for 4 MCQ photographs), (ii) failure to distinguish the correct Plasmodium species (3.4% to 7.0%), (iii) missing invalid test results (8.4% and 23.6%) and (iv) missing negative test results (10.0% and 12.4%). HW who were trained less than 12 months ago had best MCQ scores for 7/10 photographs as well as a significantly higher proportion of 10/10 scores, but absolute differences in MCQ scores were small. HW who had participated in a previous EQA performed significantly better for 4/10 photographs compared to those who had not. Except for two photographs, MCQ scores were comparable for all levels of the HF hierarchy and non-laboratory staff (HW from health posts) had similar performance as to laboratory staff. Main findings of the questionnaire were (i) use of other RDT products than recommended by the national malaria control programme (nearly 20% of participating HF), (ii) lack of training for a third (33.6%) of HF, (iii) high proportions (two-thirds, 66.5%) of HF reporting stock-outs. Conclusions: The present EQA revealed common errors in RDT reading and interpretation by HW in DRC. Performances of non-laboratory and laboratory staff were similar and dedicated training was shown to improve HW competence although to a moderate extent. Problems in supply, distribution and training of RDTs were detected.	[Mukadi, Pierre; Mumba, Dieudonne; Muyembe, Jean-Jacques; Lutumba, Pascal] Natl Inst Biomed Res, Kinshasa, Zaire; [Mukadi, Pierre; Luamba, Jean] Natl Pedag Univ, Kinshasa, Zaire; [Gillet, Philippe; Barbe, Barbara; Jacobs, Jan] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Lukuka, Albert; Likwela, Joris] Natl Malaria Control Programme, Kinshasa, Zaire; [Mumba, Dieudonne; Muyembe, Jean-Jacques; Lutumba, Pascal] Univ Kinshasa, Kinshasa, Zaire; [Lutumba, Pascal] Univ Lubumbashi, Lubumbashi, Zaire; [Jacobs, Jan] Katholieke Univ Leuven, Fac Med, Dept Microbiol & Immunol, Leuven, Belgium	Jacobs, J (reprint author), Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.	jjacobs@itg.be		gillet, philippe/0000-0001-5878-6446			Counihan H, 2012, AM J TROP MED HYG, V87, P57, DOI 10.4269/ajtmh.2012.11-0800; de la Sante M, 2013, PLAN STRATEGIQUE NAT; Gillet P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-359; Harvey SA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-160; Kettelhut MM, 2003, J CLIN PATHOL, V56, P927, DOI 10.1136/jcp.56.12.927; Likwela JL, 2012, SANTE PUBLIQUE, V24, P33; Maltha J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053102; Moonasar D, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-74; Mudanyali O, 2012, LAB CHIP, V12, P2678, DOI [10.1039/c2lc40235a, 10.1039/c21c40235a]; Mukadi P, 2011, MALARIA J, V10, P308; Mukadi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071442; Mukadi P, 2013, B WORLD HEALTH ORGAN, V91, P441, DOI 10.2471/BLT.12.112706; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Programme National de Lutte contre le Paludisme, 2014, RAPP ANN ACT LUTT PA; Rennie W, 2007, T ROY SOC TROP MED H, V101, P9, DOI 10.1016/j.trstmh.2006.03.011; Sarkinfada F, 2009, J INFECT DEV COUNTR, V3, P20; Seidahmed OME, 2008, TROP MED INT HEALTH, V13, P406, DOI 10.1111/j.1365-3156.2008.02015.x; Tuijn CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028348; UNITAID, 2013, ANN REP 2013 TRANSF; WHO, 2013, WORLD MALARIA REPORT 2013, P1; World Health Organization, 2009, MAL MICR QUAL ASS MA	21	4	4	0	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	JAN 28	2015	14								26	10.1186/s12936-014-0535-9				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CA4LT	WOS:000348876300001	25626915	DOAJ Gold, Green Published			2019-04-02	
S	Levecke, B; Anderson, RM; Berkvens, D; Charlier, J; Devleesschauwer, B; Speybroeck, N; Vercruysse, J; Van Aelst, S		Anderson, RM; Basabez, MG		Levecke, Bruno; Anderson, Roy M.; Berkvens, Dirk; Charlier, Johannes; Devleesschauwer, Brecht; Speybroeck, Niko; Vercruysse, Jozef; Van Aelst, Stefan			Mathematical Inference on Helminth Egg Counts in Stool and Its Applications in Mass Drug Administration Programmes to Control Soil-Transmitted Helminthiasis in Public Health	MATHEMATICAL MODELS FOR NEGLECTED TROPICAL DISEASES: ESSENTIAL TOOLS FOR CONTROL AND ELIMINATION, PT A	Advances in Parasitology		English	Review; Book Chapter							SCHISTOSOMA-MANSONI; ASCARIS-LUMBRICOIDES; REDUCTION TEST; EFFICACY; INFECTIONS; CHEMOTHERAPY; DIAGNOSIS; FLOTAC; AGGREGATION; COINFECTION	In the present study, we present a hierarchical model based on faecal egg counts (FECs; expressed in eggs per 1 g of stool) in which we first describe the variation in FECs between individuals in a particular population, followed by describing the variance due to counting eggs under a microscope separately for each stool sample. From this general framework, we discuss how to calculate a sample size for assessing a population mean FEC and the impact of an intervention, measured as reduction in FECs, for any scenario of soil-transmitted helminth (STH) epidemiology (the intensity and aggregation of FECs within a population) and diagnostic strategy (amount of stool examined (wsensitivity of the diagnostic technique) and examination of individual/pooled stool samples) and on how to estimate prevalence of STH in the absence of a gold standard. To give these applications the most wide relevance as possible, we illustrate each of them with hypothetical examples.	[Levecke, Bruno; Charlier, Johannes; Devleesschauwer, Brecht; Vercruysse, Jozef] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Anderson, Roy M.] Imperial Coll London, Dept Infect Dis Epidemiol, Fac Med, Sch Publ Hlth, London, England; [Berkvens, Dirk] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Devleesschauwer, Brecht; Speybroeck, Niko] Catholic Univ Louvain, Inst Hlth & Soc IRSS, Brussels, Belgium; [Van Aelst, Stefan] Univ Ghent, Fac Sci, Dept Appl Math Comp Sci & Stat, Ghent, Belgium; [Van Aelst, Stefan] KU Leuven Univ, Dept Math, Fac Sci, Leuven, Belgium	Levecke, B (reprint author), Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium.	bruno.levecke@ugent.be	Devleesschauwer, Brecht/G-9895-2018; Van Aelst, Stefan/B-5201-2012	Devleesschauwer, Brecht/0000-0002-2867-6892; Van Aelst, Stefan/0000-0002-9931-5330; Levecke, Bruno/0000-0001-8912-5595; Anderson, Roy/0000-0002-9528-3175; Charlier, Johannes/0000-0002-1332-1458			Addiss DG, 2003, FILARIA J S1, V2, pS9; Albonico M, 2013, T ROY SOC TROP MED H, V107, P493, DOI 10.1093/trstmh/trt051; Anderson R, 2012, LANCET, V379, P289, DOI 10.1016/S0140-6736(12)60120-2; Barda B, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-220; Bergquist R, 2009, TRENDS PARASITOL, V25, P151, DOI 10.1016/j.pt.2009.01.004; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Bogoch II, 2006, EUR J CLIN MICROBIOL, V25, P344, DOI 10.1007/s10096-006-0135-x; Booth M, 2003, PARASITOLOGY, V127, P525, DOI 10.1017/S0031182003004128; Brooker S, 2005, TROP MED INT HEALTH, V10, P647, DOI 10.1111/j.1365-3156.2005.01446.x; Brooker S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000779; Brooker SJ, 2012, J INFECT DIS, V205, P841, DOI 10.1093/infdis/jir844; Casella G., 2002, STAT INFERENCE; Charlier J, 2014, TRENDS PARASITOL, V30, P361, DOI 10.1016/j.pt.2014.04.009; Cringoli G, 2013, GEOSPATIAL HEALTH, V7, P399, DOI 10.4081/gh.2013.97; Cringoli G, 2010, NAT PROTOC, V5, P503, DOI 10.1038/nprot.2009.235; de Silva N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000655; Diggle P. J., 2011, EPIDEMIOL RES INT, V608719; Dobson RJ, 2009, VET PARASITOL, V161, P162, DOI 10.1016/j.vetpar.2008.12.007; GREGORY RD, 1993, ACTA TROP, V54, P131, DOI 10.1016/0001-706X(93)90059-K; Hurlimann E, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001404; Hui S L, 1998, Stat Methods Med Res, V7, P354, DOI 10.1191/096228098671192352; Humphries D, 2011, AM J TROP MED HYG, V84, P792, DOI 10.4269/ajtmh.2011.11-0003; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Knopp S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000331; Knopp S, 2009, T ROY SOC TROP MED H, V103, P1190, DOI 10.1016/j.trstmh.2009.05.012; Krauth SJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001969; Levecke B, 2014, PARASITOLOGY, V141, P1826, DOI 10.1017/S0031182013002266; Levecke B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003204; Levecke B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001427; Levecke B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001201; Ministry of Agriculture Fisheries and Food, 1986, MAN VET PAR LAB TECH, V418; Montresor A, 2011, AM J TROP MED HYG, V85, P579, DOI 10.4269/ajtmh.2011.11-0317a; Montresor A, 2011, T ROY SOC TROP MED H, V105, P361, DOI 10.1016/j.trstmh.2011.04.003; Morgan ER, 2005, VET PARASITOL, V131, P79, DOI 10.1016/j.vetpar.2005.04.021; Neglected Tropical Disease Partner Website, 2013, UN COMB NEGL TROP DI; Olives C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001806; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Pullan RL, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-81; SINNIAH B, 1982, PARASITOLOGY, V84, P167, DOI 10.1017/S0031182000051763; Speybroeck N, 2013, INT J PUBLIC HEALTH, V58, P791, DOI 10.1007/s00038-012-0439-9; Torgerson PR, 2012, VET PARASITOL, V188, P397, DOI 10.1016/j.vetpar.2012.03.043; Torgerson PR, 2005, VET PARASITOL, V128, P291, DOI 10.1016/j.vetpar.2004.12.009; Vercruysse J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000948; WHO, 2011, HELMINTH CONTROL IN SCHOOL-AGE CHILDREN: A GUIDE FOR MANAGERS OF CONTROL PROGRAMMES, SECOND EDITION, P1; World Health Organization, 2012, ACC WORK OV GLOB IMP; World Health Organization, 2012, WEEK EPIDEMIOL REC, V89, P133; World Health Organization, 2012, SOIL TRANSM HELM EL; World Health Organization, 1998, GUID EV SOIL TRANSM; World Health Organization, 2013, ASS EFF ANTH DRUGS S; World Health Organization (WHO), 1991, BAS LAB METH MED PAR; Ye XP, 1997, TROP MED INT HEALTH, V2, P261, DOI 10.1046/j.1365-3156.1997.d01-259.x	51	18	18	1	4	ELSEVIER ACADEMIC PRESS INC	SAN DIEGO	525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA	0065-308X		978-0-12-803257-2; 978-0-12-803256-5	ADV PARASIT	Adv.Parasitol.		2015	87						193	247		10.1016/bs.apar.2015.01.001				55	Public, Environmental & Occupational Health; Mathematics, Applied; Tropical Medicine	Public, Environmental & Occupational Health; Mathematics; Tropical Medicine	BF8TM	WOS:000385231200006	25765196				2019-04-02	
J	Freyne, B; Marchant, A; Curtis, N				Freyne, Bridget; Marchant, Arnaud; Curtis, Nigel			BCG-associated heterologous immunity, a historical perspective: experimental models and immunological mechanisms	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Review						BCG; Heterologous; History; Immunology; Non-specific	BACILLE CALMETTE-GUERIN; MIGRATION-INHIBITORY FACTOR; MYCOBACTERIUM-BOVIS; RANDOMIZED-TRIAL; INFECTION; MICE; HYPERSENSITIVITY; MACROPHAGES; VACCINATION; INTERFERON	Randomized controlled trials indicate that bacille Calmette-Guerin (BCG) has beneficial heterologous ('non-specific') effects on mortality in high mortality settings. These findings have stimulated interest in understanding the immunological mechanisms underlying these effects in the hope of harnessing them to reduce all-cause mortality. This line of investigation is especially important in light of BCG being discontinued in some countries as the prevalence of TB falls. Stopping routine BCG in this situation may have the unintended consequence of depriving children of the beneficial immune modulating effects of this vaccine. BCG has been recognized as a potent immunomodulator for decades. This review details experimental studies involving BCG and any heterologous antigen that aimed to interrogate potential immunological mechanisms. To provide a historical perspective, the evidence is presented chronologically. The lines of immunological enquiry can be seen to mirror the evolution of our understanding of cell-mediated immunity and its components. As new clinical trials to investigate the heterologous effects of BCG are undertaken, an understanding of the history of BCG-induced immunity against heterologous antigens may provide information on immunological pathways worthy of further interrogation using modern immunological methods.	[Freyne, Bridget; Curtis, Nigel] Univ Melbourne, Royal Childrens Hosp Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Freyne, Bridget; Curtis, Nigel] Royal Childrens Hosp Melbourne, Infect Dis Unit, Parkville, Vic 3052, Australia; [Freyne, Bridget; Curtis, Nigel] Murdoch Childrens Res Inst, Infect Dis & Microbiol Res Grp, Parkville, Vic 3052, Australia; [Marchant, Arnaud] Univ Libre Bruxelles, Inst Med Immunol, B-6041 Charleroi, Belgium	Freyne, B (reprint author), Univ Melbourne, Royal Childrens Hosp Melbourne, Dept Paediat, Flemington Rd, Parkville, Vic 3052, Australia.	bridget.freyne@rch.org.au	Curtis, Nigel/B-3491-2012	Curtis, Nigel/0000-0003-3446-4594	University of Melbourne; Nossal Institute of Global Health; European Society for Paediatric Infectious Diseases	BF is a PhD candidate at The University of Melbourne and funded by scholarships from The University of Melbourne, the Nossal Institute of Global Health and the European Society for Paediatric Infectious Diseases. AM is a senior research associate of the Fonds de la Recherche Scientifique (F.R.S.-FNRS), Belgium.	Aaby P, 2011, J INFECT DIS, V204, P245, DOI 10.1093/infdis/jir240; Arnoldussen DL, 2011, J ALLERGY CLIN IMMUN, V127, P246, DOI 10.1016/j.jaci.2010.07.039; B.C.G, 1956, BMJ-BRIT MED J, V1, P413; Biering-Sorensen S, 2012, PEDIATR INFECT DIS J, V31, P306, DOI 10.1097/INF.0b013e3182458289; BLANDEN RV, 1969, J EXP MED, V129, P1079, DOI 10.1084/jem.129.5.1079; BLOOM BR, 1968, FED PROC, V27, P13; CAMPBELL PA, 1984, J LEUKOCYTE BIOL, V36, P293; CHASE MW, 1945, P SOC EXP BIOL MED, V59, P134; Clark IA, 2001, PARASITOLOGY, V122, pS51, DOI 10.1017/S003118200100734X; CLARK IA, 1976, NATURE, V259, P309, DOI 10.1038/259309a0; DANNENBE.AM, 1968, BACTERIOL REV, V32, P85; Dienes L, 1930, J IMMUNOL, V19, P41; Hollm-Delgado MG, 2014, PEDIATRICS, V133, pE73, DOI 10.1542/peds.2013-2218; Howard JG, 1959, EFFECT MYCOBACTERIUM; KELLY MT, 1976, CELL IMMUNOL, V26, P254, DOI 10.1016/0008-8749(76)90369-5; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Kristensen I, 2000, BRIT MED J, V321, P1435, DOI 10.1136/bmj.321.7274.1435; Larsen JM, 2007, IMMUNOLOGY, V121, P276, DOI 10.1111/j.1365-2567.2007.02575.x; MACKANESS GB, 1969, J EXP MED, V129, P973, DOI 10.1084/jem.129.5.973; Marchant A, 1999, J IMMUNOL, V163, P2249; Mathurin KS, 2009, J VIROL, V83, P3528, DOI 10.1128/JVI.02393-08; Miller TE, 1973, JNCI-J NATL CANCER I, V51, P1655; MINDEN P, 1972, INFECT IMMUN, V6, P574; MOULTON RG, 1986, CAN J MICROBIOL, V32, P442, DOI 10.1139/m86-084; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; NORTH RJ, 1973, CELL IMMUNOL, V7, P166, DOI 10.1016/0008-8749(73)90193-7; OLD LJ, 1959, NATURE, V184, P291, DOI 10.1038/184291a0; PLETSITYI D F, 1973, Bulletin of Experimental Biology and Medicine, V75, P299, DOI 10.1007/BF00805013; Ristori G, 2014, NEUROLOGY, V82, P41, DOI 10.1212/01.wnl.0000438216.93319.ab; ROCKLIN RE, 1974, J EXP MED, V140, P1303, DOI 10.1084/jem.140.5.1303; SALVIN SB, 1975, J IMMUNOL, V114, P354; Shann F, 2011, J INFECT DIS, V204, P182, DOI 10.1093/infdis/jir244; Strachan David P., 2000, Thorax, V55, pS2, DOI 10.1136/thorax.55.suppl_1.S2; VANDISSEL JT, 1987, J IMMUNOL, V139, P1665; VANFURTH R, 1990, RES MICROBIOL, V141, P256, DOI 10.1016/0923-2508(90)90041-N; Welsh RM, 2010, IMMUNOL REV, V235, P244, DOI 10.1111/j.0105-2896.2010.00897.x; YAGI H, 1991, CELL IMMUNOL, V138, P142, DOI 10.1016/0008-8749(91)90139-3; YARKONI E, 1977, INFECT IMMUN, V16, P1	39	15	15	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	JAN	2015	109	1					46	51		10.1093/trstmh/tru196				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CC1LO	WOS:000350102400008	25573108				2019-04-02	
J	Freyne, B; Marchant, A; Curtis, N				Freyne, Bridget; Marchant, Arnaud; Curtis, Nigel			BCG-associated heterologous immunity, a historical perspective: intervention studies in animal models of infectious diseases	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Review						Animal; BCG; Heterologous; Non-specific; Vaccine	MYCOBACTERIUM-BOVIS BCG; ECTROMELIA VIRUS-INFECTION; ENHANCED RESISTANCE; TRYPANOSOMA-CRUZI; MICE; IMMUNIZATION; MACROPHAGES; VACCINATION; PROTECTION; MECHANISMS	The WHO Special Advisory Group of Experts (SAGE) review of the available epidemiological and trial evidence in humans concluded that bacillus Calmette-Gu,rin (BCG) vaccination leads to beneficial heterologous ('non-specific') effects, specifically on all-cause mortality. Randomized controlled trials showing this beneficial effect suggest improved survival is the result of enhanced protection against infection. This paper reviews the available evidence for the attenuating effects of BCG vaccine on experimental infections in animal models, including protection from bacteria, viruses, parasites and fungi. The reviewed studies suggest that BCG activates multiple immune pathways and that the basis for BCG-associated heterologous immunity may vary by pathogen. Modern immunological and molecular methods, exemplified by 'vaccinomics', are well placed to further investigate the basis of BCG's heterologous effects using a systems biology approach.	[Freyne, Bridget; Curtis, Nigel] Univ Melbourne, Royal Childrens Hosp Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Freyne, Bridget; Curtis, Nigel] Royal Childrens Hosp Melbourne, Infect Dis Unit, Parkville, Vic 3052, Australia; [Freyne, Bridget; Curtis, Nigel] Murdoch Childrens Res Inst, Infect Dis & Microbiol Res Grp, Parkville, Vic 3052, Australia; [Marchant, Arnaud] Univ Libre Bruxelles, Inst Med Immunol, B-6041 Charleroi, Belgium	Freyne, B (reprint author), Univ Melbourne, Royal Childrens Hosp Melbourne, Dept Paediat, Flemington Rd, Parkville, Vic 3052, Australia.	bridget.freyne@rch.org.au	Curtis, Nigel/B-3491-2012	Curtis, Nigel/0000-0003-3446-4594	University of Melbourne; Nossal Institute of Global Health; European Society for Paediatric Infectious Diseases	BF is a PhD student at The University of Melbourne and funded by scholarships from the University of Melbourne, the Nossal Institute of Global Health and the European Society for Paediatric Infectious Diseases. AM is a senior research associate of the Fonds de la Recherche Scientifique (F.R.S.-FNRS), Belgium.	BELL JF, 1966, J IMMUNOL, V97, P747; CIVIL RH, 1978, J INFECT DIS, V137, P550, DOI 10.1093/infdis/137.5.550; CLARK IA, 1976, NATURE, V259, P309, DOI 10.1038/259309a0; DUBOS R, 1957, J EXP MED, V106, P703, DOI 10.1084/jem.106.5.703; FAGELMAN KM, 1981, ARCH SURG-CHICAGO, V116, P761; Freyne B, 2015, T ROY SOC TROP MED H, V109, P46, DOI 10.1093/trstmh/tru196; Hirst JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098856; HOFF R, 1975, J EXP MED, V142, P299, DOI 10.1084/jem.142.2.299; Howard JG, 1959, EFFECT MYCOBACTERIUM; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; KUHN RE, 1975, INT J PARASITOL, V5, P557, DOI 10.1016/0020-7519(75)90049-1; LARSON CL, 1972, INFECT IMMUN, V6, P465; MACKANESS GB, 1969, J EXP MED, V129, P973, DOI 10.1084/jem.129.5.973; NAKAMURA M, 1972, INFECT IMMUN, V6, P1025; ORTIZORTIZ L, 1975, J IMMUNOL, V114, P1424; Parra M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066115; SAKUMA T, 1983, INFECT IMMUN, V42, P567; SALVIN SB, 1976, ANN NY ACAD SCI, V276, P369, DOI 10.1111/j.1749-6632.1976.tb41661.x; SALVIN SB, 1974, INFECT IMMUN, V9, P631; Salvin SB, 1975, FED PROC, V34, P4355; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; SHER NA, 1975, INFECT IMMUN, V12, P1325; SMRKOVSKI LL, 1977, INFECT IMMUN, V16, P249; SUENAGA T, 1978, INFECT IMMUN, V20, P312; TABBARA KF, 1975, AM J OPHTHALMOL, V79, P641, DOI 10.1016/0002-9394(75)90804-1; Tsilidis KK, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001609; VANTWOUT JW, 1992, SCAND J IMMUNOL, V36, P713; WERNER GT, 1979, EXPERIENTIA, V35, P1514, DOI 10.1007/BF01962818	29	8	8	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	JAN	2015	109	1					52	61		10.1093/trstmh/tru197				10	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CC1LO	WOS:000350102400009	25573109				2019-04-02	
J	Carnes, J; Anupama, A; Balmer, O; Jackson, A; Lewis, M; Brown, R; Cestari, I; Desquesnes, M; Gendrin, C; Hertz-Fowler, C; Imamura, H; Ivens, A; Koreny, L; Lai, DH; MacLeod, A; McDermott, SM; Merritt, C; Monnerat, S; Moon, W; Myler, P; Phan, I; Ramasamy, G; Sivam, D; Lun, ZR; Lukes, J; Stuart, K; Schnaufer, A				Carnes, Jason; Anupama, Atashi; Balmer, Oliver; Jackson, Andrew; Lewis, Michael; Brown, Rob; Cestari, Igor; Desquesnes, Marc; Gendrin, Claire; Hertz-Fowler, Christiane; Imamura, Hideo; Ivens, Alasdair; Koreny, Ludek; Lai, De-Hua; MacLeod, Annette; McDermott, Suzanne M.; Merritt, Chris; Monnerat, Severine; Moon, Wonjong; Myler, Peter; Phan, Isabelle; Ramasamy, Gowthaman; Sivam, Dhileep; Lun, Zhao-Rong; Lukes, Julius; Stuart, Ken; Schnaufer, Achim			Genome and Phylogenetic Analyses of Trypanosoma evansi Reveal Extensive Similarity to T. brucei and Multiple Independent Origins for Dyskinetoplasty	PLOS NEGLECTED TROPICAL DISEASES			English	Article							BLOOD-STREAM FORMS; KINETOPLAST DNA; MITOCHONDRIAL RIBOSOMES; CYCLICAL TRANSMISSION; MEGABASE CHROMOSOMES; MOLECULAR KARYOTYPE; SPECIES PROBLEM; INSECT FORMS; EQUIPERDUM; GENE	Two key biological features distinguish Trypanosoma evansi from the T. brucei group: independence from the tsetse fly as obligatory vector, and independence from the need for functional mitochondrial DNA (kinetoplast or kDNA). In an effort to better understand the molecular causes and consequences of these differences, we sequenced the genome of an akinetoplastic T. evansi strain from China and compared it to the T. b. brucei reference strain. The annotated T. evansi genome shows extensive similarity to the reference, with 94.9% of the predicted T. b. brucei coding sequences (CDS) having an ortholog in T. evansi, and 94.6% of the non-repetitive orthologs having a nucleotide identity of 95% or greater. Interestingly, several procyclin-associated genes (PAGs) were disrupted or not found in this T. evansi strain, suggesting a selective loss of function in the absence of the insect life-cycle stage. Surprisingly, orthologous sequences were found in T. evansi for all 978 nuclear CDS predicted to represent the mitochondrial proteome in T. brucei, although a small number of these may have lost functionality. Consistent with previous results, the F1FO-ATP synthase gamma subunit was found to have an A281 deletion, which is involved in generation of a mitochondrial membrane potential in the absence of kDNA. Candidates for CDS that are absent from the reference genome were identified in supplementary de novo assemblies of T. evansi reads. Phylogenetic analyses show that the sequenced strain belongs to a dominant group of clonal T. evansi strains with worldwide distribution that also includes isolates classified as T. equiperdum. At least three other types of T. evansi or T. equiperdum have emerged independently. Overall, the elucidation of the T. evansi genome sequence reveals extensive similarity of T. brucei and supports the contention that T. evansi should be classified as a subspecies of T. brucei.	[Carnes, Jason; Anupama, Atashi; Brown, Rob; Cestari, Igor; Gendrin, Claire; McDermott, Suzanne M.; Merritt, Chris; Monnerat, Severine; Moon, Wonjong; Myler, Peter; Phan, Isabelle; Ramasamy, Gowthaman; Sivam, Dhileep] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Balmer, Oliver] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Jackson, Andrew] Univ Liverpool, Inst Infect & Global Hlth, Dept Infect Biol, Liverpool L69 3BX, Merseyside, England; [Lewis, Michael] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Pathogen Mol Biol, London WC1, England; [Desquesnes, Marc] CIRAD, UMR InterTryp, Montpellier, France; [Desquesnes, Marc] Kasetsart Univ, Fac Vet Med, Bangkok, Thailand; [Hertz-Fowler, Christiane] Univ Liverpool, Ctr Genom Res, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Imamura, Hideo] Inst Trop Med, Dept Biomed Sci, Unit Mol Parasitol, B-2000 Antwerp, Belgium; [Ivens, Alasdair; Schnaufer, Achim] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland; [Koreny, Ludek; Lai, De-Hua; Lukes, Julius] Acad Sci Czech Republic, Ctr Biol, Inst Parasitol, Ceske Budejovice, Czech Republic; [Koreny, Ludek; Lai, De-Hua; Lukes, Julius] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Lai, De-Hua; Lun, Zhao-Rong] Sun Yat Sen Univ, Sch Life Sci, Ctr Parasit Organisms, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Lai, De-Hua; Lun, Zhao-Rong] Sun Yat Sen Univ, Zhongshan Sch Med, Key Lab Trop Dis Control, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China; [MacLeod, Annette] Univ Glasgow, Coll Med Vet & Life Sci, Wellcome Trust Ctr Mol Parasitol, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Lukes, Julius] Canadian Inst Adv Res, Toronto, ON, Canada; [Stuart, Ken] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Schnaufer, Achim] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland	Carnes, J (reprint author), Univ Dundee, Coll Life Sci, Dundee, Scotland.	lsslzr@mail.sysu.edu.cn; jula@paru.cas.cz; ken.stuart@seattlebiomed.org; achim.schnaufer@ed.ac.uk	Koreny, Ludek/G-9766-2014; Lai, De-Hua/G-8943-2015; Lukes, Julius/H-6760-2012	Lai, De-Hua/0000-0002-4709-1507; Lukes, Julius/0000-0002-0578-6618; Desquesnes, Marc/0000-0002-7665-2422; Hertz-Fowler, Christiane/0000-0002-0729-6479; Ivens, Al/0000-0002-0112-3876; Brown, Robert/0000-0003-4086-7699; Jackson, Andrew Paul/0000-0002-5704-8596; Balmer, Oliver/0000-0001-7572-7747; Carnes, Jason/0000-0001-7302-1935; McDermott, Suzanne M/0000-0003-2158-1695; Lewis, Michael/0000-0001-9540-3280; Imamura, Hideo/0000-0002-3282-1319; Schnaufer, Achim/0000-0003-2132-5560	US National Institutes of Health [AI014102, AI69057]; UK Medical Research Council [G0600129]; EU [316304]; Bioglobe grant [CZ.1.07/2.3.00/30.0032]; Praemium Academiae award; National Science Foundation of China [30670275, 31272305]; Medical Research Council [G0600129]	This work was supported by US National Institutes of Health (www.nih.gov) grants AI014102 (to KS) and AI69057 (to AS), UK Medical Research Council (www.mrc.ac.uk) grant G0600129 (to AS), EU grant (ec.europa.eu) FP7/2007-2013 (no. 316304), Bioglobe grant CZ.1.07/2.3.00/30.0032, and the Praemium Academiae award (to JL, who is a Fellow of the Canadian Institute for Advanced Research), and National Science Foundation of China (www.nsfc.gov.cn) grants #30670275 and #31272305 (to ZRL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acestor N, 2009, PROTEOMICS, V9, P5497, DOI 10.1002/pmic.200900354; Acosta-Serrano A, 1999, J BIOL CHEM, V274, P29763, DOI 10.1074/jbc.274.42.29763; Aggarwal G, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-23; Alfonzo JD, 2011, TRENDS PARASITOL, V27, P234, DOI 10.1016/j.pt.2011.02.003; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Aphasizhev R, 2011, RES MICROBIOL, V162, P655, DOI 10.1016/j.resmic.2011.04.015; BAJYANA SE, 1988, ANN SOC BELG MED TR, V68, P233; Balmer O, 2006, MOL ECOL NOTES, V6, P508, DOI 10.1111/j.1471-8286.2006.01297.x; Balmer O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000961; Beck K, 2013, EUKARYOT CELL, V12, P970, DOI 10.1128/EC.00352-12; Berberof M, 1996, MOL CELL BIOL, V16, P914; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BHAT GJ, 1990, CELL, V61, P885, DOI 10.1016/0092-8674(90)90199-O; Blankenberg D, 2007, GENOME RES, V17, P960, DOI 10.1101/gr.5578007; BORST P, 1987, MOL BIOCHEM PARASIT, V23, P31, DOI 10.1016/0166-6851(87)90184-8; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; Brun R, 1998, VET PARASITOL, V79, P95, DOI 10.1016/S0304-4017(98)00146-0; Callejas S, 2006, GENOME RES, V16, P1109, DOI 10.1101/gr.5147406; Capewell P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067852; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Claes F, 2005, TRENDS PARASITOL, V21, P316, DOI 10.1016/j.pt.2005.05.010; Claes F, 2003, PARASITOLOGY, V126, P425, DOI 10.1017/S0031182003002968; Claes F., 2004, KINETOPLASTID BIOL D, V3, P1, DOI DOI 10.1186/1475-9292-3-3; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dean S, 2013, P NATL ACAD SCI USA, V110, P14741, DOI 10.1073/pnas.1305404110; Desquesnes M, 2013, BIOMED RES INT, V2013, P1; Desquesnes M, 2013, BIOMED RES INT, DOI 10.1155/2013/321237; Desquesnes M, 2009, INT J PARASITOL, V39, P333, DOI 10.1016/j.ijpara.2008.07.004; Domingo GJ, 2003, EUKARYOT CELL, V2, P569, DOI 10.1128/EC.2.3.569-577.2003; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gibson W, 2007, INT J PARASITOL, V37, P829, DOI 10.1016/j.ijpara.2007.03.002; Haenni S, 2006, MOL BIOCHEM PARASIT, V150, P144, DOI 10.1016/j.molbiopara.2006.07.005; Hajduk S, 2010, RNA BIOL, V7, P229, DOI 10.4161/rna.7.2.11393; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hashimi H, 2010, INT J PARASITOL, V40, P45, DOI 10.1016/j.ijpara.2009.07.005; HENRIKSSON J, 1995, MOL BIOCHEM PARASIT, V73, P63, DOI 10.1016/0166-6851(95)00096-J; Hey J, 2001, TRENDS ECOL EVOL, V16, P326, DOI 10.1016/S0169-5347(01)02145-0; Hoare C. A., 1972, TRYPANOSOMES MAMMALS; Jackson AP, 2012, P NATL ACAD SCI USA, V109, P3416, DOI 10.1073/pnas.1117313109; Jackson AP, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000658; Jensen BC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-482; Jensen RE, 2008, TRENDS PARASITOL, V24, P428, DOI 10.1016/j.pt.2008.06.007; Joshi PP, 2005, AM J TROP MED HYG, V73, P491, DOI 10.4269/ajtmh.2005.73.491; KOENIGMARTIN E, 1992, MOL BIOCHEM PARASIT, V55, P135, DOI 10.1016/0166-6851(92)90134-6; KONIG E, 1989, NUCLEIC ACIDS RES, V17, P8727, DOI 10.1093/nar/17.21.8727; Lai DH, 2008, P NATL ACAD SCI USA, V105, P1999, DOI 10.1073/pnas.0711799105; Lai DH, 2014, EUKARYOT CELL, V13, P320, DOI 10.1128/EC.00271-13; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; LANHAM SM, 1970, EXP PARASITOL, V28, P521, DOI 10.1016/0014-4894(70)90120-7; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lejon V, 2005, INT J PARASITOL, V35, P455, DOI 10.1016/j.ijpara.2004.12.015; Li FJ, 2006, TRENDS PARASITOL, V22, P55, DOI 10.1016/j.pt.2005.12.005; Liniger M, 2004, MOL BIOCHEM PARASIT, V137, P247, DOI 10.1016/j.molbiopara.2004.06.006; Liniger M, 2001, MOL MICROBIOL, V40, P869, DOI 10.1046/j.1365-2958.2001.02426.x; Liu BY, 2005, TRENDS PARASITOL, V21, P363, DOI 10.1016/j.pt.2005.06.008; Lun ZR, 2010, TRENDS PARASITOL, V26, P424, DOI 10.1016/j.pt.2010.05.007; LUN ZR, 1992, MOL BIOCHEM PARASIT, V50, P189, DOI 10.1016/0166-6851(92)90215-6; MacGregor P, 2012, NAT REV MICROBIOL, V10, P431, DOI 10.1038/nrmicro2779; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mazet M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002587; Melville SE, 1998, MOL BIOCHEM PARASIT, V94, P155, DOI 10.1016/S0166-6851(98)00054-1; Melville SE, 2000, MOL BIOCHEM PARASIT, V111, P261, DOI 10.1016/S0166-6851(00)00316-9; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btn575; Mony BM, 2014, NATURE, V505, P681, DOI 10.1038/nature12864; Ngaira JM, 2005, EXP PARASITOL, V110, P30, DOI 10.1016/j.exppara.2005.01.001; Njiru ZK, 2006, INFECT GENET EVOL, V6, P292, DOI 10.1016/j.meegid.2005.08.002; NOLAN DP, 1992, EUR J BIOCHEM, V209, P207, DOI 10.1111/j.1432-1033.1992.tb17278.x; Otto TD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1268; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; Pusnik M, 2007, MOL CELL BIOL, V27, P6876, DOI 10.1128/MCB.00708-07; Roditi I, 1998, MOL BIOCHEM PARASIT, V91, P117, DOI 10.1016/S0166-6851(97)00195-3; Roldan A, 2011, MOL MICROBIOL, V81, P623, DOI 10.1111/j.1365-2958.2011.07721.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; ROVAI L, 1992, MOL BIOCHEM PARASIT, V50, P115, DOI 10.1016/0166-6851(92)90249-J; Sambrook J., 2001, MOL CLONING LAB MANU; Schnaufer A, 2005, EMBO J, V24, P4029, DOI 10.1038/sj.emboj.7600862; Schnaufer A, 2002, INT J PARASITOL, V32, P1071, DOI 10.1016/S0020-7519(02)00020-6; Shiba T, 2013, P NATL ACAD SCI USA, V110, P4580, DOI 10.1073/pnas.1218386110; Stephens JL, 2007, J BIOL CHEM, V282, P4427, DOI 10.1074/jbc.M609037200; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; Surve S, 2012, EUKARYOT CELL, V11, P183, DOI 10.1128/EC.05282-11; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tran T, 2009, CLIN VACCINE IMMUNOL, V16, P999, DOI 10.1128/CVI.00096-09; Turner CMR, 1997, PARASITOL TODAY, V13, P5, DOI 10.1016/S0169-4758(96)20056-0; Urakawa T, 2001, EXP PARASITOL, V99, P181, DOI 10.1006/expr.2001.4670; Vassella E, 2001, J MOL BIOL, V312, P597, DOI 10.1006/jmbi.2001.5004; Vassella E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004493; Ventura RM, 2002, INT J PARASITOL, V32, P53, DOI 10.1016/S0020-7519(01)00314-9; VERCESI AE, 1992, MOL BIOCHEM PARASIT, V56, P251, DOI 10.1016/0166-6851(92)90174-I; Verloo D, 2000, VET PARASITOL, V92, P87, DOI 10.1016/S0304-4017(00)00284-3; Wincker P, 1996, NUCLEIC ACIDS RES, V24, P1688, DOI 10.1093/nar/24.9.1688; Witola WH, 2005, PARASITOLOGY, V131, P635, DOI 10.1017/S003118200500836X; Zhang Z, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-44; Zikova A, 2009, PLOS PATHOG, V5, P1; Zikova A, 2008, MOL CELL PROTEOMICS, V7, P1286, DOI 10.1074/mcp.M700490-MCP200	96	50	50	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JAN	2015	9	1							e3404	10.1371/journal.pntd.0003404				21	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	CB0LR	WOS:000349318100020	25568942	DOAJ Gold, Green Published			2019-04-02	
J	Mwape, KE; Phiri, IK; Praet, N; Dorny, P; Muma, JB; Zulu, G; Speybroeck, N; Gabriel, S				Mwape, Kabemba E.; Phiri, Isaac K.; Praet, Nicolas; Dorny, Pierre; Muma, John B.; Zulu, Gideon; Speybroeck, Niko; Gabrieel, Sarah			Study and Ranking of Determinants of Taenia solium Infections by Classification Tree Models	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							RISK-FACTORS; PORCINE CYSTICERCOSIS; RURAL VILLAGE; TAPEWORM CARRIERS; MBULU DISTRICT; PREVALENCE; DIAGNOSIS; NEUROCYSTICERCOSIS; TANZANIA; SOUTHERN	Taenia solium taeniasis/cysticercosis is an important public health problem occurring mainly in developing countries. This work aimed to study the determinants of human T. solium infections in the Eastern province of Zambia and rank them in order of importance. A household (HH)-level questionnaire was administered to 680 HHs from 53 villages in two rural districts and the taeniasis and cysticercosis status determined. A classification tree model (CART) was used to define the relative importance and interactions between different predictor variables in their effect on taeniasis and cysticercosis. The Katete study area had a significantly higher taeniasis and cysticercosis prevalence than the Petauke area. The CART analysis for Katete showed that the most important determinant for cysticercosis infections was the number of HH inhabitants (6 to 10) and for taeniasis was the number of HH inhabitants > 6. The most important determinant in Petauke for cysticercosis was the age of head of household > 32 years and for taeniasis it was age < 55 years. The CART analysis showed that the most important determinant for both taeniasis and cysticercosis infections was the number of HH inhabitants (6 to 10) in Katete district and age in Petauke. The results suggest that control measures should target HHs with a high number of inhabitants and older individuals.	[Mwape, Kabemba E.; Phiri, Isaac K.] Univ Zambia, Sch Vet Med, Dept Clin Studies, Lusaka, Zambia; Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, ZA-0002 Pretoria, South Africa; [Praet, Nicolas; Dorny, Pierre; Gabrieel, Sarah] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Dorny, Pierre] Univ Ghent, Fac Vet Med, Lab Vet Parasitol, Merelbeke, Belgium; [Muma, John B.] Univ Zambia, Sch Vet Med, Dept Dis Control, Lusaka, Zambia; [Zulu, Gideon] Petauke Dist Hosp, Petauke, Zambia; [Speybroeck, Niko] Catholic Univ Louvain, Inst Hlth & Soc, B-1200 Brussels, Belgium	Gabriel, S (reprint author), Inst Trop Med, Dept Biomed Sci, Nationalestr 155, B-2000 Antwerp, Belgium.	evans.mwape@unza.zm; igphiri@yahoo.co.uk; npraet@itg.be; pdorny@itg.be; jmuma@unza.zm; gideonzulu@yahoo.com; Niko.Speybroeck@uclouvain.be; sgabriel@itg.be		GABRIEL, SARAH/0000-0002-2523-233X	Flemish Inter University Council; Research Initiative Programme, Zambia [VLIR-UOS.ZIUS2008RIP-8961]; Belgian Directorate for Development Co-operation through the 3rd framework agreement with ITM; EU grant ADVANZ-Advocacy for the fight against Neglected Zoonotic Diseases (FP7 KBBE) [0312030]	This work was funded by the Flemish Inter University Council, Research Initiative Programme, Zambia (VLIR-UOS.ZIUS2008RIP-8961), with the Belgian Directorate for Development Co-operation through the 3rd framework agreement with ITM, and by the EU grant ADVANZ-Advocacy for the fight against Neglected Zoonotic Diseases (FP7 KBBE contract no: 0312030, http://www.advanz.org).	ALLAN JC, 1990, PARASITOLOGY, V101, P473, DOI 10.1017/S0031182000060686; Allan JC, 1997, T ROY SOC TROP MED H, V91, P595, DOI 10.1016/S0035-9203(97)90042-0; Bhattarai NR, 2010, EMERG INFECT DIS, V16, P231, DOI 10.3201/eid1602.090623; CAMACHO SD, 1990, T ROY SOC TROP MED H, V84, P563, DOI 10.1016/0035-9203(90)90041-C; CAMACHO SPD, 1991, AM J TROP MED HYG, V45, P522, DOI 10.4269/ajtmh.1991.45.522; CHUNG WC, 1991, INT J PARASITOL, V21, P269, DOI 10.1016/0020-7519(91)90021-X; Dorny P, 2004, TRENDS PARASITOL, V20, P259, DOI 10.1016/j.pt.2004.04.001; Garcia HH, 1999, NEUROLOGY, V53, P1582, DOI 10.1212/WNL.53.7.1582; Garcia HH, 2005, AM J TROP MED HYG, V72, P3, DOI 10.4269/ajtmh.2005.72.3; Garcia HH, 2003, AM J TROP MED HYG, V68, P268, DOI 10.4269/ajtmh.2003.68.268; Kagira JM, 2010, J HELMINTHOL, V84, P398, DOI 10.1017/S0022149X10000076; Lescano AG, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000371; Mayta H, 2008, J CLIN MICROBIOL, V46, P286, DOI 10.1128/JCM.01172-07; Murrell KD, 2005, WHO OIE FAO GUIDELIN, P57; Mwanjali G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002102; Mwape KE, 2011, T ROY SOC TROP MED H, V105, P574, DOI 10.1016/j.trstmh.2011.05.010; Mwape KE, 2013, PLOS NEGLECT TROP D, V7, P2142; Mwape KE, 2012, PLOS NEGLECT TROP D, V6, P1594; Ndimubanzi PC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000870; Ngowi HA, 2004, VET PARASITOL, V120, P275, DOI 10.1016/j.vetpar.2004.01.015; Ngowi HA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000652; Phiri IK, 2003, ACTA TROP, V87, P13, DOI [10.1016/S0001-706X(03)00051-2, 10.1016/S0001-706X(03)00202-X]; Praet N, 2010, INT J PARASITOL, V40, P85, DOI 10.1016/j.ijpara.2009.07.007; Praet N, 2013, TROP MED INT HEALTH, V18, P608, DOI 10.1111/tmi.12089; Protopopoff N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008022; RITCHIE LAWRENCE S., 1948, BULL U S ARMY MED DEPT, V8, P326; Rodriguez-Canul R, 1999, ANN TROP MED PARASIT, V93, P57; Roman G, 2000, B WORLD HEALTH ORGAN, V78, P399; Sanchez AL, 1997, ANN TROP MED PARASIT, V91, P163, DOI 10.1080/00034983.1997.11813126; Sarti E, 1997, SALUD PUBLICA MEXICO, V39, P225, DOI 10.1590/S0036-36341997000300009; Sarti E, 2000, T ROY SOC TROP MED H, V94, P85, DOI 10.1016/S0035-9203(00)90451-6; SCHANTZ PM, 1992, NEW ENGL J MED, V327, P692, DOI 10.1056/NEJM199209033271004; Sikasunge CS, 2007, VET PARASITOL, V143, P59, DOI 10.1016/j.vetpar.2006.07.023; Sikasunge CS, 2008, VET J, V176, P240, DOI 10.1016/j.tvjl.2007.02.030; Speybroeck N, 2012, INT J PUBLIC HEALTH, V57, P243, DOI 10.1007/s00038-011-0315-z; Steinmann P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000322; Suman P, 2010, WASTE MANAGE RES, V28, P1076, DOI 10.1177/0734242X09356016; Thang ND, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-28; Yewhalaw D, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-21	39	4	4	0	6	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	JAN	2015	92	1					56	63		10.4269/ajtmh.13-0593				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	AZ4GU	WOS:000348180600014	25404073	Green Published, Bronze			2019-04-02	
J	Janssen, W; Ngirabega, JD; Matungwa, M; Van Bastelaere, S				Janssen, Willy; Ngirabega, Jean de Dieu; Matungwa, Michel; Van Bastelaere, Stefaan			Improving quality through performance-based financing in district hospitals in Rwanda between 2006 and 2010: A 5-year experience	TROPICAL DOCTOR			English	Article						Performance-based financing; Rwanda; district hospital; quality improvement; health centre support; hospital management; clinical activities; peer-evaluation; self-assessment	HEALTH CENTERS; SERVICES; PAYMENT; SYSTEM	Introduction Since 2000 performance-based financing (PBF) made its way to sub-Saharan health systems in an attempt to improve service delivery. In Rwanda initial experiences in 2001 and 2002 led to a scaling up of the initiative to all health centres (HC) and district hospitals (DH). In 2008 PBF became national strategy. Methods PBF was introduced in Rwanda in 2006 at the DH level. Evaluation on their service delivery was carried out quarterly in the following areas: hospital management, support to the health centres and clinical activities. We studied four DHs. Results After 5 years, an improvement in the quantity of clinical activities was observed, as well as quality in hospital management, in HC support and in clinical activities. Conclusion PBF proves to be a promising approach in strengthening and maintaining quality service delivery in the sub-Saharan district hospitals.		Van Bastelaere, S (reprint author), Belgian Tech Cooperat, Hoogstr 147, B-1000 Brussels, Belgium.	stefaan.vanbastelaere@btcctb.org					Basinga P, 2011, LANCET, V377, P1421, DOI 10.1016/S0140-6736(11)60177-3; Eichler R, 2006, GOING TO SCALE WITH; Logie DE, 2008, LANCET, V372, P256, DOI 10.1016/S0140-6736(08)60962-9; Mali C., 2012, ETUDE SUR LA CONTRIB; Mathauer Inke, 2006, Hum Resour Health, V4, P24, DOI 10.1186/1478-4491-4-24; Meessen B, 2007, B WORLD HEALTH ORGAN, V85, P108, DOI 10.2471/BLT.06.032110; Meessen B, 2006, TROP MED INT HEALTH, V11, P1303, DOI 10.1111/j.1365-3156.2006.01680.x; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Rusa L, 2009, TROP MED INT HEALTH, V14, P830, DOI 10.1111/j.1365-3156.2009.02292.x; Soeters R, 2006, B WORLD HEALTH ORGAN, V84, P884; WHO Regional Office for Africa, 1995, FORTY FIFTH SESSION	11	17	17	1	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0049-4755	1758-1133		TROP DOCT	Trop. Dr.	JAN	2015	45	1					27	35		10.1177/0049475514554481				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	AY2IN	WOS:000347412700007	25406257				2019-04-02	
J	Diro, E; Lynen, L; Gebregziabiher, B; Assefa, A; Lakew, W; Belew, Z; Hailu, A; Boelaert, M; van Griensven, J				Diro, Ermias; Lynen, Lutgarde; Gebregziabiher, Berhane; Assefa, Abraham; Lakew, Wubishet; Belew, Zewdu; Hailu, Asrat; Boelaert, Marleen; van Griensven, Johan			Clinical aspects of paediatric visceral leishmaniasis in North-west Ethiopia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						visceral leishmaniasis; children; malnutrition; helminths; vitamin D; leishmaniose viscerale; enfants; malnutrition; helminthes; vitamine D; leishmaniosis visceral; ninos; desnutricion; helmintos; vitamina D	VITAMIN-D DEFICIENCY; HELMINTH INFECTIONS; KALA-AZAR; CONTROLLED-TRIAL; IMMUNE-RESPONSE; SCHOOL-CHILDREN; AMPHOTERICIN-B; DOUBLE-BLIND; MALNUTRITION; TUBERCULOSIS	ObjectiveVisceral leishmaniasis (VL) in north-west Ethiopia is causing an overwhelming case load among adult migrant workers that masked the disease burden in children. This study describes the clinical profile and explores comorbidities in paediatric VL patients. MethodsA prospective study at two hospitals in this region (Gondar and Humera) was conducted in a year period, 2011-2012. The clinical manifestations and comorbidities such as malnutrition, intestinal parasitosis and vitamin D deficiency and HIV infection were assessed, and treatment outcomes noted. ResultsA total of 122 children with VL were detected during the study period with median age of 8.5years (IQR 5-12years); 23% were under 5years. Eighty-five (69.7%) cases were male. The clinical manifestations were similar to the adult patients. High rates of malnutrition, intestinal parasitosis (47.5%) and hypovitaminosis D (56.4%) were detected. The proportion of stunting and wasting was 63% and 22.2% in children aged under five years, and 50.5% and 75.9% in 5-year and older children, respectively, using WHO standard growth curves. Only one child had HIV infection. In 95% of the cases, sodium stibogluconate (20mg/kg/day for 30days) was used for treatment. The treatment success rate at end of therapy was 98.3%, but the definitive outcome at 6months could not be determined because of a high loss to follow-up (80.2%). ConclusionWhile HIV co-infection was rare, malnutrition, intestinal parasitosis and vitamin D deficiency were frequent indicating the need for further research on their role in the pathophysiology. Meanwhile, systematic assessment and management of malnutrition and intestinal parasitosis in VL programmes is recommended. ObjectifLa leishmaniose viscerale (LV) dans le nord-ouest de l'Ethiopie est a l'origine d'une surcharge de cas parmi les travailleurs migrants adultes qui masque la charge de morbidite chez les enfants. Cette etude decrit le profil clinique et explore les comorbidites chez les patients pediatriques souffrant de LV. MethodesUne etude prospective dans deux hopitaux de la region (Gondar et Humera) a ete realisee dans une periode d'un an, 2011a 2012. Les manifestations cliniques et les comorbidites telles que la malnutrition, les parasitoses intestinales, la carence en vitamine D et l'infection par le VIH ont ete evaluees et les resultats de traitement ont ete notes. ResultatsUn total de 122 enfants avec LV ont ete detectes au cours de la periode de l'etude avec un age median de 8,5 ans (IQR: 5 - 12 ans); 23% avaient moins de 5 ans. 85 (69,7%) cas etaient de sexe masculin. Les manifestations cliniques etaient similaires a celles des patients adultes. Les taux eleves de malnutrition, de parasitoses intestinales (47,5%) et d'hypovitaminose D (56,4%) ont ete detectes. La proportion des retards de croissance et de l'emaciation etait de 63% et de 22,2% respectivement chez les enfants de moins de cinq ans, et 50,5% et 75% chez ceux de cinq ans et plus, selon les courbes de croissance standard de l'OMS. Seul un enfant etait infecte par le VIH. Chez 95% des cas, du stibogluconate de sodium (20 mg/kg/jour pendant 30 jours) a ete utilise pour le traitement. Le taux de succes a la fin du traitement etait de 98,3%, mais le resultat definitif a six mois n'a pas pu etre determinee en raison du taux eleve de perdus au suivi (80,2%). ConclusionBien que la coinfection VIH fut rare, la malnutrition, les parasitoses intestinales et la carence en vitamine D etaient frequentes indiquant la necessite de poursuivre les recherches sur leur role dans la physiopathologie. Pendant ce temps, l'evaluation et la prise en charge systematique de la malnutrition et des parasitoses intestinales dans les programmes LV est recommandee. ObjetivoEn el nordeste de Etiopia, la leishmaniosis visceral (LV) esta causando una carga abrumadora de casos entre trabajadores adultos emigrantes, lo cual enmascara la carga de enfermedad en ninos. Este estudio describe el perfil clinico y explora la comorbilidad en pacientes pediatricos de LV. MetodosSe realizo un estudio prospectivo en dos hospitales de esta region (Gondar y Humera) durante un periodo de un ano (2011-12). Se evaluaron las manifestaciones clinicas y comorbilidades tales como desnutricion, parasitosis intestinal, deficiencia de vitamina D e infeccion con VIH, y se anotaron los resultados del tratamiento. ResultadosSe detectaron 122 ninos con LV durante el periodo de estudio, con una mediana de edad de 8.5 anos (IQR 5 - 12 anos); un 23% eran menores de 5 anos. 85 (69.7%) casos eran hombres. Las manifestaciones clinicas eran similares a las de los pacientes adultos. Se detectaron unas altas tasas de desnutricion, parasitosis intestinal (47.5%) e hipovitaminosis D (56.4%). Utilizando las curvas de crecimiento estandar de la OMS, la proporcion de retraso en el crecimiento y raquitismo, eran del 63% y 22.2% en menores de cinco anos, y de 50. 5% y 75. 9% en ninos con cinco anos y mayores, respectivamente. Solo un nino estaba infectado con VIH. En un 95% de los casos se utilizo como tratamiento es estibogluconato de sodio (20 mg/kg/dia durante 30 dias). La tasa de exito en el tratamiento al final de la terapia era del 98.3%, pero el resultado definitivo a los seis meses no se pudo determinar debido a la alta perdida durante el seguimiento (80.2%). ConclusionMientras que la coinfeccion con VIH era rara, la desnutricion, parasitosis intestinal y deficiencia de vitamina D eran frecuentes, indicando la necesidad de mas estudios sobre sus roles en la patofisiologia. Mientras tanto, se recomienda la evaluacion sistematica y el manejo de la desnutricion y la parasitosis intestinal en los programas de LV.	[Diro, Ermias; Lakew, Wubishet] Univ Gondar, Gondar, Ethiopia; [Diro, Ermias; Lynen, Lutgarde; Boelaert, Marleen; van Griensven, Johan] Inst Trop Med, B-2000 Antwerp, Belgium; [Gebregziabiher, Berhane; Belew, Zewdu] Kahsay Abera Hosp, Humera, Tigray Regional, Ethiopia; [Assefa, Abraham] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Hailu, Asrat] Univ Addis Ababa, Sch Med, Addis Ababa, Ethiopia	Diro, E (reprint author), Univ Gondar, Coll Med & Hlth Sci, Gondar, Ethiopia.	ermi_diro@yahoo.com	Aseffa, Abraham/J-3248-2016	Aseffa, Abraham/0000-0002-8028-1150; Boelaert, Marleen/0000-0001-8051-6776	UBS Optimus Foundation, Switzerland	We acknowledge the study participants and their family for volunteering to participate in the study. We also thank the study site staff at the Leishmaniasis Research and Treatment Center of the University of Gondar and those of Kahsay Abera Humera Hospital in Tigray Region. We are very grateful to UBS Optimus Foundation, Switzerland, for financially supporting this research project.	Alemu A, 2012, ASIAN PAC J TROP MED, V5, P803, DOI 10.1016/S1995-7645(12)60147-3; Alemu A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-189; Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07; Alvar J, 2007, AM J TROP MED HYG, V77, P275; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Amare B, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-7; Anstead GM, 2001, INFECT IMMUN, V69, P4709, DOI 10.1128/IAI.69.8.4709-4718.2001; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; BARCELLINI W, 1994, AIDS, V8, P757, DOI 10.1097/00002030-199406000-00006; CAMPOS FACS, 1987, AM J CLIN NUTR, V46, P91; Cascio A, 2002, EUR J CLIN MICROBIOL, V21, P277, DOI 10.1007/s10096-002-0707-3; Central Statistical Agency [Ethiopia] and ICF International, 2012, ETH DEM HLTH SURV 20; Chakravarty J, 2010, J GLOB INFECT DIS, V2, P167, DOI 10.4103/0974-777X.62887; Conesa-Botella A, 2012, CLIN INFECT DIS, V55, P1004, DOI 10.1093/cid/cis577; Elias D, 2007, EXPERT REV ANTI-INFE, V5, P475, DOI 10.1586/14787210.5.3.475; Federal democratic republic of Ethiopia, 2012, COUNTR PROGR REP HIV; Federal Ministry of Health of Ethiopia, 2013, GUID DIAGN TREATM PR; FOGELMAN Y, 1995, ISRAEL J MED SCI, V31, P221; FULLER GK, 1976, ANN TROP MED PARASIT, V70, P147, DOI 10.1080/00034983.1976.11687108; Gallagher JC, 2010, J CLIN ENDOCR METAB, V95, P2630, DOI 10.1210/jc.2010-0918; Grech V, 2000, ARCH DIS CHILD, V82, P381, DOI 10.1136/adc.82.5.381; Harhay MO, 2011, AM J TROP MED HYG, V84, P543, DOI 10.4269/ajtmh.2011.10-0321; HARRISON LH, 1986, REV INFECT DIS, V8, P447; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Hughes S, 2006, PARASITE IMMUNOL, V28, P577, DOI 10.1111/j.1365-3024.2006.00897.x; Hurissa Z, 2010, TROP MED INT HEALTH, V15, P848, DOI 10.1111/j.1365-3156.2010.02550.x; Kafetzis DA, 2005, INT J ANTIMICROB AG, V25, P26, DOI 10.1016/j.ijantimicag.2004.09.011; Kassu A, 2007, TROP DOCT, V37, P222, DOI 10.1258/004947507782333026; Koski KG, 2001, ANNU REV NUTR, V21, P297, DOI 10.1146/annurev.nutr.21.1.297; LEMIRE JM, 1992, J CELL BIOCHEM, V49, P26, DOI 10.1002/jcb.240490106; MacDonald AS, 2002, INFECT IMMUN, V70, P427, DOI 10.1128/IAI.70.2.427-433.2002; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; Malafaia G, 2009, PARASITE IMMUNOL, V31, P587, DOI 10.1111/j.1365-3024.2009.01117.x; Malafaia G, 2010, REV SOC BRAS MED TRO, V43, P478, DOI 10.1590/S0037-86822010000400033; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Mengesha Bewketu, 2014, BMC Res Notes, V7, P75, DOI 10.1186/1756-0500-7-75; Mengistu G, 2007, ETHIOP J HEALTH DEV, V21, P53; O'Neal SE, 2007, J INFECT DIS, V195, P142, DOI 10.1086/509808; Pearson RD, 1996, CLIN INFECT DIS, V22, P1, DOI 10.1093/clinids/22.1.1; Petrela R, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000814; Prentice A, 2008, NUTR REV, V66, pS153, DOI 10.1111/j.1753-4887.2008.00100.x; Prentice A, 2009, CLIN REV BONE MINER, V7, P94, DOI 10.1007/s12018-009-9038-6; Raguenaud ME, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000085; Rahim Kadivar Mohammad, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P626; Russo R, 2003, ANN TROP MED PARASIT, V97, P99, DOI 10.1179/000349803225002570; SCRIMSHAW NS, 1976, DENT CLIN N AM, V20, P461; SIDDIG M, 1990, TROP GEOGR MED, V42, P107; Singh UK, 2010, J TROP PEDIATRICS, V56, P321, DOI 10.1093/tropej/fmp132; unicef, 2014, NUTR DEF IND; Veeken H, 2000, TROP MED INT HEALTH, V5, P312, DOI 10.1046/j.1365-3156.2000.00555.x; Verkerke HP, 2012, SEMIN IMMUNOPATHOL, V34, P771, DOI 10.1007/s00281-012-0349-1; Wejse C, 2009, AM J RESP CRIT CARE, V179, P843, DOI 10.1164/rccm.200804-567OC; WHO, 2010, WHO TECH REP SER, V949, P1; Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6; World Health Organization, 2014, GLOB DAT CHILD GROWT; World Health Organization [WHO], 2013, GUID NUTR CAR SUPP P; Yifru S, 2010, ETHIOPIAN J HLTH BIO, V1, P23	58	11	11	1	24	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	JAN	2015	20	1					8	16		10.1111/tmi.12407				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	AW0GX	WOS:000345970400002	25329449	Bronze			2019-04-02	
J	Bof, JCM; Maketa, V; Bakajika, DK; Ntumba, F; Mpunga, D; Murdoch, ME; Hopkins, A; Noma, MM; Zoure, H; Tekle, AH; Katabarwa, MN; Lutumba, P				Bof, J. -C. Makenga; Maketa, V.; Bakajika, D. K.; Ntumba, F.; Mpunga, D.; Murdoch, M. E.; Hopkins, A.; Noma, M. M.; Zoure, H.; Tekle, A. H.; Katabarwa, M. N.; Lutumba, P.			Onchocerciasis control in the Democratic Republic of Congo (DRC): challenges in a post-war environment	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						onchocerciasis; Democratic Republic of Congo; community-directed treatment with ivermectin; onchocercose; Republique Democratique du Congo (RDC); traitement communautaire par l'ivermectine (TCI); Oncocercosis; Republica Democratica del Congo (RDC); tratamiento con ivermectina dirigido por la comunidad (TIDC)	COMMUNITY-DIRECTED TREATMENT; NEGLECTED TROPICAL DISEASES; RAPID ASSESSMENT PROCEDURE; AFRICAN PROGRAM; SKIN-DISEASE; CONTROL APOC; IVERMECTIN CDTI; WESTERN NIGERIA; LOIASIS RAPLOA; LOA-LOA	ObjectiveTo evaluate onchocerciasis control activities in the Democratic Republic of Congo (DRC) in the first 12years of community-directed treatment with ivermectin (CDTI). MethodsData from the National Programme for Onchocerciasis (NPO) provided by the National Onchocerciasis Task Force (NOTF) through the annual reports of the 21 CDTI projects for the years 2001-2012 were reviewed retrospectively. A hypothetical-inputs-process-outputs-outcomes table was constructed. ResultsCommunity-directed treatment with ivermectin expanded from 1968 communities in 2001 to 39100 communities by 2012 while the number of community-directed distributors (CDD) and health workers (HW) multiplied. By 2012, there were ratios of 1 CDD per 262 persons and 1 HW per 2318 persons at risk. More than 80% of the funding came from the fiduciary funds of the African Programme for Onchocerciasis Control. The cost of treatment per person treated fell from US$ 1.1 in 2001 to US$ 0.1 in 2012. The therapeutic coverage increased from 2.7% (2001) to 74.2% (2012); the geographical coverage, from 4.7% (2001) to 93.9% (2012). Geographical coverage fell in 2005 due to deaths in loiasis co-endemic areas, and the therapeutic coverage fell in 2008 due to insecurity. ConclusionsChallenges to CDTI in DRC have been serious adverse reactions to ivermectin in loiasis co-endemic areas and political conflict. Targets for personnel or therapeutic and geographical coverages were not met. Longer term funding and renewed efforts are required to achieve control and elimination of onchocerciasis in DRC. ObjectifEvaluer les activites de lutte contre l'onchocercose en Republique Democratique du Congo (RDC) au cours des douze premieres annees de traitement communautaire a l'ivermectine. MethodesLes donnees du Programme National de lutte contre l'Onchocercose fournies par le Groupe de Travail National contre l'Onchocercose a travers les rapports annuels des 21 projets de traitement communautaire a l'ivermectine (TCI) pour les annees 2001 a 2012 ont ete analysees retrospectivement. Une table hypothetique des Entrees-Sorties-Procedures-Resultats a ete construite. ResultatsLe traitement communautaire par l'ivermectine a ete elargi de 1968 communautes en 2001 a 39100 communautes en 2012 tandis que le nombre de distributeurs communautaires et d'agents de la sante a multiplie. En 2012, il y avait des rapports de 1 distributeur communautaire par 262 personnes et 1 agent de sante par 2318 personnes a risque. Plus de 80% du financement provenait des fonds fiduciaires du Programme Africain de Lutte contre l'Onchocercose. Le cout du traitement par personne traitee est passe de 1,1 $ US en 2001 a 0,1 $ US en 2012. La couverture therapeutique a augmente de 2,7% (2001) a 74,2% (2012); la couverture geographique de 4,7% (2001) a 93,9% (2012). La couverture geographique a chute en 2005 en raison de deces dans les zones co-endemiques pour la loase et la couverture therapeutique a chute en 2008 en raison de l'insecurite. ConclusionsLes defis du traitement communautaire par l'ivermectine en RDC ont ete les effets indesirables graves de l'ivermectine dans les zones co-endemiques pour la loase et les conflits politiques. Les objectifs pour le personnel ou pour les couvertures therapeutiques et geographiques n'ont pas ete atteints. Un financement a long terme et des efforts renouveles sont necessaires pour parvenir a un controle et a l'elimination de l'onchocercose en RDC. ObjetivoEvaluar las actividades de control de la oncocercosis en la Republica Democratica del Congo (RDC) en los primeros doce anos del tratamiento con ivermectina dirigido por la comunidad. MetodosSe revisaron de forma retrospectiva los datos del Programa Nacional de Oncocercosis (PNO) aportados por el Grupo de Trabajo en Oncocercosis (NOTF - National Onchocerciasis Task Force) a traves de informes anuales de los 21 proyectos del tratamiento con ivermectina dirigido por la comunidad (TIDC) para los anos 2001 a 2012. Se construyo una tabla para un modelo hipotetico de entradas-procesos-salidas-resultados. ResultadosEl TIDC se expandio de 1,968 comunidades en el 2001 a 39,100 comunidades en el 2012 mientras que el numero de distribuidores dirigidos por la comunidad y de trabajadores sanitarios se multiplicaba. En el 2012 habia una proporcion de 1 distribuidor dirigido por la comunidad para 262 personas y un 1 trabajador sanitario para 2,318 personas en riesgo. Mas de un 80% de los fondos venian de fondos fiduciarios del Programa Africano para el Control de la Oncocercosis. El coste del tratamiento por persona tratada cayo de US$ 1.1 en el 2001 a US$ 0.1 en el 2012. La cobertura terapeutica aumento del 2.7% (2001) al 74.2% (2012); la cobertura geografica del 4.7% (2001) al 93.9% (2012). La cobertura geografica cayo en el 2005 debido a la mortalidad en areas coendemicas para loiasis, y la cobertura terapeutica cayo en el 2008 debido a la inseguridad. ConclusionesLos retos del TIDC en la RDC han sido las reacciones adversas severas a la ivermectina en areas coendemicas para loiasis y el conflicto politico. Los objetivos de personal y cobertura terapeutica y geografica no se han alcanzado. Se requieren financiacion a mas largo plazo y esfuerzos renovados para conseguir controlar y eliminar la oncocercosis en la RDC.	[Bof, J. -C. Makenga] Catholic Univ Louvain, Fac Publ Hlth, B-1200 Brussels, Belgium; [Maketa, V.; Lutumba, P.] Kinshasa Univ, Dept Trop Med, Fac Med, Kinshasa, DEM REP CONGO; [Bakajika, D. K.; Ntumba, F.] Programme Natl Lutte Onchocercose, Kinshasa, DEM REP CONGO; [Mpunga, D.] Kinshasa Univ, Sch Publ Hlth, Kinshasa, DEM REP CONGO; [Murdoch, M. E.] Watford Dist Gen Hosp, Dept Dermatol, Watford WD18 0HB, Herts, England; [Hopkins, A.] Task Force Global Hlth, Mectizan Donat Program, Decatur, GA USA; [Noma, M. M.; Zoure, H.; Tekle, A. H.] African Programme Onchocerciasis Control, Ouagadougou, Burkina Faso; [Katabarwa, M. N.] Emory Univ, Carter Ctr, Atlanta, GA 30322 USA; [Lutumba, P.] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [Lutumba, P.] Natl Inst Biomed Res, Kinshasa, DEM REP CONGO	Murdoch, ME (reprint author), Watford Dist Gen Hosp, Dept Dermatol, Watford WD18 0HB, Herts, England.	michele.murdoch@nhs.net					Amazigo U, 2008, ANN TROP MED PARASIT, V102, P19, DOI 10.1179/136485908X337436; Amazigo U, 2007, SOC SCI MED, V64, P2070, DOI 10.1016/j.socscimed.2007.01.018; Amazigo UV, 2002, ANN TROP MED PARASIT, V96, P41, DOI 10.1179/000349802125000646; Benton B, 1998, ANN TROP MED PARASIT, V92, pS33, DOI 10.1080/00034983.1998.11813363; Berrang-Ford L, 2011, SOC SCI MED, V72, P398, DOI 10.1016/j.socscimed.2010.06.006; Bouchet B, 1998, TROP MED INT HEALTH, V3, P474; Brieger WR, 1998, SOC SCI MED, V47, P841, DOI 10.1016/S0277-9536(98)00007-0; BROWNE S. G., 1959, ANN TROP MED AND PARASITOL, V53, P421; DESOLE G, 1991, B WORLD HEALTH ORGAN, V69, P689; Gardon J, 1997, LANCET, V350, P18, DOI 10.1016/S0140-6736(96)11094-1; Hissette J, 1931, ANN SOC BELG MED TR, VXI, P45; Hopkins A, 2010, J COMMUNITY EYE HLTH, V7, P15; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Katabarwa MN, 2012, J PARASIT RES, V2012, DOI [10.1155/2012/748540, DOI 10.1155/2012/748540]; Katabarwa M, 2010, TROP MED INT HEALTH, V15, P216, DOI 10.1111/j.1365-3156.2009.02442.x; Katabarwa MN, 2010, T ROY SOC TROP MED H, V104, P265, DOI 10.1016/j.trstmh.2009.10.012; Kelly-Hope LA, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-178; MAERTENS K, 1990, INT OPHTHALMOL, V14, P181, DOI 10.1007/BF00158316; Ministere du Plan DRC, 2006, DOC STRAT CROISS RED; Ministere du Plan DRC, 2011, DOC STRAT CROISS RED, V1, P26; MURDOCH ME, 1993, BRIT J DERMATOL, V129, P260, DOI 10.1111/j.1365-2133.1993.tb11844.x; Murdoch ME, 2002, ANN TROP MED PARASIT, V96, P283, DOI 10.1179/000349802125000826; Ngoumou P., 1993, TDRTDEONCHO934 WHO; Noma M, 2002, ANN TROP MED PARASIT, V96, P29, DOI 10.1179/000349802125000637; Okeibunor JC, 2004, TROP MED INT HEALTH, V9, P887, DOI 10.1111/j.1365-3156.2004.01285.x; Okeibunor J, 2012, INT J HEALTH PLAN M, V27, P257, DOI 10.1002/hpm.2108; Oladepo O, 1997, TROP MED INT HEALTH, V2, P334; Remme JHF, 2010, B WORLD HEALTH ORGAN, V88, P509, DOI 10.2471/BLT.09.069203; Remme JHF, 2004, GLOBAL BURDEN ONCHOC; Rimoin AW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002118; Tamarozzi F, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-53; Tchounkeu YFL, 2012, T ROY SOC TROP MED H, V106, P340, DOI 10.1016/j.trstmh.2012.02.009; Tekle AH, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-28; Tekle AH, 2011, ACTA TROP, V120, pS81, DOI 10.1016/j.actatropica.2010.05.008; Tellier V, 1991, ALIMENTATION NUTR DE, P76; Thylefors B, 2008, ANN TROP MED PARASIT, V102, P39, DOI 10.1179/136485908X337481; Traore MO, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001825; Twum-Danso NAY, 2003, TROP MED INT HEALTH, V8, P820, DOI 10.1046/j.1365-3156.2003.01091.x; Twum-Danso NAY, 2003, FILARIA J S1, V2, pS3; UNDP, 2011, HUM DEV REP 2011 SUS; Vlassoff C, 2000, SOC SCI MED, V50, P1353, DOI 10.1016/S0277-9536(99)00389-5; Walker M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001578; Wanji S, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-25; Wanji S, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-39; Winnen M, 2002, B WORLD HEALTH ORGAN, V80, P384; World Health Organization, 2010, REP EXT MIDT EV AFR; World Health Organization, 2010, WEEKLY EPIDEMIOLOGIC, V85, P23; World Health Organization/African Programme for Onchocerciasis Control (WHO/APOC), 2005, FIN COMM 11 SESS JOI; World Health Organization/African Programme for Onchocerciasis Control (WHO/APOC), 2007, REV HLTH CAR DEL SUB; Zoure HGM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001210	50	11	13	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	JAN	2015	20	1					48	62		10.1111/tmi.12397				15	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	AW0GX	WOS:000345970400007	25302560	Green Published			2019-04-02	
J	Ravinetto, RM; Afolabi, MO; Okebe, J; Van Nuil, JI; Lutumba, P; Mavoko, HM; Nahum, A; Tinto, H; Addissie, A; D'Alessandro, U; Grietens, KP				Ravinetto, Raffaella M.; Afolabi, Muhammed O.; Okebe, Joseph; Van Nuil, Jennifer Ilo; Lutumba, Pascal; Mavoko, Hypolite Muhindo; Nahum, Alain; Tinto, Halidou; Addissie, Adamu; D'Alessandro, Umberto; Grietens, Koen Peeters			Participation in medical research as a resource-seeking strategy in socio-economically vulnerable communities: call for research and action	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						research ethics; clinical trials; informed consent; developing countries; vulnerable populations; equity; health inequalities; ethique de la recherche; essais cliniques; consentement eclaire; pays en developpement; populations vulnerables; equite; inegalites dans la sante; etica de la investigacion; ensayos clinicos; consentimiento informado; paises en vias de desarrollo; poblaciones vulnerables; equidad; inequidades en salud	CONSENT; MALARIA	The freedom to consent to participate in medical research is a complex subject, particularly in socio-economically vulnerable communities, where numerous factors may limit the efficacy of the informed consent process. Informal consultation among members of the Switching the Poles Clinical Research Network coming from various sub-Saharan African countries, that is Burkina Faso, The Gambia, Rwanda, Ethiopia, the Democratic Republic of Congo (DRC) and Benin, seems to support the hypothesis that in socio-economical vulnerable communities with inadequate access to health care, the decision to participate in research is often taken irrespectively of the contents of the informed consent interview, and it is largely driven by the opportunity to access free or better quality care and other indirect benefits. Populations' vulnerability due to poverty and/or social exclusion should obviously not lead to exclusion from medical research, which is most often crucially needed to address their health problems. Nonetheless, to reduce the possibility of exploitation, there is the need to further investigate the complex links between socio-economical vulnerability, access to health care and individual freedom to decide on participation in medical research. This needs bringing together clinical researchers, social scientists and bioethicists in transdisciplinary collaborative research efforts that require the collective input from researchers, research sponsors and funders. La liberte de consentir a participer a la recherche medicale est un sujet complexe, en particulier dans les communautes socioeconomiquement vulnerables, oU de nombreux facteurs peuvent limiter l'efficacite du processus de consentement eclaire. Une consultation informelle parmi les membres du Reseau Switching the Poles Clinical Research' en provenance de divers pays d'Afrique subsaharienne, a savoir le Burkina-Faso, la Gambie, le Rwanda, l'Ethiopie, la Republique democratique du Congo et le Benin, semble appuyer l'hypothese que dans les communautes socioeconomiquement vulnerables avec un acces inadequat aux soins de sante, la decision de participer a la recherche est souvent prise independamment du contenu de l'interview de consentement eclaire, et elle est en grande partie motivee par l'opportunite d'acceder a des soins de qualite gratuits ou meilleurs et d'autres avantages indirects. La vulnerabilite des populations due a la pauvrete et/ou l'exclusion sociale ne devrait evidemment pas conduire a leur exclusion de la recherche medicale, qui le plus souvent est crucialement necessaire pour repondre a leurs problemes de sante. Neanmoins, afin de reduire la possibilite d'exploitation, il est necessaire d'investiguer plus en details les liens complexes entre la vulnerabilite socioeconomique, l'acces aux soins de sante et la liberte individuelle a decider de la participation a la recherche medicale. Cela doit reunir les agents de la recherche clinique, des sciences sociales et de la bioethique dans des efforts de recherche en collaboration transdisciplinaire qui necessitent l'apport collectif des chercheurs, des sponsors de la recherche et des bailleurs de fonds. La libertad de dar consentimiento para participar en proyectos de investigacion medica es un tema complejo, particularmente en comunidades socioeconomicamente vulnerables, en donde numerosos factores pueden limitar la eficacia del procedimiento del consentimiento informado. Una consulta informal a miembros de la red de investigacion Switching the Poles Clinical Research Network, pertenecientes a varios paises del africa subsahariana (Burkina Faso, Gambia, Ruanda, Etiopia, la Republica Democratica del Congo y Benin), parece apoyar la hipotesis de que en comunidades socioeconomicamente vulnerables con una acceso inadecuado a cuidados sanitarios, la decision de participar en investigacion a menudo se toma independientemente del contenido de la entrevista para el consentimiento informado, y en gran parte se debe a la oportunidad de tener acceso a cuidados sanitarios gratuitos o mejores, asi como a otros beneficios indirectos. La vulnerabilidad de la poblacion debido a la pobreza y/o exclusion social obviamente no deberia llevar a la exclusion de investigaciones medicas, las cuales a menudo son cruciales para abordar sus problemas sanitarios. Sin embargo, con el fin de reducir la posibilidad de explotacion, es necesario investigar mas a fondo el nexo complejo entre la vulnerabilidad socioeconomica, el acceso a cuidados sanitarios y la libertad individual para decidir participar en investigacion medica. Ello requiere un esfuerzo conjunto de los investigadores clinicos, sociales y expertos en bioetica mediante trabajos de colaboracion transdisciplinar con la aportacion colectiva de los investigadores, patrocinadores y financiadores de la investigacion.	[Ravinetto, Raffaella M.] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Ravinetto, Raffaella M.] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium; [Afolabi, Muhammed O.; Okebe, Joseph; D'Alessandro, Umberto] MRC Unit, Fajara, Gambia; [Afolabi, Muhammed O.; Okebe, Joseph; D'Alessandro, Umberto] London Sch Hyg & Trop Med, London WC1, England; [Van Nuil, Jennifer Ilo] Rinda Ubuzima, Kigali, Rwanda; [Van Nuil, Jennifer Ilo] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Lutumba, Pascal] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Lutumba, Pascal; Mavoko, Hypolite Muhindo] Univ Kinshasa, Kinshasa, DEM REP CONGO; [Nahum, Alain] CREC, Cotonou, Benin; [Tinto, Halidou] Ctr Muraz, Inst Rech Sci Sante, Clin Res Unit Nanoro, Bobo Dioulasso, Burkina Faso; [Addissie, Adamu] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia; [D'Alessandro, Umberto; Grietens, Koen Peeters] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Grietens, Koen Peeters] Nagasaki Univ, Sch Int Hlth Dev, Nagasaki 852, Japan; [Grietens, Koen Peeters] Partners Appl Social Sci Int, Tessenderlo, Belgium	Ravinetto, RM (reprint author), Inst Trop Med, Dept Clin Sci, Natl Str 155, B-2000 Antwerp, Belgium.	rravinetto@itg.be	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009; Peeters Grietens, Koen/0000-0001-6570-9887; Tinto, Halidou/0000-0002-0472-3586; Okebe, Joseph/0000-0001-5466-1611; Afolabi, Muhammed/0000-0002-9967-6419	Belgian Directorate-General for Development Cooperation (DGD); Institute of Tropical Medicine, Antwerp (Belgium); Medical Research Council [MC_UP_A900_1119]	This Switching the Poles Clinical Research Network is funded by the Belgian Directorate-General for Development Cooperation (DGD) under the Framework Agreement 3 (FA3) with the Institute of Tropical Medicine, Antwerp (Belgium).	Afolabi MO, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004817; Afolabi MO, 2014, AM J TROP MED HYG, V90, P908, DOI 10.4269/ajtmh.13-0615; Afolabi Muhammed Olanrewaju, 2014, J Clin Res Bioeth, V5, P178; Bull S, 2012, J EMPIR RES HUM RES, V7, P37, DOI 10.1525/jer.2012.7.1.37; Chaisson LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022696; Muhindo M, 2013, TRIALS, V14, P307, DOI DOI 10.1186/1745-6215-14-307; Nahum A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-170; Peeters Grietens K, 2014, AM J TROP MED HYG, V90, P630; Ravinetto RM, 2013, MED RES SOCIOECONOMI; Saidu Y., 2013, Journal of Clinical Research and Bioethics, V4, P1000141; Tekola F, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000482; Tinto H, 2013, AM J TROP MED HYG, V88, P608, DOI 10.4269/ajtmh.12-0330; Toe LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080800; Vreeman R, 2012, BMC MED ETHICS, V13, DOI 10.1186/1472-6939-13-23	14	12	12	3	28	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	JAN	2015	20	1					63	66		10.1111/tmi.12396				4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	AW0GX	WOS:000345970400008	25302444	Bronze			2019-04-02	
J	Mitashi, P; Hasker, E; Mbo, F; Van Geertruyden, JP; Kaswa, M; Lumbala, C; Boelaert, M; Lutumba, P				Mitashi, P.; Hasker, E.; Mbo, F.; Van Geertruyden, J. P.; Kaswa, M.; Lumbala, C.; Boelaert, M.; Lutumba, P.			Integration of diagnosis and treatment of sleeping sickness in primary healthcare facilities in the Democratic Republic of the Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						human African trypanosomiasis; Democratic Republic of Congo; primary healthcare facilities; trypanosomiase humaine africaine; RDC; etablissements de soins de sante primaires; tripanosomiasis humana Africana; RD Congo; centros sanitarios de atencion primaria	HUMAN AFRICAN TRYPANOSOMIASIS; EFLORNITHINE COMBINATION THERAPY; BRUCEI-GAMBIENSE; SERVICES; SYSTEMS; RISK; PROGRAMS; DRUG; NECT	BackgroundControl of human African trypanosomiasis (HAT) in the Democratic Republic of Congo (DRC) has always been a vertical programme, although attempts at integration in general health services were made in recent years. Now that HAT prevalence is declining, the integration question becomes even more crucial. We studied the level of attainment of integration of HAT case detection and management in primary care centres in two high-prevalence districts in the province of Bandundu, DRC. MethodsWe visited all 43 first-line health centres of Mushie and Kwamouth districts, conducted structured interviews and inspected facilities using a standardised checklist. We focused on: availability of well trained staff - besides HAT, we also tested for knowledge on tuberculosis; availability of equipment, consumables and supplies; and utilisation of the services. ResultsAll health centres were operating but most were poorly equipped, and attendance rates were very low. We observed a median of 14 outpatient consultations per facility (IQR 8-21) in the week prior to our visit, that is two patients per day. The staff had good knowledge on presenting symptoms, diagnosis and treatment of both HAT and tuberculosis. Nine centres were accredited by the national programme as HAT diagnosis and treatment centres, but the most sensitive diagnostic confirmation test, the mini-anion exchange centrifugation technique (mAECT), was not present in any. Although all nine were performing the CATT screening test, only two had the required cold chain in working order. ConclusionIn these high-prevalence districts in DRC, staff is well-acquainted with HAT but lack the tools required for an adequate diagnostic procedure. Attendance rates of these primary care centres are extremely low, making timely recognition of a resurgence of HAT unlikely in the current state of affairs. ContexteLa lutte contre la trypanosomiase humaine africaine (THA) en Republique democratique du Congo (RDC) a toujours ete un programme vertical, quoique des tentatives d'integration dans les services de sante generaux aient ete faites au cours des dernieres annees. Maintenant que la prevalence de la THA est en baisse, la question de l'integration devient encore plus cruciale. Nous avons etudie le niveau d'integration de la detection et la prise en charge des cas de THA dans les centres de soins primaires dans deux districts a forte prevalence dans la province de Bandundu, en RDC. MethodesNous avons visite tous les 43 centres de sante de premiere ligne des districts de Mushie et Kwamouth, avons mene des entretiens structures et inspecte les etablissements en utilisant une liste de controle standardisee. Nous nous sommes concentres sur: la disponibilite de personnel bien forme - outre la THA nous avons egalement teste les connaissances sur la tuberculose, la disponibilite des equipements, des consommables et des fournitures, et l'utilisation des services. ResultatsTous les centres de sante fonctionnaient, mais la plupart etaient mal equipes et les taux de frequentation etaient tres faibles. Nous avons observe une mediane de 14 consultations ambulatoires par etablissement (IQR 8-21) dans la semaine avant notre visite, i.e. 2 patients par jour. Le personnel avait une bonne connaissance sur la presentation des symptomes, le diagnostic et le traitement a la fois de la THA et de la tuberculose. Neuf centres etaient accredites par le programme national comme centres de diagnostic et de traitement de la THA, mais le test le plus sensible pour la confirmation du diagnostic, la technique de chromatographie d'echange de mini-anion (mAECT) n'etait disponible dans aucun de ces centres. Bien que tous les neuf centres effectuaient le test de depistage CATT, seuls deux disposaient de la chaine de froid necessaire en bon etat de fonctionnement. ConclusionDans ces districts a forte prevalence en RDC, le personnel est bien au courant de la THA mais n'a pas les outils necessaires pour une procedure de diagnostic adequat. Les taux de visites dans ces centres de soins primaires sont extremement faibles, ce qui rend la reconnaissance en temps opportun d'une resurgence de la THA peu probable dans l'etat actuel des choses. AntecedentesEl control de la Tripanosomiasis Humana Africana (THA) en la Republica Democratica del Congo (RDC) siempre ha sido un programa vertical, aunque en anos recientes se han realizado intentos de integrarlos en los servicios sanitarios generales. Ahora que la prevalencia de la THA esta disminuyendo, el conseguir la integracion es aun mas importante. Hemos estudiado el nivel de consecucion de la integracion de la deteccion de casos y el manejo de THA en centros de atencion primaria de dos distritos con una alta prevalencia en la provincia de Bandundu, RDC. MetodosHemos visitado todos los 43 centros sanitarios de primera linea de los distritos de Mushie y Kwamouth, realizado entrevistas estructuradas e inspeccionado los centros utilizando una lista de verificacion estandarizada. Nos hemos centrado en: 1) la disponibilidad de personal bien entrenado - aparte de THA tambien evaluamos los conocimientos sobre tuberculosis; 2) la disponibilidad de equipamiento, consumibles y provisiones; 3) y la utilizacion de los servicios. ResultadosTodos los centros sanitarios estaban operativos, pero la mayoria estaban mal equipados y las tasas de asistencia eran muy bajas. Observamos una mediana de 14 consultas externas por centro (IQR 8-21) en la semana anterior a nuestra visita, es decir de 2 pacientes por dia. El personal sanitario tenia un buen conocimiento sobre los sintomas, el diagnostico y el tratamiento tanto de THA como de tuberculosis. Nueve centros estaban acreditados por el programa nacional de THA como centros de diagnostico y tratamiento pero la prueba diagnostica confirmatoria mas sensible, la cromatografia de intercambio anionico a microescala (mAECT) no estaba presente en ninguno de ellos. Aunque los nueve estaban realizando la prueba de aglutinacion en placa (CATT), solo dos tenian operativa la cadena de frio requerida. ConclusionEn estos distritos con una alta prevalencia en la RDC, el personal esta familiarizado con la THA pero no dispone de las herramientas necesarias para realizar un procedimiento diagnostico adecuado. Las tasas de asistencia a estos centros sanitarios primarios es extremadamente baja, lo cual hace que dadas las circunstancias actuales seria dificil reconocer a tiempo el resurgimiento de la THA.	[Mitashi, P.; Hasker, E.; Kaswa, M.; Boelaert, M.] Inst Trop Med, B-2000 Antwerp, Belgium; [Mitashi, P.; Lutumba, P.] Kinshasa Univ, Fac Med, Kinshasa, DEM REP CONGO; [Mitashi, P.; Kaswa, M.; Lutumba, P.] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Mitashi, P.; Van Geertruyden, J. P.] Univ Antwerp, B-2020 Antwerp, Belgium; [Mbo, F.; Lumbala, C.] Natl Program Control Human African Trypanosomiasi, Kinshasa, DEM REP CONGO; [Kaswa, M.] Natl TB Program, Kinshasa, DEM REP CONGO	Mitashi, P (reprint author), Kinshasa Univ, Fac Med, Kinshasa, DEM REP CONGO.	pmitashi@yahoo.fr	Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Boelaert, Marleen/0000-0001-8051-6776			Alirol E, 2013, CLIN INFECT DIS, V56, P195, DOI 10.1093/cid/cis886; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Buscher P, 2013, NEW ENGL J MED, V368, P1069, DOI 10.1056/NEJMc1210373; Criel B, 2004, TROP MED INT HEALTH, V9, pA1, DOI 10.1111/j.1365-3156.2004.01257.x; Criel B, 1997, STUD HLTH SERV ORG, V3, P1; DEBROUWERE V, 1989, ANN SOC BELG MED TR, V69, P221; Dudley L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003318.pub3; Franco JR, 2014, PARASITOLOGY, V141, P748, DOI 10.1017/S0031182013002102; Hasker E, 2011, TROP MED INT HEALTH, V16, P869, DOI 10.1111/j.1365-3156.2011.02772.x; Kyabayinze DJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-695; LAVEISSIERE C, 1993, ANN SOC BELG MED TR, V73, P1; Lutumba P, 2006, TROP MED INT HEALTH, V11, P470, DOI [10.1111/j.1365-3156.2006.01591.x, 10.1111/j.1365-3159.2006.01591.x]; MERCENIER P, 1977, ANN SOC BELG MED TR, V57, P323; Mitashi P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001919; Mukadi P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-308; PEPIN J, 1989, B WORLD HEALTH ORGAN, V67, P301; Ridderhof JC, 2007, B WORLD HEALTH ORGAN, V85, P354, DOI 10.2471/BLT.06.039081; ROOS BR, 1995, INT J LEPROSY, V63, P422; Schmid C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001920; Shigayeva A, 2010, HEALTH POLICY PLANN, V25, pi4, DOI 10.1093/heapol/czq060; Simarro PP, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-4; Simarro PP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001859; Simarro PP, 2011, EMERG INFECT DIS, V17, P2322, DOI 10.3201/eid1712.110921; Tarral A, 2014, CLIN PHARMACOKINET, V53, P565, DOI 10.1007/s40262-014-0136-3; World Health Organization, 1998, WHO TECH REP SER, V881, P114; World Health Organization, 2013, WHO TECH REP SER, V984, P1; Yun O, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000720	27	8	8	1	17	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	JAN	2015	20	1					98	105		10.1111/tmi.12404				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	AW0GX	WOS:000345970400012	25329353	Bronze			2019-04-02	
J	Ilunga-Ilunga, F; Leveque, A; Donnen, P; Dramaix, M				Ilunga-Ilunga, F.; Leveque, A.; Donnen, P.; Dramaix, M.			Children hospitalized with severe malaria in Kinshasa (Democratic Republic of the Congo): Household characteristics and factors associated with mortalitys	MEDECINE ET SANTE TROPICALES			French	Article						severe malaria; children; lethality; Kinshasa; Democratic Republic of the Congo		Background: Malaria is a major health problem in tropical Africa. In DRC, little is known about the characteristics of households of children with severe malaria or the factors associated with its lethality, especially relative to hospital status. Methods: This study of 9 hospitals of the city-province of Kinshasa studied 1350 children younger than 15 years and hospitalized for severe malaria from January to November 2011. Results: More than three quarters of children admitted to public (state) and church hospitals were from poor households and with uneducated mothers (P < 0.001). The case-fatality rate (5.9% of all children) differed according to hospital status: 5.3% in state hospitals, 8.4% in private hospitals, and 4.0% in the faith-based hospitals (P < 0.001). The risk of death was significantly associated with circulatory collapse (odds ratio, OR = 10.3), number of associated syndromes >2 (OR = 3.5), z-score of weight-for-age <=-2 (OR = 3.5), delay in seeking medical care (OR = 4.9), body temperature >= 40 degrees C (OR = 2.9), respiratory distress (OR = 1.9) and home rental (versus ownership) a tenant (OR = 2.8), and anorexia was a protective factor (odds ratio = 0.5). Conclusion: Severe cases of malaria are rife in poor households and periurban residential areas. Orienting prevention, control, and care-according to the vulnerability of affected households and providing early treatment are imperative if we are to reduce mortality from malaria.	[Ilunga-Ilunga, F.] Univ Libre Bruxelles, Campus Erasme,CP598,808 Route Lennik, B-1070 Brussels, Belgium; [Ilunga-Ilunga, F.] Inst Super Tech Med Kinshasa, Kinshasa, DEM REP CONGO; [Leveque, A.; Donnen, P.; Dramaix, M.] Univ Libre Bruxelles, Ctr Rech Epidemiol Biostat & Rech Clin, Ecole Sante Publ, Brussels, Belgium	Ilunga-Ilunga, F (reprint author), Univ Libre Bruxelles, Campus Erasme,CP598,808 Route Lennik, B-1070 Brussels, Belgium.	feilunga@yahoo.fr					Accardo J., 2007, INFORM SOCIALES, V137, P36; Ayivi B, 2000, BENIN MED, V14, P146; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Camara B, 2011, MED MALADIES INFECT, V41, P63, DOI 10.1016/j.medmal.2010.09.001; Gahutu JB, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-134; Gbadoe AD, 2006, MED MALADIES INFECT, V36, P52, DOI 10.1016/j.medmal.2005.10.006; Haque U, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-367; Hopkins H, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-134; Idro R, 2006, TROP MED INT HEALTH, V11, P115, DOI 10.1111/j.1365-3156.2005.01518.x; Imbert P, 2003, Bull Soc Pathol Exot, V96, P156; Issifou S, 2007, AM J TROP MED HYG, V77, P1015, DOI 10.4269/ajtmh.2007.77.1015; Jambou R., 1998, Archives de l'Institut Pasteur de Madagascar, V64, P56; KARCH S, 1992, B SOC PATHOL EXOT, V85, P304; Kazadi W, 2004, AM J TROP MED HYG, V71, P97, DOI 10.4269/ajtmh.2004.71.97; Kouadio G, 2006, REV ELECT SCI ENV, DOI [10.4000/vertigo.1776, DOI 10.4000/VERTIGO.1776]; Koueta Fla, 2007, Sante, V17, P195, DOI 10.1684/san.2007.0089; Lyke KE, 2003, AM J TROP MED HYG, V69, P253, DOI 10.4269/ajtmh.2003.69.253; Mehta U, 2007, TROP MED INT HEALTH, V12, P617, DOI 10.1111/j.1365-3156.2007.01823.x; Moummi A., 2010, WORKING PAPERS, V112; Msangeni HA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-256; Mulumba MP, 2006, CONGO MED, V9, P81; Mulumba MP, 2009, ANN AFR MED, V2, P143; Mulumba PM, 2001, CONGO MED, V4, P327; Programme des nations unies pour le developpement (PNUD), 2004, UN LUTT CONTR PAUVR; Programme national de lutte contre le Paludisme, 2000, PROJ DECL POL CONTR; Raobijaona H., 2000, Archives de l'Institut Pasteur de Madagascar, V66, P23; Roca-Feltrer A, 2008, TROP MED INT HEALTH, V13, P771, DOI 10.1111/j.1365-3156.2008.02076.x; Serengbe GB, 2004, MED MALADIES INFECT, V34, P86, DOI 10.1016/j.medmal.2003.09.003; Vidhan J, 2008, AM J TROP MED HYG, V79, P636; WHO, 2013, WORLD MAL REP 2013; World Health Organization, 2011, WORLD MAL REP GEN	32	1	1	0	0	JOHN LIBBEY EUROTEXT LTD	MONTROUGE	127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE	2261-3684	2261-2211		MED SANTE TROP	Med. Sante Trop.	JAN-MAR	2015	25	1					75	81		10.1684/mst.2014.0416				7	Tropical Medicine	Tropical Medicine	VD6OX	WOS:000437413800018	25847882				2019-04-02	
J	Jacobs, J; Barbe, B; Gillet, P; Aidoo, M; Serra-Casas, E; Van Erps, J; Daviaud, J; Incardona, S; Cunningham, J; Visser, T				Jacobs, Jan; Barbe, Barbara; Gillet, Philippe; Aidoo, Michael; Serra-Casas, Elisa; Van Erps, Jan; Daviaud, Joelle; Incardona, Sandra; Cunningham, Jane; Visser, Theodoor			Harmonization of malaria rapid diagnostic tests: best practices in labelling including instructions for use	MALARIA JOURNAL			English	Article						Malaria RDT; Harmonization; Best practices; Labeling; Instructions for use	PERFORMANCE; MICROSCOPY; SETTINGS	Background: Rapid diagnostic tests (RDTs) largely account for the scale-up of malaria diagnosis in endemic settings. However, diversity in labelling including the instructions for use (IFU) limits their interchangeability and user-friendliness. Uniform, easy to follow and consistent labelling, aligned with international standards and appropriate for the level of the end user's education and training, is crucial but a consolidated resource of information regarding best practices for IFU and labelling of RDT devices, packaging and accessories is not available. Methods: The Roll Back Malaria Partnership (RBM) commissioned the compilation of international standards and regulatory documents and published literature containing specifications and/or recommendations for RDT design, packaging and labelling of in vitro diagnostics (IVD) (which includes RDTs), complemented with a questionnaire based survey of RDT manufacturers and implementers. A summary of desirable RDT labelling characteristics was compiled, which was reviewed and discussed during a RBM Stakeholder consultation meeting and subsequently amended and refined by a dedicated task force consisting of country programme implementers, experts in RDT implementation, IVD regulatory experts and manufacturers. Results: This process led to the development of consensus documents with a list of suggested terms and abbreviations as well as specifications for labelling of box, device packaging, cassettes, buffer bottle and accessories (lancets, alcohol swabs, transfer devices, desiccants). Emphasis was placed on durability (permanent printing or water-resistant labels), legibility (font size, letter type), comprehension (use of symbols) and ease of reference (e.g. place of labelling on the box or cassette packaging allowing quick oversight). A generic IFU template was developed, comprising background information, a template for procedure and reading/interpretation, a selection of appropriate references and a symbol key of internationally recognized symbols together with suggestions about appropriate lay-out, style and readability. Conclusions: The present document together with its additional files compiled proposes best practices in labelling and IFU for malaria RDTs. It is expected that compliance with these best practices will increase harmonization among the different malaria RDT products available on the market and improve their user-friendliness.	[Jacobs, Jan; Barbe, Barbara; Gillet, Philippe; Serra-Casas, Elisa] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Jacobs, Jan] Univ Leuven, Dept Microbiol & Immunol, Leuven, KU, Belgium; [Aidoo, Michael] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Malaria Branch, Ctr Global Hlth, Atlanta, GA USA; [Van Erps, Jan] Roll Back Malaria Partnership, Geneva, Switzerland; [Daviaud, Joelle] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Incardona, Sandra] Fdn Innovat New Diagnost, Geneva, Switzerland; [Cunningham, Jane] WHO, WHO Global Malaria Programme, CH-1211 Geneva, Switzerland; [Visser, Theodoor] Clinton Hlth Access Initiat, Boston, MA USA	Jacobs, J (reprint author), Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.	jjacobs@itg.be		Incardona, Sandra/0000-0003-4994-1736; gillet, philippe/0000-0001-5878-6446	Roll Back Malaria Partnership; Directorate General for Development Cooperation of the Belgian Government through the Network Program on Laboratory Quality Management [3.21]	This study was funded by Roll Back Malaria Partnership and by the Directorate General for Development Cooperation of the Belgian Government through the Network Program on Laboratory Quality Management, Project 3.21. The funders had no role in the study design, data collection and analysis or the preparation of the manuscript.	[Anonymous], 2012, 1522312012 ISO; [Anonymous], 2011, 181132009 ISO 1; Batwala V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-372; Batwala V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-349; Clinical and Laboratory Standards Institute (CLSI), 2008, GP42A6 CLSI, V28; Counihan H, 2012, AM J TROP MED HYG, V87, P57, DOI 10.4269/ajtmh.2012.11-0800; de Oliveira AM, 2009, AM J TROP MED HYG, V80, P470, DOI 10.4269/ajtmh.2009.80.470; European Commission, 2009, ENTR F 2 SF JR 2009; European Commission, 2007, MEDDEV 2 14 3 REV 1; Foundation for Innovative New Diagnostics (FIND), WHO FIND MAL RDT LOT; Gillet P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-39; Hermans V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-331; International Medical Device Regulators Forum, 2013, IMDEF WG NYFINAL 201; *ISO, 2007, 151892007 ISO; Kamal-Yanni MM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-414; Liu L, 2005, WORKSH P 5 FACH K ME, P81; Maltha J, 2013, CLIN MICROBIOL INFEC, V19, P399, DOI 10.1111/1469-0691.12151; Maltha J, 2013, CLIN MICROBIOL INFEC, V19, P408, DOI 10.1111/1469-0691.12152; Procurement and Supply Chain Management Working Group, 2013, ENH MAL RDT HARM RDT; Roll Back Malaria Partnership, 2011, MAL RDT LANDSC WORKS; Roll Back Malaria Partnership and Institue of Tropical Medicine, 2013, REP STAK CONS ENH HA; Special Programme for Research and Training in Tropical Diseases (TDR), 2014, MAL RDTS PRIV SECT; Streat E, 10 M PROC SUPPL MAN; The Global Harmonization Task Force, 2012, GHTF SG1 N68 2012 ES; The Global Harmonization Task Force, 2011, GHTF SG1 N70 2011 LA; U. S. Food and Drug Administration, 2004, GUID IND FDA STAFF U; UNITAID, 2011, MAL DIAGN TECHN LAND; UNITAID, 2013, MAL DIAGN MARK LANDS; UNITAID, 2012, MAL DIAGN MARK LANDS; Wallace LS, 2008, DIABETES TECHNOL THE, V10, P11, DOI 10.1089/dia.2007.0258; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2011, UN ACC MAL DIAGN TES; WHO, 2010, GUID TREATM MAL; World Health Organization, 2011, GOOD PRACT SEL PROC; World Health Organization, 2012, T3 TEST TREAT TRACK; World Health Organization, WHO MAL RAP DIAGN TE; World Health Organization, WHO PREQ IN VITR DIA	38	8	8	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	DEC 17	2014	13								505	10.1186/1475-2875-13-505				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AY4UT	WOS:000347574100001	25519980	DOAJ Gold, Green Published			2019-04-02	
J	Gobbi, F; Angheben, A; Anselmi, M; Postiglione, C; Repetto, E; Buonfrate, D; Marocco, S; Tais, S; Chiampan, A; Mainardi, P; Bisoffi, Z				Gobbi, Federico; Angheben, Andrea; Anselmi, Mariella; Postiglione, Chiara; Repetto, Ernestina; Buonfrate, Dora; Marocco, Stefania; Tais, Stefano; Chiampan, Andrea; Mainardi, Paride; Bisoffi, Zeno			Profile of Trypanosoma cruzi Infection in a Tropical Medicine Reference Center, Northern Italy	PLOS NEGLECTED TROPICAL DISEASES			English	Article							CHRONIC CHAGAS-DISEASE; SPAIN; BENZNIDAZOLE; BARCELONA; DIAGNOSIS; MIGRANTS; BOLIVIA; AREA	Background: Chagas disease (CD) is endemic in Central and South America, Mexico and even in some areas of the United States. However, cases have been increasingly recorded also in non-endemic countries. The estimated number of infected people in Europe is in a wide range of 14000 to 181000 subjects, mostly resident in Spain, Italy and the United Kingdom. Methodology/Principal Findings: Retrospective, observational study describing the characteristics of patients with CD who attended the Centre for Tropical Diseases (Negrar, Verona, Italy) between 2005 and 2013. All the patients affected by CD underwent chest X-ray, ECG, echocardiography, barium X-ray of the oesophagus and colonic enema. They were classified in the indeterminate, cardiac, digestive or mixed category according to the results of the screening tests. Treatment with benznidazole (or nifurtimox in case of intolerance to the first line therapy) was offered to all patients, excluding the ones with advanced cardiomiopathy, pregnant and lactating women. Patients included were 332 (73.9% women). We classified 68.1% of patients as having Indeterminate Chagas, 11.1% Cardiac Chagas, 18.7% as Digestive Chagas and 2.1% as Mixed Form. Three hundred and twenty-one patients (96.7%) were treated with benznidazole, and most of them (83.2%) completed the treatment. At least one adverse effect was reported by 27.7% of patients, but they were mostly mild. Only a couple of patients received nifurtimox as second line treatment. Conclusions/Significance: Our case series represents the largest cohort of T. cruzi infected patients diagnosed and treated in Italy. An improvement of the access to diagnosis and cure is still needed, considering that about 9200 infected people are estimated to live in Italy. In general, there is an urgent need of common guidelines to better classify and manage patients with CD in non-endemic countries.	[Gobbi, Federico; Angheben, Andrea; Anselmi, Mariella; Buonfrate, Dora; Marocco, Stefania; Tais, Stefano; Bisoffi, Zeno] Sacro Cuore Hosp, CTD, Verona, Italy; [Anselmi, Mariella] Ctr Community Epidemiol & Trop Med CECOMET, Esmeraldas, Ecuador; [Postiglione, Chiara] ULSS 20, Prevent Dept, Verona, Italy; [Repetto, Ernestina] Med Sans Frontieres, Operat Ctr Bruxelles, Brussels, Belgium; [Chiampan, Andrea] Sacro Cuore Hosp, Cardiol Unit, Verona, Italy; [Mainardi, Paride] Sacro Cuore Hosp, Radiol Unit, Verona, Italy	Gobbi, F (reprint author), Sacro Cuore Hosp, CTD, Verona, Italy.	federico.gobbi@sacrocuore.it					Angheben A, 2011, EUROSURVEILLANCE, V16, P2; Angheben A, 2012, BLOOD TRANSFUS-ITALY, V10, P542, DOI 10.2450/2012.0015-12; Bern C, 2011, NEW ENGL J MED, V364, P2527, DOI 10.1056/NEJMct1014204; Borges-Pereira J, 2001, Rev Soc Bras Med Trop, V34, P459, DOI 10.1590/S0037-86822001000500009; Borges-Pereira José, 2002, Rev. Soc. Bras. Med. Trop., V35, P315, DOI 10.1590/S0037-86822002000400007; BRENIERE SF, 1989, AM J TROP MED HYG, V41, P521, DOI 10.4269/ajtmh.1989.41.521; Carrilero B, 2011, REV ESP QUIM, V24, P123; Coura J R, 1983, Mem Inst Oswaldo Cruz, V78, P363; Coura J R, 1997, Rev Soc Bras Med Trop, V30, P139, DOI 10.1590/S0037-86821997000200009; COURA J R, 1984, Memorias do Instituto Oswaldo Cruz, V79, P101; Dantas RO, 1999, J CLIN GASTROENTEROL, V28, P245, DOI 10.1097/00004836-199904000-00012; de REZENDE J, 1960, Rev Bras Gastroenterol, V12, P247; Gascon J, 2007, REV ESP CARDIOL, V60, P285, DOI 10.1016/S1885-5857(07)60153-4; Hotez PJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002300; Jackson Y, 2011, EUROSURVEILLANCE, V16, P10; Pinazo MJ, 2010, GASTROENT HEPAT-BARC, V33, P191, DOI 10.1016/j.gastrohep.2009.07.009; LARANJA FS, 1956, CIRCULATION, V14, P1035, DOI 10.1161/01.CIR.14.6.1035; Lescure F-X, 2009, Bull Soc Pathol Exot, V102, P295; Moretti E, 2010, MEM I OSWALDO CRUZ, V105, P621, DOI 10.1590/S0074-02762010000500004; Munoz J, 2009, ACTA TROP, V111, P51, DOI 10.1016/j.actatropica.2009.02.005; Nakazawa M, 2001, CLIN DIAGN LAB IMMUN, V8, P1024, DOI 10.1128/CDLI.8.5.1024-1027.2001; Perez-Ayala A, 2011, CLIN MICROBIOL INFEC, V17, P1108, DOI 10.1111/j.1469-0691.2010.03423.x; Perez-Ayala A, 2011, ANN TROP MED PARASIT, V105, P25, DOI 10.1179/136485910X12851868780423; PLESS M, 1992, AM J TROP MED HYG, V47, P539, DOI 10.4269/ajtmh.1992.47.539; Prata A, 2001, Lancet Infect Dis, V1, P92, DOI 10.1016/S1473-3099(01)00065-2; Ramos JM, 2012, PATHOG GLOB HEALTH, V106, P340, DOI 10.1179/2047773212Y.0000000039; Rassi A, 2012, INFECT DIS CLIN N AM, V26, P275, DOI 10.1016/j.idc.2012.03.002; Salvador F, 2014, CLIN MICROBIOL INFEC, V20, P706, DOI 10.1111/1469-0691.12443; Sanchez-Guillen MDC, 2006, MEM I OSWALDO CRUZ, V101, P733, DOI 10.1590/S0074-02762006000700005; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Sociedade Brasileira de Medicina Tropical, 2005, REV SOC BRAS MED TRO, V38, P1; Strasen J, 2014, CLIN RES CARDIOL, V103, P1, DOI 10.1007/s00392-013-0613-y; Valerio-Sallent L, 2012, REV CLIN ESP, V212, P329, DOI 10.1016/j.rce.2012.03.017; Viotti R, 2006, ANN INTERN MED, V144, P724, DOI 10.7326/0003-4819-144-10-200605160-00006; WHO, 2013, 2 WHO, P57; World Health Organization, 2002, WHO TECH REP SER, V905, P1; Ximenes CA, 1984, REV SOC BRAS MED TRO, V17, P23	37	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	DEC	2014	8	12							e3361	10.1371/journal.pntd.0003361				6	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AX1IM	WOS:000346701000037	25502927	DOAJ Gold, Green Published			2019-04-02	
J	Linsuke, S; Nundu, S; Mupoyi, S; Mukele, R; Mukunda, F; Kabongo, MM; da Luz, RI; Van Geertruyden, JP; Van Sprundel, M; Boelaert, M; Polman, K; Lutumba, P				Linsuke, Sylvie; Nundu, Sabin; Mupoyi, Sylvain; Mukele, Rodin; Mukunda, Faustin; Kabongo, Madeleine Mbuyi; da Luz, Raquel Inocencio; Van Geertruyden, Jean-Pierre; Van Sprundel, Marc; Boelaert, Marleen; Polman, Katja; Lutumba, Pascal			High Prevalence of Schistosoma mansoni in Six Health Areas of - Kasansa Health Zone, Democratic Republic of the Congo: Short Report	PLOS NEGLECTED TROPICAL DISEASES			English	Article							INTESTINAL SCHISTOSOMIASIS; KIVU-PROVINCE; ZAIRE; KINSHASA; BILHARZIASIS; INFECTION; HOOKWORM; MANIEMA	School-aged children suffer the most from schistosomiasis infection in sub Saharan Africa due to poverty and limited sanitary conditions. Mapping of disease burden is recommended and there is a need of updating prevalence data which is as old as 20 years in the Democratic Republic of Congo. An epidemiological and parasitological study was carried out in 2011 in the health zone of Kasansa. Six health areas (HA) were included in the study. In each health area, one primary school was selected. School-aged children were screened for S. mansoni infection using parallel Kato-Katz and direct microscopy techniques. A total of 335 school-aged children were screened. The average prevalence was 82.7% and ranged between 59.5-94.9%. Four of the six HAs had a prevalence level over 91%. Of all infected children, about half 112 (43.2%) had light parasite density. These results demonstrate that Schistosoma mansoni infection is a bigger problem than anticipated and there is an urgent need to implement effective control measures.	[Linsuke, Sylvie; Nundu, Sabin; Mupoyi, Sylvain; Mukele, Rodin; Lutumba, Pascal] Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO; [Linsuke, Sylvie; Nundu, Sabin; Lutumba, Pascal] Inst Natl Rech Biomed, Dept Epidemiol, Kinshasa, DEM REP CONGO; [Mupoyi, Sylvain; Mukunda, Faustin] Programme Natl Lutte Bilharziose & Parasitoses In, Kinshasa, DEM REP CONGO; [Kabongo, Madeleine Mbuyi] Georgia State Univ, Sch Publ Hlth, Atlanta, GA 30303 USA; [da Luz, Raquel Inocencio; Van Geertruyden, Jean-Pierre; Van Sprundel, Marc] Univ Antwerp, Epidemiol & Scocial Med Int Hlth Unit, B-2020 Antwerp, Belgium; [Boelaert, Marleen] Inst Trop Med, Unit Epidemiol & Control Trop Dis, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Polman, Katja] Inst Trop Med, Unit Med Helminthol, Dept Biomed Sci, B-2000 Antwerp, Belgium	Linsuke, S (reprint author), Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO.	sylvie_lin2003@yahoo.fr	Van geertruyden, Jean-Pierre/K-6425-2014; Inocencio da Luz, Raquel/L-9676-2016	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Inocencio da Luz, Raquel/0000-0002-2870-0311; Boelaert, Marleen/0000-0001-8051-6776	VLIR UOS Project [42/FA02000/13/5806]	Funding was provided by the VLIR UOS Project, Grant Nr 42/FA02000/13/5806. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNIKE T, 1976, ANN SOC BELG MED TR, V56, P419; Bonnard P, 2000, J GASTROENTEROL, V24, P409; Chitsulo L, 2000, ACTA TROP, V77, P41, DOI 10.1016/S0001-706X(00)00122-4; COLAERT J, 1978, ANN SOC BELG MED TR, V58, P315; COLAERT J, 1977, ANN SOC BELG MED TR, V57, P157; GILLET J, 1954, Bull World Health Organ, V10, P315; GRYSEELS B, 1983, ANN SOC BELG MED TR, V63, P341; Gryseels B, 1981, Ann Soc Belg Med Trop, V60, P313; Gryseels B, 2012, INFECT DIS CLIN N AM, V26, P383, DOI 10.1016/j.idc.2012.03.004; Janssens P. G, 1992, MED HYGIENE AFRIQUE, V2, P1045; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Lwambo NJS, 1999, T ROY SOC TROP MED H, V93, P497, DOI 10.1016/S0035-9203(99)90349-8; Matthys B, 2007, TROP MED INT HEALTH, V12, P709, DOI 10.1111/j.1365-3156.2007.01841.x; Montresor A, 2004, LUTTE HELMINTHIASES; Organisation Mondiale de la Sante (OMS), 2011, LUTT HELM CHEZ ENF A; POLDERMAN AM, 1985, ANN SOC BELG MED TR, V65, P243; POLDERMAN AM, 1985, ANN SOC BELG MED TR, V65, P251; Rimoin AW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002118; Ripert C, 1970, Bull Soc Pathol Exot Filiales, V63, P580; SCHWETZ J, 1956, Ann Soc Belg Med Trop (1920), V36, P845; Stephenson LS, 2000, PARASITOLOGY, V121, pS23, DOI 10.1017/S0031182000006491; VANEE JH, 1984, TROP GEOGR MED, V36, P259; WHO, 2002, WHO TECH REP SER, V912, pi; World Health Organization Expert Committee on Epidemiology and Control of Schistosomiasis, 1967, EP CONTR SCHIST REP; World Health Organization (WHO), 1991, BAS LAB METH MED PAR	26	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	DEC	2014	8	12							e3387	10.1371/journal.pntd.0003387				6	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AX1IM	WOS:000346701000050	25521351	DOAJ Gold, Green Published			2019-04-02	
J	Suleman, S; Zeleke, G; Deti, H; Mekonnen, Z; Duchateau, L; Levecke, B; Vercruysse, J; D'Hondt, M; Wynendaele, E; De Spiegeleer, B				Suleman, Sultan; Zeleke, Gemechu; Deti, Habtewold; Mekonnen, Zeleke; Duchateau, Luc; Levecke, Bruno; Vercruysse, Jozef; D'Hondt, Matthias; Wynendaele, Evelien; De Spiegeleer, Bart			Quality of Medicines Commonly Used in the Treatment of Soil Transmitted Helminths and Giardia in Ethiopia: A Nationwide Survey	PLOS NEGLECTED TROPICAL DISEASES			English	Article							DERRINGERS DESIRABILITY FUNCTION; SUBSTANDARD MEDICINES; DRUGS; ALBENDAZOLE; COUNTERFEIT; MEBENDAZOLE; INFECTIONS; OPTIMIZATION; EFFICACY; HEALTH	Background: The presence of poor quality medicines in the market is a global threat on public health, especially in developing countries. Therefore, we assessed the quality of two commonly used anthelminthic drugs [mebendazole (MEB) and albendazole (ALB)] and one antiprotozoal drug [tinidazole (TNZ)] in Ethiopia. Methods/Principal Findings: A multilevel stratified random sampling, with as strata the different levels of supply chain system in Ethiopia, geographic areas and government/privately owned medicines outlets, was used to collect the drug samples using mystery shoppers. The three drugs (106 samples) were collected from 38 drug outlets (government/privately owned) in 7 major cities in Ethiopia between January and March 2012. All samples underwent visual and physical inspection for labeling and packaging before physico-chemical quality testing and evaluated based on individual monographs in Pharmacopoeias for identification, assay/content, dosage uniformity, dissolution, disintegration and friability. In addition, quality risk was analyzed using failure mode effect analysis (FMEA) and a risk priority number (RPN) was assigned to each quality attribute. A clinically rationalized desirability function was applied in quantification of the overall quality of each medicine. Overall, 45.3% (48/106) of the tested samples were substandard, i.e. not meeting the pharmacopoeial quality specifications claimed by their manufacturers. Assay was the quality attribute most often out-of-specification, with 29.2% (31/106) failure of the total samples. The highest failure was observed for MEB (19/42, 45.2%), followed by TNZ (10/39, 25.6%) and ALB (2/25, 8.0%). The risk analysis showed that assay (RPN = 512) is the most critical quality attribute, followed by dissolution (RPN = 336). Based on Derringer's desirability function, samples were classified into excellent (14/106,13%), good (24/106, 23%), acceptable (38/106, 36%%), low (29/106, 27%) and bad (1/106,1%) quality. Conclusions/Significance: This study evidenced that there is a relatively high prevalence of poor quality MEB, ALB and TNZ in Ethiopia: up to 45% if pharmacopoeial acceptance criteria are used in the traditional, dichotomous approach, and 28% if the new risk-based desirability approach was applied. The study identified assay as the most critical quality attributes. The country of origin was the most significant factor determining poor quality status of the investigated medicines in Ethiopia.	[Suleman, Sultan; Zeleke, Gemechu; Deti, Habtewold] Jimma Univ, Sch Pharm, Jimma, Ethiopia; [Suleman, Sultan; D'Hondt, Matthias; Wynendaele, Evelien; De Spiegeleer, Bart] Univ Ghent, Fac Pharmaceut Sci, Drug Qual & Registrat DruQuaR Grp, B-9000 Ghent, Belgium; [Mekonnen, Zeleke] Jimma Univ, Sch Med Lab Sci, Jimma, Ethiopia; [Mekonnen, Zeleke; Levecke, Bruno; Vercruysse, Jozef] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Duchateau, Luc] Univ Ghent, Fac Vet Med, Dept Comparat Physiol & Biometr, Merelbeke, Belgium	Suleman, S (reprint author), Jimma Univ, Sch Pharm, Jimma, Ethiopia.	Bart.Despiegeleer@UGent.be	De Spiegeleer, Bart/A-2001-2008	De Spiegeleer, Bart/0000-0001-6794-3108; Levecke, Bruno/0000-0001-8912-5595	Jimma University; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) [101529]; Ghent University [BOF 01J22510]	This study was supported by Jimma University (http://www.ju.edu.et). SS and ZM are supported by the Infectious Diseases and Epidemiology Project within Institutional University Cooperation Programme (Jimma University) of VLIR (http://www.iucju.ugent.be). BL is a postdoctoral fellow of FWO (Grant number FWO12/PDO/099). MD is supported by the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) (No. 101529) while EW is supported by the Special Research Fund of Ghent University (Grant number BOF 01J22510). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, 1629A MILSTD DEP DEF; [Anonymous], 2006, PREV CHEM HUM HELM C; Attaran A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7381; Baert B, 2010, ANAL BIOANAL CHEM, V398, P125, DOI 10.1007/s00216-010-3912-4; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Bikbulatov ES, 2011, RUSS J GEN CHEM+, V81, P2694, DOI 10.1134/S1070363211130111; BORKA L, 1990, ACTA PHARM JUGOSL, V40, P71; Braglia M., 2000, INT J QUALITY RELIAB, V17, P1017, DOI DOI 10.1108/02656710010353885; Brits M, 2010, J PHARM SCI-US, V99, P1138, DOI 10.1002/jps.21899; Caudron JM, 2008, TROP MED INT HEALTH, V13, P1062, DOI 10.1111/j.1365-3156.2008.02106.x; Chakraborty AK, 1989, QUAL ENG, P443; Chang KH, 2009, MICROELECTRON RELIAB, V49, P1586, DOI 10.1016/j.microrel.2009.07.057; Chung MS, 2001, PARASITE, V8, pS195, DOI 10.1051/parasite/200108s2195; Coulibaly JT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-135; D'Hondt M., 2013, J PHARM ANAL; Daniel-Mwambete K, 2004, INT J PHARMACEUT, V272, P29, DOI 10.1016/j.ijpharm.2003.11.030; Dayan AD, 2003, ACTA TROP, V86, P141, DOI 10.1016/S0001-706X(03)00031-7; DERRINGER GC, 1994, QUAL PROG, V27, P51; Dickinson PA, 2008, AAPS J, V10, P380, DOI 10.1208/s12248-008-9034-7; Dressman JB, 2000, EUR J PHARM SCI, V11, pS73, DOI 10.1016/S0928-0987(00)00181-0; FMHACA, 2010, STAND TREATM GUID GE; Fogliatto FS, 2008, QUAL RELIAB ENG INT, V24, P927, DOI 10.1002/qre.939; Garcia-Rodriguez JJ, 2011, INT J PHARMACEUT, V403, P23, DOI 10.1016/j.ijpharm.2010.10.002; Heyman ML, 2011, J PHARM SCI-US, V100, P1280, DOI 10.1002/jps.22391; Honorato SB, 2012, J BRAZIL CHEM SOC, V23, P220, DOI 10.1590/S0103-50532012000200005; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Huang GQ, 1999, COMPUT IND ENG, V37, P177, DOI 10.1016/S0360-8352(99)00049-2; International Conference on Harmonization, 2006, GUID IND Q9 QUAL RIS; International Conference on Harmonization, 2006, GUID IND Q8 PHARM DE; Juillet Y, 2008, B ACAD NAT MED PARIS, V192, P1423; Jung H, 1998, J PHARM PHARMACOL, V50, P43, DOI 10.1111/j.2042-7158.1998.tb03303.x; Kahsay G, 2010, MOMONA ETHIOP J SCI, V2, P93, DOI 10.4314/mejs.v2i1.49656; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Keiser J, 2010, ADV PARASIT, V73, P197, DOI 10.1016/S0065-308X(10)73008-6; Kelesidis T, 2007, J ANTIMICROB CHEMOTH, V60, P214, DOI 10.1093/jac/dkm109; Khan MH, 2010, TROP MED INT HEALTH, V15, P639, DOI 10.1111/j.1365-3156.2010.02494.x; Mann P. S., 2010, PRACTITIONERS GUIDE; Martins JM, 1998, J PHARMACEUT BIOMED, V18, P487; Minvielle MC, 1999, PARASITOL RES, V85, P830, DOI 10.1007/s004360050640; Monteiro AM, 1998, VET REC, V142, P396, DOI 10.1136/vr.142.15.396; Nasr N, 2004, FDA ADV COMM PHARM S; Newton PN, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000052; Nsimba Stephen E D, 2008, East Afr J Public Health, V5, P205; Olsen A, 2003, ACTA TROP, V86, P255, DOI 10.1016/S0001-706X(03)00046-9; Onwujekwe O, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-22; Pranzo MB, 2010, J PHARM SCI-US, V99, P3731, DOI 10.1002/jps.22072; Safa F, 2005, J CHROMATOGR A, V1078, P42, DOI 10.1016/j.chroma.2005.04.081; Segall MD, 2009, MULTIPARAMETER OPTIM; Siriyasatien Padet, 2003, Journal of the Medical Association of Thailand, V86, pS257; Sivakumar T, 2007, ACTA CHROMATOGR, V19, P29; Steinmann P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025003; Stephenson L S, 1994, World Health Forum, V15, P169; Subramanian S, 2012, J PHARM PHARM SCI, V15, P103; Suleman S, 2007, ETHIOP J HLTH SCI, V17, P147; Talisuna A, 2012, LANCET INFECT DIS, V12, P888, DOI 10.1016/S1473-3099(12)70241-4; Taylor RB, 2001, LANCET, V357, P1933, DOI 10.1016/S0140-6736(00)05065-0; ten Ham M, 2003, DRUG SAFETY, V26, P991, DOI 10.2165/00002018-200326140-00001; Van Dorpe S, 2011, J PEPT SCI, V17, P398, DOI 10.1002/psc.1323; Vecchiato NL, 1997, ANTHR INFECT DIS INT, P241; Vercruysse J, 2011, INT J PARASITOL-DRUG, V1, P14, DOI 10.1016/j.ijpddr.2011.09.002; WHO, 1999, SPEC PREP ANT MED; WHO, 2002, STRAT DEV MON PAR DI; WHO, 2012, MED SPUR FALS LAB FA; WHO, 2011, SURV QUAL SEL ANT ME; Wiwanitkit V, 2006, CURR HIV RES, V4, P87, DOI 10.2174/157016206775197682; World Health Organization, 2009, SURV QUAL SEL ANT ME; Wu C. F. J., 2005, QUAL ENG, V17, P119, DOI [10.1081/QEN-200028725, DOI 10.1081/QEN-200028725]	67	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	DEC	2014	8	12							e3345	10.1371/journal.pntd.0003345				16	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AX1IM	WOS:000346701000027	25473966	DOAJ Gold, Green Published			2019-04-02	
J	Van Roey, K; Sokny, M; Denis, L; Van den Broeck, N; Heng, S; Siv, S; Sluydts, V; Sochantha, T; Coosemans, M; Durnez, L				Van Roey, Karel; Sokny, Mao; Denis, Leen; Van den Broeck, Nick; Heng, Somony; Siv, Sovannaroth; Sluydts, Vincent; Sochantha, Tho; Coosemans, Marc; Durnez, Lies			Field Evaluation of Picaridin Repellents Reveals Differences in Repellent Sensitivity between Southeast Asian Vectors of Malaria and Arboviruses	PLOS NEGLECTED TROPICAL DISEASES			English	Article							DOMINANT ANOPHELES VECTORS; INSECT ODORANT RECEPTOR; AEDES-ALBOPICTUS; TROPICAL ENVIRONMENT; MOSQUITO REPELLENTS; CHIKUNGUNYA VIRUS; DISTRIBUTION MAPS; GAMBIAE COMPLEX; BIONOMIC PRECIS; DEET	Scaling up of insecticide treated nets has contributed to a substantial malaria decline. However, some malaria vectors, and most arbovirus vectors, bite outdoors and in the early evening. Therefore, topically applied insect repellents may provide crucial additional protection against mosquito-borne pathogens. Among topical repellents, DEET is the most commonly used, followed by others such as picaridin. The protective efficacy of two formulated picaridin repellents against mosquito bites, including arbovirus and malaria vectors, was evaluated in a field study in Cambodia. Over a period of two years, human landing collections were performed on repellent treated persons, with rotation to account for the effect of collection place, time and individual collector. Based on a total of 4996 mosquitoes collected on negative control persons, the overall five hour protection rate was 97.4% [95% CI: 97.1-97.8%], not decreasing over time. Picaridin 20% performed equally well as DEET 20% and better than picaridin 10%. Repellents performed better against Mansonia and Culex spp. as compared to aedines and anophelines. A lower performance was observed against Aedes albopictus as compared to Aedes aegypti, and against Anopheles barbirostris as compared to several vector species. Parity rates were higher in vectors collected on repellent treated person as compared to control persons. As such, field evaluation shows that repellents can provide additional personal protection against early and outdoor biting malaria and arbovirus vectors, with excellent protection up to five hours after application. The heterogeneity in repellent sensitivity between mosquito genera and vector species could however impact the efficacy of repellents in public health programs. Considering its excellent performance and potential to protect against early and outdoor biting vectors, as well as its higher acceptability as compared to DEET, picaridin is an appropriate product to evaluate the epidemiological impact of large scale use of topical repellents on arthropod borne diseases.	[Van Roey, Karel; Denis, Leen; Van den Broeck, Nick; Sluydts, Vincent; Coosemans, Marc; Durnez, Lies] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Sokny, Mao; Heng, Somony; Siv, Sovannaroth; Sochantha, Tho] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Heng, Somony] Inst Pasteur Cambodge, Malaria Mol Epidemiol Unit, Phnom Penh, Cambodia	Van Roey, K (reprint author), Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium.	ldurnez@itg.be			Institutional Collaboration between CNM; Institute of Tropical Medicine, Belgium; Global Health Grant [OPP1032354]	The current study was financially supported by the Institutional Collaboration between CNM and the Institute of Tropical Medicine, Belgium, supported by the Belgian Co-operation (Directorate-General for Development Co-operation), and by the Bill and Melinda Gates foundation under the Global Health Grant number OPP1032354. The two picaridin formulated repellents were provided free of charge by S.C. Johnson & Son, Inc (Racine, USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badolo A, 2004, TROP MED INT HEALTH, V9, P330, DOI 10.1111/j.1365-3156.2004.01206.x; Barnard DR, 2002, J MED ENTOMOL, V39, P895, DOI 10.1603/0022-2585-39.6.895; Bettadapura J, 2013, INDIAN J MED RES, V138, P762; Bohbot JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012138; Boulanger N, 2012, PROTECTION PERSONNEL, P352; Caglioti C, 2013, NEW MICROBIOL, V36, P211; Chen-Hussey V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070664; Copeland RS, 1995, J AM MOSQUITO CONTR, V11, P438; Cornet S, 2013, ECOL LETT, V16, P323, DOI 10.1111/ele.12041; Costantini C, 2004, T ROY SOC TROP MED H, V98, P644, DOI 10.1016/j.trstmh.2003.12.015; CURTIS CF, 1987, MED VET ENTOMOL, V1, P109, DOI 10.1111/j.1365-2915.1987.tb00331.x; Dadzie S, 2013, AM J TROP MED HYG, V88, P309, DOI 10.4269/ajtmh.2012.12-0370; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; Delacollette C, 2009, SE ASIAN J TROP MED, V40, P674; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; Durnez L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-329; Durnez L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-195; Dutta P, 2011, T ROY SOC TROP MED H, V105, P327, DOI 10.1016/j.trstmh.2011.02.008; Fradin MS, 1998, ANN INTERN MED, V128, P931, DOI 10.7326/0003-4819-128-11-199806010-00013; FRANCES SP, 1993, J AM MOSQUITO CONTR, V9, P474; Frances SP, 2004, J MED ENTOMOL, V41, P414, DOI 10.1603/0022-2585-41.3.414; Frances SP, 2007, INSECT REPELLENTS PR, P495; Frances SP, 2011, J MED ENTOMOL, V48, P334, DOI 10.1603/ME10120; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hill N, 2007, BRIT MED J, V335, P1023, DOI 10.1136/bmj.39356.574641.55; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Kain P, 2013, NATURE, V502, P507, DOI 10.1038/nature12594; Kiszewski AE, 2010, J VECTOR DIS, V47, P217; Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467; Lupi E, 2013, TRAVEL MED INFECT DI, V11, P374, DOI 10.1016/j.tmaid.2013.10.005; Maia MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084875; McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968; Moore SJ, 2007, TROP MED INT HEALTH, V12, P532, DOI 10.1111/j.1365-3156.2006.01811.x; Moore Sarah J., 2007, P3; MR4, 2011, METH AN RES; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Prakash A, 2003, NATL MED J INDIA, V16, P135; Qualls WA, 2012, ACTA TROP, V122, P284, DOI 10.1016/j.actatropica.2012.01.012; Richard-Lenoble D, 2008, BIODIVERSITY MALARIA; Rowland M, 2004, TROP MED INT HEALTH, V9, P335, DOI 10.1111/j.1365-3156.2004.01198.x; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Schofield S, 2007, J MED ENTOMOL, V44, P1026, DOI 10.1603/0022-2585(2007)44[1026:LAFEOT]2.0.CO;2; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-117; Spitzen Jeroen, 2005, Proceedings of the Section Experimental and Applied Entomology of the Netherlands Entomological Society (N.E.V.), V16, P95; Stanczyk NM, 2010, P NATL ACAD SCI USA, V107, P8575, DOI 10.1073/pnas.1001313107; Thavara U, 2001, J VECTOR ECOL, V26, P172; Thisyakorn Usa, 2014, Ther Adv Vaccines, V2, P3, DOI 10.1177/2051013613507862; Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; Uzzan B, 2009, FUND CLIN PHARMACOL, V23, P589, DOI 10.1111/j.1472-8206.2009.00731.x; Van Bortel W, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-373; WHO, 2013, WORLD MALARIA REPORT 2013, P1; World Health Organisation, 2009, GUID EFF TEST MOSQ R; Xue R-D, 2007, INSECT REPELLENTS PR, P495; Xue RD, 1996, J AM MOSQUITO CONTR, V12, P58; Yap HH, 2000, J AM MOSQUITO CONTR, V16, P241; Yap HH, 1998, J VECTOR ECOL, V23, P62	62	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	DEC	2014	8	12							e3326	10.1371/journal.pntd.0003326				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AX1IM	WOS:000346701000019	25522134	DOAJ Gold, Green Published			2019-04-02	
J	Porta, MI; Lenglet, A; de Weerdt, S; Crestani, R; Sinke, R; Frawley, MJ; Van Herp, M; Zachariah, R				Porta, M. Ilaria; Lenglet, Annick; de Weerdt, Silvia; Crestani, Rosa; Sinke, Renate; Frawley, Mary Jo; Van Herp, Michel; Zachariah, Rony			Feasibility of a preventive mass vaccination campaign with two doses of oral cholera vaccine during a humanitarian emergency in South Sudan	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Oral cholera vaccine; Preventive mass vaccination campaign; Refugee camps; South Sudan	REFUGEE CAMP	Background: As an adjunct to cholera prevention measures, WHO advises the use of oral cholera vaccine through mass vaccination campaigns in high-risk areas and for vulnerable population groups. We assessed the feasibility and acceptability of a mass vaccination campaign using 1) a predominantly fixed and 2) a mobile door-to-door strategy. Methods: Vaccination included administration of two doses (given 2 weeks apart) of oral cholera vaccine to individuals older than 1 year of age, in four refugee camps: Jamam, Doro, Batil and Gendrassa, and the host population in Maban County, South Sudan, from December 2012 to February 2013. Results: A total of 258 832 doses were administered to a population of 166 000 (126 000 refugees and 40 000 host population). The first round coverage for the refugees was above 84% for Doro, Jamam and Batil and 104% for Gendrassa. The second dose reached the same coverage as the first dose. For the host population, the coverage for the first dose was above 90% in Doro and Jamam and 53% in Gendrassa and Batil. For the second round, the coverage was above 79% in Doro and Jamam and above 70% in Batil and Gendrassa. Conclusions: The vaccination of a large population in an emergency context proved to be feasible and acceptable and achieved high coverage. This is encouraging and is a way forward for reducing cholera related morbidity and mortality among vulnerable populations.	[Porta, M. Ilaria; Crestani, Rosa; Van Herp, Michel; Zachariah, Rony] Med Sans Frontieres Belgium, B-1090 Brussels, Belgium; [Lenglet, Annick; de Weerdt, Silvia; Sinke, Renate; Frawley, Mary Jo] Med Sans Frontieres Holland, Amsterdam, Netherlands	Porta, MI (reprint author), Furukollen 6, N-3924 Porsgrunn, Norway.	ilaria.porta@brussels.msf.org			Medecins Sans Frontieres, Brussels, Belgium	This intervention was fully funded by Medecins Sans Frontieres, Brussels, Belgium. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bechen R, 1996, REV EPIDEMIOL SANTE, V44, P358; Chaignat CL, 2008, EXPERT REV VACCINES, V7, P431, DOI 10.1586/14760584.7.4.431; Ciglenecki I, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001512; International Federation of the Red Cross and Red Crescent, 2009, DREF OP FIN REP; Kanungo S, 2009, VACCINE, V27, P6887, DOI 10.1016/j.vaccine.2009.09.008; Khatib AM, 2012, LANCET INFECT DIS, V12, P837, DOI 10.1016/S1473-3099(12)70196-2; Kur L., 2009, Morbidity and Mortality Weekly Report, V58, P337; Legros D, 1999, B WORLD HEALTH ORGAN, V77, P837; Lucas MES, 2005, NEW ENGL J MED, V352, P757, DOI 10.1056/NEJMoa043323; Mahamud AS, 2012, J INFECT DEV COUNTR, V6, P234, DOI 10.3855/jidc.1966; Shantha Biotechnics Ltd, 2011, SHANCH VACC PACK INS; The UN Refugee Agency, 2013, REF S SUD 2013; WHO, 2006, AC WAT DIARRH SO SUD; WHO, 2007, HLTH UPD APR JUN 200; WHO, 2012, WEEKLY EPIDEMIOLOGIC, V85, P117; WHO, 2012, S SUD EM HUM ACT EHA; World Health Organization, 2006, US 2 DOS OR CHOL VAC	17	12	13	0	11	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	DEC	2014	108	12					810	815		10.1093/trstmh/tru153				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	AU0XM	WOS:000345345500011	25311798	Green Published			2019-04-02	
J	Koole, O; Tsui, S; Wabwire-Mangen, F; Kwesigabo, G; Menten, J; Mulenga, M; Auld, A; Agolory, S; Mukadi, YD; Colebunders, R; Bangsberg, DR; van Praag, E; Torpey, K; Williams, S; Kaplan, J; Zee, A; Denison, J				Koole, Olivier; Tsui, Sharon; Wabwire-Mangen, Fred; Kwesigabo, Gideon; Menten, Joris; Mulenga, Modest; Auld, Andrew; Agolory, Simon; Mukadi, Ya Diul; Colebunders, Robert; Bangsberg, David R.; van Praag, Eric; Torpey, Kwasi; Williams, Seymour; Kaplan, Jonathan; Zee, Aaron; Denison, Julie			Retention and risk factors for attrition among adults in antiretroviral treatment programmes in Tanzania, Uganda and Zambia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						ART; HIV; retention; sub-Saharan Africa; VIH; ART; retention; Afrique subsaharienne; VIH; TAR; retencion; africa sub-Sahariana	SUB-SAHARAN AFRICA; FOLLOW-UP; THERAPY PROGRAMS; RURAL DISTRICT; HIV-INFECTION; SOUTH-AFRICA; 1ST YEAR; OUTCOMES; MORTALITY; SURVIVAL	ObjectivesWe assessed retention and predictors of attrition (recorded death or loss to follow-up) in antiretroviral treatment (ART) clinics in Tanzania, Uganda and Zambia. MethodsWe conducted a retrospective cohort study among adults (18years) starting ART during 2003-2010. We purposefully selected six health facilities per country and randomly selected 250 patients from each facility. Patients who visited clinics at least once during the 90days before data abstraction were defined as retained. Data on individual and programme level risk factors for attrition were obtained through chart review and clinic manager interviews. Kaplan-Meier curves for retention across sites were created. Predictors of attrition were assessed using a multivariable Cox-proportional hazards model, adjusted for site-level clustering. ResultsFrom 17 facilities, 4147 patients were included. Retention ranged from 52.0% to 96.2% at 1year to 25.8%-90.4% at 4years. Multivariable analysis of ART initiation characteristics found the following independent risk factors for attrition: younger age [adjusted hazard ratio (aHR) and 95% confidence interval (95%CI)=1.30 (1.14-1.47)], WHO stage 4 ([aHR (95% CI): 1.56 (1.29-1.88)], >10% bodyweight loss [aHR (95%CI)=1.17 (1.00-1.38)], poor functional status [ambulatory aHR (95%CI)=1.29 (1.09-1.54); bedridden aHR1.54 (1.15-2.07)], and increasing years of clinic operation prior to ART initiation in government facilities [aHR (95%CI)=1.17 (1.10-1.23)]. Patients with higher CD4 cell count were less likely to experience attrition [aHR (95%CI)=0.88 (0.78-1.00)] for every log (tenfold) increase. Sites offering community ART dispensing [aHR (95%CI)=0.55 (0.30-1.01) for women; 0.40 (0.21-0.75) for men] had significantly less attrition. ConclusionsPatient retention to an individual programme worsened over time especially among males, younger persons and those with poor clinical indicators. Community ART drug dispensing programmes could improve retention. ObjectifsNous avons evalue la retention et les predicteurs de l'attrition (deces ou pertes au suivi enregistres) dans le traitement antiretroviral (ART) dans des cliniques en Tanzanie, en Ouganda et en Zambie. MethodesNous avons mene une etude de cohorte retrospective chez les adultes (18 ans) ayant debute l'ART au cours de 2003-2010. Nous avons deliberement choisi six etablissements de sante par pays et avons choisi au hasard 250 patients dans chaque etablissement. Les patients qui ont visite les cliniques au moins une fois au cours des 90 jours avant l'extraction des donnees ont ete definis comme retenus. Les donnees sur les facteurs de risque individuels et a l'echelle du programme pour l'attrition ont ete obtenues par l'examen des dossiers et des entrevues avec les directeur des cliniques. Les courbes de Kaplan-Meier pour la retention a travers les sites ont ete creees. Les predicteurs de l'attrition ont ete evalues a l'aide d'un modele multivarie des risques proportionnels de Cox, corriges par le regroupement au niveau du site. ResultatsDe 17 etablissements, 4147 patients ont ete inclus. La retention variait de 52,0% a 96,2% a un an et de 25,8% a 90,4% a 4 ans. L'analyse multivariee des caracteristiques a l'initiation de l'ART a trouve les facteurs independants de risque pour l'attrition suivants: le plus jeune age [Hazard Ratio ajuste (aHR) et intervalle de confiance a 95% (IC 95%)=1,30 (1,14 a 1,47)], le stade 4 de l'OMS ([aHR (IC 95%): 1,56 (1,29 a 1,88)], > 10% de perte de poids corporel [aHR (IC 95%)=1,17 (1,00 a 1,38)], un mauvais etat fonctionnel [aHR ambulatoire=1,29 (1,09-1,54); aHR alite=1,54 (01,15 a 02,07)] et de plus en plus d'annees d'operations en clinique avant le debut de l'ART dans les etablissements publics [aHR(IC 95%)=1,17 (1,10 a 1,23)]. Les patients avec un taux plus eleve de cellules CD4 etaient moins susceptibles a l'attrition [aHR (IC 95%) = 0,88 (0,78 a 1,00)] pour chaque augmentation logarithmique. Les sites offrant la distribution communautaire de l'ART [aHR (IC 95%)=0,55 (0,30 a 1,01) pour les femmes; =0,40 (0,21 a 0,75) pour les hommes] avaient significativement moins d'attrition. ConclusionsLa retention des patients dans un programme individuel empirait au fil du temps surtout chez les hommes, les personnes plus jeunes et ceux avec de mauvais indicateurs cliniques. Les programmes de distribution communautaire de l'ART pourraient ameliorer la retention. ObjetivosHemos evaluado la retencion y los vaticinadores de abandono (muerte registrada o perdida durante el seguimiento) en centros de tratamiento antirretroviral (TAR) en Tanzania, Uganda y Zambia. MetodosHemos realizado un estudio retrospectivo de cohortes con adultos (18 anos) en TAR durante el 2003-2010. Seleccionamos seis centros sanitarios por pais, y de forma aleatoria a 250 pacientes de cada centro. Los pacientes que visitaron los centros al menos una vez durante los 90 dias anteriores a la fecha de obtencion de los datos se definieron como retenidos. Se obtuvieron datos sobre los factores de riesgo de abandono de los individuos y el nivel del programa mediante la revision de graficos y entrevistas con el gestor del centro. Se realizaron curvas de Kaplan-Meier para la retencion en los distintos centros. Los vaticinadores de abandono se evaluaron utilizando un modelo de riesgos proporcionales de Cox, ajustado para agrupacion a nivel de centros. ResultadosSe incluyeron 4147 pacientes de 17 centros. La retencion estaba entre 52.0%-96.2% al ano y 25.8%-90.4% a los 4 anos. En un analisis multivariante de las caracteristicas presentes en el momento de iniciar TAR, se encontraron los siguientes factores de riesgo de abandono independientes: ser mas joven [razon de riesgo ajustada (RRa) and IC 95=1.30 (1.14-1.47)], estadio 4 de la OMS ([RRa(IC 95%): 1.56 (1.29-1.88)], > 10% perdida de peso corporal [RRa (IC 95%)=1.17 (1.00-1.38)], un estatus funcional pobre [RRa ambulatorio (IC 95%)=1.29 (1.09-1.54); estar en cama RRa 1.54 (1.15-2.07) ], y un mayor numero de anos en clinicas privadas antes de comenzar TAR en un centro gubernamental [RRa (IC 95%)=1.17 (1.10-1.23)]. Los pacientes con un mayor conteo de CD4 tenian una menor probabilidad de experimentar abandono [RRa (IC 95%)=0.88 (0.78-1.00)] para un aumento logaritmico (x10). Los centros que ofrecian dispensarios comunitarios de TAR [aHR (IC95%)=0.55 (0.30-1.01) para mujeres; 0.40 (0.21-0.75) para hombres] tenian significativamente menos abandono. ConclusionesLa retencion de pacientes en un programa individual empeoro a lo largo del tiempo, especialmente entre los hombres, personas jovenes y aquellos con indicadores clinicos pobres. Los programas comunitarios de dispensacion de TAR podrian mejorar la retencion.	[Koole, Olivier] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England; [Koole, Olivier; Menten, Joris; Colebunders, Robert] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Tsui, Sharon; Mukadi, Ya Diul; van Praag, Eric; Torpey, Kwasi; Denison, Julie] FHI 360, Durham, NC USA; [Tsui, Sharon; Denison, Julie] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Wabwire-Mangen, Fred] Makerere Univ, Infect Dis Inst, Coll Hlth Sci, Kampala, Uganda; [Kwesigabo, Gideon] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Mulenga, Modest] Trop Dis Res Ctr, Ndola, Zambia; [Auld, Andrew; Agolory, Simon; Williams, Seymour; Kaplan, Jonathan; Zee, Aaron] US Ctr Dis Control & Prevent, Div Global AIDS, Atlanta, GA USA; [Colebunders, Robert] Univ Antwerp, B-2020 Antwerp, Belgium; [Bangsberg, David R.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Bangsberg, David R.] Harvard Univ, Sch Med, Boston, MA USA	Koole, O (reprint author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England.	olivier.koole@lshtm.ac.uk		Denison, Julie/0000-0002-4670-093X; Auld, Andrew/0000-0001-5089-9163; Koole, Olivier/0000-0002-1122-5382; Torpey, Kwasi/0000-0003-1628-2922	PEPFAR through CDC; PEPFAR through HRSA	We wish to acknowledge the study participants and participating clinics for their critical role in this study. This research was been supported by PEPFAR through CDC and HRSA. The views, opinions and content of this publication are those of the authors and do not necessarily reflect the views, opinions or policies of the CDC, HRSA or any other federal agency or office. This paper was presented in part at the XIX International AIDS Conference 2012, 22-27 July, Washington DC, USA.	Altman DG, 1998, BRIT MED J, V317, P468; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Braitstein P, 2006, LANCET, V367, P817; Calmy A, 2006, AIDS, V20, P1163, DOI 10.1097/01.aids.0000226957.79847.d6; Chan AK, 2010, TROP MED INT HEALTH, V15, P90, DOI 10.1111/j.1365-3156.2010.02503.x; Coetzee D, 2004, AIDS, V18, P887, DOI [10.1097/01.aids.0000125925.87797.38, 10.1097/00002030-200406003-00006]; Collet D, 2003, MODELLING SURIVAL DA; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; Decroo T, 2011, JAIDS-J ACQ IMM DEF, V56, pE39, DOI 10.1097/QAI.0b013e3182055138; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Forster M, 2008, B WORLD HEALTH ORGAN, V86, P939, DOI 10.2471/BLT.07.049908; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; Hougaard P, 1995, Lifetime Data Anal, V1, P255; LITTLE RJA, 1992, J AM STAT ASSOC, V87, P1227, DOI 10.2307/2290664; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; MSF and UNAIDS, 2012, CLOS HOM DEL ANT THE; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Rich ML, 2012, JAIDS-J ACQ IMM DEF, V59, pE35, DOI 10.1097/QAI.0b013e31824476c4; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Royston P, 2005, STATA J, V5, P279, DOI 10.1177/1536867X0500500212; Shepherd BE, 2013, AM J EPIDEMIOL, V178, P819, DOI 10.1093/aje/kwt030; UNAIDS (United Nations Programme on HIV and AIDS), 2014, GAP REP; Weigel R, 2012, AIDS, V26, P365, DOI 10.1097/QAD.0b013e32834ed814; Wools-Kaloustian KK, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-22; World Health Organization, 2013, CONS GUID US ANT DRU; World Health Organization, 2006, PAT MON GUID HIV CAR	33	31	31	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	DEC	2014	19	12					1397	1410		10.1111/tmi.12386				14	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	AT2TO	WOS:000344789200002	25227621	Green Accepted, Bronze			2019-04-02	
J	Battaglioli, T; Soto, A; Agapito, J; Acurio, V; Van der Stuyft, P				Battaglioli, T.; Soto, A.; Agapito, J.; Acurio, V.; Van der Stuyft, P.			Manual liquid culture on simple Middlebrook 7H9 or MGIT for the diagnosis of smear-negative pulmonary tuberculosis	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						Middlebrook 7H9; mycobacterial growth indicator tube; Ogawa; Mycobacterium tuberculosis; diagnosis; smear-negative tuberculosis; Middlebrook 7H9; MGIT; Ogawa; M; tuberculosis; diagnostic; tuberculose a frottis negatif; Middlebrook 7H9; MGIT; Ogawa; M; tuberculosis; diagnostico; tuberculosis con baciloscopia negativa	GROWTH INDICATOR TUBE; SOLID MEDIA; MYCOBACTERIA; BACTEC	ObjectivesTo compare the performance of liquid culture on simple Middlebrook 7H9 to the one of manual mycobacterial growth indicator tube (MGIT) and solid culture on Ogawa for the diagnosis of smear-negative tuberculosis (SN-TB) in a high-burden, resource-constrained setting. MethodsSputum samples from patients with clinical suspicion of SN-PTB admitted to two-third-level hospitals in Lima between September 2005 and May 2008 were cultured in parallel on simple Middlebrook 7H9, manual MGIT and Ogawa. A case of SN-TB was defined as one with a positive culture in any medium. ResultsAmong samples from 542 patients, 151 (28%) cases of SN-TB were identified. The sensitivity of Middlebrook 7H9 (0.76, 95% CI 0.69-0.83) was not substantially different from that of MGIT (0.85, 95% CI 0.79-0.91). Ogawa had the lowest sensitivity (0.63, 95% CI 0.55-0.71). The median turnaround time was similar for both liquid media (18days), and it was shorter than that of Ogawa (30days). ConclusionsCulture on simple Middlebrook 7H9 performs almost as well as MGIT, at a probably more affordable cost. Further studies on the cost-effectiveness of this overlooked technique should be performed. ObjectifsComparer les performances de la culture liquide sur milieu simple Middlebrook 7H9 a celles sur MGIT manuel et sur milieu solide Ogawa pour le diagnostic de la tuberculose pulmonaire a frottis negatif (TBP-FN) dans une region a prevalence elevee et a ressources limitees. MethodesDes echantillons de crachats de patients avec une suspicion clinique de TBP-FN, admis dans deux hopitaux tertiaires a Lima entre septembre 2005 et mai 2008, ont ete cultives en parallele sur milieu simple Middlebrook 7H9, MGIT manuel et Ogawa. La TBP-FN a ete defini comme un cas avec au moins une culture positive sur n'importe quel milieu. ResultatsParmi les echantillons de 542 patients, 151 (28%) cas de TBP-FN ont ete identifies. La sensibilite du Middlebrook 7H9 (0,76; IC 95%: 0,69 a 0,83) n'etait pas significativement differente de celle du MGIT (0,85; IC 95%: 0,79 a 0,91). Ogawa avait la sensibilite la plus faible (0,63; IC 95%: 0,55 a 0,71). Le delai median etait similaire pour les deux milieux liquides (18 jours) et etait plus court que pour Ogawa (30 jours). ConclusionsLa culture sur milieu simple Middlebrook 7H9 est presque qu'aussi performante que sur MGIT a un cout probablement plus abordable. Des etudes supplementaires sur le rapport cout-efficacite de cette technique neglige devraient etre effectuees. ObjetivosComparar el desempeno del cultivo en medio liquido Middlebrook 7H9 con el sistema manual MGIT y el cultivo solido en Ogawa, para el diagnostico de tuberculosis con baciloscopia negativa (TB-BN) en un lugar con una carga alta de enfermedad y pocos recursos. MetodosLas muestras de esputo de los pacientes con sospecha clinica de TB-BN admitidos en dos hospitales de tercer nivel en Lima, entre Septiembre 2005 y Mayo 2008, se cultivaron en paralelo en medio liquido de Middlebrook 7H9, en MGIT y en Ogawa. Un caso de TB-BN se definio como positivo para cultivo en cualquier medio. ResultadosEntre las muestras de 542 pacientes, se identificaron 151 (28%) casos de TB-BN. La sensibilidad del 7H9 (0.76, IC 95% 0.69-0.83) no era sustancialmente diferente de la del MGIT (0.85, IC95% 0.79-0.91). El Ogawa tenia la menor sensibilidad (0.63, IC 95% 0.55-0.71). El tiempo medio de respuesta era similar para los dos medios liquidos (18 dias) y era mas corto que el del Ogawa (30 dias). ConclusionesEl cultivo en medio liquido Middlebrook 7H9 tiene un desempeno casi tan bueno como el de MGIT, con un coste probablemente mas asumible. Se deberian realizar mas estudio sobre la costo-efectividad de esta tecnica olvidada.	[Battaglioli, T.; Van der Stuyft, P.] Inst Trop Med, Dept Publ Hlth, Unit Epidemiol & Dis Control, B-2000 Antwerp, Belgium; [Soto, A.; Acurio, V.] Hosp Nacl Hipolito Unanue, Lima, Peru; [Agapito, J.] Univ Peruana Cayetano Heredia, Lima, Peru; [Van der Stuyft, P.] Univ Ghent, Dept Publ Hlth, Fac Med, B-9000 Ghent, Belgium	Battaglioli, T (reprint author), Inst Trop Med, Dept Publ Hlth, Unit Epidemiol & Dis Control, Natl Str 155, B-2000 Antwerp, Belgium.	tbattaglioli@itg.be		AGAPITO, JUAN CARLOS/0000-0001-9134-7322; Soto, Alonso/0000-0001-8648-8032			Atlas-Ronald M, 2004, HDB MICROBIOLOGICAL; BANOO S, 2006, NAT REV MICROBIOL, V4, pS21; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Chew WK, 1998, J MED MICROBIOL, V47, P821, DOI 10.1099/00222615-47-9-821; Cruciani M, 2004, J CLIN MICROBIOL, V42, P2321, DOI 10.1128/JCM.42.5.2321-2325.2004; Dinnes J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11030; Flournoy D, 2001, Clin Lab Sci, V14, P85; Foundation for Innovative New Diagnostics, 2011, FIND NEG PRIC BACTEC; Kent PT, 1985, PUBLIC HLTH MYCOBACT; Martin A, 2012, PROCEDURE MANUAL THI; Mendoza Ticona A, 2008, ACTA MED PERU, V25, P247; Minion J, 2010, LANCET INFECT DIS, V10, P688, DOI 10.1016/S1473-3099(10)70165-1; Muyoyeta M, 2009, INT J TUBERC LUNG D, V13, P460; Nahid P, 2012, J INFECT DIS, V205, pS159, DOI 10.1093/infdis/jis194; Parsons LM, 2011, CLIN MICROBIOL REV, V24, P314, DOI 10.1128/CMR.00059-10; Somoskovi A, 1999, J CLIN MICROBIOL, V37, P1366; Soto A, 2009, INT J INFECT DIS, V13, P40, DOI 10.1016/j.ijid.2008.03.023; Steingart KR, 2014, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD009593.PUB3; Universidad Peruana Cayetano Heredia, 2008, MODS US GUID MICR OB; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2007, US LIQ TB CULT DRUG; World Health Organization, 2012, TUB LAB BIOS MAN	22	1	1	0	9	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	DEC	2014	19	12					1500	1503		10.1111/tmi.12384				4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	AT2TO	WOS:000344789200011	25244047	Bronze			2019-04-02	
J	Charlier, J; Soenen, K; De Roeck, E; Hantson, W; Ducheyne, E; Van Coillie, F; De Wulf, R; Hendrickx, G; Vercruysse, J				Charlier, Johannes; Soenen, Karen; De Roeck, Els; Hantson, Wouter; Ducheyne, Els; Van Coillie, Frieke; De Wulf, Robert; Hendrickx, Guy; Vercruysse, Jozef			Longitudinal study on the temporal and micro-spatial distribution of Galba truncatula in four farms in Belgium as a base for small-scale risk mapping of Fasciola hepatica	PARASITES & VECTORS			English	Article						Galba truncatula; Fasciola hepatica; Liver fluke; Species distribution; Small-scale; Risk mapping	LYMNAEA-TRUNCATULA; INTERMEDIATE HOSTS; CATTLE; TRANSMISSION; RESOLUTION; INFECTION; SWITZERLAND; INDICATORS; DIAGNOSIS; BALTHICA	Background: The trematode parasite Fasciola hepatica causes important economic losses in ruminants worldwide. Current spatial distribution models do not provide sufficient detail to support farm-specific control strategies. A technology to reliably assess the spatial distribution of intermediate host snail habitats on farms would be a major step forward to this respect. The aim of this study was to conduct a longitudinal field survey in Flanders (Belgium) to (i) characterise suitable small water bodies (SWB) for Galba truncatula and (ii) describe the population dynamics of G. truncatula. Methods: Four F. hepatica-infected farms from two distinct agricultural regions were examined for the abundance of G. truncatula from the beginning (April 2012) until the end (November 2012) of the grazing season. Per farm, 12 to 18 SWB were selected for monthly examination, using a 10 m transect analysis. Observations on G. truncatula abundance were coupled with meteorological and (micro-) environmental factors and the within-herd prevalence of F. hepatica using simple comparison or negative binomial regression models. Results: A total of 54 examined SWB were classified as a pond, ditch, trench, furrow or moist area. G. truncatula abundance was significantly associated with SWB-type, region and total monthly precipitation, but not with monthly temperature. The clear differences in G. truncatula abundance between the 2 studied regions did not result in comparable differences in F. hepatica prevalence in the cattle. Exploration of the relationship of G. truncatula abundance with (micro)-environmental variables revealed a positive association with soil and water pH and the occurrence of Ranunculus sp. and a negative association with mowed pastures, water temperature and presence of reed-like plant species. Conclusions: Farm-level predictions of G. truncatula risk and subsequent risk for F. hepatica occurrence would require a rainfall, soil type (representing the agricultural region) and SWB layer in a geographic information system. While rainfall and soil type information is easily accessible, the recent advances in very high spatial resolution cameras carried on board of satellites, planes or drones should allow the delineation of SWBs in the future.	[Charlier, Johannes; Soenen, Karen; Vercruysse, Jozef] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, B-9820 Merelbeke, Belgium; [De Roeck, Els; Van Coillie, Frieke; De Wulf, Robert] Univ Ghent, Fac Biosci Engn, Lab Forest Management & Spatial Informat Tech, B-9000 Ghent, Belgium; [Hantson, Wouter; Ducheyne, Els; Hendrickx, Guy] Avia GIS, B-2980 Zoersel, Belgium	Charlier, J (reprint author), Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Salisburylaan 133, B-9820 Merelbeke, Belgium.	johannes.charlier@ugent.be		Soenen, Karen/0000-0002-4602-3537; Charlier, Johannes/0000-0002-1332-1458	Belgian Science Policy Office (BELSPO) in the framework of the STEREO II programme [SATHELI SR/00/155]; 7th framework programme of the E.U. (GLOWORM project) [288975CP-TP-KBBE.2011.1.3-04]	We would like to thank Laura Rinaldi, David Rollinson, Elisabeth Addink, Nicolas Lewyckyj and Thomas Blaschke for their review, comments and help with the performance of the study as part of external review committee of the SATHELI-project. We would also like to thank Nathalie De Wilde, Ellen De Meyere and other lab workers for their assistance during the field work. This study received funding from the Belgian Science Policy Office (BELSPO) in the framework of the STEREO II programme (project SATHELI SR/00/155) and the 7th framework programme of the E.U. (GLOWORM project, No 288975CP-TP-KBBE.2011.1.3-04).	Bennema S, 2009, VET PARASITOL, V165, P51, DOI 10.1016/j.vetpar.2009.07.006; Bennema SC, 2011, INT J PARASITOL, V41, P225, DOI 10.1016/j.ijpara.2010.09.003; BERGHEN P., 1966, NATUURWETENSCH TLIJDSCHR, V48, P51; Caron Y, 2007, VET PARASITOL, V149, P95, DOI 10.1016/j.vetpar.2007.07.012; Caron Y, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-66; Charlier J, 2014, PARASITOLOGY, V141, P326, DOI 10.1017/S0031182013001662; Charlier J, 2008, VET PARASITOL, V153, P44, DOI 10.1016/j.vetpar.2008.01.035; Charlier J, 2011, GEOSPATIAL HEALTH, V5, P239, DOI 10.4081/gh.2011.176; Claxton JR, 1999, VET J, V157, P166, DOI 10.1053/tvjl.1998.0293; Dambach P, 2009, GLOBAL HEALTH ACTION, V2, P149, DOI 10.3402/gha.v2i0.2094; DeRoeck E, GEOSPAT HLT IN PRESS; Devriese RWT, 1997, UITGAVE JEUGDBOND NA, P192; Dohoo IMW, 2010, VET EPIDEMIOLOGIC RE, P607; Dreyfuss G, 2003, PARASITOL RES, V91, P458, DOI 10.1007/s00436-003-0892-8; Elith J, 2002, ECOL MODEL, V157, P313, DOI 10.1016/S0304-3800(02)00202-8; Enwright NM, 2014, INT J REMOTE SENS, V35, P5280, DOI 10.1080/01431161.2014.938181; GETTINBY G, 1974, INT J BIOMETEOROL, V18, P319, DOI 10.1007/BF01463722; HEPPLEST.PB, 1972, J APPL ECOL, V9, P235, DOI 10.2307/2402059; Kuijper WJ, 1998, NATL NATUURHISTORISC, P288; MALONE JB, 1984, PREV VET MED, V3, P131, DOI 10.1016/0167-5877(84)90003-5; McCann CM, 2010, INT J PARASITOL, V40, P1021, DOI 10.1016/j.ijpara.2010.02.009; Morley NJ, 2013, PARASITOLOGY, V140, P1211, DOI 10.1017/S0031182012001783; Nebiker S., 2008, INT ARCH PHOTOGRAMM, V37, P1193; Novobilsky A, 2014, VET PARASITOL, V203, P276, DOI 10.1016/j.vetpar.2014.04.015; Novobilsky A, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-251; OLLERENSHAW C. B., 1959, Veterinary Record, V71, P591; Rapsch C, 2008, VET PARASITOL, V154, P242, DOI 10.1016/j.vetpar.2008.03.030; Relf V, 2011, VET PARASITOL, V175, P287, DOI 10.1016/j.vetpar.2010.10.010; Relf V, 2009, VET PARASITOL, V163, P152, DOI 10.1016/j.vetpar.2009.04.003; Rondelaud D, 2013, PARASITE, V20, DOI 10.1051/parasite/2013009; Rondelaud D, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-296; Rondelaud D, 2011, VET PARASITOL, V181, P166, DOI 10.1016/j.vetpar.2011.03.056; Schweizer G, 2007, VET PARASITOL, V150, P164, DOI 10.1016/j.vetpar.2007.08.006; Schweizer G, 2005, VET REC, V157, P188, DOI 10.1136/vr.157.7.188; Soulsby EJL, 1982, HELMINTHS ARTHROPODS, P40; Taylor EL, 1964, VET EPIDEMIOLOGIC RE, P234; Vercauteren TSR, 2000, ANTWERPSE KOEPEL NAT, V2000, P71; Vignolles C, 2010, GEOSPATIAL HEALTH, V5, P23, DOI 10.4081/gh.2010.184; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557	39	6	6	0	29	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	NOV 26	2014	7								528	10.1186/s13071-014-0528-0				8	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	AU9FF	WOS:000345896400001	25425397	DOAJ Gold, Green Published			2019-04-02	
J	Tomczyk, S; Deribe, K; Brooker, SJ; Clark, H; Rafique, K; Knopp, S; Utzinger, J; Davey, G				Tomczyk, Sara; Deribe, Kebede; Brooker, Simon J.; Clark, Hannah; Rafique, Khizar; Knopp, Stefanie; Utzinger, Juerg; Davey, Gail			Association between Footwear Use and Neglected Tropical Diseases: A Systematic Review and Meta-Analysis	PLOS NEGLECTED TROPICAL DISEASES			English	Review							SOIL-TRANSMITTED HELMINTHIASIS; BURULI ULCER DISEASE; RISK-FACTORS; HOOKWORM INFECTION; RURAL-COMMUNITY; CONTROL STRATEGIES; SCHOOL-CHILDREN; LEPTOSPIROSIS; PREVALENCE; EPIDEMIOLOGY	Background: The control of neglected tropical diseases (NTDs) has primarily focused on preventive chemotherapy and case management. Less attention has been placed on the role of ensuring access to adequate water, sanitation, and hygiene and personal preventive measures in reducing exposure to infection. Our aim was to assess whether footwear use was associated with a lower risk of selected NTDs. Methodology: We conducted a systematic review and meta-analysis to assess the association between footwear use and infection or disease for those NTDs for which the route of transmission or occurrence may be through the feet. We included Buruli ulcer, cutaneous larva migrans (CLM), leptospirosis, mycetoma, myiasis, podoconiosis, snakebite, tungiasis, and soil-transmitted helminth (STH) infections, particularly hookworm infection and strongyloidiasis. We searched Medline, Embase, Cochrane, Web of Science, CINAHL Plus, and Popline databases, contacted experts, and hand-searched reference lists for eligible studies. The search was conducted in English without language, publication status, or date restrictions up to January 2014. Studies were eligible for inclusion if they reported a measure of the association between footwear use and the risk of each NTD. Publication bias was assessed using funnel plots. Descriptive study characteristics and methodological quality of the included studies were summarized. For each study outcome, both outcome and exposure data were abstracted and crude and adjusted effect estimates presented. Individual and summary odds ratio (OR) estimates and corresponding 95% confidence intervals (CIs) were calculated as a measure of intervention effect, using random effects meta-analyses. Principal Findings: Among the 427 studies screened, 53 met our inclusion criteria. Footwear use was significantly associated with a lower odds of infection of Buruli ulcer (OR = 0.15; 95% CI: 0.08-0.29), CLM (OR = 0.24; 95% CI: 0.06-0.96), tungiasis (OR = 0.42; 95% CI: 0.26-0.70), hookworm infection (OR = 0.48; 95% CI: 0.37-0.61), any STH infection (OR = 0.57; 95% CI: 0.39-0.84), strongyloidiasis (OR = 0.56; 95% CI: 0.38-0.83), and leptospirosis (OR = 0.59; 95% CI: 0.37-0.94). No significant association between footwear use and podoconiosis (OR = 0.63; 95% CI: 0.38-1.05) was found and no data were available for mycetoma, myiasis, and snakebite. The main limitations were evidence of heterogeneity and poor study quality inherent to the observational studies included. Conclusions/Significance: Our results show that footwear use was associated with a lower odds of several different NTDs. Access to footwear should be prioritized alongside existing NTD interventions to ensure a lasting reduction of multiple NTDs and to accelerate their control and elimination.	[Tomczyk, Sara] Inst Trop Med, B-2000 Antwerp, Belgium; [Deribe, Kebede; Clark, Hannah; Rafique, Khizar; Davey, Gail] Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Deribe, Kebede] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia; [Brooker, Simon J.] London Sch Hyg & Trop Med, London WC1, England; [Knopp, Stefanie] Nat Hist Museum, Dept Life Sci, Wolfson Wellcome Biomed Labs, London SW7 5BD, England; [Knopp, Stefanie; Utzinger, Juerg] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Knopp, Stefanie; Utzinger, Juerg] Univ Basel, Basel, Switzerland	Tomczyk, S (reprint author), Inst Trop Med, B-2000 Antwerp, Belgium.	kebededeka@yahoo.com		Knopp, Stefanie/0000-0001-5707-7963; Deribe, Kebede/0000-0002-8526-6996	Wellcome Trust Fellowship in Public Health and Tropical Medicine [099876]; Wellcome Trust Senior Fellowship in Basic Biomedical Science [098045]; Wellcome Trust University award [091956]	KD is supported by a Wellcome Trust Fellowship in Public Health and Tropical Medicine [grant number 099876]. SJB is supported by a Wellcome Trust Senior Fellowship in Basic Biomedical Science [grant number 098045]. GD is supported by a Wellcome Trust University award [grant number 091956] to do work in podoconiosis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimpun Pote, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P506; Alarcon JO, 2011, AM J TROP MED HYG, V85, P331; Albonico M, 1999, ADV PARASIT, V42, P277, DOI 10.1016/S0065-308X(08)60151-7; Alemu A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-189; Ali I., 1999, Ethiopian Journal of Health Development, V13, P157; Anderson R, 2012, LANCET, V379, P289, DOI 10.1016/S0140-6736(12)60120-2; Ayode D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002199; Bartram J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000367; Behnke JM, 2000, TROP MED INT HEALTH, V5, P343, DOI 10.1046/j.1365-3156.2000.00553.x; Bethony J, 2002, CLIN INFECT DIS, V35, P1336, DOI 10.1086/344268; Bird C, 2014, T ROY SOC TROP MED H, V108, P297, DOI 10.1093/trstmh/tru037; Bovet P, 1999, INT J EPIDEMIOL, V28, P583, DOI 10.1093/ije/28.3.583; Cairncross S, 2010, INT J EPIDEMIOL, V39, P193, DOI 10.1093/ije/dyq035; Chongsuvivatwong V, 1996, T ROY SOC TROP MED H, V90, P630, DOI 10.1016/S0035-9203(96)90412-5; Davey G, 2007, T ROY SOC TROP MED H, V101, P1175, DOI 10.1016/j.trstmh.2007.08.013; Davey G, 2007, T ROY SOC TROP MED H, V101, P91, DOI 10.1016/j.trstmh.2006.05.002; Deribe K, 2014, AM J TROP M IN PRESS; Douglin CP, 1997, EMERG INFECT DIS, V3, P78, DOI 10.3201/eid0301.970114; Ejemot RI, 2008, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD004265.P1B2; Ejere H.O., 2012, COCHRANE DB SYST REV, V4; Emerson PM, 2000, TROP MED INT HEALTH, V5, P515, DOI 10.1046/j.1365-3156.2000.00603.x; Erosie L, 2002, ETHIOP J HEALTH DEV, V16, P113; Feldmeier H, 2009, B WORLD HEALTH ORGAN, V87, P152, DOI 10.2471/BLT.07.047308; Freeman MC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002439; Gunawardena K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001341; Gutman J, 2010, AM J TROP MED HYG, V83, P534, DOI [10.4269/ajtmh.2010.10.0033, 10.4269/ajtmh.2010.10-0033]; Hotez P, 2008, ANN NY ACAD SCI, V1136, P38, DOI 10.1196/annals.1425.000; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Hotez PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002865; Humphries D, 2011, AM J TROP MED HYG, V84, P792, DOI 10.4269/ajtmh.2011.11-0003; Ilechukwu GC, 2010, NIGER J CLIN PRACT, V13, P288; Gamboa MI, 2009, REV PANAM SALUD PUBL, V26, P1; Jiraanankul V, 2011, AM J TROP MED HYG, V84, P594, DOI 10.4269/ajtmh.2011.10-0189; Johnson MAS, 2004, EMERG INFECT DIS, V10, P1016, DOI 10.3201/eid1006.030660; KHAN MY, 1979, PUBLIC HEALTH, V93, P82, DOI 10.1016/S0033-3506(79)80094-3; KILLEWO JZJ, 1991, ACTA TROP, V48, P247, DOI 10.1016/0001-706X(91)90053-M; KLOOS H, 1992, TROP DOCT, V22, P109, DOI 10.1177/004947559202200306; Knopp S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000681; Kurup R, 2010, J VECTOR DIS, V47, P228; Lacerda HG, 2008, T ROY SOC TROP MED H, V102, P1233, DOI 10.1016/j.trstmh.2008.05.010; Landier J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001392; Leal-Castellanos CB, 2003, EPIDEMIOL INFECT, V131, P1149, DOI 10.1017/S0950268803001201; Lee VJ, 2007, T ROY SOC TROP MED H, V101, P1214, DOI 10.1016/j.trstmh.2007.09.001; Lello J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2813; Liabsuetrakul T, 2009, SE ASIAN J TROP MED, V40, P211; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700; Marion E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000731; MARSTON BJ, 1995, AM J TROP MED HYG, V52, P219, DOI 10.4269/ajtmh.1995.52.219; MARTINEZ CARDENAS A, 1961, Rev Cubana Pediatr, V33, P115; Mihrshahi S, 2009, INT J PARASITOL, V39, P1037, DOI 10.1016/j.ijpara.2009.01.013; Modjarrad K, 2005, AM J TROP MED HYG, V73, P777, DOI 10.4269/ajtmh.2005.73.777; Molla YB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002554; Molla YB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001744; Muehlen M, 2006, T ROY SOC TROP MED H, V100, P371, DOI 10.1016/j.trstmh.2005.06.033; MUKERJI A. K., 1950, INDIAN JOUR MED RES, V38, P95; Njau NN, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-S1-P37; Nmor JC, 2009, IRAN J PUBLIC HEALTH, V38, P31; NUTI M, 1992, EUR J EPIDEMIOL, V8, P98; Phiri K, 2000, ANN TROP MED PARASIT, V94, P381, DOI 10.1080/00034983.2000.11813553; Phraisuwan P, 2002, EMERG INFECT DIS, V8, P1455, DOI 10.3201/eid0812.020180; Portaels F, 1999, LANCET, V353, P986, DOI 10.1016/S0140-6736(98)05177-0; PRICE EW, 1974, TROP GEOGR MED, V26, P225; Pullan RL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000713; Raghunathan PL, 2005, CLIN INFECT DIS, V40, P1445, DOI 10.1086/429623; RevMan, 2012, REVMAN VERS 5 2; Sanchez PR, 2001, QJM-MON J ASSOC PHYS, V94, P357, DOI 10.1093/qjmed/94.7.357; SASAKI DM, 1993, AM J TROP MED HYG, V48, P35, DOI 10.4269/ajtmh.1993.48.35; Singer BH, 2007, P NATL ACAD SCI USA, V104, P16038, DOI 10.1073/pnas.0700900104; Smillie WG, 1924, SOUTH MED J, V17, P494; Steinmann P, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000075; Stocks ME, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001605; Strunz EC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001620; Sulong MR, 2011, INT MED J, V18, P83; Tadesse G, 2005, ETHIOP J HEALTH DEV, V19, P140; Thielecke M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002426; Traub RJ, 2004, TROP MED INT HEALTH, V9, P688, DOI 10.1111/j.1365-3156.2004.01252.x; Tremblay A, 2000, TROP MED INT HEALTH, V5, P330, DOI 10.1046/j.1365-3156.2000.00557.x; Ugbomoiko US, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000087; Utzinger J, 2009, PARASITOLOGY, V136, P1859, DOI 10.1017/S0031182009991600; Utzinger J, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13727; WHO, 2010, WORKING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: FIRST WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1; Woodburn PW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000473; Yakob B, 2008, T ROY SOC TROP MED H, V102, P439, DOI 10.1016/j.trstmh.2008.01.023; Yori PP, 2006, AM J TROP MED HYG, V74, P97, DOI 10.4269/ajtmh.2006.74.97; Ziegelbauer K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001162	85	25	25	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	NOV	2014	8	11							e3285	10.1371/journal.pntd.0003285				11	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AU3LF	WOS:000345514000024	25393620	DOAJ Gold, Green Published			2019-04-02	
J	Hien, H; Berthe, A; Drabo, MK; Meda, N; Konate, B; Tou, F; Badini-Kinda, F; Macq, J				Hien, Herve; Berthe, Abdramane; Drabo, Maxime Koine; Meda, Nicolas; Konate, Blahima; Tou, Fatoumata; Badini-Kinda, Fatoumata; Macq, Jean			Prevalence and patterns of multimorbidity among the elderly in Burkina Faso: cross-sectional study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						multimorbidity; older adults; community-dwelling	OLDER-PEOPLE; DISEASES; CARE; POPULATION; DISABILITY; MORBIDITY; INDIA	OBJECTIVES To assess the prevalence and distribution patterns of multimorbidity among urban older adults in Burkina Faso. METHODS Cross-sectional study among community-dwelling elderly people aged >= 60 in Bobo-Dioulasso. We performed interviews, clinical examination and medical record review. Multimorbidity was defined as co-occurrence of at least two chronic diseases in one person whether as a coincidence or not. RESULTS The overall prevalence of multimorbidity among older adults was 65%. Age >= 70 was associated with multimorbidity in multivariate analysis: adjusted OR = 1.65, 95% CI (1.01-2.68, P = 0.04). The most common chronic diseases were hypertension (82%) 95% CI (78; 86), malnutrition (39%) 95% CI (34; 44), visual impairments (28%) 95% CI (24; 33) and diabetes mellitus (27%) 95% CI (22; 31). Those aged >= 70 had significantly more malnutrition (50% vs. 31%, P = 0.0003) and osteoarthritis (8% vs. 3%, P = 0.01) than those aged 60-69. CONCLUSIONS The high prevalence of multimorbidity requires a reorganization of healthcare systems in sub-Saharan Africa, especially in Burkina Faso. Interventions and care guidelines usually focused on individual diseases should be improved to better reflect this reality.	[Hien, Herve; Berthe, Abdramane; Meda, Nicolas; Konate, Blahima; Tou, Fatoumata; Badini-Kinda, Fatoumata] Ctr MURAZ, Bobo Dioulasso, Burkina Faso; [Drabo, Maxime Koine] Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso; [Macq, Jean] Catholic Univ Louvain, Inst Hlth & Soc, Brussels, Belgium	Hien, H (reprint author), Ctr MURAZ, 01P 390, Bobo Dioulasso, Burkina Faso.	hien_herve@hotmail.com		ibitoye, oluwabunmi/0000-0002-9723-2347	Belgium Development Cooperation (DGD); Belgium Development Cooperation (CUD); Interuniversity Project on Older Adults in Burkina Faso	We are grateful to all who participated in this study, and acknowledge financial support from the Belgium Development Cooperation (DGD and CUD) and the Interuniversity Project on Older Adults in Burkina Faso.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; *AM DIAB ASS, 2009, DIABETES CARE S1, V32, pS62, DOI DOI 10.2337/DC09-S062; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Britt HC, 2008, MED J AUSTRALIA, V189, P72; Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Dewhurst F, 2012, AGE AGEING, V41, P517, DOI 10.1093/ageing/afs054; FEINSTEIN AR, 1970, J CHRON DIS, V23, P455, DOI 10.1016/0021-9681(70)90054-8; Ferri CP, 2011, J NEUROL NEUROSUR PS, V82, P1074, DOI 10.1136/jnnp.2010.234153; Formiga F, 2013, EUR J INTERN MED, V24, P40, DOI 10.1016/j.ejim.2012.11.003; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Inouye SK, 2007, J AM GERIATR SOC, V55, P780, DOI 10.1111/j.1532-5415.2007.01156.x; Institut national de la statistique et de la demographie (INSD) Burkina Faso, 2009, BURK FAS ANN STAT 20; Joshi K, 2003, INT J EPIDEMIOL, V32, P978, DOI 10.1093/ije/dyg204; Khanam MA, 2011, J HEALTH POPUL NUTR, V29, P406, DOI 10.3329/jhpn.v29i4.8458; Lai HY, 2009, CLIN THER, V31, P1859, DOI 10.1016/j.clinthera.2009.08.023; Lohman TG, 1988, ANTHROPOMETRIC STAND; Marengoni A, 2008, AM J PUBLIC HEALTH, V98, P1198, DOI 10.2105/AJPH.2007.121137; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Marengoni A, 2009, J AM GERIATR SOC, V57, P225, DOI 10.1111/j.1532-5415.2008.02109.x; Mercer SW, 2009, FAM PRACT, V26, P79, DOI 10.1093/fampra/cmp020; Ministere de la sante, 2012, MIN SANT BURK FAS PR; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; Rolland Y, 2012, J AM MED DIR ASSOC, V13, P31, DOI 10.1016/j.jamda.2011.05.003; Timmreck T C, 1987, Health Educ, V18, P23; van den Akker M, 1996, EUR J GEN PRACT, V2, P65, DOI DOI 10.3109/13814789609162146; Zhou BA, 2011, J APPL GERONTOL, V30, P199, DOI 10.1177/0733464810361346	27	8	9	0	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	NOV	2014	19	11					1328	1333		10.1111/tmi.12377				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	AT2TB	WOS:000344787800004	25164626				2019-04-02	
J	Thi, NV; Pozio, E; De, NV; Praet, N; Pezzotti, P; Gabriel, S; Claes, M; Thuy, T; Dorny, P				Nga Vu Thi; Pozio, Edoardo; Nguyen Van De; Praet, Nicolas; Pezzotti, Patrizio; Gabriel, Sarah; Claes, Marleen; Nguyen Thi Thuy; Dorny, Pierre			Anti-Trichinella IgG in ethnic minorities living in Trichinella-endemic areas in northwest Vietnam: Study of the predictive value of selected clinical signs and symptoms for the diagnosis of trichinellosis	ACTA TROPICA			English	Article						Trichinellosis; Human; Facial edema; Myalgia; Serology; Vietnam	INFECTION; EPIDEMIOLOGY; OUTBREAK; ANIMALS; HUMANS; PIGS	The objective of this study was to assess the presence of anti-Trichinella IgG in the serum of persons from ethnic minorities from northwest Vietnam with clinical signs and symptoms that are compatible with trichinellosis. A total of 645 persons were enrolled, of which 200 people lived in two villages where outbreaks of human trichinellosis had been documented in 2004 and 2008, and 445 people who were hospitalized in the Dien Bien and Son La provincial hospitals without a definitive diagnosis. Presence of anti-Trichinella IgG was demonstrated in serum samples by a standardized Enzyme-linked Immunosorbant Assay (ELISA); positive serum samples were subjected to Western blot (WB) for confirmation. Seven (3.5%; 95% CI: 1.4-7.1) persons from the villages and seven (1.6%; 95% CI: 0.6-3.2) hospitalized patients, tested positive by both ELISA and WB. Fever (N = 13), eosinophilia (N = 12), myalgia (N = 9), facial edema (N = 9) and leukocytosis (N = 8) were the most common clinical signs and symptoms in the serologically positive persons. The concomitant occurrence of facial edema and myalgia among the enrolled persons from the villages, accounted for 75% of the positive predictive value (PPV) and 99.5% of the negative predictive value (NPV), suggesting that they could be used for suspecting trichinellosis when serology is not available. The high prevalence (1.6-3.5%) of anti-Trichinella IgG in persons from Vietnamese provinces where Trichinella spiralis is circulating in pigs strongly supports the need to develop control programs to eliminate the infection from pigs and for consumers' education and protection. (C) 2014 Elsevier B.V. All rights reserved.	[Nga Vu Thi; Nguyen Thi Thuy] Natl Ctr Vet Diag, Parasitol Sect, Hanoi, Vietnam; [Nga Vu Thi; Dorny, Pierre] Univ Ghent, Fac Vet Med, Parasitol Lab, B-9000 Ghent, Belgium; [Pozio, Edoardo; Pezzotti, Patrizio] Ist Super Sanita, Dept Infec Parasit & Immunomediated Dis, Rome, Italy; [Nguyen Van De] Hanoi Med Univ, Dept Parasitol, Hanoi, Vietnam; [Praet, Nicolas; Gabriel, Sarah; Claes, Marleen; Dorny, Pierre] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium	Dorny, P (reprint author), Inst Trop Med, Dept Biomed Sci, Vet Helminthol Unit, Natl Str 155, B-2000 Antwerp, Belgium.	pdorny@itg.be		GABRIEL, SARAH/0000-0002-2523-233X	Belgian Directorate General for Development Cooperation and Humanitarian Help (DGD)	This study was supported by the Belgian Directorate General for Development Cooperation and Humanitarian Help (DGD) as part of the 3rd Framework agreement between ITM and DGD.	Barennes H, 2008, AM J TROP MED HYG, V78, P40, DOI 10.4269/ajtmh.2008.78.40; Dupouy-Camet J., 2007, FAO WHO OIE GUIDELIN, P37; Dupouy-Camet Jean, 2002, Expert Opin Pharmacother, V3, P1117; Gamble HR, 2004, PARASITE, V11, P3, DOI 10.1051/parasite/20041113; Gomez-Morales MA, 2008, CLIN VACCINE IMMUNOL, V15, P1723, DOI 10.1128/CVI.00257-08; Gomez-Morales MA, 2012, INT J PARASITOL, V42, P1017, DOI 10.1016/j.ijpara.2012.08.003; HARMS G, 1993, CLIN INFECT DIS, V17, P637, DOI 10.1093/clinids/17.4.637; HOSMER DW, 2013, WILEY SER PROBAB ST, P1; Kaewpitoon N, 2006, WORLD J GASTROENTERO, V12, P6440, DOI 10.3748/wjg.v12.i40.6440; Khumjui C, 2008, EMERG INFECT DIS, V14, P1913, DOI 10.3201/eid1412.080800; Kociecka W, 2000, VET PARASITOL, V93, P365, DOI 10.1016/S0304-4017(00)00352-6; Kusolsuk T, 2010, T ROY SOC TROP MED H, V104, P433, DOI 10.1016/j.trstmh.2009.12.005; Macpherson CNL, 2005, INT J PARASITOL, V35, P1319, DOI 10.1016/j.ijpara.2005.06.004; Madariaga MG, 2007, AM J TROP MED HYG, V77, P347, DOI 10.4269/ajtmh.2007.77.347; MORAKOTE N, 1992, TROP MED PARASITOL, V43, P167; Murrell KD, 2011, EMERG INFECT DIS, V17, P2194, DOI 10.3201/eid1712.110896; Pozio E, 2001, CLIN INFECT DIS, V32, P638, DOI 10.1086/318707; Pozio E, 2007, VET PARASITOL, V149, P3, DOI 10.1016/j.vetpar.2007.07.002; Pozio E, 2006, ADV PARASIT, V63, P367, DOI 10.1016/S0065-308X(06)63005-4; Pozio E, 2014, TRENDS PARASITOL, V30, P4, DOI 10.1016/j.pt.2013.11.001; Rheinlander T, 2010, SOC SCI MED, V71, P994, DOI 10.1016/j.socscimed.2010.06.014; Sayasone S, 2006, T ROY SOC TROP MED H, V100, P1126, DOI 10.1016/j.trstmh.2006.01.010; Schantz P.M., 1983, MMWR-MORBID MORTAL W, V32, P15; Taylor WRJ, 2009, CLIN INFECT DIS, V49, pE79, DOI 10.1086/605533; Thi NV, 2013, VET PARASITOL, V193, P200, DOI 10.1016/j.vetpar.2012.11.023; Vu T.N., 2013, BIOMED RES INT; Vu T.N., 2010, VET PARASITOL, V168, P136	27	3	3	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	NOV	2014	139						93	98		10.1016/j.actatropica.2014.07.012				6	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	AR1NQ	WOS:000343352300014	25076109				2019-04-02	
J	De Nys, HM; Calvignac-Spencer, S; Boesch, C; Dorny, P; Wittig, RM; Mundry, R; Leendertz, FH				De Nys, Helene M.; Calvignac-Spencer, Sebastien; Boesch, Christophe; Dorny, Pierre; Wittig, Roman M.; Mundry, Roger; Leendertz, Fabian H.			Malaria parasite detection increases during pregnancy in wild chimpanzees	MALARIA JOURNAL			English	Article						Malaria; Chimpanzee; Plasmodium; Pregnancy; Epidemiology; Great ape	PLASMODIUM-FALCIPARUM; IMMUNE-RESPONSES; INFANT-MORTALITY; WOMEN; ANTIGENS; EPIDEMIOLOGY; DIVERSITY; EVOLUTION; AFRICA; BURDEN	Background: The diversity of malaria parasites (Plasmodium sp.) infecting chimpanzees (Pan troglodytes) and their close relatedness with those infecting humans is well documented. However, their biology is still largely unexplored and there is a need for baseline epidemiological data. Here, the effect of pregnancy, a well-known risk factor for malaria in humans, on the susceptibility of female chimpanzees to malaria infection was investigated. Methods: A series of 384 faecal samples collected during 40 pregnancies and 36 post-pregnancies from three habituated groups of wild chimpanzees in the Tai National Park, Cote d'Ivoire, were tested. Samples were tested for malaria parasites by polymerase chain reaction (PCR) and sequencing. Data were analysed using a generalized linear mixed model. Results: Probability of malaria parasite detection significantly increased towards the end of pregnancy and decreased with the age of the mother. Conclusions: This study provides evidence that susceptibility to malaria parasite infection increases during pregnancy, and, as shown before, in younger individuals, which points towards similar dynamics of malaria parasite infection in human and chimpanzee populations and raises questions about the effects of such infections on pregnancy outcome and offspring morbidity/mortality.	[De Nys, Helene M.; Calvignac-Spencer, Sebastien; Leendertz, Fabian H.] Robert Koch Inst, D-13353 Berlin, Germany; [De Nys, Helene M.; Boesch, Christophe; Wittig, Roman M.] Max Planck Inst Evolutionary Anthropol, Dept Primatol, D-04103 Leipzig, Germany; [De Nys, Helene M.; Dorny, Pierre] Univ Ghent, Fac Vet Med, Parasitol Lab, B-9820 Merelbeke, Belgium; [Dorny, Pierre] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Wittig, Roman M.] Ctr Suisse Rech Sci, Tai Chimpanzee Project, Abidjan, Cote Ivoire; [Mundry, Roger] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany	De Nys, HM (reprint author), Robert Koch Inst, Nordufer 20, D-13353 Berlin, Germany.	De-NysH@rki.de	De Nys, Helene/P-6384-2016	De Nys, Helene/0000-0002-2942-4531; Calvignac-Spencer, Sebastien/0000-0003-4834-0509	Max-Planck-Institute for Evolutionary Anthropology in Leipzig; Special Research Fund (BOF) of Ghent University	We thank the Ministry of Environment and Forests and the Ministry of Research, the directorship of the Tai National Park, the Office Ivoirien des Parcs et Reserves, and the Centre Suisse de Recherche Scientifique for long term support. We thank Florent Goulei as well as all other assistants and veterinarians who have been collecting samples and data over the past 13 years and the Tai Chimpanzee Project for logistic support. HMD was funded by the Max-Planck-Institute for Evolutionary Anthropology in Leipzig and the Special Research Fund (BOF) of Ghent University.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Bardaji A, 2011, J INFECT DIS, V203, P691, DOI 10.1093/infdis/jiq049; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D., 2013, LME4 LINEAR MIXED EF; Boesch C, 2000, CHIMPANZEES TAI FORE; Bouyou-Akotet MK, 2005, MICROBES INFECT, V7, P1217, DOI 10.1016/j.micinf.2005.04.008; Bouyou-Akotet MK, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-18; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; BRAY RS, 1979, T ROY SOC TROP MED H, V73, P427, DOI 10.1016/0035-9203(79)90170-6; De Nys HM, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1160; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Fievet N, 1995, AM J TROP MED HYG, V53, P612; Guyatt HL, 2001, T ROY SOC TROP MED H, V95, P569, DOI 10.1016/S0035-9203(01)90082-3; Kaiser M, 2010, EMERG INFECT DIS, V16, P1956, DOI 10.3201/eid1612.100424; Leendertz FH, 2006, BIOL CONSERV, V131, P325, DOI 10.1016/j.biocon.2006.05.002; Leke RFG, 2010, AM J TROP MED HYG, V83, P996, DOI [10.4269/ajtmh.2010.10.0249, 10.4269/ajtmh.2010.10-0249]; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; MCGREGOR IA, 1984, AM J TROP MED HYG, V33, P517, DOI 10.4269/ajtmh.1984.33.517; Pacheco MA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-328; R CoreTeam RC, 2013, R LANG ENV STAT COMP; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; Rayner JC, 2011, TRENDS PARASITOL, V27, P222, DOI 10.1016/j.pt.2011.01.006; RILEY EM, 1989, AM J TROP MED HYG, V40, P141, DOI 10.4269/ajtmh.1989.40.141; Rodhain J, 1936, ANN SOC BELG MED TR, V16, P237; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Smith R, 1999, J CLIN ENDOCR METAB, V84, P2820, DOI 10.1210/jc.84.8.2820; Takem EN, 2013, MEDITERR J HEMATOL I, V5, DOI DOI 10.4084/MJHID.2013.010; Taylor SM, 2011, J INFECT DIS, V204, P1762, DOI 10.1093/infdis/jir625; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; Walker-Abbey A, 2005, AM J TROP MED HYG, V72, P229, DOI 10.4269/ajtmh.2005.72.229; Wallis J, 1997, J REPROD FERTIL, V109, P297	34	11	13	0	9	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	OCT 20	2014	13								413	10.1186/1475-2875-13-413				6	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AU6LB	WOS:000345713500001	25331753	DOAJ Gold, Green Published			2019-04-02	
J	Bosman, P; Stassijns, J; Nackers, F; Canier, L; Kim, N; Khim, S; Alipon, SC; Char, MC; Chea, N; Dysoley, L; Van den Bergh, R; Etienne, W; De Smet, M; Menard, D; Kindermans, JM				Bosman, Philippe; Stassijns, Jorgen; Nackers, Fabienne; Canier, Lydie; Kim, Nimol; Khim, Saorin; Alipon, Sweet C.; Char, Meng Chuor; Chea, Nguon; Dysoley, Lek; Van den Bergh, Rafael; Etienne, William; De Smet, Martin; Menard, Didier; Kindermans, Jean-Marie			Plasmodium prevalence and artemisinin-resistant falciparum malaria in Preah Vihear Province, Cambodia: a cross-sectional population-based study	MALARIA JOURNAL			English	Article						Malaria; Plasmodium falciparum; Epidemiology; Artemisinin resistance; Polymerase chain reaction; K13-Propeller; Cambodia	PARASITE CLEARANCE; WESTERN CAMBODIA; SOLOMON-ISLANDS; ELIMINATION; CHALLENGES; TRANSMISSION; INFECTIONS; ENDEMICITY; FIELD; AREA	Background: Intensified efforts are urgently needed to contain and eliminate artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion. Medecins Sans Frontieres plans to support the Ministry of Health in eliminating P. falciparum in an area with artemisinin resistance in the north-east of Cambodia. As a first step, the prevalence of Plasmodium spp. and the presence of mutations associated with artemisinin resistance were evaluated in two districts of Preah Vihear Province. Methods: A cross-sectional population-based study using a two-stage cluster sampling was conducted in the rural districts of Chhaeb and Chey Saen, from September to October 2013. In each district, 30 clusters of 10 households were randomly selected. In total, blood samples were collected for 1,275 participants in Chhaeb and 1,224 in Chey Saen. Prevalence of Plasmodium spp. was assessed by PCR on dried blood spots. Plasmodium falciparum positive samples were screened for mutations in the K13-propeller domain gene (PF3D7_ 1343700). Result: The prevalence of Plasmodium spp. was estimated at 1.49% (95% CI 0.71-3.11%) in Chhaeb and 2.61% (95% CI 1.45-4.66%) in Chey Saen. Twenty-seven samples were positive for P. falciparum, giving a prevalence of 0.16% (95% CI 0.04-0.65) in Chhaeb and 2.04% (95% CI 1.04-3.99%) in Chey Saen. Only 4.0% of the participants testing positive presented with fever or history of fever. K13-propeller domain mutant type alleles (C580Y and Y493H) were found, only in Chey Saen district, in seven out of 11 P. falciparum positive samples with enough genetic material to allow testing. Conclusion: The overall prevalence of P. falciparum was low in both districts but parasites presenting mutations in the K13-propeller domain gene, strongly associated with artemisinin-resistance, are circulating in Chey Saen. The prevalence might be underestimated because of the absentees - mainly forest workers - and the workers of private companies who were not included in the study. These results confirm the need to urgently develop and implement targeted interventions to contain and eliminate P. falciparum malaria in this district before it spreads to other areas.	[Bosman, Philippe; Stassijns, Jorgen; Van den Bergh, Rafael; Etienne, William; De Smet, Martin; Kindermans, Jean-Marie] Med Sans Frontieres, B-1090 Brussels, Belgium; [Nackers, Fabienne] Epicentre, F-75011 Paris, France; [Canier, Lydie; Kim, Nimol; Khim, Saorin; Menard, Didier] Inst Pasteur Cambodia, Malaria Mol Epidemiol Unit, Phnom Penh, Cambodia; [Alipon, Sweet C.] Med Sans Frontieres, Phnom Penh, Chamkarmon, Cambodia; [Char, Meng Chuor; Chea, Nguon; Dysoley, Lek] Minist Hlth MoH, Natl Ctr Parasitol Entomol & Malaria Control CNM, Khan Sen Sok, Phnom Penh, Cambodia	Stassijns, J (reprint author), Med Sans Frontieres, Duprest 94, B-1090 Brussels, Belgium.	jorgenstassijns@yahoo.com	; Menard, Didier/O-3294-2013	Van den Bergh, Rafael/0000-0001-6277-8713; Menard, Didier/0000-0003-1357-4495	Medecins Sans Frontieres, Belgium; French Ministry of Foreign Affairs	This study was sponsored by Medecins Sans Frontieres, Belgium. Dr. Khoy Bun Thanny, Director of Preah Vihear Provincial Health Department, Cambodia, is acknowledged for authorizing this study. We are thankful to Pascale Chaillet, Amine Dahmane, Mark Debackere, and Pieter Pannus for their support and relevant advice. We would also like to thank the study teams, MSF field team and the villagers who took part in this study. DM was supported by the French Ministry of Foreign Affairs.	ACTwatch Group and PSI/Cambodia, 2011, KINGD CAMB HOUS SURV; Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Atkinson JA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-101; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Canier L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-405; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Delacollette C, 2009, SE ASIAN J TROP MED, V40, P674; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Flegg JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-339; Harris I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-254; Hoyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045797; Hsiang MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029550; Incardona S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-37; Laishram DD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-29; Lin JT, 2014, TRENDS PARASITOL, V30, P183, DOI 10.1016/j.pt.2014.02.004; *MALERA CONS GROUP, 2011, PLOS MED, V0008; MalERACGoIS, 2011, PLOS MED, V8, DOI DOI 10.1371/JOURNAL.PMED.1000404; Menard D, 2013, PROTOC EXCH; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Rosas-Aguirre A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-339; Steenkeste N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-108; Steenkeste N, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-86; Stresman G, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-353; Sturrock HJW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001467; Toma H, 2001, AM J TROP MED HYG, V64, P257, DOI 10.4269/ajtmh.2001.64.257; White NJ, 2014, LANCET, V383, P1439, DOI 10.1016/S0140-6736(14)60656-5; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2013, CONS MASS DRUG ADM C; WHO, 2014, WHO EV REV GROUP MAL; World Health Organization (WHO), 2011, GLOB PLAN ART RES CO; World Health Organization (WHO), 2010, GLOB REP ANT DRUG EF	33	28	28	0	7	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	OCT 6	2014	13								394	10.1186/1475-2875-13-394				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AS2OU	WOS:000344120300001	25288380	DOAJ Gold, Green Published			2019-04-02	
J	Bhattacharyya, T; Ayandeh, A; Falconar, AK; Sundar, S; El-Safi, S; Gripenberg, MA; Bowes, DE; Thunissen, C; Singh, OP; Kumar, R; Ahmed, O; Eisa, O; Saad, A; Pereira, SS; Boelaert, M; Mertens, P; Miles, MA				Bhattacharyya, Tapan; Ayandeh, Armon; Falconar, Andrew K.; Sundar, Shyam; El-Safi, Sayda; Gripenberg, Marissa A.; Bowes, Duncan E.; Thunissen, Caroline; Singh, Om Prakash; Kumar, Rajiv; Ahmed, Osman; Eisa, Osama; Saad, Alfarazdeg; Pereira, Sara Silva; Boelaert, Marleen; Mertens, Pascal; Miles, Michael A.			IgG1 as a Potential Biomarker of Post-chemotherapeutic Relapse in Visceral Leishmaniasis, and Adaptation to a Rapid Diagnostic Test	PLOS NEGLECTED TROPICAL DISEASES			English	Article							AZAR DERMAL LEISHMANIASIS; IMMUNOGLOBULIN-G SUBCLASS; INDIAN KALA-AZAR; HUMORAL IMMUNE-RESPONSE; ACTIVE CUTANEOUS LEISHMANIASIS; LINKED-IMMUNOSORBENT-ASSAY; CLINICAL CURE; ALVEOLAR ECHINOCOCCOSIS; DONOVANI INFECTION; ANTIBODY-RESPONSES	Background: Visceral leishmaniasis (VL), caused by protozoa of the Leishmania donovani complex, is a widespread parasitic disease of great public health importance; without effective chemotherapy symptomatic VL is usually fatal. Distinction of asymptomatic carriage from progressive disease and the prediction of relapse following treatment are hampered by the lack of prognostic biomarkers for use at point of care. Methodology/Principal Findings: All IgG subclass and IgG isotype antibody levels were determined using unpaired serum samples from Indian and Sudanese patients with differing clinical status of VL, which included pre-treatment active VL, post-treatment cured, post-treatment relapsed, and post kala-azar dermal leishmaniasis (PKDL), as well as seropositive (DAT and/or rK39) endemic healthy controls (EHCs) and seronegative EHCs. L. donovani antigen-specific IgG1 levels were significantly elevated in relapsed versus cured VL patients (p<0.0001). Using paired Indian VL sera, consistent with the known IgG1 half-life, IgG1 levels had not decreased significantly at day 30 after the start of treatment (p = 0.8304), but were dramatically decreased by 6 months compared to day 0 (p = 0.0032) or day 15 (p<0.0001) after start of treatment. Similarly, Sudanese sera taken soon after treatment did not show a significant change in the IgG1 levels (p = 0.3939). Two prototype lateral flow immunochromatographic rapid diagnostic tests (RDTs) were developed to detect IgG1 levels following VL treatment: more than 80% of the relapsed VL patients were IgG1 positive; at least 80% of the cured VL patients were IgG1 negative (p<0.0001). Conclusions/Significance: Six months after treatment of active VL, elevated levels of specific IgG1 were associated with treatment failure and relapse, whereas no IgG1 or low levels were detected in cured VL patients. A lateral flow RDT was successfully developed to detect anti-Leishmania IgG1 as a potential biomarker of post-chemotherapeutic relapse.	[Bhattacharyya, Tapan; Ayandeh, Armon; Gripenberg, Marissa A.; Bowes, Duncan E.; Pereira, Sara Silva; Miles, Michael A.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Falconar, Andrew K.] Univ Norte, Dept Med, Barranquilla, Colombia; [Sundar, Shyam; Singh, Om Prakash; Kumar, Rajiv] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [El-Safi, Sayda; Ahmed, Osman; Eisa, Osama; Saad, Alfarazdeg] Univ Khartoum, Fac Med, Khartoum, Sudan; [Thunissen, Caroline; Mertens, Pascal] Coris BioConcept, Gembloux, Belgium; [Kumar, Rajiv] Queensland Inst Med Res, Immunol & Infect Lab, Herston, Qld 4006, Australia; [Ahmed, Osman] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium	Bhattacharyya, T (reprint author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.	Tapan.Bhattacharyya@lshtm.ac.uk		Silva Pereira, Sara/0000-0002-6590-6626; Boelaert, Marleen/0000-0001-8051-6776; Ahmed, Osman/0000-0002-2854-2552; Kumar, Rajiv/0000-0003-2338-1494	European Commission [260260]	This work is part of the NIDIAG network research partnership supported by the European Commission under the Health Cooperation Work Programme of the 7th Framework Programme (Grant agreement no. 260260, http://cordis.europa.eu/fp7/home_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Anam K, 1999, CLIN DIAGN LAB IMMUN, V6, P231; Anam K, 1999, INFECT IMMUN, V67, P6663; Ansari NA, 2008, PARASITE IMMUNOL, V30, P403, DOI 10.1111/j.1365-3024.2008.01036.x; Baudino L, 2008, J IMMUNOL, V180, P1948, DOI 10.4049/jimmunol.180.3.1948; Bergeron LM, 2014, VET IMMUNOL IMMUNOP, V157, P31, DOI 10.1016/j.vetimm.2013.10.018; Bern C, 2007, AM J TROP MED HYG, V76, P909; Bhattacharyya T, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002675; Bhattacharyya T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002057; Boelaert M, 2008, T ROY SOC TROP MED H, V102, P32, DOI 10.1016/j.trstmh.2007.09.003; Boelaert M, 2014, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD009135.PUB2; BURNS JM, 1993, P NATL ACAD SCI USA, V90, P775, DOI 10.1073/pnas.90.2.775; Carson C, 2010, VET IMMUNOL IMMUNOP, V133, P264, DOI 10.1016/j.vetimm.2009.07.017; Castellano LR, 2009, HUM IMMUNOL, V70, P383, DOI 10.1016/j.humimm.2009.01.007; Chappuis F, 2006, BRIT MED J, V333, P723, DOI 10.1136/bmj.38917.503056.7C; Chatterjee M, 1998, CLIN EXP IMMUNOL, V114, P408, DOI 10.1046/j.1365-2249.1998.00752.x; Cunningham J, 2012, CLIN INFECT DIS, V55, P1312, DOI 10.1093/cid/cis716; Das VNR, 2011, T ROY SOC TROP MED H, V105, P661, DOI 10.1016/j.trstmh.2011.08.005; Day MJ, 2007, VET PARASITOL, V147, P2, DOI 10.1016/j.vetpar.2007.03.037; de Souza-e-Silva CH, 2013, PEDIATR INFECT DIS J, V32, P13, DOI 10.1097/INF.0b013e3182703460; ELAMIN EM, 1986, CLIN EXP IMMUNOL, V64, P14; ELASSAD AMS, 1994, CLIN EXP IMMUNOL, V95, P294; EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124; Fagundes-Silva GA, 2012, PARASITE IMMUNOL, V34, P486, DOI 10.1111/j.1365-3024.2012.01379.x; Ganguly S, 2008, J INFECT DIS, V197, P1762, DOI 10.1086/588387; GHOSH AK, 1995, CLIN DIAGN LAB IMMUN, V2, P291; Gidwani K, 2011, CLIN VACCINE IMMUNOL, V18, P346, DOI 10.1128/CVI.00473-10; Gomes IT, 2010, J IMMUNOL METHODS, V360, P76, DOI 10.1016/j.jim.2010.06.011; Hailu A, 2001, J INFECT DIS, V184, P112, DOI 10.1086/320994; Hasker E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002657; Hasker E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002053; Lawn SD, 2004, AM J TROP MED HYG, V70, P329, DOI 10.4269/ajtmh.2004.70.329; Leoratti FMS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-186; Moral L, 2002, T ROY SOC TROP MED H, V96, P129, DOI 10.1016/S0035-9203(02)90278-6; Mukhopadhyay D, 2012, T ROY SOC TROP MED H, V106, P668, DOI 10.1016/j.trstmh.2012.07.005; Nolder D, 2007, AM J TROP MED HYG, V76, P573, DOI 10.4269/ajtmh.2007.76.573; Ostyn B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001284; Ozbilge H, 2006, J MED MICROBIOL, V55, P1329, DOI 10.1099/jmm.0.46667-0; Pan Q, 2000, IMMUNOL REV, V178, P99, DOI 10.1034/j.1600-065X.2000.17815.x; Patil RR, 2012, HUM VACC IMMUNOTHER, V8, P725, DOI 10.4161/hv.19542; Pattabhi S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000822; Peeling RW, 2006, SEX TRANSM INFECT, V82, pV1, DOI 10.1136/sti.2006.024265; Picado A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087641; Ravindran R, 2004, INFECT IMMUN, V72, P863, DOI 10.1128/IAI.72.2.863-870.2004; Rijal S, 2013, CLIN INFECT DIS, V56, P1530, DOI 10.1093/cid/cit102; Saha S, 2005, J CLIN MICROBIOL, V43, P1269, DOI 10.1128/JCM.43.3.1269-1277.2005; Santana SS, 2012, IMMUNOL LETT, V143, P193, DOI 10.1016/j.imlet.2012.02.008; SCHAEFER KU, 1995, T ROY SOC TROP MED H, V89, P471, DOI 10.1016/0035-9203(95)90070-5; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; Shiddo SA, 1996, IMMUNOL LETT, V50, P87, DOI 10.1016/0165-2478(96)02529-1; Silva LD, 2006, AM J TROP MED HYG, V75, P739, DOI 10.4269/ajtmh.2006.75.739; Singh S, 2002, CLIN DIAGN LAB IMMUN, V9, P568, DOI 10.1128/CDLI.9.3.568-572.2002; Srivastava P, 2011, T ROY SOC TROP MED H, V105, P1, DOI 10.1016/j.trstmh.2010.09.006; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; Sundar S, 1998, LANCET, V351, P563, DOI 10.1016/S0140-6736(97)04350-X; Tappe D, 2010, CLIN VACCINE IMMUNOL, V17, P944, DOI 10.1128/CVI.00026-10; Taylor RR, 1998, AM J TROP MED HYG, V58, P406, DOI 10.4269/ajtmh.1998.58.406; Trujillo C, 1999, IMMUNOL LETT, V70, P203; ULRICH M, 1995, CLIN EXP IMMUNOL, V100, P54; Vallur AC, 2014, CLIN MICROBIOL INFEC, V20, pO374, DOI 10.1111/1469-0691.12421; Wen H, 1995, T ROY SOC TROP MED H, V89, P692, DOI 10.1016/0035-9203(95)90449-2; WHO, 2010, WHO TECH REP SER, V949, P1; World Health Organization, 2012, WHO TECHN REP SER, V975; Zijlstra EE, 2001, TROP MED INT HEALTH, V6, P108, DOI 10.1046/j.1365-3156.2001.00680.x; ZIJLSTRA EE, 1994, AM J TROP MED HYG, V51, P826, DOI 10.4269/ajtmh.1994.51.826; Zijlstra EE, 1998, CLIN DIAGN LAB IMMUN, V5, P717	66	14	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	OCT	2014	8	10							e3273	10.1371/journal.pntd.0003273				11	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AS9WJ	WOS:000344589000076	25340782	DOAJ Gold, Green Published			2019-04-02	
J	Leulmi, H; Socolovschi, C; Laudisoit, A; Houemenou, G; Davoust, B; Bitam, I; Raoult, D; Parola, P				Leulmi, Hamza; Socolovschi, Cristina; Laudisoit, Anne; Houemenou, Gualbert; Davoust, Bernard; Bitam, Idir; Raoult, Didier; Parola, Philippe			Detection of Rickettsia felis, Rickettsia typhi, Bartonella Species and Yersinia pestis in Fleas (Siphonaptera) from Africa	PLOS NEGLECTED TROPICAL DISEASES			English	Article							SPOTTED-FEVER GROUP; MOLECULAR-DETECTION; MURINE TYPHUS; SMALL MAMMALS; PLAGUE; TANZANIA; CONGO; ALGERIA; BORNE; TRANSMISSION	Little is known about the presence/absence and prevalence of Rickettsia spp, Bartonella spp. and Yersinia pestis in domestic and urban flea populations in tropical and subtropical African countries. Methodology/Principal findings: Fleas collected in Benin, the United Republic of Tanzania and the Democratic Republic of the Congo were investigated for the presence and identity of Rickettsia spp., Bartonella spp. and Yersinia pestis using two qPCR systems or qPCR and standard PCR. In Xenopsylla cheopis fleas collected from Cotonou (Benin), Rickettsia typhi was detected in 1% (2/199), and an uncultured Bartonella sp. was detected in 34.7% (69/199). In the Lushoto district (United Republic of Tanzania), R. typhi DNA was detected in 10% (2/20) of Xenopsylla brasiliensis, and Rickettsia felis was detected in 65% (13/20) of Ctenocephalides felis strongylus, 71.4% (5/7) of Ctenocephalides canis and 25% (5/20) of Ctenophthalmus calceatus calceatus. In the Democratic Republic of the Congo, R. felis was detected in 56.5% (13/23) of Ct. f. felis from Kinshasa, in 26.3% (10/38) of Ct. f. felis and 9% (1/11) of Leptopsylla aethiopica aethiopica from Ituri district and in 19.2% (5/26) of Ct. f. strongylus and 4.7% (1/21) of Echidnophaga gallinacea. Bartonella sp. was also detected in 36.3% (4/11) of L. a. aethiopica. Finally, in Ituri, Y. pestis DNA was detected in 3.8% (1/26) of Ct. f. strongylus and 10% (3/30) of Pulex irritans from the villages of Wanyale and Zaa. Conclusion: Most flea-borne infections are neglected diseases which should be monitored systematically in domestic rural and urban human populations to assess their epidemiological and clinical relevance. Finally, the presence of Y. pestis DNA in fleas captured in households was unexpected and raises a series of questions regarding the role of free fleas in the transmission of plague in rural Africa, especially in remote areas where the flea density in houses is high.	[Leulmi, Hamza; Socolovschi, Cristina; Davoust, Bernard; Bitam, Idir; Raoult, Didier; Parola, Philippe] Aix Marseille Univ, URMITE, Inserm 1095, UM63,CNRS 7278,IRD 198, Marseille, France; [Laudisoit, Anne] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Laudisoit, Anne] Univ Antwerp, B-2020 Antwerp, Belgium; [Houemenou, Gualbert] Univ Liege, Unite Rech Zoogeog, Sart Tilman Par Liege, Belgium; [Bitam, Idir] Univ Boumerdes, Lab VALCORE, Fac Sci, Bourmedes, Algeria; [Bitam, Idir] Univ Bab Ezzouar, Lab Ecol & Environm, Algiers, Algeria	Leulmi, H (reprint author), Aix Marseille Univ, URMITE, Inserm 1095, UM63,CNRS 7278,IRD 198, Marseille, France.	philippe.parola@univ-amu.fr	Laudisoit, Anne/F-2646-2017	Laudisoit, Anne/0000-0001-7626-9426; raoult, didier/0000-0002-0633-5974			Adjemian J, 2010, EMERG INFECT DIS, V16, P412, DOI 10.3201/eid1603.091028; Andrianaivoarimanana V, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002382; Anstey NM, 1997, AM J TROP MED HYG, V57, P187, DOI 10.4269/ajtmh.1997.57.187; Azad AF, 1997, EMERG INFECT DIS, V3, P319, DOI 10.3201/eid0303.970308; Bertherat E, 2011, EMERG INFECT DIS, V17, P778, DOI 10.3201/eid1705.100029; Bitam I, 2006, AM J TROP MED HYG, V74, P532, DOI 10.4269/ajtmh.2006.74.532; Bitam I, 2009, CLIN MICROBIOL INFEC, V15, P255, DOI 10.1111/j.1469-0691.2008.02275.x; Bitam I, 2010, EMERG INFECT DIS, V16, P1639, DOI 10.3201/eid1610.091854; Bitam I, 2010, INT J INFECT DIS, V14, pE667, DOI 10.1016/j.ijid.2009.11.011; Breitschwerdt EB, 2010, J VET EMERG CRIT CAR, V20, P8, DOI 10.1111/j.1476-4431.2009.00496.x; Cabanel N, 2013, EMERG INFECT DIS, V19, P230, DOI 10.3201/eid1902.121031; Chomel BB, 2009, VET RES, V40, DOI 10.1051/vetres/2009011; Civen R, 2008, CLIN INFECT DIS, V46, P913, DOI 10.1086/527443; Dill T, 2013, EMERG INFECT DIS, V19, P317, DOI 10.3201/eid1902.120601; Drancourt M, 2012, CLIN MICROBIOL INFEC, V18, P224, DOI 10.1111/j.1469-0691.2012.03774.x; Drancourt M, 2007, EMERG INFECT DIS, V13, P332, DOI 10.3201/eid1302.060197; Eisen RJ, 2006, P NATL ACAD SCI USA, V103, P15380, DOI 10.1073/pnas.0606831103; Eisen RJ, 2012, ANNU REV ENTOMOL, V57, P61, DOI 10.1146/annurev-ento-120710-100717; Gundi VAKB, 2012, AM J TROP MED HYG, V87, P319, DOI 10.4269/ajtmh.2012.11-0555; Hinnebusch BJ, 2005, CURR ISSUES MOL BIOL, V7, P197; Houemenou G, 2013, INT SCHOLARLY RES NO, V2013, P1; Janssens P G, 1994, Verh K Acad Geneeskd Belg, V56, P281; Kapoor R, 2012, CUTIS, V89, P157; Keita AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054679; La SB, 2002, INT J SYST EVOL MICR, V52, P2035; Laudisoit A, 2009, PARASITE, V16, P275, DOI 10.1051/parasite/2009164275; Laudisoit A, 2007, EMERG INFECT DIS, V13, P687, DOI 10.3201/eid1305.061084; Laudisoit A, 2014, AM J TROP MED HYG, V90, P463, DOI 10.4269/ajtmh.13-0216; Laudisoit A, 2011, ASIAN PAC J TROP MED, V4, P320, DOI 10.1016/S1995-7645(11)60094-1; Laudisoit A, 2009, INTEGR ZOOL, V4, P196, DOI 10.1111/j.1749-4877.2009.00150.x; Maciel JF, 2013, CIENC RURAL, V43, P2037, DOI 10.1590/S0103-84782013005000123; Mediannikov O, 2013, EMERG INFECT DIS, V19, P1775, DOI 10.3201/eid1911.130361; Mediannikov O, 2012, TICKS TICK-BORNE DIS, V3, P370, DOI 10.1016/j.ttbdis.2012.10.015; Nogueras MM, 2006, ANN NY ACAD SCI, V1078, P159, DOI 10.1196/annals.1374.028; Nogueras MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071386; Merhej V, 2009, CLIN MICROBIOL INFEC, V15, P336, DOI 10.1111/j.1469-0691.2008.02265.x; Neerinckx S, 2010, T ROY SOC TROP MED H, V104, P97, DOI 10.1016/j.trstmh.2009.07.028; NORMAN AF, 1995, J CLIN MICROBIOL, V33, P1797; Odhiambo AM, 2014, VECTOR-BORNE ZOONOT, V14, P476, DOI 10.1089/vbz.2013.1518; Parola P, 2005, VET RES, V36, P469, DOI 10.1051/vetres:2005004; Parola P, 2011, CLIN MICROBIOL INFEC, V17, P996, DOI 10.1111/j.1469-0691.2011.03516.x; Parola P, 2006, CLIN DERMATOL, V24, P191, DOI 10.1016/j.clindermatol.2005.11.007; Prabhu M, 2011, CLIN INFECT DIS, V53, pe8, DOI 10.1093/cid/cir411; Raoult D, 2013, J INFECTION, V66, P18, DOI 10.1016/j.jinf.2012.09.010; Sackal C, 2008, EMERG INFECT DIS, V14, P1972, DOI 10.3201/eid1412.080610; Socolovschi C, 2012, EMERG INFECT DIS, V18, P1687, DOI 10.3201/eid1810.120178; Socolovschi C, 2010, EMERG INFECT DIS, V16, P1140, DOI 10.3201/eid1607.100070; Stenseth NC, 2008, PLOS MED, V5, P9, DOI 10.1371/journal.pmed.0050003; Varagnol M, 2009, CLIN MICROBIOL INFEC, V15, P334, DOI 10.1111/j.1469-0691.2008.02272.x; Walter G, 2012, AM J TROP MED HYG, V86, P1049, DOI 10.4269/ajtmh.2012.11-0794; Woods ME, 2009, AM J TROP MED HYG, V80, P998, DOI 10.4269/ajtmh.2009.80.998; WORLD HEALTH ORGANIZATION Geneva, 2006, WEEKLY EPIDEMIOLOGIC, V25, P241	52	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	OCT	2014	8	10							e3152	10.1371/journal.pntd.0003152				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AS9WJ	WOS:000344589000007	25299702	DOAJ Gold, Green Published			2019-04-02	
J	Levecke, B; Montresor, A; Albonico, M; Ame, SM; Behnke, JM; Bethony, JM; Noumedem, CD; Engels, D; Guillard, B; Kotze, AC; Krolewiecki, AJ; McCarthy, JS; Mekonnen, Z; Periago, MV; Sopheak, H; Tchuem-Tchuente, LA; Duong, TT; Huong, NT; Zeynudin, A; Vercruysse, J				Levecke, Bruno; Montresor, Antonio; Albonico, Marco; Ame, Shaali M.; Behnke, Jerzy M.; Bethony, Jeffrey M.; Noumedem, Calvine D.; Engels, Dirk; Guillard, Bertrand; Kotze, Andrew C.; Krolewiecki, Alejandro J.; McCarthy, James S.; Mekonnen, Zeleke; Periago, Maria V.; Sopheak, Hem; Tchuem-Tchuente, Louis-Albert; Tran Thanh Duong; Nguyen Thu Huong; Zeynudin, Ahmed; Vercruysse, Jozef			Assessment of Anthelmintic Efficacy of Mebendazole in School Children in Six Countries Where Soil-Transmitted Helminths Are Endemic	PLOS NEGLECTED TROPICAL DISEASES			English	Article							MONITORING DRUG EFFICACY; KATZ THICK SMEAR; TRICHURIS-TRICHIURA; PEMBA ISLAND; ALBENDAZOLE; INFECTIONS; METAANALYSIS; SENSITIVITY; RESISTANCE; OXANTEL	Background: Robust reference values for fecal egg count reduction (FECR) rates of the most widely used anthelmintic drugs in preventive chemotherapy (PC) programs for controlling soil-transmitted helminths (STHs; Ascaris lumbricoides, Trichuris trichiura, and hookworm) are still lacking. However, they are urgently needed to ensure detection of reduced efficacies that are predicted to occur due to growing drug pressure. Here, using a standardized methodology, we assessed the FECR rate of a single oral dose of mebendazole (MEB; 500 mg) against STHs in six trials in school children in different locations around the world. Our results are compared with those previously obtained for similarly conducted trials of a single oral dose of albendazole (ALB; 400 mg). Methodology: The efficacy of MEB, as assessed by FECR, was determined in six trials involving 5,830 school children in Brazil, Cambodia, Cameroon, Ethiopia, United Republic of Tanzania, and Vietnam. The efficacy of MEB was compared to that of ALB as previously assessed in 8,841 school children in India and all the above-mentioned study sites, using identical methodologies. Principal Findings: The estimated FECR rate [95% confidence interval] of MEB was highest for A. lumbricoides (97.6% [95.8; 99.5]), followed by hookworm (79.6% [71.0; 88.3]). For T. trichiura, the estimated FECR rate was 63.1% [51.6; 74.6]. Compared to MEB, ALB was significantly more efficacious against hookworm (96.2% [91.1; 100], p<0.001) and only marginally, although significantly, better against A. lumbricoides infections (99.9% [99.0; 100], p = 0.012), but equally efficacious for T. trichiura infections (64.5% [44.4; 84.7], p = 0.906). Conclusions/Significance: A minimum FECR rate of 95% for A. lumbricoides, 70% for hookworm, and 50% for T. trichiura is expected in MEB-dependent PC programs. Lower FECR results may indicate the development of potential drug resistance.	[Levecke, Bruno; Vercruysse, Jozef] Univ Ghent, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Montresor, Antonio; Engels, Dirk] WHO, Dept Control Neglected Trop Dis, CH-1211 Geneva, Switzerland; [Albonico, Marco] Fdn Ivo de Carneri, Milan, Italy; [Ame, Shaali M.] Publ Hlth Lab Ivo de Carneri, Chake Chake, Tanzania; [Behnke, Jerzy M.] Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England; [Bethony, Jeffrey M.] George Washington Univ, Med Ctr, Washington, DC 20037 USA; [Noumedem, Calvine D.; Tchuem-Tchuente, Louis-Albert] Univ Yaounde I, Ctr Schistosomiasis & Parasitol, Yaounde, Cameroon; [Guillard, Bertrand; Sopheak, Hem] Inst Pasteur, Clin Lab, Phnom Penh, Cambodia; [Kotze, Andrew C.] Commonwealth Sci & Ind Res Org, Div Anim Food & Hlth Sci, St Lucia, Qld, Australia; [Krolewiecki, Alejandro J.] Univ Nacl Salta, CONICET, Inst Invest Enfermedades Trop, Oran, Argentina; [McCarthy, James S.] Univ Queensland, Queensland Inst Med Res, Brisbane, Qld, Australia; [Mekonnen, Zeleke; Zeynudin, Ahmed] Jimma Univ, Dept Med Lab Sci & Pathol, Jimma, Ethiopia; [Periago, Maria V.] Fundacao Oswaldo Cruz, Inst Rene Rachou, Belo Horizonte, MG, Brazil; [Tran Thanh Duong; Nguyen Thu Huong] Natl Inst Malariol Parasitol & Entomol, Dept Parasitol, Hanoi, Vietnam	Levecke, B (reprint author), Univ Ghent, Dept Virol Parasitol & Immunol, Merelbeke, Belgium.	bruno.levecke@ugent.be	Kotze, andrew/B-5995-2012; McCarthy, James/C-1681-2009	Periago, Maria Victoria/0000-0002-1470-5146; ALBONICO, Marco/0000-0002-7805-2391; Levecke, Bruno/0000-0001-8912-5595	World Health Organization [APW200432311]; Fund for Scientific Research-Flanders (Belgium) (F.W.O.-Vlaanderen) [FWO12/PDO/099]	This trial was financially supported by World Health Organization (grant no APW200432311, http://apps.who.int/whocc/Detail.aspx?cc_ref=BEL-42&cc_code=bel). BL is a postdoctoral fellow of the Fund for Scientific Research-Flanders (Belgium) (F.W.O.-Vlaanderen, grant no FWO12/PDO/099, www.fwo.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albonico M, 2012, T ROY SOC TROP MED H, V106, P199, DOI 10.1016/j.trstmh.2011.11.006; Albonico M, 2002, T ROY SOC TROP MED H, V96, P685, DOI 10.1016/S0035-9203(02)90352-4; Albonico M, 2013, T ROY SOC TROP MED H, V107, P493, DOI 10.1093/trstmh/trt051; Bennett A, 2000, PARASITOL TODAY, V16, P71, DOI 10.1016/S0169-4758(99)01544-6; Casella G., 2002, STAT INFERENCE; Diawara A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002247; Dobson RJ, 2009, VET PARASITOL, V161, P162, DOI 10.1016/j.vetpar.2008.12.007; Flisser A, 2008, J EPIDEMIOL COMMUN H, V62, P314, DOI 10.1136/jech.2007.066423; Gabrielli AF, 2011, T ROY SOC TROP MED H, V105, P683, DOI 10.1016/j.trstmh.2011.08.013; Geary TG, 2010, INT J PARASITOL, V40, P1, DOI 10.1016/j.ijpara.2009.11.001; Jia TW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001621; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Knopp S, 2010, CLIN INFECT DIS, V51, P1420, DOI 10.1086/657310; Kotze AC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001203; Levecke B, 2012, T ROY SOC TROP MED H, V106, P128, DOI 10.1016/j.trstmh.2011.09.007; Levecke B, 2014, PARASITOLOG IN PRESS; Levecke B, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000366; Levecke B, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-255; Levecke B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001201; Mekonnen Z, 2013, PATHOG GLOB HEALTH, V107, P207, DOI 10.1179/2047773213Y.0000000092; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Neglected Tropical Disease Partner Website, 2012, UN COMB NEGL TROP DI; Olliaro P, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001138; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Sinuon M, 2007, T ROY SOC TROP MED H, V101, P34, DOI 10.1016/j.trstmh.2006.04.011; Smout MJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000885; Speich B, 2014, NEW ENGL J MED, V370, P610, DOI 10.1056/NEJMoa1301956; Vercruysse J, 2011, INT J PARASITOL-DRUG, V1, P14, DOI 10.1016/j.ijpddr.2011.09.002; Vercruysse J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000948; Viechtbauer W, 2010, J STAT SOFTW, V36, P1; WHO, 2011, HELMINTH CONTROL IN SCHOOL-AGE CHILDREN: A GUIDE FOR MANAGERS OF CONTROL PROGRAMMES, SECOND EDITION, P1; World Health Organization, 2012, ACC WORK OV GLOB IMP; World Health Organization, 2012, SOIL TRANSM HELM EL; World Health Organization, 1998, GUID EV SOIL TRANSM	34	36	37	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	OCT	2014	8	10							e3204	10.1371/journal.pntd.0003204				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AS9WJ	WOS:000344589000023	25299391	DOAJ Gold, Green Published			2019-04-02	
J	Pati, PP; Van Reet, N; Ngoyi, DM; Lukusa, IN; Bin Shamamba, SK; Buscher, P				Pati, Patient Pyana; Van Reet, Nick; Ngoyi, Dieudonne Mumba; Lukusa, Ipos Ngay; Bin Shamamba, Stomy Karhemere; Buscher, Philippe			Melarsoprol Sensitivity Profile of Trypanosoma brucei gambiense Isolates from Cured and Relapsed Sleeping Sickness Patients from the Democratic Republic of the Congo	PLOS NEGLECTED TROPICAL DISEASES			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; T-B.-GAMBIENSE; LATE-STAGE; ADENOSINE TRANSPORTER; AQUAGLYCEROPORIN 2; TREATMENT FAILURE; DRUG-RESISTANCE; RISK-FACTORS; PENTAMIDINE; UGANDA	Background: Sleeping sickness caused by Trypanosoma brucei (T.b.)gambiense constitutes a serious health problem in sub-Sahara Africa. In some foci, alarmingly high relapse rates were observed in patients treated with melarsoprol, which used to be the first line treatment for patients in the neurological disease stage. Particularly problematic was the situation in MbujiMayi, East Kasai Province in the Democratic Republic of the Congo with a 57% relapse rate compared to a 5% relapse rate in Masi-Manimba, Bandundu Province. The present study aimed at investigating the mechanisms underlying the high relapse rate in Mbuji-Mayi using an extended collection of recently isolated T. b. gambiense strains from Mbuji-Mayi and from Masi-Manimba. Methodology/Principal Findings: Forty five T.b. gambiense strains were used. Forty one were isolated from patients that were cured or relapsed after melarsoprol treatment in Mbuji-Mayi. In vivo drug sensitivity tests provide evidence of reduced melarsoprol sensitivity in these strains. This reduced melarsoprol sensitivity was not attributable to mutations in TbAT1. However, in all these strains, irrespective of the patient treatment outcome, the two aquaglyceroporin (AQP) 2 and 3 genes are replaced by chimeric AQP2/3 genes that may be associated with resistance to pentamidine and melarsoprol. The 4 T.b. gambiense strains isolated in Masi-Manimba contain both wild-type AQP2 and a different chimeric AQP2/3. These findings suggest that the reduced in vivo melarsoprol sensitivity of the Mbuji-Mayi strains and the high relapse rates in that sleeping sickness focus are caused by mutations in the AQP2/AQP3 locus and not by mutations in TbAT1. Conclusions/Significance: We conclude that mutations in the TbAQP2/3 locus of the local T.b. gambiense strains may explain the high melarsoprol relapse rates in the Mbuji-Mayi focus but other factors must also be involved in the treatment outcome of individual patients.	[Pati, Patient Pyana; Ngoyi, Dieudonne Mumba; Lukusa, Ipos Ngay; Bin Shamamba, Stomy Karhemere] Inst Natl Rech Biomed, Dept Parasitol, Kinshasa Gombe, DEM REP CONGO; [Van Reet, Nick; Buscher, Philippe] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium	Pati, PP (reprint author), Inst Natl Rech Biomed, Dept Parasitol, Kinshasa Gombe, DEM REP CONGO.	ppyana@yahoo.fr	Buscher, Philippe/B-9956-2012	Buscher, Philippe/0000-0002-1926-7472	Belgian Development Cooperation (DGCD); Institute of Tropical Medicine (ITM), Antwerp (Belgium)	This study was funded by the Belgian Development Cooperation (DGCD) under the Framework Agreement 3 (FA3) with the Institute of Tropical Medicine (ITM), Antwerp (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacchi Cyrus J, 2009, Interdiscip Perspect Infect Dis, V2009, P195040, DOI 10.1155/2009/195040; Baker N, 2012, P NATL ACAD SCI USA, V109, P10996, DOI 10.1073/pnas.1202885109; Balasegaram M, 2006, B WORLD HEALTH ORGAN, V84, P777, DOI 10.2471/BLT.05.028399; Bridges DJ, 2007, MOL PHARMACOL, V71, P1098, DOI 10.1124/mol.106.031351; Brun R, 2001, TROP MED INT HEALTH, V6, P906, DOI 10.1046/j.1365-3156.2001.00775.x; Buscher P, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000471; BURKE J, 1971, Annales des Societes Belges de Medecine Tropicale de Parasitologie et de Mycologie, V51, P465; Burri C, 2001, TROP MED INT HEALTH, V6, P412, DOI 10.1046/j.1365-3156.2001.00725.x; Claes F, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000486; Giroud C, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000509; Graf FE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002475; Kibona SN, 2006, TROP MED INT HEALTH, V11, P144, DOI 10.1111/j.1365-3156.2005.01545.x; LANHAM SM, 1970, EXP PARASITOL, V28, P521, DOI 10.1016/0014-4894(70)90120-7; Legros D, 1999, B SOC PATHOL EXOT, V92, P171; Legros D, 1999, T ROY SOC TROP MED H, V93, P439, DOI 10.1016/S0035-9203(99)90151-7; Lejon V, 2008, CLIN INFECT DIS, V47, P15, DOI 10.1086/588668; Maina N, 2007, ACTA TROP, V104, P84, DOI 10.1016/j.actatropica.2007.07.007; Maser P, 1999, SCIENCE, V285, P242, DOI 10.1126/science.285.5425.242; Matovu E, 2003, EUKARYOT CELL, V2, P1003, DOI 10.1128/EC.2.5.1003-1008.2003; Matovu E, 2001, MOL BIOCHEM PARASIT, V117, P73, DOI 10.1016/S0166-6851(01)00332-2; Matovu E, 2001, TROP MED INT HEALTH, V6, P407, DOI 10.1046/j.1365-3156.2001.00712.x; Munday JC, 2014, J ANTIMICROB CHEMOTH, V69, P651, DOI 10.1093/jac/dkt442; Nerima B, 2007, TROP MED INT HEALTH, V12, P1361, DOI 10.1111/j.1365-3156.2007.01918.x; Ngoyi DM, 2010, J INFECT DIS, V201, P453, DOI 10.1086/649917; Ollivier G., 2001, TROP MED INT HEALTH, V6, P11; Pepin J, 2002, T ROY SOC TROP MED H, V96, P421, DOI 10.1016/S0035-9203(02)90380-9; PEPIN J, 1992, AM J TROP MED HYG, V47, P133, DOI 10.4269/ajtmh.1992.47.133; Priotto G, 2009, LANCET, V374, P56, DOI 10.1016/S0140-6736(09)61117-X; Pyana PP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001025; Robays J, 2008, EMERG INFECT DIS, V14, P966, DOI 10.3201/eid1406.071266; Schmid C, 2004, LANCET, V364, P789, DOI 10.1016/S0140-6736(04)16940-7; Simarro PP, 2012, PARASITOLOGY, V139, P842, DOI 10.1017/S0031182012000169; Simarro PP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001007; Simo G, 2005, EXP PARASITOL, V110, P353, DOI 10.1016/j.exppara.2005.04.001; Stanghellini A, 2001, TROP MED INT HEALTH, V6, P330, DOI 10.1046/j.1365-3156.2001.00724.x; Van Reet N, 2014, PLOS NEGL T IN PRESS; WIRTZ E, 1994, NUCLEIC ACIDS RES, V22, P3887, DOI 10.1093/nar/22.19.3887	37	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	OCT	2014	8	10							e3212	10.1371/journal.pntd.0003212				13	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AS9WJ	WOS:000344589000030		DOAJ Gold, Green Published			2019-04-02	
J	Barletta, F; Vandelannoote, K; Collantes, J; Evans, CA; Arevalo, J; Rigouts, L				Barletta, Francesca; Vandelannoote, Koen; Collantes, Jimena; Evans, Carlton A.; Arevalo, Jorge; Rigouts, Leen			Standardization of a TaqMan-Based Real-Time PCR for the Detection of Mycobacterium tuberculosis-Complex in Human Sputum	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							POLYMERASE-CHAIN-REACTION; ACID-AMPLIFICATION TESTS; CLINICAL-SAMPLES; META-REGRESSION; RAPID DETECTION; SPECIMENS; ASSAY; DNA; IDENTIFICATION; DIAGNOSIS	Real-time polymerase chain reaction (qPCR) was optimized for detecting Mycobacterium tuberculosis in sputum. Sputum was collected from patients (N = 112) with suspected pulmonary tuberculosis, tested by smear microscopy, decontaminated, and split into equal aliquots that were cultured in Lowenstein-Jensen medium and tested by qPCR for the small mobile genetic element 1S6110. The human ERV3 sequence was used as an internal control. 3 of 112 (3%) qPCR failed. For the remaining 109 samples, qPCR diagnosed tuberculosis in 79 of 84 patients with culture-proven tuberculosis, and sensitivity was greater than microscopy (94% versus 76%, respectively, P < 0.05). The qPCR sensitivity was similar (P = 0.9) for smear-positive (94%, 60 of 64) and smear-negative (95%, 19 of 20) samples. The qPCR was negative for 24 of 25 of the sputa with negative microscopy and culture (diagnostic specificity 96%). The qPCR had 99.5% sensitivity and specificity for 211 quality control samples including 84 non-tuberculosis mycobacteria. The qPCR cost similar to 5US$ per sample and provided same-day results compared with 2-6 weeks for culture.	[Barletta, Francesca] Inst Med Trop Alexander von Humboldt, Lima, Peru; [Vandelannoote, Koen] Prince Leopold Inst Trop Med, Antwerp, Belgium; [Collantes, Jimena; Arevalo, Jorge] Univ Peruana Cayetano Heredia, Inst Med Trop Lima, Lima, Peru; [Evans, Carlton A.] Univ London Imperial Coll Sci Technol & Med, Wellcome Ctr Trop Med, Dept Infect Dis & Immun, London, England; [Rigouts, Leen] Univ Antwerp, BMW, B-2020 Antwerp, Belgium	Barletta, F (reprint author), Inst Med Trop Alexander von Humboldt, Mol Epidemiol Unit, TB Av Honorio Delgado,430,, Lima, Peru.	francescabarletta@yahoo.es; kvandelannoote@itg.be; jimenacollantes@hotmail.com; carlton.evans@ifhad.org; biomoljazz@gmail.com; Ifigouts@itg.be		Evans, Carlton/0000-0002-6873-5447	Belgian Directorate-General for Development Cooperation (DGDC); Wellcome Trust; charity IFHAD: Innovation For Health And Development; Imperial College Biomedical Research Centre; Joint Global Health Trials consortium (MRC, DFID, and Wellcome Trust); Medical Research Council [MR/K007467/1]	This study was funded by the Belgian Directorate-General for Development Cooperation (DGDC) through an institutional collaboration between the Institute of Tropical Medicine in Antwerp, Belgium and the Instituto de Medicina Tropical Alexander von Humboldt in Lima, Peru. CAE and some sample collection and microbiology were funded by the Wellcome Trust and the charity IFHAD: Innovation For Health And Development. CAE acknowledges support from the Imperial College Biomedical Research Centre and by the Joint Global Health Trials consortium (MRC, DFID, and Wellcome Trust).	ALTAMIRANO M, 1992, J CLIN MICROBIOL, V30, P2173; BEIGE J, 1995, J CLIN MICROBIOL, V33, P90; Beqaj SH, 2007, DIAGN MOL PATHOL, V16, P169, DOI 10.1097/PDM.0b013e318037552e; Burkardt HJ, 2000, CLIN CHEM LAB MED, V38, P87, DOI 10.1515/CCLM.2000.014; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen X, 2012, INT J TUBERC LUNG D, V16, P235, DOI 10.5588/ijtld.11.0212; CLARRIDGE JE, 1993, J CLIN MICROBIOL, V31, P2049; COHEN M, 1985, VIROLOGY, V147, P449, DOI 10.1016/0042-6822(85)90147-3; COUSINS DV, 1992, J CLIN MICROBIOL, V30, P255; de Parseval N, 1998, J VIROL, V72, P3442; Eigner U, 2013, CLIN LAB, V59, P1179, DOI 10.7754/Clin.Lab.2013.121209; EISENACH KD, 1990, J INFECT DIS, V161, P977, DOI 10.1093/infdis/161.5.977; Flores LL, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-55; FOLGUEIRA L, 1993, J CLIN MICROBIOL, V31, P1019; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Kaser M, 2009, APPL ENVIRON MICROB, V75, P414, DOI 10.1128/AEM.01358-08; Katila ML, 2000, J CLIN MICROBIOL, V38, P960; KOCAGOZ T, 1993, J CLIN MICROBIOL, V31, P1435; KOX LFF, 1994, J CLIN MICROBIOL, V32, P672; Kurepina N. E., 1998, Tubercle and Lung Disease, V79, P31, DOI 10.1054/tuld.1998.0003; Lebrun L, 2005, J CLIN MICROBIOL, V43, P2567, DOI 10.1128/JCM.43.6.2567-2574.2005; Ling DI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001536; Master RN, 1992, CLIN MICROBIOLOGY PR, VI; Mazzarelli G, 2003, J CLIN MICROBIOL, V41, P1779, DOI 10.1128/JCM.41.4.1779-1782.2003; McHugh TD, 1997, J CLIN MICROBIOL, V35, P1769; MOGUEL MMC, 2000, REV PANAM SALUD PUBL, V7, P389; MOORE DF, 1995, J CLIN MICROBIOL, V33, P2686; Moure R, 2011, J CLIN MICROBIOL, V49, P1137, DOI 10.1128/JCM.01831-10; Palomino JC, 2006, CURR OPIN PULM MED, V12, P172, DOI 10.1097/01.mcp.0000219265.50310.9b; Parimango D, 2007, REV MED VALLEJIANA, V4, P24; Piersimoni C, 2003, J CLIN MICROBIOL, V41, P5355, DOI 10.1128/JCM.41.12.5355-5365.2003; Ricaldi JN, 2008, TROP DOCT, V38, P97, DOI 10.1258/td.2007.070024; Richter E, 2004, J CLIN MICROBIOL, V42, P4303, DOI 10.1128/JCM.42.9.4303-4306.2004; Somoskovi A, 2001, CHEST, V120, P250, DOI 10.1378/chest.120.1.250; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; THIERRY D, 1990, NUCLEIC ACIDS RES, V18, P188, DOI 10.1093/nar/18.1.188; Van Deun A, 2005, INT J TUBERC LUNG D, V9, P1127; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406; Yang YC, 2011, J CLIN MICROBIOL, V49, P797, DOI 10.1128/JCM.01839-10; Yuan CC, 2001, J VIROL METHODS, V91, P109	40	8	8	0	10	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2014	91	4					709	714		10.4269/ajtmh.13-0603				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	AQ6XQ	WOS:000342957600011	25114009	Green Published, Bronze			2019-04-02	
J	Laokri, S; Dramaix-Wilmet, M; Kassa, F; Anagonou, S; Dujardin, B				Laokri, Samia; Dramaix-Wilmet, Michele; Kassa, Ferdinand; Anagonou, Severin; Dujardin, Bruno			Assessing the economic burden of illness for tuberculosis patients in Benin: determinants and consequences of catastrophic health expenditures and inequities	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						Health economics; Catastrophic health expenditure; Informed policy-making; Financial and social protection; Bottom-up decision-making; Cost of illness	BURKINA-FASO; LOW-INCOME; CARE; IMPOVERISHMENT; COUNTRIES; POVERTY; EQUITY; FEES	ObjectivesTo inform policy-making, we measured the risk, causes and consequences of catastrophic expenditures for tuberculosis and investigated potential inequities. MethodsBetween August 2008 and February 2009, a cross-sectional study was conducted among all (245) smear-positive pulmonary tuberculosis patients of six health districts from southern Benin. A standardised survey questionnaire covered the period of time elapsing from onset of tuberculosis symptoms to completion of treatment. Total direct cost exceeding the conventional 10% threshold of annual income was defined as catastrophic and used as principal outcome in a multivariable logistic regression. A sensitivity analysis was performed while varying the thresholds. ResultsA pure gradient of direct costs of tuberculosis in relation to income was observed. Incidence (78.1%) and intensity (14.8%) of catastrophic expenditure were high; varying thresholds was insensitive to the intensity. Incurring catastrophic expenditure was independently associated with lower- and middle-income quintiles (adjusted odd ratio (aOR)=36.2, 95% CI [12.3-106.3] and aOR=6.4 [2.8-14.6]), adverse pre-diagnosis stage (aOR=5.4 [2.2-13.3]) and less education (aOR=4.1[1.9-8.7]). Households incurred important days lost due to TB, indebtedness (37.1%), dissaving (51.0%) and other coping strategies (52.7%). ConclusionsCatastrophic direct costs and substantial indirect and coping costs may persist under the free' tuberculosis diagnosis and treatment strategy, as well as inequities in financial hardship.	[Laokri, Samia; Dramaix-Wilmet, Michele; Dujardin, Bruno] Univ Libre Bruxelles, Brussels, Belgium; [Kassa, Ferdinand; Anagonou, Severin] Programme Natl TB, Cotonou, Benin	Laokri, S (reprint author), Route Lennik 808,CP 594, B-1070 Brussels, Belgium.	slaokri@ulb.ac.be		Laokri, Samia/0000-0002-9814-5405	Development and Cooperation-EuropeAid Directorate-General of the European Commission; Universite Libre de Bruxelles	The Development and Cooperation-EuropeAid Directorate-General of the European Commission funded local staff and data collection. A Mini-arc Grant from the Universite Libre de Bruxelles funded the analysis of data and writing of the manuscript. Neither body had a role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barter DM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-980; Boccia D, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P37, DOI 10.5588/ijtld.10.0438; Chatham House, 2012, M SUMM CTR GLOB HLTH; Chuma J, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-413; Cleary S, 2013, SOC SCI MED, V80, P37, DOI 10.1016/j.socscimed.2012.11.035; Cobelens F, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001358; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Hosmer D., 2004, APPL LOGISTIC REGRES; Kickbusch IS, 2001, HEALTH PROMOT INT, V16, P289, DOI 10.1093/heapro/16.3.289; Kim Y, 2011, HEALTH POLICY, V100, P239, DOI 10.1016/j.healthpol.2010.08.008; Knaul FM, 2006, LANCET, V368, P1828, DOI 10.1016/S0140-6736(06)69565-2; Laokri S, 2013, INT J TUBERCULOSI S2, V17, pS46; Laokri S, 2013, SHARED AIR SAFE AIR; Laokri S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096912; Laokri S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056752; Laokri S, 2013, B WORLD HEALTH ORGAN, V91, P277, DOI 10.2471/BLT.12.110015; McIntyre D, 2006, SOC SCI MED, V62, P858, DOI 10.1016/j.socscimed.2005.07.001; Misra S, 2013, CLIN EPIDEMIOLOGY GL, V10, P2213; O'Donnell O, 2007, ANAL HLTH EQUITY USI; Pal R, 2012, INT J HEALTH CARE FI, V12, P63, DOI 10.1007/s10754-012-9103-4; Rasanathan K, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P30, DOI 10.5588/ijtld.10.0691; Ridde V, 2013, J EPIDEMIOL COMMUN H, V67, P751, DOI 10.1136/jech-2012-202080; Rocha C, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P50, DOI 10.5588/ijtld.10.0447; Sambo Luis Gomes, 2013, Int Arch Med, V6, P10, DOI 10.1186/1755-7682-6-10; Su TT, 2006, B WORLD HEALTH ORGAN, V84, P21; Tanimura T, 2014, EUR RESPIR J, V43, P1763, DOI 10.1183/09031936.00193413; Ukwaja KN, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-21; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; Whitehead M, 2001, LANCET, V358, P833, DOI 10.1016/S0140-6736(01)05975-X; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2005, WHA58 33 58 WORL HLT; WHO Excecutive Board, 2014, GLOB STRAT TARG TUB; World Health Organization, 2013, EL CAT EC BURD TB UN; Zikusooka C M, 2009, Afr Health Sci, V9 Suppl 2, pS52; Zumla A, 2013, LANCET, V382, P1765, DOI 10.1016/S0140-6736(13)62078-4	36	18	18	2	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2014	19	10					1249	1258		10.1111/tmi.12365				10	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	AQ3JA	WOS:000342687100009	25040399				2019-04-02	
J	Wang, L; Cui, W; Kalala, JP; Van Hoof, T; Liu, BG				Wang, Lei; Cui, Wei; Kalala, Jean Pierre; Van Hoof, Tom; Liu, Bao-Ge			Effect of osteoporosis and intervertebral disc degeneration on endplate cartilage injury in rats	ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE			English	Article						Osteoporosis; Intervertebral disc degeneration; Vertebral bodies; Cartilage endplate; Damage	LUMBAR SPINE; BACK-PAIN	Objective: To investigate the effect of osteoporosis and intervertebral disc degeneration on the endplate cartilage injury in rats. Methods: A total of 48 female Sprague Dawley rats (3 months) were randomly divided into Groups A, B, C and D with 12 rats in each group. Osteoporosis and intervertebral disc degeneration composite model, simple degeneration model and simple osteoporosis model were prepared in Groups A, B and C respectively. After modeling, four rats of each group at 12th, 18th and 24th week were sacrificed. Intervertebral height of cervical vertebra C6/C7 was measured. Micro-CT was used to image the endplate of cephalic and caudal cartilage at C6/C7 intervertebral disc. Abraded area rate of C6 caudal and C7 cephalic cartilage endplate was calculated, and then C6/C7 intervertebral disc was routinely embedded and sectioned, stained with safranin 0 to observe histological changes microscopically. Results: At 12, 18 and 24 weeks, intervertebral disc height of C6/C7 were (0.58 +/- 0.09) mm, (0.53 +/- 0.04) mm and (0.04 +/- 0.06) mm in Group A rats, (0.55 +/- 0.05) mm, (0.52 +/- 0.07) mm and (0.07 +/- 0.05) mm in Group B rats. At 24111 week, intervertebral disc height of Group A rats was significantly lower than that of Group B rats (P<0.05); intervertebral disc height of Groups A and B rats at each time point were significantly lower than that of Groups C and D (P<0.05). There was no significantly statistical difference of intervertebral disc height between Groups C and D (P>0.05). At 12 and 18 weeks, the abraded rate of C6 caudal and C7 cephalic cartilage endplate in Group A rats were significantly higher than that in Groups B, C and D rats (P<0.05); the abraded rate in Group B was significantly higher than that in Groups C and D (P>0.05). Microscopic observation of CT showed that ventral defects in CO caudal or C7 cephalic cartilage endplate in Groups A and B appeared after 12 weeks of modeling; obvious cracks were found in front of the C6 and C7 vertebral body, and cartilage defect shown the trend of "repairing" at 18 and 24 weeks after modeling. Conclusions: Intervertebral disc degeneration and osteoporosis can cause damage to the cartilage endplate. Coexistence of these two factors can induce more serious damage to the endplate, which has possitive correlation with inteivertebral disc degeneration. Osteoporosis plays a certain role in intervertebral disc degeneration process, and accelerates the degeneration of intervertebral disc in a specific time window.	[Wang, Lei; Cui, Wei; Liu, Bao-Ge] Capital Med Univ, Beijing Tiantan Hosp, Dept Orthopaed, Beijing 100050, Peoples R China; [Kalala, Jean Pierre] Univ Ghent, Dept Neurosurg, B-9000 Ghent, Belgium; [Van Hoof, Tom] Univ Ghent, Dept Human Anat Embryol Histol & Med Phys, B-9000 Ghent, Belgium	Liu, BG (reprint author), Capital Med Univ, Beijing Tiantan Hosp, Dept Orthopaed, Beijing 100050, Peoples R China.	liubaog1971@163.com			National Science Foundation [81171764]	It is supported by National Science Foundation, Grant No. 81171764.	Bian Q, 2011, SPINE, V36, P2011, DOI 10.1097/BRS.0b013e3181ffde92; Guo YJ, 2014, POPULAR SCI TECHNOL, V15, P129; Hoozemans MJM, 2012, SPINE, V37, P1579, DOI 10.1097/BRS.0b013e31825409d8; Huang Shi-Rong, 2012, Zhongguo Gu Shang, V25, P147; Li Ju-bao, 2011, Zhong Xi Yi Jie He Xue Bao, V9, P1138; Li Kuifeng, 2012, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V26, P1356; Liang QQ, 2008, SPINE, V33, P2052, DOI 10.1097/BRS.0b013e318183f949; Liang QQ, 2011, SPINE, V36, pE14, DOI 10.1097/BRS.0b013e3181d2dec2; Ma X, 2011, J TRAUMA SURG, V13, P344; Mao HJ, 2011, SPINE, V36, pE1062, DOI 10.1097/BRS.0b013e3182027d42; [牛朋彦 NIU Pengyan], 2011, [中国脊柱脊髓杂志, Chinese Journal of Spine and Spinal Cord], V21, P597; Wang YXJ, 2011, OSTEOPOROSIS INT, V22, P91, DOI 10.1007/s00198-010-1200-y; [王拥军 Wang Yong-jun], 2009, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V13, P329; Wang Yong-jun, 2008, Zhong Xi Yi Jie He Xue Bao, V6, P1152, DOI 10.3736/jcim20091109; Wang Y, 2012, SPINE, V37, P1490, DOI 10.1097/BRS.0b013e3182608ac4; Wang Z, 2013, CHIN J TRADITI MED T, V21, P65; Wu Jing-ping, 2010, Fudan Xuebao (Yixueban), V37, P140; Xie Y, 2011, J CERVICODYNIA LUMBO, V32, P177; Xu Bing, 2012, Zhongguo Gu Shang, V25, P766; Xu HG, 2008, J WANNAN MED U, P37; Xu HG, 2008, J WANNAN MED U, V27, P31; Yang Shu, 2012, Zhongguo Zhong Xi Yi Jie He Za Zhi, V32, P1227; Zhang X, 2011, ZHONGGUO YI XUE YING, V19, P884; Zhang YG, 2012, J HUAZHONG U SCI-MED, V32, P210, DOI 10.1007/s11596-012-0037-3; 吕尧, 2009, [解剖学杂志, Chinese Journal of Anatomy], V32, P697	25	7	8	0	17	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1995-7645	2352-4146		ASIAN PAC J TROP MED	Asian Pac. J. Trop. Med.	OCT	2014	7	10					796	800		10.1016/S1995-7645(14)60139-5				5	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	AN6EN	WOS:000340687800009	25129463	DOAJ Gold			2019-04-02	
J	Sluydts, V; Heng, S; Coosemans, M; Van Roey, K; Gryseels, C; Canier, L; Kim, S; Khim, N; Siv, S; Mean, V; Uk, S; Grietens, KP; Tho, S; Menard, D; Durnez, L				Sluydts, Vincent; Heng, Somony; Coosemans, Marc; Van Roey, Karel; Gryseels, Charlotte; Canier, Lydie; Kim, Saorin; Khim, Nimol; Siv, Sovannaroth; Mean, Vanna; Uk, Sambunny; Grietens, Koen Peeters; Tho, Sochantha; Menard, Didier; Durnez, Lies			Spatial clustering and risk factors of malaria infections in Ratanakiri Province, Cambodia	MALARIA JOURNAL			English	Article							PLASMODIUM-FALCIPARUM; CENTRAL VIETNAM; FOREST MALARIA; VECTOR CONTROL; TRANSMISSION; DEFICIENCY; CHALLENGE; ANOPHELES; COMPLEX	Background: Malaria incidence worldwide has steadily declined over the past decades. Consequently, increasingly more countries will proceed from control to elimination. The malaria distribution in low incidence settings appears patchy, and local transmission hotspots are a continuous source of infection. In this study, species-specific clusters and associated risk factors were identified based on malaria prevalence data collected in the north-east of Cambodia. In addition, Plasmodium falciparum genetic diversity, population structure and gene flows were studied. Method: In 2012, blood samples from 5793 randomly selected individuals living in 117 villages were collected from Ratanakiri province, Cambodia. Malariometric data of each participant were simultaneously accumulated using a standard questionnaire. A two-step PCR allowed for species-specific detection of malaria parasites, and SNP-genotyping of P. falciparum was performed. SaTScan was used to determine species-specific areas of elevated risk to infection, and univariate and multivariate risk analyses were carried out. Result: PCR diagnosis found 368 positive individuals (6.4%) for malaria parasites, of which 22% contained mixed species infections. The occurrence of these co-infections was more frequent than expected. Specific areas with elevated risk of infection were detected for all Plasmodium species. The clusters for Falciparum, Vivax and Ovale malaria appeared in the north of the province along the main river, while the cluster for Malariae malaria was situated elsewhere. The relative risk to be a malaria parasite carrier within clusters along the river was twice that outside the area. The main risk factor associated with three out of four malaria species was overnight stay in the plot hut, a human behaviour associated with indigenous farming. Haplotypes did not show clear geographical population structure, but pairwise Fst value comparison indicated higher parasite flow along the river. Discussion: Spatial aggregation of malaria parasite carriers, and the identification of malaria species-specific risk factors provide key insights in malaria epidemiology in low transmission settings, which can guide targeted supplementary interventions. Consequently, future malaria programmes in the province should implement additional specific policies targeting households staying overnight at their farms outside the village, in addition to migrants and forest workers.	[Sluydts, Vincent; Coosemans, Marc; Van Roey, Karel; Gryseels, Charlotte; Grietens, Koen Peeters; Durnez, Lies] Inst Trop Med, B-2000 Antwerp, Belgium; [Heng, Somony; Siv, Sovannaroth; Mean, Vanna; Uk, Sambunny; Tho, Sochantha] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Canier, Lydie; Kim, Saorin; Khim, Nimol; Menard, Didier] Inst Pasteur Cambodge, Phnom Penh, Cambodia; [Grietens, Koen Peeters] Nagasaki Univ, Sch Int Hlth Dev, Nagasaki 852, Japan; [Grietens, Koen Peeters] Partners Appl Social Sci PASS Int, Tessenderlo, Belgium; [Coosemans, Marc] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium	Sluydts, V (reprint author), Inst Trop Med, B-2000 Antwerp, Belgium.	vsluydts@itg.be	; Menard, Didier/O-3294-2013	Peeters Grietens, Koen/0000-0001-6570-9887; Gryseels, Charlotte/0000-0002-8963-4469; Menard, Didier/0000-0003-1357-4495	Bill and Melinda Gates foundation under the Global Health [OPP1032354]; French Ministry of foreign Affairs	The authors sincerely thank all the participants who volunteered in the survey and the provincial health staff in Ratanakiri. Anna-Rosanas Urgell and Frederick Van den Broeck are acknowledged for their support in the interpretation of the genotyping results. This work was funded by the Bill and Melinda Gates foundation under the Global Health Grant number OPP1032354. DM was supported by the French Ministry of foreign Affairs.	Aamodt G, 2006, INT J HEALTH GEOGR, V5, P1; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Canier L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-405; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; Chuquiyauri R, 2013, AM J TROP MED HYG, V89, P326, DOI 10.4269/ajtmh.13-0060; CNM, 2013, ANN MAL REP 2012 CAM, P75; Daniels R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-223; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Durnez L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-329; Durnez L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-195; Erhart A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-58; Erhart A, 2004, AM J TROP MED HYG, V70, P110, DOI 10.4269/ajtmh.2004.70.110; Garros C, 2006, TROP MED INT HEALTH, V11, P102, DOI 10.1111/j.1365-3156.2005.01536.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Grietens KP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-23; Gupta B, 2010, TROP MED INT HEALTH, V15, P819, DOI 10.1111/j.1365-3156.2010.02549.x; Hartl D.L., 1997, PRINCIPLES POPULATIO, P542; Howard SC, 2001, PARASITOLOGY, V122, P233, DOI 10.1017/S0031182001007272; Incardona S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-37; Khim N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-171; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Mayxay M, 2004, TRENDS PARASITOL, V20, P233, DOI 10.1016/j.pt.2004.03.006; Mellor S, 2013, MOVING MALARIA ELIMI, P28; Mendis K, 2009, TROP MED INT HEALTH, V14, P802, DOI 10.1111/j.1365-3156.2009.02287.x; NEI M, 1978, GENETICS, V89, P583; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Obsomer V, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-26; Proux S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-323; Rulisa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069443; Singhasivanon P, 2013, SE ASIAN J TROP MED, V44, P73; Steenkeste N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-108; Thang ND, 2009, PLOS ONE, V4, pe7369; Van Bortel W, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-373; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2010, MAL GREAT MEK SUBR R, P59; WHO, 2007, MAL EL FIELD MAN LOW, P98; Witkowski B, 2013, LANCET INFECT DIS, V3099, P1; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450	42	30	30	0	10	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	SEP 30	2014	13								387	10.1186/1475-2875-13-387				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AU6KG	WOS:000345711500001	25269827	DOAJ Gold, Green Published			2019-04-02	
J	Gebremedhin, EZ; Abdurahaman, M; Tessema, TS; Tilahun, G; Cox, E; Goddeeris, B; Dorny, P; De Craeye, S; Darde, ML; Ajzenberg, D				Gebremedhin, Endrias Zewdu; Abdurahaman, Mukarim; Tessema, Tesfaye Sisay; Tilahun, Getachew; Cox, Eric; Goddeeris, Bruno; Dorny, Pierre; De Craeye, Stephane; Darde, Marie-Laure; Ajzenberg, Daniel			Isolation and genotyping of viable Toxoplasma gondii from sheep and goats in Ethiopia destined for human consumption	PARASITES & VECTORS			English	Article						Toxoplasma gondii; Bioassay; DAT; Ethiopia; Sheep; Goat; Genotyping; Microsatellite; Atypical; Virulent	MULTILOCUS PCR-RFLP; SAO-PAULO STATE; GENETIC DIVERSITY; IMMUNOCOMPROMISED PATIENTS; CONGENITAL TOXOPLASMOSIS; MICROSATELLITE ANALYSIS; CLINICAL FINDINGS; MULTIPLEX PCR; FRENCH-GUIANA; INFECTION	Background: Toxoplasma gondii is an obligate intracellular protozoan parasite that infects humans and a broad spectrum of warm-blooded vertebrates. The present study was undertaken with the objectives of isolation and determining the genotypes of T. gondii strains from sheep and goats slaughtered in East and West Shewa Zones of Oromia Regional State, Central Ethiopia. Methods: Hearts of 47 sheep and 44 goats that were seropositive in the Direct Agglutination Test (DAT) were bioassayed in mice. A multiplex PCR assay with 15 microsatellite markers was employed for genotyping of T. gondii isolates from sheep and goats. Results: Viable T. gondii were isolated from 47 (51.65%) animals, 27 sheep and 20 goats. Most isolates caused sub-clinical infections in mice, however, 2 sheep and 1 goat isolates were mouse-virulent, killing mice between 19-27 days post-inoculation. The success of T. gondii isolation in mice increased significantly (P = 0.0001) with higher DAT antibody titers in sheep and goats. Genotyping revealed that 29 (87.88%) of the 33 isolates were Type II, 3 (9.09%) were Type III and 1 (3.03%) was atypical. Three strains (one type II, one type III, and the atypical genotype) were virulent for mice. Conclusions: T. gondii tissue cysts in sheep and goats slaughtered for human consumption are widespread. This is the first report on isolation and genotyping of T. gondii from sheep and goats of Ethiopia.	[Gebremedhin, Endrias Zewdu] Ambo Univ, Fac Agr & Vet Sci, Dept Vet Lab Technol, Ambo, Ethiopia; [Abdurahaman, Mukarim] Jimma Univ, Coll Agr & Vet Med, Jimma, Ethiopia; [Tessema, Tesfaye Sisay] Univ Addis Ababa, Coll Nat & Computat Sci, Inst Biotechnol, Unit Hlth Biotechnol, Addis Ababa, Ethiopia; [Tilahun, Getachew] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Cox, Eric; Goddeeris, Bruno] Univ Ghent, Fac Vet Med, B-9820 Merelbeke, Belgium; [Goddeeris, Bruno] Catholic Univ Louvain, Fac Biosci Engn, Dept Biosyst, B-3001 Heverlee, Belgium; [Dorny, Pierre] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [De Craeye, Stephane] Sci Inst Publ Hlth Communicable & Infect Dis, Natl Reference Ctr Toxoplasmosis, B-1180 Brussels, Belgium; [Darde, Marie-Laure; Ajzenberg, Daniel] Univ Dupuytren, Ctr Hosp, BRC, CNR Toxoplasmose, F-87042 Limoges, France; [Darde, Marie-Laure; Ajzenberg, Daniel] Fac Med Limoges, INSERM, Lab Parasitol Mycol, UMR Neuroepidemiol Trop 1094, F-87025 Limoges, France	Gebremedhin, EZ (reprint author), Ambo Univ, Fac Agr & Vet Sci, Dept Vet Lab Technol, POB 19, Ambo, Ethiopia.	endrias.zewdu@gmail.com	Goddeeris, Bruno/L-2440-2015	Goddeeris, Bruno/0000-0003-3729-7592; Ajzenberg, Daniel/0000-0002-5357-3318; Sisay Tessema, Tesfaye/0000-0002-4103-5029	Oromia Regional State Rural Capacity Building, Addis Ababa University; VLIR-UOS [ZEIN 2010 PR 372]	The financial support of Oromia Regional State Rural Capacity Building, Addis Ababa University and VLIR-UOS project no. "ZEIN 2010 PR 372" "promotion of the PhD program in veterinary public health at the Faculty of Veterinary Medicine", Belgium are highly acknowledged. The authors also would like to extend their gratitude to Mr. Hashim Nuru, owner of HELMIX export abattoir and his employees for their collaboration during sampling.	Ajzenberg D, 2005, J CLIN MICROBIOL, V43, P1940, DOI 10.1128/JCM.43.4.1940-1943.2005; Ajzenberg D, 2004, INT J PARASITOL, V34, P1185, DOI 10.1016/j.ijpara.2004.06.007; Ajzenberg D, 2002, J INFECT DIS, V186, P684, DOI 10.1086/342663; Ajzenberg D, 2002, INT J PARASITOL, V32, P27, DOI 10.1016/S0020-7519(01)00301-0; Ajzenberg D, 2010, J CLIN MICROBIOL, V48, P4641, DOI 10.1128/JCM.01152-10; Ajzenberg D, 2009, J INFECT DIS, V199, P1155, DOI 10.1086/597477; Carme B, 2002, J CLIN MICROBIOL, V40, P4037, DOI 10.1128/JCM.40.11.4037-4044.2002; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Cook AJC, 2000, BRIT MED J, V321, P142, DOI 10.1136/bmj.321.7254.142; Delhaes L, 2010, PRENATAL DIAG, V30, P902, DOI 10.1002/pd.2563; Demar M, 2007, CLIN INFECT DIS, V45, pE88, DOI 10.1086/521246; Dubey JP, 2008, INT J PARASITOL, V38, P1057, DOI 10.1016/j.ijpara.2007.11.010; Dubey JP, 2013, VET PARASITOL, V196, P206, DOI 10.1016/j.vetpar.2013.01.015; Dubey JP, 2012, EPIDEMIOL INFECT, V140, P1935, DOI 10.1017/S0950268812001392; Dubey J.P., 1988, P1; DUBEY JP, 1995, J PARASITOL, V81, P723, DOI 10.2307/3283961; Dubey JP, 1997, PARASITOLOGY, V115, P9, DOI 10.1017/S0031182097008950; DUBEY JP, 1995, J PARASITOL, V81, P48, DOI 10.2307/3284004; Dubey JP, 2010, TOXOPLASMOSIS ANIMAL, P1; Dumetre A, 2006, VET PARASITOL, V142, P376, DOI 10.1016/j.vetpar.2006.07.005; Fekkar A, 2011, J CLIN MICROBIOL, V49, P1513, DOI 10.1128/JCM.02196-10; Ferreira AD, 2006, INFECT GENET EVOL, V6, P22, DOI 10.1016/j.meegid.2004.12.004; Ferreira IMR, 2008, EXP PARASITOL, V118, P221, DOI 10.1016/j.exppara.2007.08.006; Fritz H, 2012, J MICROBIOL METH, V88, P47, DOI 10.1016/j.mimet.2011.10.010; Gebremedhin EZ, 2013, CTR ETHIOP BMC VET R, V9, P117; Gebremedhin EZ, 2014, BMC RES NOT IN PRESS; Goodwin DG, 2008, J PARASITOL, V94, P555, DOI 10.1645/GE-1331.1; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Khan A, 2005, J CLIN MICROBIOL, V43, P5881, DOI 10.1128/JCM.43.12.5881-5887.2005; Khan A, 2005, NUCLEIC ACIDS RES, V33, P2980, DOI 10.1093/nar/gki604; Lemma H, 2012, ADV LIFE SCI TECHOL, V6, P33; Mercier A, 2011, INFECT GENET EVOL, V11, P1378, DOI 10.1016/j.meegid.2011.05.003; Pena HFJ, 2008, INT J PARASITOL, V38, P561, DOI 10.1016/j.ijpara.2007.09.004; Pena HFJ, 2006, RES VET SCI, V81, P58, DOI 10.1016/j.rvsc.2005.09.007; Ragozo AMA, 2009, J PARASITOL, V95, P323, DOI 10.1645/GE-1854.1; Ragozo AMA, 2008, J PARASITOL, V94, P1259, DOI 10.1645/GE-1641.1; Robert-Gangneux F, 2012, CLIN MICROBIOL REV, V25, P264, DOI 10.1128/CMR.05013-11; Su C, 2006, INT J PARASITOL, V36, P841, DOI 10.1016/j.ijpara.2006.03.003; Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035; Su CL, 2010, MOLECULAR DETECTION OF FOODBORNE PATHOGENS, P741; Suzuki Y, 2004, WORLD CL PARASITES, V9, P51; WONG SY, 1994, CLIN INFECT DIS, V18, P853, DOI 10.1093/clinids/18.6.853	43	6	7	0	17	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	SEP 4	2014	7								UNSP 425	10.1186/1756-3305-7-425				8	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	AO8RJ	WOS:000341621600001	25190185	DOAJ Gold, Green Published			2019-04-02	
J	Nabyonga-Orem, J; Ssengooba, F; Macq, J; Criel, B				Nabyonga-Orem, Juliet; Ssengooba, Freddie; Macq, Jean; Criel, Bart			Malaria treatment policy change in Uganda: what role did evidence play?	MALARIA JOURNAL			English	Article						Malaria treatment policy change; Evidence; Knowledge translation	ANTIMALARIAL-DRUG POLICY; MIDDLE-INCOME COUNTRIES; HEALTH SYSTEMS RESEARCH; KNOWLEDGE TRANSLATION; SULFADOXINE-PYRIMETHAMINE; SUPPORT; ORGANIZATIONS; CHLOROQUINE; AMODIAQUINE; STRATEGIES	Background: Although increasing attention is being paid to knowledge translation (KT), research findings are not being utilized to the desired extent. The present study explores the role of evidence, barriers, and factors facilitating the uptake of evidence in the change in malaria treatment policy in Uganda, building on previous work in Uganda that led to the development of a middle range theory (MRT) outlining the main facilitatory factors for KT. Application of the MRT to a health policy case will contribute to refining it. Methods: Using a case study approach and mixed methods, perceptions of respondents on whether evidence was available, had been considered and barriers and facilitatory factors to the uptake of evidence were explored. In addition, the respondents' rating of the degree of consistency between the policy decision and available evidence was assessed. Data collection methods included key informant interviews and document review. Qualitative data were analysed using content thematic analysis, whereas quantitative data were analysed using Excel spreadsheets. The two data sets were eventually triangulated. Results: Evidence was used to change the malaria treatment policy, though the consistency between evidence and policy decisions varied along the policy development cycle. The availability of high-quality and contextualized evidence, including effective dissemination, Ministry of Health institutional capacity to lead the KT process, intervention of the WHO and a regional professional network, the existence of partnerships for KT with mutual trust and availability of funding, tools, and inputs to implement evidence, were the most important facilitatory factors that enhanced the uptake of evidence. Among the barriers that had to be overcome were resistance from implementers, the health system capacity to implement evidence, and financial sustainability. Conclusion: The results agree with facilitatory factors identified in the earlier developed MRT, though additional factors emerged. These results refine the earlier MRT stating that high-quality and contextualized evidence will be taken up in policies, leading to evidence-informed policies when the MoH leads the KT process, partnerships are in place for KT, the WHO and regional professional bodies play a role, and funding, tools, and required inputs for implementing evidence are available.	[Nabyonga-Orem, Juliet] WHO Reg Off Africa, POB 6, Brazzaville, Rep Congo; [Ssengooba, Freddie] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Macq, Jean] Catholic Univ Louvain, B-1200 Brussels, Belgium; [Criel, Bart] Inst Trop Med Antwerp Belgium, B-2000 Antwerp, Belgium	Nabyonga-Orem, J (reprint author), WHO Reg Off Africa, POB 6, Brazzaville, Rep Congo.	julienabyonga@yahoo.com		Ssengooba, Freddie/0000-0003-3489-0745	International Development Research Centre (IDRC); African Doctoral Dissertation Research Fellowship award	The authors thank the study respondents who willingly gave their time to participate in the interviews. This research was funded by the International Development Research Centre (IDRC) in partnership with the Belgian Technical Cooperation, and by the African Doctoral Dissertation Research Fellowship award offered by the African Population and Health Research Centre (APHRC).	Aaserud M, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-68; Bergstrom A, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-117; Bernard HR, 2006, RES METHODS ANTHR QU, P196; Bowen S, 2005, PLOS MED, V2, P600, DOI 10.1371/journal.pmed.0020166; Burris H, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-S1-S5; Checchi F, 2005, TROP MED INT HEALTH, V10, P146, DOI 10.1111/j.1365-3156.2004.01367.x; Colon-Ramos U, 2007, HEALTH POLICY PLANN, V22, P363, DOI 10.1093/heapol/czm030; Cordero C, 2008, B WORLD HEALTH ORGAN, V86, P524, DOI 10.2471/BLT.07.040386; Creswell J. W., 2012, ED RES PLANNING COND; Daniels Karen, 2008, Health Res Policy Syst, V6, P12, DOI 10.1186/1478-4505-6-12; Donald S, 1975, ADMIN SOC, V5, P445; *EANMAT, 2003, TROP MED INT HEALTH, V8, P860; Fretheim Atle, 2006, Health Res Policy Syst, V4, P15, DOI 10.1186/1478-4505-4-15; Graham ID, 2009, J CAN ACAD CHILD ADO, V18, P46; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Hanney Stephen R, 2003, Health Res Policy Syst, V1, P2, DOI 10.1186/1478-4505-1-2; Hennink M, 2005, J HEALTH COMMUN, V10, P163, DOI 10.1080/10810730590915128; John Young, 2005, J INT DEV, V17, P727, DOI DOI 10.1002/JID.1235; Kamya MR, 2002, TROP MED INT HEALTH, V7, P1031, DOI 10.1046/j.1365-3156.2002.00974.x; Kangwana BB, 2009, AM J TROP MED HYG, V80, P737, DOI 10.4269/ajtmh.2009.80.737; Lavis JN, 2003, MILBANK Q, V81, P221, DOI 10.1111/1468-0009.t01-1-00052; Lavis JN, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-54; Lavis JN, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-53; Lawrence TP, 1986, ADM SCI Q, V31, P365; Lewin S, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3496; Malik EM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-65; Merton R. K., 1968, SOCIAL THEORY SOCIAL; Ministry of Health, 2005, NAT POL MAL TREATM; Mubyazi GM, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-51; Nanyunja Miriam, 2011, Malar Res Treat, V2011, P683167, DOI 10.4061/2011/683167; O'Cathain A, 2008, J HEALTH SERV RES PO, V13, P92, DOI 10.1258/jhsrp.2007.007074; Orem Juliet Nabyonga, 2012, BMC Public Health, V12, P109, DOI 10.1186/1471-2458-12-109; Orem JN, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-98; Pang T, 2007, B WORLD HEALTH ORGAN, V85, P247, DOI 10.2471/BLT.07.040824; Paul AA, 1983, ADM SCI Q, V28, P201; Regional Office for Africa, 2003, FRAM DEV IMPL UPD AN; Ringwald P, 2002, LANCET, V360, P875, DOI 10.1016/S0140-6736(02)09979-8; Sanders D, 2004, B WORLD HEALTH ORGAN, V82, P757; Santesso N, 2006, J CONTIN EDUC HEALTH, V26, P87, DOI 10.1002/chp.55; Sauerborn R, 1999, TROP MED INT HEALTH, V4, P827, DOI 10.1046/j.1365-3156.1999.00497.x; Shretta R, 2000, TROP MED INT HEALTH, V5, P755, DOI 10.1046/j.1365-3156.2000.00643.x; Ssengooba F, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-S1-S13; Straus SE, 2009, CAN MED ASSOC J, V181, P165, DOI 10.1503/cmaj.081229; Tomlinson M, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-19; Uganda Bureau of Statistics, 2010, UG MAL SURV PROJ MOL; van Kammen J, 2006, B WORLD HEALTH ORGAN, V84, P608, DOI 10.2471/BLT.05.028308; Varkevisser CM, 2001, HEALTH POLICY PLANN, V16, P281, DOI 10.1093/heapol/16.3.281; Wasunna B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-29; Woelk Godfrey, 2009, Health Res Policy Syst, V7, P31, DOI 10.1186/1478-4505-7-31; Yin RK, 1984, CASE STUDY RES DESIG, P8; Yin RK, 1984, CASE STUDY RES DESIG, P46; Young E, 2002, WRITING EFFECTIVE PU	53	8	8	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	SEP 2	2014	13								345	10.1186/1475-2875-13-345				17	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AP0DB	WOS:000341730100001	25179532	DOAJ Gold, Green Published			2019-04-02	
J	Amissah, NA; Gryseels, S; Tobias, NJ; Ravadgar, B; Suzuki, M; Vandelannoote, K; Durnez, L; Leirs, H; Stinear, TP; Portaels, F; Ablordey, A; Eddyani, M				Amissah, Nana Ama; Gryseels, Sophie; Tobias, Nicholas J.; Ravadgar, Bahram; Suzuki, Mitsuko; Vandelannoote, Koen; Durnez, Lies; Leirs, Herwig; Stinear, Timothy P.; Portaels, Francoise; Ablordey, Anthony; Eddyani, Miriam			Investigating the Role of Free-living Amoebae as a Reservoir for Mycobacterium ulcerans	PLOS NEGLECTED TROPICAL DISEASES			English	Article							REAL-TIME PCR; BURULI ULCER; ACANTHAMOEBA-CASTELLANII; LEGIONELLA-PNEUMOPHILA; CAUSATIVE AGENT; WATER; POLYPHAGA; GROWTH; IDENTIFICATION; SURVIVAL	Background: The reservoir and mode of transmission of Mycobacterium ulcerans, the causative agent of Buruli ulcer, still remain a mystery. It has been suggested that M. ulcerans persists with difficulty as a free-living organism due to its natural fragility and inability to withstand exposure to direct sunlight, and thus probably persists within a protective host environment. Methodology/Principal Findings: We investigated the role of free-living amoebae as a reservoir of M. ulcerans by screening the bacterium in free-living amoebae (FLA) cultures isolated from environmental specimens using real-time PCR. We also followed the survival of M. ulcerans expressing green fluorescence protein (GFP) in Acanthameoba castellanii by flow cytometry and observed the infected cells using confocal and transmission electron microscopy for four weeks in vitro. IS2404 was detected by quantitative PCR in 4.64% of FLA cultures isolated from water, biofilms, detritus and aerosols. While we could not isolate M. ulcerans, 23 other species of mycobacteria were cultivated from inside FLA and/or other phagocytic microorganisms. Laboratory experiments with GFP-expressing M. ulcerans in A. castellani trophozoites for 28 days indicated the bacteria did not replicate inside amoebae, but they could remain viable at low levels in cysts. Transmission electron microscopy of infected A. castellani confirmed the presence of bacteria within both trophozoite vacuoles and cysts. There was no correlation of BU notification rate with detection of the IS2404 in FLA (r = 0.07, n = 539, p = 0.127). Conclusion/Significance: This study shows that FLA in the environment are positive for the M. ulcerans insertion sequence IS2404. However, the detection frequency and signal strength of IS2404 positive amoabae was low and no link with the occurrence of BU was observed. We conclude that FLA may host M. ulcerans at low levels in the environment without being directly involved in the transmission to humans.	[Amissah, Nana Ama; Ablordey, Anthony] Noguchi Mem Inst Med Res, Dept Bacteriol, Accra, Ghana; [Gryseels, Sophie; Vandelannoote, Koen; Leirs, Herwig] Univ Antwerp, Evolutionary Ecol Grp, Dept Biol, B-2020 Antwerp, Belgium; [Tobias, Nicholas J.; Stinear, Timothy P.] Univ Melbourne, Dept Microbiol, Melbourne, Vic, Australia; [Ravadgar, Bahram; Stinear, Timothy P.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Suzuki, Mitsuko] Noguchi Mem Inst Med Res, Dept Parasitol, Accra, Ghana; [Vandelannoote, Koen; Durnez, Lies; Portaels, Francoise; Eddyani, Miriam] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium	Amissah, NA (reprint author), Noguchi Mem Inst Med Res, Dept Bacteriol, Accra, Ghana.	diana@noguchi.mimcom.org	Leirs, Herwig/B-8197-2008	Leirs, Herwig/0000-0002-7612-5024; Gryseels, Sophie/0000-0002-4851-9384; Tobias, Nicholas/0000-0003-2725-3043; Stinear, Timothy/0000-0003-0150-123X	Flemish Interuniversity Council - University Development Cooperation (VLIR-UOS); Stop Buruli Initiative - UBS Optimus Foundation (Zurich, Switzerland)	This study was supported by the Flemish Interuniversity Council - University Development Cooperation (VLIR-UOS) and by the Stop Buruli Initiative funded by the UBS Optimus Foundation (Zurich, Switzerland). SG was an FWO PhD fellow (1.1.671.10.N.00) during part of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd H, 2003, APPL ENVIRON MICROB, V69, P600, DOI 10.1128/AEM.69.1.600-606.2003; Abu Kwaik Y, 1998, APPL ENVIRON MICROB, V64, P3127; Adekambi T, 2006, APPL ENVIRON MICROB, V72, P5974, DOI 10.1128/AEM.03075-05; Angenent LT, 2005, P NATL ACAD SCI USA, V102, P4860, DOI 10.1073/pnas.0501235102; Ash LR, 1987, PARASITES GUIDE LAB; Auran J D, 1987, Cornea, V6, P2, DOI 10.1097/00003226-198706010-00002; BERMUDEZ LE, 1994, INFECT IMMUN, V62, P2021; BODDINGHAUS B, 1990, J CLIN MICROBIOL, V28, P1751; BOOM R, 1990, J CLIN MICROBIOL, V28, P495; Brown MRW, 1999, TRENDS MICROBIOL, V7, P46, DOI 10.1016/S0966-842X(98)01425-5; Castillo-Rodal AI, 2012, EUR J CLIN MICROBIOL, V31, P683, DOI 10.1007/s10096-011-1359-y; Cirillo JD, 1997, INFECT IMMUN, V65, P3759; CIRILLO JD, 1994, INFECT IMMUN, V62, P3254; Durnez L, 2009, J MICROBIOL METH, V76, P152, DOI 10.1016/j.mimet.2008.10.002; Durnez L, 2008, APPL ENVIRON MICROB, V74, P768, DOI 10.1128/AEM.01193-07; Eddyani M, 2008, APPL ENVIRON MICROB, V74, P6547, DOI 10.1128/AEM.01066-08; Fyfe JAM, 2007, APPL ENVIRON MICROB, V73, P4733, DOI 10.1128/AEM.02971-06; Fyfe JAM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000791; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Gryseels S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001764; Gupta T, 2013, CAN J MICROBIOL, V59, P570, DOI 10.1139/cjm-2013-0079; HARWOOD CR, 1988, MED J AUSTRALIA, V148, P47; HAYMAN J, 1991, INT J EPIDEMIOL, V20, P1093, DOI 10.1093/ije/20.4.1093; Johnson PDR, 2007, EMERG INFECT DIS, V13, P1653, DOI 10.3201/eid1311.061369; Kennedy GM, 2012, APPL ENVIRON MICROB, V78, P2049, DOI 10.1128/AEM.06965-11; KIRSCHNER P, 1993, J CLIN MICROBIOL, V31, P2882; Krishna Prasad B.N., 1978, Current Science (Bangalore), V47, P245; Landers P, 2000, EUR J CLIN MICROBIOL, V19, P121, DOI 10.1007/s100960050442; Liu RY, 2012, CAN J MICROBIOL, V58, P261, DOI [10.1139/w11-129, 10.1139/W11-129]; Marion E, 2011, Med Trop (Mars), V71, P169; Medie FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020499; Merritt RW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000911; MOFFAT JF, 1992, INFECT IMMUN, V60, P296; PAGE FC, 1976, ILLUSTRATED KEY FRES; PORTAELS F, 1988, J GEN MICROBIOL, V134, P849; Portaels F, 2001, REV SCI TECH OIE, V20, P252, DOI 10.20506/rst.20.1.1270; Portaels F, 2009, CLIN DERMATOL, V27, P291, DOI 10.1016/j.clindermatol.2008.09.021; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; Solomon JM, 2003, INFECT IMMUN, V71, P3578, DOI 10.1128/IAI.71.6.3578-3586.2003; Steinert M, 1998, APPL ENVIRON MICROB, V64, P2256; Stinear TP, 2007, GENOME RES, V17, P192, DOI 10.1101/gr.5942807; Thomas V, 2007, LETT APPL MICROBIOL, V45, P349, DOI 10.1111/j.1472-765X.2007.02206.x; Thomas V, 2006, APPL ENVIRON MICROB, V72, P2428, DOI 10.1128/AEM.72.4.2428-2438.2006; Thomson R, 2013, J CLIN MICROBIOL, V51, P3006, DOI 10.1128/JCM.00899-13; Tobias NJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000553; Vandelannoote K, 2010, FEMS MICROBIOL LETT, V304, P191, DOI 10.1111/j.1574-6968.2010.01902.x; VISVESVARA GS, 1983, J CLIN MICROBIOL, V18, P1405; Williamson HR, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001506	48	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	SEP	2014	8	9							e3148	10.1371/journal.pntd.0003148				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AQ4UZ	WOS:000342796600037	25188535	DOAJ Gold, Green Published			2019-04-02	
J	Fortin, A; Caridha, DP; Leed, S; Ngundam, F; Sena, J; Bosschaerts, T; Parriott, S; Hickman, MR; Hudson, TH; Grogl, M				Fortin, Anny; Caridha, Diana P.; Leed, Susan; Ngundam, Franklyn; Sena, Jenell; Bosschaerts, Tom; Parriott, Sandi; Hickman, Mark R.; Hudson, Thomas H.; Grogl, Max			Direct Comparison of the Efficacy and Safety of Oral Treatments with Oleylphosphocholine (OlPC) and Miltefosine in a Mouse Model of L. major Cutaneous Leishmaniasis	PLOS NEGLECTED TROPICAL DISEASES			English	Article							VISCERAL LEISHMANIASIS; TOLERABILITY; FLUCONAZOLE; THERAPY	Background: Cutaneous leishmaniasis (CL) represents a range of skin diseases caused by infection with Leishmania parasites and associated with tissue inflammation and skin ulceration. CL is clinically widespread in both the Old and New World but lacks treatments that are well tolerated, effective and inexpensive. Oleylphosphocholine (OlPC) is a new orally bioavailable drug of the alkylphosphocholine family with potent antileishmanial activity against a broad range of Leishmania species/strains. Methodology/principal findings: The potential of OlPC against Old World CL was evaluated in a mouse model of Leishmania (L.) major infection in BALB/c mice. Initial dose-response experiments showed that an oral daily dose of 40 mg/kg of OlPC was needed to impact time to cure and lesion sizes. This dose was then used to directly compare the efficacy of OlPC to the efficacy of the antileishmanial drugs miltefosine (40 mg/kg/day), fluconazole (160 mg/kg/day) and amphotericin B (25 mg/kg/day). OlPC, miltefosine and fluconazole were given orally for 21 days while amphotericin B was administered intraperitoneally for 10 days. Ulcer sizes and animal weights were followed up on a weekly basis and parasitemia was determined by means of a real-time in vivo imaging system which detects luminescence emitted from luciferase-expressing infecting L. major parasites. Amphotericin B and OlPC showed excellent efficacy against L. major lesions in terms of reduction of parasitic loads and by inducing complete healing of established lesions. In contrast, treatment with miltefosine did not significantly affect parasitemia and lesion sizes, while fluconazole was completely ineffective at the dose regimen tested. Conclusions/Significance: Given the data showing the outstanding efficacy and tolerability of OlPC, our results suggest that OlPC is a promising new drug candidate to improve and simplify current clinical management of L. major CL.	[Fortin, Anny] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Fortin, Anny; Bosschaerts, Tom] Dafra Pharma Res & Dev, Turnhout, Belgium; [Caridha, Diana P.; Leed, Susan; Ngundam, Franklyn; Sena, Jenell; Parriott, Sandi; Hickman, Mark R.; Hudson, Thomas H.; Grogl, Max] Walter Reed Army Inst Res, Div Expt Therapeut, Silver Spring, MD USA	Fortin, A (reprint author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	anny.fortin@dafra.be			Military Infectious Diseases research Program (MIDRP), U.S. Army Medical Research and Materiel Command (USAMRMC)	This research was funded by the Military Infectious Diseases research Program (MIDRP), U.S. Army Medical Research and Materiel Command (USAMRMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions or assertions contained herein are the private views of the authors, and are not to be construed as official, or as reflecting the views of the Department of the Army or the Department of Defense.	Alrajhi AA, 2002, NEW ENGL J MED, V346, P891, DOI 10.1056/NEJMoa011882; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; [Anonymous], 1996, GUIDE CARE USE LAB A; Chakravarty J, 2010, J GLOB INFECT DIS, V2, P167, DOI 10.4103/0974-777X.62887; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Croft SL, 2011, CLIN MICROBIOL INFEC, V17, P1478, DOI 10.1111/j.1469-0691.2011.03630.x; Croft SL, 2006, INDIAN J MED RES, V123, P399; Dorlo TPC, 2012, J ANTIMICROB CHEMOTH, V67, P2576, DOI 10.1093/jac/dks275; Fortin A, 2012, J ANTIMICROB CHEMOTH, V67, P2707, DOI 10.1093/jac/dks273; Goto H, 2012, INFECT DIS CLIN N AM, V26, P293, DOI 10.1016/j.idc.2012.03.001; Grogl M, 2013, AM J TROP MED HYG, V88, P216, DOI 10.4269/ajtmh.11-0812; Hernandez L, 2014, PARASITOL RES, V113, P157, DOI 10.1007/s00436-013-3638-2; Herwaldt BL, 1999, NEW ENGL J MED, V341, P1840, DOI 10.1056/NEJM199912093412411; Soto J, 2006, T ROY SOC TROP MED H, V100, pS34, DOI 10.1016/j.trstmh.2006.02.022; Sousa AQ, 2011, CLIN INFECT DIS, V53, P693, DOI 10.1093/cid/cir496; van Griensven J, 2012, INFECT DIS CLIN N AM, V26, P309, DOI 10.1016/j.idc.2012.03.005; Velez I, 2010, AM J TROP MED HYG, V83, P351, DOI 10.4269/ajtmh.2010.10-0060; WHO, 2010, WHO TECH REP SER, V949, P1	18	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	SEP	2014	8	9							e3144	10.1371/journal.pntd.0003144				7	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AQ4UZ	WOS:000342796600033	25210745	DOAJ Gold, Green Published			2019-04-02	
J	Guernier, V; Lagadec, E; LeMinter, G; Licciardi, S; Balleydier, E; Pages, F; Laudisoit, A; Dellagi, K; Tortosa, P				Guernier, Vanina; Lagadec, Erwan; LeMinter, Gildas; Licciardi, Severine; Balleydier, Elsa; Pages, Frederic; Laudisoit, Anne; Dellagi, Koussay; Tortosa, Pablo			Fleas of Small Mammals on Reunion Island: Diversity, Distribution and Epidemiological Consequences	PLOS NEGLECTED TROPICAL DISEASES			English	Article							XENOPSYLLA-BRASILIENSIS; MURINE TYPHUS; PLAGUE VECTOR; SIPHONAPTERA; MADAGASCAR; PHYLOGENY; RESISTANCE; RODENTS; UPDATE; SPP.	The diversity and geographical distribution of fleas parasitizing small mammals have been poorly investigated on Indian Ocean islands with the exception of Madagascar where endemic plague has stimulated extensive research on these arthropod vectors. In the context of an emerging flea-borne murine typhus outbreak that occurred recently in Reunion Island, we explored fleas' diversity, distribution and host specificity on Reunion Island. Small mammal hosts belonging to five introduced species were trapped from November 2012 to November 2013 along two altitudinal transects, one on the windward eastern and one on the leeward western sides of the island. A total of 960 animals were trapped, and 286 fleas were morphologically and molecularly identified. Four species were reported: (i) two cosmopolitan Xenopsylla species which appeared by far as the prominent species, X. cheopis and X. brasiliensis; (ii) fewer fleas belonging to Echidnophaga gallinacea and Leptopsylla segnis. Rattus rattus was found to be the most abundant host species in our sample, and also the most parasitized host, predominantly by X. cheopis. A marked decrease in flea abundance was observed during the cool-dry season, which indicates seasonal fluctuation in infestation. Importantly, our data reveal that flea abundance was strongly biased on the island, with 81% of all collected fleas coming from the western dry side and no Xenopsylla flea collected on almost four hundred rodents trapped along the windward humid eastern side. The possible consequences of this sharp spatio-temporal pattern are discussed in terms of flea-borne disease risks in Reunion Island, particularly with regard to plague and the currently emerging murine typhus outbreak.	[Guernier, Vanina; Lagadec, Erwan; LeMinter, Gildas; Licciardi, Severine; Dellagi, Koussay; Tortosa, Pablo] Ctr Rech & Veille Malad Emergentes Ocean Indien, Plateforme Rech CYROI, St Clothilde, Reunion, France; [Guernier, Vanina; Lagadec, Erwan; LeMinter, Gildas; Dellagi, Koussay] Inst Rech Dev, St Clothilde, Reunion, France; [Licciardi, Severine] CIRAD, Unite Mixte Rech Controle Malad Anim Exot Emergen, Montpellier, France; [Balleydier, Elsa; Pages, Frederic] French Inst Publ Hlth Surveillance Cire OI, Reg Off, Inst Veille Sanit, St Denis, Reunion, France; [Laudisoit, Anne] Univ Liverpool, Sch Biol Sci, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Laudisoit, Anne] Univ Antwerp, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium; [Tortosa, Pablo] Univ La Reunion, Joint Chair CNRS Univ La Reunion, St Clothilde, Reunion, France	Guernier, V (reprint author), Ctr Rech & Veille Malad Emergentes Ocean Indien, Plateforme Rech CYROI, St Clothilde, Reunion, France.	vanina.guernier@ird.fr	Laudisoit, Anne/F-2646-2017	Laudisoit, Anne/0000-0001-7626-9426; Guernier, Vanina/0000-0002-0960-3874; Abid, sayda/0000-0003-2488-1431; Tortosa, Pablo/0000-0002-7928-7264	(European Regional Development Funds ERDF) POCT Reunion, LeptOI project	This work was supported by (European Regional Development Funds ERDF) POCT Reunion, LeptOI project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianaivoarimanana V, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002382; [Anonymous], 1999, Wkly Epidemiol Rec, V74, P447; Aubry P, 2010, Med Trop (Mars), V70, P443; AZAD AF, 1987, J MED ENTOMOL, V24, P689, DOI 10.1093/jmedent/24.6.689; Beaucournu J. C., 1991, Archives de l'Institut Pasteur de Madagascar, V59, P57; Ben Ari T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002160; Boisier P, 1997, TROP MED INT HEALTH, V2, P422, DOI 10.1046/j.1365-3156.1997.d01-292.x; Chanteau S, 1998, EMERG INFECT DIS, V4, P101, DOI 10.3201/eid0401.980114; Drummond A, 2009, GENEIOUS V5 3; Duchemin JB, 2003, BIOGEOGRAPHIE PUCES; Duplantier JM, 2005, VET RES, V36, P437, DOI 10.1051/vetres:2005007; Durden Lance A., 2009, P115; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gauzere BA, 2013, MED SANTE TROP, V23, P145, DOI 10.1684/mst.2013.0183; Goodman SM, 2008, J MAMMAL, V89, P1316, DOI 10.1644/07-MAMM-A-232.1; Goodman SM, 2007, NATURAL HIST MADAGAS; Gratz NG, 1997, BELG J ZOOL, V127, P71; Hoogstraal H., 1965, Journal of the Egyptian Public Health Association, V40, P141; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; IKEDA J K, 1985, Proceedings of the Hawaiian Entomological Society, V25, P75; KILONZO BS, 1985, INSECT SCI APPL, V6, P111, DOI 10.1017/S1742758400002770; Lagadec E, 2012, EMERG INFECT DIS, V18, P1696, DOI 10.3201/eid1810.111898; LEWIS RE, 1967, J PARASITOL, V53, P863, DOI 10.2307/3276790; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Orloski KA, 2003, J AM VET MED ASSOC, V222, P444, DOI 10.2460/javma.2003.222.444; Pages M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-184; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; RENAPURKAR DM, 1990, MED VET ENTOMOL, V4, P89, DOI 10.1111/j.1365-2915.1990.tb00264.x; Rogers S.O., 1994, PLANT MOL BIOL MANUA, P183, DOI DOI 10.1007/978-94-011-0511-8_12; Rothschild M, 1953, ILLUSTRATED CATALOGU, V1; Sanchez S, 2012, PARASITE, V19, P423, DOI 10.1051/parasite/2012194423; Tassin J, 2004, ACTA BOT GALLICA, V151, P181, DOI 10.1080/12538078.2004.10516033; Tortosa P, 2012, INFECT GENET EVOL, V12, P1333, DOI 10.1016/j.meegid.2012.03.024; Walter G, 2012, AM J TROP MED HYG, V86, P1049, DOI 10.4269/ajtmh.2012.11-0794; Whiting MF, 2002, ZOOL SCR, V31, P93, DOI 10.1046/j.0300-3256.2001.00095.x; Whiting MF, 2008, CLADISTICS, V24, P677, DOI 10.1111/j.1096-0031.2008.00211.x; Zimba M, 2011, VECTOR-BORNE ZOONOT, V11, P1187, DOI 10.1089/vbz.2010.0095	38	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	SEP	2014	8	9							e3129	10.1371/journal.pntd.0003129				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AQ4UZ	WOS:000342796600022	25188026	DOAJ Gold, Green Published			2019-04-02	
J	Van den Bergh, R; Van Ginderachter, JA; Schouppe, E; Desimmie, BA; Hailu, A; De Baetselier, P; van Griensven, J				Van den Bergh, Rafael; Van Ginderachter, Jo A.; Schouppe, Elio; Desimmie, Belete A.; Hailu, Asrat; De Baetselier, Patrick; van Griensven, Johan			Visceral Leishmaniasis Relapse in HIV Patients-A Role for Myeloid-Derived Suppressor Cells?	PLOS NEGLECTED TROPICAL DISEASES			English	Article							MACROPHAGE MICROBICIDAL MECHANISMS; T-CELLS; INFECTED PATIENTS; SUSCEPTIBILITY; INFANTUM; BLOOD; MICE		[Van den Bergh, Rafael; Van Ginderachter, Jo A.; Schouppe, Elio; De Baetselier, Patrick] Vrije Univ Brussel, Lab Cellular & Mol Immunol, Brussels, Belgium; [Van den Bergh, Rafael; Van Ginderachter, Jo A.; Schouppe, Elio; De Baetselier, Patrick] VIB, Myeloid Cell Immunol Lab, Brussels, Belgium; [Van den Bergh, Rafael] Med Sans Frontieres Operat Ctr Brussels, Dept Med, Operat Res Unit, Brussels, Belgium; [Desimmie, Belete A.] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium; [Hailu, Asrat] Univ Addis Ababa, Fac Med, Addis Ababa, Ethiopia; [van Griensven, Johan] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium	Van den Bergh, R (reprint author), Vrije Univ Brussel, Lab Cellular & Mol Immunol, Brussels, Belgium.	jvangriensven@itg.be		Van den Bergh, Rafael/0000-0001-6277-8713			Albeituni SH, 2013, CANCER J, V19, P490, DOI 10.1097/PPO.0000000000000006; Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07; Bourgeois N, 2010, HIV MED, V11, P670, DOI 10.1111/j.1468-1293.2010.00846.x; Cota GF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001153; da Luz RI, 2011, J ANTIMICROB CHEMOTH, V66, P677, DOI 10.1093/jac/dkq508; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gelanew T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000889; Gianotti N, 2008, NEW MICROBIOL, V31, P435; Huis in ' t Veld D, 2012, EUR J CLIN MICROBIOL, V31, P919; Lachaud L, 2009, CLIN INFECT DIS, V48, pE16, DOI 10.1086/595710; Luyckx A, 2012, CLIN IMMUNOL, V143, P83, DOI 10.1016/j.clim.2012.01.011; Murray HW, 2000, INFECT IMMUN, V68, P288, DOI 10.1128/IAI.68.1.288-293.2000; Murray HW, 2000, J INFECT DIS, V181, P795, DOI 10.1086/315268; Nagaraj S, 2012, SEMIN CANCER BIOL, V22, P282, DOI 10.1016/j.semcancer.2012.01.010; Nylen S, 2007, TRENDS IMMUNOL, V28, P378, DOI 10.1016/j.it.2007.07.004; Owens BMJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002827; Pereira WF, 2011, J LEUKOCYTE BIOL, V90, P1191, DOI 10.1189/jlb.1110608; Peters N, 2006, IMMUNOL REV, V213, P159, DOI 10.1111/j.1600-065X.2006.00432.x; Santos-Oliveira JR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-358; Schmid M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00074; Singh OP, 2012, CLIN VACCINE IMMUNOL, V19, P961, DOI 10.1128/CVI.00143-12; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Van Ginderachter JA, 2010, EUR J IMMUNOL, V40, P2976, DOI 10.1002/eji.201040911; Voronov E, 2010, INT IMMUNOL, V22, P245, DOI 10.1093/intimm/dxq006	24	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	SEP	2014	8	9							e3132	10.1371/journal.pntd.0003132				3	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AQ4UZ	WOS:000342796600024	25210932	DOAJ Gold, Green Published			2019-04-02	
J	Mweresa, CK; Mukabana, WR; Omusula, P; Otieno, B; Gheysens, T; Takken, W; van Loon, JJA				Mweresa, Collins K.; Mukabana, Wolfgang R.; Omusula, Philemon; Otieno, Bruno; Gheysens, Tom; Takken, Willem; van Loon, Joop J. A.			Evaluation of textile substrates for dispensing synthetic attractants for malaria mosquitoes	PARASITES & VECTORS			English	Article						Anopheles gambiae; Anopheles funestus; IB1-impregnated nylon; Polyester; Cotton; Cellulose; Sodium polyacrylate; Attraction; Trapping; Kenya	VECTOR ANOPHELES-GAMBIAE; SENSU-STRICTO DIPTERA; BAITED ENTRY TRAPS; WESTERN KENYA; SEMIFIELD CONDITIONS; CARBON-DIOXIDE; HOST; ARABIENSIS; BEHAVIOR; NETS	Background: The full-scale impact of odour-baited technology on the surveillance, sampling and control of vectors of infectious diseases is partly limited by the lack of methods for the efficient and sustainable dispensing of attractants. In this study we investigated whether locally-available and commonly used textiles are efficient substrates for the release of synthetic odorant blends attracting malaria mosquitoes. Methods: The relative efficacy of (a) polyester, (b) cotton, (c) cellulose + polyacrylate, and (d) nylon textiles as substrates for dispensing a synthetic odour blend (Ifakara blend 1(IB1)) that attracts malaria mosquitoes was evaluated in western Kenya. The study was conducted through completely randomized Latin square experimental designs under semi-field and field conditions. Results: Traps charged with IB1-impregnated polyester, cotton and cellulose + polyacrylate materials caught significantly more female Anopheles gambiae sensu stricto (semi-field conditions) and An. gambiae sensu lato (field conditions) mosquitoes than IB1-treated nylon (P = 0.001). The IB1-impregnated cellulose + polyacrylate material was the most attractive to female An. funestus mosquitoes compared to all other dispensing textile substrates (P < 0.001). The responses of female An. funestus mosquitoes to IB1-treated cotton and polyester were equal (P = 0.45). Significantly more female Culex mosquitoes were attracted to IB1-treated cotton than to the other treatments (P < 0.001). Whereas IB1-impregnated cotton and cellulose + polyacrylate material attracted equal numbers of female Mansonia mosquitoes (P = 0.44), the catches due to these two substrates were significantly higher than those associated with the other substrates (P < 0.001). Conclusion: The number and species of mosquitoes attracted to a synthetic odour blend is influenced by the type of odour-dispensing material used. Thus, surveillance and intervention programmes for malaria and other mosquito vectors using attractive odour baits should select an odour-release material that optimizes the odour blend.	[Mweresa, Collins K.; Mukabana, Wolfgang R.; Omusula, Philemon; Otieno, Bruno] Int Ctr Insect Physiol & Ecol, Nairobi, Kenya; [Mweresa, Collins K.; Takken, Willem; van Loon, Joop J. A.] Univ Wageningen & Res Ctr, Entomol Lab, NL-6700 EH Wageningen, Netherlands; [Mukabana, Wolfgang R.] Univ Nairobi, Sch Biol Sci, Nairobi, Gpo, Kenya; [Gheysens, Tom] Univ Ghent, Dept Text, Ghent, Belgium	Mukabana, WR (reprint author), Int Ctr Insect Physiol & Ecol, POB 30772-00100, Nairobi, Kenya.	rmukabana@yahoo.co.uk			Foundations for National Institutes of Health (FNIH) through the Grand Challenges in Global Health Initiative (GCGH) [121]; Wageningen University, The Netherlands	We acknowledge Mr. David Alila for rearing the mosquitoes used during semi-field bioassays. Mr. Charles Oketch assisted with field experiments. This study was funded by a grant from the Foundations for National Institutes of Health (FNIH) through the Grand Challenges in Global Health Initiative (GCGH#121) and a PhD fellowship provided to CKM by Wageningen University, The Netherlands.	Atieli H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-108; Bayoh MN, 2010, KENYA MAL J, V9, P62, DOI DOI 10.1186/1475-2875-9-62; Bukhari T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021713; Cork A., 2004, PHEROMONE MANUAL; Dekker T, 2002, MED VET ENTOMOL, V16, P91, DOI 10.1046/j.0269-283x.2002.00345.x; Dia I, 2005, J MED ENTOMOL, V42, P104, DOI 10.1603/0022-2585(2005)042[0104:COHCAO]2.0.CO;2; Duchemin JB, 2001, MED VET ENTOMOL, V15, P50, DOI 10.1046/j.1365-2915.2001.00276.x; Eiras AE, 2010, ECOL CONT VECTOR-BOR, V2, P365; Gibson G, 1999, MED VET ENTOMOL, V13, P2, DOI 10.1046/j.1365-2915.1999.00163.x; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; Gillies MT, 1987, JOHANNESBURG S AFR I, V55, P1; Githeko AK, 1996, EXP PARASITOL, V82, P306, DOI 10.1006/expr.1996.0038; Govella NJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00199; Jawara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019676; Jawara M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008167; Kline DL, 2007, J AM MOSQUITO CONTR, V23, P241, DOI 10.2987/8756-971X(2007)23[241:STAMTT]2.0.CO;2; Kline DL, 2006, J AM MOSQUITO CONTR, V22, P490, DOI 10.2987/8756-971X(2006)22[490:TATTFA]2.0.CO;2; Kline DL, 1998, J VECTOR ECOL, V23, P171; Koenraadt CJM, 2004, ACTA TROP, V90, P141, DOI 10.1016/j.actatropica.2003.11.007; LINES JD, 1987, MED VET ENTOMOL, V1, P37, DOI 10.1111/j.1365-2915.1987.tb00321.x; Mahande AM, 2007, MALARIA J, V9, P100; Mboera L E G, 2005, Tanzan Health Res Bull, V7, P117; Mendis K, 2009, TROP MED INT HEALTH, V14, P802, DOI 10.1111/j.1365-3156.2009.02287.x; Meyrowitsch DW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-188; Minakawa N, 2002, AM J TROP MED HYG, V67, P32, DOI 10.4269/ajtmh.2002.67.32; Mukabana WR, 2012, J CHEM ECOL, V38, P235, DOI 10.1007/s10886-012-0088-8; Mukabana WR, 2010, ECOL CONT VECTOR-BOR, V2, P181; Mukabana WR, 2012, PARASITE VECTOR, V50, P123; Mweresa CK, 2014, THESIS WAGENINGEN U; N'Guessan R, 2006, T ROY SOC TROP MED H, V100, P1091, DOI 10.1016/j.trstmh.2006.04.005; Njiru BN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-39; Okumu F, 2010, J MED ENTOMOL, V47, P274, DOI 10.1603/ME09114; Okumu FO, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-12; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951; Pates HV, 2001, B ENTOMOL RES, V91, P289, DOI 10.1079/BER200198; Pennetier C, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-81; Qiu YT, 2004, MED VET ENTOMOL, V18, P429, DOI 10.1111/j.0269-283X.2004.00534.x; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Schmied WH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-230; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Smallegange RC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-292; Smallegange RC, 2009, J CHEM ECOL, V35, P933, DOI 10.1007/s10886-009-9668-7; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; TAKKEN W, 1991, INSECT SCI APPL, V12, P287, DOI 10.1017/S1742758400020816; Takken W, 2010, MALARIA J, V9, P116; Tirados I, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-68; Torr JS, 2011, PLOS NEGLECT TROP D, V5, pe1360; Torr SJ, 1997, B ENTOMOL RES, V87, P299, DOI 10.1017/S0007485300037251; Verhulst NO, 2011, ENTOMOL EXP APPL, V139, P170, DOI 10.1111/j.1570-7458.2011.01119.x; WHO, 1975, MAN PRACT ENT MAL 2; Yates A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-52; Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017	52	6	6	0	16	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	AUG 16	2014	7								376	10.1186/1756-3305-7-376				10	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	AO5QB	WOS:000341398800001	25129505	DOAJ Gold, Green Published			2019-04-02	
J	Jahfari, S; Coipan, EC; Fonville, M; Van Leeuwen, AD; Hengeveld, P; Heylen, D; Heyman, P; Van Maanen, C; Butler, CM; Foldvari, G; Szekeres, S; Van Duijvendijk, G; Tack, W; Rijks, JM; Van der Giessen, J; Takken, W; Van Wieren, SE; Takumi, K; Sprong, H				Jahfari, Setareh; Coipan, E. Claudia; Fonville, Manoj; Van Leeuwen, Arieke Docters; Hengeveld, Paul; Heylen, Dieter; Heyman, Paul; Van Maanen, Cees; Butler, Catherine M.; Foldvari, Gabor; Szekeres, Sandor; Van Duijvendijk, Gilian; Tack, Wesley; Rijks, Jolianne M.; Van der Giessen, Joke; Takken, Willem; Van Wieren, Sipke E.; Takumi, Katsuhisa; Sprong, Hein			Circulation of four Anaplasma phagocytophilum ecotypes in Europe	PARASITES & VECTORS			English	Article						Anaplasma phagocytophilum; Zoonoses; Ixodes ricinus; Wildlife; Epidemiology	CANDIDATUS NEOEHRLICHIA MIKURENSIS; HUMAN GRANULOCYTIC ANAPLASMOSIS; IXODES-RICINUS TICKS; BORRELIA-BURGDORFERI; BORNE DISEASES; PHYLOGENETIC ANALYSES; SEQUENCE-ANALYSIS; EHRLICHIOSIS; STRAINS; GENE	Background: Anaplasma phagocytophilum is the etiological agent of granulocytic anaplasmosis in humans and animals. Wild animals and ticks play key roles in the enzootic cycles of the pathogen. Potential ecotypes of A. phagocytophilum have been characterized genetically, but their host range, zoonotic potential and transmission dynamics has only incompletely been resolved. Methods: The presence of A. phagocytophilum DNA was determined in more than 6000 ixodid ticks collected from the vegetation and wildlife, in 289 tissue samples from wild and domestic animals, and 69 keds collected from deer, originating from various geographic locations in The Netherlands and Belgium. From the qPCR positive lysates, a fragment of the groEL-gene was amplified and sequenced. Additional groEL sequences from ticks and animals from Europe were obtained from GenBank, and sequences from human cases were obtained through literature searches. Statistical analyses were performed to identify A. phagocytophilum ecotypes, to assess their host range and their zoonotic potential. The population dynamics of A. phagocytophilum ecotypes was investigated using population genetic analyses. Results: DNA of A. phagocytophilum was present in all stages of questing and feeding Ixodes ricinus, feeding I. hexagonus, I. frontalis, I. trianguliceps, and deer keds, but was absent in questing I. arboricola and Dermacentor reticulatus. DNA of A. phagocytophilum was present in feeding ticks and tissues from many vertebrates, including roe deer, mouflon, red foxes, wild boar, sheep and hedgehogs but was rarely found in rodents and birds and was absent in badgers and lizards. Four geographically dispersed A. phagocytophilum ecotypes were identified, that had significantly different host ranges. All sequences from human cases belonged to only one of these ecotypes. Based on population genetic parameters, the potentially zoonotic ecotype showed significant expansion. Conclusion: Four ecotypes of A. phagocytophilum with differential enzootic cycles were identified. So far, all human cases clustered in only one of these ecotypes. The zoonotic ecotype has the broadest range of wildlife hosts. The expansion of the zoonotic A. phagocytophilum ecotype indicates a recent increase of the acarological risk of exposure of humans and animals.	[Jahfari, Setareh; Coipan, E. Claudia; Fonville, Manoj; Van Leeuwen, Arieke Docters; Hengeveld, Paul; Van der Giessen, Joke; Takken, Willem; Sprong, Hein] Natl Inst Publ Hlth & Environm RIVM, Lab Zoonoses & Environm Microbiol, Bilthoven, Netherlands; [Heylen, Dieter] Univ Antwerp, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium; [Hengeveld, Paul] Queen Astrid Mil Hosp, Research Lab Vector Borne Dis, Brussels, Belgium; [Van Maanen, Cees] Anim Hlth Serv Deventer, Deventer, Netherlands; [Butler, Catherine M.] St Georges Univ, Sch Vet Med, True Blue, West Indies, Grenada; [Foldvari, Gabor; Szekeres, Sandor] Szent Istvan Univ, Fac Vet Sci, Dept Parasitol & Zool, Budapest, Hungary; [Tack, Wesley] Univ Ghent, Dept Forest & Water Management, Lab Forestry, B-9000 Ghent, Belgium; [Rijks, Jolianne M.] Univ Utrecht, Dutch Wildlife Hlth Ctr, Utrecht, Netherlands; [Coipan, E. Claudia; Van Duijvendijk, Gilian; Takken, Willem; Sprong, Hein] Wageningen Univ, Lab Entomol, NL-6700 AP Wageningen, Netherlands; [Van Wieren, Sipke E.] Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands	Sprong, H (reprint author), Natl Inst Publ Hlth & Environm RIVM, Lab Zoonoses & Environm Microbiol, Antonie Leeuwenhoeklaan 9,POB 1, Bilthoven, Netherlands.	hein.sprong@rivm.nl		Sprong, Hein/0000-0002-0218-4320; Coipan, Elena Claudia/0000-0003-1655-5177	Dutch Food and Consumer Product Safety Authority (NVWA); Wageningen University and Research Centre (WUR); Ministry of Health, Welfare and Sport (VWS); Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences	The authors are very grateful to the volunteers of animal-shelters, particularly to Jenny Kleve for her dedicated work on hedgehogs. We thank the Centre Monitoring Vectors for collecting tick, Margriet Montizaan for collecting deer keds and Chantal Reusken for sharing rodent materials. This study was financially supported by the Dutch Food and Consumer Product Safety Authority (NVWA), Wageningen University and Research Centre (WUR) and by the Ministry of Health, Welfare and Sport (VWS). G.F. was supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. The work of CC, PHe, DH and HS was done under the frame of EurNegVec Cost Action TD1303.	Alberti A, 2005, APPL ENVIRON MICROB, V71, P6418, DOI 10.1128/AEM.71.10.6418-6422.2005; Arnez M, 2001, J CLIN MICROBIOL, V39, P4591, DOI 10.1128/JCM.39.12.4591-4592.2001; Barbet AF, 2013, PATHOGENS, V2, P544, DOI 10.3390/pathogens2030544; Bown KJ, 2006, VECTOR-BORNE ZOONOT, V6, P404, DOI 10.1089/vbz.2006.6.404; Bown KJ, 2007, J CLIN MICROBIOL, V45, P1771, DOI 10.1128/JCM.00365-07; Bown KJ, 2009, EMERG INFECT DIS, V15, P1948, DOI 10.3201/eid1512.090178; Braks M, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-192; Butler CM, 2008, VET REC, V162, P216, DOI 10.1136/vr.162.7.216; Carpi G, 2009, VECTOR-BORNE ZOONOT, V9, P179, DOI 10.1089/vbz.2008.0068; Casey ANJ, 2004, MICROBIOL-SGM, V150, P727, DOI 10.1099/mic.0.26648-0; CHEN SM, 1994, J CLIN MICROBIOL, V32, P589; Cochez C, 2011, TICKS TICK-BORNE DIS, V2, P156, DOI 10.1016/j.ttbdis.2011.06.004; Cohan FM, 2001, SYST BIOL, V50, P513, DOI 10.1080/10635150118398; Coipan EC, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00036; Coipan EC, 2013, INFECT GENET EVOL, V17, P216, DOI 10.1016/j.meegid.2013.04.009; Courtney JW, 2004, J CLIN MICROBIOL, V42, P3164, DOI 10.1128/JCM.42.7.3164-3168.2004; de la Fuente J, 2007, VET MICROBIOL, V119, P375, DOI 10.1016/j.vetmic.2006.09.011; Edouard S, 2012, TICKS TICK-BORNE DIS, V3, P402, DOI 10.1016/j.ttbdis.2012.10.002; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P240, DOI 10.1016/0040-5809(72)90035-4; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Foldvari G, 2014, EMERG INFECT DIS, V20, P496, DOI 10.3201/eid2003.130935; Franssen F, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-166; Fu YX, 1997, GENETICS, V147, P915; Haschke-Becher E, 2010, J INFECTION, V60, P300, DOI 10.1016/j.jinf.2009.12.010; Herbeck JT, 2003, GENETICS, V165, P1651; Heylen D, 2013, ENVIRON MICROBIOL, V15, P663, DOI 10.1111/1462-2920.12059; Heyman P, 2010, EXPERT REV ANTI-INFE, V8, P33, DOI 10.1586/ERI.09.118; Hofhuis A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064361; Huhn C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093725; Ismail N, 2010, CLIN LAB MED, V30, P261, DOI 10.1016/j.cll.2009.10.004; Jahfari S, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-74; Jin HT, 2012, VECTOR-BORNE ZOONOT, V12, P269, DOI 10.1089/vbz.2011.0753; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Krucken J, 2013, J CLIN MICROBIOL, V51, P1958, DOI 10.1128/JCM.00284-13; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lotric-Furlan S, 2006, WIEN KLIN WOCHENSCHR, V118, P708, DOI 10.1007/s00508-006-0700-4; Majazki J, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-235; Massung RF, 2000, J CLIN MICROBIOL, V38, P2917; Medlock JM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-1; Pacilly F, 2014, TICKS TICK BORNE DIS; Parola P, 2005, VET RES, V36, P469, DOI 10.1051/vetres:2005004; Petrovec M, 1999, J CLIN MICROBIOL, V37, P209; Rar V, 2011, INFECT GENET EVOL, V11, P1842, DOI 10.1016/j.meegid.2011.09.019; Rar VA, 2011, VECTOR-BORNE ZOONOT, V11, P1013, DOI 10.1089/vbz.2010.0266; Richter D, 2013, PARASITOL RES, V112, P107, DOI 10.1007/s00436-012-3110-8; Rikihisa Y, 2011, CLIN MICROBIOL REV, V24, P469, DOI 10.1128/CMR.00064-10; Rymaszewska A, 2008, EUR J CLIN MICROBIOL, V27, P1025, DOI 10.1007/s10096-008-0539-x; Salzburger W, 2011, MOL ECOL, V20, P1952, DOI 10.1111/j.1365-294X.2011.05066.x; Scharf W, 2011, J CLIN MICROBIOL, V49, P790, DOI 10.1128/JCM.02051-10; Silaghi C, 2011, VECTOR-BORNE ZOONOT, V11, P355, DOI 10.1089/vbz.2010.0051; SLATKIN M, 1994, GENET RES, V64, P71, DOI 10.1017/S0016672300032560; Smrdel KS, 2012, FEMS IMMUNOL MED MIC, V64, P123, DOI 10.1111/j.1574-695X.2011.00891.x; Sprong H, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-294; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stuen S, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00031; Sumner JW, 1997, J CLIN MICROBIOL, V35, P2087; Tijsse-Klasen E, 2014, FRONTIERS PUBLIC HLT, V2, P1; Tijsse-Klasen E, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-42; van Dobbenburgh A, 1999, NEW ENGL J MED, V340, P1214, DOI 10.1056/NEJM199904153401517; Vichova B, 2011, BIOLOGIA, V66, P1082, DOI 10.2478/s11756-011-0123-1; WATTERSON GA, 1977, GENETICS, V85, P789; ZAUGG JL, 1986, AM J VET RES, V47, P1060	62	71	72	1	41	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	AUG 15	2014	7								365	10.1186/1756-3305-7-365				11	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	AN9EQ	WOS:000340909300001	25127547	DOAJ Gold, Green Published			2019-04-02	
J	Zeimes, CB; Olsson, GE; Hjertqvist, M; Vanwambeke, SO				Zeimes, Caroline B.; Olsson, Gert E.; Hjertqvist, Marika; Vanwambeke, Sophie O.			Shaping zoonosis risk: landscape ecology vs. landscape attractiveness for people, the case of tick-borne encephalitis in Sweden	PARASITES & VECTORS			English	Article						Tick-borne disease; Zoonoses; Vector-borne disease; Risk	IXODES-RICINUS TICKS; GEOGRAPHICAL-DISTRIBUTION; TRANSMISSION; DISEASES; HUMANS; MODELS; REGRESSION; ABUNDANCE; FORESTS; RODENTS	Background: In this paper, the hazard and exposure concepts from risk assessment are applied in an innovative approach to understand zoonotic disease risk. Hazard is here related to the landscape ecology determining where the hosts, vectors and pathogens are and, exposure is defined as the attractiveness and accessibility to hazardous areas. Tick-borne encephalitis in Sweden was used as a case study. Methods: Three boosted regression tree models are compared: a hazard model, an exposure model and a global model which combines the two approaches. Results: The global model offers the best predictive power and the most accurate modelling. The highest probabilities were found in easy-to-reach places with high landscape diversity, holiday houses, waterbodies and, well-connected forests of oak, birch or pine, with open-area in their ecotones, a complex shape, numerous clear-cuts and, a variation in tree height. Conclusion: While conditions for access and use of hazardous areas are quite specific to Scandinavia, this study offers promising perspectives to improve our understanding of the distribution of zoonotic and vector-borne diseases in diverse contexts.	[Zeimes, Caroline B.; Vanwambeke, Sophie O.] Catholic Univ Louvain, Earth & Life Inst, Georges Lemaitre Ctr Earth & Climate Res TECLIM, GEOG, B-1348 Louvain, Belgium; [Olsson, Gert E.] Swedish Univ Agr Sci SLU, Dept Wildlife Fish & Environm Studies, Umea, Sweden; [Hjertqvist, Marika] Swedish Inst Communicable Dis Control SMI, Stockholm, Sweden	Zeimes, CB (reprint author), Catholic Univ Louvain, Earth & Life Inst, Georges Lemaitre Ctr Earth & Climate Res TECLIM, GEOG, Pl Louis Pasteur 3 Bte L4-03-07, B-1348 Louvain, Belgium.	caroline.zeimes@uclouvain.be		Vanwambeke, Sophie/0000-0001-6620-6173	EU [FP7-261504 EDENext]	This study was funded by EU grants FP7-261504 EDENext and is catalogued by the EDENext Steering Committee as EDENext180 (http://www.edenext.eu). The contents of this publication are the sole responsibility of the authors and don't necessarily reflect the views of the European Commission. The authors thank Jonas Kindberg for the data on bag statistics and for sharing his knowledge on the ecology of the study area.	BOSTEDT G, 1995, ANN TOURISM RES, V22, P671, DOI 10.1016/0160-7383(95)00007-S; Cagnacci F, 2012, INT J PARASITOL, V42, P365, DOI 10.1016/j.ijpara.2012.02.012; Dumpis U, 1999, CLIN INFECT DIS, V28, P882, DOI 10.1086/515195; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; FAO, 1999, PRINC GUID COND MICR, P53; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Jaenson TGT, 2009, MED VET ENTOMOL, V23, P226, DOI 10.1111/j.1365-2915.2009.00813.x; Jaenson TGT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-184; Jaenson TGT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-8; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Lindhjem H, 2007, J FOREST ECON, V12, P251, DOI 10.1016/j.jfe.2006.09.003; Lindstrom A, 2003, J MED ENTOMOL, V40, P375, DOI 10.1603/0022-2585-40.4.375; Lundkvist A, 2011, EUROSURVEILLANCE, V16, P39; Medlock JM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-1; Muller D. K., 2006, Current Issues in Tourism, V9, P335; Nielsen AB, 2012, J ENVIRON MANAGE, V113, P456, DOI 10.1016/j.jenvman.2012.10.014; Parola P, 2001, CLIN INFECT DIS, V32, P897, DOI 10.1086/319347; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Randolph SE, 2008, CURR OPIN INFECT DIS, V21, P462, DOI 10.1097/QCO.0b013e32830ce74b; Randolph SE, 2011, TICKS TICK-BORNE DIS, V2, P179, DOI 10.1016/j.ttbdis.2011.07.004; Randolph SE, 1996, PARASITOL TODAY, V12, P472, DOI 10.1016/S0169-4758(96)10072-7; Randolph SE, 1999, PARASITOLOGY, V118, P177, DOI 10.1017/S0031182098003643; Rosa R, 2003, J THEOR BIOL, V224, P359, DOI 10.1016/S0022-5193(03)00173-5; Shannon C., 1949, MATH THEORY COMMUNIC; Silvennionen H, 2001, LANDSCAPE URBAN PLAN, V56, P11, DOI 10.1016/S0169-2046(01)00163-3; Stefanoff P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045511; Tack W, 2012, PARASITOLOGY, V139, P1273, DOI 10.1017/S0031182012000625; Vanwambeke SO, 2010, VECTOR-BORNE ZOONOT, V10, P497, DOI 10.1089/vbz.2009.0116; Zeimes CB, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-39	29	9	10	1	28	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	AUG 15	2014	7								370	10.1186/756-3305-7-370				10	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	AN5MC	WOS:000340634400001	25128197	DOAJ Gold			2019-04-02	
J	Karl, S; Laman, M; Koleala, T; Ibam, C; Kasian, B; N'Drewei, N; Rosanas-Urgell, A; Moore, BR; Waltmann, A; Koepfli, C; Siba, PM; Betuela, I; Woodward, RC; St Pierre, TG; Mueller, I; Davis, TME				Karl, Stephan; Laman, Moses; Koleala, Tamarah; Ibam, Clemencia; Kasian, Bernadine; N'Drewei, Nola; Rosanas-Urgell, Anna; Moore, Brioni R.; Waltmann, Andreea; Koepfli, Cristian; Siba, Peter M.; Betuela, Inoni; Woodward, Robert C.; St Pierre, Timothy G.; Mueller, Ivo; Davis, Timothy M. E.			Comparison of three methods for detection of gametocytes in Melanesian children treated for uncomplicated malaria	MALARIA JOURNAL			English	Article						Malaria; Gametocyte detection; Magnetic fractionation; Reverse transcriptase PCR; Light microscopy Plasmodium falciparum; Plasmodium vivax; Papua New Guinea	PLASMODIUM-FALCIPARUM GAMETOCYTES; SEQUENCE-BASED AMPLIFICATION; MAGNETIC FRACTIONATION; VIVAX GAMETOCYTES; PARASITE DENSITY; QUANTIFICATION; PYRIMETHAMINE; INFECTIVITY; MICROSCOPY; CARRIAGE	Background: Gametocytes are the transmission stages of Plasmodium parasites, the causative agents of malaria. As their density in the human host is typically low, they are often undetected by conventional light microscopy. Furthermore, application of RNA-based molecular detection methods for gametocyte detection remains challenging in remote field settings. In the present study, a detailed comparison of three methods, namely light microscopy, magnetic fractionation and reverse transcriptase polymerase chain reaction for detection of Plasmodium falciparum and Plasmodium vivax gametocytes was conducted. Methods: Peripheral blood samples from 70 children aged 0.5 to five years with uncomplicated malaria who were treated with either artemether-lumefantrine or artemisinin-naphthoquine were collected from two health facilities on the north coast of Papua New Guinea. The samples were taken prior to treatment (day 0) and at pre-specified intervals during follow-up. Gametocytes were measured in each sample by three methods: i) light microscopy (LM), ii) quantitative magnetic fractionation (MF) and, iii) reverse transcriptase PCR (RTPCR). Data were analysed using censored linear regression and Bland and Altman techniques. Results: MF and RTPCR were similarly sensitive and specific, and both were superior to LM. Overall, there were approximately 20% gametocyte-positive samples by LM, whereas gametocyte positivity by MF and RTPCR were both more than two-fold this level. In the subset of samples collected prior to treatment, 29% of children were positive by LM, and 85% were gametocyte positive by MF and RTPCR, respectively. Conclusions: The present study represents the first direct comparison of standard LM, MF and RTPCR for gametocyte detection in field isolates. It provides strong evidence that MF is superior to LM and can be used to detect gametocytaemic patients under field conditions with similar sensitivity and specificity as RTPCR.	[Karl, Stephan; Laman, Moses; Moore, Brioni R.; Davis, Timothy M. E.] Univ Western Australia, Fremantle Hosp, Sch Med & Pharmacol, Fremantle, WA, Australia; [Karl, Stephan; Woodward, Robert C.; St Pierre, Timothy G.] Univ Western Australia, Fremantle Hosp, Sch Phys, Fremantle, WA, Australia; [Karl, Stephan; Waltmann, Andreea; Koepfli, Cristian; Mueller, Ivo] Walter & Eliza Hall Inst Med Res, Infect & Immun Div, Parkville, Vic 3052, Australia; [Karl, Stephan; Waltmann, Andreea; Koepfli, Cristian; Mueller, Ivo] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Laman, Moses; Koleala, Tamarah; Ibam, Clemencia; Kasian, Bernadine; N'Drewei, Nola; Rosanas-Urgell, Anna; Moore, Brioni R.; Siba, Peter M.; Betuela, Inoni] Papua New Guinea Inst Med Res, Madang, Papua N Guinea; [Mueller, Ivo] Ctr Recerca Salut Int Barcelona CRESIB, Barcelona, Spain; [Rosanas-Urgell, Anna] Inst Trop Med, B-2000 Antwerp, Belgium	Karl, S (reprint author), Univ Western Australia, Fremantle Hosp, Sch Med & Pharmacol, Fremantle, WA, Australia.	karl@wehi.edu.au; arosanas@itg.be; brioni.moore@uwa.edu.au	Woodward, Robert/A-1397-2008; Moore, Brioni/H-5477-2014; Davis, Timothy/M-5144-2014; St Pierre, Timothy/A-5509-2008	Woodward, Robert/0000-0001-8913-6091; Moore, Brioni/0000-0001-9792-7838; St Pierre, Timothy/0000-0003-4682-4972; Davis, Timothy/0000-0003-0749-7411; Koepfli, Cristian/0000-0002-9354-0414; Laman, Moses/0000-0003-0964-805X	National Health and Medical Research Council (NHMRC) of Australia [634343]; NHMRC [1052760, 1036951, 1043345, 572561]; Australian Award PhD Scholarship	We thank the patients and their families for their participation. We gratefully acknowledge the assistance of field staff at Mugil and Alexishafen Health Centres, and the Microscopy Unit at the Vector Borne Diseases Unit, PNG Institute of Medical Research. This study was funded by a National Health and Medical Research Council (NHMRC) of Australia project grant (#634343). SK is currently supported by an NHMRC Early Career Fellowship (#1052760), ML was supported by an Australian Award PhD Scholarship, BRM by an NHMRC Early Career Fellowship (#1036951), IM by a NHMRC Senior Research Fellowship (#1043345), TMED by an NHMRC Practitioner Fellowship (#572561).	Ali E, 2006, T ROY SOC TROP MED H, V100, P176, DOI 10.1016/j.trstmh.2005.04.021; Alves ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094193; Babiker HA, 1999, MOL BIOCHEM PARASIT, V99, P143, DOI 10.1016/S0166-6851(98)00175-3; Baird JK, 2010, LANCET, V376, P1883, DOI 10.1016/S0140-6736(10)61494-8; Baird JK, 2004, CLIN INFECT DIS, V39, P1336, DOI 10.1086/424663; Barnes KI, 2008, J INFECT DIS, V197, P1605, DOI 10.1086/587645; Beurskens M, 2009, AM J TROP MED HYG, V81, P366, DOI 10.4269/ajtmh.2009.81.366; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204; Bousema JT, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-18; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Bousema T, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-136; Buates S, 2010, PARASITOL INT, V59, P414, DOI 10.1016/j.parint.2010.05.008; Fabre AL, 2014, EUR J HUM GENET, V22, P379, DOI 10.1038/ejhg.2013.145; Karl S, 2010, 8 INT C SCI CLIN APP; Karl S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020805; Karl S, 2011, AM J TROP MED HYG, V84, P158, DOI 10.4269/ajtmh.2011.10-0416; Karl S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-116; Karl S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-98; Koepfli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019010; Laman M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-145; Lubin JH, 2004, ENVIRON HEALTH PERSP, V112, P1691, DOI 10.1289/ehp.7199; O'Meara WP, 2006, PARASITOL RES, V99, P500, DOI 10.1007/s00436-006-0135-x; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; PAYNE D, 1988, B WORLD HEALTH ORGAN, V66, P621; Robert V, 2000, AM J TROP MED HYG, V62, P210, DOI 10.4269/ajtmh.2000.62.210; Schneider P, 2004, MOL BIOCHEM PARASIT, V137, P35, DOI 10.1016/j.molbiopara.2004.03.018; Shekalaghe SA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-247; Tangpukdee N, 2008, KOREAN J PARASITOL, V46, P65, DOI 10.3347/kjp.2008.46.2.65; TARLOV AR, 1962, ARCH INTERN MED, V109, P209, DOI 10.1001/archinte.1962.03620140081013; Wampfler R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076316; Wernsdorfer W. H., 1988, MALARIA PRINCIPLES P; *WHO, 2000, T R SOC TROP MED HYG, V94, P90	32	9	9	0	10	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	AUG 14	2014	13								319	10.1186/1475-2875-13-319				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AN5PH	WOS:000340643200001	25123055	DOAJ Gold, Green Published			2019-04-02	
J	Ilombe, G; Maketa, V; Mavoko, HM; da Luz, RI; Lutumba, P; Van Geertruyden, JP				Ilombe, Gillon; Maketa, Vivi; Mavoko, Hypolite Muhindo; da Luz, Raquel Inocencio; Lutumba, Pascal; Van geertruyden, Jean-Pierre			Performance of HRP2-based rapid test in children attending the health centre compared to asymptomatic children in the community	MALARIA JOURNAL			English	Article						Clinical malaria; Asymptomatic malaria; Diagnosis; RDTs	SUB-SAHARAN AFRICA; DIAGNOSTIC-TEST; FALCIPARUM-MALARIA; CLINICAL MALARIA; CASE DEFINITIONS; ENDEMIC AREAS; BURKINA-FASO; ACCURACY; KINSHASA; TRANSMISSION	Background: The Democratic Republic of the Congo (DRC) is one of the five countries carrying half of global malaria burden with children 0-5 years old being most at risk. Rapid diagnostic tests (RDTs) are currently routinely used for the detection of Plasmodium infection in health centres and may be a useful tool for population-based survey. Methods: This study assessed, in a stable transmission zone of Kinshasa, whether a HRP2-based RDT matches the selection criteria of the National Malaria Control Programme (NMCP), DRC and assessed the most relevant fever threshold in this context. Results: RDTs and microscopy were concordant in 84.3% and 83.4% children in the health centre and at the community level, respectively. The sensitivity was high (>95%), but the specificity was too low and lower in the community (66.9%; 95%CI: 58.5-75.2) compared to the HC (79.4%; 95%CI: 75.7-83.2). The estimated parasitic threshold of 5,414 parasites/mu l was with a sensitivity of 63.3% and a specificity of 71.8% not very discriminative, and thus not a threshold. Conclusion: HRP-based RDT gives a satisfactory proxy to estimate and monitor malaria endemicity, but the low specificity, far below the selection criteria of the NMCP, DRC is problematic for use in a clinical setting.	[Ilombe, Gillon] Univ Kinshasa, Clin Pharmacol Unit, Kinshasa, Zaire; [Maketa, Vivi; Mavoko, Hypolite Muhindo; Lutumba, Pascal] Univ Kinshasa, Dept Trop Med, Kinshasa, Zaire; [Ilombe, Gillon; Lutumba, Pascal] Inst Natl Rech Biomed, Kinshasa, Zaire; [Mavoko, Hypolite Muhindo; da Luz, Raquel Inocencio; Van geertruyden, Jean-Pierre] Univ Antwerp, Fac Med, Int Hlth Unit, B-2020 Antwerp, Belgium	Ilombe, G (reprint author), Univ Kinshasa, Clin Pharmacol Unit, Kinshasa, Zaire.	gillonilombe@yahoo.fr	Van geertruyden, Jean-Pierre/K-6425-2014; Inocencio da Luz, Raquel/L-9676-2016	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Inocencio da Luz, Raquel/0000-0002-2870-0311	FWO [G.078.11]	Acknowledgements to the technical staff from the QuinAct study funded by FWO: G.078.11 and the technical staff from the VLIR project: ZRDC2012MP076. Also our acknowledgements to the non-profit organization SANRU for the kind donation of RDTs.	Bell DR, 2005, AM J TROP MED HYG, V73, P199, DOI 10.4269/ajtmh.2005.73.199; Bisoffi Z, 2013, PLOS ONE, V8; Bisoffi Z, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-226; Bisoffi Z, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-192; D'Acremont V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-240; Houeto D., 2008, Cahiers d'Etudes et de Recherches Francophones/Sante, V18, P55; Ishengoma DS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-176; KARCH S, 1992, B SOC PATHOL EXOT, V85, P304; Kyabayinze DJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-221; Mohon A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-415; Muhindo HM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-224; MULUMBA PM, 1994, ANN SOC BELG MED TR, V74, P275; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Reyburn H, 2007, MALARIA J, V10, P403; Roll Back Malaria, 2005, GLOB STRAT PLAN 2005; SCHELLENBERG JRMA, 1994, PARASITOL TODAY, V10, P439, DOI 10.1016/0169-4758(94)90179-1; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P101, DOI 10.2471/BLT.07.042259; SMITH T, 1994, PARASITOLOGY, V109, P539, DOI 10.1017/S0031182000076411; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; TDR, MAL RAP DIAGN TEST P; UNICEF, PAL PRINC CAUS DEC P; Wembonyama S, 2007, Med Trop (Mars), V67, P447; White N. J., 1999, Parassitologia (Rome), V41, P301; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2012, WORLD HLTH ORG GLOB; WHO, 2003, WHOHTMRBM200350; WHO, 2010, GUID TREATM MAL; Zwang J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-203	29	10	10	0	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	AUG 9	2014	13								308	10.1186/1475-2875-13-308				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AO0WC	WOS:000341032300001	25108305	DOAJ Gold, Green Published			2019-04-02	
J	Burza, S; Mahajan, R; Sinha, PK; van Griensven, J; Pandey, K; Lima, MA; Sanz, MG; Sunyoto, T; Kumar, S; Mitra, G; Kumar, R; Verma, N; Das, P				Burza, Sakib; Mahajan, Raman; Sinha, Prabhat K.; van Griensven, Johan; Pandey, Krishna; Angeles Lima, Maria; Gonzalez Sanz, Marta; Sunyoto, Temmy; Kumar, Sunil; Mitra, Gaurab; Kumar, Ranjeet; Verma, Neena; Das, Pradeep			Visceral Leishmaniasis and HIV Co-infection in Bihar, India: Long-term Effectiveness and Treatment Outcomes with Liposomal Amphotericin B (AmBisome)	PLOS NEGLECTED TROPICAL DISEASES			English	Article							INFECTED PATIENTS; KALA-AZAR; MILTEFOSINE; RESISTANCE; INFANTUM; DONOVANI; THERAPY; RELAPSE; NEPAL	Background: Visceral Leishmaniasis (VL; also known as kala-azar) is an ultimately fatal disease endemic in the Indian state of Bihar, while HIV/AIDS is an emerging disease in this region. A 2011 observational cohort study conducted in Bihar involving 55 VL/HIV co-infected patients treated with 20-25 mg/kg intravenous liposomal amphotericin B (AmBisome) estimated an 85.5% probability of survival and a 26.5% probability of VL relapse within 2 years. Here we report the long-term field outcomes of a larger cohort of co-infected patients treated with this regimen between 2007 and 2012. Methods and Principal Findings: Intravenous AmBisome (20-25 mg/kg) was administered to 159 VL/HIV co-infected patients (both primary infections and relapses) in four or five doses of 5 mg/kg over 4-10 days. Initial cure of VL at discharge was defined as improved symptoms, cessation of fever, improvement of appetite and recession of spleen enlargement. Test of cure was not routinely performed. Antiretroviral treatment (ART) was initiated in 23 (14.5%), 39 (24.5%) and 61 (38.4%) before, during and after admission respectively. Initial cure was achieved in all discharged patients. A total of 36 patients died during follow-up, including six who died shortly after admission. Death occurred at a median of 11 weeks (IQR 4-51) after starting VL treatment. Estimated mortality risk was 14.3% at six months, 22.4% at two years and 29.7% at four years after treatment. Among the 153 patients discharged from the hospital, 26 cases of VL relapse were diagnosed during followup, occurring at a median of 10 months (IQR 7-14) after discharge. After accounting for competing risks, the estimated risk of relapse was 16.1% at one year, 20.4% at two years and 25.9% at four years. Low hemoglobin level and concurrent infection with tuberculosis were independent risk factors for mortality, while ART initiated shortly after admission for VL treatment was associated with a 64-66% reduced risk of mortality and 75% reduced risk of relapse. Significance: This is the largest cohort of HIV-VL co-infected patients reported from the Indian subcontinent. Even after initial cure following treatment with AmBisome, these patients appear to have much higher rates of VL relapse and mortality than patients not known to be HIV-positive, although relapse rates appear to stabilize after 2 years. These results extend the earlier findings that co-infected patients are at increased risk of death and require a multidisciplinary approach for long-term management.	[Burza, Sakib; Mahajan, Raman; Gonzalez Sanz, Marta; Sunyoto, Temmy; Mitra, Gaurab; Kumar, Ranjeet] Med Sans Frontieres, New Delhi, India; [Burza, Sakib; van Griensven, Johan; Pandey, Krishna; Verma, Neena; Das, Pradeep] Inst Trop Med, B-2000 Antwerp, Belgium; [Sinha, Prabhat K.] Rajendra Mem Res Inst Med Sci, Patna, Bihar, India; [Angeles Lima, Maria] Med Sans Frontieres, Barcelona, Spain; [Kumar, Sunil] Sri Krishna Med Coll & Hosp, Muzaffarpur, Bihar, India	Burza, S (reprint author), Med Sans Frontieres, New Delhi, India.	sakibburza@gmail.com		Sunyoto, Temmy/0000-0003-0369-8830; Burza, Sakib/0000-0001-7886-8633	Rajendra Memorial Research Institute of Medical Science; Medecins Sans Frontieres	We acknowledge the support of the Rajendra Memorial Research Institute of Medical Science and Medecins Sans Frontieres teams in Bihar who have made this work possible. We also thank the Bihar State Health Society and the National Vector Borne Disease Control Program who have been pivotal in facilitating the work of MSF in Vaishali. We would like to thank Patricia Kahn for editing assistance and Margriet den Boer and Koert Ritmeijer for suggestions for the manuscript.	Alexander J, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00080; Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07; Balasegaram M, 2012, EXPERT OPIN EMERG DR, V17, P493, DOI 10.1517/14728214.2012.748036; Bora D, 1999, NATL MED J INDIA, V12, P62; Burza S, 2014, CLIN INFECT DIS, V59, P552, DOI 10.1093/cid/ciu333; Burza S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002536; Burza S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002603; Burza S, 2013, CLIN INFECT DIS, V57, P1363, DOI 10.1093/cid/cit508; Cota GF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002195; Cota GF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001153; Durand R, 1998, ANTIMICROB AGENTS CH, V42, P2141, DOI 10.1128/AAC.42.8.2141; Government of India Ministry of Health and Family Welfare, 2010, UN GEN ASS SPEC SESS; Jarvis JN, 2013, CURR OPIN INFECT DIS, V26, P1, DOI 10.1097/QCO.0b013e32835c2198; Lachaud L, 2009, CLIN INFECT DIS, V48, pE16, DOI 10.1086/595710; Lau B, 2009, AM J EPIDEMIOL, V170, P244, DOI 10.1093/aje/kwp107; Lin DY, 1997, STAT MED, V16, P901, DOI 10.1002/(SICI)1097-0258(19970430)16:8<901::AID-SIM543>3.0.CO;2-M; Mathur P, 2006, J MED MICROBIOL, V55, P919, DOI 10.1099/jmm.0.46574-0; Mock DJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002635; National AIDS Control organisation Ministry of Health and Family Welfare Government of India, 2012, OP GUID ART SERV 201; National AIDS Control Organization, 2007, ANT THER GUID HIV IN; National AIDS Control Organization And Central TB Division, 2010, TB HIV MOD ART CTR S; National Vector Borne Disease Control Programme, 2008, PROJ IMPL PLAN NAT V; Ostyn B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001284; Pandey A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000926; Patole S, 2014, INT J INFECT DIS, V25, P204, DOI 10.1016/j.ijid.2014.02.015; Purkait B, 2012, ANTIMICROB AGENTS CH, V56, P1031, DOI 10.1128/AAC.00030-11; Rai S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066860; Redhu NS, 2006, AIDS, V20, P1213, DOI 10.1097/01.aids.0000226971.42622.4e; Rijal S, 2013, CLIN INFECT DIS, V56, P1530, DOI 10.1093/cid/cit102; Ritmeijer K, 2011, CLIN INFECT DIS, V53, pE152, DOI 10.1093/cid/cir674; Royston P, 2005, STATA J, V5, P279, DOI 10.1177/1536867X0500500212; Sinha PK, 2003, JAIDS, V32, P115, DOI 10.1097/00126334-200301010-00017; Sinha PK, 2011, CLIN INFECT DIS, V53, pE91, DOI 10.1093/cid/cir521; Sinha PK, 2010, AM J TROP MED HYG, V83, P357, DOI 10.4269/ajtmh.2010.10-0156; Sundar S, 2002, CLIN DIAGN LAB IMMUN, V9, P951, DOI 10.1128/CDLI.9.5.951-958.2002; ter Horst R, 2008, CLIN INFECT DIS, V46, P1702, DOI 10.1086/587899; Thakur CP, 2000, T ROY SOC TROP MED H, V94, P696, DOI 10.1016/S0035-9203(00)90238-4; Thakur CP, 2003, JAIDS-J ACQ IMM DEF, V32, P572, DOI 10.1097/00126334-200304150-00017; van Griensven J, 2010, LANCET INFECT DIS, V10, P184, DOI 10.1016/S1473-3099(10)70011-6; WHO, 2010, IND MON EV KAL AZ EL; WHO control of the leishmaniasis, 2010, M WHO EXP COMM CONTR; World Health Organization, 2011, FIELD SAF NOT 1 2011; World Health Organization (WHO), 1995, WHO TECH REP SER, V165, P1	43	26	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	AUG	2014	8	8							e3053	10.1371/journal.pntd.0003053				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AO8AN	WOS:000341574700027	25101665	DOAJ Gold, Green Published			2019-04-02	
J	Chowdhury, R; Mondal, D; Chowdhury, V; Faria, S; Alvar, J; Nabi, SG; Boelaert, M; Dash, AP				Chowdhury, Rajib; Mondal, Dinesh; Chowdhury, Vashkar; Faria, Shyla; Alvar, Jorge; Nabi, Shah Golam; Boelaert, Marleen; Dash, Aditya Prasad			How Far Are We from Visceral Leishmaniasis Elimination in Bangladesh? An Assessment of Epidemiological Surveillance Data	PLOS NEGLECTED TROPICAL DISEASES			English	Review							CONSEQUENCES; COMMUNITY	Introduction: In 2005, Bangladesh, India, and Nepal joined forces to eliminate Visceral Leishmaniasis (or kala-azar) from the region by 2015. In Bangladesh the elimination target is set at less than one new case per 10,000 population per year at upazila (sub-district) level. As the deadline approaches, we review the status of the elimination initiative in this country. Methods: We collected all available disease surveillance data at the Disease Control Unit of the Directorate General of Health Services, Government of Bangladesh from 1994 to 2013. Additionally, we retrieved data from the Civil Surgeon Office from the Mymensingh district, one of the most heavily affected areas in Bangladesh. Results: Between 1994 and 2013, 109,266 kala-azar cases causing 329 deaths were reported from 37 endemic districts in Bangladesh. Only 16 districts reported cases every year. The Mymensingh district was the most affected with 53,582 (49.04%) cases. Between 2008 and 2013 only 16 upazilas showed incidence rates above the elimination target in which they ranged from 1.06 to 18.25 per 10,000 people per year. Discussion: While clear progress has been made towards eliminating VL, 16 upazilas in Bangladesh had not yet reached the target in 2013, based on official notification data that probably suffered from under-reporting bias. The elimination initiative urgently needs to establish methods to ascertain and monitor the elimination target.	[Chowdhury, Rajib; Faria, Shyla] Natl Inst Prevent & Social Med NIPSOM, Dhaka, Bangladesh; [Mondal, Dinesh] ICDDR, B, Dhaka, Bangladesh; [Chowdhury, Vashkar] Dhaka Coll, Dhaka, Bangladesh; [Alvar, Jorge] DNDi, Geneva, Switzerland; [Nabi, Shah Golam] Directorate Gen Hlth Serv, Dhaka, Bangladesh; [Boelaert, Marleen] Inst Trop Med, B-2000 Antwerp, Belgium; [Dash, Aditya Prasad] Natl Inst Malaria Res, New Delhi, India	Chowdhury, R (reprint author), Natl Inst Prevent & Social Med NIPSOM, Dhaka, Bangladesh.	rajib478@yahoo.com		Boelaert, Marleen/0000-0001-8051-6776; Bern, Caryn/0000-0001-8195-7303			Ahluwalia IB, 2004, J WOMENS HEALTH, V13, P360, DOI 10.1089/154099904323087024; Ahluwalia IB, 2003, AM J TROP MED HYG, V69, P624, DOI 10.4269/ajtmh.2003.69.624; Alvar A, 2012, PLOS ONE, V7, DOI DOI 10.1371/JOURNAL.PONE.0035671; Bern C, 2006, INDIAN J MED RES, V123, P275; Dorlo TPC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001544; Dye C, 1998, T R SOC TROP MED HYG, V82, P843; Islam S, 2013, AM J TROP MED HYG, V89, P345, DOI 10.4269/ajtmh.12-0711; MACKIE F. P., 1914, Indian Journal of Medical Research, V1, P626; Mondal D, 2008, HEALTH POLICY, V87, P369, DOI 10.1016/j.healthpol.2008.01.011; Mondal D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000832; RAHMAN KM, 1983, B WORLD HEALTH ORGAN, V61, P113; Sen Gupta P. C., 1947, Indian Medical Gazette, V82, P281; Sengupta PC, 1944, INDIAN MED GAZ, V79, P547; Sharma DA, 2006, TROP MED INT HEALTH, V11, P757, DOI 10.1111/j.1365-3156.2006.01604.x; WHO Regional Office for South-East Asia, 2012, DEP COMM DIS PROF VI, p[xii, 89]; World Health Organization, 2005, REG STRAT FRAM EL KA	16	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	AUG	2014	8	8							e3020	10.1371/journal.pntd.0003020				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AO8AN	WOS:000341574700014	25144317	DOAJ Gold, Green Published			2019-04-02	
J	Meurs, L; Mbow, M; Boon, N; Vereecken, K; Amoah, AS; Labuda, LA; Dieye, TN; Mboup, S; Yazdanbakhsh, M; Polman, K				Meurs, Lynn; Mbow, Moustapha; Boon, Nele; Vereecken, Kim; Amoah, Abena Serwaa; Labuda, Lucja A.; Dieye, Tandakha Ndiaye; Mboup, Souleymane; Yazdanbakhsh, Maria; Polman, Katja			Cytokine Responses to Schistosoma mansoni and Schistosoma haematobium in Relation to Infection in a Co-endemic Focus in Northern Senegal	PLOS NEGLECTED TROPICAL DISEASES			English	Article							BLADDER MORBIDITY; ANTIBODIES; PROFILES; IMMUNITY; CHILDREN; SINGLE; IMPACT; SERA	Background: In Africa, many areas are co-endemic for the two major Schistosoma species, S. mansoni and S. haematobium. Epidemiological studies have suggested that host immunological factors may play an important role in co-endemic areas. As yet, little is known about differences in host immune responses and possible immunological interactions between S. mansoni and S. haematobium in humans. The aim of this study was to analyze host cytokine responses to antigens from either species in a population from a co-endemic focus, and relate these to S. mansoni and S. haematobium infection. Methodology: Whole blood cytokine responses were investigated in a population in the north of Senegal (n = 200). Blood was stimulated for 72 h with schistosomal egg and adult worm antigens of either Schistosoma species. IL-10, IL-5, IFN-gamma, TNF-alpha, and IL-2 production was determined in culture supernatants. A multivariate (i.e. multi-response) approach was used to allow a joint analysis of all cytokines in relation to Schistosoma infection. Principal Findings: Schistosoma haematobium egg and worm antigens induced higher cytokine production, suggesting that S. haematobium may be more immunogenic than S. mansoni. However, both infections were strongly associated with similar, modified Th2 cytokine profiles. Conclusions/Significance: This study is the first to compare S. mansoni and S. haematobium cytokine responses in one population residing in a co-endemic area. These findings are in line with previous epidemiological studies that also suggested S. haematobium egg and worm stages to be more immunogenic than those of S. mansoni.	[Meurs, Lynn; Mbow, Moustapha; Boon, Nele; Vereecken, Kim; Polman, Katja] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Mbow, Moustapha; Dieye, Tandakha Ndiaye; Mboup, Souleymane] Aristide Le Dantec Teaching Hosp, Lab Bacteriol & Virol, Dakar, Senegal; [Mbow, Moustapha; Amoah, Abena Serwaa; Labuda, Lucja A.; Yazdanbakhsh, Maria] Leiden Univ, Dept Parasitol, Med Ctr, Leiden, Netherlands; [Boon, Nele] Univ Leuven, Lab Biodivers & Evolutionary Gen, Leuven, Belgium; [Amoah, Abena Serwaa] Univ Ghana, Noguchi Mem Inst Med Res, Dept Parasitol, Legon, Accra, Ghana; [Labuda, Lucja A.] Ctr Rech Med Lambarene CERMEL, Lambarene, Gabon; [Labuda, Lucja A.] Univ Tubingen, Inst Trop Med, Tubingen, Germany	Meurs, L (reprint author), Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium.	LMeurs@itg.be	Meurs, Lynn/J-8661-2016	Meurs, Lynn/0000-0002-6973-1237; Amoah, Abena/0000-0003-2270-1871	European Union [INCO-CT-2006-032405]; Flemish Inter-University Council (VLADOC)	This work was funded by the European Union's sixth framework programme (INCO-CT-2006-032405, http://cordis.europa.eu/fp6/) and the Flemish Inter-University Council (VLADOC to NB, http://www.vliruos.be/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; [Anonymous], 2006, PREV CHEM HUM HELM C; Bourke CD, 2013, J INFECT DIS, V208, P159, DOI 10.1093/infdis/jis524; BUTTERWORTH AE, 1987, PARASITOLOGY, V94, P281, DOI 10.1017/S0031182000053956; CHEEVER AW, 1977, AM J TROP MED HYG, V26, P702, DOI 10.4269/ajtmh.1977.26.702; Clarke KR, 2001, CANGE MARINE COMMUNI; Gouvras AN, 2013, ACTA TROP, V128, P309, DOI 10.1016/j.actatropica.2013.01.001; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Huyse T, 2013, INT J PARASITOL, V43, P687, DOI 10.1016/j.ijpara.2013.04.001; Joseph S, 2004, INFECT IMMUN, V72, P728, DOI 10.1128/IAI.72.2.728-734.2004; Koukounari A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-227; Meurs L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001829; Meurs L, 2012, INT J PARASITOL, V42, P305, DOI 10.1016/j.ijpara.2012.02.002; Oksanen J, 2013, VEGAN COMMUNITY ECOL; R Core Team, 2012, R LANG ENV STAT COMP; SMITH M, 1974, T ROY SOC TROP MED H, V68, P70, DOI 10.1016/0035-9203(74)90255-7; van Remoortere A, 2001, INFECT IMMUN, V69, P2396, DOI 10.1128/IAI.69.4.2396-2401.2001; Wiria AE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-77	18	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	AUG	2014	8	8							e3080	10.1371/journal.pntd.0003080				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AO8AN	WOS:000341574700044	25101661	DOAJ Gold, Green Published			2019-04-02	
J	van Griensven, J; Diro, E; Lopez-Velez, R; Ritmeijer, K; Boelaert, M; Zijlstra, EE; Hailu, A; Lynen, L				van Griensven, Johan; Diro, Ermias; Lopez-Velez, Rogelio; Ritmeijer, Koert; Boelaert, Marleen; Zijlstra, Ed E.; Hailu, Asrat; Lynen, Lutgarde			A Screen-and-Treat Strategy Targeting Visceral Leishmaniasis in HIV-Infected Individuals in Endemic East African Countries: The Way Forward?	PLOS NEGLECTED TROPICAL DISEASES			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; POLYMERASE-CHAIN-REACTION; DIRECT AGGLUTINATION-TEST; ANTIRETROVIRAL THERAPY; CRYPTOCOCCAL ANTIGENEMIA; SUBCLINICAL INFECTION; LATEX AGGLUTINATION; DONOVANI INFECTION; NORTHWEST ETHIOPIA; NORTHERN ETHIOPIA	In the wake of the HIV epidemic, visceral leishmaniasis (VL), a disseminated protozoan infection caused by the Leishmania donovani complex, has been re-emerging, particularly in North Ethiopia where up to 40% of patients with VL are co-infected with HIV. Management of VL in HIV co-infection is complicated by increased drug toxicity, and high treatment failure and relapse rates with all currently available drugs, despite initiation of antiretroviral treatment. Tackling L. donovani infection before disease onset would thus be a logical approach. A screen-and-treat approach targeting latent or the early stage of infection has successfully been implemented in other HIV-associated opportunistic infections. While conceptually attractive in the context of VL-HIV, the basic understanding and evidence underpinning such an approach is currently lacking. Prospective cohort studies will have to be conducted to quantify the risk of VL in different risk groups and across CD4 cell count levels. This will allow developing clinical prognostic tools, integrating clinical, HIV and Leishmania infection markers. Interventional studies will be needed to evaluate prophylactic or pre-emptive treatment strategies for those at risk, ideally relying on an oral (combination) regimen. Issues like tolerability, emergence of resistance and drug interactions will require due attention. The need for maintenance therapy will have to be assessed. Based on the risk-benefit data, VL risk cut-offs will have to be identified to target treatment to those most likely to benefit. Such a strategy should be complemented with early initiation of antiretroviral treatment and other strategies to prevent HIV and Leishmania infection.	[van Griensven, Johan; Diro, Ermias; Lynen, Lutgarde] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Diro, Ermias] Univ Gondar, Dept Internal Med, Gondar, Ethiopia; [Lopez-Velez, Rogelio] Hosp Ramon & Cajal, Dept Infect Dis, E-28034 Madrid, Spain; [Ritmeijer, Koert] Med Sans Frontieres, Dept Publ Hlth, Amsterdam, Netherlands; [Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Zijlstra, Ed E.] Rotterdam Ctr Trop Med, Rotterdam, Netherlands; [Hailu, Asrat] Univ Addis Ababa, Sch Med, Addis Ababa, Ethiopia	van Griensven, J (reprint author), Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.	jvangriensven@itg.be	Lynen, Lutgarde/A-1212-2014	Lynen, Lutgarde/0000-0001-7183-4895; Boelaert, Marleen/0000-0001-8051-6776	Inbev Baillet Latour Fund; Medecins Sans Frontieres [OCA014-23, OCA009-07]	JvG is supported by the Inbev Baillet Latour Fund. The Fund had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi I, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-153; Ajdary S, 2006, CLIN EXP IMMUNOL, V145, P44, DOI 10.1111/j.1365-2249.2006.03105.x; ALI A, 1994, ANN TROP MED PARASIT, V88, P289, DOI 10.1080/00034983.1994.11812869; ALI A, 1993, ANN TROP MED PARASIT, V87, P157, DOI 10.1080/00034983.1993.11812749; Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07; Angarano G, 1998, EUR J CLIN MICROBIOL, V17, P365, DOI 10.1007/s100960050086; Ates SC, 2013, ACTA TROP, V128, P54, DOI 10.1016/j.actatropica.2013.06.009; Badaro R, 1996, J INFECT DIS, V173, P758, DOI 10.1093/infdis/173.3.758; Barragan P, 2010, AM J TROP MED HYG, V83, P10, DOI 10.4269/ajtmh.2010.09-0594; Bittar RC, 2007, MEM I OSWALDO CRUZ, V102, P625, DOI 10.1590/S0074-02762007005000069; Bogdan C, 2008, CELL MICROBIOL, V10, P1221, DOI 10.1111/j.1462-5822.2008.01146.x; CDC, 2013, PAN OPP INF HIV INF; Chatelain E, 2011, DRUG DES DEV THER, V5, P175, DOI 10.2147/DDDT.S16381; Chaussabel D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-84; Cota GF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001665; Custodio E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001813; Diro E, 2007, T ROY SOC TROP MED H, V101, P908, DOI 10.1016/j.trstmh.2007.05.002; Ettinger NA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000252; Fontana JM, 2012, TRANSL RES, V159, P430, DOI 10.1016/j.trsl.2011.12.009; French N, 2002, AIDS, V16, P1031, DOI 10.1097/00002030-200205030-00009; Gadisa E, 2012, AM J TROP MED HYG, V86, P792, DOI 10.4269/ajtmh.2012.11-0196; Garcia-Garcia JA, 2006, J CLIN MICROBIOL, V44, P4455, DOI 10.1128/JCM.00921-06; Guan SP, 2009, PROTEIN PEPTIDE LETT, V16, P490, DOI 10.2174/092986609788167842; Hailu A, 2005, CLIN IMMUNOL, V117, P182, DOI 10.1016/j.clim.2005.06.015; Hailu A, 2009, ANN TROP MED PARASIT, V103, P659, DOI 10.1179/000349809X12554106963555; Hamerlinck FFV, 2000, FEMS IMMUNOL MED MIC, V27, P31, DOI 10.1016/S0928-8244(99)00157-1; Hasker E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002657; Hide M, 2013, INT J PARASITOL, V43, P389, DOI 10.1016/j.ijpara.2012.12.008; Hurissa Z, 2010, TROP MED INT HEALTH, V15, P848, DOI 10.1111/j.1365-3156.2010.02550.x; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Jarvis JN, 2011, CLIN INFECT DIS, V53, P1019, DOI 10.1093/cid/cir613; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; Kaforou M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001538; Khalil EAG, 2002, TROP MED INT HEALTH, V7, P35, DOI 10.1046/j.1365-3156.2002.00832.x; Kubar J, 1998, AIDS, V12, P2147, DOI 10.1097/00002030-199816000-00009; LAFEUILLADE A, 1992, AM J MED, V92, P449, DOI 10.1016/0002-9343(92)90281-F; Lawn SD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-103; Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x; Lopez-Velez R, 1998, AM J TROP MED HYG, V58, P436, DOI 10.4269/ajtmh.1998.58.436; Martin-Sanchez J, 2004, AM J TROP MED HYG, V70, P545, DOI 10.4269/ajtmh.2004.70.545; Maurya R, 2010, J CLIN MICROBIOL, V48, P1932, DOI 10.1128/JCM.01733-09; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; MEDRANO FJ, 1992, AIDS, V6, P1499, DOI 10.1097/00002030-199212000-00013; Medrano FJ, 1998, CLIN EXP IMMUNOL, V114, P403, DOI 10.1046/j.1365-2249.1998.00733.x; Michel G, 2011, ACTA TROP, V119, P69, DOI 10.1016/j.actatropica.2011.05.012; Molina I, 2013, AM J TROP MED HYG, V89, P105, DOI 10.4269/ajtmh.12-0527; Moller HJ, 2012, SCAND J CLIN LAB INV, V72, P1, DOI 10.3109/00365513.2011.626868; MONTALBAN C, 1990, J INFECTION, V21, P261, DOI 10.1016/0163-4453(90)93933-J; Mukherjee S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001987; Nigro L, 1996, EUR J CLIN MICROBIOL, V15, P832, DOI 10.1007/BF01701531; Nylen S, 2007, TRENDS IMMUNOL, V28, P378, DOI 10.1016/j.it.2007.07.004; Orsini M, 2012, T ROY SOC TROP MED H, V106, P283, DOI 10.1016/j.trstmh.2012.01.008; Ostyn B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001284; PETERS BS, 1990, Q J MED, V77, P1101, DOI 10.1093/qjmed/77.2.1101; Pintado V, 2001, MEDICINE, V80, P54, DOI 10.1097/00005792-200101000-00006; Rajasingham R, 2012, JAIDS-J ACQ IMM DEF, V59, pE85, DOI 10.1097/QAI.0b013e31824c837e; Riera C, 2004, EUR J CLIN MICROBIOL, V23, P899, DOI 10.1007/s10096-004-1249-7; Ritmeijer K, 2011, CLIN INFECT DIS, V53, pE152, DOI 10.1093/cid/cir674; ROSENTHAL E, 1995, T ROY SOC TROP MED H, V89, P159, DOI 10.1016/0035-9203(95)90476-X; SCHAEFER KU, 1995, T ROY SOC TROP MED H, V89, P492, DOI 10.1016/0035-9203(95)90081-0; Seden K, 2013, AIDS, V27, P675, DOI 10.1097/QAD.0b013e32835ca9b4; Sharma MC, 2000, ACTA TROP, V76, P195, DOI 10.1016/S0001-706X(00)00068-1; Silva LA, 2013, REV INST MED TROP SP, V55, P101, DOI 10.1590/S0036-46652013000200006; Singh OP, 2014, CLIN INFECT DIS, V58, P1424, DOI 10.1093/cid/ciu102; Sinha PK, 2008, ANN TROP MED PARASIT, V102, P119, DOI 10.1179/136485908X252278; Stober CB, 2012, AM J TROP MED HYG, V87, P663, DOI 10.4269/ajtmh.2012.12-0180; ter Horst R, 2008, CLIN INFECT DIS, V46, P1702, DOI 10.1086/587899; ter Horst R, 2009, AM J TROP MED HYG, V80, P929, DOI 10.4269/ajtmh.2009.80.929; Torrus D, 1996, J ANTIMICROB CHEMOTH, V37, P1042, DOI 10.1093/jac/37.5.1042; Turgay N, 2010, AM J TROP MED HYG, V83, P822, DOI 10.4269/ajtmh.2010.09-0605; van Griensven J, 2012, INFECT DIS CLIN N AM, V26, P309, DOI 10.1016/j.idc.2012.03.005; van Griensven J, 2010, LANCET INFECT DIS, V10, P184, DOI 10.1016/S1473-3099(10)70011-6; WHO, 2010, WHO TECHN REP SER; WHO, 2006, ANT THER HIV INF AD; World Health Organization, 2006, GUID COTR PROPH HIV; World Health Organization, 2011, RAP ADV DIAGN PREV M; Worodria W, 2011, JAIDS-J ACQ IMM DEF, V58, P32, DOI 10.1097/QAI.0b013e3182255dc2; Wyllie S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003326; Zandieh A, 2013, INT J DERMATOL, V52, P59, DOI 10.1111/j.1365-4632.2012.05615.x; ZIJLSTRA EE, 1994, AM J TROP MED HYG, V51, P826, DOI 10.4269/ajtmh.1994.51.826	80	10	10	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	AUG	2014	8	8							e3011	10.1371/journal.pntd.0003011				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AO8AN	WOS:000341574700008	25101627	DOAJ Gold, Green Published			2019-04-02	
J	van Griensven, J; Zijlstra, EE; Hailu, A				van Griensven, Johan; Zijlstra, Ed E.; Hailu, Asrat			Visceral Leishmaniasis and HIV Coinfection: Time for Concerted Action	PLOS NEGLECTED TROPICAL DISEASES			English	Editorial Material							LIPOSOMAL AMPHOTERICIN-B; EMERGENCE; ETHIOPIA; BIOBANK		[van Griensven, Johan] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Zijlstra, Ed E.] Rotterdam Ctr Trop Med, Rotterdam, Netherlands; [Hailu, Asrat] Univ Addis Ababa, Sch Med, Addis Ababa, Ethiopia	van Griensven, J (reprint author), Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.	jvangriensven@itg.be					Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Bourgeois N, 2010, HIV MED, V11, P670, DOI 10.1111/j.1468-1293.2010.00846.x; Burza S, 2014, CLIN INFECT DIS, V59, P552, DOI 10.1093/cid/ciu333; Cota GF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001665; De Souza YG, 2013, AIDS, V27, P303, DOI 10.1097/QAD.0b013e32835c1244; Dhai A, 2013, SAMJ S AFR MED J, V103, P225, DOI [10.7196/SAMJ.6813, 10.7196/samj.6813]; Franco JR, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001571; Hurissa Z, 2010, TROP MED INT HEALTH, V15, P848, DOI 10.1111/j.1365-3156.2010.02550.x; Lloyd-Smith JO, 2008, PARASITOLOGY, V135, P795, DOI 10.1017/S0031182008000292; Mengistu G, 2007, ETHIOP J HEALTH DEV, V21, P53; Ministry of Health Brazil, 2011, MAN REC DIAGN TRAT A; Moodley K, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-4; Nascimento ET, 2011, T ROY SOC TROP MED H, V105, P298, DOI 10.1016/j.trstmh.2011.01.006; Ritmeijer K, 2011, CLIN INFECT DIS, V53, pE152, DOI 10.1093/cid/cir674; Santos-Oliveira JR, 2013, J INFECT DIS, V208, P57, DOI 10.1093/infdis/jit135; Sinha PK, 2011, CLIN INFECT DIS, V53, pE91, DOI 10.1093/cid/cir521; ter Horst R, 2008, CLIN INFECT DIS, V46, P1702, DOI 10.1086/587899; van Griensven J, 2014, PLOS NEGL T IN PRESS; van Griensven J, 2012, INFECT DIS CLIN N AM, V26, P309, DOI 10.1016/j.idc.2012.03.005; WHO, 2012, WHO POL COLL TB HIVA; Yimer M, 2014, AM J BIOMEDICAL LIFE, P1	22	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	AUG	2014	8	8							e3023	10.1371/journal.pntd.0003023				2	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AO8AN	WOS:000341574700016	25166269	DOAJ Gold, Green Published			2019-04-02	
J	Van Reet, N; Van de Vyver, H; Pyana, PP; Van der Linden, AM; Buscher, P				Van Reet, Nick; Van de Vyver, Helene; Pyana, Patient Pati; Van der Linden, Anne Marie; Buscher, Philippe			A Panel of Trypanosoma brucei Strains Tagged with Blue and Red-Shifted Luciferases for Bioluminescent Imaging in Murine Infection Models	PLOS NEGLECTED TROPICAL DISEASES			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; CENTRAL-NERVOUS-SYSTEM; SLEEPING SICKNESS PATIENTS; REPORTER-GENE-EXPRESSION; RECENTLY ISOLATED STOCKS; BLOOD-BRAIN-BARRIER; IN-VIVO; RENILLA LUCIFERASE; FIREFLY LUCIFERASE; LABORATORY RODENTS	Background: Genetic engineering with luciferase reporter genes allows monitoring Trypanosoma brucei (T.b.) infections in mice by in vivo bioluminescence imaging (BLI). Until recently, luminescent T.b. models were based on Renilla luciferase (RLuc) activity. Our study aimed at evaluating red-shifted luciferases for in vivo BLI in a set of diverse T.b. strains of all three subspecies, including some recently isolated from human patients. Methodology/Principal findings: We transfected T.b. brucei, T.b. rhodesiense and T.b. gambiense strains with either RLuc, click beetle red (CBR) or Photinus pyralis RE9 (PpyRE9) luciferase and characterised their in vitro luciferase activity, growth profile and drug sensitivity, and their potential for in vivo BLI. Compared to RLuc, the red-shifted luciferases, CBR and PpyRE9, allow tracking of T.b. brucei AnTaR 1 trypanosomes with higher details on tissue distribution, and PpyRE9 allows detection of the parasites with a sensitivity of at least one order of magnitude higher than CBR luciferase. With CBR-tagged T.b. gambiense LiTaR1, T.b. rhodesiense RUMPHI and T.b. gambiense 348 BT in an acute, subacute and chronic infection model respectively, we observed differences in parasite tropism for murine tissues during in vivo BLI. Ex vivo BLI on the brain confirmed central nervous system infection by all luminescent strains of T.b. brucei AnTaR 1, T.b. rhodesiense RUMPHI and T.b. gambiense 348 BT. Conclusions/Significance: We established a genetically and phenotypically diverse collection of bioluminescent T.b. brucei, T.b. gambiense and T.b. rhodesiense strains, including drug resistant strains. For in vivo BLI monitoring of murine infections, we recommend trypanosome strains transfected with red-shifted luciferase reporter genes, such as CBR and PpyRE9. Red-shifted luciferases can be detected with a higher sensitivity in vivo and at the same time they improve the spatial resolution of the parasites in the entire body due to the better kinetics of their substrate D-luciferin.	[Van Reet, Nick; Pyana, Patient Pati; Buscher, Philippe] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Van de Vyver, Helene] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany; [Pyana, Patient Pati] Inst Natl Rech Biomed, Dept Parasitol, Kinshasa Gombe, DEM REP CONGO; [Van der Linden, Anne Marie] Univ Antwerp, Fac Pharmaceut Biomed & Vet Sci, Bioimaging Lab, Dept Biomed Sci, Antwerp, Belgium	Van Reet, N (reprint author), Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium.	nvanreet@itg.be	Van der Linden, Annemie/L-7855-2017; Buscher, Philippe/B-9956-2012	Van der Linden, Annemie/0000-0003-2941-6520; Buscher, Philippe/0000-0002-1926-7472	Fonds voor Wetenschappelijk Onderzoek [1.5.147.09N, G.0229.10 N]	This work was supported by grants of the Fonds voor Wetenschappelijk Onderzoek (1.5.147.09N and G.0229.10 N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu N, 2011, FEMS MICROBIOL REV, V35, P360, DOI 10.1111/j.1574-6976.2010.00252.x; Aswendt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055662; BABIKER EA, 1981, ANN SOC BELG MED TR, V61, P15; Bacchi Cyrus J, 2009, Interdiscip Perspect Infect Dis, V2009, P195040, DOI 10.1155/2009/195040; BECKERS A, 1981, Z PARASITENKD, V64, P285; Bhaumik S, 2004, J BIOMED OPT, V9, P578, DOI 10.1117/1.1647546; Branchini BR, 2010, ANAL BIOCHEM, V396, P290, DOI 10.1016/j.ab.2009.09.009; Buscher P, 2005, TROP MED INT HEALTH, V10, P850, DOI 10.1111/j.1365-3156.2005.01468.x; Buscher P, 2013, NEW ENGL J MED, V368, P1069, DOI 10.1056/NEJMc1210373; Checchi F, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-16; Chevrier C, 2005, ACTA TROP, V95, P33, DOI 10.1016/j.actatropica.2005.04.011; CHIRIMWAMI B, 1988, ANN SOC BELG MED TR, V68, P205; Claes F, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000486; Close DM, 2011, SENSORS-BASEL, V11, P180, DOI 10.3390/s110100180; D'Archivio S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001976; Darsaud A, 2003, EXP BIOL MED, V228, P1355; Doyle TC, 2004, CELL MICROBIOL, V6, P303, DOI 10.1111/j.1462-5822.2004.00378.x; Epidemiology and control of African trypanosomiasis, 1986, WHO TECHN REP SER, V739, P40; GIBSON W C, 1986, Parasitology Today, V2, P255, DOI 10.1016/0169-4758(86)90011-6; Gil JS, 2012, MOL IMAGING BIOL, V14, P462, DOI 10.1007/s11307-011-0515-1; Gillingwater K, 2007, VET PARASITOL, V148, P114, DOI 10.1016/j.vetpar.2007.05.020; Giroud C, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000509; Goodhead I, 2013, M BIO, V4, P1; Graf FE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002475; Hastings JW, 1996, GENE, V173, P5, DOI 10.1016/0378-1119(95)00676-1; Heikkila JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008603; HERBERT WJ, 1976, EXP PARASITOL, V40, P427, DOI 10.1016/0014-4894(76)90110-7; Herwaldt BL, 2001, CLIN MICROBIOL REV, V14, P659, DOI 10.1128/CMR.14.3.659-688.2001; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Holzmuller P, 2008, MICROBES INFECT, V10, P79, DOI 10.1016/j.micinf.2007.10.008; Inoue N, 1998, TROP MED INT HEALTH, V3, P408; Jackson AP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-261; JENNINGS FW, 1979, INT J PARASITOL, V9, P381, DOI 10.1016/0020-7519(79)90089-4; JENNINGS FW, 1993, T ROY SOC TROP MED H, V87, P224, DOI 10.1016/0035-9203(93)90502-H; Kanmogne GD, 1997, ACTA TROP, V63, P75, DOI 10.1016/S0001-706X(96)00600-6; Keita M, 1997, EXP PARASITOL, V85, P183, DOI 10.1006/expr.1996.4136; Kibona SN, 2006, TROP MED INT HEALTH, V11, P144, DOI 10.1111/j.1365-3156.2005.01545.x; LERAY D, 1977, ANN SOC BELG MED TR, V57, P369; Liang YJ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.016004; Loening AM, 2010, NAT METHODS, V7, P5, DOI 10.1038/nmeth0110-05; MacLean L, 2004, INFECT IMMUN, V72, P7040, DOI 10.1128/IAI.72.12.7040-7044.2004; MAGNUS E, 1978, ANN SOC BELG MED TR, V58, P169; Maina NWN, 2007, T ROY SOC TROP MED H, V101, P540, DOI 10.1016/j.trstmh.2006.11.008; Masocha W, 2012, VIRULENCE, V3, P202, DOI 10.4161/viru.19178; McCulloch Richard, 2004, Methods Mol Biol, V262, P53; McLatchie AP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002571; Mekata H, 2013, PARASITOL RES, V112, P1513, DOI 10.1007/s00436-013-3297-3; Miloud T, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2800386; MOLYNEUX DH, 1973, ANN TROP MED PARASIT, V67, P391, DOI 10.1080/00034983.1973.11686905; Morrison LJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000557; Mulenga C, 2001, NEUROPATH APPL NEURO, V27, P77, DOI 10.1046/j.0305-1846.2001.00306.x; Mulumba P M, 1983, Contrib Microbiol Immunol, V7, P120; Myburgh E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002384; Ngoyi DM, 2010, J INFECT DIS, V201, P453, DOI 10.1086/649917; Otto-Duessel M, 2006, MOL IMAGING, V5, P57, DOI 10.2310/7290.2006.00006; Pichler A, 2004, P NATL ACAD SCI USA, V101, P1702, DOI 10.1073/pnas.0304326101; Poltera A A, 1983, Contrib Microbiol Immunol, V7, P155; POLTERA AA, 1980, CLIN EXP IMMUNOL, V40, P496; POLTERA AA, 1985, BRIT MED BULL, V41, P169, DOI 10.1093/oxfordjournals.bmb.a072045; Pyana PP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001025; Raz B, 1997, ACTA TROP, V68, P139, DOI 10.1016/S0001-706X(97)00079-X; RICKMAN LR, 1974, E AFR MED J, V51, P467; SCHULTZBERG M, 1988, J NEUROSCI RES, V21, P56, DOI 10.1002/jnr.490210109; Simarro PP, 2012, J TRAVEL MED, V19, P135, DOI 10.1111/j.1708-8305.2011.00596.x; Smith DH, 1997, ANN TROP MED PARASIT, V91, P851, DOI 10.1080/00034983.1997.11813211; SOMMER JM, 1992, MOL BIOL CELL, V3, P749; Song HT, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-88; Urech K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001358; Van Reet N, 2011, EXP PARASITOL, V128, P285, DOI 10.1016/j.exppara.2011.02.018; Van Reet N, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-207; VANMARCK EAE, 1981, Z PARASITENKD, V64, P187; VANMARCK EAE, 1981, ANN SOC BELG MED TR, V61, P57; VANMEIRVENNE N, 1977, ANN SOC BELG MED TR, V57, P409; WERY M, 1977, ANN SOC BELG MED TR, V57, P425; WHO, 2013, WHO TECH REP SER, V984, P1; WOOD KV, 1989, J BIOLUM CHEMILUM, V4, P289, DOI 10.1002/bio.1170040141; Xong HV, 1998, CELL, V95, P839; ZWEYGARTH E, 1990, TROP MED PARASITOL, V41, P56	78	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	AUG	2014	8	8							e3054	10.1371/journal.pntd.0003054				16	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AO8AN	WOS:000341574700028	25144573	DOAJ Gold, Green Published			2019-04-02	
J	Grietens, KP; Ribera, JM; Erhart, A; Hoibak, S; Ravinetto, RM; Gryseels, C; Dierickx, S; O'Neill, S; Muela, SH; D'Alessandro, U				Grietens, Koen Peeters; Ribera, Joan Muela; Erhart, Annette; Hoibak, Sarah; Ravinetto, Raffaella M.; Gryseels, Charlotte; Dierickx, Susan; O'Neill, Sarah; Muela, Susanna Hausmann; D'Alessandro, Umberto			Doctors and Vampires in Sub-Saharan Africa: Ethical Challenges in Clinical Trial Research	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							MEDICAL-RESEARCH; BLOOD; GAMBIA	Collecting blood samples from individuals recruited into clinical research projects in sub-Saharan Africa can be challenging. Strikingly, one of the reasons for participant reticence is the occurrence of local rumors surrounding "blood stealing" or "blood selling." Such fears can potentially have dire effects on the success of research projects for example, high dropout rates that would invalidate the trial's results and have ethical implications related to cultural sensitivity and informed consent. Though commonly considered as a manifestation of the local population's ignorance, these rumors represent a social diagnosis and a logical attempt to make sense of sickness and health. Born from historical antecedents, they reflect implicit contemporary structural inequalities and the social distance between communities and public health institutions. We aim at illustrating the underlying logic governing patients' fear and argue that the management of these beliefs should become an intrinsic component of clinical research.	[Grietens, Koen Peeters; Gryseels, Charlotte; Dierickx, Susan; O'Neill, Sarah] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; Nagasaki Univ, Sch Int Hlth Dev, Nagasaki, Japan; Partners Appl Social Sci PASS Int, Tessenderlo, Belgium; Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Hoibak, Sarah] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Ravinetto, Raffaella M.] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Louvain, Belgium; MRC, Fajara, Gambia; London Sch Hyg & Trop Med, London WC1, England; [Ribera, Joan Muela; Muela, Susanna Hausmann] PASS Int, Tessenderlo, Belgium; [Erhart, Annette] Inst Trop Med, Antwerp, Inciralt, Belgium; [D'Alessandro, Umberto] MRC Unit, Fajara, Gambia	Grietens, KP (reprint author), Nationalestr 155, B-2000 Antwerp, Belgium.	kpeeters@itg.be; joan.muela@yahoo.com; aerhart@itg.be; Hoibak@theglobalfund.org; rravinetto@itg.be; cgryseels@itg.be; sdierickx@itg.be; soneill@itg.be; Susanna.hausmann_muela@yahoo.es; udalessandro@mrc.gm	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009; Gryseels, Charlotte/0000-0002-8963-4469; Peeters Grietens, Koen/0000-0001-6570-9887			Barnard A, 2002, ENCY SOCIAL CULTURAL, P562; Bastian M. L., 2001, MAGICAL INTERPRETATI, P71; Bildhauer B., 2013, JRAI SPECIAL ISSU SS, V19; Carsten J, 2013, JRAI SPECIAL ISSU SS, V19; Chapman RR, 2006, MED ANTHROPOL Q, V20, P487, DOI 10.1525/maq.2006.20.4.487; CIOMS, 2002, INT ETH GUID BIOM RE; Comaroff J., 1993, MODERNITY ITS MALCON; Dugger CW, 2006, RUMOR FEAR FATIGUE H; Erwin K, 2006, MED ANTHROPOL Q, V20, P139, DOI 10.1525/maq.2006.20.2.139; Fairhead J, 2006, SOC SCI MED, V63, P1109, DOI 10.1016/j.socscimed.2006.02.018; Feldman-Savelsberg P, 2000, MED ANTHROPOL Q, V14, P159, DOI 10.1525/maq.2000.14.2.159; FELDMANSAVELSBE.P, 1999, PLUNDERED KITCHENS E; Gardinier DE, 2000, J CONT AFRICAN STUDI, V18, P225; Geissler PW, 2006, TROP MED INT HEALTH, V11, P975, DOI 10.1111/j.1365-3156.2006.01682.x; Geissler PW, 2008, SOC SCI MED, V67, P696, DOI 10.1016/.j.socscimed.2008.02.004; Geissler PW, 2005, AFRICA, V75, P173, DOI 10.3366/afr.2005.75.2.173; Geschiere P., 1997, MODERNITY WITCHCRAFT; Geschiere P, 1988, CRITIQUE ANTHR, V8, P35; Grietens KP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036954; Hardon A., 2004, ENCY MED ANTHR HLTH, P262; Kaler A, 2004, STUD FAMILY PLANN, V35, P105, DOI 10.1111/j.1728-4465.2004.00012.x; Kaler A, 2009, SOC SCI MED, V68, P1711, DOI 10.1016/j.socscimed.2009.01.038; Kessel M, 2013, SCIENTIST; Kuriyama S, 1999, EXPRESSIVENESS BODY; Mayblin M., 2013, JRAI SPECIAL ISSU SS, V19; Moore H., 2002, MAGICAL INTERPRETATI; Ngolet F., 2000, AFR STUD REV, V43, P55; Niehaus I, 2005, J ROY ANTHROPOL INST, V11, P191, DOI 10.1111/j.1467-9655.2005.00232.x; Nuffield Council on Bioethics, 2002, ETH RES REL HEALTHC; Nyamnjoh F, 2001, MAGICAL INTERPRETATI, P28; Report B, 1979, ETHICAL PRINCIPLES G; Sanders T., 2001, MAGICAL INTERPRETATI, P160; Scheper-Hughes N., 1996, ANTHR TODAY, V12, P3, DOI DOI 10.2307/2783143; Shaw R, 2001, MAGICAL INTERPRETATI, P50; Soiron M, 2006, CAHIERS ETUDES AFRIC; TDR-Special Programme for Research and Training in Tropical Diseases/World Health Organization, 2007, TDRSDRSEBST072; Tonda J, 2006, CAHIERS GABONAIS DAR, V17, P1982; Tonda J, 2011, SOC COMPASS, V58, P42, DOI 10.1177/0037768610392731; WEISS B, 1998, BODIES PERSONS COMP, P172, DOI [DOI 10.1017/CBO9780511802782.008, 10.1017/CBO9780511802782.008]; White L, 1995, AM HIST REV, V100, P1379, DOI 10.2307/2169863; White L, 1993, REPRESENTATIONS, V43, P27; White Luise, 2000, SPEAKING VAMPIRES RU; White Owen, 2005, FRENCH HIST, V19, P91	43	20	20	0	10	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	AUG	2014	91	2					213	215		10.4269/ajtmh.13-0630				3	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	AM4ZD	WOS:000339863800002	24821846	Green Published, Other Gold			2019-04-02	
J	Bemelmans, M; Baert, S; Goemaere, E; Wilkinson, L; Vandendyck, M; van Cutsem, G; Silva, C; Perry, S; Szumilin, E; Gerstenhaber, R; Kalenga, L; Biot, M; Ford, N				Bemelmans, Marielle; Baert, Saar; Goemaere, Eric; Wilkinson, Lynne; Vandendyck, Martin; van Cutsem, Gilles; Silva, Carlota; Perry, Sharon; Szumilin, Elisabeth; Gerstenhaber, Rodd; Kalenga, Lucien; Biot, Marc; Ford, Nathan			Community-supported models of care for people on HIV treatment in sub-Saharan Africa	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						HIV/AIDS; antiretroviral therapy; community health services; retention in care	ANTIRETROVIRAL THERAPY PROGRAMS; HEALTH WORKERS; HIV/AIDS CARE; SOUTH-AFRICA; RETENTION; ADHERENCE; OUTCOMES; PATIENT; MOZAMBIQUE; ATTRITION	OBJECTIVES Further scale-up of antiretroviral therapy (ART) to those in need while supporting the growing patient cohort on ART requires continuous adaptation of healthcare delivery models. We describe several approaches to manage stable patients on ART developed by Medecins Sans Frontieres together with Ministries of Health in four countries in sub-Saharan Africa. METHODS Using routine programme data, four approaches to simplify ART delivery for stable patients on ART were assessed from a patient and health system perspective: appointment spacing for clinical and drug refill visits in Malawi, peer educator-led ART refill groups in South Africa, community ART distribution points in DRC and patient-led community ART groups in Mozambique. RESULTS All four approaches lightened the burden for both patients (reduced travel and lost income) and health system (reduced clinic attendance). Retention in care is high: 94% at 36 months in Malawi, 89% at 12 months in DRC, 97% at 40 months in South Africa and 92% at 48 months in Mozambique. Where evaluable, service provider costs are reported to be lower. CONCLUSION Separating ART delivery from clinical assessments was found to benefit patients and programmes in a range of settings. The success of community ART models depends on sufficient and reliable support and resources, including a flexible and reliable drug supply, access to quality clinical management, a reliable monitoring system and a supported lay workers cadre. Such models require ongoing evaluation and further adaptation to be able to reach out to more patients, including specific groups who may be challenged to meet the demands of frequent clinic visits and the integrated delivery of other essential chronic disease interventions.	[Bemelmans, Marielle; Wilkinson, Lynne; Vandendyck, Martin; van Cutsem, Gilles; Gerstenhaber, Rodd; Kalenga, Lucien; Biot, Marc] Medecins Sans Frontieres, Operat Ctr Brussels, B-1090 Brussels, Belgium; [Baert, Saar; Goemaere, Eric] Medecins Sans Frontieres, Southern Africa Med Unit, Cape Town, South Africa; [Goemaere, Eric] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Silva, Carlota] Medecins Sans Frontieres, Operat Ctr Geneva, Geneva, Switzerland; [Perry, Sharon; Szumilin, Elisabeth] Medecins Sans Frontieres, Operat Ctr Paris, Paris, France; [Ford, Nathan] WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland	Bemelmans, M (reprint author), Medecins Sans Frontieres, Operat Ctr Brussels, Anal & Advocacy Unit, Rue Dupre 94, B-1090 Brussels, Belgium.	mariellebemelmans@hotmail.com					Baert S, 2013, INT C AIDS STIS AFR; Bango F, 2013, INT C AIDS STIS AFR; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Bemelmans M, 2010, TROP MED INT HEALTH, V15, P1413, DOI 10.1111/j.1365-3156.2010.02649.x; Billaud A, 2013, INT C AIDS STIS AFR; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; CCM DRC, 2013, DRC CONC NOT SUBM AP; Chanda P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-158; CIVICUS, 2013, STAT CIV SOC CREAT E; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Decroo T, 2012, 19 INT AIDS C 22 27; Decroo T, 2014, TROP MED INT HEALTH, V19, P514, DOI 10.1111/tmi.12278; Decroo T, 2013, INT HEALTH, V5, P169, DOI 10.1093/inthealth/iht016; Decroo T, 2011, JAIDS-J ACQ IMM DEF, V56, pE39, DOI 10.1097/QAI.0b013e3182055138; Decroo T, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-6; Fatti G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012888; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; Jouquet G, 2011, EC EVALUATION UNPUB; Kalenga L, 2013, ANN AFRICAN MED S, V6, P22; Koole O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040971; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Kredo T, 2013, COCHRANE DB SYST REV, V6, DOI [10.1002/14651858.CD009987.pub2, DOI 10.102/14651858.CD009987]; Ledikwe JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061601; Loando A, 2009, THESIS I TROPICAL ME; Luque-Fernandez MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056088; McGuire M, 2011, 6 INT AIDS SOC C HIV; Meintjes G, 2012, S AFR J HIV MED, DOI 10.7196/SAJHIVMED.862; Mills EJ, 2006, PLOS MED, V3, P438, DOI DOI 10.1371/J0URNAL.PMED.0030; Ministry of Health Mozambique, 2009, REL RET TARV AN RET; Monitoring Essential Medicines Consortium: MSF TAC RUDASA Section 27 Rural Health Advocacy Project, 2013, STOCK OUTS S AFR NAT; Mwai GW, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18586; Nakiwogga-Muwanga A, 2014, INT J STD AIDS, V25, P105, DOI 10.1177/0956462413492715; Okoboi S, 2014, C RETR OPP INF 3 6 M; PNMLS, 2013, PLAN STRAT IN PRESS; Ramjan R, 2014, TROP MED INT HEALTH, V19, P501, DOI 10.1111/tmi.12297; Rasschaert F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091544; Roura M, 2009, AIDS PATIENT CARE ST, V23, P203, DOI 10.1089/apc.2008.0129; Rueda S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001442.pub2; Selke HM, 2010, JAIDS-J ACQ IMM DEF, V55, P483, DOI 10.1097/QAI.0b013e3181eb5edb; UNAIDS, 2013, GLOB REP UNAIDS REP; Wandeler G, 2012, J ACQ IMMUN DEF SYND, V59, P9; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011; Wilkinson LS, 2013, S AFR J HIV MED, V14, P48, DOI [10.7196/SAJHIVMED.924, 10.7196/sajhivmed.924]; Wools-Kaloustian KK, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-22; World Health Organisation, 2014, 2013 CONS GUID US S; World Health Organization, 2013, CONS GUID GEN HIV CA; World Health Organization, 2006, WORLD HLTH REP 2006	48	75	75	1	17	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	AUG	2014	19	8					968	977		10.1111/tmi.12332				10	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	AL2DR	WOS:000338936600008	24889337	Bronze, Green Published	Y	N	2019-04-02	
J	Samadoulougou, S; Maheu-Giroux, M; Kirakoya-Samadoulougou, F; De Keukeleire, M; Castro, MC; Robert, A				Samadoulougou, Sekou; Maheu-Giroux, Mathieu; Kirakoya-Samadoulougou, Fati; De Keukeleire, Mathilde; Castro, Marcia C.; Robert, Annie			Multilevel and geo-statistical modeling of malaria risk in children of Burkina Faso	PARASITES & VECTORS			English	Article						Burkina Faso; Plasmodium falciparum; Geo-statistics; Random effect models; Bayesian variable selection; Malaria burden; Integrated Nested Laplace Approximation	VARIABLE SELECTION; TRANSMISSION; INFECTION; ENDEMICITY; DIAGNOSIS; PATTERNS; AFRICA	Background: Previous research on determinants of malaria in Burkina Faso has largely focused on individual risk factors. Malaria risk, however, is also shaped by community, health system, and climatic/environmental characteristics. The aims of this study were: i) to identify such individual, household, community, and climatic/environmental risk factors for malaria in children under five years of age, and ii) to produce a parasitaemia risk map of Burkina Faso. Methods: The 2010 Demographic and Health Survey (DHS) was the first in Burkina Faso that tested children for malaria parasitaemia. Multilevel and geo-statistical models were used to explore determinants of malaria using this nationally representative database. Results: Parasitaemia was collected from 6,102 children, of which 66.0% (95% confidence interval (CI): 64.0-68.0%) were positive for Plasmodium spp. Older children (>23 months) were more likely to be parasitaemic than younger ones, while children from wealthier households and whose mother had higher education were at a lower risk. At the community level, living in a district with a rate of attendance to health facilities lower than 2 visits per year was significantly associated with greater odds of being infected. Malaria prevalence was also associated with higher normalized difference vegetation index, lower average monthly rainfall, and lower population densities. Predicted malaria parasitaemia was spatially variable with locations falling within an 11%-92% prevalence range. The number of parasitaemic children was nonetheless concentrated in areas of high population density, albeit malaria risk was notably higher in the sparsely populated rural areas. Conclusion: Malaria prevalence in Burkina Faso is considerably higher than in neighbouring countries. Our spatially-explicit population-based estimates of malaria risk and infected number of children could be used by local decision-makers to identify priority areas where control efforts should be enhanced.	[Samadoulougou, Sekou; Kirakoya-Samadoulougou, Fati; De Keukeleire, Mathilde; Robert, Annie] Catholic Univ Louvain, Pole Epidemiol & Biostat EPID, Inst Rech Expt & Clin, Fac Sante Publ, B-1200 Brussels, Belgium; [Maheu-Giroux, Mathieu; Castro, Marcia C.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [De Keukeleire, Mathilde] Catholic Univ Louvain, Georges Lemaitre Ctr Earth & Climate Res, Earth & Life Inst, Louvain La Neuve, Belgium	Samadoulougou, S (reprint author), Catholic Univ Louvain, Pole Epidemiol & Biostat EPID, Inst Rech Expt & Clin, Fac Sante Publ, Clos Chapelle Aux Champs 30,Bte B1-30-13, B-1200 Brussels, Belgium.	sekou.samadoulougou@uclouvain.be		Maheu-Giroux, Mathieu/0000-0002-8363-4388; De Keukeleire, Mathilde/0000-0003-4730-6798	Epidemiology and Biostatistics division of the Institut de Recherche Experimentale et Clinique (IREC); Canadian Institutes of Health Research; International Fulbright Science & Technology Award - Bureau of Educational and Cultural Affairs of the U.S. Department of State	SS is supported by a grant from Epidemiology and Biostatistics division of the Institut de Recherche Experimentale et Clinique (IREC). MMG's work is supported by a Doctoral Foreign Study Award from the Canadian Institutes of Health Research and by an 'International Fulbright Science & Technology Award' sponsored by the Bureau of Educational and Cultural Affairs of the U.S. Department of State.	[Anonymous], 2007, PLOS MED, DOI DOI 10.1371/JOURNAL.PMED.1000048; Beguin J, 2012, METHODS ECOL EVOL, V3, P921, DOI 10.1111/j.2041-210X.2012.00211.x; Bisoffi Z, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-192; Brooker S, 2002, TRENDS PARASITOL, V18, P70, DOI 10.1016/S1471-4922(01)02223-1; Burkina Faso Ministry of Health, 2011, ANN STAT; Chammartin F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-152; Cohen JM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-61; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Dellaportas P, 2002, STAT COMPUT, V12, P27, DOI 10.1023/A:1013164120801; Diarra A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-103; Direction de la Meteorologie du Burkina, 2013, PUBL DIR MET BURK FA; Edith IS, 2010, J MED ENTOMOL, V47, P618; Engle PL, 1999, WORLD DEV, V27, P1309, DOI 10.1016/S0305-750X(99)00059-5; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gemperli A, 2004, AM J EPIDEMIOL, V159, P64, DOI 10.1093/aje/kwh001; Giardina F, 2012, PLOS ONE, V7; Gosoniu L, 2009, COMPUT STAT DATA AN, V53, P3358, DOI 10.1016/j.csda.2009.02.022; Gosoniu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009322; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Ilboudo-Sanogo E, 2013, MALAR CHEMOTHER CONT, V2; Ishwaran H, 2005, ANN STAT, V33, P730, DOI 10.1214/009053604000001147; Lai YS, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-359; Macro International, 2013, 7 DHS; MCHIP/USAID/PNLP, 2013, RAPP MIS OEUVR PROGR; Mmbando BP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-145; Nebie I, 2008, TROP MED INT HEALTH, V13, P229, DOI 10.1111/j.1365-3156.2007.01994.x; Omumbo JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053198; Paaijmans KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001146; Raso G, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-160; Rue H, 2013, INLA FUNCTIONS ALLOW; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Samuel WN, 2012, THESIS; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Spiegelhalter DJ, 2002, J ROY STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stensgaard AS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-298; The malaria Atlas project, SPAT DISTR PLASM FAL; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2011, WORLD MALARIA REPORT 2011, P1; World Health Organization, VECT CONTR INS RES; Ye Y, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-101	40	8	8	1	9	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	JUL 29	2014	7								350	10.1186/1756-3305-7-350				13	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	AO5PG	WOS:000341396600001	25074132	DOAJ Gold, Green Published			2019-04-02	
J	Miura, K; Jongert, E; Deng, BB; Zhou, LW; Lusingu, JP; Drakeley, CJ; Fay, MP; Long, CA; Vekemans, J				Miura, Kazutoyo; Jongert, Erik; Deng, Bingbing; Zhou, Luwen; Lusingu, John P.; Drakeley, Chris J.; Fay, Michael P.; Long, Carole A.; Vekemans, Johan			Effect of ingested human antibodies induced by RTS, S/AS01 malaria vaccination in children on Plasmodium falciparum oocyst formation and sporogony in mosquitoes	MALARIA JOURNAL			English	Article						RTS; S/AS01; Oocyst formation; Sporogony; Standard membrane feeding assay	MEMBRANE FEEDING ASSAY; CIRCUMSPOROZOITE PROTEIN; ANOPHELES-STEPHENSI; TRANSMISSION; GAMBIAE; LOCALIZATION; SPOROZOITES; RTS,S/AS01E; PARASITES; EFFICACY	Background: The circumsporozoite protein (CS protein) on the malaria parasites in mosquitoes plays an important role in sporogony in mosquitoes. The RTS, S/AS01 malaria vaccine candidate, which has shown significant efficacy against clinical malaria in a large Phase 3 trial, targets the Plasmodium falciparum CS protein, but the ability of serum from vaccinated individuals to inhibit sporogony in mosquitoes has not been evaluated. Methods: Previously a double-blind, randomized trial of RTS, S/AS01 vaccine, as compared with rabies vaccine, in five-to 17-month old children in Tanzania was conducted. In this study, polyclonal human antibodies were purified from the pools of sera taken one month after the third vaccination. IgGs were purified from four pools of sera from 25 RTS, S/AS01 vaccinated children each, and two pools of sera from 25 children vaccinated with rabies vaccine each. The ability of antibodies to inhibit P. falciparum oocyst formation and/or sporogony in the mosquito host was evaluated by a standard membrane-feeding assay. The test antibodies were fed on day 0 (at the same time as the gametocyte feed), or on days 3 or 6 (serial-feed experiments). The oocyst and sporozoite counts were performed on days 8 and 16, respectively. In addition, two human anti-CS monoclonal antibodies (mAb) and a control mAb were also evaluated. Results: Polyclonal anti-CS IgG preparations from RTS, S-vaccinated children tested at concentrations of 149-210 ELISA units (EU)/ml did not show significant inhibition in oocyst and sporozoite formation when the antibodies were fed with gametocytes at the same time, or later (serial-feed experiments). Similarly, anti-CS mAbs tested at 6,421 or 7,122 EU/ml did not show reduction in oocyst and sporozoite formation. Conclusions: This study does not support the concept that anti-CS antibodies induced by the RTS, S/AS01 vaccines in humans noticeably reduce malaria transmission by blocking P. falciparum sporozoite development or salivary gland invasion in mosquitoes when taken up during feeding.	[Miura, Kazutoyo; Deng, Bingbing; Zhou, Luwen; Long, Carole A.] NIAID, NIH, Lab Malaria & Vector Res, Rockville, MD 20852 USA; [Jongert, Erik; Vekemans, Johan] GlaxoSmithKline Vaccines, Wavre, Belgium; [Lusingu, John P.] Natl Inst Med Res, Tanga Ctr, Tanga, Tanzania; [Lusingu, John P.] Univ Copenhagen, Ctr Med Parasitol, Dept Med Microbiol & Immunol, Copenhagen, Denmark; [Drakeley, Chris J.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Fay, Michael P.] NIAID, NIH, Biostat Res Branch, Rockville, MD 20852 USA	Miura, K (reprint author), NIAID, NIH, Lab Malaria & Vector Res, 12735 Twinbrook Pkwy, Rockville, MD 20852 USA.	kmiura@niaid.nih.gov		Fay, Michael P./0000-0002-8643-9625	PATH Malaria Vaccine Initiative; Intramural Research Program of the National Institute of Allergy and Infectious Diseases, NIH	We are very grateful to the children who participated in the Phase 2 study. We thank Andre Laughinghouse, Kevin Lee, Tovi Lehmann and Robert Gwadz for insectary support, and Ababacar Diouf and Samuel Moretz for helping with the data acquisition. Lorenz von Seidlein was a lead investigator of the Phase 2 study and led the field clinical work. This study was supported in part by the PATH Malaria Vaccine Initiative and also by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, NIH.	AIKAWA M, 1990, B WORLD HEALTH ORGAN, V68, P165; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; BEIER JC, 1989, J MED ENTOMOL, V26, P547, DOI 10.1093/jmedent/26.6.547; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Brennan JDG, 2000, P NATL ACAD SCI USA, V97, P13859, DOI 10.1073/pnas.250472597; Brooks A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032587; Churcher TS, 2012, INT J PARASITOL, V42, P1037, DOI 10.1016/j.ijpara.2012.09.002; Clement F, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-384; Coppi A, 2011, J EXP MED, V208, P341, DOI 10.1084/jem.20101488; DAVIS JR, 1993, AM J TROP MED HYG, V49, P174, DOI 10.4269/ajtmh.1993.49.174; DELARA CM, 2000, AM J TROP MED HYG, V62, P427; Dinglasan RR, 2007, P NATL ACAD SCI USA, V104, P13461, DOI 10.1073/pnas.0702239104; DOROSARIO VE, 1989, T ROY SOC TROP MED H, V83, P305, DOI 10.1016/0035-9203(89)90481-1; Fang WG, 2011, SCIENCE, V331, P1074, DOI 10.1126/science.1199115; Kappe SHI, 2003, TRENDS PARASITOL, V19, P135, DOI 10.1016/S1471-4922(03)00007-2; Lavazec C, 2007, INFECT IMMUN, V75, P1635, DOI 10.1128/IAI.00864-06; Lell B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007611; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Miura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057909; Myung JM, 2004, MOL BIOCHEM PARASIT, V133, P53, DOI 10.1016/j.molbiopara.2003.09.002; NAGASAWA H, 1987, INFECT IMMUN, V55, P2928; Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564; PONNUDURAI T, 1989, T ROY SOC TROP MED H, V83, P67, DOI 10.1016/0035-9203(89)90708-6; POSTHUMA G, 1988, EUR J CELL BIOL, V46, P18; Raz A, 2013, INFECT IMMUN, V81, P2206, DOI 10.1128/IAI.01331-12; Targett GA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S10; Van Der Kolk M, 2005, PARASITOLOGY, V130, P13, DOI 10.1017/S0031182004006067; VAUGHAN JA, 1988, EXP PARASITOL, V66, P171, DOI 10.1016/0014-4894(88)90088-4; VAUGHAN JA, 1992, J PARASITOL, V78, P716, DOI 10.2307/3283550; Viechtbauer W, 2010, J STAT SOFTW, V36, P1; Wang JL, 2013, J INFECT DIS, V208, P1161, DOI 10.1093/infdis/jit284	31	3	3	0	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	JUL 9	2014	13								263	10.1186/1475-2875-13-263				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AL4RJ	WOS:000339120000001	25007730	DOAJ Gold, Green Published			2019-04-02	
J	Van Roey, K; Sovannaroth, S; Sochantha, T; Touch, MS; Pigeon, O; Sluydts, V; Durnez, L; Coosemans, M				Van Roey, Karel; Sovannaroth, Siv; Sochantha, Tho; Touch, Mao Srey; Pigeon, Olivier; Sluydts, Vincent; Durnez, Lies; Coosemans, Marc			A phase III trial to evaluate the efficacy, fabric integrity and community acceptance of Netprotect (R) using a recommended long-lasting insecticidal net as positive control	MALARIA JOURNAL			English	Article								Background: The evaluation of new long-lasting insecticidal bed nets (LLINs) is coordinated by the WHO Pesticide Evaluation Scheme (WHOPES). In 2007, Netprotect (R) was granted WHOPES interim recommendation after Phase I and II evaluations. Present study evaluates Netprotect (R) in a Phase III trial in rural Cambodia. Methods: A randomized, prospective longitudinal study design was used to assess the performance of Netprotect (R) over a period of three years, using conventionally-treated nets and a WHOPES recommended LLIN (PermaNet (R) 2.0) as positive controls. The primary outcomes were the physical integrity, insecticide content and cone bioassay performance using. Results: The baseline deltamethrin concentration of 43% of Netprotect (R) nets were below the tolerance limit while 27% of PermaNet (R) 2.0 nets were above the target dose limits. By 36 months Netprotect (R) retained 35% while PermaNet (R) 2.0 retained 49% of baseline insecticide dose. Moreover the proportion of the inactive deltamethrin R-alpha isomer in the Netprotect (R) nets was 33% at the baseline and increased to 69% after three years while it was low and almost constant for PermaNet (R) 2.0 (3-7%). Only 71% of Netprotect (R) met the WHO criteria for bio-efficacy after three years while at least 80% is required. Moreover Netprotect (R) nets failed for the WHOPES criteria after 12 and 24 months. The reference LLIN met the WHOPES criteria throughout the study. Over the entire three years the reference LLIN did obtain significant higher mosquito mortality than Netprotect r. The physical integrity was based on the proportionate hole index and after three years, 25% of Netprotect (R) and 30% of PermaNet (R) 2.0 were in a mediocre or poor state. Conclusion: Netprotect (R) did not meet the minimum WHO criteria for bio-efficacy after 12, 24 and 36 months. The use of a reference LLIN as positive control was helpful for data interpretation. However, for future three-year studies, it is essential that before initiating any study nets should be checked for their specifications and this for both the candidate LLIN as well as for the reference LLIN. Moreover, to improve the accuracy of the success rate of the candidate LLIN more nets should be tested for their bio-efficacy at the end of the trial.	[Van Roey, Karel; Sluydts, Vincent; Durnez, Lies; Coosemans, Marc] Inst Trop Med Antwerp, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Sovannaroth, Siv; Sochantha, Tho; Touch, Mao Srey] Natl Ctr Malaria Control Parasitol & Entomol, Phnom Penh, Cambodia; [Pigeon, Olivier] Walloon Agr Res Ctr CRA W, Agr & Nat Environm Dept, Gembloux, Belgium; [Van Roey, Karel; Coosemans, Marc] Univ Antwerp, Fac Pharmaceut Vet & Biomed Sci, Dept Biomed Sci, B-2610 Antwerp, Belgium	Coosemans, M (reprint author), Inst Trop Med Antwerp, Dept Biomed Sci, Natl Str 155, B-2000 Antwerp, Belgium.	mcoosemans@itg.be			Belgian Co-operation; WHO Pesticide Evaluation Scheme	We would like to thank those in the study communities who participated to this study. The authors wish to thank the dedicated CNM entomology team and Dr M. Zaim and Dr R. Yadav of WHOPES for their advices. This study was conducted in the framework of the Institutional Collaboration between the National Centre for Malaria Control (CNM) Cambodia and the Institute of Tropical Medicine, Belgium, supported by the Belgian Co-operation (Directorate-General for Development Cooperation) and the WHO Pesticide Evaluation Scheme.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2009, REP 12 WHOPES WORK G; Batisso E, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-183; Collaborative International Pesticicides Analytical Council Limited (CIPAC), 2012, HDB N, P34; Kilian A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-49; Lengeler C, 2004, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000363.PUB2; Malaria Consortium and CNM, 2011, CAMB MAL SURV 2010; NIPH and Malaria Consortium, 2005, REP CAMB NAT MAL BAS; NIPH and Malaria Consortium, 2008, COMB MAL SURV 2007 R; R Core Team, 2013, R LANG ENV STAT COMP; Rosner B., 2010, FUNDAMENTALS BIOSTAT; Russell TL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-187; Van Bortel W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-102; WHO, 2002, INSTR TREATM US INS; WHO, 2013, EST FUNC SURV LONG L; WHO, 2013, GUID LAB FIELD LONG; WHO, 2012, REP 15 WHOPES WORK G; WHO, 2010, 333LN3 WHO; WHO, 2007, GLOB MAL PROGR INS T; WHO, 2011, GUID MON DUR LONG LA; WHO, 2009, REP 13 WHOPES WORK G; WHO, 2013, REP 16 WHOPES WORK G; WHO [World Health Organization], 2005, GUID LAB FIELD TEST; World Health Organization, 2008, REP 11 WHOPES WORK G; Zuur AF, 2012, ZERO INFLATED MODELS	26	5	5	1	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	JUL 7	2014	13								256	10.1186/1475-2875-13-256				11	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AL8AJ	WOS:000339358600001	24998677	DOAJ Gold, Green Published			2019-04-02	
J	Ducrotoy, MJ; Bertu, WJ; Ocholi, RA; Gusi, AM; Bryssinckx, W; Welburn, S; Moriyon, I				Ducrotoy, Marie J.; Bertu, Wilson J.; Ocholi, Reuben A.; Gusi, Amahyel M.; Bryssinckx, Ward; Welburn, Sue; Moriyon, Ignacio			Brucellosis as an Emerging Threat in Developing Economies: Lessons from Nigeria	PLOS NEGLECTED TROPICAL DISEASES			English	Review							ROSE-BENGAL TEST; BOVINE BRUCELLOSIS; SEROLOGICAL EVIDENCE; PLATEAU STATE; CATTLE HERDS; BORNO STATE; ABORTUS; SEROPREVALENCE; PREVALENCE; ANTIBODIES	Nigeria is the most populous country in Africa, has a large proportion of the world's poor livestock keepers, and is a hotspot for neglected zoonoses. A review of the 127 accessible publications on brucellosis in Nigeria reveals only scant and fragmented evidence on its spatial and temporal distribution in different epidemiological contexts. The few bacteriological studies conducted demonstrate the existence of Brucella abortus in cattle and sheep, but evidence for B. melitensis in small ruminants is dated and unclear. The bulk of the evidence consists of seroprevalence studies, but test standardization and validation are not always adequately described, and misinterpretations exist with regard to sensitivity and/or specificity and ability to identify the infecting Brucella species. Despite this, early studies suggest that although brucellosis was endemic in extensive nomadic systems, seroprevalence was low, and brucellosis was not perceived as a real burden; recent studies, however, may reflect a changing trend. Concerning human brucellosis, no studies have identified the Brucella species and most reports provide only serological evidence of contact with Brucella in the classical risk groups; some suggest brucellosis misdiagnoses as malaria or other febrile conditions. The investigation of a severe outbreak that occurred in the late 1970s describes the emergence of animal and human disease caused by the settling of previously nomadic populations during the Sahelian drought. There appears to be an increasing risk of reemergence of brucellosis in sub-Saharan Africa, as a result of the co-existence of pastoralist movements and the increase of intensive management resulting from growing urbanization and food demand. Highly contagious zoonoses like brucellosis pose a threat with far-reaching social and political consequences.	[Ducrotoy, Marie J.; Welburn, Sue] Univ Edinburgh, Coll Med & Vet Med, Sch Biomed Sci, Div Pathway Med, Edinburgh, Midlothian, Scotland; [Ducrotoy, Marie J.; Welburn, Sue] Univ Edinburgh, Sch Biomed Sci, Coll Med & Vet Med, Ctr Infect Dis, Edinburgh, Midlothian, Scotland; [Bertu, Wilson J.; Ocholi, Reuben A.; Gusi, Amahyel M.] Natl Inst Vet Res, Brucellosis Res Unit, Vom, Plateau State, Nigeria; [Bryssinckx, Ward] Avia GIS, Zoersel, Belgium; [Moriyon, Ignacio] Univ Navarra, Inst Salud Trop, E-31080 Pamplona, Spain; [Moriyon, Ignacio] Univ Navarra, Dept Microbiol & Parasitol, E-31080 Pamplona, Spain	Ducrotoy, MJ (reprint author), Univ Edinburgh, Coll Med & Vet Med, Sch Biomed Sci, Div Pathway Med, Chancellors Bldg, Edinburgh, Midlothian, Scotland.	imoriyon@unav.es	Moriyon, Ignacio/N-4764-2016	Moriyon, Ignacio/0000-0002-4288-0195; Welburn, Susan/0000-0002-9903-7086; Gusi, Amahyel/0000-0002-0600-5270	European Union's Seventh Framework Program [221948]; Fundacion para la Investigacion Medica Aplicada (FIMA); University of Navarra; Biotechnology and Biological Sciences Research Council [BB/H009213/1]	This research has received funding from the European Union's Seventh Framework Program (FP7/2007-2013) under grant agreement no 221948, ICONZ (Integrated control of Neglected Zoonoses). Additional funding from the "Fundacion para la Investigacion Medica Aplicada (FIMA)'' and from the University of Navarra is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JW, 1966, NATURE, V212, P217, DOI 10.1038/212217a0; Adamu NB, 2007, J CAMEL PRACT RES, V14, P135; Adamu NN, 1999, TROPICAL VET, V18, P45; ADESIYUN AA, 1986, J SMALL ANIM PRACT, V27, P31, DOI 10.1111/j.1748-5827.1986.tb02240.x; Ajogi I., 2001, Bulletin of Animal Health and Production in Africa, V49, P169; Ajogi I., 1998, Nigerian Veterinary Journal, V19, P86; Ajogi I., 1998, Nigerian Veterinary Journal, V19, P40; Ajogi I., 1996, Nigerian Veterinary Journal, V1, P73; Ajogi Ikwe, 1997, Tropical Veterinarian, V15, P21; ALAUSA KO, 1975, T ROY SOC TROP MED H, V69, P259, DOI 10.1016/0035-9203(75)90165-0; ALAUSA O, 1976, TROP GEOGR MED, V28, P54; ALAUSA OK, 1979, PUBLIC HEALTH, V93, P185, DOI 10.1016/S0033-3506(79)80124-9; ALAUSA OK, 1977, PUBLIC HEALTH, V91, P141, DOI 10.1016/S0033-3506(77)80018-8; ALAUSA OK, 1980, TROP GEOGR MED, V32, P12; Alton G.G., 1988, TECHNIQUES BRUCELLOS; ANENE BM, 1991, BRIT VET J, V147, P275; [Anonymous], 1958, ANN REPORT DEP VET S; Aregheore EM, 2009, COUNTRY PASTURE RESO; Ate IU, 2007, J ANIM VET ADV, V6, P867; Ate IU, 2007, J ANIM VET ADV, V6, P863; Baba M M, 2001, Cent Eur J Public Health, V9, P158; Bale J, 1982, Bull Anim Health Prod Afr, V30, P73; Bale J. O. O., 2003, Nigerian Journal of Animal Production, V30, P107; Bale JO, 1982, J ANIM PROD RES, V1, P53; BALE O O J, 1985, Journal of Animal Production Research, V5, P193; BALE OOJ, 1981, BRIT VET J, V137, P256; BANERJEE A K, 1970, Bulletin of Epizootic Diseases of Africa, V18, P333; Barrios S, 2006, J URBAN ECON, V60, P357, DOI 10.1016/j.jue.2006.04.005; Bertu WJ, 2010, AFR J MICROBIOL RES, V4, P1935; Bertu W. J., 2010, African Journal of Food Science, V4, P62; Bertu WJ, 2012, TROP ANIM HEALTH PRO, V44, P253, DOI 10.1007/s11250-011-0011-2; BLASCO JM, 1994, VET REC, V134, P415, DOI 10.1136/vr.134.16.415; Brisibe F, 1996, SMALL RUMINANT RES, V20, P83, DOI 10.1016/0921-4488(95)00770-9; Brisibe F, 1993, ISRN VET SCI, V11, P27, DOI DOI 10.1111/J.1865-1682.2010.01171.X; Cadmus SIB, 2011, J S AFR VET ASSOC, V82, P56; Cadmus SIB, 2010, J S AFR VET ASSOC, V81, P50; Cadmus SIB, 2008, J S AFR VET ASSOC, V79, P113; Cadmus S.I.B., 2006, AFR J BIOMED RES, V9, P163; Cadmus SIB, 2011, B ANIM HLTH PROF AFR, P58, DOI [10.4314/bahpa.v58i4.64236, DOI 10.4314/BAHPA.V58I4.64236]; Cadmus SIB, 2009, NIGERIAN VET J, V29, P43; Cadmus SIB, 2013, J S AFR VET ASSOC, V84, DOI 10.4102/jsava.v84i1.217; Cadmus Simeon I B, 2008, Vet Ital, V44, P557; Chukwu CC, 1987, ZARIYA VET, V2, P383; COLLARD P, 1962, West Afr Med J, V11, P3; COLLARD P, 1962, West Afr Med J, V11, P172; Dalrymple-Champneys W, 1960, PROGNOSIS BRUCELLA I, P151; DAVIES G, 1971, VET REC, V88, P447, DOI 10.1136/vr.88.17.447; Dean AS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001865; Diaz R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000950; Dieste-Perez L, 2014, VET MICROBIOL, V168, P161, DOI 10.1016/j.vetmic.2013.10.024; Egbe-Nwiyi T. N., 1999, Tropical Veterinarian, V17, P119; Ehizibolo D. O., 2011, African Journal of Biomedical Research, V14, P81; Elmes B. G. T., 1941, ANN TROP MED AND PARASITOL, V35, P1; Esuruoso G O, 1974, Bull Epizoot Dis Afr, V22, P35; Esuruoso G O, 1972, Bull Epizoot Dis Afr, V20, P269; ESURUOSO G O, 1980, Bulletin of Animal Health and Production in Africa, V28, P11; ESURUOSO GO, 1974, VET REC, V95, P54, DOI 10.1136/vr.95.3.54; Esuruoso GO, 1971, J AGR, V8, P147; EZE E N, 1978, Bulletin of Animal Health and Production in Africa, V26, P29; FALADE S, 1981, ZBL VET MED B, V28, P749; Falade S., 1980, Bulletin de l'Office International des Epizooties, V92, P111; Falade S, 1974, Bull Epizoot Dis Afr, V22, P335; Falade S., 1974, Journal of the Nigerian Veterinary Medical Association, V3, P21; FALADE S, 1981, ZBL VET MED B, V28, P205; Farouk UM, 2013, EUR J VET MED, V2, P29; Godfroid J, 2011, PREV VET MED, V102, P118, DOI 10.1016/j.prevetmed.2011.04.007; Greiner M, 2000, PREV VET MED, V45, P3, DOI 10.1016/S0167-5877(00)00114-8; Greiner M, 2009, PREV VET MED, V92, P373, DOI 10.1016/j.prevetmed.2009.07.014; Gugong VT, 2012, J ANIM VET ADV, V11, P418; Gusi AM, 2010, VOM J VET SCI, V7, P30; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; ILRI, 2012, MAPP POV ZOON HOTSP; Ishola O.O., 2000, B ANIMAL HLTH PRODUC, V48, P53; Iyayi E. A., 2003, Nigerian Journal of Animal Production, V30, P87; Jones BA, 2013, P NATL ACAD SCI USA, V110, P8399, DOI 10.1073/pnas.1208059110; Jones PG, 2009, ENVIRON SCI POLICY, V12, P427, DOI 10.1016/j.envsci.2008.08.006; Junaidu A. U., 2006, International Journal of Poultry Science, V5, P547; Junaidu A. U., 2011, Journal of Microbiology and Biotechnology Research, V1, P60; Junaidu A. U., 2008, Asian Journal of Epidemiology, V1, P24, DOI 10.3923/aje.2008.24.28; Junaidu AU, 2006, SAHEL J VET SCI, V5, P9; Junaidu AU, 2010, CURR RES J BIOL SCI, V2, P275; Kramer J W, 1967, Bull Epizoot Dis Afr, V15, P25; Kudi AC, 1997, J ARID ENVIRON, V37, P413, DOI 10.1006/jare.1997.0277; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; Levieux D, 1974, ANN RECH VET, V5, P343; LUCHSINGER DW, 1979, AM J VET RES, V40, P1307; Mai HM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-144; Majekodunmi AO, 2013, PARASITE VECTOR, V6, DOI [10.1186/1756-3305-6-239, 10.1186/1756-305-6-293, 10.1186/1756-3305-6-293]; Maurice N. A., 2013, Asian Pacific Journal of Tropical Disease, V3, P337, DOI 10.1016/S2222-1808(13)60081-X; Mbuk EU, 2011, NIGERIAN VET J, V1, P26; McDermott J, 2013, REV SCI TECH OIE, V32, P249; McDermott JJ, 2002, VET MICROBIOL, V90, P111, DOI 10.1016/S0378-1135(02)00249-3; Mohammed TA, 1990, STUDY PERIURBAN CATT; Ngbede E. O., 2013, Journal of Advanced Veterinary Research, V3, P57; Nuru S., 1975, Journal of the Nigerian Veterinary Medical Association, V4, P3; Nwanta JA, 2011, J SWINE HEALTH PROD, V19, P331; Ocholi R. A., 1993, Tropical Veterinarian, V11, P15; Ocholi RA, 2005, REV SCI TECH OIE, V24, P973, DOI 10.20506/rst.24.3.1627; Ocholi RA, 2004, VET REC, V155, P566, DOI 10.1136/vr.155.18.566; Ocholi RA, 1996, VET QUART, V18, P22; Ocholi RA, 2004, VET MICROBIOL, V103, P47, DOI 10.1016/j.vetmic.2004.06.012; Ofukwu AR, 2007, BRUCELLA INFECT HOSP; Ogundipe GAT, 1994, TROP VET, V12, P158; Okewole P. A., 1988, Bulletin of Animal Health and Production in Africa, V36, P251; OKOH AEJ, 1979, TROP ANIM HEALTH PRO, V11, P213, DOI 10.1007/BF02237805; OKOH AEJ, 1980, TROP ANIM HEALTH PRO, V12, P11, DOI 10.1007/BF02242624; Onoja II, 2011, B ANIM HLTH PROF AFR, P7, DOI [10.4314/sokjvs.v7i2, DOI 10.4314/SOKJVS.V7I2]; Onunkwo JI, 2009, ANIM SCI REPORTER, V3, P123; Osinubi M, 2005, NIGERIAN VET J, V25, P35, DOI [10.4314/nvj.v25i1.3464, DOI 10.4314/NVJ.V25I1.3464]; Osoba AO, 1977, GHANA MED J, V16, P251; OYEJIDE A, 1987, VET QUART, V9, P83, DOI 10.1080/01652176.1987.9694080; PULLAN NB, 1980, TROP ANIM HEALTH PRO, V12, P77, DOI 10.1007/BF02242612; Racloz V, 2013, REV SCI TECH OIE, V32, P61; Rementsova MM, 1985, BRUCELLOSIS WILD ANI; RIKIN EU, 1988, ACTA VET SCAND, P94; Sadiq M. A., 2013, Sokoto Journal of Veterinary Sciences, V11, P7; Sadiq MA, 2010, J CAMEL PRACT RES, V17, P229; Sanogo M, 2013, VET MICROBIOL, V164, P202, DOI 10.1016/j.vetmic.2013.02.009; Seimenis Aristarco, 2006, Ann Ist Super Sanita, V42, P437; Shehu LM, 1999, NIGERIAN VET J, V20, P64; SIXL W, 1987, Journal of Hygiene Epidemiology Microbiology and Immunology (Prague), V31, P493; Soulsby L, 2011, HDB ZOONOSES, P54; Sprague LD, 2012, PATHOG GLOB HEALTH, V106, P144, DOI 10.1179/2047773212Y.0000000020; Stewart R, 2010, DESERTIFICATION SAHE; Suleiman H, 1988, P NAT C PAST NIG; Tijjani AO, 2009, SAHEL J VET SCI, V8, P55; Useh M F, 1996, Cent Afr J Med, V42, P184; Waters-Bayer A, 1994, CAH ETUD AFR, V34, P213, DOI [10.3406/cea.1994.2048, DOI 10.3406/CEA.1994.2048]; Zaria LT, 1990, ZARIYA VET, V5, P64	129	45	48	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUL	2014	8	7							e3008	10.1371/journal.pntd.0003008				18	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AN4IQ	WOS:000340551500053	25058178	DOAJ Gold, Green Published			2019-04-02	
J	Roge, S; Van Nieuwenhove, L; Meul, M; Heykers, A; de Koning, AB; Bebronne, N; Guisez, Y; Buscher, P				Roge, Stijn; Van Nieuwenhove, Liesbeth; Meul, Magali; Heykers, Annick; de Koning, Annette Brouwer; Bebronne, Nicolas; Guisez, Yves; Buscher, Philippe			Recombinant Antigens Expressed in Pichia pastoris for the Diagnosis of Sleeping Sickness Caused by Trypanosoma brucei gambiense	PLOS NEGLECTED TROPICAL DISEASES			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; OPERATING CHARACTERISTIC CURVES; CEREBROSPINAL-FLUID; SEROLOGICAL DIAGNOSIS; SURFACE GLYCOPROTEIN; AGGLUTINATION-TEST; ANIMAL RESERVOIR; FOLLOW-UP; ANTIBODIES; POPULATION	Background: Screening tests for gambiense sleeping sickness, such as the CATT/T. b. gambiense and a recently developed lateral flow tests, are hitherto based on native variant surface glycoproteins (VSGs), namely LiTat 1.3 and LiTat 1.5, purified from highly virulent trypanosome strains grown in rodents. Methodology/Principal Findings: We have expressed SUMO (small ubiquitin-like modifier) fusion proteins of the immunogenic N-terminal part of these antigens in the yeast Pichia pastoris. The secreted recombinant proteins were affinity purified with yields up to 10 mg per liter cell culture. Conclusions/Significance: The diagnostic potential of each separate antigen and a mixture of both antigens was confirmed in ELISA on sera from 88 HAT patients and 74 endemic non-HAT controls. Replacement of native antigens in the screening tests for sleeping sickness by recombinant proteins will eliminate both the infection risk for the laboratory staff during antigen production and the need for laboratory animals. Upscaling production of recombinant antigens, e. g. in biofermentors, is straightforward thus leading to improved standardisation of antigen production and reduced production costs, which on their turn will increase the availability and affordability of the diagnostic tests needed for the elimination of gambiense HAT.	[Roge, Stijn; Van Nieuwenhove, Liesbeth; Meul, Magali; Heykers, Annick; de Koning, Annette Brouwer; Bebronne, Nicolas; Buscher, Philippe] Inst Trop Med, Unit Parasite Diagnost, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Roge, Stijn; Guisez, Yves] Univ Antwerp, Dept Biol, Lab Mol Plant Physiol & Biotechnol, B-2020 Antwerp, Belgium	Roge, S (reprint author), Inst Trop Med, Unit Parasite Diagnost, Dept Biomed Sci, B-2000 Antwerp, Belgium.	sroge@itg.be	Buscher, Philippe/B-9956-2012	Buscher, Philippe/0000-0002-1926-7472	Research Foundation Flanders (FWO) [1516907N]; Belgian Directorate General for Development Cooperation; Secondary Research Funding of the Institute of Tropical Medicine (SOFI-B); Institute of Tropical Medicine (RATT-project); European Commission under the Health Cooperation Work Programme of the 7th Framework Programme (NIDIAG Collaborative Project) [260260]	This work was financially supported by the Research Foundation Flanders (FWO; www.fwo.be; Krediet aan Navorsers (1516907N)), the Belgian Directorate General for Development Cooperation and the Secondary Research Funding of the Institute of Tropical Medicine (SOFI-B), the Institute of Tropical Medicine (www.itg.be; RATT-project) and by the European Commission under the Health Cooperation Work Programme of the 7th Framework Programme (NIDIAG Collaborative Project; grant agreement 260260; www.nidiag.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Buscher P, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000471; Buscher P, 1999, ACTA TROP, V73, P11, DOI 10.1016/S0001-706X(99)00009-1; Buscher P, 2014, LANCET GLOB HEALTH, V2, pE359, DOI 10.1016/S2214-109X(14)70203-7; Buscher P, 2013, NEW ENGL J MED, V368, P1069, DOI 10.1056/NEJMc1210373; Butt TR, 2005, PROTEIN EXPRES PURIF, V43, P1, DOI 10.1016/j.pep.2005.03.016; Camara M, 2010, TROP MED INT HEALTH, V15, P796, DOI 10.1111/j.1365-3156.2010.02546.x; Chappuis F, 2005, CLIN MICROBIOL REV, V18, P133, DOI 10.1128/CMR.18.1.133-146.2005; Cordon-Obras C, 2009, TROP MED INT HEALTH, V14, P535, DOI 10.1111/j.1365-3156.2009.02271.x; Daly R, 2005, J MOL RECOGNIT, V18, P119, DOI 10.1002/jmr.687; Deborggraeve S, 2010, LANCET INFECT DIS, V10, P433, DOI 10.1016/S1473-3099(10)70077-3; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Garcia A, 2000, TROP MED INT HEALTH, V5, P786, DOI 10.1046/j.1365-3156.2000.00623.x; Gibson W, 2001, TROP MED INT HEALTH, V6, P401, DOI 10.1046/j.1365-3156.2001.00711.x; HIDE G, 1994, PARASITOLOGY, V109, P95, DOI 10.1017/S0031182000077805; Ilemobade AA, 2009, ONDERSTEPOORT J VET, V76, P35; Kennedy PGE, 2013, LANCET NEUROL, V12, P186, DOI 10.1016/S1474-4422(12)70296-X; LANHAM SM, 1970, EXP PARASITOL, V28, P521, DOI 10.1016/0014-4894(70)90120-7; Lejon V, 1998, B WORLD HEALTH ORGAN, V76, P553; Lejon V, 2006, TROP MED INT HEALTH, V11, P620, DOI 10.1111/j.1365-3156.2006.01620.x; Lejon V, 2005, INT J PARASITOL, V35, P455, DOI 10.1016/j.ijpara.2004.12.015; Lejon V, 2003, LANCET INFECT DIS, V3, P804, DOI 10.1016/S1473-3099(03)00834-X; Lejon V, 2003, VET PARASITOL, V116, P87, DOI 10.1016/S0304-4017(03)00257-7; Lejon V, 1998, ACTA TROP, V69, P151, DOI 10.1016/S0001-706X(97)00137-X; LEVEY S, 1950, AM J CLIN PATHOL, V20, P1059; Lin-Cereghino Joan, 2007, V389, P11; Lumbala C, 2013, ANN AFRICAINES ME S1, V6, P49; MAGNUS E, 1978, ANN SOC BELG MED TR, V58, P169; Malvy D, 2011, CLIN MICROBIOL INFEC, V17, P986, DOI 10.1111/j.1469-0691.2011.03536.x; Mehlitz D., 1982, Tropical Medical Research Studies Series, P25; Ngoyi DM, 2010, J INFECT DIS, V201, P453, DOI 10.1086/649917; Njiokou F, 2006, INFECT GENET EVOL, V6, P147, DOI 10.1016/j.meegid.2005.04.003; NOIREAU F, 1989, TROP MED PARASITOL, V40, P9; O'Leary JM, 2004, PROTEIN EXPRES PURIF, V38, P217, DOI 10.1016/j.pep.2004.08.010; Pays E, 2004, CURR OPIN MICROBIOL, V7, P369, DOI 10.1016/j.mib.2004.05.001; Peeling RW, 2006, SEX TRANSM INFECT, V82, pV1, DOI 10.1136/sti.2006.024265; Robays J, 2004, TROP MED INT HEALTH, V9, P542, DOI 10.1111/j.1365-3156.2004.01240.x; Roge S, 2013, VET PARASITOL, V197, P571, DOI 10.1016/j.vetpar.2013.05.009; Routledge SJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-17; Rudenko G, 2011, ESSAYS BIOCHEM, V51, P47, DOI [10.1042/bse0510047, 10.1042/BSE0510047]; Segrest J. P., 1972, METHOD ENZYMOL, V28B, P54, DOI DOI 10.1016/0076-6879(72)28007-7; Van Nieuwenhove L, 2012, GENET MOL RES, V11, P1260, DOI 10.4238/2012.May.9.5; Vervecken W, 2004, APPL ENVIRON MICROB, V70, P2639, DOI 10.1128/AEM.70.5.2639-2646.2004; WESTGARD JO, 1981, CLIN CHEM, V27, P493; WHO, 2013, WHO TECH REP SER, V984, P1; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	46	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUL	2014	8	7							e3006	10.1371/journal.pntd.0003006				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AN4IQ	WOS:000340551500052	25032684	DOAJ Gold, Green Published			2019-04-02	
J	van Griensven, J; Ritmeijer, K; Lynen, L; Diro, E				van Griensven, Johan; Ritmeijer, Koert; Lynen, Lutgarde; Diro, Ermias			Visceral Leishmaniasis as an AIDS Defining Condition: Towards Consistency across WHO Guidelines	PLOS NEGLECTED TROPICAL DISEASES			English	Article							ETHIOPIA		[van Griensven, Johan; Lynen, Lutgarde; Diro, Ermias] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Ritmeijer, Koert] Medecins Sans Frontieres, Dept Publ Hlth, Amsterdam, Netherlands; [Diro, Ermias] Univ Gondar, Dept Internal Med, Gondar, Ethiopia	van Griensven, J (reprint author), Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.	jvangriensven@itg.be	Lynen, Lutgarde/A-1212-2014	Lynen, Lutgarde/0000-0001-7183-4895	Medecins Sans Frontieres [OCA014-18]		Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07; Desjeux P, 2003, ANN TROP MED PARASIT, V97, P3, DOI 10.1179/000349803225002499; Hurissa Z, 2010, TROP MED INT HEALTH, V15, P848, DOI 10.1111/j.1365-3156.2010.02550.x; Lopez-Velez R, 2001, CLIN MICROBIOL INFEC, V7, P394, DOI 10.1046/j.1198-743x.2001.00270.x; Ritmeijer K, 2011, CLIN INFECT DIS, V53, pE152, DOI 10.1093/cid/cir674; ter Horst R, 2008, CLIN INFECT DIS, V46, P1702, DOI 10.1086/587899; WHO, 2010, WHO TECH REP SER, V949, P1; WHO, 2012, WHO POL COLL TB HIV; WHO, 1990, ACQ IMM SYNDR AIDS I; WHO, 2006, ANT THER HIV INF AD; World Health Organization, 2013, CONS GUID US ANT DRU; World Health Organization, 2007, WHO CAS DEF HIV SURV; World Health Organization, 2003, SCAL ANT THER RES LI; World Health Organization, 1995, CONS M VL HIV COINF; World Health Organization (WHO), 2010, ANT THER HIV INF AD	15	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUL	2014	8	7							e2916	10.1371/journal.pntd.0002916				2	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AN4IQ	WOS:000340551500010	25032826	DOAJ Gold, Green Published			2019-04-02	
J	Watanaveeradej, V; Gibbons, RV; Simasathien, S; Nisalak, A; Jarman, RG; Kerdpanich, A; Tournay, E; De La Barrerra, R; Dessy, F; Toussaint, JF; Eckels, KH; Thomas, SJ; Innis, BL				Watanaveeradej, Veerachai; Gibbons, Robert V.; Simasathien, Sriluck; Nisalak, Ananda; Jarman, Richard G.; Kerdpanich, Angkool; Tournay, Elodie; De La Barrerra, Rafael; Dessy, Francis; Toussaint, Jean-Francois; Eckels, Kenneth H.; Thomas, Stephen J.; Innis, Bruce L.			Safety and Immunogenicity of a Rederived, Live-Attenuated Dengue Virus Vaccine in Healthy Adults Living in Thailand: A Randomized Trial	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							PHASE-I TRIAL; INFECTIONS; FORMULATIONS	Safety and immunogenicity of two formulations of a live-attenuated tetravalent dengue virus (TDEN) vaccine produced using rederived master seeds from a precursor vaccine were tested against a placebo control in a phase II, randomized, double blind trial (NCT00370682). Two doses were administered 6 months apart to 120 healthy, predominantly flavivirus-primed adults (87.5% and 97.5% in the two vaccine groups and 92.5% in the placebo group). Symptoms and signs reported after vaccination were mild to moderate and transient. There were no vaccine-related serious adverse events or dengue cases reported. Asymptomatic, low-level viremia (dengue virus type 2 [DENV-2], DENV-3, or DENV-4) was detected in 5 of 80 vaccine recipients. One placebo recipient developed a subclinical natural DENV-1 infection. All flavivirus-unprimed subjects and at least 97.1% of flavivirus-primed subjects were seropositive to antibodies against all four DENV types 1 and 3 months post-TDEN dose 2. The TDEN vaccine was immunogenic with an acceptable safety profile in flavivirus-primed adults.	Phramongkutklao Hosp PMK, Dept Pediat, Bangkok, Thailand; US Army Med Component Armed Forces Res, Inst Med Sci, Bangkok, Thailand; [Thomas, Stephen J.] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD 20910 USA; GlaxoSmithKline Vaccines, Wavre, Belgium; Walter Reed Army Inst Res, Translat Med Branch, Bioprod Facil, Silver Spring, MD 20910 USA; GlaxoSmithKline Vaccines, King Of Prussia, PA USA	Thomas, SJ (reprint author), Walter Reed Army Inst Res, Viral Dis Branch, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	stephen.j.thomas3.mil@mail.mil		Toussaint, Jean-Francois/0000-0003-1964-5039; Innis, Bruce/0000-0002-1753-7248	US Army Medical Research and Materiel Command (Fort Detrick, MD); GlaxoSmithKline Biologicals SA (Rixensart, Belgium)	This work was funded by US Army Medical Research and Materiel Command (Fort Detrick, MD) and GlaxoSmithKline Biologicals SA (Rixensart, Belgium) under a Cooperative Research and Development Agreement. GlaxoSmithKline Biologicals SA was involved in all stages of study conduct, including analysis of the data, and also took in all costs associated with the development and publication of this manuscript.	[Anonymous], MED DICT REG ACT; Beckett CG, 2005, AM J TROP MED HYG, V72, P777, DOI 10.4269/ajtmh.2005.72.777; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Capeding RZ, 2011, VACCINE, V29, P3863, DOI 10.1016/j.vaccine.2011.03.057; Edelman R, 2003, AM J TROP MED HYG, V69, P48, DOI 10.4269/ajtmh.2003.69.48; Gregory CJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001400; Guzman M G, 1987, Bull Pan Am Health Organ, V21, P270; Halstead SB, 2013, CLIN INFECT DIS, V56, P900, DOI 10.1093/cid/cis1047; Innis BL, 2003, AM J TROP MED HYG, V69, P1; Lee IK, 2010, INT J INFECT DIS, V14, pE919, DOI 10.1016/j.ijid.2010.06.011; Nisalak A, 2003, AM J TROP MED HYG, V68, P191, DOI 10.4269/ajtmh.2003.68.191; Sadon N, 2008, J VIROL METHODS, V153, P1, DOI 10.1016/j.jviromet.2008.06.023; SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932; Simasathien S, 2008, AM J TROP MED HYG, V78, P426; Sun W, 2009, HUM VACCINES, V5, P33, DOI 10.4161/hv.5.1.6348; Thai KTD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001180; Thomas SJ, 2013, AM J TROP MED HYG, V88, P73, DOI 10.4269/ajtmh.2012.12-0361; Vaughn DW, 1997, J INFECT DIS, V176, P322, DOI 10.1086/514048; Watanaveeradej V, 2011, AM J TROP MED HYG, V85, P341, DOI 10.4269/ajtmh.2011.10-0501; Wichmann O, 2011, PLOS NEGLECTED TROPI; Yoon IK, 2012, J INFECT DIS, V206, P389, DOI 10.1093/infdis/jis357	21	14	16	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	JUL	2014	91	1					119	128		10.4269/ajtmh.13-0452				10	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	AK9MH	WOS:000338750700022	24865677	Bronze, Green Published			2019-04-02	
J	Camara, O; Camara, M; Lejon, V; Ilboudo, H; Sakande, H; Leno, M; Buscher, P; Bucheton, B; Jamonneau, V				Camara, Oumou; Camara, Mamadou; Lejon, Veerle; Ilboudo, Hamidou; Sakande, Hassane; Leno, Mamadou; Buscher, Philippe; Bucheton, Bruno; Jamonneau, Vincent			Immune trypanolysis test with blood spotted on filter paper for epidemiological surveillance of sleeping sickness	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						human African trypanosomiasis; diagnosis; immune trypanolysis test; filter paper; antibody; surveillance	TRYPANOSOMA-BRUCEI-GAMBIENSE; INFECTIONS; DIAGNOSIS; GUINEA; CATT	OBJECTIVES The immune trypanolysis test (TL) is an accurate sero-diagnostic tool increasingly implemented for sleeping sickness medical surveillance, but it is restricted to the reference laboratories. To facilitate storage and transport of the test specimen, we developed a protocol for the examination of blood spotted on filter paper (TL-fp) that can be stored and shipped at ambient temperature. We compared its performance with the classical TL on plasma (TL-pl) that needs to be kept frozen until use. METHODS The study was conducted in active foci of the Republic of Guinea. In total, 438 specimens from treated and untreated sleeping sickness patients and serological suspects were tested with both methods. RESULT TL-fp gave significantly less positive results than TL-pl, but all the confirmed sleeping sickness cases were positive with the TL-fp protocol. CONCLUSION TL-fp appears to offer a good compromise between feasibility and sensitivity to detect currently infected subjects who play a role in the transmission of Trypanosoma brucei gambiense and is useful for contributing to the elimination of gambiense sleeping sickness.	[Camara, Oumou; Camara, Mamadou; Leno, Mamadou; Bucheton, Bruno] Programme Natl Lutte Trypanosomose Humaine Africa, Conakry, Guinea; [Lejon, Veerle; Bucheton, Bruno; Jamonneau, Vincent] IRD, F-34398 Montpellier, France; [Ilboudo, Hamidou; Sakande, Hassane; Jamonneau, Vincent] Ctr Int Rech Dev Elevage Zones Subhumides, Bobo Dioulasso, Burkina Faso; [Buscher, Philippe] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium	Jamonneau, V (reprint author), IRD, CIRAD 177, Unite Mixte Rech, TA A-17-G,Campus Int Baillarguet, F-34398 Montpellier, France.	vincent.jamonneau@ird.fr	Jamonneau, Vincent/K-1124-2016; Buscher, Philippe/B-9956-2012	Jamonneau, Vincent/0000-0001-8427-0769; Buscher, Philippe/0000-0002-1926-7472; ILBOUDO, Hamidou/0000-0003-3936-7718; Lejon, Veerle/0000-0002-6795-0962	WHO; Section de Cooperation et d'Action Culturelle of Ouagadougou and Conakry (SCAC, French Ministry of Foreign Affairs); Wellcome Trust; Institut de Recherche pour le Developpement (IRD)	We particularly acknowledge all the technicians from the HAT team of the CIRDES (Bobo-Dioulasso, Burkina-Faso) and the HAT NCP of the Republic of Guinea for their help in sampling. We thank WHO, Section de Cooperation et d'Action Culturelle of Ouagadougou and Conakry (SCAC, French Ministry of Foreign Affairs), Wellcome Trust and Institut de Recherche pour le Developpement (IRD) for funding. The authors also thank Sam Ankey for helpful advice in writing the manuscript.	Bucheton B, 2011, PARASITE IMMUNOL, V33, P438, DOI 10.1111/j.1365-3024.2011.01287.x; Buscher P, 2013, NEW ENGL J MED, V368, P1069, DOI 10.1056/NEJMc1210373; Camara M, 2005, Med Trop (Mars), V65, P155; Camara M, 2010, TROP MED INT HEALTH, V15, P796, DOI 10.1111/j.1365-3156.2010.02546.x; Holland WG, 2002, ACTA TROP, V81, P159, DOI 10.1016/S0001-706X(01)00211-X; Ilboudo H, 2011, MICROBES INFECT, V13, P943, DOI 10.1016/j.micinf.2011.05.007; Jamonneau V, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000917; Kagbadouno MS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001949; Lejon V, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000590; Lutumba P, 2006, TROP MED INT HEALTH, V2, P470; MAGNUS E, 1978, ANN SOC BELG MED TR, V58, P169; Miezan TW, 2003, B SOC PATHOL EXOT, V95, P362; Organization WH, 2013, WHO TECH REP SER, P1; VanMeirvenne N, 1995, ACTA TROP, V60, P189, DOI 10.1016/0001-706X(95)00127-Z; WHO, 2013, WHO TECH REP SER, V984, P1; World Health Organisation, 2012, ACC WORK OV GLOB IMP, P1	16	6	7	0	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	JUL	2014	19	7					828	831		10.1111/tmi.12316				4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	AJ6IS	WOS:000337796400009	24750463				2019-04-02	
J	Guha, R; Das, S; Ghosh, J; Sundar, S; Dujardin, JC; Roy, S				Guha, Rajan; Das, Shantanabha; Ghosh, June; Sundar, Shyam; Dujardin, Jean Claude; Roy, Syamal			Antimony Resistant Leishmania donovani but Not Sensitive Ones Drives Greater Frequency of Potent T-Regulatory Cells upon Interaction with Human PBMCs: Role of IL-10 and TGF-beta in Early Immune Response	PLOS NEGLECTED TROPICAL DISEASES			English	Article							HUMAN VISCERAL LEISHMANIASIS; AZAR DERMAL LEISHMANIASIS; SAND FLIES; ANTIGEN PRESENTATION; DENDRITIC CELLS; AMPHOTERICIN-B; MESSENGER-RNA; KALA-AZAR; INFECTION; EXPRESSION	In India the sand fly, Phlebotomus argentipes, transmitted parasitic disease termed kala-azar is caused by Leishmania donovani (LD) in humans. These immune-evading parasites have increasingly developed resistance to the drug sodium antimony gluconate in endemic regions. Lack of early diagnosis methods for the disease limits the information available regarding the early interactions of this parasite with either human tissues or cell lineages. We reasoned that peripheral blood mononuclear cells (PBMCs) from healthy human beings could help compare some of their immune signatures once they were exposed for up to 8 days, to either pentavalent antimony sensitive (Sb-S-LD) or resistant (Sb-R-LD) Leishmania donovani isolates. At day 2, PBMC cultures exposed to Sb-S-LD and Sb-R-LD stationary phase promastigotes had four and seven fold higher frequency of IL-10 secreting monocyte-macrophage respectively, compared to cultures unexposed to parasites. Contrasting with the CD4(+)CD25(-)CD127(-) type-1 T-regulatory (Tr1) cell population that displayed similar features whatever the culture conditions, there was a pronounced increase in the IL-10 producing CD4(+)CD25(+)CD127(low/-) inducible T-regulatory cells (iTregs) in the PBMC cultures sampled at day 8 post addition of Sb-R-LD. Sorted iTregs from different cultures on day 8 were added to anti-CD3/CD28 induced naive PBMCs to assess their suppressive ability. We observed that iTregs from Sb-R-LD exposed PBMCs had more pronounced suppressive ability compared to Sb-S-LD counterpart on a per cell basis and is dependent on both IL-10 and TGF-beta, whereas IL-10 being the major factor contributing to the suppressive ability of iTregs sorted from PBMC cultures exposed to Sb-S-LD. Of note, iTreg population frequency value remained at the basal level after addition of genetically modified Sb-R-LD lacking unique terminal sugar in surface glycan. Even with limitations of this artificial in vitro model of L. donovani-human PBMC interactions, the present findings suggest that Sb-R-LD have higher immunomodulatory capacity which may favour aggressive pathology.	[Guha, Rajan; Das, Shantanabha; Ghosh, June; Roy, Syamal] CSIR Indian Inst Chem Biol, Div Infect Dis & Immunol, Kolkata, India; [Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Banaras, India; [Dujardin, Jean Claude] Univ Antwerp, Dept Biol Sci, B-2020 Antwerp, Belgium	Guha, R (reprint author), CSIR Indian Inst Chem Biol, Div Infect Dis & Immunol, Kolkata, India.	sroy@iicb.res.in			European Commission [Health-F3-2008-222895]; Council of Scientific and Industrial Research, New Delhi [BSC-0114, BSC-0120]; CSIR, Government of India	This research was supported by the European Commission-funded Kaladrug-R Project (Health-F3-2008-222895) and the Council of Scientific and Industrial Research (grant no. BSC-0114 and BSC-0120), New Delhi. Fellowships from the CSIR, Government of India was awarded to RG, SD, and JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00080; Alvar J, 2013, VACCINE, V31, pB244, DOI 10.1016/j.vaccine.2012.11.080; Aslan H, 2013, J INFECT DIS, V207, P1328, DOI 10.1093/infdis/jis932; Awasthi A, 2004, INDIAN J MED RES, V119, P238; Battaglia M, 2009, EUR J IMMUNOL, V39, P3296, DOI 10.1002/eji.200940117; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Biedermann T, 2001, NAT IMMUNOL, V2, P1054, DOI 10.1038/ni725; Bosque F, 2000, SCAND J IMMUNOL, V51, P533; Chakraborty D, 2005, J IMMUNOL, V175, P3214, DOI 10.4049/jimmunol.175.5.3214; Chakravarty J, 2010, J GLOB INFECT DIS, V2, P167, DOI 10.4103/0974-777X.62887; Costa SR, 1999, MEM I OSWALDO CRUZ, V94, P367, DOI 10.1590/S0074-02761999000300015; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Facciabene A, 2012, CANCER RES, V72, P2162, DOI 10.1158/0008-5472.CAN-11-3687; Gomes R, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00110; Guha R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006406; Guha R, 2013, VACCINE, V31, P1905, DOI 10.1016/j.vaccine.2013.02.025; Haldar AK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000907; HVIID L, 1990, INFECT IMMUN, V58, P3163; Iniguez SR, 2006, ANTIMICROB AGENTS CH, V50, P1195, DOI 10.1128/AAC.50.4.1195-1201.2006; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Katara GK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001171; Kimblin N, 2008, P NATL ACAD SCI USA, V105, P10125, DOI 10.1073/pnas.0802331105; Li S, 2008, J VIROL, V82, P21, DOI 10.1128/JVI.01768-07; LIEW FY, 1989, IMMUNOL TODAY, V10, P40, DOI 10.1016/0167-5699(89)90302-2; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Maia C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001181; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Meier CL, 2003, J IMMUNOL, V171, P6706, DOI 10.4049/jimmunol.171.12.6706; Mendez S, 2004, J EXP MED, V200, P201, DOI 10.1084/jem.20040298; Mukherjee B, 2013, P NATL ACAD SCI USA, V110, pE575, DOI [10.1073/pnas.1213839110, 10.]; Mukhopadhyay R, 2011, INT J PARASITOL, V41, P1311, DOI 10.1016/j.ijpara.2011.07.013; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Nasser R, 2013, BLOOD, V121, P1102, DOI 10.1182/blood-2012-06-432153; Nylen S, 2001, CLIN EXP IMMUNOL, V124, P43, DOI 10.1046/j.1365-2249.2001.01501.x; Nylen S, 2007, TRENDS IMMUNOL, V28, P378, DOI 10.1016/j.it.2007.07.004; Nylen S, 2007, J EXP MED, V204, P805, DOI 10.1084/jem.20061141; Owens BMJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002827; Peng GP, 2008, IMMUNOLOGY, V123, P57, DOI 10.1111/j.1365-2567.2007.02691.x; Perez-Victoria JM, 2001, ANTIMICROB AGENTS CH, V45, P2468, DOI 10.1128/AAC.45.9.2468-2474.2001; Rai AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031551; Ready PD, 2013, ANNU REV ENTOMOL, V58, P227, DOI 10.1146/annurev-ento-120811-153557; Resende M, 2013, J IMMUNOL, V191, P262, DOI 10.4049/jimmunol.1203518; Rogers KA, 2004, AM J TROP MED HYG, V71, P568, DOI 10.4269/ajtmh.2004.71.568; Rogers KA, 2004, J PARASITOL, V90, P557, DOI 10.1645/GE-3317; Rogers M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000555; Rogers ME, 2010, MICROBES INFECT, V12, P875, DOI 10.1016/j.micinf.2010.05.014; Diaz YR, 2010, J INFECT DIS, V202, P406, DOI 10.1086/653829; Saha S, 2007, J IMMUNOL, V179, P5592, DOI 10.4049/jimmunol.179.8.5592; Samant M, 2009, J IMMUNOL, V183, P470, DOI 10.4049/jimmunol.0900265; Savage NDL, 2008, J IMMUNOL, V181, P2220, DOI 10.4049/jimmunol.181.3.2220; Singh OP, 2012, CLIN VACCINE IMMUNOL, V19, P961, DOI 10.1128/CVI.00143-12; Stober CB, 2005, J IMMUNOL, V175, P2517, DOI 10.4049/jimmunol.175.4.2517; Stockis J, 2009, EUR J IMMUNOL, V39, P3315, DOI 10.1002/eji.200939684; Sundar S, 2006, INDIAN J MED RES, V123, P345; Thakur CP, 2003, T ROY SOC TROP MED H, V97, P409, DOI 10.1016/S0035-9203(03)90071-X; van Vliet SJ, 2008, IMMUNOL CELL BIOL, V86, P580, DOI 10.1038/icb.2008.55; Vanaerschot M, 2012, J INFECT DIS, V206, P752, DOI 10.1093/infdis/jis424; Vanaerschot M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023120; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; Wang R, 2009, P NATL ACAD SCI USA, V106, P13439, DOI 10.1073/pnas.0901965106; WHITE AC, 1992, AM J TROP MED HYG, V46, P123, DOI 10.4269/ajtmh.1992.46.123	62	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUL	2014	8	7							e2995	10.1371/journal.pntd.0002995				11	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AN4IQ	WOS:000340551500042	25032977	DOAJ Gold, Green Published			2019-04-02	
J	Beugnet, F; Bourdeau, P; Chalvet-Monfray, K; Cozma, V; Farkas, R; Guillot, J; Halos, L; Joachim, A; Losson, B; Miro, G; Otranto, D; Renaud, M; Rinaldi, L				Beugnet, Frederic; Bourdeau, Patrick; Chalvet-Monfray, Karine; Cozma, Vasile; Farkas, Robert; Guillot, Jacques; Halos, Lenaig; Joachim, Anja; Losson, Bertrand; Miro, Guadalupe; Otranto, Domenico; Renaud, Marine; Rinaldi, Laura			Parasites of domestic owned cats in Europe: co-infestations and risk factors	PARASITES & VECTORS			English	Article						Cats; Ectoparasites; Endoparasites; Toxocara cati; Ctenocephalides; Otodectes; Europe; Risk factors; Treatments	AELUROSTRONGYLUS-ABSTRUSUS; TOXOPLASMA-GONDII; STRONGYLIDA CRENOSOMATIDAE; TROGLOSTRONGYLUS-BREVIOR; INTESTINAL PARASITES; FLEA INFESTATION; FELIS-CATUS; OTODECTES-CYNOTIS; DOGS; PREVALENCE	Background: Domestic cats can be infested by a large range of parasite species. Parasitic infestations may cause very different clinical signs. Endoparasites and ectoparasites are rarely explored in the same study and therefore multiparasitism is poorly documented. The present survey aimed to improve knowledge of the prevalence and risk factors associated with ecto-and endoparasite infestations in owned cats in Europe. Methods: From March 2012 to May 2013, 1519 owned cats were included in a multicenter study conducted in 9 veterinary faculties throughout Europe (Austria, Belgium, France, Hungary, Italy, Romania and Spain). For each cat, ectoparasites were checked by combing of the coat surface associated with otoscopic evaluation and microscopy on cerumen samples. Endoparasites were identified by standard coproscopical examinations performed on fresh faecal samples. Risk factors and their influence on parasitism were evaluated by univariate analysis followed by a multivariate statistical analysis (including center of examination, age, outdoor access, multipet status, and frequency of treatments as main criteria) with logistic regression models. Results: Overall, 50.7% of cats resulted positive for at least one internal or one external parasite species. Ectoparasites were found in 29.6% of cats (CI95 27.3-32.0%). Otodectes cynotis was the most frequently identified species (17.4%), followed by fleas (15.5%). Endoparasites were identified in 35.1% of the cats (CI95 32.7-35.7%), including gastro-intestinal helminths in 25.7% (CI95 23.5-28.0), respiratory nematodes in 5.5% (CI95 4.2-7.0%) and protozoans in 13.5% (CI95 11.8-15.3%). Toxocara cati was the most commonly diagnosed endoparasite (19.7%, CI95 17.8-21.8%). Co-infestation with endoparasites and ectoparasites was found in 14.0% of the cats, and 11.9% harbored both ectoparasites and gastro-intestinal helminths. Age, outdoor access, living with other pets, and anthelmintic or insecticide treatments were significantly associated with the prevalence of various parasites. Conclusions: This survey demonstrates that parasitism is not a rare event in European owned cat populations. The prevalence of multi-parasitism is significantly greater than expected by chance and hence there is tendency for some individual cats to be more prone to infestation by both endo-and ectoparasites due to common risk factors.	[Beugnet, Frederic; Halos, Lenaig; Renaud, Marine] Merial SAS, F-69007 Lyon, France; [Chalvet-Monfray, Karine] VetAgro Sup, Lyon, France; [Bourdeau, Patrick] Oniris, Nantes, France; [Cozma, Vasile] Univ Agr Sci & Vet, Fac Vet Med, Cluj Napoca, Romania; [Farkas, Robert] Fac Vet Sci, Budapest, Hungary; [Guillot, Jacques] Ecole Natl Vet Alfort, Maisons Alfort, France; [Joachim, Anja] Univ Vet Med Vienna, Inst Parasitol, Dept Pathobiol, Vienna, Austria; [Losson, Bertrand] Ecole Vet, Liege, Belgium; [Miro, Guadalupe] Univ Complutense Madrid, Fac Vet, Madrid, Spain; [Otranto, Domenico] Fac Vet, Bari, Italy; [Rinaldi, Laura] Fac Vet, Naples, Italy	Beugnet, F (reprint author), Merial SAS, 29 Av Tony Garnier, F-69007 Lyon, France.	frederic.beugnet@merial.com	; Guillot, Jacques/J-9428-2016; MIRO, GUADALUPE/A-9666-2019	Joachim, Anja/0000-0003-3082-6885; Otranto, Domenico/0000-0002-7518-476X; Guillot, Jacques/0000-0003-3577-6979; Halos, Lenaig/0000-0002-2623-2008; MIRO, GUADALUPE/0000-0003-0981-2470			Barutzki D, 2003, PARASITOL RES, V90, pS148, DOI 10.1007/s00436-003-0922-6; Barutzki D, 2011, PARASITOL RES, V109, P545; Barutzki D, 2013, PARASITOL RES, V112, P855, DOI 10.1007/s00436-012-3207-0; Beck W, 2006, VET PARASITOL, V137, P130, DOI 10.1016/j.vetpar.2005.12.021; Becker AC, 2012, PARASITOL RES, V111, P849, DOI 10.1007/s00436-012-2909-7; Beugnet F, 2000, REV MED VET-TOULOUSE, V151, P443; Beugnet F, 2010, PARASITE, V17, P337, DOI 10.1051/parasite/2010174337; Beugnet F, 2008, ATLAS COPROSCOPY, P277; Beugnet F, 2012, TRENDS PARASITOL, V28, P267, DOI 10.1016/j.pt.2012.04.004; Beugnet F, 2009, VET PARASITOL, V163, P298, DOI 10.1016/j.vetpar.2009.03.028; Bond R, 2007, VET REC, V160, P503, DOI 10.1136/vr.160.15.503; Boulouis HJ, 2005, VET RES, V36, P383, DOI 10.1051/vetres:2005009; BOURDEAU P, 1993, RECL MED VET, V169, P353; Brianti E, 2014, VET PARASITOL, V202, P104, DOI 10.1016/j.vetpar.2014.01.019; Brianti E, 2013, PARASITOLOGY, V140, P821, DOI 10.1017/S0031182013000188; Brianti E, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-178; Capari B, 2013, VET PARASITOL, V192, P33, DOI 10.1016/j.vetpar.2012.11.011; Claerebout E, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-183; Coati N, 2003, PARASITOL RES, V90, pS146, DOI 10.1007/s00436-003-0921-7; Cringoli G, 2010, NAT PROTOC, V5, P503, DOI 10.1038/nprot.2009.235; Deplazes P, 2011, VET PARASITOL, V182, P41, DOI 10.1016/j.vetpar.2011.07.014; Di Cesare A, 2011, PARASITOL RES, V109, P87, DOI DOI 10.1007/S00436-011-2405-5; Epe C, 2004, DEUT TIERARZTL WOCH, V111, P243; Epe C, 2010, VET PARASITOL, V173, P32, DOI 10.1016/j.vetpar.2010.06.015; Euzeby J., 1981, DIAGNOSTIC EXPT HELM; Farkas R, 2009, MED VET ENTOMOL, V23, P187, DOI 10.1111/j.1365-2915.2009.00798.x; Ferreira FS, 2011, VET PARASITOL, V179, P242, DOI 10.1016/j.vetpar.2011.02.003; Fisher M, 2003, TRENDS PARASITOL, V19, P167, DOI 10.1016/S1471-4922(03)00027-8; Franc M, 1997, REV MED VET-TOULOUSE, V148, P247; Grandi G, 2005, VET PARASITOL, V134, P177, DOI 10.1016/j.vetpar.2005.06.015; Halos L, 2014, TRENDS PARASITOL, V30, P228, DOI 10.1016/j.pt.2014.02.007; Hosmer D, 2000, APPL LOGISTIC REGRES; Jefferies R, 2010, VET PARASITOL, V173, P344, DOI 10.1016/j.vetpar.2010.06.032; Knaus M, 2011, WIEN KLIN WOCHENSCHR, V123, P31, DOI 10.1007/s00508-011-1588-1; KOUTINAS AF, 1995, VET PARASITOL, V58, P109, DOI 10.1016/0304-4017(94)00706-I; Lefkaditis MA, 2009, VET PARASITOL, V163, P374, DOI 10.1016/j.vetpar.2009.04.027; Lilly EL, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-266; Medleau L, 2006, SMALL ANIMAL DERMATO, P99; Millan J, 2009, PARASITOL RES, V106, P183, DOI 10.1007/s00436-009-1647-y; Mircean V, 2011, J FELINE MED SURG, V13, P479, DOI 10.1016/j.jfms.2011.01.003; Mircean V, 2010, VET PARASITOL, V171, P163, DOI 10.1016/j.vetpar.2010.03.005; Miro G, 2004, VET PARASITOL, V126, P249, DOI 10.1016/j.vetpar.2004.08.015; Nareaho A, 2012, J FELINE MED SURG, V14, P378, DOI 10.1177/1098612X12439257; Otranto D, 2013, TRENDS PARASITOL, V29, P517, DOI 10.1016/j.pt.2013.09.001; Lopes AP, 2008, VET PARASITOL, V155, P184, DOI 10.1016/j.vetpar.2008.05.007; Payo-Puente P, 2008, J FELINE MED SURG, V10, P242, DOI 10.1016/j.jfms.2007.12.002; Perego R, 2013, J FELINE MED SURG; Petavy AF, 2000, VET PARASITOL, V87, P151, DOI 10.1016/S0304-4017(99)00181-8; R Core Team, 2013, R LANG ENV STAT COMP; Raether W, 2003, PARASITOL RES, V91, P412, DOI 10.1007/s00436-003-0903-9; Riggio F, 2013, VET PARASITOL, V193, P78, DOI 10.1016/j.vetpar.2012.11.026; Robben SRM, 2004, TIJDSCHR DIERGENEESK, V129, P2; Robertson ID, 2002, MICROBES INFECT, V4, P867, DOI 10.1016/S1286-4579(02)01607-6; Savary De Beauregard B, 2003, THESIS ECOLE NATL VE; Schares G, 2008, VET PARASITOL, V152, P34, DOI 10.1016/j.vetpar.2007.12.004; Sotiraki ST, 2001, VET PARASITOL, V96, P309, DOI 10.1016/S0304-4017(01)00383-1; Tamponi C, 2014, VET PARASITOL, V203, P222, DOI 10.1016/j.vetpar.2014.04.001; Taubert A, 2009, VET PARASITOL, V159, P175, DOI 10.1016/j.vetpar.2008.10.005; Traversa D, 2008, VET PARASITOL, V153, P182, DOI 10.1016/j.vetpar.2008.01.024; Traversa D, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-62; Traversa D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-91; Waap H, 2013, J HELMINTHOL, V30, P1	62	44	46	3	56	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	JUN 25	2014	7								291	10.1186/1756-3305-7-291				13	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	AK9GT	WOS:000338736300001	24965063	DOAJ Gold, Green Published			2019-04-02	
J	Ruizendaal, E; Dierickx, S; Grietens, KP; Schallig, HDFH; Pagnoni, F; Mens, PF				Ruizendaal, Esmee; Dierickx, Susan; Grietens, Koen Peeters; Schallig, Henk D. F. H.; Pagnoni, Franco; Mens, Petra F.			Success or failure of critical steps in community case management of malaria with rapid diagnostic tests: a systematic review	MALARIA JOURNAL			English	Review						Malaria; Plasmodium falciparum; Community health workers; Rapid diagnostic tests; Sub-Saharan Africa	HOME-BASED MANAGEMENT; CLUSTER RANDOMIZED-TRIAL; NORTH-EASTERN TANZANIA; HEALTH-WORKERS; UNCOMPLICATED MALARIA; COMBINATION THERAPY; ARTEMETHER-LUMEFANTRINE; SIERRA-LEONE; SCALE-UP; SENEGAL	Background: Malaria still causes high morbidity and mortality around the world, mainly in sub-Saharan Africa. Community case management of malaria (CCMm) by community health workers (CHWs) is one of the strategies to combat the disease by increasing access to malaria treatment. Currently, the World Health Organization recommends to treat only confirmed malaria cases, rather than to give presumptive treatment. Objectives: This systematic review aims to provide a comprehensive overview of the success or failure of critical steps in CCMm with rapid diagnostic tests (RDTs). Methods: The databases of Medline, Embase, the Cochrane Library, the library of the 'Malaria in Pregnancy' consortium, and Web of Science were used to find studies on CCMm with RDTs in SSA. Studies were selected according to inclusion and exclusion criteria, subsequently risk of bias was assessed and data extracted. Results: 27 articles were included. CHWs were able to correctly perform RDTs, although specificity levels were variable. CHWs showed high adherence to test results, but in some studies a substantial group of RDT negatives received treatment. High risk of bias was found for morbidity and mortality studies, therefore, effects on morbidity and mortality could not be estimated. Uptake and acceptance by the community was high, however negative-tested patients did not always follow up referral advice. Drug or RDT stock-outs and limited information on CHW motivation are bottlenecks for sustainable implementation. RDT-based CCMm was found to be cost effective for the correct treatment of malaria in areas with low to medium malaria prevalence, but study designs were not optimal. Discussion: Trained CHWs can deliver high quality care for malaria using RDTs. However, lower RDT specificity could lead to missed diagnoses of non-malarial causes of fever. Other threats for CCMm are non-adherence to negative test results and low referral completion. Integrated CCM may solve some of these issues. Unfortunately, morbidity and mortality are not adequately investigated. More information is needed about influencing sociocultural aspects, CHW motivation and stock supply. Conclusion: CCMm is generally well executed by CHWs, but there are several barriers for its success. Integrated CCM may overcome some of these barriers.	[Ruizendaal, Esmee; Schallig, Henk D. F. H.; Mens, Petra F.] Koninklijk Inst Tropen KIT, Royal Trop Inst, Amsterdam, Netherlands; [Dierickx, Susan; Grietens, Koen Peeters] ITG, Inst Trop Med, Antwerp, Belgium; [Grietens, Koen Peeters] Nagasaki Univ, Sch Int Hlth Dev, Nagasaki 852, Japan; [Pagnoni, Franco] Global Malaria Programme, CH-1211 Geneva 27, Switzerland	Ruizendaal, E (reprint author), Koninklijk Inst Tropen KIT, Royal Trop Inst, Amsterdam, Netherlands.	e.ruizendaal@kit.nl		Peeters Grietens, Koen/0000-0001-6570-9887	European Community [305662]	We would like to thank all authors who sent us additional information on their studies. We would also like to thank I M Nagel (Medical Library, Academic Medical Centre, University of Amsterdam, Amsterdam) for her support with drafting the search strategies, K Vaughan (Royal Tropical Institute/Koninklijk Instituut voor de Tropen (KIT), Health Unit, Linnaeusstraat 35f, Amsterdam) for her assistance in critically assessing the cost-effectiveness studies, F Forland (Royal Tropical Institute/Koninklijk Instituut voor de Tropen (KIT), Biomedical Research, Meibergdreef 39, Amsterdam) for his suggestions for critical appraisal of unstandardized outcomes and P Klatser (Royal Tropical Institute/Koninklijk Instituut voor de Tropen (KIT), Biomedical Research, Meibergdreef 39, Amsterdam) for his comments on the manuscript. The preparation of this review has received funding from the European Community's Seventh Framework Programme under grant agreement No. 305662 (Project: Community-based scheduled screening and treatment of malaria in pregnancy for improved maternal and infant health: a cluster-randomized trial 'COSMIC').	Albertini A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-406; Batwala V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-349; Bjorkman A, 2010, CLIN INFECT DIS, V51, P512, DOI 10.1086/655689; Blanas DA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-95; Bruxvoort K, 2013, TROP MED INT HEALTH, V18, P1269, DOI 10.1111/tmi.12168; Chanda P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-159; Chanda P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-158; Chinkhumba J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-209; Counihan H, 2012, AM J TROP MED HYG, V87, P57, DOI 10.4269/ajtmh.2012.11-0800; D'Acremont V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-107; De Smet M, 2009, TROP MED INT HEALTH, V14, P63; Elmardi KA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-39; Evers S, 2005, INT J TECHNOL ASSESS, V21, P240; Glenton C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010414.pub2; Guerra CA, 2006, TRENDS PARASITOL, V22, P353, DOI 10.1016/j.pt.2006.06.006; Hamer DH, 2012, PATHOG GLOB HEALTH, V106, P32, DOI 10.1179/1364859411Y.0000000042; Harvey SA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-160; Hawkes M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-308; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Ishengoma DS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-176; Kamal-Yanni MM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-414; Kyabayinze DJ, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-200; Landsberger HA, 1958, HAWTHORNE REVISITED, P0; Lemma Hailemariam, 2011, Cost Eff Resour Alloc, V9, P2, DOI 10.1186/1478-7547-9-2; Lemma H, 2010, TROP MED INT HEALTH, V15, P241, DOI 10.1111/j.1365-3156.2009.02447.x; Lewin S, 2010, COCHRANE DB SYST REV, V28, P243; Lufesi NN, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-86; Maltha J, 2013, CLIN MICROBIOL INFEC, V19, P399, DOI 10.1111/1469-0691.12151; Masanja IM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-221; Mubi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019753; Mukanga D, 2011, TROP MED INT HEALTH, V16, P1234, DOI 10.1111/j.1365-3156.2011.02831.x; Mukanga D, 2012, AM J TROP MED HYG, V87, P21, DOI 10.4269/ajtmh.2012.11-0816; Mukanga D, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-121; Mukanga D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-203; Ndiaye Y, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-240; Nsagha DS, 2012, DRUG HEALTHC PATIENT, V4, P1, DOI 10.2147/DHPS.S25406; Okwundu CI, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009527.pub2; PREMJI Z, 1994, T ROY SOC TROP MED H, V88, P418, DOI 10.1016/0035-9203(94)90409-X; Ratsimbasoa A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-85; Review Manager (RevMan), 2012, REV MAN REVM COMP PR; Roucher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046188; Rutta ASM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-152; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Samo Gudo E, 2013, BMC INFECT DIS, V13, P244; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P101, DOI 10.2471/BLT.07.042259; Skarbinski J, 2009, AM J TROP MED HYG, V80, P919; Strachan DL, 2012, AM J TROP MED HYG, V87, P111, DOI 10.4269/ajtmh.2012.12-0030; Swarthout TD, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-58; Tayler-Smith K, 2011, J PUBLIC HEALTH AFR, V2, P50, DOI 10.4081/jphia.2011.e12; Thiam S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-334; Thomson A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-94; Tiono AB, 2010, 59 ANN M AM SOC TROP, V83, P211; Tiono AB, 2013, INFECT DIS THER, V2, P27, DOI 10.1007/s40121-013-0006-6; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1; *WHO, 2005, REP SCI WORK GROUP C, P1; World Health Organization, 2012, MAL RAP DIAGN TEST P, P0; World Health Organization, 2010, GLOB REC PHYS ACT HL, P1; Yeboah-Antwi K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000340	58	39	39	0	19	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	JUN 12	2014	13								229	10.1186/1475-2875-13-229				17	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AL1MA	WOS:000338888300001	24924295	DOAJ Gold, Green Published			2019-04-02	
J	Nambozi, M; Malunga, P; Mulenga, M; Van Geertruyden, JP; D'Alessandro, U				Nambozi, Michael; Malunga, Phidelis; Mulenga, Modest; Van Geertruyden, Jean-Pierre; D'Alessandro, Umberto			Defining the malaria burden in Nchelenge District, northern Zambia using the World Health Organization malaria indicators survey	MALARIA JOURNAL			English	Article						Malaria indicator survey; Zambia; Children; Endemicity	PLASMODIUM-FALCIPARUM INFECTION; SEVERE ANEMIA; GAMETOCYTES; CHILDREN; AFRICA; IMPACT; EPIDEMIOLOGY; MOZAMBIQUE; MODERATE	Background: Malaria is considered as one of the major public health problems and among the diseases of poverty. In areas of stable and relatively high transmission, pregnant women and their newborn babies are among the higher risk groups. A multicentre trial on the safety and efficacy of several formulations of artemisinin-based combination therapy (ACT) during pregnancy is currently on-going in four African countries, including Zambia, whose study site is in Nchelenge district. As the study outcomes may be influenced by the local malaria endemicity, this needs to be characterized. A cross-sectional survey to determine the prevalence and intensity of infection among <10 years old was carried out in March-April 2012 in Nchelenge district. Methods: The sampling unit was the household where all children < 10 years of age were included in the survey using simple random household selection on a GPS coded list. A blood sample for determining haemoglobin concentration and identifying malaria infection was collected from each recruited child. Results: Six hundred thirty households were selected and 782 children tested for malaria and anaemia. Prevalence of malaria infection was 30.2% (236/782), the large majority (97.9%, 231/236) being Plasmodium falciparum and the remaining ones (2.1%, 5/236) Plasmodium malariae. Anaemia, defined as haemoglobin concentration <11 g/dl, was detected in 51.2% (398/782) children. Conclusion: In Zambia, despite the reported decline in malaria burden, pockets of high malaria endemicity, such as Nchelenge district, still remain. This is a border area and significant progress can be achieved only by concerted efforts aimed at increasing coverage of current control interventions across the border.	[Nambozi, Michael; Malunga, Phidelis; Mulenga, Modest] Trop Dis Res Ctr, Dept Clin Sci, Ndola, Zambia; [Nambozi, Michael; Van Geertruyden, Jean-Pierre] Univ Antwerp, Unit Int Hlth, B-2020 Antwerp, Belgium; [D'Alessandro, Umberto] MRC Unit, Serrekunda, Gambia; [D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium	Nambozi, M (reprint author), Trop Dis Res Ctr, Dept Clin Sci, POB 71769, Ndola, Zambia.	michaelnambozi@yahoo.com	Van geertruyden, Jean-Pierre/K-6425-2014; D'Alessandro, Umberto/D-3457-2015	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; D'Alessandro, Umberto/0000-0001-6341-5009	EDCTP through Institute of Tropical Medicine, Antwerp, Belgium	We acknowledge the data research assistants in Nchelenge, the DMO, Chief Kambwali for allowing us carry the study in their area. The study team also acknowledge the children and their parentsguardians of Nchelenge district for participating in the study. TDRC staff Samson Mwale who did the quality control, Bridget Musonda and Lucy Phiri who did the data entry. We acknowledge David Mwakazanga and Dr Webster Kasongo for helping in data analysis. Sources of funding: EDCTP through Institute of Tropical Medicine, Antwerp, Belgium.	Abilio AP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-110; Babiker HA, 2008, TRENDS PARASITOL, V24, P525, DOI 10.1016/j.pt.2008.08.001; Bejon P, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-104; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Bouyou-Akotet MK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-166; Chizema-Kawesha E, 2010, AM J TROP MED HYG, V83, P480, DOI 10.4269/ajtmh.2010.10-0035; Eisele TP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001386; Karl S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-98; Korenromp EL, 2004, TROP MED INT HEALTH, V9, P1050, DOI 10.1111/j.1365-3156.2004.01317.x; Lozoff B, 2011, J NUTR, V1, p740S; Lusingu JP, 2004, MALARIA J, V28, P26; Mharakurwa S, 2012, ACTA TROP, V121, P202, DOI 10.1016/j.actatropica.2011.06.012; Ministry of Health, 2004, REP FOLL RBM SURV 10; Ministry of Health, 2013, GUID DIAGN TREATM MA; Ministry of Health National Malaria Control Centre, 2010, NAT MAL STRAT PLAN 2; National Malaria Control Center [Zambia], 2010, MIN HLTH CENTR STAT; National Malaria Control Center [Zambia], 2008, MIN HLTH CENTR STAT; National Malaria Control Center [Zambia] Ministry of Health, 2012, DROP; Ong'echa JM, 2006, AM J TROP MED HYG, V74, P376, DOI 10.4269/ajtmh.2006.74.376; Ouedraogo AL, 2009, PLOS ONE, V22, pe8410, DOI DOI 10.1371/J0URNAL.P0NE.0008410; Ouedraogo HZ, 2008, J TROP PEDIATRICS, V54, P395, DOI 10.1093/tropej/fmn049; Raosoft Sample Size Calculation: Raosoft. Inc, 2004, RAOS SAMPL SIZ CALC; RBM MEASURE Evaluation WHO UNICEF, 2005, MAL IND SURV; RBM: Roll Back Malaria MEASURE Evaluation World Health Organization UNICEF, 2006, GUID COR POP COV IND; Schneider P, 2007, AM J TROP MED HYG, V76, P470, DOI 10.4269/ajtmh.2007.76.470; SHARMANOV A, 2000, ANEMIA TESTING MANUA; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; Warhurst DC, 1996, J CLIN PATHOL, V49, P533, DOI 10.1136/jcp.49.7.533; *WHO, 2003, MIN MERG AN TASK FOR	29	6	6	1	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	JUN 5	2014	13								220	10.1186/1475-2875-13-220				7	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AL1PU	WOS:000338898300003	24902708	DOAJ Gold, Green Published			2019-04-02	
J	Diro, E; Lynen, L; Ritmeijer, K; Boelaert, M; Hailu, A; van Griensven, J				Diro, Ermias; Lynen, Lutgarde; Ritmeijer, Koert; Boelaert, Marleen; Hailu, Asrat; van Griensven, Johan			Visceral Leishmaniasis and HIV Coinfection in East Africa	PLOS NEGLECTED TROPICAL DISEASES			English	Review							AZAR DERMAL LEISHMANIASIS; HUMAN-IMMUNODEFICIENCY-VIRUS; DISSEMINATED CUTANEOUS LEISHMANIASIS; ACTIVE ANTIRETROVIRAL THERAPY; DIRECT AGGLUTINATION-TEST; LIPOSOMAL AMPHOTERICIN-B; INFECTED PATIENTS; SODIUM STIBOGLUCONATE; SECONDARY PROPHYLAXIS; ETHIOPIAN POPULATION	Visceral Leishmaniasis (VL) is an important protozoan opportunistic disease in HIV patients in endemic areas. East Africa is second to the Indian subcontinent in the global VL caseload and first in VL-HIV coinfection rate. Because of the alteration in the disease course, the diagnostic challenges, and the poor treatment responses, VL with HIV coinfection has become a very serious challenge in East Africa today. Field experience with the use of liposomal amphotericin B in combination with miltefosine, followed by secondary prophylaxis and antiretroviral drugs, looks promising. However, this needs to be confirmed through clinical trials. Better diagnostic and follow-up methods for relapse and prediction of relapse should also be looked for. Basic research to understand the immunological interaction of the two infections may ultimately help to improve the management of the coinfection.	[Diro, Ermias; Lynen, Lutgarde; van Griensven, Johan] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Diro, Ermias] Univ Gondar, Dept Internal Med, Gondar, Ethiopia; [Ritmeijer, Koert] Medecins Sans Frontieres, Dept Publ Hlth, Amsterdam, Netherlands; [Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Hailu, Asrat] Univ Addis Ababa, Sch Med, Addis Ababa, Ethiopia	Diro, E (reprint author), Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.	ermi_diro@yahoo.com	Lynen, Lutgarde/A-1212-2014	Lynen, Lutgarde/0000-0001-7183-4895; Boelaert, Marleen/0000-0001-8051-6776	Belgian development cooperation; Medecins Sans Frontieres [OCA014-17, OCA009-07]	ED has received individual PhD scholarship from Belgian development cooperation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ER, 2010, AM J TROP MED HYG, V82, P591, DOI 10.4269/ajtmh.2010.09-0369; Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Antinori S, 2007, BRIT J DERMATOL, V157, P1032, DOI 10.1111/j.1365-2133.2007.08157.x; Argaw D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002543; Bittencourt Achiléa, 2003, Braz J Infect Dis, V7, P229, DOI 10.1590/S1413-86702003000300009; Calza L, 2001, J CHEMOTHERAPY, V13, P653, DOI 10.1179/joc.2001.13.6.653; Catorce G, 2010, ANN DERMATOL VENER, V133, P39; CDC, 2009, MMWR-MORBID MORTAL W, V58; Chappuis F, 2005, J CLIN MICROBIOL, V43, P5973, DOI 10.1128/JCM.43.12.5973-5977.2005; Chappuis F, 2006, BRIT MED J, V333, P723, DOI 10.1136/bmj.38917.503056.7C; Cota GF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001153; Cota GF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001665; Cunningham J, 2012, CLIN INFECT DIS, V55, P1312, DOI 10.1093/cid/cis716; Deniau M, 2003, ANN TROP MED PARASIT, V97, P115, DOI 10.1179/000349803225002598; Diro E, 2013, P 5 WORLD LEISHM C 1; Diro E, 2011, P 16 INT C AIDS STIS; Diro E, 2007, T ROY SOC TROP MED H, V101, P908, DOI 10.1016/j.trstmh.2007.05.002; ENA J, 1994, CLIN INFECT DIS, V18, P901, DOI 10.1093/clinids/18.6.901; Ethiopian Health and Nutrition Research Institute (EHNRI), 2011, REP 2009 ROUND ANT C; Federal democratic republic of Ethiopia, 2012, COUNTR PROGR REP HIV; Federal Ministry of Health of Ethiopia, 2013, GUID DIAGN TREATM PR; FENSKE S, 1991, KLIN WOCHENSCHR, V69, P793, DOI 10.1007/BF01744270; GarciaSamaniego J, 1997, REV ESP ENFERM DIG, V89, P145; Gelanew T, 2011, AM J TROP MED HYG, V84, P906, DOI 10.4269/ajtmh.2011.11-0055; Gelanew T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000889; Gilad J, 2001, ISRAEL MED ASSOC J, V3, P451; Hailu A, 2002, ANN TROP MED PARASIT, V96, P25, DOI 10.1179/000349802125000475; Hailu A, 2006, EPIDEMIOLOGY ECOLOGY, P615; Hailu A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000709; Hailu W, 2010, T ROY SOC TROP MED H, V104, P706, DOI 10.1016/j.trstmh.2010.07.007; HR ter, 2008, CLIN INFECT DIS, V46, P1702, DOI [10.1086/587899, DOI 10.1086/587899]; Hurissa Z, 2010, TROP MED INT HEALTH, V15, P848, DOI 10.1111/j.1365-3156.2010.02550.x; Izri MA, 1996, B WORLD HEALTH ORGAN, V74, P91; Jarvis JN, 2013, CURR OPIN INFECT DIS, V26, P1, DOI 10.1097/QCO.0b013e32835c2198; Khalil EAG, 2013, J TROP MED, DOI 10.1155/2013/275253; Lopez-Velez R, 2004, J ANTIMICROB CHEMOTH, V53, P540, DOI 10.1093/jac/dkh084; Lyons S, 2003, TROP MED INT HEALTH, V8, P733, DOI 10.1046/j.1365-3156.2003.01088.x; Malaria Consortium, 2010, LEISHM CONTR E AFR P; Mengistu G, 2007, ETHIOP J HEALTH DEV, V21, P53; Merson MH, 2008, LANCET, V372, P475, DOI 10.1016/S0140-6736(08)60884-3; Musa A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001674; Musa AM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000855; Olivier M, 2003, ANN TROP MED PARASIT, V97, P79, DOI 10.1179/000349803225002561; Petter A, 2001, SCAND J INFECT DIS, V33, P236, DOI 10.1080/00365540151061049; Ramos A, 2008, INFECTION, V36, P184, DOI 10.1007/s15010-007-6279-5; Ridolfo AL, 2000, J INFECTION, V40, P199, DOI 10.1053/jinf.1999.0630; Ritmeijer K, 2006, CLIN INFECT DIS, V43, P357, DOI 10.1086/505217; Ritmeijer K, 2001, T ROY SOC TROP MED H, V95, P668, DOI 10.1016/S0035-9203(01)90110-5; Ritmeijer K, 2013, P 5 WORLD LEISHM C 1; Ritmeijer K, 2011, CLIN INFECT DIS, V53, pE152, DOI 10.1093/cid/cir674; Seaman J, 1996, INT J EPIDEMIOL, V25, P862, DOI 10.1093/ije/25.4.862; Sinha PK, 2011, CLIN INFECT DIS, V53, pE91, DOI 10.1093/cid/cir521; Stark D, 2006, J CLIN MICROBIOL, V44, P1178, DOI 10.1128/JCM.44.3.1178-1180.2006; Tadesse Abilo, 2009, Ethiop Med J, V47, P77; ter Horst R, 2008, CLIN INFECT DIS, V46, P1702, DOI 10.1086/587899; ter Horst R, 2009, AM J TROP MED HYG, V80, P929, DOI 10.4269/ajtmh.2009.80.929; UNAIDS, 2013, GLOB REP UNAIDS REP; van GJ, 2013, LANCET INFECT DIS, V13, P251, DOI [10.1016/S1473-3099(12)70348-1, DOI 10.1016/S1473-3099(12)70348-1]; van Griensven J, 2012, INFECT DIS CLIN N AM, V26, P309, DOI 10.1016/j.idc.2012.03.005; WHO, 2010, WHO TECHN REP SER; Word Health Organization, 2013, CONS GUID US ANT DRU; Yansouni CP, 2012, P 61 ANN M AM SOC TR; Yeung KT, 1996, CHEST, V110, P136, DOI 10.1378/chest.110.1.136; Zijistra EE, 2003, LANCET INFECT DIS, V3, P87, DOI 10.1016/S1473-3099(03)00517-6	65	49	51	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUN	2014	8	6							e2869	10.1371/journal.pntd.0002869				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AL0VW	WOS:000338846100015	24968313	DOAJ Gold, Green Published			2019-04-02	
J	Mouri, O; Morizot, G; Van der Auwera, G; Ravel, C; Passet, M; Chartrel, N; Joly, I; Thellier, M; Jaureguiberry, S; Caumes, E; Mazier, D; Marinach-Patrice, C; Buffet, P				Mouri, Oussama; Morizot, Gloriat; Van der Auwera, Gert; Ravel, Christophe; Passet, Marie; Chartrel, Nathalie; Joly, Isabelle; Thellier, Marc; Jaureguiberry, Stephane; Caumes, Eric; Mazier, Dominique; Marinach-Patrice, Carine; Buffet, Pierre			Easy Identification of Leishmania Species by Mass Spectrometry	PLOS NEGLECTED TROPICAL DISEASES			English	Article							DESORPTION IONIZATION-TIME; WORLD CUTANEOUS LEISHMANIASIS; CONTROLLED CLINICAL-TRIAL; MEGLUMINE ANTIMONIATE; VIANNIA BRAZILIENSIS; DOUBLE-BLIND; GUATEMALA; TRAVELERS; PAROMOMYCIN; PENTAMIDINE	Background: Cutaneous leishmaniasis is caused by several Leishmania species that are associated with variable outcomes before and after therapy. Optimal treatment decision is based on an accurate identification of the infecting species but current methods to type Leishmania isolates are relatively complex and/or slow. Therefore, the initial treatment decision is generally presumptive, the infecting species being suspected on epidemiological and clinical grounds. A simple method to type cultured isolates would facilitate disease management. Methodology: We analyzed MALDI-TOF spectra of promastigote pellets from 46 strains cultured in monophasic medium, including 20 short-term cultured isolates from French travelers (19 with CL, 1 with VL). As per routine procedure, clinical isolates were analyzed in parallel with Multilocus Sequence Typing (MLST) at the National Reference Center for Leishmania. Principal Findings: Automatic dendrogram analysis generated a classification of isolates consistent with reference determination of species based on MLST or hsp70 sequencing. A minute analysis of spectra based on a very simple, database-independent analysis of spectra based on the algorithm showed that the mutually exclusive presence of two pairs of peaks discriminated isolates considered by reference methods to belong either to the Viannia or Leishmania subgenus, and that within each subgenus presence or absence of a few peaks allowed discrimination to species complexes level. Conclusions/Significance: Analysis of cultured Leishmania isolates using mass spectrometry allows a rapid and simple classification to the species complex level consistent with reference methods, a potentially useful method to guide treatment decision in patients with cutaneous leishmaniasis.	[Mouri, Oussama; Passet, Marie; Chartrel, Nathalie; Joly, Isabelle; Thellier, Marc; Mazier, Dominique; Buffet, Pierre] Grp Hosp Pitie Salpetriere, AP HP, Serv Parasitol Mycol, F-75634 Paris, France; [Morizot, Gloriat] Inst Pasteur, Unite Immunol Mol Parasites, Paris, France; [Van der Auwera, Gert] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Ravel, Christophe] Ctr Natl Reference Leishmanioses, Montpellier, France; [Thellier, Marc; Jaureguiberry, Stephane; Caumes, Eric; Mazier, Dominique; Marinach-Patrice, Carine; Buffet, Pierre] Univ Paris 06, UMR S945, Paris, France; [Thellier, Marc; Mazier, Dominique; Marinach-Patrice, Carine; Buffet, Pierre] INSERM, Paris, France; [Jaureguiberry, Stephane; Caumes, Eric] Grp Hosp Pitie Salpetriere, AP HP, Serv Malad Infect, F-75634 Paris, France	Mouri, O (reprint author), Grp Hosp Pitie Salpetriere, AP HP, Serv Parasitol Mycol, F-75634 Paris, France.	pierre.buffet@upmc.fr	Buffet, Pierre/O-6189-2017; Ravel, Christophe/A-7369-2008	Buffet, Pierre/0000-0003-4010-929X; Thellier, Marc/0000-0003-4867-2423	foundation Follereau	This work has been supported by the foundation Follereau (http://www.raoul-follereau.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen EM, 2005, AM J TROP MED HYG, V72, P133, DOI 10.4269/ajtmh.2005.72.133; Arana BA, 2001, AM J TROP MED HYG, V65, P466, DOI 10.4269/ajtmh.2001.65.466; Arevalo J, 2007, J INFECT DIS, V195, P1846, DOI 10.1086/518041; Ben Salah A, 2013, NEW ENGL J MED, V368, P524, DOI 10.1056/NEJMoa1202657; Ben Salah A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000432; Bizzini A, 2010, CLIN MICROBIOL INFEC, V16, P1614, DOI 10.1111/j.1469-0691.2010.03311.x; Blum J, 2012, INT HEALTH, V4, P153, DOI 10.1016/j.inhe.2012.06.004; Blum JA, 2009, J TRAVEL MED, V16, P123, DOI 10.1111/j.1708-8305.2008.00286.x; Buchan BW, 2013, J CLIN MICROBIOL, V51, P1359, DOI 10.1128/JCM.03105-12; Buffet P, 2012, ANN DERMATOL VENER, V139, P515, DOI 10.1016/j.annder.2012.07.001; BUFFET PA, 1995, ANTIMICROB AGENTS CH, V39, P2167, DOI 10.1128/AAC.39.9.2167; Buffet PA, PRESSE MED, V40, P173; Chouicha N, 1997, PARASITOLOGY, V115, P343, DOI 10.1017/S0031182097001376; CNUDDE F, 1994, AIDS, V8, P559; Dedet JP, 1995, T ROY SOC TROP MED H, V89, P644, DOI 10.1016/0035-9203(95)90427-1; El Baidouri F, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002255; Foulet F, 2007, J CLIN MICROBIOL, V45, P2110, DOI 10.1128/JCM.02555-06; Graca GC, 2012, MEM I O CRUZ, V107, P664; HERWALDT BL, 1992, J INFECT DIS, V165, P518, DOI 10.1093/infdis/165.3.518; Marinach-Patrice C, 2009, CLIN MICROBIOL INFEC, V15, P634, DOI 10.1111/j.1469-0691.2009.02758.x; Marinach-Patrice C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008862; Modabber Farrokh, 2007, Kinetoplastid Biol Dis, V6, P3, DOI 10.1186/1475-9292-6-3; Montalvo Alvarez AM, T R SOC TROP MED HYG, V104, P364; Montalvo AM, PARASITOLOGY, V137, P1159; Morizot G, 2013, CLIN INFECT DIS, V57, P370, DOI 10.1093/cid/cit269; Morizot G, 2007, AM J TROP MED HYG, V76, P48; NAVIN TR, 1992, J INFECT DIS, V165, P528, DOI 10.1093/infdis/165.3.528; NAVIN TR, 1990, AM J TROP MED HYG, V42, P43, DOI 10.4269/ajtmh.1990.42.43; NEAL RA, 1995, J ANTIMICROB CHEMOTH, V35, P577, DOI 10.1093/jac/35.5.577; Pratlong F, 2009, TROP MED INT HEALTH, V14, P1071, DOI 10.1111/j.1365-3156.2009.02336.x; Romero GAS, 2001, AM J TROP MED HYG, V65, P456, DOI 10.4269/ajtmh.2001.65.456; Rotureau B, 2006, J CLIN MICROBIOL, V44, P459, DOI 10.1128/JCM.44.2.459-467.2006; Saravia NG, 1998, AM J TROP MED HYG, V59, P86, DOI 10.4269/ajtmh.1998.59.86; Seng P, 2013, J CLIN MICROBIOL, V51, P2182, DOI 10.1128/JCM.00492-13; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Shao Changli, 2012, Am J Biomed Sci, V4, P85; SOTO J, 1994, AM J TROP MED HYG, V50, P107, DOI 10.4269/ajtmh.1994.50.107; World Health Organization, 2011, WHO TECHN REP SER, V949, P1	38	11	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUN	2014	8	6							e2841	10.1371/journal.pntd.0002841				11	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AL0VW	WOS:000338846100006	24902030	DOAJ Gold, Green Published			2019-04-02	
J	Ngoyi, DM; Ekangu, RA; Kodi, MFM; Pyana, PP; Balharbi, F; Decq, M; Betu, VK; Van der Veken, W; Sese, C; Menten, J; Buscher, P; Lejon, V				Ngoyi, Dieudonne Mumba; Ekangu, Rosine Ali; Kodi, Marie France Mumvemba; Pyana, Patient Pati; Balharbi, Fatima; Decq, Melanie; Betu, Victor Kande; Van der Veken, Wim; Sese, Claude; Menten, Joris; Buscher, Philippe; Lejon, Veerle			Performance of Parasitological and Molecular Techniques for the Diagnosis and Surveillance of Gambiense Sleeping Sickness	PLOS NEGLECTED TROPICAL DISEASES			English	Article							TRYPANOSOMA-BRUCEI-GAMBIENSE; HUMAN AFRICAN TRYPANOSOMIASIS; EXCHANGE CENTRIFUGATION TECHNIQUE; IMMUNE TRYPANOLYSIS TEST; CARD-AGGLUTINATION-TEST; EPIDEMIOLOGIC SURVEILLANCE; HUMAN INFECTIONS; COTE-DIVOIRE; CATT; PCR	Objectives: Recently, improvements have been made to diagnostics for gambiense sleeping sickness control but their performance remains poorly documented and may depend on specimen processing prior to examination. In a prospective study in the Democratic Republic of the Congo, we compared the diagnostic performance of several parasite detection techniques, immune trypanolysis and of m18S PCR on whole blood stored in a stabilisation buffer or dried on filter paper. Methods: Individuals with CATT whole blood (WB) titer >= 1:4 or with clinical signs indicative for sleeping sickness were examined for presence of trypanosomes in lymph node aspirate (LNA) and/or in blood. Blood was examined with Capillary Centrifugation Technique (CTC), mini-Anion Exchange Centrifugation Technique (mAECT) and mAECT on buffy coat (BC). PCR was performed on whole blood (i) stored in guanidine hydrochloride EDTA (GE) stabilisation buffer and (ii) dried on filter paper, and repeatability and reproducibility were assessed. Immune trypanolysis (TL) was performed on plasma. Results: A total of 237 persons were included. Among 143 parasitologically confirmed cases, 85.3% had a CATT-WB titre of >= 1/8, 39.2% were positive in LNA, 47.5% in CTC, 80.4% in mAECT-WB, 90.9% in mAECT-BC, 95.1% in TL and up to 89.5% in PCR on GE-stabilised blood. PCR on GE-stabilised blood showed highest repeatability (87.8%) and inter-laboratory reproducibility (86.9%). Of the 94 non-confirmed suspects, respectively 39.4% and 23.4% were TL or PCR positive. Suboptimal specificity of PCR and TL was also suggested by latent class analysis. Conclusion: The combination of LNA examination with mAECT-BC offered excellent diagnostic sensitivity. For PCR, storage of blood in stabilisation buffer is to be preferred over filter paper. TL as well as PCR are useful for remote diagnosis but are not more sensitive than mAECT-BC. For TL and PCR, the specificity, and thus usefulness for management of non-confirmed suspects remain to be determined.	[Ngoyi, Dieudonne Mumba; Ekangu, Rosine Ali; Kodi, Marie France Mumvemba; Pyana, Patient Pati] Inst Natl Rech Biomed, Dept Parasitol, Kinshasa, Zaire; [Ngoyi, Dieudonne Mumba] Univ Kinshasa, Dept Trop Med, Kinshasa, Zaire; [Balharbi, Fatima; Decq, Melanie; Buscher, Philippe] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Betu, Victor Kande; Van der Veken, Wim; Sese, Claude] Programme Natl Lutte Contre Trypanosomiase Humain, Kinshasa, Zaire; [Menten, Joris] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Lejon, Veerle] Inst Rech Dev, UMR IRD CIRAD INTERTRYP 177, Montpellier, France	Ngoyi, DM (reprint author), Inst Natl Rech Biomed, Dept Parasitol, Kinshasa, Zaire.	pbuscher@itg.be	Buscher, Philippe/B-9956-2012	Buscher, Philippe/0000-0002-1926-7472; Lejon, Veerle/0000-0002-6795-0962	Belgian Directorate General for Development Cooperation 2nd Framework Agreement	The study received financial support from the Belgian Directorate General for Development Cooperation 2nd Framework Agreement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HA, 2011, PARASITE VECTOR, V4, pe68; Belgian Technical Cooperation, 2009, TECHN FIN DOSS BIL B; Buscher P, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000471; Buscher P, 2013, NEW ENGL J MED, V368, P1069, DOI 10.1056/NEJMc1210373; Camara M, 2010, TROP MED INT HEALTH, V15, P796, DOI 10.1111/j.1365-3156.2010.02546.x; Camara O, 2014, TROP MED INT HEALTH, V19, P828, DOI 10.1111/tmi.12316; Chappuis F, 2005, CLIN MICROBIOL REV, V18, P133, DOI 10.1128/CMR.18.1.133-146.2005; Chappuis F, 2004, AM J TROP MED HYG, V71, P313, DOI 10.4269/ajtmh.2004.71.313; Deborggraeve S, 2006, J CLIN MICROBIOL, V44, P2884, DOI 10.1128/JCM.02594-05; Deborggraeve S, 2012, EXPERT REV MOL DIAGN, V12, P719, DOI [10.1586/erm.12.72, 10.1586/ERM.12.72]; Deborggraeve S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000972; Frank Janet C, 2014, Policy Brief UCLA Cent Health Policy Res, P1; Jamonneau V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001691; Jamonneau V, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000917; Koffi M, 2006, ACTA TROP, V98, P183, DOI 10.1016/j.actatropica.2006.04.001; LACHIN JM, 1981, CONTROL CLIN TRIALS, V2, P93, DOI 10.1016/0197-2456(81)90001-5; LANHAM SM, 1970, EXP PARASITOL, V28, P521, DOI 10.1016/0014-4894(70)90120-7; Lumbala C, 2013, ANN AFRICAINES ME S1, V6, P49; LUMSDEN WHR, 1979, T ROY SOC TROP MED H, V73, P312, DOI 10.1016/0035-9203(79)90092-0; Lutumba P, 2006, TROP MED INT HEALTH, V11, P470, DOI [10.1111/j.1365-3156.2006.01591.x, 10.1111/j.1365-3159.2006.01591.x]; MAGNUS E, 1978, ANN SOC BELG MED TR, V58, P169; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; MIEZAN TW, 1994, B SOC PATHOL EXOT, V87, P101; Mugasa CM, 2010, TROP MED INT HEALTH, V15, P800, DOI [10.1111/0365-3156.2010.02547.x, 10.1111/j.1365-3156.2010.02547.x]; Mumba D, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001246; Njiru ZK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001572; PNLTHA, 2008, ANN REP 2008 BIL BEL; R Core Team, 2013, R LANG ENV STAT COMP; Robays J, 2004, TROP MED INT HEALTH, V9, P542, DOI 10.1111/j.1365-3156.2004.01240.x; Simarro PP, 2013, RES REP TROP MED, V4, P1, DOI 10.2147/RRTM.S40157; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Simarro PP, 1999, TROP MED INT HEALTH, V4, P858, DOI 10.1046/j.1365-3156.1999.00494.x; Solano P, 2002, ACTA TROP, V82, P349, DOI 10.1016/S0001-706X(02)00029-3; StataCorp, 2011, STAT STAT SOFTW REL; The Cooperation Council, 2012, COOP TECHN BELG RAPP, P1; van Smeden M, 2014, AM J EPIDEMIOL, V179, P423, DOI 10.1093/aje/kwt286; VanMeirvenne N, 1995, ACTA TROP, V60, P189, DOI 10.1016/0001-706X(95)00127-Z; Woo P. T. K., 1970, Acta trop., V27, P384; World Health Organization, 2013, World Health Organ Tech Rep Ser, P1	39	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUN	2014	8	6							e2954	10.1371/journal.pntd.0002954				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AL0VW	WOS:000338846100059	24921941	DOAJ Gold, Green Published			2019-04-02	
J	Ravinetto, RM				Ravinetto, Raffaella M.			Poor-quality medicines: from knowledge to control and prevention comment	PATHOGENS AND GLOBAL HEALTH			English	Editorial Material									[Ravinetto, Raffaella M.] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Ravinetto, Raffaella M.] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium	Ravinetto, RM (reprint author), Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.	rravinetto@itg.be					Bonati M, 2009, ARCH DIS CHILD, V94, P468, DOI 10.1136/adc.2009.158659; Caudron JM, 2008, TROP MED INT HEALTH, V13, P1062, DOI 10.1111/j.1365-3156.2008.02106.x; Gillet P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-39; Newton PN, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001139; Tabernero P, 2014, MAL J, V13, P19	5	0	0	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	2047-7724	2047-7732		PATHOG GLOB HEALTH	Pathog. Glob. Health	JUN	2014	108	4					171	172		10.1179/2047772414Z.000000000207				2	Public, Environmental & Occupational Health; Parasitology; Tropical Medicine	Public, Environmental & Occupational Health; Parasitology; Tropical Medicine	AK5XR	WOS:000338500900002	24954880	Green Published			2019-04-02	
J	Guha-Sapir, D; Burkle, FM				Guha-Sapir, Debarati; Burkle, Frederick M., Jr.			Health Trends in Iraq with a Focus on Children: No Cause for Optimism	JOURNAL OF TROPICAL PEDIATRICS			English	Editorial Material									[Guha-Sapir, Debarati] Catholic Univ Louvain, Ctr Res Epidemiol Disasters CRED, Inst Hlth & Soc IRSS, B-1200 Brussels, Belgium; [Burkle, Frederick M., Jr.] Harvard Univ, Sch Publ Hlth, Harvard Humanitarian Initiat, Cambridge, MA 02138 USA; [Burkle, Frederick M., Jr.] Woodrow Wilson Int Ctr Scholars, Washington, DC 20560 USA	Guha-Sapir, D (reprint author), Catholic Univ Louvain, Ctr Res Epidemiol Disasters CRED, Inst Hlth & Soc IRSS, B-1200 Brussels, Belgium.	debby.sapir@uclouvain.be; fburkle@hsph.harvard.edu					Al-Hadad SA, 2011, J PEDIAT HEMATOL ONC, V33, pS154, DOI 10.1097/MPH.0b013e318230e218; Alaani S, 2011, IRAQ CONFL HEALTH, V5, P15, DOI DOI 10.1186/1752-1505-5-15; Alrifai S. B., 2010, Eastern Mediterranean Health Journal, V16, P546; Burkle F, 2013, LANCET, V381, P877, DOI 10.1016/S0140-6736(12)62196-5; Burnham GM, 2009, SOC SCI MED, V69, P172, DOI 10.1016/j.socscimed.2009.05.021; Cetorelli V, 2015, J EPIDEMIOL COMMUN H, V69, P226, DOI 10.1136/jech-2013-203174; Federal Research Division, 2006, COUNTR STUD IR LIB C; Hagopian A, 2010, AM J PUBLIC HEALTH, V100, P1081, DOI 10.2105/AJPH.2009.164236; Jases J, 2012, INT J INFECT DIS, V16, P166; Republic of Iraq Ministry of Health UNICEF, 2012, IR MULT IND CLUST; Spinella PC, 2008, CRIT CARE MED, V36, pS293, DOI 10.1097/CCM.0b013e31817da99f; WHO, 2012, COUTN HLTH PFOF	12	0	0	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0142-6338	1465-3664		J TROP PEDIATRICS	J. Trop. Pediatr.	JUN	2014	60	3					177	178		10.1093/tropej/fmu027				2	Pediatrics; Tropical Medicine	Pediatrics; Tropical Medicine	AI7MM	WOS:000337075700001	24848997	Bronze			2019-04-02	
J	Ooms, G; Hammonds, R				Ooms, Gorik; Hammonds, Rachel			Right to health and global public health research: from tensions to synergy?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Editorial Material						right to health; global public health; universal health coverage; human rights; droit a la sante; loi international sur les droits de; l'homme; couverture sante universelle; Derecho a la salud; ley internacional de derechos humanos; cobertura universal de salud	STRATEGY	La sante publique est la science et l'art de prevenir les maladies, de prolonger la vie et de promouvoir la sante grace aux efforts organises de la societe, alors que la loi internationale sur les droits de l'homme defini ce que les gouvernements peuvent faire de nous, ne peuvent pas faire de nous et devraient faire our nous. Applique au droit a la sante, cela signifie, que la loi internationale sur les droits de l'homme defini ce que les gouvernements devraient et ne devraient pas faire pour promouvoir la sante des personnes: ainsi, algre leurs origines tres differentes les deux concepts sont assez similaires. Cet article explore les differences entre les deux concepts afin de mieux comprendre la tension naturelle entre eux. Deuxiemement, il examine comment cette tension est accrue quand les deux concepts interagissent a l'echelle mondiale, en analysant trois cas. Enfin, les implications possibles sur la couverture sante universelle sont considerees dans le cas oU les chercheurs en sante publique et ceux sur le droit a la sante travailleraient ensemble. La Salud Publica es la ciencia y el arte de prevenir enfermedades, prolongar la y promover la salud mediante esfuerzos organizados de la sociedad, ientras que la ley internacional de derechos humanos tiene que ver con definir aquello que los nos pueden hacer, lo que no nos pueden hacer y lo que deberian hacer por . Aplicado al derecho a la salud, ello quiere decir que la ley internacional de humanos tiene que ver con lo que los gobiernos deberian y no deberian para promover la salud de las personas: por lo tanto a pesar de tener origenes tan , los dos conceptos son bastante similares. Este articulo explora las diferencias los dos conceptos, para entender mejor la tension natural entre ellos. En segundo explora, mediante tres ejemplos, como esta tension es maxima cuando uan a nivel global. Finalmente, se consideran las posibles implicaciones en la universal de salud si los nvestigadores en salud publica y los intelectuales -derecho a la salud trabajasen juntos.	[Ooms, Gorik; Hammonds, Rachel] Univ Antwerp, Inst Trop Med, Law & Dev Res Grp, B-2020 Antwerp, Belgium	Ooms, G (reprint author), Inst Trop Med, 155 Natl Str, B-2000 Antwerp, Belgium.	gooms@itg.be	Ooms, Gorik/A-2537-2015	Ooms, Gorik/0000-0002-9804-0128			ACHESON ED, 1988, PUBLIC HEALTH, V102, P431, DOI 10.1016/S0033-3506(88)80080-5; Bennet B, 2013, LOGICALLY FALLACIOUS, P59; CAMPBELL O, 2006, LANCET, V367, P368; CESCR, 2013, CONCL OBS 4 PER REP; Costello A, 2006, LANCET, V368, P1477, DOI 10.1016/S0140-6736(06)69388-4; Detels R, 2009, OXFORD TXB PUBLIC HL; Fidler DP, 2010, CHALLENGES GLOBAL HL; Garrett L, 2009, LANCET, V374, P1294, DOI 10.1016/S0140-6736(09)61503-8; Gruskin S, 2002, AIDS AFRICA, P641; Marseille E, 2002, LANCET, V359, P1851, DOI 10.1016/S0140-6736(02)08705-6; Nozick Robert, 1974, ANARCHY STATE UTOPIA; Ooms G, 2013, B WORLD HEALTH ORGAN, V91, P2, DOI 10.2471/BLT.12.115808; Pinstrup-Andersen P, 1987, ADJUSTMENT HUMAN FAC, V1; Schurz G., 1997, IS OUGHT PROBLEM INV; United Nations, 1966, INT COV EC SOC CULT; United Nations High Commisssioner for Human Rights, 2012, AHRC2122 UN GEN ASS; WALSH JA, 1979, NEW ENGL J MED, V301, P967, DOI 10.1056/NEJM197911013011804; Wolff J, 2012, HUMAN RIGHT HLTH, P16; World Health Organization, 2013, WORLD HLTH STAT 2013	19	3	3	0	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	JUN	2014	19	6					620	624		10.1111/tmi.12287				5	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	AG2GJ	WOS:000335234000001					2019-04-02	
J	van der Werff, SD; Vereecken, K; van der Laan, K; Ponce, MC; Diaz, RJ; Nunez, FA; Rivero, LR; Gorbea, MB; Polman, K				van der Werff, Suzanne D.; Vereecken, Kim; van der Laan, Kim; Ponce, Maiza Campos; Junco Diaz, Raquel; Nunez, Fidel A.; Rojas Rivero, Lazara; Bonet Gorbea, Mariano; Polman, Katja			Impact of periodic selective mebendazole treatment on soiltransmitted helminth infections in Cuban schoolchildren	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						Cuba; effectiveness; mebendazole; schoolchildren; selective treatment; soil-transmitted helminths; Cuba; efficacite; mebendazole; ecoliers; traitement selectif; geohelminthes; Cuba; efectividad; mebendazol; ninos escolares; tratamiento selectivo; helmintos transmitidos por helmintos transmitidos por el suelo	SOIL-TRANSMITTED HELMINTHIASIS; TARGETED CHEMOTHERAPY; GEOHELMINTH INFECTION; MASS CHEMOTHERAPY; PROGNOSTIC MODEL; RISK-FACTORS; CHILDREN; PREVALENCE; SCHISTOSOMIASIS; ALBENDAZOLE	ObjectiveTo evaluate the impact of periodic selective treatment with 500mg mebendazole on soil-transmitted helminth (STH) infections in Cuban schoolchildren. MethodsWe followed up a cohort of 268 STH-positive schoolchildren, aged 5-14years at baseline, at six-month intervals for two years and a final follow-up after three years. Kato-Katz stool examination was used to detect infections with Ascaris lumbricoides, Trichuris trichiura and hookworm. Common risk factors related to STHs were assessed by parental questionnaire. ResultsA significant reduction in the number of STH infections was obtained after three years with the highest reduction for T.trichiura (87.8%) and the lowest for hookworm (57.9%). After six months, cure rates (CRs) were 76.9% for A.lumbricoides, 67.4% for T.trichiura and 44.4% for hookworm. After two treatment rounds, more than 75% of all STH-positive children at baseline were cured, but with important differences between STH species (95.2% for A.lumbricoides, 80.5% for T.trichiura and 76.5% for hookworm). At the end of the study, these cumulative CRs were almost 100% for all three STHs. Risk factors for STHs were sex, sanitary disposal and habit of playing in the soil. ConclusionsOur results indicate that periodic selective treatment with 500mg mebendazole is effective in reducing the number of STH infections in Cuban schoolchildren. Although important differences were found between helminth species, two rounds of treatment appeared sufficient to obtain substantial reductions.	[van der Werff, Suzanne D.; van der Laan, Kim; Ponce, Maiza Campos; Polman, Katja] Vrije Univ Amsterdam, Dept Hlth Sci, NL-1081 HV Amsterdam, Netherlands; [van der Werff, Suzanne D.; Vereecken, Kim; Polman, Katja] Prince Leopold Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Junco Diaz, Raquel; Bonet Gorbea, Mariano] Natl Inst Hyg Epidemiol & Microbiol, Havana, Cuba; [Nunez, Fidel A.; Rojas Rivero, Lazara] Pedro Kouri Inst, Havana, Cuba	van der Werff, SD (reprint author), Vrije Univ Amsterdam, Dept Hlth Sci, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	suzanne.vander.werff@vu.nl		Campos Ponce, Maiza/0000-0003-1700-4756	Directorate-General for Development	We thank Raul A. Cordovi Prado for his assistance in the parasitological examinations. We also thank Meike Wordemann, Lenina Menocal Heredia and Ana Maria Collado Madurga for their valuable help during the study. Furthermore, we thank all children, parents, teachers, school staff, the staff in the policlinics, the health authorities and all field workers in SJM and Fomento who participated in this study. The work was financed by a grant of the Directorate-General for Development. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Albonico M, 1996, B WORLD HEALTH ORGAN, V74, P577; Albonico M, 2002, ANN TROP MED PARASIT, V96, P717, DOI 10.1179/000349802125001942; Altman DG, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b605; [Anonymous], 2006, PREV CHEM HUM HELM C; Asaolu SO, 2003, ACTA TROP, V86, P283, DOI 10.1016/S0001-706X(03)00060-3; Awasthi S, 2003, BMJ-BRIT MED J, V327, P431, DOI 10.1136/bmj.327.7412.431; Beltramino Daniel, 2003, Rev Panam Salud Publica, V13, P10, DOI 10.1590/S1020-49892003000100002; Bennett A, 2000, PARASITOL TODAY, V16, P71, DOI 10.1016/S0169-4758(99)01544-6; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; BUNDY DAP, 1990, T ROY SOC TROP MED H, V84, P115, DOI 10.1016/0035-9203(90)90399-Y; Curtale F, 1995, PANMINERVA MED, V37, P214; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; ELKINS DB, 1988, PARASITOLOGY, V96, P171, DOI 10.1017/S0031182000081749; Escobedo AA, 2007, TROP DOCT, V37, P236, DOI 10.1258/004947507782332991; Fajardo Toledo E, 1978, REV CUBA MED TROP, V30, P25; Fallah M, 2002, B WORLD HEALTH ORGAN, V80, P399; Fenwick A, 2006, T ROY SOC TROP MED H, V100, P200, DOI 10.1016/j.trstmh.2005.03.014; Fernando S. D., 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P23; Geary TG, 2010, INT J PARASITOL, V40, P1, DOI 10.1016/j.ijpara.2009.11.001; Hotez PJ, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P467; Idris MA, 2001, ACTA TROP, V80, P139, DOI 10.1016/S0001-706X(01)00168-1; Kabatereine NB, 2006, TRENDS PARASITOL, V22, P332, DOI 10.1016/j.pt.2006.05.001; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Keiser J, 2011, PARASITOLOGY, V138, P1620, DOI 10.1017/S0031182011000023; Massa K, 2009, T ROY SOC TROP MED H, V103, P31, DOI 10.1016/j.trstmh.2008.07.009; Montresor A, 2003, ACTA TROP, V86, P223, DOI 10.1016/S0001-706X(03)00042-1; Montresor A, 1998, GUIDELINES EVALUATIO; Montresor A, 2002, HELMINTH CONTROL SCH; Ndenecho L, 2002, East Afr Med J, V79, P442; Nunez Fernandez F.A., 1989, REV CUBA MED TROP, V41, P371; [Organization W.H. WHO], 2011, WHO MOD LISTS ESS ME; Polderman AM, 2005, MED PARASITOLOGIE HA, P229; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Saathoff E, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-27; San Sebastian M, 2000, Rev Soc Bras Med Trop, V33, P69; Sinuon Muth, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P254; Stothard JR, 2009, T ROY SOC TROP MED H, V103, P1031, DOI 10.1016/j.trstmh.2009.03.024; TAYLOR M, 1995, S AFR MED J, V85, P870; Traub RJ, 2004, TROP MED INT HEALTH, V9, P688, DOI 10.1111/j.1365-3156.2004.01252.x; Waikagul Jitra, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P1008; WHO, 1999, REP WHO INF CONS MON; WHO, 2002, WHO TECHN REP SER; Wordemann M, 2006, TROP MED INT HEALTH, V11, P1813, DOI 10.1111/j.1365-3156.2006.01745.x; Wordemann M, 2008, TROP MED INT HEALTH, V13, P180, DOI 10.1111/j.1365-3156.2007.01988.x; World Health Organization, 2005, 3 GLOB M PARTN PAR C; World Health Organization (WHO), 1991, BAS LAB METH MED PAR; Zani Luciana Carvalho, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P63, DOI 10.1590/S0036-46652004000200002; Zhang Y, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-27	49	5	5	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	JUN	2014	19	6					706	718		10.1111/tmi.12290				13	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	AG2GJ	WOS:000335234000010		Bronze			2019-04-02	
J	Tinto, H; Bonkian, LN; Nana, LA; Yerbanga, I; Lingani, M; Kazienga, A; Valea, I; Sorgho, H; Kpoda, H; Guiguemde, TR; Ouedraogo, JB; Mens, PF; Schallig, H; D'Alessandro, U				Tinto, Halidou; Bonkian, Lea N.; Nana, Louis A.; Yerbanga, Isidore; Lingani, Moussa; Kazienga, Adama; Valea, Innocent; Sorgho, Hermann; Kpoda, Herve; Guiguemde, Tinga Robert; Ouedraogo, Jean Bosco; Mens, Petronella F.; Schallig, Henk; D'Alessandro, Umberto			Ex vivo anti-malarial drugs sensitivity profile of Plasmodium falciparum field isolates from Burkina Faso five years after the national policy change	MALARIA JOURNAL			English	Article							PLUS SULFADOXINE-PYRIMETHAMINE; IN-VITRO SUSCEPTIBILITY; COMBINATION THERAPY; ARTEMETHER-LUMEFANTRINE; MOLECULAR EPIDEMIOLOGY; UNCOMPLICATED MALARIA; RESISTANT MALARIA; RANDOMIZED-TRIAL; CENTRAL-AFRICA; AMODIAQUINE	Background: The recent reports on the decreasing susceptibility of Plasmodium falciparum to artemisinin derivatives along the Thailand and Myanmar border are worrying. Indeed it may spread to India and then Africa, repeating the same pattern observed for chloroquine resistance. Therefore, it is essential to start monitoring P. falciparum sensitivity to artemisinin derivatives and its partner drugs in Africa. Efficacy of AL and ASAQ were tested by carrying out an in vivo drug efficacy test, with an ex vivo study against six anti-malarial drugs nested into it. Results of the latter are reported here. Methods: Plasmodium falciparum ex-vivo susceptibility to chloroquine (CQ), quinine (Q), lumefantrine (Lum), monodesethylamodiaquine (MDA), piperaquine (PPQ) and dihydroartemisinin (DHA) was investigated in children (6 months - 15 years) with a parasitaemia of at least >= 4,000/mu l. The modified isotopic microtest technique was used. The results of cellular proliferation were analysed using ICEstimator software to determine the 50% inhibitory concentration (IC50) values. Results: DHA was the most potent among the 6 drugs tested, with IC50 values ranging from 0.8 nM to 0.9 nM (Geometric mean IC50 = 0.8 nM; 95% CI [0.8 - 0.9]). High IC50 values ranged between 0.8 nM to 166.1 nM were reported for lumefantrine (Geometric mean IC50 = 25.1 nM; 95% CI [22.4 - 28.2]). MDA and Q IC50s were significantly higher in CQ-resistant than in CQ-sensitive isolates (P = 0.0001). However, the opposite occurred for Lum and DHA (P < 0.001). No difference was observed for PPQ. Conclusion: Artemisinin derivatives are still very efficacious in Burkina Faso and DHA-PPQ seems a valuable alternative ACT. The high lumefantrine IC50 found in this study is worrying as it may indicate a decreasing efficacy of one of the first-line treatments. This should be further investigated and monitored over time with large in vivo and ex vivo studies that will include also plasma drug measurements.	[Tinto, Halidou; Bonkian, Lea N.; Valea, Innocent; Kpoda, Herve; Guiguemde, Tinga Robert; Ouedraogo, Jean Bosco] Ctr Muraz, Unite Rech Paludisme & Malad Trop Negligees, Bobo Dioulasso, Burkina Faso; [Tinto, Halidou; Sorgho, Hermann; Ouedraogo, Jean Bosco] IRSS DRO, Bobo Dioulasso, Burkina Faso; [Tinto, Halidou; Nana, Louis A.; Yerbanga, Isidore; Lingani, Moussa; Kazienga, Adama; Valea, Innocent; Sorgho, Hermann; Guiguemde, Tinga Robert] Clin Res Unit Nanoro IRSS CRUN, Nanoro, Burkina Faso; [Guiguemde, Tinga Robert] Inst Super Sci Sante INSSA, Bobo Dioulasso, Burkina Faso; [Mens, Petronella F.; Schallig, Henk] KIT, Royal Trop Inst, Amsterdam, Netherlands; [D'Alessandro, Umberto] MRC Unit, Fajara, Gambia; [D'Alessandro, Umberto] Prince Leopold Inst Trop Med, Antwerp, Belgium	Sorgho, H (reprint author), IRSS DRO, Bobo Dioulasso, Burkina Faso.	hsorgho@hotmail.com	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009; Tinto, Halidou/0000-0002-0472-3586	European Union Framework Program 7 (FP7)	This study was funded by the European Union Framework Program 7 (FP7) through the grant attributed to the MALACTRES Project (www.malactres.eu).	Anderson T, 2009, PLOS MED, V6, P2; Aubouy A, 2004, AM J TROP MED HYG, V71, P294, DOI 10.4269/ajtmh.2004.71.294; Barennes H, 2004, TROP MED INT HEALTH, V9, P438, DOI 10.1111/j.1365-3156.2004.01224.x; Basco LK, 2007, AM J TROP MED HYG, V76, P20, DOI 10.4269/ajtmh.2007.76.20; Basco LK, 2003, ANTIMICROB AGENTS CH, V47, P1391, DOI 10.1128/AAC.47.4.1391-1394.2003; Basco LK, 2002, AM J TROP MED HYG, V66, P117, DOI 10.4269/ajtmh.2002.66.117; Borrmann S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026005; Brasseur P, 1999, T ROY SOC TROP MED H, V93, P645, DOI 10.1016/S0035-9203(99)90083-4; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Fall B, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-107; Fall B, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-310; Four T, 2011, PLOS MED, V8; Fule Ritesh, 2013, Journal of Pharmaceutical Investigation, V43, P305, DOI 10.1007/s40005-013-0078-z; Gansane A, 2009, Bull Soc Pathol Exot, V102, P31, DOI 10.3185/pathexo3235; Gharbi M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-35; Gorissen E, 2000, TROP MED INT HEALTH, V5, P459, DOI 10.1046/j.1365-3156.2000.00570.x; Kublin JG, 2003, J INFECT DIS, V187, P1870, DOI 10.1086/375419; Lim P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-11; Maude RJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-31; Mwai L, 2009, ANTIMICROB AGENTS CH, V53, P5069, DOI 10.1128/AAC.00638-09; Na-Bangchang K, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-273; Noedl H, 2010, CLIN INFECT DIS, V51, P82; Nsobya SL, 2010, ANTIMICROB AGENTS CH, V54, P1200, DOI 10.1128/AAC.01412-09; Ouedraogo JB, 2003, TROP MED INT HEALTH, V3, P159; Pascual A, 2012, MALARIA J, V11, P9; Pettinelli FO, 2004, AM J TROP MED HYG, V70, P635, DOI 10.4269/ajtmh.2004.70.635; Pradines B, 1998, J ANTIMICROB CHEMOTH, V42, P333, DOI 10.1093/jac/42.3.333; Pradines B, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-268; Ringwald P, 1999, J CLIN MICROBIOL, V37, P700; Rogers WO, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-10; Shretta R, 2000, TROP MED INT HEALTH, V5, P755, DOI 10.1046/j.1365-3156.2000.00643.x; Sibley CH, 2010, TRENDS PARASITOL, V26, P221, DOI 10.1016/j.pt.2010.02.008; Siribie M, 2012, Bull Soc Pathol Exot, V105, P202, DOI 10.1007/s13149-012-0209-6; Staedke SG, 2001, LANCET, V358, P368, DOI 10.1016/S0140-6736(01)05557-X; Tinto H, 2006, T ROY SOC TROP MED H, V100, P509, DOI 10.1016/j.trstmh.2005.09.018; Tinto H, 2002, TROP MED INT HEALTH, V7, P925, DOI 10.1046/j.1365-3156.2002.00952.x; White NJ, 1998, ANN TROP MED PARASIT, V92, P449; WHO (World Health Organization), 2007, GLOB TUB CONTR SURV, P23; Witkowski B, 2013, LANCET INFECT DIS, V13, P1043, DOI 10.1016/S1473-3099(13)70252-4; Woitsch B, 2007, WIEN KLIN WOCHENSCHR, V122, P76; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; World Health Organization, 2011, WHO TECHNICAL REPORT, P193; World Health Organization, 2010, GUID TREATM MAL, P166; Zongo I, 2007, CLIN INFECT DIS, V45, P1453, DOI 10.1086/522985; Zongo I, 2007, LANCET, V369, P491, DOI [10.1016/S0140-6736(07)60236-0, 10.1016/S0140-6736(07)60160-3]; Zwang J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-203	47	12	12	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	MAY 31	2014	13								207	10.1186/1475-2875-13-207				7	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AL1OZ	WOS:000338896100001	24885950	DOAJ Gold, Green Published			2019-04-02	
J	Levecke, B; Buttle, DJ; Behnke, JM; Duce, IR; Vercruysse, J				Levecke, Bruno; Buttle, David J.; Behnke, Jerzy M.; Duce, Ian R.; Vercruysse, Jozef			Cysteine proteinases from papaya (Carica papaya) in the treatment of experimental Trichuris suis infection in pigs: two randomized controlled trials	PARASITES & VECTORS			English	Article						Trichuris; Papaya; Cysteine proteinases; Ethno-medicine; Soil-transmitted helminths; Egg reduction rate; Worm reduction rate	SOIL-TRANSMITTED HELMINTHS; RODENT GASTROINTESTINAL NEMATODE; PLANT-PARASITIC NEMATODES; SINGLE-DOSE ALBENDAZOLE; IN-VIVO; ANTHELMINTIC EFFICACY; HELIGMOSOMOIDES-POLYGYRUS; SCHOOL-CHILDREN; MEBENDAZOLE; TRICHIURA	Background: Cysteine proteinases (CPs) from papaya (Carica papaya) possess anthelmintic properties against human soil-transmitted helminths (STH, Ascaris lumbricoides, Trichuris trichiura and hookworm), but there is a lack of supportive and up-to-date efficacy data. We therefore conducted two randomized controlled trials in pigs to assess the efficacy of papaya CPs against experimental infections with T. suis. Methods: First, we assessed efficacy by means of egg (ERR) and adult worm reduction rate (WRR) of a single-oral dose of 450 mu mol active CPs (CP450) against low (inoculum of 300 eggs) and high (inoculum of 3,000 eggs) intensity T. suis infections and compared the efficacy with those obtained after a single-oral dose of 400 mg albendazole (ALB). In the second trial, we determined and compared the efficacy of a series of CP doses (45 [CP45], 115 [CP115], 225 [CP225], and 450 [CP450] mu mol) against high intensity infections. Results: CP450 was highly efficacious against both levels of infection intensity, resulting in ERR and WRR of more than 97%. For both levels of infection intensity, CP450 was significantly more efficacious compared to ALB by means of WRR (low infection intensity: 99.0% vs. 39.0%; high infection intensity; 97.4% vs. 23.2%). When the efficacy was assessed by ERR, a significant difference was only observed for high intensity infections, CP450 being more efficacious than ALB (98.9% vs. 59.0%). For low infection intensities, there was no significant difference in ERR between CP450 (98.3%) and ALB (64.4%). The efficacy of CPs increased as a function of increasing dose. When determined by ERR, the efficacy ranged from 2.1% for CP45 to 99.2% for CP450. For WRR the results varied from - 14.0% to 99.0%, respectively. Pairwise comparison revealed a significant difference in ERR and WRR only between CP45 and CP450, the latter being more efficacious. Conclusions: A single dose of 450 mu mol CPs provided greater efficacy against T. suis infections in pigs than a single-oral dose of 400 mg ALB. Although these results highlight the possibility of papaya CPs for controlling human STH, further development is needed in order to obtain and validate an oral formulation for human application.	[Levecke, Bruno; Vercruysse, Jozef] Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, Merelbeke, Belgium; [Buttle, David J.] Univ Sheffield, Sch Med, Dept Expt & Clin Microbiol, Sheffield S10 2RX, S Yorkshire, England; [Behnke, Jerzy M.; Duce, Ian R.] Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England	Levecke, B (reprint author), Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, Salisburylaan 133, Merelbeke, Belgium.	bruno.levecke@UGent.be		Levecke, Bruno/0000-0001-8912-5595			Albonico M, 2003, B WORLD HEALTH ORGAN, V81, P343; Albonico M, 2002, T ROY SOC TROP MED H, V96, P685, DOI 10.1016/S0035-9203(02)90352-4; Asenjo CF, 1940, SCIENCE, V91, P387; Behnke JM, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-29; Belizario VY, 2003, B WORLD HEALTH ORGAN, V81, P35; Bennett A, 2000, PARASITOL TODAY, V16, P71, DOI 10.1016/S0169-4758(99)01544-6; Buttle DJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-36; BUTTLE DJ, 1990, BIOL CHEM H-S, V371, P1083, DOI 10.1515/bchm3.1990.371.2.1083; CAYGILL JC, 1979, ENZYME MICROB TECH, V1, P233, DOI 10.1016/0141-0229(79)90042-5; Dayan AD, 2003, ACTA TROP, V86, P141, DOI 10.1016/S0001-706X(03)00031-7; Geerts S, 2000, CLIN MICROBIOL REV, V13, P207, DOI 10.1128/CMR.13.2.207-222.2000; Humphries D, 2011, AM J TROP MED HYG, V84, P792, DOI 10.4269/ajtmh.2011.11-0003; JONXIS JHP, 1953, ARCH DIS CHILD, V28, P329, DOI 10.1136/adc.28.140.329; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Keiser J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002119; Knopp S, 2010, CLIN INFECT DIS, V51, P1420, DOI 10.1086/657310; Konno K, 2004, PLANT J, V37, P370, DOI [10.1046/j.1365-313X.2003.01968.x, 10.1111/j.1365-313X.2004.01968.x]; Levecke B, 2012, T ROY SOC TROP MED H, V106, P128, DOI 10.1016/j.trstmh.2011.09.007; Luoga W, J HELMINTHO IN PRESS; Mansur F, VET PARASIT IN PRESS; Mekonnen Z, 2013, PATHOG GLOB HEALTH, V107, P207, DOI 10.1179/2047773213Y.0000000092; MILLER PM, 1977, J NEMATOL, V9, P192; Ministry of Agriculture, 1986, FISH FOOD MAN VET PA; Namwanje H, 2011, T ROY SOC TROP MED H, V105, P586, DOI 10.1016/j.trstmh.2011.07.009; Olliaro P, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001138; Pritchard EI, 1971, P I FOOD SCI TECHNOL, V4, P118; Satrija F, 1995, J ETHNOPHARMACOL, V48, P161, DOI 10.1016/0378-8741(95)01298-R; Soukhathammavong PA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001417; Speich B, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001685; Steinmann P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000322; Steinmann P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025003; Stepek G, 2007, PARASITOLOGY, V134, P1409, DOI 10.1017/S0031182007002867; Stepek G, 2007, PARASITOLOGY, V134, P103, DOI 10.1017/S0031182006001302; Stepek G, 2007, PARASITOLOGY, V134, P1831, DOI 10.1017/S0031182007003289; Stepek G, 2006, PARASITOLOGY, V132, P681, DOI 10.1017/S003118200500973X; STRANSKY E, 1955, J Trop Pediatr (Lond), V1, P174; Tritten L, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001457; Vercruysse J, 2011, INT J PARASITOL-DRUG, V1, P14, DOI 10.1016/j.ijpddr.2011.09.002; Vercruysse J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000948; ZUCKER S, 1985, BIOCHIM BIOPHYS ACTA, V828, P196, DOI 10.1016/0167-4838(85)90057-3	40	13	14	0	8	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	MAY 30	2014	7								255	10.1186/1756-3305-7-255				8	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	AI5RK	WOS:000336926600001	24886388	DOAJ Gold, Green Published			2019-04-02	
J	Garros, C; Balenghien, T; Carpenter, S; Delecolle, JC; Meiswinkel, R; Pedarrieu, A; Rakotoarivony, I; Gardes, L; Golding, N; Barber, J; Miranda, M; Borras, DB; Goffredo, M; Monaco, F; Pages, N; Sghaier, S; Hammami, S; Calvo, JH; Lucientes, J; Geysen, D; De Deken, G; Monteys, VSI; Schwenkenbecher, J; Kampen, H; Hoffmann, B; Lehmann, K; Werner, D; Baldet, T; Lancelot, R; Cetre-Sossah, C				Garros, Claire; Balenghien, Thomas; Carpenter, Simon; Delecolle, Jean-Claude; Meiswinkel, Rudy; Pedarrieu, Aurelie; Rakotoarivony, Ignace; Gardes, Laetitia; Golding, Nick; Barber, James; Miranda, Miguel; Borras Borras, David; Goffredo, Maria; Monaco, Federica; Pages, Nonito; Sghaier, Soufien; Hammami, Salah; Calvo, Jorge H.; Lucientes, Javier; Geysen, Dirk; De Deken, Gill; Sarto i Monteys, Victor; Schwenkenbecher, Jan; Kampen, Helge; Hoffmann, Bernd; Lehmann, Kathrin; Werner, Doreen; Baldet, Thierry; Lancelot, Renaud; Cetre-Sossah, Catherine			Towards the PCR-based identification of Palaearctic Culicoides biting midges (Diptera: Ceratopogonidae): results from an international ring trial targeting four species of the subgenus Avaritia	PARASITES & VECTORS			English	Article						Culicoides; Subgenus Avaritia; Obsoletus group; Molecular identification	POLYMERASE-CHAIN-REACTION; BLUETONGUE VIRUS; OBSOLETUS COMPLEX; MOLECULAR-IDENTIFICATION; SCHMALLENBERG VIRUS; SCOTICUS DIPTERA; VECTORS; ASSAYS; OLIGOCHROMATOGRAPHY; DIFFERENTIATION	Background: Biting midges of the genus Culicoides (Diptera: Ceratopogonidae) are biological vectors of internationally important arboviruses. To understand the role of Culicoides in the transmission of these viruses, it is essential to correctly identify the species involved. Within the western Palaearctic region, the main suspected vector species, C. obsoletus, C. scoticus, C. dewulfi and C. chiopterus, have similar wing patterns, which makes it difficult to separate and identify them correctly. Methods: In this study, designed as an inter-laboratory ring trial with twelve partners from Europe and North Africa, we assess four PCR-based assays which are used routinely to differentiate the four species of Culicoides listed above. The assays based on mitochondrial or ribosomal DNA or microarray hybridisation were tested using aliquots of Culicoides DNA (extracted using commercial kits), crude lysates of ground specimens and whole Culicoides (265 individuals), and non-Culicoides Ceratopogonidae (13 individuals) collected from across Europe. Results: A total of 800 molecular assays were implemented. The in-house assays functioned effectively, although specificity and sensitivity varied according to the molecular marker and DNA extraction method used. The Obsoletus group specificity was overall high (95-99%) while the sensitivity varied greatly (59.6-100%). DNA extraction methods impacted the sensitivity of the assays as well as the type of sample used as template for the DNA extraction. Conclusions: The results are discussed in terms of current use of species diagnostic assays and the future development of molecular tools for the rapid differentiation of cryptic Culicoides species.	[Garros, Claire; Balenghien, Thomas; Pedarrieu, Aurelie; Rakotoarivony, Ignace; Gardes, Laetitia; Baldet, Thierry; Lancelot, Renaud; Cetre-Sossah, Catherine] Cirad, CMAEE UMR15, F-34398 Montpellier, France; [Garros, Claire; Balenghien, Thomas; Pedarrieu, Aurelie; Rakotoarivony, Ignace; Gardes, Laetitia; Baldet, Thierry; Lancelot, Renaud; Cetre-Sossah, Catherine] INRA, CMAEE UMR1309, F-34398 Montpellier, France; [Carpenter, Simon; Golding, Nick; Barber, James] Pirbright Inst, Pirbright, England; [Delecolle, Jean-Claude] Fac Med Strasbourg, IPPTS, Strasbourg, France; [Meiswinkel, Rudy] CIDC, Cent Inst Anim Dis, Lelystad, Netherlands; [Miranda, Miguel; Borras Borras, David] Univ Balearic Isl, UIB, Zool Lab, Palma De Mallorca, Spain; [Goffredo, Maria; Monaco, Federica] IZS, Ist Zooprofilat Sperimentale Abruzzo & Molise G C, Teramo, Italy; [Pages, Nonito] UAB IRTA, Ctr Recerca Sanitat Anim CReSA, Bellaterra, Cerdanyola Del, Spain; [Sghaier, Soufien; Hammami, Salah] Univ Tunis El Manar, IRVT, Inst Rech Vet Tunisie, Tunis, Tunisia; [Calvo, Jorge H.] CITA ARAID, Ctr Invest & Tecnol Agroalimentaria Aragon, Zaragoza, Spain; [Lucientes, Javier] Univ Zaragoza, Fac Vet, UZ, Zaragoza, Spain; [Geysen, Dirk; De Deken, Gill] Inst Trop Med, B-2000 Antwerp, Belgium; [Sarto i Monteys, Victor] Inst Ciencia & Tecnol Ambientals, Bellaterra, Spain; [Schwenkenbecher, Jan] Univ Aberdeen, Inst Biol & Environm Sci, IBES, Aberdeen, Scotland; [Kampen, Helge; Hoffmann, Bernd] FLI, Friedrich Loeffler Inst, Greifswald, Germany; [Lehmann, Kathrin] Humboldt Univ, D-10099 Berlin, Germany; [Werner, Doreen] Leibniz Ctr Agr Landscape Res ZALF, Muncheberg, Germany	Garros, C (reprint author), Cirad, CMAEE UMR15, F-34398 Montpellier, France.	garros@cirad.fr; balenghien@cirad.fr; cetre-sossah@cirad.fr	Monaco, Federica/G-9282-2016; Vita, Serafina/D-9445-2016; Institute, Pirbright/K-4476-2014; Carpenter, Simon/C-2718-2013; Pages, Nonito/Q-1274-2016	Monaco, Federica/0000-0002-7827-2642; Vita, Serafina/0000-0002-8045-1236; Carpenter, Simon/0000-0001-5775-045X; Pages, Nonito/0000-0001-6020-7175; Golding, Nick/0000-0001-8916-5570; Goffredo, Maria/0000-0002-6831-4167; Miranda, Miguel Angel/0000-0003-0770-2593; Calvo Lacosta, Jorge Hugo/0000-0001-9513-0219; SARTO I MONTEYS, VICTOR/0000-0003-2701-6558	European Commission [044285, SSPE-CT-2006-044285]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001445]	This work was funded by the MedReoNet Project No. 044285 from the Sixth Framework Programme of the European Commission, SSPE-CT-2006-044285. We thank the two anonymous reviewers for their useful comments.	Afonso A, 2014, PREV VET MED, DOI [10.1016/j.prevetmed.2014.02.01212, DOI 10.1016/J.PREVETMED.2014.02.01212]; Augot D, 2010, INFECT GENET EVOL, V10, P629, DOI 10.1016/j.meegid.2010.03.016; Balenghien T, 2014, PREV VET MED, DOI [10.1016/j.prevetmed.2014.03.00713, DOI 10.1016/J.PREVETMED.2014.03.00713]; Batten CA, 2008, VET MICROBIOL, V129, P80, DOI 10.1016/j.vetmic.2007.11.005; Carpenter S, 2008, VET REC, V163, P589, DOI 10.1136/vr.163.20.589; Carpenter S, 2006, J MED ENTOMOL, V43, P73, DOI 10.1603/0022-2585(2006)043[0073:OSTBVO]2.0.CO;2; Claes F, 2007, J CLIN MICROBIOL, V45, P3785, DOI 10.1128/JCM.01244-07; De Regge N, 2012, TRANSBOUND EMERG DIS, V59, P471, DOI 10.1111/tbed.12000; DeBlauwe I, 2012, MED VET ENTOMOL, V26, P83, DOI 10.1111/j.1365-2915.2011.00979.x; DELECOLLE J. C., 1985, NOUVELLE CONTRIBUTIO; Dijkstra E, 2008, VET REC, V162, P422, DOI 10.1136/vr.162.13.422-a; Elbers ARW, 2013, EMERG INFECT DIS, V19, P106, DOI 10.3201/eid1901.121054; Garros C, 2011, INFECT GENET EVOL, V11, P1103, DOI 10.1016/j.meegid.2011.04.002; Garros C, 2010, PARASITOL RES, V107, P731, DOI 10.1007/s00436-010-1921-z; Goffredo M, 2013, PREV VET MED, V111, P230, DOI 10.1016/j.prevetmed.2013.05.014; Gomez-Morales MA, 2009, VET PARASITOL, V166, P241, DOI 10.1016/j.vetpar.2009.09.005; Gomulski LM, 2005, SYST ENTOMOL, V30, P619, DOI 10.1111/j.1365-3113.2005.00286.x; Harrup LE, 2012, J MED ENTOMOL, V49, P112, DOI 10.1603/ME11145; Hjulsager CK, 2009, VET MICROBIOL, V133, P172, DOI 10.1016/j.vetmic.2008.06.014; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; Hoffmann B, 2009, EMERG INFECT DIS, V15, P1481, DOI 10.3201/eid1509.090562; Kaufmann C, 2012, PARASITOLOGY, V139, P248, DOI 10.1017/S0031182011001764; Lassen SB, 2012, PARASITOL RES, V110, P1765, DOI 10.1007/s00436-011-2697-5; Lehmann K, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-213; Mathieu B, 2007, J MED ENTOMOL, V44, P1019, DOI 10.1603/0022-2585(2007)44[1019:MIOWES]2.0.CO;2; Mathieu B, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-137; Mathieu B, 2011, VET PARASITOL, V182, P297, DOI 10.1016/j.vetpar.2011.05.052; Meiswinkel R, 2007, VET REC, V161, P564, DOI 10.1136/vr.161.16.564; Meiswinkel R, 2004, VETER ITAL SER, V40, P151; Meiswinkel R, 2014, MED VET ENTOMOL, V28, P10, DOI 10.1111/mve.12013; Mellor PS, 2009, BIOL ANIM INFECT, P235, DOI 10.1016/B978-012369368-6.50015-0; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; MELLOR PS, 1979, B ENTOMOL RES, V69, P229, DOI 10.1017/S0007485300017697; Monaco F, 2010, VET ITAL, V46, P215; MOORE DF, 1987, J R STAT SOC C-APPL, V36, P8; Mugasa CM, 2010, TROP MED INT HEALTH, V15, P800, DOI [10.1111/0365-3156.2010.02547.x, 10.1111/j.1365-3156.2010.02547.x]; Munoz-Munoz F, 2014, MED VET ENTOMOL, DOI [10.1111/mve.1204229, DOI 10.1111/MVE.1204229]; Nolan DV, 2007, VET MICROBIOL, V124, P82, DOI 10.1016/j.vetmic.2007.03.019; Pages N, 2005, J MED ENTOMOL, V42, P1026, DOI 10.1603/0022-2585(2005)042[1026:DOCOAC]2.0.CO;2; Pages N, 2009, VET PARASITOL, V165, P298, DOI 10.1016/j.vetpar.2009.07.020; R Development Core Team, 2008, INTR R NOT R PROGR E; Rawlings Peter, 1996, Graellsia, V52, P57; Sanders CJ, 2012, J MED ENTOMOL, V49, P757, DOI 10.1603/ME11259; Santolamazza F, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-215; Savini G, 2005, VET REC, V157, P133, DOI 10.1136/vr.157.5.133; Schwenkenbecher JM, 2009, B ENTOMOL RES, V99, P371, DOI 10.1017/S0007485308006391; Schwenkenbecher JM, 2009, J MED ENTOMOL, V46, P610, DOI 10.1603/033.046.0328; Thumbi SM, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-46; Venail R., 2012, P77; Venail R, 2011, J MED ENTOMOL, V48, P351, DOI 10.1603/ME10178; Veronesi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057747; Viennet E, 2013, MED VET ENTOMOL, V27, P255, DOI 10.1111/j.1365-2915.2012.01042.x; Wenk CE, 2012, VET PARASITOL, V184, P258, DOI 10.1016/j.vetpar.2011.08.034; WILLIAMS DA, 1982, J R STAT SOC C-APPL, V31, P144	54	12	13	0	19	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	MAY 14	2014	7								223	10.1186/1756-3305-7-223				9	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	AH3CO	WOS:000335999100002	24884950	DOAJ Gold, Green Published			2019-04-02	
J	Caljon, G; Duguma, R; De Deken, R; Schauvliege, S; Gasthuys, F; Duchateau, L; Van den Abbeele, J				Caljon, Guy; Duguma, Reta; De Deken, Reginald; Schauvliege, Stijn; Gasthuys, Frank; Duchateau, Luc; Van den Abbeele, Jan			Serological Responses and Biomarker Evaluation in Mice and Pigs Exposed to Tsetse Fly Bites	PLOS NEGLECTED TROPICAL DISEASES			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; IGG ANTIBODY-RESPONSE; GLOSSINA-MORSITANS-MORSITANS; ANOPHELES SALIVARY ANTIGENS; VISCERAL LEISHMANIASIS; LUTZOMYIA-LONGIPALPIS; EPIDEMIOLOGIC TOOL; IMMUNE-RESPONSE; VECTOR CONTROL; LATIN-AMERICA	Background: Tsetse flies are obligate blood-feeding insects that transmit African trypanosomes responsible for human sleeping sickness and nagana in livestock. The tsetse salivary proteome contains a highly immunogenic family of the endonuclease-like Tsal proteins. In this study, a recombinant version of Tsal1 (rTsal1) was evaluated in an indirect ELISA to quantify the contact with total Glossina morsitans morsitans saliva, and thus the tsetse fly bite exposure. Methodology/Principal Findings: Mice and pigs were experimentally exposed to different G. m. morsitans exposure regimens, followed by a long-term follow-up of the specific antibody responses against total tsetse fly saliva and rTsal1. In mice, a single tsetse fly bite was sufficient to induce detectable IgG antibody responses with an estimated half-life of 36-40 days. Specific antibody responses could be detected for more than a year after initial exposure, and a single bite was sufficient to boost anti-saliva immunity. Also, plasmas collected from tsetse-exposed pigs displayed increased anti-rTsal1 and anti-saliva IgG levels that correlated with the exposure intensity. A strong correlation between the detection of anti-rTsal1 and anti-saliva responses was recorded. The ELISA test performance and intra-laboratory repeatability was adequate in the two tested animal models. Cross-reactivity of the mouse IgGs induced by exposure to different Glossina species (G. m. morsitans, G. pallidipes, G. palpalis gambiensis and G. fuscipes) and other hematophagous insects (Stomoxys calcitrans and Tabanus yao) was evaluated. Conclusion: This study illustrates the potential use of rTsal1 from G. m. morsitans as a sensitive biomarker of exposure to a broad range of Glossina species. We propose that the detection of anti-rTsal1 IgGs could be a promising serological indicator of tsetse fly presence that will be a valuable tool to monitor the impact of tsetse control efforts on the African continent.	[Caljon, Guy; Van den Abbeele, Jan] Inst Trop Med Antwerp ITM, Dept Biomed Sci, Unit Vet Protozool, Antwerp, Belgium; [Caljon, Guy] Vrije Univ Brussel, Unit Cellular & Mol Immunol, Brussels, Belgium; [Caljon, Guy] VIB, Lab Myeloid Cell Immunol, Brussels, Belgium; [Duguma, Reta] Univ Addis Ababa, Fac Vet Med, Debre Zeit, Ethiopia; [De Deken, Reginald] Inst Trop Med Antwerp ITM, Dept Biomed Sci, Unit Vet Entomol, Antwerp, Belgium; [Schauvliege, Stijn; Gasthuys, Frank] Ghent Univ UGent, Fac Vet Med, Dept Surg & Anaesthesia Domest Anim, Ghent, Belgium; [Duchateau, Luc] Ghent Univ UGent, Fac Vet Med, Dept Comparat Physiol & Biometr, Ghent, Belgium; [Van den Abbeele, Jan] Ghent Univ UGent, Dept Physiol, Lab Zoophysiol, Ghent, Belgium	Caljon, G (reprint author), Inst Trop Med Antwerp ITM, Dept Biomed Sci, Unit Vet Protozool, Antwerp, Belgium.	gcaljon@itg.be; jvdabbeele@itg.be	Caljon, Guy/E-1310-2017	Caljon, Guy/0000-0002-4870-3202; Schauvliege, Stijn/0000-0002-7105-6517; Van Den Abbeele, Jan/0000-0002-4533-4480; Duguma, Reta/0000-0002-5660-7720	Research Foundation-Flanders; InterUniversity Attraction Pole program, an EU/FP7 ERC [P7/41]; Belgian Development Cooperation; Institute of Tropical Medicine Antwerp	This work was funded by the Research Foundation-Flanders (www.fwo.be), the InterUniversity Attraction Pole program P7/41 (www.belspo.be), an EU/FP7 ERC starter grant (Jan Van Den Abbeele, erc.europa.eu), the Belgian Development Cooperation (PhD scholarship Reta Duguma, www.dg-d.be) and the Institute of Tropical Medicine Antwerp (www.itg.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy S, 2013, TRENDS PARASITOL, V29, P394, DOI 10.1016/j.pt.2013.06.005; Aksoy S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001008; Ali ZMI, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-439; Alves-Silva J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-213; Assana E, 2010, PARASITE IMMUNOL, V32, P399, DOI 10.1111/j.1365-3024.2009.01197.x; Caljon G, 2006, INFECT IMMUN, V74, P6324, DOI 10.1128/IAI.01046-06; Caljon G, 2006, INT J PARASITOL, V36, P1025, DOI 10.1016/j.ijpara.2006.05.002; Caljon G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047233; Caljon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009671; Caljon G, 2009, INSECT BIOCHEM MOLEC, V39, P332, DOI 10.1016/j.ibmb.2009.01.010; Cappello M, 1996, AM J TROP MED HYG, V54, P475, DOI 10.4269/ajtmh.1996.54.475; Cattand P, 2010, PAAT TECHNICAL SCI S, V10; Dama E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002455; Dama E, 2013, MICROBES INFECT, V15, P416, DOI 10.1016/j.micinf.2013.03.001; Doucoure S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001487; Drame PM, 2010, AM J TROP MED HYG, V83, P115, DOI 10.4269/ajtmh.2010.09-0684; Drame PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015596; Elanga NE, 2012, PLOS NEGLECT TROP D, V6, pe1905, DOI DOI 10.1371/JOURNAL.PNTD.0001905; ELLIS JA, 1986, VET PATHOL, V23, P661, DOI 10.1177/030098588602300603; Fontaine A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-187; Gidwani K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001296; King JG, 2011, J BIOL CHEM, V286, P40824, DOI 10.1074/jbc.M111.280552; Lindh JM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000474; MacLean L, 2006, T ROY SOC TROP MED H, V100, P270, DOI 10.1016/j.trstmh.2005.03.013; Orlandi-Pradines E, 2007, MICROBES INFECT, V9, P1454, DOI 10.1016/j.micinf.2007.07.012; Poinsignon A, 2008, AM J TROP MED HYG, V78, P750, DOI 10.4269/ajtmh.2008.78.750; Poinsignon A, 2007, AM J TROP MED HYG, V76, P327, DOI 10.4269/ajtmh.2007.76.327; Poinsignon A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-198; Poinsignon A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002472; Remoue F, 2006, T ROY SOC TROP MED H, V100, P363, DOI 10.1016/j.trstmh.2005.06.032; Rohousova I, 2005, PARASITOLOGY, V130, P493, DOI [10.1017/S003118200400681X, 10.1017/S00311200400681X]; Sagna AB, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-68; Sanders ML, 1998, AM J TROP MED HYG, V59, P279, DOI 10.4269/ajtmh.1998.59.279; Schofield CJ, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-24; SCHWARTZ BS, 1990, AM J EPIDEMIOL, V132, P58, DOI 10.1093/oxfordjournals.aje.a115643; Schwarz A, 2011, INT J PARASITOL, V41, P591, DOI 10.1016/j.ijpara.2011.02.001; Schwarz A, 2009, INT J PARASITOL, V39, P1021, DOI 10.1016/j.ijpara.2009.01.010; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Simarro PP, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-57; Somda MB, 2013, VET PARASITOL, V197, P332, DOI 10.1016/j.vetpar.2013.05.018; Souza AP, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000649; Sow A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037124; Stevens WJ, 1996, J ALLERGY CLIN IMMUN, V98, P700, DOI 10.1016/S0091-6749(96)70105-7; Teixeira C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000638; Torr SJ, 2005, TRENDS PARASITOL, V21, P537, DOI 10.1016/j.pt.2005.08.021; Van Den Abbeele J, 2007, INSECT BIOCHEM MOLEC, V37, P1075, DOI 10.1016/j.ibmb.2007.06.006; Vinhas V, 2007, EUR J IMMUNOL, V37, P3111, DOI 10.1002/eji.200737431; Vlkova M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001719; VOLF P, 1993, VET PARASITOL, V47, P327, DOI 10.1016/0304-4017(93)90033-J; Vreysen MJB, 2013, J INVERTEBR PATHOL, V112, pS15, DOI 10.1016/j.jip.2012.07.026; Vreysen MJB, 2000, J ECON ENTOMOL, V93, P123, DOI 10.1603/0022-0493-93.1.123; Wang XY, 2009, INSECT BIOCHEM MOLEC, V39, P607, DOI 10.1016/j.ibmb.2009.06.004	52	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAY	2014	8	5							e2911	10.1371/journal.pntd.0002911				11	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AJ5OS	WOS:000337735100076	24853371	DOAJ Gold, Green Published			2019-04-02	
J	Coral-Almeida, M; Rodriguez-Hidalgo, R; Celi-Erazo, M; Garcia, HH; Rodriguez, S; Devleesschauwer, B; Benitez-Ortiz, W; Dorny, P; Praet, N				Coral-Almeida, Marco; Rodriguez-Hidalgo, Richar; Celi-Erazo, Maritza; Hugo Garcia, Hector; Rodriguez, Silvia; Devleesschauwer, Brecht; Benitez-Ortiz, Washington; Dorny, Pierre; Praet, Nicolas			Incidence of Human Taenia solium Larval Infections in an Ecuadorian Endemic Area: Implications for Disease Burden Assessment and Control	PLOS NEGLECTED TROPICAL DISEASES			English	Article							PORCINE CYSTICERCOSIS; REGIONAL STATUS; EPILEPSY; NEUROCYSTICERCOSIS; SEROPREVALENCE; EPIDEMIOLOGY; PREVALENCE; FRAMEWORK; AFRICA; IMPACT	Background: Human cysticercosis is a zoonotic disease causing severe health disorders and even death. While prevalence data become available worldwide, incidence rate and cumulative incidence figures are lacking, which limits the understanding of the Taenia solium epidemiology. Methodology/Principal findings: A seroepidemiological cohort study was conducted in a south-Ecuadorian community to estimate the incidence rate of infection with and the incidence rate of exposure to T. solium based on antigen and antibody detections, respectively. The incidence rate of infection was 333.6 per 100,000 person-years (95% CI: [8.4-1,858] per 100,000 person-years) contrasting with a higher incidence rate of exposure 13,370 per 100,000 person-years (95% CI: [8,730-19,591] per 100,000 person-years). The proportion of infected individuals remained low and stable during the whole study year while more than 25% of the population showed at least one antibody seroconversion/seroreversion during the same time period. Conclusions/Significance: Understanding the transmission of T. solium is essential to develop ad hoc cost-effective prevention and control programs. The estimates generated here may now be incorporated in epidemiological models to simulate the temporal transmission of the parasite and the effects of control interventions on its life cycle. These estimates are also of high importance to assess the disease burden since incidence data are needed to make regional and global projections of morbidity and mortality related to cysticercosis.	[Coral-Almeida, Marco; Dorny, Pierre; Praet, Nicolas] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Coral-Almeida, Marco; Celi-Erazo, Maritza; Benitez-Ortiz, Washington] Univ Cent Ecuador, CIZ, Quito, Ecuador; [Coral-Almeida, Marco; Devleesschauwer, Brecht; Dorny, Pierre] Univ Ghent, Fac Vet Med, Merelbeke, Belgium; [Rodriguez-Hidalgo, Richar; Benitez-Ortiz, Washington] Univ Cent Ecuador, Fac Med Vet & Zootecnia, Quito, Ecuador; [Rodriguez-Hidalgo, Richar] Univ Cent Ecuador, Nucleo Invest, Quito, Ecuador; [Hugo Garcia, Hector] Univ Peruana Cayetano Heredia, Lima, Peru; [Hugo Garcia, Hector; Rodriguez, Silvia] Inst Nacl Ciencias Neurol, Lima, Peru; [Devleesschauwer, Brecht] Catholic Univ Louvain, Inst Hlth & Soc, B-1200 Brussels, Belgium	Coral-Almeida, M (reprint author), Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium.	marco.coralalmeida@ugent.be	Rodriguez-Hidalgo, Richar/P-8877-2015; Devleesschauwer, Brecht/G-9895-2018	Rodriguez-Hidalgo, Richar/0000-0002-9338-1062; Devleesschauwer, Brecht/0000-0002-2867-6892; Coral, Marco/0000-0003-0211-2906	Institute of Tropical Medicine in Antwerp, Belgium; Centro Internacional de Zoonosis, Quito-Ecuador; Wellcome Trust Senior International Research Fellowship in Public Health and Tropical Medicine; FIC NIH [TW001140]	This work was financially supported by the Belgian Cooperation in the framework of the Institutional Collaboration between the Institute of Tropical Medicine in Antwerp, Belgium and the Centro Internacional de Zoonosis, Quito-Ecuador. HHG is supported by a Wellcome Trust Senior International Research Fellowship in Public Health and Tropical Medicine. SR is supported by FIC NIH grant TW001140. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon T, 2010, EPITOOLS EPIDEMIOLOG; Benitez-Ortiz, 2001, CERDOS LOCALES SISTE, P37; Berkvens D, 2006, EPIDEMIOLOGY, V17, P145, DOI 10.1097/01.ede.0000198422.64801.8d; Carpio A, 1998, EPILEPSIA, V39, P1025, DOI 10.1111/j.1528-1157.1998.tb01287.x; CRUZ M, 1989, B WORLD HEALTH ORGAN, V67, P401; Deckers N, 2010, TRENDS PARASITOL, V26, P137, DOI 10.1016/j.pt.2009.12.008; Del Brutto OH, 2012, SCI WORLD J, DOI 10.1100/2012/159821; Dohoo I, 2003, VET EPIDEMIOLOGIC RE, P65; Dorny P, 2004, TRENDS PARASITOL, V20, P259, DOI 10.1016/j.pt.2004.04.001; Dorny P, 2004, INT J PARASITOL, V34, P569, DOI 10.1016/j.ijpara.2003.11.014; Dorny P., 2005, WHO FAO OIE GUIDELIN, P45; Erhart A, 2002, T ROY SOC TROP MED H, V96, P270, DOI 10.1016/S0035-9203(02)90095-7; Fleury A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000805; Flisser A, 2003, ACTA TROP, V87, P43, DOI 10.1016/S0001-706X(03)00054-8; Garcia HH, 2001, AM J TROP MED HYG, V65, P31, DOI 10.4269/ajtmh.2001.65.31; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.1080/10618600.1996.10474713; Kyvsgaard NC, 2007, INT J PARASITOL, V37, P547, DOI 10.1016/j.ijpara.2006.11.018; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mwape KE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002142; Ndimubanzi PC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000870; Ngowi HA, 2008, PREV VET MED, V85, P52, DOI 10.1016/j.prevetmed.2007.12.014; Praet N, 2010, INT J PARASITOL, V40, P85, DOI 10.1016/j.ijpara.2009.07.007; Praet N, 2013, TROP MED INT HEALTH, V18, P608, DOI 10.1111/tmi.12089; Praet N, 2010, AM J TROP MED HYG, V83, P413, DOI 10.4269/ajtmh.2010.10-0121; Preux PM, 2005, LANCET NEUROL, V4, P21, DOI 10.1016/S1474-4422(04)00963-9; R Development Core Team, 2012, R LANG ENV STAT COMP; Raccurt CP, 2009, J HELMINTHOL, V83, P113, DOI 10.1017/S0022149X09232330; Rodriguez-Hidalgo R, 2006, MEM I OSWALDO CRUZ, V101, P779, DOI 10.1590/S0074-02762006000700012; Rodriguez-Hidalgo R, 2003, VET PARASITOL, V118, P51, DOI 10.1016/j.vetpar.2003.09.019; Rosenstock S, 2000, J EPIDEMIOL COMMUN H, V54, P444, DOI 10.1136/jech.54.6.444; Schantz PM, 2002, TAENIA SOLIUM CYSTIC, P63; Sorvillo FJ, 2007, EMERG INFECT DIS, V13, P230, DOI 10.3201/eid1302.060527; Speybroeck N, 2006, ENVIRON ECOL STAT, V13, P69, DOI 10.1007/s10651-005-5691-1; TSANG VCW, 1989, J INFECT DIS, V159, P50, DOI 10.1093/infdis/159.1.50; Villaran MV, 2009, NEUROEPIDEMIOLOGY, V33, P25, DOI 10.1159/000210019; Zoli A, 2003, ACTA TROP, V87, P35, DOI 10.1016/S0001-706X(02)00289-9	36	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAY	2014	8	5							e2887	10.1371/journal.pntd.0002887				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AJ5OS	WOS:000337735100063	24852050	DOAJ Gold, Green Published			2019-04-02	
J	Diro, E; Lynen, L; Mohammed, R; Boelaert, M; Hailu, A; van Griensven, J				Diro, Ermias; Lynen, Lutgarde; Mohammed, Rezika; Boelaert, Marleen; Hailu, Asrat; van Griensven, Johan			High Parasitological Failure Rate of Visceral Leishmaniasis to Sodium Stibogluconate among HIV Co-infected Adults in Ethiopia	PLOS NEGLECTED TROPICAL DISEASES			English	Article							NEGLECTED TROPICAL DISEASES; COINFECTION; PREVALENCE; THERAPY; PATIENT; AFRICA	Background: Antimonials are still being used for visceral leishmaniasis (VL) treatment among HIV co-infected patients in East-Africa due to the shortage of alternative safer drugs like liposomal amphotericin B. Besides tolerability, emergence of resistance to antimonials is a major concern. Objectives: This study was aimed at assessing the clinical outcome of VL-HIV co-infected patients when treated with sodium stibogluconate (SSG). Methods: Retrospective patient record analysis of VL-HIV co-infected patients treated at a clinical trial site in north-west Ethiopia was done. Patients with parasitologically confirmed VL and HIV co-infection treated with SSG were included. The dose of SSG used was 20 mg Sb5 (pentavalent antimony)/kg and maximum of 850 mg Sb5 for 30 days. The clinical outcomes were defined based on the tissue aspiration results as cure or failure, and additionally the safety and mortality rates were computed. Results: The study included 57 patients treated with SSG and by the end of treatment only 43.9% of patients were cured. The parasitological treatment failure and the case fatality rate were 31.6% and 14.0% respectively. SSG was discontinued temporarily or permanently for 12 (21.1%) cases due to safety issues. High baseline parasite load (graded more than 4+) was significantly associated with treatment failure (odds ratio = 8.9, 95% confidence interval = .5-51.7). Conclusion: SSG is not only unsafe, but also has low effectiveness for VL-HIV patients. Safe and effective alternative medications are very urgently needed. Drug sensitivity surveillance should be introduced in the region.	[Diro, Ermias; Mohammed, Rezika] Univ Gondar, Gondar, Ethiopia; [Diro, Ermias; Lynen, Lutgarde; Boelaert, Marleen; van Griensven, Johan] Inst Trop Med, B-2000 Antwerp, Belgium; [Hailu, Asrat] Addis Ababa Univ Sch Med, Addis Ababa, Ethiopia	Diro, E (reprint author), Univ Gondar, Gondar, Ethiopia.	ermi_diro@yahoo.com	Lynen, Lutgarde/A-1212-2014	Lynen, Lutgarde/0000-0001-7183-4895; Boelaert, Marleen/0000-0001-8051-6776	Belgian Directorate General for Development Cooperation under the ITM-DGDC; Medecins Sans Frontieres [OCA009-07]	ED has received a PhD scholarship granted from the Belgian Directorate General for Development Cooperation under the ITM-DGDC framework agreement FA-III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 1997, CLIN MICROBIOL REV, V10, P298, DOI 10.1128/CMR.10.2.298; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; [Anonymous], TRIALS AD PANCR ISL; [Anonymous], 2007, GUID MAN OPP INF ANT; Balasegaram M, 2012, EXPERT OPIN EMERG DR, V17, P493, DOI 10.1517/14728214.2012.748036; Chakravarty J, 2010, J GLOB INFECT DIS, V2, P167, DOI 10.4103/0974-777X.62887; CORTES E, 1995, MED CLIN-BARCELONA, V104, P578; Cota GF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002195; Cota GF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001153; Delgado J, 1999, AM J TROP MED HYG, V61, P766, DOI 10.4269/ajtmh.1999.61.766; den Boer M, 2011, CLIN MICROBIOL INFEC, V17, P1471, DOI 10.1111/j.1469-0691.2011.03635.x; Federal Ministry of Health of Ethiopia, 2013, GUID DIAGN TREATM PR; FENSKE S, 1991, KLIN WOCHENSCHR, V69, P793, DOI 10.1007/BF01744270; Hailu W, 2010, T ROY SOC TROP MED H, V104, P706, DOI 10.1016/j.trstmh.2010.07.007; Harms Gundel, 2013, TROP MED INT HEALTH, V7, P479; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Hurissa Z, 2010, TROP MED INT HEALTH, V15, P848, DOI 10.1111/j.1365-3156.2010.02550.x; Khalil EAG, 1998, ANN TROP MED PARASIT, V92, P151, DOI 10.1080/00034983.1998.11813274; Liese B, 2010, LANCET, V375, P67, DOI 10.1016/S0140-6736(09)61749-9; Mengistu G, 2007, ETHIOP J HEALTH DEV, V21, P53; Musa A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001674; Petter A, 2001, SCAND J INFECT DIS, V33, P236, DOI 10.1080/00365540151061049; Ritmeijer K, 2006, CLIN INFECT DIS, V43, P357, DOI 10.1086/505217; Ritmeijer K, 2001, T ROY SOC TROP MED H, V95, P668, DOI 10.1016/S0035-9203(01)90110-5; Sundar S, 2010, INT J ENV RES PUB HE, V7, P4267, DOI 10.3390/ijerph7124267; ter Horst R, 2008, CLIN INFECT DIS, V46, P1702, DOI 10.1086/587899; van Griensven J, 2012, INFECT DIS CLIN N AM, V26, P309, DOI 10.1016/j.idc.2012.03.005; WHO, 2010, WHO TECH REP SER, V949, P1	29	24	24	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAY	2014	8	5							e2875	10.1371/journal.pntd.0002875				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AJ5OS	WOS:000337735100055	24854196	DOAJ Gold, Green Published			2019-04-02	
J	Van der Auwera, G				Van der Auwera, Gert			Development of Assays Using Hexokinase and Phosphoglucomutase Gene Sequences That Distinguish Strains of Leishmania tropica from Different Zymodemes and Microsatellite Clusters and Their Application to Palestinian Foci of Cutaneous Leishmaniasis (vol 7, e2464, 2013)	PLOS NEGLECTED TROPICAL DISEASES			English	Correction									Inst Trop Med, B-2000 Antwerp, Belgium	Van der Auwera, G (reprint author), Inst Trop Med, B-2000 Antwerp, Belgium.						Azmi K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002464	1	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAY	2014	8	5							e2963	10.1371/journal.pntd.0002963				1	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AJ5OS	WOS:000337735100081		DOAJ Gold, Green Published			2019-04-02	
J	Polonsky, JA; Wamala, JF; de Clerck, H; Van Herp, M; Sprecher, A; Porten, K; Shoemaker, T				Polonsky, Jonathan A.; Wamala, Joseph F.; de Clerck, Hilde; Van Herp, Michel; Sprecher, Armand; Porten, Klaudia; Shoemaker, Trevor			Perspective Piece Emerging Filoviral Disease in Uganda: Proposed Explanations and Research Directions	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							MARBURG HEMORRHAGIC-FEVER; EBOLA-VIRUS; OUTBREAK	Outbreaks of Ebola and Marburg virus diseases have recently increased in frequency in Uganda. This increase is probably caused by a combination of improved surveillance and laboratory capacity, increased contact between humans and the natural reservoir of the viruses, and fluctuations in viral load and prevalence within this reservoir. The roles of these proposed explanations must be investigated in order to guide appropriate responses to the changing epidemiological profile. Other African settings in which multiple filoviral outbreaks have occurred could also benefit from such information.	[Polonsky, Jonathan A.; Porten, Klaudia] Epicentre, Intervent Epidemiol & Training Dept, F-75012 Paris, France; Minist Heath, Kampala, Uganda; [Wamala, Joseph F.] Minist Hlth, Epidemiol Surveillance Div, Kampala, Uganda; [de Clerck, Hilde] Medecins Sans Frontieres Operat Ctr Brussels, Brussels, Belgium; [Van Herp, Michel] Medecins Sans Frontieres Operat Ctr Brussels, Dis Control Unit, Brussels, Belgium; [Sprecher, Armand] Medecins Sans Frontieres Operat Ctr Brussels, Publ Hlth Unit, Brussels, Belgium; [Shoemaker, Trevor] US Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Entebbe, Uganda	Polonsky, JA (reprint author), Epicentre, 53-55 Rue Crozatier, F-75012 Paris, France.	jonathan.polonsky@epicentre.msf.org; j_wamala@yahoo.com; hilde.declerck@gmail.com; michel.van.herp@brussels.msf.org; armand.sprecher@brussels.msf.org; klaudia.porten@epicentre.msf.org; tis8@cdc.gov					Adjemian J, 2011, J INFECT DIS, V204, pS796, DOI 10.1093/infdis/jir312; Amman BR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002877; Borchert M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-357; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P308; Centers for Disease Control and Prevention, 2012, OUTBR POST; Centers for Disease Control and Prevention, 2010, MMWR-MORBID MORTAL W, V303, P413; Hewlett BS, 2003, EMERG INFECT DIS, V9, P1242; Leroy E, 2011, Med Trop (Mars), V71, P111; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Leroy EM, 2009, VECTOR-BORNE ZOONOT, V9, P723, DOI 10.1089/vbz.2008.0167; MacNeil A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001546; Maganga GD, 2011, J INFECT DIS, V204, pS800, DOI 10.1093/infdis/jir358; Monath TP, 1999, J INFECT DIS, V179, pS127, DOI 10.1086/514281; Muehlenbein MP, 2005, AM J PRIMATOL, V65, P167, DOI 10.1002/ajp.20106; Mwavu EN, 2008, LAND DEGRAD DEV, V19, P606, DOI 10.1002/ldr.869; Okware SI, 2002, TROP MED INT HEALTH, V7, P1068, DOI 10.1046/j.1365-3156.2002.00944.x; Organization WH, 2012, MARB HAEM FEV; Pourrut X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-159; Shoemaker T, 2012, EMERG INFECT DIS, V18, P1480, DOI 10.3201/eid1809.111536; Timen A, 2009, EMERG INFECT DIS, V15, P1171, DOI [10.3201/eid1508.090051, 10.3201/eid1508.090015]; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Towner JS, 2011, PLOS PATHOG, V4; Wamala JF, 2010, EMERG INFECT DIS, V16, P1087, DOI 10.3201/eid1607.091525; WHO, 2012, EB UG UPD; World Health Organization, 2012, EB HAEM FEV	25	10	10	0	13	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	MAY	2014	90	5					790	793		10.4269/ajtmh.13-0374				4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	AG8ZN	WOS:000335707600004	24515940	Green Published, Bronze			2019-04-02	
J	Decroo, T; Koole, O; Remartinez, D; dos Santos, N; Dezembro, S; Jofrisse, M; Rasschaert, F; Biot, M; Laga, M				Decroo, Tom; Koole, Olivier; Remartinez, Daniel; dos Santos, Natacha; Dezembro, Sergio; Jofrisse, Mariano; Rasschaert, Freya; Biot, Marc; Laga, Marie			Four-year retention and risk factors for attrition among members of community ART groups in Tete, Mozambique	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						antiretroviral therapy; community participation; health services accessibility; HIV; peer support	ANTIRETROVIRAL TREATMENT PROGRAM; PATIENT RETENTION; THERAPY PROGRAMS; SOUTH-AFRICA; OUTCOMES; COHORT; CARE; INDIVIDUALS; MORTALITY; LINKAGE	ObjectiveCommunity ART groups (CAG), peer support groups involved in community ART distribution and mutual psychosocial support, were piloted to respond to staggering antiretroviral treatment (ART) attrition in Mozambique. To understand the impact of CAG on long-term retention, we estimated mortality and lost-to-follow-up (LTFU) rates and assessed predictors for attrition. MethodsRetrospective cohort study. Kaplan-Meier techniques were used to estimate mortality and LTFU in CAG. Individual- and CAG-level predictors of attrition were assessed using a multivariable Cox proportional hazards model, adjusted for site-level clustering. ResultsMortality and LTFU rates among 5729 CAG members were, respectively, 2.1 and 0.1 per 100 person-years. Retention was 97.7% at 12months, 96.0% at 24months, 93.4% at 36months and 91.8% at 48months. At individual level, attrition in CAG was significantly associated with immunosuppression when joining a CAG, and being male. At CAG level, attrition was associated with lack of rotational representation at the clinic, lack of a regular CD4 count among fellow members and linkage to a rural or district clinic compared with linkage to a peri-urban clinic. ConclusionsLong-term retention in this community-based ART model compares favourably with published data on stable ART patients. Nevertheless, to reduce attrition, further efforts need to be made to enrol patients earlier on ART, promote health-seeking behaviour, especially for men, promote a strong peer dynamic to assure rotational representation at the clinic and regular CD4 follow-up and reinforce referral of sick patients. ObjectifLes groupes ART communautaires (GAC), groupes de soutien par les pairs, impliques dans la dispensation communautaire de l'ART et de soutien psychosocial mutuel, ont ete mis a l'essai pour repondre a l'attrition stupefiant dans le traitement antiretroviral (ART) au Mozambique. Pour comprendre l'impact des GAC sur la retention a long terme, nous avons estime les taux de mortalite et de perdus au suivi et avons evalue les facteurs predictifs de l'attrition. MethodesIl s'agit d'une etude de cohorte retrospective. Les techniques de Kaplan-Meier ont ete utilisees pour estimer la mortalite et les perdus au suivi dans les GAC. Les predicteurs de l'attrition a l'echelle individuels et des GAC ont ete evalues en utilisant un modele multivarie de risques proportionnels de Cox, ajustes pour le regroupement au niveau du site. ResultatsLes taux de mortalite et de perdus au suivi parmi 5729 membres de GAC etaient respectivement de 2,1 et 0,1 pour 100 personnes-annees. La retention etait de 97,7%, 96,0%, 93,4% et 91,8% respectivement a 12, 24, 36 et 48 mois. A l'echelle individuelle, l'attrition dans les GAC etait significativement associee a: 1) l'immunosuppression lors de l'adhesion a un GAC et 2) etre de sexe masculin. A l'echelle des GAC, l'attrition etait associee: 1) au manque de rotation de la representation a la clinique; 2) a l'absence de mesure reguliere du taux de CD4 chez les autres membres et 3) a la liaison a une clinique rurale ou de district, compare a la liaison a une clinique periurbaine. ConclusionsLa retention a long terme dans ce modele base sur l'ART communautaire se compare favorablement avec les donnees publiees sur les patients ART stables. Neanmoins, pour reduire l'attrition, des efforts supplementaires devraient etre faits pour: 1) inscrire les patients plus tot a l'ART; 2) promouvoir le comportement de recours a la sante, en particulier pour les hommes; 3) promouvoir une forte dynamique des pairs pour assurer la rotation de la representation a la clinique et un suivi regulier des CD4 et 4) renforcer l'orientation des patients malades. ObjetivoSe pilotaron grupos comunitarios de TAR (GCT), grupos de apoyo entre iguales involucrados en la distribucion comunitaria de TAR y el apoyo psicosocial mutuo, con parte de la respuesta frente a una desercion del TAR abrumadora en Mozambique. Con el fin de entender el impacto de los GCT en la retencion a largo plazo se calcularon la mortalidad y las tasas de perdida durante el seguimiento (PDS) y se evaluaron los vaticinadores de desercion. MetodosEste es un estudio retrospectivo de cohortes. Se utilizaron tecnicas de Kaplan-Meier para calcular la mortalidad y PDS en GCT. Los vaticinadores de desercion, individuales y a nivel de GCT, se examinaron utilizando un modelo de riesgos proporcionales de Cox, ajustando para conglomerados a nivel del emplazamiento. ResultadosLa mortalidad y las tasas de PDS entre 5729 miembros de PDS eran respectivamente 2.1 y 0.1 por 100 personas-anos. La retencion era del 97.7%, 96.0%, 93.4% y 91.8% a los 12, 24, 36 y 48 meses respectivamente. A nivel individual, la desercion del GCT estaba asociada de forma significativa con: 1) inmunosupresion en el momento de unirse al GCT; y 2) ser hombre. A nivel del GCT, la desercion estaba asociada con: 1) una falta de representacion rotativa en la clinica; 2) falta de un conteo regular de CD4 entre sus companeros; y 3) remision a una clinica rural o distrital, comparado con remision a una clinica periurbana. ConclusionesLa comparacion de la retencion a largo plazo en este modelo de TAR basado en la comunidad con otros datos publicados de pacientes recibiendo el TAR de forma estable es positiva. Sin embargo, para reducir la desercion se requiere de mas esfuerzos para: 1) incluir los pacientes en TAR en fases mas tempranas; 2) promover el comportamiento de busqueda de salud, especialmente en el caso de los hombres; 3) promover una dinamica dentro del grupo que asegure la representacion rotativa en la clinica y un seguimiento regular de CD4; y 4) reforzar la remision de los pacientes enfermos.	[Decroo, Tom; dos Santos, Natacha; Dezembro, Sergio; Jofrisse, Mariano] Med Sans Frontieres, Tete, Mozambique; [Decroo, Tom; Rasschaert, Freya; Laga, Marie] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Koole, Olivier] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Remartinez, Daniel] Med Sans Frontieres, Maputo, Mozambique; [Biot, Marc] Med Sans Frontieres, Brussels, Belgium	Decroo, T (reprint author), Med Sans Frontieres, Av Eduardo Mondlane 38 CP 262, Tete, Mozambique.	tomdecroo2@gmail.com		Decroo, Tom/0000-0002-1205-1484; Koole, Olivier/0000-0002-1122-5382			Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Caluwaerts C, 2009, INT HEALTH, V1, P97, DOI 10.1016/j.inhe.2009.03.002; Decroo T, 2013, INT STD RES REV, V1, P49; Decroo T, 2011, JAIDS-J ACQ IMM DEF, V56, pE39, DOI 10.1097/QAI.0b013e3182055138; Decroo T, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-6; Druyts E, 2013, AIDS, V27, P417, DOI 10.1097/QAD.0b013e328359b89b; Fatti G, 2012, JAIDS-J ACQ IMM DEF, V61, pE50, DOI 10.1097/QAI.0b013e31826a6aee; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Gupta A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028691; Kredo T, 2013, COCHRANE DB SYST REV, V6, DOI [10.1002/14651858.CD009987.pub2, DOI 10.102/14651858.CD009987]; Lambdin BH, 2013, JAIDS-J ACQ IMM DEF, V62, pE146, DOI 10.1097/QAI.0b013e3182840d4e; Mills EJ, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-52; Ministry of Health Mozambique, 2012, GLOB AIDS RESP PROGR; Ministry of Health Mozambique, 2012, PROGR TRAT ANT TARV; Ministry of Health of Mozambique, 2010, INQ NAC PREV RISC CO; Rasschaert Freya, 2011, J Int AIDS Soc, V14 Suppl 1, pS3, DOI 10.1186/1758-2652-14-S1-S3; van Rooyen H, 2013, JAIDS-J ACQ IMM DEF, V64, pE1, DOI 10.1097/QAI.0b013e31829b567d; Wandeler G, 2012, JAIDS-J ACQ IMM DEF, V59, pE9, DOI 10.1097/QAI.0b013e31823edb6a; WHO, 2013, GLOB UPD HIV TREATM; World Health Organization, 2013, CONS GUID US ANT DRU; World Health Organization United Nations Programme on HIV/ AIDS UNICEF, 2012, GLOB HIV AIDS RESP E; Wouters E, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-194	23	51	51	1	15	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	MAY	2014	19	5					514	521		10.1111/tmi.12278				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	AE4VS	WOS:000333984600004	24898272	Bronze			2019-04-02	
J	Deblauwe, I; Sohier, C; Schaffner, F; Rakotoarivony, LM; Coosemans, M				Deblauwe, Isra; Sohier, Charlotte; Schaffner, Francis; Rakotoarivony, Laurence Marrama; Coosemans, Marc			Implementation of surveillance of invasive mosquitoes in Belgium according to the ECDC guidelines	PARASITES & VECTORS			English	Article						Invasive mosquito species; ECDC guidelines; Points of entry; Colonised area; Aedes; Oviposition trap; MMLP trap; Larval sampling; Surveillance; Europe	AEDES-ALBOPICTUS; DIPTERA-CULICIDAE; 1ST RECORD; EUROPE; VIRUS; INFECTIONS; OUTBREAK; CLIMATE; FRANCE; HEALTH	Background: In 2012, the new guidelines for the surveillance of IMS in Europe, produced by the European Centre for Disease Prevention and Control (ECDC), were tested in Belgium. This study aimed at (1) testing the usefulness and applicability in the field of the ECDC guidelines for the surveillance of IMS in Europe and (2) surveying IMS throughout Belgium. Methods: First, the scenarios, which Belgium is facing, were identified according to the ECDC guidelines. Second, the surveillance strategy and the methods were identified based on the guidelines and adjusted to the Belgium context. Two areas colonised by IMS and 20 potential points of entry (PoE) were selected. Mosquito Magnet Liberty Plus (CO2-baited) traps (23) and oviposition traps (147) were set-up, and larval sampling was performed monthly or bi-monthly from July till October 2012. Finally, the costs and workload of the surveillance activities were compared to the estimates provided by the ECDC guidelines. Results: Surveillance at 20 potential PoE (complying with scenario 1) revealed that no new IMS were established in Belgium. Surveillance at two sites colonised by IMS (scenario 2) indicated that although control measures have drastically reduced the Ae. j. japonicus population this species is still present. Furthermore, Ae. koreicus is permanently established. For both scenarios, the problems encountered are discussed and recommendations are given. In addition, the actual workload was lower than the estimated workload, while the actual costs were higher than the estimated ones. Conclusions: The ECDC guidelines are helpful, applicable and efficient to implement surveillance of IMS in Belgium. Recommendations were customised to the local context (political demands, salary and investment costs, and existing expertise). The workload and costs related to the preparatory phase (i.e., planning, contacts with the PoE, writing a protocol) were found to be missing in the cost evaluation suggested in the guidelines. Updates on the occurrence of IMS in Belgium and the related risk for disease agents they can transmit will only be available once a structured and permanent surveillance system is implemented.	[Deblauwe, Isra; Sohier, Charlotte; Coosemans, Marc] Inst Trop Med, Dept Biomed Sci, Med Entomol Unit, B-2000 Antwerp, Belgium; [Schaffner, Francis] Avia GIS, Agrovet Informat & Anal, B-2980 Zoersel, Belgium; [Schaffner, Francis] Univ Zurich, Inst Parasitol, Natl Ctr Vector Entomol, CH-8057 Zurich, Switzerland; [Rakotoarivony, Laurence Marrama] European Ctr Dis Prevent & Control ECDC, S-17183 Stockholm, Sweden; [Coosemans, Marc] Univ Antwerp, Fac Pharmaceut Vet & Biomed Sci, Dept Biomed Sci, B-2610 Antwerp, Belgium	Deblauwe, I (reprint author), Inst Trop Med, Dept Biomed Sci, Med Entomol Unit, Natl Str 155, B-2000 Antwerp, Belgium.	ideblauwe@itg.be		Schaffner, Francis/0000-0001-9166-7617	ECDC	We would like to thank the Federal, Flemish, Walloon and Brussels Capital region government for the financing and administrative help. Also many thanks to all cooperating companies for giving access to their private property. We especially acknowledge Dr. Wouter Dekoninck and Dr. Patrick Grootaert of the RBINS for loaning us 12 MMLP traps. We want to express our gratitude to Leen Denis, Famke Jansen, Karel Van Roey and Julie Demeulemeester for assistance in the laboratory or in the field, and to Professor Alexander Mathis for his input into the manuscript. Finally, we would also like to thank ECDC for the opportunity to test their guidelines, and VBORNET and Avia-GIS for their technical support (funded by ECDC) provided during the project.	Becker N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032604; Becker Norbert, 2011, European Mosquito Bulletin, V29, P88; Beeuwkes J., 2011, Proceedings of the Netherlands Entomological Society Meeting, V22, P31; Boukraa S, 2013, PARASITE, V20, DOI 10.1051/parasite/2013054; Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138; Centre National d'Expertise sur les Vecteurs, 2012, OPT SURV CONTR AED A; Chartered Institute of Environmental Health, 2009, PUBL HLTH ISS POS MO; Deblauwe I, 2012, EXOSURV IMPLEMENTATI; European Centre for Disease Prevention and Control, 2012, GUID SURV INV MOSQ E; European Centre for Disease Prevention and Control (ECDC, 2011, CONS MOSQ BORN DIS T; Fischer D, 2011, GLOBAL PLANET CHANGE, V78, P54, DOI 10.1016/j.gloplacha.2011.05.008; Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x; Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025; Gu WD, 2008, T ROY SOC TROP MED H, V102, P817, DOI 10.1016/j.trstmh.2008.03.019; Guedes DRD, 2010, J VECTOR DIS, V47, P67; Hoel DF, 2009, J AM MOSQUITO CONTR, V25, P47, DOI 10.2987/08-5800.1; Kampen H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-59; Kaufmann C, 2012, PARASITOLOGY, V139, P248, DOI 10.1017/S0031182011001764; Kondilis E, 2013, AM J PUBLIC HEALTH, V103, P973, DOI 10.2105/AJPH.2012.301126; Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814; REITER P, 1987, J AM MOSQUITO CONTR, V3, P494; Sambri V, 2013, CLIN MICROBIOL INFEC, V19, P699, DOI 10.1111/1469-0691.12211; Schaffner F, 2000, CR ACAD SCI III-VIE, V323, P373, DOI 10.1016/S0764-4469(00)00143-8; Schaffner F, 2004, J AM MOSQUITO CONTR, V20, P201; Schaffner F, 2001, MOSQUITOES EUROPE MO; Schaffner F, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-142; Schaffner F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-209; Schaffner Francis, 2003, European Mosquito Bulletin, V16, P7; Scholte EJ, 2010, EUROSURVEILLANCE, V15, P10; Scholte Ernst-Jan, 2007, European Mosquito Bulletin, V22, P5; Soumahoro MK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001197; Sousa CA, 2012, EUROSURVEILLANCE, V17, P15; Van Esbroeck M, 2013, TROP MED INT HEALTH, V18, P113; Van Esbroeck M, 2011, TROP MED INT HEALTH, V16, P236; Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000858; Versteirt V, 2013, B ENTOMOL RES, V103, P193, DOI 10.1017/S0007485312000521; Versteirt V, 2012, J MED ENTOMOL, V49, P1226, DOI 10.1603/ME11170; Versteirt V, 2009, J MED ENTOMOL, V46, P1464, DOI 10.1603/033.046.0632; Versteirt V, 2012, THESIS U ANTWERP ANT; Werner D, 2012, EUROSURVEILLANCE, V17, P14; YATES MG, 1979, B ENTOMOL RES, V69, P611, DOI 10.1017/S0007485300020162	41	6	6	0	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	APR 26	2014	7								201	10.1186/1756-3305-7-201				11	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	AG7IC	WOS:000335590600001	24766783	DOAJ Gold, Green Published			2019-04-02	
J	Okebe, J; Amambua-Ngwa, A; Parr, J; Nishimura, S; Daswani, M; Takem, EN; Affara, M; Ceesay, SJ; Nwakanma, D; D'Alessandro, U				Okebe, Joseph; Amambua-Ngwa, Alfred; Parr, Jason; Nishimura, Sei; Daswani, Melissa; Takem, Ebako N.; Affara, Muna; Ceesay, Serign J.; Nwakanma, Davis; D'Alessandro, Umberto			The prevalence of glucose-6-phosphate dehydrogenase deficiency in Gambian school children	MALARIA JOURNAL			English	Article						Glucose-6-phosphate dehydrogenase deficiency; Malaria; Genotype; Phenotype; Prevalence	G6PD DEFICIENCY; SEVERE MALARIA; GAMETOCYTOCIDAL DRUG; WEST-AFRICA; SENEGAL; ASSOCIATION; TANZANIA; SUSCEPTIBILITY; POLYMORPHISMS; TRANSMISSION	Background: Primaquine, the only available drug effective against Plasmodium falciparum sexual stages, induces also a dose-dependent haemolysis, especially in glucose-6-phosphate dehydrogenase deficient (G6PDd) individuals. Therefore, it is important to determine the prevalence of this deficiency in areas that would potentially benefit from its use. The prevalence of G6PD deficiency by genotype and enzyme activity was determined in healthy school children in The Gambia. Methods: Blood samples from primary school children collected during a dry season malaria survey were screened for G6PDd and malaria infection. Genotypes for allele mutations reported in the country; 376, 202A-, 968A- and 542 were analysed while enzyme activity (phenotype) was assayed using a semi-quantitative commercial test kit. Enzyme activity values were fitted in a finite mixture model to determine the distribution and calculate a cut-off for deficiency. The association between genotype and phenotype for boys and girls as well as the association between mutant genotype and deficient phenotype was analysed. Results: Samples from 1,437 children; 51% boys were analysed. The prevalence of P. falciparum malaria infection was 14%. The prevalence of the 202A-, 968 and 542 mutations was 1.8%, 2.1% and 1.0%, respectively, and higher in boys than in girls. The prevalence of G6PDd phenotype was 6.4% (92/1,437), 7.8% (57/728) in boys and 4.9% (35/709) in girls with significantly higher odds in the former (OR 1.64, 95% CI 1.05, 2.53, p = 0.026). The deficient phenotype was associated with reduced odds of malaria infection (OR 0.77, 95% CI 0.36, 1.62, p = 0.49). Conclusions: There is a weak association between genotype and phenotype estimates of G6PDd prevalence. The phenotype expression of deficiency represents combinations of mutant alleles rather than specific mutations. Genotype studies in individuals with a deficient phenotype would help identify alleles responsible for haemolysis.	[Okebe, Joseph; Amambua-Ngwa, Alfred; Nishimura, Sei; Daswani, Melissa; Takem, Ebako N.; Affara, Muna; Ceesay, Serign J.; Nwakanma, Davis; D'Alessandro, Umberto] MRC Unit, Fajara, Gambia; [Parr, Jason] Univ Manchester, Manchester, Lancs, England; [D'Alessandro, Umberto] London Sch Hyg & Trop Med, London WC1, England; [D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium	Okebe, J (reprint author), MRC Unit, Atlantic Blvd, Fajara, Gambia.	jokebe@mrc.gm	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009; Okebe, Joseph/0000-0001-5466-1611; Nwakanma, Davis/0000-0002-6706-6069	Medical Research Council UK; Medical Research Council [MC_EX_MR/J002364/1, MC_UP_A900_1117, MC_EX_MR/K02440X/1]	The study was funded by the Medical Research Council UK. The funders did not play any role in the study design, data collection and analysis or in drafting the manuscript. The authors acknowledge the support of the Teachers, parents and the staff of the Ministry of Basic and Secondary Education, The Gambia on this project.	ALLISON AC, 1961, NATURE, V190, P1198, DOI 10.1038/1901198a0; Baird JK, 2011, TRENDS PARASITOL, V27, P11, DOI 10.1016/j.pt.2010.08.005; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242; Clark TG, 2009, EUR J HUM GENET, V17, P1080, DOI 10.1038/ejhg.2009.8; CLYDE DF, 1981, B WORLD HEALTH ORGAN, V59, P391; De Araujo C, 2006, HAEMATOL-HEMATOL J, V91, P262; Dunyo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017371; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Johnson MK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007246; Lin ZL, 2005, MOL GENET METAB, V86, P212, DOI 10.1016/j.ymgme.2005.05.009; Luzzatto L, 2009, NATHAN OSKIS HEMATOL, P884; *MALERA CONS GROUP, 2011, PLOS MED, V0008; Mason PJ, 2007, BLOOD REV, V21, P267, DOI 10.1016/j.blre.2007.05.002; Migot-Nabias F, 2006, MICROBES INFECT, V8, P2352, DOI 10.1016/j.micinf.2006.03.021; Minucci A, 2009, IUBMB LIFE, V61, P27, DOI 10.1002/iub.137; Mtove G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-320; Ngomane L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-19; Nkhoma ET, 2009, BLOOD CELL MOL DIS, V42, P267, DOI 10.1016/j.bcmd.2008.12.005; Orimadegun AE, 2011, J INFECT DEV COUNTR, V5, P792, DOI 10.3855/jidc.1837; Peters AL, 2009, J HISTOCHEM CYTOCHEM, V57, P1003, DOI 10.1369/jhc.2009.953828; Ruwende C, 1998, J MOL MED, V76, P581, DOI 10.1007/s001090050253; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Shah SS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00299; Shekalaghe SA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-247; Shekalaghe SA, 2010, ANTIMICROB AGENTS CH, V54, P1762, DOI 10.1128/AAC.01135-09; Takem EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067108; Tine Roger C K, 2012, BMC Res Notes, V5, P565, DOI 10.1186/1756-0500-5-565; Vafa M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-17; Van Malderen C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-139; WHO, 2006, GUID TREATM MAL; World Health Organization Working Group, 1989, B WORLD HEALTH ORGAN, V67, P601	32	5	5	0	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	APR 17	2014	13								148	10.1186/1475-2875-13-148				6	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AL8AD	WOS:000339358000001	24742291	DOAJ Gold, Green Published			2019-04-02	
J	Petric, D; Bellini, R; Scholte, EJ; Rakotoarivony, LM; Schaffner, F				Petric, Dusan; Bellini, Romeo; Scholte, Ernst-Jan; Rakotoarivony, Laurence Marrama; Schaffner, Francis			Monitoring population and environmental parameters of invasive mosquito species in Europe	PARASITES & VECTORS			English	Review						Invasive mosquito; Population size; Blood feeding behaviour; Dispersal; Environmental change; Land use; Vector; Europe; Risk assessment; Surveillance	AEDES-ALBOPICTUS DIPTERA; MARK-RELEASE-RECAPTURE; RIO-DE-JANEIRO; PUBLIC-HEALTH IMPLICATIONS; DENGUE VIRUS TRANSMISSION; HOST-FEEDING PATTERNS; VECTOR-BORNE DISEASES; ITALIAN URBAN AREAS; WEST-NILE-VIRUS; AEGYPTI DIPTERA	To enable a better understanding of the overwhelming alterations in the invasive mosquito species (IMS), methodical insight into the population and environmental factors that govern the IMS and pathogen adaptations are essential. There are numerous ways of estimating mosquito populations, and usually these describe developmental and life-history parameters. The key population parameters that should be considered during the surveillance of invasive mosquito species are: (1) population size and dynamics during the season, (2) longevity, (3) biting behaviour, and (4) dispersal capacity. Knowledge of these parameters coupled with vector competence may help to determine the vectorial capacity of IMS and basic disease reproduction number (R-0) to support mosquito borne disease (MBD) risk assessment. Similarly, environmental factors include availability and type of larval breeding containers, climate change, environmental change, human population density, increased human travel and goods transport, changes in living, agricultural and farming habits (e.g. land use), and reduction of resources in the life cycle of mosquitoes by interventions (e.g. source reduction of aquatic habitats). Human population distributions, urbanisation, and human population movement are the key behavioural factors in most IMS-transmitted diseases. Anthropogenic issues are related to the global spread of MBD such as the introduction, reintroduction, circulation of IMS and increased exposure to humans from infected mosquito bites. This review addresses the population and environmental factors underlying the growing changes in IMS populations in Europe and confers the parameters selected by criteria of their applicability. In addition, overview of the commonly used and newly developed tools for their monitoring is provided.	[Petric, Dusan] Univ Novi Sad, Fac Agr, Lab Med Entomol, Novi Sad 21000, Serbia; [Bellini, Romeo] Ctr Agr Ambiente G Nicoli, I-40014 Crevalcore, Italy; [Scholte, Ernst-Jan] Natl Ctr Monitoring Vectors, Dutch Food & Consumer Prod Safety Author NVWA, NL-6700 HC Wageningen, Netherlands; [Rakotoarivony, Laurence Marrama] ECDC, European Ctr Dis Prevent & Control, S-17183 Stockholm, Sweden; [Schaffner, Francis] Avia GIS, B-2980 Zoersel, Belgium	Petric, D (reprint author), Univ Novi Sad, Fac Agr, Lab Med Entomol, Trg D Obradov 8, Novi Sad 21000, Serbia.	dusanp@polj.uns.ac.rs; fschaffner@avia-gis.com		Schaffner, Francis/0000-0001-9166-7617	European Centre for Disease Prevention and Control (ECDC, Stockholm, Sweden) [ECD.2842]	This work was funded by European Centre for Disease Prevention and Control (ECDC, Stockholm, Sweden), under contract ECD.2842, for the development of Guidelines for the surveillance of invasive mosquitoes in Europe. ECDC and the authors are grateful to all experts who contributed to the review process of the guidelines, and in particular for their welcoming during the field missions in Portugal, Spain, and USA. We are also pleased to thank Willy Wint, Alexander Mathis and Jolyon Medlock for their help in editing the text. This article is dedicated to Ernst-Jan Scholte.	Albieri A, 2010, B INSECTOL, V63, P209; Alcaide M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007092; Alexander N, 2006, ANN TROP MED PARASIT, V100, pS5, DOI 10.1179/136485906X105471; Alonso WJ, 2003, MEM I OSWALDO CRUZ, V98, P665, DOI 10.1590/S0074-02762003000500014; Angelini R, 2007, Euro Surveill, V12; Apperson CS, 2004, VECTOR-BORNE ZOONOT, V4, P71, DOI 10.1089/153036604773083013; Azil AH, 2011, ASIA-PAC J PUBLIC HE, V23, P827, DOI 10.1177/1010539511426595; BECKER N, 1995, MED VET ENTOMOL, V9, P377, DOI 10.1111/j.1365-2915.1995.tb00008.x; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; BEIER JC, 1982, J MED ENTOMOL, V19, P239, DOI 10.1093/jmedent/19.3.239; Bellini R., 2007, P505, DOI 10.1007/978-1-4020-6059-5_47; Bellini R, 2010, J MED ENTOMOL, V47, P1082, DOI 10.1603/ME09154; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Bonilauri P, 2008, EMERG INFECT DIS, V14, P852, DOI 10.3201/eid1405.071144; Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351; Brown KH, 2000, J PUBLIC HEALTH POL, V21, P20, DOI 10.2307/3343472; Carrieri M, 2012, J MED ENTOMOL, V49, P388, DOI 10.1603/ME10259; Carrieri M, 2011, J MED ENTOMOL, V48, P1214; Carrieri M, 2008, J AM MOSQUITO CONTR, V24, P377, DOI 10.2987/5612.1; Carrieri M, 2011, J VECTOR ECOL, V36, P108, DOI 10.1111/j.1948-7134.2011.00147.x; CELEDONIOHURTADO H, 1988, FLA ENTOMOL, V71, P111, DOI 10.2307/3495357; Chadee DD, 2009, TROP MED INT HEALTH, V14, P220, DOI 10.1111/j.1365-3156.2008.02216.x; Chow-Shaffer E, 2000, J MED ENTOMOL, V37, P492, DOI 10.1603/0022-2585-37.4.492; Clements AN, 1999, BIOL MOSQUITOES SENS, V2; Codeco CT, 2009, MEM I OSWALDO CRUZ, V104, P614, DOI 10.1590/S0074-02762009000400014; Colwell DD, 2011, VET PARASITOL, V182, P14, DOI 10.1016/j.vetpar.2011.07.012; CONWAY GR, 1974, J ANIM ECOL, V43, P289, DOI 10.2307/3366; Costantini C., 1993, Parassitologia (Rome), V35, P5; David MR, 2009, MEM I OSWALDO CRUZ, V104, P927, DOI 10.1590/S0074-02762009000600019; De Benedictis J, 2003, AM J TROP MED HYG, V68, P437, DOI 10.4269/ajtmh.2003.68.437; Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105; Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026; Dieng H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011790; *ECDC, 2009, DEV AED ALB RISK MAP; ECDC (European Centre for Disease Prevention and Control), 2012, GUID SURV INV MOSQ E; Eiras AE, 2014, J MED ENTOMOL, V51, P200, DOI 10.1603/ME13104; Erlanger TE, 2008, MED VET ENTOMOL, V22, P203, DOI 10.1111/j.1365-2915.2008.00740.x; Facchinelli L, 2008, AM J TROP MED HYG, V78, P904, DOI 10.4269/ajtmh.2008.78.904; Farjana T, 2013, J MED ENTOMOL, V50, P838, DOI 10.1603/ME12146; Fernandez Z, 2003, REV SAUDE PUBL, V37, P285, DOI 10.1590/S0034-89102003000300004; Focks D. A., 2007, Dengue Bulletin, V31, P83; Focks DA, 1997, AM J TROP MED HYG, V56, P159, DOI 10.4269/ajtmh.1997.56.159; Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2; Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Gu WD, 2006, P NATL ACAD SCI USA, V103, P17560, DOI 10.1073/pnas.0608452103; Gu WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015996; Gu WD, 2009, T ROY SOC TROP MED H, V103, P1105, DOI 10.1016/j.trstmh.2009.01.006; Harrington LC, 2005, AM J TROP MED HYG, V72, P209; Ho Chau-Mei, 2005, Formosan Entomologist, V25, P159; Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005; JAENSON TGT, 1985, J AM MOSQUITO CONTR, V1, P195; Kosova J, 2003, OSPREY J IDEAS INQUI, V3, P21; La Ruche G, 2010, EUROSURVEILLANCE, V15, P2; Lacroix R, 2009, J MED ENTOMOL, V46, P1117, DOI 10.1603/033.046.0519; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Latrofa MS, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-76; Lee JH, 2002, AM J TROP MED HYG, V66, P599, DOI 10.4269/ajtmh.2002.66.599; Lee Shae-Jinn, 1994, Zhonghua Kunchong, V14, P217; Leisnham PT, 2012, ECOHEALTH, V9, P217, DOI 10.1007/s10393-012-0773-7; Maciel-De-Freitas R, 2007, MED VET ENTOMOL, V21, P284, DOI 10.1111/j.1365-2915.2007.00694.x; Maciel-de-Freitas R, 2008, MEM I OSWALDO CRUZ, V103, P602, DOI 10.1590/S0074-02762008000600016; Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017; Marini F, 2010, MED VET ENTOMOL, V24, P361, DOI 10.1111/j.1365-2915.2010.00898.x; McCall PJ, 2002, TRENDS PARASITOL, V18, P429, DOI 10.1016/S1471-4922(02)02370-X; Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814; Mitchell C. J., 1995, Parassitologia (Rome), V37, P109; Molaei G, 2006, J MED ENTOMOL, V43, P1088, DOI 10.1603/0022-2585(2006)43[1088:IOAAMB]2.0.CO;2; Moore CG, 1997, EMERG INFECT DIS, V3, P329, DOI 10.3201/eid0303.970309; Muir LE, 1998, AM J TROP MED HYG, V58, P277, DOI 10.4269/ajtmh.1998.58.277; Neteler M, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-49; Neto PL, 2004, NEOTROP ENTOMOL, V33, P29, DOI 10.1590/S1519-566X2004000100006; NIEBYLSKI ML, 1994, J AM MOSQUITO CONTR, V10, P339; Nur Aida H, 2008, TROP BIOMED, V25, P117; Otranto D, 2005, PARASITOLOGY, V131, P847, DOI 10.1017/S0031182005008395; Otranto D, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-16; PETRIC D, 1995, J AM MOSQUITO CONTR, V11, P6; Petric D, 2012, INT S CURR TRENDS PL, P496; Petric D, 2012, ESSAYS FUNDAMENTAL A, P193; Petric D, 1989, SEASONAL DAILY ACTIV; Pocks D. A, 2004, REV ENTOMOLOGICAL SA; Puggioli A, 2013, J MED ENTOMOL, V50, P819, DOI 10.1603/ME13011; Reiskind MH, 2012, J INSECT PHYSIOL, V58, P911, DOI 10.1016/j.jinsphys.2012.04.006; Reiter P, 1998, J AM MOSQUITO CONTR, V14, P83; Richards SL, 2006, J MED ENTOMOL, V43, P543, DOI 10.1603/0022-2585(2006)43[543:HPOAAD]2.0.CO;2; Ritchie SA, 2013, J MED ENTOMOL, V50, P624, DOI 10.1603/ME12201; Rohani A, 2009, SE ASIAN J TROP MED, V40, P942; Russell RC, 2005, MED VET ENTOMOL, V19, P451, DOI 10.1111/j.1365-2915.2005.00589.x; Sanchez L, 2006, EMERG INFECT DIS, V12, P800; Schaffner F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-209; Scholte EJ, 2010, EUROSURVEILLANCE, V15, P10; Semenza JC, 2009, LANCET INFECT DIS, V9, P365, DOI 10.1016/S1473-3099(09)70104-5; Service M. W., 1993, P120; Service M. W., 1993, MOSQUITO ECOLOGY FIE; Shirai Y, 2000, J MED ENTOMOL, V37, P637, DOI 10.1603/0022-2585-37.4.637; Sivagnaname N, 2012, INDIAN J MED RES, V136, P739; Southwood T. R. E., 2000, ECOLOGICAL METHODS; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263; TSUDA Y, 1991, Tropical Medicine, V33, P47; Tunaz Hasan, 2004, Turkish Journal of Agriculture and Forestry, V28, P377; TunLin W, 1996, AM J TROP MED HYG, V54, P543, DOI 10.4269/ajtmh.1996.54.543; UN (United Nations), 2012, WORLD URB PROSP; Watson MS, 1967, MISCELLANEOUS PUBLIC, V22; World Health Organization (WHO), 1972, WKLY EPIDEMIOL REC, V47, P73; Xue RD, 2010, J MED ENTOMOL, V47, P778, DOI 10.1603/ME09222; Zhang Y, 2008, ASIA-PAC J PUBLIC HE, V20, P64, DOI 10.1177/1010539507308385	108	17	17	0	72	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	APR 16	2014	7								187	10.1186/1756-3305-7-187				14	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	AG3TR	WOS:000335343200001	24739334	DOAJ Gold, Green Published			2019-04-02	
J	Behet, MC; Foquet, L; van Gemert, GJ; Bijker, EM; Meuleman, P; Leroux-Roels, G; Hermsen, CC; Scholzen, A; Sauerwein, RW				Behet, Marije C.; Foquet, Lander; van Gemert, Geert-Jan; Bijker, Else M.; Meuleman, Philip; Leroux-Roels, Geert; Hermsen, Cornelus C.; Scholzen, Anja; Sauerwein, Robert W.			Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum	MALARIA JOURNAL			English	Article						Malaria; Plasmodium falciparum; Sporozoites; Liver-stage; Immunization; CPS; CHMI; Inhibitory antibodies; Human liver-uPA-SCID mouse model	HUMORAL IMMUNE-RESPONSES; MALARIA-NAIVE ADULTS; HOST-CELL TRAVERSAL; PHASE 2A TRIAL; PROTECTIVE IMMUNITY; ACQUIRED-IMMUNITY; IN-VIVO; LIVER; EFFICACY; INFECTION	Background: Long-lasting and sterile protective immunity against Plasmodium falciparum can be achieved by immunization of malaria-naive human volunteers under chloroquine prophylaxis with sporozoites delivered by mosquito bites (CPS-immunization). Protection is mediated by sporozoite/liver-stage immunity. In this study, the capacity of CPS-induced antibodies to interfere with sporozoite functionality and development was explored. Methods: IgG was purified from plasma samples obtained before and after CPS-immunization from two separate clinical trials. The functionality of these antibodies was assessed in vitro in gliding and human hepatocyte traversal assays, and in vivo in a human liver-chimeric mouse model. Results: Whereas pre-treatment of sporozoites with 2 mg/ml IgG in the majority of the volunteers did not have an effect on in vitro sporozoite gliding motility, CPS-induced IgG showed a distinct inhibitory effect in the sporozoite in vitro traversal assay. Pre-treatment of P. falciparum sporozoites with post-immunization IgG significantly inhibited sporozoite traversal through hepatocytes in 9/9 samples when using 10 and 1 mg/ml IgG, and was dose-dependent, resulting in an average 16% and 37% reduction with 1 mg/ml IgG (p = 0.003) and 10 mg/ml IgG (p = 0.002), respectively. In vivo, CPS-induced IgG reduced liver-stage infection and/or development after a mosquito infection in the human liver-chimeric mouse model by 91.05% when comparing 11 mice receiving post-immunization IgG to 11 mice receiving pre-immunization IgG (p = 0.0008). Conclusions: It is demonstrated for the first time that CPS-immunization induces functional antibodies against P. falciparum sporozoites, which are able to reduce parasite-host cell interaction by inhibiting parasite traversal and liver-stage infection. These data highlight the functional contribution of antibody responses to pre-erythrocytic immunity after whole-parasite immunization against P. falciparum malaria.	[Behet, Marije C.; van Gemert, Geert-Jan; Bijker, Else M.; Hermsen, Cornelus C.; Scholzen, Anja; Sauerwein, Robert W.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands; [Foquet, Lander; Meuleman, Philip; Leroux-Roels, Geert] Univ Ghent, Ctr Vaccinol, B-9000 Ghent, Belgium; [Foquet, Lander; Meuleman, Philip; Leroux-Roels, Geert] Univ Hosp, B-9000 Ghent, Belgium	Sauerwein, RW (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, Geert Grootepl 28,Microbiol 268, NL-6500 HB Nijmegen, Netherlands.	Robert.Sauerwein@radboudumc.nl	Behet, Marije/D-7785-2016; Bijker, Else/P-8051-2015; Scholzen, Anja/D-1046-2013; Hermsen, C.C./L-4368-2015; Foquet, Lander/P-1586-2016; Sauerwein, Robert/C-8519-2013	Behet, Marije/0000-0002-8683-4449; Scholzen, Anja/0000-0001-6481-6090; Foquet, Lander/0000-0001-9235-0814; Meuleman, Philip/0000-0001-6821-234X	Dioraphte Foundation; European Sixth Framework Programme integrated project European Malaria Vaccine Development Association (EMVDA) [LSHP-CT-2007-037506]; FP7-founded European Virtual Institute of Malaria Research (EVIMalaR) [242095]; Ghent University (GOA) [01G01712]; Belgian State [IUAP P7/47-HEPRO2]; Agency for Innovation by Science and Technology (IWT); Nijmegen Institute for Infection, Inflammation and Immunity (N4i) PhD scholarship; European Molecular Biology Organization (EMBO)	This work was supported by grants provided from the Dioraphte Foundation, the European Sixth Framework Programme integrated project European Malaria Vaccine Development Association (EMVDA; Contract LSHP-CT-2007-037506), the FP7-founded European Virtual Institute of Malaria Research (EVIMalaR, grant agreement number 242095), Ghent University (GOA #01G01712) and the Belgian State (IUAP P7/47-HEPRO2). LF is supported by a PhD grant of the Agency for Innovation by Science and Technology (IWT). MCB is supported by a Nijmegen Institute for Infection, Inflammation and Immunity (N4i) PhD scholarship. AS was supported by a long-term postdoctoral fellowship of the European Molecular Biology Organization (EMBO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcoser SY, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-124; Amino R, 2008, CELL HOST MICROBE, V3, P88, DOI 10.1016/j.chom.2007.12.007; Bijker EM, 2013, P NATL ACAD SCI USA, V110, P7862, DOI 10.1073/pnas.1220360110; BRUCE-CHWATT L. J., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P47, DOI 10.1016/0035-9203(56)90007-4; Casares S, 2010, VACCINE, V28, P4880, DOI 10.1016/j.vaccine.2010.05.033; Coggeshall LT, 1937, J EXP MED, V66, P177, DOI 10.1084/jem.66.2.177; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; COWAN G, 1992, LANCET, V339, P1412, DOI 10.1016/0140-6736(92)91229-2; Cummings JF, 2010, VACCINE, V28, P5135, DOI 10.1016/j.vaccine.2009.08.046; DIGGS CL, 1969, J IMMUNOL, V102, P298; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Doolan DL, 2008, PROTEOMICS, V8, P4680, DOI 10.1002/pmic.200800194; DORSHKIND K, 1984, J IMMUNOL, V132, P1804; DORSHKIND K, 1985, J IMMUNOL, V134, P3798; EGAN JE, 1993, AM J TROP MED HYG, V49, P166, DOI 10.4269/ajtmh.1993.49.166; Felgner PL, 2013, SCI REP-UK, V3, DOI 10.1038/srep03549; Finney OC, 2014, VACCINE, V32, P2135, DOI 10.1016/j.vaccine.2014.02.055; Foquet L, 2014, J CLIN INVEST, V124, P140, DOI 10.1172/JCI70349; Foquet L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-430; GRAZIANO RF, 1989, J IMMUNOL, V143, P3894; Gwadz R W, 1979, Bull World Health Organ, V57 Suppl 1, P165; Hermsen CC, 2001, MOL BIOCHEM PARASIT, V118, P247, DOI 10.1016/S0166-6851(01)00379-6; HERRINGTON D, 1991, AM J TROP MED HYG, V45, P539, DOI 10.4269/ajtmh.1991.45.539; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; HOLLINGDALE MR, 1984, J IMMUNOL, V132, P909; HOLLINGDALE MR, 1990, T ROY SOC TROP MED H, V84, P325, DOI 10.1016/0035-9203(90)90303-V; Ifediba T, 1981, NATURE, V294, P364, DOI 10.1038/294364a0; Ishino T, 2004, PLOS BIOL, V2, P77, DOI 10.1371/journal.pbio.0020004; Kaushansky A, 2012, MOL BIOCHEM PARASIT, V183, P100, DOI 10.1016/j.molbiopara.2012.01.006; Kebaier C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000399; Kester KE, 2008, VACCINE, V26, P2191, DOI 10.1016/j.vaccine.2008.02.048; Kester KE, 2007, VACCINE, V25, P5359, DOI 10.1016/j.vaccine.2007.05.005; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; KHUSMITH S, 1991, SCIENCE, V252, P715, DOI 10.1126/science.1827210; Leitner WW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-145; MAZIER D, 1990, IMMUNOL LETT, V25, P65, DOI 10.1016/0165-2478(90)90093-6; McGregor IA, 1963, T R SOC TROP MED HYG, V57, P170; Menard R, 2013, NAT REV MICROBIOL, V11, P701, DOI 10.1038/nrmicro3111; Meuleman P, 2005, HEPATOLOGY, V41, P847, DOI 10.1002/hep.20657; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Mota MM, 2002, NAT MED, V8, P1318, DOI 10.1038/nm785; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; NARDIN EH, 1982, J EXP MED, V156, P20, DOI 10.1084/jem.156.1.20; Nganou-Makamdop K, 2012, PARASITE IMMUNOL, V34, P562, DOI 10.1111/pim.12000.x; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; NUSSENZWEIG RS, 1984, PHILOS T ROY SOC B, V307, P117, DOI 10.1098/rstb.1984.0113; Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564; PONNUDURAI T, 1982, T ROY SOC TROP MED H, V76, P812, DOI 10.1016/0035-9203(82)90116-X; PONNUDURAI T, 1989, PARASITOLOGY, V98, P165, DOI 10.1017/S0031182000062065; PONNUDURAI T, 1986, PARASITOLOGY, V93, P263, DOI 10.1017/S003118200005143X; Prudencio M, 2008, CELL MICROBIOL, V10, P218, DOI 10.1111/j.1462-5822.2007.01032.x; Prudencio M, 2006, NAT REV MICROBIOL, V4, P849, DOI 10.1038/nrmicro1529; RENIA L, 1990, EUR J IMMUNOL, V20, P1445, DOI 10.1002/eji.1830200706; Roestenberg M, 2011, LANCET, V377, P1770, DOI 10.1016/S0140-6736(11)60360-7; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; ROGERS WO, 1992, P NATL ACAD SCI USA, V89, P9176, DOI 10.1073/pnas.89.19.9176; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Sack BK, 2014, INFECT IMMUN, V82, P808, DOI 10.1128/IAI.01249-13; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; Sattabongkot J, 2006, AM J TROP MED HYG, V74, P708, DOI 10.4269/ajtmh.2006.74.708; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Spring M, 2013, VACCINE, V31, P4975, DOI 10.1016/j.vaccine.2013.08.007; STEWART MJ, 1986, INFECT IMMUN, V51, P859; STEWART MJ, 1988, J PROTOZOOL, V35, P389, DOI 10.1111/j.1550-7408.1988.tb04115.x; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Stoute JA, 1998, J INFECT DIS, V178, P1139, DOI 10.1086/515657; Tavares J, 2013, J EXP MED, V210, P905, DOI 10.1084/jem.20121130; Teirlinck AC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002389; Trieu A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007948; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; van Schaijk BCL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003549; Vanderberg J, 2007, AM J PATHOL, V171, P1405, DOI 10.2353/ajpatb.2007.070661; Vanderberg JP, 2004, INT J PARASITOL, V34, P991, DOI 10.1016/j.ijpara.2004.05.005; Walsh DS, 2004, AM J TROP MED HYG, V70, P499, DOI 10.4269/ajtmh.2004.70.499; White MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061395; YOELI M, 1966, MIL MED, V131, P900	78	51	52	0	8	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	APR 5	2014	13								136	10.1186/1475-2875-13-136				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AF6FO	WOS:000334810000001	24708526	DOAJ Gold, Green Published			2019-04-02	
J	Matangila, JR; Lufuluabo, J; Ibalanky, AL; da Luz, RAI; Lutumba, P; Van Geertruyden, JP				Matangila, Junior R.; Lufuluabo, Jean; Ibalanky, Axel L.; da Luz, Raquel A. Inocencio; Lutumba, Pascal; Van Geertruyden, Jean-Pierre			Asymptomatic Plasmodium falciparum infection is associated with anaemia in pregnancy and can be more cost-effectively detected by rapid diagnostic test than by microscopy in Kinshasa, Democratic Republic of the Congo	MALARIA JOURNAL			English	Article						Asymptomatic P. falciparum infection; Anaemia; Pregnancy; Cost-effectiveness; Democratic Republic of the Congo	POLYMERASE CHAIN-REACTION; MALARIA INFECTION; BIRTH-WEIGHT; ERYTHROPOIETIN PRODUCTION; PERINATAL-MORTALITY; PLACENTAL MALARIA; HIV-INFECTION; WOMEN; MALAWI; PARASITEMIA	Background: In areas of high malaria transmission, Plasmodium falciparum infection during pregnancy is characterized by malaria-related anaemia, placental malaria and does not always result in clinical symptoms. This situation is associated with poor pregnancy outcomes. The aim of this study was to determine the extent of asymptomatic P. falciparum infection, its relation with anaemia as well as the most cost-effective technique for its diagnosis in healthy pregnant women living in Kinshasa, Democratic Republic of the Congo. Methods: In a cross-sectional study design, information on socio-demographic characteristics and cost data were collected in healthy pregnant women attending antenatal care consultations. Plasmodium falciparum infection was diagnosed using rapid diagnostic test (RDT), microscopy and polymerase chain reaction (PCR). Haemoglobin concentration was also determined. Results: In total, 332 pregnant women were enrolled. RDT and microscopy data were available for all the blood samples and 166 samples were analysed by PCR. The prevalence of asymptomatic P. falciparum infection using microscopy, RDTs and PCR, were respectively 21.6%, 27.4% and 29.5%. Taking PCR as a reference, RDTs had a sensitivity of 81.6% and a specificity of 94.9% to diagnose asymptomatic P. falciparum infection. The corresponding values for microscopy were 67.3% and 97.4%. The prevalence of anaemia was 61.1% and asymptomatic malaria increased five times the odds (p < 0.001) of having anaemia. RDTs were more cost-effective compared to microscopy. Incremental cost-effectiveness ratio was US$ 63.47 per microscopy adequately diagnosed case. Conclusion: These alarming results emphasize the need to actively diagnose and treat asymptomatic malaria infection during all antenatal care visits. Moreover, in DRC, malaria and anaemia control efforts should be strengthened by promoting the use of insecticide-treated nets, intermittent preventive treatment with sulphadoxine-pyrimethamine and iron and folic acid supplements.	[Matangila, Junior R.; Ibalanky, Axel L.; Lutumba, Pascal] Univ Kinshasa, Dept Trop Med, BP 747, Kinshasa, DEM REP CONGO; [Lufuluabo, Jean] Kinshasa RDC, Inst Super Tech Med, Kinshasa, DEM REP CONGO; [Matangila, Junior R.; da Luz, Raquel A. Inocencio; Van Geertruyden, Jean-Pierre] Univ Antwerp, Dept Epidemiol, Int Hlth Unit, B-2610 Antwerp, Belgium	Matangila, JR (reprint author), Univ Kinshasa, Dept Trop Med, BP 747, Kinshasa, DEM REP CONGO.	matangilaj@yahoo.fr	Inocencio da Luz, Raquel/L-9676-2016; Van geertruyden, Jean-Pierre/K-6425-2014	Inocencio da Luz, Raquel/0000-0002-2870-0311; Van geertruyden, Jean-Pierre/0000-0001-5006-6364	Southern African Centre of Infectious Diseases (SACIDS); VLIR UOS project [ZRDC2012 70447]	The authors thank all pregnant women who participated in this study and the staff of Centre Hospitalier de Kingasani II (Centre des Soeurs). We also thank Rose Tujibikila, Bruno Nsilulu, and Celestin Atero for assisting in sample collection and analysis. Eric Njunju is thanked for his technical assistance in the setting up of the PCR assays. The team thanks David Mwakazanga for assisting in statistical analysis and Professor Paul Gwakisa for participating in the revision of the manuscript. This study was sponsored by Southern African Centre of Infectious Diseases (SACIDS) and VLIR UOS project (ZRDC2012 70447).	Agan TU, 2010, IN J WOMENS HEALTH, V2, P229; Anchang-Kimbi JK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-126; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; De Beaudrap P, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-139; Dhorda M, 2012, AM J TROP MED HYG, V86, P93, DOI 10.4269/ajtmh.2012.10-0631; Douamba Z, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/198317; FAQUIN WC, 1992, BLOOD, V79, P1987; Humar A, 1997, AM J TROP MED HYG, V56, P44, DOI 10.4269/ajtmh.1997.56.44; Ismail MR, 2000, HUM PATHOL, V31, P85, DOI 10.1016/S0046-8177(00)80203-8; JELKMANN W, 1992, LIFE SCI, V50, P301, DOI 10.1016/0024-3205(92)90338-P; Kalenga M K, 2003, Sante Publique, V15, P413; Kanku T, 2000, CONGO MED, V13, P915; Kyabayinze DJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-306; Leopardi O, 1996, PATHOL RES PRACT, V192, P892, DOI 10.1016/S0344-0338(96)80068-9; Likwela JL, 2012, TROP MED INT HEALTH, V17, P322, DOI 10.1111/j.1365-3156.2011.02935.x; Lubell Y, 2007, AM J TROP MED HYG, V77, P128, DOI 10.4269/ajtmh.2007.77.128; Lukuka K A, 2006, Bull Soc Pathol Exot, V99, P200; Mathanga DP, 2006, TROP MED INT HEALTH, V11, P1367, DOI 10.1111/j.1365-3156.2006.01684.x; Mbanzulu P N, 1988, Rev Fr Gynecol Obstet, V83, P99; Menendez C, 2000, J INFECT DIS, V181, P1740, DOI 10.1086/315449; Ministere de la Sante, 2008, PRES ZON SANT KING; Minja DTR, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-211; Mount AM, 2004, LANCET, V363, P1860, DOI 10.1016/S0140-6736(04)16354-X; Muhindo HM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-224; Nkhoma ET, 2012, AM J TROP MED HYG, V87, P29, DOI 10.4269/ajtmh.2012.11-0380; Nosten F, 2004, TRENDS PARASITOL, V20, P425, DOI 10.1016/j.pt.2004.06.007; Nwagha UI, 2009, T ROY SOC TROP MED H, V103, P16, DOI 10.1016/j.trstmh.2008.07.016; Ordi J, 2001, J INFECT DIS, V183, P1100, DOI 10.1086/319295; Pettifor A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-331; President's Malaria Initiative, 2011, MAL OP PLAN FISC YEA; Rantala AM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-269; Roucher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046188; Schantz-Dunn Julianna, 2009, Rev Obstet Gynecol, V2, P186; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Steketee RW, 1996, AM J TROP MED HYG, V55, P95, DOI 10.4269/ajtmh.1996.55.95; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Sullivan AD, 1999, J INFECT DIS, V179, P1580, DOI 10.1086/314752; TRAPE JF, 1985, T ROY SOC TROP MED H, V79, P435, DOI 10.1016/0035-9203(85)90054-9; UNDP-DRC, 2009, KINSH PROF SUMM POV; Uzochukwu BSC, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-265; Valea I, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-71; Van Geertruyden JP, 2004, AM J TROP MED HYG, V71, P35, DOI 10.4269/ajtmh.2004.71.35; Verhoeff FH, 1999, ANN TROP MED PARASIT, V93, pS25, DOI 10.1080/00034989957718; WHO, 2001, IR DEF AN ASS PREV C	45	18	18	0	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	APR 2	2014	13								132	10.1186/1475-2875-13-132				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AF6FI	WOS:000334809400001	24690179	DOAJ Gold, Green Published			2019-04-02	
J	Borremans, B				Borremans, Benny			Ammonium improves elution of fixed dried blood spots without affecting immunofluorescence assay quality	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						capillaries; filter paper; heat-fixed; immuno-fluorescence assays; serology; Whatman	SAMPLES; VIRUS	ObjectiveTo solve the problem of fixed dried blood spot elution without damaging IgG antibodies. MethodsThe minimum effective concentration of liquid ammonium (NH3) in a PBS solution, which was found to elute fixed blood, was determined. By using a dilution series, the effects of NH3 on IgG antibody quality were assessed using immunofluorescence assays. ResultsThe minimum effective concentration of 0.2% NH3 has no detectable effects on IgG quality. ConclusionAmmonium greatly improves blood elution from fixed DBS while maintaining IgG antibody quality. These results are encouraging and provide a basis for further testing of the efficacy of ammonium in different situations as well as its effect on other compounds. ObjectifResoudre le probleme de l'elution du sang fixe et seche sans alterer les anticorps IgG. MethodesLa concentration minimale efficace d'ammonium liquide (NH3) dans une solution de PBS pour eluer le sang fixe, a ete determinee. En utilisant une serie de dilutions, les effets de NH3 sur la qualite des anticorps IgG a ete evaluee grace a des tests d'immunofluorescence. ResultatsLa concentration minimale efficace de 0,2% de NH3 n'a aucun effet detectable sur la qualite des IgG. Conclusion L'ammonium ameliore beaucoup l'elution du sang des echantillons de sang seches et fixes tout en conservant la qualite des anticorps IgG. Ces resultats sont encourageants et fournissent une base pour des tests supplementaires sur l'efficacite de l'ammonium dans des situations differentes, ainsi que son effet sur d'autres composes. ObjetivoResolver el problema de la elucion de sangre seca y fijada sin danar los anticuerpos IgG. MetodosSe determino la concentracion minima efectiva de amonio liquido (NH3) en una solucion de PBS capaz de eluir sangre fijada. Utilizando una serie de diluciones, se evaluaron los efectos del NH3 sobre la calidad de los anticuerpos IgG en ensayos de inmunofluorescencia. ResultadosLa concentracion minima efectiva de 0.2% NH3 no tiene efectos detectable sobre la calidad del IgG. ConclusionEl amonio mejora la elucion de sangre seca fijada, manteniendo la calidad de los anticuerpos IgG. Estos resultados son alentadores, y aportan una base para continuar probando la eficacia del amonio en diferentes situaciones, al igual que su efecto sobre otros compuestos.	Univ Antwerp, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium	Borremans, B (reprint author), Univ Antwerp, Evolutionary Ecol Grp, Groenenborgerlaan 171, B-2020 Antwerp, Belgium.	benny.borremans@uantwerpen.be	Borremans, Benny/D-2241-2009	Borremans, Benny/0000-0002-7779-4107	Deutsche Forschungsgemeinschaft Focus 576 Program [1596]	Thanks to Sophie Gryseels and to Beate Becker-Ziaja and Stephan Gunther of the Bernhard-Nocht-Institute for Tropical Medicine, Hamburg, for providing IFA slides. Thanks to two anonymous reviewers for useful comments that improved the manuscript. The author is currently a research fellow of Research Foundation Flanders (FWO). This work was supported by Deutsche Forschungsgemeinschaft Focus 576 Program 1596. No competing interests exist.	Andriamandimby SF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002339; Borremans B, 2011, VECTOR-BORNE ZOONOT, V11, P1125, DOI 10.1089/vbz.2010.0010; Burnett JEC, 2011, BIOANALYSIS, V3, P1099, DOI 10.4155/BIO.11.68; Gunther S., 2009, EMERG INFECT DIS, V15, P6; LEVY HL, 1985, J PEDIATR-US, V107, P757, DOI 10.1016/S0022-3476(85)80411-X; Mercader S, 2006, J VIROL METHODS, V137, P140, DOI 10.1016/j.jviromet.2006.06.018; National Committee for Clinical Laboratory Standards (NCCLS), 2003, LA4A4 NCCLS; Parker SP, 1999, J CLIN PATHOL, V52, P633, DOI 10.1136/jcp.52.9.633; Therrell BL, 1996, BIOCHEM MOL MED, V57, P116, DOI 10.1006/bmme.1996.0017	9	5	5	0	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	APR	2014	19	4					413	416		10.1111/tmi.12259				4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	AF0IR	WOS:000334398000005	24387145	Bronze			2019-04-02	
J	Tinto, H; Diallo, S; Zongo, I; Guiraud, I; Valea, I; Kazienga, A; Kpoda, H; Sorgho, H; Ouedraogo, JB; Guiguemde, TR; D'Alessandro, U				Tinto, Halidou; Diallo, Salou; Zongo, Issaka; Guiraud, Issa; Valea, Innocent; Kazienga, Adama; Kpoda, Herve; Sorgho, Hermann; Ouedraogo, Jean-Bosco; Guiguemde, Tinga Robert; D'Alessandro, Umberto			Effectiveness of artesunate-amodiaquine vs. artemetherlumefantrine for the treatment of uncomplicated falciparum malaria in Nanoro, Burkina Faso: a non- inferiority randomised trial	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						artemisinin-based combination therapies; effectiveness; uncomplicated malaria; Burkina Faso	PLUS SULFADOXINE-PYRIMETHAMINE; 6-DOSE ARTEMETHER-LUMEFANTRINE; PLASMODIUM-FALCIPARUM; DIHYDROARTEMISININ-PIPERAQUINE; ANTIMALARIAL TREATMENT; AFRICAN CHILDREN; RURAL TANZANIA; EFFICACY; COMMUNITY; UGANDA	ObjectivesArtemisinin-based combination therapies (ACTs) are essential for the effective control of falciparum malaria in endemic countries. However, in most countries, such choice has been carried out without knowing their effectiveness when deployed in real-life conditions, that is, when treatment is not directly observed. We report here the results of a study assessing the effectiveness of the two ACTs currently recommended in Burkina Faso for the treatment of uncomplicated malaria, that is, artemether-lumefantrine (AL) and artesunate-amodiaquine (ASAQ). MethodsBetween September 2008 and January 2010, 340 children were randomised to one of the two study arms and followed up for 42days. Treatment was administered according to routine practices, that is, the first dose was given by study nurses who explained to the parent/guardian how to administer the other doses at home during the following 2days. ResultsThe results showed a significantly higher unadjusted adequate clinical and parasitological response in the ASAQ (58.4%) than in the AL arm (46.1%) at day 28 but these trends were similar after correction with PCR data (ASAQ (89.7%) and AL (89.8%)). New infections started to appear after day 14, first in the AL and then in the ASAQ arm but at day 42day of follow-up we observed no difference in the occurrence of recrudescent infection. ConclusionDespite a lower cure rate than those reported in efficacy studies in which the treatment administration was directly observed, both AL and ASAQ can still be used for the treatment of uncomplicated malaria in Burkina Faso. ObjectifsLes traitements de combinaison a base d'artemisinine (ACT) sont essentiels pour la lutte efficace contre le paludisme a falciparum dans les pays endemiques. Cependant, dans la plupart des pays, un tel choix a ete fait sans connaitre leur efficacite lorsqu'ils sont deployes dans des conditions reelles, c'est-a-dire, lorsque le traitement n'est pas directement observe. Nous rapportons ici les resultats d'une etude visant a evaluer l'efficacite des deux ACT actuellement recommandes au Burkina-Faso pour le traitement du paludisme non complique, c'est-a-dire l'artemether-lumefantrine (AL) et l'artesunate-amodiaquine (ASAQ). MethodesEntre septembre 2008 et janvier 2010, 340 enfants ont ete randomises dans l'un des deux bras de l'etude et suivis pendant 42 jours. Le traitement a ete administre selon les pratiques de routine, c'est a dire la premiere dose a ete administree par des infirmieres de l'etude qui ont explique au parent/tuteur comment administrer les autres doses a la maison pendant les deux jours suivants. ResultatsLes resultats ont montre une reponse clinique et parasitologique adequate (RCPA) non ajustee significativement plus elevee dans le bras ASAQ (58.4 de%) que dans le bras AL (46.1%) au jour 28, mais ces tendances etaient similaires apres correction avec les donnees de PCR (ASAQ (89.7%) et AL (89.8%)). Les nouvelles infections ont commence a apparaitre apres le jour 14, d'abord dans le bras AL, puis dans le bras ASAQ mais au jour 42 de suivi, nous n'avons observe aucune difference dans l'incidence de recrudescence de l'infection. ConclusionMalgre un taux de guerison inferieur par rapport a ceux rapportes dans les etudes d'efficacite dans lesquelles l'administration du traitement a ete directement observe, autant AL que ASAQ peut toujours etre utilise pour le traitement du paludisme non complique au Burkina-Faso. Objetivos Las terapias de combinacion de artemisinina (TCA) son esenciales para el control efectivo de la malaria por falciparum en paises endemicos. Sin embargo, en la mayoria de los paises esta opcion se ha tomado sin conocer su efectividad en condiciones de la vida real, es decir cuando el tratamiento no se observa de forma directa. Reportamos los resultados de un estudio que evalua la efectividad de las dos TCAs actualmente recomendadas en Burkina Faso para el tratamiento de la malaria no complicada, es decir artemeter-lumefantrina (AL) y artesunato-amodiaquina (ASAQ). MetodosEntre Septiembre 2008 y Enero 2010, se aleatorizaron 340 ninos a uno de los dos brazos del estudio y se siguieron durante 42 dias. Se administro el tratamiento segun las practicas rutinarias, es decir la primera dosis la entrego una enfermera del estudio que explico al pariente/guardian como administrar las otras dosis en casa durante los siguientes dos dias. ResultadoLos resultados mostraban una respuesta clinica y parasitologica adecuada no ajustada significativamente mayor en el brazo de ASAQ (58.4%) que en el brazo AL (46.1%) a dia 28, pero estas tendencias eran similares despues de la correccion con datos de PCR (ASAQ (89.7%) y AL (89.8%)). Nuevas infecciones aparecieron despues del dia 14, primero en el brazo AL y despues en el brazo ASAQ pero en el dia 42 de seguimiento no se observaron diferencias en el recrudecimiento de la infeccion. ConclusionA pesar de haber encontrado una tasa de curacion menor que aquellas reportados en estudios de eficacia en los que la administracion del tratamiento se observaba de forma directa, se puede continuar utilizando tanto la AL como la ASAQ para el tratamiento de la malaria no complicada en Burkina Faso.	[Tinto, Halidou; Valea, Innocent; Kpoda, Herve; Ouedraogo, Jean-Bosco; Guiguemde, Tinga Robert] Ctr Muraz, Unite Rech Paludisme & Malad Trop Negligees, Bobo Dioulasso, Burkina Faso; [Tinto, Halidou; Zongo, Issaka; Guiraud, Issa; Sorgho, Hermann; Ouedraogo, Jean-Bosco] Inst Rech Sci Sante, Direct Reg, Bobo Dioulasso, Burkina Faso; [Tinto, Halidou; Diallo, Salou; Guiraud, Issa; Valea, Innocent; Kazienga, Adama; Sorgho, Hermann; Guiguemde, Tinga Robert] Clin Res Unit Nanoro, Nanoro, Burkina Faso; [Guiguemde, Tinga Robert] Inst Super Sci Sante, Bobo Dioulasso, Burkina Faso; [D'Alessandro, Umberto] Inst Trop Med Prince Leopold, Malariol Unit, B-2000 Antwerp, Belgium	Sorgho, H (reprint author), Inst Rech Sci Sante, Direct Reg, Bobo Dioulasso, Burkina Faso.	hsorgho@hotmail.com	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009; Tinto, Halidou/0000-0002-0472-3586	Malaria Consortium; Institute of Tropical Medicine, Antwerp	We thank the parents of the children included in this study for their participation and the health staff of the Nanoro Medical centre for their collaboration. We thank the Malaria Consortium for its financial support for the fieldwork. The study was also partly funded through a Post-doc training grant by The Institute of Tropical Medicine, Antwerp through the Belgian cooperation Framework Agreement 3 for the laboratory work.	Bassat Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007871; Checchi F, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-59; Faucher JF, 2009, J INFECT DIS, V200, P57, DOI 10.1086/599378; Kabanywanyi AM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-48; Kobbe R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-261; Maude RJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-31; Ministere de la Sante/PNLP, 2006, DIR NAT PRIS CHARG P; Mutabingwa TK, 2005, LANCET, V365, P1474, DOI 10.1016/S0140-6736(05)66417-3; Ngasala BE, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-64; Ngasala BE, 2011, CLIN INFECT DIS, V52, P873, DOI 10.1093/cid/cir066; Piola P, 2005, LANCET, V365, P1467, DOI 10.1016/S0140-6736(05)66416-1; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Premji ZG, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-244; Ranford-Cartwright LC, 1997, T ROY SOC TROP MED H, V91, P719, DOI 10.1016/S0035-9203(97)90539-3; Schmidt LE, 2002, DRUGS, V62, P1481, DOI 10.2165/00003495-200262100-00005; Siribie M, 2012, Bull Soc Pathol Exot, V105, P202, DOI 10.1007/s13149-012-0209-6; Sirima SB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-48; The Four Artemisinin-Based Combinations (4ABC) Study Group, 2011, PLOS MED, V8, DOI DOI 10.1371/JOURNAL.PMED.1001119; Tinto H, 2002, TROP MED INT HEALTH, V7, P925, DOI 10.1046/j.1365-3156.2002.00952.x; White NJ, 1999, CLIN PHARMACOKINET, V37, P105, DOI 10.2165/00003088-199937020-00002; WHO, 2003, ASS MON ANT DRUG EFF; WHO, 2007, GLOB MAL CONTR EL RE; WHO, 2010, GUID TREATM MAL; *WHO, 2000, T R SOC TROP MED S1, V94, P1; World Health Organization [WHO], 2007, CONT MAL MULT RES CA; Zongo I, 2007, CLIN INFECT DIS, V45, P1453, DOI 10.1086/522985; Zongo I, 2007, LANCET, V369, P491, DOI [10.1016/S0140-6736(07)60236-0, 10.1016/S0140-6736(07)60160-3]; Zwang J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-203	28	9	11	0	10	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	APR	2014	19	4					469	475		10.1111/tmi.12274				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	AF0IR	WOS:000334398000012	24494602	Bronze			2019-04-02	
J	Uwineza, A; Hitayezu, J; Murorunkwere, S; Ndinkabandi, J; Malu, CKK; Caberg, JH; Dideberg, V; Bours, V; Mutesa, L				Uwineza, Annette; Hitayezu, Janvier; Murorunkwere, Seraphine; Ndinkabandi, Janvier; Malu, Celestin Kaputu Kalala; Caberg, Jean Hubert; Dideberg, Vinciane; Bours, Vincent; Mutesa, Leon			Genetic Diagnosis of Duchenne and Becker Muscular Dystrophy using Multiplex Ligation-Dependent Probe Amplification in Rwandan Patients	JOURNAL OF TROPICAL PEDIATRICS			English	Article						Duchenne/Becker dystrophy; MLPA analysis; DMD/BMD genes; Rwanda	DMD GENE; GLYCOPROTEIN COMPLEX; DUPLICATIONS; DELETIONS; MUTATION; MLPA; IDENTIFICATION; FEMALES; MALES	Duchenne and Becker muscular dystrophies are the most common clinical forms of muscular dystrophies. They are genetically X-linked diseases caused by a mutation in the dystrophin (DMD) gene. A genetic diagnosis was carried out in six Rwandan patients presenting a phenotype of Duchenne and Becker muscular dystrophies and six asymptomatic female carrier relatives using multiplex ligation-dependent probe amplification (MLPA). Our results revealed deletion of the exons 48-51 in one patient, an inherited deletion of the exons 8-21 in two brothers and a de novo deletion of the exons 46-50 in the fourth patient. No copy number variation was found in two patients. Only one female carrier presented exon deletion in the DMD gene. This is the first cohort of genetic analysis in Rwandan patients affected by Duchenne and Becker muscular dystrophies. This report confirmed that MLPA assay can be easily implemented in low-income countries.	[Uwineza, Annette; Hitayezu, Janvier; Murorunkwere, Seraphine; Ndinkabandi, Janvier; Mutesa, Leon] Natl Univ Rwanda, Fac Med, Ctr Med Genet, Dept Mol Biol & Cytogenet, Butare, Rwanda; [Uwineza, Annette; Caberg, Jean Hubert; Dideberg, Vinciane; Bours, Vincent] Univ Liege, Ctr Human Genet, Dept Mol Biol, CHU Sart Tilman, B-4000 Liege, Belgium; [Malu, Celestin Kaputu Kalala] Butare Univ, Teaching Hosp, Dept Internal Med, Huye, Southern Provin, Rwanda; [Mutesa, Leon] Minist Hlth, Rwanda Biomed Ctr, Div Med Res Ctr, Kigali, Rwanda	Mutesa, L (reprint author), Natl Univ Rwanda, Fac Med, Butare, Rwanda.	lmutesa@nur.ac.rw	UWINEZA, Annette/I-3984-2016	UWINEZA, Annette/0000-0003-1749-0395	Center for Human Genetics at University of Liege, Belgium	This study was fully supported by the Center for Human Genetics at University of Liege, Belgium.	Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Bendixen RM, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-43; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Gatta V, 2005, HUM GENET, V117, P92, DOI 10.1007/s00439-005-1270-7; Henderson DM, 2011, HUM MOL GENET, V20, P2955, DOI 10.1093/hmg/ddr199; HODGSON S, 1989, J MED GENET, V26, P682, DOI 10.1136/jmg.26.11.682; Hoffman EP, 2012, PHYS MED REH CLIN N, V23, P821, DOI 10.1016/j.pmr.2012.08.003; Hwa HL, 2007, J FORMOS MED ASSOC, V106, P339, DOI 10.1016/S0929-6646(09)60318-1; Khordadpoor-Deilamani F, 2011, GENET TEST MOL BIOMA, V15, P893, DOI 10.1089/gtmb.2011.0057; KOENIG M, 1989, AM J HUM GENET, V45, P498; Lai KKS, 2006, CLIN BIOCHEM, V39, P367, DOI 10.1016/j.clinbiochem.2005.11.019; Lee BL, 2012, J KOREAN MED SCI, V27, P274, DOI 10.3346/jkms.2012.27.3.274; Lo IFM, 2006, CHINESE MED J-PEKING, V119, P1079; Mayhew A, 2011, DEV MED CHILD NEUROL, V53, P535, DOI 10.1111/j.1469-8749.2011.03939.x; Peddareddygari LR, 2011, AFR HEALTH SCI, V11, P607; Pillay KDH, 2007, J NEUROL SCI, V252, P1, DOI 10.1016/j.jns.2006.06.025; Prior TW, 2005, J MOL DIAGN, V7, P317, DOI 10.1016/S1525-1578(10)60560-0; Ricotti V, 2013, J NEUROL NEUROSUR PS, V84, P698, DOI 10.1136/jnnp-2012-303902; Sansovic I, 2013, BIOCHEM GENET, V51, P189, DOI 10.1007/s10528-012-9554-9; Singh R, 2006, INDIAN J CLIN BIOCHE, V21, P147, DOI 10.1007/BF02913084; Traverso M, 2006, BIOCHEM BIOPH RES CO, V339, P145, DOI 10.1016/j.bbrc.2005.11.006; vanEssen AJ, 1997, J MED GENET, V34, P805, DOI 10.1136/jmg.34.10.805; Verma Prashant K, 2012, Indian J Hum Genet, V18, P91, DOI 10.4103/0971-6866.96667; Verma S, 2010, CLIN PEDIATR, V49, P1011, DOI 10.1177/0009922810378738; Wong BLY, 2002, J CHILD NEUROL, V17, P183, DOI 10.1177/088307380201700306; WORTON RG, 1988, ANNU REV GENET, V22, P601, DOI 10.1146/annurev.ge.22.120188.003125; YOSHIDA M, 1990, J BIOCHEM-TOKYO, V108, P748, DOI 10.1093/oxfordjournals.jbchem.a123276	29	4	4	1	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0142-6338	1465-3664		J TROP PEDIATRICS	J. Trop. Pediatr.	APR	2014	60	2					112	117		10.1093/tropej/fmt090				6	Pediatrics; Tropical Medicine	Pediatrics; Tropical Medicine	AG0UP	WOS:000335131400005	24213305	Bronze			2019-04-02	
J	Kaputu-Kalala-Malu, C; Birindabagabo, JD; Walker, TD; Mafuta-Musalu, E; Ntumba-Tshitenge, O; Preux, PM; Misson, JP				Kaputu-Kalala-Malu, Celestin; Birindabagabo, Jean D'Amour; Walker, Timothy David; Mafuta-Musalu, Eric; Ntumba-Tshitenge, Olga; Preux, Pierre-Marie; Misson, Jean-Paul			Evaluation of Adherence to a Convulsion Management Protocol for Children in Rwanda	JOURNAL OF TROPICAL PEDIATRICS			English	Article						epileptic seizures; emergency therapy; guideline adherence; Rwanda	STATUS EPILEPTICUS; EPILEPSY; GUIDELINES; LORAZEPAM; SEIZURES; AFRICA	Inappropriate seizure management may result in high morbidity and mortality. We assessed the adherence of health professionals in southern Rwanda to a national protocol for pharmacological management of seizures in children. A questionnaire featuring a 5-year-old child with generalized prolonged seizures was administered. The questions focused on the choice of initial treatment and the sequence of management following failure of the initial treatment choice. Benzodiazepine was chosen as initial therapy by 93.7% of physicians and 90.9% of nurses. Only 49.2% of physicians and 41% of nurses would repeat the initial treatment in case of failure of the first dose and 47% of doctors would wait 30 min to intervene. In case of refractory status epilepticus, 34% of physicians would give three doses of benzodiazepine, whereas 19% did not know what to do. These results suggest poor adherence to national protocol.	[Kaputu-Kalala-Malu, Celestin] Univ Kinshasa, Kinshasa Sch Med, Teaching Hosp, Child Neurol Serv,Ctr Neuropsychopathol CNPP, Kinshasa 1, Zaire; [Birindabagabo, Jean D'Amour] Butaro Hosp, Dept Pediat, Musanze, Rwanda; [Walker, Timothy David] Butare Univ, Teaching Hosp, Dept Internal Med, Huye, Southern Provin, Rwanda; [Mafuta-Musalu, Eric] Univ Kinshasa, Kinshasa Sch Med, Teaching Hosp, Sch Publ Hlth, Kinshasa 1, Zaire; [Ntumba-Tshitenge, Olga] Butare Univ, Teaching Hosp, Dept Pediat, Huye, Southern Provin, Rwanda; [Preux, Pierre-Marie] Inst Neuroepidemiol & Trop Neurol, F-87025 Limoges, France; [Misson, Jean-Paul] Univ Liege, CHR Citadelle Hosp, Serv Paediat & Child Neurol, B-4000 Liege, Belgium; [Misson, Jean-Paul] Univ Liege, CHU Univ Hosp, B-4000 Liege, Belgium	Kaputu-Kalala-Malu, C (reprint author), Univ Kinshasa, Kinshasa Sch Med, Teaching Hosp, Child Neurol Serv,Ctr Neuropsychopathol CNPP, 56-B Mai Ndombe, Kinshasa 1, Zaire.	ckaputukalalamalu@yahoo.fr	PREUX, Pierre-Marie/B-8393-2014	PREUX, Pierre-Marie/0000-0002-2171-2977			[Anonymous], 2010, BASIC PAEDIAT PROTOC; [Anonymous], 2012, NICE GUID; Appleton R, 2000, ARCH DIS CHILD, V83, P415; Arya R, 2011, EPILEPSIA, V52, P788, DOI 10.1111/j.1528-1167.2010.02949.x; Cock HR, 2002, QJM-INT J MED, V95, P225, DOI 10.1093/qjmed/95.4.225; Idro R, 2010, J CHILD NEUROL, V25, P518, DOI 10.1177/0883073809357792; Kalviainen R, 2007, EPILEPSIA, V48, P99, DOI 10.1111/j.1528-1167.2007.01364.x; Lowenstein DH, 1999, EPILEPSIA, V40, P120, DOI 10.1111/j.1528-1157.1999.tb02000.x; Newton CR, 2012, LANCET, V380, P1193, DOI 10.1016/S0140-6736(12)61381-6; Ngoungou E B, 2006, Sante, V16, P225; Preux PM, 2005, LANCET NEUROL, V4, P21, DOI 10.1016/S1474-4422(04)00963-9; Shinnar S, 2007, J CHILD NEUROL, V22, p14S, DOI 10.1177/0883073807303065; Simms V, 2008, TROP MED INT HEALTH, V13, P1047, DOI 10.1111/j.1365-3156.2008.02108.x; THEODORE WH, 1994, NEUROLOGY, V44, P1403, DOI 10.1212/WNL.44.8.1403; Williams B, 2007, EPILEPSIA, V48, P1275, DOI 10.1111/j.1528-1167.2007.01057.x	15	1	1	0	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0142-6338	1465-3664		J TROP PEDIATRICS	J. Trop. Pediatr.	APR	2014	60	2					124	128		10.1093/tropej/fmt094				5	Pediatrics; Tropical Medicine	Pediatrics; Tropical Medicine	AG0UP	WOS:000335131400007	24336648	Bronze, Green Published			2019-04-02	
J	Stauch, A; Duerr, HP; Picado, A; Ostyn, B; Sundar, S; Rijal, S; Boelaert, M; Dujardin, JC; Eichner, M				Stauch, Anette; Duerr, Hans-Peter; Picado, Albert; Ostyn, Bart; Sundar, Shyam; Rijal, Suman; Boelaert, Marleen; Dujardin, Jean-Claude; Eichner, Martin			Model-Based Investigations of Different Vector-Related Intervention Strategies to Eliminate Visceral Leishmaniasis on the Indian Subcontinent	PLOS NEGLECTED TROPICAL DISEASES			English	Article							LASTING INSECTICIDAL NETS; AZAR DERMAL LEISHMANIASIS; CLUSTER RANDOMIZED-TRIAL; PHLEBOTOMINE SAND FLIES; KALA-AZAR; TREATED NETS; BIHAR; DONOVANI; ARGENTIPES; NEPAL	The elimination of infectious diseases requires reducing transmission below a certain threshold. The Visceral Leishmaniasis (VL) Elimination Initiative in Southeast Asia aims to reduce the annual VL incidence rate below 1 case per 10,000 inhabitants in endemic areas by 2015 via a combination of case management and vector control. Using a previously developed VL transmission model, we investigated transmission thresholds dependent on measures reducing the sand fly density either by killing sand flies (e.g., indoor residual spraying and long-lasting insecticidal nets) or by destroying breeding sites (e.g., environmental management). Model simulations suggest that elimination of VL is possible if the sand fly density can be reduced by 67% through killing sand flies, or if the number of breeding sites can be reduced by more than 79% through measures of environmental management. These results were compared to data from two recent cluster randomised controlled trials conducted in India, Nepal and Bangladesh showing a 72% reduction in sand fly density after indoor residual spraying, a 44% and 25% reduction through the use of long-lasting insecticidal nets and a 42% reduction after environmental management. Based on model predictions, we identified the parameters within the transmission cycle of VL that predominantly determine the prospects of intervention success. We suggest further research to refine model-based predictions into the elimination of VL. Author Summary Visceral leishmaniasis is suspected to be the second largest parasitic killer in the world after malaria. On the Indian subcontinent, the vector-borne disease is caused by the protozoan flagellate Leishmania donovani and transmitted by the sand fly Phlebotomus argentipes. The regional elimination programme has suggested as a target line to reduce the annual incidence below 1 case in 10,000 by 2015. Using a previously developed mathematical model, we investigated to what extent the sand fly population must be controlled to achieve elimination. These calculated thresholds were compared to data from two recent trials conducted in India, Nepal and Bangladesh to evaluate the efficacy of different vector control measures. Our results indicate that elimination should be feasible because the evaluated effect of indoor residual spraying exceeds the threshold. However, emerging insecticide resistance may compromise the effectiveness of this measure. The observed effects of long lasting insecticidal nets and environmental management do not seem to be sufficient to reach either threshold. Integrated vector management based on indoor residual spraying combined with long lasting insecticidal nets and more effective environmental management may allow overcoming the limitations of the current vector control methods and should also prevent re-emergence of the infection after local extinction.	[Stauch, Anette; Eichner, Martin] Univ Tubingen, Dept Clin Epidemiol & Appl Biometry, Tubingen, Germany; [Duerr, Hans-Peter] Numerus Ltd, Tubingen, Germany; [Picado, Albert] Hosp Clin Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Ostyn, Bart; Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Dept Med, Varanasi 221005, Uttar Pradesh, India; [Rijal, Suman] BP Koirala Inst Hlth Sci, Dept Med, Dharan, Nepal; [Dujardin, Jean-Claude] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Dujardin, Jean-Claude] Univ Antwerp, Lab Microbiol Parasitol & Hyg, B-2020 Antwerp, Belgium	Stauch, A (reprint author), Univ Tubingen, Dept Clin Epidemiol & Appl Biometry, Tubingen, Germany.	anette.stauch@medizin.uni-tuebingen.de; hans-peter.duerr@numerus-ltd.com		Duerr, Hans-Peter/0000-0001-7289-6019; Picado, Albert/0000-0001-7344-628X; Boelaert, Marleen/0000-0001-8051-6776	EU project KalaDrug-R [EC-FP7-222895]; European Union under its 6th Framework Program (INCODEV) [015374]	This investigation was funded by the EU project KalaDrug-R (EC-FP7-222895). The data used to validate the model were generated within the KALANET project funded by the European Union under its 6th Framework Program (INCODEV/Project 015374). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alam MZ, 2009, INFECT GENET EVOL, V9, P24, DOI 10.1016/j.meegid.2008.09.005; Alexander B, 2003, MED VET ENTOMOL, V17, P1, DOI 10.1046/j.1365-2915.2003.00420.x; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Ashford RW, 2000, INT J PARASITOL, V30, P1269, DOI 10.1016/S0020-7519(00)00136-3; Barnett PG, 2005, AM J TROP MED HYG, V73, P720, DOI 10.4269/ajtmh.2005.73.720; Bhattacharya SK, 2006, INDIAN J MED RES, V123, P195; Boelaert M, 2009, TROP MED INT HEALTH, V14, P639, DOI 10.1111/j.1365-3156.2009.02279.x; Bora D, 1999, NATL MED J INDIA, V12, P62; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Chowdhury R, 2011, AM J TROP MED HYG, V84, P662, DOI 10.4269/ajtmh.2011.10-0682; Das ML, 2010, ACTA TROP, V113, P162, DOI 10.1016/j.actatropica.2009.10.012; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Dinesh DS, 2008, TROP MED INT HEALTH, V13, P953, DOI 10.1111/j.1365-3156.2008.02096.x; Dinesh DS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000859; Dinesh DS, 2001, ANN TROP MED PARASIT, V95, P197, DOI 10.1080/00034980120041071; Donnelly MJ, 2009, TRENDS PARASITOL, V25, P213, DOI 10.1016/j.pt.2009.02.007; Downing T, 2012, INFECT GENET EVOL, V12, P149, DOI 10.1016/j.meegid.2011.11.005; Downing T, 2011, GENOME RES, V21, P2143, DOI 10.1101/gr.123430.111; DYE C, 1988, T ROY SOC TROP MED H, V82, P843, DOI 10.1016/0035-9203(88)90013-2; Guarga JL, 2000, ACTA TROP, V77, P203, DOI 10.1016/S0001-706X(00)00141-8; Hailu A, 2009, ANN TROP MED PARASIT, V103, P659, DOI 10.1179/000349809X12554106963555; HATI AK, 1991, INDIAN J MED RES-A, V93, P388; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Hurissa Z, 2010, TROP MED INT HEALTH, V15, P848, DOI 10.1111/j.1365-3156.2010.02550.x; Ingenloff K, 2013, MED VET ENTOMOL, V27, P10, DOI 10.1111/j.1365-2915.2012.00995.x; Joshi AB, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-54; Kishore K, 2006, INDIAN J MED RES, V123, P467; LYSENKO AJ, 1971, B WORLD HEALTH ORGAN, V44, P515; Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114; Molina R, 1999, AM J TROP MED HYG, V60, P51, DOI 10.4269/ajtmh.1999.60.51; Mondal D, 2008, HEALTH POLICY, V87, P369, DOI 10.1016/j.healthpol.2008.01.011; Mondal D, 2013, EMERG INFECT DIS, V19, P1131, DOI 10.3201/eid1907.120932; MUKHOPADHYAY AK, 1991, INDIAN J MED RES-A, V93, P152; Ostyn B, 2008, TROP MED INT HEALTH, V13, P1073, DOI 10.1111/j.1365-3156.2008.02110.x; Ostyn B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001284; Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439; Picado A, 2012, INDIAN J MED RES, V136, P22; Picado A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6760; Picado A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000587; Poche D, 2011, J VECTOR ECOL, V36, pS106, DOI 10.1111/j.1948-7134.2011.00119.x; Poche RM, 2012, J VECTOR ECOL, V37, P148, DOI 10.1111/j.1948-7134.2012.00211.x; Rahman KM, 2010, CLIN INFECT DIS, V50, P73, DOI 10.1086/648727; RAMESH V, 1995, INT J DERMATOL, V34, P85, DOI 10.1111/j.1365-4362.1995.tb03584.x; Robert LL, 1997, J AM MOSQUITO CONTR, V13, P140; SACKS DL, 1985, AM J TROP MED HYG, V34, P456, DOI 10.4269/ajtmh.1985.34.456; Singh N, 2013, J PARASITOL, V99, P64, DOI 10.1645/GE-3085.1; Singh R, 2008, ACTA TROP, V107, P117, DOI 10.1016/j.actatropica.2008.04.025; Singh SP, 2006, TROP MED INT HEALTH, V11, P899, DOI 10.1111/j.1365-3156.2006.01647.x; Srinivasan R., 1993, Southeast Asian Journal of Tropical Medicine and Public Health, V24, P536; Stauch A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001973; Stauch A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001405; Stockdale L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002278; Sundar S, 2006, T ROY SOC TROP MED H, V100, P533, DOI 10.1016/j.trstmh.2005.08.018; Swaminath CS, 2006, INDIAN J MED RES, V123, pA473; Thakur CP, 2007, INDIAN J MED RES, V126, P447; Thakur CP, 2004, INDIAN J MED RES, V120, P166; Uranw S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001433; van den Berg H, 2009, ENVIRON HEALTH PERSP, V117, P1656, DOI 10.1289/ehp.0900785; van Griensven J, 2010, LANCET INFECT DIS, V10, P184, DOI 10.1016/S1473-3099(10)70011-6; WENK P, 2003, PARASITOLOGIE BIOL H; WHO, 1996, TDRGEN961 WHO; Zijistra EE, 2003, LANCET INFECT DIS, V3, P87, DOI 10.1016/S1473-3099(03)00517-6	62	23	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	APR	2014	8	4								10.1371/journal.pntd.0002810				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AG3TK	WOS:000335342400035	24762676	DOAJ Gold, Green Published			2019-04-02	
J	Turner, JD; Bourke, CD; Meurs, L; Mbow, M; Dieye, TN; Mboup, S; Polman, K; Mountford, AP				Turner, Joseph D.; Bourke, Claire D.; Meurs, Lynn; Mbow, Moustapha; Dieye, Tandakha Ndiaye; Mboup, Souleymane; Polman, Katja; Mountford, Adrian P.			Circulating CD14(bright)CD16(+) 'Intermediate' Monocytes Exhibit Enhanced Parasite Pattern Recognition in Human Helminth Infection	PLOS NEGLECTED TROPICAL DISEASES			English	Article							SCHISTOSOMA-MANSONI; DENDRITIC CELLS; PROFILING REVEALS; IMMUNE-RESPONSES; TH2 POLARIZATION; HETEROGENEITY; ACTIVATION; DIFFERENTIATION; MACROPHAGES; OMEGA-1	Circulating monocyte sub-sets have recently emerged as mediators of divergent immune functions during infectious disease but their role in helminth infection has not been investigated. In this study we evaluated whether 'classical' (CD14(bright)CD16(-)), 'intermediate' (CD14(bright)CD16(+)), and 'non-classical' (CD14(dim)CD16(+)) monocyte sub-sets from peripheral blood mononuclear cells varied in both abundance and ability to bind antigenic material amongst individuals living in a region of Northern Senegal which is co-endemic for Schistosoma mansoni and S. haematobium. Monocyte recognition of excretory/secretory (E/S) products released by skin-invasive cercariae, or eggs, of S. mansoni was assessed by flow cytometry and compared between S. mansoni mono-infected, S. mansoni and S. haematobium co-infected, and uninfected participants. Each of the three monocyte sub-sets in the different infection groups bound schistosome E/S material. However, 'intermediate' CD14(bright)CD16(+) monocytes had a significantly enhanced ability to bind cercarial and egg E/S. Moreover, this elevation of ligand binding was particularly evident in co-infected participants. This is the first demonstration of modulated parasite pattern recognition in CD14(bright)CD16(+) intermediate monocytes during helminth infection, which may have functional consequences for the ability of infected individuals to respond immunologically to infection. Author Summary The parasite Schistosoma infects over 200 million people world-wide and can cause serious morbidity. Infection occurs following exposure to larvae (cercariae) which release excretory/secretory (E/S) material to aid their entry into exposed skin. Larvae mature into adult worms that produce hundreds of eggs per day which also release E/S material. Both sources of E/S material have the potential to stimulate the host's innate immune system. Circulating monocytes are important cells that act as potential sentinels in the recognition of these E/S materials. Different sub-sets of human monocytes can be identified according to their expression of CD14 and CD16 but their role following infection with schistosome helminths has not been investigated. In the current study, three sub-sets (classical, intermediate and non-classical) were enumerated in individuals living in a region co-endemic for S. mansoni and S. haematobium. Although all three monocyte sub-sets bound to fluorescently-labelled schistosome E/S material, the intermediate sub-set had significantly enhanced ability to recognise cercarial and egg E/S in co-infected participants. This is the first demonstration that circulating human monocytes can recognize schistosome E/S antigens and that their ability to do so is modulated by infection which may affect the development of schistosome immunopathology and/or protective immunity.	[Turner, Joseph D.; Bourke, Claire D.; Mountford, Adrian P.] Univ York, Dept Biol, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England; [Meurs, Lynn; Mbow, Moustapha; Polman, Katja] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Mbow, Moustapha; Dieye, Tandakha Ndiaye; Mboup, Souleymane] Aristide Le Dantec Univ Hosp, Lab Bacteriol & Virol, Dept Immunol, Dakar, Senegal	Turner, JD (reprint author), Univ Liverpool, Liverpool Sch Trop Med, Dept Parasitol, Liverpool L3 5QA, Merseyside, England.	adrian.mountford@york.ac.uk	Meurs, Lynn/J-8661-2016	Meurs, Lynn/0000-0002-6973-1237; Turner, Joseph/0000-0002-2185-5476; Bourke, Claire/0000-0002-7244-0895	European Union [EU INCO-CT-2006-032405 SCHISTOINIR]; Wellcome Trust [092745]	This study received funding the European Union (EU INCO-CT-2006-032405 SCHISTOINIR to APM, SM, and KP). CDB was funded by a Wellcome Trust project grant # 092745. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuta P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-403; Appleby LJ, 2013, IMMUNOL LETT, V152, P32, DOI 10.1016/j.imlet.2013.03.004; Ashton PD, 2001, PARASITOLOGY, V122, P329, DOI 10.1017/S0031182001007351; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Balboa L, 2013, EUR J IMMUNOL, V43, P335, DOI 10.1002/eji.201242557; Caldas IR, 2008, ACTA TROP, V108, P109, DOI 10.1016/j.actatropica.2008.05.027; Chimma P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000631; Cook PC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001323; Curwen RS, 2006, MOL CELL PROTEOMICS, V5, P835, DOI 10.1074/mcp.M500313-MCP200; DAMIAN RT, 1983, J PARASITOL, V69, P987, DOI 10.2307/3281069; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Dorsey CH, 2002, MICRON, V33, P279, DOI 10.1016/S0968-4328(01)00019-1; Everts B, 2012, J EXP MED, V209, P1753, DOI 10.1084/jem.20111381; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; Ferret-Bernard S, 2008, PROTEOMICS, V8, P980, DOI 10.1002/pmic.200700538; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Grage-Griebenow E, 2001, J LEUKOCYTE BIOL, V69, P11; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Jang-Lee J, 2007, MOL CELL PROTEOMICS, V6, P1485, DOI 10.1074/mcp.M700004-MCP200; Jenkins SJ, 2005, PARASITE IMMUNOL, V27, P385, DOI 10.1111/j.1365-3024.2005.00789.x; Jenkins SJ, 2005, INT IMMUNOL, V17, P1409, DOI 10.1093/intimm/dxh319; Jenkins SJ, 2005, INFECT IMMUN, V73, P395, DOI 10.1128/IAI.73.1.395-402.2005; Krutzik SR, 2005, NAT MED, V11, P653, DOI 10.1038/nm1246; Layland LE, 2007, EUR J IMMUNOL, V37, P2174, DOI 10.1002/eji.200737063; Lugo-Villarino G, 2013, EUR J IMMUNOL, V43, P327, DOI 10.1002/eji.201243256; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Mathieson W, 2010, INT J PARASITOL, V40, P617, DOI 10.1016/j.ijpara.2009.10.014; Meurs L, 2012, INT J PARASITOL, V42, P305, DOI 10.1016/j.ijpara.2012.02.002; Mountford AP, 2004, TRENDS PARASITOL, V20, P221, DOI 10.1016/j.pt.2004.03.003; Paveley RA, 2011, INT J PARASITOL, V41, P1335, DOI 10.1016/j.ijpara.2011.08.005; Paveley RA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000528; Skrzeczynska-Moncznik J, 2008, SCAND J IMMUNOL, V67, P152, DOI 10.1111/j.1365-3083.2007.02051.x; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; Tundup S, 2012, ANN NY ACAD SCI, V1253, pE1, DOI 10.1111/j.1749-6632.2012.06618.x; Turner JD, 2013, PARASITE IMMUNOL, V35, P147, DOI 10.1111/pim.12028; Turner JD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003063; Turner JD, 2009, J BIOL CHEM, V284, P22364, DOI 10.1074/jbc.M901528200; van de Veerdonk FL, 2010, IMMUNITY, V33, P289, DOI 10.1016/j.immuni.2010.09.007; van Riet E, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-9; Wong KL, 2012, IMMUNOL RES, V53, P41, DOI 10.1007/s12026-012-8297-3; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Ziegler-Heitbrock L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00023; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	48	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	APR	2014	8	4								10.1371/journal.pntd.0002817				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AG3TK	WOS:000335342400030	24762736	DOAJ Gold, Green Published			2019-04-02	
J	Asale, A; Getachew, Y; Hailesilassie, W; Speybroeck, N; Duchateau, L; Yewhalaw, D				Asale, Abebe; Getachew, Yehenew; Hailesilassie, Weriessaw; Speybroeck, Niko; Duchateau, Luc; Yewhalaw, Delenasaw			Evaluation of the efficacy of DDT indoor residual spraying and long-lasting insecticidal nets against insecticide resistant populations of Anopheles arabiensis Patton (Diptera: Culicidae) from Ethiopia using experimental huts	PARASITES & VECTORS			English	Article						Ethiopia; An. arabiensis; Insecticide resistance; Experimental huts; Long-lasting insecticide treated nets	MALARIA CONTROL; FIELD EFFICACY; TREATED NETS; GAMBIAE; SUSCEPTIBILITY; DELTAMETHRIN; COMBINATION; BIOEFFICACY; PERMETHRIN; VECTORS	Background: Indoor Residual Spraying (IRS) and Long-Lasting Insecticidal nets (LLINs) are major malaria vector control tools in Ethiopia. However, recent reports from different parts of the country showed that populations of Anopheles arabiensis, the principal malaria vector, have developed resistance to most families of insecticides recommended for public health use which may compromise the efficacy of both of these key vector control interventions. Thus, this study evaluated the efficacy of DDT IRS and LLINs against resistant populations of An. arabiensis using experimental huts in Asendabo area, southwestern Ethiopia. Methods: The susceptibility status of populations of An. arabiensis was assessed using WHO test kits to DDT, deltamethrin, malathion, lambda-cyhalothrin, fenitrothion and bendiocarb. The efficacy of LLIN (PermaNet (R) 2.0), was evaluated using the WHO cone bioassay. Moreover, the effect of the observed resistance against malaria vector control interventions (DDT IRS and LLINs) were assessed using experimental huts. Results: The findings of this study revealed that populations of An. arabiensis were resistant to DDT, deltamethrin, lambda-cyhalothrin and malathion with mortality rates of 1.3%, 18.8%, 36.3% and 72.5%, respectively but susceptible to fenitrothion and bendiocarb with mortality rates of 98.81% and 97.5%, respectively. The bio-efficacy test of LLIN (PermaNet (R) 2.0) against An. arabiensis revealed that the mosquito population showed moderate knockdown (64%) and mortality (78%). Moreover, mosquito mortalities in DDT sprayed huts and in huts with LLINs were not significantly different (p > 0.05) from their respective controls. Conclusion: The evaluation of the efficacy of DDT IRS and LLINs using experimental huts showed that both vector control tools had only low to moderate efficacy against An. arabiensis populations from Ethiopia. Despite DDT being replaced by carbamates for IRS, the low efficacy of LLINs against the resistant population of An. arabiensis is still a problem. Thus, there is a need for alternative vector control tools and implementation of appropriate insecticide resistance management strategies as part of integrated vector management by the national malaria control program.	[Asale, Abebe; Speybroeck, Niko; Yewhalaw, Delenasaw] Jimma Univ, Dept Biol, Coll Nat Sci, Jimma, Ethiopia; [Getachew, Yehenew] Jimma Univ, Dept Hort & Plant Sci, Coll Agr & Vet Med, Jimma, Ethiopia; [Hailesilassie, Weriessaw] Addis Ababa Sci & Technol Univ, Dept Hlth Sci, Addis Ababa, Ethiopia; [Asale, Abebe] Catholic Univ Louvain, Inst Hlth & Soc IRSS, B-1200 Brussels, Belgium; [Duchateau, Luc] Univ Ghent, Fac Vet Med, Dept Comparat Physiol & Biometr, B-9000 Ghent, Belgium	Yewhalaw, D (reprint author), Jimma Univ, Dept Biol, Coll Nat Sci, Jimma, Ethiopia.	delenasaw.yewhalaw@ju.edu.et		asale, abebe/0000-0003-0143-5762	Jimma University VLAR-IUC program	Jimma University VLAR-IUC program is highly acknowledged for logistic and financial support. The Authors are so grateful to Asendebo Vector Biology Laboratory, Jimma University staffs for their excellent technical support.	Abate A, 2011, TROP MED INT HEALTH, V16, P486, DOI 10.1111/j.1365-3156.2011.02728.x; Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Alou LPA, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-289; [Anonymous], 2006, WHOHTMMAL2006; Balkew M, 2012, MALARIA J, V11, P139, DOI DOI 10.1186/1475-2875-11-S1-P139; Balkew M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-40; BOUWMAN H, 2000, AFRICA ENV WILDLIFE, V8, P54; Chandre F, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-65; Corbel V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-113; Etang J, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-46; Federal Ministry of Health (FMOH), 2012, ETH NAT MAL IND SURV; Fettene M, 2013, AFR ENTOMOL, V21, P89, DOI 10.4001/003.021.0109; GEBREMARIAM N., 1988, ECOLOGY HLTH DIS ETH, P136; Gerberg E. G., 1970, AM MOSQUITO CONTROL, V5; Gillies M, 1987, ANOPHELINAE AFRICA S, P55; Guyatt HL, 2002, TROP MED INT HEALTH, V7, P298, DOI 10.1046/j.1365-3156.2002.00874.x; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Kawada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022574; Kelly-Hope L, 2008, LANCET INFECT DIS, V8, P387, DOI 10.1016/S1473-3099(08)70045-8; Kloos H, 1993, ECOLOGY HLTH DIS ETH, P341; Koffi AA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-151; Koudou BG, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-172; Koudou BG, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-91; Massebo F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-44; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Najera JA, 2001, WHOCDSWHOPES20013; Ngufor C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-343; Norris LC, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-254; Okumu Fredros O, 2012, Malar J, V11, P378, DOI 10.1186/1475-2875-11-378; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; Tungu P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-21; Van Bortel W, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-248; Vannice KS, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-372; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2010, COORD ACT INS RES PR; WHO, GLOB REP ANT DRUG EF; WHO, 1998, WHOCDSCPCMAL9812; WHO, 2006, WHOCDSNTDWHOPES20063; WHO, 2006, WHOCDSNTDWHOPESGCDPP, P114; World Health Organ. (WHO), 2007, LONG LAST INS NETS M; Yewhalaw D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-159; Yewhalaw D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016066; Yewhalaw D, 2010, AM J TROP MED HYG, V83, P122, DOI 10.4269/ajtmh.2010.09-0738	43	12	12	0	26	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	MAR 28	2014	7								131	10.1186/1756-3305-7-131				9	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	AG3TL	WOS:000335342500004	24678605	DOAJ Gold, Green Published			2019-04-02	
J	Okello, A; Ash, A; Keokhamphet, C; Hobbs, E; Khamlome, B; Dorny, P; Thomas, L; Allen, J				Okello, Anna; Ash, Amanda; Keokhamphet, Chattouphone; Hobbs, Emma; Khamlome, Boualam; Dorny, Pierre; Thomas, Lian; Allen, John			Investigating a hyper-endemic focus of Taenia solium in northern Lao PDR	PARASITES & VECTORS			English	Article						Taenia solium; Taeniasis; Cysticercosis; Lao PDR; Neglected tropical diseases; One health	PCR	Background: The Taenia solium cysticercosis-taeniasis complex is a Neglected Tropical Disease of significant public health importance in many impoverished communities worldwide. The parasite is suspected to be endemic in Lao PDR as a result of widespread risk factors including open human defecation, free ranging pigs and weak systems for meat inspection and carcass condemnation. Reported prevalences of human taeniasis throughout the country have ranged from 0-14%, although few of these have definitively diagnosed T. solium, grossly indistinguishable from Taenia saginata (beef tapeworm) and Taenia asiatica. This short communication details the suspicion of a hyper endemic "hotspot" of T. solium in a remote Tai Dam village in northern Lao PDR. Findings: Initial antibody serosurveillance of four provinces in Lao PDR in 2011 indicated human taeniasis and cysticercosis prevalences of 46.7% and 66.7% respectively, in the village of Om Phalong in the north of the country. Subsequent copro-antigen ELISA on 92 human faecal samples from this same village, representing a total 27.9% of the target community, indicated a taeniasis prevalence of 26.1% (95% CI = 18.2-35.9). Subsequent PCR and sequencing of samples (n = 5) all identified as T. solium; the other human tapeworms T. saginata and T. asiatica were not detected in any of the samples genotyped. Conclusion: This is potentially one of the highest documented prevalences of T. solium taeniasis to date in Lao PDR, if not the Southeast Asia region. This result raises suspicion that other "hotspots" of T. solium hyper endemicity may exist in the region, particularly in communities where the consumption of raw pork is commonplace as a result of cultural practices.	[Okello, Anna; Allen, John] CSIRO Anim Food & Hlth Sci, Australian Anim Hlth Lab AAHL Reg Programme, East Geelong, Vic, Australia; [Okello, Anna; Keokhamphet, Chattouphone] Natl Anim Hlth Lab, Dept Livestock & Fisheries, Viangchan, Laos; [Ash, Amanda] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Hobbs, Emma] Univ Edinburgh, Coll Med & Vet Med, Sch Biomed Sci, Edinburgh EH16 4SB, Midlothian, Scotland; [Khamlome, Boualam] Minist Hlth, Dept Hyg & Prevent, Viangchan, Laos; [Dorny, Pierre] Inst Trop Med, Dept Biomed Sci, Vet Helminthol Unit, B-2000 Antwerp, Belgium; [Thomas, Lian] Int Livestock Res Inst, Nairobi 00100, Kenya; [Thomas, Lian] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh EH9 3YJ, Midlothian, Scotland	Okello, A (reprint author), CSIRO Anim Food & Hlth Sci, Australian Anim Hlth Lab AAHL Reg Programme, 5 Portarlington Rd, East Geelong, Vic, Australia.	anna.okello@ed.ac.uk		Ash, Amanda/0000-0001-8218-7048; Thomas, Lian/0000-0001-8447-1210	Lao PDR Ministry of Health; Australian Centre for International Agricultural Research (ACIAR) Animal Health Programme [AH2009/001, AH/2009/019]	The project would like to thank the Lao PDR Ministry of Health for their support and assistance in undertaking the field work; in particular the staff from the Mai District and Phongsaly Provincial Health Offices. This research was funded by the Australian Centre for International Agricultural Research (ACIAR) Animal Health Programme, grant AH2009/001 and AH/2009/019.	Allan JC, 2006, PARASITOL INT, V55, pS75, DOI 10.1016/j.parint.2005.11.010; Chazee L, 2002, PEOPLES LAOS RURAL E; Conlan J, 2008, PARASITOL INT, V57, P252, DOI 10.1016/j.parint.2008.04.002; Conlan JV, 2012, AM J TROP MED HYG, V87, P281, DOI 10.4269/ajtmh.2012.11-0106; Deckers N, 2010, TRENDS PARASITOL, V26, P137, DOI 10.1016/j.pt.2009.12.008; Del Brutto OH, 2001, NEUROLOGY, V57, P177, DOI 10.1212/WNL.57.2.177; Fadiman A., 1998, SPIRIT CATCHES YOU Y; Inthavong P., 2012, 4 BIENN C INT ASS EC; Molyneux D, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-106; Ndimubanzi PC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000870; Praet N, 2013, TROP MED INT HEALTH, V18, P608, DOI 10.1111/tmi.12089; Trachsel D, 2007, PARASITOLOGY, V134, P911, DOI 10.1017/S0031182007002235; World Health Organisation, 2007, JOINT WHO EU ILRI DB; World Health Organisation, 2012, UN COMB NEGL TROP DI	14	18	18	0	21	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	MAR 28	2014	7								134	10.1186/1756-3305-7-134				4	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	AG3TL	WOS:000335342500007	24678662	DOAJ Gold, Green Published			2019-04-02	
J	Samadoulougou, S; Kirakoya-Samadoulougou, F; Sarrassat, S; Tinto, H; Bakiono, F; Nebie, I; Robert, A				Samadoulougou, Sekou; Kirakoya-Samadoulougou, Fati; Sarrassat, Sophie; Tinto, Halidou; Bakiono, Fidele; Nebie, Issa; Robert, Annie			Paracheck (R) rapid diagnostic test for detecting malaria infection in under five children: a population-based survey in Burkina Faso	MALARIA JOURNAL			English	Article						Malaria; Diagnosis; RDT; Microscopy; Paracheck	CHARACTERISTIC ROC CURVES; PLASMODIUM-FALCIPARUM; PYROGENIC THRESHOLD; COST-EFFECTIVENESS; SOUTHERN TANZANIA; ANTIGEN-DETECTION; GOLD STANDARD; MICROSCOPY; TRANSMISSION; PERFORMANCE	Background: Over the past ten years, Rapid Diagnostic Tests (RDT) played a major role in improving the use of biological malaria diagnosis, in particular in poor-resources settings. In Burkina Faso, a recent Demography and Health Survey (DHS) gave the opportunity to assess the performance of the Paracheck (R) test in under five children nationwide at community level. Methods: A national representative sample of 14,947 households was selected using a stratified two-stage cluster sampling. In one out of two households, all under five children were eligible to be tested for malaria using both RDT and microscopy diagnosis. Paracheck (R) performance was assessed using miscroscopy as the gold standard. Sensitivity and specificity were calculated as well as the diagnosis accuracy (DA) and the Youden index. Results: The malaria infection prevalence was estimated at 66% (95% CI: 64.8-67.2) according to microscopy and at 76.2% (95% CI: 75.1-77.3) according to Paracheck (R). The sensitivity and specificity were estimated at 89.9% (95% CI: 89.0-90.8) and 50.4% (95% CI: 48.3-52.6) respectively with a Diagnosis Accuracy of 77% and a Youden index of 40%. The positive predictive value for malaria infection was 77.9% (95% CI: 76.7-79.1) and the negative predictive value was 72.1% (95% CI: 69.7-74.3). Variations were found by age group, period of the year and urban and rural areas, as well as across the 13 regions of the country. Conclusion: While the sensitivity of the Paracheck (R) test was high, its specificity was poor in the general under five population of Burkina Faso. These results suggest that Paracheck (R) is not suitable to assess malaria infection prevalence at community level in areas with high malaria transmission. In such settings, malaria prevalence in the general population could be estimated using microscopy.	[Samadoulougou, Sekou; Kirakoya-Samadoulougou, Fati; Bakiono, Fidele; Robert, Annie] Catholic Univ Louvain, Fac Sante Publ, Inst Rech Expt & Clin, Pole Epidemiol & Biostat, B-1200 Brussels, Belgium; [Sarrassat, Sophie] London Sch Hyg & Trop Med, London WC1, England; [Tinto, Halidou] Inst Rech Sci Sante, Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Nebie, Issa] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso	Samadoulougou, S (reprint author), Catholic Univ Louvain, Fac Sante Publ, Inst Rech Expt & Clin, Pole Epidemiol & Biostat, Clos Chapelle Aux Champs 30,Bte B1-30-13, B-1200 Brussels, Belgium.	sekou.samadoulougou@uclouvain.be					Abba K, 2011, COCHRANE DB SYST REV, V7; Albertini A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-406; Bell D, 2002, CLIN MICROBIOL REV, V15, P771, DOI 10.1128/CMR.15.4.771-772.2002; Bisoffi Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058019; Bisoffi Z, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-226; Bisoffi Z, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-192; Burkina Faso Ministry of Health, 2011, ANN STAT 2011; Diarra A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-103; Dicko A, 2005, TROP MED INT HEALTH, V10, P550, DOI 10.1111/j.1365-3156.2005.01418.x; Eibach D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-188; Endeshaw T, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-118; Fancony C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-284; GODDARD MJ, 1990, STAT MED, V9, P325, DOI 10.1002/sim.4780090315; Harchut K, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-159; Hume JCC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-33; Kattenberg JH, 2012, AM J TROP MED HYG, V87, P251, DOI 10.4269/ajtmh.2012.12-0125; Laurent A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-294; Ly AB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-153; Macro international, MEAS DHS; Maltha J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-20; Nebie I, 2008, TROP MED INT HEALTH, V13, P229, DOI 10.1111/j.1365-3156.2007.01994.x; O'Brien C, 2011, CURR OPIN INFECT DIS, V24, P570, DOI 10.1097/QCO.0b013e32834cd3ed; Ochola LB, 2006, LANCET INFECT DIS, V6, P582, DOI 10.1016/S1473-3099(06)70579-5; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Reyburn H, 2004, BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Rogier C, 1996, AM J TROP MED HYG, V54, P613, DOI 10.4269/ajtmh.1996.54.613; Scott JAG, 2011, LANCET, V378, P1316, DOI 10.1016/S0140-6736(11)60888-X; Secardin Y, 1999, Med Trop (Mars), V59, P276; Strom GEA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-228; Tiono AB, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-30; Valea I, 2009, TROP MED INT HEALTH, V14, P338, DOI 10.1111/j.1365-3156.2009.02228.x; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; World Health Organization, RES WHO PROD TEST MA; Zou KH, 1997, STAT MED, V16, P2143; ZWEIG MH, 1993, CLIN CHEM, V39, P561	35	7	7	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	MAR 17	2014	13								101	10.1186/1475-2875-13-101				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AF6DH	WOS:000334804100002	24636636	DOAJ Gold, Green Published			2019-04-02	
J	Declercq, E				Declercq, Etienne			Michel Lechat (1928-2014) Obituary	LEPROSY REVIEW			English	Biographical-Item									Damien Fdn Belgium, Brussels, Belgium	Declercq, E (reprint author), Damien Fdn Belgium, Brussels, Belgium.							0	1	1	0	0	LEPRA	COLCHESTER	28 MIDDLEBOROUGH, COLCHESTER CO1 1TG, ESSEX, ENGLAND	0305-7518	2162-8807		LEPROSY REV	Lepr. Rev.	MAR	2014	85	1					68	68						1	Dermatology; Infectious Diseases; Pathology; Tropical Medicine	Dermatology; Infectious Diseases; Pathology; Tropical Medicine	AJ6CA	WOS:000337776100010	24974446				2019-04-02	
J	Walker, SL; Lebas, E; Doni, SN; Lockwood, DNJ; Lambert, SM				Walker, Stephen L.; Lebas, Eglantine; Doni, Shimelis N.; Lockwood, Diana N. J.; Lambert, Saba M.			The Mortality Associated with Erythema Nodosum Leprosum in Ethiopia: A Retrospective Hospital-Based Study	PLOS NEGLECTED TROPICAL DISEASES			English	Article							NERVE FUNCTION IMPAIRMENT; MANAGEMENT; ENL; CORTICOSTEROIDS; PROPHYLAXIS; EXPERIENCE; THERAPY; COHORT; INDIA	Background: Erythema nodosum leprosum (ENL) is a debilitating multisystem disorder which complicates leprosy. It is characterised by fever, malaise and painful erythematous cutaneous nodules. ENL is often recurrent or chronic in nature and frequently severe. Patients often require prolonged treatment with high doses of oral corticosteroids. There are no data on the mortality associated with treated ENL. Methodology: The notes of patients who were admitted, discharged, transferred to another facility or died with a diagnosis of leprosy or a leprosy-related complication for a five year period were reviewed. Result/Discussion: 414 individuals were identified from the ward database. 312 (75.4%) patient records were located and reviewed. Ninety-nine individuals had ENL and 145 had a Type 1 reaction. The median age of individuals with ENLwas 25 years. Eight patients with erythema nodosum leprosum died compared with two diagnosed with Type 1 reaction. This difference is statistically significant (p = 0.0168, Fisher's Exact Test). There is a significant mortality and morbidity associated with ENL in this Ethiopian cohort. The adverse outcomes seen are largely attributable to the chronic administration of oral corticosteroids used to control the inflammatory and debilitating symptoms of the condition.	[Walker, Stephen L.; Lockwood, Diana N. J.; Lambert, Saba M.] Fac Infect & Trop Dis, Dept Clin Res, London, England; [Lebas, Eglantine] Ctr Hosp Univ Liege, Liege, Belgium; [Doni, Shimelis N.; Lambert, Saba M.] ALERT Ctr, Addis Ababa, Ethiopia	Walker, SL (reprint author), Fac Infect & Trop Dis, Dept Clin Res, London, England.	Steve.walker@lshtm.ac.uk			Royal Society of Tropical Medicine and Hygiene; Hospital and Homes of St. Giles	SLW received a small grant from the Royal Society of Tropical Medicine and Hygiene (http://www.rstmh.org/home) and is supported in part by the Hospital and Homes of St. Giles. SML is supported by the Hospital and Homes of St. Giles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, WKLY EPIDEMIOL REC, V88, P365; BECXBLEUMINK M, 1992, INT J LEPROSY, V60, P173; BRUSCO C M, 1963, Int J Lepr, V31, P14; BWIRE R, 1993, LEPROSY REV, V64, P325; CAMPOS N S, 1954, Int J Lepr, V22, P259; Contreras F, 1958, REV LEPROLOGIA FONTI, V4, P317; DAVISON A R, 1957, Int J Lepr, V25, P91; Job CK, 1994, LEPROSY, P193; Kumar B, 2004, INT J LEPROSY, V72, P125, DOI 10.1489/1544-581X(2004)072<0125:ECOLRY>2.0.CO;2; Leang B, 2004, LEPROSY REV, V75, P398; Lockwood DN., 2004, ROOKS TXB DERMATOLOG, P21; Moraes MO, 1999, SCAND J IMMUNOL, V50, P541; Pocaterra L, 2006, AM J TROP MED HYG, V74, P868, DOI 10.4269/ajtmh.2006.74.868; Richardus JH, 2003, LEPROSY REV, V74, P319; Richardus JH, 2003, LEPROSY REV, V74, P311; Saunderson P, 2000, LEPROSY REV, V71, P318; Smith WCS, 2004, BMJ-BRIT MED J, V328, P1459, DOI 10.1136/bmj.38107.645926.AE; Sugumaran DST, 1998, INT J LEPROSY, V66, P10; SUSMAN I A, 1958, Lepr Rev, V29, P227; Van Brakel WH, 2003, LEPROSY REV, V74, P300; Van Veen N., 2009, COCHRANE DB SYST REV, V3; Voorend CGN, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002440; Walker SL, 2012, LEPROSY REV, V83, P396; Walker SL, 2008, LEPROSY REV, V79, P372; Walker SL, 2007, LEPROSY REV, V78, P197; WEMAMBU SNC, 1969, LANCET, V2, P933; WHO, 2012, 8 WHO	27	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAR	2014	8	3							e2690	10.1371/journal.pntd.0002690				6	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AJ0MU	WOS:000337348800005	24625394	DOAJ Gold, Green Published			2019-04-02	
J	Lochindarat, S; Teeratakulpisarn, J; Warachit, B; Chanta, C; Thapa, K; Gilbert, GL; Wangroongsarb, Y; Pircon, JY; Van Dyke, MK; Liu, YF; Hausdorff, WP				Lochindarat, Sorasak; Teeratakulpisarn, Jamaree; Warachit, Boonyarat; Chanta, Chulapong; Thapa, Kiran; Gilbert, Gwendolyn L.; Wangroongsarb, Yongyuth; Pircon, Jean-Yves; Van Dyke, Melissa K.; Liu, Yanfang; Hausdorff, William P.			BACTERIAL ETIOLOGY OF EMPYEMA THORACIS AND PARAPNEUMONIC PLEURAL EFFUSION IN THAI CHILDREN AGED LESS THAN 16 YEARS	SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH			English	Article						empyema thoracis; uncomplicated parapneumonic pleural effusion; etiology; Thai children	PNEUMOCOCCAL CONJUGATE VACCINE; POLYMERASE-CHAIN-REACTION; STREPTOCOCCUS-PNEUMONIAE; CHILDHOOD EMPYEMA; RISK-FACTORS; CULTURE; IMPACT; IDENTIFICATION; DIAGNOSIS	This study aimed to identify the bacterial etiology of empyema thoracis or parapneumonic pleural effusions in Thai children, with a focus on pneumococcus. This hospital-based, descriptive study included children aged <= 16 years, diagnosed with empyema thoracis or parapneumonic pleural effusion, from whom a pleural fluid (PF) sample was taken between January 2008 and November 2009. PF and blood samples were cultured and PF samples were also tested by polymerase chain reaction (PCR) to assess whether evidence of an infection might be identified among culture-negative samples. Serotyping of Streptococcus pneumoniae-positive samples was performed by molecular techniques and Quellung reaction. In this study, 29 children with empyema thoracis and 42 children with parapneumonic pleural effusion were enrolled. Potentially pathogenic bacteria were cultured in 13/71 samples at local or central laboratories; the most common bacteria were Staphylococcus aureus (8 children) and S. pneumoniae (2 children). Molecular techniques detected one or more targeted respiratory pathogens in 18/71 PP samples. S. pneumoniae and Haemophilus influenzae were identified by PCR in 13 and 6 children, respectively; PCR for S. aureus was not performed. The pneumococcal serotypes identified were 1, 3, 5, 6A/B, 9A/V, 14, 15A, 19F and 23A. This study shows that among Thai children with empyema thoracis and parapneumonic pleural effusions, S. aureus and S. pneumoniae were the most common pathogens identified by culture and PCR, respectively. These findings confirmed that molecular techniques are more sensitive for identification of S. pneumoniae and H. influenzae and enhance detection of important bacterial causes of empyema.	[Lochindarat, Sorasak] Queen Sirikit Natl Inst Child Hlth, Bangkok 10400, Thailand; [Teeratakulpisarn, Jamaree] Khon Kaen Univ, Fac Med, Dept Pediat, Khon Kaen, Thailand; [Warachit, Boonyarat] Hat Yai Hosp, Dept Pediat, Songkhla, Thailand; [Chanta, Chulapong] Chiang Rai Prachanukraw Hosp, Pediat Unit, Chiang Rai, Thailand; [Thapa, Kiran; Gilbert, Gwendolyn L.] Westmead Hosp, CIDM, Westmead, NSW 2145, Australia; [Wangroongsarb, Yongyuth] GlaxoSmithKline Vaccines, Global Vaccine Dev, Bangkok, Thailand; [Pircon, Jean-Yves; Van Dyke, Melissa K.; Hausdorff, William P.] GlaxoSmithKline Vaccines, Global Vaccine Dev, Wavre, Belgium; [Liu, Yanfang] GlaxoSmithKline Vaccines, Global Vaccine Dev, Singapore, Singapore	Lochindarat, S (reprint author), Queen Sirikit Natl Inst Child Hlth, Div Resp Med, 420-8 Ratchawithi Rd, Bangkok 10400, Thailand.	sorasakl@hotmail.com			GlaxoSmithKline Biologicals SA; GlaxoSmithKline group of companies; Merck Sharp; Dohme; Sanofi Aventis	GlaxoSmithKline Biologicals SA was the funding source and was involved in all stages of the study conduct and analysis. GlaxoSmithKline Biologicals SA also took responsibility for all costs associated with the development and publishing of the present manuscript.; SL declares no conflicts of interest. JT has received a grant and payment for lectures from the GlaxoSmithKline group of companies and travel grants from the GlaxoSmithKline group of companies, Merck Sharp and Dohme and Sanofi Aventis. BW declares no conflicts of interest. CC has received a travel grant from the GlaxoSmithKline group of companies. KT declares no conflicts of interest. GLG has received grants from the GlaxoSmithKline group of companies for performance of laboratory tests for the present project as well as for a similar project in Australia.	Blaschke AJ, 2011, PEDIATR INFECT DIS J, V30, P289, DOI 10.1097/INF.0b013e3182002d14; Byington CL, 2006, PEDIATR INFECT DIS J, V25, P250, DOI 10.1097/01.inf.0000202137.37642.ab; Byington CL, 2002, CLIN INFECT DIS, V34, P434, DOI 10.1086/338460; Calbo E, 2006, CLIN MICROBIOL INFEC, V12, P867, DOI 10.1111/j.1469-0691.2006.01502.x; CLSI, 2009, M100S19 CLSI; Fletcher M, 2006, PEDIATR INFECT DIS J, V25, P559, DOI 10.1097/01.inf.0000219535.14201.1b; Food and Drug Administration Thailand. Health Products e-Logistics and Lodgment Organizer, 2012, HLTH PROD E LOG LODG; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83; Hsieh YC, 2004, CLIN INFECT DIS, V38, P830, DOI 10.1086/381974; Lahti E, 2006, EUR J CLIN MICROBIOL, V25, P783, DOI 10.1007/s10096-006-0225-9; Le Monnier A, 2006, CLIN INFECT DIS, V42, P1135, DOI 10.1086/502680; Li STT, 2010, PEDIATRICS, V125, P26, DOI 10.1542/peds.2009-0184; Lin T-Y, 2011, SEOUL KOR 8 INT S AN; Nyambat B, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-90; Obando I, 2006, PEDIATR INFECT DIS J, V25, P962, DOI 10.1097/01.inf.0000235684.89728.38; Reechaipichitkul Wipa, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P320; Rees JHM, 1997, LANCET, V349, P402, DOI 10.1016/S0140-6736(97)80022-0; Saglani S, 2005, ARCH DIS CHILD, V90, P70, DOI 10.1136/adc.2003.042176; Spencer DA, 2006, BRIT MED J, V332, P1333, DOI 10.1136/bmj.332.7553.1333; Spencer DA, 2008, PAEDIAT CHILD HLTH, V18, P513; Srifeungfung S, 2010, VACCINE, V28, P3440, DOI 10.1016/j.vaccine.2010.02.071; Strachan RE, 2011, EMERG INFECT DIS, V17, P1839, DOI 10.3201/eid1710.101825; Tarrago D, 2008, CLIN MICROBIOL INFEC, V14, P828, DOI 10.1111/j.1469-0691.2008.02028.x; Wiramitchai W., 1998, THESIS MED COUNCIL B; Wu PS, 2010, EUR J PEDIATR, V169, P861, DOI 10.1007/s00431-009-1132-8	25	2	3	0	5	SOUTHEAST ASIAN MINISTERS EDUC ORGANIZATION	BANGKOK	SEAMEO-TROPMED, 420-6 RAJVITHI RD,, BANGKOK 10400, THAILAND	0125-1562			SE ASIAN J TROP MED	Southeast Asian J. Trop. Med. Public Health	MAR	2014	45	2					442	454						13	Public, Environmental & Occupational Health; Infectious Diseases; Tropical Medicine	Public, Environmental & Occupational Health; Infectious Diseases; Tropical Medicine	AF5BM	WOS:000334729000024	24968687				2019-04-02	
J	Laudisoit, A; Falay, D; Amundala, N; Akaibe, D; de Bellocq, JG; Van Houtte, N; Breno, M; Verheyen, E; Wilschut, L; Parola, P; Raoult, D; Socolovschi, C				Laudisoit, Anne; Falay, Dadi; Amundala, Nicaise; Akaibe, Dudu; de Bellocq, Joelle Gouey; Van Houtte, Natalie; Breno, Matteo; Verheyen, Erik; Wilschut, Liesbeth; Parola, Philippe; Raoult, Didier; Socolovschi, Cristina			High Prevalence of Rickettsia typhi and Bartonella Species in Rats and Fleas, Kisangani, Democratic Republic of the Congo	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							NEW-YORK-CITY; MURINE TYPHUS; SMALL MAMMALS; TICK-BORNE; INFECTIONS; DISEASES; FEVER; FELIS; IDENTIFICATION; DIVERSITY	The prevalence and identity of Rickettsia and Bartonella in urban rat and flea populations were evaluated in Kisangani, Democratic Republic of the Congo (DRC) by molecular tools. An overall prevalence of 17% Bartonella species and 13% Rickettsia typhi, the agent of murine typhus, was found in the cosmopolitan rat species, Rattus mutts and Rattus norvegicus that were infested by a majority of Xenopsylla cheopis fleas. Bartonella queenslandensis, Bartonella elizabethae, and three Bartonella genotypes were identified by sequencing in rat specimens, mostly in R. rattus. Rickettsia typhi was detected in 72% of X. cheopis pools, the main vector and reservoir of this zoonotic pathogen. Co-infections were observed in rodents, suggesting a common mammalian host shared by R. typhi and Bartonella spp. Thus, both infections are endemic in DRC and the medical staffs need to be aware knowing the high prevalence of impoverished populations or immunocompromised inhabitants in this area.	Univ Liverpool, Sch Biol Sci, EEID, Liverpool L69 3BX, Merseyside, England; [de Bellocq, Joelle Gouey; Van Houtte, Natalie; Breno, Matteo; Verheyen, Erik] Univ Antwerp, B-2020 Antwerp, Belgium; [Falay, Dadi] Univ Clin Kisangani, Kisangani, Zaire; [Amundala, Nicaise; Akaibe, Dudu] Univ Kisangani, Fac Sci, Kisangani, Zaire; CSB, Biodivers Monitoring Ctr, Kisangani, Zaire; Royal Belgian Inst Nat Sci, Brussels, Belgium; [Wilschut, Liesbeth] Univ Utrecht, Fac Geosci, Utrecht, Netherlands; Aix Marseille Univ, Inserm 1095, URMITE, UM63,CNRS 7278,IRD 198, F-13005 Marseille, France; [Laudisoit, Anne] Univ Liverpool, Sch Biol Sci, Liverpool EEID, Liverpool L69 3BX, Merseyside, England; [Parola, Philippe] Hop Nord Marseille, Serv Malad Infect & Trop, Marseille, France; [Raoult, Didier; Socolovschi, Cristina] Aix Marseille Univ, Fac Med, F-13005 Marseille, France	Socolovschi, C (reprint author), Fac Med, INSERM, CNRS, URMITE,UMR 7278,IRD 198,U1095, 27 Bd Jean Moulin, F-13385 Marseille 5, France.	Anne.Laudisoit@liverpool.ac.uk; dadfal@yahoo.fr; nicaisedrazo@yahoo.fr; duduakaibe@yahoo.fr; joellegouy@gmail.com; natalie.vanhoutte@ua.ac.be; Matteo.Breno@ua.ac.be; erik.verheyen@ua.ac.be; everheyen@naturalsciences.be; philippe.parola@gmail.com; didier.raoult@gmail.com; cristina.socolovschi@univ-amu.fr	VERHEYEN, ERIK/E-5550-2013; Laudisoit, Anne/F-2646-2017; Gouy de Bellocq, Joelle/J-4733-2013	VERHEYEN, ERIK/0000-0001-7157-1474; Laudisoit, Anne/0000-0001-7626-9426; Gouy de Bellocq, Joelle/0000-0001-5831-6284; raoult, didier/0000-0002-0633-5974	Belgian Development Aid project [T2-IMAB-01]	The travel grant of DF was funded by Belgian Development Aid project T2-IMAB-01: "Cooperation with the University of Kisangani for the taxonomic study and the monitoring of lowland forests." Promotor EV (RBINS/ UAntwerpen). The fieldwork was supported by VLIR-UOS: Projects DRC 2009-Special call: "Soutien academique pour le developpement de la recherche appliquee sur les petits mammiferes nuisibles en DRC." Promotor: Herwig LEIRS (UAntwerpen) & DUDU Akaibe (UNIKIS), co-promotor EV (RBINS/UAntwerpen) and VLIR PP CUI. phase I. projet 2: Apport de la biodiversite a la formation et la securite alimentaire dans le Bassin Nord-est du Congo (Kisangani, R.D. Congo). Coordinator biodiversity project: Hippolyte NSIMBA Seya wa Malale (UNIKIS) and EV (RBINS/ UAntwerpen).	Abramowicz KF, 2011, VECTOR-BORNE ZOONOT, V11, P979, DOI 10.1089/vbz.2010.0117; Angelakis E, 2010, J TRAVEL MED, V17, P310, DOI 10.1111/j.1708-8305.2010.00435.x; AZAD AF, 1990, ANNU REV ENTOMOL, V35, P553, DOI 10.1146/annurev.en.35.010190.003005; Barbara KA, 2010, J MED ENTOMOL, V47, P1173, DOI 10.1603/ME10064; Bitam I, 2009, CLIN MICROBIOL INFEC, V15, P255, DOI 10.1111/j.1469-0691.2008.02275.x; Ceianu CS, 2001, VIRAL IMMUNOL, V14, P251, DOI 10.1089/088282401753266765; Cheng L, 2009, 23 M AM SOC RICK HIL; Christou C, 2010, AM J TROP MED HYG, V83, P1301, DOI 10.4269/ajtmh.2010.10-0118; Comer JA, 2001, AM J TROP MED HYG, V65, P855, DOI 10.4269/ajtmh.2001.65.855; Cotner JA, 2001, VECTOR-BORNE ZOONOT, V1, P91; DUMLER JS, 1991, JAMA-J AM MED ASSOC, V266, P1365, DOI 10.1001/jama.266.10.1365; EYCKMANS LUC, 1960, ANN SOC BEIGE MED TROP, V40, P105; Greub G, 2002, J MED MICROBIOL, V51, P915, DOI 10.1099/0022-1317-51-11-915; Gundi VAKB, 2012, AM J TROP MED HYG, V87, P319, DOI 10.4269/ajtmh.2012.11-0555; Hamel D, 2012, PARASITOL RES, V110, P1537, DOI 10.1007/s00436-011-2659-y; Harrus S, 2005, INT J PARASITOL, V35, P1309, DOI 10.1016/j.ijpara.2005.06.005; Houpikian P, 2001, FEMS MICROBIOL LETT, V200, P1, DOI 10.1016/S0378-1097(01)00198-7; Jadin J, 1951, RICKETTSIAL DIS BELG, P107; Kakura B, 2005, MONOGRPAHIE PROVINCE, P134; Kim HC, 2010, J WILDLIFE DIS, V46, P165, DOI 10.7589/0090-3558-46.1.165; La Scola B, 2003, TRENDS MICROBIOL, V11, P318, DOI 10.1016/S0966-842X(03)00143-4; Lambin EF, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-54; Laudisoit A, 2005, P SCI RES AFR COUNTR, P151; Laudisoit A, 2011, ASIAN PAC J TROP MED, V4, P320, DOI 10.1016/S1995-7645(11)60094-1; Mediannikov O, 2012, TICKS TICK-BORNE DIS, V3, P371; Meheretu Y, 2013, VECTOR-BORNE ZOONOT, V13, P164, DOI 10.1089/vbz.2012.1004; Merhej V, 2011, BIOL REV, V86, P379, DOI 10.1111/j.1469-185X.2010.00151.x; Montgelard C, 2002, MOL PHYLOGENET EVOL, V22, P220, DOI 10.1006/mpev.2001.1056; O'Dempsey TJD, 2006, ANN TROP MED PARASIT, V100, P501, DOI 10.1179/136485906X97381; Olayemi A, 2012, ZOOL J LINN SOC-LOND, V165, P700, DOI 10.1111/j.1096-3642.2012.00823.x; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Parola P, 2005, VET RES, V36, P469, DOI 10.1051/vetres:2005004; Phongmany S, 2006, EMERG INFECT DIS, V12, P256; Renesto P, 2001, J CLIN MICROBIOL, V39, P430, DOI 10.1128/JCM.39.2.430-437.2001; Roux V, 2000, INT J SYST EVOL MICR, V50, P1449, DOI 10.1099/00207713-50-4-1449; Sackal C, 2008, EMERG INFECT DIS, V14, P1972, DOI 10.3201/eid1412.080610; SALGO MP, 1988, NEW ENGL J MED, V318, P1345, DOI 10.1056/NEJM198805263182101; Socolovschi C, 2012, EMERG INFECT DIS, V18, P1966, DOI 10.3201/eid1812.111237; Socolovschi C, 2010, EMERG INFECT DIS, V16, P1140, DOI 10.3201/eid1607.100070; van Vliet N, 2012, ORYX, V46, P196, DOI 10.1017/S0030605311000202; Walter G, 2012, AM J TROP MED HYG, V86, P1049, DOI 10.4269/ajtmh.2012.11-0794; WHO, 2005, DEMOCRATIC REPUBLI A, P136	42	6	6	0	15	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	MAR	2014	90	3					463	468		10.4269/ajtmh.13-0216				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	AC2RY	WOS:000332352900013	24445202	Green Published, Bronze			2019-04-02	
J	Dahmane, A; van Griensven, J; Van Herp, M; Van den Bergh, R; Nzomukunda, Y; Prior, J; Alders, P; Jambai, A; Zachariah, R				Dahmane, A.; van Griensven, J.; Van Herp, M.; Van den Bergh, R.; Nzomukunda, Y.; Prior, J.; Alders, P.; Jambai, A.; Zachariah, R.			Constraints in the diagnosis and treatment of Lassa Fever and the effect on mortality in hospitalized children and women with obstetric conditions in a rural district hospital in Sierra Leone	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Case fatality; Children; Lassa fever; Operational research; Ribavirin; Sierra Leone	OUTCOME CASE-REPORT; HEMORRHAGIC-FEVER; VIRUS; EPIDEMIOLOGY; LESSONS; ASSAY	Background: Lassa fever (LF) is an acute viral haemorrhagic infection, endemic in West Africa. Confirmatory diagnosis and treatment (ribavirin) is difficult, expensive, and restricted to specialised hospitals. Among confirmed and suspected LF cases, we report on clinical and laboratory features, timing and administration of ribavirin and the relationship with case fatality. Methods: We conducted an audit of patient files of suspected LF cases admitted to a pediatric and obstetric referral hospital in rural Sierra Leone (April 2011 to February 2012). Results: There were 84 suspected LF cases; 36 (43%) were laboratory-confirmed cases, of whom only 20 (56%) received ribavirin after a median duration of eight days (IQR 314 days) of hospital admission. Of 16 patients who did not receive ribavirin, 14 (87%) died before ribavirin treatment could be commenced. Starting ribavirin within six days of admission was associated with a case fatality of 29% (2/7), while starting ribavirin later than six days was associated with a case fatality of 50% (6/12). Among the 48 suspected LF cases without laboratory confirmation, there were 21 (44%) deaths. Conclusions: These findings highlight shortcomings in LF management, including diagnostic and treatment delays. More research and development efforts should be devoted to this 'neglected disease'.	[Dahmane, A.; Van den Bergh, R.; Zachariah, R.] Brussels Operat Ctr, Med Dept Operat Res, Brussels, Belgium; [van Griensven, J.] Inst Trop Med, B-2000 Antwerp, Belgium; [Van Herp, M.; Nzomukunda, Y.; Prior, J.; Alders, P.] Brussels Operat Ctr, Brussels, Belgium; [Jambai, A.] Dis Prevent & Control Program, Freetown, Sierra Leone	Dahmane, A (reprint author), Brussels Operat Ctr, Med Dept Operat Res, 68 Rue Gasperich, L-1617 Luxembourg, Luxembourg.	amine.dahmane@hotmail.com		Van den Bergh, Rafael/0000-0001-6277-8713	Department for International Development, UK; Medecins Sans Frontieres, Operational Centre Brussels	Funding for the course was from an anonymous donor and the Department for International Development, UK. The study implementation was funded by Medecins Sans Frontieres, Operational Centre Brussels.	Amorosa V, 2010, EMERG INFECT DIS, V16, P1598, DOI 10.3201/eid1610.100774; Asogun DA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001839; ATKIN S, 2009, EURO SURVEILL, V14; Bausch DG, 2000, J CLIN MICROBIOL, V38, P2670; Branco LM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-404; Fichet-Calvet E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000388; Fisher-Hoch SP, 2005, BRIT MED BULL, V73-74, P123, DOI 10.1093/bmb/ldh054; Grove JN, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-314; Gunther S, 2000, EMERG INFECT DIS, V6, P466, DOI 10.3201/eid0605.000504; Kitching A, 2009, EURO SURVEILL, V14; Macher AM, 2006, EMERG INFECT DIS, V12, P835, DOI 10.3201/eid1205.050052; McCormick JB, 2002, CURR TOP MICROBIOL, V262, P75; MCCORMICK JB, 1987, J INFECT DIS, V155, P437, DOI 10.1093/infdis/155.3.437; McCormick JB, 1999, EMERGENCE AND CONTROL OF RODENT-BORNE VIRAL DISEASES (HANTAVIRAL AND ARENAL DISEASES), P177; MSF, 2005, LASS FEV GUID; MURPHY FA, 1975, B WORLD HEALTH ORGAN, V52, P389; Ogbu O., 2007, Journal of Vector Borne Diseases, V44, P1; Richmond JK, 2003, BRIT MED J, V327, P1271, DOI 10.1136/bmj.327.7426.1271; Vieth S, 2007, T ROY SOC TROP MED H, V101, P1253, DOI 10.1016/j.trstmh.2005.03.018	19	12	14	1	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	MAR	2014	108	3					126	132		10.1093/trstmh/tru009				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	AB8NA	WOS:000332045900004	24535150	Green Published, Bronze			2019-04-02	
J	Caron, Y; Martens, K; Lempereur, L; Saegerman, C; Losson, B				Caron, Yannick; Martens, Koen; Lempereur, Laetitia; Saegerman, Claude; Losson, Bertrand			New insight in lymnaeid snails (Mollusca, Gastropoda) as intermediate hosts of Fasciola hepatica (Trematoda, Digenea) in Belgium and Luxembourg	PARASITES & VECTORS			English	Article						Fasciola sp; Radix balthica; Galba truncatula; Multiplex PCR; Epidemiology	GALBA-TRUNCATULA; RADIX-PEREGRA; PARAMPHISTOMUM-DAUBNEYI; OMPHISCOLA-GLABRA; DNA-PROBE; INFECTION; PREVALENCE; PCR; TRANSMISSION; VECTORS	Background: The present study aims to assess the epidemiological role of different lymnaeid snails as intermediate hosts of the liver fluke Fasciola hepatica in Belgium and Luxembourg. Methods: During summer 2008, 7103 lymnaeid snails were collected from 125 ponds distributed in 5 clusters each including 25 ponds. Each cluster was located in a different biogeographic area of Belgium and Luxembourg. In addition, snails were also collected in sixteen other biotopes considered as temporary wet areas. These snails were identified as Galba truncatula (n = 2474) (the main intermediate host of F. hepatica in Europe) and Radix sp. (n = 4629). Moreover, several biological and non-biological variables were also recorded from the different biotopes. DNA was extracted from each snail collected using Chelex (R) technique. DNA samples were screened through a multiplex PCR that amplifies lymnaeid internal transcribed spacer 2 gene sequences (500-600 bp) (acting as an internal control) and a 124 bp fragment of repetitive DNA from Fasciola sp. Results: Lymnaeid snails were found in 75 biotopes (53.2%). Thirty individuals of G. truncatula (1.31%) and 7 of Radix sp. (0.16%) were found to be positive for Fasciola sp. The seven positive Radix sp. snails all belonged to the species R. balthica (Linnaeus, 1758). Classification and regression tree analysis were performed in order to better understand links and relative importance of the different recorded factors. One of the best explanatory variables for the presence/ absence of the different snail species seems to be the geographic location, whereas for the infection status of the snails no obvious relationship was linked to the presence of cattle. Conclusions: Epidemiological implications of these findings and particularly the role of R. balthica as an alternative intermediate host in Belgium and Luxembourg were discussed.	[Caron, Yannick; Losson, Bertrand] Univ Liege, Fac Vet Med, Dept Infect & Parasit Dis, Res Unit Parasitol & Parasit Dis, B-4000 Liege, Belgium; [Martens, Koen] Royal Belgium Inst Nat Sci, Brussels, Belgium; [Lempereur, Laetitia] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow G61 1QH, Lanark, Scotland; [Saegerman, Claude] Univ Liege, Fac Vet Med, Dept Infect & Parasit Dis, Res Unit Epidemiol & Risk Anal Appl Vet Sci UREAR, B-4000 Liege, Belgium	Caron, Y (reprint author), Univ Liege, Fac Vet Med, Dept Infect & Parasit Dis, Res Unit Parasitol & Parasit Dis, B-4000 Liege, Belgium.	ycaron@ulg.ac.be		Caron, Yannick/0000-0003-3344-7311	European Union; Belgian Science Policy [SD/BD/02A]	This study had been made in the frame of the PONDSCAPE project ("Towards a sustainable management of pond diversity at the landscape level" - http://www.pondscape.be), financed by the European Union and the Belgian Science Policy (SD/BD/02A). The authors would like to thank PONDSCAPE partners and the Interdisciplinary Group of Applied Genoproteomics (GIGA) Genomic Facility (http://www.giga.ulg.ac.be) for sequencing support.	Abrous M, 1996, J PARASITOL, V82, P1026, DOI 10.2307/3284217; Abrous M, 1999, VET RES, V30, P113; Abrous M, 1998, J PARASITOL, V84, P1257, DOI 10.2307/3284683; Almeyda-Artigas RJ, 2000, J PARASITOL, V86, P537, DOI 10.2307/3284869; Bargues MD, 2001, INFECT GENET EVOL, V1, P85, DOI 10.1016/S1567-1348(01)00019-3; Bargues MD, 2005, J HELMINTHOL, V79, P257, DOI 10.1079/JOH2005297; Baur B, 2002, HYDROBIOLOGIA, V479, P1, DOI 10.1023/A:1021008010386; BORAY JC, 1978, VET PARASITOL, V4, P127, DOI 10.1016/0304-4017(78)90004-3; BORAY JC, 1966, ANN TROP MED PARASIT, V60, P114, DOI 10.1080/00034983.1966.11686394; Boray JC, 1967, P 3 INT C WORLD ASS, P132; Breiman L, 1984, CLASSIFICATION REGRE; Caron Y, 2007, VET PARASITOL, V149, P95, DOI 10.1016/j.vetpar.2007.07.012; Caron Y, 2011, VET PARASITOL, V178, P93, DOI 10.1016/j.vetpar.2010.12.020; Caron Y, 2008, PARASITOL RES, V103, P735, DOI 10.1007/s00436-008-1086-1; Chapuis E, 2007, MOL ECOL, V16, P3484, DOI 10.1111/j.1365-294X.2007.03386.x; Charlier J, 2009, VET PARASITOL, V166, P235, DOI 10.1016/j.vetpar.2009.09.040; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; Correa AC, 2011, INFECT GENET EVOL, V11, P1978, DOI 10.1016/j.meegid.2011.09.003; Correa AC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-381; Cucher MA, 2006, VET PARASITOL, V137, P74, DOI 10.1016/j.vetpar.2005.12.013; Dagnelie P, 1998, STAT THEORIQUE APPL, V2; Dreyfuss G, 2007, J HELMINTHOL, V81, P7, DOI 10.1017/S0022149X07161162; Dreyfuss G, 2006, PARASITOL RES, V99, P197, DOI 10.1007/s00436-006-0147-6; Dreyfuss G, 2000, PARASITOL RES, V86, P69, DOI 10.1007/s004360050013; Dreyfuss G, 2000, J PARASITOL, V86, P158, DOI 10.2307/3284929; Dreyfuss G, 2002, PARASITE, V9, P113, DOI 10.1051/parasite/2002092113; Faltynkova A, 2006, ACTA PARASITOL, V51, P87, DOI 10.2478/s11686-006-0013-9; Furmaga S., 1969, Acta Parasitologica Polonica, V17, P115; FURMAGA S, 1967, Acta Parasitologica Polonica, V15, P237; FURMAGA S, 1967, Acta Parasitologica Polonica, V15, P231; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hunova K, 2012, ACTA PARASITOL, V57, P273, DOI 10.2478/s11686-012-0040-7; JANSSEN AW, 1965, ZOETWATERMOLLUSKEN N; Jouet D, 2010, INFECT GENET EVOL, V10, P1218, DOI 10.1016/j.meegid.2010.08.001; KAPLAN RM, 1995, INT J PARASITOL, V25, P601, DOI 10.1016/0020-7519(94)00159-L; Kaplan RM, 1997, INT J PARASITOL, V27, P1585, DOI 10.1016/S0020-7519(97)00139-2; Kozak M, 2010, VET PARASITOL, V168, P25, DOI 10.1016/j.vetpar.2009.10.014; Martinez-Ibeas AM, 2013, VET PARASITOL, V195, P57, DOI 10.1016/j.vetpar.2012.12.048; MCREATH AM, 1978, PARASITOLOGY, V77, pR15; Pfenninger M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-100; Pfenninger M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-135; Pointier JP, 2007, PARASITOL RES, V101, P1389, DOI 10.1007/s00436-007-0656-y; Relf V, 2009, VET PARASITOL, V163, P152, DOI 10.1016/j.vetpar.2009.04.003; Rognlie MC, 1996, VET PARASITOL, V65, P297, DOI 10.1016/S0304-4017(96)00957-0; Rondelaud D, 2009, LIMNEE TRONQUEE MOLL; Saegerman C, 2011, REV SCI TECH OIE, V30, P555; Schweizer G, 2007, VET PARASITOL, V150, P164, DOI 10.1016/j.vetpar.2007.08.006; Schweizer G, 2005, VET REC, V157, P188, DOI 10.1136/vr.157.7.188; SINDOU P, 1991, VET PARASITOL, V40, P47, DOI 10.1016/0304-4017(91)90082-7; Skirnisson K, 2009, J HELMINTHOL, V83, P165, DOI 10.1017/S0022149X09336408; SMITH G, 1982, J PARASITOL, V68, P965, DOI 10.2307/3281020; Taylor EL, 1965, FASCIOLIASIS LIVER F, V64; Torgerson P, 1999, FASCIOLOSIS, P113; Velusamy R, 2004, VET PARASITOL, V120, P85, DOI 10.1016/j.vetpar.2003.11.009; Vignoles P, 2002, J HELMINTHOL, V76, P269, DOI 10.1079/JOH2002118; Zanella G, 2013, TRANSBOUND EMERG DIS, V60, P231, DOI 10.1111/j.1865-1682.2012.01334.x	56	18	19	0	18	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	FEB 13	2014	7								66	10.1186/1756-3305-7-66				8	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	AF9WQ	WOS:000335065800001	24524623	DOAJ Gold, Green Published			2019-04-02	
J	Bhattacharyya, T; Bowes, DE; El-Safi, S; Sundar, S; Falconar, AK; Singh, OP; Kumar, R; Ahmed, O; Boelaert, M; Miles, MA				Bhattacharyya, Tapan; Bowes, Duncan E.; El-Safi, Sayda; Sundar, Shyam; Falconar, Andrew K.; Singh, Om Prakash; Kumar, Rajiv; Ahmed, Osman; Boelaert, Marleen; Miles, Michael A.			Significantly Lower Anti-Leishmania IgG Responses in Sudanese versus Indian Visceral Leishmaniasis	PLOS NEGLECTED TROPICAL DISEASES			English	Article							LATEX AGGLUTINATION-TEST; HLA-CLASS-II; IMMUNE-RESPONSE; EASTERN SUDAN; KALA-AZAR; DONOVANI INFECTION; DIAGNOSTIC-TESTS; SUSCEPTIBILITY; POLYMORPHISMS; MALNUTRITION	Background Visceral leishmaniasis (VL), a widely distributed systemic disease caused by infection with the Leishmania donovani complex (L. donovani and L. infantum), is almost always fatal if symptomatic and untreated. A rapid point-of-care diagnostic test for anti-Leishmania antibodies, the rK39-immunochromatographic test (rK39-ICT), has high sensitivity and specificity in South Asia but is less sensitive in East Africa. One of the underlying reasons may be continent-specific molecular diversity in the rK39 antigen within the L. donovani complex. However, a second reason may be differences in specific IgG anti-Leishmania levels in patients from different geographical regions, either due to variable antigenicity or immunological response. Methodology/Principal Findings We determined IgG titres of Indian and Sudanese VL patients against whole cell lysates of Indian and Sudanese L. donovani strains. Indian VL patients had significantly higher IgG titres against both L. donovani strains compared to Sudanese VL patients (p<0.0001). Mean reciprocal log(10) 50% end-point titres (1/log(10)t(50)) were i) 3.80 and 3.88 for Indian plasma and ii) 2.13 and 2.09 for Sudanese plasma against Indian and Sudanese antigen respectively (p<0.0001). Overall, the Indian VL patients therefore showed a 46.8-61.7 -fold higher mean ELISA titre than the Sudanese VL patients. The higher IgG titres occurred in children (<16 years old) and adults of either sex from India (mean 1/log(10)t(50): 3.60-4.15) versus Sudan (mean 1/log(10)t(50): 1.88-2.54). The greatest difference in IgG responses was between male Indian and Sudanese VL patients of 16 years old (mean 1/log(10)t(50): 4.15 versus 1.99=144-fold (p<0.0001). Conclusions/Significance Anti-Leishmania IgG responses among VL patients in Sudan were significantly lower than in India; this may be due to chronic malnutrition with Zn2+ deficiency, or variable antigenicity and capacity to generate IgG responses to Leishmania antigens. Such differential anti-Leishmania IgG levels may contribute to lower sensitivity of the rK39-ICT in East Africa. Author Summary Visceral leishmaniasis (VL) is a systemic disease with highest prevalence in South Asia, East Africa, and Brazil. VL is caused by protozoan parasites of the Leishmania donovani complex, transmitted to humans when an infected sandfly takes a bloodmeal. Within the human host, the parasites replicate within cells, particularly of bone marrow and spleen. Without effective treatment, symptomatic VL is usually fatal. Correct treatment depends on accurate diagnosis, which is by detection of parasites or specific antibodies. The rK39 rapid diagnostic test for antibody is highly sensitive in South Asia but less so in East Africa, for poorly understood reasons. Here, we have directly compared the anti-Leishmania antibody response in groups of VL patients from India and Sudan. We found a strikingly higher anti-Leishmania antibody response in Indian compared to Sudanese patients, which was also seen when further analysed by age and sex of the patients. Thus in addition to parasite factors, we have shown that difference in antibody levels may contribute to the lower sensitivity of antibody-based diagnosis for VL in Sudan.	[Bhattacharyya, Tapan; Bowes, Duncan E.; Miles, Michael A.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [El-Safi, Sayda; Ahmed, Osman] Univ Khartoum, Fac Med, Khartoum, Sudan; [Sundar, Shyam; Singh, Om Prakash; Kumar, Rajiv] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [Falconar, Andrew K.] Univ Norte, Dept Med, Barranquilla, Colombia; [Kumar, Rajiv] Queensland Inst Med Res, Immunol & Infect Lab, Herston, Qld 4006, Australia; [Ahmed, Osman] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium	Bhattacharyya, T (reprint author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.	Tapan.Bhattacharyya@lshtm.ac.uk		Kumar, Rajiv/0000-0003-2338-1494; Boelaert, Marleen/0000-0001-8051-6776; Ahmed, Osman/0000-0002-2854-2552	European Commission under the Health Cooperation Work Programme of the 7th Framework Programme [260260]	This work is part of the NIDIAG network research partnership supported by the European Commission under the Health Cooperation Work Programme of the 7th Framework Programme (Grant agreement no. 260260, http://cordis.europa.eu/fp7/home_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abass E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002322; Abeijon C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002161; Ahsan M M, 2010, Mymensingh Med J, V19, P335; Alam M, 2008, Mymensingh Med J, V17, P22; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Anstead GM, 2001, INFECT IMMUN, V69, P4709, DOI 10.1128/IAI.69.8.4709-4718.2001; Attar ZJ, 2001, ACTA TROP, V78, P11, DOI 10.1016/S0001-706X(00)00155-8; Bhattacharyya T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002057; Boelaert M, 2008, T ROY SOC TROP MED H, V102, P32, DOI 10.1016/j.trstmh.2007.09.003; Bucheton B, 2007, GENES IMMUN, V8, P79, DOI 10.1038/sj.gene.6364355; Bucheton B, 2003, AM J HUM GENET, V73, P1052, DOI 10.1086/379084; Bucheton B, 2002, MICROBES INFECT, V4, P1449, DOI 10.1016/S1286-4579(02)00027-8; BURNS JM, 1993, P NATL ACAD SCI USA, V90, P775, DOI 10.1073/pnas.90.2.775; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Cunningham J, 2012, CLIN INFECT DIS, V55, P1312, DOI 10.1093/cid/cis716; Dhiman N, 2008, TISSUE ANTIGENS, V72, P211, DOI 10.1111/j.1399-0039.2008.01097.x; Fakiola M, 2013, NAT GENET, V45, P208, DOI 10.1038/ng.2518; Falconar AKI, 2006, CLIN VACCINE IMMUNOL, V13, P1044, DOI 10.1128/CVI.00105-06; Falconar Andrew K I, 2012, J Clin Med Res, V4, P33, DOI 10.4021/jocmr694w; Fischbacher CM, 2003, ARTERIOSCL THROM VAS, V23, P703, DOI 10.1161/01.ATV.0000060449.70345.8E; Gaffen SL, 2004, CYTOKINE, V28, P109, DOI 10.1016/j.cyto.2004.06.010; Ghasemi A, 2012, INT J ENDOCRINOL MET, V10, P486, DOI 10.5812/ijem.3505; Hughes S, 2006, PARASITE IMMUNOL, V28, P577, DOI 10.1111/j.1365-3024.2006.00897.x; Ibrahim ME, 1999, AM J TROP MED HYG, V61, P941, DOI 10.4269/ajtmh.1999.61.941; JENSEN JB, 1984, P NATL ACAD SCI-BIOL, V81, P922, DOI 10.1073/pnas.81.3.922; Kuhls K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001155; Liu LM, 2006, PARASITOL RES, V99, P189, DOI 10.1007/s00436-006-0168-1; Lourembam SD, 2012, VACCINE, V30, P767, DOI 10.1016/j.vaccine.2011.11.069; Mahgoub HM, 2012, T ROY SOC TROP MED H, V106, P66, DOI 10.1016/j.trstmh.2011.09.003; Maia Z, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001484; Mangalam AK, 2013, J IMMUNOL, V190, P513, DOI 10.4049/jimmunol.1201891; Meddeb-Garnaoui A, 2001, HUM IMMUNOL, V62, P509, DOI 10.1016/S0198-8859(01)00237-3; Modiano D, 1999, AM J TROP MED HYG, V61, P663, DOI 10.4269/ajtmh.1999.61.663; Moszynski P, 2010, BMJ-BRIT MED J, V341, pc7276; Nolder D, 2007, AM J TROP MED HYG, V76, P573, DOI 10.4269/ajtmh.2007.76.573; Nylen S, 2007, TRENDS IMMUNOL, V28, P378, DOI 10.1016/j.it.2007.07.004; Oliveira E, 2013, T ROY SOC TROP MED H, V107, P243, DOI 10.1093/trstmh/trt004; Pantuliano S, 2007, DISASTERS, V31, pS77, DOI 10.1111/j.1467-7717.2007.00350.x; Pattabhi S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000822; Peacock C, 2002, GENES IMMUN, V3, P350, DOI 10.1038/sj.gene.6363852; Poland GA, 2009, PHARMACOGENOMICS, V10, P837, DOI [10.2217/pgs.09.25, 10.2217/PGS.09.25]; Ritmeijer K, 2003, T ROY SOC TROP MED H, V97, P609, DOI 10.1016/S0035-9203(03)80047-0; Salam MA, 2011, T ROY SOC TROP MED H, V105, P269, DOI 10.1016/j.trstmh.2010.12.007; Sarkari B, 2002, ACTA TROP, V82, P339, DOI 10.1016/S0001-706X(02)00043-8; Seaman J, 1996, INT J EPIDEMIOL, V25, P862, DOI 10.1093/ije/25.4.862; Serafim TD, 2010, MEM I OSWALDO CRUZ, V105, P811, DOI 10.1590/S0074-02762010000600014; Shankar AH, 1998, AM J CLIN NUTR, V68, p447S, DOI 10.1093/ajcn/68.2.447S; Shiina T, 2009, J HUM GENET, V54, P15, DOI 10.1038/jhg.2008.5; Soong L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00058; Srivastava P, 2011, T ROY SOC TROP MED H, V105, P1, DOI 10.1016/j.trstmh.2010.09.006; Sundar S, 2005, AM J TROP MED HYG, V73, P269, DOI 10.4269/ajtmh.2005.73.269; Tatemichi M, 2003, CANCER SCI, V94, P64, DOI 10.1111/j.1349-7006.2003.tb01353.x; Trowsdale J, 2013, ANNU REV GENOM HUM G, V14, P301, DOI 10.1146/annurev-genom-091212-153455; Vaish M, 2012, CLIN MICROBIOL INFEC, V18, P81, DOI 10.1111/j.1469-0691.2011.03540.x; World Health Organization, 2012, RES PRIOR CHAG DIS H; Yang LPH, 2006, MED MICROBIOL IMMUN, V195, P37, DOI 10.1007/s00430-005-0245-6; Zijistra EE, 2003, LANCET INFECT DIS, V3, P87, DOI 10.1016/S1473-3099(03)00517-6	57	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	FEB	2014	8	2							e2675	10.1371/journal.pntd.0002675				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AB8CK	WOS:000332017500052	24587456	DOAJ Gold, Green Published			2019-04-02	
J	Salih, NA; van Griensven, J; Chappuis, F; Antierens, A; Mumina, A; Hammam, O; Boulle, P; Alirol, E; Alnour, M; Elhag, MS; Manzi, M; Kizito, W; Zachariah, R				Salih, Niven A.; van Griensven, Johan; Chappuis, Francois; Antierens, Annick; Mumina, Ann; Hammam, Omar; Boulle, Philippa; Alirol, Emilie; Alnour, Mubarak; Elhag, Mousab S.; Manzi, Marcel; Kizito, Walter; Zachariah, Rony			Liposomal amphotericin B for complicated visceral leishmaniasis (kala-azar) in eastern Sudan: how effective is treatment for this neglected disease?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						kala-azar; Sudan; amphotericin B; treatment; operational research	SODIUM STIBOGLUCONATE; FIELD CONDITIONS; AMBISOME; DONOVANI	ObjectivesThe aim of this study was to report the patient profile and treatment outcomes, including relapses, of patients with visceral leishmaniasis (VL) treated with liposomal amphotericin B (AmBisome) in Gedaref, Sudan. MethodsAmBisome was offered to two groups of patients: primary VL patients with specific criteria (age 2 or 45years, advanced clinical disease, pregnancy, HIV co-infection and contraindications for antimonials) and VL relapses. AmBisome was given at a total dose of 30mg/kg, over 10days. Slow responders received up to 50mg/kg. Treatment failure was confirmed parasitologically. Standardised treatment outcomes were assessed. ResultsBetween March 2010 and June 2012, a total of 281 (74%) patients with primary VL and 98 (26%) patients with VL relapses received AmBisome (54% male, median age=11years, interquartile range 2-30). End-of-treatment outcomes for primary VL were 260 (92%) initial cure including three (1%) slow responders, three (1%) treatment failures, 14 (5%) deaths and four (1%) unknown outcomes. Outcomes for VL relapses were 92 (94%) initial cure with five (5%) slow responders, four (4%) treatment failures, one (1%) death and one (1%) unknown outcome. At 6months, there were 19 (7%) relapses amongst primary VL and 10 (10%) VL relapses had a new relapse. Loss to follow-up in both groups was 38%. None of the deaths that occurred during the study period was attributed to AmBisome. ConclusionAmBisome appears to be effective for initial cure of VL and the drug seems safe, but is expensive (400USD/treatment). Sustained mechanisms to allow improved access of this expensive drug particularly in East Africa are urgently needed. Relapses and losses to follow-up require specific investigation.	[Salih, Niven A.; Mumina, Ann; Hammam, Omar] Med Sans Frontieres Switzerland, North Sudan Mission, Gedaref, Sudan; [van Griensven, Johan] Inst Trop Med, B-2000 Antwerp, Belgium; [Chappuis, Francois; Antierens, Annick; Boulle, Philippa; Alirol, Emilie] Med Sans Frontieres Switzerland, Dept Med, Geneva, Switzerland; [Chappuis, Francois; Alirol, Emilie] Univ Hosp Geneva, Geneva, Switzerland; [Alnour, Mubarak] Minist Hlth, Gedaref, Gedaref State, Sudan; [Elhag, Mousab S.] Fed Minist Hlth, Khartoum, Sudan; [Manzi, Marcel; Kizito, Walter; Zachariah, Rony] Med Sans Frontieres Luxembourg, Luxembourg, Luxembourg	Salih, NA (reprint author), Med Sans Frontieres Operat Ctr Geneva, Rue Lausanne 78, CH-1202 Geneva, Switzerland.	msfch-research-officer@geneva.msf.org		Alirol, Emilie/0000-0001-8691-3991	Kala-Azar programme; Health Research Unit at the Ministry of Health of Sudan; Operational Research Unit; Medecins sans Frontieres; Brussels-Luxembourg; Medecins sans Frontieres, Switzerland	This research was supported through an operational research course, which was jointly developed and run by the Centre for Operational Research, International Union Against Tuberculosis and Lung Disease, France, and the Operational Research Unit, Medecins sans Frontieres, Brussels-Luxembourg, and Medecins sans Frontieres, Switzerland. Additional support for running the course was provided by the Institute for Tropical Medicine, Antwerp, Belgium, the Center for International Health, University of Bergen. We thank Medecins sans Frontieres, Switzerland, staff and patients at the Tabarak Allah Kala-Azar project in East Sudan. We are also grateful for the support of the Kala-Azar programme and Health Research Unit at the Ministry of Health of Sudan.	Alvar J., 2012, PLOS ONE, V7; Balasegaram M, 2012, EXPERT OPIN EMERG DR, V17, P493, DOI 10.1517/14728214.2012.748036; Berman JD, 1998, B WORLD HEALTH ORGAN, V76, P25; Bern C, 2006, CLIN INFECT DIS, V43, P917, DOI 10.1086/507530; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Chappuis F, 2011, ANTIMICROB AGENTS CH, V55, P455, DOI 10.1128/AAC.01298-10; CHULAY JD, 1983, AM J TROP MED HYG, V32, P475, DOI 10.4269/ajtmh.1983.32.475; Collin S, 2004, CLIN INFECT DIS, V38, P612, DOI 10.1086/381203; Elnaiem DEA, 2011, J VECTOR ECOL, V36, pS23, DOI 10.1111/j.1948-7134.2011.00109.x; Medecins Sans Frontieres, 2006, MAN DIAGN TREATM VIS; Medecins Sans Frontieres, 2011, NUTR PROT KAL AZ PAT; Meheus F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000818; MEREDITH SEO, 1995, J CLIN MICROBIOL, V33, P1742; Mueller M, 2007, T ROY SOC TROP MED H, V101, P19, DOI 10.1016/j.trstmh.2006.02.005; Rijal S, 2013, CLIN INFECT DIS, V56, P1530, DOI 10.1093/cid/cit102; Ritmeijer K, 2006, AM J TROP MED HYG, V74, P76, DOI 10.4269/ajtmh.2006.74.76; Ritmeijer K, 2001, T ROY SOC TROP MED H, V95, P668, DOI 10.1016/S0035-9203(01)90110-5; Ritmeijer K, 2011, CLIN INFECT DIS, V53, pE152, DOI 10.1093/cid/cir674; SEAMAN J, 1995, CLIN INFECT DIS, V21, P188, DOI 10.1093/clinids/21.1.188; van Griensven J, 2010, LANCET INFECT DIS, V10, P184, DOI 10.1016/S1473-3099(10)70011-6; Veeken H, 2000, TROP MED INT HEALTH, V5, P312, DOI 10.1046/j.1365-3156.2000.00555.x; World Health Organization, 2010, M WHO EXP COMM CONTR	22	14	15	1	8	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	FEB	2014	19	2					146	152		10.1111/tmi.12238				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	291IM	WOS:000329822400004	24433217	Green Published			2019-04-02	
J	Fraga, J; Fernandez-Calienes, A; Montalvo, AM; Maes, I; Dujardin, JC; Van der Auwera, G				Fraga, Jorge; Fernandez-Calienes, Ayme; Margarita Montalvo, Ana; Maes, Ilse; Dujardin, Jean-Claude; Van der Auwera, Gert			Differentiation between Trypanosoma cruzi and Trypanosoma rangeli using heat-shock protein 70 polymorphisms	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						Trypanosoma cruzi; Trypanosoma rangeli; restriction fragment length polymorphism; hsp70; differentiation	POLYMERASE-CHAIN-REACTION; KINETOPLAST MINICIRCLE DNA; CHAGAS-DISEASE; SPECIES IDENTIFICATION; SEQUENCE POLYMORPHISM; PHYLOGENETIC NETWORKS; BRAZILIAN AMAZON; CLINICAL-SAMPLES; LATIN-AMERICA; RNA GENE	ObjectiveDifferential diagnosis of infection with Trypanosoma cruzi or T.rangeli is relevant for epidemiological studies and clinical practice as both species infect humans, but only T.cruzi causes Chagas' disease. Their common antigen determinants complicate the distinction between both species, while current PCR assays used for differentiation show some drawbacks. We developed and validated a generic PCR discriminating the species by restriction fragment length polymorphism (RFLP) analysis and a duplex PCR specifically amplifying a differently sized fragment of both species. MethodsThe assays are based upon a partial region of the heat-shock protein 70 gene (hsp70). The analytical sensitivity and specificity were determined for both PCRs. The assays were analytically evaluated on a panel of six T.cruzi, one T.cruzi marinkellei and four T.rangeli strains, various other infectious pathogens, a panel of spiked samples of T.cruzi, and artificially mixed infections of T.cruzi and T.rangeli. Finally, the tools were applied on 36 additional isolates of Trypanosoma species. ResultsThe detection limit of the PCRs was between 0.05 and 0.5 parasite genomes, and 1-10 parasites spiked in 200l blood. In artificial mixtures, PCR-RFLP picked up both species in ratios up to 10(2) and duplex PCR up to 10(4). In the 36 isolates tested, both single and mixed infections were identified. All assays were shown to be specific. ConclusionOur PCRs show high potential for the differential diagnosis of T.cruzi and T.rangeli, which in view of their sensitivity can aid in the confirmation of infection with these parasites in vectors, reservoirs and clinical samples. ObjectifLe diagnostic differentiel de l'infection par Trypanosoma cruzi ou T. rangeli est necessaire pour les etudes epidemiologiques et la pratique clinique car les deux especes infectent les humains, mais seul T. cruzi provoque la maladie de Chagas. Leurs determinants antigeniques communs compliquent la distinction entre les deux especes, alors que les tests actuels de PCR, utilises pour la differenciation montrent quelques inconvenients. Nous avons developpe et valide une PCR generique permettant de discriminer les especes par le polymorphisme de la taille des fragments de restriction (RFLP) et par un PCR duplex amplifiant specifiquement un fragment de taille differente pour les deux especes. MethodesLes tests sont bases sur une region partielle du gene de la proteine heat-choc 70 (hsp70). La sensibilite et la specificite analytique ont ete determinees pour les deux PCR. Les tests ont ete evalues analytiquement sur un ensemble de 6 souches de T.cruzi, 1 souche de T.cruzi marinkellei et 4 souches de T.rangeli, ainsi que divers autres agents pathogenes infectieux, une serie d'echantillons enrichis de T.cruzi et de melanges artificiels d'infections par T.cruzi et T.rangeli. Enfin, les outils ont ete appliques sur 36 isolats supplementaires d'especes Trypanosoma. ResultatsLa limite de detection de la PCR etait comprise entre 0,05 et 0,5 genomes de parasites, et de 1 a 10 parasites enrichis dans 200l de sang. Dans les melanges artificiels, la PCR-RFLP a detecte les deux especes dans des proportions allant jusqu'a 10(2) et la PCR duplex, dans des proportions allant jusqu'a 10(4). Sur les 36 isolats testes, les infections uniques et mixtes ont ete identifiees. Tous les tests ont ete trouves specifiques. ConclusionNos PCR montrent un fort potentiel pour le diagnostic differentiel de T.cruzi et T.rangeli, qui en raison de leur sensibilite pourraient aider a la confirmation de l'infection par ces parasites chez les vecteurs, dans les reservoirs et dans les echantillons cliniques. ObjetivoEl diagnostico diferencial de la infeccion por Trypanosoma cruzi o T. rangeli es relevante para estudios epidemiologicos y la practica clinica, puesto que ambas especies infectan a los humanos pero solo T. cruzi causa la enfermedad de Chagas. Sus determinantes antigenicos comunes complican la distincion entre ambas especies, mientras que los ensayos de PCR actualmente utilizados para diferenciarlos presentan problemas. Hemos desarrollado y validado una PCR generica que discrimina entre las especies mediante un analisis de polimorfismos de longitud de fragmentos de restriccion (RFLP) y una PCR-Duplex que amplifica especificamente fragmentos de tamanos diferenciados en ambas especies. MetodosLas pruebas estan basadas en una region parcial del gen de la proteina de choque termico 70 (hsp70). Para ambas PCRs se determinaron la sensibilidad y especificidad analitica. Las pruebas fueron evaluadas de forma analitica en un panel de 6 cepas de T. cruzi, 1 de T. cruzi marinkellei y 4 de T. rangeli, otros patogenos infecciosos, un panel de muestras a las que se anadio T. cruzi, y mezclas artificiales de T. cruzi y T. rangeli. Finalmente las herramientas se aplicaron en 36 aislados adicionales de especies de Trypanosoma. ResultadoEl limite de deteccion de las PCRs estaba entre 0.05 y 0.5 genomas de parasito y 1 a 10 parasitos en 200l de sangre. En mezclas artificiales, la PCR-RFLP detecto ambas especies en una proporcion de hasta 10(2) y la PCR-Duplex de hasta 10(4). En los 36 aislados evaluados se identificaron tanto las infecciones unicas como las mixtas. Todas las pruebas eran especificas. ConclusionNuestras PCRs muestran un gran potencial para el diagnostico diferencial de T.cruzi y T.rangeli, lo cual dado su nivel de sensibilidad podria ayudar a la confirmacion de la infeccion con estos parasitos en vectores, reservorios y muestras clinicas.	[Fraga, Jorge; Fernandez-Calienes, Ayme; Margarita Montalvo, Ana] Inst Trop Med Pedro Kouri, Dept Parasitol, Havana, Cuba; [Maes, Ilse; Dujardin, Jean-Claude; Van der Auwera, Gert] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Dujardin, Jean-Claude] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium	Van der Auwera, G (reprint author), Inst Trop Med, Dept Biomed Sci, Natl Str 155, B-2000 Antwerp, Belgium.	gvdauwera@itg.be			Belgian Directorate General for Development; ITM Antwerp	The authors would like to thank all colleagues and institutes who kindly donated the Trypanosoma reference strains and DNA, among whom S. Deborggraeve, P. Buscher (Institute of Tropical Medicine, Antwerp, Belgium); F. Guhl (Universidad de los Andes, Bogota, Colombia); M. D. Lewis and M. A. Miles (London School of Hygiene and Tropical Medicine, London, United Kingdom); H. J. Carrasco (Instituto de Medicina Tropical, Caracas, Venezuela); and J. A. Costales and M. J. Grijalva (Centro de Investigacion en Enfermedades Infecciosas (CIEI), Pontificia Universidad Catolica del Ecuador, Ecuador and Tropical Disease Institute (TDI), Ohio University, USA). We also thank the Molecular Biology Laboratory (Parasitology, Virology and Bacteriology), IPK, Havana, Cuba. This work was funded by the third framework agreement of the Belgian Directorate General for Development with ITM Antwerp.	ACOSTA L, 1991, AM J TROP MED HYG, V44, P676, DOI 10.4269/ajtmh.1991.44.676; BRENIERE SF, 1993, MEM I OSWALDO CRUZ, V88, P163, DOI 10.1590/S0074-02761993000100027; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Chiurillo MA, 2003, CLIN DIAGN LAB IMMUN, V10, P775, DOI 10.1128/CDLI.10.5.775-779.2003; Coura JR, 1996, T ROY SOC TROP MED H, V90, P278, DOI 10.1016/S0035-9203(96)90247-3; Cuervo C, 2013, EXP PARASITOL, V133, P447, DOI 10.1016/j.exppara.2013.01.001; DALESSANDRO A, 1999, PROTOZOAL DIS, P398; Dorn PL, 1999, AM J TROP MED HYG, V60, P740, DOI 10.4269/ajtmh.1999.60.740; Fernandes O, 2001, T ROY SOC TROP MED H, V95, P97, DOI 10.1016/S0035-9203(01)90350-5; Fraga J, 2012, DIAGN MICR INFEC DIS, V74, P142, DOI 10.1016/j.diagmicrobio.2012.06.010; Garcia AL, 2007, T ROY SOC TROP MED H, V101, P368, DOI 10.1016/j.trstmh.2006.06.009; GREIG S, 1990, T ROY SOC TROP MED H, V84, P59, DOI 10.1016/0035-9203(90)90382-O; Grisard EC, 1999, PARASITOLOGY, V118, P375, DOI 10.1017/S0031182098003928; Guhl F, 2003, MEM I OSWALDO CRUZ, V98, P435, DOI 10.1590/S0074-02762003000400001; GUHL F, 1987, PARASITOLOGY, V94, P475, DOI 10.1017/S0031182000055827; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000300; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; MACEDO AM, 1993, EXS, V67, P321; Montalvo AM, 2012, EUR J CLIN MICROBIOL, V31, P1453, DOI 10.1007/s10096-011-1463-z; Morales L, 2002, EXP PARASITOL, V102, P72, DOI 10.1016/S0014-4894(03)00027-4; MURTHY VK, 1992, MOL CELL PROBE, V6, P237, DOI 10.1016/0890-8508(92)90022-P; Ortiz PA, 2009, ACTA TROP, V112, P249, DOI 10.1016/j.actatropica.2009.07.036; Pavia Paula Ximena, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P23, DOI 10.1590/S0036-46652007000100005; Ramirez LE, 2002, ACTA TROP, V84, P189, DOI 10.1016/S0001-706X(02)00185-7; REQUENA JM, 1988, NUCLEIC ACIDS RES, V16, P1393, DOI 10.1093/nar/16.4.1393; SALDANA A, 2012, PLOS ONE, V7; SANTOS IKFD, 1984, AM J TROP MED HYG, V33, P839, DOI 10.4269/ajtmh.1984.33.839; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Silber AM, 1997, EXP PARASITOL, V85, P225, DOI 10.1006/expr.1996.4141; Souto RP, 1999, EXP PARASITOL, V91, P306, DOI 10.1006/expr.1998.4380; Dias FBS, 2007, MEM I OSWALDO CRUZ, V102, P643, DOI 10.1590/S0074-02762007005000057; STURM NR, 1989, MOL BIOCHEM PARASIT, V33, P205, DOI 10.1016/0166-6851(89)90082-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka T, 1997, Kansenshogaku Zasshi, V71, P903; Thekisoe OMM, 2010, AM J TROP MED HYG, V82, P855, DOI 10.4269/ajtmh.2010.09-0533; Vallejo GA, 2009, ACTA TROP, V110, P137, DOI 10.1016/j.actatropica.2008.10.001; Vallejo GA, 1999, ACTA TROP, V72, P203, DOI 10.1016/S0001-706X(98)00085-0; Vallejo GA, 2002, ACTA TROP, V81, P77, DOI 10.1016/S0001-706X(01)00186-3; VALLEJO GA, 1994, MOL BIOCHEM PARASIT, V67, P245, DOI 10.1016/0166-6851(94)00137-5; Vargas N, 2000, EXP PARASITOL, V96, P147, DOI 10.1006/expr.2000.4563; Veland N, 2012, J CLIN MICROBIOL, V50, P495, DOI 10.1128/JCM.05061-11; WHO, 2010, WEEKLY EPIDEMIOLOGIC, V85, P329; World Health Organization, 2007, REP SCI WORK GROUP C; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	46	2	2	0	13	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	FEB	2014	19	2					195	206		10.1111/tmi.12222				12	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	291IM	WOS:000329822400010	24224809	Bronze			2019-04-02	
J	Ale, A; Victor, B; Praet, N; Gabriel, S; Speybroeck, N; Dorny, P; Devleesschauwer, B				Ale, Anita; Victor, Bjorn; Praet, Nicolas; Gabriel, Sarah; Speybroeck, Niko; Dorny, Pierre; Devleesschauwer, Brecht			Epidemiology and genetic diversity of Taenia asiatica: a systematic review	PARASITES & VECTORS			English	Review						Transmission; Geographical distribution; Genetic diversity; Taenia asiatica	DNA DIFFERENTIAL-DIAGNOSIS; EXPERIMENTAL-INFECTION; SAGINATA-ASIATICA; DOMESTIC-ANIMALS; ASIAN TAENIA; SOUTHEAST-ASIA; TAIWAN TAENIA; T-SAGINATA; MITOCHONDRIAL GENOME; COMPLETE SEQUENCE	Taenia asiatica has made a remarkable journey through the scientific literature of the past 50 years, starting with the paradoxical observation of high prevalences of T. saginata-like tapeworms in non-beef consuming populations, to the full description of its mitochondrial genome. Experimental studies conducted in the 1980s and 1990s have made it clear that the life cycle of T. asiatica is comparable to that of T. saginata, except for pigs being the preferential intermediate host and liver the preferential location of the cysts. Whether or not T. asiatica can cause human cysticercosis, as is the case for Taenia solium, remains unclear. Given the specific conditions needed to complete its life cycle, in particular the consumption of raw or poorly cooked pig liver, the transmission of T. asiatica shows an important ethno-geographical association. So far, T. asiatica has been identified in Taiwan, South Korea, Indonesia, the Philippines, Thailand, south-central China, Vietnam, Japan and Nepal. Especially this last observation indicates that its distribution is not restricted to South-East-Asia, as was thought so far. Indeed, the molecular tools developed over the last 20 years have made it increasingly possible to differentiate T. asiatica from other taeniids. Such tools also indicated that T. asiatica is related more closely to T. saginata than to T. solium, feeding the debate on its taxonomic status as a separate species versus a subspecies of T. saginata. Furthermore, the genetic diversity within T. asiatica appears to be very minimal, indicating that this parasite may be on the verge of extinction. However, recent studies have identified potential hybrids between T. asiatica and T. saginata, reopening the debate on the genetic diversity of T. asiatica and its status as a separate species.	[Ale, Anita] Natl Zoonoses & Food Hyg Res Ctr, Kathmandu, Nepal; [Victor, Bjorn; Praet, Nicolas; Gabriel, Sarah; Dorny, Pierre] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Speybroeck, Niko; Devleesschauwer, Brecht] Catholic Univ Louvain, Inst Hlth & Soc IRSS, Brussels, Belgium; [Dorny, Pierre; Devleesschauwer, Brecht] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium	Devleesschauwer, B (reprint author), Catholic Univ Louvain, Inst Hlth & Soc IRSS, Brussels, Belgium.	brecht.devleesschauwer@ugent.be	Devleesschauwer, Brecht/G-9895-2018	Devleesschauwer, Brecht/0000-0002-2867-6892	Special Research Fund (BOF) of Ghent University	The authors would like to thank the two anonymous reviewers for their valuable comments. BD is supported by the Special Research Fund (BOF) of Ghent University.	Amin M. R., 2009, Journal of Medicine, V10, P135; Anantaphruti Malinee, 2013, Journal of Parasitology Research, P310605, DOI 10.1155/2013/310605; Anantaphruti MT, 2007, EMERG INFECT DIS, V13, P1413, DOI 10.3201/eid1309.061148; Anantaphruti MT, 2010, PARASITOL INT, V59, P326, DOI 10.1016/j.parint.2010.03.007; Anantaphruti MT, 2013, KOREAN J PARASITOL, V51, P55, DOI 10.3347/kjp.2013.51.1.55; Anantaphruti MT, 2013, KOREAN J PARASITOL, V51, P37, DOI 10.3347/kjp.2013.51.1.37; BOWLES J, 1994, AM J TROP MED HYG, V50, P33; Chai JY, 2013, KOREAN J PARASITOL, V51, P9, DOI 10.3347/kjp.2013.51.1.9; Chang SL, 2006, J HELMINTHOL, V80, P219, DOI 10.1079/JOH2005333; CHAO D, 1988, J HELMINTHOL, V62, P235, DOI 10.1017/S0022149X00011585; Chen Yan, 2003, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V21, P311; Chung W C, 1990, Gaoxiong Yi Xue Ke Xue Za Zhi, V6, P66; Chung WC, 1996, J PARASITOL, V82, P1032, DOI 10.2307/3284219; Conlan JV, 2011, VET PARASITOL, V182, P22, DOI 10.1016/j.vetpar.2011.07.013; Conlan JV, 2009, TRENDS PARASITOL, V25, P398, DOI 10.1016/j.pt.2009.06.005; de Queiroz A, 1998, J PARASITOL, V84, P379; Devleesschauwer B, 2012, TROP MED INT HEALTH, V17, P1019, DOI 10.1111/j.1365-3156.2012.03017.x; Dorny P, 2007, VET PARASITOL, V149, P22, DOI 10.1016/j.vetpar.2007.07.004; EOM K S, 1992, Korean Journal of Parasitology, V30, P21; Eom Keeseon S., 1993, Korean Journal of Parasitology, V31, P1; Eom Keeseon S., 1992, Korean Journal of Parasitology, V30, P269; Eom Keeseon S., 2001, Korean Journal of Parasitology, V39, P267; Eom KS, 2009, KOREAN J PARASITOL, V47, pS115, DOI 10.3347/kjp.2009.47.S.S115; Eom KS, 2006, PARASITOL INT, V55, pS137, DOI 10.1016/j.parint.2005.11.022; Eom KS, 2002, J PARASITOL, V88, P758, DOI 10.1645/0022-3395(2002)088[0758:IOTAIC]2.0.CO;2; Fall EH, 1995, J HELMINTHOL, V69, P367, DOI 10.1017/S0022149X00014978; Fan P.C., 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P245; Fan P C, 1992, Gaoxiong Yi Xue Ke Xue Za Zhi, V8, P266; Fan P C, 1990, Gaoxiong Yi Xue Ke Xue Za Zhi, V6, P475; Fan P. C., 1995, Chinese Journal of Microbiology and Immunology (Taipei), V28, P79; FAN PC, 1990, INT J PARASITOL, V20, P121, DOI 10.1016/0020-7519(90)90183-N; FAN PC, 1992, INT J PARASITOL, V22, P235, DOI 10.1016/0020-7519(92)90107-V; FAN PC, 1989, ANN TROP MED PARASIT, V83, P395, DOI 10.1080/00034983.1989.11812363; FAN PC, 1992, J HELMINTHOL, V66, P118, DOI 10.1017/S0022149X00012694; FAN PC, 1989, INT J PARASITOL, V19, P809, DOI 10.1016/0020-7519(89)90070-2; FAN PC, 1988, PARASITOL TODAY, V4, P86, DOI 10.1016/0169-4758(88)90204-9; Fan PC, 1997, PARASITOLOGY, V114, P541; Fan PC, 1995, J HELMINTHOL, V69, P299, DOI 10.1017/S0022149X00014863; FAN PC, 1992, ACTA TROP, V50, P305, DOI 10.1016/0001-706X(92)90065-6; Fan Ping-Chin, 2003, Journal of Microbiology Immunology and Infection, V36, P96; Flisser A, 2013, KOREAN J PARASITOL, V51, P43, DOI 10.3347/kjp.2013.51.1.43; Galan-Puchades Maria Teresa, 2000, Korean Journal of Parasitology, V38, P1; Galan-Puchades MT, 2004, LANCET, V363, P660, DOI 10.1016/S0140-6736(04)15607-9; Galan-Puchades MT, 2001, TRENDS PARASITOL, V17, P469, DOI 10.1016/S1471-4922(01)02089-X; GalanPuchades MT, 1996, PARASITOL TODAY, V12, P123, DOI 10.1016/0169-4758(96)80674-0; Gasser RB, 1999, INT J PARASITOL, V29, P1965, DOI 10.1016/S0020-7519(99)00153-8; Gonzalez LM, 2004, DIAGN MICR INFEC DIS, V49, P183, DOI 10.1016/j.diagmicrobio.2004.03.013; Gonzalez LM, 2011, MOL BIOCHEM PARASIT, V176, P131, DOI 10.1016/j.molbiopara.2010.12.014; Gonzalez LM, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-51; Hoberg EP, 2006, PARASITOL INT, V55, pS23, DOI 10.1016/j.parint.2005.11.049; Hoberg EP, 2000, J PARASITOL, V86, P89, DOI 10.1645/0022-3395(2000)086[0089:APHFSO]2.0.CO;2; Ito A, 1997, INT J PARASITOL, V27, P1203, DOI 10.1016/S0020-7519(97)00118-5; ITO A, 1994, J HELMINTHOL, V68, P83, DOI 10.1017/S0022149X00013535; Ito Akira, 2005, Southeast Asian J Trop Med Public Health, V36 Suppl 4, P123; Jeon HK, 2006, EXP PARASITOL, V113, P58, DOI 10.1016/j.exppara.2005.11.018; Jeon HK, 2005, PARASITOLOGY, V130, P717, DOI 10.1017/S0031182004007164; Jeon HK, 2007, PARASITOL INT, V56, P243, DOI 10.1016/j.parint.2007.04.001; Jeon HK, 2011, KOREAN J PARASITOL, V49, P195, DOI 10.3347/kjp.2011.49.2.195; Jeon HK, 2011, PARASITOL INT, V60, P203, DOI 10.1016/j.parint.2010.12.001; Jeon HK, 2009, KOREAN J PARASITOL, V47, P73, DOI 10.3347/kjp.2009.47.1.73; Jeon HK, 2009, EXP PARASITOL, V121, P151, DOI 10.1016/j.exppara.2008.10.014; Jeon HK, 2008, KOREAN J PARASITOL, V46, P235, DOI 10.3347/kjp.2008.46.4.235; Le T, 2003, J MALARIA PARASITE D, P65; Lee EG, 2010, T ROY SOC TROP MED H, V104, P676, DOI 10.1016/j.trstmh.2010.07.011; Li T, 2006, ACTA TROP, V100, P223, DOI 10.1016/j.actatropica.2006.11.003; Li TY, 2013, PARASITOLOGY, V140, P1602, DOI 10.1017/S003118201300111X; [刘爱波 LIU Aibo], 2011, [中华传染病杂志, Chinese Journal of Infections Diseases], V29, P236; McManus D P, 1997, Southeast Asian J Trop Med Public Health, V28 Suppl 1, P110; McManus DP, 2006, PARASITOL INT, V55, pS31, DOI 10.1016/j.parint.2005.11.004; MCMANUS DP, 1994, PARASITOL TODAY, V10, P273, DOI 10.1016/0169-4758(94)90145-7; Michelet L, 2012, BIOL REV, V87, P731, DOI 10.1111/j.1469-185X.2012.00217.x; Michelet L, 2010, MOL PHYLOGENET EVOL, V55, P744, DOI 10.1016/j.ympev.2010.01.008; Morakote N, 2000, ANN TROP MED PARASIT, V94, P521, DOI 10.1080/00034983.2000.11813572; Mou Rong, 2007, Chinese Journal of Parasitology and Parasitic Diseases, V25, P32; Nkouawa A, 2012, PARASITOL INT, V61, P723, DOI 10.1016/j.parint.2012.06.001; Nkouawa A, 2009, J CLIN MICROBIOL, V47, P168, DOI 10.1128/JCM.01573-08; Ohnishi K, 2013, INT J INFECT DIS, V 17, pE656, DOI 10.1016/j.ijid.2013.02.028; Okamoto M, 2010, PARASITOL INT, V59, P70, DOI 10.1016/j.parint.2009.10.007; Ooi HK, 2013, KOREAN J PARASITOL, V51, P31, DOI 10.3347/kjp.2013.51.1.31; RHOADS ML, 1989, VET PARASITOL, V30, P279, DOI 10.1016/0304-4017(89)90097-6; Simanjuntak GM, 1997, PARASITOL TODAY, V13, P321, DOI 10.1016/S0169-4758(97)01104-6; Somers R, 2007, T ROY SOC TROP MED H, V101, P275, DOI 10.1016/j.trstmh.2006.04.007; Suroso T, 2006, PARASITOL INT, V55, pS161, DOI 10.1016/j.parint.2005.11.025; Galan-Puchades MT, 2013, KOREAN J PARASITOL, V51, P51, DOI 10.3347/kjp.2013.51.1.51; Van De N, 2003, J MED PHARM INFORM, V10, P28; Wandra T, 2006, PARASITOL INT, V55, pS155, DOI 10.1016/j.parint.2005.11.024; Wandra T, 2006, T ROY SOC TROP MED H, V100, P346, DOI 10.1016/j.trstmh.2005.06.031; Wandra T, 2013, PARASITOLOGY, V140, P1608, DOI 10.1017/S0031182013000863; Wang Zheng-rong, 2003, Chinese Journal of Parasitology and Parasitic Diseases, V21, P20; Yamane K, 2012, PARASITOL INT, V61, P351, DOI 10.1016/j.parint.2012.01.005; Yamasaki H, 2004, J CLIN MICROBIOL, V42, P548, DOI 10.1128/JCM.42.2.548-553.2004; Yamasaki H, 2002, J CLIN MICROBIOL, V40, P3818, DOI 10.1128/JCM.40.10.3818-3821-2002; Yamasaki Hiroshi, 2005, Southeast Asian J Trop Med Public Health, V36 Suppl 4, P131; Yamasaki H, 2013, KOREAN J PARASITOL, V51, P19, DOI 10.3347/kjp.2013.51.1.19; Yan HB, 2013, PARASITOL RES, V112, P1343, DOI 10.1007/s00436-012-3199-9; Yang Yi-chao, 2012, Zhongguo Xuexichongbing Fangzhi Zazhi, V24, P307; Zarlenga D.S., 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P251; Zarlenga DS, 1995, EXP PARASITOL, V81, P604, DOI 10.1006/expr.1995.1155; ZARLENGA DS, 1991, EXP PARASITOL, V72, P174, DOI 10.1016/0014-4894(91)90135-J; Zhang Ke, 2006, Chinese Journal of Parasitology and Parasitic Diseases, V24, P420; Zhang Lili, 1999, Chinese Journal of Parasitology and Parasitic Diseases, V17, P95	101	20	20	0	19	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	JAN 22	2014	7								45	10.1186/1756-3305-7-45				11	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	AF3VZ	WOS:000334641800006	24450957	DOAJ Gold, Green Published			2019-04-02	
J	Maltha, J; Guiraud, I; Lompo, P; Kabore, B; Gillet, P; Van Geet, C; Tinto, H; Jacobs, J				Maltha, Jessica; Guiraud, Issa; Lompo, Palpouguini; Kabore, Berenger; Gillet, Philippe; Van Geet, Chris; Tinto, Halidou; Jacobs, Jan			Accuracy of PfHRP2 versus Pf-pLDH antigen detection by malaria rapid diagnostic tests in hospitalized children in a seasonal hyperendemic malaria transmission area in Burkina Faso	MALARIA JOURNAL			English	Article							PARASITE LACTATE-DEHYDROGENASE; HISTIDINE-RICH PROTEIN-2; REAL-TIME PCR; PLASMODIUM-FALCIPARUM; UNCOMPLICATED MALARIA; PERFORMANCE; INSTRUCTIONS; INFECTIONS; REACTIVITY; PROZONE	Background: In most sub-Saharan African countries malaria rapid diagnostic tests (RDTs) are now used for the diagnosis of malaria. Most RDTs used detect Plasmodium falciparum histidine-rich protein-2 (PfHRP2), though P. falciparum-specific parasite lactate dehydrogenase (Pf-pLDH)-detecting RDTs may have advantages over PfHRP2-detecting RDTs. Only few data are available on the use of RDTs in severe illness and the present study compared Pf-pLDH to PfHRP2-detection. Methods: Hospitalized children aged one month to 14 years presenting with fever or severe illness were included over one year. Venous blood samples were drawn for malaria diagnosis (microscopy and RDT), culture and complete blood count. Leftovers were stored at -80 degrees C and used for additional RDT analysis and PCR. An RDT targeting both PfHRP2 and Pf-pLDH was performed on all samples for direct comparison of diagnostic accuracy with microscopy as reference method. PCR was performed to explore false-positive RDT results. Results: In 376 of 694 (54.2%) included children, malaria was microscopically confirmed. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value were 100.0, 70.9, 69.4 and 100.0%, respectively for PfHRP2-detection and 98.7, 94.0, 91.6 and 99.1%, respectively for Pf-pLDH-detection. Specificity and PPV were significantly lower for PfHRP2-detection (p < 0.001). For both detection antigens, specificity was lowest for children one to five years and in the rainy season. PPV for both antigens was highest in the rainy season, because of higher malaria prevalence. False positive PfHRP2 results were associated with prior anti-malarial treatment and positive PCR results (98/114 (86.0%) samples tested). Conclusion: Among children presenting with severe febrile illness in a seasonal hyperendemic malaria transmission area, the present study observed similar sensitivity but lower specificity and PPV of PfHRP2 compared to Pf-pLDH-detection. Further studies should assess the diagnostic accuracy and safety of an appropriate Pf-pLDH-detecting RDT in field settings and if satisfying, replacement of PfHRP2 by Pf-pLDH-detecting RDTs should be considered.	[Maltha, Jessica; Gillet, Philippe; Jacobs, Jan] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Maltha, Jessica; Van Geet, Chris] Univ Louvain, Ctr Mol & Vasc Biol, Louvain, Belgium; [Guiraud, Issa; Lompo, Palpouguini; Kabore, Berenger; Tinto, Halidou] IRSS Clin Res Unit Nanoro CRUN, Nanoro, Burkina Faso; [Van Geet, Chris] Univ Louvain, Louvain, Belgium	Maltha, J (reprint author), Inst Trop Med, Dept Clin Sci, Natl Str 155, B-2000 Antwerp, Belgium.	jessicamaltha@gmail.com		Tinto, Halidou/0000-0002-0472-3586; gillet, philippe/0000-0001-5878-6446	Steunfonds Marguerite-Marie Delacroix; Fund for Scientific Research-Flanders (F.W.O.-Vlaanderen, Belgium); Junior Mobility program of KU Leuven and McKinsey Company	We thank CRUN laboratory staff for their contribution and clinical staff of CMA and Nanoro Health District for their collaboration and for patient care. The work of JM was funded by "Steunfonds Marguerite-Marie Delacroix". For this study, JM received additional grants from the Fund for Scientific Research-Flanders (F.W.O.-Vlaanderen, Belgium), the Junior Mobility program of KU Leuven and McKinsey & Company. The RDTs were provided for free by Standard Diagnostics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008122.pub2; Agarwal A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-254; [Anonymous], 2011, MAL RAP DIAGN TEST P, V3, P2011; [Anonymous], 2012, DIS SURV MAL EL OP M; [Anonymous], 2013, LIST RAP DIAGN TEST; Ashley EA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-241; Asiimwe C, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-5; Baker J, 2005, J INFECT DIS, V192, P870, DOI 10.1086/432010; Baker J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-129; Beshir KB, 2013, J INFECT DIS, V208, P2017, DOI 10.1093/infdis/jit431; Bisoffi Z, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-226; Bisoffi Z, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-192; Cnops L, 2011, CLIN MICROBIOL INFEC, V17, P1101, DOI 10.1111/j.1469-0691.2010.03344.x; Cnops L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-370; Counihan H, 2012, AM J TROP MED HYG, V87, P57, DOI 10.4269/ajtmh.2012.11-0800; d'Acremont V, 2010, CLIN INFECT DIS, V51, P506, DOI 10.1086/655688; Fogg C, 2008, T ROY SOC TROP MED H, V102, P25, DOI 10.1016/j.trstmh.2007.09.014; Gerstl S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-28; Gillet P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002180; Gillet P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-166; Gillet P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-271; Harvey SA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-160; Hayward RE, 2000, EXP PARASITOL, V96, P139, DOI 10.1006/expr.2000.4557; Hendriksen ICE, 2011, CLIN INFECT DIS, V52, P1100, DOI 10.1093/cid/cir143; Heutmekers M, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-359; Heutmekers M, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-204; Institut National de la Statistique et de la Demographie (INSD)/ ICF International, 2012, ENQ DEM SANT IND MUL; Iqbal J, 2004, J CLIN MICROBIOL, V42, P4237, DOI 10.1128/JCM.42.9.4237-4241.2004; Iqbal J, 2000, J CLIN MICROBIOL, V38, P1184; Kumar N, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-298; Leshem E, 2011, J CLIN MICROBIOL, V49, P2331, DOI 10.1128/JCM.00307-11; Makler MT, 1998, ANN TROP MED PARASIT, V92, P419; Maltha J, 2013, CLIN MICROBIOL INFEC, V19, P399, DOI 10.1111/1469-0691.12151; Maltha J, 2011, MALAR J, V10, P7; Maltha J, PLOS ONE IN PRESS; Maltha J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043094; Mariette N, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-219; Mayxay M, 2001, T ROY SOC TROP MED H, V95, P179, DOI 10.1016/S0035-9203(01)90156-7; MILNE LM, 1994, J CLIN PATHOL, V47, P740, DOI 10.1136/jcp.47.8.740; Ministere de la sante Burkina Faso, 2010, MAN FORM PRIS CHARG; Mtove G, 2011, TROP MED INT HEALTH, V16, P545, DOI 10.1111/j.1365-3156.2011.02737.x; Oduola AMJ, 1997, EXP PARASITOL, V87, P283, DOI 10.1006/expr.1997.4251; Ratsimbasoa A, 2007, AM J TROP MED HYG, V76, P481, DOI 10.4269/ajtmh.2007.76.481; Rennie W, 2007, T ROY SOC TROP MED H, V101, P9, DOI 10.1016/j.trstmh.2006.03.011; WHO, 2012, MAL RAP DIAGN TEST P; WHO, 2010, GUID TREATM MAL; World Health Organization, 2011, GOOD PRACT SEL PROC; World Health Organization, 2010, BAS MAL MICR 1; World Health Organization, 2012, MAN SEV MAL PRACT HD	49	20	20	0	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	JAN 13	2014	13								20	10.1186/1475-2875-13-20				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	297IQ	WOS:000330249500003	24418119	DOAJ Gold, Green Published			2019-04-02	
J	Jore, S; Vanwambeke, SO; Viljugrein, H; Isaksen, K; Kristoffersen, AB; Woldehiwet, Z; Johansen, B; Brun, E; Brun-Hansen, H; Westermann, S; Larsen, IL; Ytrehus, B; Hofshagen, M				Jore, Solveig; Vanwambeke, Sophie O.; Viljugrein, Hildegunn; Isaksen, Ketil; Kristoffersen, Anja B.; Woldehiwet, Zerai; Johansen, Bernt; Brun, Edgar; Brun-Hansen, Hege; Westermann, Sebastian; Larsen, Inger-Lise; Ytrehus, Bjornar; Hofshagen, Merete			Climate and environmental change drives Ixodes ricinus geographical expansion at the northern range margin	PARASITES & VECTORS			English	Article						Tick; Range expansion; Climate change; Climatic variability; Ixodes ricinus; Anaplasma phagocytophilum; Bush encroachment; Ecotones; Global environmental change; Remote sensing	BURGDORFERI SENSU-LATO; BORNE DISEASE SYSTEMS; ANAPLASMA-PHAGOCYTOPHILUM; POPULATION-DYNAMICS; LYME BORRELIOSIS; SPECIES DISTRIBUTIONS; INFECTIOUS-DISEASES; SOUTHERN NORWAY; LAND-USE; TICKS	Background: Global environmental change is causing spatial and temporal shifts in the distribution of species and the associated diseases of humans, domesticated animals and wildlife. In the on-going debate on the influence of climate change on vectors and vector-borne diseases, there is a lack of a comprehensive interdisciplinary multi-factorial approach utilizing high quality spatial and temporal data. Methods: We explored biotic and abiotic factors associated with the latitudinal and altitudinal shifts in the distribution of Ixodes ricinus observed during the last three decades in Norway using antibodies against Anaplasma phagocytophilum in sheep as indicators for tick presence. Samples obtained from 2963 sheep from 90 farms in 3 ecologically different districts during 1978 - 2008 were analysed. We modelled the presence of antibodies against A. phagocytophilum to climatic-, environmental and demographic variables, and abundance of wild cervids and domestic animals, using mixed effect logistic regressions. Results: Significant predictors were large diurnal fluctuations in ground surface temperature, spring precipitation, duration of snow cover, abundance of red deer and farm animals and bush encroachment/ecotones. The length of the growth season, mean temperature and the abundance of roe deer were not significant in the model. Conclusions: Our results highlight the need to consider climatic variables year-round to disentangle important seasonal variation, climatic threshold changes, climate variability and to consider the broader environmental change, including abiotic and biotic factors. The results offer novel insight in how tick and tick-borne disease distribution might be modified by future climate and environmental change.	[Jore, Solveig; Viljugrein, Hildegunn; Kristoffersen, Anja B.; Brun, Edgar; Larsen, Inger-Lise; Ytrehus, Bjornar; Hofshagen, Merete] Norwegian Vet Inst, N-0106 Oslo, Norway; [Vanwambeke, Sophie O.] Catholic Univ Louvain, Georges Lemaitre Ctr Earth & Climate Res, Earth & Life Inst, B-1348 Louvain, Belgium; [Viljugrein, Hildegunn] Univ Oslo, CEES, Dept Biosci, N-0316 Oslo, Norway; [Isaksen, Ketil] Norwegian Meteorol Inst, Dept Res & Dev, Div Model & Climate Anal, N-0313 Oslo, Norway; [Kristoffersen, Anja B.] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Woldehiwet, Zerai] Univ Liverpool, Inst Infect & Global Hlth, Dept Infect Biol, Wirral CH64 7TE, Merseyside, England; [Johansen, Bernt] Northern Res Inst, N-9294 Tromso, Norway; [Brun-Hansen, Hege] Norwegian Sch Vet Sci, N-0033 Oslo, Norway; [Westermann, Sebastian] Univ Oslo, Dept Geosci, N-0316 Oslo, Norway	Jore, S (reprint author), Norwegian Vet Inst, Ullevalsveien 68,POB 750, N-0106 Oslo, Norway.	solveig.jore@vetinst.no	Westermann, Sebastian/I-2976-2012; Viljugrein, Hildegunn/N-6657-2015	Westermann, Sebastian/0000-0003-0514-4321; Viljugrein, Hildegunn/0000-0002-3798-5267; Vanwambeke, Sophie/0000-0001-6620-6173; Isaksen, Ketil/0000-0003-2356-5330	Norwegian Veterinary Institute (NVI)	This study was funded by seed money from the Norwegian Veterinary Institute (NVI). Sincere thanks to Richard Ostfeld (Cary Institute of Ecosystem Studies, USA) for discussions around the paper, valuable advice upon modeling and for helpful review and comments on the manuscript. Thanks to Matthew Thomas (Center for Infectious Disease Dynamics and Department of Entomology, Penn State, USA) for guidance in the complex field of temperature fluctuations and transmission. Gratitude to Anita Verpe Dyrrdal (The Norwegian Meteorological Institute (met.no)) who provided the gridded data on air temperature, precipitation and snow depth; Jan Erik Haugen (met.no) and Hilde Haakenstad (met.no) which provided the hindcast data; and Hans Olav Hygen (met.no) which made a data aggregation of the climate data to provide the climate variables used in further analyses. Special thanks to farmers and people employed at the agricultural offices in the municipalities which helped tracing historical information about grazing areas for the sheep. Thanks to Preben Ottesen (Norwegian Public Health Institute) and Petter Hopp (NVI) for discussions around the study, Bruce David for language help with the paper, John Odden and Henrik Broseth at Norwegian Institute for Nature Research for providing the number of bagged roe deer per municipality, Attila Tarpai (NVI) for GIS assistance, and Gry Groneng (NVI) for generating sample overview.	Adejinmi JO, 2011, J PARASITOL RES, V2011, DOI 10.1155/2011/824162; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Anderson BJ, 2009, P ROY SOC B-BIOL SCI, V276, P1415, DOI 10.1098/rspb.2008.1681; [Anonymous], 2011, R LANG ENV STAT COMP; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Aune S, 2011, CAN J FOREST RES, V41, P437, DOI 10.1139/X10-086; Bolzoni L, 2012, INT J PARASITOL, V42, P373, DOI 10.1016/j.ijpara.2012.02.006; Bryn A, 2013, SCAND J FOREST RES, V28, P81, DOI 10.1080/02827581.2012.689005; Bryn A, 2008, NORSK GEOGR TIDSSKR, V62, P251, DOI 10.1080/00291950802517551; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cattadori IM, 2003, OIKOS, V100, P439, DOI 10.1034/j.1600-0706.2003.12072.x; Cochez C, 2011, TICKS TICK-BORNE DIS, V2, P156, DOI 10.1016/j.ttbdis.2011.06.004; Coleman PG, 2001, LANCET, V357, P1284, DOI 10.1016/S0140-6736(00)04410-X; Daszak P, 2001, ACTA TROP, V78, P103, DOI 10.1016/S0001-706X(00)00179-0; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; DIPEOLU O O, 1985, Experimental and Applied Acarology, V1, P45, DOI 10.1007/BF01262199; Dobson ADM, 2011, J APPL ECOL, V48, P1017, DOI 10.1111/j.1365-2664.2011.02003.x; Dobson ADM, 2011, J APPL ECOL, V48, P1029, DOI 10.1111/j.1365-2664.2011.02004.x; Dyrrdal AV, 2012, CLIM RES, V55, P153, DOI 10.3354/cr01125; Estrada-Pena A, 2001, J MED ENTOMOL, V38, P361, DOI 10.1603/0022-2585-38.3.361; Field CB, 2012, UK NEW YORK; Folguera G, 2011, COMP BIOCHEM PHYS A, V159, P242, DOI 10.1016/j.cbpa.2011.03.002; Gassner F, 2008, APPL ENVIRON MICROB, V74, P7138, DOI 10.1128/AEM.00310-08; Gilbert L, 2010, OECOLOGIA, V162, P217, DOI 10.1007/s00442-009-1430-x; Gray D. M., 1981, HDB SNOW; Gray J S, 2009, Interdiscip Perspect Infect Dis, V2009, P593232, DOI 10.1155/2009/593232; Gray JS, 1998, EXP APPL ACAROL, V22, P249, DOI 10.1023/A:1006070416135; Hancock PA, 2011, INT J PARASITOL, V41, P513, DOI 10.1016/j.ijpara.2010.12.012; Hanssen-Bauer I, 2009, 2013244 ESPON; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hoch T, 2010, ECOL MODEL, V221, P1798, DOI 10.1016/j.ecolmodel.2010.04.008; Hubalek Z, 2006, MED VET ENTOMOL, V20, P166, DOI 10.1111/j.1365-2915.2006.00615.x; Isaksen K, 2011, PERMAFROST PERIGLAC, V22, P361, DOI 10.1002/ppp.728; Jaenson TGT, 2009, MED VET ENTOMOL, V23, P226, DOI 10.1111/j.1365-2915.2009.00813.x; Jaenson TGT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-8; Jaeschke A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051472; James MC, 2013, PARASITOLOGY, V140, P237, DOI 10.1017/S003118201200145X; Jensen PM, 2000, SCAND J INFECT DIS, V32, P545, DOI 10.1080/003655400458857; Jore S, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-84; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kiffner C, 2010, EXP APPL ACAROL, V52, P73, DOI 10.1007/s10493-010-9341-4; Kocan KM, 2012, TICKS TICK-BORNE DIS, V3, P147, DOI 10.1016/j.ttbdis.2012.01.004; Kovats RS, 2001, PHILOS T ROY SOC B, V356, P1057, DOI 10.1098/rstb2001.0894; Lempereur L, 2012, PARASITOL RES, V110, P1525, DOI 10.1007/s00436-011-2657-0; Levi T, 2012, P NATL ACAD SCI USA, V109, P10942, DOI 10.1073/pnas.1204536109; Li S, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-149; LINDSAY LR, 1995, J MED ENTOMOL, V32, P143, DOI 10.1093/jmedent/32.2.143; Macleod J., 1936, Parasitology Cambridge, V28, P295; MACLEOD J., 1932, PARASITOLOGY, V24, P382; Martin N, 2010, THESIS U MICHIGAN; Mason SJ, 2002, Q J ROY METEOR SOC, V128, P2145, DOI 10.1256/003590002320603584; Medlock JM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-1; MEHL R, 1983, Fauna Norvegica Series B, V30, P46; Olwoch JM, 2003, J BIOGEOGR, V30, P1221, DOI 10.1046/j.1365-2699.2003.00913.x; Ostfeld RS, 2006, PLOS BIOL, V4, P1058, DOI 10.1371/journal.pbio.0040145; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7; Perret JL, 2004, J MED ENTOMOL, V41, P361, DOI 10.1603/0022-2585-41.3.361; Raffel TR, 2013, NAT CLIM CHANGE, V3, P146, DOI [10.1038/nclimate1659, 10.1038/NCLIMATE1659]; Randolph SE, 2008, TICKS: BIOLOGY, DISEASE AND CONTROL, P40, DOI 10.1017/CBO9780511551802.003; Randolph SE, 2009, PARASITOLOGY, V136, P1403, DOI 10.1017/S0031182009005782; Randolph SE, 2002, INT J PARASITOL, V32, P979, DOI 10.1016/S0020-7519(02)00030-9; Randolph SE, 1998, TRENDS ECOL EVOL, V13, P301, DOI 10.1016/S0169-5347(98)01400-1; Randolph SE, 2004, PARASITOLOGY, V129, pS37, DOI 10.1017/S0031182004004925; Randolph SE, 2004, INT J MED MICROBIOL, V293, P5, DOI 10.1016/S1433-1128(04)80004-4; Randolph SE, 2000, ADV PARASIT, V47, P217, DOI 10.1016/S0065-308X(00)47010-7; Ranta E, 2008, OIKOS, V117, P1461, DOI 10.1111/j.2008.0030-1299.16879.x; Richter D, 2010, APPL ENVIRON MICROB, V76, P7650, DOI 10.1128/AEM.01649-10; Robertson JN, 2000, EUR J EPIDEMIOL, V16, P647, DOI 10.1023/A:1007615109273; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Ruiz-Fons F, 2010, INT J PARASITOL, V40, P1013, DOI 10.1016/j.ijpara.2010.02.006; Scharf W, 2011, J CLIN MICROBIOL, V49, P790, DOI 10.1128/JCM.02051-10; Stuen S, 2001, ACTA VET SCAND, V42, P331, DOI 10.1186/1751-0147-42-331; Stuen S, 2006, INT J MED MICROBIOL, V296, P164, DOI 10.1016/j.ijmm.2006.01.018; Stuen S, 2013, TICKS TICK-BORNE DIS, V4, P197, DOI 10.1016/j.ttbdis.2012.11.014; SUTHERST RW, 1971, OECOLOGIA, V6, P208, DOI 10.1007/BF00344915; Tack W, 2012, FOREST ECOL MANAG, V265, P30, DOI 10.1016/j.foreco.2011.10.028; Tambs-Lyche H., 1943, Norsk Veterinaertidsskrift, V55, P337; Thomas RJ, 2012, J COMP PATHOL, V147, P360, DOI 10.1016/j.jcpa.2012.02.005; Trenberth KE, 2007, CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; Van den Bossche P, 2008, REV SCI TECH OIE, V27, P551; Vanwambeke SO, 2010, VECTOR-BORNE ZOONOT, V10, P497, DOI 10.1089/vbz.2009.0116; Vor T, 2010, EXP APPL ACAROL, V51, P405, DOI 10.1007/s10493-010-9337-0; Walker AR, 2001, MED VET ENTOMOL, V15, P40, DOI 10.1046/j.1365-2915.2001.00271.x; Ward SE, 2002, LAND URBAN PLANNING, V66, P91; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; WILSON ML, 1984, YALE J BIOL MED, V57, P697; Woldehiwet Z, 2005, J COMP PATHOL, V132, P322, DOI 10.1016/j.jcpa.2004.12.002; Woldehiwet Z, 2012, J COMP PATHOL, V146, P116, DOI 10.1016/j.jcpa.2011.04.004; Woldehiwet Z, 2006, ANN NY ACAD SCI, V1078, P446, DOI 10.1196/annals.1374.084; Woldehiwet Z, 2010, VET PARASITOL, V167, P108, DOI 10.1016/j.vetpar.2009.09.013; Wood S, 2006, GEN ADDITIVE MODELS	92	41	42	7	71	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	JAN 8	2014	7								11	10.1186/1756-3305-7-11				14	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	AF3SQ	WOS:000334632900003	24401487	DOAJ Gold, Green Published			2019-04-02	
J	Delgado-Ratto, C; Soto-Calle, VE; Van den Eede, P; Gamboa, D; Rosas, A; Abatih, EN; Ferrucci, HR; Llanos-Cuentas, A; Van Geertruyden, JP; Erhart, A; D'Alessandro, U				Delgado-Ratto, Christopher; Soto-Calle, Veronica E.; Van den Eede, Peter; Gamboa, Dionicia; Rosas, Angel; Abatih, Emmanuel N.; Rodriguez Ferrucci, Hugo; Llanos-Cuentas, Alejandro; Van Geertruyden, Jean-Pierre; Erhart, Annette; D'Alessandro, Umberto			Population structure and spatio-temporal transmission dynamics of Plasmodium vivax after radical cure treatment in a rural village of the Peruvian Amazon	MALARIA JOURNAL			English	Article						Plasmodium vivax; Malaria; Genotyping; Microsatellites; Population genetics; Spatio-temporal analysis; Peruvian amazon	MICROSATELLITE MARKERS; MALARIA CONTROL; FALCIPARUM; INFECTIONS; RESISTANCE; REGION; POLYMORPHISM; CHLOROQUINE; COMPLEXITY; DIVERSITY	Background: Despite the large burden of Plasmodium vivax, little is known about its transmission dynamics. This study explored the population structure and spatio-temporal dynamics of P. vivax recurrent infections after radical cure in a two-year cohort study carried out in a rural community of the Peruvian Amazon. Methods: A total of 37 P. vivax participants recruited in San Carlos community (Peru) between April and December 2008 were treated radically with chloroquine and primaquine and followed up monthly for two years with systematic blood sampling. All samples were screened for malaria parasites and subsequently all P. vivax infections genotyped using 15 microsatellites. Parasite population structure and dynamics were determined by computing different genetic indices and using spatio-temporal statistics. Results: After radical cure, 76% of the study participants experienced one or more recurrent P. vivax infections, most of them sub-patent and asymptomatic. The parasite population displayed limited genetic diversity (He = 0.49) and clonal structure, with most infections (84%) being monoclonal. Spatio-temporal clusters of specific haplotypes were found throughout the study and persistence of highly frequent haplotypes were observed over several months within the same participants/households. Conclusions: In San Carlos community, P. vivax recurrences were commonly observed after radical treatment, and characterized by asymptomatic, sub-patent and clustered infections (within and between individuals from a few neighbouring households). Moreover low genetic diversity as well as parasite inbreeding are likely to define a clonal parasite population which has important implications on the malaria epidemiology of the study area.	[Delgado-Ratto, Christopher; Van Geertruyden, Jean-Pierre] Univ Antwerp, Fac Med, ESOC Dept, Unit Int Hlth, B-2610 Antwerp, Belgium; [Delgado-Ratto, Christopher; Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Inst Trop Med Alexander von Humboldt IMTAvH, Unit Mol Epidemiol, Lab Malaria, Lima, Peru; [Soto-Calle, Veronica E.; Rosas, Angel; Llanos-Cuentas, Alejandro] Univ Peruana Cayetano Heredia, ITMAvH, GELM, Lima 31, Peru; [Van den Eede, Peter; Erhart, Annette] Inst Trop Med, Dept Biomed Sci, Malariol Unit, B-2000 Antwerp, Belgium; [Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Dept Ciencias Celulares & Mol, Lima, Peru; [Abatih, Emmanuel N.] Inst Trop Med, Unit Vet Biostat & Epidemiol, B-2000 Antwerp, Belgium; [Rodriguez Ferrucci, Hugo] Minist Hlth, Loreto, Peru; [D'Alessandro, Umberto] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [D'Alessandro, Umberto] MRC Unit, Banjul, Gambia	Delgado-Ratto, C (reprint author), Univ Antwerp, Fac Med, ESOC Dept, Unit Int Hlth, Univ Pl 1, B-2610 Antwerp, Belgium.	richardchristopher.delgadoratto@uantwerpen.be	Rosas Aguirre, Angel/A-5054-2016; D'Alessandro, Umberto/D-3457-2015; Van geertruyden, Jean-Pierre/K-6425-2014; Mashamba-Thompson, Tivani/B-6087-2014	Rosas Aguirre, Angel/0000-0002-3271-7028; D'Alessandro, Umberto/0000-0001-6341-5009; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Delgado-Ratto, Christopher/0000-0003-2300-5181; Gamboa, Dionicia/0000-0002-1420-7729	Belgian Agency Cooperation for Development; Institute of Tropical Medicine "Alexander von Humboldt" - Universidad Peruana Cayetano Heredia, Lima; Institute of Tropical Medicine in Antwerp, Belgium [95503]	We thank the San Carlos community and the field workers who participated in this study. The work was supported by the Belgian Agency Cooperation for Development, within the third framework agreement of the Institutional collaboration between the Institute of Tropical Medicine "Alexander von Humboldt" - Universidad Peruana Cayetano Heredia, Lima and the Institute of Tropical Medicine in Antwerp, Belgium (Project 95503). CD was supported by a VLIR-UOS (Vlaamse Interuniversitaire Road - University Development Cooperation, Belgium) for the data analysis and paper writing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles SR, 2013, AM J TROP MED HYG, V88, P1130, DOI 10.4269/ajtmh.12-0752; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Arnott A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-14; Baird JK, 2009, CLIN MICROBIOL REV, V22, P508, DOI 10.1128/CMR.00008-09; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Branch O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-27; Branch OH, 2001, INFECT IMMUN, V69, P7783, DOI 10.1128/IAI.69.12.7783-7792.2001; Bruce MC, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-38; Chenet SM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-412; Chuquiyauri R, 2013, AM J TROP MED HYG, V89, P326, DOI 10.4269/ajtmh.13-0060; Chuquiyauri R, 2012, ACTA TROP, V121, P292, DOI 10.1016/j.actatropica.2011.11.003; Clark EH, 2012, INFECT IMMUN, V80, P1583, DOI 10.1128/IAI.05961-11; da Silva-Nunes M, 2012, ACTA TROP, V121, P281, DOI 10.1016/j.actatropica.2011.10.001; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Ferreira MU, 2007, J INFECT DIS, V195, P1218, DOI 10.1086/512685; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Grietens KP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050294; Grietens KP, 2010, AM J TROP MED HYG, V82, P1017, DOI 10.4269/ajtmh.2010.09-0521; Gunawardena S, 2010, AM J TROP MED HYG, V82, P235, DOI 10.4269/ajtmh.2010.09-0588; Gupta S, 1996, NAT MED, V2, P437, DOI 10.1038/nm0496-437; Gutierrez S, 2003, MANUAL PROCEDIMIENTO; Hastings IM, 2000, PARASITOL TODAY, V16, P340, DOI 10.1016/S0169-4758(00)01707-5; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Imwong M, 2007, INT J PARASITOL, V37, P1013, DOI 10.1016/j.ijpara.2007.02.010; Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241; Karunaweera ND, 2007, MOL ECOL NOTES, V7, P172, DOI 10.1111/j.1471-8286.2006.01534.x; Karunaweera ND, 2008, GENE, V410, P105, DOI 10.1016/j.gene.2007.11.022; Kosek M, 2012, AM J TROP MED HYG, V86, P580, DOI 10.4269/ajtmh.2012.11-0627; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P16; Kulldorff M, 2011, SATSCANTM SOFTWARE S; Lee G, 2012, INT J EPIDEMIOL, V41, P531, DOI 10.1093/ije/dyr190; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Markus MB, 2012, TRENDS PARASITOL, V28, P39, DOI 10.1016/j.pt.2011.10.005; ORAS-CONHU, SIT MAL PER 2009; Orjuela-Sanchez P, 2009, AM J TROP MED HYG, V81, P961, DOI 10.4269/ajtmh.2009.09-0337; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Restrepo E, 2011, ACTA TROP, V119, P23, DOI 10.1016/j.actatropica.2011.03.012; Rezende AM, 2009, AM J TROP MED HYG, V80, P729, DOI 10.4269/ajtmh.2009.80.729; Roper MH, 2000, AM J TROP MED HYG, V62, P247, DOI 10.4269/ajtmh.2000.62.247; Roshanravan B, 2003, AM J TROP MED HYG, V69, P45, DOI 10.4269/ajtmh.2003.69.45; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rubio JM, 2002, T R SOC TROP MED HYG, V96, pS199, DOI DOI 10.1016/S0035-9203(02)90077-5; Ruebush TK, 2003, AM J TROP MED HYG, V69, P548, DOI 10.4269/ajtmh.2003.69.548; Sutton PL, 2009, AM J TROP MED HYG, V81, P950, DOI 10.4269/ajtmh.2009.09-0132; Van den Eede P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016257; Van den Eede P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-151; Van den Eede P, 2010, AM J TROP MED HYG, V82, P223, DOI 10.4269/ajtmh.2010.09-0458; Villalobos-Salcedo JM, 2000, ANN TROP MED PARASIT, V94, P749, DOI 10.1080/00034980020027960; Wykes MN, 2011, P NATL ACAD SCI USA, V108, P11205, DOI 10.1073/pnas.1108579108	54	17	17	1	16	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	JAN 6	2014	13								8	10.1186/1475-2875-13-8				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	285IW	WOS:000329388400001	24393454	DOAJ Gold, Green Published			2019-04-02	
J	De Winne, K; Buscher, P; Luquetti, AO; Tavares, SBN; Oliveira, RA; Solari, A; Zulantay, I; Apt, W; Diosque, P; Rumi, MM; Girones, N; Fresno, M; Lopez-Velez, R; Perez-Molina, JA; Monge-Maillo, B; Garcia, L; Deborggraeve, S				De Winne, Koen; Buescher, Philippe; Luquetti, Alejandro O.; Tavares, Suelene B. N.; Oliveira, Rodrigo A.; Solari, Aldo; Zulantay, Ines; Apt, Werner; Diosque, Patricio; Monje Rumi, Mercedes; Girones, Nuria; Fresno, Manuel; Lopez-Velez, Rogelio; Perez-Molina, Jose A.; Monge-Maillo, Begona; Garcia, Lineth; Deborggraeve, Stijn			The Trypanosoma cruzi Satellite DNA OligoC-TesT and Trypanosoma cruzi Kinetoplast DNA OligoC-TesT for Diagnosis of Chagas Disease: A Multi-cohort Comparative Evaluation Study	PLOS NEGLECTED TROPICAL DISEASES			English	Article							POLYMERASE-CHAIN-REACTION; PCR; PARASITEMIA; CONSENSUS	Background: The Trypanosoma cruzi satellite DNA (satDNA) OligoC-TesT is a standardised PCR format for diagnosis of Chagas disease. The sensitivity of the test is lower for discrete typing unit (DTU) TcI than for TcII-VI and the test has not been evaluated in chronic Chagas disease patients. Methodology/Principal Findings: We developed a new prototype of the OligoC-TesT based on kinetoplast DNA (kDNA) detection. We evaluated the satDNA and kDNA OligoC-TesTs in a multi-cohort study with 187 chronic Chagas patients and 88 healthy endemic controls recruited in Argentina, Chile and Spain and 26 diseased non-endemic controls from D. R. Congo and Sudan. All specimens were tested in duplicate. The overall specificity in the controls was 99.1% (95% CI 95.2%-99.8%) for the satDNA OligoC-TesT and 97.4% (95% CI 92.6%-99.1%) for the kDNA OligoC-TesT. The overall sensitivity in the patients was 67.9% (95% CI 60.9%-74.2%) for the satDNA OligoC-TesT and 79.1% (95% CI 72.8%-84.4%) for the kDNA OligoC-Test. Conclusions/Significance: Specificities of the two T. cruzi OligoC-TesT prototypes are high on non-endemic and endemic controls. Sensitivities are moderate but significantly (p = 0.0004) higher for the kDNA OligoC-TesT compared to the satDNA OligoC-TesT.	[De Winne, Koen; Buescher, Philippe; Deborggraeve, Stijn] Inst Trop Med, Parasite Diagnost Unit, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Luquetti, Alejandro O.; Tavares, Suelene B. N.; Oliveira, Rodrigo A.] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil; [Luquetti, Alejandro O.; Tavares, Suelene B. N.; Oliveira, Rodrigo A.] Univ Fed Goias, Hosp Clin, Goiania, Go, Brazil; [Solari, Aldo; Zulantay, Ines; Apt, Werner] Univ Chile, Fac Med, ICBM, Programa Biol Celular & Mol, Santiago 7, Chile; [Diosque, Patricio; Monje Rumi, Mercedes] Consejo Nacl Invest Cient & Tecn CONICET, Inst Patol Expt, UEM, Salta, Argentina; [Girones, Nuria; Fresno, Manuel] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Lopez-Velez, Rogelio; Perez-Molina, Jose A.; Monge-Maillo, Begona] Hosp Ramon & Cajal, Dept Infect Dis, E-28034 Madrid, Spain; [Garcia, Lineth] Univ Mayor San Simon, Fac Med, Cochabamba, Bolivia	De Winne, K (reprint author), Inst Trop Med, Parasite Diagnost Unit, Dept Biomed Sci, B-2000 Antwerp, Belgium.	sdeborggraeve@itg.be	Girones, Nuria/L-7865-2017; Buscher, Philippe/B-9956-2012	Girones, Nuria/0000-0002-8130-2750; Buscher, Philippe/0000-0002-1926-7472; Girones Pujol, Nuria/0000-0002-0932-5018; Fresno Escudero, Manuel/0000-0002-9223-5477; Perez-Molina, Jose Antonio/0000-0001-8735-4124; Deborggraeve, Stijn/0000-0003-1501-5355	European Commission Seventh Framework Programme, ChagasEpiNet project [223034]	This work was financially supported by the European Commission Seventh Framework Programme, ChagasEpiNet project, grant number 223034. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, Wkly Epidemiol Rec, V85, P334; Brasil PEAA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-337; BRENIERE SF, 1993, MEM I OSWALDO CRUZ, V88, P163, DOI 10.1590/S0074-02761993000100027; Carolina M, 2003, MOL BIOCHEM PARASIT, V129, P1, DOI 10.1016/S0166-6851(03)00054-9; Castro C, 2000, Rev Soc Bras Med Trop, V33, P427; Corredor Arjona Augusto, 1999, Revista do Instituto de Medicina Tropical de Sao Paulo, V41, P229, DOI 10.1590/S0036-46651999000400005; Coura JR, 2002, TRENDS PARASITOL, V18, P171, DOI 10.1016/S1471-4922(01)02200-0; Cuba Cuba A, 1998, Rev Soc Bras Med Trop, V31, P207; Deborggraeve S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000450; Galvao LMC, 2003, J CLIN MICROBIOL, V41, P5066, DOI 10.1128/JCM.41.11.5066-5070.2003; Higuchi MD, 2003, CARDIOVASC RES, V60, P96, DOI 10.1016/S0008-6363(03)00361-4; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Luquetti AO, 2010, ELSEV INSIGHT, P743, DOI 10.1016/B978-0-12-384876-5.00028-9; Moreira OC, 2013, ACTA TROP, V125, P23, DOI 10.1016/j.actatropica.2012.08.020; Russomando G, 1998, AM J TROP MED HYG, V59, P487, DOI 10.4269/ajtmh.1998.59.487; Sanchez G, 2005, PARASITE, V12, P353, DOI 10.1051/parasite/2005124353; Schijman AG, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000931; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; SLOOF P, 1983, J MOL BIOL, V167, P1, DOI 10.1016/S0022-2836(83)80031-X; Virreira M, 2003, AM J TROP MED HYG, V68, P574, DOI 10.4269/ajtmh.2003.68.574; World Health Organization, 2002, WHO TECH REP SER, V905, P1; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	23	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JAN	2014	8	1							e2633	10.1371/journal.pntd.0002633				6	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AJ8SI	WOS:000337977300030	24392177	DOAJ Gold, Green Published			2019-04-02	
J	Devleesschauwer, B; Ale, A; Torgerson, P; Praet, N; de Noordhout, CM; Pandey, BD; Pun, SB; Lake, R; Vercruysse, J; Joshi, DD; Havelaar, AH; Duchateau, L; Dorny, P; Speybroeck, N				Devleesschauwer, Brecht; Ale, Anita; Torgerson, Paul; Praet, Nicolas; de Noordhout, Charline Maertens; Pandey, Basu Dev; Pun, Sher Bahadur; Lake, Rob; Vercruysse, Jozef; Joshi, Durga Datt; Havelaar, Arie H.; Duchateau, Luc; Dorny, Pierre; Speybroeck, Niko			The Burden of Parasitic Zoonoses in Nepal: A Systematic Review	PLOS NEGLECTED TROPICAL DISEASES			English	Review							TAENIA-SOLIUM NEUROCYSTICERCOSIS; NEGLECTED TROPICAL DISEASES; NEEDLE-ASPIRATION-CYTOLOGY; VISCERAL LEISHMANIASIS; CUTANEOUS-LEISHMANIASIS; CONGENITAL TOXOPLASMOSIS; CYSTIC ECHINOCOCCOSIS; KATHMANDU VALLEY; HYDATID-DISEASE; EASTERN NEPAL	Background: Parasitic zoonoses (PZs) pose a significant but often neglected threat to public health, especially in developing countries. In order to obtain a better understanding of their health impact, summary measures of population health may be calculated, such as the Disability-Adjusted Life Year (DALY). However, the data required to calculate such measures are often not readily available for these diseases, which may lead to a vicious circle of under-recognition and under-funding. Methodology: We examined the burden of PZs in Nepal through a systematic review of online and offline data sources. PZs were classified qualitatively according to endemicity, and where possible a quantitative burden assessment was conducted in terms of the annual number of incident cases, deaths and DALYs. Principal Findings: Between 2000 and 2012, the highest annual burden was imposed by neurocysticercosis and congenital toxoplasmosis (14,268 DALYs [95% Credibility Interval (CrI): 5450-27,694] and 9255 DALYs [95% CrI: 6135-13,292], respectively), followed by cystic echinococcosis (251 DALYs [95% CrI: 105-458]). Nepal is probably endemic for trichinellosis, toxocarosis, diphyllobothriosis, foodborne trematodosis, taeniosis, and zoonotic intestinal helminthic and protozoal infections, but insufficient data were available to quantify their health impact. Sporadic cases of alveolar echinococcosis, angiostrongylosis, capillariosis, dirofilariosis, gnathostomosis, sparganosis and cutaneous leishmaniosis may occur. Conclusions/Significance: In settings with limited surveillance capacity, it is possible to quantify the health impact of PZs and other neglected diseases, thereby interrupting the vicious circle of neglect. In Nepal, we found that several PZs are endemic and are imposing a significant burden to public health, higher than that of malaria, and comparable to that of HIV/AIDS. However, several critical data gaps remain. Enhanced surveillance for the endemic PZs identified in this study would enable additional burden estimates, and a more complete picture of the impact of these diseases.	[Devleesschauwer, Brecht; Vercruysse, Jozef; Dorny, Pierre] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Devleesschauwer, Brecht; de Noordhout, Charline Maertens; Speybroeck, Niko] Catholic Univ Louvain, Fac Publ Hlth, Inst Hlth & Soc IRSS, B-1200 Brussels, Belgium; [Ale, Anita; Joshi, Durga Datt] Natl Zoonoses & Food Hyg Res Ctr, Kathmandu, Nepal; [Torgerson, Paul] Univ Zurich, Fac Vet, Epidemiol Sect, Zurich, Switzerland; [Praet, Nicolas; Dorny, Pierre] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Pandey, Basu Dev] Everest Int Clin & Res Ctr, Kathmandu, Nepal; [Pun, Sher Bahadur] Sukraraj Trop & Infect Dis Hosp, Clin Res Unit, Kathmandu, Nepal; [Lake, Rob] Inst Environm Sci & Res, Christchurch, New Zealand; [Havelaar, Arie H.] Natl Inst Publ Hlth & Environm RIVM, Ctr Zoonoses & Environm Microbiol, Bilthoven, Netherlands; [Havelaar, Arie H.] Univ Utrecht, Fac Vet Med, Inst Risk Assessment Sci, Utrecht, Netherlands; [Duchateau, Luc] Univ Ghent, Fac Vet Med, Dept Comparat Physiol & Biometr, Merelbeke, Belgium	Devleesschauwer, B (reprint author), Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium.	Brecht.Devleesschauwer@UGent.be	Torgerson, Paul/A-7510-2010; Torgerson, Paul/M-4447-2013; Devleesschauwer, Brecht/G-9895-2018	Torgerson, Paul/0000-0003-4277-9983; Torgerson, Paul/0000-0003-4277-9983; Devleesschauwer, Brecht/0000-0002-2867-6892	Special Research Fund (BOF) of Ghent University	This study was supported by the Special Research Fund (BOF) of Ghent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari R C, 2007, Nepal Med Coll J, V9, P234; Agarwal A, 2009, ASIAN PAC J TROP MED, V2, P49; Amatya BM, 1999, AM J SURG PATHOL, V23, P1276, DOI 10.1097/00000478-199910000-00014; [Anonymous], 2006, CONTR NEGL ZOON DIS; [Anonymous], 2010, 1 WHO REP NEGL TROP; Azzopardi L, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2991; BARONET D, 1994, ANN TROP MED PARASIT, V88, P485, DOI 10.1080/00034983.1994.11812895; Barua P, 2007, Indian J Med Microbiol, V25, P276; Bashyal K, 2003, THESIS TRIBHUVAN U K; Bhandari G P, 2011, Nepal Med Coll J, V13, P220; Bhandari RS, 2009, J NEPAL MED ASSOC, V48, P75; Bhandary Sangita, 2004, Pac Health Dialog, V11, P87; Bhattarai NR, 2010, EMERG INFECT DIS, V16, P231, DOI 10.3201/eid1602.090623; Bhattarai R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001521; Biswas R, 2004, INT J CLIN PRACT, V58, P26, DOI 10.1111/j.1368-5031.2004.0094.x; Budke CM, 2006, EMERG INFECT DIS, V12, P296; Burniston I, 2010, J MED ENTOMOL, V47, P902, DOI 10.1603/ME09184; Chakrabarti Indranil, 2014, J Parasit Dis, V38, P135, DOI 10.1007/s12639-012-0182-4; Chopra R, 2012, MIDDLE EAST AFR J OP, V19, P349, DOI 10.4103/0974-9233.97965; Coyle CM, 2012, CLIN INFECT DIS, V54, P105, DOI 10.1093/cid/cir810; Craig PS, 2008, EMERG INFECT DIS, V14, P1674, DOI 10.3201/eid1410.071636; Criscione CD, 2007, J PARASITOL, V93, P704, DOI 10.1645/GE-1058R.1; Criscione CD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000665; Devleesschauwer B, 2013, J Nepal Health Res Counc, V11, P221; Devleesschauwer B, 2013, DALY DALY CALCULATOR; Devleesschauwer B, 2012, TROP MED INT HEALTH, V17, P1019, DOI 10.1111/j.1365-3156.2012.03017.x; Dhoubhadel M, 2007, THESIS TRIBHUVAN U K; Dipesh Gupta, 2007, Nepal Journal of Neuroscience, V4, P77; Dorny P, 2009, VET PARASITOL, V163, P196, DOI 10.1016/j.vetpar.2009.05.026; Duggal S, 2011, INDIAN J MED MICROBI, V29, P283, DOI 10.4103/0255-0857.83914; FEGAN D, 1991, BRIT MED J, V302, P1402, DOI 10.1136/bmj.302.6789.1402-d; Feng YY, 2012, VET PARASITOL, V185, P309, DOI 10.1016/j.vetpar.2011.09.025; Gautam BP, 2009, THESIS TRIBHUVAN U R; Gautam V, 2002, JPN J INFECT DIS, V55, P47; Gewali L, 2002, THESIS TRIBHUVAN U K; Ghimire K, 2002, THESIS TRIBHUVAN U K; Ghimire P, 2004, J TROP MED PARASITOL, V27, P7; Gidwani K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001296; Graham LE, 2002, J TELEMED TELECARE, V8, P356, DOI 10.1258/135763302320939257; Gurung B, 2007, THESIS TRIBHUVAN U K; Gurung G, 2005, NEPAL J NEUROSCIENCE, V2, P185; Hamano S., 1999, Japanese Journal of Tropical Medicine and Hygiene, V27, P511; Hamarsheh O, 2009, MED VET ENTOMOL, V23, P69, DOI 10.1111/j.1365-2915.2008.00784.x; Havelaar AH, 2007, CLIN INFECT DIS, V44, P1467, DOI 10.1086/517511; Havelaar AH, 2012, INT J FOOD MICROBIOL, V156, P231, DOI 10.1016/j.ijfoodmicro.2012.03.029; Heap B J, 1990, J R Army Med Corps, V136, P146; Hotez PJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001224; Huang J, 2004, J FORMOS MED ASSOC, V103, P633; Imura SI, 2012, B KOBE TOKIWA U, V5, P9; Institute for Health Metrics and Evaluation, 2013, GBD UNC VIS; Ito A, 1998, AM J TROP MED HYG, V58, P790, DOI 10.4269/ajtmh.1998.58.790; Joshi A, 2000, INT J DERMATOL, V39, P317, DOI 10.1046/j.1365-4362.2000.00930-4.x; Joshi A, 2011, POSTGRADUATE MED J N, V11, P59; Joshi A B, 2006, Kathmandu Univ Med J (KUMJ), V4, P488; Joshi D D, 1997, Southeast Asian J Trop Med Public Health, V28 Suppl 1, P26; Joshi DD, 2005, VET PARASITOL, V132, P155, DOI 10.1016/j.vetpar.2005.05.046; Joshi DD, 2004, SE ASIAN J TROP MED, V35, P252; Joshi DD, 2010, J I MED, V32, P54; Kafle P, 2004, THESIS TRIBHUVAN U K; Kalra NL, 2008, T ROY SOC TROP MED H, V102, P618, DOI 10.1016/j.trstmh.2008.02.003; Karki P., 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P836; Karki S, 2003, THESIS TRIBHUVAN U K; Karmacharya B, 2012, NEPAL J MED SCI, V1, P119; Karn Santosh Kumar, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P795; Kayastha B, 2009, NEPAL J DERMATOLOGY, V8, P27; Khan JA, 2008, J NEPAL MED ASSOC, V47, P139; Khanal B, 2010, PARASITOLOGY, V137, P1597, DOI 10.1017/S0031182010000521; Khanal BP, 2004, THESIS TRIBHUVAN U K; Khatri PS, 2003, THESIS TRIBHUVAN U K; Khurana S, 2012, BMJ CASE REP; Kimura Kenji, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1371; Kortbeek LM, 2009, MEM I OSWALDO CRUZ, V104, P370, DOI 10.1590/S0074-02762009000200034; Kumar R, 2008, T ROY SOC TROP MED H, V102, P618, DOI 10.1016/j.trstmh.2008.03.005; Kumar R, 2008, T ROY SOC TROP MED H, V102, P202, DOI 10.1016/j.trstmh.2007.10.017; Kumari N, 2006, JNMA J Nepal Med Assoc, V45, P204; Kumari N, 2011, J HEALTH POPUL NUTR, V29, P77; Lakhey M, 2009, J NEPAL MED ASSOC, V48, P314; Lamichhane G, 2010, NEPAL J OPHTHALMOL, V2, P45; Lamichhane S, 2007, J NEPAL HLTH RES COU, V5, P21, DOI DOI 10.3126/JNHRC.V5I2.2467; Lee IL, 2012, PARASITOL RES, V110, P1553, DOI 10.1007/s00436-011-2665-0; Lee LI, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-130; Mahajan RK, 2010, J INFECT DEV COUNTR, V4, P401; Maharjan M, 1996, THESIS TRIBHUVAN U K; Mahato SN, 2005, TROP ANIM HEALTH PRO, V37, P285, DOI 10.1007/s11250-005-3076-y; Malhotra S, 2006, J TROP PEDIATRICS, V52, P223, DOI 10.1093/tropej/fmi092; Mamkin I, 2007, NEW ENGL J MED, V357, P1666, DOI 10.1056/NEJMc070837; Manandhar S, 2005, THESIS CHIANG MAI U; Manandhar S, 2006, BERL MUNCH TIERARZTL, V119, P308; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Ministry of Health and Population, 2010, NEP HLTH SECT PROGR; MOHP New ERA ICF International Inc., 2007, NEP DEM HLTH SURV 20; Mondal SK, 2009, J NEPAL MED ASSOC, V48, P321; Mukherjee A, 2012, INDIAN J MED MICROBI, V30, P356, DOI 10.4103/0255-0857.99505; Mukhia G, 2007, THESIS TRIBHUVAN U K; Mukhida K, 2004, NEPAL J NEUROSCIENCE, V1, P104; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murrell K D, 1991, Southeast Asian J Trop Med Public Health, V22 Suppl, P377; Nabi F, 2007, INDIAN PEDIATR, V44, P781; Navitsky RC, 1998, J PARASITOL, V84, P647, DOI 10.2307/3284746; Nepal Health Sector Support Programme & Ministry of Health and Population, 2011, CONS BUILD WORKSH ST; Neupane S, 2008, Nepal Med Coll J, V10, P64; Nkouawa A, 2009, J CLIN MICROBIOL, V47, P168, DOI 10.1128/JCM.01573-08; Panackel C, 2006, Indian J Med Microbiol, V24, P220; Pandey Basu Dev, 2006, Nepal Med Coll J, V8, P213; Pandey K, 2001, THESIS TRIBHUVAN U K; Pandey K, 2008, PARASITOL RES, V103, P293, DOI 10.1007/s00436-008-0967-7; Pant B, 2011, J NEPAL MED ASSOC, V51, P192; Parija S. C., 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P131; Patnaik MM, 2009, J TRAVEL MED, V16, P68, DOI 10.1111/j.1708-8305.2008.00275.x; Praet N, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000406; Prasad KN, 2002, T ROY SOC TROP MED H, V96, P515, DOI 10.1016/S0035-9203(02)90423-2; Prasad R, 2005, TROP DOCT, V35, P182, DOI 10.1258/0049475054620914; Prasad Rajniti, 2004, Indian Pediatr, V41, P1074; Pun SB, 2013, AM J TROP MED HYG, V88, P227, DOI 10.4269/ajtmh.2012.12-0502; Rai B. K., 2012, Health Renaissance, V10, P160; Rai P, 2002, THESIS TRIBHUVAN U K; Rai S, 2007, Indian J Med Microbiol, V25, P62; Rai S K, 2011, Nepal Med Coll J, V13, P64; Rai S. K., 1998, Journal of Infectious Diseases and Antimicrobial Agents, V15, P105; Rai S K, 1999, Asia Pac J Public Health, V11, P89; Rai S. K., 1997, Japanese Journal of Tropical Medicine and Hygiene, V25, P81; Rai Shiba Kumar, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P286; Rai Shiba Kumar, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P548; Rai Shiba Kumar, 2003, Nepal Med Coll J, V5, P89; Rai Shiba Kumar, 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P388; Rai Shiba Kumar, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P739; Rai Shiba Kumar, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P479; Rana K, 2011, MED J SHREE BIRENDRA, V10, P44; Rauniyar R, 2012, NEPALESE J RADIOLOGY, V2, P31; Rauniyar RK, 2003, CLIN RADIOL, V58, P154, DOI 10.1053/crad.2002.1101; Ray R, 2010, THESIS TRIBHUVAN U K; Rengarajan S, 2008, BRIT J NEUROSURG, V22, P784, DOI 10.1080/02688690802088073; Sah S P, 2001, Indian J Pathol Microbiol, V44, P59; Sah Shatrughan P., 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P185; Sapkota B. S., 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P1078; SAPKOTA D, 2004, J NEPAL HLTH RES COU, V2, P9; Schwarz D, 2011, AM J TROP MED HYG, V84, P508, DOI 10.4269/ajtmh.2011.11-0021; Sethi B, 2012, MULTIPLE OUTBREAKS T; Shariq S M, 2007, Kathmandu Univ Med J (KUMJ), V5, P240; Sharma A, 2008, THESIS TRIBHUVAN U R; Sharma P, 2010, Kathmandu Univ Med J (KUMJ), V8, P257; Shaw Amit Kumar, 2010, Trop Gastroenterol, V31, P119; Shrestha A, 2010, THESIS TRIBHUVAN U K; Shrestha J B, 2008, Nepal Med Coll J, V10, P139; Shrestha R, 2009, NEPAL J NEUROSCIENCE, V6, P12; Shrestha S, 2012, Kathmandu Univ Med J (KUMJ), V10, P58; Shrestha S, 2012, TROP DOCT, V42, P232, DOI 10.1258/td.2012.120284; Singh A, 2009, AM J TROP MED HYG, V81, P538, DOI 10.4269/ajtmh.2009.81.538; Smiti S, 2003, INDIAN J RADIOLOGY I, V13, P157; Stauch A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001405; Subedee A, 2012, J NOBEL MED COLL, V1, P64; Subedi PP, 2012, NEPAL J NEUROSCIENCE, V9, P21; Sundarka M., 2005, Nepal Journal of Neuroscience, V2, P137; TANEJA K, 1990, J COMPUT ASSIST TOMO, V14, P493; Thapa A, 2007, CURRENT SITUATION MO; Thapa RB, 2000, THESIS TRIBHUVAN U K; Thapa S, 2002, THESIS TRIBHUVAN U K; Torgerson PR, 2011, VET PARASITOL, V182, P79, DOI 10.1016/j.vetpar.2011.07.017; Torgerson PR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000722; Torgerson PR, 2013, VET PARASITOL; Tragard A, 2010, HEALTH POLICY PLANN, V25, pi58, DOI 10.1093/heapol/czq061; Tyagi DK, 2010, J NEUROSCI RURAL PRA, V1, P115, DOI 10.4103/0976-3147.71729; Uga Shoji, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P19; Uranw S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002062; Vanderelst D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000576; Vasantha P L, 2012, Indian J Med Microbiol, V30, P236, DOI 10.4103/0255-0857.96708; Wong YC, 2005, BRIT J OPHTHALMOL, V89, P390, DOI 10.1136/bjo.2004.052258; World Bank, 2000, NEP OP ISS PRIOR RES; Wu Zhiliang, 2004, Tropical Medicine and Health, V32, P5, DOI 10.2149/tmh.32.5; Wu ZL, 2003, APPL ENVIRON MICROB, V69, P4720, DOI 10.1128/AEM.69.8.4720-4726.2003; Yadav N, 2009, THESIS TRIBHUVAN U R; Yadav SK, 2009, NEPAL J OPHTHALMOL, V1, P143; Yong Tai-Soon, 2000, Korean Journal of Parasitology, V38, P275; Yoshikawa H, 2009, VET PARASITOL, V160, P295, DOI 10.1016/j.vetpar.2008.11.029; Zhang LH, 2000, T ROY SOC TROP MED H, V94, P258, DOI 10.1016/S0035-9203(00)90313-4	175	28	29	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JAN	2014	8	1							e2634	10.1371/journal.pntd.0002634				13	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AJ8SI	WOS:000337977300031	24392178	DOAJ Gold, Green Published			2019-04-02	
J	Hasker, E; Malaviya, P; Gidwani, K; Picado, A; Ostyn, B; Kansal, S; Singh, RP; Singh, OP; Chourasia, A; Singh, AK; Shankar, R; Wilson, ME; Khanal, B; Rijal, S; Boelaert, M; Sundar, S				Hasker, Epco; Malaviya, Paritosh; Gidwani, Kamlesh; Picado, Albert; Ostyn, Bart; Kansal, Sangeeta; Singh, Rudra Pratap; Singh, Om Prakash; Chourasia, Ankita; Singh, Abhishek Kumar; Shankar, Ravi; Wilson, Mary E.; Khanal, Basudha; Rijal, Suman; Boelaert, Marleen; Sundar, Shyam			Strong Association between Serological Status and Probability of Progression to Clinical Visceral Leishmaniasis in Prospective Cohort Studies in India and Nepal	PLOS NEGLECTED TROPICAL DISEASES			English	Article							DIRECT AGGLUTINATION-TEST; DONOVANI INFECTION; KALA-AZAR; ENDEMIC AREA; EPIDEMIOLOGY; DISEASE; BIHAR; ELIMINATION; PREVALENCE; DISTRICT	Introduction: Asymptomatic persons infected with the parasites causing visceral leishmaniasis (VL) usually outnumber clinically apparent cases by a ratio of 4-10 to 1. We assessed the risk of progression from infection to disease as a function of DAT and rK39 serological titers. Methods: We used available data on four cohorts from villages in India and Nepal that are highly endemic for Leishmania donovani. In each cohort two serosurveys had been conducted. Based on results of initial surveys, subjects were classified as seronegative, moderately seropositive or strongly seropositive using both DAT and rK39. Based on the combination of first and second survey results we identified seroconvertors for both markers. Seroconvertors were subdivided in high and low titer convertors. Subjects were followed up for at least one year following the second survey. Incident VL cases were recorded and verified. Results: We assessed a total of 32,529 enrolled subjects, for a total follow-up time of 72,169 person years. Altogether 235 incident VL cases were documented. The probability of progression to disease was strongly associated with initial serostatus and with seroconversion; this was particularly the case for those with high titers and most prominently among seroconvertors. For high titer DAT convertors the hazard ratio reached as high as 97.4 when compared to non-convertors. The strengths of the associations varied between cohorts and between markers but similar trends were observed between the four cohorts and the two markers. Discussion: There is a strongly increased risk of progressing to disease among DAT and/or rK39 seropositives with high titers. The options for prophylactic treatment for this group merit further investigation, as it could be of clinical benefit if it prevents progression to disease. Prophylactic treatment might also have a public health benefit if it can be corroborated that these asymptomatically infected individuals are infectious for sand flies.	[Hasker, Epco; Ostyn, Bart; Boelaert, Marleen] Inst Trop Med, B-2000 Antwerp, Belgium; [Malaviya, Paritosh; Gidwani, Kamlesh; Kansal, Sangeeta; Singh, Rudra Pratap; Singh, Om Prakash; Chourasia, Ankita; Singh, Abhishek Kumar; Shankar, Ravi; Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [Gidwani, Kamlesh] Univ Turku, Dept Biotechnol, Turku, Finland; [Picado, Albert] Hosp Clin Univ Barcelona, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona, Spain; [Wilson, Mary E.] Univ Iowa, Iowa City, IA USA; [Wilson, Mary E.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA; [Khanal, Basudha; Rijal, Suman] BP Koirala Inst Hlth Sci, Dharan, Nepal	Hasker, E (reprint author), Inst Trop Med, B-2000 Antwerp, Belgium.	ehasker@itg.be	Malaviya, Paritosh/B-1819-2012	Malaviya, Paritosh/0000-0002-7558-152X; Boelaert, Marleen/0000-0001-8051-6776; Picado, Albert/0000-0001-7344-628X	European Union [015374]; Tropical Medicine Research Center [P50 AI-074321]; US National Institutes of Health [R01 AI076233, NIAID R01 AI045540]; NIH; VA Merit Review grant	The KALANET community trial was part of a large project conducted by the KALANET consortium funded by the European Union under its 6th 319 Framework Programme (INCODEV/320 Project 015374). The TMRC study is supported in part with funds from Tropical Medicine Research Center P50 AI-074321 (all authors) from the US National Institutes of Health, grants R01 AI076233 and NIAID R01 AI045540 from the NIH (MEW) and a VA Merit Review grant (MEW). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI A, 1994, ANN TROP MED PARASIT, V88, P289, DOI 10.1080/00034983.1994.11812869; BADARO R, 1986, J INFECT DIS, V154, P1003, DOI 10.1093/infdis/154.6.1003; Bern C, 2007, AM J TROP MED HYG, V76, P909; Bern C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000599; Bhattarai NR, 2010, EMERG INFECT DIS, V16, P231, DOI 10.3201/eid1602.090623; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; Costa CHN, 2000, J INFECT DIS, V182, P997, DOI 10.1086/315795; Das VNR, 2011, T ROY SOC TROP MED H, V105, P661, DOI 10.1016/j.trstmh.2011.08.005; Marques LHD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001955; EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124; Gidwani K, 2009, AM J TROP MED HYG, V80, P345, DOI 10.4269/ajtmh.2009.80.345; Hasker E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002053; HO M, 1982, T ROY SOC TROP MED H, V76, P741, DOI 10.1016/0035-9203(82)90095-5; Khanal B, 2010, TROP MED INT HEALTH, V15, P1390, DOI 10.1111/j.1365-3156.2010.02631.x; MAGILL AJ, 1993, NEW ENGL J MED, V328, P1383, DOI 10.1056/NEJM199305133281904; Michel G, 2011, ACTA TROP, V119, P69, DOI 10.1016/j.actatropica.2011.05.012; Ostyn B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001284; Picado A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6760; SCHAEFER KU, 1995, T ROY SOC TROP MED H, V89, P471, DOI 10.1016/0035-9203(95)90070-5; Silva LA, 2011, AM J TROP MED HYG, V84, P261, DOI 10.4269/ajtmh.2011.10-0092; Singh OP, 2012, CLIN VACCINE IMMUNOL, V19, P961, DOI 10.1128/CVI.00143-12; Singh S, 2002, CLIN DIAGN LAB IMMUN, V9, P568, DOI 10.1128/CDLI.9.3.568-572.2002; Smieja M J, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001363; Stauch A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001405; Sundar S, 2006, T ROY SOC TROP MED H, V100, P533, DOI 10.1016/j.trstmh.2005.08.018; WHO, 2010, WHO TECH REP SER, V949, P1; ZIJLSTRA EE, 1994, AM J TROP MED HYG, V51, P826, DOI 10.4269/ajtmh.1994.51.826	27	36	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JAN	2014	8	1							e2657	10.1371/journal.pntd.0002657				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AJ8SI	WOS:000337977300047	24466361	DOAJ Gold, Green Published			2019-04-02	
J	Ribeiro, JMC; Genta, FA; Sorgine, MHF; Logullo, R; Mesquita, RD; Paiva-Silva, GO; Majerowicz, D; Medeiros, M; Koerich, L; Terra, WR; Ferreira, C; Pimentel, AC; Bisch, PM; Leite, DC; Diniz, MMP; Junior, JLDGV; Da Silva, ML; Araujo, RN; Gandara, ACP; Brosson, S; Salmon, D; Bousbata, S; Gonzalez-Caballero, N; Silber, AM; Alves-Bezerra, M; Gondim, KC; Silva-Neto, MAC; Atella, GC; Araujo, H; Dias, FA; Polycarpo, C; Vionette-Amaral, RJ; Fampa, P; Melo, ACA; Tanaka, AS; Balczun, C; Oliveira, JHM; Goncalves, RLS; Lazoski, C; Rivera-Pomar, R; Diambra, L; Schaub, GA; Garcia, ES; Azambuja, P; Braz, GRC; Oliveira, PL				Ribeiro, Jose M. C.; Genta, Fernando A.; Sorgine, Marcos H. F.; Logullo, Raquel; Mesquita, Rafael D.; Paiva-Silva, Gabriela O.; Majerowicz, David; Medeiros, Marcelo; Koerich, Leonardo; Terra, Walter R.; Ferreira, Clelia; Pimentel, Andre C.; Bisch, Paulo M.; Leite, Daniel C.; Diniz, Michelle M. P.; Junior, Joao Lidio da S. G. V.; Da Silva, Manuela L.; Araujo, Ricardo N.; Gandara, Ana Caroline P.; Brosson, Sebastien; Salmon, Didier; Bousbata, Sabrina; Gonzalez-Caballero, Natalia; Silber, Ariel Mariano; Alves-Bezerra, Michele; Gondim, Katia C.; Silva-Neto, Mario Alberto C.; Atella, Georgia C.; Araujo, Helena; Dias, Felipe A.; Polycarpo, Carla; Vionette-Amaral, Raquel J.; Fampa, Patricia; Melo, Ana Claudia A.; Tanaka, Aparecida S.; Balczun, Carsten; Oliveira, Jose Henrique M.; Goncalves, Renata L. S.; Lazoski, Cristiano; Rivera-Pomar, Rolando; Diambra, Luis; Schaub, Guenter A.; Garcia, Eloi S.; Azambuja, Patricia; Braz, Gloria R. C.; Oliveira, Pedro L.			An Insight into the Transcriptome of the Digestive Tract of the Bloodsucking Bug, Rhodnius prolixus	PLOS NEGLECTED TROPICAL DISEASES			English	Article							TRIATOMA-BRASILIENSIS HEMIPTERA; TRANSFER-RNA MODIFICATIONS; ACTIVATED PROTEIN-KINASE; INDUCED OXIDATIVE STRESS; HEME-BINDING PROTEIN; FULL-LENGTH CDNA; AEDES-AEGYPTI; DROSOPHILA-MELANOGASTER; SEQUENCE CHARACTERIZATION; TRYPANOSOMA-CRUZI	The bloodsucking hemipteran Rhodnius prolixus is a vector of Chagas' disease, which affects 7-8 million people today in Latin America. In contrast to other hematophagous insects, the triatomine gut is compartmentalized into three segments that perform different functions during blood digestion. Here we report analysis of transcriptomes for each of the segments using pyrosequencing technology. Comparison of transcript frequency in digestive libraries with a whole-body library was used to evaluate expression levels. All classes of digestive enzymes were highly expressed, with a predominance of cysteine and aspartic proteinases, the latter showing a significant expansion through gene duplication. Although no protein digestion is known to occur in the anterior midgut (AM), protease transcripts were found, suggesting secretion as proenzymes, being possibly activated in the posterior midgut (PM). As expected, genes related to cytoskeleton, protein synthesis apparatus, protein traffic, and secretion were abundantly transcribed. Despite the absence of a chitinous peritrophic membrane in hemipterans - which have instead a lipidic perimicrovillar membrane lining over midgut epithelia several gut-specific peritrophin transcripts were found, suggesting that these proteins perform functions other than being a structural component of the peritrophic membrane. Among immunity-related transcripts, while lysozymes and lectins were the most highly expressed, several genes belonging to the Toll pathway - found at low levels in the gut of most insects were identified, contrasting with a low abundance of transcripts from IMD and STAT pathways. Analysis of transcripts related to lipid metabolism indicates that lipids play multiple roles, being a major energy source, a substrate for perimicrovillar membrane formation, and a source for hydrocarbons possibly to produce the wax layer of the hindgut. Transcripts related to amino acid metabolism showed an unanticipated priority for degradation of tyrosine, phenylalanine, and tryptophan. Analysis of transcripts related to signaling pathways suggested a role for MAP kinases, GTPases, and LKBP1/AMP kinases related to control of cell shape and polarity, possibly in connection with regulation of cell survival, response of pathogens and nutrients. Together, our findings present a new view of the triatomine digestive apparatus and will help us understand trypanosome interaction and allow insights into hemipteran metabolic adaptations to a blood-based diet.	[Ribeiro, Jose M. C.] NIAID, Sect Vector Biol, Lab Malaria & Vector Res, NIH, Rockville, MD 20892 USA; [Genta, Fernando A.; Sorgine, Marcos H. F.; Mesquita, Rafael D.; Paiva-Silva, Gabriela O.; Koerich, Leonardo; Terra, Walter R.; Ferreira, Clelia; Araujo, Ricardo N.; Gondim, Katia C.; Silva-Neto, Mario Alberto C.; Atella, Georgia C.; Araujo, Helena; Polycarpo, Carla; Vionette-Amaral, Raquel J.; Melo, Ana Claudia A.; Tanaka, Aparecida S.; Lazoski, Cristiano; Garcia, Eloi S.; Azambuja, Patricia; Braz, Gloria R. C.; Oliveira, Pedro L.] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil; [Genta, Fernando A.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil; [Sorgine, Marcos H. F.; Paiva-Silva, Gabriela O.; Majerowicz, David; Gandara, Ana Caroline P.; Salmon, Didier; Alves-Bezerra, Michele; Gondim, Katia C.; Silva-Neto, Mario Alberto C.; Atella, Georgia C.; Dias, Felipe A.; Polycarpo, Carla; Vionette-Amaral, Raquel J.; Oliveira, Jose Henrique M.; Goncalves, Renata L. S.; Oliveira, Pedro L.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biotecnol & Biol Mol, Rio De Janeiro, Brazil; [Logullo, Raquel; Mesquita, Rafael D.; Melo, Ana Claudia A.; Braz, Gloria R. C.] Univ Fed Rio de Janeiro, Inst Chem, Dept Biochem, Rio De Janeiro, Brazil; [Medeiros, Marcelo; Da Silva, Manuela L.] Programa Biotecnol, Diretoria Metrol Aplicada Ciencias Vida, Inst Nacl Metrol Qualidade & Tecnol, BR-25250020 Rio De Janeiro, Brazil; [Koerich, Leonardo] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, BR-21944970 Rio De Janeiro, Brazil; [Terra, Walter R.; Ferreira, Clelia; Pimentel, Andre C.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Bisch, Paulo M.; Leite, Daniel C.; Diniz, Michelle M. P.; Junior, Joao Lidio da S. G. V.; Da Silva, Manuela L.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Junior, Joao Lidio da S. G. V.] Evandro Chagas Inst, Ctr Technol Innovat, Ananindeua, Para, Brazil; [Araujo, Ricardo N.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil; [Brosson, Sebastien; Bousbata, Sabrina] Univ Libre Bruxelles, IBMM, Gosselies, Belgium; [Silber, Ariel Mariano] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil; [Araujo, Helena] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil; [Fampa, Patricia] Univ Fed Rural Rio de Janeiro, DBA, Inst Biol, Rio de Janeiro, Brazil; [Tanaka, Aparecida S.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Bioquim, Sao Paulo, Brazil; [Balczun, Carsten; Schaub, Guenter A.] Ruhr Univ Bochum, Zool Parasitol Grp, Bochum, Germany; [Rivera-Pomar, Rolando; Diambra, Luis] Univ Nacl La Plata, Ctr Reg Estudios Genom, Florencio Varela, Argentina; [Rivera-Pomar, Rolando] Univ Nacl Noroeste Buenos Aires, Ctr Bioinvest, Pergamino, Argentina	Ribeiro, JMC (reprint author), NIAID, Sect Vector Biol, Lab Malaria & Vector Res, NIH, Rockville, MD 20892 USA.	jribeiro@niaid.nih.gov; gbraz@iq.ufrj.br; pedro@bioqmed.ufrj.br	Araujo, Helena/D-7149-2013; Ferreira, Clelia/J-3184-2016; Vionette do Amaral, Raquel Juliana/E-1192-2018; Ribeiro, Jose/J-7011-2015; Koerich, Leonardo/J-7004-2014; Silber, Ariel/O-6951-2015; Diambra, Luis/F-6319-2015; Melo, Ana C A/K-1048-2013; Majerowicz, David/B-5361-2016; Alves-Bezerra, Michele/B-4662-2014; Dias, Felipe/L-7390-2013; Lazoski, Cristiano/H-6192-2013; Oliveira, Pedro/A-9438-2010	Araujo, Helena/0000-0003-0371-9523; Ferreira, Clelia/0000-0003-0766-9287; Koerich, Leonardo/0000-0002-5668-3934; Silber, Ariel/0000-0003-4528-4732; Diambra, Luis/0000-0001-8052-4880; Melo, Ana C A/0000-0003-0686-7089; Majerowicz, David/0000-0001-7916-5315; Alves-Bezerra, Michele/0000-0003-4430-6434; Dias, Felipe/0000-0003-2074-1052; Mesquita, Rafael D/0000-0002-2882-3362; /0000-0003-3814-5312; Tanaka, Aparecida/0000-0001-9407-805X; Paiva Gandara, Ana Caroline/0000-0003-3194-4453; Oliveira, Pedro/0000-0003-0307-354X; Ribeiro, Jose/0000-0002-9107-0818	Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases; CAPES; CNPq; FAPESP; FAPERJ; FAPEMIG; PRPq/UFMG; ANPCyT [PICT-2010-0135]; UNNOBA [PFCI-512/12]; Max Planck Society Partner Laboratory Program; INBEQMeDI; Wallonie-Bruxelles International (WBI)/Fundacao Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); WHO	JMCR was supported by the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases. GRCB, FAG, ACAM, DS, SaB and SeB were supported by CAPES; CP, HMA, MHFS, PLO, GRCB, ACAM, AMS and FAG were supported by CNPq; AMS, ACP, AST, CF and WRT were supported by FAPESP; ACAM, FAG, CP, HMA, MHFS, PLO and GRCB were supported by FAPERJ; RNA was supported by FAPEMIG and PRPq/UFMG; RRP was supported by grants ANPCyT PICT-2010-0135, UNNOBA PFCI-512/12 and by the Max Planck Society Partner Laboratory Program; AMS was supported by a grant from INBEQMeDI; DS, SaB and SeB were supported by the Wallonie-Bruxelles International (WBI)/Fundacao Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) bilateral cooperation agreement; CP was also supported by a grant from the WHO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov A, 2006, MOL CELL, V21, P87, DOI 10.1016/j.molce1.2005.10.036; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMANO KI, 1978, EUR J BIOCHEM, V85, P97, DOI 10.1111/j.1432-1033.1978.tb12216.x; Amino R, 2001, INSECT BIOCHEM MOLEC, V31, P465, DOI 10.1016/S0965-1748(00)00151-X; Andersen JF, 2005, ARCH INSECT BIOCHEM, V58, P97, DOI 10.1002/arch.20032; Araujo CAC, 2006, INSECT BIOCHEM MOLEC, V36, P547, DOI 10.1016/j.ibmb.2006.04.003; Araujo RN, 2007, INT J PARASITOL, V37, P1351, DOI 10.1016/j.ijpara.2007.04.017; Araujo RN, 2009, J INSECT PHYSIOL, V55, P862, DOI 10.1016/j.jinsphys.2009.06.002; ATELLA GC, 1995, ARCH INSECT BIOCHEM, V30, P337, DOI 10.1002/arch.940300404; Atella GC, 2000, ARCH INSECT BIOCHEM, V43, P99, DOI 10.1002/(SICI)1520-6327(200003)43:3<99::AID-ARCH1>3.3.CO;2-V; Baines S., 1956, Journal of exp Ecol Cambridge, V33, P533; Balczun C, 2008, PARASITOL RES, V102, P229, DOI 10.1007/s00436-007-0751-0; Balczun C, 2012, INSECT BIOCHEM MOLEC, V42, P240, DOI 10.1016/j.ibmb.2011.12.006; Barry MK, 1999, INSECT BIOCHEM MOLEC, V29, P319, DOI 10.1016/S0965-1748(99)00004-1; Berkey CD, 2009, CELL MICROBIOL, V11, P461, DOI 10.1111/j.1462-5822.2008.01267.x; Bian GW, 2008, INSECT BIOCHEM MOLEC, V38, P190, DOI 10.1016/j.ibmb.2007.10.008; Bifano TD, 2010, COMP BIOCHEM PHYS B, V157, P1, DOI 10.1016/j.cbpb.2010.05.014; BILLINGSLEY PF, 1988, TISSUE CELL, V20, P291, DOI 10.1016/0040-8166(88)90050-X; BILLINGSLEY PF, 1990, ANNU REV ENTOMOL, V35, P219; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Bjork GR, 1999, FEBS LETT, V452, P47, DOI 10.1016/S0014-5793(99)00528-1; BOKER CA, 1984, Z PARASITENKD, V70, P459, DOI 10.1007/BF00926686; Bolognesi R, 2008, J INSECT PHYSIOL, V54, P1413, DOI 10.1016/j.jinsphys.2008.08.002; BONMATIN JM, 1992, J BIOMOL NMR, V2, P235, DOI 10.1007/BF01875319; Borovsky D, 1996, EUR J BIOCHEM, V237, P279, DOI 10.1111/j.1432-1033.1996.0279n.x; Brandon MC, 2008, INSECT BIOCHEM MOLEC, V38, P916, DOI 10.1016/j.ibmb.2008.07.003; Braz GRC, 2001, INSECT BIOCHEM MOLEC, V31, P359, DOI 10.1016/S0965-1748(00)00129-6; Brugge VAT, 2002, PEPTIDES, V23, P671, DOI 10.1016/S0196-9781(01)00661-1; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Caiaffa CD, 2010, INSECT BIOCHEM MOLEC, V40, P855, DOI 10.1016/j.ibmb.2010.08.005; Campos ITN, 2004, FEBS LETT, V577, P512, DOI 10.1016/j.febslet.2004.10.052; Campos ITN, 2002, INSECT BIOCHEM MOLEC, V32, P991, DOI 10.1016/S0965-1748(02)00035-8; Cancado FC, 2008, BRAZ J MED BIOL RES, V41, P969, DOI 10.1590/S0100-879X2008001100005; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chan CTY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1938; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; Cho PF, 2005, CELL, V121, P411, DOI 10.1016/j.cell.2005.02.024; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Chua BT, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-131; Cockcroft S, 1998, BIOESSAYS, V20, P423, DOI 10.1002/(SICI)1521-1878(199805)20:5<423::AID-BIES9>3.3.CO;2-U; Coelho HSL, 1997, ARCH INSECT BIOCHEM, V35, P301, DOI 10.1002/(SICI)1520-6327(199705)35:3<301::AID-ARCH4>3.0.CO;2-W; DANSAPETRETSKI M, 1995, J BIOL CHEM, V270, P10893, DOI 10.1074/jbc.270.18.10893; de Marco R, 2010, PEPTIDES, V31, P1280, DOI 10.1016/j.peptides.2010.03.033; Devenport M, 2006, BIOCHEMISTRY-US, V45, P9540, DOI 10.1021/bi0605991; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Dimopoulos G, 1998, EMBO J, V17, P6115, DOI 10.1093/emboj/17.21.6115; Dimopoulos G, 1996, P NATL ACAD SCI USA, V93, P13066, DOI 10.1073/pnas.93.23.13066; Dimopoulos G, 2001, CURR OPIN IMMUNOL, V13, P79, DOI 10.1016/S0952-7915(00)00186-2; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Dunkov B, 2006, INSECT BIOCHEM MOLEC, V36, P300, DOI 10.1016/j.ibmb.2006.01.007; Duraisamy S, 2008, EXPERT OPIN THER TAR, V12, P921, DOI [10.1517/14728220802250453, 10.1517/14728222.12.8.921 ]; Egan TJ, 2008, MOL BIOCHEM PARASIT, V157, P127, DOI 10.1016/j.molbiopara.2007.11.005; Eichler S, 2002, EXP PARASITOL, V100, P17, DOI 10.1006/expr.2001.4653; EMILSSON V, 1992, NUCLEIC ACIDS RES, V20, P4499, DOI 10.1093/nar/20.17.4499; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; FERREIRA C, 1988, INSECT BIOCHEM, V18, P521, DOI 10.1016/0020-1790(88)90003-0; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Forcet Christelle, 2007, Sci STKE, V2007, ppe51, DOI 10.1126/stke.4042007pe51; FRIEDRICH T, 1993, J BIOL CHEM, V268, P16216; FuentesPrior P, 1997, P NATL ACAD SCI USA, V94, P11845, DOI 10.1073/pnas.94.22.11845; Fuss B, 1998, MECH DEVELOP, V79, P83; Gaines PJ, 2003, INSECT BIOCHEM MOLEC, V33, P1061, DOI 10.1016/S0965-1748(03)00096-1; GARCIA EDS, 1977, J INSECT PHYSIOL, V23, P247, DOI 10.1016/0022-1910(77)90038-5; Garcia ES, 2010, TRENDS PARASITOL, V26, P499, DOI 10.1016/j.pt.2010.07.003; GARCIA ES, 1979, EXPERIENTIA, V35, P305, DOI 10.1007/BF01964315; GARCIA ES, 1978, ARCH BIOCHEM BIOPHYS, V188, P315, DOI 10.1016/S0003-9861(78)80015-0; Geijtenbeek TBH, 1996, FEBS LETT, V391, P333, DOI 10.1016/0014-5793(96)00770-3; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Glusa E, 1997, THROMB HAEMOSTASIS, V77, P1196; Golodne DM, 2003, J BIOL CHEM, V278, P27766, DOI 10.1074/jbc.M212421200; Goto A, 2003, DEV BIOL, V264, P582, DOI 10.1016/j.ydbio.2003.06.001; Goto A, 2001, BIOCHEM J, V359, P99, DOI 10.1042/0264-6021:3590099; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Grillo LAM, 2007, INSECT BIOCHEM MOLEC, V37, P579, DOI 10.1016/j.ibmb.2007.03.002; Grimaldi David, 2005, pi; Gromova I, 2002, INT J CANCER, V98, P539, DOI 10.1002/ijc.10244; Grosshans J, 1999, MECH DEVELOP, V81, P127, DOI 10.1016/S0925-4773(98)00236-6; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Guo HF, 2000, NATURE, V403, P895; GUTIERREZ LS, 1986, J ULTRA MOL STRUCT R, V95, P75, DOI 10.1016/0889-1605(86)90031-5; HAENDLER B, 1995, BIOCHEM J, V307, P465, DOI 10.1042/bj3070465; Hajdusek O, 2009, P NATL ACAD SCI USA, V106, P1033, DOI 10.1073/pnas.0807961106; Hardie DG, 2002, BIOCHEM SOC T, V30, P1064, DOI 10.1042/BST0301064; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Hegedus D, 2009, ANNU REV ENTOMOL, V54, P285, DOI 10.1146/annurev.ento.54.110807.090559; HELMKAMP GM, 1974, J BIOL CHEM, V249, P6382; Hernandez G, 2005, MECH DEVELOP, V122, P865, DOI 10.1016/j.mod.2005.04.002; Hernandez G, 2005, MECH DEVELOP, V122, P529, DOI 10.1016/j.mod.2004.11.011; HILL P, 1976, PROC R SOC SER B-BIO, V194, P501, DOI 10.1098/rspb.1976.0091; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Jansen M, 2009, PHYSIOL REV, V89, P777, DOI 10.1152/physrev.00026.2008; Jasrapuria S, 2010, INSECT BIOCHEM MOLEC, V40, P214, DOI 10.1016/j.ibmb.2010.01.011; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jensen J, 2000, NAT GENET, V24, P36; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Kamhawi S, 2004, CELL, V119, P329, DOI 10.1016/j.cell.2004.10.009; Kanno K, 2007, BBA-MOL CELL BIOL L, V1771, P654, DOI 10.1016/j.bbalip.2007.04.003; Kanost MR, 2004, IMMUNOL REV, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Karim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028525; Kato H, 2010, INFECT GENET EVOL, V10, P184, DOI 10.1016/j.meegid.2009.10.012; Kellenberger C, 2005, PROTEIN PEPTIDE LETT, V12, P409, DOI 10.2174/0929866054395239; Kim M, 2006, P NATL ACAD SCI USA, V103, P16358, DOI 10.1073/pnas.0603238103; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Kollien AH, 2004, INSECT MOL BIOL, V13, P569, DOI 10.1111/j.0962-1075.2004.00504.x; Kollien AH, 2003, ARCH INSECT BIOCHEM, V53, P134, DOI 10.1002/arch.10090; Kopp E, 1999, GENE DEV, V13, P2059, DOI 10.1101/gad.13.16.2059; LAKE P, 1968, J INSECT PHYSIOL, V14, P543, DOI 10.1016/0022-1910(68)90070-X; LANE NJ, 1979, J CELL SCI, V39, P355; Lang TA, 2007, P NATL ACAD SCI USA, V104, P16209, DOI 10.1073/pnas.0705984104; Ledent V, 2001, GENOME RES, V11, P754, DOI 10.1101/gr.177001; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lesch C, 2007, DEV COMP IMMUNOL, V31, P1255, DOI 10.1016/j.dci.2007.03.012; Lima VLA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038349; Lin GN, 2008, NATURE, V455, P1119, DOI 10.1038/nature07329; Liu MC, 2007, IUBMB LIFE, V59, P622, DOI 10.1080/15216540701589320; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Lopez L, 2003, INSECT BIOCHEM MOLEC, V33, P439, DOI 10.1016/S0965-1748(03)00008-0; Lopez-Ordonez T, 2001, INSECT MOL BIOL, V10, P505, DOI 10.1046/j.0962-1075.2001.00290.x; Lovato DV, 2006, BIOCHIMIE, V88, P673, DOI 10.1016/j.biochi.2005.11.011; Lowenberger CA, 1999, EXP PARASITOL, V91, P59, DOI 10.1006/expr.1999.4350; Lowenberger CA, 1996, EXP PARASITOL, V83, P191, DOI 10.1006/expr.1996.0066; Matsuda Y, 2005, DEVELOPMENT, V132, P2783, DOI 10.1242/dev.01853; McCaffrey LM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001370; Meiser CK, 2010, INSECT MOL BIOL, V19, P409, DOI 10.1111/j.1365-2583.2010.01002.x; Meiser CK, 2010, INSECT BIOCHEM MOLEC, V40, P345, DOI 10.1016/j.ibmb.2010.02.011; Meister S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000542; Mellor AL, 2002, J IMMUNOL, V168, P3771, DOI 10.4049/jimmunol.168.8.3771; Melzig J, 1998, J NEUROSCI, V18, P7160; Mende K, 1999, EUR J BIOCHEM, V266, P583, DOI 10.1046/j.1432-1327.1999.00895.x; Missirlis F, 2006, P NATL ACAD SCI USA, V103, P5893, DOI 10.1073/pnas.0601471103; Miura S, 2002, J BIOL CHEM, V277, P32253, DOI 10.1074/jbc.M204410200; MOOLENAAR WH, 1995, CURR OPIN CELL BIOL, V7, P203, DOI 10.1016/0955-0674(95)80029-8; Motorin Y, 2010, BIOCHEMISTRY-US, V49, P4934, DOI 10.1021/bi100408z; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Murataliev MB, 2008, INSECT BIOCHEM MOLEC, V38, P1008, DOI 10.1016/j.ibmb.2008.08.007; Murataliev MB, 2004, BBA-PROTEINS PROTEOM, V1698, P1, DOI 10.1016/j.bbapap.2003.10.003; Mury FB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006966; MUSIL D, 1991, EMBO J, V10, P2321, DOI 10.1002/j.1460-2075.1991.tb07771.x; Nagler DK, 1999, BIOCHEM BIOPH RES CO, V257, P313, DOI 10.1006/bbrc.1999.0461; Nakagawa Y, 2011, MECH DEVELOP, V128, P258, DOI 10.1016/j.mod.2011.02.003; Nakagoshi H, 2002, DEV BIOL, V249, P44, DOI 10.1006/dbio.2002.0746; Nakagoshi H, 1998, GENE DEV, V12, P2724, DOI 10.1101/gad.12.17.2724; Nelson N, 1999, PHYSIOL REV, V79, P361; Niu LL, 2000, INSECT MOL BIOL, V9, P613, DOI 10.1046/j.1365-2583.2000.00226.x; NOESKEJUNGBLUT C, 1994, J BIOL CHEM, V269, P5050; NOESKEJUNGBLUT C, 1995, J BIOL CHEM, V270, P28629, DOI 10.1074/jbc.270.48.28629; NOMURA A, 1992, INT J DEV BIOL, V36, P391; Noriega FG, 1997, INSECT MOL BIOL, V6, P63, DOI 10.1046/j.1365-2583.1997.00154.x; Noriega FG, 1999, J INSECT PHYSIOL, V45, P613, DOI 10.1016/S0022-1910(99)00052-9; Noriega FG, 1999, INSECT BIOCHEM MOLEC, V29, P243, DOI 10.1016/S0965-1748(98)00132-5; Oliveira MF, 1999, NATURE, V400, P517, DOI 10.1038/22910; Oliveira MF, 2002, FEBS LETT, V512, P139, DOI 10.1016/S0014-5793(02)02243-3; Onel S, 2004, DEVELOPMENT, V131, P2587, DOI 10.1242/dev.01147; Padilha MHP, 2009, INSECT BIOCHEM MOLEC, V39, P782, DOI 10.1016/j.ibmb.2009.09.003; Paes MC, 1999, ARCH INSECT BIOCHEM, V41, P171, DOI 10.1002/(SICI)1520-6327(1999)41:4<171::AID-ARCH1>3.3.CO;2-X; Paes MC, 2001, ARCH INSECT BIOCHEM, V48, P63, DOI 10.1002/arch.1058; Paiva-Silva GO, 2006, P NATL ACAD SCI USA, V103, P8030, DOI 10.1073/pnas.0602224103; Knubel CP, 2010, FASEB J, V24, P2689, DOI 10.1096/fj.09-150920; Parre E, 2010, METHODS MOL BIOL, V639, P333, DOI 10.1007/978-1-60761-702-0_21; Pasteur N, 1996, J HERED, V87, P444, DOI 10.1093/oxfordjournals.jhered.a023035; Patel RT, 2005, J BIOL CHEM, V280, P22624, DOI 10.1074/jbc.M413128200; PEREIRA MEA, 1981, SCIENCE, V211, P597, DOI 10.1126/science.7006082; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Poupardin R, 2010, INSECT MOL BIOL, V19, P185, DOI 10.1111/j.1365-2583.2009.00967.x; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; RATCLIFFE NA, 1983, DEV COMP IMMUNOL, V7, P653, DOI 10.1016/0145-305X(83)90086-1; Ratcliffe NA, 1996, EXP PARASITOL, V83, P83, DOI 10.1006/expr.1996.0052; Rawson RB, 2003, NAT REV MOL CELL BIO, V4, P631, DOI 10.1038/nrm1174; Regel R, 1998, INSECT BIOCHEM MOLEC, V28, P309, DOI 10.1016/S0965-1748(97)00108-2; Rewitz KF, 2006, BIOCHEM SOC T, V34, P1256, DOI 10.1042/BST0341256; RIBEIRO JMC, 1984, INSECT BIOCHEM, V14, P103, DOI 10.1016/0020-1790(84)90089-1; Roy SG, 2007, INSECT BIOCHEM MOLEC, V37, P1317, DOI 10.1016/j.ibmb.2007.08.004; Rubin DC, 2007, CURR OPIN GASTROEN, V23, P111, DOI 10.1097/MOG.0b013e3280145082; Ryu JH, 2010, DEV COMP IMMUNOL, V34, P369, DOI 10.1016/j.dci.2009.11.010; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; SANSOM CE, 1994, BBA-PROTEIN STRUCT M, V1208, P247, DOI 10.1016/0167-4838(94)90110-4; Scaraffia PY, 2003, J INSECT PHYSIOL, V49, P591, DOI 10.1016/S0022-1910(03)00031-3; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; SCHIMMOLLER F, 1995, EMBO J, V14, P1329, DOI 10.1002/j.1460-2075.1995.tb07119.x; Schmidt J, 1998, PARASITOL RES, V84, P527, DOI 10.1007/s004360050443; Schneider DS, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030041; Schofield CJ, 2009, ACTA TROP, V110, P88, DOI 10.1016/j.actatropica.2009.01.010; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shilo BZ, 2005, DEVELOPMENT, V132, P4017, DOI 10.1242/dev.02006; Shirai T, 2003, BIOCHEM BIOPH RES CO, V311, P473, DOI 10.1016/j.bbrc.2003.10.017; Silva CP, 2004, ARTHROPOD STRUCT DEV, V33, P139, DOI 10.1016/j.asd.2003.12.002; Silva CP, 1996, INSECT BIOCHEM MOLEC, V26, P1011, DOI 10.1016/S0965-1748(96)00010-0; Simonet G, 2003, PEPTIDES, V24, P1633, DOI 10.1016/j.peptides.2003.07.014; So WV, 2000, MOL CELL BIOL, V20, P6935, DOI 10.1128/MCB.20.18.6935-6944.2000; Souza AVG, 1997, FREE RADICAL BIO MED, V22, P209, DOI 10.1016/S0891-5849(96)00293-6; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Takac P, 2006, J EXP BIOL, V209, P343, DOI 10.1242/jeb.02003; Takagawa R, 2010, ANN SURG ONCOL, V17, P81, DOI 10.1245/s10434-009-0708-x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tellam RL, 1999, INSECT BIOCHEM MOLEC, V29, P87, DOI 10.1016/S0965-1748(98)00123-4; Terra W.R., 2005, P171; TERRA WR, 1988, BRAZ J MED BIOL RES, V21, P675; Terra WR, 2001, ARCH INSECT BIOCHEM, V47, P47, DOI 10.1002/arch.1036; TERRA WR, 1988, INSECT BIOCHEM, V18, P423, DOI 10.1016/0020-1790(88)90058-3; Thompson DM, 2009, CELL, V138, P215, DOI 10.1016/j.cell.2009.07.001; Thuraisingam T, 2010, J INVEST DERMATOL, V130, P278, DOI 10.1038/jid.2009.209; Tomiya N, 2006, J BIOL CHEM, V281, P19545, DOI 10.1074/jbc.M603312200; Tong JJY, 2007, NAT GENET, V39, P476, DOI 10.1038/ng2004; True JR, 2005, PLOS GENET, V1, P551, DOI 10.1371/journal.pgen.0010063; Tuorto F, 2012, NAT STRUCT MOL BIOL, V19, P900, DOI 10.1038/nsmb.2357; Urbonavicius J, 2001, EMBO J, V20, P4863, DOI 10.1093/emboj/20.17.4863; Ursic-Bedoya RJ, 2008, J INSECT PHYSIOL, V54, P593, DOI 10.1016/j.jinsphys.2007.12.009; Valderrama R, 2006, PLANT CELL ENVIRON, V29, P1449, DOI 10.1111/j.1365-3040.2006.01530.x; VANDELOCHT A, 1995, EMBO J, V14, P5149, DOI 10.1002/j.1460-2075.1995.tb00199.x; Venancio TM, 2009, INSECT MOL BIOL, V18, P33, DOI 10.1111/j.1365-2583.2008.00845.x; Vidal M, 2010, CELL CYCLE, V9, P3851, DOI 10.4161/cc.9.19.13280; Voght SP, 2007, CELL METAB, V5, P195, DOI 10.1016/j.cmet.2007.01.011; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; Wex T, 1999, BIOL CHEM, V380, P1439, DOI 10.1515/BC.1999.185; WIGGLESWORTH V. B., 1936, PARASITOLOGY, V28, P284; Wigglesworth V. B., 1972, PRINCIPLES INSECT PH; Wong JT, 2000, MOL CELL BIOCHEM, V207, P95, DOI 10.1023/A:1007054601256; World Health Organization, 2013, CHAG DIS; Yan YT, 2008, WORLD J GASTROENTERO, V14, P6115, DOI 10.3748/wjg.14.6115; Yarian C, 2002, J BIOL CHEM, V277, P16391, DOI 10.1074/jbc.M200253200; Yasuda S, 2011, TOXICOL APPL PHARM, V251, P104, DOI 10.1016/j.taap.2010.12.006; Yen TH, 2006, STEM CELL REV, V2, P203, DOI 10.1007/s12015-006-0048-1; Zhang D, 2002, INSECT BIOCHEM MOLEC, V32, P579, DOI 10.1016/S0965-1748(01)00138-2; Zhang J, 2004, J BIOL CHEM, V279, P22118, DOI 10.1074/jbc.M400774200; Zhao WB, 2008, CHINESE MED J-PEKING, V121, P1469, DOI 10.1097/00029330-200808010-00024; Zhao YT, 2009, CELL SIGNAL, V21, P367, DOI 10.1016/j.cellsig.2008.10.010; Zhu QS, 2008, P NATL ACAD SCI USA, V105, P6650, DOI 10.1073/pnas.0800739105	235	63	64	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JAN	2014	8	1							e2594	10.1371/journal.pntd.0002594				31	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AJ8SI	WOS:000337977300008	24416461	DOAJ Gold, Green Published			2019-04-02	
J	Roupie, V; Pidot, SJ; Einarsdottir, T; Van den Poel, C; Jurion, F; Stinear, TP; Huygen, K				Roupie, Virginie; Pidot, Sacha J.; Einarsdottir, Tobba; Van den Poel, Christophe; Jurion, Fabienne; Stinear, Timothy P.; Huygen, Kris			Analysis of the Vaccine Potential of Plasmid DNA Encoding Nine Mycolactone Polyketide Synthase Domains in Mycobacterium ulcerans Infected Mice	PLOS NEGLECTED TROPICAL DISEASES			English	Article							MYCOLYL-TRANSFERASE AG85A; BOVIS BCG VACCINATION; BURULI ULCER; PROTECTIVE EFFICACY; ANTIGEN-85 COMPLEX; INTERFERON-GAMMA; TUBERCULOSIS; DISEASE; TOXIN; OSTEOMYELITIS	There is no effective vaccine against Buruli ulcer. In experimental footpad infection of C57BL/6 mice with M. ulcerans, a prime-boost vaccination protocol using plasmid DNA encoding mycolyltransferase Ag85A of M. ulcerans and a homologous protein boost has shown significant, albeit transient protection, comparable to the one induced by M. bovis BCG. The mycolactone toxin is an obvious candidate for a vaccine, but by virtue of its chemical structure, this toxin is not immunogenic in itself. However, antibodies against some of the polyketide synthase domains involved in mycolactone synthesis, were found in Buruli ulcer patients and healthy controls from the same endemic region, suggesting that these domains are indeed immunogenic. Here we have analyzed the vaccine potential of nine polyketide synthase domains using a DNA prime/protein boost strategy. C57BL/6 mice were vaccinated against the following domains: acyl carrier protein 1, 2, and 3, acyltransferase (acetate) 1 and 2, acyltransferase (propionate), enoylreductase, ketoreductase A, and ketosynthase load module. As positive controls, mice were vaccinated with DNA encoding Ag85A or with M. bovis BCG. Strongest antigen specific antibodies could be detected in response to acyltransferase (propionate) and enoylreductase. Antigen-specific Th1 type cytokine responses (IL-2 or IFN-gamma) were induced by vaccination against all antigens, and were strongest against acyltransferase (propionate). Finally, vaccination against acyltransferase (propionate) and enoylreductase conferred some protection against challenge with virulent M. ulcerans 1615. However, protection was weaker than the one conferred by vaccination with Ag85A or M. bovis BCG. Combinations of these polyketide synthase domains with the vaccine targeting Ag85A, of which the latter is involved in the integrity of the cell wall of the pathogen, and/or with live attenuated M. bovis BCG or mycolactone negative M. ulcerans may eventually lead to the development of an efficacious BU vaccine.	[Roupie, Virginie; Einarsdottir, Tobba; Van den Poel, Christophe; Jurion, Fabienne; Huygen, Kris] Sci Inst Publ Hlth WIV ISP Site Ukkel, Serv Immunol, Brussels, Belgium; [Pidot, Sacha J.; Stinear, Timothy P.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	Roupie, V (reprint author), Sci Inst Publ Hlth WIV ISP Site Ukkel, Serv Immunol, Brussels, Belgium.	khuygen@wiv-isp.be	Pidot, Sacha/Y-3421-2018	Pidot, Sacha/0000-0003-1202-6614; Stinear, Timothy/0000-0003-0150-123X; Huygen, Kris/0000-0001-7808-0512	BuruliVac, Identification and development of vaccine candidates for Buruli Ulcer Disease [FP7 241500]	This work was funded by BuruliVac, Identification and development of vaccine candidates for Buruli Ulcer Disease (Grant agreement FP7 241500, www.burulivac.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asiedu K, 2000, BURULI ULCER MYCOBAC; Boulkroun S, 2010, J IMMUNOL, V184, P1436, DOI 10.4049/jimmunol.0902854; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Coutanceau E, 2005, CELL MICROBIOL, V7, P1187, DOI 10.1111/j.1462-5822.2005.00546.x; Einarsdottir T, 2011, HUM VACCINES, V7, P1198, DOI 10.4161/hv.7.11.17751; Feng CG, 2001, INFECT IMMUN, V69, P4174, DOI 10.1128/IAI.69.6.4174-4176.2001; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Fraga AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033406; Fyfe JAM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000791; George KM, 1999, SCIENCE, V283, P854, DOI 10.1126/science.283.5403.854; Hong H, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000325; Huygen K, 1996, NAT MED, V2, P893, DOI 10.1038/nm0896-893; HUYGEN K, 1994, INFECT IMMUN, V62, P363; Johnson P, 2006, LIBR RESOUR TECH SER, V50, P2; Johnson PDR, 2007, EMERG INFECT DIS, V13, P1653, DOI 10.3201/eid1311.061369; Kremer L, 2002, LETT APPL MICROBIOL, V34, P233, DOI 10.1046/j.1472-765x.2002.01091.x; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Marsollier L, 2002, APPL ENVIRON MICROB, V68, P4623, DOI 10.1128/AEM.68.9.4623-4628.2002; Merritt RW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000911; Phillips R, 2009, J INFECT DIS, V200, P1675, DOI 10.1086/646615; Pidot SJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000872; Portaels F, 2004, INFECT IMMUN, V72, P62, DOI 10.1128/IAI.72.1.62-65.2004; Portaels F, 2002, CLIN DIAGN LAB IMMUN, V9, P1389, DOI 10.1128/CDLI.9.6.1389-1391.2002; Porter JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070520; Prevot G, 2004, INFECT IMMUN, V72, P958, DOI 10.1128/IAI.72.2.958-965.2004; Romano M, 2006, VACCINE, V24, P3353, DOI 10.1016/j.vaccine.2005.12.066; SMITH PG, 1976, T ROY SOC TROP MED H, V70, P449, DOI 10.1016/0035-9203(76)90128-0; Stinear T, 2000, APPL ENVIRON MICROB, V66, P3206, DOI 10.1128/AEM.66.8.3206-3213.2000; Stinear T, 2000, J CLIN MICROBIOL, V38, P1482; Stinear TP, 2004, P NATL ACAD SCI USA, V101, P1345, DOI 10.1073/pnas.0305877101; Tafelmeyer P, 2008, PROTEOMICS, V8, P3124, DOI 10.1002/pmic.200701018; Tanghe A, 2001, INFECT IMMUN, V69, P5403, DOI 10.1128/IAI.69.9.5403-5411.2001; Tanghe A, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000199; Tanghe A, 2007, INFECT IMMUN, V75, P2642, DOI 10.1128/IAI.01622-06; Torrado E, 2007, INFECT IMMUN, V75, P3779; Torrado E, 2007, INFECT IMMUN, V75, P977, DOI 10.1128/IAI.00889-06; *UG BUR GROUP, 1969, LANCET, V1, P111; WIKER HG, 1990, INFECT IMMUN, V58, P272; WIKER HG, 1992, MICROBIOL REV, V56, P648	39	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JAN	2014	8	1							e2604	10.1371/journal.pntd.0002604				11	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	AJ8SI	WOS:000337977300012	24392169	DOAJ Gold, Green Published			2019-04-02	
J	Collard, JM; Wang, X; Mahamane, AE; Idi, I; Issaka, B; Ousseni, M; Mayer, LW; Nato, F; Moulia-Pelat, JP				Collard, Jean-Marc; Wang, Xin; Mahamane, Ali Elhaj; Idi, Issa; Issaka, Bassira; Ousseni, Moumouni; Mayer, Leonard W.; Nato, Farida; Moulia-Pelat, Jean-Paul			A five-year field assessment of rapid diagnostic tests for meningococcal meningitis in Niger by using the combination of conventional and real-time PCR assays as a gold standard	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Early detection; Meningitis; Neisseria meningitidis serogroups A and W; Niger; Patient treatment; Rapid diagnostic tests	NEISSERIA-MENINGITIDIS; BACTERIAL-MENINGITIS; SEROGROUP-A; IDENTIFICATION; AGREEMENT; AFRICA; W135	Meningococcocal meningitis represents an important cause of mortality and morbidity in sub-Saharan countries. Confirmatory bacteriological or molecular diagnosis is essential for patient management/treatment and meningitis surveillance, but many laboratory tests are expensive and rarely available for low-income countries. A rapid diagnostic test (RDT) represents a valuable alternative to improve case management and surveillance. A dipstick RDT developed in early 2000s that detects Neisseria meningitidis serogroups A, C, W and Y but for which a new conjugated antibody (L4-8) for the detection of serogroup A replaced the original K15-2 was assessed in the field by trained staff from health centres and district hospitals in Niger. The results were compared to those obtained in the reference laboratory and the sensitivity and specificity of RDTs were determined using conventional and real-time PCR assays as a gold standard. RDT results from field staff and the reference laboratory obtained for 2095 cerebrospinal fluid (CSF) specimens presented a strong concordance of 94 with Cohens coefficient of 0.88. The observed concordance between RDTs operated by staff from the reference laboratory vs combination of conventional and real-time PCR assays was 89 with Cohens coefficient of 0.76 indicating very good agreement. The theoretical overall sensitivity for RDT was 91.5 and the specificity 84.6. RDT has proven to be relatively sensitive and specific for the detection of meningococcal serogroups A/C/Y/W. We confirmed that these RDTs can be reliably operated by trained but non-specialised staff in basic health facilities.	[Collard, Jean-Marc; Mahamane, Ali Elhaj; Idi, Issa; Issaka, Bassira; Ousseni, Moumouni; Moulia-Pelat, Jean-Paul] Ctr Rech Med & Sanit CERMES, Niamey, Niger; [Wang, Xin; Mayer, Leonard W.] Ctr Dis Control & Prevent, Div Bacterial Dis, Atlanta, GA USA; [Nato, Farida] Inst Pasteur, Platform Recombinant Prot & Antibody Prod PT5, Paris, France	Collard, JM (reprint author), Sci Inst Publ Hlth, Brussels, Belgium.	Jean-Marc.Collard@wiv-isp.be		Collard, Jean-Marc/0000-0002-1490-3978	French Ministry of Foreign Affairs [FSP] [2005-174]; Sanofi Pasteur [Men07]; UNICEF (RDT distribution and training)	This work was financially supported by the French Ministry of Foreign Affairs [FSP No. 2005-174] by Sanofi Pasteur [contract Men07] and UNICEF (RDT distribution and training in 2009).	Amouzou A, 2012, LANCET, V380, P1169, DOI 10.1016/S0140-6736(12)61376-2; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P47; Boisier P, 2009, TROP MED INT HEALTH, V14, P111, DOI 10.1111/j.1365-3156.2008.02192.x; Chanteau S, 2006, T ROY SOC TROP MED H, V100, P677, DOI 10.1016/j.trstmh.2005.09.006; Chanteau S, 2006, PLOS MED, V3, P1579, DOI 10.1371/journal.pmed.0030337; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Collard JM, 2010, EMERG INFECT DIS, V16, P1496, DOI 10.3201/eid1609.100510; Daugla D, 2013, LANCET, DOI [10.1016/S0140-6736(13)61612-8, DOI 10.1016/S0140-6736(13)61612-8.[]; Djibo S, 2006, T ROY SOC TROP MED H, V100, P573, DOI 10.1016/j.trstmh.2005.10.002; Fleiss J. L., 1981, STAT METHODS RATES P; Higa FT, 2013, MEM I OSWALDO CRUZ, V108, P246, DOI 10.1590/0074-0276108022013020; Jusot JF, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-228; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Molyneux E, 2011, LANCET, V377, P1837, DOI 10.1016/S0140-6736(11)60580-1; Mothershed EA, 2004, J CLIN MICROBIOL, V42, P320, DOI 10.1128/JCM.42.1.320-328.2004; Nakamichi K, 2011, JPN J INFECT DIS, V64, P211; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Rose AMC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011086; Rose AMC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007326; Taha MK, 2000, J CLIN MICROBIOL, V38, P855; Terrade A, 2013, T ROY SOC TROP MED H, V107, P460, DOI 10.1093/trstmh/trt041; Thomas JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019361; Wang X, 2012, J CLIN MICROBIOL, V50, P702, DOI 10.1128/JCM.06087-11; *WHO, 1998, WHOEMCBAC983; *WHO, 2007, WHOCDSEPR20073; World Health Organization, 2012, WEEKL FEEDB B CER ME; Wu HM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-26; Xie OL, 2013, VACCINE, V31, P2852, DOI 10.1016/j.vaccine.2013.04.036; Yansouni CP, 2013, LANCET INFECT DIS, V13, P546, DOI 10.1016/S1473-3099(13)70004-5	29	7	7	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	JAN	2014	108	1					6	12		10.1093/trstmh/trt104				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	281WR	WOS:000329132200003	24300442				2019-04-02	
J	Doua, JY; Van Geertruyden, JP				Doua, Joachim Y.; Van Geertruyden, Jean-Pierre			Registering medicines for low-income countries: how suitable are the stringent review procedures of the World Health Organisation, the US Food and Drug Administration and the European Medicines Agency?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Review						drug approval; developing countries; stringent evaluation procedure	SUBSTANDARD MEDICINES; ARTEMISININ; SETTINGS	New medicines are registered after a resource-demanding process. Unfortunately, in low-income countries (LICs), demand outweighs resources. To facilitate registration in LICs, stringent review procedures of the European Medicines Agency (EMA Article-58), Food and Drug Administration (FDA PEPFAR-linked review) and WHO Prequalification programme have been established. Only the PEPFAR-linked review gives approval, while the others make recommendations for approval. This study assessed the performance and discussed the challenges of these three stringent review procedures. Data from WHO, FDA, EMA, Medline and Internet were analysed. Over 60% of medicines reviewed by stringent review procedures are manufactured in India. Until 2012, WHO prequalified 400 medicines (211 vaccines, 130 antiretrovirals, 29 tuberculostatics, 15 antimalarials and 15 others). PEPFAR-linked review approved 156 antiretrovirals, while EMA Article 58 recommended approval of 3 antiretrovirals, 1 vaccine and 1 antimalarial. WHO Prequalification and PEPFAR-linked review are free of charge and as a result have accelerated access to antiretrovirals. They both built capacity in sub-Saharan Africa, although WHO prequalification relies technically on stringent regulatory authorities and financially on donors. Article-58 offers the largest disease coverage and strongest technical capacities, is costly and involves fewer LICs. To meet the high demand for quality medicines in LICs, these stringent review procedures need to enlarge their disease coverage. To improve registration, EMA Article 58 should actively involve LICs. Furthermore, LIC regulatory activities must not be fully resigned to stringent review procedure.	[Doua, Joachim Y.; Van Geertruyden, Jean-Pierre] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium	Doua, JY (reprint author), Univ Antwerp, Int Hlth Unit, Univ Pl 1, B-2610 Antwerp, Belgium.	y.j.doua@gmail.com	Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364			Burki T, 2010, LANCET INFECT DIS, V10, P222, DOI 10.1016/S1473-3099(10)70060-8; Caudron JM, 2008, TROP MED INT HEALTH, V13, P1062, DOI 10.1111/j.1365-3156.2008.02106.x; Curtin Francois, 2011, Dialogues Clin Neurosci, V13, P183; Dorlo TPC, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7518; Efferth T, 2010, CRIT REV TOXICOL, V40, P405, DOI 10.3109/10408441003610571; European Medicines Agency (EMA), 2005, EMEACHMP557904; European Medicines Agency (EMA), 2011, EMA5317202011; European Medicines Agency (EMA), 2012, EMA4364402012; European Medicines Agency (EMA), 2012, EMA7109152009; Food and Drug Administration (FDA), 2012, DRUG SAF COMM STAT H; Food and Drug Administration (FDA), 2011, APPR TENT APPR ANT A; GREENWOOD B, 1991, PARASITOL TODAY, V7, P277, DOI 10.1016/0169-4758(91)90096-7; Holmes CB, 2010, JAMA-J AM MED ASSOC, V304, P313, DOI 10.1001/jama.2010.993; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; International Conference of Drug Regulatory Authorities (ICDRA), 2004, 11 INT C DRUG REG AU; Joppi R, 2013, EUR J CLIN PHARMACOL, V69, P1009, DOI 10.1007/s00228-012-1423-2; Lang TA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000619; Moran M, 2010, INT HEALTH, V2, P114, DOI 10.1016/j.inhe.2010.04.002; Moran M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000411; Mwanziva C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-232; President's Emergency Plan for AIDS Relief (PEPFAR), 2011, 8 ANN C, P1; Roehr B, 1998, J Int Assoc Physicians AIDS Care, V4, P19; Roey J. van, 2008, Pharmaceutical Medicine, V22, P207; Sachs JD, 2005, LANCET, V365, P347, DOI 10.1016/S0140-6736(05)17791-5; Sharma M, 2010, J PHARM BIOALLIED SC, V2, P275, DOI [10.4103/0975-7406.68510, 10.4103/0975-7406.72128]; Sigma Tau, 2012, NEW DRUG MAL EUR REC; Villa S, 2009, INT J HEALTH PLAN M, V24, P27, DOI 10.1002/hpm.930; WHO, 2010, CHRON DIS HLTH PROM; WHO, 2012, WHO DRUG INF, V26, P248; WHO, 2013, ACC MED PROD ACC ESS; WHO, 2011, WHO DRUG INF, V25, P231; WHO, 2011, WORLD MED SIT TRAD M, P6; WHO, 2010, ASS MED REG SYST SUB; WHO, 2011, WHO DRUG INF, V25, P101; WHO, 2004, WHOEDMPAR20045; WHO, 2011, WHO PREQ PROGR MED P; WHO, 2012, WHO DRUG INFO, V26, P239; WHO, 2002, REG SUPP SER, V9, P19; WHO, 2011, WHOEMPQSM20111, P37; WHO, 2012, WHO DRUG INFO, V26, P237; WHO, 2011, WHO DRUG INFO, V25, P250; WHO Prequalification of Medicines Programme (WHO-PQP), 2011, PREQ PROGR; WHO Regional Office for Africa, 2012, AFR MED REG HARM AMR	43	8	8	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	JAN	2014	19	1					23	36		10.1111/tmi.12201				14	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	270WD	WOS:000328349000003	24134396	Bronze			2019-04-02	
J	Sobry, A; Kizito, W; Van den Bergh, R; Tayler-Smith, K; Isaakidis, P; Cheti, E; Kosgei, RJ; Vandenbulcke, A; Ndegwa, Z; Reid, T				Sobry, Agnes; Kizito, Walter; Van den Bergh, Rafael; Tayler-Smith, Katie; Isaakidis, Petros; Cheti, Erastus; Kosgei, Rose J.; Vandenbulcke, Alexandra; Ndegwa, Zacharia; Reid, Tony			Caseload, management and treatment outcomes of patients with hypertension and/or diabetes mellitus in a primary health care programme in an informal setting	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						hypertension; diabetes mellitus; primary health care; Kenya; medical management; operational research	SYSTEMATIC ANALYSIS; BURDEN; DISEASES	ObjectiveIn three primary health care clinics run by Medecins Sans Frontieres in the informal settlement of Kibera, Nairobi, Kenya, we describe the caseload, management and treatment outcomes of patients with hypertension (HT) and/or diabetes mellitus (DM) receiving care from January 2010 to June 2012. MethodDescriptive study using prospectively collected routine programme data. ResultsOverall, 1465 patients were registered in three clinics during the study period, of whom 87% were hypertensive only and 13% had DM with or without HT. Patients were predominantly female (71%) and the median age was 48years. On admission, 24% of the patients were obese, with a body mass index (BMI)>30kg/m(2). Overall, 55% of non-diabetic hypertensive patients reached their blood pressure (BP) target at 24months. Only 28% of diabetic patients reached their BP target at 24months. For non-diabetic patients, there was a significant decrease in BP between first consultation and 3months of treatment, maintained over the 18-month period. Only 20% of diabetic patients with or without hypertension achieved glycaemic control. By the end of the study period, 1003 (68%) patients were alive and in care, one (<1%) had died, eight (0.5%) had transferred out and 453 (31%) were lost to follow-up. ConclusionGood management of HT and DM can be achieved in a primary care setting within an informal settlement. This model of intervention appears feasible to address the growing burden of non-communicable diseases in developing countries.	[Sobry, Agnes; Kizito, Walter; Cheti, Erastus; Vandenbulcke, Alexandra] Med Sans Frontieres, Nairobi, Kenya; [Van den Bergh, Rafael; Tayler-Smith, Katie; Isaakidis, Petros; Reid, Tony] Med Sans Frontiere, Dept Med, Luxembourg Operat Res Unit LuxOR, Operat Ctr Brussels, Brussels, Belgium; [Kosgei, Rose J.] Univ Nairobi, Dept Obstet & Gynaecol, Nairobi, Kenya; [Ndegwa, Zacharia] Minist Hlth, Div Noncommunicable Dis, Nairobi, Kenya	Sobry, A (reprint author), Med Sans Frontieres, Suguta Rd,Mugoiri Rd,POB 38897-00623, Nairobi, Kenya.	abuardsobry@gmail.com		Isaakidis, Petros/0000-0002-7881-1554; Van den Bergh, Rafael/0000-0001-6277-8713	Centre for Operational Research, International Union against Tuberculosis and Lung Disease, France; Operational Research Unit, Medecins Sans Frontieres, Brussels-Luxembourg; Institute for Tropical Medicine, Antwerp, Belgium; Center for International Health, University of Bergen	A special thanks to Cecilia Francini, medical doctor, who made valuable comments and to the Kibera project staff for their work. This research was supported through an operational research course, which was jointly developed and run by the Centre for Operational Research, International Union against Tuberculosis and Lung Disease, France, and the Operational Research Unit, Medecins Sans Frontieres, Brussels-Luxembourg. Additional support for running the course was provided by the Institute for Tropical Medicine, Antwerp, Belgium; the Center for International Health, University of Bergen. Medecins Sans Frontieres Operational Centre Brussels gave its agreement and technical support.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; International Diabetes Federation, 2011, IDF DIAB ATL; Isaakidis P, 2011, J HUM HYPERTENS, V25, P241, DOI 10.1038/jhh.2010.49; Khader A, 2012, TROP MED INT HEALTH, P1; Khader A, 2012, TROP MED INT HEALTH, V17, P1163, DOI 10.1111/j.1365-3156.2012.03048.x; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mancia G, 2007, EUR HEART J, V28, P1462, DOI 10.1093/eurheartj/ehm236; Messerli FH, 2007, LANCET, V370, P591, DOI 10.1016/S0140-6736(07)61299-9; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Raguenaud ME, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-33; World Health Organisation (WHO), 2005, PREV CHRON DIS VIT I	13	11	11	2	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	JAN	2014	19	1					47	57		10.1111/tmi.12210				11	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	270WD	WOS:000328349000005	24851259	Bronze, Green Published			2019-04-02	
J	Kishabongo, AS; Katchunga, P; Van Aken, EH; Speeckaert, MM; Lagniau, S; Husein, D; Taes, YE; Delanghe, JR				Kishabongo, Antoine Sadiki; Katchunga, Philippe; Van Aken, Elisabeth H.; Speeckaert, Marijn M.; Lagniau, Sabrina; Husein, Dashty; Taes, Youri E.; Delanghe, Joris R.			Glycated nail proteins: a new approach for detecting diabetes in developing countries	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						fructosamine; glycation; hair; keratin; nails	FRUCTOSAMINE; GLUCOSE; GLYCOSYLATION; HBA(1C); INDEX; HBA1C; HAIR; GAP	ObjectiveTo assess glycation of nail proteins as a tool in the diagnosis of diabetes. MethodsGlycation of nail proteins was assessed using a modified photometric nitroblue tetrazolium-based assay, which provides information about average glucose values of the last 6-9months. Analysis is possible on 10mg of nail clippings with a within-run coefficient of variation (CV) of 11%. The analyte is extremely stable. The reference range for glycated nail protein (0.55-3.60mol/g nail) increases upon ageing. ResultsIn diabetics (n=112), values for glycated nail protein are significantly higher (median: 4.07mol/g nail, IQR: 2.37-6.89mol/g nail, P<0.0001) than in non-diabetics (n=116). ROC analysis shows an AUC of 0.848 (specificity 93.1%; sensitivity 68.9%). ConclusionThis affordable method is a simple alternative for diagnosing diabetes in remote areas as the pre-analytical phase (including all processes from the time a laboratory request is made by a physician until the sample is ready for testing) is extremely robust.	[Kishabongo, Antoine Sadiki] Catholic Univ Bukavu, Dept Lab Med, Bukavu, DEM REP CONGO; [Katchunga, Philippe] Catholic Univ Bukavu, Dept Internal Med, Bukavu, DEM REP CONGO; [Van Aken, Elisabeth H.] Sint Elisabeth Ziekenhuis, Dept Ophthalmol, Zottegem, Belgium; [Speeckaert, Marijn M.] Ghent Univ Hosp, Dept Nephrol, Ghent, Belgium; [Lagniau, Sabrina; Delanghe, Joris R.] Ghent Univ Hosp, Dept Clin Chem, Pintelaan 185, B-9000 Ghent, Belgium; [Husein, Dashty; Taes, Youri E.] Ghent Univ Hosp, Dept Endocrinol, Ghent, Belgium	Delanghe, JR (reprint author), Ghent Univ Hosp, Dept Clin Chem, Pintelaan 185, B-9000 Ghent, Belgium.	joris.delanghe@ugent.be			IFCC scholarship	This work was financially supported by an IFCC scholarship.	BAKAN E, 1985, CLIN CHIM ACTA, V147, P1, DOI 10.1016/0009-8981(85)90003-8; Braatvedt GD, 1997, NEW ZEAL MED J, V110, P459; Cashman MW, 2010, CLIN DERMATOL, V28, P420, DOI 10.1016/j.clindermatol.2010.03.037; CHAN AYW, 1989, CLIN CHEM, V35, P315; Cohen RM, 2003, DIABETES CARE, V26, P163, DOI 10.2337/diacare.26.1.163; Delpierre G, 2004, J BIOL CHEM, V279, P27613, DOI 10.1074/jbc.M402091200; Delplanque J, 2004, J BIOL CHEM, V279, P46606, DOI 10.1074/jbc.M407678200; Dittmar M, 2008, GERONTOLOGY, V54, P100, DOI 10.1159/000128269; Elkeeb R, 2010, INT J PHARMACEUT, V384, P1, DOI 10.1016/j.ijpharm.2009.10.002; Ghasemi A, 2011, CLIN LAB, V57, P343; GOLDSMITH LA, 1983, BIOCH PHYSL SKIN, V1; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; Herman WH, 2012, J CLIN ENDOCR METAB, V97, P1067, DOI 10.1210/jc.2011-1894; Islam N., 1993, JPMA (Journal of the Pakistan Medical Association), V43, P238; Janssen K, 2010, ACTA CLIN BELG, V65, P311, DOI 10.1179/acb.2010.068; JOHNSON RN, 1983, CLIN CHIM ACTA, V127, P87, DOI 10.1016/0009-8981(83)90078-5; *KDOQI, 2007, AM J KIDNEY DIS S, V49, pS12; Kobayashi K, 1996, BIOL PHARM BULL, V19, P487; Lindsey Cameron C, 2004, Diabetes Technol Ther, V6, P370, DOI 10.1089/152091504774198070; MAROVA I, 1995, ACTA DIABETOL, V32, P38, DOI 10.1007/BF00581043; MASUTA S, 1989, Kobe Journal of Medical Sciences, V35, P1; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; MOSCA A, 1987, CLIN CHEM, V33, P1141; Narbonne H, 2001, DIABETES METAB, V27, P598; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nayak AU, 2011, DIABETES CARE, V34, P1712, DOI 10.2337/dc10-1767; Schnedl WJ, 2000, DIABETES CARE, V23, P339, DOI 10.2337/diacare.23.3.339; SEVEN A, 1993, MED SCI RES, V21, P161; Tantisiriwat Natthiya, 2008, Journal of the Medical Association of Thailand, V91, P1097; van der Sande MAB, 1999, TROP MED INT HEALTH, V4, P506; WALTERS KA, 1983, INT J COSMETIC SCI, V5, P231, DOI 10.1111/j.1467-2494.1983.tb00348.x; Yaemsiri S, 2010, J EUR ACAD DERMATOL, V24, P420, DOI 10.1111/j.1468-3083.2009.03426.x; Yajima T, 2005, BUNSEKI KAGAKU, V54, P743, DOI 10.2116/bunsekikagaku.54.743; Zemlin AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022558; 1991, OPHTHALMOLOGY, V98, P786, DOI 10.1016/S0161-6420(13)38012-9	35	12	12	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	JAN	2014	19	1					58	64		10.1111/tmi.12218				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	270WD	WOS:000328349000006	24175985	Bronze			2019-04-02	
J	Delamou, A; Koivogui, A; Dubourg, D; Delvaux, T				Delamou, Alexandre; Koivogui, Akoi; Dubourg, Dominique; Delvaux, Therese			Family planning in Guinea: a need for better public commitment	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						family planning; programme; review; Guinea	MILLENNIUM DEVELOPMENT GOALS; PROGRAMS; POLICIES; COUNTRIES	ObjectiveTo describe the evolution of family planning (FP) in Guinea and to identify strengths, weaknesses, opportunities and threats of the current FP programme. MethodsDescriptive study of the evolution of FP in Guinea between 1992 and 2010. First, national laws as well as health policies and strategic plans related to reproductive health and family planning were reviewed. Second, FP indicators were extracted from the Guinean Demographic and Health Surveys (1992, 1999 and 2005). Third, FP services, sources of supply and data on FP funding were analysed. ResultsLaws, policies and strategic plans in Guinea are supportive of FP programme and services. Public and private actors are not sufficiently coordinated. The general government expenditure on health has remained stable at 6-7% between 2005 and 2011 despite a doubling of total expenditures on health, and contraceptives are supplied by foreign aid. Modern contraceptive prevalence slightly increased from 1.5% in 1992 to 6.8% in 2005 among women aged 15-49. ConclusionA stronger national engagement in favour of repositioning FP should result in improved government funding of the FP programme and the promotion of long-acting and permanent methods.	[Delamou, Alexandre] Ctr Natl Format & Rech Sante Rurale Maferinyah, Conakry, Guinea; [Dubourg, Dominique] Inst Trop Med, Maternal & Reprod Hlth Unit, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Delvaux, Therese] Inst Trop Med, HIV AIDS Policy Unit, Dept Publ Hlth, B-2000 Antwerp, Belgium	Delamou, A (reprint author), Ctr Natl Format & Rech Sante Rurale Maferinyah, POB 4099, Conakry, Guinea.	alexdelamou@yahoo.fr		KOIVOGUI, AKOI/0000-0001-9097-3006			Alkema L, 2013, LANCET, V381, P1642, DOI 10.1016/S0140-6736(12)62204-1; Bongaarts J, 2009, INT PERSPECT SEX R H, V35, P39, DOI 10.1363/ifpp.35.039.09; Burke AE, 2005, CONTRACEPTION, V72, P247, DOI 10.1016/j.contraception.2005.07.002; Cates W, 2010, CONTRACEPTION, V81, P460, DOI 10.1016/j.contraception.2010.01.002; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Cleland J, 2013, LANCET, V381, P1604, DOI 10.1016/S0140-6736(13)60588-7; Cleland JG, 2011, B WORLD HEALTH ORGAN, V89, P137, DOI 10.2471/BLT.10.077925; Cohen A, 2012, GUTTMACHER POLICY RE, V15, P20; Commission Europeenne, 2013, AN SWOT; Direction Nationale de la Statistique (DNS) (Guinee) et ORC Macro, 2006, ENQ DEM SANT GUIN 20; Gold RB, 2011, CONTRACEPTION, V84, P437, DOI 10.1016/j.contraception.2011.07.010; Goldie SJ, 2010, PLOS MED, V7; Gribble JN, 2007, INT FAM PLAN PERSPEC, V33, P176, DOI 10.1363/ifpp.33.176.07; Guengant J, 2008, MARCHE PLANNING FAMI; Guengant J, 2011, GUINEE COMMENT BENEF; Habumuremyi PD, 2012, LANCET, V380, P78, DOI 10.1016/S0140-6736(12)60904-0; Health Policy and Planning Project, 2011, GUIN ATT OMD CONTR P; Lee K, 1998, SOC SCI MED, V47, P949, DOI 10.1016/S0277-9536(98)00168-3; Lee RB, 2009, REPROD HEALTH MATTER, V17, P99, DOI 10.1016/S0968-8080(09)34472-9; Ministere de la sante et de l'hygiene publique de Guinee, 2008, FEUILL ROUT NAT ACC; Ministere de la sante et de l'hygiene publique de Guinee, 2009, PLAN NAT SEC PROD SA; Ministere de la sante et de l'hygiene publique de Guinee, 2009, PLAN STRAT NAT REP P; MSP Guinee UNFPA, 2007, AN SIT SEC PROD SANT; Olmen J, 2010, STUDIES HLTH SERVICE, V27, P21; Potts M, 2013, CONTRACEPTION, V87, P393, DOI 10.1016/j.contraception.2013.01.001; Prabhat JHA, 1998, HLTH POLICY PLANNING, V13, P249; RAFTERY AE, 1995, DEMOGRAPHY, V32, P159, DOI 10.2307/2061738; RamaRao S, 2003, STUD FAMILY PLANN, V34, P227, DOI 10.1111/j.1728-4465.2003.00227.x; Robinson W, 2007, GLOBAL FAMILY REVOLU; Sharma Suneeta, 2005, Health Policy, V71, P347, DOI 10.1016/j.healthpol.2004.09.010; Simbar M., 2012, Eastern Mediterranean Health Journal, V18, P279; Sine J, 2002, POLICY ISSUES PLANNI; Stover J, 2010, MATERN CHILD HLTH J, V14, P687, DOI 10.1007/s10995-009-0505-y; USAID Bill & Melinda Gates Foundation, 2013, LOND SUMM FAM PLANN; WHO, 2013, COMPT NAT SANT GUIN	35	4	4	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	JAN	2014	19	1					65	73		10.1111/tmi.12219				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	270WD	WOS:000328349000007	24175994	Bronze			2019-04-02	
J	Zachariah, R; Reid, T; van den Bergh, R; Kumar, AMV; Tayler-Smith, K; Khogali, M; Hinderaker, SG; Upshur, R; Harries, AD				Zachariah, R.; Reid, T.; van den Bergh, R.; Kumar, A. M. V.; Tayler-Smith, K.; Khogali, M.; Hinderaker, S. G.; Upshur, R.; Harries, A. D.			RE: Applying the ICMJE authorship criteria to operational research in low-income countries: the need to engage programme managers and policy makers by Zachariah et al. (2013) TMIH 18, pp. 1025-1028	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Letter									[Zachariah, R.; Reid, T.; van den Bergh, R.; Tayler-Smith, K.] MSF Luxembourg, Dept Med, Operat Res Unit, Operat Ctr Brussels, Luxembourg, Luxembourg; [van den Bergh, R.] Flemish Inst Biotechnol, Dept Mol & Cellular Interact, Brussels, Belgium; [van den Bergh, R.] Inst Trop Med, Dept Microbiol, B-2000 Antwerp, Belgium; [Kumar, A. M. V.] Int Union TB & Lung Dis, South East Asia Off, New Delhi, India; [Khogali, M.] Med Sans Frontieres, Addis Ababa, Ethiopia; [Hinderaker, S. G.] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Upshur, R.] Univ Toronto, Joint Ctr Bioeth, Toronto, ON, Canada; [Hinderaker, S. G.; Harries, A. D.] Int Union TB & Lung Dis, Paris, France; [Harries, A. D.] London Sch Hyg & Trop Med, London WC1, England	Zachariah, R (reprint author), MSF Luxembourg, Dept Med, Operat Res Unit, Operat Ctr Brussels, Luxembourg, Luxembourg.	zachariah@internet.lu		Van den Bergh, Rafael/0000-0001-6277-8713			Cairncross S, 2013, TROP MED INT HEALTH, V18, P1162, DOI 10.1111/tmi.12174; Groener S, 2004, TROP MED INT HEALTH, V9, P935, DOI 10.1111/j.1365-3156.2004.01314.x; Zachariah R, 2013, TROP MED INT HEALTH, V18, P1025, DOI 10.1111/tmi.12133	3	1	1	0	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	JAN	2014	19	1					129	130		10.1111/tmi.12242				2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	270WD	WOS:000328349000015	24851261	Bronze			2019-04-02	
J	Masumbuku, LJ; Coppieters, Y				Masumbuku, Lofandjola J.; Coppieters, Y.			Qualitative analysis of palliative care and support in medical practices in DRC	MEDECINE ET SANTE TROPICALES			Indonesian	Article						representation; health professionals; palliative care		This work aims at documenting the representations that health professionals in Kinshasa have of palliative care and end-of-life support. This qualitative study was conducted among 30 doctors and 90 nurses with at least one year of experience in six hospitals in Kinshasa that receive patients at the end of life. The results show that health professionals believe that this care is time-consuming and that the inability to say some things to patients and families generates misunderstandings and concerns likely to prevent the application of palliative care. For them, it is often a futile therapeutic obstinacy, added hygienic care, and neglect of the patient. The obstacles to implementing this care might be linked to the lack of training about this approach and a health system based essentially on curative approaches. The representation of health professionals about palliative care and support are many and varied. They are, however, more structured among physicians than nurses.	[Masumbuku, Lofandjola J.; Coppieters, Y.] ULB, Ctr Rech Polit & Syst Sante Sante Int, Ecole Sante Publ, Route Lennik 808,CP 596, B-1070 Brussels, Belgium	Coppieters, Y (reprint author), ULB, Ctr Rech Polit & Syst Sante Sante Int, Ecole Sante Publ, Route Lennik 808,CP 596, B-1070 Brussels, Belgium.	yves.coppieters@ulb.ac.be					Abu Zeinah GF, 2012, AM J HOSP PALLIAT CA; Aikins ADG, 2003, J HEALTH PSYCHOL, V8, P557, DOI 10.1177/13591053030085007; Amgad M, 2012, CRIT REV ONCOL HEMAT, V84, P122, DOI 10.1016/j.critrevonc.2012.01.003; [Anonymous], 2010, PLAN NAT DEV SAN 201; Ayivi B, 1990, Dev Sante, P25; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; de Araujo MMT, 2012, REV ESC ENFERM USP, V46, P623; Downing J, 2012, BMC PALLIAT CARE, V11, DOI 10.1186/1472-684X-11-1; Ford DW, 2012, J PALLIAT MED, V15, P63, DOI 10.1089/jpm.2011.0168; Galushko M, 2012, CURR OPIN SUPPORT PA, V6, P355, DOI 10.1097/SPC.0b013e328356ab72; Gardiner C, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X641474; Goelz T, 2011, J CLIN ONCOL, V29, P3402, DOI 10.1200/JCO.2010.31.6372; Goelz T, 2010, ONKOLOGIE, V33, P65, DOI 10.1159/000264626; Gysels M, 2011, BMC PALLIAT CARE, V10, DOI 10.1186/1472-684X-10-6; Harding R, 2012, AIDS CARE, V24, P963, DOI 10.1080/09540121.2012.668175; Henoch I, 2012, J CLIN NURS, V21, P585, DOI 10.1111/j.1365-2702.2011.03923.x; Hongoro C, 2011, J PAIN SYMPTOM MANAG, V41, P1015, DOI 10.1016/j.jpainsymman.2010.08.014; Kaschula ROC, 2013, ARCH PATHOL LAB MED, V137, P752, DOI 10.5858/arpa.2011-0587-ED; Kayser-Jones J, 2005, GERIATR NURS, V26, P16, DOI 10.1016/j.gerinurse.2004.11.001; Kearney JA, 2011, PALLIAT SUPPORT CARE, V9, P367, DOI 10.1017/S1478951511000381; Kikule E, 2003, BRIT MED J, V327, P192, DOI 10.1136/bmj.327.7408.192; Lawson M, 2011, CLIN J ONCOL NURS, V15, P589, DOI 10.1188/11.CJON.589-590; Mutto EM, 2012, J PALLIAT MED, V15, P93, DOI 10.1089/jpm.2011.0238; McCarthy M, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-13; Moore Crystal Dea, 2005, Semin Oncol Nurs, V21, P11; Morgan DL, 1996, ANNU REV SOCIOL, V22, P129, DOI 10.1146/annurev.soc.22.1.129; Muller-Busch HC, 2011, INTERNIST, V52, P7, DOI 10.1007/s00108-010-2688-0; Mulder SF, 2009, PALLIATIVE MED, V23, P360, DOI 10.1177/0269216308100250; Murray S. A., 2012, Eastern Mediterranean Health Journal, V18, P178; Patel B, 2012, J PALLIAT MED, V15, P432, DOI 10.1089/jpm.2011.0336; Roeland Eric, 2010, J Support Oncol, V8, P179; Slort W, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X567081; Young T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005417.pub2; Zongo M, 2009, SANTE PUBLIQUE, V21, P631, DOI 10.3917/spub.096.0631	34	0	0	0	1	JOHN LIBBEY EUROTEXT LTD	MONTROUGE	127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE	2261-3684	2261-2211		MED SANTE TROP	Med. Sante Trop.	JAN-MAR	2014	24	1					83	88		10.1684/mst.2014.0311				6	Tropical Medicine	Tropical Medicine	VD5XV	WOS:000437174600022	24686531				2019-04-02	
J	Kibadi, K; Tiendrebeogo, A; Kinvi, BE; De Jong, B; Boelaert, M; Portaels, F				Kibadi, K.; Tiendrebeogo, A.; Kinvi, Ekoue B.; De Jong, B.; Boelaert, M.; Portaels, F.			Buruli ulcer in the health districts of the Democratic Republic of Congo from 1950 to 2013: literature review and new distribution map	MEDECINE ET SANTE TROPICALES			French	Article						Buruli ulcer; map; health zone; polymerase chain reaction (PCR); The Democratic Republic of the Congo		This paper describes the current distribution of cases of Buruli ulcer (BU) by highlighting health districts that are endemic and suspected to be endemic, based on the studies, surveys, and activity reports published from 1950 to 2013. We define as endemic any health district with BU patients positive by PCR, whether or not positive on a Ziehl- Neelsen (ZN) test, culture or histologic sample. A district is defined as suspected to be endemic when it is a historical BU area, has BU clinical cases and/or patients with positive ZN, but negative PCR. Of the 515 health districts in the DRC, 17 were found to be endemic (3%) and 26 suspected to be endemic (5%). In most cases, former focal areas, described before 1974, remain currently active. New focal points were found along the Kwango River in the province of Bandundu. We also discovered the extension of former BU focal areas to neighboring health districts in the provinces of Bas-Congo, Bandundu, and Maniema. The need for diagnostic confirmation by PCR appears to be a requirement and a priority, not only in all former historical focal areas but also in the health districts newly suspected to be endemic.	[Kibadi, K.] Univ Kinshasa, Unite Chirurg Plast Reconstruct & Esthe Chirurg M, Clin Univ Kinshasa, BP 834, Kinshasa XI, DEM REP CONGO; [Tiendrebeogo, A.; Kinvi, Ekoue B.] WHO, Malad Trop Negligees, Bur Reg Afrique, Brazzaville, Rep Congo; [De Jong, B.; Portaels, F.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Boelaert, M.] Inst Trop Med, Dept Sante Publ, Antwerp, Belgium	Kibadi, K (reprint author), Univ Kinshasa, Unite Chirurg Plast Reconstruct & Esthe Chirurg M, Clin Univ Kinshasa, BP 834, Kinshasa XI, DEM REP CONGO.	akibadi@yahoo.fr		Boelaert, Marleen/0000-0001-8051-6776; de Jong, Bouke/0000-0002-1017-4675	World Health Organization [001]		ANDERSEN F O, 1965, Cent Afr J Med, V11, P131; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P145; Bafende AE, 2004, TROP DOCT, V34, P101; Eddyani M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089407; Geurden L, 1962, ANN SOC BELG MED TR, V4, P591; HENNEBERT P. N., 1962, ANN SOC BEIGE MED TROP, V42, P549; Houssiau F, 1935, ANN SOC BELG MED TR, V15, P85; JANSSENS P G, 1959, Trop Geogr Med, V11, P293; JANSSENS P G, 1963, Ann Soc Belg Med Trop (1920), V43, P729; JANSSENS PG, 2005, B SEANCES ACAD R SCI, V51, P165; Janssens PG, 1950, ANN SOC BELG MED TR, V30, P621; Kibadi K, 2007, B DE LALLF, V21, P53; Kibadi K, 2009, B DE LALLF, V24, P72; Kibadi K, 2002, THESIS; Kibadi K, 2006, B DE LALLF, V19, P28; Kibadi K., 2013, REUNION ANN LOMS LUL; Kibadi K, 2002, CONGO MED, V8, P730; Kibadi K, 2002, MED AFR NOIRE, V49, P239; KIBADI K, 2006, B ALLF, V18, P24; Kibadi K., 2010, THESIS; Kibadi K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000736; Kibadi Kapay, 2003, Sante, V13, P39; Kibadi K, 2009, TROP MED INT HEALTH, V14, P1110, DOI 10.1111/j.1365-3156.2009.02324.x; Kiiza AM, 2012, TROP DOCT, V42, P48, DOI 10.1258/td.2011.110230; Kilbadi K, 2008, EMERG INFECT DIS, V14, P1790, DOI 10.3201/eid1411.071649; Kizonzolo M, 2010, RAPPORT LENQUE LULC; Mabiala P, 2012, LESIONS SUSPECTES DU; MELENEY F L, 1950, Ann Soc Belg Med Trop (1920), V30, P1499; Meyers W M, 1974, Ann Soc Belg Med Trop, V54, P147; Meyers WM, 1975, ANN SOC BELG MED TR, V55, P125; Monekosso GL, 1989, ACCELERER DEV SANITA; Organisation mondiale de la sante, 2013, AID MEM, V199; Pattyn SR., 1961, ANN SOC BELG MED TR, V31, P145; Perquis P, 1968, MED TROP, V26, P642; Phanzu DM, 2006, AM J TROP MED HYG, V75, P311, DOI 10.4269/ajtmh.2006.75.311; Phanzu DM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001402; Portaels F., 2003, Bulletin des Seances, Academie Royale des Sciences d'Outre- Mer, V49, P161; Portaels F, 2014, WHOHTMNTDIDM20141; Portaels F, 2001, WHOCDSCPEGBUI4; Portaels F, 2009, CLIN DERMATOL, V27, P291, DOI 10.1016/j.clindermatol.2008.09.021; SMITH JH, 1970, AM J TROP MED HYG, V19, P657, DOI 10.4269/ajtmh.1970.19.657; Suykerbuyk P, 2009, AM J TROP MED HYG, V81, P888, DOI 10.4269/ajtmh.2009.09-0049; van OYE E, 1950, Ann Soc Belg Med Trop (1920), V30, P619	43	2	2	0	0	JOHN LIBBEY EUROTEXT LTD	MONTROUGE	127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE	2261-3684	2261-2211		MED SANTE TROP	Med. Sante Trop.		2014	24	4					420	429		10.1684/mst.2014.0385				10	Tropical Medicine	Tropical Medicine	VD6OM	WOS:000437408300021	25547784				2019-04-02	
J	Tine, RCK; Ndiaye, P; Ndour, CT; Faye, B; Ndiaye, JL; Sylla, K; Ndiaye, M; Cisse, B; Sow, D; Magnussen, P; Bygbjerg, IC; Gaye, O				Tine, Roger C. K.; Ndiaye, Pascal; Ndour, Cheikh T.; Faye, Babacar; Ndiaye, Jean L.; Sylla, Khadime; Ndiaye, Magatte; Cisse, Badara; Sow, Doudou; Magnussen, Pascal; Bygbjerg, Ib C.; Gaye, Oumar			Acceptability by community health workers in Senegal of combining community case management of malaria and seasonal malaria chemoprevention	MALARIA JOURNAL			English	Article						Malaria; Chemoprevention; Acceptability; Children; Senegal	INTERMITTENT PREVENTIVE TREATMENT; RAPID DIAGNOSTIC-TESTS; HOME-BASED MANAGEMENT; RURAL AREA; CHILDREN; EXPERIENCE; POOR; CARE	Background: Community case management of malaria (CCMm) and seasonal malaria chemoprevention (SMC) are anti-malarial interventions that can lead to substantial reduction in malaria burden acting in synergy. However, little is known about the social acceptability of these interventions. A study was undertaken to assess whether combining the interventions would be an acceptable approach to malaria control for community health workers (CHWs). Methods: Sixty-one interviews and six focus group discussions were conducted nested in a cluster-randomized trial assessing the impact of combining CCMm and SMC in a rural area of Senegal. Participants consisted of: (i) members of village associations, (ii) members of families who had access to the interventions as well as members of families who did not access the interventions, (iii) CHWs, and (iv) community leaders, e g, religious guides and village chiefs. Results: The interventions were acceptable to the local population and perceived as good strategy to make health care services available to community members and thus, to reduce the delays in access to anti-malarial treatment as well as expenses related to patients' transfer to the health post. The use of malaria rapid diagnostic test (RDT) contributed to improving CHWs diagnostic capacity as well as malaria treatment practices. Study participants notified RDT and drugs stock-out as the major risk for sustainability of the intervention at community level. Conclusion: Combining CCMm and SMC is a well accepted, community-based approach that can contribute to control malaria in areas where malaria transmission is seasonal.	[Tine, Roger C. K.; Faye, Babacar; Ndiaye, Jean L.; Sylla, Khadime; Ndiaye, Magatte; Cisse, Badara; Sow, Doudou; Gaye, Oumar] Fac Med & Pharm, Serv Parasitol, Dakar, Senegal; [Ndiaye, Pascal] Agence Europeenne Dev & Sante, Brussels, Belgium; [Ndour, Cheikh T.] Ctr Hosp Univ Fann, Clin Malad Infect, Dakar, Senegal; [Magnussen, Pascal; Bygbjerg, Ib C.] Univ Copenhagen, Fac Hlth Sci, Dept Int Hlth Immunol & Microbiol, DK-1014 Copenhagen, Denmark	Tine, RCK (reprint author), Fac Med & Pharm, Serv Parasitol, Dakar, Senegal.	roger.tine@ucad.edu.sn	Mashamba-Thompson, Tivani/B-6087-2014	Ndiaye, Jean/0000-0003-0450-5551; Magnussen, Pascal/0000-0001-7372-0250; Tine, Roger C/0000-0003-3024-1270; Bygbjerg, Ib/0000-0001-9100-2754	Malaria Capacity Development Consortium (MCDC); Wellcome Trust [WT084289MA]; Bill & Melinda Gates Foundation [51941]	We are grateful to the heads of villages, families and the staff of Bonconto health post for their diligent help during this study. This work was supported by the Malaria Capacity Development Consortium (MCDC) which is funded by the Wellcome Trust (Grant number WT084289MA) and the Bill & Melinda Gates Foundation (Grant number: 51941).	Akweongo P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-240; Audibert M, 2003, TROP MED INT HEALTH, V8, P471, DOI 10.1046/j.1365-3156.2003.01051.x; Brasseur P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-203; Chibwana AI, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-219; De Plaen R, 2003, TROP MED INT HEALTH, V8, P459, DOI 10.1046/j.1365-3156.2003.01050.x; Delacollette C, 1996, B WORLD HEALTH ORGAN, V74, P423; Farquhar SA, 2008, EDUC HEALTH, V21, P39; Faye S L, 2012, Bull Soc Pathol Exot, V105, P237, DOI 10.1007/s13149-012-0225-1; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; Guyatt HL, 2002, TROP MED INT HEALTH, V7, P846, DOI 10.1046/j.1365-3156.2002.00929.x; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Herman AA, 2011, J AMBUL CARE MANAG, V34, P354, DOI 10.1097/JAC.0b013e31822cbcd0; Hermann K, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-31; Lehmann U, 2007, COMM HLTH WORK WHAT; Lehmann U, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-49; Lewin SA, 2005, COCHRANE DB SYST REV, V3; Meessen B, 2003, TROP MED INT HEALTH, V8, P581, DOI 10.1046/j.1365-3156.2003.01081.x; Mukanga D, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-121; Okello G, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-185; Pagnoni F, 2009, TRENDS PARASITOL, V25, P115, DOI 10.1016/j.pt.2008.12.003; Rosenthal EL, 2011, J AMBUL CARE MANAG, V34, P247, DOI 10.1097/JAC.0b013e31821c64d7; Sesay S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-2; Tagbor H, 2011, TROP MED INT HEALTH, V16, P280, DOI 10.1111/j.1365-3156.2010.02699.x; Thiam S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-334; Tine RCK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-358; Walley J, 2008, LANCET, V372, P1001, DOI 10.1016/S0140-6736(08)61409-9; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2008, GLOB MAL CONTR EL TE; WHO, 2005, ROLL BACK MAL STRAT, P1101; World Health Organisation, 2012, SEAS MAL CHEM SMC PL	30	7	7	0	12	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	DEC 30	2013	12								467	10.1186/1475-2875-12-467				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	285IT	WOS:000329388100002	24378018	DOAJ Gold, Green Published			2019-04-02	
J	Tahita, MC; Tinto, H; Menten, J; Ouedraogo, JB; Guiguemde, RT; van Geertruyden, JP; Erhart, A; D'Alessandro, U				Tahita, Marc C.; Tinto, Halidou; Menten, Joris; Ouedraogo, Jean-Bosco; Guiguemde, Robert T.; van Geertruyden, Jean Pierre; Erhart, Annette; D'Alessandro, Umberto			Clinical signs and symptoms cannot reliably predict Plasmodium falciparum malaria infection in pregnant women living in an area of high seasonal transmission	MALARIA JOURNAL			English	Article						Malaria; Pregnancy; Signs and symptoms	INFANT-MORTALITY; ANEMIA	Background: Malaria in pregnancy is a major public health problem in endemic countries. Though the signs and symptoms of malaria among pregnant women have been already described, clinical presentation may vary according to intensity of transmission and local perceptions. Therefore, determining common signs and symptoms among pregnant women with a malaria infection may be extremely useful to identify those in need of further investigation by rapid diagnostic test or microscopy. Methods: Six hundred pregnant women attending the maternity clinic of Nanoro District Hospital, Burkina Faso were recruited, 200 with suspected clinical malaria and 400 as controls. Cases were matched with controls by gestational age and parity. Signs and symptoms were collected and a blood sample taken for rapid diagnostic test, microscopy and haemoglobin measurement. A multivariate model was used to assess the predictive value of signs and symptoms for malaria infection. Results: The overall prevalence of malaria was 42.6% (256/600) while anaemia was found in 60.8% (365/600) of the women. Nearly half (49%) of the cases and 39.5% of the controls had a malaria infection (p = 0.03). The most common signs and symptoms among the cases were fever (36%, 72/200), history of fever (29%, 58/200) and headache (52%, 104/200). The positive predictive value for fever was 53% (95% CI: 41-64), history of fever 58% (95% CI: 37-63) and headache 51% (95% CI: 41-61). Conclusion: Signs and symptoms suggestive of malaria are frequent among pregnant women living in areas of intense transmission. Common malaria symptoms are not strong predictors of infection. For a better management of malaria in pregnancy, active screening to detect and treat malaria infection early should be performed on all pregnant women attending a health facility.	[Tahita, Marc C.; Tinto, Halidou; Ouedraogo, Jean-Bosco] Inst Rech Sci Sante, Direct Reg Ouest, Bobo Dioulasso, Burkina Faso; [Tahita, Marc C.; Tinto, Halidou; Ouedraogo, Jean-Bosco; Guiguemde, Robert T.] Ctr Muraz, Lab Parasitol & Entomol, Bobo Dioulasso, Burkina Faso; [Menten, Joris; Erhart, Annette; D'Alessandro, Umberto] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [van Geertruyden, Jean Pierre] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium; [D'Alessandro, Umberto] MRC Unit, Fajara, Gambia	D'Alessandro, U (reprint author), Inst Trop Med, Dept Publ Hlth, Natl Str 155, B-2000 Antwerp, Belgium.	udalessandro@mrc.gm	Van geertruyden, Jean-Pierre/K-6425-2014; D'Alessandro, Umberto/D-3457-2015	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; D'Alessandro, Umberto/0000-0001-6341-5009; Tinto, Halidou/0000-0002-0472-3586			Bardaji A, 2011, J INFECT DIS, V203, P691, DOI 10.1093/infdis/jiq049; Bardaji A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-27; Huynh BT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-72; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; Chima AO, 2012, MALARIA J, V11, P82; Dellicour S, 2010, PLOS MED, V7, P1; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Diagne N, 2000, NEW ENGL J MED, V343, P598, DOI 10.1056/NEJM200008313430901; Dicko A, 2003, ACTA TROP, V89, P17, DOI 10.1016/j.actatropica.2003.07.001; GREENWOOD BM, 1991, T ROY SOC TROP MED H, V85, P186, DOI 10.1016/0035-9203(91)90015-Q; Koen P, 2010, PLOS ONE, V5, P8; Kyabayinze DJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-306; Luxemburger C, 2001, AM J EPIDEMIOL, V154, P459, DOI 10.1093/aje/154.5.459; McGready R, 2012, PLOS ONE, V7, P7; Ministere de la Sante (Burkina Faso), 1994, STAT SAN; Nosten F, 2004, TRENDS PARASITOL, V20, P425, DOI 10.1016/j.pt.2004.06.007; Rodriguez-Morales AJ, 2006, AM J TROP MED HYG, V74, P755, DOI 10.4269/ajtmh.2006.74.755; Rogerson SJ, 2000, AM J TROP MED HYG, V62, P335, DOI 10.4269/ajtmh.2000.62.335; Singh N, 2001, ANN TROP MED PARASIT, V95, P15; Tagbor H, 2008, TROP MED INT HEALTH, V13, P1016, DOI 10.1111/j.1365-3156.2008.02111.x; WHO, 2012, MALARIA J, V11, P424, DOI DOI 10.1186/1475-2875-11-424; WHO/AFRO, 2004, AFRMAL0401 WHOAFRO	22	6	6	1	11	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	DEC 27	2013	12								464	10.1186/1475-2875-12-464				7	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	285IS	WOS:000329388000001	24373481	DOAJ Gold, Green Published			2019-04-02	
J	Mvumbi, DM; Boreux, R; Sacheli, R; Lelo, M; Lengu, B; Nani-Tuma, S; Melin, P; Ntumba, K; Lunganza, K; DeMol, P; Hayette, MP				Mvumbi, Dieudonne Makaba; Boreux, Raphael; Sacheli, Rosalie; Lelo, Mvumbi; Lengu, Bobanga; Nani-Tuma, Situakibanza; Melin, Pierrette; Ntumba, Kayembe; Lunganza, Kalala; DeMol, Patrick; Hayette, Marie-Pierre			Assessment of pfcrt 72-76 haplotypes eight years after chloroquine withdrawal in Kinshasa, Democratic Republic of Congo	MALARIA JOURNAL			English	Article						Malaria; pfcrt; Drug resistance; RT-PCR; Sequencing; DR Congo	PLASMODIUM-FALCIPARUM MALARIA; RESISTANCE TRANSPORTER GENE; REAL-TIME PCR; AMODIAQUINE RESISTANCE; COMBINATION THERAPY; ANTIMALARIAL-DRUG; MUTATIONS; ASSOCIATION; AFRICA; SUSCEPTIBILITY	Background: In 2001, the World Health Organization (WHO) has recommended the use of artemisinin-based combination therapy (ACT) as the first-line treatment of uncomplicated malaria cases, as monotherapies had become ineffective in many parts of the world. As a result, the Democratic Republic of Congo (DRC) withdrew chloroquine (CQ) from its malaria treatment policy in 2002 and an artesunate (AS)-amodiaquine (AQ) combination became the ACT of choice in DRC in 2005. AQ-resistance (AQR) has been reported in several parts of the world and mutations in codons 72-76 of the Plasmodium falciparum chloroquine-resistance transporter (pfcrt) gene have been strongly correlated with resistance, especially mutations encoding the SVMNT haplotype. This haplotype was first identified in Southeast Asia and South America but was recently reported in two African countries neighbouring DRC. These facts raised two questions: the first about the evolution of CQ resistance (CQR) in DRC and the second about the presence of the SVMNT haplotype, which would compromise the use of AQ as a partner drug for ACT. Methods: A total of 213 thick blood films were randomly collected in 2010 from a paediatric clinic in Kinshasa, DRC. Microscopy controls and real-time polymerase chain reaction (RT-PCR) were performed for Plasmodium species identification. Haplotypes of the pfcrt gene were determined by sequencing. Results: The K76T mutation was detected in 145 out of 198 P. falciparum-positive samples (73.2%). In these 145 resistant strains, only the CVIET haplotype was detected. Conclusions: This study is the first to assess the molecular markers of resistance to CQ and AQ after the introduction of ACT in DRC. The results suggest first that CQR is decreasing, as wild-type pfcrt haplotypes were found in only 26.8% of the samples and secondly that the SVMNT haplotype is not yet present in Kinshasa, suggesting that AQ remains valid as a partner drug for ACT in this region.	[Mvumbi, Dieudonne Makaba; Lelo, Mvumbi; Lunganza, Kalala] Univ Kinshasa, Sch Med, Dept Basic Sci, Biochem & Mol Biol Unit, Kinshasa, Zaire; [Boreux, Raphael; Sacheli, Rosalie; Melin, Pierrette; DeMol, Patrick; Hayette, Marie-Pierre] Univ Hosp Liege, Dept Clin Microbiol, Liege, Belgium; [Lengu, Bobanga; Nani-Tuma, Situakibanza] Univ Kinshasa, Sch Med, Dept Trop Med & Infect Dis, Kinshasa, Zaire; [Ntumba, Kayembe] Univ Kinshasa, Sch Med, Dept Internal Med, Kinshasa, Zaire	Mvumbi, DM (reprint author), Univ Kinshasa, Sch Med, Dept Basic Sci, Biochem & Mol Biol Unit, BP 190 KIN 11, Kinshasa, Zaire.	didimvumbi@gmail.com		Dieudonne, Mvumbi/0000-0001-6991-5178; Melin, Pierrette/0000-0002-2159-5774	Cooperation Universitaire pour le Developpement (CUD)/Belgium	This work was supported by the Cooperation Universitaire pour le Developpement (CUD)/Belgium.	Alifrangis M, 2006, J INFECT DIS, V193, P1738, DOI 10.1086/504269; Anderson TJC, 2005, ANTIMICROB AGENTS CH, V49, P2180, DOI 10.1128/AAC.49.6.2180-2188.2005; Awasthi G, 2011, INT J PARASITOL, V41, P705, DOI 10.1016/j.ijpara.2011.03.002; Beshir K, 2010, ANTIMICROB AGENTS CH, V54, P3714, DOI 10.1128/AAC.00358-10; Chen NH, 2003, ANTIMICROB AGENTS CH, V47, P3500, DOI 10.1128/AAC.47.11.3500-3505.2003; CHILDS GE, 1989, AM J TROP MED HYG, V40, P7, DOI 10.4269/ajtmh.1989.40.7; Cnops L, 2011, CLIN MICROBIOL INFEC, V17, P1101, DOI 10.1111/j.1469-0691.2010.03344.x; Cnops L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-370; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(00)00084-8; Folarin OA, 2011, ACTA TROP, V120, P224, DOI 10.1016/j.actatropica.2011.08.013; Frosch AEP, 2011, MALARIA J, V10, P11; Gama BE, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-174; Gharbi M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-35; Holmgren G, 2007, INFECT GENET EVOL, V7, P562, DOI 10.1016/j.meegid.2007.03.005; Kazadi WM, 2003, TROP MED INT HEALTH, V8, P868, DOI 10.1046/j.1365-3156.2003.01098.x; Kublin JG, 2003, J INFECT DIS, V187, P1870, DOI 10.1086/375419; Mehlotra RK, 2001, P NATL ACAD SCI USA, V98, P12689, DOI 10.1073/pnas.221440898; Menard S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-113; Mobula L, 2009, AM J TROP MED HYG, V80, P555, DOI 10.4269/ajtmh.2009.80.555; Nagesha SH, 2003, AM J TROP MED HYG, V68, P398; Nsobya SL, 2007, ANTIMICROB AGENTS CH, V51, P3023, DOI 10.1128/AAC.00012.07; Ochong EO, 2003, AM J TROP MED HYG, V69, P184, DOI 10.4269/ajtmh.2003.69.184; Sa JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-374; Sa JM, 2009, P NATL ACAD SCI USA, V106, P18883, DOI 10.1073/pnas.0911317106; Schwenke A, 2001, WIEN KLIN WOCHENSCHR, V113, P63; Severini C, 2006, INFECT GENET EVOL, V6, P262, DOI 10.1016/j.meegid.2005.07.002; Sidhu ABS, 2002, SCIENCE, V298, P210, DOI 10.1126/science.1074045; Wellems TE, 2002, SCIENCE, V298, P124, DOI 10.1126/science.1078167; *WHO, 2001, ANT DRUG COMB THER; Wilson PE, 2005, ACTA TROP, V93, P97, DOI 10.1016/j.actatropica.2004.09.010; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813	32	9	9	0	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	DEC 20	2013	12								459	10.1186/1475-2875-12-459				5	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	281OZ	WOS:000329112200001	24359280	DOAJ Gold, Green Published			2019-04-02	
J	Bossou, AD; Mangelinckx, S; Yedomonhan, H; Boko, PM; Akogbeto, MC; De Kimpe, N; Avlessi, F; Sohounhloue, DCK				Bossou, Annick D.; Mangelinckx, Sven; Yedomonhan, Hounnankpon; Boko, Pelagie M.; Akogbeto, Martin C.; De Kimpe, Norbert; Avlessi, Felicien; Sohounhloue, Dominique C. K.			Chemical composition and insecticidal activity of plant essential oils from Benin against Anopheles gambiae (Giles)	PARASITES & VECTORS			English	Article						Malaria; A. gambiae; Essential oils; Diagnostic dose; Knock-down times; Insecticide; Benin	CULEX-QUINQUEFASCIATUS SAY; CYMBOPOGON-CITRATUS; SECURIDACA-LONGEPEDUNCULATA; EUCALYPTUS-CITRIODORA; MALARIA VECTORS; CHENOPODIUM-AMBROSIOIDES; RESISTANCE MECHANISMS; PYRETHROID RESISTANCE; LARVICIDAL ACTIVITY; S.L. POPULATIONS	Background: Insecticide resistance in sub-Saharan Africa and especially in Benin is a major public health issue hindering the control of the malaria vectors. Each Anopheles species has developed a resistance to one or several classes of the insecticides currently in use in the field. Therefore, it is urgent to find alternative compounds to conquer the vector. In this study, the efficacies of essential oils of nine plant species, which are traditionally used to avoid mosquito bites in Benin, were investigated. Methods: Essential oils of nine plant species were extracted by hydrodistillation, and their chemical compositions were identified by GC-MS. These oils were tested on susceptible "kisumu" and resistant "ladji-Cotonou" strains of Anopheles gambiae, following WHO test procedures for insecticide resistance monitoring in malaria vector mosquitoes. Results: Different chemical compositions were obtained from the essential oils of the plant species. The major constituents identified were as follows: neral and geranial for Cymbopogon citratus, Z-carveol, E-p-mentha-1(7), 8-dien-2-ol and E-p-mentha-2,8-dienol for Cymbopogon giganteus, piperitone for Cymbopogon schoenanthus, citronellal and citronellol for Eucalyptus citriodora, p-cymene, caryophyllene oxide and spathulenol for Eucalyptus tereticornis, 3-tetradecanone for Cochlospermum tinctorium and Cochlospermum planchonii, methyl salicylate for Securidaca longepedunculata and ascaridole for Chenopodium ambrosioides. The diagnostic dose was 0.77% for C. citratus, 2.80% for E. tereticornis, 3.37% for E. citriodora, 4.26% for C. ambrosioides, 5.48% for C. schoenanthus and 7.36% for C. giganteus. The highest diagnostic doses were obtained with S. longepedunculata (9.84%), C. tinctorium (11.56%) and C. planchonii (15.22%), compared to permethrin 0.75%. A. gambiae cotonou, which is resistant to pyrethroids, showed significant tolerance to essential oils from C. tinctorium and S. longepedunculata as expected but was highly susceptible to all the other essential oils at the diagnostic dose. Conclusions: C. citratus, E. tereticornis, E. citriodora, C. ambrosioides and C. schoenanthus are potential promising plant sources for alternative compounds to pyrethroids, for the control of the Anopheles malaria vector in Benin. The efficacy of their essential oils is possibly based on their chemical compositions in which major and/or minor compounds have reported insecticidal activities on various pests and disease vectors such as Anopheles.	[Bossou, Annick D.; Avlessi, Felicien; Sohounhloue, Dominique C. K.] Univ Abomey Calavi, Ecole Polytech Abomey Calavi, Lab Etude & Rech Chim Appl, Cotonou 01, Benin; [Bossou, Annick D.; Mangelinckx, Sven; De Kimpe, Norbert] Univ Ghent, Fac Biosci Engn, Dept Sustainable Organ Chem & Technol, B-9000 Ghent, Belgium; [Yedomonhan, Hounnankpon] Univ Abomey Calavi, Herbier Natl Benin, Lab Bot & Ecol Vegetale, Cotonou 01, Benin; [Boko, Pelagie M.; Akogbeto, Martin C.] Ctr Rech Entomol Cotonou, Cotonou 06, Benin	Mangelinckx, S (reprint author), Univ Ghent, Fac Biosci Engn, Dept Sustainable Organ Chem & Technol, Coupure Links 653, B-9000 Ghent, Belgium.	sven.mangelinckx@ugent.be; csohoun@gmail.com			Belgian Technical Cooperation; Research Foundation-Flanders; Ghent University	We are grateful to the team of the Centre de Recherche en Entomologie de Cotonou, for the realization of insecticidal tests on A. gambiae, as well as to the Belgian Technical Cooperation, Ghent University and the Research Foundation-Flanders for financial support of this research.	Abdelgaleil SAM, 2008, BIORESOURCE TECHNOL, V99, P5947, DOI 10.1016/j.biortech.2007.10.043; Adams R, 2007, IDENTIFICATION ESSEN; Adebayo MA, 2007, J ESSENT OIL RES, V19, P452, DOI 10.1080/10412905.2007.9699949; Aikpon R, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-192; Aizoun N, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-147; Akoegninou A, 2006, FLORE ANAL BENIN; Alitonou G, 2004, CR CHIM, V7, P1051, DOI 10.1016/j.crci.2003.11.014; Alitonou GA, 2012, SCI STUDY RES-CHEM C, V13, P33; Alou LPA, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-289; Andrade EHA, 2009, J ESSENT OIL BEAR PL, V12, P41, DOI 10.1080/0972060X.2009.10643689; Awolola TS, 2002, ANN TROP MED PARASIT, V96, P849, DOI 10.1179/000349802125002581; Batish DR, 2008, FOREST ECOL MANAG, V256, P2166, DOI 10.1016/j.foreco.2008.08.008; Benayache S, 2001, J ESSENT OIL RES, V13, P210, DOI 10.1080/10412905.2001.9699668; Benoit-Vical F, 2001, J ESSENT OIL RES, V13, P65, DOI 10.1080/10412905.2001.9699609; Boeke SJ, 2004, J STORED PROD RES, V40, P423, DOI 10.1016/S0022-474X(03)00046-8; BOWERS WS, 1993, J NAT PROD, V56, P935, DOI 10.1021/np50096a019; Toloza AC, 2008, BIORESOURCE TECHNOL, V99, P7341, DOI 10.1016/j.biortech.2007.12.067; Chandre F, 1999, J AM MOSQUITO CONTR, V15, P53; Chu SS, 2011, PEST MANAG SCI, V67, P714, DOI 10.1002/ps.2112; Clemente MA, 2010, PARASITOL RES, V107, P987, DOI 10.1007/s00436-010-1965-0; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; Czeher C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-189; Dabire RK, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-127; Dagne E, 2000, J ESSENT OIL RES, V12, P467, DOI 10.1080/10412905.2000.9699567; Diabate A, 2004, TROP MED INT HEALTH, V9, P1267, DOI 10.1111/j.1365-3156.2004.01336.x; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Djegbe I, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-261; Etang J, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-46; Etang J, 2007, T ROY SOC TROP MED H, V101, P881, DOI 10.1016/j.trstmh.2007.05.012; Fanello C, 2003, INSECT MOL BIOL, V12, P241, DOI 10.1046/j.1365-2583.2003.00407.x; Franz AR, 2011, REV BRAS ENTOMOL, V55, P116, DOI 10.1590/S0085-56262011000100018; Freitas FP, 2010, CHEM BIODIVERS, V7, P2801, DOI 10.1002/cbdv.200900260; Hadjiakhoondi Abbas, 2003, Daru, V11, P125; Haji KA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-82; Hunt RH, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-107; Idris H. S., 2008, Entomological Research, V38, P243, DOI 10.1111/j.1748-5967.2008.00180.x; Jayasekara TK, 2005, J CHEM ECOL, V31, P303, DOI 10.1007/s10886-005-1342-0; Jayasekara TK, 2002, J MASS SPECTROM, V37, P577, DOI 10.1002/jms.314; Jirovetz L, 2007, J ESSENT OIL RES, V19, P485, DOI 10.1080/10412905.2007.9699959; Kanko C, 2004, CR CHIM, V7, P1039, DOI 10.1016/j.crci.2003.12.030; Ketoh GK, 2005, J STORED PROD RES, V41, P363, DOI 10.1016/j.jspr.2004.02.002; Ketoh GK, 2006, FITOTERAPIA, V77, P506, DOI 10.1016/j.fitote.2006.05.031; Kimps NW, 2011, MED VET ENTOMOL, V25, P202, DOI 10.1111/j.1365-2915.2010.00918.x; Koba K, 2004, ANN MED VET, V148, P202; KRAMER KJ, 1985, J KANSAS ENTOMOL SOC, V58, P254; Kweka EJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-129; Lucia A, 2008, ENTOMOL EXP APPL, V129, P107, DOI 10.1111/j.1570-7458.2008.00757.x; Lucia A, 2009, BIORESOURCE TECHNOL, V100, P6083, DOI 10.1016/j.biortech.2009.02.075; Machado M, 2012, EXP PARASITOL, V130, P223, DOI 10.1016/j.exppara.2011.12.012; Maciel MV, 2010, VET PARASITOL, V167, P1, DOI 10.1016/j.vetpar.2009.09.053; Massebo F, 2009, AFR J BIOTECHNOL, V8, P4183; Menut C, 2000, J ESSENT OIL RES, V12, P207, DOI 10.1080/10412905.2000.9699499; Nathan SS, 2007, BIORESOURCE TECHNOL, V98, P1856, DOI 10.1016/j.biortech.2006.07.044; Nebie RHC, 2004, CR CHIM, V7, P1003, DOI 10.1016/j.crci.2003.12.025; Nwane P, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-41; Nyamador WS, 2010, J STORED PROD RES, V46, P48, DOI 10.1016/j.jspr.2009.09.002; Ogunwande IA, 2003, J ESSENT OIL RES, V15, P297, DOI 10.1080/10412905.2003.9698595; Okia M, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-130; Olivero-Verbel J, 2010, PEST MANAG SCI, V66, P664, DOI 10.1002/ps.1927; Ouattara Lassina, 2007, Pak J Biol Sci, V10, P4177; Overgaard HJ, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-253; Oyedele AO, 2002, PHYTOMEDICINE, V9, P259, DOI 10.1078/0944-7113-00120; Padonou GG, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-72; Palacios SM, 2009, PARASITOL RES, V106, P207, DOI 10.1007/s00436-009-1651-2; Phasomkusolsil Siriporn, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, pS113, DOI 10.1016/S2221-1691(11)60136-6; Phasomkusolsil S, 2011, SE ASIAN J TROP MED, V42, P1083; Pino JA, 2002, FLAVOUR FRAG J, V17, P1, DOI 10.1002/ffj.1026; Prasad CS, 2010, MYCOSES, V53, P123, DOI 10.1111/j.1439-0507.2008.01676.x; Sidibe L, 2001, J ESSENT OIL RES, V13, P110, DOI 10.1080/10412905.2001.9699629; Singh HP, 2009, J AGR FOOD CHEM, V57, P6962, DOI 10.1021/jf9012407; Sutthanont N, 2010, J VECTOR ECOL, V35, P106, DOI 10.1111/j.1948-7134.2010.00036.x; Tapondjou LA, 2002, J STORED PROD RES, V38, P395, DOI 10.1016/S0022-474X(01)00044-3; Vulule JM, 1999, MED VET ENTOMOL, V13, P239, DOI 10.1046/j.1365-2915.1999.00177.x; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2006, GUID TEST MOSQ AD IN; World Health Organisation, 2013, TEST PROC INS RES MO; Yadouleton AW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-83; Yadouleton AWM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-103	78	25	28	0	39	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	DEC 3	2013	6								337	10.1186/1756-3305-6-337				17	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	277RI	WOS:000328836600001	24298981	DOAJ Gold, Green Published			2019-04-02	
J	Caljon, G; De Vooght, L; Hussain, S; De Ridder, K; Van den Abbeele, J				Caljon, Guy; De Vooght, Linda; Hussain, Shahid; De Ridder, Karin; Van den Abbeele, Jan			TOWARDS UNRAVELING THE ROLE OF THE TSETSE SALIVARY GLAND (TSAL) PROTEIN FAMILY	PATHOGENS AND GLOBAL HEALTH			English	Meeting Abstract									[Caljon, Guy; De Vooght, Linda; De Ridder, Karin; Van den Abbeele, Jan] Inst Trop Med, Unit Vet Protozool, B-2000 Antwerp, Belgium; [Hussain, Shahid] Vrije Univ Brussel, Unit Cellular & Mol Immunol, Brussels, Belgium; [Hussain, Shahid] VIB, Lab Myeloid Cell Immunol, Brussels, Belgium			Caljon, Guy/E-1310-2017	Caljon, Guy/0000-0002-4870-3202				0	0	0	0	1	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	2047-7724	2047-7732		PATHOG GLOB HEALTH	Pathog. Glob. Health	DEC	2013	107	8					408	409						2	Public, Environmental & Occupational Health; Parasitology; Tropical Medicine	Public, Environmental & Occupational Health; Parasitology; Tropical Medicine	AF9SZ	WOS:000335056200027					2019-04-02	
J	Duchateau, L; Getachew, Y; Asale, A; Spreybroeck, N; Yewhalaw, D				Duchateau, Luc; Getachew, Yehenew; Asale, Abebe; Spreybroeck, Niko; Yewhalaw, Delenesaw			AVOIDING THE TRAP OF NONRANDOMISATION IN EVALUATING MOSQUITO TRAPPING	PATHOGENS AND GLOBAL HEALTH			English	Meeting Abstract									[Duchateau, Luc] Univ Ghent, B-9000 Ghent, Belgium; [Getachew, Yehenew; Asale, Abebe; Yewhalaw, Delenesaw] Jimma Univ, Jimma, Ethiopia; [Spreybroeck, Niko] Catholic Univ Louvain, B-3000 Louvain, Belgium								0	0	0	0	5	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	2047-7724	2047-7732		PATHOG GLOB HEALTH	Pathog. Glob. Health	DEC	2013	107	8					437	437						1	Public, Environmental & Occupational Health; Parasitology; Tropical Medicine	Public, Environmental & Occupational Health; Parasitology; Tropical Medicine	AF9SZ	WOS:000335056200101					2019-04-02	
J	Yewhalaw, D; Asale, A; Getachew, Y; Luc, D; Speybroeck, N				Yewhalaw, Delenasaw; Asale, Abebe; Getachew, Yehenew; Luc, Duchateau; Speybroeck, Niko			GROWING INSECTICIDE RESISTANCE AND OUTDOOR TRANSMISSION: POTENTIAL ROADBLOCKS FOR GROWING MALARIA CONTROL EFFORTS IN ETHIOPIA	PATHOGENS AND GLOBAL HEALTH			English	Meeting Abstract									[Yewhalaw, Delenasaw; Asale, Abebe; Getachew, Yehenew] Jimma Univ, Jimma, Ethiopia; [Luc, Duchateau] Univ Ghent, B-9000 Ghent, Belgium; [Speybroeck, Niko] Catholic Univ Louvain, Louvain, Belgium								0	1	1	0	4	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	2047-7724	2047-7732		PATHOG GLOB HEALTH	Pathog. Glob. Health	DEC	2013	107	8					437	437						1	Public, Environmental & Occupational Health; Parasitology; Tropical Medicine	Public, Environmental & Occupational Health; Parasitology; Tropical Medicine	AF9SZ	WOS:000335056200102					2019-04-02	
J	Masure, D; Wang, T; Vlaminck, J; Claerhoudt, S; Chiers, K; Van den Broeck, W; Saunders, J; Vercruysse, J; Geldhof, P				Masure, Dries; Wang, Tao; Vlaminck, Johnny; Claerhoudt, Sarah; Chiers, Koen; Van den Broeck, Wim; Saunders, Jimmy; Vercruysse, Jozef; Geldhof, Peter			The Intestinal Expulsion of the Roundworm Ascaris suum Is Associated with Eosinophils, Intra-Epithelial T Cells and Decreased Intestinal Transit Time	PLOS NEGLECTED TROPICAL DISEASES			English	Article							SMOOTH-MUSCLE CONTRACTILITY; HELMINTH INFECTION; PIGS; LUMBRICOIDES; MECHANISMS; IMMUNITY; HUMANS; LARVAE; EPIDEMIOLOGY; RESISTANCE	Ascaris lumbricoides remains the most common endoparasite in humans, yet there is still very little information available about the immunological principles of protection, especially those directed against larval stages. Due to the natural host-parasite relationship, pigs infected with A. suum make an excellent model to study the mechanisms of protection against this nematode. In pigs, a self-cure reaction eliminates most larvae from the small intestine between 14 and 21 days post infection. In this study, we investigated the mucosal immune response leading to the expulsion of A. suum and the contribution of the hepato-tracheal migration. Self-cure was independent of previous passage through the liver or lungs, as infection with lung stage larvae did not impair self-cure. When animals were infected with 14-day-old intestinal larvae, the larvae were being driven distally in the small intestine around 7 days post infection but by 18 days post infection they re-inhabited the proximal part of the small intestine, indicating that more developed larvae can counter the expulsion mechanism. Self-cure was consistently associated with eosinophilia and intra-epithelial T cells in the jejunum. Furthermore, we identified increased gut movement as a possible mechanism of self-cure as the small intestinal transit time was markedly decreased at the time of expulsion of the worms. Taken together, these results shed new light on the mechanisms of self-cure that occur during A. suum infections. Author SummaryAscaris lumbricoides is the most common intestinal parasite in humans. A. suum is closely related to A. lumbricoides but infects pigs and can be used to study the immune response against larval stages. Most larvae are eliminated from the small intestine between 14 and 21 days after infection in what is called a self-cure reaction. The remaining larvae after this point will be able to grow into adults and reproduce. We show here that the intestinal self-cure of A. suum is locally triggered as part of an innate immune defense mechanism. When pigs received lung stage larvae, they were still able to eliminate the parasite, indicating that passage through the liver or lungs is not essential to eliminate the larvae upon their return in the small intestine. We could identify a decrease in the intestinal transit time at 17 days post infection, indicating an increase in gut movement, which could explain why the worms were being driven out at this time.	[Masure, Dries; Wang, Tao; Vlaminck, Johnny; Vercruysse, Jozef; Geldhof, Peter] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Claerhoudt, Sarah; Saunders, Jimmy] Univ Ghent, Dept Med Imaging & Small Anim Orthopaed, Merelbeke, Belgium; [Chiers, Koen] Univ Ghent, Dept Pathol Bacteriol & Avian Dis, Fac Vet Med, Merelbeke, Belgium; [Van den Broeck, Wim] Univ Ghent, Dept Morphol, Fac Vet Med, Merelbeke, Belgium	Masure, D (reprint author), Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium.	peter.geldhof@ugent.be		Wang, Tao/0000-0003-1359-8913	Agency for Innovation by Science and Technology (IWT)	This study was financed by the Agency for Innovation by Science and Technology (IWT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TJC, 2001, TRENDS PARASITOL, V17, P183, DOI 10.1016/S1471-4922(00)01944-9; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Arizono N, 2010, JPN J INFECT DIS, V63, P447; ASHRAF M, 1988, VET PARASITOL, V29, P143, DOI 10.1016/0304-4017(88)90122-7; Criscione CD, 2007, P ROY SOC B-BIOL SCI, V274, P2669, DOI 10.1098/rspb.2007.0877; Crompton DWT, 2001, ADV PARASIT, V48, P285, DOI 10.1016/S0065-308X(01)48008-0; Dawson HD, 2005, INFECT IMMUN, V73, P1116, DOI 10.1128/IAI.73.2.1116-1128.2005; Dold C, 2011, MICROBES INFECT, V13, P624, DOI 10.1016/j.micinf.2010.09.013; ERIKSEN L, 1992, VET PARASITOL, V41, P137, DOI 10.1016/0304-4017(92)90017-4; Foster N.F., 2012, PARASITOL RES, P1; Fujiwara A, 2004, J PARASITOL, V90, P1019, DOI 10.1645/GE-265R; Harris NL, 2006, J IMMUNOL, V177, P6256, DOI 10.4049/jimmunol.177.9.6256; Holland CV, 2009, PARASITOLOGY, V136, P1537, DOI 10.1017/S0031182009005952; Jungersen G, 1999, PARASITOLOGY, V119, P503, DOI 10.1017/S0031182099004928; Kermanizadeh P, 1997, PARASITOL TODAY, V13, P405, DOI 10.1016/S0169-4758(97)87088-3; Knight PA, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-78; Leles D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-42; Li RW, 2012, FUNCT INTEGR GENOMIC, V12, P35, DOI 10.1007/s10142-011-0259-7; Liu GH, 2012, GENE, V492, P110, DOI 10.1016/j.gene.2011.10.043; Masure D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002138; Mccoy KD, 2008, CELL HOST MICROBE, V4, P362, DOI 10.1016/j.chom.2008.08.014; Miquel N, 2005, PARASITE IMMUNOL, V27, P79, DOI 10.1111/j.1365-3024.2005.00752.x; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; Morimoto M, 2003, EXP PARASITOL, V104, P113, DOI 10.1016/S0014-4894(03)00139-5; Nejsum P, 2005, J CLIN MICROBIOL, V43, P1142, DOI 10.1128/JCM.43.3.1142-1148.2005; O'Lorcain P, 2000, PARASITOLOGY, V121, pS51, DOI 10.1017/S0031182000006442; Roepstorff A, 1997, PARASITOLOGY, V115, P443, DOI 10.1017/S0031182097001480; Rozen S, 2000, Methods Mol Biol, V132, P365; Schmidt S, 2012, PLOS ONE, V7; Shamri R, 2011, CELL TISSUE RES, V343, P57, DOI 10.1007/s00441-010-1049-6; STEWART TB, 1988, J ANIM SCI, V66, P1548; URBAN JF, 1986, VET CLIN N AM-FOOD A, V2, P765, DOI 10.1016/S0749-0720(15)31218-4; Uston PI, 2007, PARASITOL RES, V100, P603, DOI 10.1007/s00436-006-0362-1; Vallance BA, 1997, AM J PHYSIOL-GASTR L, V272, pG321; van Wijk F, 2009, SEMIN IMMUNOL, V21, P130, DOI 10.1016/j.smim.2009.03.003; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Zhao AP, 2008, GASTROENTEROLOGY, V135, P217, DOI 10.1053/j.gastro.2008.03.077; Zhao AP, 2003, J IMMUNOL, V171, P948, DOI 10.4049/jimmunol.171.2.948; Zhou CH, 2011, PARASITOL RES, V109, P329, DOI 10.1007/s00436-011-2260-4	39	12	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	DEC	2013	7	12							e2588	10.1371/journal.pntd.0002588				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	282JU	WOS:000329168100005	24340121	DOAJ Gold, Green Published			2019-04-02	
J	Meurs, L; Mbow, M; Boon, N; van den Broeck, F; Vereecken, K; Dieye, TN; Abatih, E; Huyse, T; Mboup, S; Polman, K				Meurs, Lynn; Mbow, Moustapha; Boon, Nele; van den Broeck, Frederik; Vereecken, Kim; Dieye, Tandakha Ndiaye; Abatih, Emmanuel; Huyse, Tine; Mboup, Souleymane; Polman, Katja			Micro-Geographical Heterogeneity in Schistosoma mansoni and S. haematobium Infection and Morbidity in a Co-Endemic Community in Northern Senegal	PLOS NEGLECTED TROPICAL DISEASES			English	Article							SOIL-TRANSMITTED HELMINTHS; EGYPT-49 PROJECT AREA; RIVER-BASIN; URINARY SCHISTOSOMIASIS; SCHOOL-CHILDREN; RISK-FACTORS; INTESTINAL SCHISTOSOMIASIS; SPATIAL-DISTRIBUTION; WESTERN KENYA; BIOMPHALARIA-PFEIFFERI	BackgroundSchistosoma mansoni and S. haematobium are co-endemic in many areas in Africa. Yet, little is known about the micro-geographical distribution of these two infections or associated disease within such foci. Such knowledge could give important insights into the drivers of infection and disease and as such better tailor schistosomiasis control and elimination efforts. Methodology In a co-endemic farming community in northern Senegal (346 children (0-19 y) and 253 adults (20-85 y); n=599 in total), we studied the spatial distribution of S. mansoni and S. haematobium single and mixed infections (by microscopy), S. mansoni-specific hepatic fibrosis, S. haematobium-specific urinary tract morbidity (by ultrasound) and water contact behavior (by questionnaire). The Kulldorff's scan statistic was used to detect spatial clusters of infection and morbidity, adjusted for the spatial distribution of gender and age. Principal FindingsSchistosoma mansoni and S. haematobium infection densities clustered in different sections of the community (p=0.002 and p=0.023, respectively), possibly related to heterogeneities in the use of different water contact sites. While the distribution of urinary tract morbidity was homogeneous, a strong geospatial cluster was found for severe hepatic fibrosis (p=0.001). Particularly those people living adjacent to the most frequently used water contact site were more at risk for more advanced morbidity (RR=6.3; p=0.043). Conclusions/SignificanceSchistosoma infection and associated disease showed important micro-geographical heterogeneities with divergent patterns for S. mansoni and S. haematobium in this Senegalese community. Further in depth investigations are needed to confirm and explain our observations. The present study indicates that local geospatial patterns should be taken into account in both research and control of schistosomiasis. The observed extreme focality of schistosomiasis even at community level, suggests that current strategies may not suffice to move from morbidity control to elimination of schistosomiasis, and calls for less uniform measures at a finer scale. Author Summary In the developing world, over 230 million people are infected with parasitic Schistosoma worms. Schistosoma mansoni and S. haematobium are the most abundant species in Africa, affecting the liver and urinary tract, respectively. Both parasites are spread through infested freshwater. Although it is known that the disease occurs focally within countries or regions, little is known on its geographic spread on a smaller scale. Here, we examined 599 people from a community in northern Senegal for S. mansoni and S. haematobium infections and related abnormalities of the liver and urinary tract. We recorded where they lived and where they had water contact and visualized this information in geographical maps. The study showed that each Schistosoma species clustered in a different section of the community, and that liver abnormalities were more severe near the mostly used water contact site. So far, this is the first study to investigate the geographical spread of both species in a single community, and the first to map schistosomal disease on such a small scale. Further studies are needed to confirm and explain these results. They could contribute to a better understanding of schistosomiasis and have important consequences for the control and elimination of this disease.	[Meurs, Lynn; Mbow, Moustapha; Boon, Nele; van den Broeck, Frederik; Vereecken, Kim; Abatih, Emmanuel; Huyse, Tine; Polman, Katja] Inst Trop Med, B-2000 Antwerp, Belgium; [Mbow, Moustapha; Dieye, Tandakha Ndiaye; Mboup, Souleymane] Ctr Hosp Univ Aristide Le Dantec, Lab Bacteriol & Virol, Dakar, Senegal; [Boon, Nele; van den Broeck, Frederik; Huyse, Tine] Univ Louvain, Lab Biodivers & Evolutionary Genom, Louvain, Belgium	Meurs, L (reprint author), Inst Trop Med, B-2000 Antwerp, Belgium.	LMeurs@itg.be	Van den Broeck, Frederik/T-6182-2017; Meurs, Lynn/J-8661-2016	Van den Broeck, Frederik/0000-0003-2542-5585; Meurs, Lynn/0000-0002-6973-1237	European Union's sixth framework programme [INCO-CT-2006-032405]; Research Foundation - Flanders [G0552.10]	This work was funded by the European Union's sixth framework programme (INCO-CT-2006-032405) (Website: http://cordis.europa.eu/fp6/). FvdB is a doctoral fellow of the Flemish Inter-University Council (VLADOC). TH is a postdoctoral fellow of the Research Foundation - Flanders (FWO-Vlaanderen). NB was financed by a Research Grant of Research Foundation - Flanders (G0552.10) and is now a doctoral fellow of the Flemish Inter-University Council (VLADOC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ES, 1996, ANN TROP MED PARASIT, V90, P173, DOI 10.1080/00034983.1996.11813041; Al-Sheikh Adel H., 2011, Journal of the Egyptian Society of Parasitology, V41, P543; AMANKWA JA, 1994, TROP MED PARASITOL, V45, P319; [Anonymous], 2006, PREV CHEM HUM HELM C; Berger C, 2006, FEMS MICROBIOL ECOL, V57, P355, DOI 10.1111/j.1574-6941.2006.00141.x; Bethony J, 2002, AM J TROP MED HYG, V67, P336, DOI 10.4269/ajtmh.2002.67.336; Bethony JM, 2008, ACTA TROP, V108, P166, DOI 10.1016/j.actatropica.2007.11.008; Booth M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-13; Brooker S, 2001, ANN TROP MED PARASIT, V95, P343, DOI 10.1080/00034980120063437; Brooker S, 2006, INT J PARASITOL, V36, P1143, DOI 10.1016/j.ijpara.2006.05.009; Brooker S, 2009, INT J PARASITOL, V39, P591, DOI 10.1016/j.ijpara.2008.10.014; Brouwer KC, 2003, ACTA TROP, V85, P339, DOI 10.1016/S0001-706X(02)00262-0; Brouwer Kimberly C, 2004, Afr Health Sci, V4, P115; CHANDIWANA SK, 1988, ANN TROP MED PARASIT, V82, P163, DOI 10.1080/00034983.1988.11812224; Clements ACA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000431; Clennon JA, 2004, AM J TROP MED HYG, V70, P443, DOI 10.4269/ajtmh.2004.70.443; Clennon JA, 2006, AM J TROP MED HYG, V75, P1034, DOI 10.4269/ajtmh.2006.75.1034; Cook GC, 2009, MANSONS TROPICAL DIS; COSTA MFFLE, 1987, B WORLD HEALTH ORGAN, V65, P57; Coutinho EM, 1997, MEM I OSWALDO CRUZ, V92, P707, DOI 10.1590/S0074-02761997000500027; De Clercq D, 1999, TROP MED INT HEALTH, V4, P544; DENNIS E, 1983, ACTA TROP, V40, P205; El-Khoby T, 2000, AM J TROP MED HYG, V62, P88, DOI 10.4269/ajtmh.2000.62.88; Ernould JC, 1999, ANN TROP MED PARASIT, V93, P135; FAROOQ M, 1966, B WORLD HEALTH ORGAN, V35, P293; FAROOQ M, 1966, AM J EPIDEMIOL, V83, P603, DOI 10.1093/oxfordjournals.aje.a120611; Garba A, 2010, ACTA TROP, V115, P84, DOI 10.1016/j.actatropica.2010.02.007; Gazzinelli A, 2006, MEM I OSWALDO CRUZ, V101, P63, DOI 10.1590/S0074-02762006000900010; Gong YY, 2012, ENVIRON HEALTH PERSP, V120, P893, DOI 10.1289/ehp.1104357; GRANT A, 2012, DISCOVER, V0033; Grant AV, 2011, GENES IMMUN, V12, P46, DOI 10.1038/gene.2010.50; GRYSEELS B, 1990, T ROY SOC TROP MED H, V84, P542, DOI 10.1016/0035-9203(90)90033-B; GRYSEELS B, 1988, ANN TROP MED PARASIT, V82, P581, DOI 10.1080/00034983.1988.11812294; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Handzel T, 2003, AM J TROP MED HYG, V69, P318, DOI 10.4269/ajtmh.2003.69.318; HEURTIER Y, 1986, AM J TROP MED HYG, V35, P1163, DOI 10.4269/ajtmh.1986.35.1163; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Huyse T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000571; Johnson PTJ, 2009, P R SOC B, V276, P1657, DOI 10.1098/rspb.2008.1718; Jung I, 2007, STAT MED, V26, P1594, DOI 10.1002/sim.2607; Kapito-Tembo AP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000361; KING CH, 1988, AM J TROP MED HYG, V39, P295; KING CH, 1992, MEM I OSWALDO CRUZ, V87, P203, DOI 10.1590/S0074-02761992000800031; KITRON UD, 1985, AM J TROP MED HYG, V34, P331, DOI 10.4269/ajtmh.1985.34.331; Kloos H, 1998, MEM I OSWALDO CRUZ, V93, P37, DOI 10.1590/S0074-02761998000700006; KLOOS H, 1988, SOC SCI MED, V26, P803, DOI 10.1016/0277-9536(88)90174-8; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M, 2010, SATSCAN USER GUIDE V; Kulldorff M, 2007, STAT MED, V26, P1824, DOI 10.1002/sim.2818; Kulldorff M, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-58; Leutscher PDC, 2000, TROP MED INT HEALTH, V5, P88, DOI 10.1046/j.1365-3156.2000.00522.x; Matthys B, 2007, TROP MED INT HEALTH, V12, P709, DOI 10.1111/j.1365-3156.2007.01841.x; Medhat A, 1997, AM J TROP MED HYG, V57, P16, DOI 10.4269/ajtmh.1997.57.16; Meurs L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001829; Meurs L, 2012, INT J PARASITOL, V42, P305, DOI 10.1016/j.ijpara.2012.02.002; Mutuku FM, 2011, AM J TROP MED HYG, V85, P1065, DOI 10.4269/ajtmh.2011.11-0186; Odiere MR, 2011, PARASITOLOGY, V138, P1569, DOI 10.1017/S003118201100059X; Peng WX, 2010, PARASITOLOGY, V137, P1099, DOI 10.1017/S003118200999206X; Picquet M, 1996, T ROY SOC TROP MED H, V90, P340, DOI 10.1016/S0035-9203(96)90501-5; POLDERMAN AM, 1985, ANN SOC BELG MED TR, V65, P251; Pullan RL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000352; Raso G, 2005, PARASITOLOGY, V131, P97, DOI 10.1017/S0031182005007432; Richter J, 1996, TDRSTRSCH001; Serieye J, 1996, T ROY SOC TROP MED H, V90, P398, DOI 10.1016/S0035-9203(96)90521-0; Simoonga C, 2008, GEOSPATIAL HEALTH, V3, P57, DOI 10.4081/gh.2008.232; Southgate VR, 2000, ANN TROP MED PARASIT, V94, P157, DOI 10.1080/00034980057491; Southgate VR, 2001, MEM I OSWALDO CRUZ, V96, P75, DOI 10.1590/S0074-02762001000900010; Stothard JR, 2011, T ROY SOC TROP MED H, V105, P500, DOI 10.1016/j.trstmh.2011.05.007; STURROCK RF, 1989, MEM I OSWALDO CRUZ, V84, P134, DOI 10.1590/S0074-02761989000500014; TALLA I, 1992, T ROY SOC TROP MED H, V86, P182, DOI 10.1016/0035-9203(92)90562-Q; TALLA I, 1990, ANN SOC BELG MED TR, V70, P173; ten Hove RJ, 2008, T ROY SOC TROP MED H, V102, P179, DOI 10.1016/j.trstmh.2007.10.011; Traore M, 1998, AM J TROP MED HYG, V59, P407, DOI 10.4269/ajtmh.1998.59.407; Tsang VCW, 1997, AM J TROP MED HYG, V56, P107, DOI 10.4269/ajtmh.1997.56.107; Utzinger J, 2003, J PARASITOL, V89, P686, DOI 10.1645/GE-75R; WHO, 2011, HELMINTH CONTROL IN SCHOOL-AGE CHILDREN: A GUIDE FOR MANAGERS OF CONTROL PROGRAMMES, SECOND EDITION, P1; WHO, 2010, SCHIST FACT SHEET; WOOLHOUSE MEJ, 1989, PARASITOLOGY, V98, P21, DOI 10.1017/S0031182000059655; World Health Organization, 2013, SCHIST PROGR REP 200; Yiannakoulias N, 2010, GEOSPATIAL HEALTH, V4, P191, DOI 10.4081/gh.2010.200	80	16	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	DEC	2013	7	12							e2608	10.1371/journal.pntd.0002608				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	282JU	WOS:000329168100017	24386499	DOAJ Gold, Green Published			2019-04-02	
J	Phanzu, DM; Suykerbuyk, P; Saunderson, P; Lukanu, PN; Minuku, JBM; Imposo, DBB; Diengidi, BM; Kayinua, M; Muyembe, JJT; Lutumba, PT; de Jong, BC; Portaels, F; Boelaert, M				Phanzu, Delphin Mavinga; Suykerbuyk, Patrick; Saunderson, Paul; Lukanu, Philippe Ngwala; Minuku, Jean-Bedel Masamba; Imposo, Desire Bofunga B.; Diengidi, Blanchard Mbadu; Kayinua, Makanzu; Muyembe, Jean-Jacques Tamfum; Lutumba, Pascal Tshindele; de Jong, Bouke C.; Portaels, Francoise; Boelaert, Marleen			Burden of Mycobacterium ulcerans Disease (Buruli Ulcer) and the Underreporting Ratio in the Territory of Songololo, Democratic Republic of Congo	PLOS NEGLECTED TROPICAL DISEASES			English	Article							NEGLECTED TROPICAL DISEASES; BAS-CONGO; INFECTION; CAMEROON; BENIN; PREVALENCE; FAMILY	Background Cutaneous infection by Mycobacterium ulcerans, also known as Buruli ulcer (BU), represents the third most common mycobacterial disease in the world after tuberculosis and leprosy. Data on the burden of BU disease in the Democratic Republic of Congo are scanty. This study aimed to estimate the prevalence rate and the distribution of BU in the Songololo Territory, and to assess the coverage of the existing hospital-based reporting system. Methods We conducted a cross-sectional survey (July-August 2008) using the door-to-door method simultaneously in the two rural health zones (RHZ) of the Songololo Territory (RHZ of Kimpese and Nsona-Mpangu), each containing twenty health areas. Cases were defined clinically as active BU and inactive BU in accordance with WHO-case definitions. Results We detected 775 BU patients (259 active and 516 inactive) in a total population of 237,418 inhabitants. The overall prevalence of BU in Songololo Territory was 3.3/1000 inhabitants, varying from 0 to 27.5/1000 between health areas. Of the 259 patients with active BU, 18 (7%) had been reported in the hospital-based reporting system at Kimpese in the 6-8 months prior to the survey. Conclusion The survey demonstrated a huge variation of prevalence between health areas in Songololo Territory and gross underreporting of BU cases in the hospital-based reporting system. Data obtained may contribute to better targeted and improved BU control interventions, and serve as a baseline for future assessments of the control program. Author Summary Buruli ulcer (BU) is a necrotizing bacterial infection of skin, subcutaneous tissue and bone, caused by an environmental pathogen, Mycobacterium ulcerans. BU is considered as one of the Neglected Tropical Diseases with a poorly known global prevalence, and mainly affects remote rural African communities. Data on the burden of BU disease in the Democratic Republic of Congo (DRC) are scanty. The present study is the first exhaustive survey in DRC on the frequency of BU in the community. The survey demonstrated large variations in prevalence between health areas in Songololo Territory. Moreover, our data showed that the BU cases in the hospital-based reporting system reflect only the tip of the iceberg of the true active BU prevalence. Indeed, only one in thirteen active BU cases was notified at the hospital at Kimpese in the 6-8 months prior to the survey. The present data will serve as a baseline assessment for the evaluation of control interventions in the study area, and, more generally, this study aims to raise awareness about the issue of underdetection of BU and the importance of increasing access to diagnosis and care. As such, we hope the study will contribute to improved control of BU.	[Phanzu, Delphin Mavinga; Imposo, Desire Bofunga B.; Diengidi, Blanchard Mbadu] Gen Reference Hosp Kimpese, Inst Med Evangel Kimpese, Bas Congo, Zaire; [Phanzu, Delphin Mavinga; Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, Unit Epidemiol & Dis Control, B-2000 Antwerp, Belgium; [Suykerbuyk, Patrick; de Jong, Bouke C.; Portaels, Francoise] Inst Trop Med, Unit Mycobacteriol, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Saunderson, Paul] Amer Leprosy Missions, Greenville, SC USA; [Lukanu, Philippe Ngwala] Cent Off Rural Hlth Zone Kimpese, Bas Congo, Zaire; [Minuku, Jean-Bedel Masamba; Kayinua, Makanzu] Cent Off Rural Hlth Zone Nsona Mpangu, Bas Congo, Zaire; [Muyembe, Jean-Jacques Tamfum; Lutumba, Pascal Tshindele] Inst Natl Rech Biomed, Kinshasa, Zaire	Phanzu, DM (reprint author), Gen Reference Hosp Kimpese, Inst Med Evangel Kimpese, Bas Congo, Zaire.	mboelaert@itg.be	de Jong, Bouke/A-3636-2013; Mashamba-Thompson, Tivani/B-6087-2014	de Jong, Bouke/0000-0002-1017-4675; Boelaert, Marleen/0000-0001-8051-6776	American Leprosy Missions (Greenville, South Carolina, United States of America); European Commission (International Science and Technology Cooperation Development Program) [INCO-CT-2005-05-051476-BURULICO]; Directorate General for Development and Cooperation (Brussels, Belgium)	This study was supported by the American Leprosy Missions (Greenville, South Carolina, United States of America), the European Commission (International Science and Technology Cooperation Development Program), Project No. INCO-CT-2005-05-051476-BURULICO and the Directorate General for Development and Cooperation (Brussels, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu Ejk, 2011, Ghana Med J, V45, P4; Amofah G, 2002, EMERG INFECT DIS, V8, P167, DOI 10.3201/eid0802.010119; ANDERSEN F O, 1965, Cent Afr J Med, V11, P131; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P145; Debacker M, 2004, TROP MED INT HEALTH, V9, P1297, DOI 10.1111/j.1365-3156.2004.01339.x; Debacker M, 2004, EMERG INFECT DIS, V10, P1391, DOI 10.3201/eid1008.030886; Grietens KP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000321; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Janssens P, 2005, B SEANCES ACAD R SCI, V51, P265; Johnson RC, 2005, TROP MED INT HEALTH, V10, P863, DOI 10.1111/j.1365-3156.2005.01465.x; Kanga JM, 2001, B SOC PATHOL EXOT, V94, P46; Kibadi AK, 2006, B ALLF, V18, P24; Kibadi K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000736; Landier J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001392; Meyers W M, 1974, Ann Soc Belg Med Trop, V54, P147; Nienhuis WA, 2010, LANCET, V375, P664, DOI 10.1016/S0140-6736(09)61962-0; Noeske J, 2004, AM J TROP MED HYG, V70, P520, DOI 10.4269/ajtmh.2004.70.520; Phanzu DM, 2006, AM J TROP MED HYG, V75, P311, DOI 10.4269/ajtmh.2006.75.311; Phanzu DM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001402; Phanzu MD, 2010, AM J TROP MED HYG, V82, P478, DOI 10.4269/ajtmh.2010.09-0256; Portaels F, 2009, CLIN DERMATOL, V27, P291, DOI 10.1016/j.clindermatol.2008.09.021; Porten K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000466; Sizaire V, 2006, LANCET INFECT DIS, V6, P288, DOI 10.1016/S1473-3099(06)70464-9; SMITH JH, 1970, AM J TROP MED HYG, V19, P657, DOI 10.4269/ajtmh.1970.19.657; Sopoh GE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000746; van der Werf TS, 2005, B WORLD HEALTH ORGAN, V83, P785; *WHO, 2004, WHOCDSCPEGBUI200410; *WHO, 2001, WHOCDSCPEGBUI20014	29	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	DEC	2013	7	12							e2563	10.1371/journal.pntd.0002563				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	282JU	WOS:000329168100034	24340112	DOAJ Gold, Green Published			2019-04-02	
J	Meheus, F; Abuzaid, AA; Baltussen, R; Younis, BM; Balasegaram, M; Khalil, EAG; Boelaert, M; Musa, AM				Meheus, Filip; Abuzaid, Abuzaid A.; Baltussen, Rob; Younis, Brima M.; Balasegaram, Manica; Khalil, Eltahir A. G.; Boelaert, Marleen; Musa, Ahmed M.			The Economic Burden of Visceral Leishmaniasis in Sudan: An Assessment of Provider and Household Costs	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							LIPOSOMAL AMPHOTERICIN-B; EAST-AFRICA; SODIUM STIBOGLUCONATE; KALA-AZAR; HEALTH-CARE; PAROMOMYCIN; BIHAR; COMBINATION; EFFICACY; PROTOCOL	Visceral leishmaniasis (VL) is a neglected parasitic disease that is fatal if left untreated and is endemic in eastern Sudan. We estimated the direct and indirect costs of treatment of VL from the perspective of the provider and the household at three public hospitals in Gedaref State. The median total cost for one VL episode was estimated to be US$450. Despite the free provision of VL drugs at public hospitals, households bore 53% of the total cost of VL with one episode of VL representing 40% of the annual household income. More than 75% of households incurred catastrophic out-of-pocket expenditures. The length of treatment of 30 days led to important costs for both health providers and households. Alternative treatment regimens that reduce the duration of treatment are urgently needed.	[Meheus, Filip] Univ Cape Town, Fac Hlth Sci, Hlth Econ Unit, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Meheus, Filip; Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium; [Abuzaid, Abuzaid A.] Univ Khartoum, Inst Endem Dis, Khartoum, Sudan; [Baltussen, Rob] Radboud Univ Nijmegen, Med Ctr, Nijmegen Int Ctr Hlth Syst Res & Educ NICHE, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands; [Younis, Brima M.; Khalil, Eltahir A. G.; Musa, Ahmed M.] Univ Khartoum, Inst Endem Dis, Dept Clin Pathol & Immunol, Khartoum, Sudan; [Balasegaram, Manica] Drugs Neglected Dis Initiat, Geneva, Switzerland	Meheus, F (reprint author), Univ Cape Town, Hlth Econ Unit, Sch Publ Hlth & Family Med, Anzio Rd, ZA-7925 Observatory, South Africa.	Filip.Meheus@uct.ac.za; abuzaidabdalla@yahoo.com; R.Baltussen@elg.umcn.nl; brimamusa@hotmail.com; manicab@hotmail.com; eltahirgasim@yahoo.ca; mboelaert@itg.be; amusa@iend.org	Boelaert, Marleen/E-2698-2012; Baltussen, R.M.P.M./L-4181-2015	Boelaert, Marleen/0000-0001-8051-6776; 	Drugs for Neglected Diseases Initiative; European Commission under the Health Cooperation Work Programme of the 7th Framework Programme (FP7); ITM VL Fund; SOFT-A programme; Flemish Government	This study received financial support from the Drugs for Neglected Diseases Initiative and the European Commission under the Health Cooperation Work Programme of the 7th Framework Programme (FP7) to the NIDIAG consortium (www.nidiag.org). Filip Meheus was supported by the ITM VL Fund and the SOFT-A programme funded by the Flemish Government.	Burki T, 2012, LANCET INFECT DIS, V12, P107, DOI 10.1016/S1473-3099(12)70024-5; Central Bureau of Statistics Sudan, 2011, 5 POP HOUS CENS 2008; Collin S, 2004, CLIN INFECT DIS, V38, P612, DOI 10.1086/381203; Collin SM, 2006, TROP MED INT HEALTH, V11, P509, DOI 10.1111/j.1365-3156.2006.01589.x; Conteh L, 2004, HEALTH POLICY PLANN, V19, P127, DOI 10.1093/heapol/czh015; Creese A, 1994, COST ANAL PRIMARY HL; Desjeux P, 1996, CLIN DERMATOL, V14, P417, DOI 10.1016/0738-081X(96)00057-0; Drummond M, 2005, METHODS EC EVALUATIO; Edwards T, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-66; Federal Ministry of Health Sudan, 2004, MAN DIAGN TREATM LEI; Gerstl S, 2006, TROP MED INT HEALTH, V11, P167, DOI 10.1111/j.1365-3156.2005.01550.x; Gold MR, 1996, COST EFFECTIVENESS H; Hailu A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000709; Hansen K, 2000, HEALTH POLICY PLANN, V15, P432, DOI 10.1093/heapol/15.4.432; Harhay MO, 2011, AM J TROP MED HYG, V84, P543, DOI 10.4269/ajtmh.2011.10-0321; Malaria Consortium, 2010, LEISHM CONTR E AFR P; McPake B, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-143; Meheus F, 2006, TROP MED INT HEALTH, V11, P1715, DOI 10.1111/j.1365-3156.2006.01732.x; Melaku Y, 2007, AM J TROP MED HYG, V77, P89, DOI 10.4269/ajtmh.2007.77.89; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Musa A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001674; O'Donnell O., 2008, ANAL HLTH EQUITY USI; Omollo R, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-166; Ranson MK, 2002, B WORLD HEALTH ORGAN, V80, P613; Rijal S, 2006, T ROY SOC TROP MED H, V100, P838, DOI 10.1016/j.trstmh.2005.09.017; Rijal S, 2003, T ROY SOC TROP MED H, V97, P350, DOI 10.1016/S0035-9203(03)90167-2; Ritmeijer K, 2007, TROP MED INT HEALTH, V12, P404, DOI 10.1111/j.1365-3156.2006.01807.x; Sarnoff R, 2010, TROP MED INT HEALTH, V15, P42, DOI 10.1111/j.1365-3156.2010.02516.x; Sharma DA, 2006, TROP MED INT HEALTH, V11, P757, DOI 10.1111/j.1365-3156.2006.01604.x; Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121; Sundar S, 2010, TROP MED INT HEALTH, V15, P50, DOI 10.1111/j.1365-3156.2010.02520.x; Uranw S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002062; Vander Plaetse B, 2005, HEALTH POLICY PLANN, V20, P243, DOI 10.1093/heapol/czi028; WHO, 2006, HLTH SYST PROF SUD; WHO-CHOICE, COUNTR SPEC UN COSTS; World Bank, WORLD DAT WORLD DEV; World Health Organization, 2010, CONTR LEISHM M WHO E; ZIJLSTRA EE, 1992, T ROY SOC TROP MED H, V86, P505, DOI 10.1016/0035-9203(92)90086-R; Zijlstra EE, 2001, T ROY SOC TROP MED H, V95, pS27, DOI 10.1016/S0035-9203(01)90218-4	39	13	13	0	7	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2013	89	6					1146	1153		10.4269/ajtmh.12-0585				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	276CQ	WOS:000328726100016	24189368	Green Published, Bronze			2019-04-02	
J	Duysburgh, E; Ye, M; Williams, A; Massawe, S; Sie, A; Williams, J; Mpembeni, R; Loukanova, S; Temmerman, M				Duysburgh, Els; Ye, Maurice; Williams, Afua; Massawe, Siriel; Sie, Ali; Williams, John; Mpembeni, Rose; Loukanova, Svetla; Temmerman, Marleen			Counselling on and women's awareness of pregnancy danger signs in selected rural health facilities in Burkina Faso, Ghana and Tanzania	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						quality of care; maternal and newborn health; antenatal care; sub-Saharan Africa; counselling; pregnancy danger signs	ANTENATAL CARE; QUALITY; COMPLICATIONS	ObjectiveThe aims of this study were to (i) assess healthcare workers' counselling practices concerning danger signs during antenatal consultations in rural primary healthcare (PHC) facilities in Burkina Faso, Ghana and Tanzania; to (ii) assess pregnant women's awareness of these danger signs; and (iii) to identify factors affecting counselling practices and women's awareness. MethodsCross-sectional study in rural PHC facilities in Burkina Faso, Ghana and Tanzania. In each country, 12 facilities were randomly selected. WHO guidelines were used as standard for good counselling. We assessed providers' counselling practice on seven danger signs through direct observation study (35 observations/facility). Exit interviews (63 interviews/facility) were used to assess women's awareness of the same seven danger signs. We used negative binomial regression to assess associations with health services' and socio-demographic characteristics and to estimate per study site the average number of danger signs on which counselling was provided and the average number of danger signs mentioned by women. ResultsAbout one in three women was not informed of any danger sign. For most danger signs, fewer than half of the women were counselled. Vaginal bleeding and severe abdominal pain were the signs most counselled on (between 52% and 66%). At study facilities in Burkina Faso, 58% of the pregnant women were not able to mention a danger sign, in Ghana this was 22% and in Tanzania 30%. Fever, vaginal bleeding and severe abdominal pain were the danger signs most frequently mentioned. The type of health worker (depending on the training they received) was significantly associated with counselling practices. Depending on the study site, characteristics significantly associated with awareness of signs were women's age, gestational age, gravidity and educational level. ConclusionCounselling practice is poor and not very efficient. A new approach of informing pregnant women on danger signs is needed. However, as effects of antenatal care education remain largely unknown, it is very well possible that improved counselling will not affect maternal and newborn mortality and morbidity.	[Duysburgh, Els; Temmerman, Marleen] Univ Ghent, Dept Urogynaecol, Int Ctr Reprod Hlth, B-9000 Ghent, Belgium; [Ye, Maurice; Sie, Ali] Ctr Rech Sante Nouna, Nouna, Burkina Faso; [Williams, Afua; Williams, John] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Massawe, Siriel; Mpembeni, Rose] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Loukanova, Svetla] Heidelberg Univ, Dept Publ Hlth, Heidelberg, Germany; [Temmerman, Marleen] World Hlth Org, Dept Reprod Hlth & Res, Geneva, Switzerland	Duysburgh, E (reprint author), Univ Ghent, Dept Urogynaecol, Int Ctr Reprod Hlth, De Pintelaan 185 P3, B-9000 Ghent, Belgium.	els.duysburgh@ugent.be		SIE, Ali/0000-0002-3959-2520	European Union	The QUALMAT research project (Quality of Maternal and Prenatal Care: Bridging the Know-do Gap) funded as part of the 7th Framework Programme of the European Union is a collaboration between the Centre de Recherche en Sante de Nouna (Burkina Faso), Ghent University (Belgium), Heidelberg University (Germany), Karolinska Institute (Sweden), Muhimbili University of Health and Allied Sciences (Tanzania), and Navrongo Health Research Centre (Ghana). The overall objective of this research is to improve the motivation and performance of healthcare workers and ultimately the quality of prenatal and maternal care services. The intervention packages include the development and implementation of a system of performance-based incentives and a computer-assisted clinical decision support system based on WHO guidelines. The interventions are being evaluated in a pre-post-controlled study design in rural Burkina Faso, Ghana and Tanzania between 2009 and 2014.	Baker U, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-31; Duysburgh E, 2013, TROP MED INT HEALTH, V18, P534, DOI 10.1111/tmi.12076; Gagnon AJ, 2007, COCHRANE DB SYST REV, V18, P1; Ghana Statistical Service (GSS) Ghana Health Service (GHS) and ICF Macro, 2009, GHAN DEM HLTH SURV 2; Ghana Statistical Service (GSS) Ghana Health Service (GHS) Macro International, 2009, GHAN MAT HLTH SURV 2; INSD (Institut National de la Statistique et de la Demographie) et ICF International, 2012, ENQ DEM SANT IND MUL; Jennings L, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-75; Kabakyenga JK, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-33; Leonard K, 2006, SOC SCI MED, V63, P2330, DOI 10.1016/j.socscimed.2006.06.003; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Magoma M, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-64; MOH, 2006, PLAN ACC RED MORT MA; MOHSW, 2008, NAT ROAD MAP STRAT P; NBS, 2011, TANZ DEM HLTH SURV 2; Nikiema B, 2009, HEALTH POLICY PLANN, V24, P367, DOI 10.1093/heapol/czp017; Nyamtema AS, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-94; Pembe AB, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-35; Pembe AB, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-12; Population Reference Bureau (PRB), 2011, 2011 WORLD POP DAT S; Sarker Malabika, 2010, BMC Res Notes, V3, P209, DOI 10.1186/1756-0500-3-209; UNICEF, 2012, REG STAT SUBS AFR; von Both Claudia, 2006, BMC Pregnancy Childbirth, V6, P22; WHO, 2001, WHORHR0122 DEP REPR; WHO, 2010, WHOMPS1003 DEP MAK P; WHO UNFPA UNICEF and World Bank, 2006, PREGN CHILDB POSTP N; World Health Organization UNICEF UNFPA The World Bank, 2012, TRENDS MAT MORT 1990	26	11	11	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	DEC	2013	18	12					1498	1509		10.1111/tmi.12214				12	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	253AL	WOS:000327053900007	24118565	Bronze			2019-04-02	
J	Foquet, L; Hermsen, CC; van Gemert, GJ; Libbrecht, L; Sauerwein, R; Meuleman, P; Leroux-Roels, G				Foquet, Lander; Hermsen, Cornelus C.; van Gemert, Geert-Jan; Libbrecht, Louis; Sauerwein, Robert; Meuleman, Philip; Leroux-Roels, Geert			Molecular detection and quantification of Plasmodium falciparum-infected human hepatocytes in chimeric immune-deficient mice	MALARIA JOURNAL			English	Article						Humanized mouse model; Malaria; Plasmodium falciparum; Sporozoite; Liver stage; in vivo; qPCR	PREERYTHROCYTIC MALARIA VACCINES; UPA-SCID MOUSE; HUMAN LIVER; IN-VIVO; VIRUS-INFECTION; HEPATITIS-B; LIFE-CYCLE; MODEL; METABOLISM; PARASITE	Background: Chimeric mice with humanized livers represent a promising tool for infections with Plasmodium falciparum to evaluate novel methods for prevention and treatment of pre-erythrocytic stages. Adequate assessment of hepatic infections is generally compromised by the limited number of human hepatocytes infected by developing parasites. Methods: A qPCR-based method has been developed that sensitively and reliably detects P. falciparum liver stage infection of humanized mice and quantitatively expresses the results as the number of parasites per human hepatocyte. Results: This assay allows for detection of liver stage parasites after challenging humanized mice with infected mosquito bites or after intravenous injection with sporozoites. The sensitivity of the protocol, which comprises approximately 25% of the total chimeric liver, allows for the detection of a single infected hepatocyte in the analysed tissue. Conclusions: This method allows for the detection and quantification of P. falciparum parasites in chimeric mice repopulated with human hepatocytes. It will be a useful tool when studying the in vivo therapeutic and/or prophylactic qualities of novel compounds, small molecules or antibodies directed against the liver stage of P. falciparum infections.	[Foquet, Lander; Meuleman, Philip; Leroux-Roels, Geert] Univ Ghent, Ctr Vaccinol, B-9000 Ghent, Belgium; [Foquet, Lander; Libbrecht, Louis; Meuleman, Philip; Leroux-Roels, Geert] Univ Hosp, B-9000 Ghent, Belgium; [Hermsen, Cornelus C.; van Gemert, Geert-Jan; Sauerwein, Robert] Radboud Univ Nijmegen, Med Ctr, NL-6525 GA Nijmegen, Netherlands; [Libbrecht, Louis] Univ Ghent, Dept Pathol, B-9000 Ghent, Belgium	Leroux-Roels, G (reprint author), Univ Ghent, Ctr Vaccinol, Pintelaan 185, B-9000 Ghent, Belgium.	geert.lerouxroels@ugent.be	Hermsen, C.C./L-4368-2015; Sauerwein, Robert/C-8519-2013; Foquet, Lander/P-1586-2016	Foquet, Lander/0000-0001-9235-0814; Meuleman, Philip/0000-0001-6821-234X	Ghent University (GOA) [01G01712]; Belgian state [IUAP P7/47-HEPRO2]; Agency for Innovation by Science and Technology (IWT)	Research funded by grants provided by the Ghent University (GOA #01G01712) and the Belgian state (IUAP P7/47-HEPRO2); LF is funded by a PhD grant of the Agency for Innovation by Science and Technology (IWT).	Alcoser SY, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-124; Angulo-Barturen I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002252; Arnold L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018045; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Jimenez-Diaz MB, 2009, ANTIMICROB AGENTS CH, V53, P4533, DOI 10.1128/AAC.00519-09; Bissig KD, 2007, P NATL ACAD SCI USA, V104, P20507, DOI 10.1073/pnas.0710528105; Booker ML, 2010, J BIOL CHEM, V285, P33054, DOI 10.1074/jbc.M110.162081; Bukh J, 2010, J INFECT DIS, V201, P1381, DOI 10.1086/651579; De Serres M, 2011, XENOBIOTICA, V41, P464, DOI 10.3109/00498254.2011.560295; Duffy PE, 2012, EXPERT REV VACCINES, V11, P1261, DOI [10.1586/erv.12.92, 10.1586/ERV.12.92]; GARNHAM P. C. C., 1996, MALARIA PARASITES OT; Hermsen CC, 2001, MOL BIOCHEM PARASIT, V118, P247, DOI 10.1016/S0166-6851(01)00379-6; Jinj Y, 2007, INFECT IMMUN, V75, P5532, DOI 10.1128/IAI.00600-07; Leitner WW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-145; Lootens L, 2009, CLIN CHEM, V55, P1783, DOI 10.1373/clinchem.2008.119396; Macchiarini Francesca, 2005, J Exp Med, V202, P1307, DOI 10.1084/jem.20051547; Marcos R, 2006, LIVER INT, V26, P116, DOI 10.1111/j.1478-3231.2005.01201.x; Meuleman P, 2004, HEPATOLOGY, V40, p267A; Meuleman P, 2003, BIOCHEM BIOPH RES CO, V308, P375, DOI 10.1016/S0006-291X(03)01388-3; Meuleman P, 2005, HEPATOLOGY, V41, P847, DOI 10.1002/hep.20657; Meuleman P, 2012, HEPATOLOGY, V55, P364, DOI 10.1002/hep.24692; Meuleman P, 2011, HEPATOLOGY, V53, P755, DOI 10.1002/hep.24171; Meuleman P, 2008, ANTIVIR RES, V80, P231, DOI 10.1016/j.antiviral.2008.07.006; Ploemen IHJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007881; PONNUDURAI T, 1989, PARASITOLOGY, V98, P165, DOI 10.1017/S0031182000062065; Pozo OJ, 2009, DRUG METAB DISPOS, V37, P2153, DOI 10.1124/dmd.109.028373; Sacci JB, 2006, INT J PARASITOL, V36, P353, DOI 10.1016/j.jipara.2005.10.014; SACCI JB, 1992, P NATL ACAD SCI USA, V89, P3701, DOI 10.1073/pnas.89.9.3701; Sauerwein RW, 2011, NAT REV IMMUNOL, V11, P57, DOI 10.1038/nri2902; Semela D, 2010, SIGNALING PATHWAYS IN LIVER DISEASES, SECOND EDITION, P421, DOI 10.1007/978-3-642-00150-5_28; Strom SC, 2010, METHODS MOL BIOL, V640, P491, DOI 10.1007/978-1-60761-688-7_27; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; Tateno C, 2013, LAB INVEST, V93, P54, DOI 10.1038/labinvest.2012.158; Vanderberg JP, 2004, INT J PARASITOL, V34, P991, DOI 10.1016/j.ijpara.2004.05.005; Vanwolleghem T, 2010, J HEPATOL, V53, P468, DOI 10.1016/j.jhep.2010.03.024; Vaughan AM, 2012, MOL BIOCHEM PARASIT, V186, P143, DOI 10.1016/j.molbiopara.2012.10.004; Vaughan AM, 2012, J CLIN INVEST, V122, P3618, DOI 10.1172/JCI62684; Vaughan AM, 2012, FUTURE MICROBIOL, V7, P657, DOI [10.2217/FMB.12.27, 10.2217/fmb.12.27]; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Yardeni T, 2011, LAB ANIMAL, V40, P155, DOI 10.1038/laban0511-155; YOELI M, 1966, MIL MED, V131, P900; Yoshizato K, 2009, EXPERT OPIN DRUG MET, V5, P1435, DOI 10.1517/17425250903216664	42	13	13	0	7	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	NOV 24	2013	12								430	10.1186/1475-2875-12-430				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	281NB	WOS:000329107200001	24267791	DOAJ Gold, Green Published			2019-04-02	
J	Canier, L; Khim, N; Kim, S; Sluydts, V; Heng, S; Dourng, D; Eam, R; Chy, S; Khean, C; Loch, K; Ken, M; Lim, H; Siv, S; Tho, S; Masse-Navette, P; Gryseels, C; Uk, S; Van Roey, K; Grietens, KP; Sokny, M; Thavrin, B; Chuor, CM; Deubel, V; Dumez, L; Coosemans, M; Menard, D				Canier, Lydie; Khim, Nimol; Kim, Saorin; Sluydts, Vincent; Heng, Somony; Dourng, Dany; Eam, Rotha; Chy, Sophy; Khean, Chanra; Loch, Kaknika; Ken, Malen; Lim, Hokkean; Siv, Sovannaroath; Tho, Sochantha; Masse-Navette, Pascal; Gryseels, Charlotte; Uk, Sambunny; Van Roey, Karel; Grietens, Koen Peeters; Sokny, Mao; Thavrin, Boukheng; Chuor, Char Meng; Deubel, Vincent; Dumez, Lies; Coosemans, Marc; Menard, Didier			An innovative tool for moving malaria PCR detection of parasite reservoir into the field	MALARIA JOURNAL			English	Article							POLYMERASE-CHAIN-REACTION; RAPID DIAGNOSTIC-TEST; PLASMODIUM-FALCIPARUM; WESTERN CAMBODIA	Background: To achieve the goal of malaria elimination in low transmission areas such as in Cambodia, new, inexpensive, high-throughput diagnostic tools for identifying very low parasite densities in asymptomatic carriers are required. This will enable a switch from passive to active malaria case detection in the field. Methods: DNA extraction and real-time PCR assays were implemented in an "in-house" designed mobile laboratory allowing implementation of a robust, sensitive and rapid malaria diagnostic strategy in the field. This tool was employed in a survey organized in the context of the MalaResT project (NCT01663831). Results: The real-time PCR screening and species identification assays were performed in the mobile laboratory between October and November 2012, in Rattanakiri Province, to screen approximately 5,000 individuals in less than four weeks and treat parasite carriers within 24-48 hours after sample collection. An average of 240 clinical samples (and 40 quality control samples) was tested every day, six/seven days per week. Some 97.7% of the results were available < 24 hours after the collection. A total of 4.9% were positive for malaria. Plasmodium vivax was present in 61.1% of the positive samples, Plasmodium falciparum in 45.9%, Plasmodium malariae in 7.0% and Plasmodium ovale in 2.0%. Conclusions: The operational success of this diagnostic set-up proved that molecular testing and subsequent treatment is logistically achievable in field settings. This will allow the detection of clusters of asymptomatic carriers and to provide useful epidemiological information. Fast results will be of great help for staff in the field to track and treat asymptomatic parasitaemic cases. The concept of the mobile laboratory could be extended to other countries for the molecular detection of malaria or other pathogens, or to culture vivax parasites, which does not support long-time delay between sample collection and culture.	[Canier, Lydie; Khim, Nimol; Kim, Saorin; Heng, Somony; Dourng, Dany; Eam, Rotha; Chy, Sophy; Khean, Chanra; Loch, Kaknika; Ken, Malen; Lim, Hokkean; Masse-Navette, Pascal; Deubel, Vincent; Menard, Didier] Inst Pasteur Cambodge, Phnom Penh, Cambodia; [Sluydts, Vincent; Heng, Somony; Gryseels, Charlotte; Van Roey, Karel; Grietens, Koen Peeters; Dumez, Lies; Coosemans, Marc] Inst Trop Med, B-2000 Antwerp, Belgium; [Siv, Sovannaroath; Tho, Sochantha; Uk, Sambunny; Sokny, Mao; Thavrin, Boukheng; Chuor, Char Meng] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Coosemans, Marc] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium	Menard, D (reprint author), Inst Pasteur Cambodge, Phnom Penh, Cambodia.	dmenard@pasteur-kh.org	; Menard, Didier/O-3294-2013	Gryseels, Charlotte/0000-0002-8963-4469; Peeters Grietens, Koen/0000-0001-6570-9887; Menard, Didier/0000-0003-1357-4495	Bill & Melinda Gates Foundation [OPP1032354]; Directorate-General for Development Co-operation of Belgium; French Ministry of Foreign Affairs	We thank everyone in Ratanakiri province for participating in the study. We are grateful to people involved in the project entitled "Repellents as added control measure to long lasting insecticidal nets to target the residual transmission in southeast Asia: a step forwards to malaria elimination", especially health workers and staff of the Ministry of Health of Cambodia in Rattanakiri, the National Center for Parasitology, Entomology and Malaria Control, the Institute of Tropical Medicine of Antwerp (ITMA) and the Institut Pasteur in Cambodia (IPC) for their collaboration. This study was supported by a grant (# OPP1032354) from the Bill & Melinda Gates Foundation and the Directorate-General for Development Co-operation of Belgium (Institutional Collaboration between CNM and the Institute of Tropical Medicine, Belgium). Didier Menard is supported by the French Ministry of Foreign Affairs. Samples collected in Burkina Faso and Uganda in 2011-2012 as part of a study of malaria in pregnancy (NCT01555255) were provided by the Foundation for Innovative New Diagnostics, Kampala, Uganda and Geneva, Switzerland; Institut de Recherche en Sciences de la Sante, Direction Regionale de l'Ouest, Bobo-Dioulasso, Burkina Faso; and TDR, the Special Programme for Research and Training in Tropical Diseases, Geneva, Switzerland); the study was approved by all relevant ethics review boards and all study participants gave written informed consent.	Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; Chou M, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-295; Cui LW, 2012, ACTA TROP, V121, P227, DOI 10.1016/j.actatropica.2011.02.016; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Farrugia C, 2011, J CLIN MICROBIOL, V49, P2191, DOI 10.1128/JCM.02156-10; Gurarie D, 2011, PLOS ONE, V7; Haanshuus CG, 2012, MALARIA J, V12, P26; Hoyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045797; Incardona S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-37; Kyaw MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057689; Leang R, 2013, ANTIMICROB AGENTS CH, V57, P818, DOI 10.1128/AAC.00686-12; *MALERA CONS GROUP, 2011, PLOS MED, V0008; Maurin M, 2012, EXPERT REV MOL DIAGN, V12, P731, DOI [10.1586/erm.12.53, 10.1586/ERM.12.53]; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Proux S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-323; Rakotonirina H, 2008, AM J TROP MED HYG, V78, P217, DOI 10.4269/ajtmh.2008.78.217; Singh B, 1999, AM J TROP MED HYG, V60, P687, DOI 10.4269/ajtmh.1999.60.687; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Snounou Georges, 2002, Methods Mol Med, V72, P189, DOI 10.1385/1-59259-271-6:189; Steenkeste N, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-86; Tran TH, 2013, MALARIA J, V11, P355; WATERS AP, 1989, LANCET, V1, P1343; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2007, MAL EL FIELD MAN LOW; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119	27	53	55	0	12	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	NOV 9	2013	12								405	10.1186/1475-2875-12-405				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	281LZ	WOS:000329104400003	24206649	DOAJ Gold, Green Published			2019-04-02	
J	Mereta, ST; Yewhalaw, D; Boets, P; Ahmed, A; Duchateau, L; Speybroeck, N; Vanwambeke, SO; Legesse, W; De Meester, L; Goethals, PLM				Mereta, Seid Tiku; Yewhalaw, Delenasaw; Boets, Pieter; Ahmed, Abdulhakim; Duchateau, Luc; Speybroeck, Niko; Vanwambeke, Sophie O.; Legesse, Worku; De Meester, Luc; Goethals, Peter L. M.			Physico-chemical and biological characterization of anopheline mosquito larval habitats (Diptera: Culicidae): implications for malaria control	PARASITES & VECTORS			English	Article						Decision trees; Generalized linear model; Macroinvertebrate predators; Mosquito control; Mosquito larvae	LAND-USE; PREDATION; SELECTION; CLIMATE; CLASSIFICATION; PRODUCTIVITY; SUPPRESSION; ARABIENSIS; ABUNDANCE; NORTHERN	Background: A fundamental understanding of the spatial distribution and ecology of mosquito larvae is essential for effective vector control intervention strategies. In this study, data-driven decision tree models, generalized linear models and ordination analysis were used to identify the most important biotic and abiotic factors that affect the occurrence and abundance of mosquito larvae in Southwest Ethiopia. Methods: In total, 220 samples were taken at 180 sampling locations during the years 2010 and 2012. Sampling sites were characterized based on physical, chemical and biological attributes. The predictive performance of decision tree models was evaluated based on correctly classified instances (CCI), Cohen's kappa statistic (kappa) and the determination coefficient (R-2). A conditional analysis was performed on the regression tree models to test the relation between key environmental and biological parameters and the abundance of mosquito larvae. Results: The decision tree model developed for anopheline larvae showed a good model performance (CCI = 84 +/- 2%, and kappa = 0.66 +/- 0.04), indicating that the genus has clear habitat requirements. Anopheline mosquito larvae showed a widespread distribution and especially occurred in small human-made aquatic habitats. Water temperature, canopy cover, emergent vegetation cover, and presence of predators and competitors were found to be the main variables determining the abundance and distribution of anopheline larvae. In contrast, anopheline mosquito larvae were found to be less prominently present in permanent larval habitats. This could be attributed to the high abundance and diversity of natural predators and competitors suppressing the mosquito population densities. Conclusions: The findings of this study suggest that targeting smaller human-made aquatic habitats could result in effective larval control of anopheline mosquitoes in the study area. Controlling the occurrence of mosquito larvae via drainage of permanent wetlands may not be a good management strategy as it negatively affects the occurrence and abundance of mosquito predators and competitors and promotes an increase in anopheline population densities.	[Mereta, Seid Tiku] Jimma Univ, Dept Environm Hlth Sci & Technol, Jimma, Ethiopia; [Yewhalaw, Delenasaw] Jimma Univ, Dept Biol, Jimma, Ethiopia; [Mereta, Seid Tiku; Boets, Pieter; Goethals, Peter L. M.] Univ Ghent, Lab Environm Toxicol & Aquat Ecol, B-9000 Ghent, Belgium; [Ahmed, Abdulhakim] Jimma Univ, Dept Geog, Jimma, Ethiopia; [Duchateau, Luc] Univ Ghent, Dept Comparat Physiol & Biometr, B-9000 Ghent, Belgium; [Speybroeck, Niko] Catholic Univ Louvain, Inst Hlth & Soc IRSS, B-1200 Brussels, Belgium; [Vanwambeke, Sophie O.] Catholic Univ Louvain, Earth & Life Inst, Georges Lemaitre Ctr Earth & Climate Res, B-1348 Louvain, Belgium; [Legesse, Worku] Univ Connecticut, Dept Environm Engn, Storrs, CT USA; [De Meester, Luc] Univ Louvain, Lab Aquat Ecol Evolut & Conservat, B-3000 Louvain, Belgium	Boets, P (reprint author), Univ Ghent, Lab Environm Toxicol & Aquat Ecol, J Plateaustr 22, B-9000 Ghent, Belgium.	pieter.boets@ugent.be	De Meester, Luc/F-3832-2015	De Meester, Luc/0000-0001-5433-6843; Vanwambeke, Sophie/0000-0001-6620-6173	VLIR-UOS; VLIR; Fund for Scientific Research (FWO-Vlaanderen)	The authors are grateful to VLIR-UOS for financing this study. STM is a recipient of an IUC (Institutional University Cooperation) PhD scholarship from VLIR to carry out this work. The authors wish to thank all people who helped with field work, and the IUC Jimma University program management team for logistic support. The authors would like to thank the two anonymous reviewers for their constructive comments that helped to improve the manuscript. PB is holder of a postdoctoral grant from the Fund for Scientific Research (FWO-Vlaanderen).	Afrane YA, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-233; Alemu A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-30; American Public Health Association (APHA), 1995, STANDARD METHODS EXA; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Antonio-Nkondjio C, 2009, ACTA TROP, V112, P270, DOI 10.1016/j.actatropica.2009.08.009; Ayala D, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-307; Balkew M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-40; Barbour MT, 1996, J N AM BENTHOL SOC, V15, P185, DOI 10.2307/1467948; Berg JA, 2010, WETLAND SCI PRACT SE, V2, P24; Blaustein L, 2004, OECOLOGIA, V138, P300, DOI 10.1007/s00442-003-1398-x; Bond JG, 2005, ECOL ENTOMOL, V30, P255, DOI 10.1111/j.0307-6946.2005.00704.x; Bouchard Jr R.W., 2004, GUIDE AQUATIC MACROI, P208; Breiman L, 1984, CLASSIFICATION REGRE; Broadbent EN, 2008, BIOL CONSERV, V141, P1745, DOI 10.1016/j.biocon.2008.04.024; Castro MC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000693; CHARBONNEAU CS, 1994, ENVIRON TOXICOL CHEM, V13, P267, DOI 10.1897/1552-8618(1994)13[267:EOBTVI]2.0.CO;2; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Culler LE, 2009, FRESHWATER BIOL, V54, P2003, DOI 10.1111/j.1365-2427.2009.02230.x; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Fradin MS, 1998, ANN INTERN MED, V128, P931, DOI 10.7326/0003-4819-128-11-199806010-00013; Gabriels W, 2007, AQUAT ECOL, V41, P427, DOI 10.1007/s10452-007-9081-7; Gabriels W, 2010, LIMNOLOGICA, V40, P199, DOI 10.1016/j.limno.2009.10.001; Ghebreyesus TA, 1999, BRIT MED J, V319, P663, DOI 10.1136/bmj.319.7211.663; Githeko AK, 2000, B WHO, V78; Gouagna LC, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-96; Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a; Jongman RHG, 1995, TONGEREN OER DATA AN; Kamdem C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039453; Kenea O, 2011, J VECTOR DIS, V48, P85; Knight TM, 2004, J VECTOR ECOL, V29, P277; Kweka EJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-128; Lambin EF, 2006, LAND LAND COVER CHAN; Lewis RJ, 2013, 2000 ANN M SOC AC EM, DOI 10.1.1.95.4103; Li L, 2011, ACTA TROP, V119, P30, DOI 10.1016/j.actatropica.2011.04.003; Li L, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-70; Maguire M, 1999, INT J ENVIRON HEAL R, V9, P253, DOI 10.1080/09603129973047; Mereta ST, 2012, ECOL INFORM, V7, P52, DOI 10.1016/j.ecoinf.2011.11.005; Millenium Ecosystem Assessment, 2005, MILL EC ASS EC HUM W; Minakawa N, 1999, AM J TROP MED HYG, V61, P1010, DOI 10.4269/ajtmh.1999.61.1010; Mutuku FM, 2006, AM J TROP MED HYG, V74, P54, DOI 10.4269/ajtmh.2006.74.54; Muturi EJ, 2008, J VECTOR ECOL, V33, P56, DOI 10.3376/1081-1710(2008)33[56:EFAWTD]2.0.CO;2; Norris DE, 2004, ECOHEALTH, V1, P19, DOI DOI 10.1007/S10393-004-0008-7; Obsomer V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050475; Otieno VO, 2012, CLIM RES, V52, P77, DOI 10.3354/cr01050; Paaijmans KP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-196; Parsons M., 2001, AUSTR RIVER ASSESSME; Pfaehler O, 2006, J VECTOR ECOL, V31, P400, DOI 10.3376/1081-1710(2006)31[400:IOSQIT]2.0.CO;2; Posa MRC, 2006, BIOL CONSERV, V129, P256, DOI 10.1016/j.biocon.2005.10.041; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Quinlan J., 1993, C4 5 PROGRAMS MACHIN; Shaalan EAS, 2009, TROP BIOMED, V26, P223; Shililu J, 2003, AM J TROP MED HYG, V69, P295, DOI 10.4269/ajtmh.2003.69.295; Society of Wetland scientists (SWS), 2009, CURR PRACT WETL MAN; Speybroeck N, 2012, INT J PUBLIC HEALTH, V57, P243, DOI 10.1007/s00038-011-0315-z; *STATS INC, 2004, STATISTICA DAT AN SO; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; TERBRAAK CJF, 1988, ADV ECOL RES, V18, P271; Tomanova S, 2006, HYDROBIOLOGIA, V556, P251, DOI 10.1007/s10750-005-1255-5; Walker K, 2007, MED VET ENTOMOL, V21, P2, DOI 10.1111/j.1365-2915.2007.00674.x; WHO, 1982, WHO OFFS PUBL, V66; WHO, 2005, WORK AFR NETW VECT R; Witten I.H., 2005, DATA MINING PRACTICA, P369; World Health Organization (WHO), 2004, GLOB BURD DIS 2004 U; Yasuoka J, 2006, T ROY SOC TROP MED H, V100, P995, DOI 10.1016/j.trstmh.2005.12.014; Yewhalaw D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016066; Yewhalaw D, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-21	67	17	17	1	27	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	NOV 4	2013	6								320	10.1186/1756-3305-6-320				16	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	277PG	WOS:000328831100004	24499518	DOAJ Gold, Green Published			2019-04-02	
J	Kane, RA; Stothard, JR; Rollinson, D; Leclipteux, T; Evraerts, J; Standley, CJ; Allan, F; Betson, M; Kaba, R; Mertens, P; Laurent, T				Kane, Richard A.; Stothard, J. Russell; Rollinson, David; Leclipteux, Thierry; Evraerts, Jonathan; Standley, Claire J.; Allan, Fiona; Betson, Martha; Kaba, Rehana; Mertens, Pascal; Laurent, Thierry			Detection and quantification of schistosome DNA in freshwater snails using either fluorescent probes in real-time PCR or oligochromatographic dipstick assays targeting the ribosomal intergenic spacer	ACTA TROPICA			English	Article						Schistosomiasis; Ribosomal intergenic spacer; Real-time PCR; Locked nucleic acid (LNA) probes; Oligochromatography; Molecular epidemiology	INTERNAL TRANSCRIBED SPACER; CHAIN-REACTION ASSAY; REPETITIVE SEQUENCES; EARLY PREPATENCY; MULTIPLEX PCR; MANSONI; HAEMATOBIUM; IDENTIFICATION; INFECTION; DIAGNOSIS	Several DNA probes were designed for use in real-time polymerase chain reaction (PCR) assays to target sequence variation within the ribosomal intergenic spacer (IGS) of schistosomes. A sub-section of the IGS (similar to 300 bp) was amplified, with cross-specific primers, after which group-specific fluorescent, locked nucleic acid probes were assessed for their ability to differentiate and quantify DNA from Schistosoma haematobium and Schistosoma mansoni group parasites. A number of fluorescent probe candidates were screened and validated against genomic DNA from adult schistosome worms and laboratory infected freshwater snails. Two fluorescent, locked nucleic acid probes ShaemLNA5 and SmanLNA2, of 20-26 bp in length, were identified and found to be effective in providing evidence of infection in field-collected snails. To adapt these real-time PCR assays for more resource-poor laboratory settings, a PCR-restriction fragment length polymorphism (RFLP) assay was developed and primer/probe combinations were modified for use in oligochromatography, a DNA 'dipstick' technology. An appropriate dipstick was developed, inclusive of internal amplification and amplicon migration controls that could be of particular importance for assessing schistosome transmission dynamics. These assays and tools also have future potential for use in detection of schistosome infections in humans and livestock. (C) 2013 Published by Elsevier B.V.	[Kane, Richard A.; Stothard, J. Russell; Rollinson, David; Standley, Claire J.; Allan, Fiona; Betson, Martha] Nat Hist Museum, Dept Zool, Wolfson Wellcome Biomed Labs, London SW7 5BD, England; [Leclipteux, Thierry; Evraerts, Jonathan; Mertens, Pascal; Laurent, Thierry] Coris BioConcept, R&D Dept, B-5032 Gembloux, Belgium; [Kaba, Rehana] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England	Stothard, JR (reprint author), Univ Liverpool, Liverpool Sch Trop Med, Dis Control Strategy Grp, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.	jrstoth@liverpool.ac.uk	Betson, Martha/D-3818-2014; Rollinson, David/C-7406-2009; Stothard, Russell/I-9717-2016	Betson, Martha/0000-0002-4220-3290; Stothard, Russell/0000-0002-9370-3420	European Union (FP6 STREP CONTRAST project) [032203]	The study benefited from primary support from the European Union (FP6 STREP CONTRAST project, contract no. 032203). We are grateful to the field teams of Zanzibar and Uganda who helped provide us with the field-collected snails.	Abath FGC, 2006, MEM I OSWALDO CRUZ, V101, P145, DOI 10.1590/S0074-02762006000900023; Abbasi I, 2010, AM J TROP MED HYG, V83, P427, DOI 10.4269/ajtmh.2010.09-0764; Akinwale OP, 2008, MOL BIOCHEM PARASIT, V160, P167, DOI 10.1016/j.molbiopara.2008.04.003; Akinwale O.P., 2010, J HELMINTHOL, V85, P283; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ameziane N., 2004, PRECLIN RES ARTICLES, V2, P275; [Anonymous], 2006, PREV CHEM HUM HELM C; Brown D. S., 1994, FRESHWATER SNAILS AF; Chitsulo L, 2000, ACTA TROP, V77, P41, DOI 10.1016/S0001-706X(00)00122-4; Copeland CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-464; Deborggraeve S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000450; Hamburger J, 1998, AM J TROP MED HYG, V59, P872, DOI 10.4269/ajtmh.1998.59.872; Hamburger J, 2001, AM J TROP MED HYG, V65, P907, DOI 10.4269/ajtmh.2001.65.907; Hanelt B, 1997, J PARASITOL, V83, P387, DOI 10.2307/3284399; Hung YW, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000337; Huyse T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000571; Jannotti-Passos LK, 2006, J PARASITOL, V92, P401, DOI 10.1645/GE-593R1.1; Kane RA, 1998, PARASITOLOGY, V117, P235, DOI 10.1017/S0031182098003059; KANE RA, 1994, MOL BIOCHEM PARASIT, V63, P153, DOI 10.1016/0166-6851(94)90018-3; Kane RA, 1996, MOL BIOCHEM PARASIT, V75, P265, DOI 10.1016/0166-6851(95)02525-1; King CH, 2009, NEW ENGL J MED, V360, P106, DOI 10.1056/NEJMp0808041; SIMPSON AJG, 1984, EUR J BIOCHEM, V139, P41, DOI 10.1111/j.1432-1033.1984.tb07973.x; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Stensgaard AS, 2013, ACTA TROP, V128, P378, DOI 10.1016/j.actatropica.2011.11.010; Stothard JR, 2009, T ROY SOC TROP MED H, V103, P325, DOI 10.1016/j.trstmh.2008.12.012; Stothard JR, 1996, ACTA TROP, V61, P19, DOI 10.1016/0001-706X(95)00137-4; ten Hove RJ, 2008, T ROY SOC TROP MED H, V102, P179, DOI 10.1016/j.trstmh.2007.10.011; Utzinger J, 2009, PARASITOLOGY, V136, P1859, DOI 10.1017/S0031182009991600; Webster BL, 2010, J HELMINTHOL, V84, P107, DOI 10.1017/S0022149X09990447; Xu J, 2010, INT J PARASITOL, V40, P327, DOI 10.1016/j.ijpara.2009.08.010	30	15	16	0	19	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	NOV	2013	128	2			SI		241	249		10.1016/j.actatropica.2011.10.019				9	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	249IW	WOS:000326771900008	22100540				2019-04-02	
J	Deribe, K; Tomczyk, S; Tekola-Ayele, F				Deribe, Kebede; Tomczyk, Sara; Tekola-Ayele, Fasil			Ten Years of Podoconiosis Research in Ethiopia	PLOS NEGLECTED TROPICAL DISEASES			English	Article							NON-FILARIAL ELEPHANTIASIS; SOUTHERN ETHIOPIA; WEST ETHIOPIA; WOREDA		[Deribe, Kebede] Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Deribe, Kebede] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia; [Tomczyk, Sara] Inst Trop Med, B-2000 Antwerp, Belgium; [Tekola-Ayele, Fasil] NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20892 USA	Deribe, K (reprint author), Brighton & Sussex Med Sch, Brighton, E Sussex, England.	kebededeka@yahoo.com		Deribe, Kebede/0000-0002-8526-6996; Tekola-Ayele, Fasil/0000-0003-4194-9370	Wellcome Trust [099876]		Alemu G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001184; Ayele FT, 2012, J COMMUN GENET, V3, P303, DOI 10.1007/s12687-012-0086-0; Ayele FT, 2013, INT HEALTH, V5, P119, DOI 10.1093/inthealth/iht003; Ayele FT, 2012, NEW ENGL J MED, V366, P1200, DOI 10.1056/NEJMoa1108448; Davey G, 2007, T ROY SOC TROP MED H, V101, P1175, DOI 10.1016/j.trstmh.2007.08.013; Davey G, 2007, T ROY SOC TROP MED H, V101, P91, DOI 10.1016/j.trstmh.2006.05.002; Debrah AY, 2006, PLOS PATHOG, V2, P829, DOI 10.1371/journal.ppat.0020092; Desta K, 2003, SO ETHIOPIA TROP DOC, V32, P217; Henok L, 2008, BRIT J DERMATOL, V159, P903, DOI 10.1111/j.1365-2133.2008.08773.x; Molla YB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001744; Oli GG, 2012, TROP MED INT HEALTH, V17, P722, DOI 10.1111/j.1365-3156.2012.02978.x; Price E., 1990, PODOCONIOSIS NONFILA; Tekola F, 2008, TROP MED INT HEALTH, V13, P1277, DOI 10.1111/j.1365-3156.2008.02133.x; Tekola F, 2006, TROP MED INT HEALTH, V11, P1136, DOI 10.1111/j.1365-3156.2006.01658.x; Yakob B, 2008, T ROY SOC TROP MED H, V102, P439, DOI 10.1016/j.trstmh.2008.01.023	15	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	OCT	2013	7	10							e2301	10.1371/journal.pntd.0002301				4	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	299DW	WOS:000330376500003	24130908	DOAJ Gold, Green Published			2019-04-02	
J	Graf, FE; Ludin, P; Wenzler, T; Kaiser, M; Brun, R; Pyana, PP; Buscher, P; de Koning, HP; Horn, D; Maser, P				Graf, Fabrice E.; Ludin, Philipp; Wenzler, Tanja; Kaiser, Marcel; Brun, Reto; Pyana, Patient Pati; Buescher, Philippe; de Koning, Harry P.; Horn, David; Maeser, Pascal			Aquaporin 2 Mutations in Trypanosoma brucei gambiense Field Isolates Correlate with Decreased Susceptibility to Pentamidine and Melarsoprol	PLOS NEGLECTED TROPICAL DISEASES			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; NITROIMIDAZOLE DRUG CANDIDATE; SLEEPING SICKNESS PATIENTS; ADENOSINE TRANSPORTER; RESISTANT TRYPANOSOMES; NUCLEOSIDE TRANSPORTER; DIMINAZENE ACETURATE; 3 AQUAGLYCEROPORINS; CROSS-RESISTANCE; DIAMIDINE DRUGS	The predominant mechanism of drug resistance in African trypanosomes is decreased drug uptake due to loss-of-function mutations in the genes for the transporters that mediate drug import. The role of transporters as determinants of drug susceptibility is well documented from laboratory-selected Trypanosoma brucei mutants. But clinical isolates, especially of T. b. gambiense, are less amenable to experimental investigation since they do not readily grow in culture without prior adaptation. Here we analyze a selected panel of 16 T. brucei ssp. field isolates that (i) have been adapted to axenic in vitro cultivation and (ii) mostly stem from treatment-refractory cases. For each isolate, we quantify the sensitivity to melarsoprol, pentamidine, and diminazene, and sequence the genomic loci of the transporter genes TbAT1 and TbAQP2. The former encodes the well-characterized aminopurine permease P2 which transports several trypanocides including melarsoprol, pentamidine, and diminazene. We find that diminazene-resistant field isolates of T. b. brucei and T. b. rhodesiense carry the same set of point mutations in TbAT1 that was previously described from lab mutants. Aquaglyceroporin 2 has only recently been identified as a second transporter involved in melarsoprol/pentamidine cross-resistance. Here we describe two different kinds of TbAQP2 mutations found in T. b. gambiense field isolates: simple loss of TbAQP2, or loss of wild-type TbAQP2 allele combined with the formation of a novel type of TbAQP2/3 chimera. The identified mutant T. b. gambiense are 40- to 50-fold less sensitive to pentamidine and 3- to 5-times less sensitive to melarsoprol than the reference isolates. We thus demonstrate for the first time that rearrangements of the TbAQP2/TbAQP3 locus accompanied by TbAQP2 gene loss also occur in the field, and that the T. b. gambiense carrying such mutations correlate with a significantly reduced susceptibility to pentamidine and melarsoprol.	[Graf, Fabrice E.; Ludin, Philipp; Wenzler, Tanja; Kaiser, Marcel; Brun, Reto; Maeser, Pascal] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Graf, Fabrice E.; Ludin, Philipp; Wenzler, Tanja; Kaiser, Marcel; Brun, Reto; Maeser, Pascal] Univ Basel, Basel, Switzerland; [Pyana, Patient Pati] Inst Natl Rech Biomed, Kinshasa, Zaire; [Pyana, Patient Pati; Buescher, Philippe] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [de Koning, Harry P.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Horn, David] Univ Dundee, Coll Life Sci, Dundee, Scotland	Graf, FE (reprint author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	pascal.maeser@unibas.ch	Buscher, Philippe/B-9956-2012	Buscher, Philippe/0000-0002-1926-7472; Graf, Fabrice/0000-0003-1132-5348; Kaiser, Marcel/0000-0003-1785-7302; Maser, Pascal/0000-0003-3122-1941; De Koning, Harry/0000-0002-9963-1827; Wenzler, Tanja/0000-0001-8637-1344; Horn, David/0000-0001-5173-9284	Swiss National Science Foundation [31003A_135746]; Institute of Tropical Medicine; Emilia Guggenheim-Schnurr Foundation; Mathieu-Stiftung; Freiwillige Akademische Gesellschaft Basel; Wellcome Trust [100320/Z/12/Z]; Medical Research Council [G0701258, MR/K000500/1]	This work was supported by the Swiss National Science Foundation (31003A_135746). PPP received a PhD grant from the Institute of Tropical Medicine; PL received fellowships from the Emilia Guggenheim-Schnurr Foundation, the Mathieu-Stiftung, and the Freiwillige Akademische Gesellschaft Basel; DH is funded by a Wellcome Trust Senior Investigator Award (100320/Z/12/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsford S, 2012, NATURE, V482, P232, DOI 10.1038/nature10771; Baker N, 2013, TRENDS PARASITOL, V29, P110, DOI 10.1016/j.pt.2012.12.005; Baker N, 2012, P NATL ACAD SCI USA, V109, P10996, DOI 10.1073/pnas.1202885109; Baker N, 2011, MOL BIOCHEM PARASIT, V176, P55, DOI 10.1016/j.molbiopara.2010.11.010; BALTZ T, 1985, EMBO J, V4, P1273, DOI 10.1002/j.1460-2075.1985.tb03772.x; Bassarak B, 2011, CELL PHYSIOL BIOCHEM, V27, P411, DOI 10.1159/000327968; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bridges DJ, 2007, MOL PHARMACOL, V71, P1098, DOI 10.1124/mol.106.031351; Brun R, 2001, TROP MED INT HEALTH, V6, P906, DOI 10.1046/j.1365-3156.2001.00775.x; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Burkard GS, 2011, MOL BIOCHEM PARASIT, V175, P91, DOI 10.1016/j.molbiopara.2010.09.002; Burri C., 2004, The trypanosomiases, P403, DOI 10.1079/9780851994758.0403; BURRI C, 1993, CHEMOTHERAPY, V39, P225, DOI 10.1159/000239130; CARTER NS, 1995, J BIOL CHEM, V270, P28153; CARTER NS, 1993, NATURE, V361, P173, DOI 10.1038/361173a0; de Koning HP, 2008, TRENDS PARASITOL, V24, P345, DOI 10.1016/j.pt.2008.04.006; de Koning HP, 2004, ANTIMICROB AGENTS CH, V48, P1515, DOI 10.1128/AAC.48.5.1515-1519.2004; de Koning HP, 2001, MOL PHARMACOL, V59, P586; Ehrlich P, 1907, BERL KLIN WOCHENZEIT, V44; FELGNER P, 1981, TROPENMED PARASITOL, V32, P134; FROMMEL TO, 1987, MOL BIOCHEM PARASIT, V26, P183, DOI 10.1016/0166-6851(87)90142-3; Gourbal B, 2004, J BIOL CHEM, V279, P31010, DOI 10.1074/jbc.M403959200; Gupta AB, 2012, NUCLEIC ACIDS RES, V40, pD362, DOI 10.1093/nar/gkr914; Hawking F, 1937, J PHARMACOL EXP THER, V59, P123; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Jackson AP, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000658; Jacobs RT, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001151; Kaiser M, 2011, ANTIMICROB AGENTS CH, V55, P5602, DOI 10.1128/AAC.00246-11; KAMINSKY R, 1989, EXP PARASITOL, V69, P281, DOI 10.1016/0014-4894(89)90074-X; KAMINSKY R, 1989, J PARASITOL, V75, P42, DOI 10.2307/3282933; Kazibwe AJN, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000523; Kennedy PGE, 2008, ANN NEUROL, V64, P116, DOI 10.1002/ana.21429; Likeufack ACL, 2006, ACTA TROP, V100, P11, DOI 10.1016/j.actatropica.2006.09.003; Liu ZJ, 2002, P NATL ACAD SCI USA, V99, P6053, DOI 10.1073/pnas.092131899; Maser P, 2012, CURR OPIN PHARMACOL, V12, P562, DOI 10.1016/j.coph.2012.05.001; Maina N, 2007, ACTA TROP, V104, P84, DOI 10.1016/j.actatropica.2007.07.007; Maina NWN, 2007, T ROY SOC TROP MED H, V101, P540, DOI 10.1016/j.trstmh.2006.11.008; Maser P, 2003, DRUG RESIST UPDATE, V6, P281, DOI 10.1016/j.drup.2003.09.001; Maser P, 1999, SCIENCE, V285, P242, DOI 10.1126/science.285.5425.242; Matovu E, 2003, EUKARYOT CELL, V2, P1003, DOI 10.1128/EC.2.5.1003-1008.2003; Matovu E, 2001, MOL BIOCHEM PARASIT, V117, P73, DOI 10.1016/S0166-6851(01)00332-2; Matovu E, 1997, TROP MED INT HEALTH, V2, P13, DOI 10.1046/j.1365-3156.1997.d01-122.x; Munday JC, 2013, INT J PARASITOL-DRUG, V3, P69, DOI 10.1016/j.ijpddr.2013.01.004; Nare B, 2010, ANTIMICROB AGENTS CH, V54, P4379, DOI 10.1128/AAC.00498-10; Nerima B, 2007, TROP MED INT HEALTH, V12, P1361, DOI 10.1111/j.1365-3156.2007.01918.x; Pyana PP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001025; Raz B, 1997, ACTA TROP, V68, P139, DOI 10.1016/S0001-706X(97)00079-X; RICHNER D, 1988, ACTA TROP, V45, P309; ROLLO IM, 1951, NATURE, V167, P147, DOI 10.1038/167147a0; Stewart ML, 2010, EUKARYOT CELL, V9, P336, DOI 10.1128/EC.00200-09; Teka IA, 2011, MOL PHARMACOL, V80, P110, DOI 10.1124/mol.111.071555; Torreele E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000923; Uzcategui NL, 2004, J BIOL CHEM, V279, P42669, DOI 10.1074/jbc.M404518200; Vincent IM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001204; ZWEYGARTH E, 1989, PARASITOL RES, V75, P178, DOI 10.1007/BF00931271	55	36	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	OCT	2013	7	10							e2475	10.1371/journal.pntd.0002475				7	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	299DW	WOS:000330376500015	24130910	DOAJ Gold, Green Published			2019-04-02	
J	Lemaire, J; Mkannez, G; Guerfali, FZ; Gustin, C; Attia, H; Sghaier, RM; Dellagi, K; Laouini, D; Renard, P				Lemaire, Julien; Mkannez, Ghada; Guerfali, Fatma Z.; Gustin, Cindy; Attia, Hanene; Sghaier, Rabiaa M.; Dellagi, Koussay; Laouini, Dhafer; Renard, Patricia		Sysco-Consortium	MicroRNA Expression Profile in Human Macrophages in Response to Leishmania major Infection	PLOS NEGLECTED TROPICAL DISEASES			English	Article							NF-KAPPA-B; MONOCYTE CHEMOTACTIC PROTEIN-1; TRANSCRIPTION FACTOR; MIR-210 EXPRESSION; INDUCED APOPTOSIS; NITRIC-OXIDE; SURVIVAL; ACTIVATION; MECHANISMS; INHIBITION	Background: Leishmania (L.) are intracellular protozoan parasites able to survive and replicate in the hostile phagolysosomal environment of infected macrophages. They cause leishmaniasis, a heterogeneous group of worldwide-distributed affections, representing a paradigm of neglected diseases that are mainly embedded in impoverished populations. To establish successful infection and ensure their own survival, Leishmania have developed sophisticated strategies to subvert the host macrophage responses. Despite a wealth of gained crucial information, these strategies still remain poorly understood. MicroRNAs (miRNAs), an evolutionarily conserved class of endogenous 22-nucleotide non-coding RNAs, are described to participate in the regulation of almost every cellular process investigated so far. They regulate the expression of target genes both at the levels of mRNA stability and translation; changes in their expression have a profound effect on their target transcripts. Methodology/Principal Findings: We report in this study a comprehensive analysis of miRNA expression profiles in L. major-infected human primary macrophages of three healthy donors assessed at different time-points post-infection (three to 24 h). We show that expression of 64 out of 365 analyzed miRNAs was consistently deregulated upon infection with the same trends in all donors. Among these, several are known to be induced by TLR-dependent responses. GO enrichment analysis of experimentally validated miRNA-targeted genes revealed that several pathways and molecular functions were disturbed upon parasite infection. Finally, following parasite infection, miR-210 abundance was enhanced in HIF-1 alpha-dependent manner, though it did not contribute to inhibiting anti-apoptotic pathways through pro-apoptotic caspase-3 regulation. Conclusions/Significance: Our data suggest that alteration in miRNA levels likely plays an important role in regulating macrophage functions following L. major infection. These results could contribute to better understanding of the dynamics of gene expression in host cells during leishmaniasis.	[Lemaire, Julien; Gustin, Cindy; Renard, Patricia] NARILIS Univ Namur, Lab Biochem & Cellular Biol URBC, Namur, Belgium; [Mkannez, Ghada; Guerfali, Fatma Z.; Attia, Hanene; Sghaier, Rabiaa M.; Dellagi, Koussay; Laouini, Dhafer] Inst Pasteur Tunis, LR11IPT02, LTCII, Tunis, Tunisia; [Mkannez, Ghada; Guerfali, Fatma Z.; Attia, Hanene; Sghaier, Rabiaa M.; Dellagi, Koussay; Laouini, Dhafer] Univ Tunis El Manar, Tunis, Tunisia; [Dellagi, Koussay] IRD, St Clotilde, Reunion, Reunion; [Dellagi, Koussay] Ctr Rech & Veille Malad Emergentes Ocean Indien C, St Clotilde, Reunion, Reunion	Lemaire, J (reprint author), NARILIS Univ Namur, Lab Biochem & Cellular Biol URBC, Namur, Belgium.	dhafer_l@yahoo.ca; patsy.renard@fundp.ac.be	Hide, Winston/V-2727-2017; Hide, Winston Hide/C-7217-2009; Kiselev, Ilya/F-3297-2017; Hofmann, Oliver/F-1800-2013	Hide, Winston/0000-0002-8621-3271; Hide, Winston Hide/0000-0002-8621-3271; Kiselev, Ilya/0000-0003-1057-5986; Herwig, Ralf/0000-0002-9335-1760; MANCHON, Laurent/0000-0001-9242-4385; Hofmann, Oliver/0000-0002-7738-1513; Jauregui, Ruy/0000-0002-3484-8937; Gabdoulline, Razif/0000-0001-8719-6234; BRUNO, ROMAN/0000-0002-9889-6938; Abid, sayda/0000-0003-2488-1431; Cazenave, Pierre-Andre/0000-0002-1345-8526; Pierrat, Fabien/0000-0001-7308-6827; Piquemal, David/0000-0002-5870-4276; Noguier, Florian/0000-0002-0276-6929; RABHI, Imen/0000-0002-9403-576X; Laouini, Dhafer/0000-0003-1222-4880; Ghedira, Kais/0000-0002-3387-6493; Kolpakov, Fedor/0000-0002-0396-0256	European Union [LSHG-CT-2006-037231]; NIH/NIAID/DMID [5P50AI074178]	This work was funded by the European Union under its 6th Framework Programme (LSHG-CT-2006-037231) and partially supported by an NIH/NIAID/DMID Grant Number 5P50AI074178 for DL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aga E, 2002, J IMMUNOL, V169, P898, DOI 10.4049/jimmunol.169.2.898; Akarid K, 2004, J LEUKOCYTE BIOL, V76, P95, DOI 10.1189/jlb.1001877; Babar IA, 2011, CANCER BIOL THER, V12, P908, DOI 10.4161/cbt.12.10.17681; Barbato C, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/803069; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Bhardwaj S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/109189; Bogdan C, 2008, CELL MICROBIOL, V10, P1221, DOI 10.1111/j.1462-5822.2008.01146.x; Brandonisio O, 2002, CLIN EXP MED, V2, P125, DOI 10.1007/s102380200017; Calegari-Silva TC, 2009, IMMUNOL LETT, V127, P19, DOI 10.1016/j.imlet.2009.08.009; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chan YC, 2012, MICROCIRCULATION, V19, P215, DOI 10.1111/j.1549-8719.2011.00154.x; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Crawford M, 2009, BIOCHEM BIOPH RES CO, V388, P483, DOI 10.1016/j.bbrc.2009.07.143; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Degrossoli A, 2007, IMMUNOL LETT, V114, P119, DOI 10.1016/j.imlet.2007.09.009; Duclos S, 2000, CELL MICROBIOL, V2, P365, DOI 10.1046/j.1462-5822.2000.00066.x; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Eulalio A, 2012, RNA BIOL, V9, P742, DOI 10.4161/rna.20018; Faria Marilia S., 2012, Journal of Parasitology Research, P930257, DOI 10.1155/2012/930257; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gallego C, 2011, INFECT IMMUN, V79, P2871, DOI 10.1128/IAI.01388-10; Ghosh J, 2013, CELL HOST MICROBE, V13, P277, DOI 10.1016/j.chom.2013.02.005; Gou D, 2012, AM J PHYSL LUNG CELL; Gregory DJ, 2008, EUR J IMMUNOL, V38, P1071, DOI 10.1002/eji.200737586; Guerfali FZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-238; Guizani-Tabbane L, 2004, INFECT IMMUN, V72, P2582, DOI 10.1128/IAI.72.5.2582-2589.2004; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hakimi MA, 2011, TRENDS PARASITOL, V27, P481, DOI 10.1016/j.pt.2011.07.001; Hulten LM, 2010, EUR J CLIN INVEST, V40, P11, DOI 10.1111/j.1365-2362.2009.02223.x; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ji HX, 2003, INFECT IMMUN, V71, P4278, DOI 10.1128/IAI.71.8.4278-4288.2003; Katiyar-Agarwal S, 2010, ANNU REV PHYTOPATHOL, V48, P225, DOI 10.1146/annurev-phyto-073009-114457; KAYE PM, 1994, EUR J IMMUNOL, V24, P2850, DOI 10.1002/eji.1830241140; Kim HW, 2009, J BIOL CHEM, V284, P33161, DOI 10.1074/jbc.M109.020925; Koch M, 2012, P NATL ACAD SCI USA, V109, pE1153, DOI 10.1073/pnas.1116125109; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Kumar R, 2010, IMMUNOLOGY, V130, P193, DOI 10.1111/j.1365-2567.2009.03223.x; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lisi S, 2005, J EUKARYOT MICROBIOL, V52, P211, DOI 10.1111/j.1550-7408.2005.00026.x; Liu YP, 2002, CELL SIGNAL, V14, P145, DOI 10.1016/S0898-6568(01)00246-7; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; McConville MJ, 2011, ANNU REV MICROBIOL, V65, P543, DOI 10.1146/annurev-micro-090110-102913; MOORE KJ, 1994, J IMMUNOL, V152, P2930; Moreno I, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000743; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Nahid MA, 2011, CELL MOL IMMUNOL, V8, P388, DOI 10.1038/cmi.2011.26; Nandan D, 2012, J IMMUNOL, V188, P367, DOI 10.4049/jimmunol.1100076; Neves BM, 2010, AM J PATHOL, V177, P2898, DOI 10.2353/ajpath.2010.100367; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Peng H, 2012, FASEB J, V26, P3140, DOI 10.1096/fj.11-198515; Peters NC, 2009, CELL MICROBIOL, V11, P1290, DOI 10.1111/j.1462-5822.2009.01348.x; Qi JN, 2012, FEBS LETT, V586, P1201, DOI 10.1016/j.febslet.2012.03.011; Quinn SR, 2011, INT IMMUNOL, V23, P421, DOI 10.1093/intimm/dxr034; REINER NE, 1987, J IMMUNOL, V138, P1926; Reinhard K, 2012, INT J MED MICROBIOL, V302, P230, DOI 10.1016/j.ijmm.2012.07.006; Ritter U, 2000, EUR J IMMUNOL, V30, P3111, DOI 10.1002/1521-4141(200011)30:11<3111::AID-IMMU3111>3.0.CO;2-O; Ritter U, 2002, PARASITE IMMUNOL, V24, P295, DOI 10.1046/j.1365-3024.2002.00467.x; Ruhland A, 2007, CELL MICROBIOL, V9, P84, DOI 10.1111/j.1462-5822.2006.00769.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Scaria V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-68; Schulte LN, 2013, NUCLEIC ACIDS RES, V41, P542, DOI 10.1093/nar/gks1030; Shadab Md, 2011, Mol Biol Int, V2011, P343961, DOI 10.4061/2011/343961; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shio MT, 2012, J TROP MED, DOI 10.1155/2012/819512; Singh AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038489; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Spath GF, 2001, EXP PARASITOL, V99, P97, DOI 10.1006/expr.2001.4656; Srivastav S, 2012, J IMMUNOL, V189, P924, DOI 10.4049/jimmunol.1102845; Stratz C, 2012, THROMB HAEMOSTASIS, V107, P634, DOI 10.1160/TH11-10-0742; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tan GY, 2012, BIOCHEM BIOPH RES CO, V417, P546, DOI 10.1016/j.bbrc.2011.11.160; Teixeira MJ, 2006, TRENDS PARASITOL, V22, P32, DOI 10.1016/j.pt.2005.11.010; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Turan N, 2010, EPIGENETICS-US, V5, P16, DOI 10.4161/epi.5.1.10557; Valdes-Reyes L, 2009, EXP PARASITOL, V121, P199, DOI 10.1016/j.exppara.2008.10.020; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vargas-Inchaustegui DA, 2010, INFECT IMMUN, V78, P301, DOI 10.1128/IAI.00959-09; Wanet A, 2012, NUCLEIC ACIDS RES, V40, P4742, DOI 10.1093/nar/gks151; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Yang W, 2012, EXP CELL RES, V318, P944, DOI 10.1016/j.yexcr.2012.02.010; Yang ZR, 2013, BIOCHEM BIOPH RES CO, V434, P143, DOI 10.1016/j.bbrc.2013.03.054; Zeiner GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008742; Zhang HY, 2012, ONCOL REP, V27, P594, DOI 10.3892/or.2011.1530	88	38	38	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	OCT	2013	7	10							e2478	10.1371/journal.pntd.0002478				13	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	299DW	WOS:000330376500018	24098824	DOAJ Gold, Green Published			2019-04-02	
J	Mitashi, P; Hasker, E; Ngoyi, DM; Pyana, PP; Lejon, V; Van der Veken, W; Lutumba, P; Buscher, P; Boelaert, M; Deborggraeve, S				Mitashi, Patrick; Hasker, Epco; Ngoyi, Dieudonne Mumba; Pyana, Pati Patient; Lejon, Veerle; Van der Veken, Wim; Lutumba, Pascal; Buscher, Philippe; Boelaert, Marleen; Deborggraeve, Stijn			Diagnostic Accuracy of Loopamp Trypanosoma brucei Detection Kit for Diagnosis of Human African Trypanosomiasis in Clinical Samples	PLOS NEGLECTED TROPICAL DISEASES			English	Article							SLEEPING SICKNESS DIAGNOSIS; MOLECULAR DIAGNOSIS; TESTS; PCR	Background: Molecular methods have great potential for sensitive parasite detection in the diagnosis of human African trypanosomiasis (HAT), but the requirements in terms of laboratory infrastructure limit their use to reference centres. A recently developed assay detects the Trypanozoon repetitive insertion mobile element (RIME) DNA under isothermal amplification conditions and has been transformed into a ready-to-use kit format, the Loopamp Trypanosoma brucei. In this study, we have evaluated the diagnostic performance of the Loopamp Trypanosoma brucei assay (hereafter called LAMP) in confirmed T.b. gambiense HAT patients, HAT suspects and healthy endemic controls from the Democratic Republic of the Congo (DRC). Methodology/Principal findings: 142 T.b. gambiense HAT patients, 111 healthy endemic controls and 97 HAT suspects with unconfirmed status were included in this retrospective evaluation. Reference standard tests were parasite detection in blood, lymph or cerebrospinal fluid. Archived DNA from blood of all study participants was analysed in duplicate with LAMP. Sensitivity of LAMP in parasitologically confirmed cases was 87.3% (95% CI 80.9-91.8%) in the first run and 93.0% (95% CI 87.5-96.1%) in the second run. Specificity in healthy controls was 92.8% (95% CI 86.4-96.3%) in the first run and 96.4% (95% CI 91.1-98.6%) in the second run. Reproducibility was excellent with a kappa value of 0.81. Conclusions/Significance: In this laboratory-based study, the Loopamp Trypanosoma brucei Detection Kit showed good diagnostic accuracy and excellent reproducibility. Further studies are needed to assess the feasibility of its routine use for diagnosis of HAT under field conditions.	[Mitashi, Patrick; Hasker, Epco; Lejon, Veerle; Buscher, Philippe; Boelaert, Marleen; Deborggraeve, Stijn] Inst Trop Med, B-2000 Antwerp, Belgium; [Mitashi, Patrick; Ngoyi, Dieudonne Mumba; Lutumba, Pascal] Kinshasa Univ, Fac Med, Kinshasa, Zaire; [Mitashi, Patrick; Ngoyi, Dieudonne Mumba; Pyana, Pati Patient; Lutumba, Pascal] Inst Natl Rech Biomed, Kinshasa, Zaire; [Van der Veken, Wim] Belgian Dev Agcy, Kinshasa, Zaire	Mitashi, P (reprint author), Inst Trop Med, B-2000 Antwerp, Belgium.	sdeborggraeve@itg.be	Buscher, Philippe/B-9956-2012	Buscher, Philippe/0000-0002-1926-7472; Deborggraeve, Stijn/0000-0003-1501-5355; Boelaert, Marleen/0000-0001-8051-6776; Lejon, Veerle/0000-0002-6795-0962	FIND; Institute of Tropical Medicine (HAT PolyB); Belgian Directorate General for Development Cooperation	FIND, the sponsor of the development of the LAMP kit, provided the required kits and reagents for this study. The views expressed by the authors do not necessarily reflect the views of the funding agency. The biological specimens were collected in collaboration with the National Human African Trypanosomiasis Control Program (PNLTHA) of the D.R. Congo, in a study financed by the Secondary Research Funding of the Institute of Tropical Medicine (HAT PolyB) and a study financed by the Belgian Directorate General for Development Cooperation. PM and PPP received a PhD grant and DMN received a Post-Doc grant from the Belgian Directorate General for Development Cooperation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Buscher P, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000471; Buscher P, 2013, NEW ENGL J MED, V368, P1069, DOI 10.1056/NEJMc1210373; Camara M, 2010, TROP MED INT HEALTH, V15, P796, DOI 10.1111/j.1365-3156.2010.02546.x; Chappuis F, 2005, CLIN MICROBIOL REV, V18, P133, DOI 10.1128/CMR.18.1.133-146.2005; Deborggraeve S, 2008, DIAGN MICR INFEC DIS, V61, P428, DOI 10.1016/j.diagmicrobio.2008.03.006; Deborggraeve S, 2012, EXPERT REV MOL DIAGN, V12, P719, DOI [10.1586/erm.12.72, 10.1586/ERM.12.72]; Deborggraeve S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000972; DUKES P, 1992, ACTA TROP, V51, P123, DOI 10.1016/0001-706X(92)90054-2; Enyaru JCK, 1998, ANN TROP MED PARASIT, V92, P845; Espinosa D, 2009, J CLIN MICROBIOL, V47, P2560, DOI 10.1128/JCM.00259-09; Gillet P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002180; Hasker E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001950; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Mitashi P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001919; Mugasa CM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001438; Njiru ZK, 2011, J CLIN MICROBIOL, V49, P1530, DOI 10.1128/JCM.01817-10; Njiru ZK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001572; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Simarro PP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001007; Solano P, 2002, ACTA TROP, V82, P349, DOI 10.1016/S0001-706X(02)00029-3; Wastling SL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000865; Woo P. T. K., 1970, Acta trop., V27, P384	22	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	OCT	2013	7	10							e2504	10.1371/journal.pntd.0002504				5	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	299DW	WOS:000330376500038	24147176	DOAJ Gold, Green Published			2019-04-02	
J	Wang, T; Van Steendam, K; Dhaenens, M; Vlaminck, J; Deforce, D; Jex, AR; Gasser, RB; Geldhof, P				Wang, Tao; Van Steendam, Katleen; Dhaenens, Maarten; Vlaminck, Johnny; Deforce, Dieter; Jex, Aaron R.; Gasser, Robin B.; Geldhof, Peter			Proteomic Analysis of the Excretory-Secretory Products from Larval Stages of Ascaris suum Reveals High Abundance of Glycosyl Hydrolases	PLOS NEGLECTED TROPICAL DISEASES			English	Article							C-TYPE LECTIN; TRANSMITTED HELMINTH INFECTIONS; PARASITE PROTEINASE-INHIBITORS; BRUGIA-MALAYI; CAENORHABDITIS-ELEGANS; IN-VITRO; EXCRETORY/SECRETORY PRODUCTS; TELADORSAGIA-CIRCUMCINCTA; MASS-SPECTROMETRY; IMMUNE-RESPONSES	Background: Ascaris lumbricoides and Ascaris suum are socioeconomically important and widespread parasites of humans and pigs, respectively. The excretory-secretory (ES) molecules produced and presented at the parasite-host interface during the different phases of tissue invasion and migration are likely to play critical roles in the induction and development of protective immune and other host responses. Methodology/Principal Findings: The aim of this study was to identify the ES proteins of the different larval stages (L3-egg, L3-lung and L4) by LC-MS/MS. In total, 106 different proteins were identified, 20 in L3-egg, 45 in L3-lung stage and 58 in L4. Although most of the proteins identified were stage-specific, 15 were identified in the ES products of at least two stages. Two proteins, i.e. a 14-3-3-like protein and a serpin-like protein, were present in the ES products from the three different larval stages investigated. Interestingly, a comparison of ES products from L4 with those of L3-egg and L3-lung showed an abundance of metabolic enzymes, particularly glycosyl hydrolases. Further study indicated that most of these glycolytic enzymes were transcriptionally upregulated from L4 onwards, with a peak in the adult stage, particularly in intestinal tissue. This was also confirmed by enzymatic assays, showing the highest glycosidase activity in protein extracts from adult worms gut. Conclusions/Significance: The present proteomic analysis provides important information on the host-parasite interaction and the biology of the migratory stages of A. suum. In particular, the high transcriptional upregulation of glycosyl hydrolases from the L4 stage onwards reveals that the degradation of complex carbohydrates forms an essential part of the energy metabolism of this parasite once it establishes in the small intestine.	[Wang, Tao; Vlaminck, Johnny; Geldhof, Peter] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, B-9000 Ghent, Belgium; [Van Steendam, Katleen; Dhaenens, Maarten; Deforce, Dieter] Univ Ghent, Fac Pharmaceut Sci, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium; [Jex, Aaron R.; Gasser, Robin B.] Univ Melbourne, Fac Vet Sci, Melbourne, Vic, Australia	Wang, T (reprint author), Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, B-9000 Ghent, Belgium.	peter.geldhof@UGent.be		Wang, Tao/0000-0003-1359-8913; Gasser, Robin B./0000-0002-4423-1690; Dhaenens, Maarten/0000-0002-9801-3509; Jex, Aaron/0000-0002-1285-7947	China Scholarship Council; Special Research Fund (BOF) of Ghent University (Belgium)	The work was supported through funding of China Scholarship Council and Special Research Fund (BOF) of Ghent University (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER KR, 1993, J NEMATOL, V25, P365; Bennuru S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000410; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; BLAXTER ML, 1992, PARASITOL TODAY, V8, P243, DOI 10.1016/0169-4758(92)90126-M; Bradley JE, 2004, PARASITE IMMUNOL, V26, P429, DOI 10.1111/j.0141-9838.2004.00730.x; Braschi S, 2006, MOL CELL PROTEOMICS, V5, P347, DOI 10.1074/mcp.M500287-MCP200; Chalmers IW, 2012, PARASITOLOGY, V139, P1231, DOI 10.1017/S0031182012000704; Craig H, 2006, PARASITOLOGY, V132, P535, DOI 10.1017/S0031182005009510; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Dold C, 2011, MICROBES INFECT, V13, P632, DOI 10.1016/j.micinf.2010.09.012; Dreesen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040985; Fetterer RH, 1996, VET PARASITOL, V65, P275, DOI 10.1016/S0304-4017(96)00956-9; Geldhof P, 2003, MOL BIOCHEM PARASIT, V128, P111, DOI 10.1016/S0166-6851(03)00044-6; Geng JM, 2002, MOL BIOCHEM PARASIT, V124, P11, DOI 10.1016/S0166-6851(02)00155-X; Hall A, 2008, MATERN CHILD NUTR, V4, P118, DOI 10.1111/j.1740-8709.2007.00127.x; Hewitson JR, 2008, MOL BIOCHEM PARASIT, V160, P8, DOI 10.1016/j.molbiopara.2008.02.007; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Islam MK, 2004, PARASITOL RES, V93, P96, DOI 10.1007/s00436-004-1101-0; Jex AR, 2011, NATURE, V479, P529, DOI 10.1038/nature10553; JUHASZ S, 1979, ACTA VET ACAD SCI H, V27, P217; Jungersen G, 2001, PARASITE IMMUNOL, V23, P185, DOI 10.1046/j.1365-3024.2001.00373.x; KENNEDY MW, 1986, IMMUNOLOGY, V58, P515; KENNEDY MW, 1987, CLIN EXP IMMUNOL, V67, P20; KENNEDY MW, 1989, CLIN EXP IMMUNOL, V75, P493; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li J, 2007, DEV BIOL, V301, P82, DOI 10.1016/j.ydbio.2006.10.013; Liegeois S, 2007, GENETICS, V175, P709, DOI 10.1534/genetics.106.066035; LIGHTOWLERS MW, 1988, PARASITOLOGY, V96, pS123; Loukas A, 1999, CURR BIOL, V9, P825, DOI 10.1016/S0960-9822(99)80366-2; Loukas A, 2000, PARASITOLOGY, V121, P545, DOI 10.1017/S0031182099006721; Marcilla A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045974; MARTZEN MR, 1986, EXP PARASITOL, V61, P138, DOI 10.1016/0014-4894(86)90145-1; MARTZEN MR, 1985, EXP PARASITOL, V60, P139, DOI 10.1016/0014-4894(85)90016-5; Masure D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002138; McGonigle S, 2002, INT J PARASITOL, V32, P685, DOI 10.1016/S0020-7519(01)00323-X; McGreal EP, 2004, MOL IMMUNOL, V41, P1109, DOI 10.1016/j.molimm.2004.06.013; Molehin AJ, 2012, PARASITOLOGY, V139, P681, DOI 10.1017/S0031182011002435; Moreno Y, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000326; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mulvenna J, 2009, MOL CELL PROTEOMICS, V8, P109, DOI 10.1074/mcp.M800206-MCP200; Nisbet AJ, 2010, EXP PARASITOL, V125, P329, DOI 10.1016/j.exppara.2010.02.014; Robinson MW, 2007, INT J PARASITOL, V37, P139, DOI 10.1016/j.ijpara.2006.08.007; SEMENZA G, 1986, ANNU REV CELL BIOL, V2, P255, DOI 10.1146/annurev.cb.02.110186.001351; SEMENZA G, 1983, CIBA F SYMP, V95, P92; Siles-Lucas M, 2003, VACCINE, V21, P431, DOI 10.1016/S0264-410X(02)00517-0; Siles-Lucas M, 2008, EXP PARASITOL, V119, P516, DOI 10.1016/j.exppara.2008.01.009; Tachu B, 2008, INFECT IMMUN, V76, P221, DOI 10.1128/IAI.00701-07; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tilleman K, 2005, PROTEOMICS, V5, P2247, DOI 10.1002/pmic.200401109; URBAN JF, 1981, J PARASITOL, V67, P800, DOI 10.2307/3280703; Van Steendam K, 2013, INT J LEGAL MED, V127, P287, DOI 10.1007/s00414-012-0747-x; Wang XC, 2010, NAT CELL BIOL, V12, P655, DOI 10.1038/ncb2068; Wu Y, 2008, MOL BIOCHEM PARASIT, V161, P55, DOI 10.1016/j.molbiopara.2008.06.007; Yatsuda AP, 2003, J BIOL CHEM, V278, P16941, DOI 10.1074/jbc.M212453200; Yoshida A, 2012, PARASITOL RES, V110, P1583, DOI 10.1007/s00436-011-2677-9; Zang XX, 2001, TRENDS BIOCHEM SCI, V26, P191, DOI 10.1016/S0968-0004(00)01761-8	57	22	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	OCT	2013	7	10							e2467	10.1371/journal.pntd.0002467				14	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	299DW	WOS:000330376500010	24098821	DOAJ Gold, Green Published			2019-04-02	
J	Hong, NV; van den Eede, P; Van Overmeir, C; Vythilingham, I; Rosanas-Urgell, A; Thanh, PV; Thang, ND; Hung, NM; Hung, LX; D'Alessandro, U; Erhart, A				Nguyen Van Hong; van den Eede, Peter; Van Overmeir, Chantal; Vythilingham, Indra; Rosanas-Urgell, Anna; Pham Vinh Thanh; Ngo Duc Thang; Nguyen Manh Hung; Le Xuan Hung; D'Alessandro, Umberto; Erhart, Annette			Short Report: A Modified Semi-Nested Multiplex Malaria PCR (SnM-PCR) for the Identification of the Five Human Plasmodium Species Occurring in Southeast Asia	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							KNOWLESI INFECTIONS; PARASITE	We have modified an existing semi-nested multiplex polymerase chain reaction (PCR) by adding one Plasmodium knowlesi-specific nested PCR, and validated the latter against laboratory and clinical samples. This new method has the advantage of being relatively affordable in low resource settings while identifying the five human Plasmodium species with a three-step PCR.	[Nguyen Van Hong] Natl Inst Malariol Parasitol & Entomol, Dept Clin Res, Hanoi, Vietnam; [Erhart, Annette] Inst Trop Med, Malariol Unit, B-2000 Antwerp, Belgium; [Vythilingham, Indra] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia; IMR, Infect Dis Res Ctr, Parasitol Unit, Kuala Lumpur, Malaysia; Med Res Unit, Fajara, Gambia; [Pham Vinh Thanh; Ngo Duc Thang; Nguyen Manh Hung; Le Xuan Hung] Natl Inst Malariol Parasitol & Entomol, Dept Epidemiol, Hanoi, Vietnam	Erhart, A (reprint author), Inst Trop Med, Malariol Unit, Natl Str 155, B-2000 Antwerp, Belgium.	nvhong1982@yahoo.com; petervandeneede@gmail.com; cvoverm@itg.be; Indra.vythilingham@gmail.com; arosanas@itg.be; phamvinht@gmail.com; thangnimpevn@yahoo.com; drmanhhung@gmail.com; xuanhungvsr@yahoo.com; udalessandro@mrc.gm; aerhart@itg.be	D'Alessandro, Umberto/D-3457-2015; Vythilingam, Indra/Q-5019-2016	D'Alessandro, Umberto/0000-0001-6341-5009; 	UBS Optimus Foundation; Belgian Cooperation within the Framework Agreement III	This study was financed by the UBS Optimus Foundation and the Belgian Cooperation within the Framework Agreement III.	Babady NE, 2009, AM J TROP MED HYG, V81, P516, DOI 10.4269/ajtmh.2009.81.516; Chew CH, 2012, J CLIN MICROBIOL, V50, P4012, DOI 10.1128/JCM.06454-11; Cox-Singh J, 2008, TRENDS PARASITOL, V24, P406, DOI 10.1016/j.pt.2008.06.001; Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888; Divis PCS, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-344; Hong Nguyen V, 2012, AM J TROP MED HYG, V87, P989; Imwong M, 2009, J CLIN MICROBIOL, V47, P4173, DOI 10.1128/JCM.00811-09; Iseki H, 2010, J CLIN MICROBIOL, V48, P2509, DOI 10.1128/JCM.00331-10; Lucchi NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031848; Ministry of Health, 2012, INTERNAL REPORT; Rubio J M, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS199, DOI 10.1016/S0035-9203(02)90077-5; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Van den Eede P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-249; Vythilingam I, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-26; White NJ, 2008, CLIN INFECT DIS, V46, P172, DOI 10.1086/524889	15	0	1	0	8	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2013	89	4					721	723		10.4269/ajtmh.13-0027				3	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	240UB	WOS:000326122100017		Bronze, Green Published			2019-04-02	
J	Prajapati, VK; Sharma, S; Rai, M; Ostyn, B; Salotra, P; Vanaerschot, M; Dujardin, JC; Sundar, S				Prajapati, Vijay Kumar; Sharma, Smriti; Rai, Madhukar; Ostyn, Bart; Salotra, Poonam; Vanaerschot, Manu; Dujardin, Jean-Claude; Sundar, Shyam			In vitro Susceptibility of Leishmania donovani to Miltefosine in Indian Visceral Leishmaniasis	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							KALA-AZAR; DRUG SUSCEPTIBILITY	Promastigote miltefosine (MIL) susceptibility was performed on Leishmania donovani isolates from Indian patients with visceral leishmaniasis treated with MIL. Isolates that were obtained before the onset of MIL treatment, after completion of treatment (29th day), or at the time of treatment failure, were screened using in vitro promastigote assay. The MIL susceptibility of the pre-treatment isolates (N = 24, mean IC50 +/- SEM = 3.74 +/- 0.38 mu M) was significantly higher than that of the post-treatment group (N = 26, mean IC50 +/- SEM = 6.15 +/- 0.52 mu M; P = 0.0006) but was similar in the cured patients (N = 22, mean IC50 +/- SEM = 5.58 +/- 0.56 mu M) and those who failed treatment (N = 28, mean IC50 +/- SEM = 4.53 +/- 0.47 mu M). The pre/post-treatment results thus showed a 2-fold difference, whereas isolated from cured versus failed patients showed a similar susceptibility, suggesting that this higher tolerance is not responsible for MIL-treatment failure. Our work highlights the need for careful monitoring of MIL susceptibility for implementation in national VL elimination programs.	[Sharma, Smriti; Rai, Madhukar; Sundar, Shyam] Banaras Hindu Univ, Dept Med, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [Ostyn, Bart] Inst Trop Med, Dept Publ Hlth, Unit Epidemiol & Control Trop Dis, B-2000 Antwerp, Belgium; [Salotra, Poonam] Indian Council Med Res, Natl Inst Pathol, New Delhi, India; [Vanaerschot, Manu; Dujardin, Jean-Claude] Inst Trop Med, Unit Mol Parasitol, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Dujardin, Jean-Claude] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium	Sundar, S (reprint author), Banaras Hindu Univ, Dept Med, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India.	vijay84bhu@gmail.com; smritibhardwaj87@gmail.com; rai_madhukar@sify.com; Bostyn@itg.be; salotra@vsnl.com; Mvanaerschot@itg.be; Jcdujardin@itg.be; drshyamsundar@hotmail.com	Vanaerschot, Manu/B-6812-2013; sharma, smriti/R-7285-2016	Vanaerschot, Manu/0000-0002-9141-2347; sharma, smriti/0000-0003-1985-4711; Salotra, Poonam/0000-0002-4057-4872	Kaladrug-R [EC-FP7-222895]; Directorate-General for Development Cooperation of the Belgian Government; Sitaram Memorial Trust, Muzaffarpur; Indian Council of Medical Research, New Delhi; Paladin Labs; Institute for One World Health; GlaxoSmithK line; Bharat Serum and Vaccine Ltd	This work was funded by Kaladrug-R (grant no. EC-FP7-222895, www.leishrisk.net/kaladrug), Directorate-General for Development Cooperation of the Belgian Government (framework agreement 03 - project 3.04 Visceral Leishmaniasis Control), Sitaram Memorial Trust, Muzaffarpur. Author V.K.P. is thankful to Indian Council of Medical Research, New Delhi, India for providing research fellowship. S.S. has received grant support for clinical trials and travel funds to attend scientific meetings from Paladin Labs, Institute for One World Health, and GlaxoSmithK line, and his institute has received grants from Bharat Serum and Vaccine Ltd.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Bhandari V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001657; Guerin PJ, 2002, LANCET INFECT DIS, V2, P494, DOI 10.1016/S1473-3099(02)00347-X; Jha TK, 1999, NEW ENGL J MED, V341, P1795, DOI 10.1056/NEJM199912093412403; Joshi A., 2008, Journal of Vector Borne Diseases, V45, P105; Kulshrestha A, 2013, PARASITOL RES, V112, P825, DOI 10.1007/s00436-012-3212-3; Kumar D, 2009, ANTIMICROB AGENTS CH, V53, P835, DOI 10.1128/AAC.01233-08; Leprohon P, 2009, NUCLEIC ACIDS RES, V37, P1387, DOI 10.1093/nar/gkn1069; Maurya R, 2010, J CLIN MICROBIOL, V48, P1932, DOI 10.1128/JCM.01733-09; Prajapati VK, 2012, AM J TROP MED HYG, V87, P655, DOI 10.4269/ajtmh.2012.12-0022; Prajapati VK, 2011, J ANTIMICROB CHEMOTH, V66, P874, DOI 10.1093/jac/dkr002; Rijal S, 2013, CLIN INFECT DIS, V56, P1530, DOI 10.1093/cid/cit102; Srivastava P, 2010, INFECT GENET EVOL, V10, P1145, DOI 10.1016/j.meegid.2010.07.009; Sundar S, 2002, NEW ENGL J MED, V347, P1739, DOI 10.1056/NEJMoa021556; Sundar S, 2012, CLIN INFECT DIS, V55, P543, DOI 10.1093/cid/cis474; WHO, 2005, EXP COMM REG STRAT F	16	20	20	0	7	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2013	89	4					750	754	UNSP :10.4269/ajtmh.13-0096	10.4269/ajtmh.13-0096				5	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	240UB	WOS:000326122100021	23980130	Bronze, Green Published			2019-04-02	
J	Cairncross, S; van Asten, H; Jaffar, S; Junghanss, T; Meyer, CG; Van der Stuyft, P				Cairncross, Sandy; van Asten, Henri; Jaffar, Shabbar; Junghanss, Thomas; Meyer, Christian G.; Van der Stuyft, Patrick			The ICMJE authorship criteria: a response from the editors	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Editorial Material						authorship; operational research; academic; policy makers	COUNTRIES; NEED		[Cairncross, Sandy; Jaffar, Shabbar] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [van Asten, Henri] Nijmegen Inst Int Hlth, Nijmegen, Netherlands; [Junghanss, Thomas] Univ Hosp, Sect Clin Trop Med, Heidelberg, Germany; [Meyer, Christian G.] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; [Van der Stuyft, Patrick] Inst Trop Med, B-2000 Antwerp, Belgium	Cairncross, S (reprint author), LSHTM, Keppel St, London WC1E 7HT, England.	sandy.cairncross@lshtm.ac.uk		Jaffar, Shabbar/0000-0002-9615-1588	Medical Research Council [MR/K012126/1]		Groener S, 2004, TROP MED INT HEALTH, V9, P935, DOI 10.1111/j.1365-3156.2004.01314.x; Hanson S, 2012, TROP MED INT HEALTH, V17, P792, DOI 10.1111/j.1365-3156.2012.02979.x; Roberts L, 2004, LANCET, V364, P1857, DOI 10.1016/S0140-6736(04)17441-2; Zachariah R, 2013, TROP MED INT HEALTH, V18, P1025, DOI 10.1111/tmi.12133	4	2	2	0	9	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2013	18	10					1162	1163		10.1111/tmi.12174				2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	213PC	WOS:000324069100002	23962362	Bronze			2019-04-02	
J	Soto, A; Solari, L; Agapito, J; Gotuzzo, E; Accinelli, R; Vargas, D; Acurio, V; Matthys, F; Van der Stuyft, P				Soto, Alonso; Solari, Lely; Agapito, Juan; Gotuzzo, Eduardo; Accinelli, Roberto; Vargas, Dante; Acurio, Vilma; Matthys, Francine; Van der Stuyft, Patrick			Algorithm for the diagnosis of smear-negative pulmonary tuberculosis in high-incidence resource-constrained settings	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						diagnosis; smear-negative; tuberculosis; pulmonary; algorithms; decision-making	MICROSCOPY; ACCURACY; SPUTUM; HIV; METAANALYSIS; PREVALENCE; RESISTANCE; CULTURE; BACILLI; ASSAY	OBJECTIVES Diagnosis of smear-negative pulmonary tuberculosis (SNPT) remains a challenge, particularly in resource-constrained settings. We evaluated a diagnostic algorithm that combines affordable laboratory tools and a clinical prediction rule (CPR). METHODS We derived, based on published evidence, a diagnostic algorithm for SNPT. Sputum concentration constitutes its first step. In suspects with negative results, SNPT probability is classified with a CPR as low (excluded), high (confirmed) or intermediate. For intermediate patients, sputum Middlebrook 7H9 liquid culture is performed, and they are assessed after 2 weeks. If clinically deteriorated, with still negative liquid culture, bronchoscopy is offered. Otherwise, results of Middlebrook 7H9 culture are awaited. We prospectively evaluated this algorithm against a reference standard of solid and liquid cultures in two reference hospitals in Lima, Peru. RESULTS 670 SNPT suspects were included from September 2005 to March 2008. The prevalence of SNPT was 27% according to the reference standard. The algorithm's overall accuracy was 0.94 (95% CI 0.91-0.95), its sensitivity was 0.88 (95% CI 0.82-0.92) and its specificity, 0.96 (95% CI 0.94-0.98). Sputum concentration, the CPR, Middlebrook 7H9 sputum culture and bronchoscopic samples defined a diagnosis of SNPT according to the algorithm in 57 (37%), 25 (16%), 63 (41%) and 8(5%) of patients, respectively. 65% of patients were diagnosed within 3 weeks. CONCLUSIONS The algorithm was accurate for SNPT diagnosis. Sputum concentration, CPR and selective Middlebrook 7H9 culture are essential components.	[Soto, Alonso; Solari, Lely; Matthys, Francine; Van der Stuyft, Patrick] Inst Trop Med, Gen Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium; [Agapito, Juan] Univ Peruana Cayetano Heredia, Fac Med, Lima, Peru; [Gotuzzo, Eduardo] Inst Med Trop Alexander von Humboldt, Lima, Peru; [Accinelli, Roberto] Univ Peruana Cayetano Heredia, Inst Invest Altura, Lima, Peru; [Vargas, Dante; Acurio, Vilma] Hosp Nacl Hipolito Unanue, Lima, Peru	Soto, A (reprint author), Inst Trop Med, Gen Epidemiol & Dis Control Unit, Natl Str 155, B-2000 Antwerp, Belgium.	asoto@itg.be		Soto, Alonso/0000-0001-8648-8032; Solari, Lely/0000-0002-8041-8807; AGAPITO, JUAN CARLOS/0000-0001-9134-7322	Damian Foundation	We thank Yeny Bravo and Rosa Reinoso, who participated in the patient recruitment and Tullia Battaglioli for her comments on the manuscript. The work was funded by the Damian Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	ABER VR, 1980, TUBERCLE, V61, P123, DOI 10.1016/0041-3879(80)90001-X; Ait-Khaled N, 2010, MANAGEMENT TUBERCULO; [Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; Apers L, 2004, INT J TUBERC LUNG D, V8, P945; Bah B, 2002, INT J TUBERC LUNG D, V6, P592; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Bonnet M, 2008, CLIN INFECT DIS, V46, P1710, DOI 10.1086/587891; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Cattamanchi A, 2010, J CLIN MICROBIOL, V48, P2433, DOI 10.1128/JCM.00208-10; Chang K, 2012, J INFECTION, V64, P580, DOI 10.1016/j.jinf.2012.02.012; Collecting group data, 2010, DELPH TECHN; DUJARDIN B, 1994, EUR J EPIDEMIOL, V10, P29, DOI 10.1007/BF01717448; Hong Kong Chest Service / Tuberculosis Research Center Madras/ British Medical Research Council, 1981, TUBERCLE, V62, P155; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Kent PT, 1985, PUBLIC HLTH MYCOBACT; LIPSKY BA, 1984, REV INFECT DIS, V6, P214; Mello FCD, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-43; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Muyoyeta M, 2009, INT J TUBERC LUNG D, V13, P460; National Institute for Health and Clinical Excellence, 2011, CLIN DIAGN MAN TUB M; Sarmiento OL, 2003, J CLIN MICROBIOL, V41, P3233, DOI 10.1128/JCM.41.7.3233-3240.2003; Shinu P, 2011, MEM I OSWALDO CRUZ, V106, P620, DOI 10.1590/S0074-02762011000500016; Siddiqi K, 2003, LANCET INFECT DIS, V3, P288, DOI 10.1016/S1473-3099(03)00609-1; Soto A, 2008, INT J INFECT DIS, V13, P40, DOI DOI 10.1016/J.IJID.2008.03.023; Soto A, 2011, PLOS ONE, V6; Soto A, 2008, BRAZ J INFECT DIS, V12, P128, DOI 10.1590/S1413-86702008000200006; Soto A, 2011, TROP MED INT HEALTH, V16, P424, DOI 10.1111/j.1365-3156.2010.02715.x; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Van Deun A, 2008, T ROY SOC TROP MED H, V102, P564, DOI 10.1016/j.trstmh.2008.02.012; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2010, WHOHTMTB2009420; World Health Organization, 2011, FLUOR LIGHT EM DIOD; World Health Organization, 2011, POL STAT AUT REAL TI; World Health Organization (WHO), 2007, WHOHTMTB2007379	34	3	3	0	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2013	18	10					1222	1230		10.1111/tmi.12172				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	213PC	WOS:000324069100009	23952335	Bronze			2019-04-02	
J	Karemere, H; Kahindo, JB; Ribesse, N; Macq, J				Karemere, H.; Kahindo, J. B.; Ribesse, N.; Macq, J.			Governance of tertiary referral hospitals in the Democratic Republic of the Congo: a critical interpretive synthesis of the literature	MEDECINE ET SANTE TROPICALES			French	Review						Democratic Republic of Congo; Referral hospital; Complex System; Governance; leadership		Introduction. Because hospitals are complex enterprises requiring adaptive systems, it is appropriate to apply the theory and terminology of governance or even better adaptive governance to the interpretation of their management. This study focused on understanding hospital governance in Logo, Bunia, and Katana, three hospitals in two regions of the eastern DRC, which has been characterized by intermittent armed conflict since 1996. In such a context of war and continuous insecurity, how can governance be interpreted for hospitals required to adapt to a constantly changing environment to be able to continue to provide health care? Methodology. A critical interpretive synthesis of the literature, identified by searching for keywords related to governance. Results. The concepts of governance, adaptive governance, performance, leadership, and complex adaptive system concepts are defined. The interpretation of the concepts helps us to better understand (1) the hospital as a complex adaptive system, (2) the governance of tertiary referral hospitals, (3) analysis of hospital performance, and (4) leadership for good governance of these hospitals. Discussion. The interpretation of these concepts raises several questions about their application to the eastern DRC. Conclusion. This critical interpretive synthesis opens the door to a new way of exploring tertiary hospitals and their governance in the eastern DRC.	[Karemere, H.] Catholic Univ Louvain, 30 Clos Chapelle Aux Champs, B-1200 Brussels, Belgium; [Kahindo, J. B.] Cemubac, Goma, Region Nord Kiv, DEM REP CONGO; [Ribesse, N.; Macq, J.] Inst Rech Sante & Soc, B-1200 Brussels, Belgium	Karemere, H (reprint author), Catholic Univ Louvain, 30 Clos Chapelle Aux Champs, B-1200 Brussels, Belgium.	hkaremere@yahoo.fr					Brunckhorst DJ, 2002, ECOLOGICAL MANAGEMEN, V3, P109; Champagne F, 2005, R0505 GRIS U MONTR; Denis JL, 2007, HUM RELAT, V60, P179, DOI 10.1177/0018726707075288; Denis JL, 2002, ETUDE 36 COMMISSION; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Ditzel Elizabeth, 2006, Health Res Policy Syst, V4, P2, DOI 10.1186/1478-4505-4-2; Dixon-Woods Mary, 2006, BMC Med Res Methodol, V6, P35, DOI 10.1186/1471-2288-6-35; et Nelson Hatfield- Dodds, 2007, ANZSEE C NOOS AUSTR; Fernandez A., NOUVEAUX TABLEAUX BO; Goodwin N., LEADERSHIP HLTH CARE; Grimshaw J., 2009, CHAPITRE SYNTHE SE C; Grodos D, 2002, TROP MED INT HEALTH, V7, P977, DOI 10.1046/j.1365-3156.2002.00925.x; Guisset AL, 2002, SCI SOC SANTE, V20, P65, DOI 10.3406/sosan.2002.1553; Holland J. H., 2006, Journal of Systems Science and Complexity, V19, P1, DOI 10.1007/s11424-006-0001-z; KAPLAN RS, 1992, HARVARD BUS REV, V70, P71; Kruk ME, 2008, HEALTH POLICY, V85, P263, DOI 10.1016/j.healthpol.2007.09.003; Ministere de la Sante, 2010, REP DEM CONG, V2011-2015; MINTZBERG H, 1987, HARVARD BUS REV, V65, P66; Minvielle E, 2008, HEALTH POLICY, V87, P8, DOI 10.1016/j.healthpol.2007.09.017; Olsson P, 2004, ENVIRON MANAGE, V34, P75, DOI 10.1007/s00267-003-0101-7; OMS, 2008, STRAT COOP OMS AV PA; Perera R, 2007, HEALTH POLICY, V80, P314, DOI 10.1016/j.healthpol.2006.03.011; Sicotte C, 1998, HLTH SERV MANAGE RES, P11; Sicotte C., 1999, RUPTURES REV TRANSDI, V6, P34; Siddiqi S, 2009, HEALTH POLICY, V90, P13, DOI 10.1016/j.healthpol.2008.08.005; Van Lerberghe W, 1992, ANN SOC BELG MED TR, P72; Walker B, 2006, ECOL SOC, V11; WHO, 2011, REF STRAT MOV I AUT; Zelman William N, 2003, J Health Care Finance, V29, P1	29	2	2	0	1	JOHN LIBBEY EUROTEXT LTD	MONTROUGE	127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE	2261-3684	2261-2211		MED SANTE TROP	Med. Sante Trop.	OCT-DEC	2013	23	4					397	402		10.1684/mst.2013.0249				6	Tropical Medicine	Tropical Medicine	VD5XK	WOS:000437166000015	24317235				2019-04-02	
J	Manou, LSB; Portaels, F; Eddyani, M; Book, AU; Vandelannoote, K; de Jong, BC				Manou, Bayonne L. S.; Portaels, F.; Eddyani, M.; Book, A. U.; Vandelannoote, K.; de Jong, B. C.			Mycobacterium ulcerans disease (Buruli ulcer) in Gabon: 2005-2011	MEDECINE ET SANTE TROPICALES			French	Article						Buruli ulcer; Mycobacterium ulcerans; Gabon		The first cases of Buruli ulcer (BU) in Gabon were described in the 1960s. Between 2005 and 2011, 301 clinically suspected cases of BU were found in all nine provinces of Gabon, and their lesions sampled for microbiological confirmation. Polymerase chain reaction (PCR) found 120 (39.9%) of these lesions positive and 181 (60.1%) negative for Mycobacterium ulcerans. The confirmed cases came mainly from the province of Moyen-Ogooue, particularly from localities along the Ogooue River (n=117; 52.5% of the samples in this province were PCR-positive). The detection rates per 100,000 inhabitants in this province ranged from 94.7 cases in 2005 to 28 in 2007, after an absence of active case-finding in 2006. The final three PCR-positive cases were found in the province of Estuaire. The characteristics of the confirmed BU patients (that is, PCR-positive) were identical to those described in other African countries: most patients were younger than 15 years old, and most lesions were found on both the upper and lower limbs. The group of suspected cases (PCR-negative) differed from the PCR-positive group for patient age (most patients were aged 15 to 49 years), lesion location (more frequently on the lower limbs), and ulceration (more frequent in the suspected cases). Some PCR-negative patients probably had other diseases; this underlines the importance of the differential diagnosis of BU. The cure rate of PCR confirmed cases in our study was 88%; treatment was the antibiotic combination recommended by the World Health Organization (WHO). Our study demonstrates that BU is endemic in Gabon and is a public health problem there. Patients consult late with often extensive lesions. Awareness campaigns should be pursued Gabon. to ensure earlier treatment of patients. The influence of HIV on BU in Gabon also deserves particular attention.	[Manou, Bayonne L. S.] Minist Sante Publ, BP 5258, Libreville, Gabon; [Portaels, F.; Eddyani, M.; Vandelannoote, K.; de Jong, B. C.] Inst Med Trop Antwerpen, Antwerp, Belgium; [Book, A. U.] Representant Reg Fairmed, Yaounde, Cameroon	Manou, LSB (reprint author), Minist Sante Publ, BP 5258, Libreville, Gabon.	bayonnemanou@yahoo.fr		de Jong, Bouke/0000-0002-1017-4675			[Anonymous], 2008, WEEKLY EPIDEMIOLOGIC, V83, P145; Burchard GD, 1985, TROP MED PARASITOL, V37, P1; CARAYON A, 1968, Bulletin de la Societe Medicale d'Afrique Noire de Langue Francaise, V13, P670; Christinet V, 2012, Rev Med Suisse, V8, P1792; CLANCEY JK, 1961, LANCET, V2, P951; Debacker M, 2004, TROP MED INT HEALTH, V9, P1297, DOI 10.1111/j.1365-3156.2004.01339.x; Debacker M, 2003, CLIN INFECT DIS, V36, pE67, DOI 10.1086/367660; Dogde OG, 1962, J TROP MED HYG, V65, P139; Eddyani M, 2008, J CLIN MICROBIOL, V46, P69, DOI 10.1128/JCM.00301-07; Janssens PG, 2005, B SEANC ACAD R SCI O, V51, P169; Johnson PDR, 2007, EMERG INFECT DIS, V13, P1653, DOI 10.3201/eid1311.061369; Johnson R C, 2004, Med Trop (Mars), V64, P145; Johnson RC, 2008, AIDS, V22, P901, DOI 10.1097/QAD.0b013e3282f7690a; Josse R, 1995, Med Trop (Mars), V55, P363; Kibadi K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000736; Kibadi K, 2010, EMERG INFECT DIS, V16, P738, DOI 10.3201/eid1604.091343; Kibadi K, 2009, TROP MED INT HEALTH, V14, P1110, DOI 10.1111/j.1365-3156.2009.02324.x; Kouame K, 2008, Med Trop (Mars), V68, P643; Lagarrigue V, 2000, Med Trop (Mars), V60, P262; Marsollier L, 2002, APPL ENVIRON MICROB, V68, P4623, DOI 10.1128/AEM.68.9.4623-4628.2002; Mensah-Quainoo E, 2008, TROP MED INT HEALTH, V13, P191, DOI 10.1111/j.1365-3156.2007.01990.x; Merritt RW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000911; MEYERS WM, 1974, AM J TROP MED HYG, V23, P919, DOI 10.4269/ajtmh.1974.23.919; Mondjo A., 2005, M LEPRAE B ALLF, V16, P37; Ndong G-P Obiang, 2008, Sante, V18, P97, DOI 10.1684/san.2008.0116; Ngoa UA, 2012, EMERG INFECT DIS, V18, P1206, DOI 10.3201/eid1807.110613; Organisation mondiale de la sante, WHOHTMIDM20121 ORG M; Ouattara D, 2002, B SOC PATHOL EXOT, V95, P287; Phanzu DM, 2011, AM J TROP MED HYG, V85, P1100, DOI 10.4269/ajtmh.2011.10-0530; Phanzu DM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001402; Phanzu MD, 2010, AM J TROP MED HYG, V82, P478, DOI 10.4269/ajtmh.2010.09-0256; PORTAELS F, 1989, ANN SOC BELG MED TR, V69, P91; Portaels F., 2003, Bulletin des Seances, Academie Royale des Sciences d'Outre- Mer, V49, P161; Portaels F., 2009, MED TROP, V69, P429; Portaels F., WHOCDS20014; Portaels F, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000178; Portaels F, 2009, CLIN DERMATOL, V27, P291, DOI 10.1016/j.clindermatol.2008.09.021; Sarfo FS, 2010, ANTIMICROB AGENTS CH, V54, P3678, DOI 10.1128/AAC.00299-10; Sopoh GE, 2010, AM J TROP MED HYG, V83, P307, DOI 10.4269/ajtmh.2010.09-0617; Stragier P, 2006, EMERG INFECT DIS, V12, P844, DOI 10.3201/eid1205.051191; Walsh DS, 2011, DERMATOL CLIN, V29, P1, DOI 10.1016/j.det.2010.09.006; WORINGER F, 1961, Bull Soc Fr Dermatol Syphiligr, V68, P325	42	7	7	0	0	JOHN LIBBEY EUROTEXT LTD	MONTROUGE	127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE	2261-3684	2261-2211		MED SANTE TROP	Med. Sante Trop.	OCT-DEC	2013	23	4					450	457		10.1684/mst.2013.0259				8	Tropical Medicine	Tropical Medicine	VD5XK	WOS:000437166000024	24413612				2019-04-02	
J	Rosas-Aguirre, A; Llanos-Cuentas, A; Speybroeck, N; Cook, J; Contreras-Mancilla, J; Soto, V; Gamboa, D; Pozo, E; Ponce, OJ; Pereira, MO; Soares, IS; Theisen, M; D'Alessandro, U; Erhart, A				Rosas-Aguirre, Angel; Llanos-Cuentas, Alejandro; Speybroeck, Niko; Cook, Jackie; Contreras-Mancilla, Juan; Soto, Veronica; Gamboa, Dionicia; Pozo, Edwar; Ponce, Oscar J.; Pereira, Mayne O.; Soares, Irene S.; Theisen, Michael; D'Alessandro, Umberto; Erhart, Annette			Assessing malaria transmission in a low endemicity area of north-western Peru	MALARIA JOURNAL			English	Article						Malaria transmission intensity; Low endemicity; Elimination; Polymerase chain reaction; Serology; Peru	ENTOMOLOGICAL INOCULATION RATE; PLASMODIUM-FALCIPARUM MALARIA; GLUTAMATE-RICH PROTEIN; SUB-SAHARAN AFRICA; CONTROL STRATEGIES; RAPID ASSESSMENT; SOUTH-AMERICA; AMAZON; ELIMINATION; PYRIMETHAMINE	Background: Where malaria endemicity is low, control programmes need increasingly sensitive tools for monitoring malaria transmission intensity (MTI) and to better define health priorities. A cross-sectional survey was conducted in a low endemicity area of the Peruvian north-western coast to assess the MTI using both molecular and serological tools. Methods: Epidemiological, parasitological and serological data were collected from 2,667 individuals in three settlements of Bellavista district, in May 2010. Parasite infection was detected using microscopy and polymerase chain reaction (PCR). Antibodies to Plasmodium vivax merozoite surface protein-1(19) (PvMSP1(19)) and to Plasmodium falciparum glutamate-rich protein (PfGLURP) were detected by ELISA. Risk factors for exposure to malaria (seropositivity) were assessed by multivariate survey logistic regression models. Age-specific antibody prevalence of both P. falciparum and P. vivax were analysed using a previously published catalytic conversion model based on maximum likelihood for generating seroconversion rates (SCR). Results: The overall parasite prevalence by microscopy and PCR were extremely low: 0.3 and 0.9%, respectively for P. vivax, and 0 and 0.04%, respectively for P. falciparum, while seroprevalence was much higher, 13.6% for P. vivax and 9.8% for P. falciparum. Settlement, age and occupation as moto-taxi driver during previous year were significantly associated with P. falciparum exposure, while age and distance to the water drain were associated with P. vivax exposure. Likelihood ratio tests supported age seroprevalence curves with two SCR for both P. vivax and P. falciparum indicating significant changes in the MTI over time. The SCR for PfGLURP was 19-fold lower after 2002 as compared to before (lambda 1 = 0.022 versus lambda 2 = 0.431), and the SCR for PvMSP119 was four-fold higher after 2006 as compared to before (lambda 1 = 0.024 versus lambda 2 = 0.006). Conclusion: Combining molecular and serological tools considerably enhanced the capacity of detecting current and past exposure to malaria infections and related risks factors in this very low endemicity area. This allowed for an improved characterization of the current human reservoir of infections, largely hidden and heterogeneous, as well as providing insights into recent changes in species specific MTIs. This approach will be of key importance for evaluating and monitoring future malaria elimination strategies.	[Rosas-Aguirre, Angel; Llanos-Cuentas, Alejandro; Contreras-Mancilla, Juan; Soto, Veronica; Gamboa, Dionicia; Ponce, Oscar J.] Univ Peruana Cayetano Heredia, Inst Trop Med, Lima, Peru; [Speybroeck, Niko] Catholic Univ Louvain, Res Inst Hlth & Soc IRSS, B-1200 Brussels, Belgium; [Cook, Jackie] Karolinska Inst, Dept Med Solna, Malaria Res Unit, Stockholm, Sweden; [Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Dept Ciencias Celulares & Mol, Lima, Peru; [Pozo, Edwar] Subreg Salud Luciano Castillo Coloma, Sullana, Peru; [Pereira, Mayne O.; Soares, Irene S.] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, Sao Paulo, Brazil; [Theisen, Michael] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark; [Theisen, Michael] Copenhagen Univ Hosp, Dept Infect Dis, Copenhagen, Denmark; [Theisen, Michael] Univ Copenhagen, Rigshosp, Dept Int Hlth Immunol & Microbiol, Ctr Med Parasitol, DK-2100 Copenhagen, Denmark; [Theisen, Michael; D'Alessandro, Umberto] MRC Unit, Fajara, Gambia; [Rosas-Aguirre, Angel; D'Alessandro, Umberto; Erhart, Annette] Inst Trop Med, B-2000 Antwerp, Belgium	Rosas-Aguirre, A (reprint author), Univ Peruana Cayetano Heredia, Inst Trop Med, Lima, Peru.	angelrosasa@gmail.com	Rosas Aguirre, Angel/A-5054-2016; D'Alessandro, Umberto/D-3457-2015; Soares, Irene/C-5974-2012	Rosas Aguirre, Angel/0000-0002-3271-7028; D'Alessandro, Umberto/0000-0001-6341-5009; Soares, Irene/0000-0002-3336-6856; Ponce, Oscar/0000-0001-5729-8408; Theisen, Michael/0000-0003-4412-1392; Gamboa, Dionicia/0000-0002-1420-7729; Contreras Mancilla, Juan Jose/0000-0003-0447-0926			Aguas R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001767; [Anonymous], 2011, PIUR COMP EST 2011; [Anonymous], 2001, AN SIT SAL AN 2000; Aramburu J, 2009, EMERG INFECT DIS, V5, P209; Bellina C, 1999, B SOC PERU MED INTER, V12, P163; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Bousema T, 2010, EMERG INFECT DIS, V16, P392, DOI 10.3201/eid1603.090732; Branch O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-27; Byass P, 2008, LANCET, V372, P1523, DOI 10.1016/S0140-6736(08)61631-1; CAMPBELL CC, 1980, AM J TROP MED HYG, V29, P151, DOI 10.4269/ajtmh.1980.29.151; Chuquiyauri R, 2012, ACTA TROP, V121, P292, DOI 10.1016/j.actatropica.2011.11.003; Cook J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-86; Cook J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025137; Cook J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-169; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195; Coura JR, 2006, MEM I OSWALDO CRUZ, V101, P229, DOI 10.1590/S0074-02762006000300001; Culleton R, 2009, J INFECT DIS, V200, P1465, DOI 10.1086/644510; da Silva-Nunes M, 2012, ACTA TROP, V121, P281, DOI 10.1016/j.actatropica.2011.10.001; de Stricker K, 2000, MOL BIOCHEM PARASIT, V111, P123, DOI 10.1016/S0166-6851(00)00304-2; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Elissa N, 2003, ACTA TROP, V85, P355, DOI 10.1016/S0001-706X(02)00266-8; Flores W, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-379; Gagnon AS, 2002, INT J BIOMETEOROL, V46, P81, DOI 10.1007/s00484-001-0119-6; Greenwood BM, 2008, TRENDS PARASITOL, V24, P449, DOI 10.1016/j.pt.2008.07.002; Guthmann JP, 2002, TROP MED INT HEALTH, V7, P518, DOI 10.1046/j.1365-3156.2002.00883.x; Guthmann JP, 2001, T ROY SOC TROP MED H, V95, P577, DOI 10.1016/S0035-9203(01)90084-7; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Johnston SP, 2006, J CLIN MICROBIOL, V44, P1087, DOI 10.1128/JCM.44.3.1087-1089.2006; Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-19; Marquino W, 2003, AM J TROP MED HYG, V68, P608, DOI 10.4269/ajtmh.2003.68.608; Marquino W, 2003, AM J TROP MED HYG, V68, P120, DOI 10.4269/ajtmh.2003.68.120; Ministerio de Salud del Peru, 2003, SER NORM TECN, V39; Ministerio de Salud del Peru - Direccion General de Epidemiologia, 2011, B EPIDEMIOL, V20, P1108; Ministerio de Salud del Peru - Direccion General de Epidemiologia, 2010, AN SIT SAL PER ASIS; Mutapi F, 2007, MEM I OSWALDO CRUZ, V102, P405, DOI 10.1590/S0074-02762007005000046; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Roberts DR, 1997, EMERG INFECT DIS, V3, P295, DOI 10.3201/eid0303.970305; Rodrigues MHC, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-39; Rosas-Aguirre Angel, 2011, Rev. perú. med. exp. salud publica, V28, P228, DOI 10.1590/s1726-46342011000200009; Rubio J M, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS199, DOI 10.1016/S0035-9203(02)90077-5; Speybroeck N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016705; Steenkeste N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-108; Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083; Taylor SM, 2010, J CLIN MICROBIOL, V48, P512, DOI 10.1128/JCM.01800-09; THEISEN M, 1995, CLIN DIAGN LAB IMMUN, V2, P30; Vinetz JM, 2002, AM J TROP MED HYG, V66, P639, DOI 10.4269/ajtmh.2002.66.639; Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3; Williams GS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-168; Williams HA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-85; World Health Organization Global Malaria Program, 2011, WORLD MAL REP 2011	51	18	18	2	11	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	SEP 22	2013	12								339	10.1186/1475-2875-12-339				13	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	227JJ	WOS:000325108500001	24053144	DOAJ Gold, Green Published			2019-04-02	
J	Durnez, L; Mao, S; Denis, L; Roelants, P; Sochantha, T; Coosemans, M				Durnez, Lies; Mao, Sokny; Denis, Leen; Roelants, Patricia; Sochantha, Tho; Coosemans, Marc			Outdoor malaria transmission in forested villages of Cambodia	MALARIA JOURNAL			English	Article							POLYMERASE-CHAIN-REACTION; ANOPHELES-DIRUS COMPLEX; DIPTERA-CULICIDAE; SOUTHEAST-ASIA; VECTOR CONTROL; MOLECULAR-IDENTIFICATION; PLASMODIUM-FALCIPARUM; WESTERN THAILAND; CENTRAL VIETNAM; BITING ACTIVITY	Background: Despite progress in malaria control, malaria remains an important public health concern in Cambodia, mostly linked to forested areas. Large-scale vector control interventions in Cambodia are based on the free distribution of long-lasting insecticidal nets (LLINs), targeting indoor- and late-biting malaria vectors only. The present study evaluated the vector density, early biting activity and malaria transmission of outdoor-biting malaria vectors in two forested regions in Cambodia. Methods: In 2005 two entomological surveys were conducted in 12 villages and their related forest plots in the east and west of Cambodia. Mosquitoes were collected outdoors by human landing collections and subjected to enzyme-linked immunosorbent assay (ELISA) to detect Plasmodium sporozoites after morphological identification. Blood samples were collected in the same villages for serological analyses. Collected data were analysed by the classification and regression tree (CART) method and linear regression analysis. Results: A total of 11,826 anophelines were recorded landing in 787 man-night collections. The majority (82.9%) were the known primary and secondary vectors. Most of the variability in vector densities and early biting rates was explained by geographical factors, mainly at village level. Vector densities were similar between forest and village sites. Based on ELISA results, 29% out of 17 Plasmodium-positive bites occurred before sleeping time, and 65% in the forest plots. The entomological inoculation rates of survey 1 were important predictors of the respective seroconversion rates in survey 2, whereas the mosquito densities were not. Discussion: In Cambodia, outdoor malaria transmission in villages and forest plots is important. In this context, deforestation might result in lower densities of the primary vectors, but also in higher densities of secondary vectors invading deforested areas. Moreover, higher accessibility of the forest could result in a higher man-vector contact. Therefore, additional vector control measures should be developed to target outdoor- and early-biting vectors.	[Durnez, Lies; Denis, Leen; Roelants, Patricia; Coosemans, Marc] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Mao, Sokny; Sochantha, Tho] Natl Ctr Malaria Control Parasitol & Entomol, Phnom Penh, Cambodia; [Coosemans, Marc] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium	Durnez, L (reprint author), Inst Trop Med, Dept Biomed Sci, Natl Str 155, B-2000 Antwerp, Belgium.	ldurnez@itg.be			CNM; Institute of Tropical Medicine, Belgium; Belgian Co-operation (Directorate-General for Development Co-operation)	We are grateful to the staff of the National Center for Malaria Control, Parasitology and Entomology in Cambodia who were involved in the planning and implementation of the anophelines collection. We acknowledge the inhabitants of the study villages who supported the study. The current study was financially supported by the Institutional Collaboration between CNM and the Institute of Tropical Medicine, Belgium, supported by the Belgian Co-operation (Directorate-General for Development Co-operation).	Amerasinghe PH, 1999, AM J TROP MED HYG, V60, P421, DOI 10.4269/ajtmh.1999.60.421; BEEBE NW, 1995, AM J TROP MED HYG, V53, P478, DOI 10.4269/ajtmh.1995.53.478; Chambers M, 2005, HANOI, V710b-710c, p[11, 710]; CNM, 2011, CAMB MAL SURV 2010; Cook J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-86; Cook J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-169; Coosemans M, 2006, P INT C HUBS HARB DE, P6; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Delacollette C, 2009, SE ASIAN J TROP MED, V40, P674; Do MC, 2010, MALARIA J, V9, P259; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; Durnez L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-195; Dysoley L, 2008, ACTA TROP, V106, P207, DOI 10.1016/j.actatropica.2007.01.007; EYLES DON E., 1964, BULL WORLD HEALTH ORGAN, V30, P7; Future Use of Materials for Dental Restoration, 2009, MAL GREAT MEK SUBR R, P58; Guerra CA, 2006, ANN TROP MED PARASIT, V100, P189, DOI 10.1179/136485906X91512; Hai NS, 2003, J MALARIA PARASITE D, V4, P61; *IMPE, 1987, KEY ID AN VIETN AD P; Kiware SS, 2012, BIOL LETTERS, V8, P874, DOI 10.1098/rsbl.2012.0352; LIEN JC, 1975, J MED ENTOMOL, V12, P333, DOI 10.1093/jmedent/12.3.333; LIEN JC, 1977, J MED ENTOMOL, V13, P719, DOI 10.1093/jmedent/13.6.719; Limrat Dakorn, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P739; malERA, 2011, PLOS MED, V8; MEEK SR, 1995, ANN TROP MED PARASIT, V89, P135, DOI 10.1080/00034983.1995.11812944; Ministry of Health Cambodia, 2011, NAT STRAT MAL EL CAM; Mouchet J, 2008, J LIBBEY EUROTEXT, V427, P427; Muenworn V, 2009, J VECTOR ECOL, V34, P62, DOI [10.1111/j.1948-7134.2009.00008.x, 10.3376/038.034.0108]; Obsomer V, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-26; Obsomer V, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-136; Peeters-Grietens K, 2012, PLOS ONE, V7; Protopopoff N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008022; Rattanarithikul R, 1996, AM J TROP MED HYG, V54, P114, DOI 10.4269/ajtmh.1996.54.114; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Rwegoshora TR, 2002, SE ASIAN J TROP MED, V33, P694; Sanh NH, 2008, AM J TROP MED HYG, V79, P652, DOI 10.4269/ajtmh.2008.79.652; SCW, 2006, SCH ATL CAMB; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; Sochantha T, 2010, TROP MED INT HEALTH, V15, P336, DOI 10.1111/j.1365-3156.2009.02457.x; Tananchai C, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-211; Tisgratog R, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-114; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; Trung HD, 2004, TROP MED INT HEALTH, V9, P230, DOI 10.1046/j.1365-3156.2003.01179.x; Van Bortel W, 2000, INSECT MOL BIOL, V9, P335, DOI 10.1046/j.1365-2583.2000.00192.x; Van Bortel W, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-373; Walton C, 1999, MED VET ENTOMOL, V13, P24, DOI 10.1046/j.1365-2915.1999.00142.x; Walton C, 2007, INFECT GENET EVOL, V7, P93, DOI 10.1016/j.meegid.2006.05.001; World Health Organization, 2011, WORLD MAL REP 2011, P278	47	51	51	0	37	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	SEP 17	2013	12								329	10.1186/1475-2875-12-329				14	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	221JG	WOS:000324653600002	24044424	DOAJ Gold, Green Published			2019-04-02	
J	Sicuri, E; Vieta, A; Lindner, L; Constenla, D; Sauboin, C				Sicuri, Elisa; Vieta, Ana; Lindner, Leandro; Constenla, Dagna; Sauboin, Christophe			The economic costs of malaria in children in three sub-Saharan countries: Ghana, Tanzania and Kenya	MALARIA JOURNAL			English	Article						Malaria; Sub Saharan Africa; Costs	INTERMITTENT PREVENTIVE TREATMENT; PLACEBO-CONTROLLED TRIAL; PLASMODIUM-FALCIPARUM MALARIA; TRANSMISSION INTENSITY; CHILDHOOD MALARIA; HEALTH-INSURANCE; AGE-PATTERNS; INFANTS; AFRICA; ANEMIA	Background: Malaria causes significant mortality and morbidity in sub-Saharan Africa (SSA), especially among children less than five years of age (U5 children). Although the economic burden of malaria in this region has been assessed previously, the extent and variation of this burden remains unclear. This study aimed to estimate the economic costs of malaria in U5 children in three countries (Ghana, Tanzania and Kenya). Methods: Health system and household costs previously estimated were integrated with costs associated with co-morbidities, complications and productivity losses due to death. Several models were developed to estimate the expected treatment cost per episode per child, across different age groups, by level of severity and with or without controlling for treatment-seeking behaviour. Total annual costs (2009) were calculated by multiplying the treatment cost per episode according to severity by the number of episodes. Annual health system prevention costs were added to this estimate. Results: Household and health system costs per malaria episode ranged from approximately US$ 5 for non-complicated malaria in Tanzania to US$ 288 for cerebral malaria with neurological sequelae in Kenya. On average, up to 55% of these costs in Ghana and Tanzania and 70% in Kenya were assumed by the household, and of these costs 46% in Ghana and 85% in Tanzania and Kenya were indirect costs. Expected values of potential future earnings (in thousands) lost due to premature death of children aged 0-1 and 1-4 years were US$ 11.8 and US$ 13.8 in Ghana, US$ 6.9 and US$ 8.1 in Tanzania, and US$ 7.6 and US$ 8.9 in Kenya, respectively. The expected treatment costs per episode per child ranged from a minimum of US$ 1.29 for children aged 2-11 months in Tanzania to a maximum of US$ 22.9 for children aged 0-24 months in Kenya. The total annual costs (in millions) were estimated at US$ 37.8, US$ 131.9 and US$ 109.0 nationwide in Ghana, Tanzania and Kenya and included average treatment costs per case of US$ 11.99, US$ 6.79 and US$ 20.54, respectively. Conclusion: This study provides important insight into the economic burden of malaria in SSA that may assist policy makers when designing future malaria control interventions.	[Sicuri, Elisa] Univ Barcelona, Hosp Clin, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona, Spain; [Sicuri, Elisa] CIBERESP, Barcelona, Spain; [Vieta, Ana; Lindner, Leandro] IMS Hlth, Hlth Econ & Outcome Res, Barcelona, Spain; [Constenla, Dagna] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Sauboin, Christophe] GlaxoSmithKline Vaccines, Hlth Econ, Wavre, Belgium	Sauboin, C (reprint author), GlaxoSmithKline Vaccines, Hlth Econ, Wavre, Belgium.	CHRISTOPHE.J.SAUBOIN@gsk.com	Sicuri, Elisa/L-8012-2014	Sicuri, Elisa/0000-0002-2499-2732	GlaxoSmithKline Biologicals SA	The authors are grateful to all the members of the cost-effectiveness working group of the IPTi (intermittent preventive treatment of malaria in infants) consortium who worked in Ghana, Kenya and Tanzania: Lesong Conteh, Guy Hutton, Fabrizio Tediosi, Fatuma Manzi, Benson Obonyo, Fred Matovu, Paul Masika and Peter Otieno. We also thank Edith Patouillard for original data collection in Ghana and Caterina Guinovart and Eusebio Macete for their advice on the treatment of epidemiological data. We thank the individuals responsible for the national malaria control programmes in the three countries for their collaboration in providing information as well as clinicians and health workers who were interviewed. We thank Kara Hanson for her helpful comments on the manuscript, Amrita Ostawal (GlaxoSmithKline Vaccines) for writing assistance, Juliette Gray (XPE Pharma & Science on behalf of GlaxoSmithKline Vaccines) for editing and language support and Abdelilah Ibrahimi (XPE Pharma & Science on behalf of GlaxoSmithKline Vaccines) and Cedric Laloyaux (Business & Decision Life Sciences on behalf of GlaxoSmithKline Vaccines) for editorial assistance and manuscript coordination. Support for this study was provided by GlaxoSmithKline Biologicals SA.	Agyepong IA, 2008, HEALTH POLICY PLANN, V23, P150, DOI 10.1093/heapol/czn002; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; AMFm Independent Evaluation Team, 2012, IND EV PHAS 1 AFF ME; [Anonymous], 2009, INT DRUG PRIC IND GU; Asante F. A., 2003, EC BURDEN MALA UNPUB; Ayieko Philip, 2009, Cost Eff Resour Alloc, V7, P3, DOI 10.1186/1478-7547-7-3; Bank W, 2009, HLTH NUTR POP STAT H; Bassat Q, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-37; Briggs AH, 2006, DECISION MODELLING H; Brugiavini A., 2010, EXTENDING HLTH INSUR; Carneiro I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008988; Case A, 2009, PAYING PIPER HIGH CO, P14456; Chandramohan D, 2005, BRIT MED J, V331, P727, DOI 10.1136/bmj.331.7519.727; Chima RI, 2003, HEALTH POLICY, V63, P17, DOI 10.1016/S0168-8510(02)00036-2; Chuma JM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-76; Conteh L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012223; Conteh L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010313; Division of Malaria Control Kenya, 2010, UNPUB; Getahun A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-320; Ghana Ministry of Health, 2008, STRAT PLAN MAL UNPUB; Ghana Statistical Service (GSS), 2009, GHAN DEM HLTH SURV; Glied S, 1996, AM J PUBLIC HEALTH, V86, P1723, DOI 10.2105/AJPH.86.12.1723; Goldie SJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000264; Gomes MF, 2009, LANCET, V373, P557, DOI 10.1016/S0140-6736(08)61734-1; Gonzalez MA, 2000, B WORLD HEALTH ORGAN, V78, P97; Gosling RD, 2009, LANCET, V374, P1521, DOI 10.1016/S0140-6736(09)60997-1; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Hu D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000750; Hutton G, 2009, B WORLD HEALTH ORGAN, V87, P123, DOI 10.2471/BLT.08.051961; International Labour Organization, EXT SOC SEC FIGHT PO; Kenya Central Bureau of Statistics (CBS) Ministry of Health (MOH) and ORC Macro, 2004, KEN DEM HLTH SURV 20; Kobbe R, 2007, CLIN INFECT DIS, V45, pS16, DOI 10.1086/518575; Kweku M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004000; Lewis M, 2007, HEALTH AFFAIR, V26, P984, DOI 10.1377/hlthaff.26.4.984; Max W, 2004, VALUING HUMAN LIFE E; McPake B, 1999, SOC SCI MED, V49, P849, DOI 10.1016/S0277-9536(99)00144-6; Ministry of health and social services, 2008, REP MED COV HLTH INS; Mockenhaupt FP, 2007, ANTIMICROB AGENTS CH, V51, P3273, DOI 10.1128/AAC.00513-07; Muela SH, 2000, HEALTH POLICY PLANN, V15, P296, DOI 10.1093/heapol/15.3.296; Murphy SC, 2001, AM J TROP MED HYG, V64, P57, DOI 10.4269/ajtmh.2001.64.57; Nelms LW, 2006, J TRANSCULT NURS, V17, P184, DOI 10.1177/1043659605285411; Nxumalo N, 2011, J PUBLIC HEALTH POL, V32, pS124, DOI 10.1057/jphp.2011.26; Nyakeriga AM, 2004, J INFECT DIS, V190, P439, DOI 10.1086/422331; Odhiambo FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010016; Okiro EA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-4; Olsen JA, 1999, SOC SCI MED, V49, P17, DOI 10.1016/S0277-9536(99)00116-1; Onwujekwe O, 2010, HEALTH POLICY, V96, P72, DOI 10.1016/j.healthpol.2009.12.014; Plowe CV, 2009, J INFECT DIS, V200, P1646, DOI 10.1086/646613; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Schellenberg DM, 2003, T ROY SOC TROP MED H, V97, P647, DOI 10.1016/S0035-9203(03)80096-2; Sicuri E, 2012, HEALTH POLICY PLANN, V27, P339, DOI 10.1093/heapol/czr046; Snow RW, 2009, COVERAGE IMPAC UNPUB; Su TT, 2007, HEALTH POLICY, V83, P353, DOI 10.1016/j.healthpol.2007.02.005; Tanzania Commission for AIDS (TACAIDS) Dar es Salaam Tanzania Zanzibar AIDS Commission (ZAC) Zanzibar National Bureau of Statistics Dar es Salaam Tanzania Office of Chief Government Statistician (OCGS) Zanzibar Macro International Inc. Calverton Maryland USA, 2008, TANZ HIV AIDS MAL IN; Tediosi F, 2006, AM J TROP MED HYG, V75, P90, DOI 10.4269/ajtmh.2006.75.90; ter Kuile FO, 2003, AM J TROP MED HYG, V68, P50, DOI 10.4269/ajtmh.2003.68.50; Wells TNC, 2009, NAT REV DRUG DISCOV, V8, P879, DOI 10.1038/nrd2972; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2009, WORLD MAL REP 2009; WHO-Whosis, 2009, LIF TABL KEN GHAN TA; Witter S, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-20	62	28	28	0	22	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	SEP 3	2013	12								307	10.1186/1475-2875-12-307				14	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	214JZ	WOS:000324130600001	24004482	DOAJ Gold, Green Published			2019-04-02	
J	Truc, P; Buscher, P; Cuny, G; Gonzatti, MI; Jannin, J; Joshi, P; Juyal, P; Lun, ZR; Mattioli, R; Pays, E; Simarro, PP; Teixeira, MMG; Touratier, L; Vincendeau, P; Desquesnes, M				Truc, Philippe; Buscher, Philippe; Cuny, Gerard; Isabel Gonzatti, Mary; Jannin, Jean; Joshi, Prashant; Juyal, Prayag; Lun, Zhao-Rong; Mattioli, Raffaele; Pays, Etienne; Simarro, Pere P.; Geraldes Teixeira, Marta Maria; Touratier, Louis; Vincendeau, Philippe; Desquesnes, Marc			Atypical Human Infections by Animal Trypanosomes	PLOS NEGLECTED TROPICAL DISEASES			English	Review							APOLIPOPROTEIN L-I; HUMAN SERUM; TRYPANOLYTIC FACTOR; EVANSI INFECTION; CROSS-REACTIONS; LYTIC FACTOR; LEWISI; INDIA; HERPETOSOMA; BRUCEI	The two classical forms of human trypanosomoses are sleeping sickness due to Trypanosoma brucei gambiense or T. brucei rhodesiense, and Chagas disease due to T. cruzi. However, a number of atypical human infections caused by other T. species (or sub-species) have been reported, namely due to T. brucei brucei, T. vivax, T. congolense, T. evansi, T. lewisi, and T. lewisi-like. These cases are reviewed here. Some infections were transient in nature, while others required treatments that were successful in most cases, although two cases were fatal. A recent case of infection due to T. evansi was related to a lack of apolipoprotein L-I, but T. lewisi infections were not related to immunosuppression or specific human genetic profiles. Out of 19 patients, eight were confirmed between 1974 and 2010, thanks to improved molecular techniques. However, the number of cases of atypical human trypanosomoses might be underestimated. Thus, improvement, evaluation of new diagnostic tests, and field investigations are required for detection and confirmation of these atypical cases.	[Truc, Philippe; Cuny, Gerard] IRD, UMR InterTryp IRD CIRAD 177, Montpellier, France; [Buscher, Philippe] Inst Trop Med, B-2000 Antwerp, Belgium; [Isabel Gonzatti, Mary] Univ Simon Bolivar, Dept Biol Celular, Caracas, Venezuela; [Jannin, Jean; Simarro, Pere P.] WHO, Innovat & Intensified Dis Management, Neglected Trop Dis Control, CH-1211 Geneva, Switzerland; [Joshi, Prashant] Indira Gandhi Govt Med Coll, Nagpur, Maharashtra, India; [Juyal, Prayag] Guru Angad Univ, Ludhiana, Punjab, India; [Lun, Zhao-Rong] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Mattioli, Raffaele] UN, Food & Agr Org, Rome, Italy; [Pays, Etienne] Univ Libre Bruxelles, Mol Parasitol Lab, Gosselies, Belgium; [Geraldes Teixeira, Marta Maria] Univ Sao Paulo, Sao Paulo, Brazil; [Touratier, Louis] World Org Anim Hlth, OIE Ad Hoc Grp Non Tsetse Transmitted Anim Trypan, Diag, Paris, France; [Vincendeau, Philippe] Univ Bordeaux 2, Lab Biol & Parasitol, UMR InterTryp IRD CIRAD 177, F-33076 Bordeaux, France; [Desquesnes, Marc] Kasetsart Univ, UMR InterTryp IRD CIRAD 177, Ctr Cooperat Int Rech Agron Dev CIRAD, Bangkok, Thailand	Truc, P (reprint author), IRD, UMR InterTryp IRD CIRAD 177, Campus Int Baillarguet, Montpellier, France.	Philippe.Truc@ird.fr	Buscher, Philippe/B-9956-2012	Buscher, Philippe/0000-0002-1926-7472; Desquesnes, Marc/0000-0002-7665-2422			ABEBE M, 1988, ACTA TROP, V45, P185; da Silva FM, 2010, INFECT GENET EVOL, V10, P522, DOI 10.1016/j.meegid.2010.02.005; Deborggraeve S, 2008, DIAGN MICR INFEC DIS, V61, P428, DOI 10.1016/j.diagmicrobio.2008.03.006; Desquesnes M, 2002, VET PARASITOL, V109, P213, DOI 10.1016/S0304-4017(02)00270-4; Desquesnes M, 2001, ANN TROP MED PARASIT, V95, P141, DOI 10.1080/00034980120050251; Desquesnes M., 2002, KINETOPLASTID BIOL D, V1, P2, DOI DOI 10.1186/1475-9292-1-2 12234387; Desquesnes M, 2007, INFECT GENET EVOL, V7, P457, DOI [10.1016/j.meegid.2007.01.007, 10.1016/j.meegid.2006.01.007]; Doke PP, 2011, ANN TROP MED PUBLIC, V4, P91, DOI 10.4103/1755-6783.85759; FERRANTE A, 1985, INFECT IMMUN, V49, P378; Gill BS, 1977, TRYPANOSOMES TRYPANO, P36; Gutierrez C, 2010, VET PARASITOL, V174, P26, DOI 10.1016/j.vetpar.2010.08.012; Haridy Fouad M., 2011, Journal of the Egyptian Society of Parasitology, V41, P65; HAWKING F, 1978, T ROY SOC TROP MED H, V72, P405, DOI 10.1016/0035-9203(78)90136-0; Hoare C. A., 1972, TRYPANOSOMES MAMMALS; Howie S, 2006, PLOS MED, V3, P1508, DOI 10.1371/journal.pmed.0030355; JARVINEN JA, 1976, INFECT IMMUN, V14, P894; Jittapalapong S, 2008, INFECT GENET EVOL, V8, P445, DOI 10.1016/j.meegid.2007.08.002; JOHNSON P. D., 1933, TRANS ROY SOC TROP MED AND HYG [LONDON], V26, P467, DOI 10.1016/S0035-9203(33)90105-4; Joshi PP, 2006, T ROY SOC TROP MED H, V100, P989, DOI 10.1016/j.trstmh.2005.11.003; Joshi PP, 2005, AM J TROP MED HYG, V73, P491, DOI 10.4269/ajtmh.2005.73.491; Juyal P. D., 1998, Journal of Parasitic Diseases, V22, P67; Kaur Raminder, 2007, J Commun Dis, V39, P71; Lai DH, 2010, INT J PARASITOL, V40, P705, DOI 10.1016/j.ijpara.2009.11.009; MARAGHI S, 1995, PARASITOL RES, V81, P693, DOI 10.1007/BF00931848; Marc D, 2011, INFECT GENET EVOL, V11, P1361, DOI 10.1016/j.meegid.2011.04.030; Ngaira JM, 2005, EXP PARASITOL, V110, P30, DOI 10.1016/j.exppara.2005.01.001; Pathak KML, 1997, VET PARASITOL, V69, P49, DOI 10.1016/S0304-4017(96)01091-6; Pays E, 2008, MICROBES INFECT, V10, P985, DOI 10.1016/j.micinf.2008.07.020; Pays E, 2006, NAT REV MICROBIOL, V4, P477, DOI 10.1038/nrmicro1428; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; RICKMAN LR, 1970, B WORLD HEALTH ORGAN, V42, P650; Sarataphan N, 2007, J MED MICROBIOL, V56, P1118, DOI 10.1099/jmm.0.47222-0; Shah I, 2011, J VECTOR DIS, V48, P122; Shegokar VR, 2006, AM J TROP MED HYG, V75, P869, DOI 10.4269/ajtmh.2006.75.869; SHRIVASTAVA KK, 1974, T ROY SOC TROP MED H, V68, P143, DOI 10.1016/0035-9203(74)90188-6; Singh N, 2004, VET PARASITOL, V126, P365, DOI 10.1016/j.vetpar.2004.08.013; SONGA EB, 1988, ANN SOC BELG MED TR, V68, P233; Tang HJ, 2012, INFECT GENET EVOL, V12, P1046, DOI 10.1016/j.meegid.2012.02.018; Touratier L, 2006, 1 RENC ALG FRANC PAR; Truc P, 1998, T ROY SOC TROP MED H, V92, P537, DOI 10.1016/S0035-9203(98)90904-X; Truc P, 2007, INFECT GENET EVOL, V7, P305, DOI 10.1016/j.meegid.2006.07.004; Van Hoff L, 1948, OBSERVATIONS TRYPANO, P359; Van Xong H, 2002, EXP PARASITOL, V102, P61, DOI 10.1016/S0014-4894(03)00032-8; Vanhamme L, 2004, INT J PARASITOL, V34, P887, DOI 10.1016/j.ijpara.2004.04.008; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Vanhollebeke B, 2007, P NATL ACAD SCI USA, V104, P4118, DOI 10.1073/pnas.0609902104; Vanhollebeke B, 2006, NEW ENGL J MED, V355, P2752, DOI 10.1056/NEJMoa063265; Verloo D, 2001, VET PARASITOL, V97, P183, DOI 10.1016/S0304-4017(01)00412-5; Verma A, 2011, AM J TROP MED HYG, V85, P221, DOI 10.4269/ajtmh.2011.11-0002	49	48	52	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	SEP	2013	7	9							e2256	10.1371/journal.pntd.0002256				7	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	224WA	WOS:000324920800003	24069464	DOAJ Gold, Green Published			2019-04-02	
J	Paul, E				Paul, E.			The Belgian development cooperation stakeholders' Charter on the recruitment and support to the development of HRH in partner countries	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Paul, E.] Univ Liege, B-4000 Liege, Belgium								0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2013	18			1	SI		36	37						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	213BS	WOS:000324029000090					2019-04-02	
J	Poppe, A; Jirovsky, E; Blacklock, C; Laxmikanth, P; Moosa, S; Maeseneer, J; Kutalek, R; Peersman, W				Poppe, A.; Jirovsky, E.; Blacklock, C.; Laxmikanth, P.; Moosa, S.; Maeseneer, J.; Kutalek, R.; Peersman, W.			Why Sub-Saharan African health workers migrate to European countries that do not actively recruit: a qualitative study post migration	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Poppe, A.; Maeseneer, J.; Peersman, W.] Univ Ghent, B-9000 Ghent, Belgium; [Jirovsky, E.; Kutalek, R.] Med Univ, Vienna, Austria; [Blacklock, C.; Laxmikanth, P.] Univ Oxford, Oxford OX1 2JD, England; [Moosa, S.] Univ Witwatersrand, ZA-2050 Johannesburg, South Africa								0	0	0	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2013	18			1	SI		37	37						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	213BS	WOS:000324029000092					2019-04-02	
J	van Bastelaere, S				van Bastelaere, S.			The HRH Charter and the Belgian Development Agency: from theory to practice	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[van Bastelaere, S.] Belgian Dev Agcy, Brussels, Belgium								0	0	0	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2013	18			1	SI		37	38						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	213BS	WOS:000324029000093					2019-04-02	
J	Decat, P; Gyselinck, K; Leyns, C; Montenegro, H; Criel, B				Decat, P.; Gyselinck, K.; Leyns, C.; Montenegro, H.; Criel, B.			Universal Health Coverage: yes, but coverage of what? The need for people-centered Care	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Decat, P.] Univ Ghent, Int Ctr Reprod Hlth, B-9000 Ghent, Belgium; [Leyns, C.] Univ Ghent, Dept Family Med & Primary Hlth Care, B-9000 Ghent, Belgium; [Montenegro, H.] World Hlth Org, Geneva, Switzerland; [Criel, B.] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium								0	0	0	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2013	18			1	SI		38	39						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	213BS	WOS:000324029000094					2019-04-02	
J	Ravinetto, R; Cloez, S; Massat, P; Luyckx, C; Andrianjafy, T; De Santi, O				Ravinetto, R.; Cloez, S.; Massat, P.; Luyckx, C.; Andrianjafy, T.; De Santi, O.			Market-driven mechanisms may improve the quality of medicines and increase patients protection in insufficiently-regulated contexts	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ravinetto, R.] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Cloez, S.; Massat, P.; Luyckx, C.] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium								0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2013	18			1	SI		45	45						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	213BS	WOS:000324029000112					2019-04-02	
J	Shio, MT; Paquet, M; Martel, C; Stienstra, S; Jansen, H; Olivier, M; Fortin, A				Shio, M. T.; Paquet, M.; Martel, C.; Stienstra, S.; Jansen, H.; Olivier, M.; Fortin, A.			Drug delivery by tattooing to treat cutaneous leishmaniasis	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Shio, M. T.; Martel, C.; Olivier, M.] McGill Univ, Dept Med, Ctr Study Host Resistance, Hlth Ctr,Res Inst, Montreal, PQ, Canada; [Shio, M. T.; Martel, C.; Olivier, M.] McGill Univ, Dept Microbiol & Immunol, Ctr Study Host Resistance, Hlth Ctr,Res Inst, Montreal, PQ, Canada; [Paquet, M.] McGill Univ, Comparat Med & Anim Resources Ctr, Montreal, PQ, Canada; [Stienstra, S.] MT Derm, Berlin, Germany; [Jansen, H.; Fortin, A.] Dafra Pharma Res & Dev, Turnhout, Belgium; [Fortin, A.] McGill Univ, Dept Biochem, Montreal, PQ, Canada								0	0	0	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2013	18			1	SI		60	61						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	213BS	WOS:000324029000153					2019-04-02	
J	de Gier, B; Ponce, MC; van de Bor, M; Doak, CM; Polman, K				de Gier, B.; Ponce, M. C.; van de Bor, M.; Doak, C. M.; Polman, K.			Helminth infections and micronutrients in schoolchildren: a systematic review and meta-analysis	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[de Gier, B.; Ponce, M. C.; Doak, C. M.; Polman, K.] Vrije Univ Amsterdam, Infect Dis Sect, Dept Hlth Sci, Amsterdam, Netherlands; [de Gier, B.; van de Bor, M.] Vrije Univ Amsterdam, Sect Hlth & Life Sci, Dept Hlth Sci, Amsterdam, Netherlands; [Polman, K.] Inst Trop Med Prince Leopold, Dept Biomed Sci, B-2000 Antwerp, Belgium								0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2013	18			1	SI		62	62						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	213BS	WOS:000324029000157					2019-04-02	
J	Mekonnen, Z; Meka, S; Ayana, M; Bogers, J; Vercruysse, J; Levecke, B				Mekonnen, Z.; Meka, S.; Ayana, M.; Bogers, J.; Vercruysse, J.; Levecke, B.			Comparison of individual and pooled stool samples for the assessment of soil-transmitted helminth infection intensity and drug efficacy	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mekonnen, Z.; Meka, S.; Ayana, M.] Jimma Univ, Jimma, Ethiopia; [Mekonnen, Z.; Vercruysse, J.; Levecke, B.] Univ Ghent, Merelbeke, Belgium; [Bogers, J.] Univ Antwerp, B-2020 Antwerp, Belgium				Bogers, John-Paul/0000-0001-9107-132X				0	0	0	0	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2013	18			1	SI		63	63						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	213BS	WOS:000324029000159					2019-04-02	
J	Rosanas-Urgell, A; Kattenberg, JH; Lin, E; Robinson, L; Rarau, P; Seen, N; Manning, L; Laman, M; Siba, P; Michon, P; Mueller, I				Rosanas-Urgell, A.; Kattenberg, J. H.; Lin, E.; Robinson, L.; Rarau, P.; Seen, N.; Manning, L.; Laman, M.; Siba, P.; Michon, P.; Mueller, I.			Erythrocyte polymorphisms associated with protection against P. vivax malaria in Papua New Guinea children	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Rosanas-Urgell, A.] Inst Trop Med, B-2000 Antwerp, Belgium; [Rosanas-Urgell, A.; Kattenberg, J. H.; Lin, E.; Robinson, L.; Rarau, P.; Seen, N.; Laman, M.; Siba, P.] Papua New Guinea Inst Med Res, Madang, Papua N Guinea; [Kattenberg, J. H.; Robinson, L.; Mueller, I.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Manning, L.; Laman, M.] Univ Western Australia, Perth, WA 6009, Australia; [Michon, P.] Divine Word Univ, Madang, Papua N Guinea; [Mueller, I.] Univ Barcelona, Barcelona Ctr Int Hlth Res, Hosp Clin, Barcelona, Spain								0	0	0	1	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2013	18			1	SI		64	64						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	213BS	WOS:000324029000162					2019-04-02	
J	Thriemer, K; Van Nguyen, H; Phuc, BQ; Ha, DM; Duong, TT; Rosanas-Urgell, A; d'Alessandro, U; Erhart, A				Thriemer, K.; Van Nguyen, H.; Phuc, B. Q.; Ha, D. M.; Duong, T. T.; Rosanas-Urgell, A.; d'Alessandro, U.; Erhart, A.			Delayed parasite clearance after treatment with dihydroartemisinin-piperaquine in Plasmodium falciparum malaria patients in Central Vietnam	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Thriemer, K.; Rosanas-Urgell, A.; d'Alessandro, U.; Erhart, A.] Inst Trop Med, B-2000 Antwerp, Belgium; [Van Nguyen, H.; Phuc, B. Q.; Ha, D. M.; Duong, T. T.] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam; [d'Alessandro, U.] MRC Unit Fajara, Dis Control & Eliminat Theme, Fajara, Gambia			D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009				0	1	1	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2013	18			1	SI		66	66						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	213BS	WOS:000324029000169					2019-04-02	
J	Njunju, E; Mwakazanga, D; Manyando, C; Chongwe, G; Van Geertruyden, JP				Njunju, E.; Mwakazanga, D.; Manyando, C.; Chongwe, G.; Van Geertruyden, J. -P.			Sulfadoxine pyrimethamine for malaria prophylaxis among antenatal care mothers in Zambia: an observational study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Njunju, E.; Mwakazanga, D.; Manyando, C.; Chongwe, G.] Trop Dis Res Ctr, Ndola, Zambia; [Van Geertruyden, J. -P.] Univ Antwerp, Antwerp, Belgium			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2013	18			1	SI		68	68						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	213BS	WOS:000324029000176					2019-04-02	
J	Ratto, CD; Soto-Calle, VE; Van den Eede, P; Gamboa, D; Rosas, A; Abatih, EN; Llanos-Cuentas, A; Van Geertruyden, JP; Erhart, A; D'Alessandro, U				Ratto, C. D.; Soto-Calle, V. E.; Van den Eede, P.; Gamboa, D.; Rosas, A.; Abatih, E. N.; Llanos-Cuentas, A.; Van Geertruyden, J. -P.; Erhart, A.; D'Alessandro, U.			Spatio-temporal clustering of clonal parasites in recurrent vivax malaria infections after radical cure treatment in the Peruvian Amazon	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ratto, C. D.; Van Geertruyden, J. -P.] Univ Antwerp, Antwerp, Belgium; [Van den Eede, P.; Rosas, A.; Abatih, E. N.; Erhart, A.; D'Alessandro, U.] Inst Trop Med Antwerp, Antwerp, Belgium			D'Alessandro, Umberto/D-3457-2015; Van geertruyden, Jean-Pierre/K-6425-2014	D'Alessandro, Umberto/0000-0001-6341-5009; Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2013	18			1	SI		72	72						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	213BS	WOS:000324029000187					2019-04-02	
J	Grietens, KP; Ribera, JM; Erhart, A; Hoiback, S; Ravinetto, R; Gryseels, C; Dierickx, S; O'Neill, S; Hausmann, S; Umberto, D				Grietens, K. P.; Ribera, J. M.; Erhart, A.; Hoiback, S.; Ravinetto, R.; Gryseels, C.; Dierickx, S.; O'Neill, S.; Hausmann, S.; Umberto, D.			Doctors and vampires in Sub-Saharan Africa: ethical challenges in clinical trial research	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Grietens, K. P.; Erhart, A.; Ravinetto, R.; Gryseels, C.; Dierickx, S.; O'Neill, S.] Inst Trop Med, Deprtment Clin Sci, B-2000 Antwerp, Belgium; Univ Louvain, Louvain, Belgium								0	0	0	0	42	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276			TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2013	18			1	SI		81	81						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	213BS	WOS:000324029000211					2019-04-02	
